PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Floor, SN; Condon, KJ; Sharma, D; Jankowsky, E; Doudna, JA				Floor, Stephen N.; Condon, Kendall J.; Sharma, Deepak; Jankowsky, Eckhard; Doudna, Jennifer A.			Autoinhibitory Interdomain Interactions and Subfamily-specific Extensions Redefine the Catalytic Core of the Human DEAD-box Protein DDX3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA HELICASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BINDING PROTEIN; TRANSLATION; YEAST; MUTATIONS; REVEALS; DED1	DEAD-box proteins utilize ATP to bind and remodel RNA and RNA-protein complexes. All DEAD-box proteins share a conserved core that consists of two RecA-like domains. The core is flanked by subfamily-specific extensions of idiosyncratic function. The Ded1/DDX3 subfamily of DEAD-box proteins is of particular interest as members function during protein translation, are essential for viability, and are frequently altered in human malignancies. Here, we define the function of the subfamily-specific extensions of the human DEAD-box protein DDX3. We describe the crystal structure of the subfamily-specific core of wild-typeDDX3 at 2.2 angstrom resolution, alone and in the presence of AMP or nonhydrolyzable ATP. These structures illustrate a unique interdomain interaction between the two ATPase domains in which the C-terminal domain clashes with the RNA-binding surface. Destabilizing this interaction accelerates RNA duplex unwinding, suggesting that it is present in solution and inhibitory for catalysis. We use this core fragment of DDX3 to test the function of two recurrent medulloblastoma variants of DDX3 and find that both inactivate the protein in vitro and in vivo. Taken together, these results redefine the structural and functional core of the DDX3 subfamily of DEAD-box proteins.	[Floor, Stephen N.; Condon, Kendall J.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 708A Stanley Hall, Berkeley, CA 94720 USA; [Floor, Stephen N.; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Sharma, Deepak; Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Sharma, Deepak; Jankowsky, Eckhard] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Case Western Reserve University; Case Western Reserve University	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 708A Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Sharma, Deepak/GPT-1692-2022	Jankowsky, Eckhard/0000-0001-7677-7412; /0000-0002-9515-8892; Sharma, Deepak/0000-0001-8436-1759; Floor, Stephen/0000-0002-9965-9694	University of California Office of the President, Multicampus Research Programs and Initiatives Grant [MR-15-328599]; Program for Breakthrough Biomedical Research - Sandler Foundation; NIGMS National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R35GM118088, R01GM099720, P41GM103311] Funding Source: NIH RePORTER	University of California Office of the President, Multicampus Research Programs and Initiatives Grant(University of California System); Program for Breakthrough Biomedical Research - Sandler Foundation; NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Angie Hilliker and the lab of Jasper Rine for help with the yeast experiments and for sharing yeast strains, Kaihong Zhou and Alison Smith for early protein characterization, Yoon-Jae Cho for advice regarding the medulloblastoma variants, and Yun Bai for critical reading of the manuscript. Structural data were collected at Beamline 8.3.1 of the Advanced Light Source at the Lawrence Berkeley National Laboratory, which acknowledges support from the University of California Office of the President, Multicampus Research Programs and Initiatives Grant MR-15-328599, and the Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. Molecular dynamics starting models were preprocessed with the UCSF Chimera package, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS National Institutes of Health Grant P41-GM103311).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banroques J, 2011, J MOL BIOL, V413, P451, DOI 10.1016/j.jmb.2011.08.032; Bol GM, 2015, EMBO MOL MED, V7, P648, DOI 10.15252/emmm.201404368; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Buchwald G, 2013, P NATL ACAD SCI USA, V110, pE4611, DOI 10.1073/pnas.1314684110; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epling LB, 2015, J MOL BIOL, V427, P1779, DOI 10.1016/j.jmb.2015.02.015; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Hubstenberger A, 2013, DEV CELL, V27, P161, DOI 10.1016/j.devcel.2013.09.024; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacewicz A, 2014, NUCLEIC ACIDS RES, V42, P12885, DOI 10.1093/nar/gku930; Jankowsky E, 2010, METHODS MOL BIOL, V587, P245, DOI 10.1007/978-1-60327-355-8_18; Jiang L, 2015, NAT GENET, V47, P1061, DOI 10.1038/ng.3358; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Lai MC, 2016, FEBS J, V283, P88, DOI 10.1111/febs.13553; Lai MC, 2010, MOL CELL BIOL, V30, P5444, DOI 10.1128/MCB.00560-10; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Ohnishi S, 2009, PROTEINS, V74, P133, DOI 10.1002/prot.22138; Ojha J, 2015, BRIT J HAEMATOL, V169, P445, DOI 10.1111/bjh.13211; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Putnam AA, 2015, MOL CELL, V59, P541, DOI 10.1016/j.molcel.2015.06.030; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Sen ND, 2015, GENOME RES, V25, P1196, DOI 10.1101/gr.191601.115; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Senissar M, 2014, NUCLEIC ACIDS RES, V42, P10005, DOI 10.1093/nar/gku584; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Shih JW, 2012, BIOCHEM J, V441, P119, DOI 10.1042/BJ20110739; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tarn WY, 2009, RNA BIOL, V6, P17, DOI 10.4161/rna.6.1.7440; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zhang ZM, 2013, CELL REP, V5, P1269, DOI 10.1016/j.celrep.2013.10.047	63	40	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2412	2421		10.1074/jbc.M115.700625	http://dx.doi.org/10.1074/jbc.M115.700625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26598523	Green Published, hybrid			2022-12-26	WOS:000369610400030
J	Barnwal, B; Karlberg, H; Mirazimi, A; Tan, YJ				Barnwal, Bhaskar; Karlberg, Helen; Mirazimi, Ali; Tan, Yee-Joo			The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUS; CELL-DEATH; NSS PROTEIN; INTERFERON; INDUCTION; COUNTERACTS; CASPASES; PATHWAYS; PATHOGENESIS; INHIBITORS	Viruses have developed distinct strategies to overcome the host defense system. Regulation of apoptosis in response to viral infection is important for virus survival and dissemination. Like other viruses, Crimean-Congo hemorrhagic fever virus (CCHFV) is known to regulate apoptosis. This study, for the first time, suggests that the non-structural protein NSs of CCHFV, a member of the genus Nairovirus, induces apoptosis. In this report, we demonstrated the expression of CCHFV NSs, which contains 150 amino acid residues, in CCHFV-infected cells. CCHFV NSs undergoes active degradation during infection. We further demonstrated that ectopic expression of CCHFV NSs induces apoptosis, as reflected by caspase-3/7 activity and cleaved poly(ADP-ribose) polymerase, in different cell lines that support CCHFV replication. Using specific inhibitors, we showed that CCHFV NSs induces apoptosis via both intrinsic and extrinsic pathways. The minimal active region of the CCHFV NSs protein was determined to be 93-140 amino acid residues. Using alanine scanning, we demonstrated that Leu-127 and Leu-135 are the key residues for NSs-induced apoptosis. Interestingly, CCHFV NSs co-localizes in mitochondria and also disrupts the mitochondrial membrane potential. We also demonstrated that Leu-127 and Leu-135 are important residues for disruption of the mitochondrial membrane potential by NSs. Therefore, these results indicate that the C terminus of CCHFV NSs triggers mitochondrial membrane permeabilization, leading to activation of caspases, which, ultimately, leads to apoptosis. Given that multiple factors contribute to apoptosis during CCHFV infection, further studies are needed to define the involvement of CCHFV NSs in regulating apoptosis in infected cells.	[Barnwal, Bhaskar; Tan, Yee-Joo] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 117548, Singapore; [Barnwal, Bhaskar] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Karlberg, Helen; Mirazimi, Ali] Publ Hlth Agcy Sweden, S-17182 Solna, Sweden; [Mirazimi, Ali] Karolinska Inst, S-17177 Stockholm, Sweden; [Mirazimi, Ali] Natl Vet Inst, S-75651 Uppsala, Sweden	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Public Health Agency of Sweden; Karolinska Institutet; National Veterinary Institute SVA	Tan, YJ (corresponding author), MD4,5 Sci Dr,2, Singapore 117597, Singapore.	Yee_Joo_TAN@NUHS.edu.sg		Tan, Yee-Joo/0000-0002-2278-4497; , Ali/0000-0003-2371-6055	NUS/NUHS [R-182-000-156-720, R-182-000-156-133]; Agency for Science, Technology, and Research	NUS/NUHS; Agency for Science, Technology, and Research(Agency for Science Technology & Research (A*STAR))	This work was supported by NUS/NUHS Startup Grants R-182-000-156-720 and R-182-000-156-133 (to Y. J. T.) and intramural funds from the Agency for Science, Technology, and Research. The authors declare that they have no conflicts of interest with the contents of this article.	Andersson I, 2004, J MED VIROL, V72, P83, DOI 10.1002/jmv.10560; Aweya JJ, 2013, VIRUS RES, V172, P24, DOI 10.1016/j.virusres.2012.12.005; Barry G, 2014, J GEN VIROL, V95, P1640, DOI 10.1099/vir.0.065425-0; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Blakqori G, 2005, J VIROL, V79, P10420, DOI 10.1128/JVI.79.16.10420-10428.2005; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; FULLER F, 1982, J VIROL, V41, P643, DOI 10.1128/JVI.41.2.643-648.1982; Gaddy DF, 2005, J VIROL, V79, P4170, DOI 10.1128/JVI.79.7.4170-4179.2005; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hewson R, 2004, VIRUS RES, V102, P185, DOI 10.1016/j.virusres.2003.12.035; Irusta PM, 2003, CURR OPIN CELL BIOL, V15, P700, DOI 10.1016/j.ceb.2003.10.007; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karlberg H, 2015, J GEN VIROL, V96, P538, DOI 10.1099/jgv.0.000011; Karlberg H, 2011, J BIOL CHEM, V286, P3227, DOI 10.1074/jbc.M110.149369; Keshtkar-Jahromi M, 2011, ANTIVIR RES, V90, P85, DOI 10.1016/j.antiviral.2011.02.010; Kohl A, 2003, J VIROL, V77, P7999, DOI 10.1128/JVI.77.14.7999-8008.2003; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Li GY, 2010, MICROBIOL IMMUNOL, V54, P20, DOI 10.1111/j.1348-0421.2009.00178.x; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Narayanan A, 2014, VIROLOGY, V449, P270, DOI 10.1016/j.virol.2013.11.023; Nomura-Takigawa Y, 2006, J GEN VIROL, V87, P1935, DOI 10.1099/vir.0.81701-0; Rodrigues R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029712; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Tan YX, 2007, J VIROL, V81, P6346, DOI 10.1128/JVI.00090-07; Tan ZH, 2010, J MED VIROL, V82, P467, DOI 10.1002/jmv.21709; TARODI B, 1994, VIROLOGY, V201, P404, DOI 10.1006/viro.1994.1309; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Terasaki K, 2013, J VIROL, V87, P676, DOI 10.1128/JVI.02192-12; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; van Knippenberg I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064137; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Xu FL, 2008, J GEN VIROL, V89, P2175, DOI 10.1099/vir.0.2008/001644-0	46	45	46	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					582	592		10.1074/jbc.M115.667436	http://dx.doi.org/10.1074/jbc.M115.667436			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26574543	Green Published, hybrid			2022-12-26	WOS:000367830500007
J	Schmidt, RL; Straseski, JA; Raphael, KL; Adams, AH; Lehman, CM				Schmidt, Robert L.; Straseski, Joely A.; Raphael, Kalani L.; Adams, Austin H.; Lehman, Christopher M.			A Risk Assessment of the Jaffe vs Enzymatic Method for Creatinine Measurement in an Outpatient Population	PLOS ONE			English	Article							KIDNEY-DISEASE; RENAL-DISEASE; EQUATION; TIME	Background The Jaffe and enzymatic methods are the two most common methods for measuring serum creatinine. The Jaffe method is less expensive than the enzymatic method but is also more susceptible to interferences. Interferences can lead to misdiagnosis but interferences may vary by patient population. The overall risk associated with the Jaffe method depends on the probability of misclassification and the consequences of misclassification. This study assessed the risk associated with the Jaffe method in an outpatient population. We analyzed the discordance rate in the estimated glomerular filtration rate based on serum creatinine measurements obtained by the Jaffe and enzymatic method. Methods Method comparison and risk analysis. Five hundred twenty-nine eGFRs obtained by the Jaffe and enzymatic method were compared at four clinical decision limits. We determined the probability of discordance and the consequence of misclassification at each decision limit to evaluate the overall risk. Results We obtained 529 paired observations. Of these, 29 (5.5%) were discordant with respect to one of the decision limits (i.e. 15, 30, 45 or 60 ml/min/1.73m(2)). The magnitude of the differences (Jaffe result minus enzymatic result) were significant relative to analytical variation in 21 of the 29 (72%) of the discordant results. The magnitude of the differences were not significant relative to biological variation. The risk associated with misclassification was greatest at the 60 ml/min/1.73m(2) decision limit because the probability of misclassification and the potential for adverse outcomes were greatest at that decision limit. Conclusion The Jaffe method is subject to bias due to interfering substances ( loss of analytical specificity). The risk of misclassification is greatest at the 60 ml/min/1.73m(2) decision limit; however, the risk of misclassification due to bias is much less than the risk of misclassification due to biological variation. The Jaffe method may pose low risk in selected populations if eGFR results near the 60 ml/min/1.73m(2) decision limit are interpreted with caution.	[Schmidt, Robert L.; Straseski, Joely A.; Adams, Austin H.; Lehman, Christopher M.] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA; [Schmidt, Robert L.; Straseski, Joely A.; Adams, Austin H.; Lehman, Christopher M.] Univ Utah, Hlth Sci Ctr, ARUP Labs, Salt Lake City, UT USA; [Raphael, Kalani L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Div Nephrol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Schmidt, RL (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA.	Robert.Schmidt@hsc.utah.edu		Raphael, Kalani/0000-0002-1378-2609				Badrick T, 2013, INDIAN J CLIN BIOCHE, V28, P242, DOI 10.1007/s12291-012-0280-1; Cobbaert CM, 2009, CLIN CHEM, V55, P549, DOI 10.1373/clinchem.2008.116863; College of American Pathologists, 2014, CHEM THER MON PART S; Drion I, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-133; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fraser CG, 2001, BIOL VARIATION PRINC; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Greenberg N, 2012, CLIN CHEM, V58, P391, DOI 10.1373/clinchem.2011.172288; Horvath AR, 2014, CLIN CHIM ACTA, V427, P49, DOI 10.1016/j.cca.2013.09.018; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Killeen AA, 2013, ARCH PATHOL LAB MED, V137, P496, DOI 10.5858/arpa.2012-0134-CP; Klee GG, 2007, CLIN CHEM LAB MED, V45, P737, DOI 10.1515/CCLM.2007.168; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Myers GL, 2008, SCAND J CLIN LAB INV, V68, P57, DOI 10.1080/00365510802149887; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Panteghini M, 2008, SCAND J CLIN LAB INV, V68, P84, DOI 10.1080/00365510802149978; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Qiu L, 2013, CLIN LAB, V59, P511, DOI 10.7754/Clin.Lab.2012.120524; Reinhard M, 2009, SCAND J CLIN LAB INV, V69, P931, DOI 10.3109/00365510903307947; Schmidt RL, 2015, CLIN CHIM ACTA, V440, P23, DOI 10.1016/j.cca.2014.10.043; Selvin E, 2013, AM J KIDNEY DIS, V61, P716, DOI 10.1053/j.ajkd.2012.11.048; Sim JJ, 2015, AM J MED; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Tholen DW, 2004, EP5A2 CLSI, V24, P25; Yoe C., 2011, PRIMER ON RISK ANALY, P1	27	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143205	10.1371/journal.pone.0143205	http://dx.doi.org/10.1371/journal.pone.0143205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599086	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600037
J	Goncalves, L; Santos, Z; Amado, M; Alves, D; Simoes, R; Delgado, AP; Correia, A; Cabral, J; Lapao, LV; Craveiro, I				Goncalves, Luzia; Santos, Zelia; Amado, Miguel; Alves, Daniela; Simoes, Rui; Delgado, Antonio Pedro; Correia, Artur; Cabral, Jorge; Lapao, Luis Velez; Craveiro, Isabel			Urban Planning and Health Inequities: Looking in a Small-Scale in a City of Cape Verde	PLOS ONE			English	Article							SOCIAL DETERMINANTS; PHYSICAL-ACTIVITY; CARDIOMETABOLIC RISK; BINOMIAL PROPORTION; BUILT ENVIRONMENT; SAMPLE-SIZE; OBESITY; ASSOCIATION; WEIGHT; POPULATIONS	Background The lack of high-quality data to support evidence-based policies continues to be a concern in African cities, which present marked social, economic and cultural disparities that may differently impact the health of the groups living in different urban contexts. This study explores three urban units-formal, transition and informal-of the capital of Cape Verde, in terms of overweight/obesity, cardiometabolic risk, physical activity and other aspects related to the urban environment. Methods Quantitative and qualitative research methods were used in this intra-urban study. A proportional stratified random sample (n = 1912 adults), based on geographical coordinates of private households, was selected to apply the UPHI-STAT questionnaire. In a second stage (n = 599), local nutritionists collected anthropometric measurements (e.g., height, waist circumference) and body composition by bioelectric impedance (e.g., body weight, body fat, muscle mass). In a third stage, pedometers were used to count study participants' steps on working and non-working days for one week (n = 118). After a preliminary statistical analysis, a qualitative study was developed to complement the quantitative approach. Generalized linear models, among others, were used in the multivariate analysis. Results Insecurity was the main concern among survey respondents in the three units, notwithstanding with significant differences (p < 0.001) among units. About three-quarters (76.6%) of the participants of the informal unit emphasised the need for more security. The formal unit presents an older age structure (61.3% above 40 years old) and the transition unit a younger age structure (only 30.5% above 40 years old). Some health-related variables were analysed in each unit, revealing an excess of chronic conditions reported by inhabitants of informal unit, compared with the formal unit despite the informal unit's younger age profile. The self-reported hypertension varied significantly among urban units (p < 0.001), with 19.3% in the formal unit, 11.4% in the transition unit and 22.5% in the informal unit. Women of the urban units present significant differences (5% level) for body mass index calculated from self-reported measures (p < 0.001), fat mass (p = 0.005), waist circumference (p = 0.046) and waist-to-height ratio (p = 0.017). For women, overall physical activity was 67.4% (95%CI [64.8,70.0]), with differences among urban units (p = 0.025). For men it was of 85.2% (95%CI [82.3,87.6]), without significant differences among urban units (p = 0.266). The percentage of women and men who reported physical activity in leisure time was discrepant, with 95%CI [22.6, 27.4] and [53.2, 60.2], respectively. The results of pedometers also indicated that men walk significantly more than women (p < 0.001), with a difference of approximately 2000 steps/day. Conclusions The data collection process itself also gave us some clues on the involvement of local communities, exploring the potential of social capital of these settings and the role of the woman in family and society in Cape Verde. The higher participation of women and residents of informal unit (the most disadvantaged groups) suggests these as the priority target groups for health promotion campaigns. The link between health planning, urban planning and security of the city needs to be reinforced to minimize health, social and gender inequalities.	[Goncalves, Luzia; Santos, Zelia; Alves, Daniela; Simoes, Rui; Delgado, Antonio Pedro; Correia, Artur; Cabral, Jorge; Lapao, Luis Velez; Craveiro, Isabel] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Saude Publ Int & Bioestat, P-1200 Lisbon, Portugal; [Goncalves, Luzia] Univ Lisbon, Ctr Estat & Aplicacoes, P-1699 Lisbon, Portugal; [Santos, Zelia] Hosp Egas Moniz, Ctr Hosp Lisboa Ocidental EPE, Serv Nutr & Dietet, Lisbon, Portugal; [Amado, Miguel] Univ Nova Lisboa, Fac Ciencias, GEOTPU, Costa Da Caparica, Portugal; [Delgado, Antonio Pedro] Minist Saude, Direccao Nacl Saude, Praia, Cabo Verde, Chile; [Correia, Artur] Minist Saude, Inst Nacl Saude Publ, Praia, Cabo Verde, Chile; [Lapao, Luis Velez; Craveiro, Isabel] IHMT UNL, Global Hlth & Trop Med, Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Egas Moniz Hospital; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL	Goncalves, L (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Saude Publ Int & Bioestat, P-1200 Lisbon, Portugal.	luziag@ihmt.unl.pt	Amado, Miguel/A-9721-2013; Gonçalves, Luzia/J-6649-2012; Lapão, Luis V/E-8465-2011; Craveiro, Isabel/J-4117-2012; Alves, Daniela Amaral/AAI-4117-2020	Amado, Miguel/0000-0002-9152-4226; Gonçalves, Luzia/0000-0002-9710-1945; Lapão, Luis V/0000-0003-0506-1294; Craveiro, Isabel/0000-0003-4348-1986; Alves, Daniela Amaral/0000-0001-6709-0504; Santos, Zelia/0000-0001-9806-5854	Fundacao para a Ciencia e Tecnologia (FCT)-Portugal [PTDC/ATP-EUR/5074/2012, PEst-OE/MAT/UI0006/2014]	Fundacao para a Ciencia e Tecnologia (FCT)-Portugal(Portuguese Foundation for Science and Technology)	This work has been supported by Fundacao para a Ciencia e Tecnologia (FCT)-Portugal-projects PTDC/ATP-EUR/5074/2012 and PEst-OE/MAT/UI0006/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801; Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Akesson L, 2012, J ETHN MIGR STUD, V38, P237, DOI 10.1080/1369183X.2012.646420; Amado M, 2014, PTDCATPEUR50742012 I; Amado M, 2014, ENRGY PROCED, V50, P277, DOI 10.1016/j.egypro.2014.06.034; Azevedo V., 2009, 1 JORN LUS CARD SOC; Bowring AL, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-175; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Carpiano RM, 2008, SOC SCI MED, V67, P568, DOI 10.1016/j.socscimed.2008.04.017; Cook I, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-7; Corburn J., 2013, PLANNING HIST ENV SE; Corburn J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001285; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Dehghan M, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-26; Dorsey RR, 2009, OBESITY, V17, P790, DOI 10.1038/oby.2008.603; Doulougou B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-893; Drotbohm H, 2009, HIST FAM, V14, P132, DOI 10.1016/j.hisfam.2009.02.002; Durand CP, 2011, OBES REV, V12, pe173, DOI 10.1111/j.1467-789X.2010.00826.x; El Ati J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048153; Escritorio Regional Africano-OMS, 2009, ESTR COOP ORG MUND S; Fosgate GT, 2009, J VET DIAGN INVEST, V21, P3, DOI 10.1177/104063870902100102; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Goncalves L, 2012, J APPL STAT, V39, P2453, DOI 10.1080/02664763.2012.713919; INE CV, 2010, POP COND VID; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kjellstrom T, 2008, ENVIRON URBAN, V20, P551, DOI 10.1177/0956247808096128; Lang Z, 2014, PREV VET MED, V113, P13, DOI 10.1016/j.prevetmed.2013.09.015; Leyden KM, 2003, AM J PUBLIC HEALTH, V93, P1546, DOI 10.2105/AJPH.93.9.1546; Madeira SLR, 2008, ANNOTATED BIBLIO RES; Malhotra R, 2008, S AFR J CLIN NUTR, V21, P315; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McGinn AP, 2008, J PHYS ACT HEALTH, V5, P117, DOI 10.1123/jpah.5.1.117; Mendes MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108136; Moges B, 2014, BMC CARDIOVASC DISOR, V14, pi2; Molata A, 2014, DIABETES CARE, V34, pi1032; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ngau P., 2013, TOWN COUNTRY NEW APP; Nicolaou M, 2012, EUR J PUBLIC HEALTH, V22, P859, DOI 10.1093/eurpub/ckr155; Northridge ME, 2011, J URBAN HEALTH, V88, P582, DOI 10.1007/s11524-011-9558-5; Ompad DC, 2007, J URBAN HEALTH, V84, pI42, DOI 10.1007/s11524-007-9168-4; Oyeyemi AL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-32; Pillay JD, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1381-6; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; R Core Team, 2021, R LANGUAGE ENV STAT; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; Rodrigues L, 2013, CONHECIMENTOS ATITUD; Roux AVD, 2007, REV EPIDEMIOL SANTE, V55, P13, DOI 10.1016/j.respe.2006.12.003; Sallis JF, 2012, CIRCULATION, V125, P729, DOI 10.1161/CIRCULATIONAHA.110.969022; Sergeant E.S.G, 2015, EPITOOLS EPIDEMIOLOG; Tomita A, 2013, J AFFECT DISORDERS, V144, P101, DOI 10.1016/j.jad.2012.05.066; UN Habitat, 2014, STAT AFR CIT 2014 RE; Unger A, 2007, PLOS MED, V4, P1561, DOI 10.1371/journal.pmed.0040295; Unit Nations, 2012, MILL DEV GOALS REP; United Nations-Office on Drugs and Crime, 2007, STUD CRIM CORR CAP V; Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3; Wan CS, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-249; Ware LJ, 2014, NUTR METAB CARDIOVAS, V24, P900, DOI 10.1016/j.numecd.2014.02.005; WHO, 2011, NCD COUNTR PROF; WHO, 2008, WAIST CIRCUMFERENCE; WHO, 2010, HIDD CIT UNM OV HLTH; WHO, 2014, NCD COUNTR PROF; World Health Organisation, 2004, WHO TECHN REP SER; World Health Organization, 2008, OUR CITIES OUR HLTH; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]; Zoettl PA, 2014, INT J CULTURAL STUD, V18, P1	68	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142955	10.1371/journal.pone.0142955	http://dx.doi.org/10.1371/journal.pone.0142955			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7AW	26599004	gold, Green Published			2022-12-26	WOS:000365853900049
J	Shen, YT; Chen, H; Zhang, JS; Chen, YM; Wang, MY; Ma, JW; Hong, L; Liu, N; Fan, QH; Lu, XG; Tian, Y; Wang, AD; Dong, J; Lan, Q; Huang, Q				Shen, Yuntian; Chen, Hua; Zhang, Jinshi; Chen, Yanming; Wang, Mengyao; Ma, Jiawei; Hong, Lei; Liu, Ning; Fan, Qiuhong; Lu, Xueguan; Tian, Ye; Wang, Aidong; Dong, Jun; Lan, Qing; Huang, Qiang			Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/Progenitor Cells	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; STEM-CELLS; NUDE-MICE; GROWTH; RADIATION; BLOCKADE	Background Host malignant stromal cells induced by glioma stem/progenitor cells were revealed to be more radiation-resistant than the glioma stem/progenitor cells themselves after malignant transformation in nude mice. However, the mechanism underlying this phenomenon remains unclear. Methods Malignant stromal cells induced by glioma stem/progenitor cell 2 (GSC-induced host brain tumor cells, ihBTC2) were isolated and identified from the double color-coded orthotopic glioma nude mouse model. The survival fraction at 2 Gy (SF2) was used to evaluate the radiation resistance of ihBTC2, the human glioma stem/progenitor cell line SU3 and its radiation resistant sub-strain SU3-5R and the rat C6 glioma cell line. The mRNA of Notch 1 and Hes1 from ihBTC2 cells were detected using qPCR before and after 4 Gy radiation. The expression of the Notch 1, pAkt and Bcl-2 proteins were investigated by Western blot. To confirm the role of the Notch pathway in the radiation resistance of ihBTC2, Notch signaling blocker gamma secretase inhibitors (GSIs) were used. Results The ihBTC2 cells had malignant phenotypes, such as infinite proliferation, hyperpentaploid karyotype, tumorigenesis in nude mice and expression of protein markers of oligodendroglia cells. The SF2 of ihBTC2 cells was significantly higher than that of any other cell line (P<0.05, n = 3). The expression of Notch 1 and Hes1 mRNAs from ihBTC2 cells was significantly increased after radiation. Moreover, the Notch 1, pAkt and Bcl-2 proteins were significantly increased after radiation (P<0.05, n = 3). Inhibition of Notch signaling markedly enhanced the radiosensitivity of ihBTC2 cells. Conclusions In an orthotopic glioma model, the malignant transformation of host stromal cells was induced by glioma stem/progenitor cells. IhBTC2 cells are more radiation-resistant than the glioma stem/progenitor cells, which may be mediated by activation of the Notch signaling pathway.	[Zhang, Jinshi; Chen, Yanming; Ma, Jiawei; Dong, Jun; Lan, Qing; Huang, Qiang] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China; [Shen, Yuntian; Wang, Mengyao; Fan, Qiuhong; Lu, Xueguan; Tian, Ye] Soochow Univ, Affiliated Hosp 2, Dept Radiotherapy & Oncol, Suzhou, Peoples R China; [Shen, Yuntian; Wang, Mengyao; Fan, Qiuhong; Lu, Xueguan; Tian, Ye] Soochow Univ, Inst Radiotherapy & Oncol, Suzhou, Peoples R China; [Shen, Yuntian; Wang, Mengyao; Fan, Qiuhong; Lu, Xueguan; Tian, Ye] Suzhou Key Lab Radiat Oncol, Suzhou, Peoples R China; [Hong, Lei; Wang, Aidong] Soochow Univ, Affiliated Hosp 2, Lab Ctr, Suzhou, Peoples R China; [Chen, Hua] Nanjing Med Univ, Nanjing Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Chen, Hua; Liu, Ning] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Nanjing Medical University; Nanjing Medical University	Dong, J (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China.	djdongjun@163.com; szlq006@163.com	Dong, Jun/R-3857-2019	Dong, Jun/0000-0002-0026-6680	National Natural Science Foundation of China [81172400, 81302180, 81472739]; Suzhou Science and Technology Development Program [SYSD2013087]; Jiangsu Provincial Special Program of Clinical Medical Science [BL2014040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Science and Technology Development Program; Jiangsu Provincial Special Program of Clinical Medical Science	This study was supported by grants from the National Natural Science Foundation of China (grant nos. 81172400, 81302180, 81472739), the Suzhou Science and Technology Development Program (no. SYSD2013087) and the Jiangsu Provincial Special Program of Clinical Medical Science (BL2014040).	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bourzac K, 2014, NATURE, V509, pS69, DOI 10.1038/509S69a; Chakraborty A, 2004, BONE MARROW TRANSPL, V34, P183, DOI 10.1038/sj.bmt.1704547; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chen H, 2011, BRAIN TUMORS CURRENT, P3; Chen PW, 2011, CLIN CANCER RES, V17, P7230, DOI 10.1158/1078-0432.CCR-11-1354; Dong J, 2012, CHINESE MED J-PEKING, V125, P4349, DOI 10.3760/cma.j.issn.0366-6999.2012.24.006; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; GOLDENBERG DM, 1981, SCIENCE, V212, P65, DOI 10.1126/science.7209521; Haase-Kohn C, 2014, BIOCHEM BIOPH RES CO, V446, P143, DOI 10.1016/j.bbrc.2014.02.126; Harris PS, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-80; Mantoni TS, 2011, CANCER RES, V71, P3453, DOI 10.1158/0008-5472.CAN-10-1633; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Papadopoulou A, 2011, INT J ONCOL, V39, P989, DOI 10.3892/ijo.2011.1132; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saito N, 2014, STEM CELLS, V32, P301, DOI 10.1002/stem.1528; Tsai CS, 2007, INT J RADIAT ONCOL, V68, P499, DOI 10.1016/j.ijrobp.2007.01.041; Wan Y, 2012, CHIN J CANCER, V31, P207, DOI 10.5732/cjc.011.10336; Wang AD, 2015, MOL MED REP, V11, P2435, DOI 10.3892/mmr.2014.3032; Wang ED, 2011, AM J CLIN PATHOL, V135, P525, DOI 10.1309/AJCPPJUQ9DNR1GHP; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Wu J, 2012, TOHOKU J EXP MED, V226, P267, DOI 10.1620/tjem.226.267	24	26	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142594	10.1371/journal.pone.0142594	http://dx.doi.org/10.1371/journal.pone.0142594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599017	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900030
J	Sakai, K; Komaki, H; Gonoi, T				Sakai, Kanae; Komaki, Hisayuki; Gonoi, Tohru			Identification and Functional Analysis of the Nocardithiocin Gene Cluster in Nocardia pseudobrasiliensis	PLOS ONE			English	Article							THIOPEPTIDE; ANTIBIOTICS; BIOSYNTHESIS; VARIANTS; STRAINS; TP-1161	Nocardithiocin is a thiopeptide compound isolated from the opportunistic pathogen Nocardia pseudobrasiliensis. It shows a strong activity against acid-fast bacteria and is also active against rifampicin-resistant Mycobacterium tuberculosis. Here, we report the identification of the nocardithiocin gene cluster in N. pseudobrasiliensis IFM 0761 based on conserved thiopeptide biosynthesis gene sequence and the whole genome sequence. The predicted gene cluster was confirmed by gene disruption and complementation. As expected, strains containing the disrupted gene did not produce nocardithiocin while gene complementation restored nocardithiocin production in these strains. The predicted cluster was further analyzed using RNA-seq which showed that the nocardithiocin gene cluster contains 12 genes within a 15.2-kb region. This finding will promote the improvement of nocardithiocin productivity and its derivatives production.	[Sakai, Kanae; Gonoi, Tohru] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Komaki, Hisayuki] Natl Inst Technol & Evaluat, Biol Resource Ctr, Chiba, Japan	Chiba University	Sakai, K (corresponding author), Chiba Univ, Med Mycol Res Ctr, Chiba, Japan.	wsakaiw@hotmail.com	gonoi, tohru/AAC-5181-2021; , gonoi/GRS-0648-2022	gonoi, tohru/0000-0003-3655-7911; , gonoi/0000-0003-3655-7911; Dalisay, Doralyn/0000-0003-2850-7797	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25305012]; Grants-in-Aid for Scientific Research [25305012] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), http://www.mext.go.jp/english/, #25305012, to TG. The funder had no role in this study.	Bhansali SG, 2015, ANTIMICROB AGENTS CH, V59, P1441, DOI 10.1128/AAC.04252-14; Bowers AA, 2010, J AM CHEM SOC, V132, P7519, DOI 10.1021/ja102339q; Chiba K, 2007, JPN J INFECT DIS, V60, P45; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; Engelhardt K, 2010, APPL ENVIRON MICROB, V76, P7093, DOI 10.1128/AEM.01442-10; Engelhardt K, 2010, APPL ENVIRON MICROB, V76, P4969, DOI 10.1128/AEM.00741-10; Haste NM, 2012, J ANTIBIOT, V65, P593, DOI 10.1038/ja.2012.77; Hwang KS, 2014, BIOTECHNOL ADV, V32, P255, DOI 10.1016/j.biotechadv.2013.10.008; Just-Baringo X, 2014, MAR DRUGS, V12, P317, DOI 10.3390/md12010317; Komaki H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-323; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Li WY, 2003, J ANTIBIOT, V56, P226, DOI 10.7164/antibiotics.56.226; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Mukai A, 2009, J ANTIBIOT, V62, P613, DOI 10.1038/ja.2009.90; Munoz J, 2007, J MED MICROBIOL, V56, P545, DOI 10.1099/jmm.0.46774-0; Minero MV, 2009, MEDICINE, V88, P250, DOI 10.1097/MD.0b013e3181afa1c8; Wang J, 2010, APPL ENVIRON MICROB, V76, P2335, DOI 10.1128/AEM.01790-09; Wilson JW, 2012, MAYO CLIN PROC, V87, P403, DOI 10.1016/j.mayocp.2011.11.016; Xu LB, 2013, BIOORG MED CHEM LETT, V23, P366, DOI 10.1016/j.bmcl.2012.10.065; Zhang FF, 2012, METHOD ENZYMOL, V516, P3, DOI 10.1016/B978-0-12-394291-3.00022-8	22	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143264	10.1371/journal.pone.0143264	http://dx.doi.org/10.1371/journal.pone.0143264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588225	gold, Green Published, Green Submitted			2022-12-26	WOS:000365251500047
J	Torgerson, DG; Giri, T; Druley, TE; Zheng, J; Huntsman, S; Seibold, MA; Young, AL; Schweiger, T; Yin-Declue, H; Sajol, GD; Schechtman, KB; Hernandez, RD; Randolph, AG; Bacharier, LB; Castro, M				Torgerson, Dara G.; Giri, Tusar; Druley, Todd E.; Zheng, Jie; Huntsman, Scott; Seibold, Max A.; Young, Andrew L.; Schweiger, Toni; Yin-Declue, Huiqing; Sajol, Geneline D.; Schechtman, Kenneth B.; Hernandez, Ryan D.; Randolph, Adrienne G.; Bacharier, Leonard B.; Castro, Mario			Pooled Sequencing of Candidate Genes Implicates Rare Variants in the Development of Asthma Following Severe RSV Bronchiolitis in Infancy	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; GENOME-WIDE ASSOCIATION; OF-FUNCTION MUTATIONS; EXHALED NITRIC-OXIDE; ATOPIC-DERMATITIS; POLYMORPHISM; FILAGGRIN; CHILDREN; NOS1; POPULATION	Severe infection with respiratory syncytial virus (RSV) during infancy is strongly associated with the development of asthma. To identify genetic variation that contributes to asthma following severe RSV bronchiolitis during infancy, we sequenced the coding exons of 131 asthma candidate genes in 182 European and African American children with severe RSV bronchiolitis in infancy using anonymous pools for variant discovery, and then directly genotyped a set of 190 nonsynonymous variants. Association testing was performed for physician-diagnosed asthma before the 7th birthday (asthma) using genotypes from 6,500 individuals from the Exome Sequencing Project (ESP) as controls to gain statistical power. In addition, among patients with severe RSV bronchiolitis during infancy, we examined genetic associations with asthma, active asthma, persistent wheeze, and bronchial hyperreactivity (methacholine PC20) at age 6 years. We identified four rare nonsynonymous variants that were significantly associated with asthma following severe RSV bronchiolitis, including single variants in ADRB2, FLG and NCAM1 in European Americans (p = 4.6x10(-4), 1.9x10(-13) and 5.0x10(-5), respectively), and NOS1 in African Americans (p = 2.3x10(-11)). One of the variants was a highly functional nonsynonymous variant in ADRB2 (rs1800888), which was also nominally associated with asthma (p = 0.027) and active asthma (p = 0.013) among European Americans with severe RSV bronchiolitis without including the ESP. Our results suggest that rare nonsynonymous variants contribute to the development of asthma following severe RSV bronchiolitis in infancy, notably in ADRB2. Additional studies are required to explore the role of rare variants in the etiology of asthma and asthma-related traits following severe RSV bronchiolitis.	[Torgerson, Dara G.; Huntsman, Scott] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Giri, Tusar; Schweiger, Toni; Yin-Declue, Huiqing; Sajol, Geneline D.; Castro, Mario] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Druley, Todd E.; Young, Andrew L.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO USA; [Zheng, Jie; Schechtman, Kenneth B.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Seibold, Max A.] Natl Jewish Hlth, Integrated Ctr Genes Environm & Hlth, Denver, CO USA; [Hernandez, Ryan D.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Inst Human Genet, San Francisco, CA 94143 USA; [Hernandez, Ryan D.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94143 USA; [Randolph, Adrienne G.] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA; [Bacharier, Leonard B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bacharier, Leonard B.] St Louis Childrens Hosp, St Louis, MO 63178 USA	University of California System; University of California San Francisco; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Jewish Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Boston Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Castro, M (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	castrom@DOM.wustl.edu		ZHENG, JIE/0000-0003-4958-2091; Young, Andrew/0000-0001-7698-3267; Giri, Tusar/0000-0003-1682-2300; Bacharier, Leonard/0000-0003-0432-2704; Druley, Todd/0000-0002-3245-7561; Randolph, Adrienne/0000-0002-3084-3071	National Institute of Health [RO1 HL092486, RO1 HL 61895, UL1 RR024992-01, R01-ES015794, R01-HL088133, T32-GM007546, R01-HL004464, R01-HL104608]; National Institute On Minority Health And Health Disparities [P60MD006902]; Alan A. and Edith L. Wolff Chair in Pulmonary and Critical Care Medicine; Flight Attendant Medical Research Institute; Sandler Foundation; American Asthma Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088133, R01HL092486, R01HL061895, R01HL104608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007546] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD006902] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute On Minority Health And Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Alan A. and Edith L. Wolff Chair in Pulmonary and Critical Care Medicine; Flight Attendant Medical Research Institute; Sandler Foundation; American Asthma Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding: This work was supported by grants from the National Institute of Health (www.nih.gov) (RO1 HL092486, RO1 HL 61895, UL1 RR024992-01, R01-ES015794, R01-HL088133, T32-GM007546, R01-HL004464, R01-HL104608), the National Institute On Minority Health And Health Disparities (P60MD006902), the Alan A. and Edith L. Wolff Chair in Pulmonary and Critical Care Medicine, the Flight Attendant Medical Research Institute (www.famri.org), the Sandler Foundation (www.sandlerfoundation.org), and the American Asthma Foundation (www.americanasthmafoundation.org).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ali M, 2003, PEDIAT ALLERG IMM-UK, V14, P261, DOI 10.1034/j.1399-3038.2003.00065.x; Ambrose HJ, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-37; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Baye Tesfaye M, 2011, BMC Proc, V5 Suppl 9, pS8, DOI 10.1186/1753-6561-5-S9-S8; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Bradley JP, 2005, PEDIATRICS, V115, pE7, DOI 10.1542/peds.2004-0059; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Brown SJ, 2009, BRIT J DERMATOL, V161, P884, DOI 10.1111/j.1365-2133.2009.09339.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dai Lu-ming, 2004, Sichuan Da Xue Xue Bao Yi Xue Ban, V35, P32; Dishy V, 2004, PHARMACOGENETICS, V14, P517, DOI 10.1097/01.fpc.0000114763.78957.ec; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Exome Variant Server, NHLBI GO EX SEQ PROJ; Gao Jin-ming, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P626; Gao PS, 2000, BIOCHEM BIOPH RES CO, V267, P761, DOI 10.1006/bbrc.1999.2030; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Grasemann H, 2000, BIOCHEM BIOPH RES CO, V272, P391, DOI 10.1006/bbrc.2000.2794; Haller G, 2009, J ALLERGY CLIN IMMUN, V124, P1204, DOI 10.1016/j.jaci.2009.09.013; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Holla LI, 2004, ALLERGY, V59, P548, DOI 10.1111/j.1398-9995.2004.00458.x; Immervoll T, 2001, HUM MUTAT, V18, P327, DOI 10.1002/humu.1194; Janzi M, 2012, GENES IMMUN, V13, P59, DOI 10.1038/gene.2011.55; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Martinez B, 2007, INT ARCH ALLERGY IMM, V144, P105, DOI 10.1159/000103221; Moore PE, 2009, PEDIATR PULM, V44, P649, DOI 10.1002/ppul.21033; Ober C, 2011, TRENDS GENET, V27, P107, DOI 10.1016/j.tig.2010.12.004; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randolph AG, 2014, CLIN EXP ALLERGY, V44, P231, DOI 10.1111/cea.12247; Ryan M, 2009, BIOINFORMATICS, V25, P1431, DOI 10.1093/bioinformatics/btp242; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Sykes A, 2008, J ALLERGY CLIN IMMUN, V122, P685, DOI 10.1016/j.jaci.2008.08.017; Todd JL, 2011, AM J RESP CRIT CARE, V184, P873, DOI 10.1164/rccm.201106-0971PP; Torgerson DG, 2012, AM J HUM GENET, V90, P273, DOI 10.1016/j.ajhg.2012.01.008; Vallania FLM, 2010, GENOME RES, V20, P1711, DOI 10.1101/gr.109157.110; Ward ME, 2005, J CLIN INVEST, V115, P3128, DOI 10.1172/JCI20806; Wechsler ME, 2000, AM J RESP CRIT CARE, V162, P2043, DOI 10.1164/ajrccm.162.6.2003089; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Xu XP, 2002, AM J RESP CRIT CARE, V166, P775; Yang IV, 2012, AM J RESP CRIT CARE, V186, P1087, DOI 10.1164/rccm.201207-1178PP; Zhang J, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-4	50	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142649	10.1371/journal.pone.0142649	http://dx.doi.org/10.1371/journal.pone.0142649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587832	gold, Green Published			2022-12-26	WOS:000365251500012
J	Alison, M; Biran, V; Tanase, A; Bendavid, M; Blouet, M; Demene, C; Sebag, G; Tanter, M; Baud, O				Alison, Marianne; Biran, Valerie; Tanase, Anca; Bendavid, Matthieu; Blouet, Marie; Demene, Charlie; Sebag, Guy; Tanter, Mickael; Baud, Olivier			Quantitative Shear-Wave Elastography of the Liver in Preterm Neonates with Intra-Uterine Growth Restriction	PLOS ONE			English	Article							IMPULSE ARFI ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; HEPATITIS-B; BLOOD-FLOW; FIBROSIS; NUTRITION; CHOLESTASIS; STIFFNESS; OPERATION; DIAGNOSIS	The feasibility and reproducibility of liver stiffness measurements using Supersonic Shear-wave Imaging (SSI) in preterm neonate have not been reported. Our aim was to determine if liver stiffness differs between intra-uterine growth restriction (IUGR) and appropriate for gestational age (AGA) preterm infants with/without cholestasis. We measured liver stiffness (in kPa) in 45 AGA and 18 IUGR preterm infants, and assessed reproducibility in 26 preterms using Intraclass Correlation Coefficients (ICC) and Bland-Altman tests. Liver stiffness values were compared between AGA and IUGR with and without cholestasis and correlated with birth weight. Measurements showed high reproducibility (ICC = 0.94-0.98 for intra-operator, 0.86 for inter-operator) with good agreement (95% limits: -1.24 to 1.24 kPa). During the first postnatal week, liver stiffness was higher in IUGR (7.50 +/- 1.53 kPa) than in AGA infants (5.11 +/- 0.80 kPa, p<0.001). After day 8, liver stiffness remained unchanged in AGA but increased progressively in IUGR infants (15.57 +/- 6.49 kPa after day 21). Liver stiffness was higher in IUGR neonates with cholestasis (19.35 +/- 9.80 kPa) than without cholestasis (7.72 +/- 1.27 kPa, p<0.001). In conclusion, quantitative liver SSI in preterms is feasible and reproducible. IUGR preterms who will develop cholestasis present high liver stiffness even at birth, before biological cholestasis occurs.	[Alison, Marianne; Tanase, Anca; Blouet, Marie; Sebag, Guy] Robert Debre Children Univ Hosp, Dept Pediat Radiol, F-75019 Paris, France; [Alison, Marianne; Biran, Valerie; Tanase, Anca; Bendavid, Matthieu; Blouet, Marie; Sebag, Guy; Baud, Olivier] Denis Diderot Paris Univ, APHP, F-75019 Paris, France; [Alison, Marianne; Biran, Valerie; Tanase, Anca; Demene, Charlie; Sebag, Guy; Tanter, Mickael; Baud, Olivier] PremUP Fdn, F-75014 Paris, France; [Biran, Valerie; Bendavid, Matthieu; Baud, Olivier] Robert Debre Children Univ Hosp, Neonatal Intens Care Unit, F-75019 Paris, France; [Biran, Valerie; Bendavid, Matthieu; Baud, Olivier] Robert Debre Children Univ Hosp, INSERM, U1141, F-75019 Paris, France; [Demene, Charlie; Tanter, Mickael] ESPCI ParisTech, CNRS, UMR 7587, Inst Langevin,INSERM,U979, F-75005 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite	Baud, O (corresponding author), PremUP Fdn, F-75014 Paris, France.	olivier.baud@rdb.aphp.fr	Alison, Marianne/A-2253-2016; Biran, Valerie/GQY-8192-2022; Mickael, Tanter/H-4657-2012	Mickael, Tanter/0000-0001-7739-8051; Alison, Marianne/0000-0002-9245-9390	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC grant [339244-FUSIMAGINE]	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC grant(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 339244-FUSIMAGINE.	Arai H, 2010, TOHOKU J EXP MED, V221, P181, DOI 10.1620/tjem.221.181; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barr RG, 2015, RADIOLOGY, V276, P845, DOI 10.1148/radiol.2015150619; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Baserga Mariana C, 2004, J Perinatol, V24, P476, DOI 10.1038/sj.jp.7211137; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bercoff J, 2004, APPL PHYS LETT, V84, P2202, DOI 10.1063/1.1667613; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOEHM G, 1988, ACTA PAEDIATR SCAND, V77, P19, DOI 10.1111/j.1651-2227.1988.tb10591.x; Bohte AE, 2014, EUR RADIOL, V24, P638, DOI 10.1007/s00330-013-3046-0; Champion V, 2012, J PEDIATR GASTR NUTR, V55, P592, DOI 10.1097/MPG.0b013e3182616916; Christensen RD, 2007, J PERINATOL, V27, P284, DOI 10.1038/sj.jp.7211686; Creasy R.K., 1994, MATERNAL FETAL MED P, V3rd ed., P558; Dillman JR, 2015, PEDIATR RADIOL, V45, P1480, DOI 10.1007/s00247-015-3345-5; Ebbing C, 2008, REPROD SCI, V15, P166, DOI 10.1177/1933719107310307; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Figueras F, 2011, AM J OBSTET GYNECOL, V204, P288, DOI 10.1016/j.ajog.2010.08.055; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Fontanilla T, 2014, ULTRASOUND MED BIOL, V40, P470, DOI 10.1016/j.ultrasmedbio.2013.10.024; Gardosi J, 2011, PAEDIATR PERINAT EP, V25, P2, DOI 10.1111/j.1365-3016.2010.01166.x; Gateau J, 2011, IEEE T ULTRASON FERR, V58, P517, DOI 10.1109/TUFFC.2011.1836; Grgurevic I, 2015, EUR RADIOL, V25, P3214, DOI 10.1007/s00330-015-3728-x; Hanquinet S, 2015, PEDIATR RADIOL, V45, P1489, DOI 10.1007/s00247-015-3352-6; Hanquinet S, 2013, PEDIATR RADIOL, V43, P545, DOI 10.1007/s00247-012-2595-8; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Jacquemin E, 1998, J PEDIATR-US, V133, P563, DOI 10.1016/S0022-3476(98)70070-8; Kahramaner Z, 2013, PEDIATR RADIOL, V43, P1464, DOI 10.1007/s00247-013-2729-7; Kelly DA, 2010, EARLY HUM DEV, V86, P683, DOI 10.1016/j.earlhumdev.2010.08.012; Kessler J, 2008, PEDIATR RES, V63, P315, DOI 10.1203/PDR.0b013e318163a1de; Kessler J, 2009, PEDIATR RES, V66, P113, DOI 10.1203/PDR.0b013e3181a29077; Leschied JR, 2015, PEDIATR RADIOL, V45, P366, DOI 10.1007/s00247-014-3149-z; Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P61; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018; Robinson DT, 2008, J PEDIATR-US, V152, P59, DOI 10.1016/j.jpeds.2007.06.002; Roca B, 2012, J VIRAL HEPATITIS, V19, P711, DOI 10.1111/j.1365-2893.2012.01608.x; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Shin NY, 2014, J ULTRAS MED, V33, P853, DOI 10.7863/ultra.33.5.853; Sirli R, 2013, ULTRASOUND MED BIOL, V39, P1362, DOI 10.1016/j.ultrasmedbio.2013.03.021; Tanter M, 2014, IEEE T ULTRASON FERR, V61, P102, DOI [10.1109/TUFFC.2014.2882, 10.1109/TUFFC.2014.6689779]; Taylor B.N., 1994, GUIDELINES EVALUATIN, DOI DOI 10.6028/NIST.TN.1297; Van Gossum A, 2015, JPEN-PARENTER ENTER, V39, P719, DOI 10.1177/0148607114538057; Yoo BW, 2014, J THORAC CARDIOV SUR, V148, P1498, DOI 10.1016/j.jtcvs.2014.04.010; Zeng J, 2014, EUR RADIOL, V24, P2572, DOI 10.1007/s00330-014-3292-9	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143220	10.1371/journal.pone.0143220	http://dx.doi.org/10.1371/journal.pone.0143220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580807	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600100
J	Goda, H; Hatta, T; Kishigami, H; Suzuki, A; Ikeda, T				Goda, Hiroshi; Hatta, Tatsuo; Kishigami, Hirotoshi; Suzuki, Ayaka; Ikeda, Tamotsu			Does a Novel-Developed Product of Wheelchair Incorporating Pelvic Support Prevent Forward Head Posture during Prolonged Sitting?	PLOS ONE			English	Article							TRUNK MUSCLE-ACTIVITY; CHRONIC NECK PAIN; SHOULDER POSTURE; CERVICAL-SPINE; VDT WORK; DISABILITY; SEVERITY; PRESSURE; MOTION; ADULTS	Disabled elderly individuals with kyphosis or loss of muscle strength often display forward head posture (FHP). This study aimed to determine the utility of a wheelchair incorporating pelvic support in preventing FHP in disabled elderly individuals. In this study, 14 disabled elderly individuals (87.1 +/- 8.1 years) were selected. A wheelchair incorporating pelvic support (RX_ABS Lo) and a basic wheelchair (RX-1) were used. Each individual sat on both wheelchairs for 30 minutes. RX_ABS Lo has two belts to support the pelvic and thorax. Postures were recorded in the sagittal plane using a video camera. Cervical and trunk angles from horizontal were measured every 5 minutes. Simultaneously, contact areas and total pressures applied to the wheelchair seats and back supports were measured every 5 minutes. Comparisons of area under the curve values between the wheelchairs were performed using the paired t-test. Comparisons of time-dependent parameters for each wheelchair were performed using repeated one-way ANOVA. Cervical angles were greater when using RX_ABS Lo than RX-1. Although cervical angles were unchanged during 30 minutes when using RX_ABS Lo, the angles were significantly decreased after 30 minutes of using RX-1. Back support pressures and contact areas were greater for RX_ABS Lo than for RX-1. No significant difference in back support pressure distributions was observed during 30 minutes in the wheelchairs. The RX_ABS Lo may have utility in improving FHP by increasing cervical angles and improving stability with a back support to the upper thorax, lower thorax, and pelvis during prolonged sitting.	[Goda, Hiroshi; Suzuki, Ayaka] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Goda, Hiroshi] Japan Hlth Care Coll, Eniwa, Japan; [Goda, Hiroshi; Ikeda, Tamotsu] Nihon Welf Rehabil Sch, Eniwa, Japan; [Hatta, Tatsuo; Kishigami, Hirotoshi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Hatta, T (corresponding author), Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan.	thatta@hs.hokudai.ac.jp						Ben Mortenson W, 2012, J AM GERIATR SOC, V60, P1310, DOI 10.1111/j.1532-5415.2012.04038.x; Bonney RA, 2002, APPL ERGON, V33, P415, DOI 10.1016/S0003-6870(02)00036-4; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Chiu TT, 2005, ARCH PHYS MED REHAB, V86, P534, DOI 10.1016/j.apmr.2004.02.030; Colombini D, 1986, ERGONOMICS WORKING P, P311; De Carvalho DE, 2012, APPL ERGON, V43, P876, DOI 10.1016/j.apergo.2011.12.007; Falla D, 2007, PHYS THER, V87, P408, DOI 10.2522/ptj.20060009; Fernandez-de-las-Penas C, 2006, CEPHALALGIA, V26, P314, DOI 10.1111/j.1468-2982.2005.01042.x; Giesbrecht EM, 2012, GERONTOLOGY, V58, P378, DOI 10.1159/000334819; Grandjean E., 1997, FITTING TASK HUMAN; HANTEN WP, 1991, ARCH PHYS MED REHAB, V72, P877, DOI 10.1016/0003-9993(91)90003-2; Harrison AL, 1996, J ORTHOP SPORT PHYS, V23, P353, DOI 10.2519/jospt.1996.23.6.353; Hiramatsu T, 2015, CLIN INTERV AGING, V10, P229, DOI 10.2147/CIA.S75211; Holmes MWR, 2013, ERGONOMICS, V56, P126, DOI 10.1080/00140139.2012.739206; Hung D, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-25; Kang JH, 2012, ANN REHABIL MED-ARM, V36, P98, DOI 10.5535/arm.2012.36.1.98; Khadilkar L, 2014, INT J SHOULDER SURG, V8, P1, DOI 10.4103/0973-6042.131847; Kishigami H, 2015, REHABIL ENG, V30, P28; Kishigami H, 2013, HOKKAIDO J OCCUP THE, V30, P116; Lau KT, 2010, MANUAL THER, V15, P457, DOI 10.1016/j.math.2010.03.009; Lee JH, 2011, J OCCUP HEALTH, V53, P350, DOI 10.1539/joh.11-0050-OA; Lee JH, 2011, IND HEALTH, V49, P403, DOI 10.2486/indhealth.MS1230; Li CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113644; Linder-Ganz E, 2007, Technol Health Care, V15, P195; MAJESKE C, 1984, PHYS THER, V64, P1531, DOI 10.1093/ptj/64.10.1531; Makhsous M, 2003, SPINE, V28, P1113, DOI 10.1097/00007632-200306010-00006; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mostamand J, 2013, J BODYW MOV THER, V17, P430, DOI 10.1016/j.jbmt.2012.11.002; Nishimura S, 2013, HOKKAIDO J OCCUP THE, V30, P8; O'Sullivan PB, 2002, SPINE, V27, P1238, DOI 10.1097/00007632-200206010-00019; Quek J, 2013, MANUAL THER, V18, P65, DOI 10.1016/j.math.2012.07.005; Roberts S. L, 2004, KINESIOLOGY MOVEMENT; Sakuma T, 2010, J ORAL REHABIL, V37, P583, DOI 10.1111/j.1365-2842.2010.02084.x; Sawada N, 2015, EUR GERIATR MED, V6, P286, DOI 10.1016/j.eurger.2014.11.001; Shahidi B, 2013, J ELECTROMYOGR KINES, V23, P1082, DOI 10.1016/j.jelekin.2013.05.009; Shaw G, 1991, Assist Technol, V3, P5; Silva AG, 2009, ARCH PHYS MED REHAB, V90, P669, DOI 10.1016/j.apmr.2008.10.018; SINAKI M, 1993, OSTEOPOROSIS INT, V3, P8, DOI 10.1007/BF01623170; Steele CM, 2011, FOLIA PHONIATR LOGO, V63, P36, DOI 10.1159/000319737; Triano JJ, 2013, CHIROPR MAN THER, V21, DOI [10.1186/2045-709X-21-36, 10.1186/2045-709X-21-21]; Tsukada N, 2006, J CROSS-CULT GERONTO, V21, P121, DOI 10.1007/s10823-006-9028-9; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Yip CHT, 2008, MANUAL THER, V13, P148, DOI 10.1016/j.math.2006.11.002; Yoo WG, 2008, IND HEALTH, V46, P289, DOI 10.2486/indhealth.46.289; Yoo WG, 2009, IND HEALTH, V47, P183, DOI 10.2486/indhealth.47.183; Zemp R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/916045	46	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142617	10.1371/journal.pone.0142617	http://dx.doi.org/10.1371/journal.pone.0142617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581089	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600050
J	Boj, M; Chauvigne, F; Zapater, C; Cerda, J				Boj, Monica; Chauvigne, Francois; Zapater, Cinta; Cerda, Joan			Gonadotropin-Activated Androgen-Dependent and Independent Pathways Regulate Aquaporin Expression during Teleost (Sparus aurata) Spermatogenesis	PLOS ONE			English	Article							NUCLEAR PROGESTERONE-RECEPTOR; FOLLICLE-STIMULATING-HORMONE; TESTICULAR GERM-CELLS; POSTNATAL-DEVELOPMENT; EFFERENT DUCTS; LEYDIG-CELL; PHARMACOLOGICAL CHARACTERIZATION; REPRODUCTIVE-CYCLE; MEIOSIS RESUMPTION; ZEBRAFISH TESTIS	The mediation of fluid homeostasis by multiple classes of aquaporins has been suggested to be essential during spermatogenesis and spermiation. In the marine teleost gilthead seabream (Sparus aurata), seven distinct aquaporins, Aqp0a, -1aa, -1ab, -7, -8b, -9b and -10b, are differentially expressed in the somatic and germ cell lineages of the spermiating testis, but the endocrine regulation of these channels during germ cell development is unknown. In this study, we investigated the in vivo developmental expression of aquaporins in the seabream testis together with plasma androgen concentrations. We then examined the in vitro regulatory effects of recombinant piscine gonadotropins, follicle-stimulating (rFsh) and luteinizing (rLh) hormones, and sex steroids on aquaporin mRNA levels during the spermatogenic cycle. During the resting phase, when plasma levels of androgens were low, the testis exclusively contained proliferating spermatogonia expressing Aqp1ab, whereas Aqp10b and -9b were localized in Sertoli and Leydig cells, respectively. At the onset of spermatogenesis and during spermiation, the increase of androgen plasma levels correlated with the additional appearance of Aqp0a and -7 in Sertoli cells, Aqp0a in spermatogonia and spermatocytes, Aqp1ab, -7 and -10b from spermatogonia to spermatozoa, and Aqp1aa and -8b in spermatids and spermatozoa. Short-term in vitro incubation of testis explants indicated that most aquaporins in Sertoli cells and early germ cells were upregulated by rFsh and/or rLh through androgen-dependent pathways, although Aqp1ab in proliferating spermatogonia was also activated by estrogens. However, expression of Aqp9b in Leydig cells, and of Aqp1aa and -7 in spermatocytes and spermatids, was also directly stimulated by rLh. These results reveal a complex gonadotropic control of aquaporin expression during seabream germ cell development, apparently involving both androgen-dependent and independent pathways, which may assure the fine tuning of aquaporin-mediated fluid secretion and absorption mechanisms in the seabream testis.	[Boj, Monica; Chauvigne, Francois; Zapater, Cinta; Cerda, Joan] CSIC, Inst Ciencias Mar, IRTA, E-08003 Barcelona, Spain; [Chauvigne, Francois] Univ Bergen, Dept Biol, Bergen High Technol Ctr, N-5020 Bergen, Norway	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); IRTA; University of Bergen	Chauvigne, F (corresponding author), CSIC, Inst Ciencias Mar, IRTA, E-08003 Barcelona, Spain.	francois.chauvigne@bio.uib.no; joan.cerda@irta.cat	Zapater, Cinta/L-9406-2017; Chauvigne, Francois/D-6854-2017; Cerdà, Joan/M-1099-2016	Zapater, Cinta/0000-0001-9326-7502; Chauvigne, Francois/0000-0001-5571-7517; Cerdà, Joan/0000-0003-2568-6398	Spanish Ministry of Economy and Competitivity (MINECO) [AGL2010-15597, BES-2011-049399]	Spanish Ministry of Economy and Competitivity (MINECO)	This work was funded by the Spanish Ministry of Economy and Competitivity (MINECO) project AGL2010-15597 to JC. MB was a recipient of a predoctoral fellowship from MINECO (BES-2011-049399).	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Arenas MI, 2001, J ANAT, V199, P465, DOI 10.1046/j.1469-7580.2001.19940465.x; Arrighi S, 2014, REPROD DOMEST ANIM, V49, P17, DOI 10.1111/rda.12213; Badran HH, 2002, J ANDROL, V23, P358; Boj M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.131524; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Bouma J, 2001, BIOL REPROD, V65, P60, DOI 10.1095/biolreprod65.1.60; Cavaco JEB, 1999, CELL TISSUE RES, V297, P291, DOI 10.1007/s004410051357; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; Chauvigne F, 2015, SCI REP-UK, V5, DOI 10.1038/srep07789; Chauvigne F, 2014, J MOL ENDOCRINOL, V53, P175, DOI 10.1530/JME-14-0087; Chauvigne F, 2014, P NATL ACAD SCI USA, V111, P1427, DOI 10.1073/pnas.1317838111; Chauvigne F, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110783; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; Chaves-Pozo E, 2011, SEX STEROIDS, P199; Chen SX, 2012, GEN COMP ENDOCR, V179, P71, DOI 10.1016/j.ygcen.2012.07.022; Chen SX, 2011, REPRODUCTION, V141, P491, DOI 10.1530/REP-10-0224; Chen SX, 2010, BIOL REPROD, V82, P171, DOI 10.1095/biolreprod.109.077644; Clulow J, 1998, J REPROD FERTIL, P1; Coward K, 2002, REV FISH BIOL FISHER, V12, P33, DOI 10.1023/A:1022613404123; de Kretser DM, 2004, MOL CELL ENDOCRINOL, V225, P57, DOI 10.1016/j.mce.2004.07.008; de Waal PP, 2008, REPRODUCTION, V136, P225, DOI 10.1530/REP-08-0055; de Waal PP, 2009, J ENDOCRINOL, V202, P287, DOI 10.1677/JOE-09-0050; DEFRANCA LR, 1995, ANAT REC, V241, P181, DOI 10.1002/ar.1092410206; Eddy EM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P3; Engel A, 2008, CURR OPIN STRUC BIOL, V18, P229, DOI 10.1016/j.sbi.2007.11.003; Fabra M, 2005, SCIENCE, V307, P545, DOI 10.1126/science.1106305; Fabra M, 2006, DEV BIOL, V295, P250, DOI 10.1016/j.ydbio.2006.03.034; Finn RN, 2015, BIOL B IN PRESS, V229; Finn RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113686; Finn RN, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00044; Ge R, 2008, ADV EXP MED BIOL, V636, P255, DOI 10.1007/978-0-387-09597-4_14; Hai MTV, 2004, BIOL CELL, V96, P133, DOI 10.1016/j.biolcel.2003.11.008; Hermo L, 2004, J ANDROL, V25, P494; Hermo L, 2011, J ANDROL, V32, P565, DOI 10.2164/jandrol.110.012831; Hinfray N, 2013, J ENDOCRINOL, V216, P375, DOI 10.1530/JOE-12-0509; HINTON BT, 1993, SERTOLI CELL, P249; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Huang HF, 2006, HUM REPROD UPDATE, V12, P785, DOI 10.1093/humupd/dml035; Ikeuchi T, 2001, COMP BIOCHEM PHYS B, V129, P449, DOI 10.1016/S1096-4959(01)00375-X; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Kagawa H, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-71; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Klein C, 2013, ANAT REC, V296, P1115, DOI 10.1002/ar.22709; Kobayashi Y, 2011, DEV DYNAM, V240, P116, DOI 10.1002/dvdy.22507; Kumari SS, 2009, BIOCHEM BIOPH RES CO, V390, P1034, DOI 10.1016/j.bbrc.2009.10.103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackay S, 2007, INT REV CYTOL, V260, P113, DOI 10.1016/S0074-7696(06)60003-X; Miura C, 1996, DEV GROWTH DIFFER, V38, P257, DOI 10.1046/j.1440-169X.1996.t01-2-00004.x; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Nagasawa K, 2014, J MOL ENDOCRINOL, V52, P357, DOI 10.1530/JME-13-0187; Nihei K, 2001, ARCH HISTOL CYTOL, V64, P81, DOI 10.1679/aohc.64.81; Pu LL, 2013, FISH PHYSIOL BIOCHEM, V39, P309, DOI 10.1007/s10695-012-9701-6; Raldua D, 2008, AM J PHYSIOL-REG I, V294, pR993, DOI 10.1152/ajpregu.00695.2007; Rato L, 2010, J MEMBRANE BIOL, V236, P215, DOI 10.1007/s00232-010-9294-x; Rossato M, 1999, STEROIDS, V64, P168, DOI 10.1016/S0039-128X(98)00104-4; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Schulz RW, 2005, BIOL REPROD, V73, P891, DOI 10.1095/biolreprod.105.039891; Setchell B. P., 1969, Biology of Reproduction Suppl, VNo. 1, P40, DOI 10.1095/biolreprod1.Supplement_1.40; SPRANDO RL, 1987, AM J ANAT, V178, P72, DOI 10.1002/aja.1001780109; Takei GL, 2015, COMP BIOCH PHYSL A, V182, P4; Thomas P, 2012, GEN COMP ENDOCR, V175, P367, DOI 10.1016/j.ygcen.2011.11.032; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Yeung CH, 2010, INT J ANDROL, V33, P629, DOI 10.1111/j.1365-2605.2009.00998.x; Yeung CH, 2010, ASIAN J ANDROL, V12, P490, DOI 10.1038/aja.2010.40; Zapater C, 2013, DEV BIOL, V377, P345, DOI 10.1016/j.ydbio.2013.03.001; Zapater C, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102533; Zapater C, 2011, MOL BIOL EVOL, V28, P3151, DOI 10.1093/molbev/msr146; Zhou XH, 1996, ANAT RECORD, V245, P509	71	11	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142512	10.1371/journal.pone.0142512	http://dx.doi.org/10.1371/journal.pone.0142512			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575371	Green Submitted, gold, Green Published			2022-12-26	WOS:000365153400012
J	Han, HX; Lei, QX; Zhou, Y; Gao, JB; Liu, W; Li, FW; Zhang, Q; Lu, Y; Cao, DG				Han, Haixia; Lei, Qiuxia; Zhou, Yan; Gao, Jinbo; Liu, Wei; Li, Fuwei; Zhang, Qian; Lu, Yan; Cao, Dingguo			Association between BMP15 Gene Polymorphism and Reproduction Traits and Its Tissues Expression Characteristics in Chicken	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-15; GROWTH-DIFFERENTIATION FACTOR-9; INCREASED OVULATION RATE; PREMATURE OVARIAN FAILURE; SYNONYMOUS CODON USAGE; IN-VITRO MATURATION; FOLLICULAR DEVELOPMENT; SYNERGISTIC ROLES; OOCYTE; GDF9	BMP15 (Bone morphogenetic protein 15) is an oocyte-secreted growth factor required for ovarian follicle development and ovulation in mammals, but its effects on reproduction in chickens are unclear. In this study, the association between BMP15 polymorphisms and reproduction traits were analyzed, and its expression characteristics in different tissues were explored in LaiWu Black chickens. Three single nucleotide polymorphisms (SNPs) were identified in four hundred LaiWu Black chickens. One SNP (NC_006091.3: g.1773T>C) located in exon 2 which was significantly associated with egg weight at first egg (EWFE) (P = 0.0389), was novel. Diplotypes based on the three SNPs were found to be significantly associated with egg weight at age of 43W (EW43) (P = 0.0058). The chickens with H3H3 diplotype had their first egg 0.57 days later than chickens with H5H5 diplotype and 1.21 days-3.96 days earlier than the other five diplotype chickens. The egg production at age of 43W (E43), egg production at age of 46W (E46) and egg production at age of 48W (E48) for chickens with H3H3 diplotype were the highest among all the chickens, and the E48 of chickens with H3H3 diplotype had 11.83 eggs higher than chickens with H1H5 diplotype. RT-qPCR results showed that the expression level of BMP15 gene in ovarian follicle was in the order of 4 mm>6mm -8mm>15 mm -19 mm>23 mm -29 mm >33 mm -34 mm in diameter. The mRNA level in follicles of 4 mm and 6-8 mm in diameter were significantly higher than that in the other follicles (P < 0.01). In the same week, the highest mRNA level was found in the ovary, and it was significantly different from that found in the liver and oviduct (P < 0.01). Our results indicate that BMP15 plays a vital role in the development of ovary and follicles, especially in the development of primary follicles. H3H3 may be an potential advantageous molecular marker for improving reproduction traits in chickens.	[Han, Haixia; Lei, Qiuxia; Zhou, Yan; Gao, Jinbo; Liu, Wei; Li, Fuwei; Zhang, Qian; Lu, Yan; Cao, Dingguo] Acad Agr Sci Shandong Prov, Inst Poultry Sci, Jinan 250023, Shandong, Peoples R China; [Han, Haixia; Lei, Qiuxia; Zhou, Yan; Gao, Jinbo; Liu, Wei; Li, Fuwei; Zhang, Qian; Lu, Yan; Cao, Dingguo] Poultry Breeding Engn Technol Ctr Shandong Prov, Jinan 250023, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences	Cao, DG (corresponding author), Acad Agr Sci Shandong Prov, Inst Poultry Sci, Jinan 250023, Shandong, Peoples R China.	jqsyzs@163.com			Youth Fund Project of Shandong Academy of Agricultural Sciences [2014QNM14, 2015YQN53]; Major Natural Science Foundation of Shandong Province, China [ZR2014CZ003]; Joint Funds of the Natural Science Foundation of Shandong Province, China [ZR2014YL024]; Major Agricultural Stock Breeding Project of Shandong Province	Youth Fund Project of Shandong Academy of Agricultural Sciences; Major Natural Science Foundation of Shandong Province, China; Joint Funds of the Natural Science Foundation of Shandong Province, China; Major Agricultural Stock Breeding Project of Shandong Province	This work was financially supported by the Youth Fund Project of Shandong Academy of Agricultural Sciences (2014QNM14, 2015YQN53), the Major Natural Science Foundation of Shandong Province, China (ZR2014CZ003), the Joint Funds of the Natural Science Foundation of Shandong Province, China (ZR2014YL024), and Major Agricultural Stock Breeding Project of Shandong Province (New Excellent Poultry Breeding). The funders had no role in study design, data collection and analysis, preparation or the publication of the manuscript.	Auclair S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078199; Bali V, 2015, INT J BIOCHEM CELL B, V64, P58, DOI 10.1016/j.biocel.2015.03.011; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; Chaney JL, 2015, ANNU REV BIOPHYS, V44, P143, DOI 10.1146/annurev-biophys-060414-034333; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chu M, 2007, CHINESE AGR SCI B, V23, P85; De La Torre AR, 2015, GENOME BIOL EVOL, V7, P1002, DOI 10.1093/gbe/evv044; Demars J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003482; Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; Eckery DC, 2002, MOL CELL ENDOCRINOL, V192, P115, DOI 10.1016/S0303-7207(02)00085-0; Elis S, 2007, J ENDOCRINOL, V194, P485, DOI 10.1677/JOE-07-0143; Erickson GF, 2000, TRENDS ENDOCRIN MET, V11, P193, DOI 10.1016/S1043-2760(00)00249-6; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; He XL, 2009, ANIMAL HUSBANDRY FEE, V2009, P129; Hosoe M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-33; Huang HY, 2015, BRIT POULTRY SCI, V56, P277, DOI 10.1080/00071668.2015.1019829; Juengel JL, 2002, BIOL REPROD, V67, P1777, DOI 10.1095/biolreprod.102.007146; Kathirvel M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-206; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Laissue P, 2006, EUR J ENDOCRINOL, V154, P739, DOI 10.1530/eje.1.02135; Laitinen M, 1998, MECH DEVELOP, V78, P135, DOI 10.1016/S0925-4773(98)00161-0; Li C., 2012, ADV HEMATOL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0030026; Lin L, 2009, J ANHUI NORMAL U NAT, V6; Lin ZL, 2014, REPROD DOMEST ANIM, V49, P219, DOI 10.1111/rda.12254; Martinez-Royo A, 2008, ANIM GENET, V39, P294, DOI 10.1111/j.1365-2052.2008.01707.x; McMahon HE, 2008, ENDOCRINOLOGY, V149, P2807, DOI 10.1210/en.2007-1550; Mullen MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053172; Onagbesan O, 2009, ANIM REPROD SCI, V111, P121, DOI 10.1016/j.anireprosci.2008.09.017; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Otsuka F, 2001, J BIOL CHEM, V276, P11387, DOI 10.1074/jbc.M010043200; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; Paradis F, 2009, REPRODUCTION, V138, P115, DOI 10.1530/REP-08-0538; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Persani L, 2014, HUM REPROD UPDATE, V20, P869, DOI 10.1093/humupd/dmu036; Shabir M, 2013, GENE, V515, P432, DOI 10.1016/j.gene.2012.12.018; Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020; Sudiman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103563; Sun RZ, 2010, J MOL HISTOL, V41, P325, DOI 10.1007/s10735-010-9294-2; Tan Q, 2009, MOL CELL ENDOCRINOL, V312, P72, DOI 10.1016/j.mce.2009.03.011; Wang Y.F., 2012, MODERN SCI INSTRUMEN, V21, P15; Williford A, 2012, MOL BIOL EVOL, V29, P3755, DOI 10.1093/molbev/mss184; Wu JS, 2009, ANIM HUS VET MED, V141; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yoshino O, 2006, P NATL ACAD SCI USA, V103, P10678, DOI 10.1073/pnas.0600507103; Zhai B, 2013, CELL PHYSIOL BIOCHEM, V32, P264, DOI 10.1159/000354435	48	12	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143298	10.1371/journal.pone.0143298	http://dx.doi.org/10.1371/journal.pone.0143298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26574748	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400058
J	Inoue, Y; Inui, N; Hashimoto, D; Enomoto, N; Fujisawa, T; Nakamura, Y; Suda, T				Inoue, Yusuke; Inui, Naoki; Hashimoto, Dai; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Nakamura, Yutaro; Suda, Takafumi			Cumulative Incidence and Predictors of Progression in Corticosteroid-Naive Patients with Sarcoidosis	PLOS ONE			English	Article							PULMONARY SARCOIDOSIS; RACIAL DIFFERENCE; PROGNOSIS; INVOLVEMENT; INSTRUMENT; THERAPY	Background Assessment of the clinical course of sarcoidosis requires long-term observation. However, the appropriate period of follow-up for sarcoidosis remains unclear, especially in patients without indication of corticosteroid therapy at the time of diagnosis. Objective This study aimed to clarify the cumulative incidence and identify risk factors for disease progression in corticosteroid-naive sarcoidosis patients. Methods The clinical courses of 150 Japanese patients with sarcoidosis, who were followed for more than 2 years and had no indication for corticosteroid therapy at diagnosis, were retrospectively reviewed. Disease progression was defined as worsening of pulmonary sarcoidosis, development of new organ involvement, or extrapulmonary organ damage. The cumulative incidence of progression was estimated by generating a cumulative incidence curve with the Fine and Gray method. Results The median follow-up duration was 7.7 years (interquartile range, 4.7-13.6 years). Thirty-two (21%) patients experienced disease progression. New organ involvement appeared in 16 patients (11%). The 6-month, and 1-, 5-, 10-, and 15-year cumulative incidence of progression was 2%, 5%, 15%, 28%, and 31%, respectively. The number of organs involved at diagnosis was an independent predictor for progression with a multifactorial adjusted hazard ratio of 1.71 (95% confidence interval, 1.11-2.62). The optimal cut-off of the number of organs involved at diagnosis to identify future progression was three. Conclusions In corticosteroid-naive sarcoidosis patients, the risks of disease progression are comparable from 0-5 years and 5-10 years after diagnosis. The number of organs involved at diagnosis is a useful predictor for progression of sarcoidosis.	[Inoue, Yusuke; Inui, Naoki; Hashimoto, Dai; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Nakamura, Yutaro; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan; [Inui, Naoki] Hamamatsu Univ Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Inui, N (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan.	inui@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264				Baughman Robert P, 2015, Sarcoidosis Vasc Diffuse Lung Dis, V31, P275; Boros PW, 2010, EUR RESPIR J, V36, P1315, DOI 10.1183/09031936.00166809; Costabel U, 2001, EUR RESPIR J, V18, p56S; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gottlieb JE, 1997, CHEST, V111, P623, DOI 10.1378/chest.111.3.623; Huggins JT, 2006, CHEST, V129, P1599, DOI 10.1378/chest.129.6.1599; HUNNINGHAKE CW, 1994, AM J RESP CRIT CARE, V149, P893, DOI 10.1164/ajrccm.149.4.8143052; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Inui N, 2001, J ALLERGY CLIN IMMUN, V107, P337, DOI 10.1067/mai.2001.112273; ISRAEL HL, 1986, ANN NY ACAD SCI, V465, P609, DOI 10.1111/j.1749-6632.1986.tb18537.x; IWAI K, 1994, SARCOIDOSIS, V11, P26; JOHNS CJ, 1986, ANN NY ACAD SCI, V465, P702, DOI 10.1111/j.1749-6632.1986.tb18549.x; Judson MA, 2014, SARCOIDOSIS VASC DIF, V31, P19; Judson MA, 1999, SARCOIDOSIS VASC DIF, V16, P75; Judson MA, 2003, SARCOIDOSIS VASC DIF, V20, P204; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; MANA J, 1994, RESPIRATION, V61, P219; Mirsaeidi M, 2015, CHEST, V147, P438, DOI 10.1378/chest.14-1120; Panselinas E, 2012, CHEST, V142, P827, DOI 10.1378/chest.12-1060; Pietinalho A, 2000, SARCOIDOSIS VASC DIF, V17, P158; REICH JM, 1985, AM J MED, V78, P61, DOI 10.1016/0002-9343(85)90463-2; Rizzato G, 1998, SARCOIDOSIS VASC DIF, V15, P52; Rodrigues SCS, 2011, SARCOIDOSIS VASC DIF, V28, P34; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204; Subramanian I, 2006, SARCOIDOSIS, V210, P415; Tsuda T, 2006, JPN J SARCOIDOSIS OT, V27, P89; WARR GA, 1976, AM REV RESPIR DIS, V113, P96	28	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143371	10.1371/journal.pone.0143371	http://dx.doi.org/10.1371/journal.pone.0143371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575272	Green Submitted, gold, Green Published			2022-12-26	WOS:000365153400061
J	Kondrashova, O; Love, CJ; Lunke, S; Hsu, AL; Waring, PM; Taylor, GR				Kondrashova, Olga; Love, Clare J.; Lunke, Sebastian; Hsu, Arthur L.; Waring, Paul M.; Taylor, Graham R.		AOCS Grp	High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq	PLOS ONE			English	Article							CANCER; AMPLIFICATION; MUTATION; DESIGN; BRCA1	Whilst next generation sequencing can report point mutations in fixed tissue tumour samples reliably, the accurate determination of copy number is more challenging. The conventional Multiplex Ligation-dependent Probe Amplification (MLPA) assay is an effective tool for measurement of gene dosage, but is restricted to around 50 targets due to size resolution of the MLPA probes. By switching from a size-resolved format, to a sequence-resolved format we developed a scalable, high-throughput, quantitative assay. MLPA-seq is capable of detecting deletions, duplications, and amplifications in as little as 5ng of genomic DNA, including from formalin-fixed paraffin-embedded (FFPE) tumour samples. We show that this method can detect BRCA1, BRCA2, ERBB2 and CCNE1 copy number changes in DNA extracted from snap-frozen and FFPE tumour tissue, with 100% sensitivity and >99.5% specificity.	[Kondrashova, Olga; Love, Clare J.; Lunke, Sebastian; Hsu, Arthur L.; Waring, Paul M.; Taylor, Graham R.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; Univ Sydney, Westmead Millennium Inst, Ctr Canc Res, Sydney, NSW 2006, Australia; Westmead Hosp, Dept Gynaecol Oncol, Sydney, NSW, Australia; [AOCS Grp] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia	University of Melbourne; Peter Maccallum Cancer Center; University of Sydney; Westmead Institute for Medical Research; University of Sydney; QIMR Berghofer Medical Research Institute	Kondrashova, O (corresponding author), Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia.	okon@student.unimelb.edu.au	Whiteman, David C/P-2728-2014; DeFazio, Anna/O-2385-2019; Bowtell, David/H-1007-2016; Haviv, Izhak/E-3782-2015; Webb, Penelope/D-5736-2013; Fox, Stephen/G-9719-2016; Zeps, Nikolajs/C-4180-2013; Rogers, Peter/C-2651-2008; Wyld, David/B-8893-2015	Whiteman, David C/0000-0003-2563-9559; DeFazio, Anna/0000-0003-0057-4744; Bowtell, David/0000-0001-9089-7525; Haviv, Izhak/0000-0002-0837-5005; Alsop, Kathryn/0000-0002-4107-3041; Traficante, Nadia/0000-0001-7459-8576; Kondrashova, Olga/0000-0003-0022-5149; Perrin, Lewis/0000-0002-6119-8458; Webb, Penelope/0000-0003-0733-5930; Chenevix-Trench, Georgia/0000-0002-1878-2587; Fox, Stephen/0000-0002-7648-8896; Beale, Philip/0000-0003-3628-4597; Zeps, Nikolajs/0000-0002-6404-6839; Moore, Suzanne/0000-0002-8045-0305; Hsu, Arthur/0000-0001-8308-1106; Byth Wilson, Karen/0000-0002-1253-6393; friedlander, michael/0000-0003-3090-795X; Rogers, Peter/0000-0002-7399-8997; Obermair, Andreas/0000-0003-2199-1117; Wyld, David/0000-0001-9523-4333; Hacker, Neville/0000-0002-1445-2302	U.S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Tasmania; National Health and Medical Research Council of Australia (NHMRC) [ID400413]; Peter MacCallum Cancer Foundation; Victorian Comprehensive Cancer Centre; Victorian Cancer Agency [TRP13088]; National Health and Medical Research Council [APP1034301]; Cancer Foundation of Western Australia; Ovarian Cancer Australia (OCA); Herman Trust; Victorian Government	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Peter MacCallum Cancer Foundation; Victorian Comprehensive Cancer Centre; Victorian Cancer Agency; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Ovarian Cancer Australia (OCA); Herman Trust; Victorian Government	The AOCS was supported by the U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Tasmania and The Cancer Foundation of Western Australia and the National Health and Medical Research Council of Australia (NHMRC, ID400413), the Peter MacCallum Cancer Foundation and Ovarian Cancer Australia (OCA). This work was supported by research grants from the Victorian Comprehensive Cancer Centre, the Victorian Cancer Agency (TRP13088), and the National Health and Medical Research Council (APP1034301) with infrastructure support for sequencing from the University of Melbourne and Therapeutic Innovation Australia. The Victorian Cancer Biobank is supported by the Victorian Government. GT is part supported by the Herman Trust.	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berry Ian R., 2007, V381, P247; Bruno DL, 2011, HUM MUTAT, V32, P1500, DOI 10.1002/humu.21581; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Feliubadalo L, 2013, EUR J HUM GENET, V21, P864, DOI 10.1038/ejhg.2012.270; Gilks CB, 2010, J ONCOLOGY, V2010, P1; Hsu AL, 2015, HUM MUTAT, V36, P411, DOI 10.1002/humu.22763; Kolasa IK, 2006, GYNECOL ONCOL, V103, P692, DOI 10.1016/j.ygyno.2006.05.007; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Mendiola M, 2009, HUM PATHOL, V40, P631, DOI 10.1016/j.humpath.2008.10.011; Nakayama N, 2010, CANCER-AM CANCER SOC, V116, P2621, DOI 10.1002/cncr.24987; PRICE CM, 1993, BLOOD REV, V7, P127, DOI 10.1016/S0268-960X(05)80023-2; Sellner LN, 2004, HUM MUTAT, V23, P413, DOI 10.1002/humu.20035; Sluiter MD, 2011, BREAST CANCER RES TR, V125, P325, DOI 10.1007/s10549-010-0817-z; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70; Yan M, 2014, CANCER TREAT REV, V40, P770, DOI 10.1016/j.ctrv.2014.02.008; Zhang Yu-Wen, 2015, World J Biol Chem, V6, P16, DOI 10.4331/wjbc.v6.i2.16	21	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143006	10.1371/journal.pone.0143006	http://dx.doi.org/10.1371/journal.pone.0143006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569395	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700114
J	Pinal, D; Zurron, M; Diaz, F				Pinal, Diego; Zurron, Montserrat; Diaz, Fernando			An Event Related Potentials Study of the Effects of Age, Load and Maintenance Duration on Working Memory Recognition	PLOS ONE			English	Article							INFORMATION LOAD; P300; LATENCY; TASK; COMPONENT; CAPACITY; FEATURES; MODELS; ADULTS; TESTS	Age-related decline in cognitive capacities has been attributed to a generalized slowing of processing speed and a reduction in working memory (WM) capacity. Nevertheless, it is unclear how age affects visuospatial WM recognition and its underlying brain electrical activity. Whether age modulates the effects of memory load or information maintenance duration, which determine the limits of WM, remains also elusive. In this exploratory study, performance in a delayed match to sample task declined with age, particularly in conditions with high memory load. Event related potentials analysis revealed longer N2 and P300 latencies in old than in young adults during WM recognition, which may reflect slowing of stimulus evaluation and classification processes, respectively. Although there were no differences between groups in N2 or P300 amplitudes, the latter was more homogeneously distributed in old than in young adults, which may indicate an age-related increased reliance in frontal vs parietal resources during WM recognition. This was further supported by an age-related reduced posterior cingulate activation and increased superior frontal gyrus activation revealed through standardized low resolution electromagnetic tomography. Memory load and maintenance duration effects on brain activity were similar in both age groups. These behavioral and electrophysiological results add evidence in support of age-related decline in WM recognition theories, with a slowing of processing speed that may be limited to stimulus evaluation and categorization processes -with no effects on perceptual processes- and a posterior to anterior shift in the recruitment of neural resources.	[Pinal, Diego; Zurron, Montserrat; Diaz, Fernando] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Fac Psychol, Appl Cognit Neurosci Lab, Galiza, Spain	Universidade de Santiago de Compostela	Pinal, D (corresponding author), Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Fac Psychol, Appl Cognit Neurosci Lab, Galiza, Spain.	diego.pinal@usc.es	Díaz, Fernando/C-9217-2011; Zurrón, Montserrat/AGN-5132-2022; Pinal, Diego/A-4407-2016; Zurrón, Montserrat/J-6005-2013	Díaz, Fernando/0000-0003-3373-4855; Zurrón, Montserrat/0000-0001-9948-8840; Pinal, Diego/0000-0002-2228-955X; Zurrón, Montserrat/0000-0001-9948-8840	Ministerio de Educacion [BES 2008-005929]; Ministerio de Economia y Competitividad, Gobierno de Espana [PSI2010-22224-C03-03]; Conselleria de Economia e Industria [10 PXIB 211070 PR]; Conselleria de Educacion e Ordenacion Universitaria, Xunta de Galicia [GPC 2014/047]	Ministerio de Educacion; Ministerio de Economia y Competitividad, Gobierno de Espana(Spanish Government); Conselleria de Economia e Industria; Conselleria de Educacion e Ordenacion Universitaria, Xunta de Galicia(Xunta de Galicia)	This work was financially supported by the Ministerio de Educacion (BES 2008-005929) and Ministerio de Economia y Competitividad (PSI2010-22224-C03-03), Gobierno de Espana; and by the Conselleria de Economia e Industria (10 PXIB 211070 PR), and Conselleria de Educacion e Ordenacion Universitaria (Ref: GPC 2014/047), Xunta de Galicia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Amenedo E, 1998, BIOL PSYCHIAT, V43, P210, DOI 10.1016/S0006-3223(97)00255-2; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Bauser DAS, 2011, BEHAV BRAIN RES, V220, P65, DOI 10.1016/j.bbr.2011.01.032; Cabeza, 2012, PRINCIPLES FRONTAL L, P628, DOI DOI 10.1093/ACPROF:OSO/9780195134971.001.0001; Chen J, 2003, AGING NEUROPSYCHOL C, V10, P122, DOI 10.1076/anec.10.2.122.14461; Cornelissen FW, 2000, VISION RES, V40, P287, DOI 10.1016/S0042-6989(99)00137-6; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Fjell AM, 2001, BRAIN TOPOGR, V14, P25, DOI 10.1023/A:1012563605837; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fort A, 2005, NEUROSCI LETT, V379, P144, DOI 10.1016/j.neulet.2004.12.076; Friedman D., 2012, OXFORD HDB EVENT REL, DOI DOI 10.1093/OXFORDHB/9780195374148.013.0243; Friedman D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00111; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; John ER, 1996, INT J PSYCHOPHYSIOL, V24, P127, DOI 10.1016/S0167-8760(96)00056-6; Kennett S, 2001, J COGNITIVE NEUROSCI, V13, P462, DOI 10.1162/08989290152001899; Knott V, 2004, CLIN EEG NEUROSCI, V35, P185, DOI 10.1177/155005940403500408; Kotchoubey B, 1997, BIOL PSYCHOL, V46, P25, DOI 10.1016/S0301-0511(96)05236-2; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Morgan HM, 2008, J COGNITIVE NEUROSCI, V20, P989, DOI 10.1162/jocn.2008.20072; Muller NG, 2002, COGNITIVE BRAIN RES, V13, P221, DOI 10.1016/S0926-6410(01)00119-7; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Connell RG, 2012, NEUROBIOL AGING, V33, P2448, DOI 10.1016/j.neurobiolaging.2011.12.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park D. C., 2000, COGNITIVE AGING PRIM, V11, P3; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pelosi L, 1999, COGNITIVE BRAIN RES, V7, P321, DOI 10.1016/S0926-6410(98)00035-4; Pinal D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00165; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PRATT H, 1989, ELECTROEN CLIN NEURO, V72, P507, DOI 10.1016/0013-4694(89)90228-9; SALTHOUSE TA, 1990, DEV REV, V10, P101, DOI 10.1016/0273-2297(90)90006-P; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Townsend JT, 1978, COGNITIVE THEORY, P199; van der Ham IJM, 2007, NEUROPSYCHOLOGIA, V45, P2492, DOI 10.1016/j.neuropsychologia.2007.03.021; van der Ham IJM, 2010, INT J PSYCHOPHYSIOL, V77, P83, DOI 10.1016/j.ijpsycho.2010.04.008; Verleger R, 1997, PSYCHOPHYSIOLOGY, V34, P131, DOI 10.1111/j.1469-8986.1997.tb02125.x; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Wechsler D., 1997, WECHSLER ADULT INTEL; Yin J, 2011, NEUROSCI LETT, V491, P26, DOI 10.1016/j.neulet.2011.01.001	45	9	9	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143117	10.1371/journal.pone.0143117	http://dx.doi.org/10.1371/journal.pone.0143117			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW5XP	26569113	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700140
J	Tunc, B; Verma, R				Tunc, Birkan; Verma, Ragini			Unifying Inference of Meso-Scale Structures in Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE; BRAIN NETWORKS	Networks are among the most prevalent formal representations in scientific studies, employed to depict interactions between objects such as molecules, neuronal clusters, or social groups. Studies performed at meso-scale that involve grouping of objects based on their distinctive interaction patterns form one of the main lines of investigation in network science. In a social network, for instance, meso-scale structures can correspond to isolated social groupings or groups of individuals that serve as a communication core. Currently, the research on different meso-scale structures such as community and core-periphery structures has been conducted via independent approaches, which precludes the possibility of an algorithmic design that can handle multiple meso-scale structures and deciding which structure explains the observed data better. In this study, we propose a unified formulation for the algorithmic detection and analysis of different meso-scale structures. This facilitates the investigation of hybrid structures that capture the interplay between multiple meso-scale structures and statistical comparison of competing structures, all of which have been hitherto unavailable. We demonstrate the applicability of the methodology in analyzing the human brain network, by determining the dominant organizational structure (communities) of the brain, as well as its auxiliary characteristics (core-periphery).	[Tunc, Birkan; Verma, Ragini] Univ Penn, Ctr Biomed Image Comp & Analyt, Philadelphia, PA 19104 USA	University of Pennsylvania	Tunc, B (corresponding author), Univ Penn, Ctr Biomed Image Comp & Analyt, Philadelphia, PA 19104 USA.	Birkan.Tunc@uphs.upenn.edu			National Institutes of Health [R01-MH092862]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the grant from the National Institutes of Health (R01-MH092862, PI: Ragini Verma).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrieu C, 2003, MACH LEARN, V50, P5, DOI 10.1023/A:1020281327116; [Anonymous], [No title captured]; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bassett DS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003171; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bishop Christopher M., 2006, PATTERN RECOGNITION; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Everett MG, 1999, SOC NETWORKS, V21, P397; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Garas A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/8/083030; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hinne M, 2013, NEUROIMAGE, V66, P543, DOI 10.1016/j.neuroimage.2012.09.068; Hothna S, 2014, SYST BIOL, V63, P753, DOI 10.1093/sysbio/syu039; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; MacMahon M, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021006; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; Mukherjee S, 2008, P NATL ACAD SCI USA, V105, P14313, DOI 10.1073/pnas.0802272105; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rombach MP, 2014, SIAM J APPL MATH, V74, P167, DOI 10.1137/120881683; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schwarz AJ, 2008, MAGN RESON IMAGING, V26, P914, DOI 10.1016/j.mri.2008.01.048; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott J., 2012, SOCIAL NETWORK ANAL; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Zhao J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-311	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143133	10.1371/journal.pone.0143133	http://dx.doi.org/10.1371/journal.pone.0143133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569619	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700143
J	van Blijswijk, SCE; Chan, OYA; van Houwelingen, AH; Gussekloo, J; den Elzen, WPJ; Blom, JW				van Blijswijk, Sophie C. E.; Chan, On Ying A.; van Houwelingen, Anne H.; Gussekloo, Jacobijn; den Elzen, Wendy P. J.; Blom, Jeanet W.			Self-Reported Hindering Health Complaints of Community-Dwelling Older Persons: A Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PEOPLE; CARE; DISABILITY; ASSOCIATION; POPULATION; LIMITATION; DEPRESSION; SYMPTOMS; PATIENT	Purpose Proactive care for community-dwelling older persons targeting self-reported hindering health complaints might prevent a decline in function. We investigated the spectrum of self-reported hindering complaints of community-dwelling older persons, the association with functional outcomes, and help-seeking behavior for these complaints. Methods Within the ISCOPE trial, participants (aged >= 75 years) received the ISCOPE screening questionnaire, including the open-ended question "At the moment, which health complaints limit you the most in your day-to-day life?". After coding the answers with the ICPC-1-NL, we examined the prevalence and the association between the number and type of complaints and functional outcomes (Groningen Activities Restriction Scale, quality of life measured on Cantril's Ladder, Mini-Mental State Examination, Geriatric Depression Scale-15, and De Jong Gierveld Loneliness Scale). Electronic patient registers were searched for the most reported complaints. Results 7285 participants (median age: 81.0 years [IQR 77.8-85.3], 38.6% males) reported 13,524 hindering complaints (median 1, range 0-18); 32.7% reported no complaints. Participants mostly reported problems with walking/standing (22.1%), pain (20.8%) or weakness/tiredness (8.5%). These complaints were mentioned in the electronic patient registers in 28.3%, 91.3% and 55.5%, respectively. Higher numbers of hindering complaints were related to poorer scores on the number of domains with problems, Cantril's Ladder for quality of life, Groningen Activities Restriction Scale, Geriatric Depression Scale, and De Jong Gierveld Loneliness Scale. Self-reported weakness, problems with walking/standing, visual limitations, cognitive problems, dyspnea and back complaints were associated with poorer scores on the number of domains with problems, Groningen Activities Restriction Scale, MMSE or Geriatric Depression Scale. Conclusion One third of the participants reported no hindering complaints. Problems with walking/standing, pain, and weakness/tiredness were most reported, but not always found in electronic patient registers. A higher number of, and specific self-reported hindering complaints, were associated with poorer scores on functional outcomes. It may be helpful for general practitioners to ask about these complaints and their influence on daily life.	[van Blijswijk, Sophie C. E.; Chan, On Ying A.; van Houwelingen, Anne H.; Gussekloo, Jacobijn; den Elzen, Wendy P. J.; Blom, Jeanet W.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Blom, JW (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands.	j.w.blom@lumc.nl	Gussekloo, Jacobijn/ABE-3879-2021; Chan, On Ying/P-9557-2015	Gussekloo, Jacobijn/0000-0001-7186-8278; Chan, On Ying/0000-0002-8474-2073; den Elzen, Wendy/0000-0002-6774-4077	ZonMw, the Netherlands, Organization for Health Research and Development: ZonMw [311060201]	ZonMw, the Netherlands, Organization for Health Research and Development: ZonMw	This study was funded by ZonMw, the Netherlands, Organization for Health Research and Development: ZonMw No. 311060201; www.zonmw.nl (JWB, JG). The sponsor had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Avlund K, 2002, J CLIN EPIDEMIOL, V55, P965, DOI 10.1016/S0895-4356(02)00463-8; Barry LC, 2009, J GERONTOL A-BIOL, V64, P1325, DOI 10.1093/gerona/glp135; Beekman ATF, 2002, ACTA PSYCHIAT SCAND, V105, P20, DOI 10.1034/j.1600-0447.2002.10078.x; Bergman H, 2013, CAN GERIATR J, V16, P61, DOI 10.5770/cgj.16.60; Blom JW, 2015, AGE AGEING IN PRESS; Borglin G, 2005, INT J NURS STUD, V42, P147, DOI 10.1016/j.ijnurstu.2004.06.003; Brown CJ, 2013, JAMA-J AM MED ASSOC, V310, P1168, DOI 10.1001/jama.2013.276566; Cantril H., 1965, PATTERN HUMAN CONCER; DATH P, 1994, FAM PRACT, V11, P260, DOI 10.1093/fampra/11.3.260; De Maeseneer J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652553; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; Department of Economic and Social Affairs, 2010, WORLD POP AGE 2009; Drennan V, 2007, FAM PRACT, V24, P454, DOI 10.1093/fampra/cmm034; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gebel RS, 2000, ICPC 1 DUTCH SUBTITL; Guralnik JM, 2002, AM J PUBLIC HEALTH, V92, P1244, DOI 10.2105/AJPH.92.8.1244; HARROW BS, 1995, GERONTOLOGIST, V35, P803, DOI 10.1093/geront/35.6.803; Hellstrom Y, 2001, HEALTH SOC CARE COMM, V9, P61, DOI 10.1046/j.1365-2524.2001.00282.x; Hertogh C MPM, 1996, CLIN REHABIL, V10, P135; Hertogh CMPM, 1999, FUNCTIONAL GERIATRIC; Kempen GIJM, 1996, SOC SCI MED, V43, P1601, DOI 10.1016/S0277-9536(96)00057-3; Macintyre S, 1999, SOC SCI MED, V48, P89, DOI 10.1016/S0277-9536(98)00292-5; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Stenzelius K, 2005, ARCH GERONTOL GERIAT, V40, P85, DOI 10.1016/j.archger.2004.06.001; van de Linden MW, 2004, 2 NATL SURVEY DIS P; van Duin C, 2012, CBS PROGNOSIS POPULA; van Lindert H, 2004, 2 NATL DIS P GEN PRA; Vestergaard S, 2009, J GERONTOL A-BIOL, V64, P76, DOI 10.1093/gerona/gln017; Visentin P, 1998, ARCH GERONTOL GERIAT, V26, P247, DOI 10.1016/S0167-4943(98)00007-7; Walters K, 2001, FAM PRACT, V18, P277, DOI 10.1093/fampra/18.3.277	30	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142416	10.1371/journal.pone.0142416	http://dx.doi.org/10.1371/journal.pone.0142416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW5XP	26571233	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700036
J	Wolwer, CB; Pase, LB; Pearson, HB; Godde, NJ; Lackovic, K; Huang, DCS; Russell, SM; Humbert, PO				Woelwer, Christina B.; Pase, Luke B.; Pearson, Helen B.; Goedde, Nathan J.; Lackovic, Kurt; Huang, David C. S.; Russell, Sarah M.; Humbert, Patrick O.			A Chemical Screening Approach to Identify Novel Key Mediators of Erythroid Enucleation	PLOS ONE			English	Article							CHROMATIN CONDENSATION; DIFFERENTIATION; ERYTHROPOIESIS; ERYTHROBLASTS; TRANSCRIPTION; MATURATION; INHIBITION; CELLS; MCL-1; RB	Erythroid enucleation is critical for terminal differentiation of red blood cells, and involves extrusion of the nucleus by orthochromatic erythroblasts to produce reticulocytes. Due to the difficulty of synchronizing erythroblasts, the molecular mechanisms underlying the enucleation process remain poorly understood. To elucidate the cellular program governing enucleation, we utilized a novel chemical screening approach whereby orthochromatic cells primed for enucleation were enriched ex vivo and subjected to a functional drug screen using a 324 compound library consisting of structurally diverse, medicinally active and cell permeable drugs. Using this approach, we have confirmed the role of HDACs, proteasomal regulators and MAPK in erythroid enucleation and introduce a new role for Cyclin-dependent kinases, in particular CDK9, in this process. Importantly, we demonstrate that when coupled with imaging analysis, this approach provides a powerful means to identify and characterize rate limiting steps involved in the erythroid enucleation process.	[Woelwer, Christina B.; Pase, Luke B.; Pearson, Helen B.; Goedde, Nathan J.; Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet, Melbourne, Vic, Australia; [Woelwer, Christina B.; Pase, Luke B.; Pearson, Helen B.; Goedde, Nathan J.; Russell, Sarah M.; Humbert, Patrick O.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Lackovic, Kurt; Huang, David C. S.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Lackovic, Kurt; Huang, David C. S.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Russell, Sarah M.] Peter MacCallum Canc Ctr, Immune Signaling Lab, Melbourne, Vic, Australia; [Russell, Sarah M.] Swinburne Univ Technol, Fac Engn & Ind Sci, Ctr Microphoton, Hawthorn, Vic 3122, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Swinburne University of Technology; University of Melbourne; University of Melbourne	Humbert, PO (corresponding author), Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet, Melbourne, Vic, Australia.	Patrick.Humbert@petermac.org	Godde, Nathan/C-2698-2018; Humbert, Patrick O/L-4264-2016; Russell, Sarah M/B-9341-2009; Huang, David C. S./C-7586-2013	Humbert, Patrick O/0000-0002-1366-6691; Russell, Sarah M/0000-0001-5826-9641; Huang, David C. S./0000-0002-3101-4873; Godde, Nathan/0000-0002-3413-407X; Pearson, Helen/0000-0002-3284-0843	Australian Postgraduate Award; National Health and Medical Research Council (NH&MRC) of Australia [1016701, 361646, 1043149]; Leukemia Lymphoma Society [SCoR 7001-13]; Victorian State Government Operational Infrastructure Support (OIS) grant; National Health and Medical Research Council; National Health and Medical Research Council of Australia; Australian Research Council (ARC) of Australia	Australian Postgraduate Award(Australian Government); National Health and Medical Research Council (NH&MRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Victorian State Government Operational Infrastructure Support (OIS) grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) of Australia(Australian Research Council)	CBW was supported by the Australian Postgraduate Award. DCSH is supported by grants (program 1016701 and Independent Research Institutes Infrastructure Support Scheme grant 361646) and a fellowship (1043149) from the National Health and Medical Research Council (NH&MRC) of Australia; the Leukemia Lymphoma Society (SCoR 7001-13); and a Victorian State Government Operational Infrastructure Support (OIS) grant. SMR was supported by grants and fellowships from the National Health and Medical Research Council and Australian Research Council (ARC) of Australia. POH was supported by a Senior Research Fellowship and a project grant from the National Health and Medical Research Council of Australia.	Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; CHASIS JA, 1989, BLOOD, V74, P1112, DOI 10.1182/blood.V74.3.1112.1112; Chen CY, 2002, EXP HEMATOL, V30, P634, DOI 10.1016/S0301-472X(02)00826-3; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Clark AJ, 2004, BLOOD, V104, P1324, DOI 10.1182/blood-2004-02-0618; Fischer PM, 2005, EXPERT OPIN INV DRUG, V14, P457, DOI 10.1517/13543784.14.4.457; Ji P, 2011, TRENDS CELL BIOL, V21, P409, DOI 10.1016/j.tcb.2011.04.003; Ji P, 2010, HAEMATOL-HEMATOL J, V95, P2013, DOI 10.3324/haematol.2010.029827; Keerthivasan G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/139851; Keerthivasan G, 2010, BLOOD, V116, P3331, DOI 10.1182/blood-2010-03-277426; Konstantinidis DG, 2012, BLOOD, V119, P6118, DOI 10.1182/blood-2011-09-379263; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; Lemke J, 2014, CELL DEATH DIFFER, V21, P491, DOI 10.1038/cdd.2013.179; Popova EY, 2009, CHROMOSOME RES, V17, P47, DOI 10.1007/s10577-008-9005-y; Schultze SM, 2012, CELL RES, V22, P539, DOI 10.1038/cr.2011.159; Thomas D, 2013, BLOOD, V122, P738, DOI 10.1182/blood-2012-08-447441; Walkley CR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-13; Wang JX, 2012, J CELL SCI, V125, P340, DOI 10.1242/jcs.088286; Xu Y, 2006, LEUKEMIA, V20, P1261, DOI 10.1038/sj.leu.2404252; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142655	10.1371/journal.pone.0142655	http://dx.doi.org/10.1371/journal.pone.0142655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569102	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700057
J	Diersch, S; Wirth, M; Schneeweis, C; Jors, S; Geisler, F; Siveke, JT; Rad, R; Schmid, RM; Saur, D; Rustgi, AK; Reichert, M; Schneider, G				Diersch, S.; Wirth, M.; Schneeweis, C.; Joers, S.; Geisler, F.; Siveke, J. T.; Rad, R.; Schmid, R. M.; Saur, D.; Rustgi, A. K.; Reichert, M.; Schneider, G.			Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells	ONCOGENE			English	Article							C-MYC; FAMILY PROTEINS; BETA-CELLS; CANCER; MOUSE; KRAS; ADENOCARCINOMA; RECEPTOR; CARCINOGENESIS; TRANSCRIPTION	Epidermal growth factor receptor (EGFR) signaling has a critical role in oncogenic Kras-driven pancreatic carcinogenesis. However, the downstream targets of this signaling network are largely unknown. We developed a novel model system utilizing murine primary pancreatic ductal epithelial cells (PDECs), genetically engineered to allow time-specific expression of oncogenic Kras(G12D) from the endogenous promoter. We show that primary PDECs are susceptible to Kras(G12D)-driven transformation and form pancreatic ductal adenocarcinomas in vivo after Cdkn2a inactivation. In addition, we demonstrate that activation of Kras(G12D) induces an EGFR signaling loop to drive proliferation. Interestingly, pharmacological inhibition of EGFR fails to decrease Kras(G12D)-activated ERK or PI3K signaling. Instead our data provide novel evidence that EGFR signaling is needed to activate the oncogenic and pro-proliferative transcription factor c-MYC. EGFR and c-MYC have been shown to be essential for pancreatic carcinogenesis. Importantly, our data link both pathways and thereby explain the crucial role of EGFR for Kras(G12D)-driven carcinogenesis in the pancreas.	[Diersch, S.; Wirth, M.; Schneeweis, C.; Joers, S.; Geisler, F.; Siveke, J. T.; Rad, R.; Schmid, R. M.; Saur, D.; Reichert, M.; Schneider, G.] Tech Univ Munich, Med Klin 2, Munich, Germany; [Siveke, J. T.] German Canc Consortium DKTK, Div Translat Solid Tumor Oncol, Partner Site Essen & German Canc Res Ctr DKFZ, Heidelberg, Germany; [Rustgi, A. K.; Reichert, M.] Univ Penn, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rustgi, A. K.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rustgi, A. K.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rustgi, A. K.; Reichert, M.] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Schneider, G (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin 2, Ismaninger Str 22, D-81675 Munich, Germany.	guenter.schneider@tum.de	Siveke, Jens/AAQ-6170-2021; Wirth, Matthias/AEG-6333-2022; Reichert, Maximilian/GOH-1246-2022; Saur, Dieter/O-8355-2015	Saur, Dieter/0000-0001-5874-0210; Wirth, Matthias/0000-0002-8340-0872	Wilhelm-Sander Foundation [2012.084.1]; Deutsche Forschungsgemeinschaft (DFG) [SCHN 959/1-2, SCHN 959/2-1, GE2289/1, SI 1549/2-1, SFB824]; Deutsche Krebshilfe [110908, 111273, 109992]; NIH [NIHP30 DK050306, NIH R01DK060694]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060694, P30DK050306] Funding Source: NIH RePORTER	Wilhelm-Sander Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs S. Hingorani, I. Verma, D. Tuveson, H. Zeng, F. Costantini, T. Jacks, R. DePhino, J. Ferrer, I. de Alboran and F. Alt for generating or providing mouse lines/plasmids. This work was supported by the Wilhelm-Sander Foundation (2012.084.1 to GS), Deutsche Forschungsgemeinschaft (DFG) (SCHN 959/1-2, SCHN 959/2-1 to GS, GE2289/1 to FG, SI 1549/2-1 to JTS and SFB824 to GS and DS), Deutsche Krebshilfe (110908 to GS, 111273 (Max-Eder Program) to MR and 109992 to JTS) and NIH (NIHP30 DK050306 Center for Molecular Studies in Digestive and Liver Diseases (Molecular Pathology and Imaging, Molecular Biology/Gene Expression, Cell Culture, and Transgenic and Chimeric Mouse Cores) to MR and AKR and the NIH R01DK060694 to MR and AKR).	Appleman VA, 2012, MOL CANCER RES, V10, P1228, DOI 10.1158/1541-7786.MCR-12-0340-T; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Bonal C, 2009, GASTROENTEROLOGY, V136, P309, DOI 10.1053/j.gastro.2008.10.015; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Grippo PJ, 2012, INT J CANCER, V131, P1243, DOI 10.1002/ijc.27322; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hessmann E, 2016, ONCOGENE, V35, P1609, DOI 10.1038/onc.2015.216; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Ischenko I, 2014, P NATL ACAD SCI USA, V111, P3466, DOI 10.1073/pnas.1319911111; Ischenko I, 2013, P NATL ACAD SCI USA, V110, P3937, DOI 10.1073/pnas.1219592110; Jors S, 2015, J CLIN INVEST, V125, P2445, DOI 10.1172/JCI78585; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee KE, 2010, CANCER CELL, V18, P448, DOI 10.1016/j.ccr.2010.10.020; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lin WC, 2013, CANCER RES, V73, P1821, DOI 10.1158/0008-5472.CAN-12-2067; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakhai H, 2008, DEVELOPMENT, V135, P3191, DOI 10.1242/dev.017137; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Perera RM, 2012, CANCER CELL, V22, P281, DOI 10.1016/j.ccr.2012.08.019; Pinho AV, 2011, CELL CYCLE, V10, P1312, DOI 10.4161/cc.10.8.15363; Pinho AV, 2011, GUT, V60, P958, DOI 10.1136/gut.2010.225920; Puri S, 2015, CELL STEM CELL, V16, P18, DOI 10.1016/j.stem.2014.11.001; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Reichert M, 2013, GENE DEV, V27, P288, DOI 10.1101/gad.204453.112; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Sancho R, 2014, CELL STEM CELL, V15, P139, DOI 10.1016/j.stem.2014.06.019; SANDGREN EP, 1993, MOL CELL BIOL, V13, P320, DOI 10.1128/MCB.13.1.320; SANDGREN EP, 1991, P NATL ACAD SCI USA, V88, P93, DOI 10.1073/pnas.88.1.93; Schild C, 2009, MOL CARCINOGEN, V48, P1149, DOI 10.1002/mc.20569; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Skoudy Anouchka, 2011, J Gastrointest Cancer, V42, P76, DOI 10.1007/s12029-011-9258-0; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; von Burstin J, 2015, MOL CANCER RES, V13, P863, DOI 10.1158/1541-7786.MCR-14-0709; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wang CG, 2011, CELL CYCLE, V10, P57, DOI 10.4161/cc.10.1.14449; Wirth M, 2014, NUCLEIC ACIDS RES, V42, P10433, DOI 10.1093/nar/gku763; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	53	29	29	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3880	3886		10.1038/onc.2015.437	http://dx.doi.org/10.1038/onc.2015.437			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26592448	Green Accepted			2022-12-26	WOS:000380753200013
J	Ochoa, V; George, AA; Nishi, R; Whiteaker, P				Ochoa, Vanessa; George, Andrew A.; Nishi, Rae; Whiteaker, Paul			The prototoxin LYPD6B modulates heteromeric alpha 3 beta 4-containing nicotinic acetylcholine receptors, but not alpha 7 homomers	FASEB JOURNAL			English	Article						LYNX1; LYNX2; Ly6/uPAR; CHRNA5; PSCA	ALTERNATE STOICHIOMETRIES; SUBUNIT; IDENTIFICATION; PHARMACOLOGY; GENES; ASSOCIATION; EXPRESSION; NEURONS; MEMBER; LYNX1	Prototoxins are a diverse family of membrane-tethered molecules expressed in the nervous system that modulate nicotinic cholinergic signaling, but their functions and specificity have yet to be completely explored. We tested the selectivity and efficacy of leukocyte antigen, PLAUR (plasminogen activator, urokinase receptor) domain-containing (LYPD)-6B on alpha 3 beta 4-, alpha 3 alpha 5 beta 4-, and alpha 7-containing nicotinic acetylcholine receptors (nAChRs). To constrain stoichiometry, fusion proteins encoding concatemers of human alpha 3, beta 4, and alpha 5 (D and N variants) subunits were expressed in Xenopuslaevis oocytes and tested with or without LYPD6B. We used the 2-electrode voltage-clamp method to quantify responses to acetylcholine (ACh): agonist sensitivity (EC50), maximal agonist-induced current (I-max), and time constant (tau) of desensitization. For beta 4-alpha 3-alpha 3-beta 4-alpha 3 and beta 4-alpha 3-beta 4-alpha 3-alpha 3, LYPD6B decreased EC50 from 631 to 79 mu M, reduced I-max by at least 59%, and decreased . For beta 4-alpha 3-alpha 5D-beta 4-alpha 3 and beta 4-alpha 3-beta 4-alpha-alpha 5D, LYPD6B decreased I-max by 63 and 32%, respectively. Thus, LYPD6B acted only on (3)(3)(4)(2) and (3)(2)(5D)(4)(2) and did not affect the properties of (alpha 3)(2)(beta 4)(3), alpha 7, or (alpha 3)(2)(alpha 5N)(beta 4)(2) nAChRs. Therefore, LYPD6B acts as a mixed modulator that enhances the sensitivity of (alpha 3)(3)(beta 4)(2) nAChRs to ACh while reducing ACh-induced whole-cell currents. LYPD6B also negatively modulates 34 nAChRs that include the alpha 5D common human variant, but not the N variant associated with nicotine dependence.	[Ochoa, Vanessa; Nishi, Rae] Univ Vermont, Grad Program Neurosci, Burlington, VT USA; [Ochoa, Vanessa; Nishi, Rae] Univ Vermont, Dept Neurol Sci, Burlington, VT USA; [George, Andrew A.; Whiteaker, Paul] Barrow Neurol Inst, Div Neurobiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA; [Nishi, Rae] Marine Biol Lab, Div Educ, 7 MBL St, Woods Hole, MA 02543 USA	University of Vermont; University of Vermont; Barrow Neurological Institute; Marine Biological Laboratory - Woods Hole	Nishi, R (corresponding author), Univ Vermont, Dept Neurol Sci, Burlington, VT USA.; Nishi, R (corresponding author), Marine Biol Lab, Div Educ, 7 MBL St, Woods Hole, MA 02543 USA.	rnishi@mbl.edu			U.S. National Institutes of Health (NIH) National Institute on Drug Abuse Grants [R21 DA027070, R21 DA026627]; Men's and Women's Boards of the Barrow Neurological Foundation; NIH National Institute of Neurological Disorders and Stroke Grant [R21 NS076969]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027070, R21DA026627] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse Grants; Men's and Women's Boards of the Barrow Neurological Foundation; NIH National Institute of Neurological Disorders and Stroke Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the U.S. National Institutes of Health (NIH) National Institute on Drug Abuse Grants R21 DA027070 and R21 DA026627 (to P.W.); by endowment and capital funds from the Men's and Women's Boards of the Barrow Neurological Foundation (to P.W. and A.A.G.); and NIH National Institute of Neurological Disorders and Stroke Grant R21 NS076969 (to R.N.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Blumenthal EM, 1999, J NEUROPHYSIOL, V81, P111, DOI 10.1152/jn.1999.81.1.111; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; FLEMING TJ, 1993, J IMMUNOL, V150, P5379; Fowler CD, 2013, PSYCHOPHARMACOLOGY, V229, P503, DOI 10.1007/s00213-013-3235-1; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; George AA, 2012, J BIOL CHEM, V287, P25151, DOI 10.1074/jbc.M112.379339; Girod R, 1999, ANN NY ACAD SCI, V868, P578, DOI 10.1111/j.1749-6632.1999.tb11331.x; GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; HALVORSEN SW, 1990, J NEUROSCI, V10, P1711; HALVORSEN SW, 1986, J NEUROSCI, V6, P3405; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Holford M, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.021.2009; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; KEYSER KT, 1993, J NEUROSCI, V13, P442; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Lindstrom J, 1996, PROG BRAIN RES, V109, P125; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Miwa JM, 2012, PHYSIOLOGY, V27, P187, DOI 10.1152/physiol.00002.2012; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Moretti M, 2014, MOL PHARMACOL, V86, P306, DOI 10.1124/mol.114.093377; Morley BJ, 1998, MOL BRAIN RES, V53, P78, DOI 10.1016/S0169-328X(97)00272-6; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, J MOL NEUROSCI, V30, P95, DOI 10.1385/JMN:30:1:95; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nichols WA, 2014, J BIOL CHEM, V289, P31423, DOI 10.1074/jbc.M114.573667; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Rothlin CV, 2003, MOL PHARMACOL, V63, P1067, DOI 10.1124/mol.63.5.1067; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Thomsen MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130572; VERNALLIS AB, 1993, NEURON, V10, P451, DOI 10.1016/0896-6273(93)90333-M; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7	53	19	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1109	1119		10.1096/fj.15-274548	http://dx.doi.org/10.1096/fj.15-274548			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26586467	Green Published			2022-12-26	WOS:000370387800010
J	Yuasa, D; Ohashi, K; Shibata, R; Mizutani, N; Kataoka, Y; Kambara, T; Uemura, Y; Matsuo, K; Kanemura, N; Hayakawa, S; Hiramatsu-Ito, M; Ito, M; Ogawa, H; Murate, T; Murohara, T; Ouchi, N				Yuasa, Daisuke; Ohashi, Koji; Shibata, Rei; Mizutani, Naoki; Kataoka, Yoshiyuki; Kambara, Takahiro; Uemura, Yusuke; Matsuo, Kazuhiro; Kanemura, Noriyoshi; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Ogawa, Hayato; Murate, Takashi; Murohara, Toyoaki; Ouchi, Noriyuki			C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart	FASEB JOURNAL			English	Article						ischemia-reperfusion injury; inflammation; apoptosis; adipokine; CTRP1	MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; REPERFUSION INJURY; CARDIAC MYOCYTES; IN-VIVO; RECEPTORS; SPHINGOSINE-1-PHOSPHATE; INFLAMMATION	Obesity is associated with an increased risk of cardiovascular disease. C1q/TNF-related protein (CTRP)-1 is a poorly characterized adipokine that is up-regulated in association with ischemic heart disease. We investigated the role of CTRP1 in myocardial ischemia injury. CTRP1-knockout mice showed increased myocardial infarct size, cardiomyocyte apoptosis, and proinflammatory gene expression after I/R compared with wild-type (WT) mice. In contrast, systemic delivery of CTRP1 attenuated myocardial damage after I/R in WT mice. Treatment of cardiomyocytes with CTRP1 led to reduction of hypoxia-reoxygenation-induced apoptosis and lipopolysaccharide-stimulated expression of proinflammatory cytokines, which was reversed by inhibition of sphingosine-1-phosphate (S1P) signaling. Treatment of cardiomyocytes with CTRP1 also resulted in the increased production of cAMP, which was blocked by suppression of S1P signaling. The antiapoptotic and anti-inflammatory actions of CTRP1 were cancelled by inhibition of adenylyl cyclase or knockdown of adiponectin receptor 1. Furthermore, blockade of S1P signaling reversed CTRP1-mediated inhibition of myocardial infarct size, apoptosis, and inflammation after I/R in vivo. These data indicate that CTRP1 protects against myocardial ischemic injury by reducing apoptosis and inflammatory response through activation of the S1P/cAMP signaling pathways in cardiomyocytes, suggesting that CTRP1 plays a crucial role in the pathogenesis of ischemic heart disease.	[Yuasa, Daisuke; Shibata, Rei; Kataoka, Yoshiyuki; Kambara, Takahiro; Uemura, Yusuke; Matsuo, Kazuhiro; Kanemura, Noriyoshi; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Ogawa, Hayato; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiovasc Med, Nagoya, Aichi 4668550, Japan; [Mizutani, Naoki; Murate, Takashi] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4668550, Japan; [Murate, Takashi] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan; [Mizutani, Naoki] Nagoya Univ, Grad Sch Med, Mol Cardiovasc Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University; Chubu University; Nagoya University	Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiovasc Med, Nagoya, Aichi 4668550, Japan.; Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Mol Cardiovasc Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ohashik@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014	Hiramatsu-Ito, Mizuho/0000-0003-1740-1794	Takeda Science Foundation; AstraZeneca Research and Development; Suzuken Memorial Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); AstraZeneca Research and Development(AstraZeneca); Suzuken Memorial Foundation	The authors thank Y. Inoue and M. Tatsumi for technical assistance. This work was supported by a Grant-in-Aid for Scientific Research, a Grant-in-Aid for Challenging Exploratory Research, grants from Takeda Science Foundation and AstraZeneca Research and Development (to N.O.), and Grant-in-Aid for Scientific Research C and the Suzuken Memorial Foundation (to K.O.). The authors declare no conflicts of interest.	Barron HV, 2001, J AM COLL CARDIOL, V38, P1654, DOI 10.1016/S0735-1097(01)01613-8; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Damirin A, 2005, MOL PHARMACOL, V67, P1177, DOI 10.1124/mol.104.004317; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Fukuda Y, 2003, BIOCHEM BIOPH RES CO, V309, P155, DOI 10.1016/S0006-291X(03)01551-1; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Hla T, 2000, ANN NY ACAD SCI, V905, P16; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Karliner JS, 2001, J MOL CELL CARDIOL, V33, P1713, DOI 10.1006/jmcc.2001.1429; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Kim YS, 2010, INT HEART J, V51, P348, DOI 10.1536/ihj.51.348; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Mazurais D, 2002, J HISTOCHEM CYTOCHEM, V50, P661, DOI 10.1177/002215540205000507; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Nakanishi H, 2009, METHODS MOL BIOL, V579, P287, DOI 10.1007/978-1-60761-322-0_15; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009; Ouchi N, 2012, CIRCULATION, V125, P3066, DOI 10.1161/CIRCULATIONAHA.112.114181; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094478; Panda SK, 2013, GENETICS, V195, P703, DOI 10.1534/genetics.113.156570; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xin YP, 2014, ENDOCR J, V61, P841, DOI 10.1507/endocrj.EJ14-0016; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yan WJ, 2014, J MOL CELL CARDIOL, V74, P183, DOI 10.1016/j.yjmcc.2014.05.010; Yuasa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099846; Zhang JQ, 2007, AM J PHYSIOL-HEART C, V293, pH3150, DOI 10.1152/ajpheart.00587.2006	43	55	60	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1065	1075		10.1096/fj.15-279885	http://dx.doi.org/10.1096/fj.15-279885			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26578687				2022-12-26	WOS:000370387800006
J	Kyeong, S; Jeong, C; Kang, H; Cho, HJ; Park, SJ; Yang, JK; Kim, S; Kim, HM; Jun, BH; Lee, YS				Kyeong, San; Jeong, Cheolhwan; Kang, Homan; Cho, Hong-Jun; Park, Sung-Jun; Yang, Jin-Kyoung; Kim, Sehoon; Kim, Hyung-Mo; Jun, Bong-Hyun; Lee, Yoon-Sik			Double-Layer Magnetic Nanoparticle-Embedded Silica Particles for Efficient Bio-Separation	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; HOLLOW SPHERES; DRUG-DELIVERY; CELL-SEPARATION; QUANTUM DOTS; NANOCLUSTERS	Superparamagnetic Fe3O4 nanoparticles (NPs) based nanomaterials have been exploited in various biotechnology fields including biomolecule separation. However, slow accumulation of Fe3O4 NPs by magnets may limit broad applications of Fe3O4 NP-based nanomaterials. In this study, we report fabrication of Fe3O4 NPs double-layered silica nanoparticles (DL MNPs) with a silica core and highly packed Fe3O4 NPs layers. The DL MNPs had a superparamagnetic property and efficient accumulation kinetics under an external magnetic field. Moreover, the magnetic field-exposed DL MNPs show quantitative accumulation, whereas Fe3O4 NPs single-layered silica nanoparticles (SL MNPs) and silica-coated Fe3O4 NPs produced a saturated plateau under full recovery of the NPs. DL MNPs are promising nanomaterials with great potential to separate and analyze biomolecules.	[Kyeong, San; Jeong, Cheolhwan; Park, Sung-Jun; Yang, Jin-Kyoung; Lee, Yoon-Sik] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Kang, Homan] Seoul Natl Univ, Nano Syst Inst, Seoul, South Korea; [Kang, Homan] Seoul Natl Univ, Interdisciplinary Program Nanosci & Technol, Seoul, South Korea; [Cho, Hong-Jun; Kim, Sehoon] Korea Inst Sci & Technol, Ctr Theragnosis, Seoul, South Korea; [Kim, Hyung-Mo; Jun, Bong-Hyun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Konkuk University	Jun, BH (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	bjun@konkuk.ac.kr; yslee@snu.ac.kr	Kang, Homan/I-1528-2013; Lee, Yoon-Sik/W-3770-2018	Kang, Homan/0000-0002-0732-9779; Kim, Hyung-Mo/0000-0001-8507-089X	National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning [2014-A002-0065]	National Research Foundation of Korea(NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science, ICT & Future Planning(2014-A002-0065). Consulting service from Microbial Carbohydrate Resource Bank (MCRB) is gratefully acknowledged.	Amstad E, 2009, NANO LETT, V9, P4042, DOI 10.1021/nl902212q; Bai LL, 2014, J MATER CHEM B, V2, P4080, DOI 10.1039/c4tb00456f; Bourgeat-Lami E, 1998, J COLLOID INTERF SCI, V197, P293, DOI 10.1006/jcis.1997.5265; Bucak S, 2003, BIOTECHNOL PROGR, V19, P477, DOI 10.1021/bp0200853; Caruso F, 2001, CHEM MATER, V13, P109, DOI 10.1021/cm001164h; Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111; De M, 2008, ADV MATER, V20, P4225, DOI 10.1002/adma.200703183; Di Corato R, 2011, ACS NANO, V5, P1109, DOI 10.1021/nn102761t; Graf C, 2003, LANGMUIR, V19, P6693, DOI 10.1021/la0347859; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hui C, 2011, NANOSCALE, V3, P701, DOI 10.1039/c0nr00497a; Insin N, 2008, ACS NANO, V2, P197, DOI 10.1021/nn700344x; Jeong U, 2007, ADV MATER, V19, P33, DOI 10.1002/adma.200600674; Jia L, 2014, CHEM-EUR J, V20, P2065, DOI 10.1002/chem.201303659; Lalatonne Y, 2004, NAT MATER, V3, P121, DOI 10.1038/nmat1054; Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t; Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866; Mahmoudi M, 2011, ADV DRUG DELIVER REV, V63, P24, DOI 10.1016/j.addr.2010.05.006; Ovsyannikov SV, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/17/172201; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Rho WY, 2014, J IND ENG CHEM, V20, P2646, DOI 10.1016/j.jiec.2013.12.014; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; SONTI SV, 1995, J COLLOID INTERF SCI, V170, P575, DOI 10.1006/jcis.1995.1137; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Stoeva SI, 2005, J AM CHEM SOC, V127, P15362, DOI 10.1021/ja055056d; Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018; Tadic M, 2014, APPL SURF SCI, V322, P255, DOI 10.1016/j.apsusc.2014.09.181; Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202; Tartaj P, 2001, ADV MATER, V13, P1620, DOI 10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z; Teja AS, 2009, PROG CRYST GROWTH CH, V55, P22, DOI 10.1016/j.pcrysgrow.2008.08.003; Vollmer C, 2011, COORDIN CHEM REV, V255, P2039, DOI 10.1016/j.ccr.2011.03.005; Xu CJ, 2004, J AM CHEM SOC, V126, P3392, DOI 10.1021/ja031776d; Xu HY, 2011, BIOMATERIALS, V32, P9758, DOI 10.1016/j.biomaterials.2011.08.076; Yi DK, 2005, J AM CHEM SOC, V127, P4990, DOI 10.1021/ja0428863	35	20	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143727	10.1371/journal.pone.0143727	http://dx.doi.org/10.1371/journal.pone.0143727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599084	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600110
J	Daubenspeck, JM; Jordan, DS; Simmons, W; Renfrow, MB; Dybvig, K				Daubenspeck, James M.; Jordan, David S.; Simmons, Warren; Renfrow, Matthew B.; Dybvig, Kevin			General N-and O-Linked Glycosylation of Lipoproteins in Mycoplasmas and Role of Exogenous Oligosaccharide	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; PULMONIS; SYSTEM; GENOME; ARTHRITIDIS; HOST	The lack of a cell wall, flagella, fimbria, and other extracellular appendages and the possession of only a single membrane render the mycoplasmas structurally simplistic and ideal model organisms for the study of glycoconjugates. Most species have genomes of about 800 kb and code for few proteins predicted to have a role in glycobiology. The murine pathogens Mycoplasma arthritidis and Mycoplasma pulmonis have only a single gene annotated as coding for a glycosyltransferase but synthesize glycolipid, polysaccharide and glycoproteins. Previously, it was shown that M. arthritidis glycosylated surface lipoproteins through O-linkage. In the current study, O-linked glycoproteins were similarly found in M. pulmonis and both species of mycoplasma were found to also possess N-linked glycans at residues of asparagine and glutamine. Protein glycosylation occurred at numerous sites on surface-exposed lipoproteins with no apparent amino acid sequence specificity. The lipoproteins of Mycoplasma pneumoniae also are glycosylated. Glycosylation was dependent on the glycosidic linkages from host oligosaccharides. As far as we are aware, N-linked glycoproteins have not been previously described in Gram-positive bacteria, the organisms to which the mycoplasmas are phylogenetically related. The findings indicate that the mycoplasma cell surface is heavily glycosylated with implications for the modulation of mycoplasma-host interactions.	[Daubenspeck, James M.; Simmons, Warren; Dybvig, Kevin] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA; [Jordan, David S.; Dybvig, Kevin] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Renfrow, Matthew B.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Dybvig, K (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA.	dybvig@uab.edu		Renfrow, Matthew B./0000-0002-4193-7305	National Institutes of Health [AI63909, AI93750]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093750, R01AI063909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI63909 and AI93750) to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonsen JH, 2012, J PROTEOME RES, V11, P5781, DOI 10.1021/pr300584x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brooks SA, 2009, MOL BIOTECHNOL, V43, P76, DOI 10.1007/s12033-009-9184-6; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Coyne MJ, 2013, MOL MICROBIOL, V88, P772, DOI 10.1111/mmi.12220; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Daubenspeck JM, 2009, MOL MICROBIOL, V72, P1235, DOI 10.1111/j.1365-2958.2009.06720.x; Dybvig K, 2008, INFECT IMMUN, V76, P4000, DOI 10.1128/IAI.00516-08; Dybvig K, 2010, FEMS MICROBIOL LETT, V311, P51, DOI 10.1111/j.1574-6968.2010.02078.x; Fletcher CM, 2011, J BIOL CHEM, V286, P3219, DOI 10.1074/jbc.M110.194506; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Gedcke D. A., 2001, AN58 ORTEC; Herrmann JL, 2000, FEBS LETT, V473, P358, DOI 10.1016/S0014-5793(00)01553-2; Iwashkiw JA, 2013, MOL MICROBIOL, V89, P14, DOI 10.1111/mmi.12265; Jordan DS, 2013, MOL MICROBIOL, V90, P1046, DOI 10.1111/mmi.12415; Jordan DS, 2013, MOL MICROBIOL, V89, P918, DOI 10.1111/mmi.12320; LINDSEY JR, 1971, AM J PATHOL, V64, P675; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lu QH, 2015, TRENDS MICROBIOL, V23, P630, DOI 10.1016/j.tim.2015.07.003; Luo WY, 2008, INFECT IMMUN, V76, P4989, DOI 10.1128/IAI.00667-08; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Plou FJ, 2002, CAN J CHEM, V80, P743, DOI 10.1139/V02-104; Russell D, 2009, CARBOHYD RES, V344, P1508, DOI 10.1016/j.carres.2009.06.033; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Simmons WL, 2013, MICROBIOL-SGM, V159, P737, DOI 10.1099/mic.0.064782-0; Staats CC, 2007, GENET MOL BIOL, V30, P225, DOI 10.1590/S1415-47572007000200009; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Valliere-Douglass JF, 2010, J BIOL CHEM, V285, P16012, DOI 10.1074/jbc.M109.096412; Wise Kim S., 1995, P227, DOI 10.1016/B978-012583805-4/50024-8; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	31	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143362	10.1371/journal.pone.0143362	http://dx.doi.org/10.1371/journal.pone.0143362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599081	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900099
J	He, YF; Wang, CQ; Yu, Y; Qian, J; Song, K; Sun, QM; Zhou, J				He, Yi-Feng; Wang, Chao-Qun; Yu, Yao; Qian, Jing; Song, Kang; Sun, Qi-Man; Zhou, Jian			Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection	PLOS ONE			English	Article							EXPRESSION; ANGIOGENESIS; CELLS	Background Tie2-expressing monocytes (TEMs) are found in various tumors, involved in forming tumor blood vessels and expressing several important proangiogenic factors. The goals of this study were to evaluate the value of TEMs in diagnosing and predicting the prognosis of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Methods Flow cytometry was performed to identify and count TEMs in peripheral blood monocytes from HCC patients (n = 84) receiving hepatectomy, HBV cirrhotic patients (n = 21), benign tumors patients (n = 15) and healthy volunteers (n = 23). Angiopoietin-2 (Ang-2) levels in the plasma were determined by enzyme linked immunosorbent assay. The distribution of TEMs in tumor tissue was observed by immunofluorescence staining. Then we determined the vascular area as a percentage of tumor area (vascular area/tumor area) by immunohistochemical staining. Finally the prognostic significance of TEMs and other clinicopathologic factors was evaluated. Results Percentage of TEMs in peripheral blood monocytes significantly increased in HCC patients compared with HBV cirrhotic patients and healthy donors (both P < 0.001). However there was no significance in benign liver tumor (P = 0.482). In addition, the percentage of circulating TEMs was positively correlated with plasma Ang-2 concentration (P < 0.001, r(2) = 0.294) and vascular area/tumor area (P < 0.001, r(2) = 0.126). Furthermore the percentage of intratumoral TEMs was significantly higher than that of paratumoral TEMs (P < 0.001). Increased circulating TEMs was associated with poor overall survival (P = 0.043) and a shorter time to recurrence (P = 0.041). Multivariate Cox analysis also revealed that the percentage of TEMs in peripheral blood was an independent factor for HCC patients' prognosis. Conclusions TEMs may promote angiogenesis in HCC regarding the angiopoietin/Tie2 signal pathway. Percentage of TEMs in peripheral blood monocytes may be applied as a biomarker for identifying HBV-related HCC and predicting the prognosis of these patients after resection.	[He, Yi-Feng; Wang, Chao-Qun; Yu, Yao; Song, Kang; Sun, Qi-Man; Zhou, Jian] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, Shanghai 200032, Peoples R China; [He, Yi-Feng; Wang, Chao-Qun; Yu, Yao; Song, Kang; Sun, Qi-Man; Zhou, Jian] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Qian, Jing] Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhou, Jian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhou, J (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, Shanghai 200032, Peoples R China.	zhou.jian@zs-hospital.sh.cn		Zhou, Jian/0000-0002-7650-7540	National Natural Science Foundation of China [81101805]; Shanghai Health Bureau Scientific Research Found Projects [2009Y007]; Central Universities Research Found Projects for Improving Young Teachers' Ability of Fudan University [JJF152045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Health Bureau Scientific Research Found Projects; Central Universities Research Found Projects for Improving Young Teachers' Ability of Fudan University	This work was supported by grants from National Natural Science Foundation of China (No. 81101805; www.nsfc.gov.cn; YFH), Shanghai Health Bureau Scientific Research Found Projects (No. 2009Y007; www.wsjsw.gov.cn/wsj/; YFH) and Central Universities Research Found Projects for Improving Young Teachers' Ability of Fudan University (No. JJF152045; www.fudan.edu.cn; YFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chebib I, 2007, BIOMARK INSIGHTS, V2, P59; Coffelt SB, 2011, J IMMUNOL, V186, P4183, DOI 10.4049/jimmunol.1002802; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Escobar G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006353; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Forget MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098623; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Goede V, 2012, CANCER INVEST, V30, P225, DOI 10.3109/07357907.2011.636114; Huang HH, 2011, CLIN CANCER RES, V17, P1001, DOI 10.1158/1078-0432.CCR-10-2317; Lekas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043568; Matsubara T, 2012, HEPATOLOGY; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sugimachi K, 2003, J CLIN PATHOL, V56, P854, DOI 10.1136/jcp.56.11.854; Tanaka F, 2002, CANCER RES, V62, P7124; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; Yu Y, 2001, AM J PATHOL, V159, P2271, DOI 10.1016/S0002-9440(10)63077-5	21	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143657	10.1371/journal.pone.0143657	http://dx.doi.org/10.1371/journal.pone.0143657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599011	Green Published, gold			2022-12-26	WOS:000365853900152
J	Mishra, SR; Sharma, A; Bhandari, PM; Bhochhibhoya, S; Thapa, K				Mishra, Shiva Raj; Sharma, Abhishek; Bhandari, Parash Mani; Bhochhibhoya, Shristi; Thapa, Kiran			Depression and Health-Related Quality of Life among Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Nepal	PLOS ONE			English	Article							PREVALENCE; EQ-5D; CARE	Background Diabetes is accompanied by a marked reduction in patient's quality of life (QOL) and leads to higher disability-adjusted life years than most diseases. Depression further deteriorates QOL and is associated with poor treatment outcomes and lowered glycemic control in diabetes. We analysed the QOL and depression among the people living with diabetes in Nepal. Methods We conducted a cross-sectional survey among a random sample of 157 diabetic patients visiting diabetes clinic at a major teaching hospital in Kathmandu, Nepal. We administered the Nepali version of WHO-BREF for face to face interviews to obtain data on QOL scores. The Nepali version of Patient Health Questionnaire-9was also used to record responses on depression items. Results More than half of the respondents (54.1%) experienced depression with mean PHQ-9 score of 6.15 +/- 5.01 on a scale of 0-27. On a scale of 0 to 100, highest QOL mean score was reported in social relationship domain (57.32 +/- 11.83), followed by environment domain (54.71 +/- 7.74), psychological health (53.25 +/- 10.32) and physical health (50.74 +/- 11.83). After adjusting for other covariates, urban residence decreased the physical health score by 4.74 (beta = -4.74, 95% CI: -8.664,-0.821), social relationship domain score by 3.420 (beta = -3.420, 95% CI: -6.433,-0.406) and the overall QOL by 2.773 (beta = -2.773, 95% CI: -5.295,0.252). Having diagnosed with diabetes since more than 10 years increased physical health by 5.184 score points (beta = 5.184; 95% CI: 0.753, 9.615). Similarly, having severe depression decreased social relation domain score by 6.053 (beta = -6.053, 95% CI:-11.169,-. 936). Conclusion Having urban residence significantly decreased the physical health and social relation domain scores as well as the overall QOL scores. Similarly, having diagnosed since more than 10 years increased physical health domain score. Severe depression decreased social relationship domain score. Since depression affects QOL, we suggest early diagnosis and prompt treatment of depression in T2DM people as part of their routine primary care in Nepal.	[Mishra, Shiva Raj] Nepal Dev Soc, Bharatpur 10, Chitwan, Nepal; [Sharma, Abhishek] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Sharma, Abhishek] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA; [Bhandari, Parash Mani; Bhochhibhoya, Shristi; Thapa, Kiran] Tribhuvan Univ, Inst Med, Kathmandu, Nepal	Boston University; Boston University; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Mishra, SR (corresponding author), Nepal Dev Soc, Bharatpur 10, Chitwan, Nepal.	shivarajmishra@gmail.com	Mishra, Shiva Raj/C-4172-2014; Sharma, Abhishek/D-3730-2017	Mishra, Shiva Raj/0000-0002-2993-3504; 	Department of Medicine, Maharajgunj Medical Campus	Department of Medicine, Maharajgunj Medical Campus	We thank all the study participants for their time and information. We are grateful to the Department of Medicine, Maharajgunj Medical Campus and the staff members for their generous support during the study. We also thank Dipika Neupane, Sabita Thapa and Sarmila Dhakal for their support during data collection.	Baral N., 2000, SMJ, V41, P264; Bloom DE., 2012, GLOBAL EC BURDEN NON; Chaveepojnkamjorn Wisit, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P328; Chhetri M R, 2009, Nepal Med Coll J, V11, P34; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Eren I, 2008, DEPRESS ANXIETY, V25, P98, DOI 10.1002/da.20288; Giri S, 2013, HIV AIDS-RES PALLIAT, V5, P277, DOI 10.2147/HIV.S50726; Grandy S, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-99; Institute of Digital Research and Education UCLA, SPSS FAQ WHAT DOES C; Kiadaliri AA, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-54; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Porojan M, 2012, Rom J Intern Med, V50, P27; Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; Sharma A, 2015, BMJ-BRIT MED J, V2015, ph2430; Shrestha S S, 2013, Kathmandu Univ Med J (KUMJ), V11, P226; Singh DL, 2003, DIABETIC MED, V20, P170, DOI 10.1046/j.1464-5491.2003.00829_4.x; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Thommasen Harvey V, 2005, Rural Remote Health, V5, P441; Wandell PE, 2005, SCAND J PRIM HEALTH, V23, P68, DOI 10.1080/02813430510015296; World Health Organization, PREV DIAB S E AS REG; World Health Organization, 1996, WHOQOL BRIEF INTR AD; Yekta Z, 2011, DIABETES METAB SYNDR, V4, P393, DOI 10.2147/DMSO.S27050	26	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0141385	10.1371/journal.pone.0141385	http://dx.doi.org/10.1371/journal.pone.0141385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599008	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900011
J	Ma, L; Han, X; Shen, ZS; Wang, WX; Di, ZR				Ma, Long; Han, Xiao; Shen, Zhesi; Wang, Wen-Xu; Di, Zengru			Efficient Reconstruction of Heterogeneous Networks from Time Series via Compressed Sensing	PLOS ONE			English	Article							EVOLUTIONARY GAMES	Recent years have witnessed a rapid development of network reconstruction approaches, especially for a series of methods based on compressed sensing. Although compressed-sensing based methods require much less data than conventional approaches, the compressed sensing for reconstructing heterogeneous networks has not been fully exploited because of hubs. Hub neighbors require much more data to be inferred than small-degree nodes, inducing a cask effect for the reconstruction of heterogeneous networks. Here, a conflict-based method is proposed to overcome the cast effect to considerably reduce data amounts for achieving accurate reconstruction. Moreover, an element elimination method is presented to use the partially available structural information to reduce data requirements. The integration of both methods can further improve the reconstruction performance than separately using each technique. These methods are validated by exploring two evolutionary games taking place in scale-free networks, where individual information is accessible and an attempt to decode the network structure from measurable data is made. The results demonstrate that for all of the cases, much data are saved compared to that in the absence of these two methods. Due to the prevalence of heterogeneous networks in nature and society and the high cost of data acquisition in large-scale networks, these approaches have wide applications in many fields and are valuable for understanding and controlling the collective dynamics of a variety of heterogeneous networked systems.	[Ma, Long; Han, Xiao; Shen, Zhesi; Wang, Wen-Xu; Di, Zengru] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Beijing Normal University	Wang, WX (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	wenxuwang@bnu.edu.cn; zdi@bnu.edu.cn	Shen, Zhesi/A-9307-2015	Shen, Zhesi/0000-0001-8414-7912; Han, Xiao/0000-0003-4219-7721	NNSFC [61573064, 61074116, 61374175]; Beijing Nova Programme, China; Fundamental Research Funds for the Central Universities	NNSFC(National Natural Science Foundation of China (NSFC)); Beijing Nova Programme, China(Beijing Municipal Science & Technology Commission); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	W.-X.W. was supported by NNSFC under Grant No. 61573064, NNSFC under Grant No. 61074116, Beijing Nova Programme, China and the Fundamental Research Funds for the Central Universities. Z.-R.D. was supported by NNSFC under Grant No. 61374175. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Barabasi AL, 2005, NAT PHYS, V1, P68, DOI 10.1038/nphys162; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baraniuk RG, 2007, IEEE SIGNAL PROC MAG, V24, P6, DOI 10.1109/MSP.2007.909718; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Caldarelli G, 2000, EUROPHYS LETT, V52, P386, DOI 10.1209/epl/i2000-00450-8; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Cohen R., 2010, COMPLEX NETWORKS STR; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Gutig R, 2002, NEURAL COMPUT, V14, P121, DOI 10.1162/089976602753284473; Han X, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.028701; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Pipa G, 2003, NEUROCOMPUTING, V52-4, P31, DOI 10.1016/S0925-2312(02)00823-8; Ren J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058701; Romberg J, 2008, IEEE SIGNAL PROC MAG, V25, P14, DOI 10.1109/MSP.2007.914729; Shen Zhesi, 2014, Nat Commun, V5, P4323, DOI 10.1038/ncomms5323; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Timme M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.224101; Wang WX, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.021021; Wang WX, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/48006; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106	30	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142837	10.1371/journal.pone.0142837	http://dx.doi.org/10.1371/journal.pone.0142837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588832	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500018
J	Verloop, WL; Hubens, LEG; Spiering, W; Doevendans, PA; Goldschmeding, R; Bleys, RLAW; Voskuil, M				Verloop, Willemien L.; Hubens, Lisette E. G.; Spiering, Wilko; Doevendans, Pieter A.; Goldschmeding, Roel; Bleys, Ronald L. A. W.; Voskuil, Michiel			The Effects of Renal Denervation on Renal Hemodynamics and Renal Vasculature in a Porcine Model	PLOS ONE			English	Article							SYMPATHETIC DENERVATION; ABLATION; PRESSURE	Rationale Recently, the efficacy of renal denervation (RDN) has been debated. It is discussed whether RDN is able to adequately target the renal nerves. Objective We aimed to investigate how effective RDN was by means of functional hemodynamic measurements and nerve damage on histology. Methods and Results We performed hemodynamic measurements in both renal arteries of healthy pigs using a Doppler flow and pressure wire. Subsequently unilateral denervation was performed, followed by repeated bilateral hemodynamic measurements. Pigs were terminated directly after RDN or were followed for 3 weeks or 3 months after the procedure. After termination, both treated and control arteries were prepared for histology to evaluate vascular damage and nerve damage. Directly after RDN, resting renal blood flow tended to increase by 29 +/- 67% (P = 0.01). In contrast, renal resistance reserve increased from 1.74 (1.28) to 1.88 (1.17) (P = 0.02) during follow-up. Vascular histopathology showed that most nerves around the treated arteries were located outside the lesion areas (8 +/- 7 out of 55 +/- 25 (14%) nerves per pig were observed within a lesion area). Subsequently, a correlation was noted between a more impaired adventitia and a reduction in renal resistance reserve (beta: -0.33; P = 0.05) at three weeks of follow-up. Conclusion Only a small minority of renal nerves was targeted after RDN. Furthermore, more severe adventitial damage was related to a reduction in renal resistance in the treated arteries at follow-up. These hemodynamic and histological observations may indicate that RDN did not sufficiently target the renal nerves. Potentially, this may explain the significant spread in the response after RDN.	[Verloop, Willemien L.; Hubens, Lisette E. G.; Doevendans, Pieter A.; Voskuil, Michiel] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Spiering, Wilko] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bleys, Ronald L. A. W.] Univ Med Ctr Utrecht, Dept Anat, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Voskuil, M (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	m.voskuil@umcutrecht.nl						Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; DIBONA GF, 1989, AM J HYPERTENS, V2, pS119, DOI 10.1093/ajh/2.3.119S; Henegar JR, 2014, AM J HYPERTENS, V27, P1285, DOI 10.1093/ajh/hpu048; Kjeldsen SE, 2014, BLOOD PRESSURE, V23, P135, DOI 10.3109/08037051.2014.916896; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Mahfoud F, 2013, EUR HEART J; Mancia G, 1997, Ann Ital Med Int, V12, P217; Rippy MK, 2011, CLIN RES CARDIOL, V100, P1095, DOI 10.1007/s00392-011-0346-8; Sakakura K, 2014, J AM COLL CARDIOL, V64, P635, DOI 10.1016/j.jacc.2014.03.059; Schlaich MP, 2009, HYPERTENSION, V54, P1195, DOI 10.1161/HYPERTENSIONAHA.109.138610; Schlaich MP, 2009, NEW ENGL J MED, V361, P932, DOI 10.1056/NEJMc0904179; SMITHWICK RH, 1953, JAMA-J AM MED ASSOC, V152, P1501, DOI 10.1001/jama.1953.03690160001001; Steigerwald K, 2012, J HYPERTENS, V30, P2230, DOI 10.1097/HJH.0b013e32835821e5; Tellez A, 2013, TRANSL RES, V162, P381, DOI 10.1016/j.trsl.2013.07.002; Tsioufis C, 2013, INT J CARDIOL, V168, P987, DOI 10.1016/j.ijcard.2012.10.038; van de Hoef TP, 2012, CIRC-CARDIOVASC INTE, V5, P508, DOI 10.1161/CIRCINTERVENTIONS.111.965707; Vink EE, 2014, NEPHROL DIAL TRANSPL; Voskuil M, 2011, NETH HEART J, V19, P319, DOI 10.1007/s12471-011-0143-z; Voskuil M, 2014, ENDOVASCULAR INTERVE, P419; Waksman R, 2013, EUROINTERVENTION, V9, P738, DOI 10.4244/EIJV9I6A118; Wang Z, 2015, AM J HYPERTENS	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0141609	10.1371/journal.pone.0141609	http://dx.doi.org/10.1371/journal.pone.0141609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587981	Green Submitted, gold, Green Published			2022-12-26	WOS:000365251500005
J	Witzig, M; da Silva, AC; Green-Engert, R; Hoelzle, K; Zeller, E; Seifert, J; Hoelzle, LE; Rodehutscord, M				Witzig, Maren; da Silva, Amelia Camarinha; Green-Engert, Rebecca; Hoelzle, Katharina; Zeller, Ellen; Seifert, Jana; Hoelzle, Ludwig E.; Rodehutscord, Markus			Spatial Variation of the Gut Microbiota in Broiler Chickens as Affected by Dietary Available Phosphorus and Assessed by T-RFLP Analysis and 454 Pyrosequencing	PLOS ONE			English	Article							LENGTH-POLYMORPHISM ANALYSIS; LACTIC-ACID BACTERIA; RIBOSOMAL-RNA GENES; COMMUNITY STRUCTURE; GASTROINTESTINAL-TRACT; MINERAL PHOSPHORUS; INTESTINAL MICROBIOTA; PHYTATE HYDROLYSIS; PERFORMANCE; ILEAL	Molecular fingerprinting and sequencing based techniques have been widely used to characterize microbial communities. Terminal restriction fragment length polymorphism (T-RFLP) and 454-pyrosequencing were used to determine the microorganisms present in the different sections of the chicken gastrointestinal tract (GIT) (crop, jejunum, ileum and caeca). Broilers fed with diets differing in phosphorous (P) and calcium (Ca) as well as in phytase levels were used to study the microbiota of the upper and lower part of the GIT. A database with terminal restriction fragments (T-RF) of the most important organism present in the different gastrointestinal sections was constructed. The analysis revealed a distinct microbial assemblage on each section. Regardless of the diet, crop, jejunum and ileum were mainly colonized by Lactobacillaceae, and caeca were the most diverse site. The correlation between Lactobacillus crispatus and L. reuteri was positive in the crop, but negative in the jejunum. In crop samples, higher P and Ca levels led to a shift in the abundance of L. reuteri and L. crispatus to L. salivarius and L. taiwanensis whereas in the ileum supplementation of phytase favored L. salivarius and L. taiwanensis but resulted in decreased abundance of L. crispatus. Both methods were correlating significantly, being T-RFLP a reliable fingerprinting method to rapidly analyze large numbers of samples in a cost-effective and rapid manner. Results are easy to interpret with no need of deep bioinformatics knowledge and can be integrated with taxonomic information.	[Witzig, Maren; da Silva, Amelia Camarinha; Green-Engert, Rebecca; Hoelzle, Katharina; Zeller, Ellen; Seifert, Jana; Hoelzle, Ludwig E.; Rodehutscord, Markus] Univ Hohenheim, Inst Nutztierwissensch, Stuttgart, Germany	University Hohenheim	Witzig, M (corresponding author), Univ Hohenheim, Inst Nutztierwissensch, Stuttgart, Germany.	inst450@uni-hohenheim.de	Hoelzle, Ludwig/U-9030-2019	Camarinha Silva, Amelia/0000-0001-7814-6569; Rodehutscord, Markus/0000-0003-3156-7889; Seifert, Jana/0000-0002-7690-8539	Ministerium fur Wissenschaft, Forschung und Kultur des Landes Baden-Wurttemberg	Ministerium fur Wissenschaft, Forschung und Kultur des Landes Baden-Wurttemberg	This study was funded by the Ministerium fur Wissenschaft, Forschung und Kultur des Landes Baden-Wurttemberg. MR and LEH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Akyurek H, 2011, AFR J AGR RES, V6, P642; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Aydin A, 2010, J APPL POULTRY RES, V19, P422, DOI 10.3382/japr.2009-00123; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bovee-Oudenhoven IM, 1999, J NUTR, V129, P607, DOI 10.1093/jn/129.3.607; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brugger SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052241; Castro-Carrera T, 2015, ANIMAL, V9, P582, DOI 10.1017/S1751731114002882; Castro-Carrera T, 2014, J DAIRY SCI, V97, P1661, DOI 10.3168/jds.2013-7243; Chambers JR, 2011, FOOD RES INT, V44, P3149, DOI 10.1016/j.foodres.2011.08.017; Chee SH, 2010, BRIT POULTRY SCI, V51, P368, DOI 10.1080/00071668.2010.503477; Choe HS, 2012, AM J INFECT CONTROL, V40, pE249, DOI 10.1016/j.ajic.2012.05.010; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collins RE, 2007, NUCLEIC ACIDS RES, V35, pW58, DOI 10.1093/nar/gkm384; Craven SE, 1998, J FOOD PROTECT, V61, P265, DOI 10.4315/0362-028X-61.3.265; Dersjant-Li Y, 2015, J SCI FOOD AGR, V95, P878, DOI 10.1002/jsfa.6998; Edelman S, 2003, VET MICROBIOL, V91, P41, DOI 10.1016/S0378-1135(02)00153-0; Egert M, 2003, APPL ENVIRON MICROB, V69, P2555, DOI 10.1128/AEM.69.5.2555-2562.2003; Egert M, 2005, J MICROBIOL METH, V61, P69, DOI 10.1016/j.mimet.2004.11.002; Geier MS, 2011, BRIT POULTRY SCI, V52, P564, DOI 10.1080/00071668.2011.607429; Geier MS, 2009, J APPL MICROBIOL, V106, P1540, DOI 10.1111/j.1365-2672.2008.04116.x; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Hanshew AS, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-43; Hilmi HTA, 2007, APPL ENVIRON MICROB, V73, P7867, DOI 10.1128/AEM.01128-07; Huber K, 2015, POULTRY SCI, V94, P1009, DOI 10.3382/ps/pev065; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Joo S, 2010, J MICROBIOL METH, V81, P61, DOI 10.1016/j.mimet.2010.01.025; Kiarie E, 2013, NUTR RES REV, V26, P71, DOI 10.1017/S0954422413000048; KOMISARCZUK S, 1987, REPROD NUTR DEV, V27, P907, DOI 10.1051/rnd:19870703; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Larsen N, 2007, INT J FOOD MICROBIOL, V114, P113, DOI 10.1016/j.ijfoodmicro.2006.10.033; Lee NK, 2013, ANN MICROBIOL, V63, P555, DOI 10.1007/s13213-012-0503-y; Maenz DD, 1998, POULTRY SCI, V77, P557, DOI 10.1093/ps/77.4.557; Mann E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086950; Metzler BU, 2008, J ANIM SCI, V86, P1544, DOI 10.2527/jas.2007-0267; Metzler-Zebeli BU, 2010, J ANIM SCI, V88, P147, DOI 10.2527/jas.2008-1560; Metzler-Zebeli BU, 2010, APPL ENVIRON MICROB, V76, P3692, DOI 10.1128/AEM.00257-10; Nordentoft S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-187; Palaciosa MC, 2008, LWT-FOOD SCI TECHNOL, V41, P82, DOI 10.1016/j.lwt.2007.02.005; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Ptak A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119770; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Shastak Y, 2014, POULTRY SCI, V93, P2548, DOI 10.3382/ps.2014-03961; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Taheri HR, 2009, POULTRY SCI, V88, P1586, DOI 10.3382/ps.2009-00041; Torok VA, 2008, APPL ENVIRON MICROB, V74, P783, DOI 10.1128/AEM.01384-07; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; Torok VA, 2011, APPL ENVIRON MICROB, V77, P3380, DOI 10.1128/AEM.02300-10; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; Vital M, 2015, ISME J, V9, P832, DOI 10.1038/ismej.2014.179; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Weremko D, 1997, ASIAN AUSTRAL J ANIM, V10, P551, DOI 10.5713/ajas.1997.551; Zeller E, 2015, POULTRY SCI, V94, P1018, DOI 10.3382/ps/pev087	60	38	39	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143442	10.1371/journal.pone.0143442	http://dx.doi.org/10.1371/journal.pone.0143442			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588075	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500062
J	Bell, A; Chiappe, LM				Bell, Alyssa; Chiappe, Luis M.			Identification of a New Hesperornithiform from the Cretaceous Niobrara Chalk and Implications for Ecologic Diversity among Early Diving Birds	PLOS ONE			English	Article							NORTH-AMERICA; BODY-SIZE; PENGUINS; CANADA; AVES	The Smoky Hill Member of the Niobrara Chalk in Kansas (USA) has yielded the remains of numerous members of the Hesperornithiformes, toothed diving birds from the late Early to Late Cretaceous. This study presents a new taxon of hesperornithiform from the Smoky Hill Member, Fumicollis hoffmani, the holotype of which is among the more complete hesperornithiform skeletons. Fumicollis has a unique combination of primitive (e.g. proximal and distal ends of femur not expanded, elongate pre-acetabular ilium, small and pyramidal patella) and derived (e.g. dorsal ridge on metatarsal IV, plantarly-projected curve in the distal shaft of phalanx III:1) hesperornithiform characters, suggesting it was more specialized than small hesperornithiforms like Baptornis advenus but not as highly derived as the larger Hesperornis regalis. The identification of Fumicollis highlights once again the significant diversity of hesperornithiforms that existed in the Late Cretaceous Western Interior Seaway. This diversity points to the existence of a complex ecosystem, perhaps with a high degree of niche partitioning, as indicated by the varying degrees of diving specializations among these birds.	[Bell, Alyssa; Chiappe, Luis M.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA		Bell, A (corresponding author), Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA.	abell@nhm.org		Chiappe, Luis/0000-0001-9661-0601	Dinosaur Institute	Dinosaur Institute	This study was made possible by Gretchen Augustyn, whose support of the Dinosaur Institute funded the postdoctoral fellowship of A. Bell.	Bardack D., 1968, Canadian Journal of Earth Sciences, V5, P145; BAUMEL JJ, 1993, HDB AVIAN ANATOMY NO, P00133; Bell A., 2013, THESIS; BRYANT LJ, 1983, PALEOBIOS, V40, P1; Buttendieck E, 1980, BENENNUNG SKELETTS B; Carpenter K., 2008, TOPICS GEOBIOLOGY, P421, DOI DOI 10.1017/S001675680530077X; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Chiappe LM, 2015, J SYST PAL; Chiappe LM, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3594[1:JBFTEC]2.0.CO;2; Cumbaa Stephen L., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P139; Dyke GJ, 2006, CRETACEOUS RES, V27, P947, DOI 10.1016/j.cretres.2006.05.001; Elzanowski A, 2000, J VERTEBR PALEONTOL, V20, P712, DOI 10.1671/0272-4634(2000)020[0712:AAQFTL]2.0.CO;2; Everhart Michael J., 2001, Transactions of the Kansas Academy of Science, V104, P59, DOI 10.1660/0022-8443(2001)104[0059:RTTBOT]2.0.CO;2; Everhart MJ, 2009, J VERTEBR PALEONTOL, V29, P952, DOI 10.1671/039.029.0301; Galton Peter M., 2002, P317; Hou L.I., 1999, GU JI ZHUI DONG WU X, V37, P231; Johansson LC, 2001, J EXP BIOL, V204, P1687; Kurochkin EN, 2005, AGE DINOSAURS RUSSIA, P533; Marsh O.C., 1872, AM J SCI ARTS, V3, P1; Marsh O.C., 1877, AM J SCI ARTS, V14, P79; Marsh O.C., 1880, ODONTORNITHES MONOGR, DOI [10.5962/bhl.title.61298, DOI 10.5962/BHL.TITLE.61298]; Martin L.D., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P35; MARTIN L D, 1984, Transactions of the Kansas Academy of Science, V87, P141, DOI 10.2307/3627850; Martin Larry D., 2012, Palaeoworld, V21, P59, DOI 10.1016/j.palwor.2012.02.005; Martin Larry D., 2002, P165; Miller AK, 2010, CONDOR, V112, P683, DOI 10.1525/cond.2010.090221; MONDEJAR SANCHEZ J. M., 2010, THESIS; Nessov L.A., 1983, Trudy Zoologicheskogo Instituta, V116, P108; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; Panteleyev AV, 2004, PAL RES, V8, P1115; Rees J, 2005, PALAEONTOLOGY, V48, P1321, DOI 10.1111/j.1475-4983.2005.00507.x; Tokaryk TT, 1997, J VERTEBR PALEONTOL, V17, P172, DOI 10.1080/02724634.1997.10010961; Wilson LE, 2011, J SYST PALAEONTOL, V9, P9, DOI 10.1080/14772019.2010.502910; Wilson RP, 2010, FUNCT ECOL, V24, P646, DOI 10.1111/j.1365-2435.2009.01654.x; Zavalaga CB, 2007, MAR ECOL PROG SER, V336, P291, DOI 10.3354/meps336291; Zavalaga CB, 1997, CONDOR, V99, P1002, DOI 10.2307/1370156; Zinoviev AV, 2011, J SYST PALAEONTOL, V9, P65, DOI 10.1080/14772019.2010.512615	37	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141690	10.1371/journal.pone.0141690	http://dx.doi.org/10.1371/journal.pone.0141690			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580402	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600019
J	Heidary, N; Utesch, T; Zerball, M; Horch, M; Millo, D; Fritsch, J; Lenz, O; von Klitzing, R; Hildebrandt, P; Fischer, A; Mroginski, MA; Zebger, I				Heidary, Nina; Utesch, Tillmann; Zerball, Maximilian; Horch, Marius; Millo, Diego; Fritsch, Johannes; Lenz, Oliver; von Klitzing, Regine; Hildebrandt, Peter; Fischer, Anna; Mroginski, Maria Andrea; Zebger, Ingo			Orientation-Controlled Electrocatalytic Efficiency of an Adsorbed Oxygen-Tolerant Hydrogenase	PLOS ONE			English	Article							MEMBRANE-BOUND HYDROGENASE; RALSTONIA-EUTROPHA H16; NIFE HYDROGENASE; MOLECULAR-DYNAMICS; ABSORPTION-SPECTROSCOPY; ELECTRON-TRANSFER; ENZYME; IMMOBILIZATION; OXIDATION; SUBUNIT	Protein immobilization on electrodes is a key concept in exploiting enzymatic processes for bioelectronic devices. For optimum performance, an in-depth understanding of the enzyme-surface interactions is required. Here, we introduce an integral approach of experimental and theoretical methods that provides detailed insights into the adsorption of an oxygen-tolerant [NiFe] hydrogenase on a biocompatible gold electrode. Using atomic force microscopy, ellipsometry, surface-enhanced IR spectroscopy, and protein film voltammetry, we explore enzyme coverage, integrity, and activity, thereby probing both structure and catalytic H-2 conversion of the enzyme. Electrocatalytic efficiencies can be correlated with the mode of protein adsorption on the electrode as estimated theoretically by molecular dynamics simulations. Our results reveal that pre-activation at low potentials results in increased current densities, which can be rationalized in terms of a potential-induced re-orientation of the immobilized enzyme.	[Heidary, Nina; Utesch, Tillmann; Zerball, Maximilian; Horch, Marius; Lenz, Oliver; von Klitzing, Regine; Hildebrandt, Peter; Fischer, Anna; Mroginski, Maria Andrea; Zebger, Ingo] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Millo, Diego] Vrije Univ Amsterdam, Biomol Spectroscopy LaserLaB Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Fritsch, Johannes] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; [Fischer, Anna] Univ Freiburg, Inst Anorgan & Analyt Chem, D-79104 Freiburg, Germany	Technical University of Berlin; Vrije Universiteit Amsterdam; Humboldt University of Berlin; University of Freiburg	Fischer, A (corresponding author), Tech Univ Berlin, Inst Chem, Str 17 Juni 135 & 124, D-10623 Berlin, Germany.	anna.fischer@ac.uni-freiburg.de; andrea.mroginski@tu-berlin.de; ingo.zebger@tu-berlin.de	Lenz, Oliver/C-1582-2019; von Klitzing, Regine/ABD-9728-2020; Horch, Marius/AAK-5439-2020; Fischer, Anna/ABG-8100-2021; Fischer, Anna T. L./L-8830-2015; Lenz, Oliver/N-5130-2019; Hildebrandt, Peter/J-5658-2014	Lenz, Oliver/0000-0003-4550-5128; von Klitzing, Regine/0000-0003-0555-5104; Horch, Marius/0000-0001-6656-1749; Fischer, Anna/0000-0003-4567-3009; Fischer, Anna T. L./0000-0003-4567-3009; Lenz, Oliver/0000-0003-4550-5128; Hildebrandt, Peter/0000-0003-1030-5900	Deutsche Forschungsgemeinschaft [EXC 314]; Technische Universitat Berlin; NWO [722.011.003]; Alexander von Humboldt-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Technische Universitat Berlin; NWO(Netherlands Organization for Scientific Research (NWO)); Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation)	This work was supported by EXC 314, "UniCat", Deutsche Forschungsgemeinschaft (http://www.dfg.de/); Technische Universitat Berlin (http://www.tu-berlin.de/) (to MZ); grant 722.011.003, NWO (http://www.nwo.nl); and Alexander von Humboldt-Stiftung (https://www.humboldt-foundation.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu Y, 2011, CHEM MATER, V23, P1798, DOI 10.1021/cm103087p; Ciaccafava A, 2012, ANGEW CHEM INT EDIT, V51, P953, DOI 10.1002/anie.201107053; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Gutierrez-Sanchez C, 2011, LANGMUIR, V27, P6449, DOI 10.1021/la200141t; Gutierrez-Sanz O, 2013, J PHYS CHEM LETT, V4, P2794, DOI 10.1021/jz4013678; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Latour RA, 2008, BIOINTERPHASES, V3, pFC2, DOI 10.1116/1.2965132; Leopold MC, 2002, LANGMUIR, V18, P978, DOI 10.1021/la011683e; Lojou E, 2011, ELECTROCHIM ACTA, V56, P10385, DOI 10.1016/j.electacta.2011.03.002; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Millo D, 2011, ANGEW CHEM INT EDIT, V50, P2632, DOI 10.1002/anie.201006646; Millo D, 2009, J PHYS CHEM B, V113, P15344, DOI 10.1021/jp906575r; Miyake H, 2002, ELECTROCHEM COMMUN, V4, P973, DOI 10.1016/S1388-2481(02)00510-6; Oteri F, 2014, PHYS CHEM CHEM PHYS, V16, P11318, DOI 10.1039/c4cp00510d; Parkin A, 2012, CURR OPIN CHEM BIOL, V16, P26, DOI 10.1016/j.cbpa.2012.01.012; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plumere N, 2014, NAT CHEM, V6, P822, DOI [10.1038/nchem.2022, 10.1038/NCHEM.2022]; Rippers Y, 2012, CHEMPHYSCHEM, V13, P3852, DOI 10.1002/cphc.201200562; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Sezer M, 2011, J PHYS CHEM B, V115, P10368, DOI 10.1021/jp204665r; Utesch T, 2013, LANGMUIR, V29, P673, DOI 10.1021/la303635q; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Wisitruangsakul N, 2009, ANGEW CHEM INT EDIT, V48, P611, DOI 10.1002/anie.200802633	29	23	23	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143101	10.1371/journal.pone.0143101	http://dx.doi.org/10.1371/journal.pone.0143101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580976	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600083
J	Bechade, C; Goovaerts, T; Cougnet, P; Labriola, L; Jadoul, M; Goffin, E				Bechade, Clemence; Goovaerts, Tony; Cougnet, Philippe; Labriola, Laura; Jadoul, Michel; Goffin, Eric			Buttonhole Cannulation Is Not Associated with More AVF Infections in a Low-Care Satellite Dialysis Unit: A Long-Term Longitudinal Study	PLOS ONE			English	Article							ROPE-LADDER; ARTERIOVENOUS-FISTULAS; HEMODIALYSIS; TRIAL; OUTCOMES	Background Buttonhole cannulation (BHC) has been associated with a greater risk of arteriovenous fistula (AVF)-related infections and septicemia than the rope ladder cannulation (RLC) in incenter hemodialysis (HD). Such infections have never been studied in satellite HD units. Study Design Retrospective single center study. Setting and Participant All patients in our satellite HD unit using a native AVF from 1 January, 1990, to 31 December, 2012. Study Period Two different kinds of cannulation have been used during the study period: From 1 January, 1990 to 1, January, 1998 RLC was used in the unit (period 1). After 1 January, 1998 onwards, all the patients were switched within 3 months to BHC (period 2). Outcomes Three different infectious events were observed during the two periods: local AVF infection, bacteremia, and combined infection. The aim of this study was to evaluate the incidence of AVF-related infections in our low-care HD unit and to determine whether BHC is associated with an increased risk of infection in this population. Results 162 patients were analyzed; 68 patients participated to period 1 and 115 to period 2. Sixteen infectious events occurred. Incidences of AVF-related infectious events were 0.05 [95% CI, 0.02-0.16] and 0.13/1000 AVF-days [95% CI, 0.0.8-0.23], for period 1 and 2 (p = 0.44) respectively. Recurrence of AVF-related infection was observed only during period 2. Unadjusted incidence rate ratio (IRR) of all infections was 0.39 (95% CI 0.12-1.37). Two complicated infections occurred during the study period: one in period 1 and one in period 2. Limitations Observational retrospective single centre study Conclusions BHC is not associated with an increased infectious incidence in our HD population from a satellite dialysis unit. In the rare patients with AVF-related infection it seems necessary to change cannulation sites as recurrence of infection might be an event more frequent with BHC.	[Bechade, Clemence] CHU Clemenceau, Nephrol, Caen, France; [Goovaerts, Tony; Cougnet, Philippe; Labriola, Laura; Jadoul, Michel; Goffin, Eric] Catholic Univ Louvain, Clin Univ St Luc, Nephrol, B-1200 Brussels, Belgium	CHU de Caen NORMANDIE; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Bechade, C (corresponding author), CHU Clemenceau, Nephrol, Caen, France.	bechade-c@chu-caen.fr	béchade, Clémence/ABD-8756-2020	Goffin, Eric/0000-0001-9242-7148; Labriola, Laura/0000-0003-4133-881X; Bechade, Clemence/0000-0002-8481-6589				Birchenough E, 2010, NEPHROL NURS J, V37, P491; Goovaerts T, 2005, NEPHROL DIAL TRANSPL, V20, P1842, DOI 10.1093/ndt/gfh905; Labriola L, 2011, AM J KIDNEY DIS, V57, P442, DOI 10.1053/j.ajkd.2010.10.045; Lassalle Mathilde, 2013, Nephrol Ther, V9 Suppl 1, pS1, DOI 10.1016/S1769-7255(13)70035-X; Lee JH, 2012, EPIDEMIOL INFECT, V140, P1087, DOI 10.1017/S095026881100166X; Lindsay RM, 2009, CLIN J AM SOC NEPHRO, V4, P603, DOI 10.2215/CJN.02890608; MacRae JM, 2014, AM J KIDNEY DIS, V63, P636, DOI 10.1053/j.ajkd.2013.09.015; MacRae JM, 2012, CLIN J AM SOC NEPHRO, V7, P1632, DOI 10.2215/CJN.02730312; Marticorena RM, 2011, HEMODIAL INT, V15, P243, DOI 10.1111/j.1542-4758.2010.00506.x; Muir CA, 2014, CLIN J AM SOC NEPHRO, V9, P110, DOI 10.2215/CJN.03930413; Nesrallah GE, 2010, CLIN J AM SOC NEPHRO, V5, P1047, DOI 10.2215/CJN.00280110; Shinzato T, 2014, ANN DIAL C ATL FEBR; Twardowski Z, 1977, CONT DIAL NEPHROL, V18, P18; van Loon MM, 2010, NEPHROL DIAL TRANSPL, V25, P225, DOI 10.1093/ndt/gfp420; Vaux E, 2013, AM J KIDNEY DIS, V62, P81, DOI 10.1053/j.ajkd.2013.01.011; Verhallen AM, 2007, NEPHROL DIAL TRANSPL, V22, P2601, DOI 10.1093/ndt/gfm043; Wong B, 2014, AM J KIDNEY DIS, V64, P918, DOI 10.1053/j.ajkd.2014.06.018	17	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142256	10.1371/journal.pone.0142256	http://dx.doi.org/10.1371/journal.pone.0142256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575267	Green Submitted, gold, Green Published			2022-12-26	WOS:000365153400011
J	Millon, A; Sigovan, M; Boussel, L; Mathevet, JL; Louzier, V; Paquet, C; Geloen, A; Provost, N; Majd, Z; Patsouris, D; Serusclat, A; Canet-Soulas, E				Millon, Antoine; Sigovan, Monica; Boussel, Loic; Mathevet, Jean-Louis; Louzier, Vanessa; Paquet, Christian; Geloen, Alain; Provost, Nicolas; Majd, Zouher; Patsouris, David; Serusclat, Andre; Canet-Soulas, Emmanuelle			Low WSS Induces Intimal Thickening, while Large WSS Variation and Inflammation Induce Medial Thinning, in an Animal Model of Atherosclerosis	PLOS ONE			English	Article							APOLIPOPROTEIN E-DEFICIENT; ENDOTHELIAL SHEAR-STRESS; PLAQUE INFLAMMATION; VEIN GRAFTS; NANOPARTICLES; MACROPHAGES; PROGRESSION; RABBITS; FLOW; MRI	Objective Atherosclerotic plaque development in the arterial wall is the result of complex interaction between the wall's endothelial layer and blood hemodynamics. However, the interaction between hemodynamic parameters and inflammation in plaque evolution is not yet fully understood. The aim of the present study was to investigate the relation between wall shear stress (WSS) and vessel wall inflammation during atherosclerotic plaque development in a minipig model of carotid stenosis. Methods A surgical procedure was performed to create left common carotid artery stenosis by placement of a perivascular cuff in minipigs under atherogenic diet. Animals were followed up on 3T MRI, 1 week after surgery and 3, 6, and 8 months after initiation of the diet. Computational fluid dynamics simulation estimated WSS distribution for the first imaging point. Vascular geometries were co-registered for direct comparison of plaque development and features (Gadolinium-and USPIO-Contrast Enhanced MRI, for permeability and inflammation respectively) with the initial WSS. Histological analysis was performed and sections were matched to MR images, based on spatial landmarks. Results Vessel wall thickening, permeability and inflammation were observed distally from the stenosis. They were eccentric and facing regions of normal wall thickness. Histological analysis confirmed eccentric plaque formation with lipid infiltration, intimal thickening and medial degradation. High phagocytic activity in the stenosis region was co-localized with high WSS, corresponding to intense medial degradation observed on histology samples. Conclusion Lower WSS promotes atherosclerotic plaque development distal to an induced stenosis. Vascular and perivascular inflammation locations were predominant in the high WSS stenosis segment, where medial thinning was the major consequence.	[Millon, Antoine; Sigovan, Monica; Boussel, Loic] Univ Lyon 1, CREATIS Lab, F-69365 Lyon, France; [Millon, Antoine; Boussel, Loic; Mathevet, Jean-Louis; Serusclat, Andre] Hosp Civils Lyon, Lyon, France; [Louzier, Vanessa; Paquet, Christian] Univ Lyon 1, VetAgro Sup, F-69365 Lyon, France; [Geloen, Alain; Patsouris, David; Canet-Soulas, Emmanuelle] Univ Lyon 1, CARMEN Lab, INSERM, U1060, F-69365 Lyon, France; [Provost, Nicolas; Majd, Zouher] Genfit Res, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Millon, A (corresponding author), Univ Lyon 1, CREATIS Lab, F-69365 Lyon, France.	antoinemillon@hotmail.com	Carmen, Team3/Y-7384-2019; Sigovan, Monica/N-3729-2016; Boussel, Loic/H-7184-2014	Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; Louzier, Vanessa/0000-0003-1889-7189; GELOEN, Alain/0000-0001-7921-1254				Bessaad A, 2010, INVEST RADIOL, V45, P262, DOI 10.1097/RLI.0b013e3181d78030; BOOTH RFG, 1989, ATHEROSCLEROSIS, V76, P257, DOI 10.1016/0021-9150(89)90109-3; Calcagno C, 2013, CURR CARDIOVASC IMAG, V6, P11, DOI 10.1007/s12410-012-9177-x; Chalouhi N, 2013, STROKE, V44, P3613, DOI 10.1161/STROKEAHA.113.002390; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; Hanyu M, 2001, ATHEROSCLEROSIS, V158, P313, DOI 10.1016/S0021-9150(01)00446-4; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; Ishii A, 2006, AM J NEURORADIOL, V27, P1893; Lardenoye JHP, 2002, CIRC RES, V91, P577, DOI 10.1161/01.RES.0000036901.58329.D7; Li ZY, 2011, CIRC J, V75, P1486, DOI 10.1253/circj.CJ-10-1210; Metaxa E, 2010, STROKE, V41, P1774, DOI 10.1161/STROKEAHA.110.585992; Millon A, 2013, ATHEROSCLEROSIS, V228, P339, DOI 10.1016/j.atherosclerosis.2013.03.019; Millon A, 2012, STROKE, V43, P3023, DOI 10.1161/STROKEAHA.112.662692; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Morishige K, 2010, CIRCULATION, V122, P1707, DOI 10.1161/CIRCULATIONAHA.109.891804; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Peiffer V, 2013, CARDIOVASC RES, V99, P242, DOI 10.1093/cvr/cvt044; Sameshima N, 2014, J ATHEROSCLER THROMB, V21, P831, DOI 10.5551/jat.23093; Sasaki T, 2006, ARTERIOSCL THROM VAS, V26, P1304, DOI 10.1161/01.ATV.0000219687.71607.f7; Seneviratne A, 2013, CARDIOVASC RES, V99, P284, DOI 10.1093/cvr/cvt097; Shi ZS, 2009, AM J NEURORADIOL, V30, P469, DOI 10.3174/ajnr.A1410; Sigovan M, 2009, RADIOLOGY, V252, P401, DOI 10.1148/radiol.2522081484; Tang TY, 2008, ATHEROSCLEROSIS, V196, P879, DOI 10.1016/j.atherosclerosis.2007.02.004; Thim Troels, 2012, J Cardiovasc Dis Res, V3, P76, DOI 10.4103/0975-3583.95358; Thim Troels, 2010, Dan Med Bull, V57, pB4161; Verhagen SN, 2011, ATHEROSCLEROSIS, V214, P3, DOI 10.1016/j.atherosclerosis.2010.05.034; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Yang C, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-61	34	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0141880	10.1371/journal.pone.0141880	http://dx.doi.org/10.1371/journal.pone.0141880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575029	Green Submitted, gold, Green Published			2022-12-26	WOS:000365153400009
J	Okada, K; Sato, S; Sato, A; Mandelboim, O; Yamasoba, T; Kiyono, H				Okada, Kazunari; Sato, Shintaro; Sato, Ayuko; Mandelboim, Ofer; Yamasoba, Tatsuya; Kiyono, Hiroshi			Identification and Analysis of Natural Killer Cells in Murine Nasal Passages	PLOS ONE			English	Article							INFLUENZA-VIRUS INFECTION; NK-CELLS; SELF-TOLERANCE; IMMUNE DEFENSE; TARGET-CELLS; MICE; EXPRESSION; RESPONSES; ADJUVANT; RECEPTOR	Background Natural killer (NK) cells in the upper respiratory airways are not well characterized. In the current study, we sought to characterize and functionally assess murine nasal NK cells. Methods Using immunohistochemistry and flow cytometry, we compared the nasal NK cells of Ncr1(GFP/+) knock-in mice, whose NK cells produced green fluorescent protein, with their splenic and pulmonary counterparts. In addition, we functionally analyzed the nasal NK cells of these mice in vitro. To assess the in vivo functions of nasal NK cells, C57BL/6 mice depleted of NK cells after treatment with PK136 antibody were nasally infected with influenza virus PR8. Results Immunohistochemical analysis confirmed the presence of NK cells in the lamina propria of nasal mucosa, and flow cytometry showed that these cells were of NK cell lineage. The expression patterns of Ly49 receptor, CD11b/CD27, CD62L and CD69 revealed that nasal NK cells had an immature and activated phenotype compared with that of their splenic and pulmonary counterparts. Effector functions including degranulation and IFN(interferon)-gamma production after in vitro stimulation with phorbol 12-myristate-13-acetate plus ionomycin or IL(interleukin)-12 plus IL-18 were dampened in nasal NK cells, and the depletion of NK cells led to an increased influenza virus titer in nasal passages. Conclusions The NK cells of the murine nasal passage belong to the conventional NK cell linage and characteristically demonstrate an immature and activated phenotype. Despite their hyporesponsiveness in vitro, nasal NK cells play important roles in the host defense against nasal influenza virus infection.	[Okada, Kazunari; Sato, Shintaro; Sato, Ayuko; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan; [Okada, Kazunari; Yamasoba, Tatsuya] Univ Tokyo, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Tokyo, Japan; [Sato, Shintaro; Sato, Ayuko; Kiyono, Hiroshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo, Japan; [Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Hebrew University of Jerusalem	Kiyono, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan.	kiyono@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022	Mandelboim, Ofer/0000-0002-9354-1855; Sato, Shintaro/0000-0001-5156-3354	Ministry of Education, Culture, Sports, Science and Technology of Japan [25860353]; Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	Funding provided by The Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Young Scientists B [25860353 to S.S.]), http://www.jsps.go.jp/jgrantsinaid/, and The Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (to H.K.), http://www.jst.go.jp/kisoken/crest/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Anderson SK, 2001, IMMUNOL REV, V181, P79, DOI 10.1034/j.1600-065X.2001.1810106.x; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Blasius AL, 2007, J EXP MED, V204, P2561, DOI 10.1084/jem.20070991; Borrego F, 1999, IMMUNOLOGY, V97, P159, DOI 10.1046/j.1365-2567.1999.00738.x; Bot A, 1996, J VIROL, V70, P5668, DOI 10.1128/JVI.70.8.5668-5672.1996; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Hall LJ, 2010, J IMMUNOL, V184, P4327, DOI 10.4049/jimmunol.0903357; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Huntington ND, 2007, NAT REV IMMUNOL, V7, P703, DOI 10.1038/nri2154; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Joncker NT, 2008, IMMUNOL REV, V224, P85, DOI 10.1111/j.1600-065X.2008.00658.x; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kane KP, 2004, CRIT REV IMMUNOL, V24, P321; Kimura MY, 2005, CRIT REV IMMUNOL, V25, P361, DOI 10.1615/CritRevImmunol.v25.i5.20; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Mallidi TV, 2009, BIOL REPROD, V81, P310, DOI 10.1095/biolreprod.109.076448; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]; Nogusa S, 2008, MECH AGEING DEV, V129, P223, DOI 10.1016/j.mad.2008.01.003; Ortaldo JR, 1999, J LEUKOCYTE BIOL, V66, P512, DOI 10.1002/jlb.66.3.512; Radulovic K, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/497056; Rodriguez-Monroy MA, 2007, SCAND J IMMUNOL, V65, P276, DOI 10.1111/j.1365-3083.2006.01898.x; Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; SHRESTA S, 1995, P NATL ACAD SCI USA, V92, P5679, DOI 10.1073/pnas.92.12.5679; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Stein-Streilein J, 1988, Reg Immunol, V1, P100; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Tamura S, 1996, J IMMUNOL, V156, P3892; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Tavakkol Z, 2010, J AM ASSOC LAB ANIM, V49, P588; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Winchester B G, 2001, Eur J Paediatr Neurol, V5 Suppl A, P11, DOI 10.1053/ejpn.2000.0428; Zhou G, 2013, EUR J IMMUNOL, V43, P929, DOI 10.1002/eji.201242620	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142920	10.1371/journal.pone.0142920	http://dx.doi.org/10.1371/journal.pone.0142920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575399	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400022
J	Alabia, ID; Saitoh, SI; Mugo, R; Igarashi, H; Ishikawa, Y; Usui, N; Kamachi, M; Awaji, T; Seito, M				Alabia, Irene D.; Saitoh, Sei-Ichi; Mugo, Robinson; Igarashi, Hiromichi; Ishikawa, Yoichi; Usui, Norihisa; Kamachi, Masafumi; Awaji, Toshiyuki; Seito, Masaki			Identifying Pelagic Habitat Hotspots of Neon Flying Squid in the Temperate Waters of the Central North Pacific	PLOS ONE			English	Article							ALBACORE THUNNUS-ALALUNGA; OMMASTREPHES-BARTRAMII; SPECIES DISTRIBUTION; OCEANOGRAPHIC REGIME; DISTRIBUTION MODELS; TRANSITION REGION; HOT-SPOTS; WESTERN; OCEAN; FISHERY	We identified the pelagic habitat hotspots of the neon flying squid (Ommastrephes bartramii) in the central North Pacific from May to July and characterized the spatial patterns of squid aggregations in relation to oceanographic features such as mesoscale oceanic eddies and the Transition Zone Chlorophyll-a Front (TZCF). The data used for the habitat model construction and analyses were squid fishery information, remotely-sensed and numerical model-derived environmental data from May to July 1999-2010. Squid habitat hotspots were deduced from the monthly Maximum Entropy (MaxEnt) models and were identified as regions of persistent high suitable habitat across the 12-year period. The distribution of predicted squid habitat hotspots in central North Pacific revealed interesting spatial and temporal patterns likely linked with the presence and dynamics of oceanographic features in squid's putative foraging grounds from late spring to summer. From May to June, the inferred patches of squid habitat hotspots developed within the Kuroshio-Oyashio transition zone (KOTZ; 37-40 degrees N) and further expanded north towards the subarctic frontal zone (SAFZ; 40-44 degrees N) in July. The squid habitat hotspots within the KOTZ and areas west of the dateline (160 degrees W-180 degrees) were likely influenced and associated with the highly dynamic and transient oceanic eddies and could possibly account for lower squid suitable habitat persistence obtained from these regions. However, predicted squid habitat hotspots located in regions east of the dateline (180 degrees-160 degrees W) from June to July, showed predominantly higher squid habitat persistence presumably due to their proximity to the mean position of the seasonally-shifting TZCF and consequent utilization of the highly productive waters of the SAFZ.	[Alabia, Irene D.; Saitoh, Sei-Ichi] Hokkaido Univ, Arctic Res Ctr, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Alabia, Irene D.; Saitoh, Sei-Ichi] Hokkaido Univ, Grad Sch Fisheries Sci, Lab Marine Environm & Resource Sensing, Hakodate, Hokkaido 0418611, Japan; [Mugo, Robinson] Reg Ctr Mapping Resources Development SERVIR Afri, Nairobi, Kenya; [Igarashi, Hiromichi; Ishikawa, Yoichi] JAMSTEC, Japan Agcy Marine Earth Sci & Technol, Data Res Ctr Marine Earth Sci, Yokohama, Kanagawa 2360001, Japan; [Usui, Norihisa; Kamachi, Masafumi] Meteorol Res Inst, Oceanog Res Dept, Tsukuba, Ibaraki 3050052, Japan; [Awaji, Toshiyuki] Kyoto Univ, Div Earth & Planetary Sci, Grad Sch Sci, Kyoto 6068502, Japan; [Seito, Masaki] Aomori Prefectural Ind Technol Res Ctr, Aomori, Aomori 0300113, Japan	Hokkaido University; Hokkaido University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Meteorological Research Institute - Japan; Kyoto University	Alabia, ID (corresponding author), Hokkaido Univ, Arctic Res Ctr, Kita Ku, N21 W11, Sapporo, Hokkaido 0010021, Japan.	irenealabia@salmon.fish.hokudai.ac.jp	Alabia, Irene D./V-2858-2019	Alabia, Irene D./0000-0002-4336-6876; Usui, Norihisa/0000-0003-0222-2355	Research on Climate Change Adaptation (RECCA) Project from Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT) [10101028]	Research on Climate Change Adaptation (RECCA) Project from Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This study was supported by the Research on Climate Change Adaptation (RECCA) Project from the Grant-in-Aid (Grant No. 10101028) from Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1993, FISH RES, V15, P315, DOI 10.1016/0165-7836(93)90082-I; Alabia ID, 2015, FISH OCEANOGR, V24, P190, DOI 10.1111/fog.12102; Amante C., 2009, PSYCHOLOGIST, DOI [10.7289/V5C8276M, DOI 10.7289/V5C8276M]; Andrade HA, 2003, FISH OCEANOGR, V12, P10, DOI 10.1046/j.1365-2419.2003.00220.x; Ayers JM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005596; Becares J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120799; Bower JR, 2005, FISH RES, V76, P39, DOI 10.1016/j.fishres.2005.05.009; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P1, DOI 10.1002/9780470995310; Chavanne CP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045057; Chen X, 2010, FISHERY B, V108, P14; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Etnoyer P, 2004, OCEANOGRAPHY, V17, P12; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Halo I, 2014, DEEP-SEA RES PT II, V100, P38, DOI 10.1016/j.dsr2.2013.10.015; Hormazabal S, 2004, Gayana (Concepc.), V68, P291; Ichii T, 2006, FISH RES, V78, P286, DOI 10.1016/j.fishres.2006.01.003; Ichii T, 2004, FISH OCEANOGR, V13, P295, DOI 10.1111/j.1365-2419.2004.00293.x; Ichii T, 2011, MAR ECOL PROG SER, V441, P151, DOI 10.3354/meps09365; Ichii T, 2009, MAR ECOL PROG SER, V378, P1, DOI 10.3354/meps07873; Igarashi H, 2015, PROGR OCEANOGRAPHY; Itoh S, 2010, J PHYS OCEANOGR, V40, P2624, DOI 10.1175/2010JPO4475.1; JEREB P., 2010, FAO SPECIES CATALOGU, V2, P1; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Kato Y, 2014, HIDROBIOLOGICA, V24, P33; Logerwell EA, 2001, PROG OCEANOGR, V49, P391, DOI 10.1016/S0079-6611(01)00032-5; Marchese C, 2015, GLOB ECOL CONSERV, V3, P297, DOI 10.1016/j.gecco.2014.12.008; McKinney JA, 2012, MAR ECOL PROG SER, V458, P199, DOI 10.3354/meps09777; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Mori J, 2001, FISH RES, V52, P91, DOI 10.1016/S0165-7836(01)00233-8; Mugo RM, 2014, DEEP-SEA RES PT II, V107, P29, DOI 10.1016/j.dsr2.2013.11.005; Nishikawa H, 2014, FISH OCEANOGR, V23, P289, DOI 10.1111/fog.12064; Nur N, 2011, ECOL APPL, V21, P2241, DOI 10.1890/10-1460.1; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 1995, DEEP-SEA RES PT I, V42, P1701, DOI 10.1016/0967-0637(95)00075-H; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Rijnsdorp AD, 2000, ICES J MAR SCI, V57, P927, DOI 10.1006/jmsc.2000.0580; RODEN GI, 1972, J GEOPHYS RES, V77, P7175, DOI 10.1029/JC077i036p07175; Roper C. F. E., 1984, FAO FISH SYNOP, V125, P1; Rose GA, 2005, ICES J MAR SCI, V62, P1360, DOI 10.1016/j.icesjms.2005.05.007; Rupprecht F, 2011, J VEG SCI, V22, P647, DOI 10.1111/j.1654-1103.2011.01269.x; SANDWELL DT, 1984, J GEOPHYS RES-OCEANS, V89, P2041, DOI 10.1029/JC089iC02p02041; Sassa C, 2004, MAR BIOL, V144, P417, DOI 10.1007/s00227-003-1214-5; Seki Michael P., 1993, International North Pacific Fisheries Commission Bulletin, V53, P207; Seki MP, 2002, J OCEANOGR, V58, P739, DOI 10.1023/A:1022854609312; SEKINE Y, 1988, J GEOPHYS RES-OCEANS, V93, P2247, DOI 10.1029/JC093iC03p02247; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Shao Q. Q., 2005, OCEANOL LIMNOL SIN, V5, P111; Shiomoto A, 2000, J PLANKTON RES, V22, P1, DOI 10.1093/plankt/22.1.1; Storlie C., 2014, SDMTOOLS SPECIES DIS; Swain DP, 2003, CAN J FISH AQUAT SCI, V60, P897, DOI 10.1139/F03-076; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tarjuelo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087847; Thiers L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115057; Tian SQ, 2009, FISH RES, V95, P181, DOI 10.1016/j.fishres.2008.08.012; Usui N, 2006, ADV SPACE RES, V37, P806, DOI 10.1016/j.asr.2005.09.022; Watanabe H, 2004, MAR ECOL PROG SER, V266, P173, DOI 10.3354/meps266173; Watanabe H, 2008, J MAR BIOL ASSOC UK, V88, P381, DOI 10.1017/S0025315408000635; Watanabe H, 2006, MAR ECOL PROG SER, V315, P187, DOI 10.3354/meps315187; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Yasuda I, 2003, J OCEANOGR, V59, P389, DOI 10.1023/A:1025580313836; Yatsu A, 2000, FISH OCEANOGR, V9, P163, DOI 10.1046/j.1365-2419.2000.00130.x; Yatsu A, 2013, ICES J MARINE SCI; Young JW, 2001, MAR FRESHWATER RES, V52, P463, DOI 10.1071/MF99168; Yu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122997; Yuan XJ, 1996, J GEOPHYS RES-OCEANS, V101, P16491, DOI 10.1029/96JC01249; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	72	18	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142885	10.1371/journal.pone.0142885	http://dx.doi.org/10.1371/journal.pone.0142885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571118	Green Submitted, gold, Green Published			2022-12-26	WOS:000365070700091
J	Fernandez-Pujals, AM; Adams, MJ; Thomson, P; McKechanie, AG; Blackwood, DHR; Smith, BH; Dominiczak, AF; Morris, AD; Matthews, K; Campbell, A; Linksted, P; Haley, CS; Deary, IJ; Porteous, DJ; MacIntyre, DJ; McIntosh, AM				Fernandez-Pujals, Ana Maria; Adams, Mark James; Thomson, Pippa; McKechanie, Andrew G.; Blackwood, Douglas H. R.; Smith, Blair H.; Dominiczak, Anna F.; Morris, Andrew D.; Matthews, Keith; Campbell, Archie; Linksted, Pamela; Haley, Chris S.; Deary, Ian J.; Porteous, David J.; MacIntyre, Donald J.; McIntosh, Andrew M.			Epidemiology and Heritability of Major Depressive Disorder, Stratified by Age of Onset, Sex, and Illness Course in Generation Scotland: Scottish Family Health Study (GS: SFHS)	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; LIFETIME PREVALENCE; TWIN; DISEASE; ASSOCIATION; POPULATION; PATHWAYS; GENETICS; SMOKING; RATES	The heritability of Major Depressive Disorder (MDD) has been estimated at 37% based largely on twin studies that rely on contested assumptions. More recently, the heritability of MDD has been estimated on large populations from registries such as the Swedish, Finnish, and Chinese cohorts. Family-based designs utilise a number of different relationships and provide an alternative means of estimating heritability. Generation Scotland: Scottish Family Health Study (GS:SFHS) is a large (n = 20,198), family-based population study designed to identify the genetic determinants of common diseases, including Major Depressive Disorder. Two thousand seven hundred and six individuals were SCID diagnosed with MDD, 13.5% of the cohort, from which we inferred a population prevalence of 12.2% (95% credible interval: 11.4% to 13.1%). Increased risk of MDD was associated with being female, unemployed due to a disability, current smokers, former drinkers, and living in areas of greater social deprivation. The heritability of MDD in GS:SFHS was between 28% and 44%, estimated from a pedigree model. The genetic correlation of MDD between sexes, age of onset, and illness course were examined and showed strong genetic correlations. The genetic correlation between males and females with MDD was 0.75 (0.43 to 0.99); between earlier (<= age 40) and later (> age 40) onset was 0.85 (0.66 to 0.98); and between single and recurrent episodic illness course was 0.87 (0.72 to 0.98). We found that the heritability of recurrent MDD illness course was significantly greater than the heritability of single MDD illness course. The study confirms a moderate genetic contribution to depression, with a small contribution of the common family environment (variance proportion = 0.07, CI: 0.01 to 0.15), and supports the relationship of MDD with previously identified risk factors. This study did not find robust support for genetic differences in MDD due to sex, age of onset, or illness course. However, we found an intriguing difference in heritability between recurrent and single MDD illness course. These findings establish GS:SFHS as a valuable cohort for the genetic investigation of MDD.	[Fernandez-Pujals, Ana Maria; Adams, Mark James; Blackwood, Douglas H. R.; MacIntyre, Donald J.; McIntosh, Andrew M.] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland; [Thomson, Pippa; Linksted, Pamela] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [McKechanie, Andrew G.] Univ Edinburgh, Patrick Wild Ctr, Edinburgh, Midlothian, Scotland; [Smith, Blair H.] Univ Dundee, Div Populat Hlth Sci, Dundee, Scotland; [Dominiczak, Anna F.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Morris, Andrew D.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Matthews, Keith] Univ Dundee, Div Neurosci, Dundee, Scotland; [Campbell, Archie; Porteous, David J.] Univ Edinburgh, Generat Scotland, Ctr Genom & Expt Med, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Haley, Chris S.] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Deary, Ian J.; McIntosh, Andrew M.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Dundee; University of Glasgow; University of Edinburgh; University of Dundee; University of Edinburgh; University of Edinburgh; University of Edinburgh	Fernandez-Pujals, AM (corresponding author), Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland.	A.Fernandez-2@sms.ed.ac.uk	Campbell, Archie/AAZ-1757-2021; Smith, Blair H/G-2834-2012; Fernandez-Pujals, Ana Maria/A-9355-2016; Dominiczak, Anna F/P-9390-2017; blackwood, douglas/AIB-8874-2022; Deary, Ian J/C-6297-2009; Porteous, David/AAA-3446-2021; McIntosh, Andrew M/B-9379-2008	Smith, Blair H/0000-0002-5362-9430; Fernandez-Pujals, Ana Maria/0000-0002-9543-6362; Dominiczak, Anna F/0000-0003-4913-3608; Deary, Ian J/0000-0002-1733-263X; Porteous, David/0000-0003-1249-6106; McIntosh, Andrew M/0000-0002-0198-4588; Matthews, Keith/0000-0002-4478-5888; Campbell, Archie/0000-0003-0198-5078; McKechanie, Andrew/0000-0003-4273-9906; Adams, Mark James/0000-0002-3599-6018; Haley, Chris/0000-0002-9811-0210; MacIntyre, Donald J/0000-0001-6963-1335	Wellcome Trust Strategic Award "STratifying Resilience and Depression Longitudinally" (STRaDL) [104036/Z/14/Z]; Chief Scientist Office (CSO) of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; NRS Career Fellowship - CSO; Scottish Funding Council Senior Clinical Fellowship; Dame Theresa and Mortimer Sackler Foundation; Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council (BBSRC); MRC-BBSRC, Centre for Cognitive Ageing and Cognitive Epidemiology part of the cross council Lifelong Health and Wellbeing Initiative [MR/K026992/1]; BBSRC; MRC; UK's Medical Research Council; Wellcome Trust; Medical Research Council [MC_PC_U127592696, MR/K026992/1, MR/K007017/1] Funding Source: researchfish; MRC [MR/K007017/1, MC_PC_U127592696] Funding Source: UKRI	Wellcome Trust Strategic Award "STratifying Resilience and Depression Longitudinally" (STRaDL); Chief Scientist Office (CSO) of the Scottish Government Health Directorates; Scottish Funding Council; NRS Career Fellowship - CSO; Scottish Funding Council Senior Clinical Fellowship; Dame Theresa and Mortimer Sackler Foundation; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC-BBSRC, Centre for Cognitive Ageing and Cognitive Epidemiology part of the cross council Lifelong Health and Wellbeing Initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK's Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study is supported by a Wellcome Trust Strategic Award "STratifying Resilience and Depression Longitudinally" (STRaDL) (Reference 104036/Z/14/Z). Generation Scotland (GS:SFHS) received core support from the Chief Scientist Office (CSO) of the Scottish Government Health Directorates [grant number CZD/16/6] and the Scottish Funding Council [HR03006]. DJM is supported by a NRS Career Fellowship, funded by the CSO. AMF is supported by a Scottish Funding Council Senior Clinical Fellowship and by the Dame Theresa and Mortimer Sackler Foundation. CSH acknowledges support from the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC). IJD is supported by the MRC-BBSRC, Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1). Funding from the BBSRC and MRC is gratefully acknowledged. The funders had no role in study design, interpretation, or decision to publish.; We are grateful to Jarrod D Hadfield for analysis insight into the use of MCMCglmm for binary (unobserved) traits and also to Pau Navarro for advice on some early iterations of the age of onset models. Generation Scotland received core funding from the Chief Scientist Office of the Scottish Government Health Directorate CZD/16/6 and the Scottish Funding Council HR03006. Genotyping of the GS:SFHS samples was carried out by the Genetics Core Laboratory at the Wellcome Trust Clinical Research Facility, Edinburgh, Scotland and was funded by the UK's Medical Research Council and the Wellcome Trust. Ethics approval for the study was given by the NHS Tayside committee on research ethics (reference 05/S1401/89). We are grateful to all the families who took part, the general practitioners and the Scottish School of Primary Care for their help in recruiting them, and the whole Generation Scotland team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, healthcare assistants and nurses.	ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; [Anonymous], 2014, GLOBAL HLTH ESTIMATE; Berg CJ, 2013, AM J ADDICTION, V22, P581, DOI 10.1111/j.1521-0391.2013.12041.x; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; Bouchard TJ, 2004, CURR DIR PSYCHOL SCI, V13, P148, DOI 10.1111/j.0963-7214.2004.00295.x; Bromet Evelyn, 2011, BMC Med, V9, P90, DOI 10.1186/1741-7015-9-90; CADORET RJ, 1972, ARCH GEN PSYCHIAT, V26, P133; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028734; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; First M.B., 2016, STRUCTURED CLIN INTE; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Glahn DC, 2012, BIOL PSYCHIAT, V71, P6, DOI 10.1016/j.biopsych.2011.08.022; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hasin DS, 2002, ARCH GEN PSYCHIAT, V59, P794, DOI 10.1001/archpsyc.59.9.794; Health and Social Care Information Centre, 2011, ATTR DAT SET GP REG; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Jenkins R, 1998, BRIT J PSYCHIAT, V173, P4, DOI 10.1192/bjp.173.1.4; Kendler KS, 2014, AM J PSYCHIAT, V171, P426, DOI 10.1176/appi.ajp.2013.13101375; Kendler KS, 2009, BIOL PSYCHIAT, V65, P808, DOI 10.1016/j.biopsych.2008.11.015; Kendler KS, 1999, ARCH GEN PSYCHIAT, V56, P39, DOI 10.1001/archpsyc.56.1.39; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; KESSLER RC, 1994, J AFFECT DISORDERS, V30, P15, DOI 10.1016/0165-0327(94)90147-3; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KLERMAN GL, 1989, JAMA-J AM MED ASSOC, V261, P2229, DOI 10.1001/jama.261.15.2229; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Levinson DF, 2014, BIOL PSYCHIAT, V76, P510, DOI 10.1016/j.biopsych.2014.07.029; Lubke GH, 2012, BIOL PSYCHIAT, V72, P707, DOI 10.1016/j.biopsych.2012.03.011; Lynch Michael, 1998; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; McGuffin P, 1996, ARCH GEN PSYCHIAT, V53, P129; Mendlewicz J, 1981, MORBIDITY RISKS SUBT; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Pedersen CB, 2014, JAMA PSYCHIAT, V71, P573, DOI 10.1001/jamapsychiatry.2014.16; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Power RA, 2012, AM J MED GENET B, V159B, P859, DOI 10.1002/ajmg.b.32093; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Scottish Executive, SCOTT IND MULT DEPR; Smith BH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-74; Smith BH, 2013, INT J EPIDEMIOL, V42, P689, DOI 10.1093/ije/dys084; Stan Development Team, 2015, STAN C LIB PROB SAMP; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, GENETIC EPIDEMIOLOGY, V157; Susser E, 2010, PSYCHOL MED, V40, P895, DOI 10.1017/S0033291709991504; Susser E, 2006, PSYCHIAT EPIDEMIOLOG; Takayanagi Y, 2014, JAMA PSYCHIAT, V71, P273, DOI 10.1001/jamapsychiatry.2013.3579; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tenesa A, 2013, NAT REV GENET, V14, P139, DOI 10.1038/nrg3377; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wilson AJ, 2008, J EVOLUTION BIOL, V21, P647, DOI 10.1111/j.1420-9101.2008.01500.x; WINOKUR G, 1979, ARCH GEN PSYCHIAT, V36, P47; Wray NR., 2014, CURR EPIDEMIOL REP, V1, P220, DOI DOI 10.1007/S40471-014-0023-3; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	62	59	59	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142197	10.1371/journal.pone.0142197	http://dx.doi.org/10.1371/journal.pone.0142197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW5XP	26571028	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700025
J	Higuchi, CM; Maeda, Y; Horiuchi, T; Yamazaki, Y				Higuchi, Carolyn M.; Maeda, Yuuki; Horiuchi, Toshitaka; Yamazaki, Yukiko			A Simplified Method for Three-Dimensional (3-D) Ovarian Tissue Culture Yielding Oocytes Competent to Produce Full-Term Offspring in Mice	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; RECOMBINANT ACTIVIN-A; IN-VITRO CULTURE; FOLLICLE GROWTH; PREANTRAL FOLLICLES; PRIMORDIAL FOLLICLES; BASEMENT-MEMBRANE; MOUSE OOCYTES; IV COLLAGEN; LOCALIZATION	In vitro growth of follicles is a promising technology to generate large quantities of competent oocytes from immature follicles and could expand the potential of assisted reproductive technologies (ART). Isolated follicle culture is currently the primary method used to develop and mature follicles in vitro. However, this procedure typically requires complicated, time-consuming procedures, as well as destruction of the normal ovarian microenvironment. Here we describe a simplified 3-D ovarian culture system that can be used to mature multilayered secondary follicles into antral follicles, generating developmentally competent oocytes in vitro. Ovaries recovered from mice at 14 days of age were cut into 8 pieces and placed onto a thick Matrigel drop (3-D culture) for 10 days of culture. As a control, ovarian pieces were cultured on a membrane filter without any Matrigel drop (Membrane culture). We also evaluated the effect of activin A treatment on follicle growth within the ovarian pieces with or without Matrigel support. Thus we tested four different culture conditions: C (Membrane/activin-), A (Membrane/activin+), M (Matrigel/activin-), and M+ A (Matrigel/activin+). We found that the cultured follicles and oocytes steadily increased in size regardless of the culture condition used. However, antral cavity formation occurred only in the follicles grown in the 3-D culture system (M, M+ A). Following ovarian tissue culture, full-grown GV oocytes were isolated from the larger follicles to evaluate their developmental competence by subjecting them to in vitro maturation (IVM) and in vitro fertilization (IVF). Maturation and fertilization rates were higher using oocytes grown in 3-D culture (M, M+ A) than with those grown in membrane culture (C, A). In particular, activin A treatment further improved 3-D culture (M+ A) success. Following IVF, two-cell embryos were transferred to recipients to generate full-term offspring. In summary, this simple and easy 3-D ovarian culture system using a Matrigel drop and activin A supplementation (M+ A) provides optimal and convenient conditions to support growth of developmentally competent oocytes in vitro.	[Higuchi, Carolyn M.; Maeda, Yuuki; Yamazaki, Yukiko] Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96822 USA; [Horiuchi, Toshitaka] Prefectural Univ Hiroshima, Grad Sch Comprehens Sci Res, Hiroshima, Japan	University of Hawaii System	Yamazaki, Y (corresponding author), Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96822 USA.	yyamazak@ahwaii.edu			National Institute of Health [P20GM103457, G12MD007601]; Victoria S. and Bradley L. Geist Foundation [HCF 13ADVC-60320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victoria S. and Bradley L. Geist Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by National Institute of Health Grant P20GM103457 to YY, National Institute of Health Grant G12MD007601 to YY, and the Victoria S. and Bradley L. Geist Foundation grant HCF 13ADVC-60320 to YY.	Belli M, 2012, INT J DEV BIOL, V56, P931, DOI 10.1387/ijdb.120175mz; Berkholtz CB, 2006, HISTOCHEM CELL BIOL, V126, P583, DOI 10.1007/s00418-006-0194-1; Berkholtz CB, 2006, SEMIN REPROD MED, V24, P262, DOI 10.1055/s-2006-948555; Das S, 1996, ENDOCRINOLOGY, V137, P967, DOI 10.1210/en.137.3.967; Desai N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-119; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; EPPIG JJ, 1989, BIOL REPROD, V41, P268, DOI 10.1095/biolreprod41.2.268; FIGUEIREDO JR, 1995, THERIOGENOLOGY, V43, P845, DOI 10.1016/0093-691X(95)00036-8; Filatov MA, 2015, ACTA NATURAE, V7, P48, DOI 10.32607/20758251-2015-7-2-48-56; Guzel Y, 2014, GYNECOL ENDOCRINOL, V30, P388, DOI 10.3109/09513590.2014.888411; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hovatta O, 1997, HUM REPROD, V12, P1032; Jackson KS, 2009, ENDOCRINOLOGY, V150, P3921, DOI 10.1210/en.2008-1674; Jin SY, 2010, FERTIL STERIL, V93, P2633, DOI 10.1016/j.fertnstert.2009.10.027; Kidder GM, 2002, REPRODUCTION, V123, P613, DOI 10.1530/rep.0.1230613; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; King SM, 2011, JOVE-J VIS EXP, DOI 10.3791/2804; King SM, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-12; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Laronda MM, 2014, J ASSIST REPROD GEN, V31, P1013, DOI 10.1007/s10815-014-0252-x; Lee VH, 1996, J REPROD FERTIL, V108, P115, DOI 10.1530/jrf.0.1080115; LI RH, 1995, ENDOCRINOLOGY, V136, P849, DOI 10.1210/en.136.3.849; Li SL, 2010, J BIOL CHEM, V285, P36645, DOI 10.1074/jbc.M110.177865; Luciano AM, 2011, BIOL REPROD, V85, P1252, DOI 10.1095/biolreprod.111.092858; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Oktay K, 2000, BIOL REPROD, V63, P457, DOI 10.1095/biolreprod63.2.457; Oktem O, 2007, REPROD SCI, V14, P358, DOI 10.1177/1933719107303397; Pangas SA, 2003, TISSUE ENG, V9, P1013, DOI 10.1089/107632703322495655; Parrish EM, 2011, REPRODUCTION, V142, P309, DOI 10.1530/REP-10-0481; Picton HM, 2008, REPRODUCTION, V136, P703, DOI 10.1530/REP-08-0290; RABINOVICI J, 1992, J CLIN INVEST, V89, P1528, DOI 10.1172/JCI115745; Rodgers HF, 1998, BIOL REPROD, V59, P1334, DOI 10.1095/biolreprod59.6.1334; Rodgers RJ, 1999, J REPROD FERTIL, P343; Smitz J, 1998, MOL REPROD DEV, V50, P294, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;294::AID-MRD5&gt;3.0.CO;2-E; Stefansdottir A, 2014, REPROD TOXICOL, V49, P117, DOI 10.1016/j.reprotox.2014.08.001; Tan JH, 2009, MOL HUM REPROD, V15, P1, DOI 10.1093/molehr/gan069; Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070; Thomas Fiona H, 2003, Reprod Biol Endocrinol, V1, P76, DOI 10.1186/1477-7827-1-76; Tiemann U, 2008, REPROD TOXICOL, V25, P316, DOI 10.1016/j.reprotox.2008.03.002; van Wezel IL, 1998, J REPROD FERTIL, V112, P267, DOI 10.1530/jrf.0.1120267; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; West ER, 2007, BIOMATERIALS, V28, P4439, DOI 10.1016/j.biomaterials.2007.07.001; West ER, 2007, SEMIN REPROD MED, V25, P287, DOI 10.1055/s-2007-980222; XIAO S, 1992, ENDOCRINOLOGY, V131, P1009, DOI 10.1210/en.131.3.1009; Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739; Xu M, 2006, BIOL REPROD, V75, P916, DOI 10.1095/biolreprod.106.054833; Yokota H, 1997, ENDOCRINOLOGY, V138, P4572, DOI 10.1210/en.138.11.4572; Zhang ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041771; Zhao J, 2001, BIOL REPROD, V65, P967, DOI 10.1095/biolreprod65.3.967	49	35	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143114	10.1371/journal.pone.0143114	http://dx.doi.org/10.1371/journal.pone.0143114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571501	Green Submitted, gold, Green Published			2022-12-26	WOS:000365070700139
J	Shpigler, HY; Robinson, GE				Shpigler, Hagai Y.; Robinson, Gene E.			Laboratory Assay of Brood Care for Quantitative Analyses of Individual Differences in Honey Bee (Apis mellifera) Affiliative Behavior	PLOS ONE			English	Article							GENE-EXPRESSION; QUEEN LARVAE; WORKER; RECOGNITION; AGGRESSION; PHEROMONE; MECHANISMS; MATURATION; EXPERIENCE; COLONIES	Care of offspring is a form of affiliative behavior that is fundamental to studies of animal social behavior. Insects do not figure prominently in this topic because Drosophila melanogaster and other traditional models show little if any paternal or maternal care. However, the eusocial honey bee exhibits cooperative brood care with larvae receiving intense and continuous care from their adult sisters, but this behavior has not been well studied because a robust quantitative assay does not exist. We present a new laboratory assay that enables quantification of group or individual honey bee brood "nursing behavior" toward a queen larva. In addition to validating the assay, we used it to examine the influence of the age of the larva and the genetic background of the adult bees on nursing performance. This new assay also can be used in the future for mechanistic analyses of eusociality and comparative analyses of affilative behavior with other animals.	[Shpigler, Hagai Y.; Robinson, Gene E.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Urbana, IL USA; [Robinson, Gene E.] Univ Illinois, Neurosci Program, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Shpigler, HY (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	hagaishp@illinois.edu			Simons Foundation; National Institutes of Health Pioneer Award Program [DP1 OD006416]; Binational Agricultural Research & Development Fund, Vaadia-BARD Postdoctoral Fellowship [FI-462-2012]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006416] Funding Source: NIH RePORTER	Simons Foundation; National Institutes of Health Pioneer Award Program; Binational Agricultural Research & Development Fund, Vaadia-BARD Postdoctoral Fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Simons Foundation to GER and L. Stubbs; National Institutes of Health Pioneer Award Program DP1 OD006416 to GER; and the Binational Agricultural Research & Development Fund, Vaadia-BARD Postdoctoral Fellowship Award No. FI-462-2012 to HYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Alcock J, 2009, ANIMAL BEHAV EVOLUTI; [Anonymous], 1971, INSECT SOC; [Anonymous], 1974, SOCIAL BEHAV BEES; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; Bloch G, 2001, NATURE, V410, P1048, DOI 10.1038/35074183; BREED MD, 1983, ANIM BEHAV, V31, P86, DOI 10.1016/S0003-3472(83)80176-6; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; BREED MD, 1994, BEHAV PROCESS, V33, P25, DOI 10.1016/0376-6357(94)90058-2; Chandrasekaran S, 2011, P NATL ACAD SCI USA, V108, P18020, DOI 10.1073/pnas.1114093108; Eban-Rothschild AD, 2008, J EXP BIOL, V211, P2408, DOI 10.1242/jeb.016915; Eggert AK, 1998, ANIM BEHAV, V55, P97, DOI 10.1006/anbe.1997.0588; Gerber B, 1996, ANIM BEHAV, V52, P1079, DOI 10.1006/anbe.1996.0255; HAYDAK MH, 1958, SCIENCE, V127, P1113, DOI 10.1126/science.127.3306.1113; He XJ, 2014, J ASIA-PAC ENTOMOL, V17, P911, DOI 10.1016/j.aspen.2014.10.006; Heimken C, 2009, J EXP BIOL, V212, P1032, DOI 10.1242/jeb.022582; HUANG ZY, 1991, J INSECT BEHAV, V4, P305, DOI 10.1007/BF01048280; Ismail N, 2006, P NATL ACAD SCI USA, V103, P207, DOI 10.1073/pnas.0508318102; Laidlaw HH., 1997, QUEEN REARING BEE BR; LE CONTE Y, 1994, NATURWISSENSCHAFTEN, V81, P462, DOI 10.1007/BF01136651; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; Li-Byarlay H, 2014, P NATL ACAD SCI USA, V111, P12533, DOI 10.1073/pnas.1412306111; Miller JS, 2012, ANIM BEHAV, V83, P1387, DOI 10.1016/j.anbehav.2012.03.006; Mohammedi A, 1998, NATURWISSENSCHAFTEN, V85, P455, DOI 10.1007/s001140050531; Mohammedi A, 1996, CR ACAD SCI III-VIE, V319, P769; Muscedere ML, 2013, BEHAV ECOL SOCIOBIOL, V67, P775, DOI 10.1007/s00265-013-1501-1; Muscedere ML, 2009, ANIM BEHAV, V77, P911, DOI 10.1016/j.anbehav.2008.12.018; Nagari M, 2012, J INSECT PHYSIOL, V58, P1096, DOI 10.1016/j.jinsphys.2012.05.007; NOONAN KC, 1989, J INSECT BEHAV, V2, P473, DOI 10.1007/BF01053349; NOONAN KC, 1986, ETHOLOGY, V73, P295, DOI 10.1111/j.1439-0310.1986.tb00811.x; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pearce AN, 2001, J INSECT PHYSIOL, V47, P1243, DOI 10.1016/S0022-1910(01)00109-3; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Rittschof CC, 2013, GENES BRAIN BEHAV, V12, P802, DOI 10.1111/gbb.12087; Rittschof CC, 2014, P NATL ACAD SCI USA, V111, P17929, DOI 10.1073/pnas.1420369111; ROBINSON GE, 1994, BEHAV ECOL SOCIOBIOL, V34, P125, DOI 10.1007/BF00164183; Sagili RR, 2009, J INSECT BEHAV, V22, P339, DOI 10.1007/s10905-009-9176-1; Schulte C, 2014, P NATL ACAD SCI USA, V111, P9003, DOI 10.1073/pnas.1402341111; Siegel AJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P1623, DOI 10.1007/s00265-013-1573-y; Thamm M, 2014, J COMP NEUROL, V522, P1786, DOI 10.1002/cne.23500; Toth AL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-75; van der Burg NMD, 2014, APIDOLOGIE, V45, P478, DOI 10.1007/s13592-013-0263-0; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Winston M.L., 1991, BIOL HONEY BEE	48	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143183	10.1371/journal.pone.0143183	http://dx.doi.org/10.1371/journal.pone.0143183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569402	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700150
J	Wang, YC; Wang, SA; Chen, PH; Hsu, TI; Yang, WB; Chuang, YP; Su, WC; Liaw, HJ; Chang, WC; Hung, JJ				Wang, Y-C; Wang, S-A; Chen, P-H; Hsu, T-I; Yang, W-B; Chuang, Y-P; Su, W-C; Liaw, H-J; Chang, W-C; Hung, J-J			Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy	ONCOGENE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HEPATOCELLULAR-CARCINOMA; DNA METHYLATION; RNA; METASTASIS; USP24; MDM2; STABILITY; SUV39H1; DISEASE	Ubiquitin is a critical modifier regulating the degradation and function of its target proteins during posttranslational modification. Here we found that ubiquitin-specific peptidase 24 (USP24) is highly expressed in cell lines with enhanced malignancy and in late-stage lung cancer clinical samples. Studying single-nucleotide polymorphisms (SNPs) of USP24 using genomic DNA of lung cancer patients revealed an increase in SNP 7656C/T. When using RNA specimens instead of the genomic DNA of lung cancer patients, we found significant increases in the ratios of variants 930C/T and 7656T/C, suggesting that variants at these two sites are not only caused by the SNP of DNA but also by the RNA editing. USP24-930T and USP24-7656C increase USP24 expression levels by increasing RNA stability. Knocking down USP24 increased Suv39h1 level through a decrease in mouse double-minute 2 homolog levels, thus enhancing lysine-9 methylation of histone H3, and resulting in the prevention of lung cancer malignancy. In conclusion, as USP24 variant analysis revealed a higher ratio of variants in blood specimens of lung cancer patients than that in normal individuals, USP24-930T and USP24-7656C might be useful as diagnostic markers for cancer detection.	[Wang, Y-C; Hung, J-J] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan, Taiwan; [Wang, S-A; Hsu, T-I; Yang, W-B; Hung, J-J] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan, Taiwan; [Chen, P-H; Chuang, Y-P] Natl Cheng Kung Univ, Dept Pharmacol, Tainan, Taiwan; [Hsu, T-I; Hung, J-J] Natl Cheng Kung Univ, Ctr Infect Dis & Signal Transduct, Tainan, Taiwan; [Hsu, T-I] Taipei Med Univ, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Su, W-C] Natl Cheng Kung Univ, Dept Internal Med, Coll Med & Hosp, Tainan, Taiwan; [Liaw, H-J] Natl Cheng Kung Univ, Dept Life Sci, Coll Biosci Biotechnol, Tainan, Taiwan; [Chang, W-C; Hung, J-J] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Hung, JJ (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, 1 Univ Rd, Tainan 701, Taiwan.	petehung@mail.ncku.edu.tw	Hsu, Tsung-I/AAK-9942-2020; Yang, Wen-Bin/AAO-3593-2021; Liaw, Hungjiun/G-7034-2014	Hsu, Tsung-I/0000-0002-7524-7740; Yang, Wen-Bin/0000-0002-6497-4176; Liaw, Hungjiun/0000-0002-3481-709X; Wang, Yi-Chang/0000-0001-9346-5234; Su, Wu-Chou/0000-0003-2953-4105; Wang, Shao-an/0000-0002-5473-4195	National Cheng Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers; Ministry of Science and Technology, Taiwan [MOST 103-2320-B-006-035-MY3, MOST 103-2321-B-006-023-MY3]; National Research Program for Biopharmaceuticals of National Science Council, Taiwan	National Cheng Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Biopharmaceuticals of National Science Council, Taiwan	This work was supported by the National Cheng Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers, together with grants MOST 103-2320-B-006-035-MY3 and MOST 103-2321-B-006-023-MY3 obtained from the Ministry of Science and Technology, Taiwan. In addition, we thank the Taiwan Lung Cancer Tissue/Specimen and Information Resource Center at National Health Research Institute (NHRI), Taiwan for blood samples' support. This Center was supported by grants from National Research Program for Biopharmaceuticals of National Science Council, Taiwan.	Avesson L, 2014, BBA-REV CANCER, V1845, P308, DOI 10.1016/j.bbcan.2014.03.001; Blanc V, 2010, WIRES SYST BIOL MED, V2, P594, DOI 10.1002/wsbm.82; Blons H, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-25; Bosch-Presegue L, 2011, MOL CELL, V42, P210, DOI 10.1016/j.molcel.2011.02.034; Chiba T, 2015, INT J CANCER, V136, P289, DOI 10.1002/ijc.28985; Das TK, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.34; Dominissini D, 2011, CARCINOGENESIS, V32, P1569, DOI 10.1093/carcin/bgr124; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Torres AG, 2014, FEBS LETT, V588, P4279, DOI 10.1016/j.febslet.2014.09.025; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Guo WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117075; Heideker J, 2015, BIOCHEM J, V467, P191, DOI 10.1042/bj4670191; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Katono K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121460; Khanal P, 2013, FASEB J, V27, P4606, DOI 10.1096/fj.13-236851; Kramer K, 2014, TISSUE ANTIGENS, V84, P370, DOI 10.1111/tan.12411; Li SM, 2014, J BIOL CHEM, V289, P34152, DOI 10.1074/jbc.M113.546077; Li YH, 2006, HUM MUTAT, V27, P1017, DOI 10.1002/humu.20382; Liu CC, 2014, NUCLEIC ACIDS RES, V42, P9543, DOI 10.1093/nar/gku675; Nagahara A, 2010, BIOCHEM BIOPH RES CO, V391, P1641, DOI 10.1016/j.bbrc.2009.12.105; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Ranaweera RS, 2013, J BIOL CHEM, V288, P18939, DOI 10.1074/jbc.M113.454470; Rebbani K, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0340-2; Schmid F, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-49; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Tomaselli S, 2014, CELL TISSUE RES, V356, P527, DOI 10.1007/s00441-014-1863-3; Vage J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-10; Villegas J, 2002, NUCLEIC ACIDS RES, V30, P1895, DOI 10.1093/nar/30.9.1895; Wang YQ, 2015, AUTOPHAGY, V11, P595, DOI 10.1080/15548627.2015.1034408; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wu PC, 2014, CANCER RES, V74, P7333, DOI 10.1158/0008-5472.CAN-13-3572; Wu YR, 2010, CLIN CHIM ACTA, V411, P955, DOI 10.1016/j.cca.2010.03.013; Xu C, 2015, ONCOGENE, V34, P342, DOI 10.1038/onc.2013.557; Yanagisawa T, 2003, THEOR APPL GENET, V107, P84, DOI 10.1007/s00122-003-1235-y; Yang Y, 2015, ONCOGENE, V34, P104, DOI 10.1038/onc.2013.522; Zhang L, 2015, CELL REP, V10, P140, DOI 10.1016/j.celrep.2014.12.024; Zhang L, 2012, CELL CYCLE, V11, P4378, DOI 10.4161/cc.22688; Zhao B, 2012, EUR NEUROL, V68, P181, DOI 10.1159/000339641; Zhao GY, 2015, TUMOR BIOL, V36, P1721, DOI 10.1007/s13277-014-2773-4; Zou Q, 2014, NAT IMMUNOL, V15, P562, DOI 10.1038/ni.2885	42	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3669	3680		10.1038/onc.2015.432	http://dx.doi.org/10.1038/onc.2015.432			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26568301				2022-12-26	WOS:000379622800006
J	Chen, X; Kamranvar, SA; Masucci, MG				Chen, X.; Kamranvar, S. A.; Masucci, M. G.			Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors	ONCOGENE			English	Article							MEMBRANE-PROTEIN 1; SIGNAL-BINDING-PROTEIN; NF-KAPPA-B; DNA-DAMAGE; NUCLEAR ANTIGEN; GENOMIC INSTABILITY; TYROSINE KINASES; ACTIVATION; EXPRESSION; INDUCTION	Infection of human B lymphocytes by Epstein-Barr virus (EBV) leads to the establishment of immortalized lymphoblastoid cell lines (LCLs) that are widely used as a model of viral oncogenesis. An early consequence of infection is the induction of DNA damage and activation of the DNA damage response, which limits the efficiency of growth transformation. The cause of the DNA damage remains poorly understood. We have addressed this question by comparing the response of B lymphocytes infected with EBV or stimulated with a potent B-cell mitogen. We found that although the two stimuli induce comparable proliferation during the first 10 days of culture, the EBV-infected blasts showed significantly higher levels of DNA damage, which correlated with stronger and sustained accumulation of reactive oxygen species (ROS). Treatment with ROS scavengers decreased DNA damage in both mitogen-stimulated and EBV-infected cells. However, while mitogen-induced proliferation was slightly improved, the proliferation of EBV-infected cells and the establishment of LCLs were severely impaired. Quenching of ROS did not affect the kinetics and magnitude of viral gene expression but was associated with selective downregulation of the viral LMP1 and phosphorylated cellular transcription factor STAT3 that have key roles in transformation. Analysis of the mechanism by which high levels of ROS support LMP1 expression revealed selective inhibition of viral microRNAs that target the LMP1 transcript. Our study provides novel insights into the role of EBV-induced oxidative stress in promoting B-cell immortalization and malignant transformation.	[Chen, X.; Kamranvar, S. A.; Masucci, M. G.] Karolinska Inst, Dept Cell & Mol Biol, Berzelius Vag 35, S-17177 Stockholm, Sweden; [Kamranvar, S. A.] Uppsala Univ, Biomed Ctr BMC, Med Biochem & Microbiol IMBIM, Uppsala, Sweden	Karolinska Institutet; Uppsala University	Masucci, MG (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Berzelius Vag 35, S-17177 Stockholm, Sweden.	maria.masucci@ki.se	Masucci, Maria/AAC-6666-2019	Masucci, Maria/0000-0002-5541-2809; Chen, Xinsong/0000-0002-3214-9075	Swedish Cancer Society; Swedish Medical Research Council; Karolinska Institutet, Stockholm, Sweden; China Scholarship Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet, Stockholm, Sweden; China Scholarship Council(China Scholarship Council)	This study was supported by grants awarded by the Swedish Cancer Society, the Swedish Medical Research Council and the Karolinska Institutet, Stockholm, Sweden. XC was partly supported by a fellowship awarded by the China Scholarship Council. We are grateful to Dr Glenn Goldstein (David Pharmaceuticals, NY, USA), Dr Svante Norgren (Karolinska University Hospital, Stockholm, Sweden) and Dr Jaap Middeldorp (Vrije Universiteit, Amsterdam, The Netherlands) for providing chemicals and antibodies. The contribution of the master student Iris Valent is gratefully acknowledged.	Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; Ates B, 2008, FREE RADICAL RES, V42, P372, DOI 10.1080/10715760801998638; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bottero V, 2013, J VIROL, V87, P1733, DOI 10.1128/JVI.02958-12; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Dando I, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/425708; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; DIEHL V, 1968, J VIROL, V2, P663, DOI 10.1128/JVI.2.7.663-669.1968; Dolcetti R, 2003, J CELL PHYSIOL, V196, P207, DOI 10.1002/jcp.10263; Gargouri B, 2011, BIOL TRACE ELEM RES, V144, P1449, DOI 10.1007/s12011-011-9135-5; Gires O, 1999, EMBO J, V18, P3064, DOI 10.1093/emboj/18.11.3064; Grand RJA, 1998, VIROLOGY, V244, P330, DOI 10.1006/viro.1998.9102; GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HENKEL T, 1994, SCIENCE, V265, P92, DOI 10.1126/science.8016657; HU LF, 1993, ONCOGENE, V8, P1575; HUEN DS, 1995, ONCOGENE, V10, P549; Ingham RJ, 2005, J BIOL CHEM, V280, P34133, DOI 10.1074/jbc.M507831200; Jochum S, 2012, P NATL ACAD SCI USA, V109, pE1396, DOI 10.1073/pnas.1115906109; Kaiser C, 1999, J VIROL, V73, P4481, DOI 10.1128/JVI.73.5.4481-4484.1999; Kinjo T, 2010, J VIROL, V84, P5431, DOI 10.1128/JVI.02460-09; Knight JS, 2003, J VIROL, V77, P4261, DOI 10.1128/JVI.77.7.4261-4272.2003; Koganti S, 2014, P NATL ACAD SCI USA, V111, P4946, DOI 10.1073/pnas.1400683111; Koganti S, 2014, J VIROL, V88, P516, DOI 10.1128/JVI.02601-13; Koopal S, 2007, PLOS PATHOG, V3, P1348, DOI 10.1371/journal.ppat.0030140; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Le Clorennec C, 2008, J VIROL, V82, P6721, DOI 10.1128/JVI.02250-07; Lee YJ, 2007, AM J PHYSIOL-RENAL, V293, pF1036, DOI 10.1152/ajprenal.00034.2007; LEIBOLD W, 1975, J NATL CANCER I, V54, P65, DOI 10.1093/jnci/54.1.65; Liu TS, 2004, J BIOL CHEM, V279, P2461, DOI 10.1074/jbc.M307251200; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Ma Q, 2013, ANTIOXID REDOX SIGN, V18, P80, DOI 10.1089/ars.2012.4584; Maya-Mendoza A, 2015, MOL ONCOL, V9, P601, DOI 10.1016/j.molonc.2014.11.001; MILLER CL, 1995, IMMUNITY, V2, P155, DOI 10.1016/S1074-7613(95)80040-9; MILLER G, 1972, P NATL ACAD SCI USA, V69, P383, DOI 10.1073/pnas.69.2.383; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; NALESNIK MA, 1988, AM J PATHOL, V133, P173; Nikitin PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087299; Nikitin PA, 2010, CELL HOST MICROBE, V8, P510, DOI 10.1016/j.chom.2010.11.004; Portal D, 2013, P NATL ACAD SCI USA, V110, P18537, DOI 10.1073/pnas.1317608110; Price AM, 2014, ADV VIRUS RES, V88, P279, DOI 10.1016/B978-0-12-800098-4.00006-4; REISMAN D, 1986, MOL CELL BIOL, V6, P3838, DOI 10.1128/MCB.6.11.3838; Rickinson A, 2002, VIRUS RES, V82, P109; Rickinson AB, 1996, VIROLOGY, P2397; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Schwarz KB, 1996, FREE RADICAL BIO MED, V21, P641, DOI 10.1016/0891-5849(96)00131-1; Skalsky RL, 2014, J VIROL, V88, P1617, DOI 10.1128/JVI.02071-13; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Sompallae R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012052; Souza V, 2009, TOXICOL LETT, V187, P180, DOI 10.1016/j.toxlet.2009.02.021; Sunitha K, 2013, FREE RADICAL RES, V47, P357, DOI 10.3109/10715762.2013.781595; Touitou R, 2001, J VIROL, V75, P7749, DOI 10.1128/JVI.75.16.7749-7755.2001; Weitzman MD, 2014, CELL HOST MICROBE, V15, P283, DOI 10.1016/j.chom.2014.02.010; White RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013979; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; Zhao B, 2011, P NATL ACAD SCI USA, V108, P14902, DOI 10.1073/pnas.1108892108	61	30	31	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3807	3816		10.1038/onc.2015.450	http://dx.doi.org/10.1038/onc.2015.450			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26592445	Bronze			2022-12-26	WOS:000380753200006
J	Cadwell, CM; Jenkins, PM; Bennett, V; Kowalczyk, AP				Cadwell, Chantel M.; Jenkins, Paul M.; Bennett, Vann; Kowalczyk, Andrew P.			Ankyrin-G Inhibits Endocytosis of Cadherin Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VE-CADHERIN; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; ALPHA-CATENIN; P120 CATENIN; P120-CATENIN; BINDING; INTERNALIZATION; ADHESION	Dynamic regulation of endothelial cell adhesion is central to vascular development and maintenance. Furthermore, altered endothelial adhesion is implicated in numerous diseases. Therefore, normal vascular patterning and maintenance require tight regulation of endothelial cell adhesion dynamics. However, the mechanisms that control junctional plasticity are not fully understood. Vascular endothelial cadherin (VE-cadherin) is an adhesive protein found in adherens junctions of endothelial cells. VE-cadherin mediates adhesion through trans interactions formed by its extracellular domain. Trans binding is followed by cis interactions that laterally cluster the cadherin in junctions. VE-cadherin is linked to the actin cytoskeleton through cytoplasmic interactions with beta- and alpha-catenin, which serve to increase adhesive strength. Furthermore, p120-catenin binds to the cytoplasmic tail of cadherin and stabilizes it at the plasma membrane. Here we report that induced cis dimerization of VE-cadherin inhibits endocytosis independent of both p120 binding and trans interactions. However, we find that ankyrin-G, a protein that links membrane proteins to the spectrin-actin cytoskeleton, associates with VE-cadherin and inhibits its endocytosis. Ankyrin-G inhibits VE-cadherin endocytosis independent of p120 binding. We propose a model in which ankyrin-G associates with and inhibits the endocytosis of VE-cadherin cis dimers. Our findings support a novel mechanism for regulation of VE-cadherin endocytosis through ankyrin association with cadherin engaged in lateral interactions.	[Cadwell, Chantel M.] Emory Univ, Sch Med, Biochem Cell & Dev Biol Grad Program, Atlanta, GA 30322 USA; [Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; [Kowalczyk, Andrew P.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Jenkins, Paul M.; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem Cell Biol & Neurobiol, Durham, NC 27710 USA	Emory University; Emory University; Emory University; Emory University; Duke University; Howard Hughes Medical Institute	Kowalczyk, AP (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Dept Cell Biol, Atlanta, GA 30322 USA.	akowalc@emory.edu	Jenkins, Paul/C-9098-2015	Jenkins, Paul/0000-0002-4207-5823	National Institutes of Health [RO1AR050501, RO1AR048266]; American Heart Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048266, R01AR050501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants RO1AR050501 and RO1AR048266 (to A.P.K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a fellowship from the American Heart Association.	Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Brasch J, 2011, J MOL BIOL, V408, P57, DOI 10.1016/j.jmb.2011.01.031; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen J, 2012, J CELL BIOL, V199, P699, DOI 10.1083/jcb.201202105; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Hofman EG, 2010, J BIOL CHEM, V285, P39481, DOI 10.1074/jbc.M110.164731; Hordijk PL, 1999, J CELL SCI, V112, P1915; Jefford G, 2000, J BIOL CHEM, V275, P27726; Jenkins PM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500301; Jenkins PM, 2013, J BIOL CHEM, V288, P14018, DOI 10.1074/jbc.M113.454439; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Oas RG, 2013, MOL BIOL CELL, V24, P704, DOI 10.1091/mbc.E12-06-0471; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012; Saito M, 2012, J CELL SCI, V125, P2547, DOI 10.1242/jcs.066654; Sato K, 2011, MOL BIOL CELL, V22, P3103, DOI 10.1091/mbc.E11-03-0274; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Song GJ, 2005, MOL ENDOCRINOL, V19, P2859, DOI 10.1210/me.2005-0133; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Tseng WC, 2015, P NATL ACAD SCI USA, V112, P1214, DOI 10.1073/pnas.1417989112; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	40	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					691	704		10.1074/jbc.M115.648386	http://dx.doi.org/10.1074/jbc.M115.648386			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26574545	Green Published, hybrid			2022-12-26	WOS:000367830500018
J	Kryvalap, Y; Lo, CW; Manuylova, E; Baldzizhar, R; Jospe, N; Czyzyk, J				Kryvalap, Yury; Lo, Chi-Wen; Manuylova, Ekaterina; Baldzizhar, Raman; Jospe, Nicholas; Czyzyk, Jan			Antibody Response to Serpin B13 Induces Adaptive Changes in Mouse Pancreatic Islets and Slows Down the Decline in the Residual Beta Cell Function in Children with Recent Onset of Type 1 Diabetes Mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; beta cell (B-cell); pancreatic islet; serpin; Type 1 diabetes	ADULT MICE; APOPTOSIS; TURNOVER; MASS; INHIBITOR; EXOCRINE; PROTECTS; REGENERATION; PROGENITORS; NEOGENESIS	Type 1 diabetes mellitus (T1D) is characterized by a heightened antibody (Ab) response to pancreatic islet self-antigens, which is a biomarker of progressive islet pathology. We recently identified a novel antibody to clade B serpin that reduces islet-associated T cell accumulation and is linked to the delayed onset of T1D. As natural immunity to clade B arises early in life, we hypothesized that it may influence islet development during that time. To test this possibility healthy young Balb/c male mice were injected with serpin B13 mAb or IgG control and examined for the number and cellularity of pancreatic islets by immunofluorescence and FACS. Beta cell proliferation was assessed by measuring nucleotide analog 5-ethynyl-2-deoxyuridine (5-EdU) incorporation into the DNA and islet Reg gene expression was measured by real time PCR. Human studies involved measuring anti-serpin B13 autoantibodies by Luminex. We found that injecting anti-serpin B13 monoclonal Ab enhanced beta cell proliferation and Reg gene expression, induced the generation of approximate to 80 pancreatic islets per animal, and ultimately led to increase in the beta cell mass. These findings are relevant to human T1D because our analysis of subjects just diagnosed with T1D revealed an association between baseline anti-serpin activity and slower residual beta cell function decline in the first year after the onset of diabetes. Our findings reveal a new role for the anti-serpin immunological response in promoting adaptive changes in the endocrine pancreas and suggests that enhancement of this response could potentially help impede the progression of T1D in humans.	[Kryvalap, Yury; Lo, Chi-Wen; Baldzizhar, Raman; Czyzyk, Jan] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Manuylova, Ekaterina] Univ Rochester, Div Endocrinol Diabet & Metab, Rochester, NY 14642 USA; [Jospe, Nicholas] Univ Rochester, Div Pediat Endocrinol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Czyzyk, J (corresponding author), 601 Elmwood Ave, Rochester, NY 14642 USA.	jan_czyzyk@URMC.rochester.edu			Juvenile Diabetes Research Foundation [17-2013-428]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085499, U01DK061058, U01DK061010, U01DK107014, U01DK103266, U01DK085465, U01DK106984, U01DK103153, U01DK085476] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Juvenile Diabetes Research Foundation Grant 17-2013-428 (to J. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abts HF, 1999, J MOL BIOL, V293, P29, DOI 10.1006/jmbi.1999.3159; Baldzizhar R, 2013, J BIOL CHEM, V288, P1612, DOI 10.1074/jbc.M112.409664; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Cacoub P, 2001, ARTHRITIS RHEUM, V44, P1836, DOI 10.1002/1529-0131(200108)44:8<1836::AID-ART321>3.0.CO;2-Y; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Czyzyk J, 2012, J IMMUNOL, V188, P6319, DOI 10.4049/jimmunol.1200467; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; HARTMANN K, 1989, EXP CLIN ENDOCRINOL, V93, P225, DOI 10.1055/s-0029-1210861; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; Jones LC, 2001, DIABETES, V50, pS186, DOI 10.2337/diabetes.50.2007.S186; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Millet I, 2006, J AUTOIMMUN, V26, P7, DOI 10.1016/j.jaut.2005.10.005; Mortensen HB, 2009, DIABETES CARE, V32, P1384, DOI 10.2337/dc08-1987; Okamoto H, 1999, J Hepatobiliary Pancreat Surg, V6, P254, DOI 10.1007/s005340050115; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Phillips JM, 2007, DIABETES, V56, P634, DOI 10.2337/db06-0832; Pittenger GL, 2009, CURR PROTEIN PEPT SC, V10, P37, DOI 10.2174/138920309787315211; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Reichert M, 2013, NAT PROTOC, V8, P1354, DOI 10.1038/nprot.2013.079; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; Weir GC, 2011, DIABETES, V60, P2018, DOI 10.2337/db10-1808; Welss T, 2003, BIOCHEMISTRY-US, V42, P7381, DOI 10.1021/bi027307q; Wu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072132; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273	37	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					266	278		10.1074/jbc.M115.687848	http://dx.doi.org/10.1074/jbc.M115.687848			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578518	Green Published, hybrid			2022-12-26	WOS:000367589500021
J	Su, SS; Hong, F; Liang, YL; Zhou, JQ; Liang, Y; Chen, KQ; Wang, XY; Wang, ZQ; Wang, ZQ; Chang, C; Han, WH; Gong, W; Qin, HT; Jiang, B; Xiong, HB; Peng, L				Su, Shasha; Hong, Feng; Liang, Yanling; Zhou, Jieqiong; Liang, Yan; Chen, Kequan; Wang, Xinying; Wang, Zhongqiu; Wang, Zhiqing; Chang, Cassie; Han, Weihua; Gong, Wei; Qin, Haitao; Jiang, Bo; Xiong, Huabao; Peng, Liang			Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; COLON-CANCER; SELF-RENEWAL; IN-VITRO; EPIGENETIC REGULATION; DNA METHYLATION; SMALL-INTESTINE; EXPRESSION; OVEREXPRESSION; IDENTIFICATION	Objective Leucine-rich-repeat-containing G-protein-coupled receptor 5 (lgr5) is a candidate marker for colorectal cancer stem cells (CSC). In the current study, we investigated the methylation status within thelgr5 promoter and evaluated its relationship with CSC differentiation, prognosis for colorectal cancer, and its clinicopathological features. Methods The methylation status within Lgr5 promoter was detected with a methylation-specific PCR in six colorectal cancer cell lines as well as 169 primary colorectal tumor tissues. Differentiation of CSC was examined with immunofluorescence and immunocytochemistry. Down-regulation of lgr5 was achieved with gene-specific siRNA. The associations between lgr5 methylation and the clinicopathological features as well as survival of patients were analyzed with statistical methods. Results The lgr5 promoter was methylated to different degrees for the six colorectal cell lines examined, with complete methylation observed in HCT116 cells in which the lgr5 expression was partially recovered following DAC treatment. The stem-cell sphere formation from HCT116 cells was accompanied by increasing methylation within the lgr5 promoter and decreasing expression of lgr5. Knocking down lgr5 by siRNA also led to stem-cell spheres formation. Among primary colorectal tumors, 40% (67/169) were positive for lgr5 methylation, while none of the normal colon tissues were positive for lgr5 methylation. Furthermore, lgr5 methylation significantly associated with higher tumor grade, and negative distant metastasis (p < 0.05), as well as better prognosis (p = 0.001) in patients with colorectal cancer. Conclusions Our data suggests that lgr5 methylation, through the regulation of lgr5 expression and colorectal CSC differentiation, may constitute a novel prognostic marker for colorectal cancer patients.	[Su, Shasha; Liang, Yanling; Zhou, Jieqiong; Liang, Yan; Chen, Kequan; Wang, Xinying; Wang, Zhongqiu; Wang, Zhiqing; Gong, Wei; Qin, Haitao; Jiang, Bo; Peng, Liang] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China; [Hong, Feng] Jining Med Univ, Inst Liver Dis, Affiliated Hosp, Jinan 273100, Shandong, Peoples R China; [Chang, Cassie; Xiong, Huabao] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Med, New York, NY 10029 USA; [Han, Weihua] XingTai Med Coll, Affiliated Hosp 2, Hebei 054002, Anhui, Peoples R China	Southern Medical University - China; Jining Medical University; Icahn School of Medicine at Mount Sinai	Peng, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Guangdong, Peoples R China.	wsfirefly@126.com	Gong, Wei/AAH-3274-2019		National Natural Science foundation of China (NSFC) [81302156]; Guangzhou Pilot Project of Clinical and Translational Research Center [7415696196402]; Guangdong Provincial Bio-engineering Research Center for Gastroenterology Diseases	National Natural Science foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangzhou Pilot Project of Clinical and Translational Research Center; Guangdong Provincial Bio-engineering Research Center for Gastroenterology Diseases	This project was in part supported by National Natural Science foundation of China (NSFC. NO. 81302156), Guangzhou Pilot Project of Clinical and Translational Research Center (early gastrointestinal cancers, No.7415696196402), Guangdong Provincial Bio-engineering Research Center for Gastroenterology Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Chen KL, 2011, CLIN EXP METASTAS, V28, P751, DOI 10.1007/s10585-011-9407-7; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107013; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Fukuma M, 2013, EXP CELL RES, V319, P113, DOI 10.1016/j.yexcr.2012.10.011; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Ghods AJ, 2007, STEM CELLS, V25, P1645, DOI 10.1634/stemcells.2006-0624; Gopisetty G, 2013, ONCOGENE, V32, P3119, DOI 10.1038/onc.2012.331; Hammoud SS, 2013, CURR OPIN CELL BIOL, V25, P177, DOI 10.1016/j.ceb.2013.01.007; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hirsch D, 2014, CARCINOGENESIS, V35, P849, DOI 10.1093/carcin/bgt377; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Infanger DW, 2013, CANCER RES, V73, P7079, DOI 10.1158/0008-5472.CAN-13-1355; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu Z, 2014, NEOPLASMA, V61, P177, DOI 10.4149/neo_2014_016; Mancikova V, 2014, INT J CANCER, V135, P598, DOI 10.1002/ijc.28703; McClanahan T, 2006, CANCER BIOL THER, V5, P419, DOI 10.4161/cbt.5.4.2521; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Raggi C, 2014, HEPATOLOGY, V59, P2251, DOI 10.1002/hep.27026; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rubinfeld B, 1997, CANCER RES, V57, P4624; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Spizzo G, 2007, CANCER LETT, V246, P253, DOI 10.1016/j.canlet.2006.03.002; Su N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-43; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Ung M, 2014, EPIGENETICS OFFICIAL, V9; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Woodson K, 2006, EPIGENETICS-US, V1, P183, DOI 10.4161/epi.1.4.3530; Yamamoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3299; Yamamoto Y, 2003, HEPATOLOGY, V37, P528, DOI 10.1053/jhep.2003.50029; Yamanoi K, 2013, PATHOL INT, V63, P13, DOI 10.1111/pin.12013; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	52	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143513	10.1371/journal.pone.0143513	http://dx.doi.org/10.1371/journal.pone.0143513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599100	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600077
J	Scheiner, B; Mandorfer, M; Schwabl, P; Payer, BA; Bucsics, T; Bota, S; Aichelburg, MC; Grabmeier-Pfistershammer, K; Stattermayer, A; Ferenci, P; Trauner, M; Peck-Radosavljevic, M; Reiberger, T				Scheiner, Bernhard; Mandorfer, Mattias; Schwabl, Philipp; Payer, Berit Anna; Bucsics, Theresa; Bota, Simona; Aichelburg, Maximilian C.; Grabmeier-Pfistershammer, Katharina; Staettermayer, Albert; Ferenci, Peter; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas			The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection	PLOS ONE			English	Article							VIRUS/HEPATITIS-C-VIRUS; INTERFERON PLUS RIBAVIRIN; HIV-INFECTED PATIENTS; TRANSIENT ELASTOGRAPHY; PEGYLATED INTERFERON; VIRAL-HEPATITIS; HCV GENOTYPE; RISK-FACTORS; ANTIRETROVIRAL THERAPY; VIROLOGICAL RESPONSE	Background Faster fibrosis progression and hepatic steatosis are hallmarks of HIV/HCV coinfection. A single nucleotide polymorphism (SNP) of the PNPLA3-gene is associated with development of non-alcoholic steatohepatitis and a worse outcome in alcoholic liver disease. However, the role of PNPLA3 rs738409 SNP on liver fibrosis and steatosis, portal hypertension, and virological response in HIV/HCV coinfection remains unclear. Methods In this cross-sectional study PNPLA3 (rs738409) and IL28B (rs12979860) SNPs were determined in 177 HIV/HCV coinfected patients. Liver fibrosis and steatosis-staged by liver biopsy and transient elastography using the Controlled Attenuation Parameter (CAP)-and portal hypertension (hepatic venous pressure gradient, HVPG) were compared across PNPLA3 genotypes. Results 75 (42.4%) patients tested positive for a PNPLA3 minor/major risk allele (G/C: 66; G/G: 9) showed comparable fibrosis stages (median F2 vs. F2; p = 0.292) and similar amounts of hepatic steatosis (CAP: 203.5 +/- 41.9 vs. 215.5 +/- 59.7dB/m; p = 0.563) as compared to patients without a PNPLA3 risk allele. Advanced liver fibrosis was neither associated with PNPLA3 (p = 0.253) nor IL28B-genotype (p = 0.628), but with HCV-GT3 (p = 0.003), higher BMI (p = 0.008) and higher age (p = 0.007). Fibrosis progression rate (0.27 +/- 0.41 vs. 0.20 +/- 0.26 units/year; p = 0.984) and HVPG (3.9 +/- 2.6 vs. 4.4 +/- 3.0 mmHg; p = 0.472) were similar in patients with and without PNPLA3 risk alleles. SVR rates to PEGIFN/RBV therapy were similar across PNPLA3 genotypes. Conclusions The presence of a PNPLA3 risk allele had no independent impact on liver disease or virological response rates to PEGIFN/RBV therapy in our cohort of HIV/HCV coinfected patients.	[Scheiner, Bernhard; Mandorfer, Mattias; Schwabl, Philipp; Payer, Berit Anna; Bucsics, Theresa; Bota, Simona; Staettermayer, Albert; Ferenci, Peter; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria; [Scheiner, Bernhard; Mandorfer, Mattias; Schwabl, Philipp; Payer, Berit Anna; Aichelburg, Maximilian C.; Grabmeier-Pfistershammer, Katharina; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Vienna HIV & Liver Study Grp, Vienna, Austria; [Aichelburg, Maximilian C.; Grabmeier-Pfistershammer, Katharina] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Reiberger, T (corresponding author), Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria.	thomas.reiberger@meduniwien.ac.at	Mandorfer, Mattias/H-7603-2019; Reiberger, Thomas/H-7613-2019	Mandorfer, Mattias/0000-0003-2330-0017; Reiberger, Thomas/0000-0002-4590-3583; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414; Schwabl, Philipp/0000-0002-7183-8076; Scheiner, Bernhard/0000-0002-4904-5133; Trauner, Michael/0000-0002-1275-6425; Mullner-Bucsics, Theresa/0000-0003-3901-4111; Stattermayer, Albert/0000-0003-0737-4091				Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Adinolfi LE, 2005, ALIMENT PHARM THER, V22, P52, DOI 10.1111/j.1365-2036.2005.02597.x; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Ampuero J, 2014, ANN HEPATOL, V13, P356, DOI 10.1016/S1665-2681(19)30842-7; Bani-Sadr F, 2006, AIDS, V20, P525, DOI 10.1097/01.aids.0000210606.63138.f5; Barreiro P, 2006, CLIN INFECT DIS, V42, P1032, DOI 10.1086/501021; Barreiro P, 2011, J INFECT DIS, V203, P1629, DOI 10.1093/infdis/jir113; Boursier J, 2015, HEPATOLOGY, V61, P18, DOI 10.1002/hep.27445; Castera L, 2014, HIV MED, V15, P30, DOI 10.1111/hiv.12082; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chang CC, 2013, IMMUNOL REV, V254, P114, DOI 10.1111/imr.12063; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Garcia-Tsao G, 2001, CURR OPIN GASTROEN, V17, P281, DOI 10.1097/00001574-200105000-00012; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Konerman MA, 2014, HEPATOLOGY, V59, P767, DOI 10.1002/hep.26741; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Labarga P, 2014, ANTIVIR THER, V19, P799, DOI 10.3851/IMP2816; Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926; Macias J, 2014, EXPERT OPIN PHARMACO, V15, P1837, DOI 10.1517/14656566.2014.934810; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Mandorfer M, 2014, J VIRAL HEPATITIS, V21, P33, DOI 10.1111/jvh.12118; Mandorfer M, 2014, LIVER INT; Mandorfer M, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12253; Mandorfer M, 2013, AIDS, V27, P227, DOI 10.1097/QAD.0b013e32835aa161; Morse CG, 2015, CLIN INFECT DIS; Neukam K, 2012, J HEPATOL, V56, P788, DOI 10.1016/j.jhep.2011.11.008; Payer BA, 2012, EUR J CLIN INVEST, V42, P599, DOI 10.1111/j.1365-2362.2011.02623.x; Peck-Radosavljevic M, 2013, WIEN KLIN WOCHENSCHR, V125, P200, DOI 10.1007/s00508-013-0337-z; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Price JC, 2014, AM J GASTROENTEROL, V109, P695, DOI 10.1038/ajg.2014.32; Reiberger T, 2008, EUR J CLIN INVEST, V38, P421, DOI 10.1111/j.1365-2362.2008.01958.x; Reiberger T, 2010, J VIRAL HEPATITIS, V17, P400, DOI 10.1111/j.1365-2893.2009.01197.x; Reiberger T, 2014, MINERVA GASTROENTERO; Reiberger T, 2012, ANTIVIR THER, V17, P1327, DOI 10.3851/IMP2349; Reiberger T, 2012, WIEN KLIN WOCHENSCHR, V124, P395, DOI 10.1007/s00508-012-0190-5; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, CURR OPIN LIPIDOL, V21, P247, DOI 10.1097/MOL.0b013e328338ca61; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P1059, DOI 10.1111/apt.12717; Stattermayer AF, 2012, J HEPATOL, V57, P492, DOI 10.1016/j.jhep.2012.04.036; Sterling RK, 2008, HEPATOLOGY, V47, P1118, DOI 10.1002/hep.22134; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sulkowski MS, 2005, AIDS, V19, P585, DOI 10.1097/01.aids.0000163935.99401.25; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Theise ND, 2007, MODERN PATHOL, V20, pS3, DOI 10.1038/modpathol.3800693; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Valenti L, 2012, ALIMENT PHARM THER, V35, P1434, DOI 10.1111/j.1365-2036.2012.05109.x; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Yasui K, 2014, J GASTROENTEROL; Zampino R, 2013, J VIRAL HEPATITIS, V20, P517, DOI 10.1111/jvh.12053	53	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143429	10.1371/journal.pone.0143429	http://dx.doi.org/10.1371/journal.pone.0143429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599080	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900118
J	Castede, S; Campoy, JA; Le Dantec, L; Quero-Garcia, J; Barreneche, T; Wenden, B; Dirlewanger, E				Castede, Sophie; Campoy, Jose Antonio; Le Dantec, Loick; Quero-Garcia, Jose; Barreneche, Teresa; Wenden, Benedicte; Dirlewanger, Elisabeth			Mapping of Candidate Genes Involved in Bud Dormancy and Flowering Time in Sweet Cherry (Prunus avium)	PLOS ONE			English	Article							MADS-BOX GENE; CONTROLS GROWTH CESSATION; PERSICA L. BATSCH; CHILLING REQUIREMENT; LOCUS-T; PHENOLOGICAL TRAITS; HEAT REQUIREMENTS; LOW-TEMPERATURE; BLOOM DATE; PEACH	The timing of flowering in perennial plants is crucial for their survival in temperate climates and is regulated by the duration of bud dormancy. Bud dormancy release and bud break depend on the perception of cumulative chilling during endodormancy and heat during the bud development. The objectives of this work were to identify candidate genes involved in dormancy and flowering processes in sweet cherry, their mapping in two mapping progenies 'Regina' x 'Garnet' and 'Regina' x 'Lapins', and to select those candidate genes which co-localized with quantitative trait loci (QTLs) associated with temperature requirements for bud dormancy release and flowering. Based on available data on flowering processes in various species, a list of 79 candidate genes was established. The peach and sweet cherry orthologs were identified and primers were designed to amplify sweet cherry candidate gene fragments. Based on the amplified sequences of the three parents of the mapping progenies, SNPs segregations in the progenies were identified. Thirty five candidate genes were genetically mapped in at least one of the two progenies and all were in silico mapped. Co-localization between candidate genes and QTLs associated with temperature requirements and flowering date were identified for the first time in sweet cherry. The allelic composition of the candidate genes located in the major QTL for heat requirements and flowering date located on linkage group 4 have a significant effect on these two traits indicating their potential use for breeding programs in sweet cherry to select new varieties adapted to putative future climatic conditions.	[Castede, Sophie; Campoy, Jose Antonio; Le Dantec, Loick; Quero-Garcia, Jose; Barreneche, Teresa; Wenden, Benedicte; Dirlewanger, Elisabeth] INRA, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France; [Castede, Sophie; Campoy, Jose Antonio; Le Dantec, Loick; Quero-Garcia, Jose; Barreneche, Teresa; Wenden, Benedicte; Dirlewanger, Elisabeth] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux	Dirlewanger, E (corresponding author), INRA, UMR Biol Fruit & Pathol 1332, F-33140 Villenave Dornon, France.	dirlewan@bordeaux.inra.fr	Wenden, Bénédicte/P-9519-2019; Campoy, José A/L-2699-2015	Wenden, Bénédicte/0000-0002-3064-5446; Campoy, José A/0000-0002-6018-5698; Dirlewanger, Elisabeth/0000-0003-3244-5197; BARRENECHE, Teresa/0000-0002-7852-1418	Aquitaine Region of France [2011-1201001]; INRA Meta Program 'Adaptation de l'agriculture et de la foret au changement climatique (ACCAF)	Aquitaine Region of France(Region Nouvelle-Aquitaine); INRA Meta Program 'Adaptation de l'agriculture et de la foret au changement climatique (ACCAF)	Sophie Castede's PhD grant was funded by the Aquitaine Region of France (2011-1201001: Etude et comprehension du determinisme genetique et moleculaire de la floraison chez le cerisier doux (Prunus avium) dans le but, a terme, de favoriser le choix de geniteurs et la creation de materiel vegetal adapte a lelevation de temperature prevue dans le cadre du rechauffement climatique et produisant des fruits de qualite) and by INRA Meta Program 'Adaptation de l'agriculture et de la foret au changement climatique (ACCAF; http://www.accaf.inra.fr/).	Alburquerque N, 2008, ENVIRON EXP BOT, V64, P162, DOI 10.1016/j.envexpbot.2008.01.003; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bielenberg DG, 2008, TREE GENET GENOMES, V4, P495, DOI 10.1007/s11295-007-0126-9; Bielenberg DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139406; Campoy JA, 2011, SCI HORTIC-AMSTERDAM, V130, P357, DOI 10.1016/j.scienta.2011.07.011; Campoy JA, 2012, EUR J AGRON, V37, P43, DOI 10.1016/j.eja.2011.10.004; Castede S, 2014, NEW PHYTOL, V202, P703, DOI 10.1111/nph.12658; Cooke JEK, 2012, PLANT CELL ENVIRON, V35, P1707, DOI 10.1111/j.1365-3040.2012.02552.x; Darbyshire R, 2013, INT J BIOMETEOROL, V57, P355, DOI 10.1007/s00484-012-0558-2; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; Dirlewanger E, 2012, HEREDITY, V109, P280, DOI 10.1038/hdy.2012.38; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Fan S, 2010, NEW PHYTOL, V185, P917, DOI 10.1111/j.1469-8137.2009.03119.x; FISHMAN S, 1987, J THEOR BIOL, V124, P473, DOI 10.1016/S0022-5193(87)80221-7; Guedon Y, 2008, ECOL MODEL, V219, P189, DOI 10.1016/j.ecolmodel.2008.08.010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hedley PE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-202; Heide OM, 2008, SCI HORTIC-AMSTERDAM, V115, P309, DOI 10.1016/j.scienta.2007.10.005; Heide OM, 2011, J EXP BOT, V62, P5397, DOI 10.1093/jxb/err213; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Jimenez S, 2012, ACTA HORTIC, V962, P161, DOI 10.17660/ActaHortic.2012.962.24; Jimenez S, 2010, PLANT MOL BIOL, V73, P157, DOI 10.1007/s11103-010-9608-5; Jimenez S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-25; Jimenez S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-81; Khan MRG, 2014, WIRES RNA, V5, P347, DOI 10.1002/wrna.1215; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Klagges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054743; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kryvych S, 2008, PLANT PHYSIOL BIOCH, V46, P160, DOI 10.1016/j.plaphy.2007.11.001; LANG GA, 1987, HORTSCIENCE, V22, P817; Lavee S., 1973, Acta Horticulturae, P225; Le Dantec L, 2012, 6 ROS GEN C; Leida C, 2012, NEW PHYTOL, V193, P67, DOI 10.1111/j.1469-8137.2011.03863.x; Li ZG, 2009, J EXP BOT, V60, P3521, DOI 10.1093/jxb/erp195; Luedeling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020155; Luedeling E, 2009, ERWERBS-OBSTBAU, V51, P81, DOI 10.1007/s10341-009-0085-4; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Okie WR, 2011, HORTSCIENCE, V46, P245, DOI 10.21273/HORTSCI.46.2.245; Oliver SN, 2013, J EXP BOT, V64, P2413, DOI 10.1093/jxb/ert095; Olukolu BA, 2009, GENOME, V52, P819, DOI [10.1139/G09-050, 10.1139/g09-050]; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; RICHARDSON E A, 1974, Hortscience, V9, P331; Rinne PLH, 2011, PLANT CELL, V23, P130, DOI 10.1105/tpc.110.081307; Rinne PLH, 2001, PLANT J, V26, P249, DOI 10.1046/j.1365-313X.2001.01022.x; Ruckle ME, 2012, PLANT PHYSIOL, V159, P366, DOI 10.1104/pp.112.193599; Sanchez-Perez R, 2012, TREE GENET GENOMES, V8, P379, DOI 10.1007/s11295-011-0448-5; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Socquet-Juglard D, 2013, PLANT MOL BIOL REP, V31, P387, DOI 10.1007/s11105-012-0511-x; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trainin T, 2013, TREE GENET GENOMES, V9, P753, DOI 10.1007/s11295-012-0590-8; Van Ooijen J., 2006, SOFTWARE CALCULATION; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamane H, 2008, J AM SOC HORTIC SCI, V133, P708, DOI 10.21273/JASHS.133.5.708; Yamane H, 2011, J EXP BOT, V62, P3481, DOI 10.1093/jxb/err028; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092; Zhebentyayeva TN, 2014, TREE GENET GENOMES, V10, P35, DOI 10.1007/s11295-013-0660-6	69	51	51	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143250	10.1371/journal.pone.0143250	http://dx.doi.org/10.1371/journal.pone.0143250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587668	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500043
J	Kim, JS; Son, Y; Bae, MJ; Lee, SS; Park, SH; Lee, HJ; Lee, SI; Lee, CG; Kim, SD; Jo, WS; Kim, SH; Shin, IS				Kim, Joong Sun; Son, Yeonghoon; Bae, Min Ji; Lee, Seung Sook; Park, Sun Hoo; Lee, Hae June; Lee, Soong In; Lee, Chang Geun; Kim, Sung Dae; Jo, Wol Soon; Kim, Sung Ho; Shin, In Sik			Continuous Exposure to Low-Dose-Rate Gamma Irradiation Reduces Airway Inflammation in Ovalbumin-Induced Asthma	PLOS ONE			English	Article							REGULATORY T-CELLS; UP-REGULATION; RATE RADIATION; MATRIX-METALLOPROTEINASE-9; MICE	Although safe doses of radiation have been determined, concerns about the harmful effects of low-dose radiation persist. In particular, to date, few studies have investigated the correlation between low-dose radiation and disease development. Asthma is a common chronic inflammatory airway disease that is recognized as a major public health problem. In this study, we evaluated the effects of low-dose-rate chronic irradiation on allergic asthma in a murine model. Mice were sensitized and airway-challenged with ovalbumin (OVA) and were exposed to continuous low-dose-rate irradiation (0.554 or 1.818 mGy/h) for 24 days after initial sensitization. The effects of chronic radiation on proinflammatory cytokines and the activity of matrix metalloproteinase-9 (MMP-9) were investigated. Exposure to low-dose-rate chronic irradiation significantly decreased the number of inflammatory cells, methylcholine responsiveness (PenH value), and the levels of OVA-specific immunoglobulin E, interleukin (IL)-4, and IL-5. Furthermore, airway inflammation and the mucus production in lung tissue were attenuated and elevated MMP-9 expression and activity induced by OVA challenge were significantly suppressed. These results indicate that low-dose-rate chronic irradiation suppresses allergic asthma induced by OVA challenge and does not exert any adverse effects on asthma development. Our findings can potentially provide toxicological guidance for the safe use of radiation and relieve the general anxiety about exposure to low-dose radiation.	[Kim, Joong Sun; Bae, Min Ji; Lee, Chang Geun; Kim, Sung Dae; Jo, Wol Soon] DIRAMS, Res Ctr, Busan, South Korea; [Lee, Seung Sook; Park, Sun Hoo] Lab Radiat Exposure & Therapeut, Seoul, South Korea; [Son, Yeonghoon; Lee, Hae June] KIRAMS, Div Radiat Effect, Seoul, South Korea; [Lee, Soong In] Dongshin Univ, Coll Oriental Med, Jeonnam, South Korea; [Kim, Sung Ho; Shin, In Sik] Chonnam Natl Univ, Coll Vet Med, Gwangju, South Korea	Korea Institute of Radiological & Medical Sciences; Dongshin University; Chonnam National University	Kim, JS (corresponding author), DIRAMS, Res Ctr, Busan, South Korea.	jskim@dirams.re.kr; dvmshin@jnu.ac.kr			National R&D Program through the Korea Institute of Radiological and Medical Sciences [50586-2015]; Nuclear R&D Program of the Ministry of Science, ICT & Future Planning, Korea [50492-2015]; Global ATC program of Ministry of Trade, Industry Energy, Korea [51316-2014]	National R&D Program through the Korea Institute of Radiological and Medical Sciences; Nuclear R&D Program of the Ministry of Science, ICT & Future Planning, Korea; Global ATC program of Ministry of Trade, Industry Energy, Korea	This work was supported by National R&D Program through the Korea Institute of Radiological and Medical Sciences [50586-2015] and Nuclear R&D Program [50492-2015] of the Ministry of Science, ICT & Future Planning, Korea, and Global ATC program of Ministry of Trade, Industry & Energy, Korea [51316-2014].	Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Eldh T, 2012, STRAHLENTHER ONKOL, V188, P274, DOI 10.1007/s00066-011-0046-3; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; Fang SP, 2005, J RADIAT RES, V46, P151, DOI 10.1269/jrr.46.151; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Gong EJ, 2014, J RADIAT RES, V55, P54, DOI 10.1093/jrr/rrt090; HALL EJ, 1991, INT J RADIAT BIOL, V59, P595, DOI 10.1080/09553009114550531; Hong GU, 2014, RADIAT RES, V181, P425, DOI 10.1667/RR13547.1; Ina Y, 2005, INT J RADIAT BIOL, V81, P721, DOI 10.1080/09553000500519808; Jeon CM, 2014, INT IMMUNOPHARMACOL, V22, P414, DOI 10.1016/j.intimp.2014.07.013; Kim S-D., 2012, J RADIAT PROT RES, V37, P159; Ko FWS, 2005, CHEST, V127, P1919, DOI 10.1378/chest.127.6.1919; Lee MY, 2011, FOOD CHEM TOXICOL, V49, P829, DOI 10.1016/j.fct.2010.12.004; Mirzaie-Joniani H, 2002, CANCER, V94, P1210, DOI 10.1002/cncr.10287; Nakatsukasa H, 2010, RADIAT RES, V174, P313, DOI 10.1667/RR2121.1; Park BS, 2013, RADIAT RES, V179, P570, DOI 10.1667/RR3082.1; Park HR, 2013, INFLAMM RES, V62, P27, DOI 10.1007/s00011-012-0547-2; Piirila P, 2010, ALLERGY, V65, P61, DOI 10.1111/j.1398-9995.2009.02146.x; Ren HW, 2006, CELL IMMUNOL, V244, P50, DOI 10.1016/j.cellimm.2007.02.009; Rosanna D, 2012, CURR PHARM DESIGN, V18, P3889, DOI 10.2174/138161212802083716; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; SON YEONGHOON, 2013, [Journal of Radiation Protection and Research, 방사선방어학회지], V38, P179, DOI 10.14407/jrp.2013.38.4.179; Tanaka T, 2005, INT J RADIAT BIOL, V81, P731, DOI 10.1080/09553000500519790; Tsukimoto M, 2008, RADIAT RES, V170, P429, DOI 10.1667/RR1352.1; *UNSCEAR, 2000, HEALTH PHYS, V79, P314, DOI DOI 10.1097/00004032-200009000-00017; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Zhang YP, 2013, PHARMACOL RES, V71, P9, DOI 10.1016/j.phrs.2013.02.004; Zhang YH, 2014, ONCOL REP, V32, P1787, DOI 10.3892/or.2014.3419; Zhou Y, 2010, MOL MED REP, V3, P809, DOI 10.3892/mmr.2010.326	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143403	10.1371/journal.pone.0143403	http://dx.doi.org/10.1371/journal.pone.0143403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588845	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500058
J	Paerhati, Y; Ishiguro, S; Ueda-Matsuo, R; Yang, P; Yamashita, T; Ito, K; Maekawa, H; Tani, H; Suzuki, K				Paerhati, Yisilahaiti; Ishiguro, Shinichi; Ueda-Matsuo, Risa; Yang, Ping; Yamashita, Tetsuro; Ito, Kikukatsu; Maekawa, Hideaki; Tani, Hiroko; Suzuki, Koichi			Expression of AmGR10 of the Gustatory Receptor Family in Honey Bee Is Correlated with Nursing Behavior	PLOS ONE			English	Article							APIS-MELLIFERA L; GENE-EXPRESSION; CHEMORECEPTOR SUPERFAMILY; MOLECULAR EVOLUTION; HEMOLYMPH SUGARS; SOCIAL-BEHAVIOR; DROSOPHILA; BRAIN; FOXP2	We investigated the association between the expression of a gene encoding gustatory receptor (G10) and division of labor in the honey bee, Apis mellifera. Among 10 GR genes encoding proteins 15% similar to 99% amino acid identity in the honey bee, we found that AmGR10 with 99% identity is involved in nursing or brood care. Expression of AmGR10 was restricted to organs of the hypopharyngeal gland, brain, and ovary in the nurse bee phase. Members of an extended nursing caste under natural conditions continued to express this gene. RNAi knockdown of AmGR10 accelerated the transition to foraging. Our findings demonstrate that this one gene has profound effects on the division of labor associated with the development and physiology of honeybee society.	[Paerhati, Yisilahaiti; Yang, Ping; Yamashita, Tetsuro; Ito, Kikukatsu] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 020, Japan; [Ishiguro, Shinichi; Ueda-Matsuo, Risa; Suzuki, Koichi] Iwate Univ, Org Res Promot, Morioka, Iwate 020, Japan; [Maekawa, Hideaki] Biochem Sci Assoc, Shinagawa Ku, Tokyo, Japan; [Tani, Hiroko] Yamada Apiculture Ctr Inc, Inst Bee Prod & Hlth Sci, Okayama, Japan	Iwate University; Iwate University	Suzuki, K (corresponding author), Iwate Univ, Org Res Promot, Morioka, Iwate 020, Japan.	koichi@iwate-u.ac.jp			Yamada Honey Bee; JSPS KAKENHI [23228001]; Yamada Apicultural Center, Inc.	Yamada Honey Bee; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yamada Apicultural Center, Inc.	Funding: This study was supported by a grant from Yamada Honey Bee (http://www.bee-lab.jp/) and in part by JSPS KAKENHI Grand no. 23228001 (http://www.jsps.go.jp/aboutus/index.html). Yamada Apicultural Center, Inc. provided support in the form of a salary for Dr. Hiroko Tani, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Amdam GV, 2010, ANIM BEHAV, V79, P973, DOI 10.1016/j.anbehav.2010.02.007; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Ament SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002596; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Denison Rachel, 2008, Invertebrate Neuroscience, V8, P1, DOI 10.1007/s10158-008-0066-6; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; FELL RD, 1990, COMP BIOCHEM PHYS A, V95, P539, DOI 10.1016/0300-9629(90)90735-B; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; Jung JW, 2015, J ASIA-PAC ENTOMOL, V18, P19, DOI 10.1016/j.aspen.2014.10.011; Leta MA, 1996, J INSECT PHYSIOL, V42, P239, DOI 10.1016/0022-1910(95)00106-9; Miyamoto T, 2013, CURR BIOL, V23, pR369, DOI 10.1016/j.cub.2013.04.002; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Ohashi K, 1997, EUR J BIOCHEM, V249, P797, DOI 10.1111/j.1432-1033.1997.t01-1-00797.x; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Tanaka H, 2005, J INSECT PHYSIOL, V51, P701, DOI 10.1016/j.jinsphys.2005.03.018; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807	31	8	9	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142917	10.1371/journal.pone.0142917	http://dx.doi.org/10.1371/journal.pone.0142917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588091	gold, Green Submitted, Green Published			2022-12-26	WOS:000365251500022
J	Kowalczyk, JE; Gruben, BS; Battaglia, E; Wiebenga, A; Majoor, E; de Vries, RP				Kowalczyk, Joanna E.; Gruben, Birgit S.; Battaglia, Evy; Wiebenga, Ad; Majoor, Eline; de Vries, Ronald P.			Genetic Interaction of Aspergillus nidulans galR, xlnR and araR in Regulating D-Galactose and L-Arabinose Release and Catabolism Gene Expression	PLOS ONE			English	Article							L-ARABINITOL 4-DEHYDROGENASE; D-XYLOSE REDUCTASE; BETA-GALACTOSIDASE; PATHWAY; NIGER; ENZYMES; DEHYDROGENASE; DEGRADATION; EVOLUTION; PENTOSE	In Aspergillus nidulans, the xylanolytic regulator XlnR and the arabinanolytic regulator AraR co-regulate pentose catabolism. In nature, the pentose sugars D-xylose and L-arabinose are both main building blocks of the polysaccharide arabinoxylan. In pectin and arabinogalactan, these two monosaccharides are found in combination with D-galactose. GalR, the regulator that responds to the presence of D-galactose, regulates the D-galactose catabolic pathway. In this study we investigated the possible interaction between XlnR, AraR and GalR in pentose and/or D-galactose catabolism in A. nidulans. Growth phenotypes and metabolic gene expression profiles were studied in single, double and triple disruptant A. nidulans strains of the genes encoding these paralogous transcription factors. Our results demonstrate that AraR and XlnR not only control pentose catabolic pathway genes, but also genes of the oxido-reductive D-galactose catabolic pathway. This suggests an interaction between three transcriptional regulators in D-galactose catabolism. Conversely, GalR is not involved in regulation of pentose catabolism, but controls only genes of the oxido-reductive D-galactose catabolic pathway.	[Kowalczyk, Joanna E.; Gruben, Birgit S.; Battaglia, Evy; Wiebenga, Ad; Majoor, Eline; de Vries, Ronald P.] Univ Utrecht, Fungal Physiol, CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [Kowalczyk, Joanna E.; Gruben, Birgit S.; Battaglia, Evy; Wiebenga, Ad; Majoor, Eline; de Vries, Ronald P.] Univ Utrecht, Fungal Mol Physiol, Utrecht, Netherlands; [Gruben, Birgit S.; Battaglia, Evy] Univ Utrecht, Microbiol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Utrecht University; Utrecht University; Utrecht University	de Vries, RP (corresponding author), Univ Utrecht, Fungal Physiol, CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands.	r.devries@cbs.knaw.nl	de Vries, Ronald P./F-8125-2011	de Vries, Ronald P./0000-0002-4363-1123; Kowalczyk, Joanna/0000-0002-4417-0250	Dutch Technology Foundation STW; Applied Science division of NWO; Technology Program of the Ministry of Economic Affairs [016.130.609, UGC 07063, UGC 07938, UGC 14270]; Netherlands Organization for Scientific Research (NWO); Netherlands Genomics Initiative [93511035]; DOE-JGI CSP program [CSP2011-350]	Dutch Technology Foundation STW(Technologiestichting STW); Applied Science division of NWO(Netherlands Organization for Scientific Research (NWO)); Technology Program of the Ministry of Economic Affairs; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; DOE-JGI CSP program	JEK, EB and BSG were supported by grants of the Dutch Technology Foundation STW, Applied Science division of NWO and the Technology Program of the Ministry of Economic Affairs (http://www.stw.nl/) 016.130.609, UGC 07063, UGC 07938, & 14270 to RPdV. EM was supported by a grant from the Netherlands Organization for Scientific Research (NWO, www.nwo.nl) and the Netherlands Genomics Initiative 93511035 to R. P. de Vries. The authors acknowledge support of the DOE-JGI CSP program (http://jgi.doe.gov/collaborate-with-jgi/community-science-program/), project number CSP2011-350, for the genome sequences of the additional Aspergilli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JEK, EB and BSG were supported by grants of the Dutch Technology Foundation STW, Applied Science division of NWO and the Technology Program of the Ministry of Economic Affairs UGC 07063, 07938 & 14270 to RPdV. EM was supported by a grant from the Netherlands Organisation for Scientific Research (NWO) and the Netherlands Genomics Initiative 93511035 to RPdV. We acknowledge support of the DOE-JGI CSP program, project number CSP2011-350, for the genome sequences of the additional Aspergilli.	Battaglia E, 2011, STUD MYCOL, P31, DOI 10.3114/sim.2011.69.03; Battaglia E, 2014, RES MICROBIOL, V165; Christensen U, 2011, APPL ENVIRON MICROB, V77, P7084, DOI 10.1128/AEM.05290-11; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; de Groot MJL, 2007, FOOD TECHNOL BIOTECH, V45, P134; de Vries RP, 2004, APPL ENVIRON MICROB, V70, P3954, DOI 10.1128/AEM.70.7.3954-3959.2004; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; DEVRIES RP, 1994, FEMS MICROBIOL LETT, V123, P83, DOI 10.1016/0378-1097(94)90278-X; Fekete E, 2004, ARCH MICROBIOL, V181, P35, DOI 10.1007/s00203-003-0622-8; Fekete E, 2002, ARCH MICROBIOL, V179, P7, DOI 10.1007/s00203-002-0491-6; Fekete E, 2012, FEMS MICROBIOL LETT, V329, P198, DOI 10.1111/j.1574-6968.2012.02524.x; Flipphi M, 2009, FUNGAL GENET BIOL, V46, pS19, DOI 10.1016/j.fgb.2008.07.018; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gouet P, 2014, NUCLEIC ACIDS RES, V43; Gruben BS, 2012, FEBS LETT; Hasper AA, 2000, MOL MICROBIOL, V36, P193, DOI 10.1046/j.1365-2958.2000.01843.x; Koivistoinen OM, 2012, FEBS LETT, V586, P378, DOI 10.1016/j.febslet.2012.01.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohnen D, 1999, COMPREHENSIVE NATURA, V3, P497; Mojzita D, 2012, J BIOL CHEM, V287, P26010, DOI 10.1074/jbc.M112.372755; Mojzita D, 2012, FUNGAL GENET BIOL, V49, P152, DOI 10.1016/j.fgb.2011.11.005; Mojzita D, 2010, FEBS LETT, V584, P3540, DOI 10.1016/j.febslet.2010.06.037; Mojzita D, 2010, J BIOL CHEM, V285, P23622, DOI 10.1074/jbc.M110.113399; Pail M, 2004, EUR J BIOCHEM, V271, P1864, DOI 10.1111/j.1432-1033.2004.04088.x; Richard P, 2001, J BIOL CHEM, V276, P40631, DOI 10.1074/jbc.M104022200; ROBERTS CF, 1970, BIOCHIM BIOPHYS ACTA, V201, P267, DOI 10.1016/0304-4165(70)90301-6; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Todd RB, 2007, NAT PROTOC, V2, P811, DOI 10.1038/nprot.2007.112; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; vanKuyk PA, 2001, EUR J BIOCHEM, V268, P5414, DOI 10.1046/j.0014-2956.2001.02482.x; WITTEVEEN CFB, 1989, J GEN MICROBIOL, V135, P2163	34	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143200	10.1371/journal.pone.0143200	http://dx.doi.org/10.1371/journal.pone.0143200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580075	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600096
J	Miczajka, VL; Klein, AM; Pufal, G				Miczajka, Victoria L.; Klein, Alexandra-Maria; Pufal, Gesine			Elementary School Children Contribute to Environmental Research as Citizen Scientists	PLOS ONE			English	Article							ECOLOGICAL RESEARCH; DATA QUALITY; SCIENCE; BIODIVERSITY; PLANTS	Research benefits increasingly from valuable contributions by citizen scientists. Mostly, participating adults investigate specific species, ecosystems or phenology to address conservation issues, but ecosystem functions supporting ecosystem health are rarely addressed and other demographic groups rarely involved. As part of a project investigating seed predation and dispersal as ecosystem functions along an urban-rural gradient, we tested whether elementary school children can contribute to the project as citizen scientists. Specifically, we compared data estimating vegetation cover, measuring vegetation height and counting seeds from a seed removal experiment, that were collected by children and scientists in schoolyards. Children counted seeds similarly to scientists but under-or overestimated vegetation cover and measured different heights. We conclude that children can be involved as citizen scientists in research projects according to their skill level. However, more sophisticated tasks require specific training to become familiarized with scientific experiments and the development of needed skills and methods.	[Miczajka, Victoria L.; Klein, Alexandra-Maria; Pufal, Gesine] Univ Luneburg, Inst Ecol, D-21335 Luneburg, Germany	Leuphana University Luneburg	Pufal, G (corresponding author), Univ Freiburg, Chair Nat Conservat & Landscape Ecol, Inst Earth & Environm Sci, Tennenbacherstr 4, D-79106 Freiburg, Germany.	gesine.pufal@nature.uni-freiburg.de	Klein, Alexandra-Maria/J-5871-2016; Pufal, Gesine/K-7872-2016	Klein, Alexandra-Maria/0000-0003-2139-8575; Pufal, Gesine/0000-0002-2513-254X	Leuphana University of Luneburg; German Research Foundation (DFG); Albert Ludwigs University Freiburg; ProScience from the Leuphana University of Luneburg	Leuphana University of Luneburg; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg; ProScience from the Leuphana University of Luneburg	Victoria L. Miczajka was supported through a PhD scholarship from the Leuphana University of Luneburg and Gesine Pufal was financed by ProScience from the Leuphana University of Luneburg. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.; We thank all participating children, teachers, schools and the education authority in Hamburg and Lower Saxony. We are particularly grateful for the assistance given by Dr. Brunhild Landwehr for her very helpful didactical improvement of our environmental education concept and Felix Fornoff for many helpful discussions that improved the manuscript. Victoria L. Miczajka was supported through a PhD scholarship from the Leuphana University of Luneburg and Gesine Pufal was financed by ProScience from the Leuphana University of Luneburg. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. We also thank the editor and the anonymous reviewers for their helpful comments and suggestions, which greatly improved the manuscript.	[Anonymous], 2015, R PROJECT STAT COMPU; Balvanera P, 2014, BIOSCIENCE, V64, P49, DOI 10.1093/biosci/bit003; BENWARE CA, 1984, AM EDUC RES J, V21, P755, DOI 10.3102/00028312021004755; Bickford D, 2012, BIOL CONSERV, V151, P74, DOI 10.1016/j.biocon.2011.12.016; Bogner F. X., 1998, J ENVIRON EDUC, V29, P17, DOI DOI 10.1080/00958969809599124; Bonner RE, 2009, CAMB STUD AMER S, P1; Bouillion LM, 2001, J RES SCI TEACH, V38, P878, DOI 10.1002/tea.1037.abs; Braschler B, 2009, BIOSCIENCE, V59, P103, DOI 10.1525/bio.2009.59.2.2; Canfield DE, 2002, LAKE RESERV MANAGE, V18, P1; Carstens A, 2006, KERNCURRICULUM GRUND, P1; Carwardine J, 2012, CONSERV LETT, V5, P196, DOI 10.1111/j.1755-263X.2012.00228.x; Chandler M, 2012, FRONT ECOL ENVIRON, V10, P328, DOI 10.1890/110283; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Cooper CB, 2007, ECOL SOC, V12; Crall AW, 2011, CONSERV LETT, V4, P433, DOI 10.1111/j.1755-263X.2011.00196.x; Danielsen F, 2014, BIOSCIENCE, V64, P236, DOI 10.1093/biosci/biu001; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Donges C, 2006, KERNCURRICULUM GYMNA, P1; Droege S., 2007, CIT SCI TOOLK C, DOI [10.2190/PM.49.1.b, DOI 10.2190/PM.49.1.B]; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Galloway AWE, 2006, WILDLIFE SOC B, V34, P1425, DOI 10.2193/0091-7648(2006)34[1425:TROCSA]2.0.CO;2; Galton M., 2009, CAMB J EDUC, V39, P119, DOI DOI 10.1080/03057640802701994; Genet KS, 2003, WILDLIFE SOC B, V31, P703; Havens K, 2012, FRONT ECOL ENVIRON, V10, P321, DOI 10.1890/110258; Henderson S, 2012, FRONT ECOL ENVIRON, V10, P283, DOI 10.1890/1540-9295-10.6.283; Hepper FN, 2003, BIODIVERS CONSERV, V12, P2503, DOI 10.1023/A:1025847029377; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Izard CE, 2000, IMAGIN COGN PERS, V19, P305, DOI [DOI 10.2190/GVVR-FTTL-VH9H-KKEL, 10.2190/GVVR-FTTL-VH9H-KKEL]; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Lemke A, 2009, J APPL ECOL, V46, P1122, DOI 10.1111/j.1365-2664.2009.01691.x; Lindemann-Matthies P, 2008, HUM ECOL, V36, P731, DOI 10.1007/s10745-008-9194-1; Low B, 2009, BIOL CONSERV, V142, P1548, DOI 10.1016/j.biocon.2009.02.003; Magnuson CS, 2000, J CAREER DEV, V27, P89, DOI 10.1177/089484530002700203; Michael J, 2006, ADV PHYSIOL EDUC, V30, P159, DOI 10.1152/advan.00053.2006; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Niven D, 2010, AM BIRDS, P1; Oberhauser K., 2008, AM ENTOMOL, V54, P103, DOI [10.1093/ae/54.2.103, DOI 10.1093/AE/54.2.103, DOI 10.1093/ae/54.2.103]; Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x; Pufal G, 2013, J PLANT ECOL, V6, P468, DOI 10.1093/jpe/rtt011; Renz W, 2011, BILDUNGSPLAN GRUNDSC, P1; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Thomas M, 2011, GENET RESOUR CROP EV, V58, P321, DOI 10.1007/s10722-011-9662-0; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Turke M, 2013, RENEW AGR FOOD SYST, P1; WYNN K, 1990, COGNITION, V36, P155, DOI 10.1016/0010-0277(90)90003-3	46	12	12	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143229	10.1371/journal.pone.0143229	http://dx.doi.org/10.1371/journal.pone.0143229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581087	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600102
J	Fitzhugh, CD; Hsieh, MM; Allen, D; Coles, WA; Seamon, C; Ring, M; Zhao, XC; Minniti, CP; Rodgers, GP; Schechter, AN; Tisdale, JF; Taylor, JG				Fitzhugh, Courtney D.; Hsieh, Matthew M.; Allen, Darlene; Coles, Wynona A.; Seamon, Cassie; Ring, Michael; Zhao, Xiongce; Minniti, Caterina P.; Rodgers, Griffin P.; Schechter, Alan N.; Tisdale, John F.; Taylor, James G.			Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; DISEASE; MORTALITY; CHILDREN; DEATH; RISK; HYDROXYCARBAMIDE; COMPLICATIONS; MORBIDITY; THERAPY	Background Adults with sickle cell anemia (HbSS) are inconsistently treated with hydroxyurea. Objectives We retrospectively evaluated the effects of elevating fetal hemoglobin with hydroxyurea on organ damage and survival in patients enrolled in our screening study between 2001 and 2010. Methods An electronic medical record facilitated development of a database for comparison of study parameters based on hydroxyurea exposure and dose. This study is registered with ClinicalTrials.gov, number NCT00011648. Results Three hundred eighty-three adults with homozygous sickle cell disease were analyzed with 59 deaths during study follow-up. Cox regression analysis revealed deceased subjects had more hepatic dysfunction (elevated alkaline phosphatase, Hazard Ratio = 1.005, 95% CI 1.003-1.006, p<0.0.0001), kidney dysfunction (elevated creatinine, Hazard Ratio = 1.13, 95% CI 1.00-1.27, p = 0.043), and cardiopulmonary dysfunction (elevated tricuspid jet velocity on echocardiogram, Hazard Ratio = 2.22, 1.23-4.02, p = 0.0082). Sixty-six percent of subjects were treated with hydroxyurea, although only 66% of those received a dose within the recommended therapeutic range. Hydroxyurea use was associated with improved survival (Hazard Ratio = 0.58, 95% CI 0.34-0.97, p = 0.040). This effect was most pronounced in those taking the recommended dose of 15-35 mg/kg/day (Hazard Ratio 0.36, 95% CI 0.17-0.73, p = 0.0050). Hydroxyurea use was not associated with changes in organ function over time. Further, subjects with higher fetal hemoglobin responses to hydroxyurea were more likely to survive (p = 0.0004). While alkaline phosphatase was lowest in patients with the best fetal hemoglobin response (95.4 versus 123.6, p = 0.0065 and 96.1 versus 113.6U/L, p = 0.041 at first and last visits, respectively), other markers of organ damage were not consistently improved over time in patients with the highest fetal hemoglobin levels. Conclusions Our data suggest that adults should be treated with the maximum tolerated hydroxyurea dose, ideally before organ damage occurs. Prospective studies are indicated to validate these findings.	[Fitzhugh, Courtney D.; Hsieh, Matthew M.; Coles, Wynona A.; Rodgers, Griffin P.; Tisdale, John F.] NHLBI, Mol & Clin Hematol Branch, NIDDK, NIH, Bethesda, MD 20892 USA; [Fitzhugh, Courtney D.; Allen, Darlene; Seamon, Cassie; Minniti, Caterina P.; Taylor, James G.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Ring, Michael] NIDDK, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Zhao, Xiongce] NIDDK, Intramural Res, NIH, Bethesda, MD 20892 USA; [Schechter, Alan N.] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Taylor, JG (corresponding author), NHLBI, Mol & Clin Hematol Branch, NIDDK, NIH, Bldg 10, Bethesda, MD 20892 USA.	jamesta@mail.nih.gov	Minniti, Caterina/AAX-3187-2021; Taylor, James G./AAH-4782-2021	Taylor, James G./0000-0002-4421-1809	intramural programs of the Molecular and Clinical Hematology Branch, NHLBI; NIDDK, NIH; Hematology Branch, NHLBI, NIH [1ZIAHL006012-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006012, ZIAHL006160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025016] Funding Source: NIH RePORTER	intramural programs of the Molecular and Clinical Hematology Branch, NHLBI; NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hematology Branch, NHLBI, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the intramural programs of the Molecular and Clinical Hematology Branch, NHLBI and NIDDK, NIH and the Hematology Branch, NHLBI, NIH (1ZIAHL006012-04).	[Anonymous], 2012, HYDR DRUG LAB, P1; Bakanay SM, 2005, BLOOD, V105, P545, DOI 10.1182/blood-2004-01-0322; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Darbari DS, 2006, AM J HEMATOL, V81, P858, DOI 10.1002/ajh.20685; Darbari DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079923; Lobo CLD, 2013, BRIT J HAEMATOL, V161, P852, DOI 10.1111/bjh.12323; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; Estepp JH, 2013, BRIT J HAEMATOL, V161, P402, DOI 10.1111/bjh.12238; Fitzhugh CD, 2010, AM J HEMATOL, V85, P36, DOI 10.1002/ajh.21569; Gladwin MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099489; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Hankins JS, 2008, PEDIATR BLOOD CANCER, V50, P293, DOI 10.1002/pbc.21271; Lanzkron S, 2008, J NATL MED ASSOC, V100, P968; Lanzkron S, 2013, PUBLIC HEALTH REP, V128, P110, DOI 10.1177/003335491312800206; Nottage K, 2013, PEDIATR BLOOD CANCER, V60, pS24; Perronne Veronique, 2002, Hematol J, V3, P56, DOI 10.1038/sj.thj.6200147; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; RODGERS GP, 1990, NEW ENGL J MED, V322, P1037, DOI 10.1056/NEJM199004123221504; Ross J., 2014, JAMA INT MED; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; Taylor JG, 2008, AM J HEMATOL, V83, P6, DOI 10.1002/ajh.21035; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; Voskaridou E, 2010, BLOOD, V115, P2354, DOI 10.1182/blood-2009-05-221333; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852; Zumberg MS, 2005, AM J HEMATOL, V79, P107, DOI 10.1002/ajh.20353	31	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0141706	10.1371/journal.pone.0141706	http://dx.doi.org/10.1371/journal.pone.0141706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26576059	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400007
J	Ibach, J; Radon, Y; Gelleri, M; Sonntag, MH; Brunsveld, L; Bastiaens, PIH; Verveer, PJ				Ibach, Jenny; Radon, Yvonne; Gelleri, Marton; Sonntag, Michael H.; Brunsveld, Luc; Bastiaens, Philippe I. H.; Verveer, Peter J.			Single Particle Tracking Reveals that EGFR Signaling Activity Is Amplified in Clathrin-Coated Pits	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-TYROSINE PHOSPHATASES; PLASMA-MEMBRANE; LIVING CELLS; MEDIATED ENDOCYTOSIS; ACTIVATED EGFR; KINASE; DIMERIZATION; DOMAIN; PHOSPHORYLATION	Signaling from the epidermal growth factor receptor (EGFR) via phosphorylation on its C-terminal tyrosine residues requires self-association, which depends on the diffusional properties of the receptor and its density in the plasma membrane. Dimerization is a key event for EGFR activation, but the role of higher order clustering is unknown. We employed single particle tracking to relate the mobility and aggregation of EGFR to its signaling activity. EGFR mobility alternates between short-lived free, confined and immobile states. In the immobile state, EGFR tends to aggregate in clathrin-coated pits, which is further enhanced in a phosphorylation-dependent manner and does not require ligand binding. EGFR phosphorylation is further amplified by cross-phosphorylation in clathrin-coated pits. Because phosphorylated receptors can escape from the pits, local gradients of signaling active EGFR are formed. These results show that amplification of EGFR phosphorylation by receptor clustering in clathrin-coated pits supports signal activation at the plasma membrane.	[Ibach, Jenny; Radon, Yvonne; Gelleri, Marton; Bastiaens, Philippe I. H.; Verveer, Peter J.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44139 Dortmund, Germany; [Sonntag, Michael H.; Brunsveld, Luc] Eindhoven Univ Technol, Biol Chem Lab, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Sonntag, Michael H.; Brunsveld, Luc] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands	Max Planck Society; Eindhoven University of Technology; Eindhoven University of Technology	Verveer, PJ (corresponding author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Rheinlanddamm 201, D-44139 Dortmund, Germany.	pjverveer@gmail.com		Brunsveld, Luc/0000-0001-5675-511X	Bundesministerium fur Bildung und Forschung, FORSYS initiative grant [0315257]; Deutsche Forschungsgemeinschaft, DFG [VE 579/1-1, VE 579/3-1]; Stichting Technische Wetenschappen, STW [11022-NanoActuate]	Bundesministerium fur Bildung und Forschung, FORSYS initiative grant; Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); Stichting Technische Wetenschappen, STW(Technologiestichting STW)	Funding provided by Bundesministerium fur Bildung und Forschung, FORSYS initiative grant 0315257, http://www.bmbf.de, Deutsche Forschungsgemeinschaft, DFG grant VE 579/1-1, http://www.dfg.de, Deutsche Forschungsgemeinschaft, DFG grant VE 579/3-1, http://www.dfg.de and Stichting Technische Wetenschappen, STW grant 11022-NanoActuate, http://www.stw.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; COCHET C, 1988, J BIOL CHEM, V263, P3290; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Endres NF, 2011, CURR OPIN STRUC BIOL, V21, P777, DOI 10.1016/j.sbi.2011.07.007; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Fortian A, 2014, J CELL SCI, V127, P432, DOI 10.1242/jcs.137786; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X; Gelleri M, 2013, THESIS; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hofman EG, 2010, J BIOL CHEM, V285, P39481, DOI 10.1074/jbc.M110.164731; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Monast CS, 2012, BIOPHYS J, V102, P2012, DOI 10.1016/j.bpj.2012.03.037; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Offterdinger M, 2004, J BIOL CHEM, V279, P36972, DOI 10.1074/jbc.M405830200; Offterdinger M, 2008, TRAFFIC, V9, P147, DOI 10.1111/j.1600-0854.2007.00665.x; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Persson F, 2013, NAT METHODS, V10, P265, DOI [10.1038/NMETH.2367, 10.1038/nmeth.2367]; Rappoport JZ, 2009, J CELL SCI, V122, P1301, DOI 10.1242/jcs.040030; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Sonntag MH, 2014, CHEM-EUR J, V20, P6019, DOI 10.1002/chem.201304090; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Tiganis T, 2002, IUBMB LIFE, V53, P3, DOI 10.1080/15216540210811; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Weigel AV, 2013, P NATL ACAD SCI USA, V110, pE4591, DOI 10.1073/pnas.1315202110; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; Zhou MM, 1995, J BIOL CHEM, V270, P31119, DOI 10.1074/jbc.270.52.31119	58	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143162	10.1371/journal.pone.0143162	http://dx.doi.org/10.1371/journal.pone.0143162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575183	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400050
J	Li, P; Nie, YL; Yu, JK				Li, Ping; Nie, Yaling; Yu, Jingkai			An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative Diseases	PLOS ONE			English	Article							PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CELL-DEATH; HUNTINGTONS-DISEASE; GENE-EXPRESSION; NERVOUS-SYSTEM; MOTOR SYMPTOMS; UPDATE; MODEL; BRAIN	Groups of distinct but related diseases often share common symptoms, which suggest likely overlaps in underlying pathogenic mechanisms. Identifying the shared pathways and common factors among those disorders can be expected to deepen our understanding for them and help designing new treatment strategies effected on those diseases. Neurodegeneration diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD), were taken as a case study in this research. Reported susceptibility genes for AD, PD and HD were collected and human protein-protein interaction network (hPPIN) was used to identify biological pathways related to neurodegeneration. 81 KEGG pathways were found to be correlated with neurodegenerative disorders. 36 out of the 81 are human disease pathways, and the remaining ones are involved in miscellaneous human functional pathways. Cancers and infectious diseases are two major subclasses within the disease group. Apoptosis is one of the most significant functional pathways. Most of those pathways found here are actually consistent with prior knowledge of neurodegenerative diseases except two cell communication pathways: adherens and tight junctions. Gene expression analysis showed a high probability that the two pathways were related to neurodegenerative diseases. A combination of common susceptibility genes and hPPIN is an effective method to study shared pathways involved in a group of closely related disorders. Common modules, which might play a bridging role in linking neurodegenerative disorders and the enriched pathways, were identified by clustering analysis. The identified shared pathways and common modules can be expected to yield clues for effective target discovery efforts on neurodegeneration.	[Li, Ping; Nie, Yaling; Yu, Jingkai] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China; [Li, Ping; Nie, Yaling] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, JK (corresponding author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.	jkyu@ipe.ac.cn			National Natural Science Foundation of China [61179008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 61179008, www.nsfc.gov.cn) JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DA, 2010, NEUROLOGY, V74, P100, DOI 10.1212/WNL.0b013e3181cbb89a; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Blanc EM, 1998, J NEUROCHEM, V70, P958; Caltagarone J, 2007, BBA-MOL BASIS DIS, V1772, P438, DOI 10.1016/j.bbadis.2006.11.007; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Deleidi M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003492; Deleidi M, 2010, J NEUROSCI, V30, P16091, DOI 10.1523/JNEUROSCI.2400-10.2010; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; Dewey RB, 2012, COGN BEHAV NEUROL, V25, P115, DOI 10.1097/WNN.0b013e31826dfd62; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frank-Cannon TC, 2008, J NEUROSCI, V28, P10825, DOI 10.1523/JNEUROSCI.3001-08.2008; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harper S, 2014, SCIENCE, V346, P587, DOI 10.1126/science.1254405; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kirkwood SC, 2001, ARCH NEUROL-CHICAGO, V58, P273, DOI 10.1001/archneur.58.2.273; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Li SF, 2014, BONE, V61, P164, DOI 10.1016/j.bone.2014.01.010; Li TX, 2014, HUM MOL GENET, V23, P6212, DOI 10.1093/hmg/ddu341; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Mitsui T, 2010, NEUROCHEM INT, V56, P679, DOI 10.1016/j.neuint.2010.01.016; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Morris LGT, 2010, ONCOGENE, V29, P3453, DOI 10.1038/onc.2010.127; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Godoy MCP, 2008, BRAIN, V131, P1880, DOI 10.1093/brain/awn101; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Qin C, 2014, NUCLEIC ACIDS RES, V42, pD1118, DOI 10.1093/nar/gkt1129; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Song F, 2009, BRAIN RES REV, V61, P69, DOI 10.1016/j.brainresrev.2009.05.003; Sorensen SA, 1999, CANCER, V86, P1342, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1342::AID-CNCR33>3.3.CO;2-V; Stavitsky K, 2006, ARCH NEUROL-CHICAGO, V63, P1450, DOI 10.1001/archneur.63.10.1450; Sun XC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006667; Tenreiro S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00042; van den Pol AN, 2006, TRENDS NEUROSCI, V29, P398, DOI 10.1016/j.tins.2006.06.002; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wang S, 2012, J ALZHEIMERS DIS, V31, P193, DOI 10.3233/JAD-2012-120454; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	68	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143045	10.1371/journal.pone.0143045	http://dx.doi.org/10.1371/journal.pone.0143045			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575483	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400033
J	Pan, X; Song, YB; Jiang, C; Liu, GF; Ye, XH; Xie, XF; Hu, YK; Zhao, WW; Cui, LJ; Cornelissen, JHC; Dong, M; Prinzing, A				Pan, Xu; Song, Yao-Bin; Jiang, Can; Liu, Guo-Fang; Ye, Xue-Hua; Xie, Xiu-Fang; Hu, Yu-Kun; Zhao, Wei-Wei; Cui, Lijuan; Cornelissen, Johannes H. C.; Dong, Ming; Prinzing, Andreas			Evolutionary Position and Leaf Toughness Control Chemical Transformation of Litter, and Drought Reinforces This Control: Evidence from a Common Garden Experiment across 48 Species	PLOS ONE			English	Article							SCOTS PINE; NUTRIENT RELEASE; PHOSPHORUS DYNAMICS; DECOMPOSITION RATE; FUNCTIONAL TRAITS; NEEDLE LITTER; MIXED FOREST; NITROGEN; CARBON; PATTERNS	Plant leaf litter is an important source of soil chemicals that are essential for the ecosystem and changes in leaf litter chemical traits during decomposition will determine the availability of multiple chemical elements recycling in the ecosystem. However, it is unclear whether the changes in litter chemical traits during decomposition and their similarities across species can be predicted, respectively, using other leaf traits or using the phylogenetic related-ness of the litter species. Here we examined the fragmentation levels, mass losses, and the changes of 10 litter chemical traits during 1-yr decomposition under different environmental conditions (within/above surrounding litter layer) for 48 temperate tree species and related them to an important leaf functional trait, i.e. leaf toughness. Leaf toughness could predict the changes well in terms of amounts, but poorly in terms of concentrations. Changes of 7 out of 10 litter chemical traits during decomposition showed a significant phylogenetic signal notably when litter was exposed above surrounding litter. These phylogenetic signals in element dynamics were stronger than those of initial elementary composition. Overall, relatively hard-to-measure ecosystem processes like element dynamics during decomposition could be partly predicted simply from phylogenies and leaf toughness measures. We suggest that the strong phylogenetic signals in chemical ecosystem functioning of species may reflect the concerted control by multiple moderately conserved traits, notably if interacting biota suffer microclimatic stress and spatial isolation from ambient litter.	[Pan, Xu; Song, Yao-Bin; Jiang, Can; Xie, Xiu-Fang; Hu, Yu-Kun; Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China; [Pan, Xu] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Pan, Xu; Liu, Guo-Fang; Ye, Xue-Hua; Xie, Xiu-Fang; Hu, Yu-Kun; Zhao, Wei-Wei; Dong, Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Zhao, Wei-Wei; Cornelissen, Johannes H. C.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Ecol Sci, Syst Ecol, NL-1081 HV Amsterdam, Netherlands; [Prinzing, Andreas] Univ Rennes 1, CNRS, Res Unit Ecobio, F-35042 Rennes, France	Hangzhou Normal University; Chinese Academy of Forestry; Institute of Wetland Research, CAF; Chinese Academy of Sciences; Institute of Botany, CAS; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Dong, M (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China.	dongming@hznu.edu.cn	Ye, Xuehua/I-3116-2013; Pan, Xu/W-1607-2017	Ye, Xuehua/0000-0002-5625-9877; Pan, Xu/0000-0003-3733-1981	NSFC [31261120580, 31400346]; Innovative R & D grant from Hangzhou Normal University [201203]; China Postdoctoral Science Foundation	NSFC(National Natural Science Foundation of China (NSFC)); Innovative R & D grant from Hangzhou Normal University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the NSFC (Grant 31261120580, 31400346) and the Innovative R & D grant (201203) from Hangzhou Normal University. This work was also funded by China Postdoctoral Science Foundation funded project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; BERG B, 1987, PEDOBIOLOGIA, V30, P55; Berg B., 2008, PLANT LITTER DECOMPO, DOI DOI 10.1007/978-3-540-74923-3; Berg B, 1986, SCAND J FOREST RES, V1, P359, DOI 10.1080/02827588609382428; BLAIR JM, 1988, SOIL BIOL BIOCHEM, V20, P693, DOI 10.1016/0038-0717(88)90154-X; BLAIR JM, 1988, PLANT SOIL, V110, P49, DOI 10.1007/BF02143538; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bokhorst S, 2013, SOIL BIOL BIOCHEM, V58, P147, DOI 10.1016/j.soilbio.2012.12.001; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; CROMACK K, 1975, SOIL BIOL BIOCHEM, V7, P265, DOI 10.1016/0038-0717(75)90065-6; Davies TJ, 2012, ECOLOGY, V93, P242, DOI 10.1890/11-1360.1; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; DZIADOWIEC H, 1987, ACTA SOC BOT POL, V56, P169, DOI 10.5586/asbp.1987.019; DZIADOWIEC H, 1980, EKOL POL-POL J ECOL, V28, P111; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HATCH DJ, 1994, PLANT SOIL, V166, P181, DOI 10.1007/BF00008331; Hermant M, 2012, PERSPECT PLANT ECOL, V14, P283, DOI 10.1016/j.ppees.2012.02.001; Hirobe M, 2004, J FOREST RES-JPN, V9, P347, DOI 10.1007/s10310-004-0088-9; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Homann PS, 2012, PLANT SOIL, V358, P240, DOI 10.1007/s11104-012-1174-y; Kainulainen P, 2002, SOIL BIOL BIOCHEM, V34, P37, DOI 10.1016/S0038-0717(01)00147-X; Kiikkila O, 2013, PLANT SOIL, V373, P787, DOI 10.1007/s11104-013-1837-3; LASKOWSKI R, 1995, ECOLOGY, V76, P1393, DOI 10.2307/1938143; Lee H, 2012, GLOBAL CHANGE BIOL, V18, P1185, DOI 10.1111/j.1365-2486.2011.02579.x; Lehto T, 2010, PLANT SOIL, V330, P225, DOI 10.1007/s11104-009-0195-7; Lehto T, 2010, PLANT SOIL, V329, P195, DOI 10.1007/s11104-009-0145-4; Liu GF, 2014, J ECOL, V102, P337, DOI 10.1111/1365-2745.12192; Ma YN, 2014, SOIL BIOL BIOCHEM, V69, P212, DOI 10.1016/j.soilbio.2013.10.043; MAHESWARAN J, 1987, CAN J BOT, V65, P2601, DOI 10.1139/b87-350; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Meyer WM, 2011, SOIL BIOL BIOCHEM, V43, P206, DOI 10.1016/j.soilbio.2010.10.005; OCONNELL AM, 1988, J ECOL, V76, P1186, DOI 10.2307/2260642; Ostrofsky A, 1997, CAN J FOREST RES, V27, P567, DOI 10.1139/cjfr-27-4-567; Palviainen M, 2004, PLANT SOIL, V259, P123, DOI 10.1023/B:PLSO.0000020938.78215.bd; Pan X, 2015, SCI REP-UK, V5, DOI 10.1038/srep13217; Pan X, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0103; Pan X, 2014, ECOL EVOL, V4, P3339, DOI 10.1002/ece3.1115; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Perez-Harguindeguy N, 2000, PLANT SOIL, V218, P21, DOI 10.1023/A:1014981715532; Preston CM, 2009, ECOSYSTEMS, V12, P1053, DOI 10.1007/s10021-009-9266-0; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; PURVIS A, 1993, SYST BIOL, V42, P569, DOI 10.2307/2992489; REDDY MV, 1989, BIOL FERT SOILS, V8, P319, DOI 10.1007/BF00263162; RUSTAD LE, 1988, CAN J FOREST RES, V18, P947, DOI 10.1139/x88-144; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; STAAF H, 1982, CAN J BOT, V60, P1561, DOI 10.1139/b82-199; STARK N, 1972, BIOSCIENCE, V22, P355, DOI 10.2307/1296341; Swift MJ, 1979, DECOMPOSITION IN TER; Vestgarden LS, 2001, SOIL BIOL BIOCHEM, V33, P465, DOI 10.1016/S0038-0717(00)00187-5; Wallenstein MD, 2013, SOIL BIOL BIOCHEM, V57, P311, DOI 10.1016/j.soilbio.2012.09.027	57	11	12	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143140	10.1371/journal.pone.0143140	http://dx.doi.org/10.1371/journal.pone.0143140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575641	Green Submitted, Green Published, gold			2022-12-26	WOS:000365153400044
J	Baek, IC; Jang, JP; Choi, EJ; Kim, TG				Baek, In-Cheol; Jang, Jung-Pil; Choi, Eun-Jeong; Kim, Tai-Gyu			MICB Allele Genotyping on Microarrays by Improving the Specificity of Extension Primers	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; POLYMERASE-CHAIN-REACTION; SEQUENCE-SPECIFIC PRIMERS; CHINESE HAN POPULATION; GENE-B MICB; DNA-POLYMERASE; IDENTIFICATION; SYSTEM; AMPLIFICATION; ASSAY	Major histocompatibility complex (MHC) class I chain-related gene B (MICB) encodes a ligand for activating NKG2D that expressed in natural killer cells, gamma delta T cells, and alpha beta CD8(+) T cells, which is associated with autoimmune diseases, cancer, and infectious diseases. Here, we have established a system for genotyping MICB alleles using allele-specific primer extension (ASPE) on microarrays. Thirty-six high quality, allele-specific extension primers were evaluated using strict and reliable cut-off values using mean fluorescence intensity (MFI), whereby an MFI >30,000 represented a positive signal and an MFI <10,000 represented a negative signal. Eight allele-specific extension primers were found to be false positives, five of which were improved by adjusting their length, and three of which were optimized by refractory modification. The MICB alleles (*002: 01, *003, *005:02/*010, *005:03, *008, *009N, *018, and *024) present in the quality control panel could be exactly defined by 22 allele-specific extension primers. MICB genotypes that were identified by ASPE on microarrays were in full concordance with those identified by PCR-sequencebased typing. In conclusion, we have developed a method for genotyping MICB alleles using ASPE on microarrays; which can be applicable for large-scale single nucleotide polymorphism typing studies of population and disease associations.	[Baek, In-Cheol; Jang, Jung-Pil; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea; [Choi, Eun-Jeong; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Hematopoiet Stem Cell Bank, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, TG (corresponding author), Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea.	kimtg@catholic.ac.kr		Baek, In-Cheol/0000-0003-3630-3364	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI14C3417]	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C3417).	Ayyadevara S, 2000, ANAL BIOCHEM, V284, P11, DOI 10.1006/abio.2000.4635; Baek IC, 2013, TISSUE ANTIGENS, V82, P259, DOI 10.1111/tan.12201; Bahram S, 2000, Adv Immunol, V76, P1; Cha CH, 2011, TISSUE ANTIGENS, V78, P38, DOI 10.1111/j.1399-0039.2011.01694.x; Chun SM, 2007, MOL DIAGN THER, V11, P21, DOI 10.1007/BF03256220; Garcia G, 2011, HUM IMMUNOL, V72, P904, DOI 10.1016/j.humimm.2011.06.010; Gonzalez S, 2003, IMMUNOGENETICS, V54, P850, DOI 10.1007/s00251-002-0533-x; Jang JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118008; Jumnainsong A, 2008, CLIN EXP IMMUNOL, V153, P205, DOI 10.1111/j.1365-2249.2008.03682.x; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Kitcharoen K, 2006, HUM IMMUNOL, V67, P238, DOI 10.1016/j.humimm.2006.02.012; Li Y, 2010, INT J COLORECTAL DIS, V25, P153, DOI 10.1007/s00384-009-0787-y; Liu XX, 2012, HUM IMMUNOL, V73, P818, DOI 10.1016/j.humimm.2012.05.008; Liu XX, 2011, HUM IMMUNOL, V72, P727, DOI 10.1016/j.humimm.2011.05.013; Lopez-Arbesu R, 2007, RHEUMATOLOGY, V46, P426, DOI 10.1093/rheumatology/kel331; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; O'Meara D, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf074; Pastinen T, 2000, GENOME RES, V10, P1031, DOI 10.1101/gr.10.7.1031; Qin SY, 2005, INDIAN J BIOCHEM BIO, V42, P308; Rees MT, 2005, GENET TEST, V9, P93, DOI 10.1089/gte.2005.9.93; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Rodriguez-Rodero S, 2006, HUM IMMUNOL, V67, P208, DOI 10.1016/j.humimm.2006.02.011; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; VanderHorn PB, 1997, BIOTECHNIQUES, V22, P758, DOI 10.2144/97224pf02; Ying YL, 2013, IMMUNOGENETICS, V65, P485, DOI 10.1007/s00251-013-0699-4; Zhou GH, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.19.e93	27	1	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142467	10.1371/journal.pone.0142467	http://dx.doi.org/10.1371/journal.pone.0142467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569110	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700039
J	Becker, C; Urlic, B; Spika, MJ; Klaring, HP; Krumbein, A; Baldermann, S; Ban, SG; Perica, S; Schwarz, D				Becker, Christine; Urlic, Branimir; Spika, Maja Jukic; Klaering, Hans-Peter; Krumbein, Angelika; Baldermann, Susanne; Ban, Smiljana Goreta; Perica, Slavko; Schwarz, Dietmar			Nitrogen Limited Red and Green Leaf Lettuce Accumulate Flavonoid Glycosides, Caffeic Acid Derivatives, and Sucrose while Losing Chlorophylls, B-Carotene and Xanthophylls	PLOS ONE			English	Article							LACTUCA-SATIVA; ANTHOCYANIN BIOSYNTHESIS; TEMPERATURE; DEFICIENCY; LEAVES; CYCLE; METABOLISM; EXPRESSION; EVOLUTION; PRODUCTS	Reduction of nitrogen application in crop production is desirable for ecological and health-related reasons. Interestingly, nitrogen deficiency can lead to enhanced concentrations of polyphenols in plants. The reason for this is still under discussion. The plants' response to low nitrogen concentration can interact with other factors, for example radiation intensity. We cultivated red and green leaf lettuce hydroponically in a Mediterranean greenhouse, supplying three different levels of nitrogen (12 mM, 3 mM, 0.75 mM), either in full or reduced (-50%) radiation intensity. In both red and green lettuce, we found clear effects of the nitrogen treatments on growth characteristics, phenolic and photosynthetic compounds, nitrogen, nitrate and carbon concentration of the plants. Interestingly, the concentrations of all main flavonoid glycosides, caffeic acid derivatives, and sucrose increased with decreasing nitrogen concentration, whereas those of chlorophylls, beta-carotene, neoxanthin, lactucaxanthin, all trans-and cis-violaxanthin decreased. The constitutive concentrations of polyphenols were lower in the green cultivar, but their relative increase was more pronounced than in the red cultivar. The constitutive concentrations of chlorophylls, a-carotene, neoxanthin, all trans-and cis-violaxanthin were similar in red and green lettuce and with decreasing nitrogen concentration they declined to a similar extent in both cultivars. We only detected little influence of the radiation treatments, e.g. on anthocyanin concentration, and hardly any interaction between radiation and nitrogen concentration. Our results imply a greater physiological plasticity of green compared to the red lettuce regarding its phenolic compounds. They support the photoprotection theory regarding anthocyanins as well as theory that the deamination activity of phenylalanine ammonia-lyase drives phenylpropanoid synthesis.	[Becker, Christine; Klaering, Hans-Peter] Leibniz Inst Vegetable & Ornamental Crops eV, Dept Modelling & Knowledge Transfer, Grossbeeren, Germany; [Urlic, Branimir] Inst Adriat Crops & Karst Reclamat, Dept Plant Sci, Split, Croatia; [Spika, Maja Jukic; Perica, Slavko] Inst Adriat Crops & Karst Reclamat, Dept Appl Sci, Split, Croatia; [Krumbein, Angelika; Baldermann, Susanne] Leibniz Inst Vegetable & Ornamental Crops eV, Dept Plant Qual, Grossbeeren, Germany; [Ban, Smiljana Goreta] Inst Agr & Tourism, Dept Agr & Nutr, Porec, Croatia; [Schwarz, Dietmar] Leibniz Inst Vegetable & Ornamental Crops eV, Dept Plant Nutr, Grossbeeren, Germany	Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Institute for Adriatic Crops and Karst Reclamation Split; Institute for Adriatic Crops and Karst Reclamation Split; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Institute of Agriculture & Tourism Porec; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Becker, C (corresponding author), INRA, UMR 1355, Inst Sophia Agrobiotech, Sophia Antipolis, France.	c_becker@gmx.org	Scwarz, Dietmar/X-3671-2019; Baldermann, Susanne/C-4292-2014; Špika, Maja Jukić/O-2448-2018; Baldermann, Susanne/AAH-6303-2020; Becker, Christine/GQA-7873-2022	Scwarz, Dietmar/0000-0002-7742-7227; Baldermann, Susanne/0000-0002-1501-4320; Špika, Maja Jukić/0000-0002-8834-518X; Baldermann, Susanne/0000-0002-1501-4320; Becker, Christine/0000-0001-7542-9694	German Academic Exchange Service [54388867]; German Federal Ministry of Agriculture, Food, and Consumer Protection; Croatian Ministry of Science, Education and Sports	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); German Federal Ministry of Agriculture, Food, and Consumer Protection; Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	CB received a grant from the German Academic Exchange Service (project ID: 54388867; www.daad.org) and was supported by the German Federal Ministry of Agriculture, Food, and Consumer Protection (http://www.bmel.de/EN/Homepage/homepage_node.html;jsessionid=3E5F5B0D3C4DE2F534ED66C2DCF995A7.2_cid376) and the Croatian Ministry of Science, Education and Sports (http://public.mzos.hr/Default.aspx?sec=2428). The funders had no role in study design, data collection and Analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2009, TRENDS ECOL EVOL, V24, P166, DOI 10.1016/j.tree.2008.10.006; Baslam M, 2013, SCI HORTIC-AMSTERDAM, V151, P103, DOI 10.1016/j.scienta.2012.12.023; Becker C, 2014, J AGR FOOD CHEM, V62, P6911, DOI 10.1021/jf404782n; Becker C, 2013, PLANT PHYSIOL BIOCH, V72, P154, DOI 10.1016/j.plaphy.2013.05.006; Becker C, 2014, FOOD CHEM, V146, P404, DOI 10.1016/j.foodchem.2013.09.061; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; Boudet AM, 2007, PHYTOCHEMISTRY, V68, P2722, DOI 10.1016/j.phytochem.2007.06.012; Caldwell CR, 2003, J AGR FOOD CHEM, V51, P4589, DOI 10.1021/jf030005q; DuPont MS, 2000, J AGR FOOD CHEM, V48, P3957, DOI 10.1021/jf0002387; Fu WG, 2012, SCI HORTIC-AMSTERDAM, V135, P45, DOI 10.1016/j.scienta.2011.12.004; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gould K. S., 2006, Flavonoids: chemistry, biochemistry and applications, P397; Hughes NM, 2012, J EXP BOT, V63, P1895, DOI 10.1093/jxb/err362; Ibrahim MH, 2011, MOLECULES, V16, P162, DOI 10.3390/molecules16010162; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Klopotek Y, 2014, SCI HORTIC-AMSTERDAM, V180, P262, DOI 10.1016/j.scienta.2014.10.036; Konstantopoulou E, 2012, J PLANT NUTR, V35, P1246, DOI 10.1080/01904167.2012.676135; Lamers PP, 2008, TRENDS BIOTECHNOL, V26, P631, DOI 10.1016/j.tibtech.2008.07.002; Larbat R, 2012, PHYTOCHEMISTRY, V77, P119, DOI 10.1016/j.phytochem.2012.02.004; Lea US, 2007, PLANTA, V225, P1245, DOI 10.1007/s00425-006-0414-x; Liaaen-Jensen S, 1995, CAROTENOIDS B, V1b; Liu W, 2010, J PLANT NUTR, V33, P240, DOI 10.1080/01904160903434287; Lovdal T, 2010, PHYTOCHEMISTRY, V71, P605, DOI 10.1016/j.phytochem.2009.12.014; MAKINO A, 1991, PLANT PHYSIOL, V96, P355, DOI 10.1104/pp.96.2.355; Moise AR, 2014, CHEM REV, V114, P164, DOI 10.1021/cr400106y; Mulabagal V, 2010, FOOD CHEM, V118, P300, DOI 10.1016/j.foodchem.2009.04.119; Neilson EH, 2013, TRENDS PLANT SCI, V18, P250, DOI 10.1016/j.tplants.2013.01.001; Niedzwiedzki D, 2005, J PHOTOCH PHOTOBIO B, V78, P109, DOI 10.1016/j.jphotobiol.2004.09.012; Olsen KM, 2009, PLANT CELL ENVIRON, V32, P286, DOI 10.1111/j.1365-3040.2008.01920.x; PHILLIP D, 1995, PHOTOSYNTH RES, V43, P273, DOI 10.1007/BF00029940; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; ROUCHAUD J, 1984, PLANT SOIL, V80, P139, DOI 10.1007/BF02232948; Rubio-Wilhelmi MD, 2012, PLANT PHYSIOL BIOCH, V57, P231, DOI 10.1016/j.plaphy.2012.06.004; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Schopfer P, 2010, PFLANZENPHYSIOLOGIE; Skibola CF, 2000, FREE RADICAL BIO MED, V29, P375, DOI 10.1016/S0891-5849(00)00304-X; Coria-Cayupan YS, 2009, J AGR FOOD CHEM, V57, P10122, DOI 10.1021/jf903019d; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Stefanelli D., 2011, Agricultural Sciences, V2, P477, DOI 10.4236/as.2011.24061; Stewart AJ, 2001, PLANT CELL ENVIRON, V24, P1189, DOI 10.1046/j.1365-3040.2001.00768.x; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Tattini M, 2014, PHYSIOL PLANTARUM, V152, P585, DOI 10.1111/ppl.12201; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Trebst A, 2003, Z NATURFORSCH C, V58, P609; Treutter D, 2010, INT J MOL SCI, V11, P807, DOI 10.3390/ijms11030807; Zhang KM, 2013, PLANT BIOLOGY, V15, P991, DOI 10.1111/j.1438-8677.2012.00721.x	47	48	51	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142867	10.1371/journal.pone.0142867	http://dx.doi.org/10.1371/journal.pone.0142867			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569488	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700088
J	Aiken, J; Roudier, E; Ciccone, J; Drouin, G; Stromberg, A; Vojnovic, J; Olfert, IM; Haas, T; Gustafsson, T; Grenier, G; Birot, O				Aiken, Julian; Roudier, Emilie; Ciccone, Joseph; Drouin, Genevieve; Stromberg, Anna; Vojnovic, Jovana; Olfert, I. Mark; Haas, Tara; Gustafsson, Thomas; Grenier, Guillaume; Birot, Olivier			Phosphorylation of murine double minute-2 on Ser(166) is downstream of VEGF-A in exercised skeletal muscle and regulates primary endothelial cell migration and FoxO gene expression	FASEB JOURNAL			English	Article						Mdm2; physical exercise; angiogenesis	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; GROWTH-FACTOR; ANGIOGENESIS; HDM2; MDM2; IDENTIFICATION; STABILIZATION; ANTAGONIST	We demonstrated in a previous study that murine double minute (Mdm)-2 is essential for exercise-induced skeletal muscle angiogenesis. In the current study, we investigated the mechanisms that regulate Mdm2 activity in response to acute exercise and identified VEGF-A as a key stimulator of Mdm2 phosphorylation on Ser(166) (p-Ser166-Mdm2). VEGF-A and p-Ser166-Mdm2 protein levels were measured in human and rodent muscle biopsy specimens after 1 bout of exercise. VEGF-A-dependent Mdm2 phosphorylation was demonstrated in vivo in mice harboring myofiber-specific deletion of VEGF-A (mVEGF(-/-)) and in vitro in primary human and rodent endothelial cells (ECs). Exercise increased VEGF-A and p-Ser166-Mdm2 protein levels respectively by 157 and 68% in human muscle vs. pre-exercise levels. Similar results were observed in exercised rodent muscles compared to sedentary controls; however, exercise-induced Mdm2 phosphorylation was significantly attenuated in mVEGF(-/-) mice. Recombinant VEGF-A elevated p-Ser166-Mdm2 by 50-125% and stimulated migration by 33% in ECs when compared to untreated cells, whereas the Mdm2 antagonist Nutlin-3a abrogated VEGF-driven EC migration. Finally, overexpression of a Ser166-Mdm2 phosphorylation mimetic increased EC migration, increased Mdm2 to FoxO1 binding (+55%), and decreased FoxO1-dependent gene expression compared with ECs overexpressing WT-Mdm2. Our results suggest that VEGF-mediated Mdm2 phosphorylation on Ser(166) is a novel proangiogenic pathway within the skeletal muscle.	[Aiken, Julian; Roudier, Emilie; Ciccone, Joseph; Vojnovic, Jovana; Haas, Tara; Birot, Olivier] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Angiogenesis Res Grp, Toronto, ON M3J 1P3, Canada; [Drouin, Genevieve; Grenier, Guillaume] Univ Sherbrooke, Dept Surg, Sherbrooke, PQ J1K 2R1, Canada; [Stromberg, Anna; Gustafsson, Thomas] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Physiol, Stockholm, Sweden; [Olfert, I. Mark] W Virginia Univ, Ctr Cardiovasc & Resp Sci, Morgantown, WV 26506 USA; [Olfert, I. Mark] W Virginia Univ, Div Exercise Physiol, Morgantown, WV 26506 USA	York University - Canada; University of Sherbrooke; Karolinska Institutet; Karolinska University Hospital; West Virginia University; West Virginia University	Roudier, E (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Angiogenesis Res Grp, Norman Bethune Coll, Room 365,4700 Keele St, Toronto, ON M3J 1P3, Canada.	eroudier@yorku.ca	Gustafsson, Thomas/AAH-1056-2019	Gustafsson, Thomas/0000-0002-1559-4206	Natural Sciences and Engineering Research Council of Canada [RGPIN341258]; Canadian Institutes of Health Research; Fonds de Recherche du Quebec-Sante (FRQS); FRQS	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); FRQS	This work was supported by Grant RGPIN341258 from the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research. G.D. received a scholarship from Fonds de Recherche du Quebec-Sante (FRQS). G.G. is recipient of an Investigator Award from FRQS. E.R., J.A., and O.B. formulated and designed the experiments. J.A., E.R., J.C., G.D., J.V., A.S., and O.B. performed the experiments. E.R., J.A., and O.B. analyzed the data. T.H., G.G., T.G., I.M.O., and O.B. contributed reagents, materials, and analytical tools. J.A., E.R., and O.B. wrote the manuscript. All authors contributed significantly to the editing. The authors declare no conflicts of interest.	Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Joshi S, 2014, J BIOL CHEM, V289, P22785, DOI 10.1074/jbc.M114.587493; Karadedou CT, 2012, ONCOGENE, V31, P1845, DOI 10.1038/onc.2011.368; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Lee YM, 2009, CARCINOGENESIS, V30, P1768, DOI 10.1093/carcin/bgp196; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Meek DW, 2010, SEMIN CANCER BIOL, V20, P19, DOI 10.1016/j.semcancer.2009.10.005; Milkiewicz M, 2011, AM J PATHOL, V178, P935, DOI 10.1016/j.ajpath.2010.10.042; Narasimhan M, 2008, LIFE SCI, V82, P1231, DOI 10.1016/j.lfs.2008.04.004; Olfert IM, 2011, MICROCIRCULATION, V18, P316, DOI 10.1111/j.1549-8719.2011.00092.x; Olfert IM, 2010, AM J PHYSIOL-REG I, V299, pR1059, DOI 10.1152/ajpregu.00347.2010; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Robertson E Douglas, 2014, Subcell Biochem, V85, P199, DOI 10.1007/978-94-017-9211-0_11; Roudier E, 2013, ANGIOGENESIS, V16, P759, DOI 10.1007/s10456-013-9353-x; Roudier E, 2012, FASEB J, V26, P4530, DOI 10.1096/fj.12-212720; Secchiero P, 2007, CIRC RES, V100, P61, DOI 10.1161/01.RES.0000253975.76198.ff; Shikatani EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046625; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Slopack D, 2014, J PHYSIOL-LONDON, V592, P4069, DOI 10.1113/jphysiol.2014.275867; Wagner PD, 2011, BIOCHEM SOC T, V39, P1556, DOI 10.1042/BST20110646; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11	28	12	12	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1120	1134		10.1096/fj.15-276964	http://dx.doi.org/10.1096/fj.15-276964			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26578686				2022-12-26	WOS:000370387800011
J	Sinha, P; Aarnisalo, P; Chubb, R; Poulton, IJ; Guo, J; Nachtrab, G; Kimura, T; Swami, S; Saeed, H; Chen, M; Weinstein, LS; Schipani, E; Sims, NA; Kronenberg, HM; Wu, JY				Sinha, Partha; Aarnisalo, Piia; Chubb, Rhiannon; Poulton, Ingrid J.; Guo, Jun; Nachtrab, Gregory; Kimura, Takaharu; Swami, Srilatha; Saeed, Hamid; Chen, Min; Weinstein, Lee S.; Schipani, Ernestina; Sims, Natalie A.; Kronenberg, Henry M.; Wu, Joy Y.			Loss of G(s)alpha in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLASTIC CELLS; MESENCHYMAL PROGENITORS; POSTMENOPAUSAL WOMEN; INTERMITTENT PTH; PHOSPHOLIPASE-C; MINERAL DENSITY; PROTEIN-KINASE; IN-VIVO; DIFFERENTIATION; RECEPTOR	Parathyroid hormone (PTH) is an important regulator of osteoblast function and is the only anabolic therapy currently approved for treatment of osteoporosis. The PTH receptor (PTH1R) is a G protein-coupled receptor that signals via multiple G proteins including G(s)alpha. Mice expressing a constitutively active mutant PTH1R exhibited a dramatic increase in trabecular bone that was dependent upon expression of G(s)alpha in the osteoblast lineage. Postnatal removal of G(s)alpha in the osteoblast lineage (P-G(s)alpha(OsxKO) mice) yielded markedly reduced trabecular and cortical bone mass. Treatment with anabolic PTH(1-34) (80 mu g/kg/day) for 4 weeks failed to increase trabecular bone volume or cortical thickness in male and female P-G(s)alpha(OsxKO) mice. Surprisingly, in both male and female mice, PTH administration significantly increased osteoblast numbers and bone formation rate in both control and P-G(s)alpha(OsxKO) mice. In mice that express a mutated PTH1R that activates adenylyl cyclase and protein kinase A (PKA) via G(s)alpha but not phospholipase C via G(q/11) (D/D mice), PTH significantly enhanced bone formation, indicating that phospholipase C activation is not required for increased bone turnover in response to PTH. Therefore, although the anabolic effect of intermittent PTH treatment on trabecular bone volume is blunted by deletion of G(s)alpha in osteoblasts, PTH can stimulate osteoblast differentiation and bone formation. Together these findings suggest that alternative signaling pathways beyond G(s)alpha and G(q/11) act downstream of PTH on osteoblast differentiation.	[Sinha, Partha; Aarnisalo, Piia; Chubb, Rhiannon; Guo, Jun; Nachtrab, Gregory; Kronenberg, Henry M.; Wu, Joy Y.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Aarnisalo, Piia] Univ Helsinki, Dept Clin Chem, Helsinki 00029, Finland; [Aarnisalo, Piia] Univ Helsinki, Cent Hosp, HUSLAB, Lab Serv, Helsinki 00029, Finland; [Poulton, Ingrid J.; Sims, Natalie A.] Univ Melbourne, St Vincents Inst, Fitzroy, Vic 3065, Australia; [Poulton, Ingrid J.; Sims, Natalie A.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Kimura, Takaharu; Swami, Srilatha; Saeed, Hamid; Wu, Joy Y.] Stanford Univ, Sch Med, Div Endocrinol, 300 Pasteur Dr,S-025, Stanford, CA 94305 USA; [Chen, Min; Weinstein, Lee S.] NIDDK, NIH, Metab Dis Branch, Bethesda, MD 20892 USA; [Schipani, Ernestina] Univ Michigan, Dept Orthoped Surg, Ann Arbor, MI 48109 USA; [Schipani, Ernestina] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts General Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wu, JY (corresponding author), Stanford Univ, Sch Med, Div Endocrinol, 300 Pasteur Dr,S-025, Stanford, CA 94305 USA.	jywu1@stanford.edu	Sims, Natalie Ann/A-7192-2012	Sims, Natalie Ann/0000-0003-1421-8468; Weinstein, Lee/0000-0002-1899-5152	National Institutes of Health [AR054741, AR059942, AR061228, DK011794]; NIDDK Intramural Research Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065403, F32AR061228, K08AR054741, R03AR059942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313, P01DK011794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants AR054741 and AR059942 (to J. Y. W.), AR061228 (to P. S.), and DK011794 (to H. M. K.) and the NIDDK Intramural Research Program (to M. C. and L. S. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Boguslawski G, 2000, J BIOL CHEM, V275, P999, DOI 10.1074/jbc.275.2.999; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dobnig H, 1997, ENDOCRINOLOGY, V138, P4607, DOI 10.1210/en.138.11.4607; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6; Guo J, 2010, ENDOCRINOLOGY, V151, P3502, DOI 10.1210/en.2009-1494; Hsiao EC, 2008, P NATL ACAD SCI USA, V105, P1209, DOI 10.1073/pnas.0707457105; Hsiao EC, 2010, J BONE MINER RES, V25, P584, DOI 10.1002/jbmr.3; Iida-Klein A, 2002, J BONE MINER RES, V17, P808, DOI 10.1359/jbmr.2002.17.5.808; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Kedlaya R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006627; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lindsay R, 2006, J BONE MINER RES, V21, P366, DOI 10.1359/JBMR.051109; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; PARTRIDGE NC, 1982, ENDOCRINOLOGY, V111, P178, DOI 10.1210/endo-111-1-178; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Sinder BP, 2013, J BONE MINER RES, V28, P73, DOI 10.1002/jbmr.1717; Singh ATK, 2005, ENDOCRINOLOGY, V146, P2171, DOI 10.1210/en.2004-1283; Sinha P, 2014, J BONE MINER RES, V29, P2414, DOI 10.1002/jbmr.2270; Song LG, 2012, J BONE MINER RES, V27, P2344, DOI 10.1002/jbmr.1694; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Yang DH, 2008, ENDOCRINOLOGY, V149, P1728, DOI 10.1210/en.2007-0826	50	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1631	1642		10.1074/jbc.M115.679753	http://dx.doi.org/10.1074/jbc.M115.679753			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26598522	hybrid, Green Published			2022-12-26	WOS:000368620700008
J	Tominaga, T; Dutta, RK; Joladarashi, D; Doi, T; Reddy, JK; Kanwar, YS				Tominaga, Tatsuya; Dutta, Rajesh K.; Joladarashi, Darukeshwara; Doi, Toshio; Reddy, Janardan K.; Kanwar, Yashpal S.			Transcriptional and Translational Modulation of myo-Inositol Oxygenase (Miox) by Fatty Acids IMPLICATIONS IN RENAL TUBULAR INJURY INDUCED IN OBESITY AND DIABETES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDOREDUCTASE/MYO-INOSITOL OXYGENASE; METABOLIC SYNDROME; OXIDATIVE STRESS; INSULIN-RESISTANCE; EPITHELIAL-CELLS; GENE-EXPRESSION; KIDNEY-DISEASE; HIGH-GLUCOSE; PROTEIN; ALBUMIN	The kidney is one of the target organs for various metabolic diseases, including diabetes, metabolic syndrome, and obesity. Most of the metabolic studies underscore glomerular pathobiology, although the tubulo-interstitial compartment has been underemphasized. This study highlights mechanisms concerning the pathobiology of tubular injury in the context of myoinositol oxygenase (Miox), a tubular enzyme. The kidneys of mice fed a high fat diet (HFD) had increased Miox expression and activity, and the latter was related to phosphorylation of serine/threonine residues. Also, expression of sterol regulatory element-binding protein1 (Srebp1) and markers of cellular/nuclear damage was increased along with accentuated apoptosis and loss of tubular brush border. Similar results were observed in cells treated with palmitate/BSA. Multiple sterol-response elements and E-box motifs were found in the miox promoter, and its activity was modulated by palmitate/BSA. Electrophoretic mobility and ChIP assays confirmed binding of Srebp to consensus sequences of the miox promoter. Exposure of palmitate/ BSA-treated cells to rapamycin normalized Miox expression and prevented Srebp1 nuclear translocation. In addition, rapamycin treatment reduced p53 expression and apoptosis. Like rapamycin, srebp siRNA reduced Miox expression. Increased expression of Miox was associated with the generation of reactive oxygen species (ROS) in kidney tubules of mice fed an HFD and cell exposed to palmitate/BSA. Both miox and srebp1 siRNAs reduced generation of ROS. Collectively, these findings suggest that HFD or fatty acids modulate transcriptional, translational, and post-translational regulation of Miox expression/activity and underscore Miox being a novel target of the transcription factor Srebp1. Conceivably, activation of the mTORC1/Srebp1/Miox pathway leads to the generation of ROS culminating into tubulo-interstitial injury in states of obesity.	[Kanwar, Yashpal S.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Doi, Toshio] Univ Tokushima, Dept Nephrol, Tokushima 770, Japan	Northwestern University; Feinberg School of Medicine; Tokushima University	Kanwar, YS (corresponding author), Northwestern Univ, Sch Med, Dept Pathol, 300 E Chicago Ave, Chicago, IL 60611 USA.	y-kanwar@northwestern.edu	Dutta, Rajesh Kumar/J-7790-2019	Dutta, Rajesh Kumar/0000-0002-1394-0961	National Institutes of Health [DK60636]; Manpei Suzuki Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK60636 and the Manpei Suzuki Diabetes Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arici M, 2002, NEPHROL DIAL TRANSPL, V17, P1751, DOI 10.1093/ndt/17.10.1751; Arner RJ, 2001, BIOCHEM J, V360, P313, DOI 10.1042/bj3600313; Bayliss G, 2012, CURR DIABETES REP, V12, P440, DOI 10.1007/s11892-012-0288-1; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Carmiel-Haggai M, 2004, FASEB J, V18, P136, DOI 10.1096/fj.04-2291fje; CHARALAMPOUS FC, 1957, J BIOL CHEM, V228, P1; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Csernus K, 2005, EUR J PEDIATR, V164, P44, DOI 10.1007/s00431-004-1546-2; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jain SS, 2014, DIABETES, V63, P1907, DOI 10.2337/db13-0816; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Narayanan A, 2009, CURR OPIN STRUC BIOL, V19, P156, DOI 10.1016/j.sbi.2009.02.007; Nayak B, 2005, P NATL ACAD SCI USA, V102, P17952, DOI 10.1073/pnas.0509089102; Nayak B, 2011, J BIOL CHEM, V286, P27594, DOI 10.1074/jbc.M110.217141; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prabhu KS, 2005, J BIOL CHEM, V280, P19895, DOI 10.1074/jbc.M502621200; Redon J, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0555-z; Ritz E, 2011, CURR OPIN NEPHROL HY, V20, P44, DOI 10.1097/MNH.0b013e3283414ca1; Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Ruggiero C, 2014, AM J PHYSIOL-RENAL, V306, pF896, DOI 10.1152/ajprenal.00484.2013; Sahin-Efe A, 2012, METABOLISM, V61, P1659, DOI 10.1016/j.metabol.2012.09.001; Satriano J, 2013, NEPHROL DIAL TRANSPL, V28, P29, DOI 10.1093/ndt/gft229; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Singhal SS, 2013, J BIOL CHEM, V288, P23394, DOI 10.1074/jbc.M113.480194; Tanner RM, 2012, CURR HYPERTENS REP, V14, P152, DOI 10.1007/s11906-012-0254-y; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; THOMAS ME, 1993, AM J NEPHROL, V13, P385, DOI 10.1159/000168653; Thomas ME, 2002, AM J PHYSIOL-RENAL, V283, pF640, DOI 10.1152/ajprenal.00001.2002; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Xie P, 2011, J BIOL CHEM, V286, P34131, DOI 10.1074/jbc.M111.241778; Xie P, 2010, AM J PHYSIOL-RENAL, V298, pF1393, DOI 10.1152/ajprenal.00137.2010; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Yang QW, 2000, P NATL ACAD SCI USA, V97, P9896, DOI 10.1073/pnas.160266197; Yasuda M, 2014, BBA-MOL BASIS DIS, V1842, P1097, DOI 10.1016/j.bbadis.2014.04.001; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746	56	24	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1348	1367		10.1074/jbc.M115.698191	http://dx.doi.org/10.1074/jbc.M115.698191			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26578517	Green Published, hybrid			2022-12-26	WOS:000368068300028
J	Nakakita, S; Itoh, A; Nakakita, Y; Nonaka, Y; Ogawa, T; Nakamura, T; Nishi, N				Nakakita, Shin-ichi; Itoh, Aiko; Nakakita, Yukari; Nonaka, Yasuhiro; Ogawa, Takashi; Nakamura, Takanori; Nishi, Nozomu			Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; NUCLEOTIDE-SEQUENCE; T-CELLS; MICE; GLYCOSYLATION; PROTEIN; CHROMATOGRAPHY; RECOGNITION; SUPPRESSES; IMMUNITY	We previously showed that galectin-9 suppresses degranulation of mast cells through protein-glycan interaction with IgE. To elucidate the mechanism of the interaction in detail, we focused on identification and structural analysis of IgE glycans responsible for the galectin-9-induced suppression using mouse monoclonal IgE (TIB-141). TIB-141 in combination with the antigen induced degranulation of RBL-2H3 cells, which was almost completely inhibited by human and mouse galectin-9. Sequential digestion of TIB-141 with lysyl endopeptidase and trypsin resulted in the identification of a glycopeptide (H-Lys13-Try3; 48 amino acid residues) with a single N-linked oligosaccharide near the N terminus capable of neutralizing the effect of galectin-9 and another glycopeptide with two N-linked oligosaccharides (H-Lys13-Try1; 16 amino acid residues) having lower activity. Enzymatic elimination of the oligosaccharide chain from H-Lys13-Try3 and H-Lys13-Try1 completely abolished the activity. Removal of the C-terminal 38 amino acid residues of H-Lys13-Try3 with glutamyl endopeptidase, however, also resulted in loss of the activity. We determined the structures of N-linked oligosaccharides of H-Lys13-Try1. The galectin-9-binding fraction of pyri-dylaminated oligosaccharides contained asialo-and monosialylated bi/tri-antennary complex type oligosaccharides with a core fucose residue. The structures of the oligosaccharides were consistent with the sugar-binding specificity of galectin-9, whereas the nonbinding fraction contained monosialylated and disialylated biantennary complex type oligosaccharides with a core fucose residue. Although the oligosaccharides linked to H-Lys13-Try3 could not be fully characterized, these results indicate the possibility that cooperative binding of oligosaccharide and neighboring polypeptide structures of TIB-141 to galectin-9 affects the overall affinity and specificity of the IgE-lectin interaction.	[Nakakita, Shin-ichi; Nakakita, Yukari] Kagawa Univ, Div Funct Glyc, Miki, Kagawa 7610793, Japan; [Itoh, Aiko; Nishi, Nozomu] Kagawa Univ, Div Res Instrument & Equipment, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Nonaka, Yasuhiro; Ogawa, Takashi; Nakamura, Takanori] Kagawa Univ, Dept Endocrinol, Fac Med, Miki, Kagawa 7610793, Japan	Kagawa University; Kagawa University; Kagawa University	Nishi, N (corresponding author), Kagawa Univ, Div Res Instrument & Equipment, Life Sci Res Ctr, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	nnishi@med.kagawa-u.ac.jp		Nishi, Nozomu/0000-0001-7050-3226; Nonaka, Yasuhiro/0000-0003-0302-5409	Japan Society for the Promotion of Science [15K06974]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research (C) 15K06974 (to N. N.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; FULLMER CS, 1984, ANAL BIOCHEM, V142, P336, DOI 10.1016/0003-2697(84)90473-1; He WT, 2009, TRANSPLANTATION, V88, P782, DOI 10.1097/TP.0b013e3181b47f25; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hirashima M, 2002, GLYCOCONJUGATE J, V19, P593, DOI 10.1023/B:GLYC.0000014090.63206.2f; Hua S, 2012, ANAL BIOANAL CHEM, V403, P1291, DOI 10.1007/s00216-011-5109-x; ISHIDA N, 1982, EMBO J, V1, P1117, DOI 10.1002/j.1460-2075.1982.tb01306.x; Iwaki J, 2011, BBA-GEN SUBJECTS, V1810, P643, DOI 10.1016/j.bbagen.2011.04.001; Jung ID, 2009, CELL SIGNAL, V21, P1698, DOI 10.1016/j.cellsig.2009.07.008; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; KOFLER H, 1992, MOL IMMUNOL, V29, P161, DOI 10.1016/0161-5890(92)90097-H; Linwong W, 2005, BRIT J PHARMACOL, V145, P818, DOI 10.1038/sj.bjp.0706240; LIU FT, 1982, P NATL ACAD SCI-BIOL, V79, P7852, DOI 10.1073/pnas.79.24.7852; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Nagae M, 2015, CURR OPIN STRUC BIOL, V34, P108, DOI 10.1016/j.sbi.2015.08.005; Nagae M, 2014, STRUCTURE, V22, P1711, DOI 10.1016/j.str.2014.09.009; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; Niki T, 2009, J BIOL CHEM, V284, P32344, DOI 10.1074/jbc.M109.035196; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Nobumoto A, 2009, CLIN IMMUNOL, V130, P322, DOI 10.1016/j.clim.2008.09.014; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Pioche-Durieu C, 2005, J VIROL, V79, P13326, DOI 10.1128/JVI.79.21.13326-13337.2005; Plomp R, 2014, J PROTEOME RES, V13, P536, DOI 10.1021/pr400714w; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Sumiyoshi W, 2010, BIOSCI BIOTECH BIOCH, V74, P606, DOI 10.1271/bbb.90821; Suzuki N, 2004, GLYCOBIOLOGY, V14, P275, DOI 10.1093/glycob/cwh031; Tsuboi Y, 2007, CLIN IMMUNOL, V124, P221, DOI 10.1016/j.clim.2007.04.015; Tureci O, 1997, J BIOL CHEM, V272, P6416, DOI 10.1074/jbc.272.10.6416; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wang F, 2003, ANAL BIOCHEM, V314, P266, DOI 10.1016/S0003-2697(02)00693-0; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	36	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					968	979		10.1074/jbc.M115.694448	http://dx.doi.org/10.1074/jbc.M115.694448			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582205	Green Published, hybrid			2022-12-26	WOS:000367830500042
J	Alshboul, Z; Lorke, A				Alshboul, Zeyad; Lorke, Andreas			Carbon Dioxide Emissions from Reservoirs in the Lower Jordan Watershed	PLOS ONE			English	Article							METHANE EMISSIONS; SURFACE WATERS; SUPERSATURATION; TERRESTRIAL; VARIABILITY; IRRIGATION; ALKALINITY; MECHANISMS; HYDRATION; QUALITY	We have analyzed monthly hydrological, meteorological and water quality data from three irrigation and drinking water reservoirs in the lower Jordan River basin and estimated the atmospheric emission rates of CO2. The data were collected between 2006 and 2013 and show that the reservoirs, which differ in size and age, were net sources of CO2. The estimated surface fluxes were comparable in magnitude to those reported for hydroelectric reservoirs in the tropical and sub-tropical zones. Highest emission rates were observed for a newly established reservoir, which was initially filled during the sampling period. In the two older reservoirs, CO2 partial pressures and fluxes were significantly decreasing during the observation period, which could be related to simultaneously occurring temporal trends in water residence time and chemical composition of the water. The results indicate a strong influence of water and reservoir management (e.g. water consumption) on CO2 emission rates, which is affected by the increasing anthropogenic pressure on the limited water resources in the study area. The low wind speed and relatively high pH favored chemical enhancement of the CO2 gas exchange at the reservoir surfaces, which caused on average a four-fold enhancement of the fluxes. A sensitivity analysis indicates that the uncertainty of the estimated fluxes is, besides pH, mainly affected by the poorly resolved wind speed and resulting uncertainty of the chemical enhancement factor.	[Alshboul, Zeyad; Lorke, Andreas] Univ Koblenz Landau, Inst Environm Sci, D-76829 Landau, Germany	University of Koblenz & Landau	Alshboul, Z (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Fortstr 7, D-76829 Landau, Germany.	zeyad@uni-landau.de	Lorke, Andreas/B-9195-2008	Lorke, Andreas/0000-0001-5533-1817; Alshboul, Zeyad/0000-0002-9445-3347	Sustainable Water Management Program (NAWAM) of German Academic Exchange Service (DAAD) [A/12/91768]	Sustainable Water Management Program (NAWAM) of German Academic Exchange Service (DAAD)	This work was funded by Sustainable Water Management Program (NAWAM) of German Academic Exchange Service (DAAD), (Grant number: A/12/91768).	Abril G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002457; Abril G, 2014, BIOGEOSCI DISC, V11, P11701, DOI [10.5194/bgd-11-11701-2014, DOI 10.5194/BGD-11-11701-2014]; Al-Ghazawi ZD, 2008, CLEAN TECHNOL ENVIR, V10, P341, DOI 10.1007/s10098-008-0145-8; Al-Sheriadeh MS, 1999, ENVIRON GEOL, V37, P234, DOI 10.1007/s002540050381; Al-Taani AA, 2013, ARAB J GEOSCI, V6, P1131, DOI 10.1007/s12517-011-0428-y; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Bade DL, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002684; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; Crawford JT, 2014, GLOBAL BIOGEOCHEM CY; Crusius J, 2003, LIMNOL OCEANOGR, V48, P1010, DOI 10.4319/lo.2003.48.3.1010; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Evans JP, 2009, CLIMATIC CHANGE, V92, P417, DOI 10.1007/s10584-008-9438-5; Farber E, 2004, GEOCHIM COSMOCHIM AC, V68, P1989, DOI 10.1016/j.gca.2003.09.021; Gunkel A, 2012, WATER RESOUR MANAG, V26, P963, DOI 10.1007/s11269-011-9903-1; HOOVER TE, 1969, J GEOPHYS RES, V74, P456, DOI 10.1029/JB074i002p00456; Humborg C, 2010, GLOBAL CHANGE BIOL, V16, P1966, DOI 10.1111/j.1365-2486.2009.02092.x; Jiang ZP, 2014, GLOBAL BIOGEOCHEM CY, V28, P729, DOI 10.1002/2013GB004678; JOHNSON KS, 1982, LIMNOL OCEANOGR, V27, P849, DOI 10.4319/lo.1982.27.5.0849; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Lopez P, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001614; Maeck A, 2014, BIOGEOSCIENCES, V11, P2925, DOI 10.5194/bg-11-2925-2014; Maeck A, 2013, ENVIRON SCI TECHNOL, V47, P8130, DOI 10.1021/es4003907; Millero FJ, 1998, MAR CHEM, V60, P111, DOI 10.1016/S0304-4203(97)00084-4; Morales-Pineda M, 2014, J GEOPHYS RES-BIOGEO, V119, P509, DOI 10.1002/2013JG002317; Parkhurst D L, 2013, DESCRIPTION INPUT EX, V6, DOI 10.3133/tm6A43; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; Saadoun I., 2008, JORDAN J BIOL SCI, V1, P67; Saadoun I, 2008, TURK J BIOL, V32, P291; Saadoun I, 2010, OCEANOL HYDROBIOL ST, V39, P189, DOI 10.2478/v10009-010-0057-x; Shatanawi M, 1996, WATER RES, V30, P2915, DOI 10.1016/S0043-1354(96)00176-5; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; Teodoru CR, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004187; Teodoru CR, 2011, ECOSYSTEMS, V14, P28, DOI 10.1007/s10021-010-9393-7; Tortajada C, 2012, IMPACTS LARGE DAMS G; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; von Schiller D, 2014, INLAND WATERS, V4, P377, DOI 10.5268/IW-4.4.746; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Wanninkhof R, 1996, LIMNOL OCEANOGR, V41, P689, DOI 10.4319/lo.1996.41.4.0689; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140	45	4	4	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143381	10.1371/journal.pone.0143381	http://dx.doi.org/10.1371/journal.pone.0143381			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588241	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500055
J	Petrovic, I; Milivojevic, M; Popovic, J; Schwirtlich, M; Rankovic, B; Stevanovic, M				Petrovic, Isidora; Milivojevic, Milena; Popovic, Jelena; Schwirtlich, Marija; Rankovic, Branislava; Stevanovic, Milena			SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; IN-VITRO; PANCREATIC-CANCER; REDUNDANT ROLES; HUMAN EPIDERMIS; TGF-BETA; EXPRESSION; PATHWAY; GROWTH; INHIBITION	Although there is much evidence showing functional relationship between Hedgehog pathway, in particular Sonic hedgehog, and SOX transcription factors during embryonic development, scarce data are available regarding their crosstalk in cancer cells. SOX18 protein plays an important role in promoting tumor angiogenesis and therefore emerged as a promising potential target in antiangiogenic tumor therapy. Recently it became evident that expression of SOX18 gene in tumors is not restricted to endothelium of accompanying blood and lymphatic vessels, but in tumor cells as well. In this paper we have identified human SOX18 gene as a novel target gene of Hedgehog signaling in cervical carcinoma cell lines. We have presented data showing that expression of SOX18 gene is regulated by GLI1 and GLI2 transcription factors, final effectors of Hedgehog signaling, and that modulation of Hedgehog signaling activity in considerably influence SOX18 expression. We consider important that Hedgehog pathway inhibitors reduced SOX18 expression, thus showing, for the first time, possibility for manipulationwith SOX18 gene expression. In addition, we analyzed the role of SOX18 in malignant potential of cervical carcinoma cell line, and showed that its overexpression has no influence on cells proliferation and viability, but substantially promotes migration and invasion of cells in vitro. Pro-migratory effect of SOX18 suggests its role in promoting malignant spreading, possibly in response to Hedgehog activation.	[Petrovic, Isidora; Milivojevic, Milena; Popovic, Jelena; Schwirtlich, Marija; Rankovic, Branislava; Stevanovic, Milena] Univ Belgrade, Lab Human Mol Genet, Inst Mol Genet & Genet Engn, Belgrade 11000, Serbia	University of Belgrade	Petrovic, I (corresponding author), Univ Belgrade, Lab Human Mol Genet, Inst Mol Genet & Genet Engn, POB 23, Belgrade 11000, Serbia.	isidorapetrovic@imgge.bg.ac.rs	Popovic, Jelena/S-6304-2017	Popovic, Jelena/0000-0001-8565-1555; milivojevic, milena/0000-0002-1938-8020; Schwirtlich, Marija/0000-0002-2183-0164; Petrovic, Isidora/0000-0002-9816-2184	Ministry of Education, Science and Technological Development, Republic of Serbia [173051]	Ministry of Education, Science and Technological Development, Republic of Serbia	This work was funded by the Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No 173051, www.mpn.gov.rs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; Alexandrova AY, 2008, BIOCHEMISTRY-MOSCOW+, V73, P733, DOI 10.1134/S0006297908070018; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Castillo SD, 2012, EXPERT OPIN THER TAR, V16, P903, DOI 10.1517/14728222.2012.709239; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chaudary N, 2012, CANCER-AM CANCER SOC, V118, P3105, DOI 10.1002/cncr.26635; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Darby IA, 2001, LAB INVEST, V81, P937, DOI 10.1038/labinvest.3780304; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Dong C, 2004, CYTOGENET GENOME RES, V105, P442, DOI 10.1159/000078217; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Eichberger T, 2004, J INVEST DERMATOL, V122, P1180, DOI 10.1111/j.0022-202X.2004.22505.x; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Grujicic NK, 2005, GENE, V344, P287, DOI 10.1016/j.gene.2004.11.006; Gu DS, 2013, MOL CANCER THER, V12, P1038, DOI 10.1158/1535-7163.MCT-12-1030; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; Hoeth M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030982; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Khoshyomn S, 1999, J NEURO-ONCOL, V45, P111, DOI 10.1023/A:1006375316331; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kwon YJ, 2011, CLIN EXP METASTAS, V28, P437, DOI 10.1007/s10585-011-9382-z; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lin SH, 2013, JNCI-J NATL CANCER I, V105, P686, DOI 10.1093/jnci/djt055; Lu BJ, 2008, AM J CLIN PATHOL, V130, P897, DOI 10.1309/AJCPW1W8GJBQGCNI; Luo M, 2008, MED HYPOTHESES, V70, P880, DOI 10.1016/j.mehy.2007.07.024; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; MERZAK A, 1994, BRIT J CANCER, V70, P199, DOI 10.1038/bjc.1994.280; Milivojevic M, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1287, DOI 10.1134/S0006297913110096; Mordhorst LB, 2014, GYNECOL ONCOL, V135, P305, DOI 10.1016/j.ygyno.2014.08.026; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Perrot CY, 2013, PHARMACOL THERAPEUT, V137, P183, DOI 10.1016/j.pharmthera.2012.10.002; Petrovic I, 2010, EXP MOL MED, V42, P132, DOI 10.3858/emm.2010.42.2.015; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Popovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091852; Popovic J, 2010, BBA-GENE REGUL MECH, V1799, P411, DOI 10.1016/j.bbagrm.2010.01.002; Pula B, 2014, ANTICANCER RES, V34, P4029; Pula B, 2013, CELL ONCOL, V36, P469, DOI 10.1007/s13402-013-0151-7; Ramaswamy B, 2012, CANCER RES, V72, P5048, DOI 10.1158/0008-5472.CAN-12-1248; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Roy S, 2002, J CELL SCI, V115, P4393, DOI 10.1242/jcs.00158; Samarzija I, 2012, BIOCHEM BIOPH RES CO, V425, P64, DOI 10.1016/j.bbrc.2012.07.051; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Scotting PJ, 1996, NEUROPATH APPL NEURO, V22, P469, DOI 10.1111/j.1365-2990.1996.tb01118.x; Shevde LA, 2014, INT J CANCER, V135, P1, DOI 10.1002/ijc.28424; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Thu Kelsie L, 2014, Oncoscience, V1, P326; Vervoort SJ, 2013, ONCOGENE, V32, P3397, DOI 10.1038/onc.2012.506; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wickstrom M, 2013, INT J CANCER, V132, P1516, DOI 10.1002/ijc.27820; Woo WM, 2012, GENE DEV, V26, P1235, DOI 10.1101/gad.187401.112; Xuan YH, 2006, MODERN PATHOL, V19, P1139, DOI 10.1038/modpathol.3800600; Young N, 2006, J NATL CANCER I, V98, P1060, DOI 10.1093/jnci/djj299; Zhu YZ, 2012, INT J MOL SCI, V13, P15767, DOI 10.3390/ijms131215767	70	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143591	10.1371/journal.pone.0143591	http://dx.doi.org/10.1371/journal.pone.0143591			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588701	Green Published, gold, Green Submitted			2022-12-26	WOS:000365251500065
J	Allen, JE; Crowder, R; El-Deiry, WS				Allen, Joshua E.; Crowder, Roslyn; El-Deiry, Wafik S.			First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent	PLOS ONE			English	Article							INDUCED APOPTOSIS; TRAIL; GENE; CHEMOTHERAPY; TOXICITY; CONVERGE	We previously identified ONC201 (TIC10) as a first-in-class orally active small molecule with robust antitumor activity that is currently in clinical trials in advanced cancers. Here, we further investigate the safety characteristics of ONC201 in preclinical models that reveal an excellent safety profile at doses that exceed efficacious doses by 10-fold. In vitro studies indicated a strikingly different dose-response relationship when comparing tumor and normal cells where maximal effects are much stronger in tumor cells than in normal cells. In further support of a wide therapeutic index, investigation of tumor and normal cell responses under identical conditions demonstrated large apoptotic effects in tumor cells and modest anti-proliferative effects in normal cells that were non-apoptotic and reversible. Probing the underlying mechanism of apoptosis indicated that ONC201 does not induce DR5 in normal cells under conditions that induce DR5 in tumor cells; DR5 is a pro-apoptotic TRAIL receptor previously linked to the anti-tumor mechanism of ONC201. GLP toxicology studies in Sprague-Dawley rats and beagle dogs at therapeutic and exaggerated doses revealed no dose-limiting toxicities. Observations in both species at the highest doses were mild and reversible at doses above 10-fold the expected therapeutic dose. The no observed adverse event level (NOAEL) was >= 42 mg/kg in dogs and >= 125 mg/kg in rats, which both correspond to a human dose of approximately 1.25 g assuming standard allometric scaling. These results provided the rationale for the 125 mg starting dose in dose escalation clinical trials that began in 2015 in patients with advanced cancer.	[Allen, Joshua E.] Oncoceutics Inc, Philadelphia, PA 19103 USA; [Crowder, Roslyn] Stetson Univ, Dept Biol, Deland, FL 32723 USA; [El-Deiry, Wafik S.] Fox Chase Canc Ctr, Lab Translat Oncol & Expt Canc Therapeut, Dept Oncol & Mol Therapeut Program, Philadelphia, PA 19111 USA	Stetson University; Fox Chase Cancer Center	El-Deiry, WS (corresponding author), Fox Chase Canc Ctr, Lab Translat Oncol & Expt Canc Therapeut, Dept Oncol & Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	wafik.eldeiry@gmail.com	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266	Oncoceutics; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA173453] Funding Source: NIH RePORTER	Oncoceutics; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	W. S. El-Deiry is an American Cancer Society Research Professor. This work was supported by Oncoceutics and a Pennsylvania Department of Health grant awarded to Oncoceutics.	Allen JE, 2015, CANCER RES, V75, P1668, DOI 10.1158/0008-5472.CAN-14-2356; Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Allen JE, 2012, CANCER BIOL THER, V13, P1143, DOI 10.4161/cbt.21354; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Ishizawa J, 2014, ONC201 INDUCES P53 I; Kuribayashi K, 2008, CANCER BIOL THER, V7, P2034, DOI 10.4161/cbt.7.12.7460; Liu S, 2014, CANCER TREAT REV, V40, P883, DOI 10.1016/j.ctrv.2014.05.003; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Mohile Supriya Gupta, 2012, Am Soc Clin Oncol Educ Book, P321, DOI 10.14694/EdBook_AM.2012.32.321; PLENDERLEITH IH, 1990, CAN FAM PHYSICIAN, V36, P1827; Prabhu VV, 2015, CANCER RES, V75, P1423, DOI 10.1158/0008-5472.CAN-13-3451; Talekar MK, 2015, CELL CYCLE, V14, P2422, DOI 10.1080/15384101.2015.1054086; Wagner J, 2014, ONCOTARGET, V5, P12728, DOI 10.18632/oncotarget.2890; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200	17	32	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143082	10.1371/journal.pone.0143082	http://dx.doi.org/10.1371/journal.pone.0143082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580220	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600079
J	Stavrinou, P; Mavrogiorgou, MC; Polyzoidis, K; Kreft-Kerekes, V; Timmer, M; Marselos, M; Pappas, P				Stavrinou, Pantelis; Mavrogiorgou, Maria-Christina; Polyzoidis, Konstantinos; Kreft-Kerekes, Vincenzo; Timmer, Marco; Marselos, Marios; Pappas, Periklis			Expression Profile of Genes Related to Drug Metabolism in Human Brain Tumors	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; RODENT GLIOMA MODEL; PHASE-II TRIAL; CYTOCHROME-P450 EXPRESSION; ALDEHYDE DEHYDROGENASES; PLUS O-6-BENZYLGUANINE; LUNG-CANCER; ENZYMES; TEMOZOLOMIDE; RISK	Background Endogenous and exogenous compounds as well as carcinogens are metabolized and detoxified by phase I and II enzymes, the activity of which could be crucial to the inactivation and hence susceptibility to carcinogenic factors. The expression of these enzymes in human brain tumor tissue has not been investigated sufficiently. We studied the association between tumor pathology and the expression profile of seven phase I and II drug metabolizing genes (CYP1A1, CYP1B1, ALDH3A1, AOX1, GSTP1, GSTT1 and GSTM3) and some of their proteins. Methods Using qRT-PCR and western blotting analysis the gene and protein expression in a cohort of 77 tumors were investigated. The major tumor subtypes were meningioma, astrocytoma and brain metastases, -the later all adenocarcinomas from a lung primary. Results Meningeal tumors showed higher expression levels for AOX1, CYP1B1, GSTM3 and GSTP1. For AOX1, GSTM and GSTP1 this could be verified on a protein level as well. A negative correlation between the WHO degree of malignancy and the strength of expression was identified on both transcriptional and translational level for AOX1, GSTM3 and GSTP1, although the results could have been biased by the prevalence of meningiomas and glioblastomas in the inevitably bipolar distribution of the WHO grades. A correlation between the gene expression and the protein product was observed for AOX1, GSTP1 and GSTM3 in astrocytomas. Conclusions The various CNS tumors show different patterns of drug metabolizing gene expression. Our results suggest that the most important factor governing the expression of these enzymes is the histological subtype and to a far lesser extent the degree of malignancy itself.	[Stavrinou, Pantelis; Kreft-Kerekes, Vincenzo; Timmer, Marco] Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany; [Polyzoidis, Konstantinos] AHEPA Univ Hosp, Dept Neurosurg, Thessaloniki, Greece; [Mavrogiorgou, Maria-Christina; Marselos, Marios; Pappas, Periklis] Univ Ioannina, Pharmacol Lab, GR-45110 Ioannina, Greece	University of Cologne; Aristotle University of Thessaloniki; Ahepa University Hospital; University of Ioannina	Stavrinou, P (corresponding author), Univ Cologne, Dept Neurosurg, D-50931 Cologne, Germany.	pantelis.stavrinou@uk-koeln.de	Stavrinou, Pantelis/R-9115-2019	Stavrinou, Pantelis/0000-0001-8653-1395	KESY grant (Central Health Committee - Ministry of Health) [61/2048]	KESY grant (Central Health Committee - Ministry of Health)	This work was supported by the KESY grant 61/2048 (Central Health Committee - Ministry of Health; M.M.).	Achary MP, 2000, CYTOGENET CELL GENET, V91, P39, DOI 10.1159/000056815; Backos DS, 2012, BIOCHEM PHARMACOL, V83, P1005, DOI 10.1016/j.bcp.2011.11.016; Barnett JA, 2007, CLIN CANCER RES, V13, P3559, DOI 10.1158/1078-0432.CCR-06-2430; Brem S, 2007, CANCER CHEMOTH PHARM, V60, P643, DOI 10.1007/s00280-006-0407-2; Chen LC, 2011, ONCOL REP, V26, P1617, DOI 10.3892/or.2011.1458; De Roos AJ, 2006, NEURO-ONCOLOGY, V8, P145, DOI 10.1215/15228517-2005-003; De Roos AJ, 2003, CANCER EPIDEM BIOMAR, V12, P14; Dolan ME, 1997, CLIN CANCER RES, V3, P837; Fichtner I, 2004, BREAST CANCER RES TR, V87, P97, DOI 10.1023/B:BREA.0000041586.64371.88; Goth-Goldstein R, 2000, CARCINOGENESIS, V21, P2119, DOI 10.1093/carcin/21.11.2119; Gribben JG, 2005, CLIN CANCER RES, V11, P4430, DOI 10.1158/1078-0432.CCR-04-2111; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Huang HG, 2005, NEUROL RES, V27, P371, DOI 10.1179/016164105X39833; Iyer L, 1998, EUR J CANCER, V34, P1493, DOI 10.1016/S0959-8049(98)00230-5; Jounaidi Y, 2002, CURR DRUG METAB, V3, P609, DOI 10.2174/1389200023337027; Kim B, 2007, CANCER RES, V67, P7431, DOI 10.1158/0008-5472.CAN-07-0003; Kitamura S, 2006, DRUG METAB PHARMACOK, V21, P83, DOI 10.2133/dmpk.21.83; Lai R, 2005, CANCER EPIDEM BIOMAR, V14, P1784, DOI 10.1158/1055-9965.EPI-05-0105; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; McFadyen Morag C E, 2005, Future Oncol, V1, P259, DOI 10.1517/14796694.1.2.259; Milne E, 2013, INT J CANCER, V133, P253, DOI 10.1002/ijc.28004; Mukherjee A, 2006, INT J ONCOL, V29, P1287; MURRAY GI, 1994, GUT, V35, P599, DOI 10.1136/gut.35.5.599; Murray GI, 1997, CANCER RES, V57, P3026; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nishimura M, 2006, DRUG METAB PHARMACOK, V21, P357, DOI 10.2133/dmpk.21.357; Oyama T, 2007, FRONT BIOSCI, V12, P4497, DOI 10.2741/2404; Oyama T, 2007, FRONT BIOSCI-LANDMRK, V12, P2299, DOI 10.2741/2232; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Peters S, 2013, INT J CANCER, V132, P2975, DOI 10.1002/ijc.27972; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Quinn JA, 2009, J CLIN ONCOL, V27, P1262, DOI 10.1200/JCO.2008.18.8417; Quinn JA, 2009, CLIN CANCER RES, V15, P1064, DOI 10.1158/1078-0432.CCR-08-2130; Recinos VR, 2010, NEUROSURGERY, V66, P530, DOI 10.1227/01.NEU.0000365263.14725.39; Salnikova LE, 2010, ACTA NATURAE, V2, P58, DOI 10.32607/20758251-2010-2-4-58-65; Schafer A, 2012, NEURO-ONCOLOGY, V14, P1452, DOI 10.1093/neuonc/nos270; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Sreerama L, 1997, CLIN CANCER RES, V3, P1901; STRANGE RC, 1992, BIOCHIM BIOPHYS ACTA, V1139, P222, DOI 10.1016/0925-4439(92)90138-D; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Uchida Y, 2013, UROL ONCOL-SEMIN ORI, V31, P115, DOI 10.1016/j.urolonc.2010.09.017; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Vergote I, INT J GYNECOL CANC, V20, P772; Wahid M, 2013, ASIAN PAC J CANCER P, V14, P7187, DOI 10.7314/APJCP.2013.14.12.7187; Wrensch M, 2004, CANCER EPIDEM BIOMAR, V13, P461	47	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143285	10.1371/journal.pone.0143285	http://dx.doi.org/10.1371/journal.pone.0143285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580399	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600107
J	Tripathi, KP; Evangelista, D; Zuccaro, A; Guarracino, MR				Tripathi, Kumar Parijat; Evangelista, Daniela; Zuccaro, Antonio; Guarracino, Mario Rosario			Transcriptator: An Automated Computational Pipeline to Annotate Assembled Reads and Identify Non Coding RNA	PLOS ONE			English	Article							NONCODING RNAS; PROTEIN FAMILIES	RNA-seq is a new tool to measure RNA transcript counts, using high-throughput sequencing at an extraordinary accuracy. It provides quantitative means to explore the transcriptome of an organism of interest. However, interpreting this extremely large data into biological knowledge is a problem, and biologist-friendly tools are lacking. In our lab, we developed Transcriptator, a web application based on a computational Python pipeline with a user-friendly Java interface. This pipeline uses the web services available for BLAST (Basis Local Search Alignment Tool), QuickGO and DAVID (Database for Annotation, Visualization and Integrated Discovery) tools. It offers a report on statistical analysis of functional and Gene Ontology (GO) annotation's enrichment. It helps users to identify enriched biological themes, particularly GO terms, pathways, domains, gene/proteins features and protein-protein interactions related informations. It clusters the transcripts based on functional annotations and generates a tabular report for functional and gene ontology annotations for each submitted transcript to the web server. The implementation of QuickGo web-services in our pipeline enable the users to carry out GO-Slim analysis, whereas the integration of PORTRAIT (Prediction of transcriptomic non coding RNA (ncRNA) by ab initio methods) helps to identify the non coding RNAs and their regulatory role in transcriptome. In summary, Transcriptator is a useful software for both NGS and array data. It helps the users to characterize the de-novo assembled reads, obtained from NGS experiments for non-referenced organisms, while it also performs the functional enrichment analysis of differentially expressed transcripts/genes for both RNA-seq and micro-array experiments. It generates easy to read tables and interactive charts for better understanding of the data. The pipeline is modular in nature, and provides an opportunity to add new plugins in the future. Web application is freely available at: http://www-labgtp.na.icar.cnr.it/Transcriptator	[Tripathi, Kumar Parijat; Evangelista, Daniela; Zuccaro, Antonio; Guarracino, Mario Rosario] Natl Res Council Italy CNR, High Performance Comp & Networking Inst ICAR, Lab Genom Transcript & Prote LAB GTP, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Calcolo e Reti ad Alte Prestazioni (ICAR-CNR)	Tripathi, KP (corresponding author), Natl Res Council Italy CNR, High Performance Comp & Networking Inst ICAR, Lab Genom Transcript & Prote LAB GTP, Via Pietro Castellino 111, Naples, Italy.	kumpar@na.icar.cnr.it	Guarracino, Mario Rosario/L-3815-2013	Guarracino, Mario Rosario/0000-0003-2870-8134; EVANGELISTA, DANIELA/0000-0001-6602-2382	INTEROMICS flagship project [PON02-00612-3461281, PON02-00619-3470457]; National Research University Higher School of Economics RSF grant [365 14-41-00039]	INTEROMICS flagship project; National Research University Higher School of Economics RSF grant	Mario R Guarracino received funding from INTEROMICS flagship project PON02-00612-3461281 and PON02-00619-3470457 and National Research University Higher School of Economics RSF grant 365 14-41-00039.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arrial RT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-239; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Cokelaer T, 2013, BIOINFORMATICS, V29, P3241, DOI 10.1093/bioinformatics/btt547; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Karntanut W, 2002, CHEMOSPHERE, V47, P1059, DOI 10.1016/S0045-6535(02)00050-4; Karntanut Wanchamai, 2007, Songklanakarin Journal of Science and Technology, V29, P869; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Liu JF, 2006, PLOS GENET, V2, P529, DOI 10.1371/journal.pgen.0020029; Martin VJ, 1997, BIOL BULL, V192, P345, DOI 10.2307/1542745; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nagaraj SH, 2007, NUCLEIC ACIDS RES, V35, pW143, DOI 10.1093/nar/gkm378; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Rosa A, 2013, INT J MOL SCI, V14, P14346, DOI 10.3390/ijms140714346; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Shimizu Kana, 2006, Journal of Bioinformatics and Computational Biology, V4, P649, DOI 10.1142/S0219720006002260; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toffano-Nioche C, 2013, METHODS, V63, P60, DOI 10.1016/j.ymeth.2013.06.003; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251; Wang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S16; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wenger Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-204; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wu SC, 2010, CELL RES, V20, P1109, DOI 10.1038/cr.2010.114	44	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140268	10.1371/journal.pone.0140268	http://dx.doi.org/10.1371/journal.pone.0140268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581084	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600005
J	Awais, M; Hayat, T; Irum, S; Saleem, S				Awais, Muhammad; Hayat, Tasawar; Irum, Sania; Saleem, Salman			Dual Solutions for Nonlinear Flow Using Lie Group Analysis	PLOS ONE			English	Article							STAGNATION POINT FLOW; MAXWELL FLUID; MHD; SLIP	The aim of this analysis is to investigate the existence of the dual solutions for magnetohy-drodynamic (MHD) flow of an upper-convected Maxwell (UCM) fluid over a porous shrinking wall. We have employed the Lie group analysis for the simplification of the nonlinear differential system and computed the absolute invariants explicitly. An efficient numerical technique namely the shooting method has been employed for the constructions of solutions. Dual solutions are computed for velocity profile of an upper-convected Maxwell (UCM) fluid flow. Plots reflecting the impact of dual solutions for the variations of Deborah number, Hartman number, wall mass transfer are presented and analyzed. Streamlines are also plotted for the wall mass transfer effects when suction and blowing situations are considered.	[Awais, Muhammad; Irum, Sania; Saleem, Salman] COMSATS Inst Informat Technol, Dept Math, Attock 43600, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan	COMSATS University Islamabad (CUI); Quaid I Azam University	Awais, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Attock 43600, Pakistan.	awais_mm@yahoo.com	Awais, Muhammad/AAZ-3455-2020; Awais, Muhammad/HCI-3725-2022; Saleem, Salman/AAR-1941-2020; Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/A-3853-2013	Saleem, Salman/0000-0001-6217-3626; 				Abbasbandy S, 2014, APPL MATH COMPUT, V242, P569, DOI 10.1016/j.amc.2014.04.102; Awad FG, 2010, APPL MATH MODEL, V34, P3509, DOI 10.1016/j.apm.2010.02.038; Awais M, 2014, COMPUT FLUIDS, V91, P21, DOI 10.1016/j.compfluid.2013.12.002; Ellahi R, 2015, J MAGN MAGN MATER, V393, P284, DOI 10.1016/j.jmmm.2015.05.071; Fetecau C, 2009, COMPUT MATH APPL, V57, P596, DOI 10.1016/j.camwa.2008.09.052; Hayat T, 2015, APPL MATH MECH-ENGL, V36, P61, DOI 10.1007/s10483-015-1895-9; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P3777, DOI 10.1016/j.ijheatmasstransfer.2011.03.003; Hayat T, 2011, INT J NUMER METH FL, V66, P875, DOI 10.1002/fld.2289; Hayat T, 2011, INT J HEAT MASS TRAN, V54, P854, DOI 10.1016/j.ijheatmasstransfer.2010.09.069; Jamil M, 2010, NONLINEAR ANAL-REAL, V11, P4302, DOI 10.1016/j.nonrwa.2010.05.016; Mukhopadhyay S., 2012, J EGYPT MATH SOC, V20, P229, DOI [10.1016/j.joems.2012.08.019, DOI 10.1016/J.JOEMS.2012.08.019]; Ramesh GK, 2014, AIN SHAMS ENG J, V5, P991, DOI 10.1016/j.asej.2014.04.003; Rashidi MM, 2014, INT J HEAT MASS TRAN, V70, P892, DOI 10.1016/j.ijheatmasstransfer.2013.11.058; Rashidi MM, 2012, ENG COMPUTATION, V29, P562, DOI 10.1108/02644401211246283; Sadeghy K, 2007, INT J ENG SCI, V45, P923, DOI 10.1016/j.ijengsci.2007.05.007; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V90, P51, DOI 10.1016/j.compfluid.2013.11.005; Wang SW, 2011, INT J HEAT FLUID FL, V32, P88, DOI 10.1016/j.ijheatfluidflow.2010.10.005; Yang D, 2010, COMPUT MATH APPL, V60, P2231, DOI 10.1016/j.camwa.2010.08.013; Zhao ML, 2014, APPL MATH MODEL, V38, P2345, DOI 10.1016/j.apm.2013.10.053; Zheng LC, 2011, COMPUT MATH APPL, V62, P1105, DOI 10.1016/j.camwa.2011.02.044; Zierep J, 2007, INT J ENG SCI, V45, P617, DOI 10.1016/j.ijengsci.2007.04.015	21	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142732	10.1371/journal.pone.0142732	http://dx.doi.org/10.1371/journal.pone.0142732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575996	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400016
J	Kober, SE; Gressenberger, B; Kurzmann, J; Neuper, C; Wood, G				Kober, Silvia Erika; Gressenberger, Bettina; Kurzmann, Juergen; Neuper, Christa; Wood, Guilherme			Voluntary Modulation of Hemodynamic Responses in Swallowing Related Motor Areas: A Near-Infrared Spectroscopy-Based Neurofeedback Study	PLOS ONE			English	Article							CEREBRAL CORTICAL REPRESENTATION; REAL-TIME FMRI; STROKE REHABILITATION; BRAIN ACTIVATION; IMAGERY; CORTEX; HUMANS; FEEDBACK; SIGNALS; TASKS	In the present study, we show for the first time that motor imagery of swallowing, which is defined as the mental imagination of a specific motor act without overt movements by muscular activity, can be successfully used as mental strategy in a neurofeedback training paradigm. Furthermore, we demonstrate its effects on cortical correlates of swallowing function. Therefore, N = 20 healthy young adults were trained to voluntarily increase their hemodynamic response in swallowing related brain areas as assessed with near-infrared spectroscopy (NIRS). During seven training sessions, participants received either feedback of concentration changes in oxygenated hemoglobin (oxy-Hb group, N = 10) or deoxygenated hemoglobin (deoxy-Hb group, N = 10) over the inferior frontal gyrus (IFG) during motor imagery of swallowing. Before and after the training, we assessed cortical activation patterns during motor execution and imagery of swallowing. The deoxy-Hb group was able to voluntarily increase deoxy-Hb over the IFG during imagery of swallowing. Furthermore, swallowing related cortical activation patterns were more pronounced during motor execution and imagery after the training compared to the pre-test, indicating cortical reorganization due to neurofeedback training. The oxy-Hb group could neither control oxy-Hb during neurofeedback training nor showed any cortical changes. Hence, successful modulation of deoxy-Hb over swallowing related brain areas led to cortical reorganization and might be useful for future treatments of swallowing dysfunction.	[Kober, Silvia Erika; Gressenberger, Bettina; Kurzmann, Juergen; Neuper, Christa; Wood, Guilherme] Graz Univ, Dept Psychol, Graz, Austria; [Kober, Silvia Erika; Neuper, Christa; Wood, Guilherme] BioTechMed Graz, Graz, Austria; [Neuper, Christa] Graz Univ Technol, Lab Brain Comp Interfaces, Inst Knowledge Discovery, A-8010 Graz, Austria	University of Graz; Graz University of Technology	Kober, SE (corresponding author), Graz Univ, Dept Psychol, Graz, Austria.	silvia.kober@uni-graz.at		Maia de Oliveira Wood, Guilherme/0000-0001-5055-5336	European STREP Program [FP7-287320]	European STREP Program	This work was supported by the European STREP Program - Collaborative Project no. FP7-287320 - CONTRAST. Possible inaccuracies of information are under the responsibility of the project team. The text reflects solely the views of its authors. The European Commission is not liable for any use that may be made of the information contained therein. This paper was published with the support of the University of Graz, Austria.	Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Braun SM, 2006, ARCH PHYS MED REHAB, V87, P842, DOI 10.1016/j.apmr.2006.02.034; Bray S, 2007, J NEUROSCI, V27, P7498, DOI 10.1523/JNEUROSCI.2118-07.2007; Burianova H, 2013, NEUROIMAGE, V71, P50, DOI 10.1016/j.neuroimage.2013.01.001; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Daniels SK, 1997, DYSPHAGIA, V12, P146, DOI 10.1007/PL00009529; DeCharms RC, 2004, NEUROIMAGE, V21, P436, DOI 10.1016/j.neuroimage.2003.08.041; Ertekin C, 2003, CLIN NEUROPHYSIOL, V114, P2226, DOI 10.1016/S1388-2457(03)00237-2; Ertekin C, 2011, DYSPHAGIA, V26, P183, DOI 10.1007/s00455-010-9319-8; Faralli A, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/854597; Furlong PL, 2004, NEUROIMAGE, V22, P1447, DOI 10.1016/j.neuroimage.2004.02.041; Garrison KA, 2010, NEUROREHAB NEURAL RE, V24, P404, DOI 10.1177/1545968309354536; Gentili RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00277; Guillot A, 2009, HUM BRAIN MAPP, V30, P2157, DOI 10.1002/hbm.20658; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hamdy S, 1999, J NEUROPHYSIOL, V81, P1917, DOI 10.1152/jn.1999.81.4.1917; Hamdy S, 1999, AM J PHYSIOL-GASTR L, V277, pG219, DOI 10.1152/ajpgi.1999.277.1.G219; Hamdy S, 2000, CLIN SCI, V99, P151, DOI 10.1042/CS19990300; Hamdy S, 1996, NAT MED, V2, P1217, DOI 10.1038/nm1196-1217; Hartnick C., 2001, LARYNGOSCOPE, V111; Hoshi Y, 1997, NEUROIMAGE, V5, P292, DOI 10.1006/nimg.1997.0270; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Humbert IA, 2007, DYSPHAGIA, V22, P266, DOI 10.1007/s00455-007-9080-9; Jadcherla SR, 2014, AM J PHYSIOL-GASTR L, V307, pG41, DOI 10.1152/ajpgi.00350.2013; Kern MK, 2001, AM J PHYSIOL-GASTR L, V280, pG354, DOI 10.1152/ajpgi.2001.280.3.G354; Khedr EM., 2013, NEUROENTEROLOGY, V2, P1, DOI [10.4303/ne/235663, DOI 10.4303/NE/235663]; Kobayakawa T, 1996, NEUROSCI LETT, V212, P155, DOI 10.1016/0304-3940(96)12798-1; Kober SE, 2014, NEUROIMAGE, V93, P1, DOI 10.1016/j.neuroimage.2014.02.019; Kober SE, 2014, BIOL PSYCHOL, V95, P21, DOI 10.1016/j.biopsycho.2013.05.005; Kober SE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00151; Kropotov JD, 2009, QUANTITATIVE EEG, EVENT-RELATED POTENTIALS AND NEUROTHERAPY, P1; Laffont I., 2014, Annals of Physical and Rehabilitation Medicine, V57, P543, DOI 10.1016/j.rehab.2014.08.007; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lowell SY, 2012, EXP BRAIN RES, V219, P85, DOI 10.1007/s00221-012-3069-9; Luan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073577; Malandraki GA, 2009, HUM BRAIN MAPP, V30, P3209, DOI 10.1002/hbm.20743; Martin RE, 2001, J NEUROPHYSIOL, V85, P938, DOI 10.1152/jn.2001.85.2.938; Martin R, 2007, EXP BRAIN RES, V176, P12, DOI 10.1007/s00221-006-0592-6; Matthews F, 2008, IEEE SIGNAL PROC MAG, V25, P87, DOI 10.1109/MSP.2008.4408445; Mihara M, 2013, STROKE, V44, P1091, DOI 10.1161/STROKEAHA.111.674507; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032234; Mihara Masahito, 2011, Rinsho Shinkeigaku, V51, P924; Miller AJ., 1986, DYSPHAGIA, V1, P91, DOI [DOI 10.1007/BF02407121, 10.1007/BF02407121]; Mosier K, 2001, EXP BRAIN RES, V140, P280, DOI 10.1007/s002210100813; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Nolte C, 1998, ADV EXP MED BIOL, V454, P115; PENFIELD W, 1955, BRAIN, V78, P445, DOI 10.1093/brain/78.4.445; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Sato H, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3565048; Satow T, 2004, AM J PHYSIOL-GASTR L, V287, pG459, DOI 10.1152/ajpgi.00323.2003; Schoenfeld MA, 2004, NEUROSCIENCE, V127, P347, DOI 10.1016/j.neuroscience.2004.05.024; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; Soros P, 2009, HUM BRAIN MAPP, V30, P2426, DOI 10.1002/hbm.20680; Suntrup S, 2013, NEUROIMAGE, V83, P346, DOI 10.1016/j.neuroimage.2013.06.055; Suzuki M, 2003, DYSPHAGIA, V18, P71, DOI 10.1007/s00455-002-0088-x; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Talairach J., 1988, COPLANAR STEREOTAXIC; Teismann IK, 2010, NEUROBIOL AGING, V31, P1044, DOI 10.1016/j.neurobiolaging.2008.07.001; Teo WP, 2014, PM&R, V6, P723, DOI 10.1016/j.pmrj.2014.01.006; Terzi N., 2011, EMG METHODS EVALUATI; Terzi N, 2007, AM J RESP CRIT CARE, V175, P269, DOI 10.1164/rccm.200608-1067OC; Toogood JA, 2005, EXP BRAIN RES, V161, P81, DOI 10.1007/s00221-004-2048-1; Uludag K, 2004, NEUROIMAGE, V22, P583, DOI 10.1016/j.neuroimage.2004.02.023; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009; Wilkins T, 2007, J AM BOARD FAM MED, V20, P144, DOI 10.3122/jabfm.2007.02.060045; Wriessnegger SC, 2008, INT J PSYCHOPHYSIOL, V67, P54, DOI 10.1016/j.ijpsycho.2007.10.004; Wu MC, 2004, DYSPHAGIA, V19, P43, DOI 10.1007/s00455-003-0030-x; Yang H., 2012, WCCI 2012 IEEE WORLD, P1710; Yoo SS, 2008, INT J IMAG SYST TECH, V18, P69, DOI 10.1002/ima.20139; Zich C, 2015, NEUROIMAGE, V114, P438, DOI 10.1016/j.neuroimage.2015.04.020; Zimmermann-Schlatter A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-8	75	14	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143314	10.1371/journal.pone.0143314	http://dx.doi.org/10.1371/journal.pone.0143314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575032	Green Submitted, Green Published, gold			2022-12-26	WOS:000365153400059
J	Amano, R; Nakayama, H; Morohoshi, Y; Kawakatsu, Y; Ferjani, A; Kimura, S				Amano, Rumi; Nakayama, Hokuto; Morohoshi, Yurika; Kawakatsu, Yaichi; Ferjani, Ali; Kimura, Seisuke			A Decrease in Ambient Temperature Induces Post-Mitotic Enlargement of Palisade Cells in North American Lake Cress	PLOS ONE			English	Article							DEVELOPING LEAVES; LEAF DEVELOPMENT; EXPANSION; GROWTH; COMPENSATION; KEY; PROLIFERATION; MORPHOLOGY; MUTATION; MUTANTS	In order to maintain organs and structures at their appropriate sizes, multicellular organisms orchestrate cell proliferation and post-mitotic cell expansion during morphogenesis. Recent studies using Arabidopsis leaves have shown that compensation, which is defined as post-mitotic cell expansion induced by a decrease in the number of cells during lateral organ development, is one example of such orchestration. Some of the basic molecular mechanisms underlying compensation have been revealed by genetic and chimeric analyses. However, to date, compensation had been observed only in mutants, transgenics, and gamma-ray-treated plants, and it was unclear whether it occurs in plants under natural conditions. Here, we illustrate that a shift in ambient temperature could induce compensation in Rorippa aquatica (Brassicaceae), a semi-aquatic plant found in North America. The results suggest that compensation is a universal phenomenon among angiosperms and that the mechanism underlying compensation is shared, in part, between Arabidopsis and R. aquatica.	[Amano, Rumi; Nakayama, Hokuto; Kawakatsu, Yaichi; Kimura, Seisuke] Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Kyoto 603, Japan; [Nakayama, Hokuto] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Morohoshi, Yurika; Ferjani, Ali] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 184, Japan	Kyoto Sangyo University; University of California System; University of California Davis; Tokyo Gakugei University	Kimura, S (corresponding author), Kyoto Sangyo Univ, Dept Bioresource & Environm Sci, Kyoto 603, Japan.	seisuke@cc.kyoto-su.ac.jp		Amano, Rumi/0000-0002-3607-2829; Kawakatsu, Yaichi/0000-0001-8470-706X; Kimura, Seisuke/0000-0002-6796-3675	MEXT; Japan Society for the Promotion of Science (JSPS) [22870031, 24770047]; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan; JSPS	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by Grants-in-Aid from MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2015-2019), the Japan Society for the Promotion of Science (JSPS; http://www.jsps.go.jp/english/e-grants/index.html) (KAKENHI Grant Numbers 22870031 and 24770047), The Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (http://www.shigaku.go.jp/g_about_pmac.htm) to S.K., by a Research Fellowship from JSPS to H.N., MEXT Grant-in-Aid for Young Scientists (B) and Grant-in-Aid for Scientific Research on Innovative Areas to A.F.	Barroco RM, 2006, PLANT PHYSIOL, V142, P1053, DOI 10.1104/pp.106.087056; Beemster GTS, 2003, TRENDS PLANT SCI, V8, P154, DOI 10.1016/S1360-1385(03)00046-3; Bell A. D., 2008, PLANT FORM ILLUSTRAT; Breuninger H, 2010, CURR TOP DEV BIOL, V91, P185, DOI 10.1016/S0070-2153(10)91007-7; Delgado-Benarroch L, 2009, J PLANT RES, V122, P559, DOI 10.1007/s10265-009-0236-6; Delgado-Benarroch L, 2009, PLANTA, V229, P1219, DOI 10.1007/s00425-009-0910-x; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Fassett N. C., 1930, MANUAL AQUATIC PLANT; Ferjani A, 2007, PLANT PHYSIOL, V144, P988, DOI [10.1104/pp.107.099325, 10.1104/PP.107.099325]; Ferjani A, 2011, PLANT CELL, V23, P2895, DOI 10.1105/tpc.111.085415; Fujikura U, 2009, PLANT J, V59, P499, DOI 10.1111/j.1365-313X.2009.03886.x; HABER AH, 1962, AM J BOT, V49, P583, DOI 10.2307/2439715; Hisanaga T, 2015, J EXP BOT, V66, P1055, DOI 10.1093/jxb/erv028; Hisanaga T, 2013, PLANT PHYSIOL, V162, P831, DOI 10.1104/pp.113.216796; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Horiguchi Gorou, 2011, Front Plant Sci, V2, P24, DOI 10.3389/fpls.2011.00024; Ichihashi Y, 2011, PLANT PHYSIOL, V157, P1151, DOI 10.1104/pp.111.185066; Kawade K, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-143; Kazama T, 2010, PLANT CELL PHYSIOL, V51, P1046, DOI 10.1093/pcp/pcq051; Kimura S, 2008, CURR BIOL, V18, P672, DOI 10.1016/j.cub.2008.04.008; La Rue C., 1943, MICH ACAD, V28, P51; Nakayama H, 2012, PLANT MORPHOL, V24, P57, DOI DOI 10.5685/PLMORPHOL.24.57; Nakayama H, 2014, PLANT CELL, V26, P4733, DOI 10.1105/tpc.114.130229; Piazza P, 2010, CURR BIOL, V20, P2223, DOI 10.1016/j.cub.2010.11.037; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsuge T, 1996, DEVELOPMENT, V122, P1589; Tsukaya H, 2002, INT REV CYTOL, V217, P1; Tsukaya H, 2014, CURR OPIN PLANT BIOL, V17, P103, DOI 10.1016/j.pbi.2013.11.012; Vlad D, 2014, SCIENCE, V343, P780, DOI 10.1126/science.1248384	30	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0141247	10.1371/journal.pone.0141247	http://dx.doi.org/10.1371/journal.pone.0141247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569502	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700005
J	Gao, CY; Xie, R; Yu, CY; Ma, RS; Dong, WJ; Meng, H; Zhang, Y; Si, Y; Zhang, Z; Novakovic, V; Zhang, Y; Kou, JJ; Bi, YY; Li, BX; Xie, RJ; Gilbert, GE; Zhou, J; Shi, JL				Gao, Chunyan; Xie, Rui; Yu, Chengyuan; Ma, Ruishuang; Dong, Weijun; Meng, Huan; Zhang, Yan; Si, Yu; Zhang, Zhuo; Novakovic, Valerie; Zhang, Yong; Kou, Junjie; Bi, Yayan; Li, Baoxin; Xie, Rujuan; Gilbert, Gary E.; Zhou, Jin; Shi, Jialan			Thrombotic Role of Blood and Endothelial Cells in Uremia through Phosphatidylserine Exposure and Microparticle Release	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; CIRCULATING MICROPARTICLES; RISK; APOPTOSIS; MEMBRANES; PROLIFERATION; EPIDEMIOLOGY; HEMODIALYSIS; COAGULATION	The mechanisms contributing to an increased risk of thrombosis in uremia are complex and require clarification. There is scant morphological evidence of membrane-dependent binding of factor Xa (FXa) and factor Va (FVa) on endothelial cells (EC) in vitro. Our objectives were to confirm that exposed phosphatidylserine (PS) on microparticle (MP), EC, and peripheral blood cell (PBC) has a prothrombotic role in uremic patients and to provide visible and morphological evidence of PS-dependent prothrombinase assembly in vitro. We found that uremic patients had more circulating MP (derived from PBC and EC) than controls. Additionally, patients had more exposed PS on their MPs and PBCs, especially in the hemodialysis group. In vitro, EC exposed more PS in uremic toxins or serum. Moreover, reconstitution experiments showed that at the early stages, PS exposure was partially reversible. Using confocal microscopy, we observed that PS-rich membranes of EC and MP provided binding sites for FVa and FXa. Further, exposure of PS in uremia resulted in increased generation of FXa, thrombin, and fibrin and significantly shortened coagulation time. Lactadherin, a protein that blocks PS, reduced 80% of procoagulant activity on PBC, EC, and MP. Our results suggest that PBC and EC in uremic milieu are easily injured or activated, which exposes PS and causes a release of MP, providing abundant procoagulant membrane surfaces and thus facilitating thrombus formation. Blocking PS binding sites could become a new therapeutic target for preventing thrombosis.	[Gao, Chunyan; Shi, Jialan] Harbin Med Univ, Hosp 1, Dept Hematol, Harbin, Peoples R China; [Gao, Chunyan; Ma, Ruishuang; Zhang, Yan; Si, Yu; Zhang, Zhuo; Zhou, Jin] Harbin Med Univ Daqing, Dept Med Lab Sci & Technol, Daqing, Peoples R China; [Xie, Rui; Xie, Rujuan] Harbin Med Univ, Hosp 3, Dept Gastrointestinal Oncol, Harbin, Peoples R China; [Yu, Chengyuan] Harbin Med Univ, Hosp 1, Dept Nephrol, Harbin, Peoples R China; [Dong, Weijun] Harbin Med Univ, Hosp 5, Dept Gen Surg, Harbin, Peoples R China; [Meng, Huan; Kou, Junjie; Bi, Yayan] Harbin Med Univ, Hosp 2, Dept Cardiol, Harbin, Peoples R China; [Zhang, Yong; Li, Baoxin] Harbin Med Univ, Dept Pharmacol, Harbin, Peoples R China; [Novakovic, Valerie; Gilbert, Gary E.; Shi, Jialan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Med Dept,VA Boston Healthcare Syst, Boston, MA 02115 USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Xie, RJ (corresponding author), Harbin Med Univ, Hosp 3, Dept Gastrointestinal Oncol, Harbin, Peoples R China.	hydwkyuliang@yahoo.com.cn; jinzhouh85@163.com; jialan_shi@hms.harvard.edu		Shi, Jialan/0000-0001-5642-5436	National Natural Science Foundation of China [81470301, 81400097, 81270588]; National Natural Science Foundation of Heilongjiang Province [H2015109]; Heilongjiang Postdoctoral Science Foundation [LBH-Z13153]; China Postdoctoral Science Foundation [2014M550202]; Seed Fund of Harbin Medical University-Daqing [DQ2013-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Heilongjiang Postdoctoral Science Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Seed Fund of Harbin Medical University-Daqing	The study design, data collection, and analysis were supported by grants from the National Natural Science Foundation of China (81470301, 81400097, 81270588). The decision to publish and preparation of the manuscript were surpported by the National Natural Science Foundation of Heilongjiang Province (H2015109), Project Funded by Heilongjiang Postdoctoral Science Foundation (LBH-Z13153), Project Funded by China Postdoctoral Science Foundation (2014M550202), and Seed Fund of Harbin Medical University-Daqing (DQ2013-05).	Al-Dorzi HM, 2013, THROMB RES, V132, P671, DOI 10.1016/j.thromres.2013.09.036; Amabile N, 2012, NEPHROL DIAL TRANSPL, V27, P1873, DOI 10.1093/ndt/gfr573; Atkinson BT, 2010, BLOOD, V116, P4675, DOI 10.1182/blood-2010-05-283986; Bonomini M, 2004, J THROMB HAEMOST, V2, P1275, DOI 10.1111/j.1538-7836.2004.00837.x; Bonomini M, 1999, J AM SOC NEPHROL, V10, P1982; Capodanno D, 2012, CIRCULATION, V125, P2649, DOI 10.1161/CIRCULATIONAHA.111.084996; Carracedo J, 1995, J AM SOC NEPHROL, V6, P1586; Carracedo J, 2013, EXP GERONTOL, V48, P766, DOI 10.1016/j.exger.2013.04.004; Cendoroglo M, 1999, J AM SOC NEPHROL, V10, P93; Chitalia VC, 2013, CIRCULATION, V127, P365, DOI 10.1161/CIRCULATIONAHA.112.118174; Daniel L, 2006, KIDNEY INT, V69, P1416, DOI 10.1038/sj.ki.5000306; Daniel L, 2008, NEPHROL DIAL TRANSPL, V23, P2129, DOI 10.1093/ndt/gfn029; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gao CY, 2013, THROMB HAEMOSTASIS, V109, P1079, DOI 10.1160/TH12-12-0894; Hiramoto JS, 2012, AM J KIDNEY DIS, V60, P225, DOI 10.1053/j.ajkd.2012.02.335; Hou J, 2011, VOX SANG, V100, P187, DOI 10.1111/j.1423-0410.2010.01375.x; Hvarregaard J, 1996, EUR J BIOCHEM, V240, P628, DOI 10.1111/j.1432-1033.1996.0628h.x; Lutz J, 2014, NEPHROL DIAL TRANSPL, V29, P29, DOI 10.1093/ndt/gft209; Ocak G, 2014, CIRCULATION, V129, P683, DOI 10.1161/CIRCULATIONAHA.113.002385; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Pavord S, 2011, BLOOD REV, V25, P271, DOI 10.1016/j.blre.2011.07.001; Ple H, 2012, THROMB HAEMOSTASIS, V108, P605, DOI 10.1160/TH12-03-0153; Serradell M, 2003, NEPHROL DIAL TRANSPL, V18, P1079, DOI 10.1093/ndt/gfg161; Shantsila E, 2014, THROMB HAEMOSTASIS, V111, P1009, DOI 10.1160/TH13-11-0937; Shashar M, 2014, SEMIN DIAL; Shi J, 2008, J THROMB HAEMOST, V6, P1167, DOI 10.1111/j.1538-7836.2008.03010.x; Shi J, 2006, CYTOM PART A, V69A, P1193, DOI 10.1002/cyto.a.20345; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Whitman IR, 2012, J AM SOC NEPHROL, V23, P1929, DOI 10.1681/ASN.2012010037; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	36	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142835	10.1371/journal.pone.0142835	http://dx.doi.org/10.1371/journal.pone.0142835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26580207	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700081
J	Yang, CF; Yang, GD; Huang, TJ; Li, R; Chu, QQ; Xu, L; Wang, MS; Cai, MD; Zhong, L; Wei, HJ; Huang, HB; Huang, JL; Qian, CN; Huang, BJ				Yang, C-F; Yang, G-D; Huang, T-J; Li, R.; Chu, Q-Q; Xu, L.; Wang, M-S; Cai, M-D; Zhong, L.; Wei, H-J; Huang, H-B; Huang, J-L; Qian, C-N; Huang, B-J			EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop	ONCOGENE			English	Article							EPSTEIN-BARR-VIRUS; TUMOR-SUPPRESSOR GENE; NF-KAPPA-B; CANCER CELLS; MICRORNA-21; EXPRESSION; IDENTIFICATION; PTEN; MEMBRANE-PROTEIN-1; HEAD	Our previous study reported that Epstein-Barr virus(EBV)-encoded latent membrane protein 1 (LMP1) could induce development of CD44(+/High) stem-like cells in nasopharyngeal carcinoma (NPC). However, the molecular mechanisms that underlie modulation of cancer stem cells (CSCs) in NPC remain unclear. Here, we show that LMP1 induced CSC-like properties through promotion of the expression of epithelial-mesenchymal transition-like cellular markers and through alterations in differentiation markers. Furthermore, LMP1 activated and triggered phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway, which subsequently stimulated expression of CSC markers, development of side population and tumor sphere formation. This suggests that PI3K/AKT pathway has an important role in the induction and maintenance of CSC properties in NPC. Similarly, PI3K/AKT pathway was also activated by phosphorylase in LMP1-induced CD44(+/High) cells. In addition, LMP1 greatly increased expression of miR-21 and downregulated expression of the miR-21 target, PTEN. Overexpression of miR-21 by transfection of miR-21 mimics into LMP1-transformed cells led to phosphorylase-mediated activation of the PI3K/AKT pathway and induction of CSCs. On the contrary, phosphorylation of the PI3K/AKT pathway and the expression of CSC were reversed by an miR-21 inhibitor. The specific inhibitor (Ly294002) of PI3K/AKT pathway significantly decreased expression of miR-21 and CSC markers and upregulated the expression of PTEN, which indicates that miR-21 and PTEN are the downstream effectors of PI3K/AKT and that expression of these two effectors are related to the development of NPC CSCs. Taken together, our novel findings indicate that LMP1, PI3K/AKT, miR-21 and PTEN constitute a positive feedback loop and have a key role in LMP1-induced CSCs in NPC.	[Yang, C-F; Xu, L.; Qian, C-N; Huang, B-J] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Expt Res,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Yang, C-F; Wang, M-S; Cai, M-D; Zhong, L.; Wei, H-J] Gaozhou Peoples Hosp, Dept Canc Chemotherapy, Gaozhou, Peoples R China; [Yang, G-D] Sun Yat Sen Univ, BoJi Affiliated Hosp, Zengcheng Peoples Hosp, Dept Canc Chemotherapy, Zengcheng, Peoples R China; [Huang, T-J] Second Peoples Hosp Shenzhen, Dept Nucl Med, Shenzhen, Peoples R China; [Li, R.] Soothern Med Univ, Coll Clin Med 2, Guangzhou, Guangdong, Peoples R China; [Chu, Q-Q] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Huang, H-B] Sun Yat Sen Univ, Ctr Canc, Dept Pharm, Guangzhou, Guangdong, Peoples R China; [Huang, J-L] St Barnabas Hosp, Dept Pathol, Livingston, NJ USA; [Qian, C-N] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Second People's Hospital of Shenzhen; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qian, CN; Huang, BJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Dept Expt Res, 651 Dongfeng East Rd, Guangzhou 510060, Guangdong, Peoples R China.	qianchn@sysucc.org.cn; huangbj@sysucc.org.cn	Huang, Bi-Jun/GSD-2430-2022; Huang, Huang/AAN-5671-2020		National Natural Science Foundation of China [81572901, 31170151, 81272340, 30770108, 81030043]; Science and Technology Planning Project of Guangdong Province, China [2014B020212017, 2014A020209024, 2009A030331005]; Guangzhou Key Program of Science and Technology [2012Y2-00026]; Shenzhen Basic Research Program of Science and Technology RD [JC201105170709A, JCYJ20150330102720115]; Guangdong Natural Science Foundation [2014A030310029]; National High Technology Research and Development Program of China (863 Program) [2012AA02A501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Guangzhou Key Program of Science and Technology; Shenzhen Basic Research Program of Science and Technology RD; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (grant no. 81572901, 31170151, 81272340, 30770108 and 81030043), the Science and Technology Planning Project of Guangdong Province, China (grant no. 2014B020212017, 2014A020209024 and 2009A030331005), the Guangzhou Key Program of Science and Technology (grant no. 2012Y2-00026), the Shenzhen Basic Research Program of Science and Technology R&D (grant no. JC201105170709A and JCYJ20150330102720115), the Guangdong Natural Science Foundation (grant no. 2014A030310029) and the National High Technology Research and Development Program of China (863 Program; No. 2012AA02A501).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Asuthkar S, 2012, ONCOTARGET, V3, P1439; Bao B, 2012, BBA-REV CANCER, V1826, P272, DOI 10.1016/j.bbcan.2012.04.008; Bao LL, 2013, CANCER LETT, V337, P226, DOI 10.1016/j.canlet.2013.05.007; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Chen CC, 2010, CELL SIGNAL, V22, P1132, DOI 10.1016/j.cellsig.2010.03.008; Chen Jiezhong, 2012, World J Virol, V1, P154, DOI 10.5501/wjv.v1.i6.154; Chen YR, 2008, J VIROL, V82, P8124, DOI 10.1128/JVI.00430-08; Chew MMS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-574; Chung WM, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt247; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Han M, 2012, CANCER SCI, V4, P1058; Hannigan A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-184; Kondo S, 2011, J VIROL, V85, P11255, DOI 10.1128/JVI.00188-11; Kutz H, 2008, VIROLOGY, V371, P246, DOI 10.1016/j.virol.2007.09.044; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Lavorgna A, 2012, P NATL ACAD SCI USA, V109, P2188, DOI 10.1073/pnas.1121357109; Lee JW, 2009, CANCER LETT, V279, P193, DOI 10.1016/j.canlet.2009.01.037; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Qian CN, 2009, CANCER RES, V69, P8256, DOI 10.1158/0008-5472.CAN-09-1689; Sayed D, 2010, J BIOL CHEM, V285, P20281, DOI 10.1074/jbc.M110.109207; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Singh SK, 2003, CANCER RES, V63, P5821; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yamamoto C, 2010, CANCER RES, V70, P8715, DOI 10.1158/0008-5472.CAN-10-0043; Yang CF, 2014, CANCER LETT, V344, P260, DOI 10.1016/j.canlet.2013.11.006; Yang GW, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/507828; Yang SM, 2013, TOXICOLOGY, V306, P162, DOI 10.1016/j.tox.2013.02.014; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu XS, 2013, CANCER IMMUNOL IMMUN, V62, P689, DOI 10.1007/s00262-012-1367-5	51	43	45	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 30	2016	35	26					3419	3431		10.1038/onc.2015.402	http://dx.doi.org/10.1038/onc.2015.402			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DQ5UI	26568302				2022-12-26	WOS:000379270100007
J	Abe, T; Hashimoto, Y; Zhuang, Y; Ge, Y; Kumano, T; Kobayashi, M				Abe, Tomoko; Hashimoto, Yoshiteru; Zhuang, Ye; Ge, Yin; Kumano, Takuto; Kobayashi, Michihiko			Peptide Bond Synthesis by a Mechanism Involving an Enzymatic Reaction and a Subsequent Chemical Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL-COA SYNTHETASE; ALANYL CARRIER PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COENZYME-A; LIGATION; BIOSYNTHESIS; ACID; LIGASE; PHENYLALANINE	We recently reported that an amide bond is unexpectedly formed by an acyl-CoA synthetase (which catalyzes the formation of a carbon-sulfur bond) when a suitable acid and L-cysteine are used as substrates. DltA, which is homologous to the adenylation domain of nonribosomal peptide synthetase, belongs to the same superfamily of adenylate-forming enzymes, which includes many kinds of enzymes, including the acyl-CoA synthetases. Here, we demonstrate that DltA synthesizes not only N-(D-alanyl)-L-cysteine (a dipeptide) but also various oligopeptides. We propose that this enzyme catalyzes peptide synthesis by the following unprecedented mechanism: (i) the formation of S-acyl-L-cysteine as an intermediate via its "enzymatic activity" and (ii) subsequent "chemical" S -> N acyl transfer in the intermediate, resulting in peptide formation. Step ii is identical to the corresponding reaction in native chemical ligation, a method of chemical peptide synthesis, whereas step i is not. To the best of our knowledge, our discovery of this peptide synthesis mechanism involving an enzymatic reaction and a subsequent chemical reaction is the first such one to be reported. This new process yields peptides without the use of a thioesterified fragment, which is required in native chemical ligation. Together with these findings, the same mechanism-dependent formation of N-acyl compounds by other members of the above-mentioned superfamily demonstrated that all members most likely form peptide/amide compounds by using this novel mechanism. Each member enzyme acts on a specific substrate; thus, not only the corresponding peptides but also new types of amide compounds can be formed.	[Abe, Tomoko; Hashimoto, Yoshiteru; Zhuang, Ye; Ge, Yin; Kumano, Takuto; Kobayashi, Michihiko] Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Abe, Tomoko; Hashimoto, Yoshiteru; Zhuang, Ye; Ge, Yin; Kumano, Takuto; Kobayashi, Michihiko] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Abe, Tomoko] Tokyo Denki Univ, Sch Sci & Engn, Div Life Sci & Engn, Hatoyama, Saitama 3500394, Japan	University of Tsukuba; University of Tsukuba; Tokyo Denki University	Kobayashi, M (corresponding author), Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.; Kobayashi, M (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	kobay@agbi.tsukuba.ac.jp	Kumano, Takuto/ABC-3242-2020	Kumano, Takuto/0000-0002-9240-4074	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2008, J BIOL CHEM, V283, P11312, DOI 10.1074/jbc.M709654200; Bennett CS, 2007, CHEM SOC REV, V36, P1227, DOI 10.1039/b617709c; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Crich D, 2007, J AM CHEM SOC, V129, P10064, DOI 10.1021/ja072804l; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hackenberger CPR, 2008, ANGEW CHEM INT EDIT, V47, P10030, DOI 10.1002/anie.200801313; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; Ingenito R, 1999, J AM CHEM SOC, V121, P11369, DOI 10.1021/ja992668n; Katano H, 2012, ANAL BIOCHEM, V421, P308, DOI 10.1016/j.ab.2011.10.031; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Kimura Y, 2004, ANAL BIOCHEM, V326, P262, DOI 10.1016/j.ab.2003.12.012; Kiriukhin MY, 2001, J BACTERIOL, V183, P2051, DOI 10.1128/JB.183.6.2051-2058.2001; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Lazos O, 2010, CHEM BIOL, V17, P160, DOI 10.1016/j.chembiol.2010.01.011; Lee S G, 1975, Methods Enzymol, V43, P585; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Maruyama C, 2012, NAT CHEM BIOL, V8, P791, DOI [10.1038/NCHEMBIO.1040, 10.1038/nchembio.1040]; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; Mende F, 2011, ANGEW CHEM INT EDIT, V50, P1232, DOI 10.1002/anie.201005180; Morgan-Kiss RM, 2004, J BIOL CHEM, V279, P37324, DOI 10.1074/jbc.M405233200; MORIHARA K, 1987, TRENDS BIOTECHNOL, V5, P164, DOI 10.1016/0167-7799(87)90090-4; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Osman KT, 2009, J MOL BIOL, V388, P345, DOI 10.1016/j.jmb.2009.03.040; Schneider K, 2003, P NATL ACAD SCI USA, V100, P8601, DOI 10.1073/pnas.1430550100; Sewing A, 2001, ANGEW CHEM INT EDIT, V40, P3395, DOI 10.1002/1521-3773(20010917)40:18<3395::AID-ANIE3395>3.0.CO;2-G; Shang SY, 2011, P NATL ACAD SCI USA, V108, P5986, DOI 10.1073/pnas.1103118108; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Usuki H, 2011, ORG BIOMOL CHEM, V9, P2327, DOI 10.1039/c0ob00403k; Yokozeki K, 2005, J BIOTECHNOL, V115, P211, DOI 10.1016/j.jbiotec.2004.07.017; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	43	12	12	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1735	1750		10.1074/jbc.M115.700989	http://dx.doi.org/10.1074/jbc.M115.700989			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26586916	Green Published, hybrid			2022-12-26	WOS:000368620700016
J	Garcia, P; del Dedo, JE; Ayte, J; Hidalgo, E				Garcia, Patricia; Encinar del Dedo, Javier; Ayte, Jose; Hidalgo, Elena			Genome-wide Screening of Regulators of Catalase Expression ROLE OF A TRANSCRIPTION COMPLEX AND HISTONE AND tRNA MODIFICATION COMPLEXES ON ADAPTATION TO STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAF1 COMPLEX; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; STRESS RESPONSES; TRANSLATION; METHYLATION; PAP1; ELONGATION; ANTIOXIDANT; ACTIVATION	In response to environmental cues, the mitogen-activated protein kinase Sty1-driven signaling cascade activates hundreds of genes to induce a robust anti-stress cellular response in fission yeast. Thus, upon stress imposition Sty1 transiently accumulates in the nucleus where it up-regulates transcription through the Atf1 transcription factor. Several regulators of transcription and translation have been identified as important to mount an integral response to oxidative stress, such as the Spt-Ada-Gcn5-acetyl transferase or Elongator complexes, respectively. With the aim of identifying new regulators of this massive gene expression program, we have used a GFP-based protein reporter and screened a fission yeast deletion collection using flow cytometry. We find that the levels of catalase fused to GFP, both before and after a threat of peroxides, are altered in hundreds of strains lacking components of chromatin modifiers, transcription complexes, and modulators of translation. Thus, the transcription elongation complex Paf1, the histone methylase Set1-COMPASS, and the translation-related Trm112 dimers are all involved in full expression of Ctt1-GFP and in wild-type tolerance to peroxides.	[Garcia, Patricia; Encinar del Dedo, Javier; Ayte, Jose; Hidalgo, Elena] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona 08003, Spain	Pompeu Fabra University	Ayte, J (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, C Dr Aiguader 88, Barcelona 08003, Spain.	jose.ayte@upf.edu; elena.hidalgo@upf.edu	Garcia, Patricia/O-7561-2014; DEL DEDO, JAVIER ENCINAR/T-3837-2019; Hidalgo, Elena/K-2919-2014; ENCINAR DEL DEDO, JAVIER/L-5222-2014	Garcia, Patricia/0000-0001-7513-1847; DEL DEDO, JAVIER ENCINAR/0000-0001-6876-9957; Hidalgo, Elena/0000-0002-3768-6785; ENCINAR DEL DEDO, JAVIER/0000-0001-6876-9957	Spanish Ministry of Science and Innovation [BFU2012-32045, BFU2012-31939]; Generalitat de Catalunya (Spain) [2014-SGR-154]; ICREA Academia Award (Generalitat de Catalunya, Spain)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); ICREA Academia Award (Generalitat de Catalunya, Spain)(ICREA)	This work was supported by the Spanish Ministry of Science and Innovation (BFU2012-32045 (to E. H.) and BFU2012-31939 (to J. A.), PLAN E and FEDER, and by 2014-SGR-154 from Generalitat de Catalunya (Spain) (to E. H. and J. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an ICREA Academia Award (Generalitat de Catalunya, Spain).	Alfa C, 1993, EXPT FISSION YEAST L; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Calvo IA, 2012, NUCLEIC ACIDS RES, V40, P4816, DOI 10.1093/nar/gks141; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fernandez-Vazquez J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003647; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guy MP, 2014, RNA BIOL, V11, P1608, DOI 10.1080/15476286.2015.1008360; Heurgue-Hamard V, 2005, J BIOL CHEM, V280, P2439, DOI 10.1074/jbc.M407252200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Johnsson A, 2006, EUKARYOT CELL, V5, P1337, DOI 10.1128/EC.00101-06; Kowalik KM, 2015, NATURE, V520, P248, DOI 10.1038/nature14337; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; Lackner DH, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r25; Leupold U., 1970, METHODS CELL PHYSL, V4, P169; Liger D, 2011, NUCLEIC ACIDS RES, V39, P6249, DOI 10.1093/nar/gkr176; Mbogning J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004029; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Patil A, 2012, RNA BIOL, V9, P990, DOI 10.4161/rna.20531; Paulo E, 2014, MOL MICROBIOL, V92, P246, DOI 10.1111/mmi.12548; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Tomson BN, 2013, BBA-GENE REGUL MECH, V1829, P116, DOI 10.1016/j.bbagrm.2012.08.011; Towns WL, 2012, DNA CELL BIOL, V31, P434, DOI 10.1089/dna.2011.1437; Verrier L, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150045; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200	38	4	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					790	799		10.1074/jbc.M115.696658	http://dx.doi.org/10.1074/jbc.M115.696658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26567340	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000367830500026
J	Kumar, P; Segers-Nolten, IMJ; Schilderink, N; Subramaniam, V; Huber, M				Kumar, Pravin; Segers-Nolten, Ine M. J.; Schilderink, Nathalie; Subramaniam, Vinod; Huber, Martina			Parkinson's Protein alpha-Synuclein Binds Efficiently and with a Novel Conformation to Two Natural Membrane Mimics	PLOS ONE			English	Article							COMPREHENSIVE SOFTWARE PACKAGE; LEWY-BODY FORMATION; NEUROTRANSMITTER RELEASE; LIPID VESICLES; BROKEN HELIX; IN-VITRO; DISEASE; EPR; AFFINITY; DYNAMICS	Binding of human alpha-Synuclein, a protein associated with Parkinson's disease, to natural membranes is thought to be crucial in relation to its pathological and physiological function. Here the binding of alpha S to small unilamellar vesicles mimicking the inner mitochondrial and the neuronal plasma membrane is studied in situ by continuous wave and pulsed electron paramagnetic resonance. Local binding information of alpha S spin labeled by MTSL at positions 56 and 69 respectively shows that also helix 2 (residues 50-100) binds firmly to both membranes. By double electron-electron resonance (DEER) on the mutant spin labeled at positions 27 and 56 (alpha S 27/56) a new conformation on the membrane is found with a distance of 3.6 nm/3.7 nm between residues 27 and 56. In view of the low negative charge density of these membranes, the strong interaction is surprising, emphasizing that function and pathology of alpha S could involve synaptic vesicles and mitochondria.	[Kumar, Pravin; Huber, Martina] Leiden Univ, Dept Phys, Huygens Kammerlingh Onnes Lab, Leiden, Netherlands; [Segers-Nolten, Ine M. J.; Schilderink, Nathalie; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, Nanobiophys, NL-7500 AE Enschede, Netherlands; [Subramaniam, Vinod] FOM Inst AMOLF, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Twente; AMOLF	Huber, M (corresponding author), Leiden Univ, Dept Phys, Huygens Kammerlingh Onnes Lab, Leiden, Netherlands.	huber@physics.leidenuniv.nl	Subramaniam, Vinod/B-4197-2010	Subramaniam, Vinod/0000-0001-6712-7266; Kumar, Pravin/0000-0002-7966-578X	Netherlands Organisation for Scientific Research (NWO) [700.58.014]; Foundation for Fundamental Research on Matter (FOM) part of NWO [10SMPA04]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation for Fundamental Research on Matter (FOM) part of NWO	Funding: This work was supported by the Netherlands Organisation for Scientific Research (NWO), grant 700.58.014 to M.H. (http://www.nwo.nl/), and the Foundation for Fundamental Research on Matter (FOM), which is part of NWO, grant number 10SMPA04 in the context of the program entitled "A Single Molecule View on Protein Aggregation" to M. H. and V.S. (http://www.fom.nl/live/home.pag). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Devi L, 2010, BBA-MOL BASIS DIS, V1802, P11, DOI 10.1016/j.bbadis.2009.07.007; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Milov AD, 1997, APPL MAGN RESON, V12, P495, DOI 10.1007/BF03164129; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Parkinson J, 1817, ESSAY SHAKING PALSY; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Robotta M, 2014, CHEMBIOCHEM, V15, P2499, DOI 10.1002/cbic.201402281; Robotta M, 2012, BIOCHEMISTRY-US, V51, P3960, DOI 10.1021/bi300357a; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Shvadchak VV, 2014, BIOCHEMISTRY-US, V53, P279, DOI 10.1021/bi401427t; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanovic AND, 2014, FEBS J, V281, P2838, DOI 10.1111/febs.12824; Steigmiller S, 2005, BBA-BIOENERGETICS, V1708, P143, DOI 10.1016/j.bbabio.2005.03.013; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Veldhuis G, 2009, CHEMBIOCHEM, V10, P436, DOI 10.1002/cbic.200800644; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yong-Kee CJ, 2012, NEUROTOX RES, V21, P185, DOI 10.1007/s12640-011-9259-6; Zigoneanu IG, 2012, BBA-BIOMEMBRANES, V1818, P512, DOI 10.1016/j.bbamem.2011.11.024	48	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142795	10.1371/journal.pone.0142795	http://dx.doi.org/10.1371/journal.pone.0142795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588454	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500016
J	Mellerup, E; Andreassen, OA; Bennike, B; Dam, H; Djurovic, S; Hansen, T; Jorgensen, MB; Kessing, LV; Koefoed, P; Melle, I; Mors, O; Werge, T; Moeller, GL				Mellerup, Erling; Andreassen, Ole A.; Bennike, Bente; Dam, Henrik; Djurovic, Srdjan; Hansen, Thomas; Jorgensen, Martin Balslev; Kessing, Lars Vedel; Koefoed, Pernille; Melle, Ingrid; Mors, Ole; Werge, Thomas; Moeller, Gert Lykke			Combinations of Genetic Data Present in Bipolar Patients, but Absent in Control Persons	PLOS ONE			English	Article							SNP INTERACTIONS; BREAST-CANCER; ASSOCIATION; POLYMORPHISMS; EXPRESSION; DISEASE; SEARCH; NRF2	The main objective of the study was to find combinations of genetic variants significantly associated with bipolar disorder. In a previous study of bipolar disorder, combinations of three single nucleotide polymorphism (SNP) genotypes taken from 803 SNPs were analyzed, and four clusters of combinations were found to be significantly associated with bipolar disorder. In the present study, combinations of four SNP genotypes taken from the same 803 SNPs were analyzed, and one cluster of combinations was found to be significantly associated with bipolar disorder. Combinations from the new cluster and from the four previous clusters were identified in the genomes of 209 of the 607 patients in the study whereas none of the 1355 control participants had any of these combinations in their genome.	[Mellerup, Erling; Bennike, Bente; Koefoed, Pernille] Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Blegdamsvej 9 O-6102, DK-2100 Copenhagen, Denmark; [Dam, Henrik; Jorgensen, Martin Balslev; Kessing, Lars Vedel; Koefoed, Pernille] Rigshosp, Copenhagen Univ Hosp, Dept O, Psychiat Ctr Copenhagen, DK-2100 Copenhagen, Denmark; [Andreassen, Ole A.; Melle, Ingrid] Oslo Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [Andreassen, Ole A.; Djurovic, Srdjan; Melle, Ingrid] Univ Oslo, Inst Psychiat, N-0407 Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0407 Oslo, Norway; [Hansen, Thomas; Werge, Thomas] Copenhagen Univ Hosp, Dept Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, DK-4000 Roskilde, Denmark; [Mors, Ole] Aarhus Univ Hosp, Ctr Psyciatr Res, iPSYCH, DK-8240 Risskov, Denmark; [Moeller, Gert Lykke] Tech Univ Denmark, Genokey ApS, ScionDTU, DK-2970 Horsholm, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oslo; University of Oslo; University of Oslo; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Technical University of Denmark	Mellerup, E (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Lab Neuropsychiat, Blegdamsvej 9 O-6102, DK-2100 Copenhagen, Denmark.	mellerup@sund.ku.dk	Jorgensen, Martin Balslev MBJ/K-5758-2012; Hansen, Thomas/GWZ-2858-2022; Andreassen, Ole A./AAY-7531-2020; Hansen, Thomas Folkmann/O-5965-2014; Melle, Ingrid S/B-4858-2011	Jorgensen, Martin Balslev MBJ/0000-0002-1321-8901; Hansen, Thomas Folkmann/0000-0001-6703-7762; Melle, Ingrid S/0000-0002-9783-548X; Mors, Ole/0000-0002-5660-0393; Kessing, Lars/0000-0001-9377-9436; Djurovic, Srdjan/0000-0002-8140-8061	Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		Brunner G, 2013, J CANCER RES CLIN, V139, P249, DOI 10.1007/s00432-012-1322-z; Capasso M, 2014, CANCER GENET-NY, V207, P94, DOI 10.1016/j.cancergen.2014.02.004; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Goudey B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S10; Hartikainen JM, 2012, CANCER RES, V72, P5537, DOI 10.1158/0008-5472.CAN-12-1474; Hu XH, 2010, CELL RES, V20, P854, DOI 10.1038/cr.2010.68; Jiang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046771; Kam-Thong T, 2011, EUR J HUM GENET, V19, P465, DOI 10.1038/ejhg.2010.196; Koefoed P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023812; Mellerup E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044623; Milne RL, 2014, HUM MOL GENET, V23, P1934, DOI 10.1093/hmg/ddt581; Pers TH, 2011, GENET EPIDEMIOL, V35, P318, DOI 10.1002/gepi.20580; Prabhu S, 2012, GENOME RES, V22, P2230, DOI 10.1101/gr.137885.112; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Wu QQ, 2011, AM J PHYSIOL-RENAL, V300, pF1180, DOI 10.1152/ajprenal.00353.2010; Xie Q, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S4; Yee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069321	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143432	10.1371/journal.pone.0143432	http://dx.doi.org/10.1371/journal.pone.0143432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587987	Green Published, gold, Green Submitted			2022-12-26	WOS:000365251500061
J	Wang, ZS; Guo, WD; Wu, LQ; Yi, X; Geng, C; Li, YJ; Yao, RY				Wang, Zu-Sen; Guo, Wei-Dong; Wu, Li-Qun; Yi, Xin; Geng, Chao; Li, Yu-Jun; Yao, Ru-Yong			Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration	PLOS ONE			English	Article							POOR-PROGNOSIS; BREAST-CANCER; EXPRESSION; MARKERS; SURVIVAL; CELLS; PROGRESSION; METASTASIS	Cytokeratin 19 (CK-19) is a prognostic indicator of recurrence and metastasis of hepatocellular carcinoma (HCC) following radical resection. To investigate the role of CK-19 in assessment of early recurrence and prognosis in patients with hepatitis B virus (HBV)-related HCC following radical resection. In total, 235 patients with HBV-related HCC (age, 15-82 years; mean age, 54 +/- 10 years) undergoing radical resection were screened for inclusion from January 2005 to December 2010. Malignant tissues and adjacent non-malignant tissues were sampled during surgery, and CK-19 and Ki-67 expression was determined by tissue microarray and immunohistochemistry. CK-19 mRNA levels in 30 randomly selected frozen HCC specimens were examined by reverse transcription polymerase chain reaction from January 2011 to June 2011. Correlations of CK-19 and Ki-67 expression with tumor recurrence, metastasis, disease-free survival (DFS), and overall survival (OS) were analyzed. Elevated CK-19 expression was correlated with early recurrence (P=0.001), shorter DFS (P=0.001), and reduced OS (P = 0.010). CK-19 expression was correlated with the Ki-67 index (P = 0.037), histological differentiation (P = 0.016), focal number (P = 0.044), and blood vessel tumor embolism (P = 0.002). Patients with metastasis within 1 year exhibited stronger CK-19 expression than did patients withoutmetastasis (P < 0.05). Furthermore, early recurrence was associated with elevated CK-19 mRNA levels (chi(2) = 5.761, P = 0.016). When confirmed by a low alpha-fetoprotein concentration (< 400 mu g/L), CK-19 expression in surgical biopsy specimens taken from patients with HCC during radical resection is an additional valuable indicator of early recurrence, distant metastasis, and poor prognosis in HBV-positive patients.	[Wang, Zu-Sen; Guo, Wei-Dong; Wu, Li-Qun; Yi, Xin; Geng, Chao] Qingdao Univ, Dept Hepatobiliary Surg, Coll Med, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China; [Li, Yu-Jun] Qingdao Univ, Dept Pathol, Coll Med, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China; [Yao, Ru-Yong] Qingdao Univ, Dept Cent Lab, Coll Med, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Wu, LQ (corresponding author), Qingdao Univ, Dept Hepatobiliary Surg, Coll Med, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China.	wulq5810@126.com						Alix-Panabieres C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2326; Ananthakrishnan Ashwin, 2006, Semin Intervent Radiol, V23, P47, DOI 10.1055/s-2006-939841; Ding SJ, 2004, MOL CELL PROTEOMICS, V3, P73, DOI 10.1074/mcp.M300094-MCP200; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; Hsu YC, 2006, J CLIN ONCOL, V24, P3780, DOI 10.1200/JCO.2005.03.7499; Kao WY, 2012, CLIN RADIOL, V67, P429, DOI 10.1016/j.crad.2011.10.009; King KL, 1998, J GASTROEN HEPATOL, V13, P273, DOI 10.1111/j.1440-1746.1998.01555.x; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Lang HK, 2007, J AM COLL SURGEONS, V205, P27, DOI 10.1016/j.jamcollsurg.2007.03.002; MAEDA T, 1995, HUM PATHOL, V26, P956, DOI 10.1016/0046-8177(95)90084-5; Oh BK, 2008, LAB INVEST, V88, P144, DOI 10.1038/labinvest.3700710; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Shim JH, 2013, ANN SURG, V257, P708, DOI 10.1097/SLA.0b013e318273be70; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Uenishi T, 2003, CANCER SCI, V94, P851, DOI 10.1111/j.1349-7006.2003.tb01366.x; Wang YB, 2011, EUR REV MED PHARMACO, V15, P592; Wu F, 2002, INT J ONCOL, V20, P31; Wu PC, 1999, J HEPATOL, V31, P965; Xiang ZL, 2011, MOL BIOL REP, V38, P3531, DOI 10.1007/s11033-010-0463-x; Yang XR, 2008, CLIN CANCER RES, V14, P3850, DOI 10.1158/1078-0432.CCR-07-4338; Zhang Guo-Qing, 2008, Ai Zheng, V27, P1297	22	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142727	10.1371/journal.pone.0142727	http://dx.doi.org/10.1371/journal.pone.0142727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588210	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500015
J	Brasier, AR; Zhao, YX; Spratt, HM; Wiktorowicz, JE; Ju, HU; Wheat, LJ; Baden, L; Stafford, S; Wu, Z; Issa, N; Caliendo, AM; Denning, DW; Soman, K; Clancy, CJ; Nguyen, MH; Sugrue, MW; Alexander, BD; Wingard, JR				Brasier, Allan R.; Zhao, Yingxin; Spratt, Heidi M.; Wiktorowicz, John E.; Ju, Hyunsu; Wheat, L.; Baden, Lindsey; Stafford, Susan; Wu, Zheng; Issa, Nicolas; Caliendo, Angela M.; Denning, David W.; Soman, Kizhake; Clancy, Cornelius J.; Nguyen, M. Hong; Sugrue, Michele W.; Alexander, Barbara D.; Wingard, John R.			Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens	PLOS ONE			English	Article							FUMIGATUS CONIDIA; BIOMARKER PANEL; DIAGNOSIS; INFECTIONS; DISEASE; BINDING; GALACTOMANNAN; INFLAMMATION; SPECTRUM	Invasive pulmonary aspergillosis (IPA) is an opportunistic fungal infection in patients undergoing chemotherapy for hematological malignancy, hematopoietic stem cell transplant, or other forms of immunosuppression. In this group, Aspergillus infections account for the majority of deaths due to mold pathogens. Although early detection is associated with improved outcomes, current diagnostic regimens lack sensitivity and specificity. Patients undergoing chemotherapy, stem cell transplantation and lung transplantation were enrolled in a multi-site prospective observational trial. Proven and probable IPA cases and matched controls were subjected to discovery proteomics analyses using a biofluid analysis platform, fractionating plasma into reproducible protein and peptide pools. From 556 spots identified by 2D gel electrophoresis, 66 differentially expressed post-translationally modified plasma proteins were identified in the leukemic subgroup only. This protein group was rich in complement components, acute-phase reactants and coagulation factors. Low molecular weight peptides corresponding to abundant plasma proteins were identified. A candidate marker panel of host response (9 plasma proteins, 4 peptides), fungal polysaccharides (galactomannan), and cell wall components (beta-D glucan) were selected by statistical filtering for patients with leukemia as a primary underlying diagnosis. Quantitative measurements were developed to qualify the differential expression of the candidate host response proteins using selective reaction monitoring mass spectrometry assays, and then applied to a separate cohort of 57 patients with leukemia. In this verification cohort, a machine learning ensemble-based algorithm, generalized pathseeker (GPS) produced a greater case classification accuracy than galactomannan (GM) or host proteins alone. In conclusion, Integration of host response proteins with GM improves the diagnostic detection of probable IPA in patients undergoing treatment for hematologic malignancy. Upon further validation, early detection of probable IPA in leukemia treatment will provide opportunities for earlier interventions and interventional clinical trials.	[Brasier, Allan R.; Zhao, Yingxin] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Brasier, Allan R.; Zhao, Yingxin; Spratt, Heidi M.; Wiktorowicz, John E.; Ju, Hyunsu] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Brasier, Allan R.; Zhao, Yingxin; Spratt, Heidi M.; Wiktorowicz, John E.; Soman, Kizhake] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Spratt, Heidi M.; Ju, Hyunsu] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Wiktorowicz, John E.; Soman, Kizhake] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Wheat, L.] MiraVista Labs, Indianapolis, IN USA; [Baden, Lindsey; Issa, Nicolas] Harvard Univ, Boston, MA 02115 USA; [Stafford, Susan; Wu, Zheng] Univ Texas Med Branch, Biomol Resource Facil, Galveston, TX 77555 USA; [Caliendo, Angela M.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Denning, David W.] Univ Manchester, Manchester, Lancs, England; [Clancy, Cornelius J.] Univ Pittsburgh, Pittsburgh, PA USA; [Nguyen, M. Hong; Sugrue, Michele W.; Wingard, John R.] Univ Florida, Gainesville, FL USA; [Alexander, Barbara D.] Duke Univ, Med Ctr, Durham, NC USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Harvard University; University of Texas System; University of Texas Medical Branch Galveston; Brown University; University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; Duke University	Brasier, AR (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	arbrasie@utmb.edu	Denning, David/AAC-6931-2019	Denning, David/0000-0001-5626-2251; Brasier, Allan/0000-0002-5012-4090; Alexander, Barbara/0000-0001-5868-0529; Wingard, John/0000-0001-7478-5398	NIAID Clinical Proteomics Center [HHSN272200800048C, UL1TR000071 UTMB CTSA]; NIEHS [P30 ES006676]; Aspergillus Technology Consortium NIAID [HHSN266200700023C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	NIAID Clinical Proteomics Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Aspergillus Technology Consortium NIAID; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the following grants: the NIAID Clinical Proteomics Center, HHSN272200800048C (ARB), UL1TR000071 UTMB CTSA (ARB), NIEHS P30 ES006676 (ARB), and the Aspergillus Technology Consortium NIAID Contract # HHSN266200700023C (JW). The funding agencies had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Balloy V, 2005, INFECT IMMUN, V73, P494, DOI 10.1128/IAI.73.1.494-503.2005; Barnes PD, 2006, INFECT DIS CLIN N AM, V20, P545, DOI 10.1016/j.idc.2006.06.001; BOUCHARA JP, 1995, TRENDS MICROBIOL, V3, P327, DOI 10.1016/S0966-842X(00)88965-9; Brasier AR, 2012, CTS-CLIN TRANSL SCI, V5, P8, DOI 10.1111/j.1752-8062.2011.00377.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Clancy CJ, 2007, J CLIN MICROBIOL, V45, P1759, DOI 10.1128/JCM.00077-07; COULOT P, 1994, INFECT IMMUN, V62, P2169, DOI 10.1128/IAI.62.6.2169-2177.1994; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Erjavec Z, 2009, CLIN MICROBIOL INFEC, V15, P625, DOI 10.1111/j.1469-0691.2009.02929.x; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Jamaluddin M, 2010, J VIROL, V84, P9533, DOI 10.1128/JVI.01005-10; Ju Hyunsu, 2013, BMC Res Notes, V6, P365, DOI 10.1186/1756-0500-6-365; Kami M, 2005, BONE MARROW TRANSPL, V36, P85, DOI 10.1038/sj.bmt.1704997; KOZEL TR, 1989, INFECT IMMUN, V57, P3412, DOI 10.1128/IAI.57.11.3412-3417.1989; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Marty FM, 2009, MED MYCOL, V47, pS233, DOI 10.1080/13693780802308454; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Pickering JW, 2005, J CLIN MICROBIOL, V43, P5957, DOI 10.1128/JCM.43.12.5957-5962.2005; Pretzer E, 2008, ANAL BIOCHEM, V374, P250, DOI 10.1016/j.ab.2007.12.014; Rodland EK, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-144; Speth Cornelia, 2012, Interdiscip Perspect Infect Dis, V2012, P463794, DOI 10.1155/2012/463794; Spratt H., 2013, METHODS IN PRESS; STURTEVANT JE, 1992, INFECT IMMUN, V60, P1913, DOI 10.1128/IAI.60.5.1913-1918.1992; Tyagarajan K, 2003, ELECTROPHORESIS, V24, P2348, DOI 10.1002/elps.200305478; Vogl G, 2008, MOL IMMUNOL, V45, P1485, DOI 10.1016/j.molimm.2007.08.011; VONEIFF M, 1995, RESPIRATION, V62, P341, DOI 10.1159/000196477; Wheat L. J., 2005, Clinical Microbiology Newsletter, V27, P51, DOI 10.1016/j.clinmicnews.2005.04.001	37	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143165	10.1371/journal.pone.0143165	http://dx.doi.org/10.1371/journal.pone.0143165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581097	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600094
J	Cervantes-Yoshida, K; Leidy, RA; Carlson, SM				Cervantes-Yoshida, Kristina; Leidy, Robert A.; Carlson, Stephanie M.			Contemporary Land Change Alters Fish Communities in a San Francisco Bay Watershed, California, USA	PLOS ONE			English	Article							MACROINVERTEBRATE ASSEMBLAGES; STREAM BIODIVERSITY; URBANIZATION; LANDSCAPE; HABITAT; CATCHMENT; COVER; SCALE; CLASSIFICATION; PERSISTENCE	Urbanization is one of the leading threats to freshwater biodiversity, and urban regions continue to expand globally. Here we examined the relationship between recent urbanization and shifts in stream fish communities. We sampled fishes at 32 sites in the Alameda Creek Watershed, near San Francisco, California, in 1993-1994 and again in 2009, and we quantified univariate and multivariate changes in fish communities between the sampling periods. Sampling sites were classified into those downstream of a rapidly urbanizing area ("urbanized sites"), and those found in less impacted areas ("low-impacted sites"). We calculated the change from non-urban to urban land cover between 1993 and 2009 at two scales for each site (the total watershed and a 3km buffer zone immediately upstream of each site). Neither the mean relative abundance of native fish nor nonnative species richness changed significantly between the survey periods. However, we observed significant changes in fish community composition (as measured by Bray-Curtis dissimilarity) and a decrease in native species richness between the sampling periods at urbanized sites, but not at low-impacted sites. Moreover, the relative abundance of one native cyprinid (Lavinia symmetricus) decreased at the urbanized sites but not at low-impacted sites. Increased urbanization was associated with changes in the fish community, and this relationship was strongest at the smaller (3km buffer) scale. Our results suggest that ongoing land change alters fish communities and that contemporary resurveys are an important tool for examining how freshwater taxa are responding to recent environmental change.	[Cervantes-Yoshida, Kristina; Carlson, Stephanie M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Leidy, Robert A.] US EPA, San Francisco, CA USA	University of California System; University of California Berkeley; United States Environmental Protection Agency	Cervantes-Yoshida, K (corresponding author), San Francisco Bay Reg Water Qual Control Board, Oakland, CA 94612 USA.	kcervantesyoshida@gmail.com		Carlson, Stephanie/0000-0003-3055-6483	National Science Foundation Graduate Research Fellowship Program [DGE1106400]; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	Support was provided by the National Science Foundation Graduate Research Fellowship Program, grant number: DGE1106400 to KCY [https://www.nsfgrfp.org]. Publication made possible in part by support from the Berkeley Research Impact Initiative (BRII) sponsored by the UC Berkeley Library. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; Brim-Box J, 2014, MAR FRESHWATER RES, V65, P562, DOI 10.1071/MF13131; Burkhead NM, 2012, BIOSCIENCE, V62, P798, DOI 10.1525/bio.2012.62.9.5; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; de Jesus-Crespo R, 2011, J N AM BENTHOL SOC, V30, P739, DOI 10.1899/10-081.1; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Esselman PC, 2010, ECOL FRESHW FISH, V19, P439, DOI 10.1111/j.1600-0633.2010.00430.x; Fitzpatrick FA, 2001, J AM WATER RESOUR AS, V37, P1489, DOI 10.1111/j.1752-1688.2001.tb03655.x; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Gibbs JP, 2005, ECOL APPL, V15, P1148, DOI 10.1890/03-5408; Gutierrez M, 2014, SAN FRANCISCO G 0501; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; Heard MJ, 2012, DIVERS DISTRIB, V18, P1232, DOI 10.1111/j.1472-4642.2012.00918.x; Helms BS, 2009, J N AM BENTHOL SOC, V28, P991, DOI 10.1899/08-162.1; Henshaw PC, 2000, J AM WATER RESOUR AS, V36, P1219, DOI 10.1111/j.1752-1688.2000.tb05722.x; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Johnston CE, 2009, ECOL FRESHW FISH, V18, P33, DOI 10.1111/j.1600-0633.2008.00319.x; Kearns FR, 2005, LANDSCAPE ECOL, V20, P113, DOI 10.1007/s10980-004-2261-0; King RS, 2011, ECOL APPL, V21, P1659, DOI 10.1890/10-1357.1; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Labay B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025145; Lammert M, 1999, ENVIRON MANAGE, V23, P257, DOI 10.1007/s002679900184; Leidy R.A, 2007, SAN FRANCISCO ESTUAR, P530; Leidy RA, 2005, CALIF FISH GAME, V91, P219; Leidy RA, 2011, AQUAT CONSERV, V21, P472, DOI 10.1002/aqc.1208; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Maloney KO, 2011, FRESHWATER BIOL, V56, P611, DOI 10.1111/j.1365-2427.2010.02522.x; Marchetti MP, 2006, BIOL CONSERV, V127, P310, DOI 10.1016/j.biocon.2005.04.025; Matthews WJ, 2013, OECOLOGIA, V173, P955, DOI 10.1007/s00442-013-2646-3; McDonald Robert I., 2013, P31; Meals DW, 2010, J ENVIRON QUAL, V39, P85, DOI 10.2134/jeq2009.0108; Morgan RP, 2005, J N AM BENTHOL SOC, V24, P643, DOI 10.1899/0887-3593(2005)024\\[0643:UEOSFA\\]2.0.CO;2; Moyle P.B., 2002, INLAND FISHES CALIFO; Moyle P.B., 2015, FISH SPECIES SPECIAL; Moyle PB, 2011, BIOL CONSERV, V144, P2414, DOI 10.1016/j.biocon.2011.06.002; Patton TM, 1998, CONSERV BIOL, V12, P1120, DOI 10.1046/j.1523-1739.1998.97087.x; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Peter S, 2011, ECOL FRESHW FISH, V20, P251, DOI 10.1111/j.1600-0633.2011.00490.x; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Poole KE, 2004, J N AM BENTHOL SOC, V23, P114, DOI 10.1899/0887-3593(2004)023<0114:RODMBT>2.0.CO;2; Riley SPD, 2005, CONSERV BIOL, V19, P1894, DOI 10.1111/j.1523-1739.2005.00295.x; Roy AH, 2005, J N AM BENTHOL SOC, V24, P656, DOI 10.1899/0887-3593(2005)024\\[0656:IHAAAM\\]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Stanfield LW, 2013, RIVER RES APPL, V29, P891, DOI 10.1002/rra.2585; Stanford B, 2013, SFEI PUBLICATION, V679; Strayer DL, 2003, ECOSYSTEMS, V6, P407, DOI 10.1007/s10021-002-0170-0; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wang LZ, 2001, ENVIRON MANAGE, V28, P255, DOI 10.1007/s0026702409; Weijters MJ, 2009, AQUAT CONSERV, V19, P104, DOI 10.1002/aqc.989; Wenger SJ, 2008, CAN J FISH AQUAT SCI, V65, P1250, DOI 10.1139/F08-046	57	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141707	10.1371/journal.pone.0141707	http://dx.doi.org/10.1371/journal.pone.0141707			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580560	gold, Green Submitted, Green Published			2022-12-26	WOS:000365154600020
J	Kang, H; Chung, YS; Kim, SW; Choi, GJ; Kim, BG; Park, SW; Seok, JW; Hong, J				Kang, Hyun; Chung, Yoon Sang; Kim, Sang Wook; Choi, Geun Joo; Kim, Beom Gyu; Park, Suk Won; Seok, Ju Won; Hong, Joonhwa			Effect of Temperature-Sensitive Poloxamer Solution/Gel Material on Pericardial Adhesion Prevention: Supine Rabbit Model Study Mimicking Cardiac Surgery	PLOS ONE			English	Article							HYALURONIC-ACID; MITOMYCIN-C; REDUCTION; MEMBRANE; BARRIER; COMBINATION; EFFICACY; CLOSURE; FILM; GEL	Objective We investigated the mobility of a temperature-sensitive poloxamer/Alginate/CaCl2 mixture (PACM) in relation to gravity and cardiac motion and the efficacy of PACM on the prevention of pericardial adhesion in a supine rabbit model. Methods A total of 50 rabbits were randomly divided into two groups according to materials applied after epicardial abrasion: PACM and dye mixture (group PD; n = 25) and saline as the control group (group CO; n = 25). In group PD, rabbits were maintained in a supine position with appropriate sedation, and location of mixture of PACM and dye was assessed by CT scan at the immediate postoperative period and 12 hours after surgery. The grade of adhesions was evaluated macroscopically and microscopically two weeks after surgery. Results In group PD, enhancement was localized in the anterior pericardial space, where PACM and dye mixture was applied, on immediate post-surgical CT scans. However, the volume of the enhancement was significantly decreased at the anterior pericardial space 12 hours later (P < .001). Two weeks after surgery, group PD had significantly lower macroscopic adhesion score (P = .002) and fibrosis score (P = .018) than did group CO. Inflammation score and expression of anti-macrophage antibody in group PD were lower than those in group CO, although the differences were not significant. Conclusions In a supine rabbit model study, the anti-adhesion effect was maintained at the area of PACM application, although PACM shifted with gravity and heart motion. For more potent pericardial adhesion prevention, further research and development on the maintenance of anti-adhesion material position are required.	[Kang, Hyun; Choi, Geun Joo] Chung Ang Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul 156756, South Korea; [Chung, Yoon Sang; Kim, Sang Wook; Hong, Joonhwa] Chung Ang Univ, Coll Med, Heart Res Inst, Seoul 156756, South Korea; [Kim, Sang Wook] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Kang, Hyun; Chung, Yoon Sang; Hong, Joonhwa] Chung Ang Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 156756, South Korea; [Kim, Beom Gyu] Chung Ang Univ, Coll Med, Dept Surg, Seoul 156756, South Korea; [Park, Suk Won] Chung Ang Univ, Coll Med, Dept Radiat Oncol, Seoul 156756, South Korea; [Seok, Ju Won] Chung Ang Univ, Coll Med, Dept Nucl Med, Seoul 156756, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Hong, J (corresponding author), Chung Ang Univ, Coll Med, Heart Res Inst, Seoul 156756, South Korea.	jhong@cau.ac.kr	Kang, Hyun/AAE-7872-2020; Choi, Geun Joo/AAF-5102-2021	Kang, Hyun/0000-0003-2844-5880; Hong, Joonhwa/0000-0003-2212-2861	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology [NRF-2015R1A2A2A01005153]	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (NRF-2015R1A2A2A01005153) (http://www.nrf.re.kr/nrftot_cms/index.jsp?pmi-sso-return2=none). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (NRF-2015R1A2A2A01005153).	Alizzi AM, 2012, HEART LUNG CIRC, V21, P22, DOI 10.1016/j.hlc.2011.10.002; Colak N, 2013, CARDIOVASC PATHOL, V22, P368, DOI 10.1016/j.carpath.2013.02.001; Colak N, 2013, CAN J CARDIOL, V29, P712, DOI 10.1016/j.cjca.2012.05.005; Connors RC, 2007, J SURG RES, V140, P237, DOI 10.1016/j.jss.2007.03.014; DUNCAN DA, 1988, J SURG RES, V45, P44, DOI 10.1016/0022-4804(88)90019-4; Edwards GA, 1997, J BIOMED MATER RES, V34, P291; GALLO JI, 1978, ANN THORAC SURG, V26, P149, DOI 10.1016/S0003-4975(10)63658-2; Hong JH, 2011, J SURG RES, V166, P206, DOI 10.1016/j.jss.2010.09.034; Kaushal S, 2011, J THORAC CARDIOV SUR, V141, P789, DOI 10.1016/j.jtcvs.2010.11.043; Lassaletta AD, 2012, J THORAC CARDIOV SUR, V143, P953, DOI 10.1016/j.jtcvs.2011.12.016; LEACH RE, 1990, AM J OBSTET GYNECOL, V162, P1317, DOI 10.1016/0002-9378(90)90044-8; MEUS PJ, 1983, J THORAC CARDIOV SUR, V85, P54; MITCHELL JD, 1994, J THORAC CARDIOV SUR, V107, P1481, DOI 10.1016/S0022-5223(12)70149-6; Naito Y, 2008, J THORAC CARDIOV SUR, V135, P850, DOI 10.1016/j.jtcvs.2007.10.062; Oh SH, 2005, J BIOMED MATER RES A, V72A, P306, DOI 10.1002/jbm.a.30239; Orhan A, 2014, HEART LUNG CIRC, V23, P357, DOI 10.1016/j.hlc.2013.10.080; Park JS, 2011, J SURG RES, V168, P49, DOI 10.1016/j.jss.2009.09.025; Park SO, 2013, AESTHET PLAST SURG, V37, P543, DOI 10.1007/s00266-013-0087-3; REVUELTA JM, 1985, J THORAC CARDIOV SUR, V89, P451; Saeidi Mahmood, 2009, Interact Cardiovasc Thorac Surg, V9, P26, DOI 10.1510/icvts.2009.204669; SEIFER DB, 1990, J GYNECOL SURG, V6, P3, DOI 10.1089/gyn.1990.6.3; Shen J, 2014, ARTIF ORGANS, V38, P224, DOI 10.1111/aor.12140; Sohn EJ, 2013, OPHTHAL PLAST RECONS, V29, P458, DOI 10.1097/IOP.0b013e3182a22bae; Vlahos A, 2001, AM SURGEON, V67, P15	24	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143359	10.1371/journal.pone.0143359	http://dx.doi.org/10.1371/journal.pone.0143359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580394	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600116
J	Shen, KN; Sun, J; Cao, XX; Zhou, DB; Li, J				Shen, Kaini; Sun, Jian; Cao, Xinxin; Zhou, Daobin; Li, Jian			Comparison of Different Buffers for Protein Extraction from Formalin-Fixed and Paraffin-Embedded Tissue Specimens	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; ANTIGEN RETRIEVAL; MASS-SPECTROMETRY; EXPRESSION; SAMPLES; GENE	We determined the best extraction buffer for proteomic investigation using formalin-fixation and paraffin-embedded (FFPE) specimens. A Zwittergent 3-16 based buffer, sodium dodecyl sulfate (SDS)-containing buffer with/without polyethylene glycol 20000 (PEG20000), urea-containing buffer, and FFPE-FASP protein preparation kit were compared for protein extraction from different types of rat FFPE tissues, including the heart, brain, liver, lung, and kidney. All of the samples were divided into two groups of laser microdissected (LMD) and non-LMD specimens. For both kinds of specimens, Zwittergent was the most efficient buffer for identifying peptides and proteins, was broadly applicable to different tissues without impairing the enzymatic digestion, and was well compatible with mass spectrometry analysis. As a high molecular weight carrier substance, PEG20000 improved the identification of peptides and proteins; however, such an advantage is limited to tissues containing submicrograms to micrograms of protein. Considering its low lytic strength, urea-containing buffer would not be the first alternative for protein recovery. In conclusion, Zwittergent 3-16 is an effective buffer for extracting proteins from FFPE specimens for downstream proteomics analysis.	[Shen, Kaini; Cao, Xinxin; Zhou, Daobin; Li, Jian] Chinese Acad Med Sci, Dept Hematol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Shen, Kaini; Sun, Jian; Cao, Xinxin; Zhou, Daobin; Li, Jian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Jian] Chinese Acad Med Sci, Dept Pathol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, J (corresponding author), Chinese Acad Med Sci, Dept Hematol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	lijian@pumch.cn		Sun, Jian/0000-0003-4997-2604; Li, Jian/0000-0002-4549-0694	National Nature Science Foundation of China [81370672]; Beijing Municipal Science & Technology Commission [Z131107002213050]; Peking Union Medical College New Star	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Peking Union Medical College New Star	This work was funded by the National Nature Science Foundation of China (81370672, for Jian Li), Beijing Municipal Science & Technology Commission (Z131107002213050, for Jian Li), and Peking Union Medical College New Star (2011, for Jian Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; Azimzadeh O, 2010, J PROTEOME RES, V9, P4710, DOI 10.1021/pr1004168; Craven RA, 2013, PROTEOM CLIN APPL, V7, P273, DOI 10.1002/prca.201200065; Crockett DK, 2005, LAB INVEST, V85, P1405, DOI 10.1038/labinvest.3700343; Fowler CB, 2007, LAB INVEST, V87, P836, DOI 10.1038/labinvest.3700596; Grantzdorffer I, 2010, EXP MOL PATHOL, V88, P190, DOI 10.1016/j.yexmp.2009.09.009; Guo T, 2007, J HISTOCHEM CYTOCHEM, V55, P763, DOI 10.1369/jhc.7A7177.2007; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Klockenbusch C, 2012, ANAL BIOANAL CHEM, V404, P1057, DOI 10.1007/s00216-012-6065-9; Maes E, 2013, AMINO ACIDS, V45, P205, DOI 10.1007/s00726-013-1494-0; Magdeldin S, 2012, PROTEOMICS, V12, P1045, DOI 10.1002/pmic.201100550; Nirmalan NJ, 2011, J PROTEOME RES, V10, P896, DOI 10.1021/pr100812d; Palmer-Toy DE, 2005, J PROTEOME RES, V4, P2404, DOI 10.1021/pr050208p; Rodriguez FJ, 2008, LAB INVEST, V88, P1024, DOI 10.1038/labinvest.2008.72; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scicchitano MS, 2009, J HISTOCHEM CYTOCHEM, V57, P849, DOI 10.1369/jhc.2009.953497; SEKINE M, 1990, J BIOCHEM-TOKYO, V108, P103, DOI 10.1093/oxfordjournals.jbchem.a123147; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Sun W, 2006, MOL CELL PROTEOMICS, V5, P769, DOI 10.1074/mcp.T500022-MCP200; Tanca A, 2012, PROTEOM CLIN APPL, V6, P7, DOI 10.1002/prca.201100044; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wisniewski JR, 2013, PROTEOM CLIN APPL, V7, P225, DOI 10.1002/prca.201200046; Wisniewski JR, 2011, J PROTEOME RES, V10, P3040, DOI 10.1021/pr200019m; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001	24	19	19	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142650	10.1371/journal.pone.0142650	http://dx.doi.org/10.1371/journal.pone.0142650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580073	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600053
J	Chen, XF; Wei, ZC; Wang, TT; Zhang, ZL; Wang, YW; Heckman, MG; Diehl, NN; Zhang, YW; Xu, HX; Bu, GJ				Chen, Xiao-Fen; Wei, Zichen; Wang, Tingting; Zhang, Zhen-Lian; Wang, Yiwei; Heckman, Michael G.; Diehl, Nancy N.; Zhang, Yun-Wu; Xu, Huaxi; Bu, Guojun			Demographic and Lifestyle Characteristics, but Not Apolipoprotein E Genotype, Are Associated with Intelligence among Young Chinese College Students	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; APOE GENOTYPE; CHOLESTEROL-METABOLISM; MEMORY CONSOLIDATION; TRANSPORT PROTEIN; COGNITIVE CHANGE; SLEEP; RISK; EPSILON-4; ALLELE	Background Intelligence is an important human feature that strongly affects many life outcomes, including health, life-span, income, educational and occupational attainments. People at all ages differ in their intelligence but the origins of these differences are much debated. A variety of environmental and genetic factors have been reported to be associated with individual intelligence, yet their nature and contribution to intelligence differences have been controversial. Objective To investigate the contribution of apolipoprotein E (APOE) genotype, which is associated with the risk for Alzheimer's disease, as well as demographic and lifestyle characteristics, to the variation in intelligence. Methods A total of 607 Chinese college students aged 18 to 25 years old were included in this prospective observational study. The Chinese revision of Wechsler Adult Intelligence Scale (the fourth edition, short version) was used to determine the intelligence level of participants. Demographic and lifestyle characteristics data were obtained from self-administered questionnaires. Results No significant association was found between APOE polymorphic alleles and different intelligence quotient (IQ) measures. Interestingly, a portion of demographic and lifestyle characteristics, including age, smoking and sleep quality were significantly associated with different IQ measures. Conclusions Our findings indicate that demographic features and lifestyle characteristics, but not APOE genotype, are associated with intelligence measures among young Chinese college students. Thus, although APOE epsilon 4 allele is a strong genetic risk factor for Alzheimer's disease, it does not seem to impact intelligence at young ages.	[Chen, Xiao-Fen; Wei, Zichen; Wang, Tingting; Zhang, Zhen-Lian; Zhang, Yun-Wu; Xu, Huaxi; Bu, Guojun] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China; [Wang, Yiwei] Xiamen Univ, Affiliated Hosp 1, Xiamen 361003, Peoples R China; [Heckman, Michael G.; Diehl, Nancy N.] Mayo Clin, Div Biomed Stat & Informat, Jacksonville, FL 32224 USA; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Xiamen University; Xiamen University; Mayo Clinic; Mayo Clinic	Chen, XF (corresponding author), Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China.	chenxf@xmu.edu.cn; bu.guojun@mayo.edu	wang, tingting/AAK-2640-2020; Xu, Huaxi/AAV-7177-2021	Zhang, Yun-wu/0000-0002-7152-7630	National Institutes of Health [R01AG027924, R01AG035355, R01AG046205, RF1AG051504]; National Natural Science Foundation of China [81370459, 31400914]; Fundamental Research Funds for the Central Universities [20720150051]; NATIONAL INSTITUTE ON AGING [R01AG046205, P50AG016574, RF1AG051504, R01AG035355, R01AG027924, RF1AG046205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (http://www.nih.gov/) grants R01AG027924, R01AG035355, R01AG046205, RF1AG051504 (to GB) and grants (81370459, 31400914) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/) (to XC). The study was also supported by the Fundamental Research Funds for the Central Universities (20720150051, to XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; Bloss CS, 2008, BIOL PSYCHIAT, V64, P904, DOI 10.1016/j.biopsych.2008.07.004; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bunce D, 2014, J GERONTOL A-BIOL, V69, P379, DOI 10.1093/gerona/glt103; Cai SR, 2015, AM J CLIN NUTR, V101, P326, DOI 10.3945/ajcn.114.095414; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fujioka H, 2013, J HEALTH CARE POOR U, V24, P70, DOI 10.1353/hpu.2014.0009; Giorgetti R, 2015, FORENSIC SCI INT, V252, P127, DOI 10.1016/j.forsciint.2015.04.024; Hamanaka H, 2000, HUM MOL GENET, V9, P353, DOI 10.1093/hmg/9.3.353; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Keene CD, 2011, CURR OPIN NEUROBIOL, V21, P920, DOI 10.1016/j.conb.2011.08.002; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Liraz O, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-16; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Loeber S, 2009, ALCOHOL ALCOHOLISM, V44, P372, DOI 10.1093/alcalc/agp030; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Medway CW, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-11; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889; Rapp A, 2006, BIOCHIMIE, V88, P473, DOI 10.1016/j.biochi.2005.10.007; Richards M, 2003, AM J PUBLIC HEALTH, V93, P994, DOI 10.2105/AJPH.93.6.994; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schultz MR, 2008, NEUROLOGY, V70, P1771, DOI 10.1212/01.wnl.0000286941.74372.cc; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Taylor AE, 2011, BIOL PSYCHIAT, V70, P152, DOI 10.1016/j.biopsych.2010.10.033; Turic D, 2001, NEUROSCI LETT, V299, P97, DOI 10.1016/S0304-3940(00)01789-4; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Van Der Werf YD, 2009, NAT NEUROSCI, V12, P122, DOI 10.1038/nn.2253; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851	46	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143157	10.1371/journal.pone.0143157	http://dx.doi.org/10.1371/journal.pone.0143157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7BR	26574747	Green Submitted, gold, Green Published			2022-12-26	WOS:000365153400048
J	Baras, AS; Mitchell, CJ; Myers, JR; Gupta, S; Weng, LC; Ashton, JM; Cornish, TC; Pandey, A; Halushka, MK				Baras, Alexander S.; Mitchell, Christopher J.; Myers, Jason R.; Gupta, Simone; Weng, Lien-Chun; Ashton, John M.; Cornish, Toby C.; Pandey, Akhilesh; Halushka, Marc K.			miRge - A Multiplexed Method of Processing Small RNA-Seq Data to Determine MicroRNA Entropy	PLOS ONE			English	Article							SEQUENCING DATA; QUALITY-CONTROL; GENES; EXPRESSION	Small RNA RNA-seq for microRNAs (miRNAs) is a rapidly developing field where opportunities still exist to create better bioinformatics tools to process these large datasets and generate new, useful analyses. We built miRge to be a fast, smart small RNA-seq solution to process samples in a highly multiplexed fashion. miRge employs a Bayesian alignment approach, whereby reads are sequentially aligned against customized mature miRNA, hairpin miRNA, noncoding RNA and mRNA sequence libraries. miRNAs are summarized at the level of raw reads in addition to reads per million (RPM). Reads for all other RNA species (tRNA, rRNA, snoRNA, mRNA) are provided, which is useful for identifying potential contaminants and optimizing small RNA purification strategies. miRge was designed to optimally identify miRNA isomiRs and employs an entropy based statistical measurement to identify differential production of isomiRs. This allowed us to identify decreasing entropy in isomiRs as stem cells mature into retinal pigment epithelial cells. Conversely, we show that pancreatic tumor miRNAs have similar entropy to matched normal pancreatic tissues. In a head-to-head comparison with other miRNA analysis tools (miRExpress 2.0, sRNAbench, omiRAs, miRDeep2, Chimira, UEA small RNA Workbench), miRge was faster (4 to 32-fold) and was among the top-two methods in maximally aligning miRNAs reads per sample. Moreover, miRge has no inherent limits to its multiplexing. miRge was capable of simultaneously analyzing 100 small RNA-Seq samples in 52 minutes, providing an integrated analysis of miRNA expression across all samples. As miRge was designed for analysis of single as well as multiple samples, miRge is an ideal tool for high and low-throughput users. miRge is freely available at http://atlas.pathology.jhu.edu/baras/miRge.html.	[Baras, Alexander S.; Weng, Lien-Chun; Cornish, Toby C.; Halushka, Marc K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Mitchell, Christopher J.; Gupta, Simone; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Myers, Jason R.; Ashton, John M.] Univ Rochester, Genom Res Ctr, Rochester, NY USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of Rochester; Johns Hopkins University	Halushka, MK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	mhalush1@jhmi.edu	Pandey, Akhilesh/CAI-9458-2022; Cornish, Toby C/A-4394-2015	Pandey, Akhilesh/0000-0001-9943-6127; Cornish, Toby C/0000-0002-1902-2109; Halushka, Marc/0000-0002-7112-7389; Ashton, John/0000-0001-9875-5994	American Heart Association [13GRNT16420015]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association (13GRNT16420015 to MKH, https://research.americanheart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Civelek M, 2013, HUM MOL GENET, V22, P3023, DOI 10.1093/hmg/ddt159; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Guo L, 2012, MOL BIOL REP, V39, P6699, DOI 10.1007/s11033-012-1493-3; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hu GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037224; Kent OA, 2014, NUCLEIC ACIDS RES, V42, P7528, DOI 10.1093/nar/gku461; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Monk M, 2001, ONCOGENE, V20, P8085, DOI 10.1038/sj.onc.1205088; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mueller S, 2013, BIOINFORMATICS, V29, P2651, DOI 10.1093/bioinformatics/btt457; Muller S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0358-5; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Tan GC, 2014, NUCLEIC ACIDS RES, V42, P9424, DOI 10.1093/nar/gku656; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Vitsios DM, 2015, BIOINFORMATICS, V31, P3365, DOI 10.1093/bioinformatics/btv380; Wang SQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118856; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93	35	50	51	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143066	10.1371/journal.pone.0143066	http://dx.doi.org/10.1371/journal.pone.0143066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571139	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700127
J	Chen, YZ; Yang, YL; Chu, WL; You, MS; Lo, HJ				Chen, Yin-Zhi; Yang, Yun-Liang; Chu, Wen-Li; You, May-Su; Lo, Hsiu-Jung			Zebrafish Egg Infection Model for Studying Candida albicans Adhesion Factors	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; DROSOPHILA-MELANOGASTER; FILAMENTOUS GROWTH; GENE-EXPRESSION; IMMUNE-RESPONSE; VIRULENCE; BIOFILMS; MUTANT; SUSCEPTIBILITY; SURVEILLANCE	Disseminated candidiasis is associated with 30-40% mortality in severely immunocompromised patients. Among the causal agents, Candida albicans is the dominant one. Various animal models have been developed for investigating gene functions in C. albicans. Zebrafish injection models have increasingly been applied in elucidating C. albicans pathogenesis because of the conserved immunity, prolific fecundity of the zebrafish and the low costs of care systems. In this study, we established a simple, noninvasive zebrafish egg bath infection model, defined its optimal conditions, and evaluated the model with various C. albicans mutant strains. The deletion of SAP6 did not have significant effect on the virulence. By contrast, the deletion of BCR1, CPH1, EFG1, or TEC1 significantly reduced the virulence under current conditions. Furthermore, all embryos survived when co-incubated with bcr1/bcr1, cph1/cph1 efg1/efg1, efg1/efg1, or tec1/tec1 mutant cells. The results indicated that our novel zebrafish model is time-saving and cost effective.	[Chen, Yin-Zhi; Chu, Wen-Li; Lo, Hsiu-Jung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Yang, Yun-Liang] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yang, Yun-Liang] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan; [You, May-Su] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Lo, Hsiu-Jung] China Med Univ, Sch Dent, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; China Medical University Taiwan	Lo, HJ (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan.	hjlo@nhri.org.tw			Ministry of Science and Technology, Taiwan [99-2320-B-400-006-MY3, 102-2311-B-400-001, 99-2320-B-009-001-MY3, 102-2320-B-009-001]; National Health Research Institutes, Taiwan [01A1-IV-PP09-014, 02A1-IVPP08-014]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported in parts by grants from the Ministry of Science and Technology, Taiwan (99-2320-B-400-006-MY3 and 102-2311-B-400-001 to HJL, as well as 99-2320-B-009-001-MY3 and 102-2320-B-009-001 to YLY) and the National Health Research Institutes, Taiwan, (01A1-IV-PP09-014 and 02A1-IVPP08-014 to HJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarco AM, 2004, J IMMUNOL, V172, P5622, DOI 10.4049/jimmunol.172.9.5622; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Brothers KM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003634; Brothers KM, 2011, EUKARYOT CELL, V10, P932, DOI 10.1128/EC.05005-11; Buu LM, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-101; Chamilos G, 2006, J INFECT DIS, V193, P1014, DOI 10.1086/500950; Chamilos G, 2009, J INFECT DIS, V200, P152, DOI 10.1086/599363; Chandra J, 2008, NAT PROTOC, V3, P1909, DOI 10.1038/nprot.2008.192; Chao CC, 2010, INFECT IMMUN, V78, P2512, DOI 10.1128/IAI.01293-09; Chen CG, 2006, INT J IMMUNOPATH PH, V19, P561, DOI 10.1177/039463200601900312; Chen YC, 1997, INFECT CONT HOSP EP, V18, P369, DOI 10.1086/647628; Cheng MF, 2004, DIAGN MICR INFEC DIS, V48, P33, DOI 10.1016/j.diagmicrobio.2003.08.002; Correia A, 2010, INFECT IMMUN, V78, P4839, DOI 10.1128/IAI.00248-10; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; DABROWA N, 1981, J GEN MICROBIOL, V127, P391; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gratacap RL, 2013, DIS MODEL MECH, V6, P1260, DOI 10.1242/dmm.012039; Harriott MM, 2010, MICROBIOL-SGM, V156, P3635, DOI 10.1099/mic.0.039354-0; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kais B, 2013, AQUAT TOXICOL, V140, P229, DOI 10.1016/j.aquatox.2013.05.022; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lewis RE, 2002, ANTIMICROB AGENTS CH, V46, P1153, DOI 10.1128/AAC.46.4.1153-1155.2002; Lin CH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003305; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI DOI 10.1016/S0092-8674(00)80358-X; MONOD M, 1994, MOL MICROBIOL, V13, P357, DOI 10.1111/j.1365-2958.1994.tb00429.x; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Nailis H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-114; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Pfaller MA, 2001, J CLIN MICROBIOL, V39, P3254, DOI 10.1128/JCM.39.9.3254-3259.2001; Pukkila-Worley R, 2009, EUKARYOT CELL, V8, P1750, DOI 10.1128/EC.00163-09; Schweizer A, 2000, MOL MICROBIOL, V38, P435, DOI 10.1046/j.1365-2958.2000.02132.x; SHEPHERD MG, 1980, CAN J MICROBIOL, V26, P21, DOI 10.1139/m80-004; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Westerfield M, 1993, ZEBRAFISH BOOK; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yang YL, 2010, MED MYCOL, V48, P328, DOI 10.3109/13693780903154070; Yang Yun-Liang, 2001, Journal of Microbiology Immunology and Infection, V34, P79; Yang Yun-Liang, 2003, Journal of Microbiology Immunology and Infection, V36, P223	42	17	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143048	10.1371/journal.pone.0143048	http://dx.doi.org/10.1371/journal.pone.0143048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569623	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700125
J	Loy, SL; Lek, N; Yap, F; Soh, SE; Padmapriya, N; Tan, KH; Biswas, A; Yeo, GSH; Kwek, K; Gluckman, PD; Godfrey, KM; Saw, SM; Muller-Riemenschneider, F; Chong, YS; Chong, MFF; Chan, JKY				Loy, See Ling; Lek, Ngee; Yap, Fabian; Soh, Shu E.; Padmapriya, Natarajan; Tan, Kok Hian; Biswas, Arijit; Yeo, George Seow Heong; Kwek, Kenneth; Gluckman, Peter D.; Godfrey, Keith M.; Saw, Seang Mei; Mueller-Riemenschneider, Falk; Chong, Yap-Seng; Chong, Mary Foong-Fong; Chan, Jerry Kok Yen		Growing Up Singapore Towards	Association of Maternal Vitamin D Status with Glucose Tolerance and Caesarean Section in a Multi-Ethnic Asian Cohort: The Growing Up in Singapore Towards Healthy Outcomes Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; GESTATIONAL DIABETES-MELLITUS; PREGNANCY OUTCOMES; 1ST TRIMESTER; D DEFICIENCY; D INADEQUACY; FETAL SEX; RISK; METABOLISM; PREVALENCE	Objective Epidemiological studies relating maternal 25-hydroxyvitamin D (25OHD) with gestational diabetes mellitus (GDM) and mode of delivery have shown controversial results. We examined if maternal 25OHD status was associated with plasma glucose concentrations, risks of GDM and caesarean section in the Growing Up in Singapore Towards healthy Outcomes (GUSTO) study. Methods Plasma 25OHD concentrations, fasting glucose (FG) and 2-hour postprandial glucose (2HPPG) concentrations were measured in 940 women from a Singapore mother-offspring cohort study at 26-28 weeks' gestation. 25OHD inadequacy and adequacy were defined based on concentrations of 25OHD <= 75nmol/l and >75nmol/l respectively. Mode of delivery was obtained from hospital records. Multiple linear regression was performed to examine the association between 25OHD status and glucose concentrations, while multiple logistic regression was performed to examine the association of 25OHD status with risks of GDM and caesarean section. Results In total, 388 (41.3%) women had 25OHD inadequacy. Of these, 131 (33.8%), 155 (39.9%) and 102 (26.3%) were Chinese, Malay and Indian respectively. After adjustment for confounders, maternal 25OHD inadequacy was associated with higher FG concentrations (beta = 0.08mmol/l, 95% Confidence Interval (CI) = 0.01, 0.14), but not 2HPPG concentrations and risk of GDM. A trend between 25OHD inadequacy and higher likelihood of emergency caesarean section (Odds Ratio (OR) = 1.39, 95% CI = 0.95, 2.05) was observed. On stratification by ethnicity, the association with higher FG concentrations was significant in Malay women (beta = 0.19mmol/l, 95% CI = 0.04, 0.33), while risk of emergency caesarean section was greater in Chinese (OR = 1.90, 95% CI = 1.06, 3.43) and Indian women (OR = 2.41, 95% CI = 1.01, 5.73). Conclusions 25OHD inadequacy is prevalent in pregnant Singaporean women, particularly among the Malay and Indian women. This is associated with higher FG concentrations in Malay women, and increased risk of emergency caesarean section in Chinese and Indian women.	[Loy, See Ling; Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore; [Lek, Ngee; Yap, Fabian; Chan, Jerry Kok Yen] Duke NUS Grad Med Sch, Singapore, Singapore; [Lek, Ngee; Yap, Fabian] KK Womens & Childrens Hosp, Dept Paediat, Singapore, Singapore; [Soh, Shu E.; Gluckman, Peter D.; Chong, Yap-Seng; Chong, Mary Foong-Fong] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Padmapriya, Natarajan; Biswas, Arijit; Chong, Yap-Seng] Natl Univ Hlth Syst, Natl Univ Singapore, Dept Obstet & Gynaecol, Yong Loo Lin Sch Med, Singapore, Singapore; [Tan, Kok Hian] KK Womens & Childrens Hosp, Div Obstet & Gynaecol, Singapore, Singapore; [Yeo, George Seow Heong; Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Godfrey, Keith M.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Saw, Seang Mei; Mueller-Riemenschneider, Falk] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Mueller-Riemenschneider, Falk] Charite, Med Ctr, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Chong, Mary Foong-Fong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore 117595, Singapore; [Chong, Mary Foong-Fong] Natl Univ Hlth Syst, Singapore, Singapore; [Chong, Mary Foong-Fong] ASTAR, Clin Nutr Res Ctr, Singapore Inst Clin Sci, Singapore, Singapore; [Chan, Jerry Kok Yen] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore	KK Women's & Children's Hospital; National University of Singapore; KK Women's & Children's Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; KK Women's & Children's Hospital; KK Women's & Children's Hospital; University of Auckland; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; National University of Singapore; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); KK Women's & Children's Hospital	Chong, MFF (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	mary_chong@sics.a-star.edu.sg; jerrychan@duke-nus.edu.sg	Tan, Kok Hian/AFS-6514-2022; Loy, SeeLing/AGW-6714-2022; Lee, Yung Seng/F-2169-2014; Henry, Christiani Jeyakumar/AHB-2632-2022; Qiu, Anqi/H-2267-2011; Hsu, Chin-ying/E-7855-2016	Lee, Yung Seng/0000-0002-1253-0557; Henry, Christiani Jeyakumar/0000-0002-1602-0140; SOH, SHU E/0000-0002-0790-4200; Richmond, Jenny/0000-0002-5808-4249; Qiu, Anqi/0000-0002-0215-6338; Hsu, Chin-ying/0000-0001-7367-3204; Chong, Yap Seng/0000-0002-7232-8473; Tan, Kok Hian/0000-0003-1945-0266; Yap, Fabian/0000-0003-1083-7958; Muller-Riemenschneider, Falk/0000-0003-1402-7477; Godfrey, Keith/0000-0002-4643-0618; TINT, Mya Thway/0000-0002-9548-7186; Kapur, Jeevesh/0000-0002-5696-0233; BISWAS, ARIJIT/0000-0002-3311-2135; Shek, Lynette/0000-0001-9064-8983; Amutha, Chinnaiah/0000-0003-1395-2089	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union [289346]; Ministry of Health's National Medical Research Council, Singapore [NMRC/CSA/043/2012]; MRC [MC_UU_12011/4, MC_UP_A620_1017] Funding Source: UKRI; Medical Research Council [MC_UP_A620_1017, MC_UU_12011/4] Funding Source: researchfish	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme(National Research Foundation, Singapore); Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; European Union(European Commission); Ministry of Health's National Medical Research Council, Singapore(Ministry of Health-SingaporeNational Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore-NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014. Additional funding is provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore. KMG is supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre and by the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement number 289346. JKYC received salary support from the Ministry of Health's National Medical Research Council, Singapore (NMRC/CSA/043/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud M, 2013, ENDOCRINOLOGY, V154, P3022, DOI 10.1210/en.2012-2245; Aghajafari F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1169; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aris IM, 2014, J CLIN ENDOCR METAB, V99, P240, DOI 10.1210/jc.2013-2738; Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844; Bruyere O, 2014, ARCH GERONTOL GERIAT, V59, P78, DOI 10.1016/j.archger.2014.03.010; Burris HH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.022; Charatcharoenwitthaya N, 2013, CLIN ENDOCRINOL, V78, P126, DOI 10.1111/j.1365-2265.2012.04470.x; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Cho GJ, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.015; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000; Clifton-Bligh RJ, 2008, DIABETIC MED, V25, P678, DOI 10.1111/j.1464-5491.2008.02422.x; El Lithy A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-362; Fernandez-Alonso AM, 2012, INT J GYNECOL OBSTET, V116, P6, DOI 10.1016/j.ijgo.2011.07.029; Gernand AD, 2015, J PERINATOL, V35, P23, DOI 10.1038/jp.2014.139; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Joergensen JS, 2014, CURR OPIN CLIN NUTR, V17, P360, DOI 10.1097/MCO.0000000000000064; Lacroix M, 2014, ACTA DIABETOL, V51, P609, DOI 10.1007/s00592-014-0564-4; Levin GP, 2012, JAMA-J AM MED ASSOC, V308, P1898, DOI 10.1001/jama.2012.17304; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; McLeod DSA, 2012, DIABETIC MED, V29, pE199, DOI 10.1111/j.1464-5491.2011.03551.x; Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mission JF, 2015, OBSTET GYN CLIN N AM, V42, P335, DOI 10.1016/j.ogc.2015.01.008; Mulligan ML, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.002; Nimitphong H, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24054; Organization WH, 1998, WELLB MEAS PRIM HLTH; Padmapriya N, 2015, MATERN CHILD HLTH J, V19, P2523, DOI 10.1007/s10995-015-1773-3; Parlea L, 2012, DIABETIC MED, V29, pE25, DOI 10.1111/j.1464-5491.2011.03550.x; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Retnakaran R, 2015, J CLIN ENDOCR METAB, V100, P2574, DOI 10.1210/jc.2015-1763; Retnakaran R, 2015, DIABETES CARE, V38, P844, DOI 10.2337/dc14-2551; Robien K, 2013, BRIT J NUTR, V109, P493, DOI 10.1017/S0007114512001675; Savvidou MD, 2012, BRIT J NUTR, V108, P1972, DOI 10.1017/S0007114512000207; Schneuer FJ, 2014, AM J CLIN NUTR, V99, P287, DOI 10.3945/ajcn.113.065672; Scholl TO, 2012, NUTRIENTS, V4, P319, DOI 10.3390/nu4040319; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Slominski AT, 2014, MOL CELL ENDOCRINOL, V383, P181, DOI 10.1016/j.mce.2013.12.012; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Soh SE, 2014, INT J EPIDEMIOL, V43, P1401, DOI 10.1093/ije/dyt125; Sung CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/634195; Tan KML, 2013, J CLIN LAB ANAL, V27, P301, DOI 10.1002/jcla.21602; Thota C, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.027; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Vienonen A, 2004, J SOC GYNECOL INVEST, V11, P104, DOI 10.1016/j.jsgi.2003.09.003; Wang O, 2012, BIOMED ENVIRON SCI, V25, P399, DOI 10.3967/0895-3988.2012.04.004; Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849; Zuhur SS, 2013, CLINICS, V68, P658, DOI 10.6061/clinics/2013(05)13	49	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142239	10.1371/journal.pone.0142239	http://dx.doi.org/10.1371/journal.pone.0142239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571128	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000365070700026
J	Radinger, J; Wolter, C; Kail, J				Radinger, Johannes; Wolter, Christian; Kail, Jochem			Spatial Scaling of Environmental Variables Improves Species-Habitat Models of Fishes in a Small, Sand-Bed Lowland River	PLOS ONE			English	Article							ECOLOGICAL STATUS; RUNNING WATERS; AUTOCORRELATION; SUITABILITY; DISPERSAL; ACCURACY; STREAMS; TROUT	Habitat suitability and the distinct mobility of species depict fundamental keys for explaining and understanding the distribution of river fishes. In recent years, comprehensive data on river hydromorphology has been mapped at spatial scales down to 100 m, potentially serving high resolution species-habitat models, e.g., for fish. However, the relative importance of specific hydromorphological and in-stream habitat variables and their spatial scales of influence is poorly understood. Applying boosted regression trees, we developed species-habitat models for 13 fish species in a sand-bed lowland river based on river morphological and in-stream habitat data. First, we calculated mean values for the predictor variables in five distance classes (from the sampling site up to 4000 m up-and downstream) to identify the spatial scale that best predicts the presence of fish species. Second, we compared the suitability of measured variables and assessment scores related to natural reference conditions. Third, we identified variables which best explained the presence of fish species. The mean model quality (AUC = 0.78, area under the receiver operating characteristic curve) significantly increased when information on the habitat conditions up-and downstream of a sampling site (maximum AUC at 2500 m distance class, +0.049) and topological variables (e.g., stream order) were included (AUC = +0.014). Both measured and assessed variables were similarly well suited to predict species' presence. Stream order variables and measured cross section features (e.g., width, depth, velocity) were best-suited predictors. In addition, measured channel-bed characteristics (e.g., substrate types) and assessed longitudinal channel features (e.g., naturalness of river planform) were also good predictors. These findings demonstrate (i) the applicability of high resolution river morphological and instream-habitat data (measured and assessed variables) to predict fish presence, (ii) the importance of considering habitat at spatial scales larger than the sampling site, and (iii) that the importance of (river morphological) habitat characteristics differs depending on the spatial scale.	[Radinger, Johannes; Wolter, Christian] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Kail, Jochem] Univ Duisburg Essen, Dept Aquat Ecol, Essen, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Duisburg Essen	Radinger, J (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany.	jradinger@igb-berlin.de	Wolter, Christian/F-6210-2014; Radinger, Johannes/B-9113-2013	Radinger, Johannes/0000-0002-2637-9464; Wolter, Christian/0000-0002-2819-2900	Commission of the European Communities; German Federal Ministry for Education and Research [02WM1134]	Commission of the European Communities(European Commission); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This project has been carried out with financial support from the Commission of the European Communities, specifically the RTD programme "IWRMNET". It does not necessarily reflect its views and in no way anticipates the Commission's future policy in this area. The authors have been funded by the German Federal Ministry for Education and Research (grant number 02WM1134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens U, 2007, JAHRESBERICHT 200607, P115; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Angermeier PL, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P519; [Anonymous], 2010, GEOGR RES AN SUPP SY; AUSTIN MP, 1984, VEGETATIO, V55, P11, DOI 10.1007/BF00039976; Bates D., 2013, LME4 LINEAR MIXED EF; Bellamy C, 2013, J APPL ECOL, V50, P892, DOI 10.1111/1365-2664.12117; Belletti B, 2015, ENVIRON EARTH SCI, V73, P2079, DOI 10.1007/s12665-014-3558-1; Bivand R, 2013, SPGRASS6 INTERFACE G; Brunke M., 2008, HYDROL WASSERBEWIRTS, V5, P234; Buisson L, 2008, ECOL FRESHW FISH, V17, P244, DOI 10.1111/j.1600-0633.2007.00276.x; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dirnbock T, 2004, J VEG SCI, V15, P77, DOI 10.1111/j.1654-1103.2004.tb02239.x; Dussling U, 2009, HDB FIBS SCHRIFTENRE, P1; Ehrlen J, 2015, ECOL LETT, V18, P303, DOI 10.1111/ele.12410; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2013, BOOSTED REGRESSION T, P1; Environment Agency, 2003, RIV HAB SURV BRIT IR; Fernandez D, 2011, LIMNETICA, V30, P217; Filipe AF, 2013, DIVERS DISTRIB, V19, P1059, DOI 10.1111/ddi.12086; Franklin J, 2009, MAPPING SPECIES DIST; Gellert G, 2014, ENVIRON MONIT ASSESS, V186, P3365, DOI 10.1007/s10661-014-3623-y; Gowan C, 1996, CAN J FISH AQUAT SCI, V53, P1370, DOI 10.1139/cjfas-53-6-1370; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hijmans R.J., 2014, DISMO SPECIES DISTRI; Hijmans R.J., 2014, RASTER GEOGRAPHIC AN; Hijmans RJ, 2013, CRAN VIGNETTE; Illies J, 1961, INT REV GESAMTEN HYD, V46, P205, DOI [10.1002/iroh, DOI 10.1002/IROH.19610460205, 10.1002/iroh.19610460205]; Jahnig SC, 2013, HYDROBIOLOGIA, V712, P89, DOI 10.1007/s10750-012-1264-0; Kail J, 2013, SCI TOTAL ENVIRON, V454, P40, DOI 10.1016/j.scitotenv.2013.02.096; Kail J, 2009, RIVER RES APPL, V25, P537, DOI 10.1002/rra.1238; Kamp U, 2007, ENVIRON MONIT ASSESS, V127, P209, DOI 10.1007/s10661-006-9274-x; Knighton D., 1998, FLUVIAL FORMS PROCES; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LAWA, 2000, GEW BUND DTSCH VERF; Leclere J, 2011, ECOL INFORM, V6, P276, DOI 10.1016/j.ecoinf.2011.05.001; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Logez M, 2013, ECOGRAPHY, V36, P80, DOI 10.1111/j.1600-0587.2012.07447.x; Lucas M, 2001, MIGRATION FRESHWATER; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Markovic D, 2014, DIVERS DISTRIB, V20, P1097, DOI 10.1111/ddi.12232; Markovic D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040530; Melcher A, 2007, FISHERIES MANAG ECOL, V14, P453, DOI 10.1111/j.1365-2400.2007.00583.x; Muhar S, 1998, HYDROBIOLOGIA, V386, P195, DOI 10.1023/A:1003588631679; Olden JD, 2002, FRESHWATER BIOL, V47, P1976, DOI 10.1046/j.1365-2427.2002.00945.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pottgiesser T., 2008, BESCHREIBUNG BEWERTU; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Radinger J, 2015, ECOL APPL, V25, P914, DOI 10.1890/14-0422.1; Radinger J, 2014, FISH FISH, V15, P456, DOI 10.1111/faf.12028; Ruiz JC, 2007, T AM FISH SOC, V136, P1640, DOI 10.1577/T06-086.1; Schaarschmidt T, 2005, FISCHFAUNA KLEINEN F; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; SHREVE RL, 1966, J GEOL, V74, P17, DOI 10.1086/627137; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Trautwein C, 2012, AQUAT SCI, V74, P329, DOI 10.1007/s00027-011-0224-5; Wuellner MR, 2013, J FISH BIOL, V82, P1497, DOI 10.1111/jfb.12081; Zuur Alain F., 2009, P1	61	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142813	10.1371/journal.pone.0142813	http://dx.doi.org/10.1371/journal.pone.0142813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569119	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700075
J	Ranjha, R; Aggarwal, S; Bopanna, S; Ahuja, V; Paul, J				Ranjha, Raju; Aggarwal, Surbhi; Bopanna, Sawan; Ahuja, Vineet; Paul, Jaishree			Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; CROHNS-DISEASE; RISK; CARCINOGENESIS; PROLIFERATION; PROGRESSION; DIAGNOSIS; CONSENSUS; INVASION	Background and Aim Ulcerative Colitis (UC) is a type of inflammatory bowel disease, considered as an important disease of gastrointestinal tract having a huge impact on the health of the patient. Prolonged inflammation of colon in UC patients increases the risk of developing colorectal cancer. MiRNA are reported as a connecting link between inflammation and cancer. Differential miRNA expression is reported in Crohn's disease (CD) patients involving various regions of the gastrointestinal tract. The current study was performed to dissect out the site specific miRNA expression in the colon biopsy samples of UC patients from Northern India. Methods Biopsy samples were collected from UC patients and healthy controls from Rectosigmoid Area (RS) and Ascending Colon (AC). MiRNA expression was compared between patients with RS and AC using a microarray platform. Differential expression was further validated by Real Time PCR analysis. Demographic and pathological data of UC -associated CRC patients was collected from the hospital database and analyzed for assessing the site of cancer. Results Upon analysis of data generated on a microarray platform and qRT PCR revealed that the expression of six miRNAs hsa-miR-146b-5p, hsa-miR-335-3p, hsa-miR-342-3p, hsa-miR-644b-3p, hsa-miR-491-3p, hsa-miR-4732-3p were downregulated in patients where RS was involved as compared to AC. The expression of hsa-miR-141-3p was upregulated in patients where RS region was involved as compared to AC. Analysis of the registered UC patient's database from the hospital revealed that the site of CRC was predomimnantly the rectosigmoid region of the colon in most of the cases. Conclusion This is the first study to show the differential expression of miRNA involving different sites of colon in UC patients. Taking our data and previous reports into consideration, we propose that differential miRNA expression during UC perhaps contribute in the development of UC-associated CRC at the rectosigmoid area.	[Ranjha, Raju; Aggarwal, Surbhi; Paul, Jaishree] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Bopanna, Sawan; Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India	Jawaharlal Nehru University, New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Paul, J (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	jpaul33@hotmail.com	Ahuja, Vineet/N-1705-2019	Ahuja, Vineet/0000-0002-5474-9709; Aggarwal, Surbhi/0000-0002-0629-9838	Department of Biotechnology, New Delhi [BT/PR8348/MED/30/1023/2013]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India)	The research was supported by a research grant from the Department of Biotechnology, New Delhi, received by JP (No. BT/PR8348/MED/30/1023/2013). http://dbtepromis.nic.in/Login.aspx.	Bai J, 2014, MOL BIOSYST, V10, P2317, DOI 10.1039/c4mb00169a; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bates MD, 2002, GASTROENTEROLOGY, V122, P1467, DOI 10.1053/gast.2002.32975; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Vega AB, 2013, ONCOL REP, V30, P320, DOI 10.3892/or.2013.2475; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; CHOI PM, 1994, GUT, V35, P950, DOI 10.1136/gut.35.7.950; Dalal Sushila R, 2010, Gastroenterol Hepatol (N Y), V6, P714; Diaz-Beya M, 2014, LEUKEMIA, V28, P804, DOI 10.1038/leu.2013.281; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; Hardin H, 2014, AM J PATHOL, V184, P2342, DOI 10.1016/j.ajpath.2014.04.011; Iliopoulos D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005053; Kanaan Z, 2012, HUM MUTAT, V33, P551, DOI 10.1002/humu.22021; Kutty RK, 2013, MOL VIS, V19, P737; Mei ZF, 2014, FEBS LETT, V588, P3055, DOI 10.1016/j.febslet.2014.06.020; Necela BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018501; Nowacki TM, 2015, DIGEST DIS SCI, V60, P492, DOI 10.1007/s10620-014-3373-2; Ooi CJ, 2010, J GASTROEN HEPATOL, V25, P453, DOI 10.1111/j.1440-1746.2010.06241.x; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Ranjha R, 2013, INFLAMM RES, V62, P343, DOI 10.1007/s00011-013-0600-9; Sun ZF, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0982-8; Ueda Y, 2014, DIGEST DIS SCI, V59, P2444, DOI 10.1007/s10620-014-3193-4; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vickers MM, 2012, CLIN EXP METASTAS, V29, P123, DOI 10.1007/s10585-011-9435-3; Wang H, 2011, CARCINOGENESIS, V32, P1033, DOI 10.1093/carcin/bgr081; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Xiang M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004497; Zhang L, 2015, CLIN RES HEPATOL GAS, V39, P174, DOI 10.1016/j.clinre.2014.06.013	32	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142869	10.1371/journal.pone.0142869	http://dx.doi.org/10.1371/journal.pone.0142869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569605	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700089
J	Zhang, ZL; Chen, Y; Wang, R; Cai, RH; Fu, YN; Jiao, NZ				Zhang, Zilian; Chen, Yi; Wang, Rui; Cai, Ruanhong; Fu, Yingnan; Jiao, Nianzhi			The Fate of Marine Bacterial Exopolysaccharide in Natural Marine Microbial Communities	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; EXTRACELLULAR POLYMERIC SUBSTANCES; SEA HYDROTHERMAL VENT; SP NOV.; AQUATIC ENVIRONMENTS; OCEAN; FLUORESCENCE; CARBON; WATER; SEAWATER	Most marine bacteria produce exopolysaccharides (EPS), and bacterial EPS represent an important source of dissolved organic carbon in marine ecosystems. It was proposed that bacterial EPS rich in uronic acid is resistant to mineralization by microbes and thus has a long residence time in global oceans. To confirm this hypothesis, bacterial EPS rich in galacturonic acid was isolated from Alteromonas sp. JL2810. The EPS was used to amend natural seawater to investigate the bioavailability of this EPS by native populations, in the presence and absence of ammonium and phosphate amendment. The data indicated that the bacterial EPS could not be completely consumed during the cultivation period and that the bioavailability of EPS was not only determined by its intrinsic properties, but was also determined by other factors such as the availability of inorganic nutrients. During the experiment, the humic-like component of fluorescent dissolved organic matter (FDOM) was freshly produced. Bacterial community structure analysis indicated that the class Flavobacteria of the phylum Bacteroidetes was the major contributor for the utilization of EPS. This report is the first to indicate that Flavobacteria are a major contributor to bacterial EPS degradation. The fraction of EPS that could not be completely utilized and the FDOM (e.g., humic acid-like substances) produced de novo may be refractory and may contribute to the carbon storage in the oceans.	[Zhang, Zilian; Chen, Yi; Wang, Rui; Cai, Ruanhong; Fu, Yingnan; Jiao, Nianzhi] Xiamen Univ, Inst Marine Microbes & Ecospheres, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China	Xiamen University	Zhang, ZL (corresponding author), Xiamen Univ, Inst Marine Microbes & Ecospheres, State Key Lab Marine Environm Sci, Xiamen, Fujian, Peoples R China.	zhangzilian@xmu.edu.cn; jiao@xmu.edu.cn			National Key Basic Research Program of China [2013CB955700]; SOA project [GASI-03-01-02-05]; NSFC [91428308]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy [DE-FG02-93ER20097];  [CNOOCKJ 125 FZDXM 00TJ 001-2014]	National Key Basic Research Program of China(National Basic Research Program of China); SOA project; NSFC(National Natural Science Foundation of China (NSFC)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); 	This work was supported by the National Key Basic Research Program of China (2013CB955700), SOA project (GASI-03-01-02-05), NSFC project (91428308), and the project CNOOCKJ 125 FZDXM 00TJ 001-2014. This research was also supported by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U.S. Department of Energy grant (DE-FG02-93ER20097) to Parastoo Azadi at the Complex Carbohydrate Research Center.	Andersen CM, 2003, J CHEMOMETR, V17, P200, DOI 10.1002/cem.790; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bakunina I, 2013, MAR DRUGS, V11, P1977, DOI 10.3390/md11061977; BAUMANN L, 1972, J BACTERIOL, V110, P402, DOI 10.1128/JB.110.1.402-429.1972; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; Bhaskar PV, 2005, CURR SCI INDIA, V88, P45; Brachvogel T, 2001, AQUAT MICROB ECOL, V26, P23, DOI 10.3354/ame026023; Brakstad OG, 2005, MICROB ECOL, V49, P94, DOI 10.1007/s00248-003-0225-6; CHEN RF, 1992, MAR CHEM, V37, P191, DOI 10.1016/0304-4203(92)90078-O; CHO BC, 1990, MAR ECOL PROG SER, V63, P253, DOI 10.3354/meps063253; Coble PG, 1998, DEEP-SEA RES PT II, V45, P2195, DOI 10.1016/S0967-0645(98)00068-X; Collen PN, 2011, J BIOL CHEM, V286, P42063, DOI 10.1074/jbc.M111.271825; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eichinger M, 2006, AQUAT MICROB ECOL, V43, P139, DOI 10.3354/ame043139; GELLER A, 1986, LIMNOL OCEANOGR, V31, P755, DOI 10.4319/lo.1986.31.4.0755; Gutierrez T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067717; HEDGES JI, 1992, MAR CHEM, V39, P67, DOI 10.1016/0304-4203(92)90096-S; Heissenberger A, 1996, APPL ENVIRON MICROB, V62, P4521, DOI 10.1128/AEM.62.12.4521-4528.1996; HOPPE HG, 1988, APPL ENVIRON MICROB, V54, P784, DOI 10.1128/AEM.54.3.784-790.1988; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; KENNEDY AFD, 1987, BIOTECHNOL APPL BIOC, V9, P12; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kothawala DN, 2012, SCI TOTAL ENVIRON, V433, P238, DOI 10.1016/j.scitotenv.2012.06.029; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Li CF, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-18; Liu J, 2014, BIOGEOSCIENCES, V11, P5115, DOI 10.5194/bg-11-5115-2014; Mann AJ, 2013, APPL ENVIRON MICROB, V79, P6813, DOI 10.1128/AEM.01937-13; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; MERKLE RK, 1994, METHOD ENZYMOL, V230, P1; Milbrandt EC, 2010, LIMNOL OCEANOGR, V55, P2037, DOI 10.4319/lo.2010.55.5.2037; MYKLESTAD S, 1977, J EXP MAR BIOL ECOL, V29, P161, DOI 10.1016/0022-0981(77)90046-6; Nedashkovskaya OI, 2005, INT J SYST EVOL MICR, V55, P375, DOI 10.1099/ijs.0.63381-0; Nelson CE, 2012, ENVIRON MICROBIOL, V14, P1500, DOI 10.1111/j.1462-2920.2012.02738.x; Poli A, 2010, MAR DRUGS, V8, P1779, DOI 10.3390/md8061779; Raguenes G, 2003, CURR MICROBIOL, V46, P448, DOI 10.1007/s00284-002-3922-3; Reeburgh W.S., 1997, B ECOL SOC AM, V78, P260; Roger O, 2004, CARBOHYD RES, V339, P2371, DOI 10.1016/j.carres.2004.07.021; Romera-Castillo C, 2011, APPL ENVIRON MICROB, V77, P7490, DOI 10.1128/AEM.00200-11; Rougeaux H, 1998, CARBOHYD RES, V312, P53, DOI 10.1016/S0008-6215(97)10061-1; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; Singh N, 1999, PROCESS BIOCHEM, V35, P63, DOI 10.1016/S0032-9592(99)00033-3; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Stoderegger K, 1998, LIMNOL OCEANOGR, V43, P877, DOI 10.4319/lo.1998.43.5.0877; Sutherland I W, 1972, Adv Microb Physiol, V8, P143, DOI 10.1016/S0065-2911(08)60190-3; SUTHERLAND IW, 1982, ADV MICROB PHYSIOL, V23, P79, DOI 10.1016/S0065-2911(08)60336-7; Sutherland IW, 1999, CARBOHYD POLYM, V38, P319, DOI 10.1016/S0144-8617(98)00114-3; TRANVIK LJ, 1993, FEMS MICROBIOL ECOL, V12, P177; Vandecandelaere I, 2008, INT J SYST EVOL MICR, V58, P2589, DOI 10.1099/ijs.0.65691-0; Wang ZC, 2014, ENVIRON TECHNOL, V35, P2821, DOI 10.1080/09593330.2014.924563; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Yamashita Y, 2008, NAT GEOSCI, V1, P579, DOI 10.1038/ngeo279; Yamashita Y, 2007, MAR CHEM, V106, P498, DOI 10.1016/j.marchem.2007.05.004; Yamashita Y, 2010, DEEP-SEA RES PT II, V57, P1478, DOI 10.1016/j.dsr2.2010.02.016; Yoon JH, 2003, INT J SYST EVOL MICR, V53, P1625, DOI 10.1099/ijs.0.02536-0; ZWEIFEL UL, 1993, MAR ECOL PROG SER, V101, P23, DOI 10.3354/meps101023	58	25	27	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142690	10.1371/journal.pone.0142690	http://dx.doi.org/10.1371/journal.pone.0142690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571122	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700062
J	Hong, SM; Park, CW; Kim, SW; Nam, YJ; Yu, JH; Shin, JH; Yun, CH; Im, SH; Kim, KT; Sung, YC; Choi, KY				Hong, S. M.; Park, C. W.; Kim, S. W.; Nam, Y. J.; Yu, J. H.; Shin, J. H.; Yun, C. H.; Im, S-H; Kim, K-T; Sung, Y. C.; Choi, K. Y.			NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer	ONCOGENE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT; TUMOR-CELL SURVIVAL; METABOLISM; INHIBITION; AUTOPHAGY; ENZYME; BIOSYNTHESIS; HOMEOSTASIS; GLYCOGEN; DEATH	Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme involved in NAD+ biosynthesis. Although NAMPT has emerged as a critical regulator of metabolic stress, the underlying mechanisms by which it regulates metabolic stress in cancer cells have not been completely elucidated. In this study, we determined that breast cancer cells expressing a high level of NAMPT were resistant to cell death induced by glucose depletion. Furthermore, NAMPT inhibition suppressed tumor growth in vivo in a xenograft model. Under glucose deprivation conditions, NAMPT inhibition was found to increase the mitochondrial reactive oxygen species (ROS) level, leading to cell death. This cell death was rescued by treatment with antioxidants or NAD+. Finally, we showed that NAMPT increased the pool of NAD+ that could be converted to NADPH through the pentose phosphate pathway and inhibited the depletion of reduced glutathione under glucose deprivation. Collectively, our results suggest a novel mechanism by which tumor cells protect themselves against glucose deprivation-induced oxidative stress by utilizing NAMPT to maintain NADPH levels.	[Hong, S. M.; Park, C. W.; Kim, S. W.; Nam, Y. J.; Yu, J. H.; Shin, J. H.; Im, S-H; Kim, K-T; Sung, Y. C.; Choi, K. Y.] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Park, C. W.] Biokogen Inc, POSTECH Biotech Ctr 226, Pohang, South Korea; [Yun, C. H.; Im, S-H] AIM, IBS, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Institute for Basic Science - Korea (IBS)	Choi, KY (corresponding author), Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, PBC, Room 327, Pohang 790784, South Korea.	kchoi@postech.ac.kr	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; KIM, KYONG-TAI/0000-0001-7292-2627	National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea [1320240]; National Research Foundation of Korea (NRF) grant - Korea government (MEST) [NRF-2014R1A2A2A01002931]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01121601]; BK21 Plus - Ministry of Education, Korea [10Z20130012243]	National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea; National Research Foundation of Korea (NRF) grant - Korea government (MEST); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; BK21 Plus - Ministry of Education, Korea	This research was supported by the National R&D Program for Cancer Control, Ministry for Health and Welfare, Korea (1320240), by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (NRF-2014R1A2A2A01002931), by the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (PJ01121601) and by BK21 Plus funded by the Ministry of Education, Korea (10Z20130012243). We thank Kwan-Suk Lee at the POSTECH animal facility for assistance with animal experiments. Slide scanning images were obtained using Virtual Microscope in UNIST-Olympus Biomed Imaging Center (UOBC). We are grateful to Jin-Hoe Hur and UNIST-Olympus Biomed Imaging Center (UOBC) for providing the data of slide scanning images.	Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Bajrami I, 2012, EMBO MOL MED, V4, P1087, DOI 10.1002/emmm.201201250; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cerna D, 2012, J BIOL CHEM, V287, P22408, DOI 10.1074/jbc.M112.357301; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Choi YJ, 2014, HORM METAB RES, V46, P233, DOI 10.1055/s-0034-1370907; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Galli U, 2013, J MED CHEM, V56, P6279, DOI 10.1021/jm4001049; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; KIRKMAN HN, 1984, P NATL ACAD SCI-BIOL, V81, P4343, DOI 10.1073/pnas.81.14.4343; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Liang HL, 2009, AM J PHYSIOL-RENAL, V296, pF266, DOI 10.1152/ajprenal.90533.2008; Madhok BM, 2011, AM J CLIN ONCOL-CANC, V34, P628, DOI 10.1097/COC.0b013e3181e84dec; Magni G, 2006, MINI-REV MED CHEM, V6, P739, DOI 10.2174/138955706777698688; Park CW, 2013, AUTOPHAGY, V9, P345, DOI 10.4161/auto.23072; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Romero-Garcia S, 2011, CANCER BIOL THER, V12, P939, DOI 10.4161/cbt.12.11.18140; ROUSSET M, 1981, CANCER RES, V41, P1165; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Simons AL, 2009, J CANCER RES THER, V5, P2, DOI 10.4103/0973-1482.55133; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tew KD, 2012, ANTIOXID REDOX SIGN, V17, P1728, DOI 10.1089/ars.2012.4640; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Xiao Y, 2013, NEOPLASIA, V15, P1137, DOI 10.1593/neo.131304; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	38	39	43	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3544	3554		10.1038/onc.2015.415	http://dx.doi.org/10.1038/onc.2015.415			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26568303				2022-12-26	WOS:000379621500007
J	Liu, Y; Zhou, MY; Gao, ZX; Ren, W; Yang, FL; He, H; Zhao, JR				Liu, Ya; Zhou, Miaoyi; Gao, Zhaoxu; Ren, Wen; Yang, Fengling; He, Hang; Zhao, Jiuran			RNA-Seq Analysis Reveals MAPKKK Family Members Related to Drought Tolerance in Maize	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MEDIATES OSMOTIC-STRESS; SIGNAL-TRANSDUCTION; GENE FAMILY; ZEA-MAYS; DIFFERENTIAL GENE; CANDIDATE GENES; SALICYLIC-ACID; ARABIDOPSIS; EXPRESSION	The mitogen-activated protein kinase (MAPK) cascade is an evolutionarily conserved signal transduction pathway that is involved in plant development and stress responses. As the first component of this phosphorelay cascade, mitogen-activated protein kinase kinase kinases (MAPKKKs) act as adaptors linking upstream signaling steps to the core MAPK cascade to promote the appropriate cellular responses; however, the functions of MAPKKKs in maize are unclear. Here, we identified 71 MAPKKK genes, of which 14 were novel, based on a computational analysis of the maize (Zea mays L.) genome. Using an RNA-seq analysis in the leaf, stem and root of maize under well-watered and drought-stress conditions, we identified 5,866 differentially expressed genes (DEGs), including 8 MAPKKK genes responsive to drought stress. Many of the DEGs were enriched in processes such as drought stress, abiotic stimulus, oxidation-reduction, and metabolic processes. The other way round, DEGs involved in processes such as oxidation, photosynthesis, and starch, proline, ethylene, and salicylic acid metabolism were clearly co-expressed with the MAPKKK genes. Furthermore, a quantitative real-time PCR (qRT-PCR) analysis was performed to assess the relative expression levels of MAPKKKs. Correlation analysis revealed that there was a significant correlation between expression levels of two MAPKKKs and relative biomass responsive to drought in 8 inbred lines. Our results indicate that MAPKKKs may have important regulatory functions in drought tolerance in maize.	[Liu, Ya; Zhou, Miaoyi; Ren, Wen; Yang, Fengling; Zhao, Jiuran] Beijing Acad Agr & Forestry Sci, Maize Res Ctr, Beijing 100097, Peoples R China; [Gao, Zhaoxu; He, Hang] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Beijing 100871, Peoples R China; [Gao, Zhaoxu; He, Hang] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Adv Agr Sci, Beijing 100871, Peoples R China	Beijing Academy of Agriculture & Forestry; Peking University; Peking University	He, H (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Beijing 100871, Peoples R China.	hehang@pku.edu.cn; maizezhao@126.com	He, Hang/ABF-4074-2020; Ren, Wen/HCI-0284-2022	Ren, Wen/0000-0003-1698-6161; He, Hang/0000-0003-3165-283X	National Transgenic Major Program of China [2014ZX0800303B]; Program of Beijing New Scientific Star [Z111105054511066]	National Transgenic Major Program of China; Program of Beijing New Scientific Star	This work was supported by the National Transgenic Major Program of China (2014ZX0800303B) and the Program of Beijing New Scientific Star (Z111105054511066).	Agrawal GK, 2003, BIOCHEM BIOPH RES CO, V300, P775, DOI 10.1016/S0006-291X(02)02868-1; Agrawal GK, 2002, BIOCHEM BIOPH RES CO, V294, P1009, DOI 10.1016/S0006-291X(02)00571-5; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; BANNO H, 1993, MOL CELL BIOL, V13, P4745, DOI 10.1128/MCB.13.8.4745; BARKOSKY RR, 1993, J CHEM ECOL, V19, P237, DOI 10.1007/BF00993692; Berberich T, 1999, MOL GEN GENET, V262, P534, DOI 10.1007/s004380051115; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Cai GH, 2014, J PLANT PHYSIOL, V171, P1003, DOI 10.1016/j.jplph.2014.02.012; Champion A, 2004, TRENDS PLANT SCI, V9, P123, DOI 10.1016/j.tplants.2004.01.005; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Ding Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-141; Dolezal AL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00384; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; He Q, 2014, J PLANT GROWTH REGUL; Huang HJ, 2002, PHYSIOL PLANTARUM, V114, P572, DOI 10.1034/j.1399-3054.2002.1140410.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Jeong MJ, 2006, PLANT CELL TISS ORG, V85, P151, DOI 10.1007/s11240-005-9064-0; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; Jouannic S, 1999, GENE, V229, P171, DOI 10.1016/S0378-1119(99)00012-8; Jouannic S, 1999, GENE, V233, P1, DOI 10.1016/S0378-1119(99)00152-3; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kim SH, 2011, BIOCHEM BIOPH RES CO, V412, P150, DOI 10.1016/j.bbrc.2011.07.064; Kong XP, 2013, BIOCHEM BIOPH RES CO, V441, P964, DOI 10.1016/j.bbrc.2013.11.008; Kong XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057714; Kong XP, 2011, PLANT CELL REP, V30, P2097, DOI 10.1007/s00299-011-1116-9; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Krugman T, 2011, FUNCT INTEGR GENOMIC, V11, P565, DOI 10.1007/s10142-011-0231-6; Kumar K, 2008, PLANT PHYSIOL BIOCH, V46, P891, DOI 10.1016/j.plaphy.2008.05.014; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Ligterink W, 2001, INT REV CYTOL, V201, P209, DOI 10.1016/S0074-7696(01)01004-X; Lin F, 2009, J EXP BOT, V60, P3221, DOI 10.1093/jxb/erp157; Liu YK, 2013, PLANT MOL BIOL REP, V31, P1446, DOI 10.1007/s11105-013-0623-y; Liu YK, 2012, MOL BIOL REP, V39, P2957, DOI 10.1007/s11033-011-1057-y; Long L, 2014, PLANT CELL TISS ORG, V116, P153, DOI 10.1007/s11240-013-0392-1; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Matsuoka D, 2002, PLANT J, V29, P637, DOI 10.1046/j.0960-7412.2001.01246.x; Mizoguchi T, 2000, RES PRO CEL, V27, P29; Mizoguchi T, 1996, P NATL ACAD SCI USA, V93, P765, DOI 10.1073/pnas.93.2.765; Morris PC, 2001, NEW PHYTOL, V151, P67, DOI 10.1046/j.1469-8137.2001.00167.x; Muoma JVO, 2014, AMERICAN JOURNAL OF, V5; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Ronde J. A. de, 2000, African Crop Science Journal, V8, P85; Roosens NH, 2002, MOL BREEDING, V9, P73, DOI 10.1023/A:1026791932238; Salvo SAGD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111407; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Shou HX, 2004, J EXP BOT, V55, P1013, DOI 10.1093/jxb/erh129; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Virk N, 2013, ACTA PHYSIOL PLANT, V35, P1211, DOI 10.1007/s11738-012-1160-2; Wang JX, 2010, J INTEGR PLANT BIOL, V52, P442, DOI 10.1111/j.1744-7909.2010.00906.x; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wrzaczek M, 2001, BIOL CELL, V93, P81, DOI 10.1016/S0248-4900(01)01121-2; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Wu T, 2011, MOL BIOL REP, V38, P3967, DOI 10.1007/s11033-010-0514-3; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Xu J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-83; Yue X, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/546930; Zhang HW, 2010, TRANSGENIC RES, V19, P809, DOI 10.1007/s11248-009-9357-x; Zhang MY, 2012, J PLANT PHYSIOL, V169, P1501, DOI 10.1016/j.jplph.2012.06.008; Zhang ZJ, 2010, PLANTA, V232, P765, DOI 10.1007/s00425-010-1208-8	74	24	26	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143128	10.1371/journal.pone.0143128	http://dx.doi.org/10.1371/journal.pone.0143128			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599013	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600031
J	Verty, ANA; Stefanidis, A; McAinch, AJ; Hryciw, DH; Oldfield, B				Verty, A. N. A.; Stefanidis, A.; McAinch, A. J.; Hryciw, D. H.; Oldfield, Brian			Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; CANNABINOID RECEPTOR; INSULIN SENSITIVITY; INDUCED EMESIS; WEIGHT-LOSS; BRAIN-STEM; HIGH-FAT; ANTAGONIST; ACTIVATION; EXPRESSION	The cannabinoid receptor 2 (CB2) is well known for its immune modulatory role. However, recent localisation of CB2 receptors in metabolically active tissue suggests that the CB2 receptor plays a significant role in energy homeostasis. This study was designed to investigate the impact of chronic CB2 receptor stimulation on food intake, body weight and mood. Lean male C57BL/6 mice were injected i.p. with the selective CB2 receptor agonist, JWH-015 (0.0, 1.0, 5.0 and 10.0 mg kg(-1)) to establish dose response parameters. Mice made obese following exposure to a diet consisting of 19.4 MJ/kg (4641 Kcal/kg) of energy (19.0% protein, 21.0% total fat, 4.7% crude fiber, and 4.7% AD fiber were given either vehicle or 10 mg/kg JWH-015. Impact on mood, food intake, body weight, plasma metabolites, expression of key metabolic proteins in the brown adipose tissue (BAT) and white adipose tissue (WAT), and markers of inflammation were measured. High dose (10 mg/kg) JWH-015 reduced food intake after 1, 2, 4, and 24 h in lean mice. When given to diet induced obese (DIO) mice, a 10 mg/kg dose of JWH-015 significantly reduced body weight compared to vehicle. This dose led to a shift in markers of lipid metabolism and inflammation in WAT consistent with lipolysis and improved immune response. Furthermore, JWH-015 (10 mg/kg) produced a transient reduction in food intake and significant reduction in fat mass and adipocyte cell size. Importantly, JWH-015 produced an anxiolytic response in the elevated plus maze while having no effect on immobility time in the forced swim test. It should be noted that though the 10 mg/kg dose produced positive effects on the obese state, the possibility that these effects are mediated via non-CB2 receptor mechanisms cannot be ruled out. These results demonstrate a role for CB2 receptors in modulating energy homeostasis and obesity associated metabolic pathologies in the absence of any adverse impact on mood.	[Verty, A. N. A.; Stefanidis, A.; Oldfield, Brian] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia; [Verty, A. N. A.; McAinch, A. J.; Hryciw, D. H.] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis Prevent & Management, St Albans, Vic 3021, Australia; [Hryciw, D. H.] Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia	Monash University; Victoria University; University of Melbourne	Oldfield, B (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.	brian.oldfield@monash.edu	Hryciw, Deanne/P-2642-2019	Hryciw, Deanne/0000-0003-1697-8890; Oldfield, Brian/0000-0002-8609-6589; McAinch, Andrew/0000-0002-8762-4865	National Health and Medical Research Council (NHMRC) Principle Research Fellowship; NHMRC Peter Doherty Postdoctoral Research Fellowship; Australian Government's Collaborative Research Networks (CRN) program; National Health and Medical Research Council (NHMRC) Peter Doherty Postdoctoral Research Fellowship	National Health and Medical Research Council (NHMRC) Principle Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Postdoctoral Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government's Collaborative Research Networks (CRN) program(Australian Government); National Health and Medical Research Council (NHMRC) Peter Doherty Postdoctoral Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Funding: BJO was the recipient of a National Health and Medical Research Council (NHMRC) Principle Research Fellowship. ANAV was the recipient of a NHMRC Peter Doherty Postdoctoral Research Fellowship during the conduct of these studies. ANAV is currently a Research Fellow at the Centre for Chronic Disease Prevention and Management, College of Health and Biomedicine, Victoria University. AJM was supported through the Australian Government's Collaborative Research Networks (CRN) program.; ANAV was the recipient of the National Health and Medical Research Council (NHMRC) Peter Doherty Postdoctoral Research Fellowship during the conduct of these studies. ANAV is currently a Research Fellow at the Centre for Chronic Disease Prevention and Management, College of Health and Biomedicine, Victoria University. AJM is supported through the Australian Government's Collaborative Research Networks (CRN) program.	Agirregoitia E, 2010, FERTIL STERIL, V93, P1378, DOI 10.1016/j.fertnstert.2009.01.153; Agudo J, 2010, DIABETOLOGIA, V53, P2629, DOI 10.1007/s00125-010-1894-6; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bermudez-Silva FJ, 2007, EUR J PHARMACOL, V565, P207, DOI 10.1016/j.ejphar.2007.02.066; Borner C, 2009, J BIOL CHEM, V284, P35450, DOI 10.1074/jbc.M109.006338; Buckley NE, 2008, BRIT J PHARMACOL, V153, P309, DOI 10.1038/sj.bjp.0707527; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cavuoto P, 2007, BIOCHEM BIOPH RES CO, V364, P105, DOI 10.1016/j.bbrc.2007.09.099; Chin CN, 1999, J PHARMACOL EXP THER, V291, P837; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Darmani NA, 2001, PHARMACOL BIOCHEM BE, V69, P239, DOI 10.1016/S0091-3057(01)00531-7; Darmani NA, 2001, EUR J PHARMACOL, V430, P49, DOI 10.1016/S0014-2999(01)01355-3; De Vry J, 2004, EUR J PHARMACOL, V483, P55, DOI 10.1016/j.ejphar.2003.10.012; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Doyon C, 2006, DIABETES, V55, P3403, DOI 10.2337/db06-0504; Garcia-Gutierrez MS, 2011, J PSYCHOPHARMACOL, V25, P111, DOI 10.1177/0269881110379507; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Griffin G, 1997, EUR J PHARMACOL, V339, P53, DOI 10.1016/S0014-2999(97)01336-8; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Ishiguro H, 2007, PHARMACOGENOMICS J, V7, P380, DOI 10.1038/sj.tpj.6500431; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Li C, 2011, DIABETES OBES METAB, V13, P903, DOI 10.1111/j.1463-1326.2011.01422.x; Mallat A, 2006, J Endocrinol Invest, V29, P58; Manganiello VC, 1996, CURR TOP CELL REGUL, V34, P63, DOI 10.1016/S0070-2137(96)80003-3; McKallip RJ, 2002, BLOOD, V100, P627, DOI 10.1182/blood-2002-01-0098; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; McLaughlin PJ, 2005, PSYCHOPHARMACOLOGY, V180, P286, DOI 10.1007/s00213-005-2171-0; MEIER MK, 1984, INT J OBESITY, V8, P215; Molina-Holgado F, 2003, J NEUROSCI, V23, P6470; Murataeva N, 2012, PHARMACOL RES, V66, P437, DOI 10.1016/j.phrs.2012.08.002; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P426, DOI 10.1196/annals.1432.035; Onaivi ES, 2008, ANN NY ACAD SCI, V1139, P434, DOI 10.1196/annals.1432.036; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Parker LA, 2011, BRIT J PHARMACOL, V163, P1411, DOI 10.1111/j.1476-5381.2010.01176.x; Perwitz N, 2010, DIABETES OBES METAB, V12, P158, DOI 10.1111/j.1463-1326.2009.01133.x; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Roche R, 2006, HISTOCHEM CELL BIOL, V126, P177, DOI 10.1007/s00418-005-0127-4; Romero-Sandoval A, 2008, ANESTHESIOLOGY, V108, P722, DOI 10.1097/ALN.0b013e318167af74; Romero-Zerbo SY, 2012, J NEUROENDOCRINOL, V24, P1106, DOI 10.1111/j.1365-2826.2012.02325.x; Ryan AS, 2004, DIABETES CARE, V27, P1699, DOI 10.2337/diacare.27.7.1699; Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Simoneau II, 2001, ANESTHESIOLOGY, V94, P882, DOI 10.1097/00000542-200105000-00029; Sindelka G, 2002, PHYSIOL RES, V51, P85; Spoto B, 2006, BIOCHIMIE, V88, P1889, DOI 10.1016/j.biochi.2006.07.019; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Straczkowski M, 2005, DIABETES CARE, V28, P2036, DOI 10.2337/diacare.28.8.2036; Thornton C, 2008, J BIOL CHEM, V283, P17116, DOI 10.1074/jbc.M708987200; Trebicka J, 2011, LIVER INT, V31, P862, DOI 10.1111/j.1478-3231.2011.02496.x; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Van Sickle MD, 2003, AM J PHYSIOL-GASTR L, V285, pG566, DOI 10.1152/ajpgi.00113.2003; Van Sickle MD, 2001, GASTROENTEROLOGY, V121, P767, DOI 10.1053/gast.2001.28466; Verty ANA, 2009, OBESITY, V17, P254, DOI 10.1038/oby.2008.509; Verty ANA, 2005, NEUROPHARMACOLOGY, V49, P1101, DOI 10.1016/j.neuropharm.2005.03.025; Verty ANA, 2004, NEUROSCI LETT, V354, P217, DOI 10.1016/j.neulet.2003.10.035; Wang Mengmeng, 2011, Drug Metab Lett, V5, P55, DOI 10.2174/187231211794455280; Werner NA, 2003, BRAIN RES, V967, P290, DOI 10.1016/S0006-8993(02)04274-9; Williams CM, 2002, PHYSIOL BEHAV, V76, P241, DOI 10.1016/S0031-9384(02)00725-4; Williams CM, 2002, PHARMACOL BIOCHEM BE, V71, P333, DOI 10.1016/S0091-3057(01)00694-3; Zhang Q, 2006, ANAL BIOANAL CHEM, V386, P1345, DOI 10.1007/s00216-006-0717-6; Zhang X, 2009, CLIN EXP PHARMACOL P, V36, P631, DOI 10.1111/j.1440-1681.2008.05129.x	76	60	60	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0140592	10.1371/journal.pone.0140592	http://dx.doi.org/10.1371/journal.pone.0140592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588700	Green Published, Green Accepted, gold			2022-12-26	WOS:000365251500001
J	Zaske, R; Muhl, C; Schweinberger, SR				Zaeske, Romi; Muehl, Constanze; Schweinberger, Stefan R.			Benefits for Voice Learning Caused by Concurrent Faces Develop over Time	PLOS ONE			English	Article							EARWITNESS TESTIMONY; RECOGNITION; VARIETY; SPEAKER; MEMORY	Recognition of personally familiar voices benefits from the concurrent presentation of the corresponding speakers' faces. This effect of audiovisual integration is most pronounced for voices combined with dynamic articulating faces. However, it is unclear if learning unfamiliar voices also benefits from audiovisual face-voice integration or, alternatively, is hampered by attentional capture of faces, i.e., "face-overshadowing". In six study-test cycles we compared the recognition of newly-learned voices following unimodal voice learning vs. bimodal face-voice learning with either static (Exp. 1) or dynamic articulating faces (Exp. 2). Voice recognition accuracies significantly increased for bimodal learning across study-test cycles while remaining stable for unimodal learning, as reflected in numerical costs of bimodal relative to unimodal voice learning in the first two study-test cycles and benefits in the last two cycles. This was independent of whether faces were static images (Exp. 1) or dynamic videos (Exp. 2). In both experiments, slower reaction times to voices previously studied with faces compared to voices only may result from visual search for faces during memory retrieval. A general decrease of reaction times across study-test cycles suggests facilitated recognition with more speaker repetitions. Overall, our data suggest two simultaneous and opposing mechanisms during bimodal face-voice learning: while attentional capture of faces may initially impede voice learning, audiovisual integration may facilitate it thereafter.	[Zaeske, Romi; Schweinberger, Stefan R.] Univ Jena, Inst Psychol, Dept Gen Psychol & Cognit Neurosci, Jena, Germany; [Muehl, Constanze] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	Friedrich Schiller University of Jena; Bangor University	Zaske, R (corresponding author), Univ Jena, Inst Psychol, Dept Gen Psychol & Cognit Neurosci, Jena, Germany.	romi.zaeske@uni-jena.de	Schweinberger, Stefan/A-1860-2009	Schweinberger, Stefan/0000-0001-5762-0188	Deutsche Forschungsgemeinschaft [ZA 745/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was funded by ZA 745/1-1, granted to RZ and SS (Deutsche Forschungsgemeinschaft; http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2003, PSYCHOL SCI, V14, P427, DOI 10.1111/1467-9280.01458; Armstrong HA, 1996, J GEN PSYCHOL, V123, P259, DOI 10.1080/00221309.1996.9921278; Boersma Paul, 2002, GLOT INT, V5, P341; BRICKER PD, 1966, J ACOUST SOC AM, V40, P1441, DOI 10.1121/1.1910246; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Cook S, 1997, APPL COGNITIVE PSYCH, V11, P95; Cook S, 1997, APPL COGNITIVE PSYCH, V11, P527, DOI 10.1002/(SICI)1099-0720(199712)11:6<527::AID-ACP483>3.0.CO;2-B; Hanley JR, 2009, MEMORY, V17, P830, DOI 10.1080/09658210903264175; Hanley JR, 2000, Q J EXP PSYCHOL-A, V53, P1105, DOI 10.1080/02724980050156317; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Kamachi M, 2003, CURR BIOL, V13, P1709, DOI 10.1016/j.cub.2003.09.005; LEGGE GE, 1984, J EXP PSYCHOL LEARN, V10, P298; MACMILLAN NA, 1985, PSYCHOL BULL, V98, P185, DOI 10.1037/0033-2909.98.1.185; MCALLISTER HA, 1993, BASIC APPL SOC PSYCH, V14, P161, DOI 10.1207/s15324834basp1402_3; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Neuner F, 2000, BRAIN COGNITION, V44, P342, DOI 10.1006/brcg.1999.1196; POLLACK I, 1954, J ACOUST SOC AM, V26, P403, DOI 10.1121/1.1907349; ROEBUCK R, 1993, APPL COGNITIVE PSYCH, V7, P475, DOI 10.1002/acp.2350070603; Schweinberger SR, 2007, Q J EXP PSYCHOL, V60, P1446, DOI 10.1080/17470210601063589; Schweinberger SR, 2011, CORTEX, V47, P1026, DOI 10.1016/j.cortex.2010.11.011; Sheffert SM, 2004, PERCEPT PSYCHOPHYS, V66, P352, DOI 10.3758/BF03194884; Stevenage SV, 2011, APPL COGNITIVE PSYCH, V25, P112, DOI 10.1002/acp.1649; von Kriegstein K, 2005, J COGNITIVE NEUROSCI, V17, P367, DOI 10.1162/0898929053279577; Wiese H, 2014, NEUROPSYCHOLOGIA, V56, P26, DOI 10.1016/j.neuropsychologia.2013.12.023; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004; Zaske R, 2014, J NEUROSCI, V34, P10821, DOI 10.1523/JNEUROSCI.0581-14.2014	26	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143151	10.1371/journal.pone.0143151	http://dx.doi.org/10.1371/journal.pone.0143151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26588847	gold, Green Published			2022-12-26	WOS:000365251500034
J	Bled, F; Summers, S; Martell, D; Petroelje, TR; Beyer, DE; Belant, JL				Bled, Florent; Summers, Savanna; Martell, Deborah; Petroelje, Tyler R.; Beyer, Dean E., Jr.; Belant, Jerrold L.			Effects of Prey Presence and Scale on Bobcat Resource Selection during Winter	PLOS ONE			English	Article							HARES LEPUS-AMERICANUS; DEN-SITE SELECTION; HOME-RANGE SIZE; HABITAT SELECTION; SNOWSHOE HARES; LYNX-RUFUS; GRIZZLY BEARS; SPACE USE; ROADS; LANDSCAPE	Factors relevant to resource selection in carnivores may vary across spatial and temporal scales, both in magnitude and rank. Understanding relationships among carnivore occupancy, prey presence, and habitat characteristics, as well as their interactions across multiple scales, is necessary to improve our understanding of resource selection and predict population changes. We used a multi-scale dynamic hierarchical co-occurrence model with camera data to study bobcat and snowshoe hare occupancy in the Upper Peninsula of Michigan during winter 2012-2013. Bobcat presence was influenced at the local scale by snowshoe hare presence, and by road density at the local and larger scale when hare were absent. Hare distribution was related primarily to vegetation cover types, and detectability varied in space and time. Bobcat occupancy dynamics were influenced by different factors depending on the spatial scale considered and the resource availability context. Moreover, considering observed co-occurrence, we suggest that bobcat presence had a greater effect on hare occupancy than hare presence on bobcat occupancy. Our results highlight the importance of studying carnivore distributions in the context of predator-prey relationships and its interactions with environmental covariates at multiple spatial scales. Our approach can be applied to other carnivore species to provide insights beneficial for management and conservation.	[Bled, Florent; Summers, Savanna; Martell, Deborah; Petroelje, Tyler R.; Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA; [Beyer, Dean E., Jr.] Michigan Dept Nat Resources, Wildlife Div, Marquette, MI USA	Mississippi State University	Bled, F (corresponding author), Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Mississippi State, MS 39762 USA.	florent.bled@gmail.com	Belant, Jerrold/HDM-7749-2022	Petroelje, Tyler/0000-0003-4957-6732	Federal Aid in Wildlife Restoration; Michigan Department of Natural Resources; Safari Club International Foundation; Michigan Involvement Committee of Safari Club International Foundation; Undergraduate Research Scholars Program of Mississippi State University	Federal Aid in Wildlife Restoration; Michigan Department of Natural Resources; Safari Club International Foundation; Michigan Involvement Committee of Safari Club International Foundation; Undergraduate Research Scholars Program of Mississippi State University	This study was supported by the Federal Aid in Wildlife Restoration; Michigan Department of Natural Resources; Safari Club International Foundation; Michigan Involvement Committee of Safari Club International Foundation; and Undergraduate Research Scholars Program of Mississippi State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, US CENSUS TOPOLOGICA; BAILEY TN, 1974, J WILDLIFE MANAGE, V38, P435, DOI 10.2307/3800874; Bailey TN, 1979, P BOBC RES C NAT WIL, V6, P62; BERGIN TM, 1992, CONDOR, V94, P903, DOI 10.2307/1369287; Bled F, 2013, ECOL EVOL, V3, P4896, DOI 10.1002/ece3.858; BOUTIN S, 1984, OECOLOGIA, V62, P393, DOI 10.1007/BF00384273; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Boyle KA, 1987, BIOL REPORT, V82; BRADLEY LC, 1988, J RANGE MANAGE, V41, P322, DOI 10.2307/3899388; Cain AT, 2003, BIOL CONSERV, V114, P189, DOI 10.1016/S0006-3207(03)00023-5; Carpenter B., 2009, BAYESIAN COUNTERPART; Chamberlain M, 2003, AM MIDL NAT, V149, P395, DOI 10.1674/0003-0031(2003)149[0395:SUMAHS]2.0.CO;2; Congdon P, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0470092394; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dussault C, 2005, ECOGRAPHY, V28, P619, DOI 10.1111/j.2005.0906-7590.04263.x; Elfstrom M, 2008, WILDLIFE BIOL, V14, P176, DOI 10.2981/0909-6396(2008)14[176:SODHBS]2.0.CO;2; Erb PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042574; Evink GL., 1996, P TRANSPORTATION REL; Fahrig L, 2009, ECOL SOC, V14; Feierabend D, 2014, J MAMMAL, V95, P525, DOI 10.1644/13-MAMM-A-199; FULLER TK, 1985, J MAMMAL, V66, P568, DOI 10.2307/1380938; Gelman A., 2009, WHAT IS BAYESIAN COU; Gelman A., 2021, BAYESIAN DATA ANAL; Godbois IA, 2003, PROCEEDINGS OF THE FIFTY-SEVENTH ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P228; Hodges KE, 2005, CAN J ZOOL, V83, P280, DOI 10.1139/Z05-015; Jin S., 2011, REMOTE SENS ENVIRON, V132, P159, DOI DOI 10.1016/J.RSE.2013.01.012; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Kamler JF, 2000, CAN FIELD NAT, V114, P388; KEITH LB, 1993, CAN J ZOOL, V71, P1385, DOI 10.1139/z93-191; KEITH LB, 1984, WILDLIFE MONOGR, P1; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; KNICK ST, 1990, WILDLIFE MONOGR, P1; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Krebs C.J., 2001, ECOSYSTEM DYNAMICS B; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lewis CW, 2011, J MAMMAL, V92, P561, DOI 10.1644/10-MAMM-A-095.1; Libal NS, 2012, URSUS, V23, P226, DOI 10.2192/URSUS-D-12-00002.1; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; LITVAITIS JA, 1985, J WILDLIFE MANAGE, V49, P866, DOI 10.2307/3801359; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mao JS, 2005, J WILDLIFE MANAGE, V69, P1691, DOI 10.2193/0022-541X(2005)69[1691:HSBEBA]2.0.CO;2; McCann NP, 2011, CAN J ZOOL, V89, P509, DOI [10.1139/Z11-016, 10.1139/z11-016]; MCCORD CM, 1974, J MAMMAL, V55, P428, DOI 10.2307/1379010; McLoughlin PD, 2002, OECOLOGIA, V132, P102, DOI 10.1007/s00442-002-0941-5; MURRAY DL, 1994, CAN J ZOOL, V72, P1444, DOI 10.1139/z94-191; O'Donoghue M, 1997, THESIS; Ordenana MA, 2010, J MAMMAL, V91, P1322, DOI 10.1644/09-MAMM-A-312.1; ORR C D, 1982, Wildlife Society Bulletin, V10, P147; PIETZ PJ, 1983, J WILDLIFE MANAGE, V47, P686, DOI 10.2307/3808604; R Core Team, 2014, LANG ENV STAT COMP; ROLLEY RE, 1985, J WILDLIFE MANAGE, V49, P913, DOI 10.2307/3801369; Royle J. A., 2008, HIERARCHICAL MODELIN; Saunders SC, 2002, BIOL CONSERV, V103, P209, DOI 10.1016/S0006-3207(01)00130-6; Shannon G, 2014, PEERJ, V2, DOI 10.7717/peerj.532; SIEVERT PR, 1985, J WILDLIFE MANAGE, V49, P854, DOI 10.2307/3801358; Squires JR, 2008, J WILDLIFE MANAGE, V72, P1497, DOI 10.2193/2007-396; Stricker HK, 2012, WILDLIFE SOC B, V36, P257, DOI 10.1002/wsb.137; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Ten Hwang Y, 2007, CAN J ZOOL, V85, P33, DOI 10.1139/Z06-192; Thorn M, 2009, S AFR J WILDL RES, V39, P1, DOI 10.3957/056.039.0101; Thornton DH, 2013, ECOGRAPHY, V36, P610, DOI 10.1111/j.1600-0587.2012.07737.x; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Tucker SA, 2008, J WILDLIFE MANAGE, V72, P1114, DOI 10.2193/2007-291; Waddle JH, 2010, ECOL APPL, V20, P1467, DOI 10.1890/09-0850.1; Waller BW, 2013, MAMM STUDY, V38, P211, DOI 10.3106/041.038.0309; Whittington J, 2004, ECOL SOC, V9; Wilton CM, 2016, J MAMMAL IN PRESS; WOLFF JO, 1980, ECOL MONOGR, V50, P111, DOI 10.2307/2937249	69	3	3	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143347	10.1371/journal.pone.0143347	http://dx.doi.org/10.1371/journal.pone.0143347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581103	Green Published, gold			2022-12-26	WOS:000365154600112
J	Palagi, E; Norscia, I				Palagi, Elisabetta; Norscia, Ivan			The Season for Peace: Reconciliation in a Despotic Species (Lemur catta)	PLOS ONE			English	Article							RING-TAILED LEMURS; POST-CONFLICT BEHAVIOR; MACAQUES MACACA-FASCICULARIS; CHIMPANZEES PAN-TROGLODYTES; FECAL TESTOSTERONE LEVELS; WILD MOUNTAIN GORILLAS; HYENA CROCUTA-CROCUTA; SOCIAL-ORGANIZATION; EULEMUR-FULVUS; SPOTTED HYENA	However despotic a social group may be, managing conflicts of interest is crucial to preserve group living benefits, mainly based on cooperation. In despotic groups, post-conflict management via reconciliation (the first post-conflict reunion between former opponents) can occur, even if conciliatory rates are considerably different. Lemur catta is defined as a despotic species because groups are characterized by a strict linear hierarchy maintained by the adult females (the dominant sex) mainly via aggression. Reconciliation was reported in one out of four captive groups of L. catta. Here we investigate which variables influence the occurrence of reconciliation in these despotic groups. We analyzed 2339 Post Conflict (PC)-Matched Control (MC) observation pairs, collected on eight groups (five in the Berenty forest, Madagascar; three hosted at the Pistoia Zoo, Italy). Since L. catta is characterized by steep female dominance but shows female-female coalitionary support, we expected to confirm the presence of reconciliation in the study species. Consistently, we found reconciliation in one captive group and two wild groups, thus providing the first evidence of the presence of this phenomenon in wild L. catta. Moreover, because this species is a seasonal breeder (with mating occurring once a year), we expected seasonal fluctuations in reconciliation levels. Via a GLMM analysis using data from all wild groups and on a captive group followed for more than one year, we found that season (but not rank; individuals' identity, sex, and age; or group identity) significantly affected individual reconciliation rates, and such rates were lowest during the mating period. Thus, reconciliation can be present in groups in which dominants strongly influence and limit social relationships (steep dominance hierarchy) except when the advantages of intra-group cooperation are overcome by competition, as occurs in seasonal breeders when reproduction is at stake. We conclude that in despotic social groups in which coalitions are observed, the right question is not if but when reconciliation can be present.	[Palagi, Elisabetta; Norscia, Ivan] Univ Pisa, Nat Hist Museum, Pisa, Italy; [Palagi, Elisabetta] CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy; [Palagi, Elisabetta] CNR, Ctr Primate, Rome, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Consiglio Nazionale delle Ricerche (CNR)	Palagi, E (corresponding author), Univ Pisa, Nat Hist Museum, Pisa, Italy.	elisabetta.palagi@unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717	Giardino Zoologico di Pistoia; Parco Zoo Falconara (Falconara, Italy); Parco Zoo Punta Verde (Lignano Sabbiadoro, Italy)	Giardino Zoologico di Pistoia; Parco Zoo Falconara (Falconara, Italy); Parco Zoo Punta Verde (Lignano Sabbiadoro, Italy)	The authors only received reimbursement for travel and accommodation fees from Giardino Zoologico di Pistoia, Parco Zoo Falconara (Falconara, Italy), and Parco Zoo Punta Verde (Lignano Sabbiadoro, Italy). No official grant or funding (with grant numbers) was obtained and no salary was received for the investigation, which was carried out with the authors' own funds.	Arnold K, 2001, BEHAVIOUR, V138, P649, DOI 10.1163/156853901316924520; Aureli F, 2002, ANIM BEHAV, V64, P325, DOI 10.1006/anbe.2002.3071; AURELI F, 1992, BEHAV ECOL SOCIOBIOL, V31, P329; AURELI F, 1989, AM J PRIMATOL, V19, P39, DOI 10.1002/ajp.1350190105; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F., 2000, NATURAL CONFLICT RES; Aureli F, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P121, DOI 10.1007/3-540-28277-7_7; Aureli Filippo, 2000, P199; Baan C, 2014, ANIM BEHAV, V90, P327, DOI 10.1016/j.anbehav.2014.01.033; Barrett GM, 2002, HORM BEHAV, V42, P85, DOI 10.1006/hbeh.2002.1804; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOTCHIN MB, 1993, NEUROPSYCHOPHARMACOL, V9, P93, DOI 10.1038/npp.1993.47; Budnitz N., 1975, P219; Butovskaya Marina L., 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P333, DOI 10.2114/jpa.24.333; BYGOTT JD, 1979, NATURE, V282, P839, DOI 10.1038/282839a0; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; Castles DL, 1998, ETHOLOGY, V104, P126; Cavigelli SA, 2000, HORM BEHAV, V37, P246, DOI 10.1006/hbeh.2000.1585; CHAFFIN CL, 1995, AM J PRIMATOL, V35, P103, DOI 10.1002/ajp.1350350203; CHENEY DL, 1995, ANIM BEHAV, V50, P249, DOI 10.1006/anbe.1995.0237; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; Cools AKA, 2008, ETHOLOGY, V114, P53, DOI 10.1111/j.1439-0310.2007.01443.x; Cooper MA, 2002, AM J PRIMATOL, V56, P215, DOI 10.1002/ajp.1076; Cooper MA, 2007, ETHOLOGY, V113, P26, DOI 10.1111/j.1439-0310.2006.01287.x; Cordoni G, 2008, ETHOLOGY, V114, P298, DOI 10.1111/j.1439-0310.2008.01474.x; Cordoni G, 2006, INT J PRIMATOL, V27, P1365, DOI 10.1007/s10764-006-9078-4; Cordoni G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086859; CORDS M, 1993, ETHOLOGY, V93, P315; CORDS M, 1992, ANIM BEHAV, V44, P57, DOI 10.1016/S0003-3472(05)80754-7; Cozzi A, 2010, BEHAV PROCESS, V85, P185, DOI 10.1016/j.beproc.2010.07.007; Das M, 1998, INT J PRIMATOL, V19, P53, DOI 10.1023/A:1020354826422; de Waal FBM, 2004, J LAW MED ETHICS, V32, P18, DOI 10.1111/j.1748-720X.2004.tb00444.x; Demaria C, 2001, BEHAVIOUR, V138, P397, DOI 10.1163/15685390152032514; DEVRIES H, 1993, PSYCHOMETRIKA, V58, P53, DOI 10.1007/BF02294470; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; DEWAAL FBM, 1983, BEHAVIOUR, V85, P224, DOI 10.1163/156853983X00237; Donati G, 2013, AM J PHYS ANTHROPOL, V150, P99, DOI 10.1002/ajpa.22180; Dovidio JF, 2009, J SOC ISSUES, V65, P429, DOI 10.1111/j.1540-4560.2009.01607.x; DRAGO F, 1986, BRAIN RES, V368, P287, DOI 10.1016/0006-8993(86)90573-1; Duboscq J, 2013, AM J PRIMATOL, V75, P361, DOI 10.1002/ajp.22114; Duffy KG, 2007, CURR BIOL, V17, pR586, DOI 10.1016/j.cub.2007.06.001; EVANS CS, 1968, J ZOOL, V156, P181; Feldman R, 2012, HORM BEHAV, V61, P380, DOI 10.1016/j.yhbeh.2012.01.008; Fentress J.C., 1987, Perspectives in Vertebrate Science, V4, P253; Flack J.C., 2004, MACAQUE SOC, P157; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; Fraser ON, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018118; Fry DP, 2012, SCIENCE, V336, P879, DOI 10.1126/science.1217987; Fujisawa KK, 2005, AGGRESSIVE BEHAV, V31, P138, DOI 10.1002/ab.20076; Gabriel DN, 2014, BEHAVIOUR, V151, P935, DOI 10.1163/1568539X-00003130; GALTUNG J, 1969, J PEACE RES, P167; Gettler LT, 2009, AM J PHYS ANTHROPOL, V148, P362; Goldey KM, 2014, ADAPT HUM BEHAV PHYS; Gould L, 2007, AM J PRIMATOL, V69, P1325, DOI 10.1002/ajp.20438; Gould L, 2005, AM J PRIMATOL, V67, P5, DOI 10.1002/ajp.20166; Gould L, 1997, AM J PHYS ANTHROPOL, V103, P163, DOI 10.1002/(SICI)1096-8644(199706)103:2<163::AID-AJPA3>3.3.CO;2-3; Gould L, 2015, FOLIA PRIMATOL, V86, P16, DOI 10.1159/000369580; Gould Lisa, 1999, P133; HENSCHEL JR, 1991, ETHOLOGY, V88, P223; Holekamp KE, 2012, MOL ECOL, V21, P613, DOI 10.1111/j.1365-294X.2011.05240.x; Ichino S, 2006, AM J PRIMATOL, V68, P97, DOI 10.1002/ajp.20208; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; Jolly A., 1984, Monographs in Primatology, V4, P197; Jolly A, 2003, THE NATURAL HISTORY, P1329; Jolly A, 2012, LONG TERM FIELD STUD, P22; Jolly A, 1966, LEMUR BEHAVIOR A MAD; Jolly A, 1967, SOCIAL COMMUNICATION, P1; Jolly Alison, 2006, P32, DOI 10.1007/978-0-387-34126-2_3; KAPPELER PM, 1990, FOLIA PRIMATOL, V55, P92, DOI 10.1159/000156504; KAPPELER PM, 1993, ANIM BEHAV, V45, P901, DOI 10.1006/anbe.1993.1110; KAPPELER PM, 1992, ETHOLOGY, V92, P51; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; KAPPELER PM, 1990, ANIM BEHAV, V40, P774, DOI 10.1016/S0003-3472(05)80706-7; Koyama N, 2005, PRIMATES, V46, P225, DOI 10.1007/s10329-005-0155-7; KOYAMA N, 1988, PRIMATES, V29, P163, DOI 10.1007/BF02381120; Koyama NF, 2001, ETHOLOGY, V107, P975, DOI 10.1046/j.1439-0310.2001.00731.x; Kutsukake N, 2001, Anim Cogn, V4, P259, DOI 10.1007/s10071-001-0119-2; LaFleur M, 2014, PRIMATES, V55, P207, DOI 10.1007/s10329-013-0391-1; Leca JB, 2002, INT J PRIMATOL, V23, P979, DOI 10.1023/A:1019641830918; Majolo B, 2006, INT J PRIMATOL, V27, P1383, DOI 10.1007/s10764-006-9079-3; Martin P., 2007, MEASURING BEHAVIOUR; Mech L. David, 2003, P1; MECH LD, 1977, J MAMMAL, V58, P559, DOI 10.2307/1380004; MESSIER F, 1985, CAN J ZOOL, V63, P1068, DOI 10.1139/z85-160; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Nakamichi M, 1997, INT J PRIMATOL, V18, P73, DOI 10.1023/A:1026393223883; Norscia I, 2015, PEERJ, V3, DOI 10.7717/peerj.729; Norscia I, 2011, J ETHOL, V29, P181, DOI 10.1007/s10164-010-0228-y; Palagi E, 2005, INT J PRIMATOL, V26, P279, DOI 10.1007/s10764-005-2925-x; Palagi E, 2004, INT J PRIMATOL, V25, P1019, DOI 10.1023/B:IJOP.0000043349.23082.c0; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2003, INT J PRIMATOL, V24, P335, DOI 10.1023/A:1023001316988; Palagi E, 2002, INT J PRIMATOL, V23, P587, DOI 10.1023/A:1014973717945; Palagi E, 2008, AM J PRIMATOL, V70, P949, DOI 10.1002/ajp.20587; Palagi E, 2008, ANIM BEHAV, V76, P737, DOI 10.1016/j.anbehav.2008.04.016; Palagi E, 2014, EVOL HUM BEHAV, V35, P341, DOI 10.1016/j.evolhumbehav.2014.04.002; Palagi E, 2011, STRESS, V14, P93, DOI 10.3109/10253890.2010.505272; Palagi E, 2009, AM J PHYS ANTHROPOL, V139, P182, DOI 10.1002/ajpa.20971; Pereira ME, 2000, AM J PRIMATOL, V50, P159, DOI 10.1002/(SICI)1098-2345(200002)50:2<159::AID-AJP6>3.0.CO;2-F; PEREIRA ME, 1991, PHYSIOL BEHAV, V49, P47, DOI 10.1016/0031-9384(91)90228-G; Pereira ME, 1997, BEHAVIOUR, V134, P225, DOI 10.1163/156853997X00467; PETIT O, 1994, ANIM BEHAV, V48, P1427, DOI 10.1006/anbe.1994.1378; Roeder JJ, 2002, AGGRESSIVE BEHAV, V28, P62, DOI 10.1002/ab.90006; SAPOLSKY RM, 1990, SCI AM, V262, P116, DOI 10.1038/scientificamerican0190-116; Sauther ML, 1999, EVOL ANTHROPOL, V8, P120, DOI 10.1002/(SICI)1520-6505(1999)8:4<120::AID-EVAN3>3.0.CO;2-O; SAUTHER ML, 1991, AM J PHYS ANTHROPOL, V84, P463, DOI 10.1002/ajpa.1330840409; Schino G, 1998, BEHAVIOUR, V135, P343, DOI 10.1163/156853998793066302; Sclafani V, 2012, PRIMATES, V53, P247, DOI 10.1007/s10329-012-0294-6; Siegel S., 2009, NONPARAMETRIC STAT B, V2nd; Silk JB, 2009, PHILOS T R SOC B, V364, P3243, DOI 10.1098/rstb.2009.0118; Smith AS, 2010, HORM BEHAV, V57, P255, DOI 10.1016/j.yhbeh.2009.12.004; Smith JE, 2010, BEHAV ECOL, V21, P284, DOI 10.1093/beheco/arp181; Snyder-Mackler N, 2012, P ROY SOC B-BIOL SCI, V279, P3788, DOI 10.1098/rspb.2012.0842; Soma Takayo, 2013, P137; Starling AP, 2010, HORM BEHAV, V57, P76, DOI 10.1016/j.yhbeh.2009.09.016; Sueur C, 2011, ANIM BEHAV, V82, P845, DOI 10.1016/j.anbehav.2011.07.020; Sussman R. W., 1974, PRIMATE AGGRESSION T, P50; TAYLOR L, 1985, INT J PRIMATOL, V6, P601, DOI 10.1007/BF02692291; THIERRY B, 1985, BEHAV PROCESS, V11, P89, DOI 10.1016/0376-6357(85)90105-6; THIERRY B, 1985, AGGRESSIVE BEHAV, V11, P223, DOI 10.1002/1098-2337(1985)11:3<223::AID-AB2480110305>3.0.CO;2-A; Turner RA, 1999, PSYCHIATRY, V62, P97, DOI 10.1080/00332747.1999.11024859; VEENEMA HC, 1994, BEHAV PROCESS, V31, P29, DOI 10.1016/0376-6357(94)90035-3; VICK LG, 1989, BEHAV ECOL SOCIOBIOL, V25, P3, DOI 10.1007/BF00299705; Wahaj SA, 2001, ETHOLOGY, V107, P1057, DOI 10.1046/j.1439-0310.2001.00717.x; Wallen K, 1997, ANN NY ACAD SCI, V807, P185, DOI 10.1111/j.1749-6632.1997.tb51920.x; WATTS DP, 1995, ETHOLOGY, V100, P139; WATTS DP, 1995, ETHOLOGY, V100, P158; Weaver A, 2003, MAR MAMMAL SCI, V19, P836, DOI 10.1111/j.1748-7692.2003.tb01134.x; Wittig RM, 2005, ETHOLOGY, V111, P736, DOI 10.1111/j.1439-0310.2005.01093.x; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31; YORK AD, 1988, ANIM BEHAV, V36, P502, DOI 10.1016/S0003-3472(88)80021-6; Zak PJ, 2005, BEHAV BRAIN SCI, V28, P368; Zimen E, 1981, THE WOLF A SPECIES I	136	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142150	10.1371/journal.pone.0142150	http://dx.doi.org/10.1371/journal.pone.0142150			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569400	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700022
J	Miyamoto, T; Kim, D; Knox, JA; Johnson, E; Mucke, L				Miyamoto, Takashi; Kim, Daniel; Knox, Joseph A.; Johnson, Erik; Mucke, Lennart			Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-beta-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED SYNAPTIC DEPRESSION; PROTEIN TRANSGENIC MICE; ALZHEIMERS-DISEASE; PRION PROTEIN; A-BETA; MOUSE MODELS; COGNITIVE IMPAIRMENTS; INDUCED NEUROTOXICITY; HIPPOCAMPAL-NEURONS; AXONAL-TRANSPORT	Diverse lines of evidence suggest that amyloid-beta (A beta) peptides causally contribute to the pathogenesis of Alzheimer disease (AD), the most frequent neurodegenerative disorder. However, the mechanisms by which A beta impairs neuronal functions remain to be fully elucidated. Previous studies showed that soluble A beta oligomers interfere with synaptic functions by depleting NMDA-type glutamate receptors (NMDARs) from the neuronal surface and that overexpression of the receptor tyrosine kinase EphB2 can counteract this process. Through pharmacological treatments and biochemical analyses of primary neuronal cultures expressing wild-type or mutant forms of EphB2, we demonstrate that this protective effect of EphB2 depends on its PDZ-binding motif and the presence of neuronal activity but not on its kinase activity. We further present evidence that the protective effect of EphB2 may be mediated by the AMPA-type glutamate receptor subunit GluA2, which can become associated with the PDZ-binding motif of EphB2 through PDZ domain-containing proteins and can promote the retention of NMDARs in the membrane. In addition, we show that the A beta-induced depletion of surface NMDARs does not depend on several factors that have been implicated in the pathogenesis of A beta-induced neuronal dysfunction, including aberrant neuronal activity, tau, prion protein (PrPC), and EphB2 itself. Thus, although EphB2 does not appear to be directly involved in the A beta-induced depletion of NMDARs, increasing its expression may counteract this pathogenic process through a neuronal activity-and PDZ-dependent regulation of AMPA-type glutamate receptors.	[Miyamoto, Takashi; Kim, Daniel; Knox, Joseph A.; Johnson, Erik; Mucke, Lennart] Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA; [Miyamoto, Takashi; Johnson, Erik; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	Lmucke@gladstone.ucsf.edu		Johnson, Erik/0000-0002-0604-2944	National Institutes of Health [NS041787]; Japan Society for the Promotion of Science; Uehara Memorial Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS041787 (to L. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by fellowships from the Japan Society for the Promotion of Science and the Uehara Memorial Foundation.	Alfonso S, 2014, EUR J NEUROSCI, V39, P1225, DOI 10.1111/ejn.12499; Almawi WY, 2000, NEPHROL DIAL TRANSPL, V15, P1916, DOI 10.1093/ndt/15.12.1916; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Briggs CA, 1996, NEUROPHARMACOLOGY, V35, P407, DOI 10.1016/0028-3908(96)00006-8; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Colgan LA, 2014, ANNU REV PHYSIOL, V76, P365, DOI 10.1146/annurev-physiol-021113-170400; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dawson HN, 2001, J CELL SCI, V114, P1179; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Geng DD, 2013, NEUROCHEM INT, V63, P283, DOI 10.1016/j.neuint.2013.06.016; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kessels HW, 2013, P NATL ACAD SCI USA, V110, P4033, DOI 10.1073/pnas.1219605110; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Malinow R, 2012, CURR OPIN NEUROBIOL, V22, P559, DOI 10.1016/j.conb.2011.09.001; Simon AM, 2009, J ALZHEIMERS DIS, V17, P773, DOI 10.3233/JAD-2009-1096; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Park JE, 2013, GENES-BASEL, V4, P334, DOI 10.3390/genes4030334; Puzzo D, 2013, J ALZHEIMERS DIS, V33, pS111, DOI 10.3233/JAD-2012-129033; Ranasinghe KG, 2014, NEUROIMAGE-CLIN, V5, P385, DOI 10.1016/j.nicl.2014.07.006; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Seward ME, 2013, J CELL SCI, V126, P1278, DOI 10.1242/jcs.1125880; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sheffler-Collins SI, 2012, TRENDS NEUROSCI, V35, P293, DOI 10.1016/j.tins.2012.03.003; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tackenberg C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.129; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Um JW, 2013, PRION, V7, P37, DOI 10.4161/pri.22212; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Viola KL, 2015, NAT NANOTECHNOL, V10, P91, DOI [10.1038/NNANO.2014.254, 10.1038/nnano.2014.254]; Vossel KA, 2015, J CELL BIOL, V209, P419, DOI 10.1083/jcb.201407065; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zhang YF, 2011, J NEUROCHEM, V119, P664, DOI 10.1111/j.1471-4159.2011.07450.x	71	24	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1719	1734		10.1074/jbc.M115.666529	http://dx.doi.org/10.1074/jbc.M115.666529			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26589795	Green Published, hybrid			2022-12-26	WOS:000368620700015
J	Fite, K; Gomez-Cambronero, J				Fite, Kristen; Gomez-Cambronero, Julian			Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; METASTASIS; MIRNAS; EXPRESSION; MIGRATION; GROWTH; PLANT; PLD2	Breast cancer is a leading cause of morbidity and mortality among women. Metastasis is initiated after epithelial-mesenchymal-transition (EMT). We have found a connection between EMT markers and the expression of four microRNAs (miRs) mediated by the signaling enzyme phospholipase D (PLD). Low aggressive MCF-7 breast cancer cells have low endogenous PLD enzymatic activity and cell invasion, concomitant with high expression of miR-203, -887, and -3619 (that decrease PLD2 translation and a luciferase reporter) and miR-182 (targeting PLD1) that are, therefore, "tumor-suppressor-like" miRs. The combination miR-887 + miR-3619 abolished >90% of PLD enzymatic activity. Conversely, post-EMT MDA-MB-231 cells have low miR expression, high levels of PLD1/2, and high aggressiveness. The latter was reversed by ectopically transfecting the miRs, which was negated by silencing miRs with specific siRNAs. We determined that the molecular mechanism is that E-cadherin triggers expression of the miRs in pre-EMT cells, whereas vimentin dampens expression of the miRs in post-EMT invasive cells. This novel work identifies for the first time a set of miRs that are activated by a major pre-EMT marker and deactivated by a post-EMT marker, boosting the transition from low invasion to high invasion, as mediated by the key phospholipid metabolism enzyme PLD.	[Fite, Kristen; Gomez-Cambronero, Julian] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Gomez-Cambronero, Julian] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Gomez-Cambronero, Julian] Harvard Univ, Sch Med, Boston, MA 02115 USA	University System of Ohio; Wright State University Dayton; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gomez-Cambronero, J (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health [HL056653-14]; American Heart Association [13GRNT17230097]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653-14 (to J. G.-C.) and American Heart Association Grant 13GRNT17230097. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Baehrecke EH, 2003, CURR BIOL, V13, pR473, DOI 10.1016/S0960-9822(03)00405-6; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen ZG, 2014, MOL MED REP, V9, P503, DOI 10.3892/mmr.2013.1814; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Eroles P., 2015, CURR DRUG T IN PRESS; Gomez-Cambronero J, 2014, J BIOL CHEM, V289, P22557, DOI 10.1074/jbc.R114.574152; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Henkels KM, 2011, J MOL BIOL, V408, P850, DOI 10.1016/j.jmb.2011.03.017; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nygaard S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-35; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; Uchida H, 1999, ANTICANCER RES, V19, P671; Uchida N, 1997, J CANCER RES CLIN, V123, P280, DOI 10.1007/s004320050060; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Yamada Y, 2003, J MOL MED, V81, P126, DOI 10.1007/s00109-002-0411-x	23	31	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					719	730		10.1074/jbc.M115.686006	http://dx.doi.org/10.1074/jbc.M115.686006			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26567912	hybrid, Green Published			2022-12-26	WOS:000367830500020
J	Kim, S; Oh, Y; Schweighofer, N				Kim, Sungshin; Oh, Youngmin; Schweighofer, Nicolas			Between-Trial Forgetting Due to Interference and Time in Motor Adaptation	PLOS ONE			English	Article							OPPOSING VISUOMOTOR ROTATIONS; CONTEXTUAL INTERFERENCE; SKILL ACQUISITION; DUAL ADAPTATION; MEMORY; MODELS; PERFORMANCE; INTERVALS; STATE	Learning a motor task with temporally spaced presentations or with other tasks intermixed between presentations reduces performance during training, but can enhance retention post training. These two effects are known as the spacing and contextual interference effect, respectively. Here, we aimed at testing a unifying hypothesis of the spacing and contextual interference effects in visuomotor adaptation, according to which forgetting between trials due to either spaced presentations or interference by another task will promote between-trial forgetting, which will depress performance during acquisition, but will promote retention. We first performed an experiment with three visuomotor adaptation conditions: a short inter-trial-interval (ITI) condition (SHORT-ITI); a long ITI condition (LONG-ITI); and an alternating condition with two alternated opposite tasks (ALT), with the same single-task ITI as in LONG-ITI. In the SHORT-ITI condition, there was fastest increase in performance during training and largest immediate forgetting in the retention tests. In contrast, in the ALT condition, there was slowest increase in performance during training and little immediate forgetting in the retention tests. Compared to these two conditions, in the LONG-ITI, we found intermediate increase in performance during training and intermediate immediate forgetting. To account for these results, we fitted to the data six possible adaptation models with one or two time scales, and with interference in the fast, or in the slow, or in both time scales. Model comparison confirmed that two time scales and some degree of interferences in either time scale are needed to account for our experimental results. In summary, our results suggest that retention following adaptation is modulated by the degree of between-trial forgetting, which is due to time-based decay in single adaptation task and interferences in multiple adaptation tasks.	[Kim, Sungshin; Oh, Youngmin] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Schweighofer, Nicolas] Univ So Calif, Biokinesiol & Phys Therapy, Los Angeles, CA 90089 USA; [Schweighofer, Nicolas] Univ Montpellier I, Euromov, Lab M2H, Montpellier, France	University of Southern California; University of Southern California; Universite de Montpellier	Kim, S (corresponding author), Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA.	sung.kim3@northwestern.edu	Schweighofer, Nicolas/A-3675-2008; Kim, Sungshin/AAE-5645-2019	Schweighofer, Nicolas/0000-0003-3362-6088; Kim, Sungshin/0000-0001-9500-4677	NSF BCS (National Science Foundation Behavioral and Cognitive Sciences) [1031899]	NSF BCS (National Science Foundation Behavioral and Cognitive Sciences)	This work was funded by grant NSF BCS (National Science Foundation Behavioral and Cognitive Sciences) 1031899.	Anguera JA, 2010, J COGNITIVE NEUROSCI, V22, P1917, DOI 10.1162/jocn.2009.21351; Bock O, 2005, EXP BRAIN RES, V163, P258, DOI 10.1007/s00221-005-2231-z; Callan DE, 2010, HUM BRAIN MAPP, V31, P645, DOI 10.1002/hbm.20894; Choi YG, 2008, J MOTOR BEHAV, V40, P273, DOI 10.3200/JMBR.40.4.273-280; CUDDY LJ, 1982, J VERB LEARN VERB BE, V21, P451, DOI 10.1016/S0022-5371(82)90727-7; Della-Maggiore V, 2005, J NEUROPHYSIOL, V93, P2254, DOI 10.1152/jn.00984.2004; DiCiccio TJ, 1996, STAT SCI, V11, P189; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Francis JT, 2005, EXP BRAIN RES, V167, P128, DOI 10.1007/s00221-005-0062-6; Hirashima M, 2012, CURR BIOL, V22, P432, DOI 10.1016/j.cub.2012.01.042; Huang VS, 2007, J NEUROPHYSIOL, V97, P3976, DOI 10.1152/jn.01281.2006; Imamizu H, 2007, EXP BRAIN RES, V181, P395, DOI 10.1007/s00221-007-0940-1; Ingram JN, 2013, CURR BIOL, V23, P1107, DOI 10.1016/j.cub.2013.04.079; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Keisler A, 2010, J NEUROSCI, V30, P14817, DOI 10.1523/JNEUROSCI.4160-10.2010; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Lee JY, 2009, J NEUROSCI, V29, P10396, DOI 10.1523/JNEUROSCI.1294-09.2009; LEE TD, 1983, J EXP PSYCHOL LEARN, V9, P730, DOI 10.1037/0278-7393.9.4.730; MAGILL RA, 1990, HUM MOVEMENT SCI, V9, P241, DOI 10.1016/0167-9457(90)90005-X; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Pauwels L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100906; Pekny SE, 2011, J NEUROSCI, V31, P13829, DOI 10.1523/JNEUROSCI.1704-11.2011; Pyle WH, 1919, J EDUC PSYCHOL, V10, P107, DOI 10.1037/h0064909; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Roediger HL, 1985, CONTEMP PSYCHOL, V30, P519; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Schweighofer N, 2011, J NEUROPHYSIOL, V106, P2632, DOI 10.1152/jn.00399.2011; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Shelhamer M, 2005, ANN NY ACAD SCI, V1039, P166, DOI 10.1196/annals.1325.016; Sing Gary N B, 2009, ADV COMPUTATIONAL MO; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Tanaka H, 2012, NEURAL COMPUT, V24, P939, DOI 10.1162/NECO_a_00262; Taylor JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001096; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Woolley DG, 2007, EXP BRAIN RES, V179, P155, DOI 10.1007/s00221-006-0778-y; Woolley DG, 2011, EXP BRAIN RES, V212, P213, DOI 10.1007/s00221-011-2720-1; Wrisberg C, 2004, MOTOR LEARNING PERFO; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	40	24	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142963	10.1371/journal.pone.0142963	http://dx.doi.org/10.1371/journal.pone.0142963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CX7DU	26599075	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600022
J	Craig, JM; Laszlo, AH; Derrington, IM; Ross, BC; Brinkerhoff, H; Nova, IC; Doering, K; Tickman, BI; Svet, MT; Gundlach, JH				Craig, Jonathan M.; Laszlo, Andrew H.; Derrington, Ian M.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Doering, Kenji; Tickman, Benjamin I.; Svet, Mark T.; Gundlach, Jens H.			Direct Detection of Unnatural DNA Nucleotides dNaM and d5SICS using the MspA Nanopore	PLOS ONE			English	Article							SINGLE; DISCRIMINATION; MOLECULES	Malyshev et al. showed that the four-letter genetic code within a living organism could be expanded to include the unnatural DNA bases dNaM and d5SICS. However, verification and detection of these unnatural bases in DNA requires new sequencing techniques. Here we provide proof of concept detection of dNaM and d5SICS in DNA oligomers via nanopore sequencing using the nanopore MspA. We find that both phi29 DNA polymerase and Hel308 helicase are capable of controlling the motion of DNA containing dNaM and d5SICS through the pore and that single reads are sufficient to detect the presence and location of dNaM and d5SICS within single molecules.	[Craig, Jonathan M.; Laszlo, Andrew H.; Derrington, Ian M.; Ross, Brian C.; Brinkerhoff, Henry; Nova, Ian C.; Doering, Kenji; Tickman, Benjamin I.; Svet, Mark T.; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gundlach, JH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	jens@phys.washington.edu		Laszlo, Andrew/0000-0002-7853-0533; Gundlach, Jens Horst/0000-0002-0773-8038; Craig, Jonathan M/0000-0003-4791-5112	National Human Genome Research Institute [R01HG005115]; Amgen Foundation; Amgen scholars program at University of Washington; National Institute of Health, NHGRI [R01HG005115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005115] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Amgen Foundation(Amgen); Amgen scholars program at University of Washington; National Institute of Health, NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Human Genome Research Institute grant R01HG005115 https://www.genome.gov/ to JMC AHL IMD BCR HB ICN KD BIT JHG, and Amgen Foundation; Amgen scholars program at University of Washington www.amgen.com to MTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institute of Health, NHGRI grant R01HG005115. M. T.S. was supported through the Amgen Scholars program at the University of Washington. We thank Illumina for providing Hel308.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Derrington IM, 2015, NAT BIOTECHNOL, V33, P1073, DOI 10.1038/nbt.3357; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Laszlo AH, 2013, P NATL ACAD SCI USA, V110, P18904, DOI 10.1073/pnas.1310240110; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; Schreiber J, 2013, P NATL ACAD SCI USA, V110, P18910, DOI 10.1073/pnas.1310615110; Wescoe ZL, 2014, J AM CHEM SOC, V136, P16582, DOI 10.1021/ja508527b; Yang ZY, 2011, J AM CHEM SOC, V133, P15105, DOI 10.1021/ja204910n	13	23	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143253	10.1371/journal.pone.0143253	http://dx.doi.org/10.1371/journal.pone.0143253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588074	gold, Green Published, Green Submitted			2022-12-26	WOS:000365251500046
J	Nishimura, O; Hosoda, K; Kawaguchi, E; Yazawa, S; Hayashi, T; Inoue, T; Umesono, Y; Agata, K				Nishimura, Osamu; Hosoda, Kazutaka; Kawaguchi, Eri; Yazawa, Shigenobu; Hayashi, Tetsutaro; Inoue, Takeshi; Umesono, Yoshihiko; Agata, Kiyokazu			Unusually Large Number of Mutations in Asexually Reproducing Clonal Planarian Dugesia japonica	PLOS ONE			English	Article							RNA-SEQ DATA; STEM-CELLS; SCHMIDTEA-MEDITERRANEA; SEXUAL REPRODUCTION; HEAD-REGENERATION; READ ALIGNMENT; TIGRINA GIRARD; FAR-EAST; GENE; GENOME	We established a laboratory clonal strain of freshwater planarian (Dugesia japonica) that was derived from a single individual and that continued to undergo autotomous asexual reproduction for more than 20 years, and we performed large-scale genome sequencing and transcriptome analysis on it. Despite the fact that a completely clonal strain of the planarian was used, an unusually large number of mutations were detected. To enable quantitative genetic analysis of such a unique organism, we developed a new model called the Reference Gene Model, and used it to conduct large-scale transcriptome analysis. The results revealed large numbers of mutations not only outside but also inside gene-coding regions. Non-synonymous SNPs were detected in 74% of the genes for which valid ORFs were predicted. Interestingly, the high-mutation genes, such as metabolism- and defense-related genes, were correlated with genes that were previously identified as diverse genes among different planarian species. Although a large number of amino acid substitutions were apparently accumulated during asexual reproduction over this long period of time, the planarian maintained normal body-shape, behaviors, and physiological functions. The results of the present study reveal a unique aspect of asexual reproduction.	[Nishimura, Osamu; Kawaguchi, Eri; Yazawa, Shigenobu; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Global COE Program Evolut & Biodivers, Sakyo Ku, Kyoto, Japan; [Nishimura, Osamu; Hosoda, Kazutaka; Yazawa, Shigenobu; Inoue, Takeshi; Agata, Kiyokazu] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan; [Yazawa, Shigenobu] Nagoya Univ, Cellular & Struct Physiol Inst, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hayashi, Tetsutaro] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan; [Hayashi, Tetsutaro] RIKEN, Adv Ctr Comp & Commun, Wako, Saitama, Japan; [Umesono, Yoshihiko] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan	Kyoto University; Kyoto University; Nagoya University; RIKEN; RIKEN; University of Hyogo	Agata, K (corresponding author), Kyoto Univ, Grad Sch Sci, Global COE Program Evolut & Biodivers, Sakyo Ku, Kyoto, Japan.	agata@mdb.biophys.kyoto-u.ac.jp	Yazawa, Shigenobu/E-6395-2014; Nishimura, Osamu/AAC-1236-2020; Hayashi, Tetsutaro/Q-5085-2018; Inoue, Takeshi/S-5623-2019	Yazawa, Shigenobu/0000-0003-4539-3875; Nishimura, Osamu/0000-0003-1969-2580; Hayashi, Tetsutaro/0000-0003-1679-5525; Inoue, Takeshi/0000-0003-3289-4478; Agata, Kiyokazu/0000-0002-5195-2576	Ministry of Education, Culture, Sports, Science and Technology of Japan [A06, 17GS0318]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Frontier Research Program, a Grant-in-Aid for Global COE Program to KA (A06) (http://www.jsps.go.jp/j-globalcoe/05_kyoten.html), and a Grant-in-Aid for Creative Scientific Research to KA (17GS0318) (https://www.jsps.go.jp/j-grantsinaid/18_sousei/c_hyouka_kekka20.html) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-731; Agata K, 1999, SEMIN CELL DEV BIOL, V10, P377, DOI 10.1006/scdb.1999.0324; Agata K, 1998, ZOOL SCI, V15, P433, DOI 10.2108/zsj.15.433; Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; BESSHO Y, 1992, J MOL EVOL, V34, P324, DOI 10.1007/BF00160239; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Curtis W., 1902, PROC BOST SOC NAT HI, V30, P515; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldsmith E, 1939, ANAT REC           S, V75, P158; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Handberg-Thorsager M, 2007, DEV GENES EVOL, V217, P403, DOI 10.1007/s00427-007-0146-3; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hayashi T, 2010, DEV GROWTH DIFFER, V52, P131, DOI 10.1111/j.1440-169X.2009.01157.x; HYMAN LIBBIE H., 1939, TRANS AMER MICROSC SOC, V58, P264, DOI 10.2307/3222879; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Inoue T, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0010-z; Inoue T, 2014, J NEUROSCI, V34, P15701, DOI 10.1523/JNEUROSCI.5379-13.2014; Kajitani R., 2014, GENOME RES; KAWAKATSU M, 1995, HYDROBIOLOGIA, V305, P55, DOI 10.1007/BF00036363; Kenk R, 1937, BIOL BULL-US, V73, P280, DOI 10.2307/1537589; Kobayashi C, 2007, DEV BIOL, V306, P714, DOI 10.1016/j.ydbio.2007.04.010; Kobayashi K, 1999, ZOOL SCI, V16, P291, DOI 10.2108/zsj.16.291; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krueger F., TRIM GALORE; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lapan SW, 2012, CELL REP, V2, P294, DOI 10.1016/j.celrep.2012.06.018; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ma CX, 2010, J GENET GENOMICS, V37, P713, DOI 10.1016/S1673-8527(09)60089-8; Ma CX, 2010, J GENET GENOMICS, V37, P621, DOI 10.1016/S1673-8527(09)60081-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MIX MC, 1969, NATL CANCER I MONOGR, P693; Morgan T. H., 1898, Archiv fuer Entwicklungsmechanik, Vvii, P364; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nishimura O, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-289; Ogawa K, 2002, DEV BIOL, V250, P59, DOI 10.1006/dbio.2002.0790; OKI I, 1981, HYDROBIOLOGIA, V84, P53, DOI 10.1007/BF00026163; ORII H, 1993, BIOCHEM BIOPH RES CO, V192, P1395, DOI 10.1006/bbrc.1993.1571; Oviedo NJ, 2008, DIS MODEL MECH, V1, P131, DOI 10.1242/dmm.000117; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Pineda D, 2002, MECH DEVELOP, V119, pS167, DOI 10.1016/S0925-4773(03)00111-4; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Raska O, 2011, FOLIA BIOL-PRAGUE, V57, P223; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sakai M, 2012, ZOOL SCI, V29, P672, DOI 10.2108/zsj.29.672; Salo E, 2002, J EXP ZOOL, V292, P528, DOI 10.1002/jez.90001; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Sato K, 2006, DEV GROWTH DIFFER, V48, P615, DOI 10.1111/j.1440-169x.2006.00897.x; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Smed_Genome, SCHM MED GEN SEQ PRO; Tasaka K, 2013, INT J DEV BIOL, V57, P69, DOI 10.1387/ijdb.120114mm; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tyler S, 2013, TURBELLARIAN TAXONOM; VOWINCKEL C, 1970, BIOL BULL-US, V138, P77, DOI 10.2307/1540293; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang YY, 2007, P NATL ACAD SCI USA, V104, P5901, DOI 10.1073/pnas.0609708104; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Welch DBM, 2004, P NATL ACAD SCI USA, V101, P1622, DOI 10.1073/pnas.2136686100; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211; Yang X, 2013, BRIEF BIOINFORM, V14, P56, DOI 10.1093/bib/bbs015; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106	72	32	34	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143525	10.1371/journal.pone.0143525	http://dx.doi.org/10.1371/journal.pone.0143525			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588467	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500064
J	Oliveira, TL; Grassmann, AA; Schuch, RA; Neto, ACPS; Mendonca, M; Hartwig, DD; Alexander McBride, AJ; Dellagostin, OA				Oliveira, Thais Larre; Grassmann, Andre Alex; Schuch, Rodrigo Andrade; Pinto Seixas Neto, Amilton Clair; Mendonca, Marcelo; Hartwig, Daiane Drawanz; Alexander McBride, Alan John; Dellagostin, Odir Antonio			Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate	PLOS ONE			English	Article							PROTECTIVE IMMUNITY; PATHOGENIC LEPTOSPIRA; GENE-EXPRESSION; HAMSTER MODEL; GENOME; IDENTIFICATION; LIPL32; LIGA; CHALLENGE; INFECTION	The identification of potential vaccine candidates against leptospirosis remains a challenge. However, one such candidate is OmpL37, a potentially surface-exposed antigen that has the highest elastin-binding ability described to date, suggesting that it plays an important role in host colonization. In order to evaluate OmpL37's ability to induce a protective immune response, prime-boost, DNA and subunit vaccine strategies were tested in the hamster model of lethal leptospirosis. The humoral immune response was evaluated using an indirect ELISA test, and the cytokine profile in whole blood was determined by quantitative real-time PCR. Unlike the DNA vaccine, the administration of recombinant OmpL37 induced a strong IgG antibody response. When individually administrated, both formulations stimulated a TNF-alpha mediated inflammatory response. However, none of the OmpL37 formulations or vaccination strategies induced protective immunity. Further studies are required towards the identification of new vaccine targets against leptospirosis.	[Oliveira, Thais Larre; Grassmann, Andre Alex; Schuch, Rodrigo Andrade; Pinto Seixas Neto, Amilton Clair; Mendonca, Marcelo; Hartwig, Daiane Drawanz; Alexander McBride, Alan John; Dellagostin, Odir Antonio] Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Programa Posgrad Biotecnol, Pelotas, RS, Brazil; [Hartwig, Daiane Drawanz] Univ Fed Pelotas, Inst Biol, Dept Microbiol & Parasitol, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas	Dellagostin, OA (corresponding author), Univ Fed Pelotas, Ctr Desenvolvimento Tecnol, Programa Posgrad Biotecnol, Pelotas, RS, Brazil.	odirad@terra.com.br	Oliveira, Thaís/P-5974-2019; McBride, Alan/D-4106-2012; Dellagostin, Odir/C-2331-2009; Mendonça, Marcelo MM/I-6435-2013	McBride, Alan/0000-0001-9682-540X; Dellagostin, Odir/0000-0003-2803-4088; Mendonça, Marcelo MM/0000-0001-7415-457X; Grassmann, Andre/0000-0002-3910-2165; Hartwig, Daiane/0000-0003-3604-0832	CAPES; CNPq [407180/2013-3]; FAPERGS; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian funding agencies CAPES, CNPq (grant # 407180/2013-3), and FAPERGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Michele dos Santos for the technical assistance provided during this study. This work was supported by Brazilian funding agencies CAPES, CNPq and FAPERGS.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Bulach DM, 2000, J MOL MICROB BIOTECH, V2, P375; Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004; Cao XJ, 2010, CELL RES, V20, P197, DOI 10.1038/cr.2009.127; CAVAILLON JM, 1992, CIRC SHOCK, V38, P145; Chirathaworn C, 2014, BRAZ J INFECT DIS, V18, P77, DOI 10.1016/j.bjid.2013.08.002; Chou LF, 2012, GENE, V511, P364, DOI 10.1016/j.gene.2012.09.074; del Rio B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011199; Dellagostin OA, 2011, HUM VACCINES, V7, P1215, DOI 10.4161/hv.7.11.17944; Etz H, 2002, P NATL ACAD SCI USA, V99, P6573, DOI 10.1073/pnas.092569199; Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102; Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029; Feng CY, 2009, BRAZ J MED BIOL RES, V42, P796, DOI 10.1590/S0100-879X2009005000013; Fernandes CPH, 2007, HYBRIDOMA, V26, P35, DOI 10.1089/hyb.2006.033; Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Grassmann AA, 2012, CLIN VACCINE IMMUNOL, V19, P740, DOI 10.1128/CVI.05720-11; Haake David A, 2006, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12e02s02; Hartwig DD, 2013, CLIN VACCINE IMMUNOL, V20, P747, DOI 10.1128/CVI.00034-13; He HJ, 2008, CELL MOL IMMUNOL, V5, P385, DOI 10.1038/cmi.2008.48; Health Surveillance Secretary, 2013, LEPT CAS NOT REC; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Koizumi N, 2005, J Postgrad Med, V51, P210; Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007; Lourdault K, 2014, INFECT IMMUN, V82, P893, DOI 10.1128/IAI.01533-13; Lucas DSD, 2011, VACCINE, V29, P3413, DOI 10.1016/j.vaccine.2011.02.084; Matsui M, 2012, APPL ENVIRON MICROB, V78, P6372, DOI 10.1128/AEM.00911-12; Matsunaga J, 2010, MOL MICROBIOL; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06; Murray GL, 2013, VACCINE, V31, P495, DOI 10.1016/j.vaccine.2012.11.028; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Picardeau M, 2014, DIAGN MICR INFEC DIS, V78, P1, DOI 10.1016/j.diagmicrobio.2013.09.012; Pinne M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000815; Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ricaldi JN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001853; Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053; Sorensen HP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-27; Vernel-Pauillac F, 2006, INFECT IMMUN, V74, P4172, DOI 10.1128/IAI.00447-06; Vernel-Pauillac F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000582; Zuerner RL, 2011, CLIN VACCINE IMMUNOL, V18, P684, DOI 10.1128/CVI.00288-10	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142821	10.1371/journal.pone.0142821	http://dx.doi.org/10.1371/journal.pone.0142821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588685	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500017
J	Portale, AA; Zhang, MYH; David, V; Martin, A; Jiao, Y; Gu, WK; Perwad, F				Portale, Anthony A.; Zhang, Martin Y. H.; David, Valentin; Martin, Aline; Jiao, Yan; Gu, Weikuan; Perwad, Farzana			Characterization of FGF23-Dependent Egr-1 Cistrome in the Mouse Renal Proximal Tubule	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; CHRONIC KIDNEY-DISEASE; VITAMIN-D METABOLISM; X-LINKED HYPOPHOSPHATEMIA; PHOSPHATE-TRANSPORT; PARATHYROID-HORMONE; MINERAL METABOLISM; HYP MICE; SIGNALING PATHWAY; SERUM PHOSPHORUS	Fibroblast growth factor 23 (FGF23) is a potent regulator of phosphate (Pi) and vitamin D homeostasis. The transcription factor, early growth response 1 (egr-1), is a biomarker for FGF23-induced activation of the ERK1/2 signaling pathway. We have shown that ERK1/2 signaling blockade suppresses renal egr-1 gene expression and prevents FGF23-induced hypophosphatemia and 1,25-dihydroxyvitamin D (1,25(OH)(2)D) suppression in mice. To test whether egr-1 itself mediates these renal actions of FGF23, we administered FGF23 to egr-1(-/-) and wild-type (WT) mice. In WT mice, FGF23 induced hypophosphatemia and suppressed expression of the renal Na/Pi cotransporters, Npt2a and Npt2c. In FGF23-treated egr-1(-/-) mice, hypophosphatemic response was greatly blunted and Na/Pi cotransporter expression was not suppressed. In contrast, FGF23 induced equivalent suppression of serum 1,25(OH) 2D concentrations by suppressing renal cyp27b1 and stimulating cyp24a1 mRNA expression in both groups of mice. Thus, downstream of receptor binding and ERK1/2 signaling, we can distinguish the effector pathway that mediates FGF23-dependent inhibition of Pi transport from the pathway that mediates inhibition of 1,25(OH) 2D synthesis in the kidney. Furthermore, we demonstrate that the hypophosphatemic effect of FGF23 is significantly blunted in Hyp/egr-1(-/-) mice; specifically, serum Pi concentrations and renal Npt2a and Npt2c mRNA expression are significantly higher in Hyp/egr-1(-/-) mice than in Hyp mice. We then characterized the egr-1 cistrome in the kidney using ChIP-sequencing and demonstrate recruitment of egr-1 to regulatory DNA elements in proximity to several genes involved in Pi transport. Thus, our data demonstrate that the effect of FGF23 on Pi homeostasis is mediated, at least in part, by activation of egr-1.	[Portale, Anthony A.; Zhang, Martin Y. H.; Perwad, Farzana] Univ Calif San Francisco, Dept Pediat, Div Nephrol, San Francisco, CA 94110 USA; [David, Valentin; Martin, Aline] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Nephrol Hypertens, Chicago, IL 60611 USA; [Jiao, Yan; Gu, Weikuan] Univ Tennessee, Ctr Hlth Sci, Dept Orthopaed Surg, Memphis, TN 38163 USA	University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine; University of Tennessee System; University of Tennessee Health Science Center	Perwad, F (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Nephrol, San Francisco, CA 94110 USA.	perwadf@peds.ucsf.edu			University of California San Francisco Clinical and Translational Science Institute-Strategic Opportunity Support grant; UCSF Pediatric Nephrology Innovative Research Fund	University of California San Francisco Clinical and Translational Science Institute-Strategic Opportunity Support grant; UCSF Pediatric Nephrology Innovative Research Fund	Funding: This work was supported by University of California San Francisco Clinical and Translational Science Institute-Strategic Opportunity Support grant (to FP), and the UCSF Pediatric Nephrology Innovative Research Fund (to AAP).	Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barthel TK, 2007, J STEROID BIOCHEM, V103, P381, DOI 10.1016/j.jsbmb.2006.12.054; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Biber J, 2013, ANNU REV PHYSIOL, V75, P535, DOI 10.1146/annurev-physiol-030212-183748; Blaine J, 2009, AM J PHYSIOL-CELL PH, V297, pC1339, DOI 10.1152/ajpcell.00260.2009; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; Cunningham R, 2010, UROL RES, V38, P257, DOI 10.1007/s00240-010-0294-1; Dai B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044161; Farrow EG, 2009, J AM SOC NEPHROL, V20, P955, DOI 10.1681/ASN.2008070783; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FRIEDLAENDER MM, 1989, PFLUG ARCH EUR J PHY, V415, P372, DOI 10.1007/BF00370890; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Koldamova R, 2014, NEUROBIOL DIS, V63, P107, DOI 10.1016/j.nbd.2013.11.005; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lanzano L, 2011, AM J PHYSIOL-CELL PH, V301, pC850, DOI 10.1152/ajpcell.00412.2010; Lederer ED, 2008, FASEB J, V22; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; LU MQ, 1994, AM J PHYSIOL-RENAL, V267, pF624, DOI 10.1152/ajprenal.1994.267.4.F624; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Marks J, 2010, AM J PHYSIOL-RENAL, V299, pF285, DOI 10.1152/ajprenal.00508.2009; Marsell R, 2008, NEPHROL DIAL TRANSPL, V23, P827, DOI 10.1093/ndt/gfm672; Meyer MH, 2004, PHYSIOL GENOMICS, V18, P4, DOI 10.1152/physiolgenomics.00210.2003; Miyamoto K, 2005, THER APHER DIAL, V9, P331, DOI 10.1111/j.1744-9987.2005.00292.x; Nagano N, 2006, KIDNEY INT, V69, P531, DOI 10.1038/sj.ki.5000020; O'Geen H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-689; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Pietrosemoli N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003144; PITTS TO, 1988, J CLIN ENDOCR METAB, V67, P876, DOI 10.1210/jcem-67-5-876; Portale AA, 2014, CLIN J AM SOC NEPHRO, V9, P344, DOI 10.2215/CJN.05840513; Ranch D, 2011, J BONE MINER RES, V26, P1883, DOI 10.1002/jbmr.401; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2011, J BIOL CHEM, V286, P37216, DOI 10.1074/jbc.M111.288357; Weinman EJ, 2011, AM J PHYSIOL-RENAL, V300, pF231, DOI 10.1152/ajprenal.00532.2010; Weinman EJ, 2010, J BIOL CHEM, V285, P25134, DOI 10.1074/jbc.M110.132423; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; Zhang MYH, 2012, ENDOCRINOLOGY, V153, P1806, DOI 10.1210/en.2011-1831; Zhang MYH, 2002, ENDOCRINOLOGY, V143, P587, DOI 10.1210/en.143.2.587; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142924	10.1371/journal.pone.0142924	http://dx.doi.org/10.1371/journal.pone.0142924			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588476	gold, Green Published			2022-12-26	WOS:000365251500024
J	Welz, C; Emmert, S; Canis, M; Becker, S; Baumeister, P; Shimizu, T; Morfill, GE; Harreus, U; Zimmermann, JL				Welz, Christian; Emmert, Steffen; Canis, Martin; Becker, Sven; Baumeister, Philipp; Shimizu, Tetsuji; Morfill, Gregor E.; Harreus, Uli; Zimmermann, Julia L.			Cold Atmospheric Plasma: A Promising Complementary Therapy for Squamous Head and Neck Cancer	PLOS ONE			English	Article							NONTHERMAL PLASMA; CELL	Head and neck squamous cell cancer (HNSCC) is the 7th most common cancer worldwide. Despite the development of new therapeutic agents such as monoclonal antibodies, prognosis did not change for the last decades. Cold atmospheric plasma (CAP) presents the most promising new technology in cancer treatment. In this study the efficacy of a surface micro discharging (SMD) plasma device against two head and neck cancer cell lines was proved. Effects on the cell viability, DNA fragmentation and apoptosis induction were evaluated with the MTT assay, alkaline microgel electrophoresis (comet assay) and Annexin-V/PI staining. MTT assay revealed that the CAP treatment markedly decreases the cell viability for all tested treatment times (30, 60, 90, 120 and 180 s). IC 50 was reached within maximal 120 seconds of CAP treatment. Comet assay analysis showed a dose dependent high DNA fragmentation being one of the key players in anti-cancer activity of CAP. Annexin-V/PI staining revealed induction of apoptosis in CAP treated HNSCC cell lines but no significant dose dependency was seen. Thus, we confirmed that SMD Plasma technology is definitely a promising new approach on cancer treatment.	[Welz, Christian; Canis, Martin] Univ Gottingen, Dept Otorhinolaryngol Head & Neck Surg, D-37073 Gottingen, Germany; [Emmert, Steffen] Univ Gottingen, Dept Dermatol Venereol & Allergol, D-37073 Gottingen, Germany; [Becker, Sven] Johannes Gutenberg Univ Mainz, Dept Otolaryngol Head & Neck Surg, D-55122 Mainz, Germany; [Baumeister, Philipp] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany; [Shimizu, Tetsuji; Morfill, Gregor E.; Zimmermann, Julia L.] Terraplasma GmbH, Garching, Germany; [Harreus, Uli] Evangel Hosp Dusseldorf, Dept Otolaryngol Head & Neck Surg, Dusseldorf, Germany	University of Gottingen; University of Gottingen; Johannes Gutenberg University of Mainz; University of Munich	Welz, C (corresponding author), Univ Gottingen, Dept Otorhinolaryngol Head & Neck Surg, D-37073 Gottingen, Germany.	Christian.welz@med.uni-goettingen.de	Becker, Sven/AAV-5316-2021; Becker, Sven/AEN-1860-2022; Strebhardt, Klaus/E-8765-2011; Shimizu, Tetsuji/L-1478-2018	Shimizu, Tetsuji/0000-0001-9432-1152	Friedrich-Baur-Stiftung Munich [40/13]	Friedrich-Baur-Stiftung Munich	Funding: The work was supported by the Friedrich-Baur-Stiftung Munich (GrandNumber 40/13) [http://www.baur-stiftung.de/front_content.php?idcat=76]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, CANC FACTS FIG 2014; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; David B. G., 2012, J PHYS D, V45; Denaro N, 2014, ONCOLOGY-BASEL, V86, P212, DOI 10.1159/000357712; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Guerrero-Preston R, 2014, INT J MOL MED; Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45; Heinlin J, 2013, WOUND REPAIR REGEN, V21, P800, DOI 10.1111/wrr.12078; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x; Isbary G, 2013, EXPERT REV MED DEVIC, V10, P367, DOI [10.1586/erd.13.4, 10.1586/ERD.13.4]; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Koritzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064498; Lupu Andreea-Roxana, 2010, Roum Arch Microbiol Immunol, V69, P67; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Morfill G, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113041; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Seaman JC, 2013, CLIN CHEST MED, V34, P417, DOI 10.1016/j.ccm.2013.04.006; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tokar JL, 2013, GASTROINTEST ENDOSC, V78, P197, DOI 10.1016/j.gie.2013.04.164; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Welz C, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/4/045401; Yan X, 2010, IEEE T PLASMA SCI, V38, P2451, DOI 10.1109/TPS.2010.2056393; YOKOI T, 1989, Tumor Research, V24, P57; Zhang XH, 2008, APPL PHYS LETT, V93, P1; Zimmermann JL, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073037	31	42	43	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0141827	10.1371/journal.pone.0141827	http://dx.doi.org/10.1371/journal.pone.0141827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588072	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500006
J	Baarine, M; Khan, M; Singh, A; Singh, I				Baarine, Mauhamad; Khan, Mushfiquddin; Singh, Avtar; Singh, Inderjit			Functional Characterization of IPSC-Derived Brain Cells as a Model for X-Linked Adrenoleukodystrophy	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; C6 GLIAL-CELLS; AXONAL DEGENERATION; MOUSE MODEL; SKIN FIBROBLASTS; OXIDATIVE STRESS; GENE-EXPRESSION; LIGNOCERIC ACID; BETA-OXIDATION; STEM-CELLS	X-ALD is an inherited neurodegenerative disorder where mutations in the ABCD1 gene result in clinically diverse phenotypes: the fatal disorder of cerebral childhood ALD (cALD) or a milder disorder of adrenomyeloneuropathy (AMN). The various models used to study the pathobiology of X-ALD disease lack the appropriate presentation for different phenotypes of cALD vs AMN. This study demonstrates that induced pluripotent stem cells (IPSC) derived brain cells astrocytes (Ast), neurons and oligodendrocytes (OLs) express morphological and functional activities of the respective brain cell types. The excessive accumulation of saturated VLCFA, a "hallmark" of X-ALD, was observed in both AMN OLs and cALD OLs with higher levels observed in cALD OLs than AMN OLs. The levels of ELOVL1 (ELOVL Fatty Acid Elongase 1) mRNA parallel the VLCFA load in AMN and cALD OLs. Furthermore, cALD Ast expressed higher levels of proinflammatory cytokines than AMN Ast and control Ast with or without stimulation with lipopolysaccharide. These results document that IPSC-derived Ast and OLs from cALD and AMN fibroblasts mimic the respective biochemical disease phenotypes and thus provide an ideal platform to investigate the mechanism of VLCFA load in cALD OLs and VLCFA-induced inflammatory disease mechanisms of cALD Ast and thus for testing of new therapeutics for AMN and cALD disease of X-ALD.	[Baarine, Mauhamad; Khan, Mushfiquddin; Singh, Avtar; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Childrens Res Inst, Charleston, SC 29425 USA	Medical University of South Carolina	Singh, I (corresponding author), Med Univ S Carolina, Dept Pediat, Childrens Res Inst, 171 Ashley Ave, Charleston, SC 29425 USA.	singhi@musc.edu	Singh, Ashok/HGF-2506-2022		NIH, Bethesda, MD [NS-22576, NS72511, NS-64195, NS-37766]; NIH Grants from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR-018823, C06 RR-015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037766, R01NS022576, R37NS022576, R01NS064195, R01NS072511] Funding Source: NIH RePORTER	NIH, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Grants from the Extramural Research Facilities Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by grants (NS-22576, NS72511, NS-64195, and NS-37766) from the NIH, Bethesda, MD. This work was also supported by NIH Grants C06 RR-018823 and C06 RR-015455 from the Extramural Research Facilities Program of the National Center for Research Resources.; The authors would like to thank Dr. Choi Sueng for calcium efflux analysis assistance. We greatly appreciate the help of Ms. Joyce Bryan for technical assistance. These studies were supported by grants (NS-22576, NS72511, NS-64195, and NS-37766) from the NIH, Bethesda, MD. This work was also supported by NIH Grants C06 RR-018823 and C06 RR-015455 from the Extramural Research Facilities Program of the National Center for Research Resources.	Aubourg P, 2007, ANN ENDOCRINOL-PARIS, V68, P403, DOI 10.1016/j.ando.2007.04.002; Baarine M, 2012, NEUROSCIENCE, V213, P1, DOI 10.1016/j.neuroscience.2012.03.058; Baarine M., 2014, J NEUROCHEM; Baarine M, 2009, J NEUROCHEM, V111, P119, DOI 10.1111/j.1471-4159.2009.06311.x; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Berger J, 2010, BRAIN PATHOL, V20, P845, DOI 10.1111/j.1750-3639.2010.00393.x; Di Benedetto R, 2008, NEUROCHEM INT, V52, P1106, DOI 10.1016/j.neuint.2007.11.007; Di Biase A, 2004, NEUROCHEM INT, V44, P215, DOI 10.1016/S0197-0186(03)00162-1; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dubois-Dalcq M, 1999, TRENDS NEUROSCI, V22, P4, DOI 10.1016/S0166-2236(98)01319-8; Engelen M, 2012, J INHERIT METAB DIS, V35, P1137, DOI 10.1007/s10545-012-9471-4; Ferrer I, 2005, HUM MOL GENET, V14, P3565, DOI 10.1093/hmg/ddi384; FEUTZ AC, 1995, J NEUROCYTOL, V24, P865, DOI 10.1007/BF01179985; ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W; Fourcade S, 2008, HUM MOL GENET, V17, P1762, DOI 10.1093/hmg/ddn085; Fourcade S, 2014, BIOCHIMIE, V98, P143, DOI 10.1016/j.biochi.2013.09.012; Galea E, 2012, BBA-MOL BASIS DIS, V1822, P1475, DOI 10.1016/j.bbadis.2012.02.005; Galino J, 2011, ANTIOXID REDOX SIGN, V15, P2095, DOI 10.1089/ars.2010.3877; GANSER AL, 1988, DEV NEUROSCI-BASEL, V10, P99, DOI 10.1159/000111961; Gondcaille C, 2005, J CELL BIOL, V169, P93, DOI 10.1083/jcb.200501036; Grimm S, 2004, NAT REV GENET, V5, P179, DOI 10.1038/nrg1291; Hein S, 2008, HUM MOL GENET, V17, P1750, DOI 10.1093/hmg/ddn066; Hopfl G, 2004, METH MOL B, V254, P79; Jang J, 2011, ANN NEUROL, V70, P402, DOI 10.1002/ana.22486; Khan M, 1998, J NEUROCHEM, V71, P78; Khan M, 2010, J LIPID RES, V51, P1685, DOI 10.1194/jlr.M002329; Kobayashi T, 1997, BIOCHEM BIOPH RES CO, V232, P631, DOI 10.1006/bbrc.1997.6340; LAZO O, 1990, J LIPID RES, V31, P583; Lopez-Erauskin J, 2013, HUM MOL GENET, V22, P3296, DOI 10.1093/hmg/ddt186; Lopez-Erauskin J, 2012, BRAIN, V135, P3584, DOI 10.1093/brain/aws292; Lopez-Erauskin J, 2011, ANN NEUROL, V70, P84, DOI 10.1002/ana.22363; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; Lu JF, 1997, P NATL ACAD SCI USA, V94, P9366, DOI 10.1073/pnas.94.17.9366; Moser H, 2001, METABOLIC MOL BASIS; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Niedringhaus M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08353; Ofman R, 2010, EMBO MOL MED, V2, P90, DOI 10.1002/emmm.201000061; POULOS A, 1986, CLIN GENET, V29, P397; POWERS JM, 1974, AM J PATHOL, V76, P481; Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499; Ross CA, 2014, HUM MOL GENET; SINGH I, 1984, PEDIATR RES, V18, P286, DOI 10.1203/00006450-198403000-00016; SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203; Singh I, 1998, FEBS LETT, V426, P342, DOI 10.1016/S0014-5793(98)00370-6; SINGH I, 1992, J BIOL CHEM, V267, P13306; Singh I, 2010, BRAIN PATHOL, V20, P838, DOI 10.1111/j.1750-3639.2010.00392.x; Singh J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070712; Smith BT, 2000, EXP CELL RES, V254, P309, DOI 10.1006/excr.1999.4757; Uto Takuhiro, 2008, Dev Neurosci, V30, P410, DOI 10.1159/000191212; WANDERS RJA, 1987, CLIN CHIM ACTA, V166, P255, DOI 10.1016/0009-8981(87)90428-1; WANDERS RJA, 1988, BIOCHEM BIOPH RES CO, V153, P618, DOI 10.1016/S0006-291X(88)81140-9; Wang XM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt130; Weber FD, 2014, HUM MOL GENET, V23, P2542, DOI 10.1093/hmg/ddt645; Xu H, 2013, FASEB J, V27, P4157, DOI 10.1096/fj.12-226555; Yamada T, 2004, J NEUROL SCI, V218, P91, DOI 10.1016/j.jns.2003.11.006; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	56	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143238	10.1371/journal.pone.0143238	http://dx.doi.org/10.1371/journal.pone.0143238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581106	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600103
J	Schilling, J; Loziuk, PL; Muddiman, DC; Daniels, HV; Reading, BJ				Schilling, Justin; Loziuk, Philip L.; Muddiman, David C.; Daniels, Harry V.; Reading, Benjamin J.			Mechanisms of Egg Yolk Formation and Implications on Early Life History of White Perch (Morone americana)	PLOS ONE			English	Article							VERTEBRATE VITELLOGENIN GENE; MULLET MUGIL-CEPHALUS; PATTERN-RECOGNITION RECEPTOR; TANDEM MASS-SPECTROMETRY; MULTIPLE VITELLOGENINS; OOCYTE MATURATION; 2 FORMS; LIPOPROTEIN RECEPTORS; FUNDULUS-HETEROCLITUS; PELAGOPHIL TELEOST	The three white perch (Morone americana) vitellogenins (VtgAa, VtgAb, VtgC) were quantified accurately and precisely in the liver, plasma, and ovary during pre-, early-, mid-, and post-vitellogenic oocyte growth using protein cleavage-isotope dilution mass spectrometry (PC-IDMS). Western blotting generally mirrored the PC-IDMS results. By PC-IDMS, VtgC was quantifiable in pre-vitellogenic ovary tissues and VtgAb was quantifiable in pre-vitellogenic liver tissues however, neither protein was detected by western blotting in these respective tissues at this time point. Immunohistochemistry indicated that VtgC was present within pre-vitellogenic oocytes and localized to lipid droplets within vitellogenic oocytes. Affinity purification coupled to tandem mass spectrometry using highly purified VtgC as a bait protein revealed a single specific interacting protein (Y-box binding protein 2a-like [Ybx2a-like]) that eluted with suramin buffer and confirmed that VtgC does not bind the ovary vitellogenin receptors (LR8 and Lrp13). Western blotting for LR8 and Lrp13 showed that both receptors were expressed during vitellogenesis with LR8 and Lrp13 expression highest in early-and mid-vitellogenesis, respectively. The VtgAa within the ovary peaked during post-vitellogenesis, while VtgAb peaked during early-vitellogenesis in both white perch and the closely related striped bass (M. saxatilis). The VtgC was steadily accumulated by oocytes beginning during pre-vitellogenesis and continued until post-vitellogenesis and its composition varies widely between striped bass and white perch. In striped bass, the VtgC accounted for 26% of the vitellogenin-derived egg yolk, however in the white perch it comprised only 4%. Striped bass larvae have an extended developmental window and these larvae have yolk stores that may enable them to survive in the absence of food for twice as long as white perch after hatch. Thus, the VtgC may play an integral role in providing nutrients to late stage fish larvae prior to the onset of exogenous feeding and its composition in the egg yolk may relate to different early life histories among this diverse group of animals.	[Schilling, Justin; Daniels, Harry V.; Reading, Benjamin J.] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Loziuk, Philip L.; Muddiman, David C.] N Carolina State Univ, Dept Chem, WM Keck FTMS Lab Human Hlth Res, Raleigh, NC 27695 USA; [Muddiman, David C.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Reading, BJ (corresponding author), N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA.	bjreadin@ncsu.edu		Muddiman, David/0000-0003-2216-499X; Reading, Benjamin/0000-0002-0778-4069	North Carolina Hatch Project [NC 06819]; North Carolina Agricultural Foundation	North Carolina Hatch Project; North Carolina Agricultural Foundation	This research was funded by North Carolina Hatch Project NC 06819 and the North Carolina Agricultural Foundation.	Aebersold R, 2013, MOL CELL PROTEOMICS, V12, P2381, DOI 10.1074/mcp.E113.031658; Amano H, 2008, MOL REPROD DEV, V75, P1307, DOI 10.1002/mrd.20864; Amano H, 2007, MAR BIOL, V152, P1215, DOI 10.1007/s00227-007-0768-z; Amano H, 2007, J EXP ZOOL PART A, V307A, P324, DOI 10.1002/jez.388; BABIN PJ, 1989, J LIPID RES, V30, P467; Bergey LL, 2003, N AM J FISH MANAGE, V23, P558, DOI 10.1577/1548-8675(2003)023<0558:VOACSB>2.0.CO;2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN SA, 1986, BIOCHEM BIOPH RES CO, V139, P333, DOI 10.1016/S0006-291X(86)80118-8; Cohen AM, 2006, J MASS SPECTROM, V41, P646, DOI 10.1002/jms.1023; Cohen AM, 2009, RAPID COMMUN MASS SP, V23, P1049, DOI 10.1002/rcm.3966; ELDRIDGE MB, 1981, T AM FISH SOC, V110, P111, DOI 10.1577/1548-8659(1981)110<111:EOFAFF>2.0.CO;2; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Finn RN, 2007, BIOL REPROD, V76, P936, DOI 10.1095/biolreprod.106.055772; Finn RN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-2; Garcia J, 2010, FISH SHELLFISH IMMUN, V29, P293, DOI 10.1016/j.fsi.2010.04.010; Hiramatsu N, 2013, FISH PHYSIOL BIOCHEM, V39, P29, DOI 10.1007/s10695-012-9612-6; Hiramatsu N, 2002, FISH PHYSIOL BIOCHEM, V26, P355, DOI 10.1023/B:FISH.0000009266.58556.9a; JACKSON LF, 1995, T AM FISH SOC, V124, P563, DOI 10.1577/1548-8659(1995)124&lt;0563:ROWPTA&gt;2.3.CO;2; Kingon GLA, 2013, METHODS, V61, P323, DOI 10.1016/j.ymeth.2013.04.004; Kolarevic J, 2008, MOL REPROD DEV, V75, P1011, DOI 10.1002/mrd.20845; LAFLEUR GJ, 1995, J MOL EVOL, V41, P505, DOI 10.1007/BF00160323; LaFleur GJ, 2005, BIOL REPROD, V73, P815, DOI 10.1095/biolreprod.105.041335; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; MANSUETI ROMEO J., 1964, CHESAPEAKE SCI, V5, P3, DOI 10.2307/1350789; Matsubara T, 1999, DEV BIOL, V213, P18, DOI 10.1006/dbio.1999.9365; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; North EW, 2003, MAR ECOL PROG SER, V260, P219, DOI 10.3354/meps260219; Ohkubo N, 2003, GEN COMP ENDOCR, V131, P353, DOI 10.1016/S0016-6480(03)00035-2; Plumel MI, 2013, J PROTEOME RES, V12, P4122, DOI 10.1021/pr400444m; Reading BJ, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P635; Reading BJ, 2014, J LIPID RES, V55, P2287, DOI 10.1194/jlr.M050286; Reading BJ, 2011, BIOL REPROD, V84, P392, DOI 10.1095/biolreprod.110.087981; Reading BJ, 2009, MAR BIOTECHNOL, V11, P169, DOI 10.1007/s10126-008-9133-6; Reith M, 2001, J EXP ZOOL, V291, P58, DOI 10.1002/jez.5; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sawaguchi S, 2006, MOL REPROD DEV, V73, P719, DOI 10.1002/mrd.20446; Sawaguchi S, 2005, BIOL REPROD, V72, P1045, DOI 10.1095/biolreprod.104.037895; Sawaguchi S, 2005, ZOOL SCI, V22, P701, DOI 10.2108/zsj.22.701; Sawaguchi S, 2008, CYBIUM, V32, P262; Schilling J, 2015, PROTEOMICS, V15, P2678, DOI 10.1002/pmic.201400606; Schilling J, 2014, J PROTEOME RES, V13, P1515, DOI 10.1021/pr401067g; TAFURI SR, 1990, P NATL ACAD SCI USA, V87, P9028, DOI 10.1073/pnas.87.22.9028; Wang H, 2000, GENE, V256, P303, DOI 10.1016/S0378-1119(00)00376-0; Wang H, 2005, GENE, V356, P91, DOI 10.1016/j.gene.2005.03.041; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Williams VN, 2014, FISH PHYSIOL BIOCHEM, V40, P395, DOI 10.1007/s10695-013-9852-0; Williams VN, 2014, J EXP ZOOL PART A, V321, P301, DOI 10.1002/jez.1859; Zhang FG, 2004, ENVIRON TOXICOL CHEM, V23, P1408, DOI 10.1897/03-425; Zhang J, 2011, MAR BIOTECHNOL, V13, P441, DOI 10.1007/s10126-010-9315-x; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	51	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143225	10.1371/journal.pone.0143225	http://dx.doi.org/10.1371/journal.pone.0143225			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580971	Green Published, gold			2022-12-26	WOS:000365154600101
J	Shuert, C; Horning, M; Mellish, JA				Shuert, Courtney; Horning, Markus; Mellish, Jo-Ann			The Effect of Novel Research Activities on Long-term Survival of Temporarily Captive Steller Sea Lions (Eumetopias jubatus)	PLOS ONE			English	Article							CAPTURE-RECAPTURE DATA; AIC MODEL SELECTION; MARKED ANIMALS; FLIPPER BANDS; ALASKA; POPULATIONS; TRANSMITTERS; DISPERSAL; PINNIPEDS; INFERENCE	Two novel research approaches were developed to facilitate controlled access to, and long-term monitoring of, juvenile Steller sea lions for periods longer than typically afforded by traditional fieldwork. The Transient Juvenile Steller sea lion Project at the Alaska SeaLife Center facilitated nutritional, physiological, and behavioral studies on the platform of temporary captivity. Temporarily captive sea lions (TJs, n = 35) were studied, and were intraperitoneally implanted with Life History Transmitters (LHX tags) to determine causes of mortality post-release. Our goal was to evaluate the potential for long-term impacts of temporary captivity and telemetry implants on the survival of study individuals. A simple open-population Cormack-Jolly-Seber mark-recapture model was built in program MARK, incorporating resightings of uniquely branded study individuals gathered by several contributing institutions. A priori models were developed to weigh the evidence of effects of experimental treatment on survival with covariates of sex, age, capture age, cohort, and age class. We compared survival of experimental treatment to a control group of n = 27 free-ranging animals (FRs) that were sampled during capture events and immediately released. Sex has previously been show to differentially affect juvenile survival in Steller sea lions. Therefore, sex was included in all models to account for unbalanced sex ratios within the experimental group. Considerable support was identified for the effects of sex, accounting for over 71% of total weight for all a priori models with delta AICc < 5, and over 91% of model weight after removal of pretending variables. Overall, most support was found for the most parsimonious model based on sex and excluding experimental treatment. Models including experimental treatment were not supported after post-hoc considerations of model selection criteria. However, given the limited sample size, alternate models including effects of experimental treatments remain possible and effects may yet become apparent in larger sample sizes.	[Shuert, Courtney; Mellish, Jo-Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA; [Shuert, Courtney; Horning, Markus; Mellish, Jo-Ann] Alaska SeaLife Ctr, Seward, AK 99664 USA; [Horning, Markus] Oregon State Univ, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Mellish, Jo-Ann] North Pacific Res Board, Anchorage, AK 99501 USA	University of Alaska System; University of Alaska Fairbanks; Oregon State University	Shuert, C (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA.	crshuert@alaska.edu	Horning, Markus/I-3019-2015	Horning, Markus/0000-0001-6178-4935; Shuert, Courtney/0000-0002-3202-4897	Alaska SeaLife Center; National Marine Fisheries Service; North Pacific Research Board [R1011, R1310]; Pollock Conservation Cooperative Research Center; School of Fisheries and Ocean Sciences at the University of Alaska Fairbanks; Graduate Student Research Award	Alaska SeaLife Center; National Marine Fisheries Service; North Pacific Research Board; Pollock Conservation Cooperative Research Center; School of Fisheries and Ocean Sciences at the University of Alaska Fairbanks; Graduate Student Research Award	This work was supported by funding over the last decade by the Alaska SeaLife Center (to JM www.alaskasealife.org), the National Marine Fisheries Service, the North Pacific Research Board (R1011 and R1310 to JM and MH), the Pollock Conservation Cooperative Research Center (to JM and MH, https://www.sfos.uaf.edu/pcc/) and the School of Fisheries and Ocean Sciences at the University of Alaska Fairbanks. This work was also supported by 2014 Graduate Student Research Award (to CS, www.nprb.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Alaska Department of Fish and Game, the National Marine Mammal Laboratory, as well as the Alaska SeaLife Center for their generous exchange of brand resighting data and research framework advice. We would also like to thank the many husbandry technicians and researchers that have participated in the Transient Juvenile Steller sea lion project over the last decade. This work was supported by funding over the last decade by the Alaska SeaLife Center (no grant numbers-to JM www.alaskasealife.org), the National Marine Fisheries Service, the North Pacific Research Board (R1011 and R1310 to JM and MH), the Pollock Conservation Cooperative Research Center (no grant numbers-to JM and MH https://www.sfos.uaf.edu/pcc/.), and the School of Fisheries and Ocean Sciences at the University of Alaska Fairbanks. This work was also supported by 2014 Graduate Student Research Award to CS www.nprb.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Anderson DR, 1998, J APPL STAT, V25, P263, DOI 10.1080/02664769823250; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Bonner SJ, 2010, BIOMETRICS, V66, P1256, DOI 10.1111/j.1541-0420.2010.01390.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Calkins DG, 2013, J EXP MAR BIOL ECOL, V441, P55, DOI 10.1016/j.jembe.2013.01.011; CASTELLINI MA, 1993, MAR MAMMAL SCI, V9, P48, DOI 10.1111/j.1748-7692.1993.tb00425.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Fritz LW, 2014, ENDANGER SPECIES RES, V26, P13, DOI 10.3354/esr00634; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Goldstein Tracey, 2007, Aquatic Mammals, V33, P337, DOI 10.1578/AM.33.3.2007.337; Hall AJ, 2002, FUNCT ECOL, V16, P462, DOI 10.1046/j.1365-2435.2002.00649.x; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Horning M, 2005, IEEE J OCEANIC ENG, V30, P807, DOI 10.1109/JOE.2005.862135; Horning Markus, 2010, Endangered Species Research, V10, P135, DOI 10.3354/esr00220; Horning M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-51; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; King JC, 2007, MAR MAMMAL SCI, V23, P262, DOI 10.1111/j.1748-7692.2007.00108.x; Laake J., 2013, 201301 AFSC NOAA NAT, P1; Le Maho Y, 2011, CR BIOL, V334, P378, DOI 10.1016/j.crvi.2011.04.004; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096328; McAllister DC, 2001, COLD WATER DIVING SC, P98, DOI DOI 10.4027/CWDS.2001; Mellish Jo-Ann E., 2006, Aquatic Mammals, V32, P58, DOI 10.1578/AM.32.1.2006.58; Merrick RL, 1996, HOT BRANDING TECHNIQ, P1; Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Thomton JD, 2007, J WILDLIFE DIS, V43, P258, DOI 10.7589/0090-3558-43.2.258; Thomton Jamie D., 2008, Endangered Species Research, V4, P195, DOI 10.3354/esr00062; TRITES AW, 1990, FUNCT ECOL, V4, P753, DOI 10.2307/2389442; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	35	11	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141948	10.1371/journal.pone.0141948	http://dx.doi.org/10.1371/journal.pone.0141948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580549	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600029
J	Maione, V; Ruggiero, A; Russo, L; De Simone, A; Pedone, PV; Malgieri, G; Berisio, R; Isernia, C				Maione, Vincenzo; Ruggiero, Alessia; Russo, Luigi; De Simone, Alfonso; Pedone, Paolo Vincenzo; Malgieri, Gaetano; Berisio, Rita; Isernia, Carla			NMR Structure and Dynamics of the Resuscitation Promoting Factor RpfC Catalytic Domain	PLOS ONE			English	Article							GROWTH IN-VITRO; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN STRUCTURES; GLOBULAR-PROTEINS; CRYSTAL-STRUCTURE; BACTERIAL-GROWTH; T4 LYSOZYME; RELAXATION; SPECTROSCOPY; PREDICTION	Mycobacterium tuberculosis latent infection is maintained for years with no clinical symptoms and no adverse effects for the host. The mechanism through which dormant M. tuberculosis resuscitates and enters the cell cycle leading to tuberculosis is attracting much interest. The RPF family of proteins has been found to be responsible for bacteria resuscitation and normal proliferation. This family of proteins in M. tuberculosis is composed by five homologues (named RpfA-E) and understanding their conformational, structural and functional peculiarities is crucial to the design of therapeutic strategies. Therefore, we report the structural and dynamics characterization of the catalytic domain of RpfC from M. tubercolosis by combining Nuclear Magnetic Resonance, Circular Dichroism and Molecular Dynamics data. We also show how the formation of a disulfide bridge, highly conserved among the homologues, is likely to modulate the shape of the RpfC hydrophobic catalytic cleft. This might result in a protein function regulation via a "conformational editing" through a disulfide bond formation.	[Maione, Vincenzo; Pedone, Paolo Vincenzo; Malgieri, Gaetano; Isernia, Carla] Univ Naples 2, Dipartimento Sci Tecnol Ambientali Biol & Farmace, I-81100 Caserta, Italy; [Ruggiero, Alessia; Berisio, Rita] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Russo, Luigi; Pedone, Paolo Vincenzo; Isernia, Carla] Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioatt, I-80134 Naples, Italy; [De Simone, Alfonso] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Nat Sci, London, England	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; Imperial College London	Isernia, C (corresponding author), Univ Naples 2, Dipartimento Sci Tecnol Ambientali Biol & Farmace, Via Vivaldi 43, I-81100 Caserta, Italy.	carla.isernia@unina2.it	Ruggiero, Alessia/GRJ-9538-2022; Isernia, Carla/ABD-8156-2021; Malgieri, Gaetano/N-1678-2016	Ruggiero, Alessia/0000-0002-3508-385X; Berisio, Rita/0000-0001-5025-6483; MALGIERI, Gaetano/0000-0002-4070-9458; RUSSO, Luigi/0000-0002-1577-176X; Maione, Vincenzo/0000-0002-8229-6612; Isernia, Carla/0000-0002-1504-2479	Ministero dell' Istruzione, dell'Universita e della Ricerca (MIUR) [PRIN 2010 2010M2JARJ_002, MERIT RBNE08HWLZ_014]	Ministero dell' Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was funded by grants PRIN 2010 2010M2JARJ_002 and Programma MERIT RBNE08HWLZ_014 from Ministero dell' Istruzione, dell'Universita e della Ricerca (MIUR).	BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Chauviac FX, 2014, ACTA CRYSTALLOGR F, V70, P1022, DOI 10.1107/S2053230X1401317X; Chruszcz M, 2008, BIOPHYS J, V95, P1, DOI 10.1529/biophysj.108.131789; Cohen Y, 2005, ANGEW CHEM INT EDIT, V44, P520, DOI 10.1002/anie.200300637; Cohen-Gonsaud M, 2005, NAT STRUCT MOL BIOL, V12, P270, DOI 10.1038/nsmb905; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Downing KJ, 2005, INFECT IMMUN, V73, P3038, DOI 10.1128/IAI.73.5.3038-3043.2005; Downing KJ, 2004, TUBERCULOSIS, V84, P167, DOI 10.1016/j.tube.2003.12.004; FABER HR, 1990, NATURE, V348, P263, DOI 10.1038/348263a0; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall JB, 2003, J BIOMOL NMR, V27, P261, DOI 10.1023/A:1025467918856; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; HIDER RC, 1988, BIOPHYS CHEM, V31, P45, DOI 10.1016/0301-4622(88)80007-3; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kana BD, 2010, FEMS IMMUNOL MED MIC, V58, P39, DOI 10.1111/j.1574-695X.2009.00606.x; Keep NH, 2006, TRENDS MICROBIOL, V14, P271, DOI 10.1016/j.tim.2006.04.003; KHAN MY, 1989, J BIOL CHEM, V264, P2139; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehtivarjo J, 2012, J BIOMOL NMR, V52, P257, DOI 10.1007/s10858-012-9609-6; Lehtivarjo J, 2009, J BIOMOL NMR, V45, P413, DOI 10.1007/s10858-009-9384-1; Liu PF, 2009, ANAL BIOCHEM, V389, P165, DOI 10.1016/j.ab.2009.03.028; Mavrici D, 2014, PROTEIN SCI, V23, P481, DOI 10.1002/pro.2431; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; Nikitushkin VD, 2015, FEBS J, V282, P2500, DOI 10.1111/febs.13292; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Ravagnani A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-39; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shilton BH, 1996, J MOL BIOL, V264, P350, DOI 10.1006/jmbi.1996.0645; Squeglia F, 2013, BIOPHYS J, V104, P2530, DOI 10.1016/j.bpj.2013.04.040; Tufariello JM, 2006, INFECT IMMUN, V74, P2985, DOI 10.1128/IAI.74.5.2985-2995.2006; Tufariello JM, 2004, INFECT IMMUN, V72, P515, DOI 10.1128/IAI.72.1.515-526.2004; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANGUNSTEREN WF, 1984, J MOL BIOL, V176, P559, DOI 10.1016/0022-2836(84)90177-3; Viles JH, 2001, J BIOMOL NMR, V21, P1, DOI 10.1023/A:1011966718826; WAGNER G, 1992, ANNU REV BIOPH BIOM, V21, P167, DOI 10.1146/annurev.biophys.21.1.167; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; ZHANG XJ, 1995, J MOL BIOL, V250, P527, DOI 10.1006/jmbi.1995.0396	44	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142807	10.1371/journal.pone.0142807	http://dx.doi.org/10.1371/journal.pone.0142807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26576056	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400017
J	Wagner, F				Wagner, Florian			GO-PCA: An Unsupervised Method to Explore Gene Expression Data Using Prior Knowledge	PLOS ONE			English	Article							GENOME-WIDE; CELL; DISCOVERY; VISUALIZATION; NEUTROPHILS; REGULATORS	Method Genome-wide expression profiling is a widely used approach for characterizing heterogeneous populations of cells, tissues, biopsies, or other biological specimen. The exploratory analysis of such data typically relies on generic unsupervised methods, e.g. principal component analysis (PCA) or hierarchical clustering. However, generic methods fail to exploit prior knowledge about the molecular functions of genes. Here, I introduce GO-PCA, an unsupervised method that combines PCA with nonparametric GO enrichment analysis, in order to systematically search for sets of genes that are both strongly correlated and closely functionally related. These gene sets are then used to automatically generate expression signatures with functional labels, which collectively aim to provide a readily interpretable representation of biologically relevant similarities and differences. The robustness of the results obtained can be assessed by bootstrapping. Results I first applied GO-PCA to datasets containing diverse hematopoietic cell types from human and mouse, respectively. In both cases, GO-PCA generated a small number of signatures that represented the majority of lineages present, and whose labels reflected their respective biological characteristics. I then applied GO-PCA to human glioblastoma (GBM) data, and recovered signatures associated with four out of five previously defined GBM subtypes. My results demonstrate that GO-PCA is a powerful and versatile exploratory method that reduces an expression matrix containing thousands of genes to a much smaller set of interpretable signatures. In this way, GO-PCA aims to facilitate hypothesis generation, design of further analyses, and functional comparisons across datasets.	[Wagner, Florian] Duke Univ, Grad Program Computat Biol & Bioinformat, Durham, NC 27710 USA; [Wagner, Florian] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA	Duke University; Duke University	Wagner, F (corresponding author), Duke Univ, Grad Program Computat Biol & Bioinformat, Durham, NC 27710 USA.	florian.wagner@duke.edu		Wagner, Florian/0000-0001-7639-3486				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cheng Jill, 2004, J Biopharm Stat, V14, P687, DOI 10.1081/BIP-200025659; Chung NC, 2015, BIOINFORMATICS, V31, P545, DOI 10.1093/bioinformatics/btu674; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Doan T, 2012, IMMUNOLOGY; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Efron B, 1994, INTRO BOOTSTRAP; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gajewski TF, INNATE ADAPTIVE IMMU, V14, P1014; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Goldman SJ, 2010, MITOCHONDRION, V10, P309, DOI 10.1016/j.mito.2010.01.005; Greer JP, WINTROBES CLIN HEMAT; Hashimshony T, 2015, NATURE, V519, P219, DOI 10.1038/nature13996; Huang DS, 2006, BIOINFORMATICS, V22, P1259, DOI 10.1093/bioinformatics/btl065; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Klein AM, DROPLET BARCODING SI, V161, P1187; Kustra R, 2006, COMP MED SY, P555, DOI 10.1109/CBMS.2006.100; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lommel ATLV., CELLS ORGANS HISTOLO; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; McLachlan GJ, 2002, BIOINFORMATICS, V18, P413, DOI 10.1093/bioinformatics/18.3.413; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; O'Reilly D, DIFFERENTIALLY EXPRE, V23, P281; Pan W, 2006, BIOINFORMATICS, V22, P795, DOI 10.1093/bioinformatics/btl011; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips HS, MOL SUBCLASSES HIGH, V9, P157; Reshetova P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S2-S2; Robinson DG, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv636; Rothenberg EV., TRANSCRIPTIONAL CONT, V32, P283; Sabroe I, 2005, CLIN INFECT DIS, V41, pS421, DOI 10.1086/431992; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shen YJ, 2010, BIOINFORMATICS, V26, P341, DOI 10.1093/bioinformatics/btp671; Silva MT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00174; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tseng GC, 2007, BIOINFORMATICS, V23, P2247, DOI 10.1093/bioinformatics/btm320; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wagner F, XL MHG TEST ENRICHME	52	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143196	10.1371/journal.pone.0143196	http://dx.doi.org/10.1371/journal.pone.0143196			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575370	Green Submitted, Green Published, gold			2022-12-26	WOS:000365153400052
J	Chaari, A; Fahy, C; Chevillot-Biraud, A; Rholam, M				Chaari, Ali; Fahy, Christine; Chevillot-Biraud, Alexandre; Rholam, Mohamed			Insights into Kinetics of Agitation-Induced Aggregation of Hen Lysozyme under Heat and Acidic Conditions from Various Spectroscopic Methods	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; FIBRIL FORMATION; SECONDARY STRUCTURE; ALPHA-SYNUCLEIN; TRYPTOPHAN FLUORESCENCE; PROTEIN; ALZHEIMERS; AMYLOIDOGENESIS; NUCLEATION; INSULIN	Protein misfolding and amyloid formation are an underlying pathological hallmark in a number of prevalent diseases of protein aggregation ranging from Alzheimer's and Parkinson's diseases to systemic lysozyme amyloidosis. In this context, we have used complementary spectroscopic methods to undertake a systematic study of the self-assembly of hen egg-white lysozyme under agitation during a prolonged heating in acidic pH. The kinetics of lysozyme aggregation, monitored by Thioflavin T fluorescence, dynamic light scattering and the quenching of tryptophan fluorescence by acrylamide, is described by a sigmoid curve typical of a nucleation-dependent polymerization process. Nevertheless, we observe significant differences between the values deduced for the kinetic parameters (lag time and aggregation rate). The fibrillation process of lysozyme, as assessed by the attenuated total reflection-Fourier transform infrared spectroscopy, is accompanied by an increase in the beta-sheet conformation at the expense of the alpha-helical conformation but the time-dependent variation of the content of these secondary structures does not evolve as a gradual transition. Moreover, the tryptophan fluorescence-monitored kinetics of lysozyme aggregation is described by three phases in which the temporal decrease of the tryptophan fluorescence quantum yield is of quasilinear nature. Finally, the generated lysozyme fibrils exhibit a typical amyloid morphology with various lengths (observed by atomic force microscopy) and contain exclusively the full-length protein (analyzed by highly performance liquid chromatography). Compared to the data obtained by other groups for the formation of lysozyme fibrils in acidic pH without agitation, this work provides new insights into the structural changes (local, secondary, oligomeric/fibrillar structures) undergone by the lysozyme during the agitation-induced formation of fibrils.	[Chaari, Ali; Fahy, Christine; Chevillot-Biraud, Alexandre; Rholam, Mohamed] Univ Paris Diderot, Sorbonne Paris Cite, ITODYS, CNRS,UMR 7086, F-75205 Paris, France; [Chaari, Ali] Univ Versailles St Quentin En Yvelines, Lab Genet & Biol Cellulaire, F-78035 Versailles, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Rholam, M (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, ITODYS, CNRS,UMR 7086, F-75205 Paris, France.	mohamed.rholam@univ-paris-diderot.fr	Chaari, Ali/AEQ-0174-2022	chaari, Ali/0000-0003-0171-143X				Ansari MA, 2010, PROTEIN PEPTIDE LETT, V17, P11, DOI 10.2174/092986610789909502; Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; Bellotti V, 2009, OPEN BIOL J, V2, P228; Benseny-Cases N, 2007, BIOCHEM BIOPH RES CO, V361, P916, DOI 10.1016/j.bbrc.2007.07.082; Bhattacharya M, 2011, J PHYS CHEM B, V115, P4195, DOI 10.1021/jp111528c; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Buell AK, 2011, J AM CHEM SOC, V133, P7737, DOI 10.1021/ja109620d; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dannies PS, 2002, MOL GENET METAB, V76, P6, DOI 10.1016/S1096-7192(02)00011-2; Dumoulin M, 2006, ACCOUNTS CHEM RES, V39, P603, DOI 10.1021/ar050070g; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Fatima S, 2008, PROTEIN PEPTIDE LETT, V15, P346, DOI 10.2174/092986608784246425; Foley J, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811343; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frare E, 2004, J MOL BIOL, V340, P1153, DOI 10.1016/j.jmb.2004.05.056; Frare E, 2009, J MOL BIOL, V387, P17, DOI 10.1016/j.jmb.2009.01.049; FRASER KJ, 1972, BIOCHEMISTRY-US, V11, P4974, DOI 10.1021/bi00776a016; Garzon-Rodriguez W, 2000, J BIOL CHEM, V275, P22645, DOI 10.1074/jbc.M000756200; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Grudzielanek S, 2007, J MOL BIOL, V370, P372, DOI 10.1016/j.jmb.2007.04.053; Hameed M, 2009, PROTEIN PEPTIDE LETT, V16, P56, DOI 10.2174/092986609787049448; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hill SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018171; Hisatomi O., 2014, OPEN J BIOPHYS, V4, P83, DOI [10.4236/ojbi-phy.2014.42009, DOI 10.4236/OJBI-PHY.2014.42009, DOI 10.4236/ojbiphy.2014.42009]; Holley M, 2008, BIOCHEM BIOPH RES CO, V373, P164, DOI 10.1016/j.bbrc.2008.06.018; Iconomidou VA, 2008, CURR PROTEIN PEPT SC, V9, P291, DOI 10.2174/138920308784534041; Ishtikhar M, 2015, INT J BIOL MACROMOL, V78, P379, DOI 10.1016/j.ijbiomac.2015.03.069; Jayaraman M, 2014, EUR J PHARM BIOPHARM, V87, P299, DOI 10.1016/j.ejpb.2014.01.004; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Jean L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001834; Jeong JS, 2013, J MOL BIOL, V425, P1765, DOI 10.1016/j.jmb.2013.02.005; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; JOHNSON DA, 1985, BIOPHYS J, V48, P949, DOI 10.1016/S0006-3495(85)83858-3; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x; Khan JM, 2014, SOFT MATTER, V10, P2591, DOI 10.1039/c3sm52435c; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; Khan MV, 2015, INT J BIOL MACROMOL, V78, P417, DOI 10.1016/j.ijbiomac.2015.04.021; Khodarahmi R, 2009, PROTEIN J, V28, P349, DOI 10.1007/s10930-009-9200-5; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lee S, 2007, PROTEIN SCI, V16, P723, DOI 10.1110/ps.062514807; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li AQ, 2001, ANAL CHEM, V73, P5395, DOI 10.1021/ac010619z; Li SJ, 2004, BIOCHEM BIOPH RES CO, V324, P529, DOI 10.1016/j.bbrc.2004.09.078; Lindner AB, 2009, BBA-GEN SUBJECTS, V1790, P980, DOI 10.1016/j.bbagen.2009.06.005; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Malisauskas M, 2003, J MOL BIOL, V330, P879, DOI 10.1016/S0022-2836(03)00551-5; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; Merlini G, 2005, CLIN CHIM ACTA, V357, P168, DOI 10.1016/j.cccn.2005.03.022; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Morinaga A, 2010, BBA-PROTEINS PROTEOM, V1804, P986, DOI 10.1016/j.bbapap.2010.01.012; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nishimoto E, 1998, BIOCHEMISTRY-US, V37, P5599, DOI 10.1021/bi9718651; NORTON RS, 1977, J BIOL CHEM, V252, P1795; Parmar AS, 2007, BIOPHYS CHEM, V129, P224, DOI 10.1016/j.bpc.2007.06.002; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; Poduslo JF, 2012, BIOCHEMISTRY-US, V51, P3993, DOI 10.1021/bi300275g; Ravi VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087256; RHOLAM M, 1984, BIOCHEMISTRY-US, V23, P6793, DOI 10.1021/bi00321a079; Ruzafa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049690; Sasahara K, 2007, J MOL BIOL, V372, P981, DOI 10.1016/j.jmb.2007.06.088; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SEGALAS I, 1995, FEBS LETT, V371, P171, DOI 10.1016/0014-5793(95)00844-Y; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Strambini GB, 2010, J PHYS CHEM B, V114, P1089, DOI 10.1021/jp909567q; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Tokunaga Y, 2013, INT J BIOL SCI, V9, P219, DOI 10.7150/ijbs.5380; Touchette JC, 2010, ARCH BIOCHEM BIOPHYS, V494, P192, DOI 10.1016/j.abb.2009.12.007; Uversky V, 2004, BIOCHIM BIOPHYS ACTA, V1698, P130; Vaney MC, 1996, ACTA CRYSTALLOGR D, V52, P505, DOI 10.1107/S090744499501674X; Varshney A, 2010, AMINO ACIDS, V39, P899, DOI 10.1007/s00726-010-0524-4; Vernaglia BA, 2004, BIOMACROMOLECULES, V5, P1362, DOI 10.1021/bm0498979; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Zou Y, 2013, J PHYS CHEM B, V117, P4003, DOI 10.1021/jp4003559	89	35	35	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142095	10.1371/journal.pone.0142095	http://dx.doi.org/10.1371/journal.pone.0142095			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571264	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700018
J	da Cunha, BR; Gonzalez-Avella, JC; Goncalves, S				da Cunha, Bruno Requiao; Gonzalez-Avella, Juan Carlos; Goncalves, Sebastian			Fast Fragmentation of Networks Using Module-Based Attacks	PLOS ONE			English	Article							ROBUSTNESS ANALYSIS; VULNERABILITY; CENTRALITY; INTERNET; ERROR; MAP	In the multidisciplinary field of Network Science, optimization of procedures for efficiently breaking complex networks is attracting much attention from a practical point of view. In this contribution, we present a module-based method to efficiently fragment complex networks. The procedure firstly identifies topological communities through which the network can be represented using a well established heuristic algorithm of community finding. Then only the nodes that participate of inter-community links are removed in descending order of their betweenness centrality. We illustrate the method by applying it to a variety of examples in the social, infrastructure, and biological fields. It is shown that the module-based approach always outperforms targeted attacks to vertices based on node degree or betweenness centrality rankings, with gains in efficiency strongly related to the modularity of the network. Remarkably, in the US power grid case, by deleting 3% of the nodes, the proposed method breaks the original network in fragments which are twenty times smaller in size than the fragments left by betweenness-based attack.	[da Cunha, Bruno Requiao; Gonzalez-Avella, Juan Carlos; Goncalves, Sebastian] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil; [da Cunha, Bruno Requiao] Dept Policia Fed, Porto Alegre, RS, Brazil; [Gonzalez-Avella, Juan Carlos] Pontificia Univ Catolica Rio de Janeiro, Dept Fis, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica do Rio de Janeiro	Goncalves, S (corresponding author), Ave Bento Goncalves 9500,Caixa Postal 15051, BR-91501970 Porto Alegre, RS, Brazil.	sgonc@if.ufrgs.br	goncalves, sebastian/AAN-5534-2020; Gonçalves, Sebastián/I-4356-2013; da Cunha, Bruno Requião/B-2373-2015	goncalves, sebastian/0000-0002-3100-9126; Gonçalves, Sebastián/0000-0002-3100-9126; da Cunha, Bruno Requião/0000-0002-9985-6030				Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], ARXIV14044748; [Anonymous], 2011, PHYS REP, DOI DOI 10.1016/j.physrep.2010.11.002; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brummitt CD, 2012, P NATL ACAD SCI USA, V109, pE680, DOI 10.1073/pnas.1110586109; Bu YL, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042801; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Crucitti P, 2004, PHYSICA A, V340, P388, DOI 10.1016/j.physa.2004.04.031; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; De Meo P, 2014, COMMUN ACM, V57, P78, DOI 10.1145/2629438; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Duijn PAC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04238; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056109; Hwang W, 2006, P 12 ACM SIGKDD INT, P20; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; McAuley J, 2014, ACM T KNOWL DISCOV D, V8, P73, DOI 10.1145/2556612; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Opsahl T, 2011, WHY ANCHORAGE IS NOT; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Peixoto TP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118703; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Pu CL, 2015, PHYSICA A, V419, P622, DOI 10.1016/j.physa.2014.10.038; Pu CL, 2013, PHYSICA A, V392, P3293, DOI 10.1016/j.physa.2013.03.059; Pu CL, 2012, PHYSICA A, V391, P4420, DOI 10.1016/j.physa.2012.04.019; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rosvall M, 2009, EUR PHYS J-SPEC TOP, V178, P13, DOI 10.1140/epjst/e2010-01179-1; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Subelj L, 2011, EUR PHYS J B, V81, P353, DOI 10.1140/epjb/e2011-10979-2; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Valente TW, 2010, SOC NETWORKS, V32, P212, DOI 10.1016/j.socnet.2010.03.003; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xu J, 2008, COMMUN ACM, V51, P58, DOI 10.1145/1400181.1400198	46	42	42	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142824	10.1371/journal.pone.0142824	http://dx.doi.org/10.1371/journal.pone.0142824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569610	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700078
J	da Silva, CM; Leal, MP; Brochetti, RA; Braga, T; Vitoretti, LB; Camara, NOS; Damazo, AS; Ligeiro-De-Oliveira, AP; Chavantes, MC; Lino-dos-Santos-Franco, A				da Silva, Cristiane Miranda; Leal, Mayara Peres; Brochetti, Robson Alexandre; Braga, Tarcio; Vitoretti, Luana Beatriz; Saraiva Camara, Niels Olsen; Damazo, Amilcar Sabino; Ligeiro-de-Oliveira, Ana Paula; Chavantes, Maria Cristina; Lino-dos-Santos-Franco, Adriana			Low Level Laser Therapy Reduces the Development of Lung Inflammation Induced by Formaldehyde Exposure	PLOS ONE			English	Article							ALLERGIC-ASTHMA; MAST-CELLS; RAT MODEL; LLLT; GRANULOPOIESIS; NEUTROPHILS; PRODUCTS; RELEASE; MARROW; TISSUE	Lung diseases constitute an important public health problem and its growing level of concern has led to efforts for the development of new therapies, particularly for the control of lung inflammation. Low Level Laser Therapy (LLLT) has been highlighted as a non-invasive therapy with few side effects, but its mechanisms need to be better understood and explored. Considering that pollution causes several harmful effects on human health, including lung inflammation, in this study, we have used formaldehyde (FA), an environmental and occupational pollutant, for the induction of neutrophilic lung inflammation. Our objective was to investigate the local and systemic effects of LLLT after FA exposure. Male Wistar rats were exposed to FA (1%) or vehicle (distillated water) during 3 consecutive days and treated or not with LLLT (1 and 5 hours after each FA exposure). Non-manipulated rats were used as control. 24 h after the last FA exposure, we analyzed the local and systemic effects of LLLT. The treatment with LLLT reduced the development of neutrophilic lung inflammation induced by FA, as observed by the reduced number of leukocytes, mast cells degranulated, and a decreased myeloperoxidase activity in the lung. Moreover, LLLT also reduced the microvascular lung permeability in the parenchyma and the intrapulmonary bronchi. Alterations on the profile of inflammatory cytokines were evidenced by the reduced levels of IL-6 and TNF-alpha and the elevated levels of IL-10 in the lung. Together, our results showed that LLLT abolishes FA-induced neutrophilic lung inflammation by a reduction of the inflammatory cytokines and mast cell degranulation. This study may provide important information about the mechanisms of LLLT in lung inflammation induced by a pollutant.	[da Silva, Cristiane Miranda; Leal, Mayara Peres; Brochetti, Robson Alexandre; Vitoretti, Luana Beatriz; Ligeiro-de-Oliveira, Ana Paula; Lino-dos-Santos-Franco, Adriana] Univ Nove de Julho UNINOVE, Post Grad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil; [Braga, Tarcio; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil; [Damazo, Amilcar Sabino] Fed Univ Cuiaba, Dept Basic Sci Hlth, Fac Med Sci, Cuiaba, Brazil; [Chavantes, Maria Cristina] Univ Nove de Julho UNINOVE, Post Grad Program Med, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade de Sao Paulo; Universidade Nove de Julho	Lino-dos-Santos-Franco, A (corresponding author), Univ Nove de Julho UNINOVE, Post Grad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil.	alsantosfranco@gmail.com	camara, niels olsen saraiva/AAX-3269-2020; Damazo, Amilcar S/B-6659-2014; Braga, Tarcio/AAG-4475-2020; Franco, Adriana Lino dos Santos/AAA-7081-2019; Lino-dos-Santos-Franco, Adriana/F-6336-2012; Camara, Niels OS/G-8336-2011; Braga, Tarcio T/E-4827-2014; Chavantes, Maria Cristina/AAC-2459-2019	camara, niels olsen saraiva/0000-0001-5436-1248; Damazo, Amilcar S/0000-0003-2323-008X; Franco, Adriana Lino dos Santos/0000-0002-7854-2833; Camara, Niels OS/0000-0001-5436-1248; Braga, Tarcio T/0000-0002-2989-1076; Chavantes, Maria Cristina/0000-0002-8625-5076; Ligeiro de Oliveira, Ana Paula/0000-0001-6089-5107	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/51711-9, 2012/16498-5, 2015/00830-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was sponsored by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: 2011/51711-9; 2012/16498-5; 2015/00830-9). Adriana Lino-dos-Santos-Franco is a research fellow from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimbire F, 2006, LASER MED SCI, V21, P238, DOI 10.1007/s10103-006-0405-y; Aimbire F, 2005, LASER MED SCI, V20, P11, DOI 10.1007/s10103-005-0339-9; Avci P, 2013, SEMIN CUTAN MED SURG, V32, P41; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Carlson Ryan M, 2004, Dermatitis, V15, P169, DOI 10.2310/6620.2004.04021; Chavantes M.C, 2005, PHOTOMED LASER SURG, V1, P113; de Lima FM, 2014, J LASERS MED SCI, V5, P63; de Lima FM, 2011, LASER MED SCI, V26, P389, DOI 10.1007/s10103-010-0874-x; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Faradzheva N A, 2007, Probl Tuberk Bolezn Legk, P50; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Franco ALD, 2006, TOXICOL APPL PHARM, V214, P35, DOI 10.1016/j.taap.2005.11.014; FUJIMAKI H, 1992, INT ARCH ALLERGY IMM, V98, P324, DOI 10.1159/000236206; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Garrett M.H., 1996, P 7 INT C IND AIR QU, V1, P617; Gulec M, 2006, TOXICOL IND HEALTH, V22, P117, DOI 10.1191/0748233706th248oa; Joensen J, 2012, PHOTOMED LASER SURG, V30, P688, DOI 10.1089/pho.2012.3306; Kashanskaia E P, 2009, Vopr Kurortol Fizioter Lech Fiz Kult, P19; Landyshev Iu S, 2002, Ter Arkh, V74, P25; Lino-dos-Santos-Franco A, 2013, FOOD CHEM TOXICOL, V59, P731, DOI 10.1016/j.fct.2013.07.027; Lino-dos-Santos-Franco A, 2011, TOXICOL LETT, V207, P278, DOI 10.1016/j.toxlet.2011.09.026; Lino-dos-Santos-Franco A, 2010, TOXICOL LETT, V197, P211, DOI 10.1016/j.toxlet.2010.05.022; NORBACK D, 1995, OCCUP ENVIRON MED, V52, P388, DOI 10.1136/oem.52.6.388; Oliveira MC, 2014, J PHOTOCH PHOTOBIO B, V134, P57, DOI 10.1016/j.jphotobiol.2014.03.021; Sagai Masaru, 2015, Nihon Eiseigaku Zasshi, V70, P220, DOI 10.1265/jjh.70.220; Salthammer T, 2013, ANGEW CHEM INT EDIT, V52, P3320, DOI 10.1002/anie.201205984; Peron JPS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136942; Silva VR, 2014, RESP PHYSIOL NEUROBI, V194, P37, DOI 10.1016/j.resp.2014.01.008; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stronosova NS, 2006, TERAPEVT ARKH, V78, P41; Tillie-Leblond I, 2005, ALLERGY, V60, P23, DOI 10.1111/j.1398-9995.2005.00632.x; Tomimura S, 2014, ARQ BRAS CARDIOL, V103, P161, DOI 10.5935/abc.20140117; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Wu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-5	34	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142816	10.1371/journal.pone.0142816	http://dx.doi.org/10.1371/journal.pone.0142816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569396	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700076
J	de Bekker-Grob, EW; Bergstra, AD; Bliemer, MCJ; Trijssenaar-Buhre, IJM; Burdorf, A				de Bekker-Grob, Esther W.; Bergstra, Arnold D.; Bliemer, Michiel C. J.; Trijssenaar-Buhre, Inge J. M.; Burdorf, Alex			Protective Behaviour of Citizens to Transport Accidents Involving Hazardous Materials: A Discrete Choice Experiment Applied to Populated Areas nearby Waterways	PLOS ONE			English	Article							DECISION-MAKING; STATED PREFERENCE; HEALTH ECONOMICS; EVACUATION; CARE; VALUATION; MODEL	Background To improve the information for and preparation of citizens at risk to hazardous material transport accidents, a first important step is to determine how different characteristics of hazardous material transport accidents will influence citizens' protective behaviour. However, quantitative studies investigating citizens' protective behaviour in case of hazardous material transport accidents are scarce. Methods A discrete choice experiment was conducted among subjects (19-64 years) living in the direct vicinity of a large waterway. Scenarios were described by three transport accident characteristics: odour perception, smoke/vapour perception, and the proportion of people in the environment that were leaving at their own discretion. Subjects were asked to consider each scenario as realistic and to choose the alternative that was most appealing to them: staying, seeking shelter, or escaping. A panel error component model was used to quantify how different transport accident characteristics influenced subjects' protective behaviour. Results The response was 44% (881/1,994). The predicted probability that a subject would stay ranged from 1% in case of a severe looking accident till 62% in case of a mild looking accident. All three transport accident characteristics proved to influence protective behaviour. Particularly a perception of strong ammonia or mercaptan odours and visible smoke/vapour close to citizens had the strongest positive influence on escaping. In general, 'escaping' was more preferred than 'seeking shelter', although stated preference heterogeneity among subjects for these protective behaviour options was substantial. Males were less willing to seek shelter than females, whereas elderly people were more willing to escape than younger people. Conclusion Various characteristics of transport accident involving hazardous materials influence subjects' protective behaviour. The preference heterogeneity shows that information needs to be targeted differently depending on gender and age to prepare citizens properly.	[de Bekker-Grob, Esther W.; Burdorf, Alex] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Bergstra, Arnold D.] Zeeland Publ Hlth Serv, Goes, Netherlands; [Bliemer, Michiel C. J.] Univ Sydney, Sch Business, Inst Transport & Logist Studies, Sydney, NSW 2006, Australia; [Trijssenaar-Buhre, Inge J. M.] Netherlands Org Appl Sci Res, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Sydney; Netherlands Organization Applied Science Research	de Bekker-Grob, EW (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	e.debekker@erasmusmc.nl	Burdorf, Alex/A-2226-2008	Burdorf, Alex/0000-0003-3129-2862; Bliemer, Michiel/0000-0001-7602-5827	Dutch organization for Health Research and Development (ZonMW) [204000005]	Dutch organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This study was funded by the Dutch organization for Health Research and Development (ZonMW; project number 204000005); http://www.zonmw.nl/nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMOWICZ W, 1994, J ENVIRON ECON MANAG, V26, P271, DOI 10.1006/jeem.1994.1017; Baker E.J., 1991, INT J MASS EMERGENCI, V9, P287; Bliemer MCJ, 2011, TRANSPORT RES A-POL, V45, P63, DOI 10.1016/j.tra.2010.09.003; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Burton I, 1981, FINAL REPORT MISSISS; Cameron TA, 2002, J ENVIRON ECON MANAG, V44, P391, DOI 10.1006/jeem.2001.1210; Campbell D, 2011, DISASTERS NATURAL TE; Carlsson F, 2001, J ENVIRON ECON MANAG, V41, P179, DOI 10.1006/jeem.2000.1138; Clark MD, 2014, PHARMACOECONOMICS, V32, P883, DOI 10.1007/s40273-014-0170-x; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; de Bekker-Grob EW, 2010, VALUE HEALTH, V13, P315, DOI 10.1111/j.1524-4733.2009.00670.x; DUCLOS P, 1987, DISASTERS, V11, P286, DOI 10.1111/j.1467-7717.1987.tb00651.x; Fifer S, 2014, TRANSPORT RES A-POL, V61, P164, DOI 10.1016/j.tra.2013.12.010; Hall J, 2006, J HEALTH ECON, V25, P520, DOI 10.1016/j.jhealeco.2005.09.002; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hiselius LW, 2005, RISK ANAL, V25, P1199, DOI 10.1111/j.1539-6924.2005.00660.x; Huang SK, 2012, NAT HAZARDS REV, V13, P283, DOI 10.1061/(ASCE)NH.1527-6996.0000074; Huber J, 1996, J MARKETING RES, V33, P307, DOI 10.2307/3152127; Hundley V, 2004, BJOG-INT J OBSTET GY, V111, P550, DOI 10.1111/j.1471-0528.2004.00152.x; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Kang JE, 2007, J APPL SOC PSYCHOL, V37, P887, DOI 10.1111/j.1559-1816.2007.00191.x; Kesternich I, 2013, J HEALTH ECON, V32, P1313, DOI 10.1016/j.jhealeco.2012.11.006; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x; Lindell MK, 2012, RESPONSE ENV DISASTE; Linley WG, 2013, PHARMACOECONOMICS, V31, P345, DOI 10.1007/s40273-013-0030-0; LIVERMAN DM, 1981, CAN GEOGR-GEOGR CAN, V25, P365, DOI 10.1111/j.1541-0064.1981.tb01339.x; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Mark TL, 2004, HEALTH ECON, V13, P563, DOI 10.1002/hec.845; Mitchell J. T., 2007, J EMERG MANAGE, V5, P28, DOI 10.5055/jem.2007.0041; Mueller S, 2010, FOOD QUAL PREFER, V21, P741, DOI 10.1016/j.foodqual.2010.06.008; Natter M, 2002, EUR J OPER RES, V137, P448, DOI 10.1016/S0377-2217(01)00147-3; Nobelprize.org, 2014, SVER RIKSB PRIZ EC S; Orme B.K., 2006, GETTING STARTED CONJ; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Perry R.W., 1986, MINORITY CITIZENS DI; Perry R.W., 1984, DISASTER MANAGEMENT; Ratcliffe J, 2002, THORAX, V57, P503, DOI 10.1136/thorax.57.6.503; ROGERS GO, 1989, J HAZARD MATER, V22, P57, DOI 10.1016/0304-3894(89)85028-9; Rose JM, 2009, TRANSPORT REV, V29, P587, DOI 10.1080/01441640902827623; Ryan M, 2004, BMJ-BRIT MED J, V328, P360, DOI 10.1136/bmj.328.7436.360; Ryan M, 2008, ECON NON-MARK GOOD, V11, P1, DOI 10.1007/978-1-4020-5753-3; Ryan M, 2009, HEALTH ECON, V18, P389, DOI 10.1002/hec.1364; SORENSEN JH, 1987, J HAZARD MATER, V14, P247, DOI 10.1016/0304-3894(87)87017-6; Sorensen JH, 2004, J HAZARD MATER, V109, P1, DOI 10.1016/j.jhazmat.2004.03.004; Sorensen JH, 2007, COMMUNITY PROCESSES; Sorensen JH., 1991, INT J MASS EMERG DIS, V9, P153; SUTTON S, 1987, BRIT J ADDICT, V82, P355; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Train K. E., 2003, DISCRETE CHOICE METH; WEINSTEIN ND, 1993, HEALTH PSYCHOL, V12, P324, DOI 10.1037/0278-6133.12.4.324; Wordsworth S, 2006, INT J TECHNOL ASSESS, V22, P344, DOI 10.1017/S0266462306051245	55	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142507	10.1371/journal.pone.0142507	http://dx.doi.org/10.1371/journal.pone.0142507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW5XP	26571374	Green Published, gold			2022-12-26	WOS:000365070700046
J	Deaux, EC; Clarke, JA; Charrier, I				Deaux, Eloise C.; Clarke, Jennifer A.; Charrier, Isabelle			Aggressive Bimodal Communication in Domestic Dogs, Canis familiaris	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; MULTIMODAL COMMUNICATION; FIGHTING EXPERIENCE; MANED WOLF; BUSH DOG; SIGNAL; EVOLUTION; CONTEXT; RESPOND; DISPLAY	Evidence of animal multimodal signalling is widespread and compelling. Dogs' aggressive vocalisations (growls and barks) have been extensively studied, but without any consideration of the simultaneously produced visual displays. In this study we aimed to categorize dogs' bimodal aggressive signals according to the redundant/non-redundant classification framework. We presented dogs with unimodal (audio or visual) or bimodal (audio-visual) stimuli and measured their gazing and motor behaviours. Responses did not qualitatively differ between the bimodal and two unimodal contexts, indicating that acoustic and visual signals provide redundant information. We could not further classify the signal as 'equivalent' or 'enhancing' as we found evidence for both subcategories. We discuss our findings in relation to the complex signal framework, and propose several hypotheses for this signal's function.	[Deaux, Eloise C.; Clarke, Jennifer A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Deaux, Eloise C.; Charrier, Isabelle] Univ Paris 11, Univ Paris Saclay, CNRS, UMR 9197,Inst Neurosci Paris Saclay, Orsay, France	Macquarie University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Deaux, EC (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	eloise.deaux@mq.edu.au	; Deaux, Eloise/N-8748-2017	CHARRIER, Isabelle/0000-0003-4873-2342; Deaux, Eloise/0000-0002-3150-8267	Macquarie University	Macquarie University	This work was supported by a Macquarie University Postgraduate Research fund awarded to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Anderson RC, 2013, BEHAV ECOL SOCIOBIOL, V67, P593, DOI 10.1007/s00265-013-1478-9; Aquiloni L, 2009, NATURWISSENSCHAFTEN, V96, P103, DOI 10.1007/s00114-008-0458-9; Autier-Derian D, 2013, ANIM COGN, V16, P637, DOI 10.1007/s10071-013-0600-8; Beerda B, 1997, APPL ANIM BEHAV SCI, V52, P307, DOI 10.1016/S0168-1591(96)01131-8; BEKOFF M, 1977, SCIENCE, V197, P1097, DOI 10.1126/science.197.4308.1097; BEKOFF M, 1974, BIOSCIENCE, V24, P225, DOI 10.2307/1296803; Bergman M, 2010, P ROY SOC LOND B BIO; BIBEN M, 1983, ANIM BEHAV, V31, P814, DOI 10.1016/S0003-3472(83)80238-3; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Darwin C, 1965, EXPRESSION EMOTION A; de Luna AG, 2010, ANIM BEHAV, V79, P739, DOI 10.1016/j.anbehav.2009.12.031; Deaux EC, 2013, BEHAVIOUR, V150, P75, DOI 10.1163/1568539X-00003038; Elias DO, 2008, ANIM BEHAV, V76, P901, DOI 10.1016/j.anbehav.2008.01.032; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Farago T., 2014, BIOCOMMUNICATION ANI, P41, DOI DOI 10.1007/978-94-007-7414-8_4; Farago T, 2010, ANIM BEHAV, V79, P917, DOI 10.1016/j.anbehav.2010.01.005; FOX MW, 1970, BEHAVIOUR, V36, P49, DOI 10.1163/156853970X00042; FOX MW, 1969, BEHAVIOUR, V35, P242, DOI 10.1163/156853969X00224; Genty E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084738; Halfwerk W, 2014, CURR BIOL, V24, P1751, DOI 10.1016/j.cub.2014.05.068; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hebets EA, 2008, BEHAV ECOL, V19, P1250, DOI 10.1093/beheco/arn080; Higham JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P1381, DOI 10.1007/s00265-013-1590-x; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; KLEIMAN DG, 1967, AM ZOOL, V7, P365; KLEIMAN DG, 1972, J MAMMAL, V53, P791, DOI 10.2307/1379214; MARLER P, 1967, SCIENCE, V157, P769, DOI 10.1126/science.157.3790.769; Molnar C, 2009, BEHAV PROCESS, V82, P198, DOI 10.1016/j.beproc.2009.06.011; MORAN G, 1982, ANIM BEHAV, V30, P75, DOI 10.1016/S0003-3472(82)80239-X; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Partan S, 1999, SCIENCE, V283, P1272, DOI 10.1126/science.283.5406.1272; Partan S, 2005, ANIM BEHAV, V70, P957, DOI 10.1016/j.anbehav.2005.03.002; Partan SR, 2009, ANIM BEHAV, V77, P1127, DOI 10.1016/j.anbehav.2008.12.029; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Peter A, 2013, ETHOLOGY, V119, P898, DOI 10.1111/eth.12131; Peter P, 2014, APPL ANIM BEHAV SCI, V159, P62, DOI 10.1016/j.applanim.2014.08.003; Pongracz P, 2003, ETHOLOGY, V109, P809, DOI 10.1046/j.0179-1613.2003.00923.x; Preininger D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055367; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Reaney LT, 2011, BEHAV ECOL SOCIOBIOL, V65, P217, DOI 10.1007/s00265-010-1030-0; Riede T, 1999, J EXP BIOL, V202, P2859; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Rowe C, 1999, EVOL ECOL, V13, P655, DOI 10.1023/A:1011021630244; RUDZINSKI DR, 1982, J WILDLIFE MANAGE, V46, P877, DOI 10.2307/3808220; Rypstra AL, 2009, ANIM BEHAV, V77, P937, DOI 10.1016/j.anbehav.2008.12.026; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Smith CL, 2008, J EXP BIOL, V211, P2052, DOI 10.1242/jeb.017194; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; Taylor AM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017069, 10.1371/journal.pone.0026651]; Taylor AM, 2009, ETHOLOGY, V115, P905, DOI 10.1111/j.1439-0310.2009.01681.x; Uetz GW, 2013, BEHAV ECOL SOCIOBIOL, V67, P1471, DOI 10.1007/s00265-013-1557-y; Uetz GW, 2009, ANIM BEHAV, V78, P299, DOI 10.1016/j.anbehav.2009.04.023; Uetz GW, 2002, BRAIN BEHAV EVOLUT, V59, P222, DOI 10.1159/000064909; Wood PA, 2014, APPL ANIM BEHAV SCI; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016; Zeyl JN, 2011, ZOOLOGY, V114, P369, DOI 10.1016/j.zool.2011.08.001	59	5	5	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142975	10.1371/journal.pone.0142975	http://dx.doi.org/10.1371/journal.pone.0142975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571266	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700110
J	Hossain, IA; Akter, S; Rahman, MK; Ali, L				Hossain, Israt Ara; Akter, Salima; Rahman, Mohammad Khalilur; Ali, Liaquat			Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic Subjects	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; METABOLIC SYNDROME; PLASMA LEPTIN; HEPATIC STEATOSIS; NONDIABETIC SUBJECTS; RESISTANCE; ADIPOSITY; ACCUMULATION; SENSITIVITY; HOMEOSTASIS	Adipose tissue-derived hormone leptin plays a functional role in glucose tolerance through its effects on insulin secretion and insulin sensitivity which also represent the risk factors for nonalcoholic fatty liver disease (NAFLD). The present study explored the gender specific association of serum leptin and insulinemic indices with NAFLD in Bangladeshi prediabetic subjects. Under a cross-sectional analytical design a total of 110 ultrasound examined prediabetic subjects, aged 25-68 years consisting of 57.3% male (55.6% non NAFLD and 44.4% NAFLD) and 42.7% female (57.4% non NAFLD and 42.6% NAFLD), were investigated. Insulin secretory function (HOMA% B) and insulin sensitivity (HOMA% S) were calculated from homeostasis model assessment (HOMA). Serum leptin showed significant positive correlation with fasting insulin (r = 0.530, P = 0.004), postprandial insulin (r = 0.384, P = 0.042) and HOMA-IR (r = 0.541, P = 0.003) as well as significant negative correlation with HOMA% S (r = -0.388, P = 0.046) and HOMA% B (r = -0.356, P = 0.039) in male prediabetic subjects with NAFLD. In multiple linear regression analysis, log transformed leptin showed significant positive association with HOMA-IR (beta = 0.706, P < 0.001) after adjusting the effects of body mass index (BMI), triglyceride (TG) and HOMA% B in male subjects with NAFLD. In binary logistic regression analysis, only log leptin [OR 1.29 95% (C. I) (1.11-1.51), P = 0.001] in male subjects as well as HOMA% B [OR 0.94 95% (C. I) (0.89-0.98), P = 0.012], HOMA-IR [OR 3.30 95% (C. I) (0.99-10.95), P = 0.049] and log leptin [OR 1.10 95% (C. I) (1.01-1.20), P = 0.026] in female subjects were found to be independent determinants of NAFLD after adjusting the BMI and TG. Serum leptin seems to have an association with NAFLD both in male and female prediabetic subjects and this association in turn, is mediated by insulin secretory dysfunction and insulin resistance among these subjects.	[Hossain, Israt Ara; Akter, Salima; Ali, Liaquat] Bangladesh Univ Hlth Sci, Dept Biochem & Cell Biol, Dhaka, Bangladesh; [Rahman, Mohammad Khalilur] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka 1000, Bangladesh	Bangladesh University of Health Sciences (BUHS); University of Dhaka	Hossain, IA (corresponding author), Bangladesh Univ Hlth Sci, Dept Biochem & Cell Biol, Dhaka, Bangladesh.	israt.ru84@gmail.com		Ali, Prof Liaquat/0000-0001-9024-0291	Bangladesh Medical Research Council; Government of the People's Republic of Bangladesh, Ministry of Science and Technology [39.012.002.02.01.016.2013-335]	Bangladesh Medical Research Council; Government of the People's Republic of Bangladesh, Ministry of Science and Technology	Bangladesh Medical Research Council and Government of the People's Republic of Bangladesh, Ministry of Science and Technology (No. 39.012.002.02.01.016.2013-335).	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Apiratpracha W, 2004, THAI J GASTROENTEROL, V5, P87; Ayonrinde OT, 2011, HEPATOLOGY, V53, P800, DOI 10.1002/hep.24097; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Chitturi S, 2002, HEPATOLOGY, V36, P403, DOI 10.1053/jhep.2002.34738; Couillard C, 1997, DIABETOLOGIA, V40, P1178, DOI 10.1007/s001250050804; deCourten M, 1997, DIABETIC MED, V14, P200, DOI 10.1002/(SICI)1096-9136(199703)14:3<200::AID-DIA336>3.0.CO;2-V; El-Attar MM, 2010, JASMR, V5, P101; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gnacinska M, 2010, ENDOKRYNOL POL, V61, P36; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Hattori A, 2000, ENDOCR J, V47, P615, DOI 10.1507/endocrj.47.615; Huang XD, 2008, WORLD J GASTROENTERO, V14, P2888, DOI 10.3748/wjg.14.2888; Kelley DE, 2003, AM J PHYSIOL-ENDOC M, V285, pE906, DOI 10.1152/ajpendo.00117.2003; Kennedy A, 1997, J CLIN ENDOCR METAB, V82, P1293, DOI 10.1210/jc.82.4.1293; Larsson H, 1996, DIABETES, V45, P1580, DOI 10.2337/diabetes.45.11.1580; Lichnovska R, 2002, CARDIOVASC DIABETOL, V1, DOI 10.1186/1475-2840-1-4; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Nobili V, 2006, EUR J ENDOCRINOL, V155, P735, DOI 10.1530/eje.1.02288; Nowak KW, 1998, LIFE SCI, V63, P1347, DOI 10.1016/S0024-3205(98)00398-1; Palmentieri B, 2006, DIGEST LIVER DIS, V38, P485, DOI 10.1016/j.dld.2006.03.021; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Schwartz MW, 1997, DIABETES CARE, V20, P1476, DOI 10.2337/diacare.20.9.1476; Segal KR, 1996, DIABETES, V45, P988, DOI 10.2337/diabetes.45.7.988; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shannon A, 2011, J PEDIATR GASTR NUTR, V53, P190, DOI 10.1097/MPG.0b013e31821b4b61; Tsochatzis E, 2006, AM J GASTROENTEROL, V101, P2629, DOI 10.1111/j.1572-0241.2006.00848.x; Woods SC, 2003, EXP BIOL MED, V228, P1175; World Health Organization, 2006, DEF DIAGN DIAB MELL	34	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142165	10.1371/journal.pone.0142165	http://dx.doi.org/10.1371/journal.pone.0142165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569494	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700023
J	Li, RJ; Rashotte, AM; Singh, NK; Lawrence, KS; Weaver, DB; Locy, RD				Li, Ruijuan; Rashotte, Aaron M.; Singh, Narendra K.; Lawrence, Kathy S.; Weaver, David B.; Locy, Robert D.			Transcriptome Analysis of Cotton (Gossypium hirsutum L.) Genotypes That Are Susceptible, Resistant, and Hypersensitive to Reniform Nematode (Rotylenchulus reniformis)	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; SOYBEAN CYST-NEMATODE; RNA-SEQ DATA; CELL-WALL; HETERODERA-SCHACHTII; PLANT-RESPONSES; SALICYLIC-ACID; REFERENCE GENOME; FEEDING CELLS; ARABIDOPSIS	Reniform nematode is a semi-endoparasitic nematode species causing significant yield loss in numerous crops, including cotton (Gossypium hirsutum L.). An RNA-sequencing analysis was conducted to measure transcript abundance in reniform nematode susceptible (DP90 & SG747), resistant (BARBREN-713), and hypersensitive (LONREN-1) genotypes of cotton (Gossypium hirsutum L.) with and without reniform nematode infestation. Over 90 million trimmed high quality reads were assembled into 84,711 and 80, 353 transcripts using the G. arboreum and the G. raimondii genomes as references. Many transcripts were significantly differentially expressed between the three different genotypes both prior to and during nematode pathogenesis, including transcripts corresponding to the gene ontology categories of cell wall, hormone metabolism and signaling, redox reactions, secondary metabolism, transcriptional regulation, stress responses, and signaling. Further analysis revealed that a number of these differentially expressed transcripts mapped to the G. raimondii and/or the G. arboreum genomes within 1 megabase of quantitative trait loci that had previously been linked to reniform nematode resistance. Several resistance genes encoding proteins known to be strongly linked to pathogen perception and resistance, including LRR-like and NBS-LRR domain-containing proteins, were among the differentially expressed transcripts mapping near these quantitative trait loci. Further investigation is required to confirm a role for these transcripts in reniform nematode susceptibility, hypersensitivity, and/or resistance. This study presents the first systemic investigation of reniform nematode resistance-associated genes using different genotypes of cotton. The candidate reniform nematode resistance-associated genes identified in this study can serve as the basis for further functional analysis and aid in further development of reniform a nematode resistant cotton germplasm.	[Li, Ruijuan; Rashotte, Aaron M.; Singh, Narendra K.; Locy, Robert D.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Lawrence, Kathy S.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Weaver, David B.] Auburn Univ, Dept Crop Soil & Environm Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University	Locy, RD (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	locyrob@auburn.edu	Lawrence, Kathy/AAA-3808-2020	Lawrence, Kathy/0000-0002-5358-2011; Rashotte, Aaron/0000-0001-5034-4395	Alabama Agreicultural Experiment Station, Hatch Multistate by National Institute of Food and Agriculture, USDA [ALA021-1-10008]	Alabama Agreicultural Experiment Station, Hatch Multistate by National Institute of Food and Agriculture, USDA	Alabama Agreicultural Experiment Station, Hatch Multistate Grant No. ALA021-1-10008 Awarded by the National Institute of Food and Agriculture, USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absmanner B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00241; Agudelo P, 2005, J NEMATOL, V37, P444; Agudelo P, 2005, J NEMATOL, V37, P185; Ali MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102360; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Atamian HS, 2012, PLANTA, V235, P299, DOI 10.1007/s00425-011-1509-6; Barcala M, 2010, PLANT J, V61, P698, DOI 10.1111/j.1365-313X.2009.04098.x; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Bell AA, 2015, J PLANT REGIST, V9, P89, DOI 10.3198/jpr2014.04.0021crg; Bell AA, 2014, J PLANT REGIST, V8, P187, DOI 10.3198/jpr2013.11.0069crg; Bhattarai KK, 2010, PLANT J, V63, P229, DOI 10.1111/j.1365-313X.2010.04232.x; Bhattarai KK, 2008, MOL PLANT MICROBE IN, V21, P1205, DOI 10.1094/MPMI-21-9-1205; Bohlmann H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00089; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Chico JM, 2014, ARABIDOPSIS, V26, P1967; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Choi DS, 2011, PLANT CELL, V23, P823, DOI 10.1105/tpc.110.082081; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Cooper WR, 2005, J CHEM ECOL, V31, P1953, DOI 10.1007/s10886-005-6070-y; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Denance N, 2014, PLANT CELL PHYSIOL, V55, P469, DOI 10.1093/pcp/pct198; Dighe ND, 2009, CROP SCI, V49, P1151, DOI 10.2135/cropsci2008.03.0129; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Fujimoto T, 2011, J PLANT PHYSIOL, V168, P1084, DOI 10.1016/j.jplph.2010.12.002; Gal TZ, 2006, PLANTA, V224, P155, DOI 10.1007/s00425-005-0204-x; Gao XQ, 2008, MOL PLANT MICROBE IN, V21, P98, DOI 10.1094/MPMI-21-1-0098; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Goellner M, 2001, PLANT CELL, V13, P2241, DOI 10.1105/tpc.13.10.2241; Gonzalez-Rabade N, 2012, APPL BIOCHEM BIOTECH, V166, P1644, DOI 10.1007/s12010-012-9558-2; Goverse A, 2000, MOL PLANT MICROBE IN, V13, P1121, DOI 10.1094/MPMI.2000.13.10.1121; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grunewald W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000266; Guan Xueying, 2014, BMC Res Notes, V7, P493, DOI 10.1186/1756-0500-7-493; Guo WJ, 2008, PLANT PHYSIOL, V147, P1710, DOI 10.1104/pp.108.120238; Gutierrez OA, 2011, THEOR APPL GENET, V122, P271, DOI 10.1007/s00122-010-1442-2; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hamann T, 2009, PLANT J, V57, P1015, DOI 10.1111/j.1365-313X.2008.03744.x; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hewezi T, 2008, MOL PLANT MICROBE IN, V21, P1622, DOI 10.1094/MPMI-21-12-1622; Hewezi T, 2014, MOL PLANT PATHOL, V15, P730, DOI 10.1111/mpp.12121; Hewezi T, 2013, MOL PLANT MICROBE IN, V26, P9, DOI 10.1094/MPMI-05-12-0106-FI; Hewezi T, 2012, PLANT PHYSIOL, V159, P321, DOI 10.1104/pp.112.193649; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Iberkleid I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1426-3; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kammerhofer N, 2015, NEW PHYTOL, V207, P778, DOI 10.1111/nph.13395; Karczmarek A, 2004, MOL PLANT PATHOL, V5, P343, DOI 10.1111/j.1364-3703.2004.00230.x; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klink VP, 2011, PLANT MOL BIOL, V75, P141, DOI 10.1007/s11103-010-9715-3; Klink VP, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/491217; Kyndt T, 2012, PLANT BIOLOGY, V14, P73, DOI 10.1111/j.1438-8677.2011.00524.x; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li RJ, 2015, PLANT CELL REP, V34, P5, DOI 10.1007/s00299-014-1676-6; Lin JY, 2013, PLANT BIOTECHNOL J, V11, P1135, DOI 10.1111/pbi.12108; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Matthews BF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-96; Mazarei M, 2011, THEOR APPL GENET, V123, P1193, DOI 10.1007/s00122-011-1659-8; Mitchum MG, 2013, NEW PHYTOL, V199, P879, DOI 10.1111/nph.12323; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nahar K, 2011, PLANT PHYSIOL, V157, P305, DOI 10.1104/pp.111.177576; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; Ozalvo R, 2014, MOL PLANT PATHOL, V15, P319, DOI 10.1111/mpp.12094; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pickel B, 2013, APPL MICROBIOL BIOT, V97, P8427, DOI 10.1007/s00253-013-5167-4; Portillo M, 2013, NEW PHYTOL, V197, P1276, DOI 10.1111/nph.12121; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Radwan O, 2011, MOL PLANT MICROBE IN, V24, P958, DOI 10.1094/MPMI-11-10-0271; Robinson AF, 2007, ANNU REV PHYTOPATHOL, V45, P263, DOI 10.1146/annurev.phyto.45.011107.143949; Romano GB, 2009, THEOR APPL GENET, V120, P139, DOI 10.1007/s00122-009-1165-4; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; Sikkens RB, 2011, NEMATROPICA, V41, P68; Simonetti E, 2010, PLANT CELL REP, V29, P1169, DOI 10.1007/s00299-010-0903-z; Spoel SH, 2011, CURR OPIN PLANT BIOL, V14, P358, DOI 10.1016/j.pbi.2011.03.007; Uehara T, 2010, PLANT CELL PHYSIOL, V51, P1524, DOI 10.1093/pcp/pcq109; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang C, 2006, THEOR APPL GENET, V112, P770, DOI 10.1007/s00122-005-0183-0; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang XH, 2007, MOL PLANT PATHOL, V8, P423, DOI 10.1111/J.1364-3703.2007.00403.X; Wieczorek K, 2014, MOL PLANT MICROBE IN, V27, P901, DOI 10.1094/MPMI-01-14-0005-R; Wubben MJ, 2010, MOL BIOCHEM PARASIT, V172, P31, DOI 10.1016/j.molbiopara.2010.03.011; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980	96	15	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143261	10.1371/journal.pone.0143261	http://dx.doi.org/10.1371/journal.pone.0143261			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571375	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700156
J	Nguyen, P; Greene, E; Ishola, P; Huff, G; Donoghue, A; Bottje, W; Dridi, S				Phuong Nguyen; Greene, Elizabeth; Ishola, Peter; Huff, Geraldine; Donoghue, Annie; Bottje, Walter; Dridi, Sami			Chronic Mild Cold Conditioning Modulates the Expression of Hypothalamic Neuropeptide and Intermediary Metabolic-Related Genes and Improves Growth Performances in Young Chicks	PLOS ONE			English	Article							REGULATES FOOD-INTAKE; MTOR COMPLEX 1; GALLUS-DOMESTICUS; SKELETAL-MUSCLE; EARLY-AGE; NONSHIVERING THERMOGENESIS; TRANSCRIPTION FACTOR; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; MESSENGER-RNA	Background Low environmental temperatures are among the most challenging stressors in poultry industries. Although landmark studies using acute severe cold exposure have been conducted, still the molecular mechanisms underlying cold-stress responses in birds are not completely defined. In the present study we determine the effect of chronic mild cold conditioning (CMCC) on growth performances and on the expression of key metabolic-related genes in three metabolically important tissues: brain (main site for feed intake control), liver (main site for lipogenesis) and muscle (main site for thermogenesis). Methods 80 one-day old male broiler chicks were divided into two weight-matched groups and maintained in two different temperature floor pen rooms (40 birds/room). The temperature of control room was 32 degrees C, while the cold room temperature started at 26.7 degrees C and gradually reduced every day (1 degrees C/day) to reach 19.7 degrees C at the seventh day of the experiment. At day 7, growth performances were recorded (from all birds) and blood samples and tissues were collected (n = 10). The rest of birds were maintained at the same standard environmental condition for two more weeks and growth performances were measured. Results Although feed intake remained unchanged, body weight gain was significantly increased in CMCC compared to the control chicks resulting in a significant low feed conversion ratio (FCR). Circulating cholesterol and creatine kinase levels were higher in CMCC chicks compared to the control group (P<0.05). CMCC significantly decreased the expression of both the hypothalamic orexigenic neuropeptide Y (NPY) and anorexigenic cocaine and amphetamine regulated transcript (CART) in chick brain which may explain the similar feed intake between the two groups. Compared to the control condition, CMCC increased the mRNA abundance of AMPK alpha 1/alpha 2 and decreased mTOR gene expression (P<0.05), the master energy and nutrient sensors, respectively. It also significantly decreased the expression of fatty acid synthase (FAS) gene in chick brain compared to the control. Although their roles are still unknown in avian species, adiponectin (Adpn) and its related receptors (Adi-poR1 and 2) were down regulated in the brain of CMCC compared to control chicks (P<0.05). In the liver, CMCC significantly down regulated the expression of lipogenic genes namely FAS, acetyl-CoA carboxylase alpha (ACC alpha) and malic enzyme (ME) and their related transcription factors sterol regulatory element binding protein 1/2 (SREBP-1 and 2). Hepatic mTOR mRNA levels and phosphorylated mTOR at Ser(2448) were down regulated (P<0.05), however phosphorylated ACC alpha(Ser79) (inactivation) was up regulated (P<0.05) in CMCC compared to control chicks, indicating that CMCC switch hepatic catabolism on and inhibits hepatic lipogenesis. In the muscle however, CMCC significantly up regulated the expression of carnitine palmitoyltransferase 1 (CPT-1) gene and the mRNA and phosphorylated protein levels of mTOR compared to the control chicks, indicating that CMCC enhanced muscle fatty acid beta-oxidation. Conclusions In conclusion, this is the first report indicating that CMCC may regulate AMPK-mTOR expression in a tissue specific manner and identifying AMPK-mTOR as a potential molecular signature that controls cellular fatty acid utilization (inhibition of hepatic lipogenesis and induction of muscle fatty acid beta-oxidation) to enhance growth performance during mild cold acclimation.	[Phuong Nguyen; Greene, Elizabeth; Ishola, Peter; Bottje, Walter; Dridi, Sami] Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA; [Huff, Geraldine; Donoghue, Annie] ARS, USDA, Poultry Prod & Prod Safety Res Unit, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA)	Dridi, S (corresponding author), Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA.	dridi@uark.edu	Dridi, Sami/Q-8207-2019		Arkansas State	Arkansas State	This study was supported by Arkansas State start-up fundings.	Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Baarendse PJJ, 2006, BRIT POULTRY SCI, V47, P125, DOI 10.1080/00071660600610575; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CHAFFEE RRJ, 1971, ANNU REV PHYSIOL, V33, P155, DOI 10.1146/annurev.ph.33.030171.001103; Chen HS, 2006, J ENDOCRINOL, V190, P433, DOI 10.1677/joe.1.06692; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chen XY, 2014, MOL BIOL REP, V41, P2243, DOI 10.1007/s11033-014-3075-z; Coope A, 2008, FEBS LETT, V582, P1471, DOI 10.1016/j.febslet.2008.03.037; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dadgar S, 2012, POULTRY SCI, V91, P1454, DOI 10.3382/ps.2011-01520; Dagon Y, 2006, BIOCHEM BIOPH RES CO, V340, P43, DOI 10.1016/j.bbrc.2005.11.159; DENBOW DM, 1985, NEUROSCI BIOBEHAV R, V9, P223, DOI 10.1016/0149-7634(85)90047-8; Dhahbi JM, 2002, J NUTR, V132, P31, DOI 10.1093/jn/132.1.31; Dridi S, 2008, J EXP ZOOL PART A, V309A, P381, DOI 10.1002/jez.461; Dridi S, 2006, AM J PHYSIOL-REG I, V291, pR138, DOI 10.1152/ajpregu.00899.2005; Dridi S, 2013, POULTRY SCI, V92, P2745, DOI 10.3382/ps.2013-03242; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; DUCHAMP C, 1993, AM J PHYSIOL, V265, pR1076, DOI 10.1152/ajpregu.1993.265.5.R1076; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Figueiredo D, 2007, CELL TISSUE RES, V329, P91, DOI 10.1007/s00441-007-0414-6; Gerets HHJ, 2000, J COMP NEUROL, V417, P250; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hangalapura BN, 2004, POULTRY SCI, V83, P765, DOI 10.1093/ps/83.5.765; Hangalapura BN, 2003, POULTRY SCI, V82, P1692, DOI 10.1093/ps/82.11.1692; Huang YN, 2012, GENE, V502, P87, DOI 10.1016/j.gene.2012.04.052; Ijiri D, 2009, DOMEST ANIM ENDOCRIN, V37, P12, DOI 10.1016/j.domaniend.2009.01.002; Jayasundara N, 2015, J EXP BIOL, V218, P1359, DOI 10.1242/jeb.118760; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; KUENZEL WJ, 1987, PEPTIDES, V8, P823, DOI 10.1016/0196-9781(87)90066-0; Lassiter K, 2015, AM J PHYSIOL-REG I, V308, pR173, DOI 10.1152/ajpregu.00394.2014; Lazra Y, 2015, J CELL BIOCHEM, V116, P754, DOI 10.1002/jcb.25031; LEVEILLE GA, 1968, P SOC EXP BIOL MED, V128, P398; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MITCHELL MA, 1995, RES VET SCI, V59, P30, DOI 10.1016/0034-5288(95)90026-8; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Ohta Y, 2009, J CLIN BIOCHEM NUTR, V45, P347, DOI 10.3164/jcbn.09-59; Overath T, 2012, MOL CELL PROTEOMICS, V11, P467, DOI 10.1074/mcp.M111.015966; PERKINS MN, 1981, NATURE, V289, P401, DOI 10.1038/289401a0; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Phillips-Singh D, 2003, CELL TISSUE RES, V313, P217, DOI 10.1007/s00441-003-0755-8; PLUMIER JCL, 1995, J CLIN INVEST, V95, P1854, DOI 10.1172/JCI117865; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Portner HO, 2004, PHYSIOL BIOCHEM ZOOL, V77, P959, DOI 10.1086/423742; Raimbault S, 2001, BIOCHEM J, V353, P441, DOI 10.1042/0264-6021:3530441; RENWICK GM, 1985, POULTRY SCI, V64, P785, DOI 10.3382/ps.0640785; SAGHER BM, 1975, GROWTH, V39, P281; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shahir MH, 2012, BRIT POULTRY SCI, V53, P538, DOI 10.1080/00071668.2012.719604; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shinder D, 2007, POULTRY SCI, V86, P2200, DOI 10.1093/ps/86.10.2200; Shinder D, 2011, POULTRY SCI, V90, P633, DOI 10.3382/ps.2010-01089; SHUEY DJ, 1986, NATURE, V323, P459, DOI 10.1038/323459a0; SPINU M, 1993, BRIT POULTRY SCI, V34, P177, DOI 10.1080/00071669308417573; Tachibana T, 2003, NEUROSCI LETT, V337, P131, DOI 10.1016/S0304-3940(02)01321-6; Teulier L, 2010, J EXP BIOL, V213, P2476, DOI 10.1242/jeb.043489; Toyomizu M, 2002, FEBS LETT, V529, P313, DOI 10.1016/S0014-5793(02)03395-1; Valles A, 2000, AM J PHYSIOL-REG I, V279, pR1138, DOI 10.1152/ajpregu.2000.279.3.R1138; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; WAGNER WD, 1971, P SOC EXP BIOL MED, V137, P1199; Wang JT, 2009, POULTRY SCI, V88, P2549, DOI 10.3382/ps.2009-00404; Wang YW, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-41; Yuan MS, 2012, J BIOL CHEM, V287, P29579, DOI 10.1074/jbc.M112.386854; Zhang ZW, 2011, POULTRY SCI, V90, P1555, DOI 10.3382/ps.2010-01333; Zhang ZW, 2014, AVIAN DIS, V58, P415, DOI 10.1637/10763-010814-Reg.1; Zhao FQ, 2014, CELL STRESS CHAPERON, V19, P635, DOI 10.1007/s12192-013-0489-9; Zhao FQ, 2013, CELL STRESS CHAPERON, V18, P773, DOI 10.1007/s12192-013-0429-8; Zhao FQ, 2013, RES VET SCI, V95, P146, DOI 10.1016/j.rvsc.2013.01.021; Zhu Y, 2013, AM J PHYSIOL-HEART C, V305, pH41, DOI 10.1152/ajpheart.00877.2012	73	28	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142319	10.1371/journal.pone.0142319	http://dx.doi.org/10.1371/journal.pone.0142319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569484	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700032
J	Zhu, JY; Cynader, MS; Jia, W				Zhu, Jingyan; Cynader, Max S.; Jia, William			TDP-43 Inhibits NF-kappa B Activity by Blocking p65 Nuclear Translocation	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; DNA-BINDING PROTEIN-43; LOCALIZATION SIGNALS; DISEASE; REDISTRIBUTION; INCLUSIONS; COMPLEXES; PATHWAYS; IMPORT	TDP-43 (TAR DNA binding protein 43) is a heterogeneous nuclear ribonucleoprotein (hnRNP) that has been found to play an important role in neurodegenerative diseases. TDP-43's involvement in nuclear factor-kappaB pathways has been reported in both neurons and microglial cells. The NF-kappa B pathway targets hundreds of genes, many of which are involved in inflammation, immunity and cancer. p50/p65 (p50/RelA) heterodimers, as the major Rel complex in the NF-kappa B family, are induced by diverse external physiological stimuli and modulate transcriptional activity in almost all cell types. Both p65 and TDP-43 translocation occur through the classic nuclear transportation system. In this study, we report that TDP-43 overexpression prevents TNF-alpha induced p65 nuclear translocation in a dose dependent manner, and that this further inhibits p65 transactivation activity. The inhibition by TDP-43 does not occur through preventing I kappa B degradation but probably by competing for the nuclear transporter-importin alpha 3 (KPNA4). This competition is dependent on the presence of the nuclear localization signal (NLS) in TDP-43. Silencing TDP-43 using a specific siRNA also increased p65 nuclear localization upon TNF-alpha stimulation, suggesting that endogenous TDP-43 may be a default suppressor of the NF-kappa B pathway. Our results indicate that TDP-43 may play an important role in regulating the levels of NF-kappa B activity by controlling the nuclear translocation of p65.	[Zhu, Jingyan; Cynader, Max S.; Jia, William] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Zhu, Jingyan; Jia, William] Univ British Columbia, Dept Surg, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia	Jia, W (corresponding author), Univ British Columbia, Brain Res Ctr, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	w.jia@ubc.ca	JIA, WILLIAM/AAE-4322-2020		Pacific Alzheimer Research Foundation (PARF)	Pacific Alzheimer Research Foundation (PARF)	This work was supported by the Pacific Alzheimer Research Foundation (PARF).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Badr CE, 2009, MOL IMAGING, V8, P278, DOI 10.2310/7290.2009.00026; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Calzado MA, 2007, CURR MED CHEM, V14, P367, DOI 10.2174/092986707779941113; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; GOLDFARB DS, 1986, NATURE, V322, P641, DOI 10.1038/322641a0; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Hong DS, 2014, INVEST NEW DRUG, V32, P1204, DOI 10.1007/s10637-014-0127-0; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Miller ZA, 2013, J NEUROL NEUROSUR PS, V84, P956, DOI 10.1136/jnnp-2012-304644; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Ohta Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-37; Oishi T, 2006, BIOCHEM BIOPH RES CO, V340, P125, DOI 10.1016/j.bbrc.2005.11.161; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Shindo A, 2013, BRAIN RES, V1533, P131, DOI 10.1016/j.brainres.2013.08.007; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Wider C, 2008, NEURODEGENER DIS, V5, P122, DOI 10.1159/000113680; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200	30	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142296	10.1371/journal.pone.0142296	http://dx.doi.org/10.1371/journal.pone.0142296			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571498	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700029
J	Jeong, YK; Kim, MS; Lee, JY; Kim, EH; Ha, H				Jeong, Youn Kyoung; Kim, Mi-Sook; Lee, Ji Young; Kim, Eun Ho; Ha, Hunjoo			Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins	PLOS ONE			English	Article							IN-VITRO; RAD51 OVEREXPRESSION; IONIZING-RADIATION; NECK-CANCER; P53; RESISTANCE; HEAD; PROLIFERATION; TARGET; AMPK	The present study addressed whether the combination of metformin and ionizing radiation (IR) would show enhanced antitumor effects in radioresistant p53-deficient colorectal cancer cells, focusing on repair pathways for IR-induced DNA damage. Metformin caused a higher reduction in clonogenic survival as well as greater radiosensitization and inhibition of tumor growth of p53(-/-) than of p53(+/+) colorectal cancer cells and xenografts. Metformin combined with IR induced accumulation of tumor cells in the G2/M phase and delayed the repair of IR-induced DNA damage. In addition, this combination significantly decreased levels of p53-related homologous recombination (HR) repair compared with IR alone, especially in p53(-/-) colorectal cancer cells and tumors. In conclusion, metformin enhanced radiosensitivity by inducing G2/M arrest and reducing the expression of DNA repair proteins even in radioresistant HCT116 p53(-/)-colorectal cancer cells and tumors. Our study provides a scientific rationale for the clinical use of metformin as a radiosensitizer in patients with p53-deficient colorectal tumors, which are often resistant to radiotherapy.	[Jeong, Youn Kyoung; Ha, Hunjoo] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Jeong, Youn Kyoung; Lee, Ji Young] Korea Inst Radiol & Med Sci, Res Ctr Radiotherapy, Seoul, South Korea; [Kim, Mi-Sook] Korea Inst Radiol & Med Sci, Dept Radiat Oncol, Seoul, South Korea; [Kim, Eun Ho] Korea Inst Radiol & Med Sci, Div Heavy Ion Clin Res, Seoul, South Korea	Ewha Womans University; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences	Kim, MS (corresponding author), Korea Inst Radiol & Med Sci, Dept Radiat Oncol, Seoul, South Korea.	mskim@kirams.re.kr; hha@ewha.ac.kr		Ha, Hunjoo/0000-0002-5601-1265	Ministry of Science, ICT and Future Planning, Republic of Korea [50541-2014]; National Research Foundation - Korean Ministry of Education, Science, and Technology [2012R1A2A1A0300692]	Ministry of Science, ICT and Future Planning, Republic of Korea; National Research Foundation - Korean Ministry of Education, Science, and Technology	The work was supported by the following: 1. MSK: grant (50541-2014) from the Ministry of Science, ICT and Future Planning, Republic of Korea (http://www.msip.go.kr); and 2. HH: National Research Foundation grants (2012R1A2A1A0300692) funded by Korean Ministry of Education, Science, and Technology. (http://www.nrf.re.kr).	Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Collis SJ, 2001, NUCLEIC ACIDS RES, V29, P1534, DOI 10.1093/nar/29.7.1534; Couture C, 2002, CANCER-AM CANCER SOC, V94, P713, DOI 10.1002/cncr.10232; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Fong V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028714; Gray R, 2001, LANCET, V358, P1291; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Hiro J, 2008, INT J ONCOL, V32, P1305; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Kawashima A, 2012, ADV UROL, V2012, DOI 10.1155/2012/812398; Kim EH, 2014, J RADIAT RES, V55, P432, DOI 10.1093/jrr/rrt131; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Koukourakis MI, 2001, INT J RADIAT ONCOL, V50, P27, DOI 10.1016/S0360-3016(00)01561-3; Lazaro-Trueba I, 2006, CELL CYCLE, V5, P1062, DOI 10.4161/cc.5.10.2764; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; Liu JF, 2012, ONCOL REP, V28, P1406, DOI 10.3892/or.2012.1932; Luo QQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-517; Muaddi H, 2013, RADIOTHER ONCOL, V108, P446, DOI 10.1016/j.radonc.2013.06.014; Nunez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; Zhang T, 2013, INT J MOL SCI, V14, P24603, DOI 10.3390/ijms141224603	31	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143596	10.1371/journal.pone.0143596	http://dx.doi.org/10.1371/journal.pone.0143596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599019	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900147
J	Bencsik, M; Le Conte, Y; Reyes, M; Pioz, M; Whittaker, D; Crauser, D; Delso, NS; Newton, MI				Bencsik, Martin; Le Conte, Yves; Reyes, Maritza; Pioz, Maryline; Whittaker, David; Crauser, Didier; Delso, Noa Simon; Newton, Michael I.			Honeybee Colony Vibrational Measurements to Highlight the Brood Cycle	PLOS ONE			English	Article							APIS-MELLIFERA; BEES; GROWTH; GAIN	Insect pollination is of great importance to crop production worldwide and honey bees are amongst its chief facilitators. Because of the decline of managed colonies, the use of sensor technology is growing in popularity and it is of interest to develop new methods which can more accurately and less invasively assess honey bee colony status. Our approach is to use accelerometers to measure vibrations in order to provide information on colony activity and development. The accelerometers provide amplitude and frequency information which is recorded every three minutes and analysed for night time only. Vibrational data were validated by comparison to visual inspection data, particularly the brood development. We show a strong correlation between vibrational amplitude data and the brood cycle in the vicinity of the sensor. We have further explored the minimum data that is required, when frequency information is also included, to accurately predict the current point in the brood cycle. Such a technique should enable beekeepers to reduce the frequency with which visual inspections are required, reducing the stress this places on the colony and saving the beekeeper time.	[Bencsik, Martin; Whittaker, David; Newton, Michael I.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Le Conte, Yves; Reyes, Maritza; Pioz, Maryline; Crauser, Didier] INRA, UR Abeilles & Environm 406, F-84914 Avignon, France; [Delso, Noa Simon] CARI, B-1348 Louvain, Belgium	Nottingham Trent University; INRAE	Bencsik, M (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.	Martin.Bencsik@ntu.ac.uk	Pioz, Maryline/AAI-3325-2020; Le Conte, Yves/M-4442-2018; Newton, Michael I/B-8866-2008; Le Conte, Yves M/B-3246-2016; Le Conte, Yves/AAP-2379-2021	Le Conte, Yves/0000-0002-8466-5370; Newton, Michael I/0000-0003-4231-1002; Le Conte, Yves M/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370; Pioz, Maryline/0000-0003-0331-4403	Research Executive Agency [315146]; European Union's Research Executive Agency [315146]	Research Executive Agency; European Union's Research Executive Agency	The authors received funding from the Research Executive Agency through the Grant 'Swarmonitor', ref nb 315146.; We gratefully acknowledge the European Union's Research Executive Agency for funding under project reference No 315146. We acknowledge Claudia Dussaubat at INRA, David Parker and Catherine Procter at NTU for their contribution and to the Swarmonitor consortium members for helpful discussions.	[Anonymous], 2013, HOL APPR RISK ASS MU, DOI [10.2805/53269, DOI 10.2805/53269]; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Bencsik M, 2011, COMPUT ELECTRON AGR, V76, P44, DOI 10.1016/j.compag.2011.01.004; Delaplane K. S., 2010, CROP POLLINATION BEE; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; Engel Michael S., 1999, Journal of Hymenoptera Research, V8, P165; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Grzeda U, 2014, MED WETER, V70, P729; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; Health Canada, 2013, EV CAN BEE MORT 2013; Human H., 2013, J APICULT RES, V52; Imdorf A., 2001, COURSE DETERMINATION; Jarvis RM, 2004, ANAL CHEM, V76, P40, DOI 10.1021/ac034689c; Kaplan K, 2008, AGR RES, V56, P8; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Leonhardt SD, 2013, BASIC APPL ECOL, V14, P461, DOI 10.1016/j.baae.2013.06.003; LOUVEAUX J., 1966, ANN ABEILLE [PARIS], V9, P323, DOI 10.1051/apido:19660402; Maisonnasse A, 2015, 3 JOURN RECH AP PAR; Marletto Franco, 1992, Apicoltore Moderno, V83, P209; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Meikle WG, 2015, APIDOLOGIE, V46, P10, DOI 10.1007/s13592-014-0298-x; Mussen EC, 2004, ENVIRON ENTOMOL, V33, P1151, DOI 10.1603/0046-225X-33.5.1151; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Tasei JN, 2001, APIDOLOGIE, V32, P527, DOI 10.1051/apido:2001102; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Zacepins A, 2015, BIOSYST ENG, V130, P60, DOI 10.1016/j.biosystemseng.2014.12.001; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	31	23	23	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141926	10.1371/journal.pone.0141926	http://dx.doi.org/10.1371/journal.pone.0141926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580393	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600028
J	Gagliani, N; Jofra, T; Posgai, AL; Atkinson, MA; Battaglia, M				Gagliani, Nicola; Jofra, Tatiana; Posgai, Amanda L.; Atkinson, Mark A.; Battaglia, Manuela			Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice	PLOS ONE			English	Article							TRANSPLANT TOLERANCE; PANCREATIC-ISLETS; TYPE-1	The destruction of beta cells in type 1 diabetes (T1D) results in loss of insulin production and glucose homeostasis. Treatment of non-obese diabetic (NOD) mice with immunedepleting/modulating agents (e.g., anti-CD3, murine anti-thymocyte-globulin (mATG)) can lead to diabetes reversal. However, for preclinical studies with these and other agents seeking to reverse disease at onset, the necessity for exogenous insulin administration is debated. Spontaneously diabetic NOD mice were treated with a short-course of mATG and insulin provided as drug therapy or by way of allogeneic islet implants. Herein we demonstrate that exogenous insulin administration is required to achieve disease reversal with mATG in NOD mice. Unexpectedly, we also observed that provision of insulin by way of allogeneic islet implantation in combination with mATG leads to a pronounced reversal of diabetes as well as restoration of tolerance to self-islets. Expansion/induction of regulatory cells was observed in NOD mice stably cured with mATG and allogeneic islets. These data suggest that transient provision of allogeneic insulin-producing islets might provide a temporary window for immune depletion to be more effective and instilling stable tolerance to endogenous beta cells. These findings support the use of a never before explored approach for preserving beta cell function in patients with recent onset T1D.	[Gagliani, Nicola; Jofra, Tatiana; Battaglia, Manuela] IRCCS San Raffaele Sci Inst, DRI, Milan, Italy; [Gagliani, Nicola] Univ Vita Salute San Raffaele, Milan, Italy; [Posgai, Amanda L.; Atkinson, Mark A.] Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32610 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; State University System of Florida; University of Florida	Battaglia, M (corresponding author), IRCCS San Raffaele Sci Inst, DRI, Milan, Italy.	battaglia.manuela@hsr.it	Jofra, Tatiana/AAN-4727-2020	Jofra, Tatiana/0000-0003-2825-155X; Battaglia, Manuela/0000-0003-4535-3152; Posgai, Amanda/0000-0002-9491-0958; Gagliani, Nicola/0000-0001-8514-1395	Juvenile Diabetes Research Foundation Grant [7-2006-328]	Juvenile Diabetes Research Foundation Grant(Juvenile Diabetes Research Foundation)	This work has been supported by the Juvenile Diabetes Research Foundation Grant 7-2006-328 (http://jdrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav E, 2008, DIABETES, V57, P2883, DOI 10.2337/db07-1817; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Atkinson MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002757; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Fousteri G, 2015, DIABETOLOGIA, V58, P1319, DOI 10.1007/s00125-015-3540-9; Gagliani N, 2013, AM J TRANSPLANT, V13, P1963, DOI 10.1111/ajt.12333; Haller MJ, 2015, J CLIN INVEST, V125, P448, DOI 10.1172/JCI78492; MAKI T, 1992, P NATL ACAD SCI USA, V89, P3434, DOI 10.1073/pnas.89.8.3434; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Parker MJ, 2009, DIABETES, V58, P2277, DOI 10.2337/db09-0557; Pettus J, 2013, CLIN IMMUNOL, V149, P317, DOI 10.1016/j.clim.2013.04.006; Roep BO, 2014, NAT REV ENDOCRINOL, V10, P229, DOI 10.1038/nrendo.2014.2; Zhao CF, 2008, IMMUNOLOGY, V125, P48, DOI 10.1111/j.1365-2567.2008.02819.x	13	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142318	10.1371/journal.pone.0142318	http://dx.doi.org/10.1371/journal.pone.0142318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580221	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600045
J	Bedran, TBL; Morin, MP; Spolidorio, DP; Grenier, D				Lombardo Bedran, Telma Blanca; Morin, Marie-Pierre; Spolidorio, Denise Palomari; Grenier, Daniel			Black Tea Extract and Its Theaflavin Derivatives Inhibit the Growth of Periodontopathogens and Modulate Interleukin-8 and beta-Defensin Secretion in Oral Epithelial Cells	PLOS ONE			English	Article							GREEN TEA; PORPHYROMONAS-GINGIVALIS; PERIODONTAL-DISEASE; HEALTH; POLYPHENOLS; COMBINATION; CONSUMPTION; EXPRESSION; CHEMOKINES; THERAPY	Over the years, several studies have brought evidence suggesting that tea polyphenols, mostly from green tea, may have oral health benefits. Since few data are available concerning the beneficial properties of black tea and its theaflavin derivatives against periodontal disease, the objective of this study was to investigate their antibacterial activity as well as their ability to modulate interleukin-8 and human beta-defensin (hBD) secretion in oral epithelial cells. Among the periodontopathogenic bacteria tested, Porphyromonas gingivalis was found to be highly susceptible to the black tea extract and theaflavins. Moreover, our data indicated that the black tea extract, theaflavin and theaflavin-3,3'-digallate can potentiate the antibacterial effect of metronidazole and tetracycline against P. gingivalis. Using lipopolysaccharide-stimulated oral epithelial cells, the black tea extract (100 mu g/ml), as well as theaflavin and theaflavin-3,3'-digallate (50 mu g/ml) reduced interleukin-8 (IL-8) secretion by 85%, 79%, and 86%, respectively, thus suggesting an anti-inflammatory property. The ability of the black tea extract and its theaflavin derivatives to induce the secretion of the antimicrobial peptides hBD-1, hBD-2 and hBD-4 by oral epithelial cells was then evaluated. Our results showed that the black tea extract as well as theaflavin-3,3'-digallate were able to increase the secretion of the three hBDs. In conclusion, the ability of a black tea extract and theaflavins to exert antibacterial activity against major periodontopathogens, to attenuate the secretion of IL-8, and to induce hBD secretion in oral epithelial cells suggest that these components may have a beneficial effect against periodontal disease.	[Lombardo Bedran, Telma Blanca] UNINOVE Univ, Sao Paulo Dent Sch, Sao Paulo, Brazil; [Morin, Marie-Pierre; Grenier, Daniel] Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada; [Spolidorio, Denise Palomari] State Univ Sao Paulo, Araraquara Dent Sch, Dept Oral Diag & Surg, Sao Paulo, Brazil	Universidade Nove de Julho; Laval University; Universidade Estadual Paulista	Grenier, D (corresponding author), Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Spolidorio, Denise Madalena Palomari/P-3530-2016	Spolidorio, Denise Madalena Palomari/0000-0003-2376-1024	Laboratoire de Controle Microbiologique	Laboratoire de Controle Microbiologique	This work was supported by Laboratoire de Controle Microbiologique 2015 (DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrian E, 2006, J DENT RES, V85, P392, DOI 10.1177/154405910608500502; Aneja R, 2004, CRIT CARE MED, V32, P2097, DOI 10.1097/01.CCM.0000142661.73633.15; Asahi Y, 2014, J APPL MICROBIOL, V116, P1164, DOI 10.1111/jam.12458; Berezow AB, 2011, PERIODONTOL 2000, V55, P36, DOI 10.1111/j.1600-0757.2010.00350.x; Betts JW, 2012, J MICROB BIOTEC FOOD, V2, P1068; Butt MS, 2014, CRIT REV FOOD SCI, V54, P1002, DOI 10.1080/10408398.2011.623198; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Canas PG, 2015, J AM DENT ASSOC, V146, P150, DOI 10.1016/j.adaj.2014.12.015; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Chung WO, 2007, CURR PHARM DESIGN, V13, P3073, DOI 10.2174/138161207782110435; Dale BA, 2002, PERIODONTOL 2000, V30, P70, DOI 10.1034/j.1600-0757.2002.03007.x; Ebersole JL, 2013, PERIODONTOL 2000, V62, P163, DOI 10.1111/prd.12005; Gamonal J, 2001, J PERIODONTAL RES, V36, P194, DOI 10.1034/j.1600-0765.2001.360309.x; Gardner EJ, 2007, EUR J CLIN NUTR, V61, P3, DOI 10.1038/sj.ejcn.1602489; Gursoy Ulvi Kahraman, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.15127; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Hayat K, 2015, CRIT REV FOOD SCI, V55, P939, DOI 10.1080/10408398.2012.678949; Hirasawa M, 2002, J PERIODONTAL RES, V37, P433, DOI 10.1034/j.1600-0765.2002.01640.x; Hosokawa Y, 2010, MOL NUTR FOOD RES, V54, pS151, DOI 10.1002/mnfr.200900549; Jain A, 2013, TOXICOL LETT, V220, P82, DOI 10.1016/j.toxlet.2013.04.010; Jin LJ, 2002, J CLIN PERIODONTOL, V29, P604, DOI 10.1034/j.1600-051X.2002.290704.x; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Komatsuzawa H, 2007, CURR PHARM DESIGN, V13, P3084, DOI 10.2174/138161207782110426; Kong LX, 2015, ARCH ORAL BIOL, V60, P12, DOI 10.1016/j.archoralbio.2014.08.019; Koyama Y, 2010, PREV MED, V50, P173, DOI 10.1016/j.ypmed.2010.01.010; Kushiyama M, 2009, J PERIODONTOL, V80, P372, DOI 10.1902/jop.2009.080510 ; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Loesche WJ, 2001, CLIN MICROBIOL REV, V14, P727, DOI 10.1128/CMR.14.4.727-752.2001; Lombardo Bedran TB, J PERIODONT RES, V201, P615; Milward MR, 2007, CLIN EXP IMMUNOL, V148, P307, DOI 10.1111/j.1365-2249.2007.03342.x; Morin MP, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0557-z; Narotzki B, 2012, ARCH ORAL BIOL, V57, P429, DOI 10.1016/j.archoralbio.2011.11.017; Otomo-Corgel Joan, 2012, J Evid Based Dent Pract, V12, P20, DOI 10.1016/S1532-3382(12)70006-4; Otte JM, 2008, J CELL BIOCHEM, V104, P2286, DOI 10.1002/jcb.21787; Palaska I, 2013, EUR J PHARMACOL, V720, P77, DOI 10.1016/j.ejphar.2013.10.047; PANYANGARM Y, 1988, CU DENT J, V11, P43; Pinto MD, 2013, FOOD RES INT, V53, P558, DOI 10.1016/j.foodres.2013.01.038; Ramos R, 2011, PEPTIDES, V32, P1469, DOI 10.1016/j.peptides.2011.06.005; Sharma V, 2009, CRIT REV FOOD SCI, V49, P379, DOI 10.1080/10408390802068066; Silva TA, 2007, J DENT RES, V86, P306, DOI 10.1177/154405910708600403; Sirk TW, 2011, J AGR FOOD CHEM, V59, P3780, DOI 10.1021/jf2006547; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Varoni EM, 2012, CURR MED CHEM, V19, P1706; Vuong QV, 2014, CRIT REV FOOD SCI, V54, P523, DOI 10.1080/10408398.2011.594184; Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10; Zhang J, 1998, CARIES RES, V32, P233, DOI 10.1159/000016458	47	34	36	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143158	10.1371/journal.pone.0143158	http://dx.doi.org/10.1371/journal.pone.0143158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581041	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600093
J	Burns, M; Muthupalani, S; Ge, ZM; Wang, TC; Bakthavatchalu, V; Cunningham, C; Ennis, K; Georgieff, M; Fox, JG				Burns, Monika; Muthupalani, Sureshkumar; Ge, Zhongming; Wang, Timothy C.; Bakthavatchalu, Vasudevan; Cunningham, Catriona; Ennis, Kathleen; Georgieff, Michael; Fox, James G.			Helicobacter pylori Infection Induces Anemia, Depletes Serum Iron Storage, and Alters Local Iron-Related and Adult Brain Gene Expression in Male INS-GAS Mice	PLOS ONE			English	Article							DEFICIENCY ALTERS; MEDICAL PROGRESS; GASTRIC-CANCER; MOUSE MODELS; HEPCIDIN; PREVALENCE; ERADICATION; HOMEOSTASIS; CARCINOGENESIS; EPIDEMIOLOGY	Iron deficiency anemia (IDA) affects > 500 million people worldwide, and is linked to impaired cognitive development and function in children. Helicobacter pylori, a class 1 carcinogen, infects about half of the world's population, thus creating a high likelihood of overlapping risk. This study determined the effect of H. pylori infection on iron homeostasis in INS-GAS mice. Two replicates of INS-GAS/FVB male mice (n = 9-12/group) were dosed with H. pylori (Hp) strain SS1 or sham dosed at 6-9 weeks of age, and were necropsied at 27-29 weeks of age. Hematologic and serum iron parameters were evaluated, as was gene expression in gastric and brain tissues. Serum ferritin was lower in Hp SS1-infected mice than uninfected mice (p < 0.0001). Infected mice had a lower red blood cell count (p < 0.0001), hematocrit (p < 0.001), and hemoglobin concentration (p < 0.0001) than uninfected mice. Relative expression of gastric hepcidin antimicrobial peptide (Hamp) was downregulated in mice infected with Hp SS1 compared to sham-dosed controls (p 0.001). Expression of bone morphogenic protein 4 (Bmp4), a growth factor upstream of hepcidin, was downregulated in gastric tissue of Hp SS1-infected mice (p < 0.001). Hp SS1-infected mice had downregulated brain expression of tyrosine hydroxylase (Th) (p = 0.02). Expression of iron-responsive genes involved in myelination (myelin basic protein (Mbp) and proteolipid protein 2 (Plp2)) was downregulated in infected mice (p = 0.001 and p = 0.02). Expression of synaptic plasticity markers (brain derived neurotrophic factor 3 (Bdnf3), Psd95 (a membrane associated guanylate kinase), and insulin-like growth factor 1 (Igf1)) was also downregulated in Hp SS1-infected mice (p = 0.09, p = 0.04, p = 0.02 respectively). Infection of male INS-GAS mice with Hp SS1, without concurrent dietary iron deficiency, depleted serum ferritin, deregulated gastric and hepatic expression of iron regulatory genes, and altered iron-dependent neural processes. The use of Hp SS1-infected INS-GAS mice will be an appropriate animal model for further study of the effects of concurrent H. pylori infection and anemia on iron homeostasis and adult iron-dependent brain gene expression.	[Burns, Monika; Muthupalani, Sureshkumar; Ge, Zhongming; Bakthavatchalu, Vasudevan; Cunningham, Catriona; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Fox, James G.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Wang, Timothy C.] Columbia Univ, Dept Med, New York, NY USA; [Cunningham, Catriona] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Ennis, Kathleen; Georgieff, Michael] Univ Minnesota, Sch Med, Dept Pediat, Div Neonatol, Minneapolis, MN 55455 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Columbia University; University of Aberdeen; University of Minnesota System; University of Minnesota Twin Cities	Fox, JG (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	jgfox@mit.edu	Muthupalani, Sureshkumar/C-7244-2015; Cunningham, Catriona/V-8577-2019	Cunningham, Catriona/0000-0002-9216-9414; Ge, Zhongming/0000-0003-0924-7563; Wang, Timothy/0000-0001-5730-3019	Office of The Director of the National Institutes of Health [T3200010978, R01CA093405, P01CA028842-23]; National Institute of Environmental Health Sciences [P30ES0022109]; NATIONAL CANCER INSTITUTE [R01CA093405, R01CA067529, P01CA028842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109, Z01ES022109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010978] Funding Source: NIH RePORTER	Office of The Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by Office of The Director of the National Institutes of Health under award number T3200010978, R01CA093405, P01CA028842-23, and National Institute of Environmental Health Sciences under award P30ES0022109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarado-Esquivel C, 2013, HELICOBACTER, V18, P215, DOI 10.1111/hel.12032; [Anonymous], 2001, IRON DEFICIENCY ANAE; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Bercik P, 2009, AM J PHYSIOL-REG I, V296, pR587, DOI 10.1152/ajpregu.90752.2008; Budzynski J, 2014, WORLD J GASTROENTERO, V20, P5212, DOI 10.3748/wjg.v20.i18.5212; Burkhard MJ, 2001, VET CLIN PATH, V30, P76, DOI 10.1111/j.1939-165X.2001.tb00262.x; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Carter PR, 2013, INFLAMM BOWEL DIS, V19, P1260, DOI 10.1097/MIB.0b013e3182813466; COOK JD, 1974, AM J CLIN NUTR, V27, P681, DOI 10.1093/ajcn/27.7.681; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Cortese S, 2014, POSTGRAD MED, V126, P155, DOI 10.3810/pgm.2014.07.2793; Dainty JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111824; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Enko D, 2015, CLIN BIOCHEM, V48, P891, DOI 10.1016/j.clinbiochem.2015.05.008; Everds N.E., 2007, MOUSE BIOMEDICAL RES, V3, P133, DOI DOI 10.1016/B978-012369454-6/50059-5; Flores SE, 2015, BIOMETALS, V28, P143, DOI 10.1007/s10534-014-9810-z; FORMAN D, 1993, GUT, V34, P1672, DOI 10.1136/gut.34.12.1672; Fox JG, 2007, AM J PATHOL, V171, P1520, DOI 10.2353/ajpath.2007.070249; Fox JG, 2003, GASTROENTEROLOGY, V124, P1879, DOI 10.1016/S0016-5085(03)00406-2; Fox JG, 2003, CANCER RES, V63, P942; Franceschi F, 2014, NAT REV GASTRO HEPAT, V11, P234, DOI 10.1038/nrgastro.2013.243; FUCHS CS, 1995, NEW ENGL J MED, V333, P32, DOI 10.1056/NEJM199507063330107; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gobel R, 2006, HELICOBACTER, V11, P529, DOI 10.1111/j.1523-5378.2006.00455.x; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Hayakawa Yoku, 2013, Cancers (Basel), V5, P92, DOI 10.3390/cancers5010092; Huang XL, 2010, POSTGRAD MED J, V86, P272, DOI 10.1136/pgmj.2009.089987; Jellen LC, 2013, NEUROSCIENCE, V252, P13, DOI 10.1016/j.neuroscience.2013.07.058; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keenan JI, 2004, HELICOBACTER, V9, P643, DOI 10.1111/j.1083-4389.2004.00278.x; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Kovac S, 2008, AM J PHYSIOL-GASTR L, V295, pG855, DOI 10.1152/ajpgi.90359.2008; Kuvibidila SR, 2012, NUTR RES, V32, P107, DOI 10.1016/j.nutres.2011.12.005; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lee CW, 2008, CANCER RES, V68, P3540, DOI 10.1158/0008-5472.CAN-07-6786; Lee CW, 2009, CANCER RES, V69, P8166, DOI 10.1158/0008-5472.CAN-08-3856; LETENDRE ED, 1983, INFECT IMMUN, V39, P50, DOI 10.1128/IAI.39.1.50-59.1983; Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Lozoff B, 2006, AM J CLIN NUTR, V84, P1412, DOI 10.1093/ajcn/84.6.1412; Maurer KJ, 2006, AM J PHYSIOL-GASTR L, V290, pG175, DOI 10.1152/ajpgi.00272.2005; Mearin F, 2013, GASTROENT HEPAT-BARC, V36, P499, DOI 10.1016/j.gastrohep.2013.05.006; Muhsen K, 2008, HELICOBACTER, V13, P323, DOI 10.1111/j.1523-5378.2008.00617.x; Naigamwalla DZ, 2012, CAN VET J, V53, P250; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Neufeld Karen-Anne M, 2011, Commun Integr Biol, V4, P492, DOI 10.4161/cib.4.4.15702; Noto JM, 2013, J CLIN INVEST, V123, P479, DOI 10.1172/JCI64373; O'Connell KE, 2015, COMPARATIVE MED, V65, P96; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Porras C, 2013, CANCER CAUSE CONTROL, V24, P209, DOI 10.1007/s10552-012-0117-5; Queiroz DMM, 2013, GUT MICROBES, V4, P494, DOI 10.4161/gmic.26277; Ramakrishnan U, 2002, NUTR REV, V60, pS46, DOI 10.1301/00296640260130731; Rogers AB, 2005, CANCER RES, V65, P10709, DOI 10.1158/0008-5472.CAN-05-1846; Rogers Arlin B., 2009, V511, P267, DOI 10.1007/978-1-59745-447-6_11; Sasaki Y, 2012, INT J HEMATOL, V96, P692, DOI 10.1007/s12185-012-1217-4; Sato Y, 2015, HELICOBACTER, V20, P11, DOI 10.1111/hel.12170; Schneck K, 2000, COMPARATIVE MED, V50, P32; Schwarz P, 2012, GUT, V61, P193, DOI 10.1136/gut.2011.241208; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tan SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002050; Thomson MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050194; Tran PV, 2013, AM J PHYSIOL-REG I, V305, pR1297, DOI 10.1152/ajpregu.00292.2013; Vecchi C, 2014, GASTROENTEROLOGY, V146, P1060, DOI 10.1053/j.gastro.2013.12.016; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4	67	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142630	10.1371/journal.pone.0142630	http://dx.doi.org/10.1371/journal.pone.0142630			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575645	Green Submitted, Green Published, gold			2022-12-26	WOS:000365153400014
J	Fang, JZ; Li, C; Liu, XY; Hu, TT; Fan, ZS; Han, ZG				Fang, Jia-Zhu; Li, Chong; Liu, Xiao-Yan; Hu, Tao-Tao; Fan, Zu-Sen; Han, Ze-Guang			Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma	PLOS ONE			English	Article							REMODELING GENE ARID1A; TUMOR-SUPPRESSOR GENE; SOMATIC MUTATIONS; LIVER-CANCER; FREQUENT MUTATIONS; HEPATITIS-B; EXOME; INFLAMMATION; IL-6; TUMORIGENESIS	ARID1A, encoding a subunit of chromatin remodeling SWI/SNF complexes, has recently been considered as a new type of tumor suppressor gene for its somatic mutations frequently found in various human tumors, including hepatocellular carcinoma (HCC). However, the role and mechanism of inactivated ARID1A mutations in tumorigenesis remain unclear. To investigate the role of ARID1A inactivation in HCC pathogenesis, we generated hepatocyte-specific Arid1a knockout (Arid1a(LKO)) mice by crossing mice carrying loxP-flanked Arid1a exon 8 alleles (Arid1a(f/f)) with albumin promoter-Cre transgenic mice. Significantly, the hepatocyte-specific Arid1a deficiency results in mouse steatohepatitis and HCC development. In Arid1a(LKO) mice, we found that innate immune cells, including F4/80+ macrophages and CD11c+ neutrophil cells, infiltrate into the liver parenchyma, accompanied by the increased tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, and activation of STAT3 and NF-kappa B pathways. In conclusion, hepatocyte-specific Arid1a deficiency could lead to mouse steatohepatitis and HCC development. This study provides an alternative mechanism by which Arid1a deficiency contributes to HCC tumorigenesis.	[Fang, Jia-Zhu; Liu, Xiao-Yan; Hu, Tao-Tao; Han, Ze-Guang] Shanghai Jiao Tong Univ, Sch Med, Key Lab Syst Biomed, Minist Educ, Shanghai 200030, Peoples R China; [Fang, Jia-Zhu; Liu, Xiao-Yan; Hu, Tao-Tao; Han, Ze-Guang] Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Syst Biomed, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Fang, Jia-Zhu; Liu, Xiao-Yan; Hu, Tao-Tao; Han, Ze-Guang] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Fang, Jia-Zhu; Hu, Tao-Tao; Han, Ze-Guang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Li, Chong; Fan, Zu-Sen] Chinese Acad Sci, Inst Biophys, Chinese Acad Sci Key Lab Infect & Immun, Beijing 100080, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Fan, ZS (corresponding author), Chinese Acad Sci, Inst Biophys, Chinese Acad Sci Key Lab Infect & Immun, Beijing 100080, Peoples R China.	fanz@moon.ibp.ac.cn; hanzg@sjtu.edu.cn		Han, Ze-Guang/0000-0002-1018-1752	National Natural Science Foundation of China [81472621, 81272271, 81201690]; China National Key Projects for Infectious Disease [2012ZX10002012-008, 2013ZX10002010-006]; Chinese National Key Program on Basic Research [2010CB529200, 2012CB722308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Key Projects for Infectious Disease; Chinese National Key Program on Basic Research	This work was supported by grants from the National Natural Science Foundation of China (81472621, 81272271 and 81201690), the China National Key Projects for Infectious Disease (2012ZX10002012-008 and 2013ZX10002010-006), and Chinese National Key Program on Basic Research (2010CB529200 and 2012CB722308).	Abe H, 2012, VIRCHOWS ARCH, V461, P367, DOI 10.1007/s00428-012-1303-2; Amaddeo G, 2012, ONCOIMMUNOLOGY, V1, P1612, DOI 10.4161/onci.21480; Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Bumrungthai S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127109; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Chandler RL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7118; Cornen S, 2012, ONCOGENE, V31, P4255, DOI 10.1038/onc.2011.598; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; El-Serag HB, 2011, GUT, V60, P992, DOI 10.1136/gut.2010.230508; Elinav Eran, 2013, Methods Mol Biol, V1040, P185, DOI 10.1007/978-1-62703-523-1_14; Facciorusso A, 2013, CURR DIABETES REV, V9, P382, DOI 10.2174/15733998113099990068; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guan B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju146; Guan B, 2012, NEOPLASIA, V14, P986, DOI 10.1593/neo.121218; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; He F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0164-3; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Jia MY, 2014, HEPATOL RES, V44, P1151, DOI 10.1111/hepr.12220; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Jones S, 2012, HUM MUTAT, V33, P100, DOI 10.1002/humu.21633; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Karagozian R, 2014, METABOLISM, V63, P607, DOI 10.1016/j.metabol.2014.01.011; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lei IL, 2012, J BIOL CHEM, V287, P24255, DOI 10.1074/jbc.M112.365080; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Liaskou E, 2013, HEPATOLOGY, V57, P385, DOI 10.1002/hep.26016; Libbrecht L, 2005, LIVER INT, V25, P16, DOI 10.1111/j.1478-3231.2005.01016.x; Libbrecht L, 2001, HISTOPATHOLOGY, V39, P66, DOI 10.1046/j.1365-2559.2001.01172.x; Lin Y, 2012, LAB INVEST, V92, P265, DOI 10.1038/labinvest.2011.159; Liu Y, 2010, CELL CYCLE, V9, P3423, DOI 10.4161/cc.9.17.12946; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Michielsen P, 2011, ACTA GASTRO-ENT BELG, V74, P4; Miyagi T, 2004, HEPATOLOGY, V40, P1190, DOI 10.1002/hep.20447; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nault JC, 2016, CLIN RES HEPATOL GAS, V40, P9, DOI 10.1016/j.clinre.2015.07.006; Newell P, 2008, J HEPATOL, V48, P858, DOI 10.1016/j.jhep.2008.01.008; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Shimizu M, 2013, SEMIN IMMUNOPATHOL, V35, P191, DOI 10.1007/s00281-012-0336-6; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Vlach KD, 2000, COMPARATIVE MED, V50, P160; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	60	19	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143042	10.1371/journal.pone.0143042	http://dx.doi.org/10.1371/journal.pone.0143042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569409	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700123
J	Katsifa, A; Kaffe, E; Nikolaidou-Katsaridou, N; Economides, AN; Newbigging, S; McKerlie, C; Aidinis, V				Katsifa, Aggeliki; Kaffe, Eleanna; Nikolaidou-Katsaridou, Nefeli; Economides, Aris N.; Newbigging, Susan; McKerlie, Colin; Aidinis, Vassilis			The Bulk of Autotaxin Activity Is Dispensable for Adult Mouse Life	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID PRODUCTION; REGRESSION IN-VIVO; LYSOPHOSPHOLIPASE-D; PULMONARY-FIBROSIS; BREAST-CANCER; EXPRESSION; RECEPTOR; LPA; GENERATION; RECOMBINATION	Autotaxin (ATX, Enpp2) is a secreted lysophospholipase D catalysing the production of lysophosphatidic acid, a pleiotropic growth factor-like lysophospholipid. Increased ATX expression has been detected in a number of chronic inflammatory diseases and different types of cancer, while genetic interventions have proven a role for ATX in disease pathogenesis. Therefore, ATX has emerged as a potential drug target and a large number of ATX inhibitors have been developed exhibiting promising therapeutic potential. However, the embryonic lethality of ATX null mice and the ubiquitous expression of ATX and LPA receptors in adult life question the suitability of ATX as a drug target. Here we show that inducible, ubiquitous genetic deletion of ATX in adult mice, as well as long-term potent pharmacologic inhibition, are well tolerated, alleviating potential toxicity concerns of ATX therapeutic targeting.	[Katsifa, Aggeliki; Kaffe, Eleanna; Nikolaidou-Katsaridou, Nefeli; Aidinis, Vassilis] Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Athens, Greece; [Economides, Aris N.] Regeneron Pharmaceut Inc, Genome Engn Technol Grp, Tarrytown, NY 10591 USA; [Economides, Aris N.] Regeneron Pharmaceut Inc, Skeletal Dis TFA Grp, Tarrytown, NY 10591 USA; [Newbigging, Susan; McKerlie, Colin] Hosp Sick Children, Ctr Phenogen, Physiol & Expt Med Res Program, Toronto, ON M5G 1X8, Canada; [Newbigging, Susan; McKerlie, Colin] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Alexander Fleming Biomedical Sciences Research Center; Regeneron; Regeneron; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Aidinis, V (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Athens, Greece.	v.aidinis@fleming.gr	Aidinis, Vassilis/AAF-5380-2021	McKerlie, Colin/0000-0002-2232-0967; Economides, Aris/0000-0002-6508-8942; Aidinis, Vassilis/0000-0001-9531-7729	National SYNERGASIA Grant [09SYN-11-679]; National ARISTIA II Grant [3311]; European Union (European Regional Development Fund); European Union (European Social Fund); National resources through the Operational Program "Competitiveness and Entrepreneurship" of the National Strategic Reference Framework (NSRF); National resources through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	National SYNERGASIA Grant; National ARISTIA II Grant; European Union (European Regional Development Fund)(European Commission); European Union (European Social Fund)(European Social Fund (ESF)European Commission); National resources through the Operational Program "Competitiveness and Entrepreneurship" of the National Strategic Reference Framework (NSRF); National resources through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF)	The present work was funded by 1) a National SYNERGASIA 2009 Grant (Project Code 09SYN-11-679), and 2) a National ARISTIA II Grant (Project Code 3311), co-financed by the European Union (European Regional Development Fund and European Social Fund respectively) and National resources through the Operational Programs "Competitiveness and Entrepreneurship" and "Education and Lifelong Learning", respectively, of the National Strategic Reference Framework (NSRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. Economides is an employee of Regeneron Pharmaceuticals Inc., which provided the R26Cre mouse and paid a salary to author A. Economides, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Albers HM, 2012, CHEM REV; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Barbayianni E, 2015, PROG LIPID RES, V58, P76, DOI 10.1016/j.plipres.2015.02.001; Barbayianni E, 2013, EXPERT OPIN THER PAT, V23, P1123, DOI 10.1517/13543776.2013.796364; Benesch MGK, 2015, FASEB J, V29, P3990, DOI 10.1096/fj.15-274480; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Bourgoin SG, 2010, CURR OPIN INVEST DR, V11, P515; Brake Rachael L, 2004, Genet Mol Res, V3, P456; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Gierse JK, 2010, J PHARM EXPT THERAPE; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Leblanc R, 2014, BLOOD, V124, P3141, DOI 10.1182/blood-2014-04-568683; Lee S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/967462; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nikitopoulou I, 2013, PLOS ONE IN PRESS; Nikitopoulou I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070941; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Oikonomou N, 2012, AM J RESP CELL MOL, V47, P566, DOI 10.1165/rcmb.2012-0004OC; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Parrill AL, 2013, BBA-MOL CELL BIOL L, V1831, P2, DOI 10.1016/j.bbalip.2012.09.002; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Rai V, 2012, J EXP MED, V209, P2339, DOI 10.1084/jem.20120873; Saga H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093230; Saulnier-Blache JS, 2004, M S-MED SCI, V20, P799, DOI 10.1051/medsci/2004208-9799; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tager AM, 2012, AM J RESP CELL MOL, V47, P563, DOI 10.1165/rcmb.2012-0235ED; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tigyi G, 2003, PROG LIPID RES, V42, P498, DOI 10.1016/S0163-7827(03)00035-3; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Venkatraman G, 2015, FASEB J, V29, P772, DOI 10.1096/fj.14-262659; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Yanagida K, 2013, BBA-MOL CELL BIOL L, V1831, P33, DOI 10.1016/j.bbalip.2012.08.003; Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302	50	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143083	10.1371/journal.pone.0143083	http://dx.doi.org/10.1371/journal.pone.0143083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569406	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700132
J	Pan, F; Han, LZ; Huang, WC; Tang, J; Xiao, SZ; Wang, C; Qin, HH; Zhang, H				Pan, Fen; Han, Lizhong; Huang, Weichun; Tang, Jin; Xiao, Shuzhen; Wang, Chun; Qin, Huihong; Zhang, Hong			Serotype Distribution, Antimicrobial Susceptibility, and Molecular Epidemiology of Streptococcus pneumoniae Isolated from Children in Shanghai, China	PLOS ONE			English	Article							INVASIVE DISEASE; MAJOR CLONES; RESISTANCE; IDENTIFICATION; SURVEILLANCE; TRENDS	Objective Streptococcus pneumoniae is a common pathogenic cause of pediatric infections. This study investigated the serotype distribution, antimicrobial susceptibility, and molecular epidemiology of pneumococci before the introduction of conjugate vaccines in Shanghai, China. Methods A total of 284 clinical pneumococcal isolates (270, 5, 4,3, and 2 of which were isolated from sputum, bronchoalveolar lavage fluid, blood, cerebral spinal fluid, and ear secretions, respectively) from children less than 14 years of age who had not been vaccinated with a conjugate vaccine, were collected between January and December in 2013. All isolates were serotyped by multiplex polymerase chain reaction or quellung reactions and antimicrobial susceptibility testing was performed using the broth microdilution method. The molecular epidemiology of S. pneumoniae was analyzed by multilocus sequence typing (MLST). Results Among the 284 pneumococcal isolates, 19F (33.5%), 19A (14.1%), 23F (12.0%), and 6A (8.8%) were the most common serotypes and the coverage rates of the 7-, 10-, and 13-valent pneumococcal conjugate vaccines (PCV7, PCV10, and PCV13) were 58.6%, 59.4% and 85.1%, respectively. Antimicrobial susceptibility showed that the prevalence rates of S. pneumoniae resistance to penicillin were 11.3%(32/284). Approximately 88.0% (250/284) of the isolates exhibited multi-drug resistance. MLST analysis revealed a high level of diversity, with 65 sequence types (STs) among 267 isolates. Specifically, the four predominant STs were ST271 (24.3%, 65/267), ST320 (11.2%, 30/267), ST81 (9.7%, 26/267), and ST3173 (5.2%, 14/267), which were mainly associated with serotypes 19F, 19A, 23F, and 6A, respectively. Conclusions The prevalent serotypes among clinical isolates from children were 19F, 19A, 23F, and 6A and these isolates showed high resistance rates to beta-lactams and macrolides. The Taiwan (19F)-14 clone played a predominant role in the dissemination of pneumococcal isolates in Shanghai, China. Therefore, continued and regional surveillance on pneumococcal isolates may be necessary.	[Pan, Fen; Wang, Chun; Qin, Huihong; Zhang, Hong] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Han, Lizhong; Xiao, Shuzhen] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai, Peoples R China; [Huang, Weichun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai, Peoples R China; [Tang, Jin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Han, LZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Clin Microbiol, Shanghai, Peoples R China.	13916291150@163.com; schjyk2015@126.com			Shanghai Municipal Commission of Health and Family Planning [20124026]	Shanghai Municipal Commission of Health and Family Planning	This study was partly supported by funding (NO. 20124026) from the Shanghai Municipal Commission of Health and Family Planning. The funders had no a role in study, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Bean DC, 2005, J ANTIMICROB CHEMOTH, V55, P375, DOI 10.1093/jac/dki001; Chiba N, 2014, EMERG INFECT DIS, V20, P1132, DOI 10.3201/eid2007.131485; Clinical and Laboratory Standards Institute (CLSI), 2014, M100 S24; Ding H, 2008, ACTA PAEDIATR, V97, P100, DOI 10.1111/j.1651-2227.2007.00580.x; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Geng Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093752; HANSMAN D, 1967, LANCET, V2, P264; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hsieh YC, 2013, J INFECT DIS, V208, P203, DOI 10.1093/infdis/jit145; Huang FuHong, 2010, Chinese Journal of Nosocomiology, V20, P87; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Ip M, 2015, ANTIMICROB AGENTS CH, V59, P4040, DOI 10.1128/AAC.00094-15; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Jones RN, 2013, DIAGN MICR INFEC DIS, V75, P107, DOI 10.1016/j.diagmicrobio.2012.08.024; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Mendes RE, 2014, DIAGN MICR INFEC DIS, V80, P19, DOI 10.1016/j.diagmicrobio.2014.05.020; Torne AN, 2014, VACCINE, V32, P3644, DOI 10.1016/j.vaccine.2014.04.066; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Shi ZY, 1998, J CLIN MICROBIOL, V36, P3514, DOI 10.1128/JCM.36.12.3514-3519.1998; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Wang XF, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-367; Wessels E, 2012, J CLIN MICROBIOL, V50, P1171, DOI 10.1128/JCM.06609-11; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yang F, 2008, INT J ANTIMICROB AG, V32, P386, DOI 10.1016/j.ijantimicag.2008.05.004; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027; Zhao CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082361; Zhou L, 2011, VACCINE, V29, P7704, DOI 10.1016/j.vaccine.2011.07.137	30	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142892	10.1371/journal.pone.0142892	http://dx.doi.org/10.1371/journal.pone.0142892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571373	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700093
J	Sanchez-Hernandez, J; Cobo, F; Amundsen, PA				Sanchez-Hernandez, Javier; Cobo, Fernando; Amundsen, Per-Arne			Food Web Topology in High Mountain Lakes	PLOS ONE			English	Article							CHARR SALVELINUS-ALPINUS; SALMO-TRUTTA L.; TROPHIC LEVELS; TOP PREDATOR; OMNIVORY; TROUT; ECOLOGY; SPAIN; SIZE	Although diversity and limnology of alpine lake systems are well studied, their food web structure and properties have rarely been addressed. Here, the topological food webs of three high mountain lakes in Central Spain were examined. We first addressed the pelagic networks of the lakes, and then we explored how food web topology changed when benthic biota was included to establish complete trophic networks. We conducted a literature search to compare our alpine lacustrine food webs and their structural metrics with those of 18 published lentic webs using a meta-analytic approach. The comparison revealed that the food webs in alpine lakes are relatively simple, in terms of structural network properties (linkage density and connectance), in comparison with lowland lakes, but no great differences were found among pelagic networks. The studied high mountain food webs were dominated by a high proportion of omnivores and species at intermediate trophic levels. Omnivores can exploit resources at multiple trophic levels, and this characteristic might reduce competition among interacting species. Accordingly, the trophic overlap, measured as trophic similarity, was very low in all three systems. Thus, these alpine networks are characterized by many omnivorous consumers with numerous prey species and few consumers with a single or few prey and with low competitive interactions among species. The present study emphasizes the ecological significance of omnivores in high mountain lakes as promoters of network stability and as central players in energy flow pathways via food partitioning and enabling energy mobility among trophic levels.	[Sanchez-Hernandez, Javier; Amundsen, Per-Arne] UiT, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway; [Sanchez-Hernandez, Javier; Cobo, Fernando] Univ Santiago de Compostela, Fac Biol, Dept Zool & Phys Anthropol, Santiago De Compostela, Spain; [Cobo, Fernando] Stn Hydrobiol Encoro do Con, Vilagarcia De Arousa 36617, Pontevedra, Spain	UiT The Arctic University of Tromso; Universidade de Santiago de Compostela	Amundsen, PA (corresponding author), UiT, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway.	per-arne.amundsen@uit.no	Cobo, Fernando/AAA-1318-2019; Sánchez-Hernández, Javier/J-2544-2014	Sánchez-Hernández, Javier/0000-0001-9684-4774; Amundsen, Per-Arne/0000-0002-2203-8216	Galician Plan for Research, Innovation, and Growth (Plan I2C, Xunta de Galicia); University of Tromso; Norwegian research council [NFR 213610/F20]	Galician Plan for Research, Innovation, and Growth (Plan I2C, Xunta de Galicia); University of Tromso; Norwegian research council(Research Council of NorwayEuropean Commission)	Sanchez-Hernandez was supported by a postdoctoral grant from the Galician Plan for Research, Innovation, and Growth 2011-2015 (Plan I2C, Xunta de Galicia). The work is also supported as a spin-off from a project financed by University of Tromso and the Norwegian research council (NFR 213610/F20).	Alcorlo P, 2001, HYDROBIOLOGIA, V466, P307, DOI 10.1023/A:1014594408119; Aldasoro J, 1984, COMUNIDADES PLANTAS, V1, P111; Aldasoro JJ, 2001, MONOGRAFIAS RED ESPA, P67; Amundsen PA, 2013, OECOLOGIA, V171, P993, DOI 10.1007/s00442-012-2461-2; Amundsen PA, 2009, J ANIM ECOL, V78, P563, DOI 10.1111/j.1365-2656.2008.01518.x; ARNQVIST G, 1995, TRENDS ECOL EVOL, V10, P236, DOI 10.1016/S0169-5347(00)89073-4; BORNETTE G, 1994, VEGETATIO, V110, P171, DOI 10.1007/BF00033397; Bystrom P, 2007, FRESHWATER BIOL, V52, P1271, DOI 10.1111/j.1365-2427.2007.01763.x; Cavalli L., 1997, Fisheries Management and Ecology, V4, P167, DOI 10.1046/j.1365-2400.1997.00116.x; Cavalli L, 1998, HYDROBIOLOGIA, V386, P9, DOI 10.1023/A:1003466725314; Chessel D., 2004, R NEWS, V4, P5; Clitherow LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060899; Coll M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022591; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; de Manuel J.B., 2000, LIMNETICA, V19, P91; Doi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037856; Dunne JA, 2004, MAR ECOL PROG SER, V273, P291, DOI 10.3354/meps273291; Dunne JA, 2009, ENCY COMPLEXITY SYST, P3661, DOI DOI 10.1007/978-0-387-30440-3_216; Dunne JA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001579; Eloranta AP, 2015, ECOL EVOL, V5, P1664, DOI 10.1002/ece3.1464; Eloranta AP, 2013, FRESHWATER BIOL, V58, P207, DOI 10.1111/fwb.12052; Fagan WF, 1997, AM NAT, V150, P554, DOI 10.1086/286081; Fernandez P, 1999, ENVIRON SCI TECHNOL, V33, P3716, DOI 10.1021/es9904639; Garcia-Chicote J., 2007, Limnetica, V26, P265; Granados Ignacio, 2000, Journal of Limnology, V59, P109; Guerrero F, 1990, FOLIA ZOOL, V89, P841; Gulati RD, 2001, J PLANKTON RES, V23, P705, DOI 10.1093/plankt/23.7.705; Harper-Smith Sarah, 2005, P407; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; Havens KE, 1996, OIKOS, V75, P20, DOI 10.2307/3546317; Hellmann C, 2013, FRESHW SCI, V32, P548, DOI 10.1899/12-020.1; Hobbie JE, 1999, POLAR RES, V18, P207, DOI 10.1111/j.1751-8369.1999.tb00295.x; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ilmi Yoon, 2004, Proceedings of the SPIE, V5295, P124, DOI 10.1117/12.526956; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Kampe H, 2007, LIMNOLOGICA, V37, P137, DOI 10.1016/j.limno.2007.01.001; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Kratina P, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00121.1; LACASSE S, 1992, CAN J FISH AQUAT SCI, V49, P1001, DOI 10.1139/f92-112; Lampman GG, 1999, J GREAT LAKES RES, V25, P239, DOI 10.1016/S0380-1330(99)70733-1; Layer K, 2011, ADV ECOL RES, V44, P69, DOI 10.1016/B978-0-12-374794-5.00002-X; Lazzaro X, 2009, J ANIM ECOL, V78, P1307, DOI 10.1111/j.1365-2656.2009.01588.x; Lizana M, 1990, THESIS; Lizana M, 1986, REV ESP HERPETOL, V1, P207; Lopez-Rodriguez M.J., 2006, Acta Granatense, V4-5, P41; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Martinez-Sanz C, 2012, J LIMNOL, V71, P154, DOI 10.4081/jlimnol.2012.e16; McCann K. S., 2012, MONOGRAPHS POPULATIO; McNaught AS, 1999, LIMNOL OCEANOGR, V44, P127, DOI 10.4319/lo.1999.44.1.0127; Merritt R.W., 1996, INTRO AQUATIC INSECT; Modenutti Beatriz E., 1998, Lakes Reservoirs Research and Management, V3, P179, DOI 10.1046/j.1440-1770.1998.00071.x; Morales-Baquero R., 1992, Limnetica, V8, P39; Parker SM, 2013, LIMNOL OCEANOGR, V58, P2158, DOI 10.4319/lo.2013.58.6.2158; Pedrazaa J, 2013, QUATERN INT, V302, P88, DOI 10.1016/j.quaint.2012.10.038; PIMM SL, 1980, OIKOS, V35, P139, DOI 10.2307/3544422; Robles Santiago, 2000, International Microbiology, V3, P187; Rodriguez-Lozano P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117630; Romani AM, 2006, ECOLOGY, V87, P2559, DOI 10.1890/0012-9658(2006)87[2559:IOBAFO]2.0.CO;2; Rush SA, 2012, FRESHWATER BIOL, V57, P2342, DOI 10.1111/fwb.12014; Sanchez J., 2008, NACC Bioloxia, V16, P129; Sanchez-Carmona R, 2012, AQUAT ECOL, V46, P311, DOI 10.1007/s10452-012-9400-5; Sanchez-Hernandez J, 2009, CUADERNOS ABULENSES, V38, P197; Sanchez-Hernandez J, 2015, ECOL FRESHW FISH, V24, P148, DOI 10.1111/eff.12139; Sanchez-Lopez G, 2015, CLIMATIC CHANGE, V130, P101, DOI 10.1007/s10584-015-1353-y; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Sheath Robert G., 2003, P197, DOI 10.1016/B978-012741550-5/50006-4; SPRULES WG, 1988, ECOLOGY, V69, P418, DOI 10.2307/1940440; Straskrabova V, 2000, SILVA GABRETA, V4, P199; Straskrabova Viera, 1999, Journal of Limnology, V58, P77; SUTTON MF, 1951, P ZOOL SOC LOND, V121, P465; Tachet H, 2002, INVERTEBRATEBRES EAU; Thioulouse J, 2012, ENVIRON ECOL STAT, V19, P499, DOI 10.1007/s10651-012-0198-z; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Tiberti R, 2011, THESIS; Tiberti R, 2014, J LIMNOL, V73, P593, DOI 10.4081/jlimnol.2014.969; Tiberti R, 2014, HYDROBIOLOGIA, V724, P1, DOI 10.1007/s10750-013-1696-1; TORO M, 1993, PROC INT ASSOC THEOR, V25, P1108; Toro M, 2001, MONOGRAFIAS RED ESPA; Toro Manuel, 2006, Limnetica, V25, P217; Tronstad LM, 2010, T AM FISH SOC, V139, P1536, DOI 10.1577/T09-151.1; VADAS RL, 1990, ENVIRON BIOL FISH, V27, P285, DOI 10.1007/BF00002747; Vadeboncoeur Y, 2002, BIOSCIENCE, V52, P44, DOI 10.1641/0006-3568(2002)052[0044:PTLBTR]2.0.CO;2; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Williams RJ, 2004, AM NAT, V163, P458, DOI 10.1086/381964; Williams RJ, 2010, NETWORK3D COMPUTER P	86	21	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143016	10.1371/journal.pone.0143016	http://dx.doi.org/10.1371/journal.pone.0143016			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571235	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700119
J	Wang, MX; Zhang, KH; Zhang, JL; Dong, GH; Zhang, H; Du, XX				Wang, Mengxing; Zhang, Kaihua; Zhang, Jilei; Dong, Guangheng; Zhang, Hui; Du, Xiaoxia			Abnormal Neural Responses to Emotional Stimuli but Not Go/NoGo and Stroop Tasks in Adults with a History of Childhood Nocturnal Enuresis	PLOS ONE			English	Article							ANXIETY DISORDER; CHILDREN; FMRI; SUPPRESSION; INHIBITION; POTENTIALS; ACTIVATION; DEPRESSION	Background Nocturnal enuresis (NE) is a common disorder in school-aged children. Previous studies have reported that children with NE exhibit structural, functional and neurochemical abnormalities in the brain, suggesting that children with NE may have cognitive problems. Additionally, children with NE have been shown to process emotions differently from control children. In fact, most cases of NE resolve with age. However, adults who had experienced NE during childhood may still have potential cognitive or emotion problems, and this possibility has not been thoroughly investigated. Methodology/Principal Findings In this work, we used functional magnetic resonance imaging (fMRI) to evaluate brain functional changes in adults with a history of NE. Two groups, consisting of 21 adults with NE and 21 healthy controls, were scanned using fMRI. We did not observe a significant abnormality in activation during the Go/NoGo and Stroop tasks in adults with a history of NE compared with the control group. However, compared to healthy subjects, young adults with a history of NE mainly showed increased activation in the bilateral temporoparietal junctions, bilateral dorsolateral prefrontal cortex, and bilateral anterior cingulate cortex while looking at negative vs. neutral pictures. Conclusions/Significance Our results demonstrate that adults with a history of childhood NE have no obvious deficit in response inhibition or cognitive control but showed abnormal neural responses to emotional stimuli.	[Wang, Mengxing; Zhang, Kaihua; Zhang, Jilei; Zhang, Hui; Du, Xiaoxia] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Wang, Mengxing; Zhang, Kaihua; Zhang, Jilei; Zhang, Hui; Du, Xiaoxia] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China; [Dong, Guangheng] Zhejiang Normal Univ, Dept Psychol, Jinhua City, Zhejiang, Peoples R China	East China Normal University; East China Normal University; Zhejiang Normal University	Du, XX (corresponding author), E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.	merryxiaoxia@163.com		Du, Xiaoxia/0000-0001-8470-7852	Natural Science Foundation of China [81201082, 81571658]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (No. 81201082 and 81571658) (http://www.nsfc.gov.cn/) to XD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Merhi B, 2014, CLIN MED INSIGHTS-PE, V8, P5, DOI [10.4137/CMPed.s13068, 10.4137/CMPed.S13068]; Aljefri Hasan Mohamed, 2013, Saudi J Kidney Dis Transpl, V24, P1233, DOI 10.4103/1319-2442.121312; [白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Bradley MM, 1994, MEASURING EMOTION SE; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; DiBianco John Michael, 2014, Avicenna J Med, V4, P77, DOI 10.4103/2231-0770.140641; Dong GH, 2013, BIOL PSYCHOL, V94, P282, DOI 10.1016/j.biopsycho.2013.07.009; Equit M, 2014, ACTA PAEDIATR, V103, P868, DOI 10.1111/apa.12676; Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P921, DOI 10.2147/NDT.S46772; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Freitag CM, 2006, DEV MED CHILD NEUROL, V48, P278, DOI 10.1017/S0012162206000600; Gaebler M, 2014, J PSYCHIATR NEUROSCI, V39, P249, DOI 10.1503/jpn.130080; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Igelstrom KM, 2015, J NEUROSCI, V35, P9432, DOI 10.1523/JNEUROSCI.0551-15.2015; Iscan A, 2002, BRAIN DEV-JPN, V24, P681, DOI 10.1016/S0387-7604(02)00077-3; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Karlidag R, 2004, NEUROUROL URODYNAM, V23, P237, DOI 10.1002/nau.20031; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Koenigs M, 2008, J NEUROSCI, V28, P12341, DOI 10.1523/JNEUROSCI.2324-08.2008; Lei D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/463708; Lei D, 2012, HUM BRAIN MAPP, V33, P2913, DOI 10.1002/hbm.21411; Lei D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031023; Lei D, 2012, NEUROUROL URODYNAM, V31, P99, DOI 10.1002/nau.21205; MARK SD, 1995, BRIT J UROL, V75, P427, DOI 10.1111/j.1464-410X.1995.tb07259.x; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mochcoyitch MD, 2014, J AFFECT DISORDERS, V167, P336, DOI 10.1016/j.jad.2014.06.041; Murakami H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128005; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; Neveus T, 2009, CURR OPIN PEDIATR, V21, P199, DOI 10.1097/MOP.0b013e3283229b12; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Okon-Singer H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00058; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Qiao Y, 2012, EUR CHILD ADOLES PSY, V21, P193, DOI 10.1007/s00787-012-0252-2; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Steele VR, 2013, BEHAV BRAIN RES, V256, P529, DOI 10.1016/j.bbr.2013.06.001; Theunis M, 2002, EUR UROL, V41, P660, DOI 10.1016/S0302-2838(02)00127-6; Toros F, 2003, SCAND J UROL NEPHROL, V37, P471, DOI 10.1080/00365590310014544; Ucer O, 2014, WORLD J UROL, V32, P239, DOI 10.1007/s00345-013-1193-1; Yazici CM, 2012, CAN J UROL, V19, P6383; Zhang J, 2014, NEUROCHEM RES, V39, P1355, DOI 10.1007/s11064-014-1320-4; Zhang K, 2015, PEDIAT RES	42	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142957	10.1371/journal.pone.0142957	http://dx.doi.org/10.1371/journal.pone.0142957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571500	Green Submitted, gold, Green Published			2022-12-26	WOS:000365070700103
J	Zhang, AJ; Ning, B; Sun, NZ; Wei, JL; Ju, XL				Zhang, Aijun; Ning, Bin; Sun, Nianzheng; Wei, Jianlu; Ju, Xiuli			Indirubin Increases CD4(+)CD25(+)Foxp3(+) Regulatory T Cells to Prevent Immune Thrombocytopenia in Mice	PLOS ONE			English	Article							CHINESE ANTILEUKEMIA MEDICINE; PURPURA; DERIVATIVES; MODEL; INDUCTION; ITP	Indirubin, a traditional Chinese medicine, is used to treat autoimmune diseases in clinics. However, the effects of indirubin on the immunosuppressive CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) have not been addressed. Thus, we aimed to investigate the effects of indirubin on CD4(+)CD25(+)Treg cells in immune thrombocytopenia (ITP) CBA mice, which were established by immunization with Wistar rat platelets. 50 mg/kg indirubin treatment daily for 4 weeks significantly decreased anti-platelet antibody production and prevented the decrease of platelets caused by immunization in ITP mice. Consistently, indirubin significantly enhanced the percentage and cell number of CD4(+)CD25(+)Foxp3(+)Treg cells in the peripheral blood, spleen and lymph nodes. We also observed a significant increase of the frequency and cell number of CD4(+)CD25(+)Foxp3(+)Treg cells in the thymus upon indirubin treatment. Furthermore, CD4(+)CD25(+)Treg cells from indirubin-treated mice showed similar immunosuppression on T effector cells as compared to those from control mice. Altogether, indirubin ameliorates ITP by enhancing CD4(+)CD25(+)Foxp3(+)Treg cell level with preserving immunosuppressive function.	[Zhang, Aijun; Sun, Nianzheng; Ju, Xiuli] Shandong Univ, Dept Pediat, Qilu Hosp, Jinan 250100, Peoples R China; [Ning, Bin; Wei, Jianlu] Shandong Univ, Jinan Cent Hosp, Dept Orthopaed, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Ju, XL (corresponding author), Shandong Univ, Dept Pediat, Qilu Hosp, Jinan 250100, Peoples R China.	psyga@163.com			National Natural Science Foundation of China [30801258, 81401014]; China Postdoctoral Science Foundation [2013T6675, 2012M511036]; National Natural Science Foundation of Shandong Province [ZR2014HM093, BS2013YY049]; Star of Jinan Youth Science and Technology Project [20100114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of Shandong Province; Star of Jinan Youth Science and Technology Project	This work was supported by grants from National Natural Science Foundation of China (30801258, 81401014), China Postdoctoral Science Foundation (2013T6675, 2012M511036), National Natural Science Foundation of Shandong Province (ZR2014HM093, BS2013YY049), the Star of Jinan Youth Science and Technology Project (20100114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Rosa F, 2000, BLOOD, V96, P2834, DOI 10.1182/blood.V96.8.2834.h8002834_2834_2840; Boruchov DM, 2007, BLOOD, V110, P3526, DOI 10.1182/blood-2007-01-065763; Chen H, 2013, FASEB J, V27, P3979, DOI 10.1096/fj.13-235408; Cines DB, 2009, BLOOD, V113, P6511, DOI 10.1182/blood-2009-01-129155; Ding Y, 2010, NEUROBIOL DIS, V39, P156, DOI 10.1016/j.nbd.2010.03.022; Heredia A, 2005, AIDS, V19, P2087, DOI 10.1097/01.aids.0000194805.74293.11; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; Hu XL, 2012, CELL MOL IMMUNOL, V9, P464, DOI 10.1038/cmi.2012.47; Jin D, 2012, INFLAMM RES, V61, P53, DOI 10.1007/s00011-011-0388-4; Kim SA, 2007, CLIN CANCER RES, V13, P253, DOI 10.1158/1078-0432.CCR-06-1154; Ma M Z, 1983, J Tradit Chin Med, V3, P245; McMillan R, 2007, SEMIN HEMATOL, V44, pS3, DOI 10.1053/j.seminhematol.2007.11.002; Moon MJ, 2006, BIOORGAN MED CHEM, V14, P237, DOI 10.1016/j.bmc.2005.08.008; Musaji A, 2004, EXP HEMATOL, V32, P87, DOI 10.1016/j.exphem.2003.09.024; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Ning B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131152; Qu YY, 2007, TRANSPL IMMUNOL, V17, P153, DOI 10.1016/j.trim.2007.01.002; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakakura M, 2007, THROMB RES, V120, P187, DOI 10.1016/j.thromres.2006.09.008; Sanchez-Fueyo A, 2006, J IMMUNOL, V176, P329, DOI 10.4049/jimmunol.176.1.329; Stasi R, 2012, SEMIN THROMB HEMOST, V38, P454, DOI 10.1055/s-0032-1305780; Sun Z, 2006, AM J TRANSPLANT, V6, P2841, DOI 10.1111/j.1600-6143.2006.01549.x; Wang HJ, 2006, TRANSPLANTATION, V82, P1484, DOI 10.1097/01.tp.0000246312.89689.17; Wu TT, 2012, TRANSPL IMMUNOL, V27, P30, DOI 10.1016/j.trim.2012.05.001; Yi HF, 2008, TRANSPL IMMUNOL, V19, P37, DOI 10.1016/j.trim.2007.12.001; Yu J, 2008, BLOOD, V112, P1325, DOI 10.1182/blood-2008-01-135335; Zhen Y, 2012, CELL MOL IMMUNOL, V9, P75, DOI 10.1038/cmi.2011.37; Zheng QH, 2009, J MOL MED, V87, P1191, DOI 10.1007/s00109-009-0530-8	28	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142634	10.1371/journal.pone.0142634	http://dx.doi.org/10.1371/journal.pone.0142634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571298	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700054
J	Yang, Z; Hong, LK; Follett, J; Wabitsch, M; Hamilton, NA; Collins, BM; Bugarcic, A; Teasdale, RD				Yang, Zhe; Hong, Lee Kian; Follett, Jordan; Wabitsch, Martin; Hamilton, Nicholas A.; Collins, Brett M.; Bugarcic, Andrea; Teasdale, Rohan D.			Functional characterization of retromer in GLUT4 storage vesicle formation and adipocyte differentiation	FASEB JOURNAL			English	Article						adipogenesis; endosome; plasma membrane; protein trafficking	INSULIN-RECEPTOR SUBSTRATE-1; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; ADIPOSE DIFFERENTIATION; GLUCOSE TRANSPORTERS; PROTEOMIC ANALYSIS; TRAFFICKING; SORTILIN; CELLS; ASSOCIATION	Insulin-stimulated translocation of glucose transporter 4 (GLUT4) storage vesicles (GSVs), the specialized intracellular compartments within mature adipocytes, to the plasma membrane (PM) is a fundamental cellular process for maintaining glucose homeostasis. Using 2 independent adipocyte cell line models, human primary Simpson-Golabi-Behmel syndrome and mouse 3T3-L1 fibroblast cell lines, we demonstrate that the endosome-associated protein-sorting complex retromer colocalizes with GLUT4 on the GSVs by confocal microscopy in mature adipocytes. By use of both confocal microscopy and differential ultracentrifugation techniques, retromer is redistributed to the PM of mature adipocytes upon insulin stimulation. Furthermore, stable knockdown of the retromer subunit-vacuolar protein-sorting 35, or the retromer-associated protein sorting nexin 27, by lentivirus-delivered small hairpin RNA impaired the adipogenesis process when compared to nonsilence control. The knockdown of retromer decreased peroxisome proliferator activated receptor gamma expression during differentiation, generating adipocytes with decreased levels of GSVs, lipid droplet accumulation, and insulin-stimulated glucose uptake. In conclusion, our study demonstrates a role for retromer in the GSV formation and adipogenesis.	[Yang, Zhe; Hong, Lee Kian; Follett, Jordan; Hamilton, Nicholas A.; Collins, Brett M.; Bugarcic, Andrea; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Wabitsch, Martin] Univ Ulm, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany	University of Queensland; Ulm University	Teasdale, RD (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	r.teasdale@uq.edu.au	Teasdale, Rohan D/B-2538-2009; Hamilton, Nicholas A/A-6033-2010; Teasdale, Rohan/AAD-6698-2019; Yang, Zhe/O-3489-2019; Bugarcic, Andrea/AAN-8952-2021; Collins, Brett/J-1563-2014	Teasdale, Rohan D/0000-0001-7455-5269; Hamilton, Nicholas A/0000-0003-0331-3427; Teasdale, Rohan/0000-0001-7455-5269; Yang, Zhe/0000-0002-7987-0855; Collins, Brett/0000-0002-6070-3774; Bugarcic, Andrea/0000-0003-2525-2450	National Health and Medical Research Council of Australia [606788, 1042082]; Australian Research Council Grant [DP120103930]; National Health and Medical Research Council Senior Research Fellowship [APP1041929]; National Health and Medical Research Council Career Development Fellowship [APP1061574]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Grant(Australian Research Council); National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Professors D. James (The University of Sydney, Sydney, NSW, Australia) and J. Whitehead (Mater Research, South Brisbane, QLD, Australia) for supplying reagents and technical advice. This work was supported by National Health and Medical Research Council of Australia Grants 606788 and 1042082 and Australian Research Council Grant DP120103930. R.D.T. is supported by National Health and Medical Research Council Senior Research Fellowship APP1041929, and B.M.C. is supported by National Health and Medical Research Council Career Development Fellowship APP1061574. Microscopy was carried out at the Australian Cancer Research Foundation/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology (Sydney, NSW, Australia). The authors declare no conflicts of interest.	Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bridges D, 2012, CURR TOP MICROBIOL, V362, P61, DOI 10.1007/978-94-007-5025-8_3; Bugarcic A, 2011, TRAFFIC, V12, P1759, DOI 10.1111/j.1600-0854.2011.01284.x; Canuel M, 2008, BIOCHEM BIOPH RES CO, V366, P724, DOI 10.1016/j.bbrc.2007.12.015; Chen Y, 2009, BIOCHEM J, V422, P229, DOI 10.1042/BJ20090624; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Fazakerley DJ, 2015, J BIOL CHEM, V290, P23528, DOI 10.1074/jbc.M115.657361; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Ghai R, 2015, J CELL SCI, V128, P553, DOI 10.1242/jcs.158204; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; Kim JH, 2005, TOXICOL SCI, V85, P585, DOI 10.1093/toxsci/kfi118; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Langhorst Matthias F., 2009, Biotechnology Journal, V4, P858, DOI 10.1002/biot.200900025; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; Menendez JA, 2009, CLIN CHEM, V55, P425, DOI 10.1373/clinchem.2008.115352; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Newell FS, 2006, FASEB J, V20, P2615, DOI 10.1096/fj.05-5710fje; Ngo S, 2009, MOL CELL ENDOCRINOL, V302, P33, DOI 10.1016/j.mce.2008.10.020; Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Prior MJ, 2011, J PROTEOME RES, V10, P4970, DOI 10.1021/pr200446r; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Ralston E, 1996, J CELL SCI, V109, P2967; Rincon E, 2011, J CELL SCI, V124, P776, DOI 10.1242/jcs.072447; Roccisana J, 2013, MOL BIOL CELL, V24, P2389, DOI 10.1091/mbc.E13-01-0011; Ross SA, 1997, BIOCHEM BIOPH RES CO, V239, P247, DOI 10.1006/bbrc.1997.7459; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Spiegelman B M, 1997, Eur J Med Res, V2, P457; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Thomas EC, 2006, INT J BIOCHEM CELL B, V38, P1686, DOI 10.1016/j.biocel.2006.03.009; Tiller G, 2011, INT J OBESITY, V35, P208, DOI 10.1038/ijo.2010.126; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; VOLDSTEDLUND M, 1995, EUR J ENDOCRINOL, V133, P626, DOI 10.1530/eje.0.1330626; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	64	20	20	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1037	1050		10.1096/fj.15-274704	http://dx.doi.org/10.1096/fj.15-274704			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26581601				2022-12-26	WOS:000370387800004
J	Bloemink, MJ; Melkani, GC; Bernstein, SI; Geeves, MA				Bloemink, Marieke J.; Melkani, Girish C.; Bernstein, Sanford I.; Geeves, Michael A.			The Relay/Converter Interface Influences Hydrolysis of ATP by Skeletal Muscle Myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL; CONFORMATIONAL STATES; MICROGRAM QUANTITIES; KINETIC-ANALYSIS; MOLECULAR MOTOR; RECOVERY STROKE; DROSOPHILA; RELAY; ACTOMYOSIN; DOMAINS	The interface between relay and converter domain of muscle myosin is critical for optimal myosin performance. Using Drosophila melanogaster indirect flight muscle S1, we performed a kinetic analysis of the effect of mutations in the converter and relay domain. Introduction of a mutation (R759E) in the converter domain inhibits the steady-state ATPase of myosin S1, whereas an additional mutation in the relay domain (N509K) is able to restore the ATPase toward wild-type values. The R759E S1 construct showed little effect on most steps of the actomyosin ATPase cycle. The exception was a 25-30% reduction in the rate constant of the hydrolysis step, the step coupled to the cross-bridge recovery stroke that involves a change in conformation at the relay/converter domain interface. Significantly, the double mutant restored the hydrolysis step to values similar to the wildtype myosin. Modeling the relay/converter interface suggests a possible interaction between converter residue 759 and relay residue 509 in the actin-detached conformation, which is lost in R759E but is restored in N509K/R759E. This detailed kinetic analysis of Drosophila myosin carrying the R759E mutation shows that the interface between the relay loop and converter domain is important for fine-tuning myosin kinetics, in particular ATP binding and hydrolysis.	[Bloemink, Marieke J.; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Melkani, Girish C.; Bernstein, Sanford I.] San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA; [Melkani, Girish C.; Bernstein, Sanford I.] San Diego State Univ, SDSU Heart Inst, San Diego, CA 92182 USA; [Bloemink, Marieke J.] Canterbury Christ Church Univ, Sch Human & Life Sci, Biomol Res Grp, Canterbury CT1 1QU, Kent, England	University of Kent; California State University System; San Diego State University; California State University System; San Diego State University; Canterbury Christ Church University	Geeves, MA (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.; Bernstein, SI (corresponding author), San Diego State Univ, Dept Biol, Inst Mol Biol, San Diego, CA 92182 USA.; Bernstein, SI (corresponding author), San Diego State Univ, SDSU Heart Inst, San Diego, CA 92182 USA.	sbernstein@mail.sdsu.edu; m.a.geeves@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Melkani, Girish/0000-0003-0353-4633; Bloemink, Marieke Johanna/0000-0001-9441-2783; Bernstein, Sanford/0000-0001-7094-5390	National Institutes of Health [GM32443]; Wellcome Trust [085309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM32443 (to S. I. B.) and Wellcome Trust Grant 085309 (to M. A. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; Baumann BAJ, 2012, J MOL BIOL, V415, P274, DOI 10.1016/j.jmb.2011.10.047; Bernstein SI, 1997, J MOL BIOL, V271, P1, DOI 10.1006/jmbi.1997.1160; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; Bloemink MJ, 2011, J BIOL CHEM, V286, P28435, DOI 10.1074/jbc.M111.258228; Clark RJ, 2003, J MUSCLE RES CELL M, V24, P315; Geeves MA, 2005, CELL MOL LIFE SCI, V62, P1462, DOI 10.1007/s00018-005-5015-5; Greenberg MJ, 2015, P NATL ACAD SCI USA, V112, pE3337, DOI 10.1073/pnas.1506633112; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Koppole S, 2007, STRUCTURE, V15, P825, DOI 10.1016/j.str.2007.06.008; Kronert WA, 2008, J MOL BIOL, V379, P443, DOI 10.1016/j.jmb.2008.04.010; Kronert WA, 2014, J BIOL CHEM, V289, P12779, DOI 10.1074/jbc.M114.550673; Kronert WA, 2010, J MOL BIOL, V398, P625, DOI 10.1016/j.jmb.2010.03.049; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Malnasi-Csizmadia A, 2007, J BIOL CHEM, V282, P17658, DOI 10.1074/jbc.M701447200; Miller BM, 2003, J BIOL CHEM, V278, P50293, DOI 10.1074/jbc.M308318200; O'Connell CB, 2007, BBA-MOL CELL RES, V1773, P615, DOI 10.1016/j.bbamcr.2006.06.012; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Ramanath S, 2011, BIOPHYS J, V101, P1114, DOI 10.1016/j.bpj.2011.07.045; Reggiani C, 2000, NEWS PHYSIOL SCI, V15, P26; Sasaki N, 2003, BIOCHEMISTRY-US, V42, P90, DOI 10.1021/bi026051l; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shih WM, 2001, J BIOL CHEM, V276, P19491, DOI 10.1074/jbc.M010887200; Shuman H, 2014, P NATL ACAD SCI USA, V111, P2116, DOI 10.1073/pnas.1321022111; Silva R, 2003, J MUSCLE RES CELL M, V24, P489, DOI 10.1023/B:JURE.0000009809.69829.74; Swank DM, 2000, MICROSC RES TECHNIQ, V50, P430, DOI 10.1002/1097-0029(20000915)50:6<430::AID-JEMT2>3.0.CO;2-E; Swank DM, 2002, NAT CELL BIOL, V4, P312, DOI 10.1038/ncb776; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Webb MR, 2001, BIOPHYS J, V81, P1562, DOI 10.1016/S0006-3495(01)75810-9; Weiss S, 2000, J MUSCLE RES CELL M, V21, P423, DOI 10.1023/A:1005690106951; Yang CX, 2008, BIOPHYS J, V95, P5228, DOI 10.1529/biophysj.108.136192	36	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1763	1773		10.1074/jbc.M115.688002	http://dx.doi.org/10.1074/jbc.M115.688002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26586917	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000368620700018
J	Verma, N; Manna, SK				Verma, Neeharika; Manna, Sunil K.			Advanced Glycation End Products (AGE) Potently Induce Autophagy through Activation of RAF Protein Kinase and Nuclear Factor kappa B (NF-kappa B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; DIABETIC-PATIENTS; CELLS; PATHWAY; DEGRADATION; LIPOGENESIS; APOPTOSIS; ERK; METHYLGLYOXAL; TRANSCRIPTION	Advanced glycation end products (AGE) accumulate in diabetic patients and aging people because of high amounts of three- or four-carbon sugars derived from glucose, thereby causing multiple consequences, including inflammation, apoptosis, obesity, and age-related disorders. It is important to understand the mechanism of AGE-mediated signaling leading to the activation of autophagy (self-eating) that might result in obesity. We detected AGE as one of the potent inducers of autophagy compared with doxorubicin and TNF. AGE-mediated autophagy is inhibited by suppression of PI3K and potentiated by the autophagosome maturation blocker bafilomycin. It increases autophagy in different cell types, and that correlates with the expression of its receptor, receptor for AGE. LC3B, the marker for autophagosomes, is shown to increase upon AGE stimulation. AGE-mediated autophagy is partially suppressed by inhibitor of NF-kappa B, PKC, or ERK alone and significantly in combination. AGE increases sterol regulatory element binding protein activity, which leads to an increase in lipogenesis. Although AGE-mediated lipogenesis is affected by autophagy inhibitors, AGE-mediated autophagy is not influenced by lipogenesis inhibitors, suggesting that the turnover of lipid droplets overcomes the autophagic clearance. For the first time, we provide data showing that AGE induces several cell signaling cascades, like NF-kappa B, PKC, ERK, and MAPK, that are involved in autophagy and simultaneously help with the accumulation of lipid droplets that are not cleared effectively by autophagy, therefore causing obesity.	[Verma, Neeharika; Manna, Sunil K.] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India; [Verma, Neeharika] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Immunol, Hyderabad 500001, Andhra Pradesh, India.	manna@cdfd.org.in	Verma, Neeharika/AAY-9171-2021	verma, neeharika/0000-0003-2086-6795	Centre for DNA Fingerprinting and Diagnostics and fellowship from the University Grant Commission, Government of India	Centre for DNA Fingerprinting and Diagnostics and fellowship from the University Grant Commission, Government of India	This work was supported by a core grant from the Centre for DNA Fingerprinting and Diagnostics and fellowship from the University Grant Commission, Government of India (to N.V.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JH, 2013, BIOMOL THER, V21, P114, DOI 10.4062/biomolther.2013.012; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Cachefo A, 2003, J LIPID RES, V44, P1349, DOI 10.1194/jlr.M300030-JLR200; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Cui Q, 2007, J PHARMACOL SCI, V105, P317, DOI 10.1254/jphs.FP0070336; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Dimitrakis P, 2012, CELL TISSUE RES, V350, P361, DOI 10.1007/s00441-012-1475-8; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kaini RR, 2012, PROSTATE, V72, P1412, DOI 10.1002/pros.22489; Khuhawar MY, 2006, ANAL LETT, V39, P2205, DOI 10.1080/00032710600754093; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kotzka J, 2004, J BIOL CHEM, V279, P22404, DOI 10.1074/jbc.M401198200; Lapolla A, 2003, CLIN CHEM LAB MED, V41, P1166, DOI 10.1515/CCLM.2003.180; Lappas M, 2007, J ENDOCRINOL, V193, P269, DOI 10.1677/JOE-06-0081; Ma TA, 2013, EXP CELL RES, V319, P779, DOI 10.1016/j.yexcr.2013.01.018; Mahali S, 2011, J BIOL CHEM, V286, P34903, DOI 10.1074/jbc.M111.279190; Mahali SK, 2014, J CELL PHYSIOL, V229, P1972, DOI 10.1002/jcp.24647; Mahali SK, 2012, BIOCHEM PHARMACOL, V84, P1681, DOI 10.1016/j.bcp.2012.09.033; Manna SK, 2010, J BIOL CHEM, V285, P11617, DOI 10.1074/jbc.M109.094961; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Odani H, 1999, BIOCHEM BIOPH RES CO, V256, P89, DOI 10.1006/bbrc.1999.0221; Rubenstein David A, 2011, J Diabetes Sci Technol, V5, P703; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Skop V, 2012, PHYSIOL RES, V61, P287, DOI 10.33549/physiolres.932285; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yamagishi Sho-ichi, 2006, Curr Drug Discov Technol, V3, P83, DOI 10.2174/157016306776637555; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	38	32	33	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1481	1491		10.1074/jbc.M115.667576	http://dx.doi.org/10.1074/jbc.M115.667576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26586913	Green Published, hybrid			2022-12-26	WOS:000368068300038
J	Dauletbaev, N; Das, M; Cammisano, M; Chen, H; Singh, S; Kooi, C; Leigh, R; Beaudoin, T; Rousseau, S; Lands, LC				Dauletbaev, Nurlan; Das, Mithun; Cammisano, Maria; Chen, He; Singh, Sareen; Kooi, Cora; Leigh, Richard; Beaudoin, Trevor; Rousseau, Simon; Lands, Larry C.			Rhinovirus Load Is High despite Preserved Interferon-beta Response in Cystic Fibrosis Bronchial Epithelial Cells	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; PSEUDOMONAS-AERUGINOSA; RESPIRATORY VIRUSES; CYTOKINE PRODUCTION; VIRAL REPLICATION; AIRWAY EPITHELIUM; DOWN-REGULATION; HELA-CELLS; IFN-BETA; INFECTION	Lung disease in cystic fibrosis (CF) is often exacerbated following acute upper respiratory tract infections caused by the human rhinovirus (HRV). Pathophysiology of these exacerbations is presently unclear and may involve deficient innate antiviral or exaggerated inflammatory responses in CF airway epithelial cells. Furthermore, responses of CF cells to HRV may be adversely affected by pre-exposure to virulence factors of Pseudomonas (P.) aeruginosa, the microorganism that frequently colonizes CF airways. Here we examined production of antiviral cytokine interferon-beta and inflammatory chemokine interleukin-8, expression of the interferon-responsive antiviral gene 2'-5'-oligoadenylate synthetase 1 (OAS1), and intracellular virus RNA load in primary CF (delF508 CFTR) and healthy airway epithelial cells following inoculation with HRV16. Parallel cells were exposed to virulence factors of P. aeruginosa prior to and during HRV16 inoculation. CF cells exhibited production of interferon-beta and interleukin-8, and expression of OAS1 at levels comparable to those in healthy cells, yet significantly higher HRV16 RNA load during early hours post-inoculation with HRV16. In line with this, HRV16 RNA load was higher in the CFBE41o-dF cell line overexpessing delF508 CFTR, compared with the isogenic control CFBE41o-WT (wildtype CFTR). Pre-exposure to virulence factors of P. aeruginosa did not affect OAS1 expression or HRV16 RNA load, but potentiated interleukin-8 production. In conclusion, CF cells demonstrate elevated HRV RNA load despite preserved interferon-beta and OAS1 responses. High HRV load in CF airway epithelial cells appears to be due to deficiencies manifesting early during HRV infection, and may not be related to interferon-beta.	[Dauletbaev, Nurlan; Das, Mithun; Cammisano, Maria; Chen, He; Singh, Sareen; Lands, Larry C.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Kooi, Cora; Leigh, Richard] Univ Calgary, Dept Med & Physiol & Pharmacol, Calgary, AB, Canada; [Beaudoin, Trevor; Rousseau, Simon] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada; [Lands, Larry C.] Montreal Childrens Hosp, Div Resp, Montreal, PQ H3H 1P3, Canada	McGill University; University of Calgary; McGill University; McGill University	Dauletbaev, N (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada.	nurlan.dauletbaev@mail.mcgill.ca		Das, Mithun/0000-0002-6752-9633; Rousseau, Simon/0000-0002-8773-575X	Cystic Fibrosis Canada; Krieble Foundation	Cystic Fibrosis Canada; Krieble Foundation	The funders of the authors' study were Cystic Fibrosis Canada and Krieble Foundation (recipient for both: Larry Lands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amineva SP, 2011, J GEN VIROL, V92, P2549, DOI 10.1099/vir.0.031302-0; ARRUDA E, 1995, J INFECT DIS, V171, P1329, DOI 10.1093/infdis/171.5.1329; Bai JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118286; BARDIN PG, 1994, AM J RESP CELL MOL, V10, P207, DOI 10.1165/ajrcmb.10.2.8110476; Becker TM, 2013, ANN ALLERG ASTHMA IM, V111, P397, DOI 10.1016/j.anai.2013.07.029; Berube J, 2010, J BIOL CHEM, V285, P22299, DOI 10.1074/jbc.M109.098566; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Burns JL, 2012, INFLUENZA OTHER RESP, V6, P218, DOI 10.1111/j.1750-2659.2011.00292.x; Chattoraj SS, 2011, INFECT IMMUN, V79, P4131, DOI 10.1128/IAI.05120-11; Dauletbaev N, 2015, BRIT J PHARMACOL, V172, P4757, DOI 10.1111/bph.13249; Dauletbaev N, 2015, J IMMUNOL, V195, P2829, DOI 10.4049/jimmunol.1400840; Dauletbaev N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.205724; Dauletbaev N, 2010, RESPIRATION, V79, P234, DOI 10.1159/000255342; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Djukanovic R, 2014, AM J RESP CRIT CARE, V190, P145, DOI 10.1164/rccm.201312-2235OC; Esposito S, 2014, JPN J INFECT DIS, V67, P399, DOI 10.7883/yoken.67.399; Flight WG, 2014, THORAX, V69, P247, DOI 10.1136/thoraxjnl-2013-204000; Goffard A, 2014, J CLIN VIROL, V60, P147, DOI 10.1016/j.jcv.2014.02.005; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; HAFF RF, 1966, J BACTERIOL, V91, P2339, DOI 10.1128/JB.91.6.2339-2342.1966; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Kelly C, 2013, AM J PHYSIOL-LUNG C, V304, pL371, DOI 10.1152/ajplung.00372.2011; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Kieninger E, 2013, CHEST, V143, P782, DOI 10.1378/chest.12-0954; LONBERGHOLM K, 1972, J VIROL, V9, P29, DOI 10.1128/JVI.9.1.29-40.1972; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Mosser AG, 2002, J INFECT DIS, V185, P734, DOI 10.1086/339339; Nakagome K, 2014, J ALLERGY CLIN IMMUN, V134, P332, DOI 10.1016/j.jaci.2014.01.029; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; PONOMARIEVA TI, 1972, ARCH GES VIRUSFORSCH, V39, P92, DOI 10.1007/BF01241532; Roussel L, 2011, J CYST FIBROS, V10, P107, DOI 10.1016/j.jcf.2010.11.005; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Schogler A, 2015, EUR RESPIR J, V45, P428, DOI 10.1183/09031936.00102014; Shabram P, 2000, MOL THER, V2, P420, DOI 10.1006/mthe.2000.0212; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; STOTT EJ, 1970, J GEN VIROL, V6, P15, DOI 10.1099/0022-1317-6-1-15; Sutanto EN, 2011, AM J RESP CELL MOL, V44, P761, DOI 10.1165/rcmb.2010-0368OC; TOMASSINI JE, 1989, P NATL ACAD SCI USA, V86, P4907, DOI 10.1073/pnas.86.13.4907; WINTHER B, 1986, JAMA-J AM MED ASSOC, V256, P1763, DOI 10.1001/jama.256.13.1763; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Wu Q, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-26; Zhang SY, 2007, IMMUNOL REV, V220, P225, DOI 10.1111/j.1600-065X.2007.00564.x	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143129	10.1371/journal.pone.0143129	http://dx.doi.org/10.1371/journal.pone.0143129			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599098	gold, Green Submitted, Green Published			2022-12-26	WOS:000365853900068
J	Slocum, C; Gerrard, P; Black-Schaffer, R; Goldstein, R; Singhal, A; DiVita, MA; Ryan, CM; Mix, J; Purohit, M; Niewczyk, P; Kazis, L; Zafonte, R; Schneider, JC				Slocum, Chloe; Gerrard, Paul; Black-Schaffer, Randie; Goldstein, Richard; Singhal, Aneesh; DiVita, Margaret A.; Ryan, Colleen M.; Mix, Jacqueline; Purohit, Maulik; Niewczyk, Paulette; Kazis, Lewis; Zafonte, Ross; Schneider, Jeffrey C.			Functional Status Predicts Acute Care Readmissions from Inpatient Rehabilitation in the Stroke Population	PLOS ONE			English	Article							HOSPITAL READMISSIONS; PERFORMANCE; COMPLICATIONS; VALIDATION; DISCHARGE; HEALTH	Objective Acute care readmission risk is an increasingly recognized problem that has garnered significant attention, yet the reasons for acute care readmission in the inpatient rehabilitation population are complex and likely multifactorial. Information on both medical comorbidities and functional status is routinely collected for stroke patients participating in inpatient rehabilitation. We sought to determine whether functional status is a more robust predictor of acute care readmissions in the inpatient rehabilitation stroke population compared with medical comorbidities using a large, administrative data set. Methods A retrospective analysis of data from the Uniform Data System for Medical Rehabilitation from the years 2002 to 2011 was performed examining stroke patients admitted to inpatient rehabilitation facilities. A Basic Model for predicting acute care readmission risk based on age and functional status was compared with models incorporating functional status and medical comorbidities (Basic-Plus) or models including age and medical comorbidities alone (Age-Comorbidity). C-statistics were compared to evaluate model performance. Findings There were a total of 803,124 patients: 88,187 (11%) patients were transferred back to an acute hospital: 22,247 (2.8%) within 3 days, 43,481 (5.4%) within 7 days, and 85,431 (10.6%) within 30 days. The C-statistics for the Basic Model were 0.701, 0.672, and 0.682 at days 3, 7, and 30 respectively. As compared to the Basic Model, the best-performing Basic-Plus model was the Basic+Elixhauser model with C-statistics differences of +0.011, +0.011, and +0.012, and the best-performing Age-Comorbidity model was the Age+Elixhauser model with C-statistic differences of -0.124, -0.098, and -0.098 at days 3, 7, and 30 respectively. Conclusions Readmission models for the inpatient rehabilitation stroke population based on functional status and age showed better predictive ability than models based on medical comorbidities.	[Slocum, Chloe; Gerrard, Paul; Black-Schaffer, Randie; Goldstein, Richard; Zafonte, Ross; Schneider, Jeffrey C.] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02138 USA; [Slocum, Chloe; Gerrard, Paul; Black-Schaffer, Randie; Zafonte, Ross; Schneider, Jeffrey C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Singhal, Aneesh] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [DiVita, Margaret A.; Mix, Jacqueline; Niewczyk, Paulette] Uniform Data Syst Med Rehabil, Amherst, NY USA; [Niewczyk, Paulette] Daemen Coll, Hlth Care Studies Dept, Amherst, NY USA; [Ryan, Colleen M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Sumner Redstone Burn Ctr,Surg Serv, Boston, MA USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Boston, MA USA; [Purohit, Maulik] Ft Belvoir Community Hosp, Natl Intrepid Ctr Excellence, Intrepid Spirit 1, Neurorehabil & Traumat Brain Injury, Ft Belvoir, VA USA; [Kazis, Lewis] Boston Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA	Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University	Schneider, JC (corresponding author), Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02138 USA.	jcschneider@partners.org	Schneider, Jeffrey/AAO-2126-2020; Black-Schaffer, Randie/AAY-4671-2021	Ryan, Colleen/0000-0002-6455-936X; DiVita, Margaret/0000-0002-4878-2959				Bhattacharya P, 2011, J NEUROL SCI, V307, P50, DOI 10.1016/j.jns.2011.05.022; BREZINSKI D, 1991, AM HEART J, V121, P1374, DOI 10.1016/0002-8703(91)90141-4; Brosseau Lucie, 1996, Physiotherapy Theory and Practice, V12, P161, DOI 10.3109/09593989609036432; Burke RE, 2013, JAMA INTERN MED, V173, P695, DOI 10.1001/jamainternmed.2013.171; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari Matteo, 2008, BMC Geriatr, V8, P34, DOI 10.1186/1471-2318-8-34; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chung DM, 2012, AM J PHYS MED REHAB, V91, P387, DOI 10.1097/PHM.0b013e3182aac27; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faulk CE, 2013, PM&R, V5, P757, DOI 10.1016/j.pmrj.2013.06.002; Gerrard P, 2015, AM J MANAG CARE, V21, pE282; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Hamilton BB, 1999, ARCH PHYS MED REHAB, V80, P385, DOI 10.1016/S0003-9993(99)90274-5; Hodgson CL, 2013, CRIT CARE, V17, DOI 10.1186/cc11820; Hoyer EH, 2014, J HOSP MED, V9, P277, DOI 10.1002/jhm.2152; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Lin MF, 2013, INFORM SYST RES, V24, P906, DOI 10.1287/isre.2013.0480; Lo A, 2012, INT J STROKE, V7, P118, DOI 10.1111/j.1747-4949.2011.00694.x; Marks E, 2013, JAMA INTERN MED, V173, P629, DOI 10.1001/jamainternmed.2013.4065; Ohman EM, 2000, JAMA-J AM MED ASSOC, V284, P876, DOI 10.1001/jama.284.7.876; Ottenbacher KJ, 2012, J GERONTOL A-BIOL, V67, P875, DOI 10.1093/gerona/glr247; Pepe MS, 2013, STAT MED, V32, P1467, DOI 10.1002/sim.5727; Roth EJ, 2001, STROKE, V32, P523, DOI 10.1161/01.STR.32.2.523; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneider JC, 2013, PM&R, V5, P114, DOI 10.1016/j.pmrj.2012.07.014; Schneider JC, 2012, J TRAUMA ACUTE CARE, V73, P1596, DOI 10.1097/TA.0b013e318270d73d; Stillman G, 2009, PM&R, V1, P234, DOI 10.1016/j.pmrj.2008.10.014; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P712, DOI 10.1016/S0003-9993(03)04850-5; UB Foundation Activities Inc., 2004, UN DAT SYST MED REH; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	35	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0142180	10.1371/journal.pone.0142180	http://dx.doi.org/10.1371/journal.pone.0142180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599009	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900021
J	Shin, SH; Jung, DH; Kim, JH; Chung, HS; Park, JC; Shin, SK; Lee, SK; Lee, YC				Shin, Seung Hwan; Jung, Da Hyun; Kim, Jie-Hyun; Chung, Hyun Soo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan			Helicobacter pylori Eradication Prevents Metachronous Gastric Neoplasms after Endoscopic Resection of Gastric Dysplasia	PLOS ONE			English	Article							CANCER; SEROPREVALENCE; INFECTION; DIAGNOSIS; KOREA	Purpose There is insufficient data about the role of eradication of H. pylori after endoscopic resection (ER) for gastric dysplasia. The aim was to investigate the benefit of H. pylori eradication after ER in patients with gastric dysplasia to prevent metachronous gastric neoplasms. Materials and Methods We retrospectively reviewed 1872 patients who underwent ER of gastric dysplasia. We excluded patients with a follow-up period of <2 years or who had not undergone tests for active H. pylori infection. A total of 282 patients were enrolled. The patients were categorized into those without active H. pylori infection (H. pylori-negative group, n = 124), those who successfully underwent H. pylori eradication (eradicated group, n = 122), and those who failed or did not undergo H. pylori eradication (persistent group, n = 36). Results Metachronous recurrence was diagnosed in 36 patients, including 19 in the H. pylori-negative group, 10 in the eradicated group, and 7 in the persistent group. The cumulative incidence of metachronous recurrence was significantly lower in the H. pylori-eradicated group in comparison with either of the H. pylori-persistent (non-eradicated or failed) groups (p = 0.039). Similarly, the incidence of metachronous recurrence was significantly lower in the H. pylori-eradicated group compared with the H. pylori-negative group (p = 0.041). Conclusion Successful H. pylori eradication may reduce the development of metachronous gastric neoplasms after ER in patients with gastric dysplasia.	[Shin, Seung Hwan; Jung, Da Hyun; Chung, Hyun Soo; Park, Jun Chul; Shin, Sung Kwan; Lee, Sang Kil; Lee, Yong Chan] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Jie-Hyun] Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, DH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	leah1004@yuhs.ac	Park, Jun Chul/H-7218-2019; Kim, Jie-Hyun/Q-9061-2019	Park, Jun Chul/0000-0001-8018-0010; Kim, Jie-Hyun/0000-0002-9198-3326; Lee, Yong Chan/0000-0001-8800-6906; Chung, Hyunsoo/0000-0001-5159-357X; Shin, Sung Kwan/0000-0001-5466-1400; Lee, Sang Kil/0000-0002-0721-0364; Jung, Da Hyun/0000-0001-6668-3113				[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Bae SE, 2014, AM J GASTROENTEROL, V109, P60, DOI 10.1038/ajg.2013.404; Choi CW, 2014, DIGEST DIS SCI, V59, P421, DOI 10.1007/s10620-013-2874-8; Choi J, 2014, CLIN GASTROENTEROL H, V12, P793, DOI 10.1016/j.cgh.2013.09.057; CORREA P, 1988, CANCER RES, V48, P3554; de Vries AC, 2007, HELICOBACTER, V12, P1, DOI 10.1111/j.1523-5378.2007.00541.x; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Genta RM, 2010, AM J SURG PATHOL, V34, pE25, DOI 10.1097/PAS.0b013e3181e51067; Gutierrez-Gonzalez L, 2011, GASTROENTEROLOGY, V140, P1251, DOI 10.1053/j.gastro.2010.12.051; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kang KJ, 2010, J KOREAN MED ASSOC, V53, P283, DOI 10.5124/jkma.2010.53.4.283; Kato M, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1928-5; Kim SG, 2014, J GASTROEN HEPATOL, V29, P1371, DOI 10.1111/jgh.12607; Kim YJ, 2010, ENDOSCOPY, V42, P620, DOI 10.1055/s-0030-1255524; Kim YI, 2014, HELICOBACTER, V19, P194, DOI 10.1111/hel.12116; Maehata Y, 2012, GASTROINTEST ENDOSC, V75, P39, DOI 10.1016/j.gie.2011.08.030; Nasu J, 2005, ENDOSCOPY, V37, P990, DOI 10.1055/s-2005-870198; Schlansky B, 2011, AM J GASTROENTEROL, V106, P1978, DOI 10.1038/ajg.2011.213; Stolte M, 2003, VIRCHOWS ARCH, V442, P99, DOI 10.1007/s00428-002-0680-3; Sugano K, 2013, J GASTROEN HEPATOL, V28, P906, DOI 10.1111/jgh.12209; Woodward M, 2000, J CLIN EPIDEMIOL, V53, P175, DOI 10.1016/S0895-4356(99)00171-7; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x	24	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143257	10.1371/journal.pone.0143257	http://dx.doi.org/10.1371/journal.pone.0143257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580072	gold, Green Submitted, Green Published			2022-12-26	WOS:000365154600105
J	Suri, AK; Fleysher, R; Lipton, ML				Suri, Asif K.; Fleysher, Roman; Lipton, Michael L.			Subject Based Registration for Individualized Analysis of Diffusion Tensor MRI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ALGORITHMS; FSL; DTI	Registration of subject and control brains to a common anatomical space or template is the basis for quantitatively delineating regions of abnormality in an individual brain. Normally, a brain atlas is chosen as the template. Limitations in the registration process result in persistent differences between individual subject brains and template, which can be a source of error in an analysis. We propose a new approach to the registration process where the subject of interest is the registration template. Through this change, we eliminate errors due to differences between a brain template and a subject's brain. We applied this method to the analysis of FA values derived from DTI data of 20 individual mTBI patients as compared to 48 healthy controls. Subject-centered analysis resulted in identification of significantly fewer regions of abnormally low FA compared to two separate atlas-centered analyses, with subject-centered abnormalities essentially representing the common subset of abnormal low FA regions detected by the two atlas-centered methods. Whereas each atlas-centered approach demonstrated abnormalities in nearly every subject (19/20 and 20/20), the subject-centered approach demonstrated abnormalities in fewer than half the subjects (9/20). This reduction of diffusion abnormalities observed using the subject-centered approach is due to elimination of misregistration errors that occur when registering the subject of interest to a template. Evaluation of atlas-centered analyses demonstrated that 9.8% to 13.3% of subject GM and CSF was misregistered onto the WM of the brain atlas, resulting in the observation of additional low FA clusters compared to the subject-centered approach. Without careful evaluation, these misregistrations could be misinterpreted as pathology. An additional benefit of the subject-centered approach is that diffusion abnormalities can now be visualized directly in the subject's anatomical space, rather than interpolating results from the brain atlas space, and can thereby enhance correlation with other components of an imaging protocol.	[Suri, Asif K.; Fleysher, Roman; Lipton, Michael L.] Albert Einstein Coll Med, Dept Radiol, New York, NY 10010 USA; [Suri, Asif K.] Bronx Psychiat Ctr, Dept Psychiat, New York, NY USA; [Suri, Asif K.; Lipton, Michael L.] Montefiore Med Ctr, Dept Radiol, New York, NY USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, New York, NY USA; [Lipton, Michael L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA	Yeshiva University; Montefiore Medical Center; Yeshiva University; Yeshiva University	Lipton, ML (corresponding author), Albert Einstein Coll Med, Dept Radiol, New York, NY 10010 USA.	Michael.Lipton@einstein.yu.edu			National Institutes of Health; National Institutes of Neurological Disorders and Stroke [R01 NS082432]; Dana Foundation David Mahoney Neuroimaging Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dana Foundation David Mahoney Neuroimaging Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health, National Institutes of Neurological Disorders and Stroke (grant R01 NS082432) and the Dana Foundation David Mahoney Neuroimaging Program.	Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; ARDEKANI BA, 1995, J COMPUT ASSIST TOMO, V19, P615, DOI 10.1097/00004728-199507000-00022; Aubert-Broche B, 2006, NEUROIMAGE, V32, P138, DOI 10.1016/j.neuroimage.2006.03.052; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Naidich TP, 2001, AM J NEURORADIOL, V22, P885; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Sabuncu MR, 2009, LECT NOTES COMPUT SC, V5761, P565, DOI 10.1007/978-3-642-04268-3_70; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yeo BTT, 2008, MED IMAGE ANAL, V12, P603, DOI 10.1016/j.media.2008.06.005	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142288	10.1371/journal.pone.0142288	http://dx.doi.org/10.1371/journal.pone.0142288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580077	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600044
J	Westgate, MJ; Scheele, BC; Ikin, K; Hoefer, AM; Beaty, RM; Evans, M; Osborne, W; Hunter, D; Rayner, L; Driscoll, DA				Westgate, Martin J.; Scheele, Ben C.; Ikin, Karen; Hoefer, Anke Maria; Beaty, R. Matthew; Evans, Murray; Osborne, Will; Hunter, David; Rayner, Laura; Driscoll, Don A.			Citizen Science Program Shows Urban Areas Have Lower Occurrence of Frog Species, but Not Accelerated Declines	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ECOLOGICAL RESEARCH; CONSERVATION; EXTINCTION; LANDSCAPE; BIODIVERSITY; HABITAT; TOOL; CHRONOSEQUENCES; URBANIZATION	Understanding the influence of landscape change on animal populations is critical to inform biodiversity conservation efforts. A particularly important goal is to understand how urban density affects the persistence of animal populations through time, and how these impacts can be mediated by habitat provision; but data on this question are limited for some taxa. Here, we use data from a citizen science monitoring program to investigate the effect of urbanization on patterns of frog species richness and occurrence over 13 years. Sites surrounded by a high proportion of bare ground (a proxy for urbanization) had consistently lower frog occurrence, but we found no evidence that declines were restricted to urban areas. Instead, several frog species showed declines in rural wetlands with low-quality habitat. Our analysis shows that urban wetlands had low but stable species richness; but also that population trajectories are strongly influenced by vegetation provision in both the riparian zone and the wider landscape. Future increases in the extent of urban environments in our study area are likely to negatively impact populations of several frog species. However, existing urban areas are unlikely to lose further frog species in the medium term. We recommend that landscape planning and management focus on the conservation and restoration of rural wetlands to arrest current declines, and the revegetation of urban wetlands to facilitate the re-expansion of urban-sensitive species.	[Westgate, Martin J.; Scheele, Ben C.; Ikin, Karen; Rayner, Laura] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 2601, Australia; [Ikin, Karen; Driscoll, Don A.] Australian Natl Univ, ARC Ctr Excellence Environm Decis, Canberra, ACT 2601, Australia; [Hoefer, Anke Maria] ACT & Reg Frogwatch, Ginninderra Catchment Grp, Canberra, ACT 2615, Australia; [Beaty, R. Matthew] CSIRO Land & Water, Canberra, ACT 2601, Australia; [Evans, Murray] ACT Govt, Environm & Planning Directorate, Canberra, ACT 2601, Australia; [Osborne, Will] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Hunter, David] NSW Off Environm & Heritage, Queanbeyan, NSW 2620, Australia; [Driscoll, Don A.] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Burwood, Vic 3125, Australia	Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Canberra; Office of Environment & Heritage - New South Wales; Deakin University	Westgate, MJ (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, GPO Box 4, Canberra, ACT 2601, Australia.	martin.westgate@anu.edu.au	Ikin, Karen/G-2845-2012; Westgate, Martin/I-1839-2019	Westgate, Martin/0000-0003-0854-2034; Driscoll, Don/0000-0002-1560-5235; Scheele, Benjamin/0000-0001-7284-629X	Ginninderra Catchment Group; ACT Government's Environment and Planning Directorate; Australian Government's 'Caring for Country' scheme; Australian Research Council Centre of Excellence for Environmental Decisions	Ginninderra Catchment Group; ACT Government's Environment and Planning Directorate; Australian Government's 'Caring for Country' scheme(Australian Government); Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council)	ACT Frogwatch and region is supported by the Ginninderra Catchment Group, and has received funding from the ACT Government's Environment and Planning Directorate and the Australian Government's 'Caring for Country' scheme. The Australian Research Council Centre of Excellence for Environmental Decisions funded publication of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Aronson MFJ, 2014, P ROY SOC B, P281; Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Bennett, 2011, REPTILES FROGS AUSTR; BIVAND R., 2014, SPDEP SPATIAL DEPEND; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brand AB, 2010, CONSERV BIOL, V24, P295, DOI 10.1111/j.1523-1739.2009.01301.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cooper CB, 2007, ECOL SOC, V12; Darcovich Kerry, 2008, Australian Zoologist, V34, P236; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Feyisa GL, 2014, LANDSCAPE URBAN PLAN, V123, P87, DOI 10.1016/j.landurbplan.2013.12.008; Ficetola GF, 2004, BIOL CONSERV, V119, P219, DOI 10.1016/j.biocon.2003.11.004; Gagne SA, 2010, ENVIRON CONSERV, V37, P128, DOI 10.1017/S0376892910000421; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Hamer AJ, 2008, BIOL CONSERV, V141, P2432, DOI 10.1016/j.biocon.2008.07.020; Hamer AJ, 2011, ECOL APPL, V21, P378, DOI 10.1890/10-0390.1; Hamer AJ, 2010, AUSTRAL ECOL, V35, P568, DOI 10.1111/j.1442-9993.2009.02068.x; Hazell D, 2001, BIOL CONSERV, V102, P155, DOI 10.1016/S0006-3207(01)00096-9; Heard GW, 2015, ECOL LETT, V18, P853, DOI 10.1111/ele.12463; Hitchings SP, 1997, HEREDITY, V79, P117, DOI 10.1038/hdy.1997.134; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hunter DA, 2010, DIS AQUAT ORGAN, V92, P209, DOI 10.3354/dao02118; Ikin K, 2013, LANDSCAPE ECOL, V28, P45, DOI 10.1007/s10980-012-9811-7; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Jansen A, 2003, BIOL CONSERV, V109, P207, DOI 10.1016/S0006-3207(02)00148-9; Jenkins M, 2003, CONSERV BIOL, V17, P20, DOI 10.1046/j.1523-1739.2003.01719.x; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Kazemi F, 2011, LANDSCAPE URBAN PLAN, V101, P139, DOI 10.1016/j.landurbplan.2011.02.006; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Osborne W, 1990, BOGONG, V11, P4; Osborne W. S., 1996, Australian Zoologist, V30, P190; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parris KM, 2006, J ANIM ECOL, V75, P757, DOI 10.1111/j.1365-2656.2006.01096.x; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Pillsbury FC, 2008, ECOL APPL, V18, P1107, DOI 10.1890/07-1899.1; Piper PJ, 2001, INT J OSTEOARCHAEOL, V11, P336, DOI 10.1002/oa.571; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; Rayner L, 2015, DIVERS DISTRIB, V21, P428, DOI 10.1111/ddi.12293; Rayner L, 2014, ECOGRAPHY, V37, P43, DOI 10.1111/j.1600-0587.2013.00388.x; Scheele B, 2014, BIOL CONSERV, V170, P86, DOI 10.1016/j.biocon.2013.12.034; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schwartz MW, 2002, BIOSCIENCE, V52, P601, DOI 10.1641/0006-3568(2002)052[0601:CSDUP]2.0.CO;2; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Shanahan DF, 2015, BIOSCIENCE, V65, P476, DOI 10.1093/biosci/biv032; Shulse CD, 2012, ECOL APPL, V22, P1675, DOI 10.1890/11-0212.1; Skelly DK, 2001, ISRAEL J ZOOL, V47, P313, DOI 10.1092/BVT1-LUYF-2XG6-B007; Smallbone LT, 2011, LANDSCAPE URBAN PLAN, V101, P43, DOI 10.1016/j.landurbplan.2011.01.002; Soga M, 2013, ANIM CONSERV, V16, P1, DOI 10.1111/j.1469-1795.2012.00572.x; Stagoll K, 2012, CONSERV LETT, V5, P115, DOI 10.1111/j.1755-263X.2011.00216.x; Szabo JK, 2012, IBIS, V154, P468, DOI 10.1111/j.1474-919X.2012.01229.x; Szabo JK, 2010, ECOL APPL, V20, P2157, DOI 10.1890/09-0877.1; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Tulloch AIT, 2013, DIVERS DISTRIB, V19, P465, DOI 10.1111/j.1472-4642.2012.00947.x; United Nations, 2014, REV WORLD URB PROSP; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; van Dijk AIJM, 2013, WATER RESOUR RES, V49, P1040, DOI 10.1002/wrcr.20123; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wilson HB, 2011, CONSERV BIOL, V25, P747, DOI 10.1111/j.1523-1739.2011.01671.x	67	17	18	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140973	10.1371/journal.pone.0140973	http://dx.doi.org/10.1371/journal.pone.0140973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580412	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600010
J	Sun, MH; Zheng, J; Xie, FY; Shen, W; Yin, S; Ma, JY				Sun, Ming-Hong; Zheng, Jie; Xie, Feng-Yun; Shen, Wei; Yin, Shen; Ma, Jun-Yu			Cumulus Cells Block Oocyte Meiotic Resumption via Gap Junctions in Cumulus Oocyte Complexes Subjected to DNA Double-Strand Breaks	PLOS ONE			English	Article							MAMMALIAN OOCYTES; MOUSE OOCYTE; DAMAGE CHECKPOINTS; PROTEIN-KINASE; ARREST; MATURATION; CAMP; GPR3; FOLLICULOGENESIS; MAINTENANCE	During mammalian oocyte growth, genomic DNA may accumulate DNA double-strand breaks (DSBs) induced by factors such as reactive oxygen species. Recent evidence demonstrated that slight DSBs do not activate DNA damage checkpoint proteins in denuded oocytes. These oocytes, even with DNA DSBs, can resume meiosis and progress to metaphase of meiosis II. Meiotic resumption in oocytes is also controlled by the surrounding cumulus cells; accordingly, we analyzed whether cumulus-cell enclosed oocytes (CEOs) with DNA damage are able to resume meiosis. Compared with DNA-damaged denuded oocytes, we found that meiotic resumption rates of CEOs significantly decreased. To assess the mechanism by which cumulus cells block meiotic resumption in CEOs with DNA DSBs, we treated the cumulus oocyte complex with the gap junction inhibitor carbenoxolone and found that carbenoxolone can rescue the block in CEO meiosis induced by DNA DSBs. Since cumulus cell-synthesized cAMPs can pass through the gap junctions between oocyte and cumulus cell to block oocyte meiosis, we measured the expression levels of adenylate cyclase 1 (Adcy1) in cumulus cells, and G-protein coupled receptor 3 (Gpr3) and phosphodiesterase 3A (Pde3a) in oocytes, and found that the mRNA expression level of Adcy1 increased significantly in DNA-damaged cumulus cells. In conclusion, our results indicate that DNA DSBs promote cAMP synthesis in cumulus cells, and cumulus cAMPs can inhibit meiotic resumption of CEOs through gap junctions.	[Sun, Ming-Hong; Zheng, Jie; Xie, Feng-Yun; Shen, Wei; Yin, Shen; Ma, Jun-Yu] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Shandong, Peoples R China; [Shen, Wei; Yin, Shen; Ma, Jun-Yu] Qingdao Agr Univ, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Shandong, Peoples R China; [Sun, Ming-Hong; Shen, Wei; Yin, Shen; Ma, Jun-Yu] Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement Univ, Inst Reprod Sci, Qingdao, Shandong, Peoples R China	Qingdao Agricultural University; Qingdao Agricultural University; Qingdao Agricultural University	Ma, JY (corresponding author), Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Shandong, Peoples R China.	jyma@qau.edu.cn			Basic Research Program of Shandong Province, China [2014BSB01356]; Advanced Talents Foundation of Qingdao Agricultural University [631401]	Basic Research Program of Shandong Province, China; Advanced Talents Foundation of Qingdao Agricultural University	This study is supported by the Basic Research Program of Shandong Province, China (2014BSB01356) and the Advanced Talents Foundation of Qingdao Agricultural University (631401). Both fundings are received by JYM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; BORNSLAEGER EA, 1985, BIOL REPROD, V33, P698, DOI 10.1095/biolreprod33.3.698; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; Glover L, 2012, MOL BIOCHEM PARASIT, V183, P78, DOI 10.1016/j.molbiopara.2012.01.008; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Kidder GM, 2002, REPRODUCTION, V123, P613, DOI 10.1530/rep.0.1230613; Langerak P, 2011, PHILOS T R SOC B, V366, P3562, DOI 10.1098/rstb.2011.0070; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Ma JY, 2013, CELL CYCLE, V12, P1233, DOI 10.4161/cc.24311; Marangos P, 2012, CURR BIOL, V22, P989, DOI 10.1016/j.cub.2012.03.063; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Mehlmann LM, 2005, DEV BIOL, V288, P397, DOI 10.1016/j.ydbio.2005.09.030; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shitsukawa K, 2001, BIOL REPROD, V65, P188, DOI 10.1095/biolreprod65.1.188; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; Wang YJ, 2015, DEVELOPMENT, V142, P343, DOI 10.1242/dev.112755; Webb RJ, 2002, DEV BIOL, V246, P441, DOI 10.1006/dbio.2002.0630; Wigglesworth K, 2013, P NATL ACAD SCI USA, V110, pE3723, DOI 10.1073/pnas.1314829110; Yuen WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043875	21	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143223	10.1371/journal.pone.0143223	http://dx.doi.org/10.1371/journal.pone.0143223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575642	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400054
J	van Hees, VT; Sabia, S; Anderson, KN; Denton, SJ; Oliver, J; Catt, M; Abell, JG; Kivimaki, M; Trenell, MI; Singh-Manoux, A				van Hees, Vincent T.; Sabia, Severine; Anderson, Kirstie N.; Denton, Sarah J.; Oliver, James; Catt, Michael; Abell, Jessica G.; Kivimaeki, Mika; Trenell, Michael I.; Singh-Manoux, Archana			A Novel, Open Access Method to Assess Sleep Duration Using a Wrist-Worn Accelerometer	PLOS ONE			English	Article							WAKE IDENTIFICATION; AMERICAN ACADEMY; ACTIGRAPHY; SCALE; DISAGREEMENT; DISTURBANCE; POPULATION; DEPRESSION; DISORDERS; RHYTHMS	Wrist-worn accelerometers are increasingly being used for the assessment of physical activity in population studies, but little is known about their value for sleep assessment. We developed a novel method of assessing sleep duration using data from 4,094 Whitehall II Study (United Kingdom, 2012-2013) participants aged 60-83 who wore the accelerometer for 9 consecutive days, filled in a sleep log and reported sleep duration via questionnaire. Our sleep detection algorithm defined (nocturnal) sleep as a period of sustained inactivity, itself detected as the absence of change in arm angle greater than 5 degrees for 5 minutes or more, during a period recorded as sleep by the participant in their sleep log. The resulting estimate of sleep duration had a moderate (but similar to previous findings) agreement with questionnaire based measures for time in bed, defined as the difference between sleep onset and waking time (kappa = 0.32, 95%CI:0.29,0.34) and total sleep duration (kappa = 0.39, 0.36,0.42). This estimate was lower for time in bed for women, depressed participants, those reporting more insomnia symptoms, and on weekend days. No such group differences were found for total sleep duration. Our algorithm was validated against data from a polysomnography study on 28 persons which found a longer time window and lower angle threshold to have better sensitivity to wakefulness, while the reverse was true for sensitivity to sleep. The novelty of our method is the use of a generic algorithm that will allow comparison between studies rather than a "count" based, device specific method.	[van Hees, Vincent T.; Denton, Sarah J.; Catt, Michael; Trenell, Michael I.] Newcastle Univ, Inst Cellular Med, MoveLab Phys Act & Exercise Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [van Hees, Vincent T.] Netherlands ESci Ctr, Amsterdam, Netherlands; [Sabia, Severine; Abell, Jessica G.; Kivimaeki, Mika; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London, England; [Anderson, Kirstie N.; Oliver, James] Freeman Rd Hosp, Reg Sleep Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Singh-Manoux, Archana] INSERM, U1018, Ctr Res Epidemiol & Populat Hlth, Villejuif, France	Newcastle University - UK; University of London; University College London; Newcastle Freeman Hospital; Newcastle University - UK; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	van Hees, VT (corresponding author), Newcastle Univ, Inst Cellular Med, MoveLab Phys Act & Exercise Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	vincentvanhees@gmail.com	Sabia, Séverine/G-2966-2017; Kivimaki, Mika/B-3607-2012; Singh-Manoux, Archana/F-6804-2013	Sabia, Séverine/0000-0003-3109-9720; Kivimaki, Mika/0000-0002-4699-5627; Singh-Manoux, Archana/0000-0002-1244-5037; van Hees, Vincent/0000-0003-0182-9008; Catt, Michael/0000-0003-0935-7973; Trenell, Michael/0000-0001-8253-5620; Abell, Jessica/0000-0002-2125-2229; Charman, Sarah/0000-0002-3029-7672; Anderson, Kirstie N/0000-0001-5767-918X	US National Institutes of Health [R01AG013196, R01AG034454, R01HL036310]; UK Medical Research Council [K013351]; British Heart Foundation [PG/29605]; Economic and Social Research Council [ES/J023299]; National Institute for Health Research; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K006312/1, MR/K013351/1, G0700718] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K006312/1, MR/K013351/1, G0700718] Funding Source: researchfish; National Institute for Health Research [SRF-2011-04-017] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (R01AG013196; R01AG034454; R01HL036310), the UK Medical Research Council (K013351), the British Heart Foundation (PG/29605) and the Economic and Social Research Council (ES/J023299). MIT was supported by a Senior Fellowship from the National Institute for Health Research for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KN, 2014, AGE AGEING, V43, P57, DOI 10.1093/ageing/aft153; Arora T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072406; Blackwell T, 2011, J CLIN SLEEP MED, V7, P357, DOI 10.5664/JCSM.1190; Borazio M, 2014, IEEE INT C HEALTHC I, P125, DOI [10.1109/ICHI.2014.24, DOI 10.1109/ICHI.2014.24]; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; da Silva ICM, 2014, INT J EPIDEMIOL, V43, P1959, DOI 10.1093/ije/dyu203; Freedson PS, 2013, MED SCI SPORT EXER, V45, P962, DOI 10.1249/MSS.0b013e31827f024d; Girschik J, 2012, J EPIDEMIOL, V22, P462, DOI 10.2188/jea.JE20120012; Haba-Rubio J, 2015, SLEEP, V38, P391, DOI 10.5665/sleep.4496; Hassani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110816; Head J, 2013, PSYCHOL MED, V43, P2649, DOI 10.1017/S0033291713000342; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Iber C., 2007, AASM MANUAL SCORING; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Jean-Louis G, 2001, PHYSIOL BEHAV, V72, P21, DOI 10.1016/S0031-9384(00)00355-3; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Maglione JE, 2014, SLEEP, V37, P1179, DOI 10.5665/sleep.3834; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; Meltzer LJ, 2011, SLEEP MED, V12, P793, DOI 10.1016/j.sleep.2011.03.011; Mitterling T, 2015, SLEEP, V38, P867, DOI 10.5665/sleep.4730; Ornat L, 2014, MATURITAS, V77, P344, DOI 10.1016/j.maturitas.2014.01.005; Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; te Lindert BHW, 2013, SLEEP, V36, P781, DOI 10.5665/sleep.2648; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Van Den Berg JF, 2008, J SLEEP RES, V17, P295, DOI 10.1111/j.1365-2869.2008.00638.x; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; van Hees VT, 2013, J APPL PHYSIOL, V114, P1042, DOI 10.1152/japplphysiol.00984.2012; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922; van Hees VT, 2010, 2 IEEE INT WOWMOM WO, P1	37	242	245	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142533	10.1371/journal.pone.0142533	http://dx.doi.org/10.1371/journal.pone.0142533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569414	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700049
J	Zhang, B; Qiangba, YZ; Shang, P; Wang, ZX; Ma, J; Wang, LY; Zhang, H				Zhang, Bo; Qiangba, Yangzong; Shang, Peng; Wang, Zhixiu; Ma, Jun; Wang, Liyuan; Zhang, Hao			A Comprehensive MicroRNA Expression Profile Related to Hypoxia Adaptation in the Tibetan Pig	PLOS ONE			English	Article							GENE-EXPRESSION; HIGH-ALTITUDE; DOWN-REGULATION; TUMOR-CELLS; IDENTIFICATION; TARGET; TISSUES; PACKAGE; STRESS; ROLES	Tibetan pigs live between 2500 and 4300 m above sea level on the Tibetan Plateau, and are better adapted to hypoxia than lowland pigs. MicroRNAs (miRNAs) are involved in a wide variety of cellular processes; however, their regulatory role in hypoxia adaptation remains unclear. In this study, miRNA-seq was used to identify differentially expressed miRNAs (DE miRNAs) in the cardiac muscle of Tibetan and Yorkshire pigs, which were both raised in high elevation environments. We obtained 108 M clean reads and 372 unique miRNAs, which included 210 known porcine miRNAs, 136 conserved in other mammals, and 26 novel pre-miRNAs. In addition, 20 DE miRNAs, including 10 up-regulated and 10 down-regulated miRNAs, were also found after comparison between Tibetan and Yorkshire pigs. We predicted miRNA targets based on differential expression and abundance in the two populations. Furthermore, the results of a Kyoto Encyclopedia of Genes and Genomes pathway analysis suggested that DE miRNAs in Tibetan and Yorkshire pigs are involved in hypoxia-related signaling pathways such as the mitogen-activated protein kinase, which is the mechanistic target of rapamycin, and the vascular endothelial growth factor, as well as cancer-related signaling pathways. Five DE miRNAs were randomly selected to validate the results of miRNA-seq using real-time polymerase chain reaction, and the results corresponded to those from the miRNA-seq, confirming that deep-sequencing methods are feasible and efficient. In our study, we identified various previously unknown hypoxia-related miRNAs in pigs, and the data obtained suggest that hypoxia-related miRNA expression patterns are significantly altered in the Tibetan pig compared to other species. Therefore, DE miRNAs may play an important role in organisms that have adapted to hypoxic environments.	[Zhang, Bo; Shang, Peng; Wang, Zhixiu; Ma, Jun; Wang, Liyuan; Zhang, Hao] China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; [Qiangba, Yangzong; Shang, Peng] Tibet Univ, Coll Agr & Anim Husb, Linzhi, Peoples R China	China Agricultural University; Tibet University	Zhang, H (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	zhanghao827@163.com		Zhang, Bo/0000-0002-7331-1550; Zhang, Hao/0000-0001-9576-3059	National Natural Science Foundation of China [31160441]; National Major Special Project on New Varieties Cultivation for Transgenic Organisms [2014ZX08009-003-006]; National Key Technology Research and Development Program [2012BAD03B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Special Project on New Varieties Cultivation for Transgenic Organisms; National Key Technology Research and Development Program(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (31160441), the National Major Special Project on New Varieties Cultivation for Transgenic Organisms (2014ZX08009-003-006), and the National Key Technology Research and Development Program (2012BAD03B03), to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bi D, 2013, BRAZ ARCH BIOL TECHN, V56, P53, DOI 10.1590/S1516-89132013000100007; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Chan CK, 2013, ACTA PHARM SIN B, V3, P1, DOI 10.1016/j.apsb.2012.12.007; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Dong XL, 2014, ALCOHOL CLIN EXP RES, V38, P68, DOI 10.1111/acer.12209; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gerassimou C, 2007, BRIT J PHARMACOL, V150, P1084, DOI 10.1038/sj.bjp.0707179; Gong JianJun, 2007, Southwest China Journal of Agricultural Sciences, V20, P1109; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krawczynski K, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123588; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Liang XH, 2008, ANTICANCER RES, V28, P1659; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lou HY, 2015, AM J HUM GENET, V97, P54, DOI 10.1016/j.ajhg.2015.05.005; Magder S, 2006, CRIT CARE, V10, DOI 10.1186/cc3992; Martini P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089755; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Oladipupo S, 2011, P NATL ACAD SCI USA, V108, P13264, DOI 10.1073/pnas.1101321108; Pan PW, 2003, ASIAN AUSTRAL J ANIM, V16, P1066, DOI 10.5713/ajas.2003.1066; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Qi S, 2009, LIVEST SCI, V123, P161, DOI 10.1016/j.livsci.2008.11.009; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rybnikova E, 2009, NEUROSCI RES, V65, P360, DOI 10.1016/j.neures.2009.08.013; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028215; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yuen RKC, 2013, EPIGENETICS-US, V8, P192, DOI 10.4161/epi.23400; Zardo G, 2012, BLOOD, V119, P4034, DOI 10.1182/blood-2011-08-371344; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhou SS, 2013, LIFE SCI, V93, P855, DOI 10.1016/j.lfs.2013.08.023; Zhou Y, 2013, REPROD DOMEST ANIM, V48, P112, DOI 10.1111/j.1439-0531.2012.02040.x	56	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143260	10.1371/journal.pone.0143260	http://dx.doi.org/10.1371/journal.pone.0143260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571238	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700155
J	Sethi, D; Mahajan, S; Singh, C; Lama, A; Nadel, MD; Gupta, P; Dikshit, KL				Sethi, Deepti; Mahajan, Sahil; Singh, Chaahat; Lama, Amrita; Nadel, Mangesh Dattu; Gupta, Pawan; Dikshit, Kanak L.			Lipoprotein LprI of Mycobacterium tuberculosis Acts as a Lysozyme Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; TRUNCATED HEMOGLOBIN; MULTIDRUG-RESISTANCE; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; STRUCTURAL BASIS; OXYGEN-BINDING; NITRIC-OXIDE; CELL-LINES; MACROPHAGES	Mycobacterium tuberculosis executes numerous defense strategies for the successful establishment of infection under a diverse array of challenges inside the host. One such strategy that has been delineated in this study is the abrogation of lytic activity of lysozyme by a novel glycosylated and surface-localized lipoprotein, LprI, which is exclusively present in M. tuberculosis complex. The lprI gene co-transcribes with the glbNgene (encoding hemoglobin (HbN)) and both are synchronously up-regulated in M. tuberculosis during macrophage infection. Recombinant LprI, expressed in Escherichia coli, exhibited strong binding (K-d <= 2 nM) with lysozyme and abrogated its lytic activity completely, thereby conferring protection to fluorescein-labeled Micrococcus lysodeikticus from lysozyme-mediated hydrolysis. Expression of the lprI gene in Mycobacterium smegmatis (8-10-fold) protected its growth from lysozyme inhibition in vitro and enhanced its phagocytosis and survival during intracellular infection of peritoneal and monocyte-derived macrophages, known to secrete lysozyme, and in the presence of exogenously added lysozyme in secondary cell lines where lysozyme levels are low. In contrast, the presence of HbN enhanced phagocytosis and intracellular survival of M. smegmatis only in the absence of lysozyme but not under lysozyme stress. Interestingly, co-expression of the glbN-lprI gene pair elevated the invasion and survival of M. smegmatis 2-3-fold in secondary cell lines in the presence of lysozyme in comparison with isogenic cells expressing these genes individually. Thus, specific advantage against macrophage-generated lysozyme, conferred by the combination of LprI-HbN during invasion of M. tuberculosis, may have vital implications on the pathogenesis of tuberculosis.	[Sethi, Deepti; Mahajan, Sahil; Singh, Chaahat; Lama, Amrita; Nadel, Mangesh Dattu; Gupta, Pawan; Dikshit, Kanak L.] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Dikshit, KL (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	kanak@irntech.res.in	Hade, Mangesh/ABD-8535-2021; Hade, Mangesh/AAF-7217-2019	Hade, Mangesh/0000-0002-5937-9049; Gupta, Pawan/0000-0001-6692-7237	Council of Scientific and Industrial Research (CSIR); Department of Science and Technology; Indian Council of Medical Research, Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work was supported in part by the Council of Scientific and Industrial Research (CSIR). The authors declare that they have no conflict of interest.; Supported by Department of Science and Technology, CSIR, and Indian Council of Medical Research, Government of India research fellowships.	Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; Arya S, 2013, J BIOL CHEM, V288, P29987, DOI 10.1074/jbc.M113.507301; Babu MM, 2002, BIOINFORMATICS, V18, P641, DOI 10.1093/bioinformatics/18.4.641; Bartels KM, 2011, J BACTERIOL, V193, P1107, DOI 10.1128/JB.01507-10; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Callewaert L, 2012, TRENDS MICROBIOL, V20, P501, DOI 10.1016/j.tim.2012.06.005; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Chaturvedi V, 2007, J GEN APPL MICROBIOL, V53, P333, DOI 10.2323/jgam.53.333; COHN ZA, 1963, J EXP MED, V118, P991, DOI 10.1084/jem.118.6.991; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Daigle F, 2001, MOL MICROBIOL, V41, P1211, DOI 10.1046/j.1365-2958.2001.02593.x; Dajani R, 2005, AM J RESP CELL MOL, V32, P548, DOI 10.1165/rcmb.2005-0059OC; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dkhar HK, 2014, J IMMUNOL, V193, P295, DOI 10.4049/jimmunol.1400092; Dubnau E, 2005, INFECT IMMUN, V73, P3754, DOI 10.1128/IAI.73.6.3754-3757.2005; Espitia C, 2010, MOL BIOSYST, V6, P775, DOI 10.1039/b916394h; Farrow MF, 2008, J BACTERIOL, V190, P1783, DOI 10.1128/JB.01046-07; GARBE T, 1993, INFECT IMMUN, V61, P260, DOI 10.1128/IAI.61.1.260-267.1993; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; HANEBERG B, 1984, J LEUKOCYTE BIOL, V35, P573; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Helal R, 2008, PHARMAZIE, V63, P415, DOI 10.1691/ph.2008.7846; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Jena P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050345; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kanetsuna F., 1980, MICROBIOL IMMUNOL, V24; KASUKABE T, 1979, BIOCHIM BIOPHYS ACTA, V586, P615, DOI 10.1016/0304-4165(79)90052-7; KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; KLOCKARS M, 1979, ARCH INTERN MED, V139, P73, DOI 10.1001/archinte.139.1.73; Kopacek P, 1999, INSECT BIOCHEM MOLEC, V29, P989, DOI 10.1016/S0965-1748(99)00075-2; Lama A, 2006, FEBS LETT, V580, P4031, DOI 10.1016/j.febslet.2006.06.037; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu CF, 2013, P NATL ACAD SCI USA, V110, P6560, DOI 10.1073/pnas.1219704110; Mahajan S, 2015, J BIOL CHEM, V290, P18304, DOI 10.1074/jbc.M115.638064; Martin A, 2007, J ANTIMICROB CHEMOTH, V59, P175, DOI 10.1093/jac/dkl477; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; MYRVIK QN, 1953, AM REV TUBERC PULM, V67, P217; NEAR KA, 1992, J CLIN MICROBIOL, V30, P1105, DOI 10.1128/JCM.30.5.1105-1110.1992; Nguyen HT, 2010, MOL MICROBIOL, V76, P348, DOI 10.1111/j.1365-2958.2010.07110.x; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Sander P, 2004, MOL MICROBIOL, V52, P1543, DOI 10.1111/j.1365-2958.2004.04041.x; Severin A, 2007, J BACTERIOL, V189, P1514, DOI 10.1128/JB.01132-06; Smith J B, 1991, J Clin Lab Immunol, V35, P147; SORBER WA, 1973, INFECT IMMUN, V7, P86, DOI 10.1128/IAI.7.1.86-92.1973; Sutcliffe IC, 2004, FEMS MICROBIOL REV, V28, P645, DOI 10.1016/j.femsre.2004.06.002; Torrelles JB, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P77; Um SH, 2013, BIOCHEMISTRY-US, V52, P9385, DOI 10.1021/bi401241c; Vanderkelen L, 2011, CELL MOL LIFE SCI, V68, P1053, DOI 10.1007/s00018-010-0507-3; Voet A, 2011, BIOCHEM BIOPH RES CO, V405, P527, DOI 10.1016/j.bbrc.2011.01.053; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yum S, 2009, BIOCHEM BIOPH RES CO, V378, P244, DOI 10.1016/j.bbrc.2008.11.039; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	62	24	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2938	2953		10.1074/jbc.M115.662593	http://dx.doi.org/10.1074/jbc.M115.662593			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26589796	Green Published, hybrid			2022-12-26	WOS:000369626900031
J	Tedesco, P; Visone, M; Parrilli, E; Tutino, ML; Perrin, E; Maida, I; Fani, R; Ballestriero, F; Santos, R; Pinilla, C; Di Schiavi, E; Tegos, G; de Pascale, D				Tedesco, Pietro; Visone, Marco; Parrilli, Ermenegilda; Tutino, Maria Luisa; Perrin, Elena; Maida, Isabel; Fani, Renato; Ballestriero, Francesco; Santos, Radleigh; Pinilla, Clemencia; Di Schiavi, Elia; Tegos, George; de Pascale, Donatella			Investigating the Role of the Host Multidrug Resistance Associated Protein Transporter Family in Burkholderia cepacia Complex Pathogenicity Using a Caenorhabditis elegans Infection Model	PLOS ONE			English	Article							CYSTIC-FIBROSIS; VIRULENCE FACTORS; IVERMECTIN RESISTANCE; CENOCEPACIA STRAINS; PSEUDOMALLEI KILLS; FULL VIRULENCE; SP NOV.; EFFLUX; IDENTIFICATION; DIVERSITY	This study investigated the relationship between host efflux system of the non-vertebrate nematode Caenorhabditis elegans and Burkholderia cepacia complex (Bcc) strain virulence. This is the first comprehensive effort to profile host-transporters within the context of Bcc infection. With this aim, two different toxicity tests were performed: a slow killing assay that monitors mortality of the host by intestinal colonization and a fast killing assay that assesses production of toxins. A Virulence Ranking scheme was defined, that expressed the toxicity of the Bcc panel members, based on the percentage of surviving worms. According to this ranking the 18 Bcc strains were divided in 4 distinct groups. Only the Cystic Fibrosis isolated strains possessed profound nematode killing ability to accumulate in worms' intestines. For the transporter analysis a complete set of isogenic nematode single Multidrug Resistance associated Protein (MRP) efflux mutants and a number of efflux inhibitors were interrogated in the host toxicity assays. The Bcc pathogenicity profile of the 7 isogenic C. elegans MRP knock-out strains functionality was classified in two distinct groups. Disabling host transporters enhanced nematode mortality more than 50% in 5 out of 7 mutants when compared to wild type. In particular mrp-2 was the most susceptible phenotype with increased mortality for 13 out 18 Bcc strains, whereas mrp-3 and mrp-4 knockouts had lower mortality rates, suggesting a different role in toxin-substrate recognition. The use of MRP efflux inhibitors in the assays resulted in substantially increased (>40% on average) mortality of wild-type worms.	[Tedesco, Pietro; Visone, Marco; de Pascale, Donatella] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Tedesco, Pietro; Parrilli, Ermenegilda; Tutino, Maria Luisa] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy; [Tedesco, Pietro; Parrilli, Ermenegilda; Tutino, Maria Luisa] Univ Naples Federico II, Sch Biotechnol Sci, I-80126 Naples, Italy; [Perrin, Elena; Maida, Isabel; Fani, Renato] Univ Florence, Dept Biol, Lab Microbial & Mol Evolut, I-50019 Florence, Italy; [Ballestriero, Francesco] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Ballestriero, Francesco] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia; [Santos, Radleigh; Pinilla, Clemencia; Tegos, George] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Santos, Radleigh; Pinilla, Clemencia; Tegos, George] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Di Schiavi, Elia] CNR, Inst Biosci & BioResources, I-80131 Naples, Italy; [Di Schiavi, Elia] CNR, Inst Genet & Biophys, I-80131 Naples, Italy; [Tegos, George] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Tegos, George] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Naples Federico II; University of Naples Federico II; University of Florence; University of New South Wales Sydney; University of New South Wales Sydney; Torrey Pines Institute for Molecular Studies, Florida; Torrey Pines Institute for Molecular Studies, California; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Tegos, G (corresponding author), Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA.	gtegos@tpims.org; d.depascale@ibp.cnr.it	parrilli, ermenegilda/K-4616-2016; Di Schiavi, Elia/B-8046-2015; Tedesco, Pietro/AAB-5740-2021; Perrin, Elena/AAX-2762-2020	parrilli, ermenegilda/0000-0002-9002-5409; Di Schiavi, Elia/0000-0002-8179-6666; Tutino, Maria Luisa/0000-0002-4978-6839; Tedesco, Pietro/0000-0003-0165-5386; Perrin, Elena/0000-0001-5148-3178	EU-KBBE project PharmaSea [312184]; "Fondazione Adriano Buzzati-Traverso" fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	EU-KBBE project PharmaSea; "Fondazione Adriano Buzzati-Traverso" fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was supported by the EU-KBBE 2012-2016 project PharmaSea, grant No 312184. Elena Perrin is financially supported by a "Fondazione Adriano Buzzati-Traverso" fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2011, VIRULENCE, V2, P158, DOI 10.4161/viru.2.2.15337; Ardelli BF, 2013, VET PARASITOL, V191, P264, DOI 10.1016/j.vetpar.2012.09.021; Bazzini S, 2011, APPL MICROBIOL BIOT, V92, P887, DOI 10.1007/s00253-011-3616-5; Bhatt S, 2011, J BACTERIOL, V193, P4516, DOI 10.1128/JB.05197-11; BRENNER S, 1974, GENETICS, V77, P71; Buroni S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-200; Cardona ST, 2005, FEMS MICROBIOL LETT, V250, P97, DOI 10.1016/j.femsle.2005.06.050; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Currie E, 2007, GENETICS, V177, P1569, DOI 10.1534/genetics.107.080689; De Smet B, 2015, INT J SYST EVOL MICR, V65, P2265, DOI 10.1099/ijs.0.000251; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Eilers M, 2008, EXP BIOL MED, V233, P1149, DOI 10.3181/0802-RM-59; Fallon JP, 2011, MICROBIOL-SGM, V157, P1481, DOI 10.1099/mic.0.043786-0; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; Harland DN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-83; Horger KS, 2015, BBA-BIOMEMBRANES, V1848, P643, DOI 10.1016/j.bbamem.2014.10.023; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; James CE, 2009, INT J PARASITOL, V39, P213, DOI 10.1016/j.ijpara.2008.06.009; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Kurz CL, 2007, BIOCHEM BIOPH RES CO, V363, P438, DOI 10.1016/j.bbrc.2007.08.190; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lee SH, 2013, P NATL ACAD SCI US; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016707; Leitao J.H., 2011, INT J MICROBIOL, V2011; Lionakis MS, 2011, VIRULENCE, V2, P521, DOI 10.4161/viru.2.6.18520; Lu SE, 2009, BIOCHEMISTRY-US, V48, P8312, DOI 10.1021/bi900814c; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Markey KM, 2006, J MED MICROBIOL, V55, P967, DOI 10.1099/jmm.0.46618-0; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Mylonakis Eleftherios, 2003, Expert Rev Anti Infect Ther, V1, P167, DOI 10.1586/14787210.1.1.167; Nash EF, 2010, PEDIAT PULMONOL; O'Grady EP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037611; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Olsen RJ, 2011, VIRULENCE, V2, P111, DOI 10.4161/viru.2.2.14338; Ooi SK, 2012, VIRULENCE, V3, P485, DOI 10.4161/viru.21808; Peeters C, 2013, SYST APPL MICROBIOL, V36, P483, DOI 10.1016/j.syapm.2013.06.003; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; Ramsay KA, 2013, J CLIN MICROBIOL, V51, P3975, DOI 10.1128/JCM.01360-13; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rose H, 2009, J ANTIMICROB CHEMOTH, V63, P502, DOI 10.1093/jac/dkn540; Schwager S, 2013, INFECT IMMUN, V81, P143, DOI 10.1128/IAI.00768-12; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Sousa SA, 2010, MICROBIOL-SGM, V156, P896, DOI 10.1099/mic.0.035139-0; Springman AC, 2009, APPL ENVIRON MICROB, V75, P5250, DOI 10.1128/AEM.00877-09; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Strouse JJ, 2013, ANAL BIOCHEM, V437, P77, DOI 10.1016/j.ab.2013.02.018; Tan MW, 2000, CURR OPIN MICROBIOL, V3, P29, DOI 10.1016/S1369-5274(99)00047-8; Tegos GP, 2012, VIRULENCE, V3, P234, DOI 10.4161/viru.19844; Thomson ELS, 2012, VIRULENCE, V3, P286, DOI 10.4161/viru.19355; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Wei SP, 2014, J BIOL CHEM, V289, P19942, DOI 10.1074/jbc.M114.562116; Wopperer J, 2006, APPL ENVIRON MICROB, V72, P1579, DOI 10.1128/AEM.72.2.1579-1587.2006; Yan RF, 2012, VET PARASITOL, V190, P519, DOI 10.1016/j.vetpar.2012.06.038	58	3	4	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142883	10.1371/journal.pone.0142883	http://dx.doi.org/10.1371/journal.pone.0142883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587842	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500020
J	Adams, RV; Burg, TM				Adams, Rachael V.; Burg, Theresa M.			Gene Flow of a Forest-Dependent Bird across a Fragmented Landscape	PLOS ONE			English	Article							PLANT HYBRID ZONES; MALURUS-CORONATUS-CORONATUS; GAP-CROSSING DECISIONS; RIPARIAN COTTONWOODS; POPULATION-GENETICS; SOUTHERN ALBERTA; RIVER; PATTERNS; HABITAT; SOFTWARE	Habitat loss and fragmentation can affect the persistence of populations by reducing connectivity and restricting the ability of individuals to disperse across landscapes. Dispersal corridors promote population connectivity and therefore play important roles in maintaining gene flow in natural populations inhabiting fragmented landscapes. In the prairies, forests are restricted to riparian areas along river systems which act as important dispersal corridors for forest dependent species across large expanses of unsuitable grassland habitat. However, natural and anthropogenic barriers within riparian systems have fragmented these forested habitats. In this study, we used microsatellite markers to assess the fine-scale genetic structure of a forest-dependent species, the black-capped chickadee (Poecile atricapillus), along 10 different river systems in Southern Alberta. Using a landscape genetic approach, landscape features (e.g., land cover) were found to have a significant effect on patterns of genetic differentiation. Populations are genetically structured as a result of natural breaks in continuous habitat at small spatial scales, but the artificial barriers we tested do not appear to restrict gene flow. Dispersal between rivers is impeded by grasslands, evident from isolation of nearby populations (similar to 50 km apart), but also within river systems by large treeless canyons (> 100 km). Significant population genetic differentiation within some rivers corresponded with zones of different cottonwood (riparian poplar) tree species and their hybrids. This study illustrates the importance of considering the impacts of habitat fragmentation at small spatial scales as well as other ecological processes to gain a better understanding of how organisms respond to their environmental connectivity. Here, even in a common and widespread songbird with high dispersal potential, small breaks in continuous habitats strongly influenced the spatial patterns of genetic variation.	[Adams, Rachael V.; Burg, Theresa M.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Adams, RV (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	rachael.adams@uleth.ca		Wilbourn, Rachael V./0000-0003-3015-6332	ACA Grants in Biodiversity [43559-4115-8001]; Alberta Conservation Association (ACA Grants in Biodiversity Program)	ACA Grants in Biodiversity; Alberta Conservation Association (ACA Grants in Biodiversity Program)	RVA-ACA Grants in Biodiversity (Grant number: 43559-4115-8001) funded this work (http://www.acabiodiversity.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for the project was provided by the Alberta Conservation Association (ACA Grants in Biodiversity Program). We thank E. Carpenter, A. Curtis, K. Dohms, J. Hindley, L. Lait, P. Narvez and P. Pulgarin for help with sample collection and to C. Goater and H. Jiskoot for their constructive comments. We are also grateful to C. Langhorn, C. Bonifacio and L. Philipsen for their assistance with GIS as well as S. Rood and K. Floate for sharing their expertise and knowledge. Finally we thank the two anonymous reviewers and editor, Sam Banks, for their constructive comments on the manuscript.	Adams RV, 2015, HEREDITY, V114, P143, DOI 10.1038/hdy.2014.64; Alp M, 2012, FRESHWATER BIOL, V57, P969, DOI 10.1111/j.1365-2427.2012.02758.x; Amlin NM, 2003, TREES-STRUCT FUNCT, V17, P351, DOI 10.1007/s00468-003-0245-3; Amos JN, 2014, ECOLOGY, V95, P1556, DOI 10.1890/13-1328.1; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barton K, 2015, MUMLN MULT INFERENCE; Bates D., 2015, LME4 LINEAR MIXED EF; Benjamini Y, 2001, ANN STAT, V29, P1165; Brayshaw TC, 1965, CAN DEP FOR PUBL, V1109; Christian DP, 1997, J WILDLIFE MANAGE, V61, P171, DOI 10.2307/3802426; Clarke RT, 2002, J AGRIC BIOL ENVIR S, V7, P361, DOI 10.1198/108571102320; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; Dallimer M, 2012, DIVERS DISTRIB, V18, P742, DOI 10.1111/j.1472-4642.2012.00891.x; Dawson GM, 1885, GEOLOGICAL MAP REGIO; Desrochers A, 1997, CONSERV BIOL, V11, P1204, DOI 10.1046/j.1523-1739.1997.96187.x; Desrochers Andre, 2007, P243; Doherty PF, 2002, ECOLOGY, V83, P844, DOI 10.1890/0012-9658(2002)083[0844:SOPRBI]2.0.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans LM, 2012, CONSERV GENET, V13, P1601, DOI 10.1007/s10592-012-0409-z; Evans LM, 2008, EVOLUTION, V62, P3027, DOI 10.1111/j.1558-5646.2008.00497.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Falush D, 2003, GENETICS, V164, P1567; FINCH DM, 1989, ECOLOGY, V70, P866, DOI 10.2307/1941355; Floate KD, 1997, J ANIM ECOL, V66, P179, DOI 10.2307/6020; Floate KD, 2004, CAN J BOT, V82, P253, DOI [10.1139/B03-135, 10.1139/b03-135]; Floate KD, 2016, NEW PHYTOL, V209, P832, DOI 10.1111/nph.13622; GILL FB, 1993, EVOLUTION, V47, P195, DOI 10.1111/j.1558-5646.1993.tb01210.x; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Gom LA, 1999, CAN J BOT, V77, P1095, DOI 10.1139/cjb-77-8-1095; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gray LJ, 1989, 11 N AM PRAIR C U NE, P292; HAAS CA, 1995, CONSERV BIOL, V9, P845, DOI 10.1046/j.1523-1739.1995.09040845.x; Hannon SJ, 2002, CAN J FOREST RES, V32, P1784, DOI 10.1139/X02-092; Heggenes J, 2006, ECOL FRESHW FISH, V15, P366, DOI 10.1111/j.1600-0633.2006.00146.x; Hindley JA, 2013, THESIS; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Hudman SP, 2013, FRESHWATER BIOL, V58, P441, DOI 10.1111/fwb.12079; Jansen A, 2001, BIOL CONSERV, V100, P173, DOI 10.1016/S0006-3207(00)00235-4; Jansson R, 2000, ECOLOGY, V81, P899, DOI 10.1890/0012-9658(2000)081[0899:FORFIR]2.0.CO;2; Jedlicka JA, 2014, WILSON J ORNITHOL, V126, P60, DOI 10.1676/13-058.1; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; JOHNSON AR, 1992, LANDSCAPE ECOL, V7, P63, DOI 10.1007/BF02573958; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalischuk AR, 1997, CAN J BOT, V75, P1349, DOI 10.1139/b97-847; Koen EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011785; Kondo T, 2009, AM J BOT, V96, P1532, DOI 10.3732/ajb.0800273; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MARTINSEN GD, 1994, WILSON BULL, V106, P474; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Mosner E, 2012, BIOL CONSERV, V153, P211, DOI 10.1016/j.biocon.2012.05.005; Naiman RJ, 2005, ECOSYSTEM FUNCTION IN HETEROGENEOUS LANDSCAPES, P279, DOI 10.1007/0-387-24091-8_14; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neraas LP, 2001, MOL ECOL, V10, P1153, DOI 10.1046/j.1365-294X.2001.01269.x; Olson DH, 2007, FOREST ECOL MANAG, V246, P81, DOI 10.1016/j.foreco.2007.03.053; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phillipsen IC, 2013, ECOGRAPHY, V36, P731, DOI 10.1111/j.1600-0587.2012.00002.x; Pollux BJA, 2007, MOL ECOL, V16, P313, DOI 10.1111/j.1365-294X.2006.03146.x; Pravosudov VV, 2012, MOL ECOL, V21, P4486, DOI 10.1111/j.1365-294X.2012.05721.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robertson OJ, 2009, AUSTRAL ECOL, V34, P435, DOI 10.1111/j.1442-9993.2009.01945.x; ROOD SB, 1989, CAN J BOT, V67, P1744, DOI 10.1139/b89-221; Rood SB, 2003, BIOSCIENCE, V53, P647, DOI 10.1641/0006-3568(2003)053[0647:FFFFAS]2.0.CO;2; ROOD SB, 1995, CAN J BOT, V73, P1250, DOI 10.1139/b95-136; ROOD SB, 1990, ENVIRON MANAGE, V14, P451, DOI 10.1007/BF02394134; ROOD SB, 1986, CAN J BOT, V64, P1382, DOI 10.1139/b86-189; Rood Stewart B., 1995, Rivers, V5, P195; Rottenborn SC, 1999, BIOL CONSERV, V88, P289, DOI 10.1016/S0006-3207(98)00128-1; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sieving KE, 1996, AUK, V113, P944, DOI 10.2307/4088877; Skroblin A, 2014, AUST J ZOOL, V62, P251, DOI 10.1071/ZO13087; Skroblin A, 2012, AUSTRAL ECOL, V37, P874, DOI 10.1111/j.1442-9993.2011.02331.x; Smith SM, 1993, BIRDS N AM, P39; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Van Looy K, 2009, BIOL CONSERV, V142, P870, DOI 10.1016/j.biocon.2008.12.006; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Vignieri SN, 2005, MOL ECOL, V14, P1925, DOI 10.1111/j.1365-294X.2005.02568.x; Werth S, 2014, FRESHWATER BIOL, V59, P2502, DOI 10.1111/fwb.12449; WHITHAM TG, 1989, SCIENCE, V244, P1490, DOI 10.1126/science.244.4911.1490; Whitham TG, 1999, ECOLOGY, V80, P416; Whitham TG, 1996, USDA ROCKY, V283, P103; Whitham Thomas G., 1996, P247; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wright S, 1943, GENETICS, V28, P114; WWF, 2006, FREE FLOW RIV EC LUX; Yang RC, 2004, EVOLUTION, V58, P1839; Young PS, 2011, REV FISH BIOL FISHER, V21, P713, DOI 10.1007/s11160-011-9211-0	102	14	14	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140938	10.1371/journal.pone.0140938	http://dx.doi.org/10.1371/journal.pone.0140938			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580222	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600009
J	Bublin, M; Kostadinova, M; Fuchs, JE; Ackerbauer, D; Moraes, AH; Almeida, FCL; Lengger, N; Hafner, C; Ebner, C; Radauer, C; Liedl, KR; Valente, AP; Breiteneder, H				Bublin, Merima; Kostadinova, Maria; Fuchs, Julian E.; Ackerbauer, Daniela; Moraes, Adolfo H.; Almeida, Fabio C. L.; Lengger, Nina; Hafner, Christine; Ebner, Christof; Radauer, Christian; Liedl, Klaus R.; Valente, Ana Paula; Breiteneder, Heimo			A Cross-Reactive Human Single-Chain Antibody for Detection of Major Fish Allergens, Parvalbumins, and Identification of a Major IgE-Binding Epitope	PLOS ONE			English	Article							REPORTED FOOD ALLERGY; CARP PARVALBUMIN; COD; PREVALENCE; IMMUNOTHERAPY; DESIGN; EUROPE	Fish allergy is associated with moderate to severe IgE-mediated reactions to the calcium binding parvalbumins present in fish muscle. Allergy to multiple fish species is caused by parvalbumin-specific cross-reactive IgE recognizing conserved epitopes. In this study, we aimed to produce cross-reactive single chain variable fragment (scFv) antibodies for the detection of parvalbumins in fish extracts and the identification of IgE epitopes. Parvalbumin- specific phage clones were isolated from the human ETH-2 phage display library by three rounds of biopanning either against cod parvalbumin or by sequential biopanning against cod (Gad m 1), carp (Cyp c 1) and rainbow trout (Onc m 1) parvalbumins. While biopanning against Gad m 1 resulted in the selection of clones specific exclusively for Gad m 1, the second approach resulted in the selection of clones cross-reacting with all three parvalbumins. Two clones, scFv-gco9 recognizing all three parvalbumins, and scFv-goo8 recognizing only Gad m 1 were expressed in the E. coli non-suppressor strain HB2151 and purified from the periplasm. scFv-gco9 showed highly selective binding to parvalbumins in processed fish products such as breaded cod sticks, fried carp and smoked trout in Western blots. In addition, the scFv-gco9-AP produced as alkaline phosphatase fusion protein, allowed a single-step detection of the parvalbumins. In competitive ELISA, scFv-gco9 was able to inhibit binding of IgE from fish allergic patients' sera to all three mu-parvalbumins by up to 80%, whereas inhibition by scFv-goo8 was up to 20%. H-1/N-15 HSQC NMR analysis of the rGad m 1:scFv-gco9 complex showed participation of amino acid residues conserved among these three parvalbumins explaining their cross-reactivity on a molecular level. In this study, we have demonstrated an approach for the selection of cross-reactive parvalbumin-specific antibodies that can be used for allergen detection and for mapping of conserved epitopes.	[Bublin, Merima; Kostadinova, Maria; Ackerbauer, Daniela; Lengger, Nina; Radauer, Christian; Breiteneder, Heimo] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Fuchs, Julian E.; Liedl, Klaus R.] Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria; [Moraes, Adolfo H.; Almeida, Fabio C. L.; Valente, Ana Paula] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magnet, Rio De Janeiro, Brazil; [Hafner, Christine] Karl Landsteiner Inst Dermatol Res, St Polten, Austria; [Hafner, Christine] Karl Landsteiner Univ Med Sci, Dept Dermatol, St Polten, Austria; [Ebner, Christof] Allergy Clin Reumannpl, Vienna, Austria	Medical University of Vienna; University of Innsbruck; Universidade Federal do Rio de Janeiro	Bublin, M (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Vienna, Austria.	merima.bublin@meduniwien.ac.at	Almeida, Fabio/O-4989-2018; Moraes, Adolfo/G-3931-2018; Liedl, Klaus R/F-3099-2015; Liedl, Klaus/ABB-4725-2021; Valente, Ana Paula/J-3010-2017; Radauer, Christian/AAN-6260-2021	Almeida, Fabio/0000-0001-6046-7006; Moraes, Adolfo/0000-0002-3344-4084; Liedl, Klaus R/0000-0002-0985-2299; Liedl, Klaus/0000-0002-0985-2299; Valente, Ana Paula/0000-0001-7219-1123; Radauer, Christian/0000-0001-9920-4449; Breiteneder, Heimo/0000-0003-2022-8689; Bublin, Merima/0000-0002-7191-9431	Austrian Science Fund (FWF) [SFB-F4608]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF; http://www.fwf.ac.at/) grant: SFB-F4608 to HB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugajska-Schretter A, 1998, J ALLERGY CLIN IMMUN, V101, P67, DOI 10.1016/S0091-6749(98)70195-2; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chen LY, 2006, J AGR FOOD CHEM, V54, P5577, DOI 10.1021/jf060291g; DEMARTINO M, 1990, J ALLERGY CLIN IMMUN, V86, P909, DOI 10.1016/S0091-6749(05)80154-X; ELSAYED S, 1983, ALLERGY, V38, P449, DOI 10.1111/j.1398-9995.1983.tb02353.x; Faeste CK, 2008, J IMMUNOL METHODS, V329, P45, DOI 10.1016/j.jim.2007.09.007; Failler P., 2007, FAO FISHERIES CIRCUL; Gajewski KG, 2009, J FOOD PROTECT, V72, P818, DOI 10.4315/0362-028X-72.4.818; Griesmeier U, 2010, ALLERGY, V65, P191, DOI 10.1111/j.1398-9995.2009.02162.x; Gruber P, 2009, BIOL CHEM, V390, P445, DOI 10.1515/BC.2009.063; Jenkins JA, 2007, J ALLERGY CLIN IMMUN, V120, P1399, DOI 10.1016/j.jaci.2007.08.019; Kerschbaumer RJ, 1997, ANAL BIOCHEM, V249, P219, DOI 10.1006/abio.1997.2171; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; KUMAR VD, 1990, BIOCHEMISTRY-US, V29, P1404, DOI 10.1021/bi00458a010; Lapteva YS, 2013, BBA-PROTEINS PROTEOM, V1834, P1607, DOI 10.1016/j.bbapap.2013.04.025; Lee PW, 2011, J AGR FOOD CHEM, V59, P12309, DOI 10.1021/jf203277z; Lopata AL, 2005, INT ARCH ALLERGY IMM, V138, P21, DOI 10.1159/000087354; Ma Y, 2008, MOL NUTR FOOD RES, V52, pS196, DOI 10.1002/mnfr.200700284; McGowan EC, 2013, J ALLERGY CLIN IMMUN, V132, P1216, DOI 10.1016/j.jaci.2013.07.018; Moraes AH, 2014, PROTEINS, V82, P3032, DOI 10.1002/prot.24664; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; PASCUAL C, 1992, J PEDIATR-US, V121, pS29, DOI 10.1016/S0022-3476(05)81403-9; Perez-Gordo M, 2013, MOL NUTR FOOD RES, V57, P1283, DOI 10.1002/mnfr.201200332; Perez-Gordo M, 2012, INT ARCH ALLERGY IMM, V157, P31, DOI 10.1159/000324677; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Sharp MF, 2015, MOL IMMUNOL, V63, P437, DOI 10.1016/j.molimm.2014.09.019; Sharp MF, 2014, CLIN REV ALLERG IMMU, V46, P258, DOI 10.1007/s12016-013-8363-1; Soller L, 2012, J ALLERGY CLIN IMMUN, V130, P986, DOI 10.1016/j.jaci.2012.06.029; Swoboda I, 2002, J IMMUNOL, V168, P4576, DOI 10.4049/jimmunol.168.9.4576; Swoboda I, 2007, J IMMUNOL, V178, P6290, DOI 10.4049/jimmunol.178.10.6290; Swoboda I, 2013, J ALLERGY CLIN IMMUN, V132, P979, DOI 10.1016/j.jaci.2013.04.027; Untersmayr E, 2006, MOL IMMUNOL, V43, P1454, DOI 10.1016/j.molimm.2005.07.038; Van Do T, 2005, J ALLERGY CLIN IMMUN, V116, P1314, DOI 10.1016/j.jaci.2005.07.033; Viti F, 2000, METHOD ENZYMOL, V326, P480; Yoshida S, 2008, FOOD CHEM, V111, P857, DOI 10.1016/j.foodchem.2008.04.062	36	10	10	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142625	10.1371/journal.pone.0142625	http://dx.doi.org/10.1371/journal.pone.0142625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579717	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600052
J	Combs, D; Goodwin, JL; Quan, SF; Morgan, WJ; Parthasarathy, S				Combs, Daniel; Goodwin, James L.; Quan, Stuart F.; Morgan, Wayne J.; Parthasarathy, Sairam			Modified STOP-Bang Tool for Stratifying Obstructive Sleep Apnea Risk in Adolescent Children	PLOS ONE			English	Article							QUALITY-OF-LIFE; PUBERTAL SELF-ASSESSMENT; NECK CIRCUMFERENCE; PROXY PROBLEM; QUESTIONNAIRE; POLYSOMNOGRAPHY; RELIABILITY; MATURATION; DIAGNOSIS; PATTERN	Purpose Obstructive sleep apnea (OSA) is prevalent in children and diagnostic polysomnography is costly and not readily available in all areas. We developed a pediatric modification of a commonly used adult clinical prediction tool for stratifying the risk of OSA and the need for polysomnography. Methods A total of 312 children (age 9-17 years) from phase 2 of the Tucson Children's Assessment of Sleep Apnea cohort study, with complete anthropomorphic data, parent questionnaires, and home polysomnograms were included. An adolescent modification of STOP-Bang (teen STOP-Bang) was developed and included snoring, tired, observed apnea, blood pressure >= 95th percentile, BMI > 95th percentile, academic problems, neck circumference > 95th percentile for age, and male gender. An apnea-hypopnea index >= 1.5 events/hour was considered diagnostic of OSA. Results Receiver Operator Characteristic (ROC) curves for parent-reported STOP-Bang scores were generated for teenage and pre-teen children. A STOP-Bang score of < 3 in teenagers was associated with a negative predictive value of 0.96. ROC curves were also generated based upon child-reported sexual maturity rating (SMR; n = 291). The ability of teen STOP-Bang to discriminate the presence or absence of OSA as measured by the AUC for children with SMR >= 4 (0.83; 95% CI 0.71-0.95) was better than children with SMR < 4 (0.63; 95% CI 0.46-0.81; p = 0.048). Conclusions In community dwelling adolescents, teen STOP-Bang may be useful in stratifying the risk of OSA.	[Combs, Daniel; Morgan, Wayne J.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Combs, Daniel; Goodwin, James L.; Quan, Stuart F.; Morgan, Wayne J.; Parthasarathy, Sairam] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Combs, Daniel; Parthasarathy, Sairam] Univ Arizona, Dept Med, Tucson, AZ USA; [Quan, Stuart F.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Quan, Stuart F.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Parthasarathy, Sairam] Univ Arizona, Ctr Sleep Disorders, Tucson, AZ USA; [Parthasarathy, Sairam] Univ Arizona, Div Pulm Allergy Crit Care & Sleep Med, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Arizona; University of Arizona	Combs, D (corresponding author), Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA.	dcombs@peds.arizona.edu		Combs, Daniel/0000-0003-3821-3629	National Institutes of Health Grant [HL062373, HL095748, HL095799]; Patient Centered Outcomes Research Institute contract [IHS-1306-2505]; Arizona Respiratory Center, University of Arizona, Tucson, AZ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062373, R01HL095748, R01HL095799] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patient Centered Outcomes Research Institute contract(Patient-Centered Outcomes Research Institute - PCORI); Arizona Respiratory Center, University of Arizona, Tucson, AZ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grants (HL062373 to S.Q. and HL095748 and HL095799 to S.P.); Patient Centered Outcomes Research Institute contract (IHS-1306-2505 to S.P.); and salary support for D.C. from Arizona Respiratory Center, University of Arizona, Tucson, AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca CB, 2010, VALUE HEALTH, V13, P778, DOI 10.1111/j.1524-4733.2010.00732.x; Boynton Grace, 2013, J Sleep Disord Treat Care, V2, DOI 10.4172/2325-9639.1000121; Budhiraja R, 2009, SLEEP MED CLIN, V4, P9, DOI 10.1016/j.jsmc.2008.11.002; Chan NPT, 2008, J PAEDIATR CHILD H, V44, P353, DOI 10.1111/j.1440-1754.2008.01311.x; Chervin RD, 2000, SLEEP MED, V1, P21, DOI 10.1016/S1389-9457(99)00009-X; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Constantin E, 2010, PEDIATRICS, V125, pE162, DOI 10.1542/peds.2009-0731; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Dayyat E, 2007, SLEEP MED CLIN, V2, P433, DOI 10.1016/j.jsmc.2007.05.004; Erichsen D, 2012, CLIN PEDIATR, V51, P1125, DOI 10.1177/0009922812464548; Friedman BC, 2003, SLEEP, V26, P999, DOI 10.1093/sleep/26.8.999; Fuentes-Pradera MA, 2004, EUR RESPIR J, V23, P250, DOI 10.1183/09031936.03.00022003; Goodwin JL, 2005, J CLIN SLEEP MED, V1, P247; Goodwin JL, 2001, SLEEP, V24, P937, DOI 10.1093/sleep/24.8.937; Kadmon G, 2014, INT J PEDIATR OTORHI, V78, P2116, DOI 10.1016/j.ijporl.2014.09.018; Kadmon G, 2013, INT J PEDIATR OTORHI, V77, P1461, DOI 10.1016/j.ijporl.2013.06.009; Kaemingk KL, 2003, J INT NEUROPSYCH SOC, V9, P1016, DOI 10.1017/S1355617703970056; Katz S, 2015, PEDIATR PULM, V50, P196, DOI 10.1002/ppul.23003; Katz SL, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-159; Lohman T.G., 1991, ANTHROPOMETRIC STAND, Vvi; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Montgomery-Downs HE, 2005, EUR RESPIR J, V25, P336, DOI 10.1183/09031936.05.00082904; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Perfect MM, 2013, SLEEP, V36, P517, DOI 10.5665/sleep.2536; Prevention CfDCa, CLIN GROWTH CHARTS; Raslich MA, 2007, BIOCHEM MEDICA, V17, P151; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Rollof L, 2012, J PEDIATR ENDOCR MET, V25, P125, DOI 10.1515/JPEM.2011.440; Sattoe JNT, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-10; Spilsbury JC, 2014, SLEEP; Tapia IE, 2013, PAEDIATR RESPIR REV, V14, P199, DOI 10.1016/j.prrv.2012.05.006; Taylor SJC, 2001, PAEDIATR PERINAT EP, V15, P88; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Vetter TR, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-85; Willis BH, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000746; Witmans MB, 2003, AM J RESP CRIT CARE, V168, P1540, DOI 10.1164/ajrccm.168.12.954; Wu Y, 2001, J ADOLESCENT HEALTH, V28, P197, DOI 10.1016/S1054-139X(00)00163-4; Xu ZF, 2008, CHEST, V133, P684, DOI 10.1378/chest.07-1611	41	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142242	10.1371/journal.pone.0142242	http://dx.doi.org/10.1371/journal.pone.0142242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581088	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600041
J	Ke, CF; Hou, Y; Zhang, HY; Yang, K; Wang, JT; Guo, B; Zhang, F; Li, HL; Zhou, XH; Li, Y; Li, K				Ke, Chaofu; Hou, Yan; Zhang, Haiyu; Yang, Kai; Wang, Jingtao; Guo, Bing; Zhang, Fan; Li, Hailong; Zhou, Xiaohua; Li, Ying; Li, Kang			Plasma Metabolic Profiles in Women are Menopause Dependent	PLOS ONE			English	Article							OVARIAN-CANCER; SPECTROMETRY DATA; MASS; IDENTIFICATION; BIOMARKERS; DENSITY; CELL	Menopause is an endocrinological transition that greatly affects health and disease susceptibility in middle-aged and elderly women. To gain new insights into the metabolic process of menopause, plasma metabolic profiles in 115 pre-and post-menopausal women were systematically analyzed by ultra-performance liquid chromatography/mass spectrometry in conjunction with univariate and multivariate statistical analysis. Metabolic signatures revealed considerable differences between pre-and post-menopausal women, and clear separations were observed between the groups in partial least-squares discriminant analysis score plots. In total, 28 metabolites were identified as potential metabolite markers for menopause, including up-regulated acylcarnitines, fatty acids, lysophosphatidylcholines, lysophosphatidylethanolamines, and down-regulated pregnanediol-3-glucuronide, dehydroepiandrosterone sulfate, p-hydroxyphenylacetic acid and dihydrolipoic acid. These differences highlight that significant alterations occur in fatty acid beta-oxidation, phospholipid metabolism, hormone metabolism and amino acid metabolism in post-menopausal women. In conclusion, our plasma metabolomics study provides novel understanding of the metabolic profiles related to menopause, and will be useful for investigating menopause-related diseases and assessing metabolomic confounding factors.	[Ke, Chaofu; Hou, Yan; Zhang, Haiyu; Yang, Kai; Wang, Jingtao; Guo, Bing; Zhang, Fan; Li, Hailong; Li, Kang] Harbin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Harbin 150086, Peoples R China; [Zhou, Xiaohua] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Li, Ying] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin 150086, Peoples R China	Harbin Medical University; University of Washington; University of Washington Seattle; Harbin Medical University	Li, Y (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin 150086, Peoples R China.	liying_helen@163.com; likang@ems.hrbmu.edu.cn		Zhou, Xiaohua/0000-0001-7935-1222	National Natural Science Foundation of China [NSFC 81473072, 81172767]; Specialized Research Fund for the Doctoral Program of Higher Education of China [SRFDP 20122307110004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Financial support by grants from the National Natural Science Foundation of China (NSFC 81473072, 81172767, http://www.nsfc.gov.cn/) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP 20122307110004, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm) are gratefully acknowledged. Kang Li is the recipient of all three funders.; Financial support by grants from the National Natural Science Foundation of China (NSFC 81473072, 81172767) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (SRFDP 20122307110004) are gratefully acknowledged.	Auro K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5708; Bulati Matteo, 2008, Immun Ageing, V5, P9, DOI 10.1186/1742-4933-5-9; Fong MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019963; Hsu YH, 2006, AM J CLIN NUTR, V83, P146; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Ke CF, 2015, INT J CANCER, V136, P516, DOI 10.1002/ijc.29010; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Magnusson M, 2013, EUR HEART J, V34, P1982, DOI 10.1093/eurheartj/ehs424; Ng DJY, 2011, METABOLOMICS, V7, P155, DOI 10.1007/s11306-010-0250-7; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Oliveira PJ, 2012, J LIPIDS, V2012, DOI 10.1155/2012/365798; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Rizzoli R, 2001, J MOL ENDOCRINOL, V26, P79, DOI 10.1677/jme.0.0260079; Sammaritano LR, 2012, AUTOIMMUN REV, V11, pA430, DOI 10.1016/j.autrev.2011.11.006; Shufelt C, 2010, J CLIN ENDOCR METAB, V95, P4985, DOI 10.1210/jc.2010-0143; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; STOKES J, 1987, CIRCULATION, V75, P65; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Sun M, 2013, MOL BIOSYST, V9, P3059, DOI 10.1039/c3mb70216b; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Twiss JJ, 2007, J AM ACAD NURSE PRAC, V19, P602, DOI 10.1111/j.1745-7599.2007.00260.x; Wang CS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05383; Warburton Darren E R, 2007, Vasc Health Risk Manag, V3, P673; Watanabe T, 2002, J CARDIOVASC PHARM, V39, P449, DOI 10.1097/00005344-200203000-00017; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yamatani H, 2014, MENOPAUSE, V21, P170, DOI 10.1097/GME.0b013e318296431a; Yang J, 2013, MOL PSYCHIATR, V18, P67, DOI 10.1038/mp.2011.131; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x; Zhang HY, 2015, MOL BIOSYST, V11, P516, DOI 10.1039/c4mb00407h; Zhang T, 2013, J PROTEOME RES, V12, P505, DOI 10.1021/pr3009572; Zheng H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/537157; Zhou MS, 2010, CANCER EPIDEM BIOMAR, V19, P2262, DOI 10.1158/1055-9965.EPI-10-0126	33	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141743	10.1371/journal.pone.0141743	http://dx.doi.org/10.1371/journal.pone.0141743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580805	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600021
J	Pialasse, JP; Descarreaux, M; Mercier, P; Blouin, J; Simoneau, M				Pialasse, Jean-Philippe; Descarreaux, Martin; Mercier, Pierre; Blouin, Jean; Simoneau, Martin			The Vestibular-Evoked Postural Response of Adolescents with Idiopathic Scoliosis Is Altered	PLOS ONE			English	Article							LORDOSIS BEHAVIOR; BALANCE REACTIONS; STIMULATION; ORGANIZATION; SENSITIVITY; INTEGRATION; MECHANISMS; INCREASES; VELOCITY; ETIOLOGY	Adolescent idiopathic scoliosis is a multifactorial disorder including neurological factors. A dysfunction of the sensorimotor networks processing vestibular information could be related to spine deformation. This study investigates whether feed-forward vestibulomotor control or sensory reweighting mechanisms are impaired in adolescent scoliosis patients. Vestibular evoked postural responses were obtained using galvanic vestibular stimulation while participants stood with their eyes closed and head facing forward. Lateral forces under each foot and lateral displacement of the upper body of adolescents with mild (n = 20) or severe (n = 16) spine deformation were compared to those of healthy control adolescents (n = 16). Adolescent idiopathic scoliosis patients demonstrated greater lateral displacement and net lateral forces than controls both during and immediately after vestibular stimulation. Altered sensory reweighting of vestibular and proprioceptive information changed balance control of AIS patients during and after vestibular stimulation. Therefore, scoliosis onset could be related to abnormal sensory reweighting, leading to altered sensorimotor processes.	[Pialasse, Jean-Philippe; Simoneau, Martin] Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada; [Pialasse, Jean-Philippe; Simoneau, Martin] CHU Quebec, Ctr Rech, Quebec City, PQ, Canada; [Descarreaux, Martin] Univ Quebec Trois Rivieres, Dept Sci Act Phys, Trois Rivieres, PQ GA9 5H7, Canada; [Mercier, Pierre] Clin Orthopedie Infantile Quebec, Quebec City, PQ, Canada; [Blouin, Jean] Aix Marseille Univ, Lab Neurosci Cognit, FR 3C 3512, CNRS, Marseille, France	Laval University; Laval University; University of Quebec; University of Quebec Trois Rivieres; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Simoneau, M (corresponding author), Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada.	martin.simoneau@kin.ulaval.ca	Simoneau, Martin/AAE-3727-2020	Simoneau, Martin/0000-0003-3207-1973; Descarreaux, Martin/0000-0002-3545-5860; Blouin, Jean/0000-0002-8118-8994	Fondation Yves Cotrel-Institut de France; Fondation Chiropratique du Quebec; Ordre des chiropraticiens du Quebec; Fonds de Recherche du Quebec en Sante; European Chiropractic Union	Fondation Yves Cotrel-Institut de France; Fondation Chiropratique du Quebec; Ordre des chiropraticiens du Quebec; Fonds de Recherche du Quebec en Sante(Fonds de la Recherche en Sante du Quebec); European Chiropractic Union	Funding for this study was provided by a research grant from the Fondation Yves Cotrel-Institut de France (MS and JB). The first author (JPP) received scholarships (JPP) from the Fondation Chiropratique du Quebec and the Ordre des chiropraticiens du Quebec in partnership with the Fonds de Recherche du Quebec en Sante and from the European Chiropractic Union.	ADLER N, 1986, J ORTHOPAED RES, V4, P102, DOI 10.1002/jor.1100040113; Ali AS, 2003, J PHYSIOL-LONDON, V546, P615, DOI 10.1113/jphysiol.2002.030031; Ardic FN, 2000, ACTA OTO-LARYNGOL, V120, P39; BARRIOS C, 1992, INT ORTHOP, V16, P146, DOI 10.1007/BF00180206; BARRIOS C, 1987, SPINE, V12, P433, DOI 10.1097/00007632-198706000-00003; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; BYL NN, 1993, J ORTHOP RES, V11, P215, DOI 10.1002/jor.1100110209; Byl NN, 1997, J ORTHOP SPORT PHYS, V26, P60, DOI 10.2519/jospt.1997.26.2.60; Day BL, 2002, BRAIN, V125, P2081, DOI 10.1093/brain/awf212; Domenech J, 2011, EUR SPINE J, V20, P1069, DOI 10.1007/s00586-011-1776-8; Gauchard GC, 2001, SPINE, V26, P1052, DOI 10.1097/00007632-200105010-00014; GENTINE A, 1990, ACTA OTO-LARYNGOL, V110, P328, DOI 10.3109/00016489009122556; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; Haumont T, 2011, SPINE, V36, pE847, DOI 10.1097/BRS.0b013e3181ff5837; HERMAN R, 1985, SPINE, V10, P1, DOI 10.1097/00007632-198501000-00001; Horak FB, 2001, J NEUROPHYSIOL, V86, P575, DOI 10.1152/jn.2001.86.2.575; Lambert FM, 2013, J NEUROSCI, V33, P6845, DOI 10.1523/JNEUROSCI.4842-12.2013; Lambert FM, 2009, J NEUROSCI, V29, P12477, DOI 10.1523/JNEUROSCI.2583-09.2009; Lion A, 2013, SPINE, V38, P238, DOI 10.1097/BRS.0b013e31826a3b05; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; Manzoni D, 2002, ARCH ITAL BIOL, V140, P67; Marsden JF, 2005, J NEUROL NEUROSUR PS, V76, P670, DOI 10.1136/jnnp.2004.046565; Marsden JF, 2003, J PHYSIOL-LONDON, V548, P949, DOI 10.1113/jphysiol.2002.029991; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; SAHLSTRAND T, 1978, ACTA ORTHOP SCAND, V49, P354, DOI 10.3109/17453677809050088; SAHLSTRAND T, 1980, SCAND J REHABIL MED, V12, P25; SAHLSTRAND T, 1979, ACTA ORTHOP SCAND, V50, P275, DOI 10.3109/17453677908989768; SAHLSTRAND T, 1980, SPINE, V5, P512, DOI 10.1097/00007632-198011000-00005; SCHWARTZGIBLIN S, 1984, EXP NEUROL, V85, P297, DOI 10.1016/0014-4886(84)90142-0; SCHWARTZGIBLIN S, 1984, BRAIN RES, V299, P247, DOI 10.1016/0006-8993(84)90706-6; SIEGEL JM, 1983, J NEUROPHYSIOL, V50, P696, DOI 10.1152/jn.1983.50.3.696; Simoneau M, 2006, EXP BRAIN RES, V170, P576, DOI 10.1007/s00221-005-0246-0; Simoneau M, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-68; Simoneau M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-102; WANG Wen, 2011, J METEOROL ENV, V27, P1, DOI DOI 10.1097/BP0.0B013E3181F73C12; Wardman DL, 2003, J PHYSIOL-LONDON, V547, P293, DOI 10.1113/jphysiol.2002.030767; WEINSTEIN SL, 1994, J PEDIATR ORTHOPED, V14, P561, DOI 10.1097/01241398-199409000-00001; Wiener-Vacher SR, 1998, J PEDIATR-US, V132, P1028, DOI 10.1016/S0022-3476(98)70403-2; YAMADA K, 1984, CLIN ORTHOP RELAT R, P50; [No title captured]	42	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143124	10.1371/journal.pone.0143124	http://dx.doi.org/10.1371/journal.pone.0143124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580068	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600087
J	te Molder, L; Sonnenberg, A				te Molder, Lisa; Sonnenberg, Arnoud			PKD2 and RSK1 Regulate Integrin beta 4 Phosphorylation at Threonine 1736	PLOS ONE			English	Article							PROTEIN-KINASE; EPIDERMOLYSIS-BULLOSA; CYTOPLASMIC DOMAIN; IN-VITRO; ALPHA-6-BETA-4; ACTIVATION; PLECTIN; SUBUNIT; SKIN; HEMIDESMOSOMES	The integrin alpha 6 beta 4, a major component of hemidesmosomes (HDs), stabilizes keratinocyte cell adhesion to the epidermal basement membrane through binding to the cytoskeletal linker protein plectin and association with keratin filaments. Disruption of the alpha 6 beta 4-plectin interaction through phosphorylation of the beta 4 subunit results in a reduction in adhesive strength of keratinocytes to laminin-332 and the dissolution of HDs. Previously, we have demonstrated that phosphorylation of T1736 in the C-terminal end of the beta 4 cytoplasmic domain disrupts the interaction of beta 4 with the plakin domain of plectin. Furthermore, we showed that beta 4-T1736 can be phosphorylated by PKD1 in vitro, and although both PMA and EGF induced T1736 phosphorylation, only PMA was able to activate PKD1. Here, we show that depletion of [Ca2+](i) augments PMA- and EGF-induced phosphorylation of beta 4-T1736 and that this is caused by inhibition of the calcium-sensitive protein phosphatase calcineurin and augmentation of ERK1/2 activation. We also show that in keratinocytes the PMA-stimulated phosphorylation of beta 4-T1736 primarily is mediated by PKD2 activation downstream of PKC delta. On the other hand, both the EGF-stimulated phosphorylation of T1736 and the EGF-induced dissolution of HDs are dependent on a functional MAPK signaling pathway, and treatment with the RSK inhibitor BI-D1870 prevented EGF-stimulated phosphorylation of beta 4-T1736. Moreover, phosphorylation of beta 4-T1736 is enhanced by overexpression of wild-type RSK1, while it is reduced by the expression of kinase-inactive RSK1 or by siRNA-mediated depletion of RSK1. In summary, our data indicate that different stimuli can lead to the phosphorylation of beta 4-T1736 by either PKD2 or RSK1.	[te Molder, Lisa; Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Sonnenberg, A (corresponding author), Netherlands Canc Inst, Div Cell Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.sonnenberg@nki.nl			Dutch Cancer Society [2009-4485]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by a grant (2009-4485) from the Dutch Cancer Society. The funder had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Alt A, 2004, BIOCHEM BIOPH RES CO, V314, P17, DOI 10.1016/j.bbrc.2003.12.053; Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bouameur JE, 2013, J CELL SCI, V126, P4195, DOI 10.1242/jcs.127779; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Ji QS, 2000, ONCOGENE, V19, P1853, DOI 10.1038/sj.onc.1203517; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kashyap T, 2012, J BIOL CHEM, V287, P32440, DOI 10.1074/jbc.M112.385245; Koster J, 2003, J CELL SCI, V116, P387, DOI 10.1242/jcs.00241; Koster J, 2001, J INVEST DERMATOL, V117, P1405, DOI 10.1046/j.0022-202x.2001.01567.x; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Niessen CM, 1997, MOL BIOL CELL, V8, P555, DOI 10.1091/mbc.8.4.555; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; Ohkura K, 1998, BIOL PHARM BULL, V21, P1; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Seltmann K, 2013, J INVEST DERMATOL, V133, P181, DOI 10.1038/jid.2012.256; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; Uitto J, 2001, ARCH DERMATOL, V137, P1458; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	41	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143357	10.1371/journal.pone.0143357	http://dx.doi.org/10.1371/journal.pone.0143357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580203	Green Submitted, gold, Green Published			2022-12-26	WOS:000365154600115
J	Guo, JP; Pan, JX; Xiong, L; Xia, WF; Cui, S; Xiong, WC				Guo, Jun-Peng; Pan, Jin-Xiu; Xiong, Lei; Xia, Wen-Fang; Cui, Shun; Xiong, Wen-Cheng			Iron Chelation Inhibits Osteoclastic Differentiation In Vitro and in Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							OSTEOPOROSIS; OVERLOAD	Patients of Alzheimer's disease (AD) frequently have lower bone mineral density and higher rate of hip fracture. Tg2576, a well characterized AD animal model that ubiquitously express Swedish mutant amyloid precursor protein (APPswe), displays not only AD-relevant neuropathology, but also age-dependent bone deficits. However, the underlying mechanisms remain poorly understood. As APP is implicated as a regulator of iron export, and the metal chelation is considered as a potential therapeutic strategy for AD, we examined iron chelation's effect on the osteoporotic deficit in Tg2576 mice. Remarkably, in vivo treatment with iron chelator, clinoquinol (CQ), increased both trabecular and cortical bone-mass, selectively in Tg2576, but not wild type (WT) mice. Further in vitro studies showed that low concentrations of CQ as well as deferoxamine (DFO), another iron chelator, selectively inhibited osteoclast (OC) differentiation, without an obvious effect on osteoblast (OB) differentiation. Intriguingly, both CQ and DFO's inhibitory effect on OC was more potent in bone marrow macrophages (BMMs) from Tg2576 mice than that of wild type controls. The reduction of intracellular iron levels in BMMs by CQ was also more dramatic in APPswe-expressing BMMs. Taken together, these results demonstrate a potent inhibition on OC formation and activation in APPswe-expressing BMMs by iron chelation, and reveal a potential therapeutic value of CQ in treating AD-associated osteoporotic deficits.	[Guo, Jun-Peng; Pan, Jin-Xiu; Xiong, Lei; Xia, Wen-Fang; Cui, Shun; Xiong, Wen-Cheng] Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Guo, Jun-Peng; Pan, Jin-Xiu; Xiong, Lei; Xia, Wen-Fang; Cui, Shun; Xiong, Wen-Cheng] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Guo, Jun-Peng; Xiong, Lei; Xiong, Wen-Cheng] Charlie Norwood VA Med Ctr, Augusta, GA USA; [Guo, Jun-Peng] Changchun Univ Chinese Med, Dept Pathol, Changchun, Jilin, Peoples R China; [Xia, Wen-Fang; Cui, Shun] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Rheumatol, Wuhan 430074, Peoples R China	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Changchun University of Chinese Medicine; Huazhong University of Science & Technology	Xiong, WC (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA.	wxiong@gru.edu	PAN, JIN-XIU/O-4840-2019	Pan, Jinxiu/0000-0003-4013-1390; Xiong, Wen-Cheng/0000-0001-9071-7598	Department of Veterans Affairs [BX000838]; Veterans Affairs [I01BX000838] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grant from Department of Veterans Affairs (WCX).; We thank members of the Xiong laboratory for helpful discussions. This study was supported by grant from Department of Veterans Affairs (BX000838 to WCX).	Ayton S, 2013, FREE RADICAL BIO MED, V62, P76, DOI 10.1016/j.freeradbiomed.2012.10.558; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cui S, 2011, J BONE MINER RES, V26, P1084, DOI 10.1002/jbmr.299; De Domenico I, 2011, SEMIN LIVER DIS, V31, P272, DOI 10.1055/s-0031-1286058; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; Kim H, 2013, CELL METAB, V17, P249, DOI 10.1016/j.cmet.2013.01.002; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; MELTON LJ, 1994, J AM GERIATR SOC, V42, P614, DOI 10.1111/j.1532-5415.1994.tb06859.x; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Pauk M, 2015, INT ORTHOP, V39, P161, DOI 10.1007/s00264-014-2550-4; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Roodman GD, 2009, CELL METAB, V9, P405, DOI 10.1016/j.cmet.2009.04.005; Rossi F, 2014, HAEMATOLOGICA, V99, P1876, DOI 10.3324/haematol.2014.104463; Steven L., 2000, SCIENCE, V289, P1504; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Tysiewicz-Dudek Marzena, 2008, Ortop Traumatol Rehabil, V10, P315; Voronov I, 2013, J BONE MINER RES, V28, P108, DOI 10.1002/jbmr.1727; Wright I, 2013, J PHYSIOL BIOCHEM, V69, P889, DOI 10.1007/s13105-013-0266-3; Xia WF, 2013, J BONE MINER RES, V28, P2122, DOI 10.1002/jbmr.1954; Zatta P, 2009, TRENDS PHARMACOL SCI, V30, P346, DOI 10.1016/j.tips.2009.05.002; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947; Zhou Z, 2008, J BONE MINER RES, V23, P1084, DOI 10.1359/JBMR.080234	30	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0139395	10.1371/journal.pone.0139395	http://dx.doi.org/10.1371/journal.pone.0139395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575486	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400003
J	Oreshkova, N; Schreur, PJW; Spel, L; Vloet, RPM; Moormann, RJM; Boes, M; Kortekaas, J				Oreshkova, Nadia; Schreur, Paul J. Wichgers; Spel, Lotte; Vloet, Rianka P. M.; Moormann, Rob J. M.; Boes, Marianne; Kortekaas, Jeroen			Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; MESSENGER-RNA; RECYCLING COMPARTMENT; INTERFERON-PRODUCTION; CROSS-PRESENTATION; NSS PROTEIN; HUMAN BLOOD; APOPTOSIS; DEGRADATION; RECEPTORS	Vaccines based on nonspreading Rift Valley fever virus (NSR) induce strong humoral and robust cellular immune responses with pronounced Th1 polarisation. The present work was aimed to gain insight into the molecular basis of NSR-mediated immunity. Recent studies have demonstrated that wild-type Rift Valley fever virus efficiently targets and replicates in dendritic cells (DCs). We found that NSR infection of cultured human DCs results in maturation of DCs, characterized by surface upregulation of CD40, CD80, CD86, MHC-I and MHC-II and secretion of the proinflammatory cytokines IFN-beta, IL-6 and TNF. Interestingly, expression of the most prominent marker of DC maturation, CD83, was consistently downregulated at 24 hours post infection. Remarkably, NSR infection also completely abrogated CD83 upregulation by LPS. Downregulation of CD83 was not associated with reduced mRNA levels or impaired CD83 mRNA transport from the nucleus and could not be prevented by inhibition of the proteasome or endocytic degradation pathways, suggesting that suppression occurs at the translational level. In contrast to infected cells, bystander DCs displayed full maturation as evidenced by upregulation of CD83. Our results indicate that bystander DCs play an important role in NSR-mediated immunity.	[Oreshkova, Nadia; Schreur, Paul J. Wichgers; Vloet, Rianka P. M.; Moormann, Rob J. M.; Kortekaas, Jeroen] Univ Wageningen & Res Ctr, Cent Vet Inst, Dept Virol, Lelystad, Netherlands; [Oreshkova, Nadia; Moormann, Rob J. M.] Univ Utrecht, Fac Vet Med, Div Virol, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Spel, Lotte; Boes, Marianne] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Lab Translat Immunol, Utrecht, Netherlands	Wageningen University & Research; Utrecht University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Kortekaas, J (corresponding author), Univ Wageningen & Res Ctr, Cent Vet Inst, Dept Virol, Lelystad, Netherlands.	jeroen.kortekaas@wur.nl	Spel, Lotte/AAC-2125-2022	Boes, Marianne/0000-0003-2590-1692; Oreshkova, Nadia/0000-0001-8830-7055	Dutch Ministry of Economic Affairs [KB-12-004.02-003]; RM	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); RM	This work was supported by the Dutch Ministry of Economic Affairs, project code KB-12-004.02-003, and the recipient of the grant was RM.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Cao WP, 2005, BIOCHEM J, V385, P85, DOI 10.1042/BJ20040741; Chemnitz J, 2010, IMMUNOBIOLOGY, V215, P370, DOI 10.1016/j.imbio.2009.05.008; del Prete MJ, 2002, FASEB J, V16, P2003, DOI 10.1096/fj.02-0392fje; Dodd KA, 2012, J VIROL, V86, P4204, DOI 10.1128/JVI.07104-11; Durrbach A, 1996, J CELL SCI, V109, P457; Ehlers C, 2013, NUCLEIC ACIDS RES, V41, P206, DOI 10.1093/nar/gks1069; Ermler ME, 2013, J VIROL, V87, P4846, DOI 10.1128/JVI.01997-12; Flinsenberg TWH, 2012, BLOOD, V120, P5163, DOI 10.1182/blood-2012-06-434498; Gommet C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001421; Haas T., 2012, J MED MICROB DIAGN, V1, P4, DOI [10.4172/2161-0703.1000117., DOI 10.4172/2161-0703.1000117, 10.4172/2161-0703.1000117]; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Hirano N, 2006, BLOOD, V107, P1528, DOI 10.1182/blood-2005-05-2073; Ignatius R, 2000, J VIROL, V74, P11329, DOI 10.1128/JVI.74.23.11329-11338.2000; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Klein E, 2005, INT IMMUNOL, V17, P477, DOI 10.1093/intimm/dxh228; Kortekaas J, 2014, VACCINE, V32, P4901, DOI 10.1016/j.vaccine.2014.07.037; Kortekaas J, 2012, VACCINE, V30, P3423, DOI 10.1016/j.vaccine.2012.03.027; Kortekaas J, 2011, J VIROL, V85, P12622, DOI 10.1128/JVI.00841-11; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Kummer M, 2007, J VIROL, V81, P6326, DOI 10.1128/JVI.02327-06; Kuss SK, 2013, VIRUSES-BASEL, V5, P1824, DOI 10.3390/v5071824; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Leitner WW, 2004, VACCINE, V22, P1537, DOI 10.1016/j.vaccine.2003.10.013; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Luft T, 1998, J IMMUNOL, V161, P1947; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; Mc Dermott R, 2002, MOL BIOL CELL, V13, P317, DOI 10.1091/mbc.01-06-0300; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moran TP, 2005, J IMMUNOL, V175, P3431, DOI 10.4049/jimmunol.175.5.3431; Nishimoto KP, 2007, VIRAL IMMUNOL, V20, P88, DOI 10.1089/vim.2006.0090; Oreshkova N, 2015, J VIROL, V89, P9124, DOI 10.1128/JVI.01105-15; Oreshkova N, 2014, VACCINE, V32, P5323, DOI 10.1016/j.vaccine.2014.07.051; Oreshkova N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077461; Pascutti MF, 2011, J VIROL, V85, P5532, DOI 10.1128/JVI.02267-10; Pieper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023290; Prechtel AT, 2007, ARCH DERMATOL RES, V299, P59, DOI 10.1007/s00403-007-0743-z; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Racanelli V, 2004, IMMUNITY, V20, P47, DOI 10.1016/S1074-7613(03)00353-4; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Roberts KK, 2015, J GEN VIROL, V96, P1651, DOI 10.1099/vir.0.000119; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Servet-Delprat C, 2000, J VIROL, V74, P4387, DOI 10.1128/JVI.74.9.4387-4393.2000; Steinbrink K, 1999, BLOOD, V93, P1634, DOI 10.1182/blood.V93.5.1634.405k11_1634_1642; Thomas MP, 2015, CELL REP, V11, P1079, DOI 10.1016/j.celrep.2015.04.026; Vander Veen Ryan L., 2012, Animal Health Research Reviews, V13, P1, DOI 10.1017/S1466252312000011; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	63	3	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142670	10.1371/journal.pone.0142670	http://dx.doi.org/10.1371/journal.pone.0142670			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575844	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400015
J	Abbas, M; Kushwaha, VS; Srivastava, K; Banerjee, M				Abbas, Mohammad; Kushwaha, Vandana Singh; Srivastava, Kirti; Banerjee, Monisha			Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation	PLOS ONE			English	Article							CELL LUNG-CANCER; P1 POLYMORPHISMS; GST-PI; SURVIVAL; ASSOCIATION; CHEMOTHERAPY; CISPLATIN; RISK; M1; T1	Purpose Cisplatin based concomitant chemoradiation (CRT) is the standard treatment for locally advanced cervical cancer (CC). Glutathione S-transferase (GST), a phase II antioxidant enzyme is induced by oxidative stress generated by drugs and reactive oxidants. The present study was undertaken to evaluate the association of GSTM1, T1 and P1 polymorphisms with the outcome of CRT treatment in CC patients. Methods A total of 227 cervical cancer patients with stages IIB-IIIB treated with the same chemoradiotherapy regimen were enrolled and genotyped for GSTM1, T1 and P1 gene polymorphisms by multiplex polymerase chain reaction (mPCR) and PCR-restriction fragment length polymorphism (PCR-RFLP). Overall survival was evaluated using Kaplan-Meier survival function and Cox proportional hazards model. All data were analyzed using SPSS (version 21.0). Results Stratified analysis showed that GSTM1 null (M1-) genotype was associated with a significantly better survival among patients with stage IIB cervical cancer (log-rank P = 0.004) than cases with stage IIIA/IIIB. Death and recurrence were significantly higher in patients with GSTM1 present genotype (M1+) (P = 0.037 and P = 0.003 respectively) and those with M1-showed reduced hazard of death with an adjusted hazard ratio 'HR' of 0.47 (95% CI, 0.269-0.802, P = 0.006). Women with M1-genotype as well as in combination with GSTT1 null (T1-), GSTP1 (AG+GG) and GSTT1 null/GSTP1 (AG+GG) showed better survival and also reduced risk of death (HR = 0.31, P = 0.016; HR = 0.45, P = 0.013; HR = 0.31, P = 0.02 respectively). Conclusions To the best of our knowledge, this is the first study to correlate the association of GSTM1, T1 and P1 gene polymorphisms with treatment outcome of CRT treated CC patients. Our results suggested that individuals with GSTM1 null genotype and in combination with GSTT1 null and GSTP1 (AG+GG) had a survival advantage. Such genetic studies may provide prognostic information in CRT treated CC patients.	[Abbas, Mohammad; Banerjee, Monisha] Univ Lucknow, Dept Zool, Mol & Human Genet Lab, Lucknow 226007, Uttar Pradesh, India; [Kushwaha, Vandana Singh; Srivastava, Kirti] King Georges Med Univ, Dept Radiotherapy, Lucknow 226003, Uttar Pradesh, India	Lucknow University; King George's Medical University	Banerjee, M (corresponding author), Univ Lucknow, Dept Zool, Mol & Human Genet Lab, Lucknow 226007, Uttar Pradesh, India.	banerjee_monisha30@rediffmail.com	Banerjee, Monisha/AAP-2485-2020	Banerjee, Monisha/0000-0002-5371-8791	Council of Science and Technology, Uttar Pradesh, India; Centre of Excellence (Higher Education) Uttar Pradesh, Lucknow, India; Indian Council of Medical Research, New Delhi, India; Department of Science and Technology, New Delhi, India; Council of Science and Technology-Uttar Pradesh (CST-UP); Centre of Excellence (Higher Education) UP Govt., Lucknow, India; Indian Council of Medical Research (ICMR); Department of Science and Technology (DST), New Delhi, India; ICMR	Council of Science and Technology, Uttar Pradesh, India; Centre of Excellence (Higher Education) Uttar Pradesh, Lucknow, India; Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); Council of Science and Technology-Uttar Pradesh (CST-UP); Centre of Excellence (Higher Education) UP Govt., Lucknow, India; Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); ICMR(Indian Council of Medical Research (ICMR))	This work was supported by the Council of Science and Technology, Uttar Pradesh, India; Centre of Excellence (Higher Education) Uttar Pradesh, Lucknow, India; Indian Council of Medical Research, New Delhi, India; and Department of Science and Technology, New Delhi, India.; We thank the Council of Science and Technology-Uttar Pradesh (CST-UP) and Centre of Excellence (Higher Education) UP Govt., Lucknow, India; Indian Council of Medical Research (ICMR) and Department of Science and Technology (DST), New Delhi, India for their financial support. M. A. is thankful to ICMR for research fellowship.	Abbas M, 2013, IJBR, V4, P1; Abbas M, 2014, EUR J OBSTET GYN R B, V176, P68, DOI 10.1016/j.ejogrb.2014.02.036; Ambrosone CB, 2001, CANCER RES, V61, P7130; Ambrosone CB, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1526; Ban N, 1996, CANCER RES, V56, P3577; Cheng XD, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-91; Davies SM, 2001, J CLIN ONCOL, V19, P1279, DOI 10.1200/JCO.2001.19.5.1279; Duggan C, 2013, SPRINGERPLUS, V2, P1; Economopoulos KP, 2010, INT J GYNECOL CANCER, V20, P732, DOI 10.1111/IGC.0b013e3181dedeb5; Ekhart C, 2009, CANCER TREAT REV, V35, P18, DOI 10.1016/j.ctrv.2008.07.003; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Fodale V, 2011, CANCER J, V17, P89, DOI 10.1097/PPO.0b013e318212dd3d; Goekkurt E, 2006, BRIT J CANCER, V94, P281, DOI 10.1038/sj.bjc.6602891; Goto S, 1999, FREE RADICAL RES, V31, P549, DOI 10.1080/10715769900301121; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Hareyama M, 2002, CANCER, V94, P2217, DOI 10.1002/cncr.10473; Hellman S, 1993, CANC PRINCIPLES PRAC, P248; Hirano T, 2005, INT J CANCER, V117, P460, DOI 10.1002/ijc.21172; Howells REJ, 1998, CLIN CANCER RES, V4, P2439; Jiao L, 2007, CANCER-AM CANCER SOC, V109, P840, DOI 10.1002/cncr.22468; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Lallas TA, 2000, CANCER EPIDEM BIOMAR, V9, P587; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; MCLEOD HL, 2003, P AN M AM SOC CLIN, V22, P253; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nogueira A, 2012, GENE, V504, P279, DOI 10.1016/j.gene.2012.05.037; Noordhuis MG, 2011, INT J RADIAT ONCOL, V79, P325, DOI 10.1016/j.ijrobp.2010.09.043; Okcu MF, 2004, CLIN CANCER RES, V10, P2618, DOI 10.1158/1078-0432.CCR-03-0053; Rednam S, 2013, PEDIATR BLOOD CANCER, V60, P593, DOI 10.1002/pbc.24366; Rolland D, 2010, ANTICANCER RES, V30, P3951; Ryu JS, 2004, LUNG CANCER, V44, P311, DOI 10.1016/j.lungcan.2003.11.019; Stanulla M, 2000, BLOOD, V95, P1222, DOI 10.1182/blood.V95.4.1222.004k20_1222_1228; Stoehlmacher J, 2002, J NATL CANCER I, V94, P936; Sun XX, 2013, J BIOL CHEM, V288, P8826, DOI 10.1074/jbc.M112.429316; Sweeney C, 2003, CANCER EPIDEM BIOMAR, V12, P527; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tulsyan S, 2013, MOL DIAGN THER, V17, P371, DOI 10.1007/s40291-013-0045-4; Vale C, 2008, J CLIN ONCOL, V26, P5802, DOI 10.1200/JCO.2008.16.4368; Wang JR, 2011, ONCOL REP, V26, P1081, DOI 10.3892/or.2011.1405; Xiang Fenggang, 2007, Zhongguo Fei Ai Za Zhi, V10, P398, DOI 10.3779/j.issn.1009-3419.2007.05.11; Yang YQ, 2009, HYPERTENSION, V54, P1360, DOI 10.1161/HYPERTENSIONAHA.109.139428	41	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142501	10.1371/journal.pone.0142501	http://dx.doi.org/10.1371/journal.pone.0142501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571237	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700045
J	Bozzetti, C; Quaini, F; Squadrilli, A; Tiseo, M; Frati, C; Lagrasta, C; Azzoni, C; Bottarelli, L; Galetti, M; Alama, A; Belletti, S; Gatti, R; Passaro, A; Gradilone, A; Cavazzoni, A; Alfieri, R; Petronini, PG; Bonelli, M; Falco, A; Carubbi, C; Pedrazzi, G; Nizzoli, R; Naldi, N; Pinto, C; Ardizzoni, A				Bozzetti, Cecilia; Quaini, Federico; Squadrilli, Anna; Tiseo, Marcello; Frati, Caterina; Lagrasta, Costanza; Azzoni, Cinzia; Bottarelli, Lorena; Galetti, Maricla; Alama, Angela; Belletti, Silvana; Gatti, Rita; Passaro, Antonio; Gradilone, Angela; Cavazzoni, Andrea; Alfieri, Roberta; Petronini, Pier Giorgio; Bonelli, Mara; Falco, Angela; Carubbi, Cecilia; Pedrazzi, Giuseppe; Nizzoli, Rita; Naldi, Nadia; Pinto, Carmine; Ardizzoni, Andrea			Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER; LEVEL	Introduction The exclusion of circulating tumor cells (CTCs) that have lost epithelial antigens during the epithelial-to-mesenchymal transition (EMT) process by using Epithelial Cell Adhesion Molecule (EpCAM) based capture methods is still a matter of debate. In this study, cells obtained after depletion procedure from blood samples of squamous cell lung cancer (SQCLC) patients were identified based on morphology and characterized with the combination of FISH assessment and immunophenotypic profile. Materials and Methods Five mL blood samples, collected from 55 advanced SQCLC patients, were analyzed by a non-EpCAM-based capture method. After depletion of leukocytes and erythroid cells, the negative fraction was characterized by both FISH using a fibroblast growth factor receptor 1 (FGFR1) probe and by immunocytochemistry. Thirty healthy donors were also tested. Results Based on morphology (nuclear dimension >= 10 mu m, shape and hypercromatic aspect) suspicious circulating cells clearly distinguishable from contaminant leukocytes were observed in 49/55 (89%) SQCLC patients. Thirty-four of the 44 (77%) samples evaluable for FGFR1 FISH showed >= 6 FGFR1 gene copy number on average per cell. Vimentin expression involved 43% (18/42) of pooled circulating SQCLC cells, whereas only 29% (14/48) were EpCAM positive. Confocal microscopy confirmed the localization of FGFR1 probe in suspicious circulating cells. Suspicious circulating elements were also observed in healthy donors and did not show any epithelial associated antigens. A significantly lower number of suspicious circulating cells in healthy donors compared to SQCLC patients was found. Conclusions Among the heterogeneous cell population isolated by depletion procedure, the coexistence of cells with epithelial and/or mesenchymal phenotype suggests that EMT may participate to transendothelial invasion and migration of tumor cells in advanced SQCLC. The finding of cells with neither EpCAM or EMT phenotype, retrieved after non-EpCAM-based systems, underlines the presence of suspicious elements in the blood of both SQCLC patients and healthy donors. Further phenotyping and molecular analyses are necessary to fully characterize these circulating elements.	[Bozzetti, Cecilia; Squadrilli, Anna; Tiseo, Marcello; Nizzoli, Rita; Naldi, Nadia] Univ Hosp Parma, Div Oncol, Parma, Italy; [Quaini, Federico; Frati, Caterina; Galetti, Maricla; Cavazzoni, Andrea; Alfieri, Roberta; Petronini, Pier Giorgio; Bonelli, Mara; Falco, Angela] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Lagrasta, Costanza; Belletti, Silvana; Gatti, Rita; Carubbi, Cecilia] Univ Parma, Dept Biomed Biotechnol & Translat Sci, I-43100 Parma, Italy; [Azzoni, Cinzia; Bottarelli, Lorena] Univ Hosp Parma, Ctr Mol & Translat Oncol COMT, Dept Biomed Biotechnol & Translat Sci, Anat Pathol Unit, Parma, Italy; [Alama, Angela] IRCCS AOU S Martino IST Natl Inst Canc Res, Lung Canc Unit, Genoa, Italy; [Passaro, Antonio] European Inst Oncol, Div Thorac Oncol, Milan, Italy; [Gradilone, Angela] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Pedrazzi, Giuseppe] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Pinto, Carmine] S Maria Nuova Hosp IRCCS, Div Med Oncol, Reggio Emilia, Italy; [Ardizzoni, Andrea] St Orsola Marcello Malpighi Hosp, Div Oncol, Bologna, Italy	University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Parma; University of Parma; University Hospital of Parma; University of Genoa; IRCCS AOU San Martino IST; IRCCS European Institute of Oncology (IEO); Sapienza University Rome; University of Parma; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Bozzetti, C (corresponding author), Univ Hosp Parma, Div Oncol, Parma, Italy.	cbozzetti@ao.pr.it	Pinto, Carmine/AAC-2184-2020; Galetti, Maricla/AAJ-8927-2020; Cavazzoni, Andrea/J-8079-2019; Alfieri, Roberta R/G-6350-2012; carubbi, cecilia/P-8112-2015; Tiseo, Marcello/K-6119-2016; Passaro, Antonio/M-1888-2016; Galetti, Maricla/CAG-4178-2022; ardizzoni, andrea/AAC-4337-2021; Alama, Angela/AAE-7203-2019	Pinto, Carmine/0000-0002-3159-5268; Galetti, Maricla/0000-0002-8061-8649; Cavazzoni, Andrea/0000-0002-3752-1868; carubbi, cecilia/0000-0003-4853-2658; Tiseo, Marcello/0000-0002-9553-8465; Passaro, Antonio/0000-0002-7575-3870; Galetti, Maricla/0000-0002-8061-8649; ardizzoni, andrea/0000-0003-2678-0714; Alama, Angela/0000-0002-9726-201X; BELLETTI, Silvana/0000-0003-0262-4485; Frati, Caterina/0000-0002-3343-6471	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan [IG-14214]	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan(Fondazione AIRC per la ricerca sul cancro)	The work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan grant IG-14214 (Andrea Ardizzoni). He has conceived and designed the experiments and contributed to the writing of the manuscript.	Alama A, 2014, DRUG DISCOV TODAY, V19, P1671, DOI 10.1016/j.drudis.2014.06.001; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Balasubramanian P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042048; Bozzetti C, 2012, RIV ITAL MED LAB, V8, P116; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Ilie M, 2012, ANN ONCOL, V23, P2907, DOI 10.1093/annonc/mds137; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405; Lin HC, 2013, CLIN CHIM ACTA, V419, P77, DOI 10.1016/j.cca.2013.01.018; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Marchetti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103883; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; Pailler E, 2015, ANN ONCOL, V26, P1408, DOI 10.1093/annonc/mdv165; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiseo M, 2015, CANCER TREAT REV, V41, P527, DOI 10.1016/j.ctrv.2015.04.011; Tomlinson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038972; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wu SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123976; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	27	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142891	10.1371/journal.pone.0142891	http://dx.doi.org/10.1371/journal.pone.0142891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571236	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700092
J	Frohlich, H; Bahamondez, G; Gotschel, F; Korf, U				Froehlich, Holger; Bahamondez, Gloria; Goetschel, Frank; Korf, Ulrike			Dynamic Bayesian Network Modeling of the Interplay between EGFR and Hedgehog Signaling	PLOS ONE			English	Article							FACTOR RECEPTOR PATHWAY; MUTUAL INFORMATION; CANCER; TRANSDUCTION; EXPRESSION; INDUCTION; INFERENCE; TARGET	Aberrant activation of sonic Hegdehog (SHH) signaling has been found to disrupt cellular differentiation in many human cancers and to increase proliferation. The SHH pathway is known to cross-talk with EGFR dependent signaling. Recent studies experimentally addressed this interplay in Daoy cells, which are presumable a model system for medulloblastoma, a highly malignant brain tumor that predominately occurs in children. Currently ongoing are several clinical trials for different solid cancers, which are designed to validate the clinical benefits of targeting the SHH in combination with other pathways. This has motivated us to investigate interactions between EGFR and SHH dependent signaling in greater depth. To our knowledge, there is no mathematical model describing the interplay between EGFR and SHH dependent signaling in medulloblastoma so far. Here we come up with a fully probabilistic approach using Dynamic Bayesian Networks (DBNs). To build our model, we made use of literature based knowledge describing SHH and EGFR signaling and integrated gene expression (Illumina) and cellular location dependent time series protein expression data (Reverse Phase Protein Arrays). We validated our model by sub-sampling training data and making Bayesian predictions on the left out test data. Our predictions focusing on key transcription factors and p70S6K, showed a high level of concordance with experimental data. Furthermore, the stability of our model was tested by a parametric bootstrap approach. Stable network features were in agreement with published data. Altogether we believe that our model improved our understanding of the interplay between two highly oncogenic signaling pathways in Daoy cells. This may open new perspectives for the future therapy of Hedghog/EGF-dependent solid tumors.	[Froehlich, Holger; Bahamondez, Gloria] Univ Bonn, Algorithm Bioinformat, Inst Comp Sci, Bonn Aachen Int Ctr IT B IT, Bonn, Germany; [Goetschel, Frank; Korf, Ulrike] German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany	University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ)	Frohlich, H (corresponding author), Univ Bonn, Algorithm Bioinformat, Inst Comp Sci, Bonn Aachen Int Ctr IT B IT, Bonn, Germany.	frohlich@bit.uni-bonn.de	Fröhlich, Holger/H-1976-2017	Fröhlich, Holger/0000-0002-5328-1243; Valderrama Bahamondez, Gloria Isabel/0000-0003-2462-3248	German Federal Ministry of Education and Science (BMBF) [0315394A/0315394B]	German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by German Federal Ministry of Education and Science (BMBF): grant numbers 0315394A/0315394B (http://pybios.molgen.mpg.de/MoGLI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brechbiel J, 2014, CANCER TREAT REV, V40, P750, DOI 10.1016/j.ctrv.2014.02.003; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Choi CH, 2012, BIOCHEM BIOPH RES CO, V418, P759, DOI 10.1016/j.bbrc.2012.01.095; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; de Campos LM, 2006, J MACH LEARN RES, V7, P2149; Dojer N., 2013, BIOINFORMATICS; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Eaton D, 2007, P MACHINE LEARNING R, V2, P107; Falkenstein KN, 2014, SEMIN CELL DEV BIOL, V33, P73, DOI 10.1016/j.semcdb.2014.05.010; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N., 1998, Uncertainty in Artificial Intelligence. Proceedings of the Fourteenth Conference (1998), P139; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P196; Ghahramani Z, 1998, LECT NOTES ARTIF INT, V1387, P168, DOI 10.1007/BFb0053999; Gotschel F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065403; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hill SM, 2012, BIOINFORMATICS, V28, P2804, DOI 10.1093/bioinformatics/bts514; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KOLLER D., 2009, PROBABILISTIC GRAPHI; Larsen P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-317; Law C, 2014, THESIS; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; Mukherjee S, 2008, P NATL ACAD SCI USA, V105, P14313, DOI 10.1073/pnas.0802272105; Vinh NX, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-131; Vinh NX, 2011, BIOINFORMATICS, V27, P2765, DOI 10.1093/bioinformatics/btr457; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pearl J, 1995, BIOMETRIKA, V82, P669, DOI 10.2307/2337329; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Phipson B., 2013, TECHNICAL REPORT; Praveen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067410; Riobo NA, 2006, CELL CYCLE, V5, P1612, DOI 10.4161/cc.5.15.3130; Robinson JW, 2010, J MACH LEARN RES, V11, P3647; Robinson RW., 1977, LECT NOTES MATH, P28, DOI DOI 10.1007/BFB0069178; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Tamada Y, 2003, BIOINFORMATICS, V19, pII227, DOI 10.1093/bioinformatics/btg1082; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	47	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142646	10.1371/journal.pone.0142646	http://dx.doi.org/10.1371/journal.pone.0142646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571415	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700055
J	Li, ZN; Yin, WH; Lu, B; Yan, HB; Mu, CW; Gao, Y; Hou, ZH; Wang, ZQ; Liu, K; Parinella, AH; Leipsic, JA				Li, Zhen-Nan; Yin, Wei-Hua; Lu, Bin; Yan, Hong-Bing; Mu, Chao-Wei; Gao, Yang; Hou, Zhi-Hui; Wang, Zhi-Qiang; Liu, Kun; Parinella, Ashley H.; Leipsic, Jonathon A.			Improvement of Image Quality and Diagnostic Performance by an Innovative Motion-Correction Algorithm for Prospectively ECG Triggered Coronary CT Angiography	PLOS ONE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; HEART-RATE; ARTERY MOTION; CARDIAC CYCLE; ACCURACY; INTERPRETABILITY; IMPACT	Objective To investigate the effect of a novel motion-correction algorithm (Snap-short Freeze, SSF) on image quality and diagnostic accuracy in patients undergoing prospectively ECG-triggered CCTA without administering rate-lowering medications. Materials and Methods Forty-six consecutive patients suspected of CAD prospectively underwent CCTA using prospective ECG-triggering without rate control and invasive coronary angiography (ICA). Image quality, interpretability, and diagnostic performance of SSF were compared with conventional multisegment reconstruction without SSF, using ICA as the reference standard. Results All subjects (35 men, 57.6 +/- 8.9 years) successfully underwent ICA and CCTA. Mean heart rate was 68.8 +/- 8.4 (range: 50-88 beats/min) beats/min without rate controlling medications during CT scanning. Overall median image quality score (graded 1-4) was significantly increased from 3.0 to 4.0 by the new algorithm in comparison to conventional reconstruction. Overall interpretability was significantly improved, with a significant reduction in the number of non-diagnostic segments (690 of 694, 99.4% vs 659 of 694, 94.9%; P<0.001). However, only the right coronary artery (RCA) showed a statistically significant difference (45 of 46, 97.8% vs 35 of 46, 76.1%; P = 0.004) on a per-vessel basis in this regard. Diagnostic accuracy for detecting >= 50% stenosis was improved using the motion-correction algorithm on per-vessel [96.2% (177/184) vs 87.0% (160/184); P = 0.002] and per-segment [96.1% (667/694) vs 86.6%(601/694); P < 0.001] levels, but there was not a statistically significant improvement on a per-patient level [97.8 (45/46) vs 89.1 (41/46); P = 0.203]. By artery analysis, diagnostic accuracy was improved only for the RCA [97.8% (45/46) vs 78.3% (36/46); P = 0.007]. Conclusion The intracycle motion correction algorithm significantly improved image quality and diagnostic interpretability in patients undergoing CCTA with prospective ECG triggering and no rate control.	[Li, Zhen-Nan; Yin, Wei-Hua; Lu, Bin; Gao, Yang; Hou, Zhi-Hui; Wang, Zhi-Qiang; Liu, Kun] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Radiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Zhen-Nan; Yin, Wei-Hua; Lu, Bin; Yan, Hong-Bing; Mu, Chao-Wei; Gao, Yang; Hou, Zhi-Hui; Wang, Zhi-Qiang; Liu, Kun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yan, Hong-Bing; Mu, Chao-Wei] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Cardiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Parinella, Ashley H.] Med Univ S Carolina, Coll Med, Dept Radiol, Charleston, SC 29425 USA; [Leipsic, Jonathon A.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Leipsic, Jonathon A.] Univ British Columbia, Div Cardiol, Vancouver, BC V5Z 1M9, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Medical University of South Carolina; University of British Columbia; University of British Columbia	Lu, B (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Radiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	blu@vip.sina.com	Leipsic, Jonathon/ABE-6194-2020; Li, Zhennan/AAM-7840-2020	Liu, Kun/0000-0001-7608-1335	 [10023-1002-3007]		Funding was provided by Grant No: 10023-1002-3007 URLs: http://graduate.pumc.edu.cn/.	Achenbach S, 2012, J CARDIOVASC COMPUT, V6, P91, DOI 10.1016/j.jcct.2011.11.006; Andreini D, 2015, EUR HEART J-CARD IMG, V16, P1093, DOI 10.1093/ehjci/jev033; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Buechel RR, 2011, J AM COLL CARDIOL, V57, P332, DOI 10.1016/j.jacc.2010.08.634; Carrascosa P, 2015, ACAD RADIOL, V22, P81, DOI 10.1016/j.acra.2014.07.016; Cho I, 2015, CLIN IMAG, V39, P421, DOI 10.1016/j.clinimag.2014.11.020; Fuchs TA, 2014, ACAD RADIOL, V21, P312, DOI 10.1016/j.acra.2013.10.014; Hassan A, 2011, EUR J RADIOL, V79, P161, DOI 10.1016/j.ejrad.2010.02.011; Husmann L, 2007, RADIOLOGY, V245, P567, DOI 10.1148/radiol.2451061791; Lee H, 2014, INT J CARDIOVAS IMAG, V30, P1603, DOI 10.1007/s10554-014-0499-4; Leipsic J, 2014, J CARDIOVASC COMPUT, V8, P342, DOI 10.1016/j.jcct.2014.07.003; Leipsic J, 2012, J CARDIOVASC COMPUT, V6, P164, DOI 10.1016/j.jcct.2012.04.004; Li QW, 2014, EUR J RADIOL, V83, P2024, DOI 10.1016/j.ejrad.2014.08.002; Lu B, 2001, INVEST RADIOL, V36, P250, DOI 10.1097/00004424-200105000-00002; Lu B, 2011, AM J CARDIOL, V107, P1278, DOI 10.1016/j.amjcard.2010.12.038; Machida H, 2015, JPN J RADIOL, V33, P84, DOI 10.1007/s11604-014-0382-1; Mao SS, 2000, J COMPUT ASSIST TOMO, V24, P253, DOI 10.1097/00004728-200003000-00012; Mark DB, 2010, J AM COLL CARDIOL, V55, P1029, DOI [10.1016/j.jacc.2009.11.048, 10.1016/j.jacc.2009.11.013]; Min JK, 2013, J CARDIOVASC COMPUT, V7, P200, DOI 10.1016/j.jcct.2013.05.005; Pontone G, 2009, J AM COLL CARDIOL, V54, P346, DOI 10.1016/j.jacc.2009.04.027; Srichai MB, 2012, ACAD RADIOL, V19, P554, DOI 10.1016/j.acra.2012.01.009; Yin WH, 2013, JACC-CARDIOVASC IMAG, V6, P1239, DOI 10.1016/j.jcmg.2013.08.008	22	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142796	10.1371/journal.pone.0142796	http://dx.doi.org/10.1371/journal.pone.0142796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571417	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700073
J	Liu, CH; Lin, JK				Liu, Chang-Hua; Lin, Jian-Kun			Integral Histogram with Random Projection for Pedestrian Detection	PLOS ONE			English	Article								In this paper, we give a systematic study to report several deep insights into the HOG, one of the most widely used features in the modern computer vision and image processing applications. We first show that, its magnitudes of gradient can be randomly projected with random matrix. To handle over-fitting, an integral histogram based on the differences of randomly selected blocks is proposed. The experiments show that both the random projection and integral histogram outperform the HOG feature obviously. Finally, the two ideas are combined into a new descriptor termed IHRP, which outperforms the HOG feature with less dimensions and higher speed.	[Liu, Chang-Hua; Lin, Jian-Kun] Xiamen Univ, Hosp Chnese PLA 174, Dept Med Imaging, Succeed Hosp, Xiamen, Fujian, Peoples R China	Xiamen University	Liu, CH (corresponding author), Xiamen Univ, Hosp Chnese PLA 174, Dept Med Imaging, Succeed Hosp, Xiamen, Fujian, Peoples R China.	liuxingc@126.com						Alexander K, 2008, BMVC; [Anonymous], 2015, CVPR; Benenson R., 2014, ECCV; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dalal N., 2006, THESIS; Dollar P, 2012, IEEE T PATTERN ANAL, V34, P743, DOI 10.1109/TPAMI.2011.155; Enzweiler M, 2009, IEEE T PATTERN ANAL, V31, P2179, DOI 10.1109/TPAMI.2008.260; Felzenszwalb PF, 2010, IEEE T PATTERN ANAL, V32, P1627, DOI 10.1109/TPAMI.2009.167; Geronimo D., 2014, SPRINGER BRIEFS COMP; Hall D., 2015, CVPR; Hattori H., 2015, CVPR; Hinterstoisser S., 2010, IEEE C COMP VIS PATT; Hiromoto M, 2009, INT C COMP VIS SYST; Levi K, 2004, IEEE C COMP VIS PATT; Maji S., 2008, CVPR; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Oreifej O., 2013, IEEE C COMP VIS PATT; Oren M., 1997, IEEE C COMP VIS PATT; Pedersoli M, 2009, LECT NOTES COMPUT SC, V5524, P48, DOI 10.1007/978-3-642-02172-5_8; Porikli F, 2005, PROC CVPR IEEE, P829, DOI 10.1109/CVPR.2005.188; Schwartz W.R., 2009, P ICCV; Sermanet P., 2013, CVPR; Tang D, 2012, BRIT MACH VIS C; Tuzel O, 2008, IEEE T PATTERN ANAL, V30, P1713, DOI 10.1109/TPAMI.2008.75; Viola P, 2001, CVPR, pII, DOI DOI 10.1109/CVPR.2001.990517; Wang X., 2009, INT C COMP VIS KYOT; Wang X, 2009, P ICCV; Watanabe T, 2009, PAC RIM S IM VID TEC; Watanabe T, 2009, LECT NOTES COMPUT SC, V5414, P37, DOI 10.1007/978-3-540-92957-4_4; Wojek C, 2008, LECT NOTES COMPUT SC, V5096, P82, DOI 10.1007/978-3-540-69321-5_9; Yang B., 2015, ARXIV150407339; Zhang KH, 2012, LECT NOTES COMPUT SC, V7574, P864, DOI 10.1007/978-3-642-33712-3_62; Zhang S., 2015, CVPR; Zhang WF, 2007, PR IEEE COMP DESIGN, P10; Zhu Qiang, 2006, CVPR, DOI DOI 10.1109/CVPR.2006.119	35	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142820	10.1371/journal.pone.0142820	http://dx.doi.org/10.1371/journal.pone.0142820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569486	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700077
J	Sarkar, N; Pal, A; Das, D; Saha, D; Biswas, A; Bandopadhayay, B; Chakraborti, M; Ghosh, M; Chakravarty, R				Sarkar, Neelakshi; Pal, Ananya; Das, Dipanwita; Saha, Debraj; Biswas, Avik; Bandopadhayay, Bhaswati; Chakraborti, Mandira; Ghosh, Mrinmoy; Chakravarty, Runu			Virological Characteristics of Acute Hepatitis B in Eastern India: Critical Differences with Chronic Infection	PLOS ONE			English	Article							SURFACE-ANTIGEN VARIANTS; VIRUS GENOTYPES; CORE PROMOTER; MOLECULAR EPIDEMIOLOGY; CLINICAL-SIGNIFICANCE; PRECORE MUTATIONS; VIRAL GENOTYPES; HBV GENOTYPE; FULMINANT; PATTERN	Hepatitis B Virus (HBV) manifests high genetic variability and is classifiable into ten genotypes (A-J). HBV infection can lead to variable clinical outcomes, ranging from self-limiting acute hepatitis to active chronic hepatitis, cirrhosis and hepatocellular carcinoma. The present study characterizes HBV strains circulating among patients with acute (AHB) and chronic HBV infection (CHB). Among a total of 653 HBsAg positive cases, 40 manifested acute infection. After sequencing the surface(S), basal core promoter/pre-core(BCP/PC) and the X gene regions, phylogenetic tree was constructed using MEGA4 by neighbor-joining method. Statistical robustness was established with bootstrap analysis. Nucleotide diversity was determined by Shannon entropy per site using the Entropy program of the Los Alamos National Laboratories. Analyses of acute patients revealed that HBV/D2 is the major circulating sub-genotype and commonly associated with sexual promiscuity and the age group between15-30 years. Comparison of AHB and CHB patients revealed that HBeAg positivity, ALT levels and genotype D were significantly high in AHB, whereas CHB patients were predominantly male, had a high viral load, and were commonly associated with genotype C. The frequencies of mutations in the S, BCP/PC, and X gene were low in AHB as compared to CHB. Drug resistant mutations were not detectable in the polymerase gene of AHB. Average nucleotide diversity in AHB was considerably low as compared to CHB. Further, the highest average Delta H (average difference in entropy between chronic and acute infection) was observed in the BCP/PC region implying that this region was most vulnerable to mutations upon HBV persistence, especially in case of genotype C. Additionally, among all substitutions, the A1762T and G1764A BCP mutations were the strongest indicators of chronicity. In conclusion, the study exhibits a general portrait of HBV strains circulating among acute hepatitis B patients in Eastern India and their intricate differences with chronic patients which should be useful from the clinical point of view.	[Sarkar, Neelakshi; Pal, Ananya; Das, Dipanwita; Saha, Debraj; Biswas, Avik; Chakravarty, Runu] ID & BG Hosp Campus, ICMR Virus Unit, Kolkata, W Bengal, India; [Bandopadhayay, Bhaswati; Chakraborti, Mandira] Calcutta Sch Trop Med, Dept Virol, Kolkata, W Bengal, India; [Ghosh, Mrinmoy] ID & BG Hosp Campus, Dept Med, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; Calcutta School of Tropical Medicine (CSTM)	Chakravarty, R (corresponding author), ID & BG Hosp Campus, ICMR Virus Unit, Kolkata, W Bengal, India.	runugc@gmail.com			Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research intramural project fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas A, 2012, INFECT GENET EVOL, V12, P384, DOI 10.1016/j.meegid.2012.01.007; Biswas A, 2011, J MED VIROL, V83, P253, DOI 10.1002/jmv.21979; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Chan HLY, 2009, CLIN GASTROENTEROL H, V7, P1361, DOI 10.1016/j.cgh.2009.08.004; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chandra PK, 2009, J VIRAL HEPATITIS, V16, P749, DOI 10.1111/j.1365-2893.2009.01129.x; Chandra PK, 2007, INTERVIROLOGY, V50, P173, DOI 10.1159/000098960; Chattopadhyay S, 2006, HEPATOL RES, V35, P79, DOI 10.1016/j.hepres.2006.03.002; CHEN HS, 1992, J VIROL, V66, P5682, DOI 10.1128/JVI.66.9.5682-5684.1992; Datta S, 2006, J MED VIROL, V78, P53, DOI 10.1002/jmv.20503; Datta S, 2008, INTERVIROLOGY, V51, P275, DOI 10.1159/000170902; Datta S, 2008, VIROLOGY, V382, P190, DOI 10.1016/j.virol.2008.09.007; Glebe D, 2013, SEMIN LIVER DIS, V33, P103, DOI 10.1055/s-0033-1345717; Imamura T, 2003, GUT, V52, P1630, DOI 10.1136/gut.52.11.1630; Ireland JH, 2000, HEPATOLOGY, V31, P1176, DOI 10.1053/he.2000.6407; Jindal A, 2013, LIVER INT, V33, P164, DOI 10.1111/liv.12081; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lahariya Chandrakant, 2013, Indian J Public Health, V57, P8, DOI 10.4103/0019-557X.111357; Lee JH, 2015, J MED VIROL, V87, P993, DOI 10.1002/jmv.24148; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu Y, 2010, J CLIN VIROL, V47, P243, DOI 10.1016/j.jcv.2009.12.013; Ledesma MMGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121436; Matsuura K, 2009, J CLIN MICROBIOL, V47, P1476, DOI 10.1128/JCM.02081-08; Ozasa A, 2006, HEPATOLOGY, V44, P326, DOI 10.1002/hep.21249; Pal A, 2013, VIROLOGY, V436, P134, DOI 10.1016/j.virol.2012.11.003; Panassie L, 2012, CLIN RES HEPATOL GAS, V36, pE1, DOI 10.1016/j.clinre.2011.09.002; Pei RJ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-9; Sagnelli C, 2014, J MED VIROL, V86, P1683, DOI 10.1002/jmv.24005; Saha D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090432; Sainokami S, 2007, J GASTROENTEROL, V42, P241, DOI 10.1007/s00535-006-1997-5; Sarkar N, 2015, J VIRAL HEPATITIS, V22, P817, DOI 10.1111/jvh.12390; Schaefer S, 2007, WORLD J GASTROENTERO, V13, P14, DOI 10.3748/wjg.v13.i1.14; Sharma SK, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-82; Singla B, 2013, J MED VIROL, V85, P1155, DOI 10.1002/jmv.23608; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Roosmalen MH, 2006, INTERVIROLOGY, V49, P127, DOI 10.1159/000089373; Wai CT, 2005, J VIRAL HEPATITIS, V12, P192, DOI 10.1111/j.1365-2893.2005.00581.x; Xibing G, 2013, J VIRAL HEPATITIS, V20, pe1, DOI 10.1111/jvh.12009; Xu ZH, 2010, J CLIN VIROL, V48, P270, DOI 10.1016/j.jcv.2010.05.010; Zhang Ai-Min, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P178; Zhang HW, 2008, GUT, V57, P1713, DOI 10.1136/gut.2008.157149; Zuccaro O, 2015, INFECTION, V43, P431, DOI 10.1007/s15010-015-0747-0	42	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0141741	10.1371/journal.pone.0141741	http://dx.doi.org/10.1371/journal.pone.0141741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571502	Green Submitted, gold, Green Published			2022-12-26	WOS:000365070700011
J	Shen, ZT; Zheng, SK; Gounis, MJ; Sigalov, AB				Shen, Zu T.; Zheng, Shaokuan; Gounis, Matthew J.; Sigalov, Alexander B.			Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; NEPHROGENIC SYSTEMIC FIBROSIS; VULNERABLE PLAQUE DETECTION; CORONARY-ARTERY-DISEASE; A-I; INFLAMMATION; MECHANISMS; THROMBOSIS; OXIDATION; RUPTURE	Cardiovascular disease is the leading cause of death in Western cultures. The vast majority of cardiovascular events, including stroke and myocardial infarction, result from the rupture of vulnerable atherosclerotic plaques, which are characterized by high and active macrophage content. Current imaging modalities including magnetic resonance imaging (MRI) aim to characterize anatomic and structural features of plaques rather than their content. Previously, we reported that macrophage-targeted delivery of gadolinium (Gd)-based contrast agent (GBCA-HDL) using high density lipoproteins (HDL)-like particles significantly enhances the detection of plaques in an apolipoprotein (apo) E knockout (KO) mouse model, with an atherosclerotic wall/muscle normalized enhancement ratio (NER) of 120% achieved. These particles are comprised of lipids and synthetic peptide fragments of the major protein of HDL, apo A-I, that contain a naturally occurring modification which targets the particles to macrophages. Targeted delivery minimizes the Gd dose and thus reduces the adverse effects of Gd. The aims of the current study were to test whether varying the GBCA-HDL particle shape and composition can further enhance atherosclerotic plaque MRI and control organ clearance of these agents. We show that the optimized GBCA-HDL particles are efficiently delivered intracellularly to and uptaken by both J774 macrophages in vitro and more importantly, by intraplaque macrophages in vivo, as evidenced by NER up to 160% and higher. This suggests high diagnostic power of our GBCA-HDL particles in the detection of vulnerable atherosclerotic plaques. Further, in contrast to discoidal, spherical GBCA-HDL exhibit hepatic clearance, which could further diminish adverse renal effects of Gd. Finally, activated macrophages are reliable indicators of any inflamed tissues and are implicated in other areas of unmet clinical need such as rheumatoid arthritis, sepsis and cancer, suggesting the expanded diagnostic and prognostic use of this method.	[Shen, Zu T.; Sigalov, Alexander B.] SignaBlok Inc, Shrewsbury, MA 01545 USA; [Zheng, Shaokuan; Gounis, Matthew J.] Univ Massachusetts, Sch Med, Dept Radiol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Sigalov, AB (corresponding author), SignaBlok Inc, Shrewsbury, MA 01545 USA.	sigalov@signablok.com			National Heart, Lung and Blood Institute/National Institutes of Health [R44HL110417]; SignaBlok, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL110417] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); SignaBlok, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by a grant R44HL110417 (Alexander B. Sigalov, Principal investigator) from the National Heart, Lung and Blood Institute/National Institutes of Health (www.nhlbi.nih.gov) and by SignaBlok, Inc. Alexander B. Sigalov and Zu T. Shen are employees of SignaBlok, Inc (www.signablok.com). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders provided support in the form of salaries for authors [ABS and ZTS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; ANANTHARAMAIAH GM, 1988, J LIPID RES, V29, P309; Barazza A, 2013, BIOCONJUGATE CHEM, V24, P1039, DOI 10.1021/bc400105j; Bhatia V, 2003, J Postgrad Med, V49, P361; Bucala R., 2009, APPL RADIOL, V38, P22; Chen W, 2008, CONTRAST MEDIA MOL I, V3, P233, DOI 10.1002/cmmi.257; Choudhury RP, 2009, ARTERIOSCL THROM VAS, V29, P983, DOI 10.1161/ATVBAHA.108.165498; Choudhury RP, 2005, NAT CLIN PRACT CARD, V2, P309, DOI 10.1038/ncpcardio0195; Collidge TA, 2007, RADIOLOGY, V245, P168, DOI 10.1148/radiol.2451070353; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heier CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112477; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Korkusuz H, 2012, MOL IMAGING, V11, P272, DOI 10.2310/7290.2011.00047; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MacNeill BD, 2004, J AM COLL CARDIOL, V44, P972, DOI 10.1016/j.jacc.2004.05.066; Marckmann P, 2006, J AM SOC NEPHROL, V17, P2359, DOI 10.1681/ASN.2006060601; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Oda MN, 2006, J LIPID RES, V47, P260, DOI 10.1194/jlr.D500033-JLR200; Pankhurst G, 2003, J LIPID RES, V44, P349, DOI 10.1194/jlr.M200256-JLR200; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; Rudd JHF, 2009, ARTERIOSCL THROM VAS, V29, P1009, DOI 10.1161/ATVBAHA.108.165563; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Schaar JA, 2007, CURR PHARM DESIGN, V13, P995, DOI 10.2174/138161207780487511; Shah PK, 2002, PROG CARDIOVASC DIS, V44, P357, DOI 10.1053/pcad.2002.123473; Sharif F, 2010, CATHETER CARDIO INTE, V75, P135, DOI 10.1002/ccd.22164; Sigalov AB, 1998, FEBS LETT, V433, P196, DOI 10.1016/S0014-5793(98)00908-9; Sigalov AB, 2001, CHEM PHYS LIPIDS, V113, P133, DOI 10.1016/S0009-3084(01)00186-4; Sigalov AB, 2014, CONTRAST MEDIA MOL I, V9, P372, DOI 10.1002/cmmi.1587; Sorci-Thomas MG, 1998, J BIOL CHEM, V273, P11776, DOI 10.1074/jbc.273.19.11776; Tolar M, 1999, J NEUROSCI, V19, P7100, DOI 10.1523/JNEUROSCI.19-16-07100.1999; VONECKARDSTEIN A, 1991, J LIPID RES, V32, P1465; Wakhloo Ajay K, 2004, J Vasc Interv Radiol, V15, pS111; Wang XS, 1997, J CELL PHYSIOL, V173, P73, DOI 10.1002/(SICI)1097-4652(199710)173:1<73::AID-JCP9>3.3.CO;2-B	37	18	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143453	10.1371/journal.pone.0143453	http://dx.doi.org/10.1371/journal.pone.0143453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569115	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700158
J	Tsai, ST; Wang, PJ; Liou, NJ; Lin, PS; Chen, CH; Chang, WC				Tsai, Sheng-Ta; Wang, Po-Jen; Liou, Nia-Jhen; Lin, Pei-Shan; Chen, Chung-Hsuan; Chang, Wei-Chao			ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; PROSPECTIVE IDENTIFICATION; PROTEIN EXPRESSION; BREAST-CANCER; CROSS-TALK; PROGNOSIS; MECHANISMS; PATHWAYS; P53	Esophageal squamous cell carcinoma (ESCC) accounts for about 90% of esophageal cancer diagnosed in Asian countries, with its incidence on the rise. Cancer stem cell (CSC; also known as tumor-initiating cells, TIC) is inherently resistant to cytotoxic chemotherapy and radiation and associates with poor prognosis and therapy failure. Targeting therapy against cancer stem cell has emerged as a potential therapeutic approach to develop effective regimens. However, the suitable CSC marker of ESCC for identification and targeting is still limited. In this study, we screened the novel CSC membrane protein markers using two distinct stemness characteristics of cancer cell lines by a comparative approach. After the validation of RT-PCR, qPCR and western blot analyses, intercellular adhesion molecule 1 (ICAM1) was identified as a potential CSC marker of ESCC. ICAM1 promotes cancer cell migration, invasion as well as increasing mesenchymal marker expression and attenuating epithelial marker expression. In addition, ICAM1 contributes to CSC properties, including sphere formation, drug resistance, and tumorigenesis in mouse xenotransplantation model. Based on the analysis of ICAM1-regulated proteins, we speculated that ICAM1 regulates CSC properties partly through an ICAM1-PTTG1IP-p53-DNMT1 pathway. Moreover, we observed that ICAM1 and CD44 could have a compensation effect on maintaining the stemness characteristics of ESCC, suggesting that the combination of multi-targeting therapies should be under serious consideration to acquire a more potent therapeutic effect on CSC of ESCC.	[Tsai, Sheng-Ta; Chen, Chung-Hsuan] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wang, Po-Jen; Chang, Wei-Chao] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Liou, Nia-Jhen; Lin, Pei-Shan; Chang, Wei-Chao] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Tsai, Sheng-Ta; Chen, Chung-Hsuan] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Chung-Hsuan] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Chen, Chung-Hsuan] Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan	Chang, WC (corresponding author), China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan.	proma@mail.cmu.edu.tw			Ministry of Science and Technology, Taiwan [NSC102-2320-B-039-050, MOST 102-2911-I-002-303]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology, Taiwan Grants NSC102-2320-B-039-050 and MOST 102-2911-I-002-303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aloni-Grinstein R, 2014, FEBS LETT, V588, P2580, DOI 10.1016/j.febslet.2014.02.011; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; Chang WC, 2010, INT J PROTEOMICS, V2010, DOI DOI 10.1155/2010/726968; Chang YL, 2010, ACTA PHARMACOL SIN, V31, P546, DOI 10.1038/aps.2010.34; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chen ML, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-539; Chen Y, 2014, J ASIAN NAT PROD RES, V19, P1, DOI DOI 10.1155/2014/701395; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; De Marzo AM, 1999, CANCER RES, V59, P3855; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fong CY, 2012, J CELL BIOCHEM, V113, P658, DOI 10.1002/jcb.23395; Girault I, 2003, CLIN CANCER RES, V9, P4415; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kayani B, 2011, EJSO-EUR J SURG ONC, V37, P747, DOI 10.1016/j.ejso.2011.06.018; Kleinberg L, 2007, J CLIN ONCOL, V25, P4110, DOI 10.1200/JCO.2007.12.0881; Kranenburg O, 2012, EXPERT REV PROTEOMIC, V9, P325, DOI [10.1586/EPR.12.24, 10.1586/epr.12.24]; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Landry Y, 2008, FUND CLIN PHARMACOL, V22, P1, DOI 10.1111/j.1472-8206.2007.00548.x; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Liu SP, 2013, GASTROENTEROLOGY, V144, P1031, DOI 10.1053/j.gastro.2013.01.046; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Metcalf D, 2010, NAT REV CANCER, V10, P425, DOI 10.1038/nrc2843; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Prabhu VV, 2012, EXPERT OPIN THER TAR, V16, P1161, DOI 10.1517/14728222.2012.726985; Ramos TN, 2014, J IMMUNOL, V192, P4469, DOI 10.4049/jimmunol.1400135; Read ML, 2014, ENDOCRINOLOGY, V155, P1222, DOI 10.1210/en.2013-1646; Saito Y, 2003, INT J CANCER, V105, P527, DOI 10.1002/ijc.11127; Sato F, 2015, CANCER BIOL THER, V16, P933, DOI 10.1080/15384047.2015.1040959; Scatena R, 2011, PROTEOM CLIN APPL, V5, P590, DOI 10.1002/prca.201000142; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sununliganon L, 2012, CYTOTECHNOLOGY, V64, P53, DOI 10.1007/s10616-011-9390-5; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Zhao JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021419	49	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142834	10.1371/journal.pone.0142834	http://dx.doi.org/10.1371/journal.pone.0142834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571024	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700080
J	Nouws, J; Goswami, AV; Bestwick, M; McCann, BJ; Surovtseva, YV; Shadel, GS				Nouws, Jessica; Goswami, Arvind V.; Bestwick, Megan; McCann, Beverly Jo; Surovtseva, Yulia V.; Shadel, Gerald S.			Mitochondrial Ribosomal Protein L12 Is Required for POLRMT Stability and Exists as Two Forms Generated by Alternative Proteolysis during Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA SYNTHESIS; URACIL PHOSPHORIBOSYLTRANSFERASE; TRANSCRIPTION MACHINERY; CALORIE RESTRICTION; POLYMERASE; MRPL12; L7/L12; PHOSPHORYLATION; PEPTIDES; GROWTH	To translate the 13 mtDNA-encoded mRNAs involved in oxidative phosphorylation (OXPHOS), mammalian mitochondria contain a dedicated set of ribosomes comprising rRNAs encoded by the mitochondrial genome and mitochondrial ribosomal proteins (MRPs) that are encoded by nuclear genes and imported into the matrix. In addition to their role in the ribosome, several MRPs have auxiliary functions or have been implicated in other cellular processes like cell cycle regulation and apoptosis. For example, we have shown that human MRPL12 binds and activates mitochondrial RNA polymerase (POLRMT), and hence has distinct functions in the ribosome and mtDNA transcription. Here we provide concrete evidence that there are two mature forms of mammalian MRPL12 that are generated by a two-step cleavage during import, involving efficient cleavage by mitochondrial processing protease and a second inefficient or regulated cleavage by mitochondrial intermediate protease. We also show that knock-down of MRPL12 by RNAi results in instability of POLRMT, but not other primary mitochondrial transcription components, and a corresponding decrease in mitochondrial transcription rates. Knock-down of MRPL10, the binding partner of MRPL12 in the ribosome, results in selective degradation of the mature long form of MRPL12, but has no effect on POLRMT. We propose that the two forms of MRPL12 are involved in homeostatic regulation of mitochondrial transcription and ribosome biogenesis that likely contribute to cell cycle, growth regulation, and longevity pathways to which MRPL12 has been linked.	[Nouws, Jessica; Goswami, Arvind V.; Bestwick, Megan; McCann, Beverly Jo; Surovtseva, Yulia V.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Bestwick, Megan] Linfield Coll, Dept Chem, Mcminnville, OR 97128 USA; [McCann, Beverly Jo] Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany	Yale University; Yale University; Linfield University; Technical University of Darmstadt	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA.	gerald.shadel@yale.edu		Bestwick, Megan/0000-0003-3670-5507; Nouws, Jessica/0000-0003-3347-3595	National Institutes of Health [AG047632]; EMBO [EMBO ALTF 1328-2012]; National Institutes of Health NRSA [F32 DK091042, F32 GM093590-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG047632 (to G. S. S.). The authors have no conflicts of interest to declare. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by EMBO postdoctoral fellowship EMBO ALTF 1328-2012.; Supported by National Institutes of Health NRSA F32 DK091042.; Supported by National Institues of Health NRSA F32 GM093590-01.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006; Bocharov EV, 1998, FEBS LETT, V423, P347, DOI 10.1016/S0014-5793(98)00121-5; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bralha FN, 2015, ONCOTARGET, V6, P37216, DOI 10.18632/oncotarget.6129; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Cleary MD, 2008, METHOD ENZYMOL, V448, P379, DOI 10.1016/S0076-6879(08)02619-0; Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484; Frei C, 2005, EMBO J, V24, P623, DOI 10.1038/sj.emboj.7600523; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Goertzel B, 2008, REJUV RES, V11, P735, DOI 10.1089/rej.2007.0627; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Han MJ, 2011, PROTEIN EXPRES PURIF, V78, P48, DOI 10.1016/j.pep.2011.03.004; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Marty L, 1996, J BIOL CHEM, V271, P11468, DOI 10.1074/jbc.271.19.11468; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610; Rebelo AP, 2011, J INHERIT METAB DIS, V34, P941, DOI 10.1007/s10545-011-9330-8; Seidel-Rogol BL, 2002, NUCLEIC ACIDS RES, V30, P1929, DOI 10.1093/nar/30.9.1929; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shutt TE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-203; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Surovtseva YV, 2011, P NATL ACAD SCI USA, V108, P17921, DOI 10.1073/pnas.1108852108; Vogtle FN, 2011, MOL BIOL CELL, V22, P2135, DOI 10.1091/mbc.E11-02-0169; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035	36	30	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					989	997		10.1074/jbc.M115.689299	http://dx.doi.org/10.1074/jbc.M115.689299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26586915	Green Published, hybrid			2022-12-26	WOS:000367830500044
J	Kaye, KS; Patel, DA; Stephens, JM; Khachatryan, A; Patel, A; Johnson, K				Kaye, Keith S.; Patel, Dipen A.; Stephens, Jennifer M.; Khachatryan, Alexandra; Patel, Ayush; Johnson, Kenneth			Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic Impact	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; RESISTANT STAPHYLOCOCCUS-AUREUS; PRACTICE GUIDELINES; DISEASES SOCIETY; EMERGENCE; AMERICA; VISITS	Background The number of ambulatory patients seeking treatment for skin and skin structure infections (SSSI) are increasing. The objective of this study is to determine recent trends in hospital admissions and healthcare resource utilization and identify covariates associated with hospital costs and mortality for hospitalized adult patients with a primary SSSI diagnosis in the United States. Methods We performed a retrospective cross-sectional analysis (years 2005-2011) of data from the US Healthcare Cost and Utilization Project National Inpatient Sample. Recent trends, patient characteristics, and healthcare resource utilization for patients hospitalized with a primary SSSI diagnosis were evaluated. Descriptive and bivariate analyses were conducted to assess patient and hospital characteristics. Results A total of 1.8% of hospital admissions for the years 2005 through 2011 were for adult patients with a SSSI primary diagnosis. SSSI-related hospital admissions significantly changed during the study period (P<.001 for trend) ranging from 1.6% (in 2005) to 2.0% (in 2011). Mean hospital length of stay (LOS) decreased from 5.4 days in the year 2005 to 5.0 days in the year 2011 (overall change, P<.001) with no change in hospital costs. Patients with postoperative wound infections had the longest hospital stays (adjusted mean, 5.81 days; 95% confidence interval (CI), 5.80-5.83) and highest total costs (adjusted mean, $9388; 95% CI, $9366-$9410). Year of hospital admission was strongly associated with mortality; infection type, all patient refined diagnosis related group severity of illness level, and LOS were strongly associated with hospital costs. Conclusions Hospital admissions for adult patients in the United States with a SSSI primary diagnosis continue to increase. Decreasing hospital inpatient LOS and mortality rate may be due to improved early treatment. Future research should focus on identifying alternative treatment processes for patients with SSSI that could shift management from inpatient to outpatient treatment settings.	[Kaye, Keith S.] Wayne State Univ, Detroit, MI USA; [Kaye, Keith S.] Detroit Med Ctr, Detroit, MI USA; [Patel, Dipen A.; Stephens, Jennifer M.; Khachatryan, Alexandra; Patel, Ayush] Pharmerit Int, Bethesda, MD 20814 USA; [Johnson, Kenneth] Durata Therapeut, Chicago, IL USA	Wayne State University; Detroit Medical Center	Stephens, JM (corresponding author), Pharmerit Int, Bethesda, MD 20814 USA.	jstephens@pharmerit.com	Kaye, Keith/AAF-1048-2019		Durata Therapeutics	Durata Therapeutics	This study was funded by Durata Therapeutics, and the funders had role in study conceptualization, design and manuscript writing. Pharmerit authors were involved with study design, data analysis and preparation of the manuscript.	Edelsberg J, 2008, INFECT CONT HOSP EP, V29, P160, DOI 10.1086/526444; Edelsberg J, 2009, EMERG INFECT DIS, V15, P1516, DOI 10.3201/eid1509.081228; [Food and Drug Administration Center for Drug Evaluation Research Guidance for industry US Department of Health and Human Services], 2013, GUID IND AC BACT SKI; HCUP Nationwide Inpatient Sample (NIS), 2012, HCUP NATIONWIDE INPA; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Merritt C, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-26; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Qualls ML, 2012, CLIN INFECT DIS, V55, P103, DOI 10.1093/cid/cis342; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Suaya JA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-296	11	62	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143276	10.1371/journal.pone.0143276	http://dx.doi.org/10.1371/journal.pone.0143276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599005	Green Submitted, gold, Green Published			2022-12-26	WOS:000365862600043
J	Maeda, D; Akiyama, Y; Morikawa, T; Kunita, A; Ota, Y; Katoh, H; Niimi, A; Nomiya, A; Ishikawa, S; Goto, A; Igawa, Y; Fukayama, M; Homma, Y				Maeda, Daichi; Akiyama, Yoshiyuki; Morikawa, Teppei; Kunita, Akiko; Ota, Yasunori; Katoh, Hiroto; Niimi, Aya; Nomiya, Akira; Ishikawa, Shumpei; Goto, Akiteru; Igawa, Yasuhiko; Fukayama, Masashi; Homma, Yukio			Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation	PLOS ONE			English	Article							BLADDER PAIN SYNDROME; SYNDROME/INTERSTITIAL CYSTITIS; RHEUMATOID-ARTHRITIS; TISSUE; CLASSIFICATION; REPERTOIRE; EXPRESSION; SYMPTOMS; PREDICT	Interstitial cystitis (IC) is a chronic bladder disease with urinary frequency, bladder discomfort or bladder pain of unknown etiology. Based on cystoscopic findings, patients with IC are classified as either Hunner-type/classic IC (HIC), presenting with a specific Hunner lesion, or non-Hunner-type IC (NHIC), presenting with no Hunner lesion, but post-hydrodistension mucosal bleeding. Inflammatory cell infiltration, composed predominantly of lymphocytes, plasma cells and epithelial denudation, has in the past been documented as a major pathological IC finding. However, the significance of the pathological evaluation of IC, especially with regard to the difference between HIC and NHIC, has been downplayed in recent years. In this study, we performed immunohistochemical quantification of infiltrating T-lymphocytes, B-lymphocytes and plasma cells, and measured the amount of residual epithelium in urinary bladder biopsy specimens taken from patients with HIC and NHIC, and those with no IC, using image analysis software. In addition, in situ hybridization of the light chains was performed to examine clonal B-cell expansion. Lymphoplasmacytic infiltration was significantly more severe in HIC specimens than in NHIC specimens (P <0.0001). Substantial lymphoplasmacytic inflammation (>= 200 cells/mm(2)) was observed in 93% of HIC specimens, whereas only 8% of NHIC specimens were inflamed. Plasmacytic infiltration was more prominent in HIC specimens compared with NHIC and non-IC cystitis specimens (P <0.005). Furthermore, expansion of light-chain-restricted B-cells was observed in 31% of cases of HIC. The amount of residual epithelium was decreased in HIC specimens compared with NHIC specimens and non-IC cystitis specimens (P <0.0001). These results suggest that NHIC and HIC are distinct pathological entities, with the latter characterized by pancystitis, frequent clonal B-cell expansion and epithelial denudation. An abnormality in the B-cell population may be involved in the pathogenesis of HIC.	[Maeda, Daichi; Morikawa, Teppei; Kunita, Akiko; Fukayama, Masashi] Univ Tokyo, Dept Pathol, Grad Sch Med, Tokyo, Japan; [Maeda, Daichi; Goto, Akiteru] Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita 010, Japan; [Akiyama, Yoshiyuki; Niimi, Aya; Nomiya, Akira; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Akiyama, Yoshiyuki; Igawa, Yasuhiko] Univ Tokyo, Grad Sch Med, Dept Continence Med, Tokyo, Japan; [Ota, Yasunori] Univ Tokyo, Inst Med Sci, Dept Pathol, Tokyo, Japan; [Katoh, Hiroto; Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo, Japan	University of Tokyo; Akita University; University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU)	Maeda, D (corresponding author), Univ Tokyo, Dept Pathol, Grad Sch Med, Tokyo, Japan.	maeda-tky@umin.ac.jp	Igawa, Yasuhiko/AAY-9505-2021; Katoh, Hiroto/ADO-8117-2022; Goto, Akiteru/P-5775-2014	Goto, Akiteru/0000-0001-8776-9004	Ministry of Education, Science, Sports and Culture; Mitsui Life Social Welfare Foundation	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsui Life Social Welfare Foundation	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) (YH), 'Basic Science and Platform Technology Program for Innovative Biological Medicine' (SI) from the Ministry of Education, Science, Sports and Culture, and Mitsui Life Social Welfare Foundation (DM).	Bahler DW, 1998, BLOOD, V91, P1864, DOI 10.1182/blood.V91.6.1864.1864_1864_1872; CHRISTMAS TJ, 1994, BRIT J UROL, V73, P508, DOI 10.1111/j.1464-410X.1994.tb07635.x; Denson MA, 2000, J UROLOGY, V164, P1908, DOI 10.1016/S0022-5347(05)66915-7; Doorenspleet ME, 2014, ANN RHEUM DIS, V73, P756, DOI 10.1136/annrheumdis-2012-202861; FALL M, 1987, J UROLOGY, V137, P35, DOI 10.1016/S0022-5347(17)43863-8; Fall M, 2001, Urology, V57, P129, DOI 10.1016/S0090-4295(01)01101-3; Fall M, 2014, INT J UROL, V21, P79, DOI 10.1111/iju.12325; Ferraccioli G, 2007, AUTOIMMUN REV, V7, P109, DOI 10.1016/j.autrev.2007.02.013; Gamper M, 2013, INT UROGYNECOL J, V24, P2049, DOI 10.1007/s00192-013-2112-0; Gamper M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-199; GILLENWATER JY, 1988, J UROLOGY, V140, P203, DOI 10.1016/S0022-5347(17)41529-1; HANNO P, 1990, J UROLOGY, V143, P278, DOI 10.1016/S0022-5347(17)39933-0; Hanno P, 2009, NEUROUROL URODYNAM, V28, P274, DOI 10.1002/nau.20687; HARRINGTON DS, 1990, J UROLOGY, V144, P868, DOI 10.1016/S0022-5347(17)39611-8; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Hunner GL, 1915, BOSTON MED SURG J, V172, P660, DOI 10.1056/NEJM191505061721802; Keller JJ, 2013, NEUROUROL URODYNAM, V32, P980, DOI 10.1002/nau.22348; Leiby BE, 2007, J UROLOGY, V177, P142, DOI 10.1016/j.juro.2006.08.096; Logadottir Y, 2014, INT J UROL, V21, P75, DOI 10.1111/iju.12370; Logadottir Y, 2013, SCAND J UROL, V47, P52, DOI 10.3109/00365599.2012.699100; LYNES WL, 1990, AM J SURG PATHOL, V14, P969, DOI 10.1097/00000478-199010000-00011; MACDERMOTT JP, 1991, BRIT J UROL, V67, P44, DOI 10.1111/j.1464-410X.1991.tb15068.x; MESSING E M, 1978, Urology, V12, P381, DOI 10.1016/0090-4295(78)90286-8; Nitze M, 1907, LEHRBUCH KYSTOSKOPIE; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Pacella Mauro, 2010, Arch Ital Urol Androl, V82, P122; Peeker R, 1998, SCAND J UROL NEPHROL, V32, P395; Peeker R, 2002, J UROLOGY, V167, P2470, DOI 10.1016/S0022-5347(05)65006-9; Pereira MI, 2014, WORLD J GASTROENTERO, V20, P684, DOI 10.3748/wjg.v20.i3.684; Rossberger J, 2010, SCAND J UROL NEPHROL, V44, P433, DOI 10.3109/00365599.2010.515613; SAMOSZUK MK, 1985, DIAGN CLIN IMMUNOL, V3, P133; Tomaszewski JE, 2001, UROLOGY, V57, P67, DOI 10.1016/S0090-4295(01)01166-9; Ueda T, 2003, INT J UROL, V10, pS1, DOI 10.1046/j.1442-2042.10.s1.1.x; van de Merwe JP, 2008, EUR UROL, V53, P60, DOI 10.1016/j.eururo.2007.09.019; van de Merwe JP, 2007, NAT CLIN PRACT UROL, V4, P484, DOI 10.1038/ncpuro0874; Wenniger LJMD, 2013, HEPATOLOGY, V57, P2390, DOI 10.1002/hep.26232	36	99	100	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143316	10.1371/journal.pone.0143316	http://dx.doi.org/10.1371/journal.pone.0143316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587589	Green Published, gold, Green Submitted			2022-12-26	WOS:000365251500051
J	Pavulraj, S; Bera, BC; Joshi, A; Anand, T; Virmani, M; Vaid, RK; Shanmugasundaram, K; Gulati, BR; Rajukumar, K; Singh, R; Misri, J; Singh, RK; Tripathi, BN; Virmani, N				Pavulraj, Selvaraj; Bera, Bidhan Chandra; Joshi, Alok; Anand, Taruna; Virmani, Meenakshi; Vaid, Rajesh Kumar; Shanmugasundaram, Karuppusamy; Gulati, Baldev Raj; Rajukumar, K.; Singh, Rajendra; Misri, Jyoti; Singh, Raj Kumar; Tripathi, Bhupendra Nath; Virmani, Nitin			Pathology of Equine Influenza virus (H3N8) in Murine Model	PLOS ONE			English	Article							A H5N1 VIRUS; MOUSE MODEL; ENHANCED VIRULENCE; ANIMAL-MODELS; MICE; INFECTION; PATHOGENESIS; VACCINE; REPLICATION; DISEASE	Equine influenza viruses (EIV)-H3N8 continue to circulate in equine population throughout the world. They evolve by the process of antigenic drift that leads to substantial change in the antigenicity of the virus, thereby necessitating substitution of virus strain in the vaccines. This requires frequent testing of the new vaccines in the in vivo system; however, lack of an appropriate laboratory animal challenge model for testing protective efficacy of equine influenza vaccine candidates hinders the screening of new vaccines and other therapeutic approaches. In the present investigation, BALB/c mouse were explored for suitability for conducting pathogenecity studies for EIV. The BALB/c mice were inoculated intranasally @ 2x10(6.24) EID50 with EIV (H3N8) belonging to Clade 2 of Florida sublineage and monitored for setting up of infection and associated parameters. All mice inoculated with EIV exhibited clinical signs viz. loss in body weights, lethargy, dyspnea, etc, between 3 and 5 days which commensurate with lesions observed in the respiratory tract including rhinitis, tracheitis, bronchitis, bronchiolitis, alveolitis and diffuse interstitial pneumonia. Transmission electron microscopy, immunohistochemistry, virus quantification through titration and qRT-PCR demonstrated active viral infection in the upper and lower respiratory tract. Serology revealed rise in serum lactate dehydrogenase levels along with sero-conversion. The pattern of disease progression, pathological lesions and virus recovery from nasal washings and lungs in the present investigations in mice were comparable to natural and experimental EIV infection in equines. The findings establish BALB/c mice as small animal model for studying EIV (H3N8) infection and will have immense potential for dissecting viral pathogenesis, vaccine efficacy studies, preliminary screening of vaccine candidates and antiviral therapeutics against EIV.	[Pavulraj, Selvaraj; Bera, Bidhan Chandra; Anand, Taruna; Vaid, Rajesh Kumar; Shanmugasundaram, Karuppusamy; Gulati, Baldev Raj; Tripathi, Bhupendra Nath; Virmani, Nitin] Natl Res Ctr Equines, Hisar, Haryana, India; [Joshi, Alok] Vet Hosp Naini, Almora, Uttarakhand, India; [Virmani, Meenakshi] Lala Lajpat Rai Univ Vet & Anim Sci, Dept Vet Physiol & Biochem, Hisar, Haryana, India; [Rajukumar, K.] Natl Inst High Secur Anim Dis, Bhopal, MP, India; [Singh, Rajendra] Indian Vet Res Inst, Div Pathol, Bareilly, UP, India; [Misri, Jyoti] Krishi Bhavan, Div Anim Sci, New Delhi, India; [Singh, Raj Kumar] Indian Vet Res Inst, Bareilly, UP, India	Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Lala Lajpat Rai University of Veterinary & Animal Sciences; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of High Security Animal Diseases; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Virmani, N (corresponding author), Natl Res Ctr Equines, Hisar, Haryana, India.	nvirmani@gmail.com	Gulati, Baldev/AAF-7492-2020; Selvaraj, Pavulraj/AAV-8266-2021; Pavulraj, Selvaraj/AAA-3927-2021; Vaid, Rajesh K./E-3519-2013	Gulati, Baldev/0000-0002-4338-7941; Vaid, Rajesh K./0000-0002-7554-5238; , Shanmugasundaram Karuppusamy/0000-0001-5965-2087; Singh, Rajendra/0000-0002-8586-3221; Singh, Rajkumar/0000-0003-4649-2015	Indian Council of Agricultural Research; Indian Veterinary Research Institute	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR)); Indian Veterinary Research Institute(Indian Council of Agricultural Research (ICAR))	Funding: The present study was funded by Indian Council of Agricultural Research from institutional grant. Indian Veterinary Research Institute provided junior research fellowship to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewes CH, 1934, LANCET, V2, P859; Baz M, 2015, J VIROL, V89, P1652, DOI 10.1128/JVI.02449-14; Baz M, 2013, J VIROL, V87, P6901, DOI 10.1128/JVI.03520-12; Begg AP, 2011, AUST VET J, V89, P19, DOI 10.1111/j.1751-0813.2011.00731.x; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Belser JA, 2011, J VIROL, V85, P1563, DOI 10.1128/JVI.02231-10; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Castleman WL, 2010, VET PATHOL, V47, P507, DOI 10.1177/0300985810363718; Crouch CF, 2004, VACCINE, V23, P418, DOI 10.1016/j.vaccine.2004.01.074; Cullinane A, 2013, VET MICROBIOL, V167, P205, DOI 10.1016/j.vetmic.2013.03.029; Driskell EA, 2010, VIROLOGY, V399, P280, DOI 10.1016/j.virol.2010.01.005; Dybing JK, 2000, J VIROL, V74, P1443, DOI 10.1128/JVI.74.3.1443-1450.2000; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Gerber H., 1970, Proceedings 2nd int. Conf. Equine Infect. Dis., Paris, 1969., P63; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Guarner J, 2006, CLIN INFECT DIS, V43, P132, DOI 10.1086/505122; Heldens JGM, 2010, VACCINE, V28, P6989, DOI 10.1016/j.vaccine.2010.08.043; Hirst GK, 1941, SCIENCE, V94, P22, DOI 10.1126/science.94.2427.22; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Kendra W, 2012, THESIS; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kuiken T, 2003, VET PATHOL, V40, P304, DOI 10.1354/vp.40-3-304; Landolt GA, 2006, EQUINE INFECT DIS; Lau YF, 2010, J VIROL, V84, P8639, DOI 10.1128/JVI.00596-10; Lee YN, 2011, VIROLOGY, V417, P57, DOI 10.1016/j.virol.2011.05.005; Liu GL, 2013, VACCINE, V31, P5398, DOI 10.1016/j.vaccine.2013.09.009; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Lu ZC, 2009, J CLIN MICROBIOL, V47, P3907, DOI 10.1128/JCM.00598-09; LUNA LG, 1968, MANUAL HISTOLOGY STA; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; MANICASSAMY B, 2010, PLOS PATHOG, V6, DOI DOI 10.1371/J0URNAL.PPAT.1000745; Mernoli MJ, 2009, VIROLOGY, V393, P338, DOI 10.1016/j.virol.2009.08.021; Mette V, 2011, INFLUENZA RES TREAT; MILLER WC, 1965, VET REC, V77, P455; Mukhopadhyay S, 2010, AM J CLIN PATHOL, V133, P380, DOI 10.1309/AJCPXY17SULQKSWK; MUMFORD JA, 1990, EQUINE VET J, V22, P93, DOI 10.1111/j.2042-3306.1990.tb04217.x; MUMFORD JA, 1994, EPIDEMIOL INFECT, V112, P421, DOI 10.1017/S0950268800057848; MUMFORD JA, 1994, VACCINE, V12, P857, DOI 10.1016/0264-410X(94)90297-6; MUMFORD JA, 1998, TXB INFLUENZA, P146; Muranaka Masanori, 2012, Journal of Equine Science, V23, P17, DOI 10.1294/jes.23.17; Muto NA, 2012, JPN J INFECT DIS, V65, P383, DOI 10.7883/yoken.65.383; Ning ZY, 2009, VET RES COMMUN, V33, P895, DOI 10.1007/s11259-009-9307-3; Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503; Paillot R, 2013, VET MICROBIOL, V162, P396, DOI 10.1016/j.vetmic.2012.10.019; Patterson-Kane JC, 2008, EQUINE VET J, V40, P199, DOI 10.2746/042516408X292214; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Pica N, 2011, J VIROL, V85, P12825, DOI 10.1128/JVI.05930-11; Quan FS, 2008, VACCINE, V26, P3352, DOI 10.1016/j.vaccine.2008.03.055; REED L. J., 1938, AMER JOUR HYG, V27, P493; Scocco P, 2008, HISTOL HISTOPATHOL, V23, P973, DOI 10.14670/HH-23.973; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tang XH, 2009, J GEN VIROL, V90, P386, DOI 10.1099/vir.0.007054-0; Tate MD, 2011, MICROBES INFECT, V13, P202, DOI 10.1016/j.micinf.2010.10.004; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Teluguakula N., 2011, AM J PATHOL, V179, P199, DOI [10.1016/i.aipath.2011.03.013, DOI 10.1016/J.AJPATH.2011.03.013]; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Uraki R, 2013, J VIROL, V87, P2226, DOI 10.1128/JVI.01565-12; Virmani N, 2008, VET REC, V163, P607, DOI 10.1136/vr.163.20.607-a; Virmani N, 2010, VET MICROBIOL, V143, P224, DOI 10.1016/j.vetmic.2009.12.007; WEBSTER RG, 1993, EQUINE VET J, V25, P537, DOI 10.1111/j.2042-3306.1993.tb03009.x; Wu J, 2010, VACCINE, V28, P2775, DOI 10.1016/j.vaccine.2010.01.037; Xu JP, 2011, INFECT GENET EVOL, V11, P2125, DOI 10.1016/j.meegid.2011.07.002; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zachary TP, 2012, INFLUENZA OTHER RESP, V7, P472; Zhu ZQ, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.50	75	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143094	10.1371/journal.pone.0143094	http://dx.doi.org/10.1371/journal.pone.0143094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587990	Green Published, gold, Green Submitted			2022-12-26	WOS:000365251500029
J	Abokyi, LN; Asante, KP; Mahama, E; Gyaase, S; Sulemana, A; Kwarteng, A; Ayaam, J; Dosoo, D; Adu-Gyasi, D; Etego, SA; Ogutu, B; Akweongo, P; Owusu-Agyei, S				Abokyi, Livesy Naafoe; Asante, Kwaku Poku; Mahama, Emmanuel; Gyaase, Stephaney; Sulemana, Abubakari; Kwarteng, Anthony; Ayaam, Jennifer; Dosoo, David; Adu-Gyasi, Dennis; Etego, Seeba Amenga; Ogutu, Bernhards; Akweongo, Patricia; Owusu-Agyei, Seth			Use of Antimalarial in the Management of Fever during a Community Survey in the Kintampo Districts of Ghana	PLOS ONE			English	Article							ARTEMISININ-COMBINATION THERAPY; AFFORDABLE MEDICINES FACILITY; MALARIA TREATMENT; TREATMENT BEHAVIOR; AFRICAN COUNTRIES; TANZANIA; DECLINE; BURDEN; IMPLEMENTATION; EPIDEMIOLOGY	Background Epidemiology of malaria and related fevers in most parts of Africa is changing due to scale up of interventions such as appropriate use of ACTs in the effort towards sustained control and eventual elimination of malaria. The use of ACTs in the management of malaria-associated fever was evaluated in the Kintampo districts of Ghana. Methods Household survey was conducted between October 2009 and February, 2011. A random selection of 370 households was generated from 25,000 households existing within the Health and Demographic Surveillance Systems in Kintampo, Ghana at the time. All household members present at the time of survey in the eligible households were interviewed based on a two weeks reported fever recall and the use of antimalarial for the management of fever. A finger-prick blood sample was also obtained from each member of the household present and later examined for malaria parasites using microscopy. Descriptive analysis was performed, with univariate and multivariate analysis used to identify predictors of fever and malaria parasitemia. Results A total of 1436 individuals were interviewed from 370 households. Overall, fever prevalence was 23.8% (341/1436) and was 38.8% (77/198) in children < 5 years, 21.3% (264/1238) in older children plus adults. Participants who sought treatment for fever were 84% (285/341) with 47.7%(136/285) using any anti-malarial. Artemisinin-based Combination Therapy use was in 69.1% (94/136) of cases while 30.9% used mono-therapies. Malaria parasitaemia rate was 28.2% (397/1407). Conclusion The study reports high community fever prevalence, frequent use of antimalarials for fever treatment and relatively high use of mono-therapies especially in children < 5 years in an area with high malaria parasite prevalence in Ghana.	[Abokyi, Livesy Naafoe; Asante, Kwaku Poku; Mahama, Emmanuel; Gyaase, Stephaney; Sulemana, Abubakari; Kwarteng, Anthony; Ayaam, Jennifer; Dosoo, David; Adu-Gyasi, Dennis; Etego, Seeba Amenga; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo Reg, Ghana; [Ogutu, Bernhards] INDEPTH Network, Accra, Ghana; [Akweongo, Patricia] Coll Hlth Sci, Sch Publ Hlth, Legon, Accra, Ghana	Kintampo Health Research Centre; INDEPTH Network	Abokyi, LN (corresponding author), Kintampo Hlth Res Ctr, POB 200, Kintampo, Brong Ahafo Reg, Ghana.	livesy.abokyi@kintampo-hrc.org		AKWEONGO, PATRICIA/0000-0001-6728-3365; Adu-Gyasi, Dennis/0000-0002-9449-2565; Owusu-Agyei, Seth/0000-0002-0807-1781	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was part of a bigger project (Indepth Effectiveness and safety studies of antimalarials in AFrica-INESS) funded by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study team is most grateful to the community members of Kintampo North Municipality and Kintampo South District particularly the study participants. We also thank the field, computing, laboratory and administrative staff of the Kintampo Health Research Centre for their support. We acknowledge the pivotal role of INDEPTH Network especially the INESS secretariat in securing funds and coordinating the study. The study was supported by grant from the Bill and Melinda Gates Foundation to the INDEPTH-Network. Kintampo Health Research Centre is a member of the INDEPTH Network.	Abdelgader TM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-11; Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; [Anonymous], 1998, COCHRANE DB SYST REV; [Anonymous], GHAN MULT IND CLUST; Ansah EK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1019; Asante KP, 2009, J TROPICAL MED; Asante KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-211; Asante KP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-409; Baiden F, 2014, Ghana Med J, V48, P112; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bosman A, 2007, AM J TROP MED HYG, V77, P193, DOI 10.4269/ajtmh.2007.77.193; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-300; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Dodoo ANO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-2; Elmardi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-128; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; GHS, 2009, GHAN NAT ANT POL; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-132; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-317; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Malm KL, 2013, J PUBLIC HEALTH POL, V34, P302, DOI 10.1057/jphp.2013.12; Mazigo Humphrey D, 2011, BMC Res Notes, V4, P359, DOI 10.1186/1756-0500-4-359; Meyrowitsch DW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-188; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Novignon Jacob, 2012, BMC Res Notes, V5, P380, DOI 10.1186/1756-0500-5-380; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Osei-Kwakye K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058107; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Owusu-Agyei S, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19033; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Owusu-Agyei S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002530; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Sabot O, 2011, HEALTH POLICY PLANN, V26, P441, DOI 10.1093/heapol/czr067; Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO Guidelines Approved by the Guidelines Review Committee, 2010, GLOB TUB CONTR WHO R, P2010; World Health Organization, 2008, WORLD MALARIA REPORT; Yusuf OB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-235	47	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142106	10.1371/journal.pone.0142106	http://dx.doi.org/10.1371/journal.pone.0142106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580076	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600035
J	Ishibashi, Y; Kasa, S; Sakamoto, M; Aoki, N; Kai, K; Yuasa, T; Hanada, A; Yamaguchi, S; Iwaya-Inoue, M				Ishibashi, Yushi; Kasa, Shinsuke; Sakamoto, Masatsugu; Aoki, Nozomi; Kai, Kyohei; Yuasa, Takashi; Hanada, Atsushi; Yamaguchi, Shinjiro; Iwaya-Inoue, Mari			A Role for Reactive Oxygen Species Produced by NADPH Oxidases in the Embryo and Aleurone Cells in Barley Seed Germination	PLOS ONE			English	Article							INDUCED ANTIOXIDANT DEFENSE; ABSCISIC-ACID; HYDROGEN-PEROXIDE; NITRIC-OXIDE; GIBBERELLIC-ACID; STOMATAL CLOSURE; INTRACELLULAR PH; DORMANCY; ARABIDOPSIS; CALCIUM	Reactive oxygen species (ROS) promote the germination of several seeds, and antioxidants suppress it. However, questions remain regarding the role and production mechanism of ROS in seed germination. Here, we focused on NADPH oxidases, which produce ROS. After imbibition, NADPH oxidase mRNAs were expressed in the embryo and in aleurone cells of barley seed; these expression sites were consistent with the sites of ROS production in the seed after imbibition. To clarify the role of NADPH oxidases in barley seed germination, we examined gibberellic acid (GA) / abscisic acid (ABA) metabolism and signaling in barley seeds treated with diphenylene iodonium chloride (DPI), an NADPH oxidase inhibitor. DPI significantly suppressed germination, and suppressed GA biosynthesis and ABA catabolism in embryos. GA, but not ABA, induced NADPH oxidase activity in aleurone cells. Additionally, DPI suppressed the early induction of alpha-amylase by GA in aleurone cells. These results suggest that ROS produced by NADPH oxidases promote GA biosynthesis in embryos, that GA induces and activates NADPH oxidases in aleurone cells, and that ROS produced by NADPH oxidases induce alpha-amylase in aleurone cells. We conclude that the ROS generated by NADPH oxidases regulate barley seed germination through GA / ABA metabolism and signaling in embryo and aleurone cells.	[Ishibashi, Yushi; Kasa, Shinsuke; Sakamoto, Masatsugu; Aoki, Nozomi; Kai, Kyohei; Yuasa, Takashi; Iwaya-Inoue, Mari] Kyushu Univ, Fac Agr, Crop Sci Lab, Higashi Ku, Fukuoka 812, Japan; [Hanada, Atsushi; Yamaguchi, Shinjiro] RIKEN, Plant Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa, Japan	Kyushu University; RIKEN	Ishibashi, Y (corresponding author), Kyushu Univ, Fac Agr, Crop Sci Lab, Higashi Ku, Fukuoka 812, Japan.	yushi@agr.kyushu-u.ac.jp						AHMED Z, 1980, J GEN PHYSIOL, V75, P403, DOI 10.1085/jgp.75.4.403; Amicucci E, 1999, PLANT BIOLOGY, V1, P524, DOI 10.1111/j.1438-8677.1999.tb00778.x; An YQ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-105; Aoki N, 2014, J PLANT PHYSIOL, V171, P615, DOI 10.1016/j.jplph.2014.01.005; Bahin E, 2011, PLANT CELL ENVIRON, V34, P980, DOI 10.1111/j.1365-3040.2011.02298.x; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Barba-Espin G, 2010, PLANT CELL ENVIRON, V33, P981, DOI 10.1111/j.1365-3040.2010.02120.x; Batak I, 2002, SEED SCI RES, V12, P253, DOI 10.1079/SSR2002118; Bethke PC, 2006, PLANTA, V223, P805, DOI 10.1007/s00425-005-0116-9; Bethke PC, 1997, J EXP BOT, V48, P1337, DOI 10.1093/jxb/48.7.1337; Bethke PC, 2004, PLANTA, V219, P847, DOI 10.1007/s00425-004-1282-x; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caliskan M, 1998, PLANT J, V15, P165, DOI 10.1046/j.1365-313X.1998.00191.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Chono M, 2006, J EXP BOT, V57, P2421, DOI 10.1093/jxb/erj215; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; El-Maarouf-Bouteau H, 2008, PLANT SIGNAL BEHAV, V3, P175, DOI 10.4161/psb.3.3.5539; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Fath A, 2001, PLANT PHYSIOL, V126, P156, DOI 10.1104/pp.126.1.156; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; FONTAINE O, 1994, PLANT PHYSIOL BIOCH, V32, P677; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; GILROY S, 1993, PLANTA, V190, P289, DOI 10.1007/BF00196956; Gilroy S, 1996, PLANT CELL, V8, P2193, DOI 10.1105/tpc.8.12.2193; GILROY S, 1992, P NATL ACAD SCI USA, V89, P3591, DOI 10.1073/pnas.89.8.3591; Groom QJ, 1996, PLANT J, V10, P515, DOI 10.1046/j.1365-313X.1996.10030515.x; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; HEIMOVAARADIJKSTRA S, 1994, PLANT PHYSIOL, V106, P359, DOI 10.1104/pp.106.1.359; Hite DRC, 1999, REDOX REP, V4, P29, DOI 10.1179/135100099101534710; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Ishibashi Y, 2013, ANN BOT-LONDON, V111, P95, DOI 10.1093/aob/mcs240; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; Ishibashi Y, 2010, PLANT PROD SCI, V13, P45, DOI 10.1626/pps.13.45; Jiang M, 2003, PLANT CELL ENVIRON, V26, P929, DOI 10.1046/j.1365-3040.2003.01025.x; Jiang MY, 2002, PLANTA, V215, P1022, DOI 10.1007/s00425-002-0829-y; Kaneko M, 2003, PLANT J, V35, P104, DOI 10.1046/j.1365-313X.2003.01780.x; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Leymarie J, 2008, PLANT CELL PHYSIOL, V49, P1830, DOI 10.1093/pcp/pcn164; Lightfoot DJ, 2008, FUNCT PLANT BIOL, V35, P347, DOI 10.1071/FP08109; Liu YG, 2010, J EXP BOT, V61, P2979, DOI 10.1093/jxb/erq125; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Muller K, 2009, NEW PHYTOL, V184, P885, DOI 10.1111/j.1469-8137.2009.03005.x; Neill S, 2008, J EXP BOT, V59, P165, DOI 10.1093/jxb/erm293; Nonogaki H, 2000, PLANT PHYSIOL, V123, P1235, DOI 10.1104/pp.123.4.1235; Ogawa K, 2001, PLANT CELL PHYSIOL, V42, P286, DOI 10.1093/pcp/pce032; OKane D, 1996, PLANTA, V198, P371, DOI 10.1007/BF00620053; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PUNTARULO S, 1988, PLANT PHYSIOL, V86, P626, DOI 10.1104/pp.86.2.626; Sarath G, 2006, PLANTA, V223, P1154, DOI 10.1007/s00425-005-0162-3; Sarath G, 2007, PLANTA, V226, P697, DOI 10.1007/s00425-007-0517-z; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trujillo M, 2006, J EXP BOT, V57, P3781, DOI 10.1093/jxb/erl191; VanGestelen P, 1997, PLANT PHYSIOL, V115, P543, DOI 10.1104/pp.115.2.543; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Wang PT, 2008, NEW PHYTOL, V178, P703, DOI 10.1111/j.1469-8137.2008.02431.x; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Yoshie Y., 2005, PLANT BIOTECHNOL-NAR, V22, P127, DOI [10.5511/plantbiotechnology.22.127, DOI 10.5511/PLANTBIOTECHNOLOGY.22.127]; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Yoshioka H, 2001, MOL PLANT MICROBE IN, V14, P725, DOI 10.1094/MPMI.2001.14.6.725; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438	70	62	67	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143173	10.1371/journal.pone.0143173	http://dx.doi.org/10.1371/journal.pone.0143173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579718	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600095
J	Potestio, ML; Boyd, JM; Bagshaw, SM; Heyland, D; Oxland, P; Doig, CJ; Zygun, D; Stelfox, HT				Potestio, Melissa L.; Boyd, Jamie M.; Bagshaw, Sean M.; Heyland, Daren; Oxland, Peter; Doig, Christopher J.; Zygun, Dave; Stelfox, Henry T.			Engaging the Public to Identify Opportunities to Improve Critical Care: A Qualitative Analysis of an Open Community Forum	PLOS ONE			English	Article							OF-LIFE CARE; INTENSIVE-CARE; HOSPITALIZED-PATIENTS; FAMILY SATISFACTION; MORAL DISTRESS; FOCUS GROUPS; HEALTH-CARE; UNIT; ICU; DISCUSSIONS	Objective To engage the public to understand how to improve the care of critically ill patients. Design A qualitative content analysis of an open community forum (Cafe Scientifique). Setting Public venue in Calgary, Alberta, Canada. Participants Members of the general public including patients, families of patients, health care providers, and members of the community at large. Methods A panel of researchers, decision-makers, and a family member led a Cafe Scientifique, an informal dialogue between the populace and experts, over three-hours to engage the public to understand how to improve the care of critically ill patients. Conventional qualitative content analysis was used to analyze the data. The inductive analysis occurred in three phases: coding, categorizing, and developing themes. Results Thirty-eight members of the public (former ICU patients, family members of patients, providers, community members) attended. Participants focused the discussion and provided concrete suggestions for improvement around communication (family as surrogate voice, timing of conversations, decision tools) and provider well-being and engagement, as opposed to medical interventions in critical care. Conclusions Cafe participants believe patient and family centered care is important to ensure high-quality care in the ICU. A Cafe Scientifique is a valuable forum to engage the public to contribute to priority setting areas for research in critical care, as well as a platform to share lived experience. Research stakeholders including health care organizations, governments, and funding organizations should provide more opportunities for the public to engage in meaningful conversations about how to best improve healthcare.	[Potestio, Melissa L.] Alberta Hlth Serv, Res Prior & Implementat, Calgary, AB, Canada; [Potestio, Melissa L.; Boyd, Jamie M.; Stelfox, Henry T.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Boyd, Jamie M.] Univ Calgary, Res & Innovat Ctr W21C, Calgary, AB, Canada; [Bagshaw, Sean M.; Zygun, Dave] Univ Alberta, Div Crit Care Med, Fac Med & Dent, Alberta Hlth Serv, Edmonton, AB, Canada; [Heyland, Daren] Queens Univ, Kingston Gen Hosp, Dept Crit Care Med, Clin Evaluat Res Unit, Kingston, ON, Canada; [Oxland, Peter] Alberta Hlth Serv, Crit Care, Calgary, AB, Canada; [Oxland, Peter] Univ Calgary, Calgary, AB, Canada; [Doig, Christopher J.] Univ Calgary, Dept Crit Care Med, Alberta Hlth Serv, Calgary, AB, Canada	Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Alberta; Queens University - Canada; Alberta Health Services (AHS); University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary	Stelfox, HT (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.	tstelfox@ucalgary.ca	Doig, Christopher/AAC-7949-2020	Doig, Christopher/0000-0002-8576-9139; Stelfox, Henry/0000-0003-1231-1490	Canadian Institutes of Health Research [SCI-131811]; O'Brien Institute for Public Health at the University of Calgary; Alberta Innovates [201300477, 201201137] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); O'Brien Institute for Public Health at the University of Calgary; Alberta Innovates	This work was supported by an operating grant from Canadian Institutes of Health Research (SCI-131811). The funder had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.; We thank the O'Brien Institute for Public Health at the University of Calgary for their financial support of the Cafe Scientifique. We thank Dr. Day, Ms. Roe and Ms. Rabatach for assisting with coordination of the Cafe Scientifique.	Arnetz BB, 2001, SOC SCI MED, V52, P203, DOI 10.1016/S0277-9536(00)00220-3; Auriemma CL, 2014, JAMA INTERN MED, V174, P1085, DOI 10.1001/jamainternmed.2014.1183; Bagshaw SM, 2014, CAN MED ASSOC J, V186, pE95, DOI 10.1503/cmaj.130639; Beumer CM, 2008, DIMENS CRIT CARE NUR, V27, P263, DOI 10.1097/01.DCC.0000338871.77658.03; Brondani MA, 2010, ARCH SEX BEHAV, V39, P1453, DOI 10.1007/s10508-009-9578-3; Brown S, 2010, STRATEGY PATIENT ORI; Bryman A., 2008, SOCIAL RES METHODS; Corley MC, 2002, NURS ETHICS, V9, P636, DOI 10.1191/0969733002ne557oa; Cullen DJ, 1997, CRIT CARE MED, V25, P1289, DOI 10.1097/00003246-199708000-00014; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; Gagliardi AR, 2014, J TRAUMA ACUTE CARE, V77, P749, DOI 10.1097/TA.0000000000000432; Glaser B.G, 1978, THEORETICAL SENSITIV; Guevara-Lopez U, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0003-2; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Hartog CS, 2014, J CRIT CARE, V29, P128, DOI 10.1016/j.jcrc.2013.08.024; Heyland DK, 2010, CAN MED ASSOC J, V182, pE747, DOI 10.1503/cmaj.100131; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Institute of Medicine Committee on the Quality of Health Care in America, 1990, MED STRAT QUAL ASS; Johnson AR, 2013, J PALLIAT CARE, V29, P99, DOI 10.1177/082585971302900206; Karanikola MNK, 2012, DIMENS CRIT CARE NUR, V31, P37, DOI 10.1097/DCC.0b013e31823a55b8; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kompanje EJO, 2013, CURR OPIN CRIT CARE, V19, P630, DOI 10.1097/MCC.0000000000000026; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lind R, 2011, INTENS CARE MED, V37, P1143, DOI 10.1007/s00134-011-2253-x; MacQueen K.M., 1998, CAM J, V10, P31, DOI [10.1177/1525822X980100020301, DOI 10.1177/1525822X980100020301, 10.1177/1525822x980100020301]; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Morse J. M., 1995, QUALITATIVE RES METH; Moyen E, 2008, CRIT CARE, V12, DOI 10.1186/cc6813; Nelson JE, 2010, CRIT CARE MED, V38, P808, DOI 10.1097/CCM.0b013e3181c5887c; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Price Bob, 2010, Paediatr Nurs, V22, P26; Reimer-Kirkham S, 2015, HEALTH COMMUN, V30, P496, DOI 10.1080/10410236.2013.868398; Robinson R, 2010, DIMENS CRIT CARE NUR, V29, P197, DOI 10.1097/DCC.0b013e3181e6c344; Schenker Y, 2012, J GEN INTERN MED, V27, P1657, DOI 10.1007/s11606-012-2129-y; St Ledger U, 2013, J ADV NURS, V69, P1869, DOI 10.1111/jan.12053; Sundararajan K, 2012, ANAESTH INTENS CARE, V40, P159, DOI 10.1177/0310057X1204000120; Thelen Mary, 2005, Crit Care Nurse, V25, P28; Wall RJ, 2007, CHEST, V132, P1425, DOI 10.1378/chest.07-0419; Wiegand DL, 2015, AACN ADV CRIT CARE, V26, P142, DOI 10.1097/NCI.0000000000000085; Wiegand DL, 2013, J GERONTOL NURS, V39, P60, DOI 10.3928/00989134-20130530-04; Wong P, 2015, INTENS CRIT CARE NUR, V31, P51, DOI 10.1016/j.iccn.2014.06.005; You JJ, 2014, CMAJ, V186, P679, DOI DOI 10.1503/CMAJ.140673; You JJ, 2015, JAMA INTERN MED, V175, P549, DOI 10.1001/jamainternmed.2014.7732; You JJ, 2014, CAN MED ASSOC J, V186, P425, DOI 10.1503/cmaj.121274	46	20	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143088	10.1371/journal.pone.0143088	http://dx.doi.org/10.1371/journal.pone.0143088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26580406	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600080
J	Rode, KD; Wilson, RR; Regehr, EV; St Martin, M; Douglas, DC; Olson, J				Rode, Karyn D.; Wilson, Ryan R.; Regehr, Eric V.; St Martin, Michelle; Douglas, David C.; Olson, Jay			Increased Land Use by Chukchi Sea Polar Bears in Relation to Changing Sea Ice Conditions	PLOS ONE			English	Article							URSUS-MARITIMUS; TERRESTRIAL FOODS; BEHAVIOR; PREDATOR; ECOLOGY; GEESE; SIZE	Recent observations suggest that polar bears (Ursus maritimus) are increasingly using land habitats in some parts of their range, where they have minimal access to their preferred prey, likely in response to loss of their sea ice habitat associated with climatic warming. We used location data from female polar bears fit with satellite radio collars to compare land use patterns in the Chukchi Sea between two periods (1986-1995 and 2008-2013) when substantial summer sea-ice loss occurred. In both time periods, polar bears predominantly occupied sea-ice, although land was used during the summer sea-ice retreat and during the winter for maternal denning. However, the proportion of bears on land for > 7 days between August and October increased between the two periods from 20.0% to 38.9%, and the average duration on land increased by 30 days. The majority of bears that used land in the summer and for denning came to Wrangel and Herald Islands (Russia), highlighting the importance of these northernmost land habitats to Chukchi Sea polar bears. Where bears summered and denned, and how long they spent there, was related to the timing and duration of sea ice retreat. Our results are consistent with other studies supporting increased land use as a common response of polar bears to sea-ice loss. Implications of increased land use for Chukchi Sea polar bears are unclear, because a recent study observed no change in body condition or reproductive indices between the two periods considered here. This result suggests that the ecology of this region may provide a degree of resilience to sea ice loss. However, projections of continued sea ice loss suggest that polar bears in the Chukchi Sea and other parts of the Arctic may increasingly use land habitats in the future, which has the potential to increase nutritional stress and human-polar bear interactions.	[Rode, Karyn D.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Wilson, Ryan R.; Regehr, Eric V.; St Martin, Michelle] US Fish & Wildlife Serv, Marine Mammals Management, Anchorage, AK 99503 USA; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, Juneau, AK 99801 USA; [Olson, Jay] Brigham Young Univ, Plant & Wildlife Sci, Provo, UT 84602 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; Brigham Young University	Rode, KD (corresponding author), US Geol Survey, Alaska Sci Ctr, 4210 Univ Dr, Anchorage, AK 99508 USA.	krode@usgs.gov	Douglas, David C./AAU-1087-2021	Douglas, David C./0000-0003-0186-1104; Rode, Karyn/0000-0002-3328-8202	USFWS Marine Mammals Management; USGS Changing Arctic Ecosystem Initiative; Detroit Zoological Association; State of Alaska Coastal Impact Assessment Program	USFWS Marine Mammals Management; USGS Changing Arctic Ecosystem Initiative; Detroit Zoological Association; State of Alaska Coastal Impact Assessment Program	Funding for this study was provided by the USFWS Marine Mammals Management, USGS Changing Arctic Ecosystem Initiative, the Detroit Zoological Association and the State of Alaska Coastal Impact Assessment Program. Only the USFWS and USGS contributed to study design, data collection and analysis, decision to publish and preparation of the manuscript. In-kind support was received from Teck Alaska, Inc.	Aars J, 2009, MAR MAMMAL SCI, V25, P35, DOI 10.1111/j.1748-7692.2008.00228.x; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Atkinson SN, 1996, PHYSIOL ZOOL, V69, P304, DOI 10.1086/physzool.69.2.30164186; Bengtson JL, 2005, POLAR BIOL, V28, P833, DOI 10.1007/s00300-005-0009-1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Derocher AE, 2011, MAR ECOL PROG SER, V441, P273, DOI 10.3354/meps09406; Derocher A.E., 2012, POLAR BEARS COMPLETE; Derocher AE, 2004, INTEGR COMP BIOL, V44, P163, DOI 10.1093/icb/44.2.163; Derocher AE, 2013, CONSERV LETT, V6, P368, DOI 10.1111/conl.12009; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Durner GM, 2006, 701815N240 USGS AL S; Ferguson SH, 2000, J MAMMAL, V81, P1118, DOI 10.1644/1545-1542(2000)081<1118:RBDOPB>2.0.CO;2; Fischbach AS, 2007, POLAR BIOL, V30, P1395, DOI 10.1007/s00300-007-0300-4; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Freitas C, 2012, MAR ECOL PROG SER, V447, P289, DOI 10.3354/meps09516; Hobson KA, 2009, CAN J ZOOL, V87, P50, DOI 10.1139/Z08-137; Hooten MB, 2014, STAT METHODOL, V17, P82, DOI 10.1016/j.stamet.2012.12.001; Iverson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3128; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Johnson DS, 2013, CRAWL FIT CONTINUOUS; Kelly B, 2010, NATURE, V468, P891, DOI 10.1038/468891a; Kochnev AA, 2002, P MAR MAMM HOL M SEP; Kochnev AA, 2003, TRADITIONAL KNOWLEDG, P1; Lunn NJ, 2014, DEMOGRAPHY POPULATIO; Mahoney A. R., 2012, MAPPING CHARACTERIZA; Manly B.F.J., 2002, RESOURCE SELECTION A; Miller S, 2015, J MAMM IN PRESS; Obbard M., 2010, POL BEARS P 15 WORK; Olson J, 2015, THESIS; Ovsyanikov NG, 2005, ZOOL ZH, V84, P94; Ovsyanikov NG, 2010, P MAR MAMM HOL M OCT; Ovsyanikov NG, 2008, P MAR MAMM HOL OD UK, P407; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Prop J, 2015, FRONTIERS E IN PRESS; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAMSAY MA, 1991, OECOLOGIA, V86, P598, DOI 10.1007/BF00318328; RAMSAY MA, 1991, CAN J ZOOL, V69, P298, DOI 10.1139/z91-048; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Rockwell RF, 2011, OIKOS, V120, P696, DOI 10.1111/j.1600-0706.2010.18837.x; Rode KD, 2015, FRONT ECOL ENVIRON, V13, P138, DOI 10.1890/140202; Rode KD, 2014, GLOBAL CHANGE BIOL, V20, P76, DOI 10.1111/gcb.12339; Rode KD, 2010, J MAMMAL, V91, P1517, DOI 10.1644/09-MAMM-A-399.1; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Schliebe S, 2008, POLAR BIOL, V31, P999, DOI 10.1007/s00300-008-0439-7; Smith PA, 2010, POLAR BIOL, V33, P1149, DOI 10.1007/s00300-010-0791-2; Stempniewicz L, 2006, ARCTIC, V59, P247; Stirling I, 1999, ARCTIC, V52, P294; STIRLING I, 1989, J WILDLIFE DIS, V25, P159, DOI 10.7589/0090-3558-25.2.159; Stroeve JC, 2014, GEOPHYS RES LETT, V41, P1216, DOI 10.1002/2013GL058951; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Therneau T., 2013, PACKAGE SURVIVAL ANA, P37; VanDerWal J., 2014, R PACKAGE VERSION, V1, P1, DOI DOI 10.1016/J.TWS.2014.06.001; Voorhees H, 2014, ARCTIC IN PRESS, P67; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Whiteman JP, 2015, SCIENCE, V349, P295, DOI 10.1126/science.aaa8623; Zar JH, 1999, BIOSTATISTICAL ANAL	61	59	60	2	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142213	10.1371/journal.pone.0142213	http://dx.doi.org/10.1371/journal.pone.0142213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580809	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600039
J	Tyminski, JP; de la Parra-Venegas, R; Cano, JG; Hueter, RE				Tyminski, John P.; de la Parra-Venegas, Rafael; Gonzzlez Cano, Jaime; Hueter, Robert E.			Vertical Movements and Patterns in Diving Behavior of Whale Sharks as Revealed by Pop-Up Satellite Tags in the Eastern Gulf of Mexico	PLOS ONE			English	Article							RHINCODON-TYPUS SMITH; NINGALOO REEF; CARCHARODON-CARCHARIAS; HABITAT PREFERENCES; WESTERN-AUSTRALIA; GEOMAGNETIC-FIELD; PACIFIC-OCEAN; INDIAN-OCEAN; DIEL; MIGRATION	The whale shark (Rhincodon typus) is a wide-ranging, filter-feeding species typically observed at or near the surface. This shark's sub-surface habits and behaviors have only begun to be revealed in recent years through the use of archival and satellite tagging technology. We attached pop-up satellite archival transmitting tags to 35 whale sharks in the southeastern Gulf of Mexico off the Yucatan Peninsula from 2003-2012 and three tags to whale sharks in the northeastern Gulf off Florida in 2010, to examine these sharks' long-term movement patterns and gain insight into the underlying factors influencing their vertical habitat selection. Archived data were received from 31 tags deployed on sharks of both sexes with total lengths of 5.5-9 m. Nine of these tags were physically recovered facilitating a detailed long-term view into the sharks' vertical movements. Whale sharks feeding inshore on fish eggs off the northeast Yucatan Peninsula demonstrated reverse diel vertical migration, with extended periods of surface swimming beginning at sunrise followed by an abrupt change in the mid-afternoon to regular vertical oscillations, a pattern that continued overnight. When in oceanic waters, sharks spent about 95% of their time within epipelagic depths (<200 m) but regularly undertook very deep ("extreme") dives (>500 m) that largely occurred during daytime or twilight hours (max. depth recorded 1,928 m), had V-shaped depth-time profiles, and comprised more rapid descents (0.68 m sec(-1)) than ascents (0.50 m sec(-1)). Nearly half of these extreme dives had descent profiles with brief but conspicuous changes in vertical direction at a mean depth of 475 m. We hypothesize these stutter steps represent foraging events within the deep scattering layer, however, the extreme dives may have additional functions. Overall, our results demonstrate complex and dynamic patterns of habitat utilization for R. typus that appear to be in response to changing biotic and abiotic conditions influencing the distribution and abundance of their prey.	[Tyminski, John P.; Hueter, Robert E.] Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA; [de la Parra-Venegas, Rafael] Chooj Ajauil AC, Cancun, Quintana Roo, Mexico; [Gonzzlez Cano, Jaime] Comis Nacl Areas Nat Protegidas, Proyecto Domino, Cancun, Quintana Roo, Mexico	Mote Marine Laboratory & Aquarium	Tyminski, JP (corresponding author), Mote Marine Lab, Ctr Shark Res, Sarasota, FL 34236 USA.	johnski@mote.org			Georgia Aquarium; Christopher Reynolds Foundation; National Geographic Society; Mote Marine Laboratory; Mexico Small Grants Program - UNDP/Global Environment Facility	Georgia Aquarium; Christopher Reynolds Foundation; National Geographic Society(National Geographic Society); Mote Marine Laboratory; Mexico Small Grants Program - UNDP/Global Environment Facility	This research was supported by funding from Georgia Aquarium (www.georgiaaquarium.org), Christopher Reynolds Foundation (www.creynolds.org), National Geographic Society (www.ngs.org), Mote Marine Laboratory (www.mote.org) and an anonymous private foundation. The Natural Protected Areas National Commission of Mexico (SEMARNAT/CONANP) provided personnel, biological station facilities, boats, fuel and conventional tags during the early stages of the work (2003-2009). Those stages also were supported in part by a Mexico Small Grants Program funded by the UNDP/Global Environment Facility, as provided by the Mexican NGO SER de Quintana Roo A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhilesh KV, 2013, ENVIRON BIOL FISH, V96, P713, DOI 10.1007/s10641-012-0063-9; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Berumen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103536; Braun CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088170; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Brunnschweiler JM, 2012, AM FISH S S, V76, P457; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Cartamil D, 2010, MAR FRESHWATER RES, V61, P596, DOI 10.1071/MF09153; Chapman DD, 2007, MAR ECOL PROG SER, V344, P271, DOI 10.3354/meps06941; Chatfield C., 2004, ANAL TIME SERIES INT; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Collette BB, 1983, FAO FISH SYNOPOSIS, V125, P137; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Comfort CM, 2015, DEEP-SEA RES PT II, V115, P116, DOI 10.1016/j.dsr2.2014.04.005; Compango LJV, 2001, FAO SPECIES CATALOGU, P269; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Di Santo V, 2011, J FISH BIOL, V78, P195, DOI 10.1111/j.1095-8649.2010.02853.x; Dove ADM, 2015, BIOL BULL-US, V228, P65, DOI 10.1086/BBLv228n1p65; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Gleiss AC, 2013, MAR BIOL, V160, P2981, DOI 10.1007/s00227-013-2288-3; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Graves JE, 2009, FISH B-NOAA, V107, P373; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Hays GC, 2015, J ANIM ECOL, V84, P587, DOI 10.1111/1365-2656.12355; Hoffmayer Eric R., 2007, Gulf and Caribbean Research, V19, P69; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Kaartvedt S, 2009, MAR ECOL PROG SER, V395, P109, DOI 10.3354/meps08174; Kaltenberg A. M., 2007, Gulf of Mexico Science, V25, P97; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Krylov VV., 2014, BIOL B REV, V4, P222, DOI [10.1134/S2079086414030049, DOI 10.1134/S2079086414030049]; Li W, 2012, J FISH BIOL, V80, P1608, DOI 10.1111/j.1095-8649.2012.03250.x; MACDONALD KC, 1980, J GEOPHYS RES, V85, P3670, DOI 10.1029/JB085iB07p03670; Meyer CG, 2005, J R SOC INTERFACE, V2, P129, DOI 10.1098/rsif.2004.0021; Moretzsohn F, 2015, GULFBASE RESOURCE DA; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Nakamura I, 2015, J ANIM ECOL, V84, P590, DOI 10.1111/1365-2656.12346; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; Norman B, IUCN RED LIST THREAT; Pade NG, 2009, J EXP MAR BIOL ECOL, V370, P64, DOI 10.1016/j.jembe.2008.12.002; R Core Team, 2018, R LANG ENV STAT COMP; Riley MJ, 2009, ENVIRON BIOL FISH, V86, P371, DOI 10.1007/s10641-009-9541-0; Rohner CA, 2015, J PLANKTON RES, V37, P352, DOI 10.1093/plankt/fbv010; Rohner CA, 2013, MAR ECOL PROG SER, V493, P219, DOI 10.3354/meps10500; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 2010, CRC MAR BIOL SER, P351; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sims DW, 2006, J ANIM ECOL, V75, P176, DOI 10.1111/j.1365-2656.2005.01033.x; Sims DW, 2009, FISH LOCOMOTION ETHO, P407; Stewart BS, 2005, ENVIRON BIOL FISH, V74, P184, DOI 10.1007/s10641-005-2229-1; Thorrold SR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5274; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Tyminski JP, 2012, MOTE MARINE LAB TECH, V1633, P1; Wang YM, 2012, INTEGR ZOOL, V7, P94, DOI [10.1111/j.1749-4877.2012.00279.x, 10.1111/j.1749-4877.2011.00278.x]; Weng KC, 2009, J FISH BIOL, V74, P1434, DOI 10.1111/j.1095-8649.2009.02209.x; Weng KC, 2004, FISH B-NOAA, V102, P221; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; Willis J, 2009, BEHAV ECOL SOCIOBIOL, V64, P57, DOI 10.1007/s00265-009-0818-2; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8	65	38	38	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142156	10.1371/journal.pone.0142156	http://dx.doi.org/10.1371/journal.pone.0142156			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580405	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600037
J	Zhang, XY; Hou, JL; Wang, GX; Jiang, HB; Wang, YF; Sun, ZH; Jiang, XF; Yu, QH; Liu, HJ				Zhang, Xiaoyan; Hou, Jilun; Wang, Guixing; Jiang, Hongbo; Wang, Yufen; Sun, Zhaohui; Jiang, Xiufeng; Yu, Qinghai; Liu, Haijin			Gonadal Transcriptome Analysis in Sterile Double Haploid Japanese Flounder	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; RAINBOW-TROUT; FOLLICULAR ATRESIA; 11-BETA-HYDROXYLASE GENE; OVARIAN DEVELOPMENT; MOLECULAR-CLONING; GROWTH-HORMONE; EXPRESSION; PROLACTIN; FISH	Sterility is a serious problem that can affect all bionts. In teleosts, double haploids (DHs) induced by mitogynogenesis are often sterile. This sterility severely restricts the further application of DHs for production of clones, genetic analysis, and breeding. However, sterile DH individuals are good source materials for investigation of the molecular mechanisms of gonad development, especially for studies into the role of genes that are indispensable for fish reproduction. Here, we used the Illumina sequencing platform to analyze the transcriptome of sterile female DH Japanese flounder in order to identify major genes that cause sterility and to provide a molecular basis for an intensive study of gonadal development in teleosts. Through sequencing, assembly, and annotation, we obtained 52,474 contigs and found that 60.7% of these shared homologies with existing sequences. A total of 1225 differentially expressed unigenes were found, including 492 upregulated and 733 downregulated genes. Gene Ontology and KEGG analyses showed that genes showing significant upregulation, such as CYP11A1, CYP11B2, CYP17, CYP21, HSD3 beta, bcl2l1, and PRLR, principally correlated with sterol metabolic process, steroid biosynthetic process, and the Jak-stat signaling pathway. The significantly downregulated genes were primarily associated with immune response, antigen processing and presentation, cytokine-cytokine receptor interaction, and protein digestion and absorption. Using a co-expression network analysis, we conducted a comprehensive comparison of gene expression in the gonads of fertile and sterile female DH Japanese flounder. Identification of genes showing significantly different expression will provide further insights into DH reproductive dysfunction and oocyte maturation processes in teleosts.	[Zhang, Xiaoyan; Hou, Jilun; Wang, Guixing; Wang, Yufen; Sun, Zhaohui; Jiang, Xiufeng; Yu, Qinghai] Chinese Acad Fishery Sci, Beidaihe Cent Expt Stn, Qinhuangdao, Peoples R China; [Jiang, Hongbo] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110161, Peoples R China; [Liu, Haijin] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China	Chinese Academy of Fishery Sciences; Beidaihe Central Experiment Station, CAFS; Shenyang Agricultural University; Chinese Academy of Fishery Sciences	Hou, JL (corresponding author), Chinese Acad Fishery Sci, Beidaihe Cent Expt Stn, Qinhuangdao, Peoples R China.	jilunhou@126.com; liuhaijin2005@126.com	wang, guixing/GQP-1217-2022		National High Technology Research and Development Program in China [2012BAD26B01]; Special Scientific Research Funds for Central Non-profit Institutes Chinese Academy of Fishery Sciences [2014A03XK02]	National High Technology Research and Development Program in China(National High Technology Research and Development Program of China); Special Scientific Research Funds for Central Non-profit Institutes Chinese Academy of Fishery Sciences	The work was funded by National High Technology Research and Development Program in China (2012BAD26B01) and Special Scientific Research Funds for Central Non-profit Institutes Chinese Academy of Fishery Sciences (2014A03XK02).	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Arukwe A, 2001, MAR POLLUT BULL, V42, P643, DOI 10.1016/S0025-326X(01)00062-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BABIN PJ, 1987, J BIOL CHEM, V262, P4290; Bannister LA, 2007, PLOS BIOL, V5, P1016, DOI 10.1371/journal.pbio.0050105; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; BESSEAU L, 1994, CELL TISSUE RES, V276, P123, DOI 10.1007/BF00354791; Bobe J, 2009, COMP BIOCHEM PHYS A, V153, P63, DOI 10.1016/j.cbpa.2008.10.021; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bongers ABJ, 1999, VIABLE ANDROGENETIC; Bureik M, 2002, BIOL CHEM, V383, P1537, DOI 10.1515/BC.2002.174; Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007; Cavaco JEB, 2003, QUANTIFICATION PROLA, P588; Cerda J, 2008, REV FISH SCI, V16, P56, DOI 10.1080/10641260802324685; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; de Vlaming VL, 1972, ENV CONTROL TELEOST, P131; Ding YX, 2013, GENE, V527, P82, DOI 10.1016/j.gene.2013.05.037; Ding YX, 2012, GEN COMP ENDOCR, V179, P107, DOI 10.1016/j.ygcen.2012.08.003; Draghici S, 2007, SYSTEMS BIOL APPROAC, P1537; EDERY M, 1984, GEN COMP ENDOCR, V56, P19, DOI 10.1016/0016-6480(84)90056-X; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063259; Guraya SS, 1994, GONADAL DEV PRODUCTI, P15; Hayashi M, 2012, MOL REPROD DEV, V79, P870, DOI 10.1002/mrd.22127; Hsu HJ, 2009, MOL CELL ENDOCRINOL, V312, P31, DOI 10.1016/j.mce.2009.07.030; Huang S, 2010, FERTIL STERIL, V94, P205, DOI 10.1016/j.fertnstert.2009.03.005; Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-711; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Izquierdo MS, 2001, AQUACULTURE, V197, P25, DOI 10.1016/S0044-8486(01)00581-6; Jiang JQ, 1998, MOL CELL ENDOCRINOL, V146, P207, DOI 10.1016/S0303-7207(98)00147-6; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; KAGAWA H, 1983, BIOL REPROD, V29, P301, DOI 10.1095/biolreprod29.2.301; Kazeto Y, 2000, GEN COMP ENDOCR, V118, P123, DOI 10.1006/gcen.1999.7449; Keller L, 2002, INBREEDING EFFECTS W, P230; KJORSVIK E, 1990, ADV MAR BIOL, V26, P71, DOI 10.1016/S0065-2881(08)60199-6; Komen H, 2007, AQUACULTURE, V269, P150, DOI 10.1016/j.aquaculture.2007.05.009; Kuribayashi K, 2008, CANCER BIOL THER, V7, P2034, DOI 10.4161/cbt.7.12.7460; Kusakabe M, 2002, MOL REPROD DEV, V62, P456, DOI 10.1002/mrd.10145; LANG I, 1981, CELL TISSUE RES, V220, P201; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lisurek M, 2004, MOL CELL ENDOCRINOL, V215, P149, DOI 10.1016/j.mce.2003.11.008; Liu SJ, 2000, J STEROID BIOCHEM, V75, P291, DOI 10.1016/S0960-0760(00)00186-2; Ma DL, 2014, BIOCHIMIE, V103, P101, DOI 10.1016/j.biochi.2014.04.010; Miranda ACL, 1999, TISSUE CELL, V31, P480, DOI 10.1054/tice.1999.0045; MullerBelecke A, 1995, AQUACULTURE, V137, P57, DOI 10.1016/0044-8486(95)01114-5; NAGAHAMA Y, 1985, DEV BIOL, V109, P428, DOI 10.1016/0012-1606(85)90469-5; Nematollahi MA, 2014, AQUACULTURE, V418, P165, DOI [10.1016/j.aquaculture.2013.10.011, 10.1016/j.aquaculture.2013.10.0]; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reisch N, 2015, BEST PRACT RES CL EN, V29, P33, DOI 10.1016/j.beem.2014.11.002; Saidapur S K, 1978, Int Rev Cytol, V54, P225, DOI 10.1016/S0074-7696(08)60169-2; Sandra O, 2000, J MOL ENDOCRINOL, V24, P215, DOI 10.1677/jme.0.0240215; Santos HB, 2005, J FISH BIOL, V67, P1446, DOI 10.1111/j.1095-8649.2005.00854.x; SJ TC, 1996, REV FISH BIOL FISHER, V6, P287; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Tacon P, 2000, GEN COMP ENDOCR, V117, P54, DOI 10.1006/gcen.1999.7388; Takesono A, 2012, P NATL ACAD SCI USA, V109, P3371, DOI 10.1073/pnas.1200642109; Tingaud-Sequeira A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-434; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967; WALLACE RA, 1990, J ELECTRON MICR TECH, V16, P175, DOI 10.1002/jemt.1060160302; Wood AW, 2003, MOL REPROD DEV, V65, P219, DOI 10.1002/mrd.10272; Yamamoto E, 1999, AQUACULTURE, V173, P235, DOI 10.1016/S0044-8486(98)00448-7; Zhang Xiao-yan, 2014, Marine Fisheries, V36, P503; Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230; Zhou LY, 2007, BIOCHEM BIOPH RES CO, V362, P619, DOI 10.1016/j.bbrc.2007.08.044	69	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143204	10.1371/journal.pone.0143204	http://dx.doi.org/10.1371/journal.pone.0143204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580217	Green Submitted, gold, Green Published			2022-12-26	WOS:000365154600097
J	Hargrove, AE; Martinez, TF; Hare, AA; Kurmis, AA; Phillips, JW; Sud, S; Pienta, KJ; Dervan, PB				Hargrove, Amanda E.; Martinez, Thomas F.; Hare, Alissa A.; Kurmis, Alexis A.; Phillips, John W.; Sud, Sudha; Pienta, Kenneth J.; Dervan, Peter B.			Tumor Repression of VCaP Xenografts by a Pyrrole-Imidazole Polyamide	PLOS ONE			English	Article							DNA TOPOISOMERASE-II; GROOVE BINDING-DRUGS; MINOR-GROOVE; ANDROGEN RECEPTOR; PROSTATE-CANCER; NUCLEAR-LOCALIZATION; STRUCTURAL BASIS; GENE; FUSION; TRANSCRIPTION	Pyrrole-imidazole (Py-Im) polyamides are high affinity DNA-binding small molecules that can inhibit protein-DNA interactions. In VCaP cells, a human prostate cancer cell line overexpressing both AR and the TMPRSS2-ERG gene fusion, an androgen response element (ARE)-targeted Py-Im polyamide significantly downregulates AR driven gene expression. Polyamide exposure to VCaP cells reduced proliferation without causing DNA damage. Py-Im polyamide treatment also reduced tumor growth in a VCaP mouse xenograft model. In addition to the effects on AR regulated transcription, RNA-seq analysis revealed inhibition of topoisomerase-DNA binding as a potential mechanism that contributes to the antitumor effects of polyamides in cell culture and in xenografts. These studies support the therapeutic potential of Py-Im polyamides to target multiple aspects of transcriptional regulation in prostate cancers without genotoxic stress.	[Hargrove, Amanda E.; Martinez, Thomas F.; Hare, Alissa A.; Kurmis, Alexis A.; Phillips, John W.; Dervan, Peter B.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Sud, Sudha; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA	California Institute of Technology; University of Michigan System; University of Michigan	Pienta, KJ (corresponding author), Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA.	kpienta1@jhmi.edu; dervan@caltech.edu	Martinez, Thomas/AAT-8672-2021	Martinez, Thomas/0000-0002-4011-8164	National Institutes of Health [R01GM027681, F32CA156833, F31CA159896, F32CA173977, T32GM007616]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [F32CA173977, F31CA159896, F32CA156833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, R01GM027681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research has been supported by the National Institutes of Health (www.nih.gov, Grants R01GM027681 to PBD, F32CA156833 to AEH, F31CA159896 to TFM, F32CA173977 to AAH, and T32GM007616 to AAK) and the Prostate Cancer Foundation (www.pcf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BEERMAN TA, 1991, BIOCHIM BIOPHYS ACTA, V1090, P52, DOI 10.1016/0167-4781(91)90036-L; BEERMAN TA, 1992, BIOCHIM BIOPHYS ACTA, V1131, P53, DOI 10.1016/0167-4781(92)90098-K; Best TP, 2003, P NATL ACAD SCI USA, V100, P12063, DOI 10.1073/pnas.2035074100; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chenoweth DM, 2010, J AM CHEM SOC, V132, P14521, DOI 10.1021/ja105068b; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Chenoweth DM, 2009, J AM CHEM SOC, V131, P7182, DOI 10.1021/ja901309z; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Dose C, 2008, J AM CHEM SOC, V130, P6859, DOI 10.1021/ja800888d; Edelson BS, 2004, NUCLEIC ACIDS RES, V32, P2802, DOI 10.1093/nar/gkh609; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Kielkopf CL, 1998, NAT STRUCT BIOL, V5, P104, DOI 10.1038/nsb0298-104; Kielkopf CL, 1998, SCIENCE, V282, P111, DOI 10.1126/science.282.5386.111; Kim SYH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054790, 10.1371/journal.pone.0053908, 10.1371/journal.pone.0063749, 10.1371/journal.pone.0068092]; Korenchuk S, 2001, IN VIVO, V15, P163; Li BC, 2013, J ORG CHEM, V78, P124, DOI 10.1021/jo302053v; Li HL, 2015, ONCOTARGET, V6, P20474, DOI 10.18632/oncotarget.4105; Liu SC, 2010, BIOCHEM BIOPH RES CO, V394, P297, DOI 10.1016/j.bbrc.2010.02.164; Liu SC, 2010, ONCOL REP, V23, P165, DOI 10.3892/or_00000618; Liu WN, 2008, NEOPLASIA, V10, P897, DOI 10.1593/neo.08428; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makkonen H, 2011, MOL CELL ENDOCRINOL, V331, P57, DOI 10.1016/j.mce.2010.08.008; Martinez TF, 2014, NUCLEIC ACIDS RES, V42, P11546, DOI 10.1093/nar/gku866; MCHUGH MM, 1989, BIOCHEM PHARMACOL, V38, P2323, DOI 10.1016/0006-2952(89)90472-3; MCHUGH MM, 1990, BIOCHEM PHARMACOL, V39, P707, DOI 10.1016/0006-2952(90)90149-F; Muzikar KA, 2011, ORG LETT, V13, P5612, DOI 10.1021/ol202285y; Muzikar KA, 2009, P NATL ACAD SCI USA, V106, P16598, DOI 10.1073/pnas.0909192106; Nickols NG, 2007, ACS CHEM BIOL, V2, P561, DOI 10.1021/cb700110z; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Nickols NG, 2007, NUCLEIC ACIDS RES, V35, P363, DOI 10.1093/nar/gkl1042; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Olenyuk BZ, 2004, P NATL ACAD SCI USA, V101, P16768, DOI 10.1073/pnas.0407617101; Perlmutter Mark A, 2007, Rev Urol, V9 Suppl 1, pS3; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Puckett JW, 2012, ORG LETT, V14, P2774, DOI 10.1021/ol3010003; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P1023, DOI 10.1073/pnas.1118506109; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; Synold TW, 2012, CANCER CHEMOTH PHARM, V70, P617, DOI 10.1007/s00280-012-1954-3; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; WOYNAROWSKI JM, 1989, BIOCHEMISTRY-US, V28, P3850, DOI 10.1021/bi00435a034; Yang F, 2013, J MED CHEM, V56, P7449, DOI 10.1021/jm401100s; Yang F, 2013, P NATL ACAD SCI USA, V110, P1863, DOI 10.1073/pnas.1222035110	52	22	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143161	10.1371/journal.pone.0143161	http://dx.doi.org/10.1371/journal.pone.0143161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571387	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000365070700147
J	Jimenez-Guerrero, I; Perez-Montano, F; Medina, C; Ollero, FJ; Lopez-Baena, FJ				Jimenez-Guerrero, Irene; Perez-Montano, Francisco; Medina, Carlos; Javier Ollero, Francisco; Javier Lopez-Baena, Francisco			NopC Is a Rhizobium-Specific Type 3 Secretion System Effector Secreted by Sinorhizobium (Ensifer) fredii HH103	PLOS ONE			English	Article							NODULATION OUTER PROTEINS; SP STRAIN NGR234; LEGUMES; PLANT; GENE; PHOSPHORYLATION; EXPRESSION; STRATEGIES; USDA257	Sinorhizobium (Ensifer) fredii HH103 is a broad host-range nitrogen-fixing bacterium able to nodulate many legumes, including soybean. In several rhizobia, root nodulation is influenced by proteins secreted through the type 3 secretion system (T3SS). This specialized secretion apparatus is a common virulence mechanism of many plant and animal pathogenic bacteria that delivers proteins, called effectors, directly into the eukaryotic host cells where they interfere with signal transduction pathways and promote infection by suppressing host defenses. In rhizobia, secreted proteins, called nodulation outer proteins (Nops), are involved in host-range determination and symbiotic efficiency. S. fredii HH103 secretes at least eight Nops through the T3SS. Interestingly, there are Rhizobium-specific Nops, such as NopC, which do not have homologues in pathogenic bacteria. In this work we studied the S. fredii HH103 nopC gene and confirmed that its expression was regulated in a flavonoid-, NodD1- and TtsI-dependent manner. Besides, in vivo bioluminescent studies indicated that the S. fredii HH103 T3SS was expressed in young soybean nodules and adenylate cyclase assays confirmed that NopC was delivered directly into soybean root cells by means of the T3SS machinery. Finally, nodulation assays showed that NopC exerted a positive effect on symbiosis with Glycine max cv. Williams 82 and Vigna unguiculata. All these results indicate that NopC can be considered a Rhizobium-specific effector secreted by S. fredii HH103.	[Jimenez-Guerrero, Irene; Perez-Montano, Francisco; Javier Ollero, Francisco; Javier Lopez-Baena, Francisco] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Medina, Carlos] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Lopez-Baena, FJ (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	jlopez@us.es	Jiménez-Guerrero, Irene/G-7859-2015; Pérez-Montaño, Francisco/K-8971-2014; Medina Morillas, Carlos/L-1773-2014; Lopez-Baena, Francisco Javier/L-4670-2014; Ollero Marquez, Francisco Javier/G-3271-2015	Jiménez-Guerrero, Irene/0000-0001-8661-5361; Pérez-Montaño, Francisco/0000-0002-6272-2063; Medina Morillas, Carlos/0000-0003-0069-7330; Lopez-Baena, Francisco Javier/0000-0001-7799-0338; Ollero Marquez, Francisco Javier/0000-0002-3641-7946	Junta de Andalucia [P11-CVI-7050]; Ministerio de Economia y Competitividad [AGL2012-38831]; Universidad de Sevilla; IV Plan Propio de Investigacion de la Universidad de Sevilla; Beca para la formacion de doctores; V Plan propio de investigacion de la Universidad de Sevilla; Centro Superior de investigaciones Cientificas; FEDER, JAE DOC	Junta de Andalucia(Junta de Andalucia); Ministerio de Economia y Competitividad(Spanish Government); Universidad de Sevilla; IV Plan Propio de Investigacion de la Universidad de Sevilla; Beca para la formacion de doctores; V Plan propio de investigacion de la Universidad de Sevilla; Centro Superior de investigaciones Cientificas; FEDER, JAE DOC	This work was supported by the Junta de Andalucia, Grant number P11-CVI-7050 to FJLB, Ministerio de Economia y Competitividad, Grant number AGL2012-38831 to FJO, Universidad de Sevilla, IV Plan Propio de Investigacion de la Universidad de Sevilla, Beca para la formacion de doctores to IJG, Universidad de Sevilla, V Plan propio de investigacion de la Universidad de Sevilla to FJLB FJO FPM and Centro Superior de investigaciones Cientificas and FEDER, JAE DOC to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Bartsev AV, 2003, FEBS LETT, V554, P271, DOI 10.1016/S0014-5793(03)01145-1; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Buttner D, 2003, CURR OPIN PLANT BIOL, V6, P312, DOI 10.1016/S1369-5266(03)00064-5; Chang WS, 2007, MOL PLANT MICROBE IN, V20, P1298, DOI 10.1094/mpmi-20-10-1298; Cooper JE, 2007, J APPL MICROBIOL, V103, P1355, DOI 10.1111/j.1365-2672.2007.03366.x; de Lyra MDCP, 2006, INT MICROBIOL, V9, P125; Deakin WJ, 2009, NAT REV MICROBIOL, V7, P312, DOI 10.1038/nrmicro2091; Deakin WJ, 2005, MOL PLANT MICROBE IN, V18, P499, DOI 10.1094/MPMI-18-0499; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Griffitts JS, 2008, MOL MICROBIOL, V67, P1292, DOI 10.1111/j.1365-2958.2008.06123.x; He SY, 1998, ANNU REV PHYTOPATHOL, V36, P363, DOI 10.1146/annurev.phyto.36.1.363; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Lopez-Baena FJ, 2009, MOL PLANT MICROBE IN, V22, P1445, DOI 10.1094/MPMI-22-11-1445; Jimenez-Guerrero I, 2015, MOL PLANT MICROBE IN, V28, P790, DOI 10.1094/MPMI-01-15-0020-R; Krause A, 2002, MOL PLANT MICROBE IN, V15, P1228, DOI 10.1094/MPMI.2002.15.12.1228; Krishnan HB, 2002, J BACTERIOL, V184, P831, DOI 10.1128/JB.184.3.831-839.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez-Baena FJ, 2008, MICROBIOL-SGM, V154, P1825, DOI 10.1099/mic.0.2007/016337-0; Lorio JC, 2004, MOL PLANT MICROBE IN, V17, P1259, DOI 10.1094/MPMI.2004.17.11.1259; Madinabeitia N, 2002, MOL PLANT MICROBE IN, V15, P150, DOI 10.1094/MPMI.2002.15.2.150; Margaret I, 2011, J BIOTECHNOL, V155, P11, DOI 10.1016/j.jbiotec.2011.03.016; Marie C, 2004, MOL PLANT MICROBE IN, V17, P958, DOI 10.1094/MPMI.2004.17.9.958; Marie C, 2003, MOL PLANT MICROBE IN, V16, P743, DOI 10.1094/MPMI.2003.16.9.743; Okazaki S, 2013, P NATL ACAD SCI USA, V110, P17131, DOI 10.1073/pnas.1302360110; Perez-Montano F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105901; Perez-Montano F, 2011, RES MICROBIOL, V162, P715, DOI 10.1016/j.resmic.2011.05.002; Rodrigues JA, 2007, J PROTEOME RES, V6, P1029, DOI 10.1021/pr060519f; Saad MM, 2008, J BACTERIOL, V190, P750, DOI 10.1128/JB.01116-07; Saad MM, 2005, J BACTERIOL, V187, P1173, DOI 10.1128/JB.187.3.1173-1181.2005; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schechter LM, 2010, APPL ENVIRON MICROB, V76, P3758, DOI 10.1128/AEM.03122-09; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; Skorpil P, 2005, MOL MICROBIOL, V57, P1304, DOI 10.1111/j.1365-2958.2005.04768.x; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Tampakaki AP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00114; Thomas NA, 2012, J BACTERIOL, V194, P3767, DOI 10.1128/JB.00406-12; Vessey JK, 2004, PLANT SOIL, V266, P205; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vinardell JM, 2015, MOL PLANT MICROBE IN, V28, P811, DOI 10.1094/MPMI-12-14-0397-FI; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; Wassem R, 2008, MOL MICROBIOL, V68, P736, DOI 10.1111/j.1365-2958.2008.06187.x; Wenzel M, 2010, MOL PLANT MICROBE IN, V23, P124, DOI 10.1094/MPMI-23-1-0124; Zhang L, 2011, J BIOL CHEM, V286, P32178, DOI 10.1074/jbc.M111.265942	49	31	35	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142866	10.1371/journal.pone.0142866	http://dx.doi.org/10.1371/journal.pone.0142866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569401	gold, Green Published			2022-12-26	WOS:000365070700087
J	Karajamaki, AJ; Patsi, OP; Savolainen, M; Kesaniemi, YA; Huikuri, H; Ukkola, O				Karajamaki, Aki J.; Patsi, Olli-Pekka; Savolainen, Markku; Kesaniemi, Y. Antero; Huikuri, Heikki; Ukkola, Olavi			Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; INCREASED PREVALENCE; GENERAL-POPULATION; RECENT MORTALITY; FOLLOW-UP; INFLAMMATION; COMPLICATIONS	Non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) are widespread diseases and have multiple common risk factors and comorbidities. No studies of association between ultrasonography-diagnosed NAFLD and AF exist in other than diabetic population. The goal of this prospective study was to study the value of NAFLD as a predictor of atrial fibrillation. This study had 958 subjects from the OPERA (Oulu Project Elucidating Risk of Atherosclerosis) cohort, and the mean follow-up time was 16.3 years. NAFLD was diagnosed if the subject had fatty liver in ultrasonography and no excess alcohol intake. AF was followed in the National Registers. In this study 249 subjects (26.0%) had NAFLD and 37 (14.9%) of these had AF whereas only 56 (7.9%) of those without NAFLD experienced AF during the follow-up time (p = 0.001). In the multiple Cox regression analysis including potential confounders (age, sex, study group, diabetes, body mass index (BMI), waist circumference, alcohol consumption, smoking, serum alanine aminotransferase concentration (ALT), systolic blood pressure, quick index, left ventricular mass index, left atrial diameter, coronary artery disease (CAD), atrial natriuretic peptide (ANP) and high sensitive C-reactive protein (hs-CRP)), NAFLD remained as an independent predictor of AF (Adjusted OR, 1.88 (95% Confidence interval (CI) 1.03-3.45)). In conclusion, our data shows that NAFLD is independently associated with the risk of AF.	[Ukkola, Olavi] Oulu Univ Hosp, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland; Univ Oulu, Oulu, Finland	University of Oulu; University of Oulu	Ukkola, O (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland.	olavi.ukkola@oulu.fi			Finnish Foundation for Cardiovascular Research	Finnish Foundation for Cardiovascular Research	This study was supported by the Finnish Foundation for Cardiovascular Research.	Alonso A, 2014, HEART, V100, P1511, DOI 10.1136/heartjnl-2014-305756; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Ballestri S, 2014, WORLD J GASTROENTERO, V20, P1724, DOI 10.3748/wjg.v20.i7.1724; Baumeister SE, 2008, GASTROENTEROLOGY, V134, P85, DOI 10.1053/j.gastro.2007.10.024; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Cassidy S, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0187-2; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Farkkila Martti, 2003, Duodecim, V119, P519; Fotbolcu H, 2010, CARDIOL J, V17, P457; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Graner M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.001979; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Harada M, 2015, CIRC J, V79, P495, DOI 10.1253/circj.CJ-15-0138; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Karjalainen AH, 2004, MATURITAS, V47, P201, DOI 10.1016/S0378-5122(03)00279-2; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Liu H, 2014, WORLD J GASTROENTERO, V20, P8407, DOI 10.3748/wjg.v20.i26.8407; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061803; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Machado MV, 2014, WORLD J GASTROENTERO, V20, P12956, DOI 10.3748/wjg.v20.i36.12956; Mantovani A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135329; Mehta SR, 2008, WORLD J GASTROENTERO, V14, P3476, DOI 10.3748/wjg.14.3476; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nagarakanti R, 2008, J INTERV CARD ELECTR, V22, P111, DOI 10.1007/s10840-008-9203-8; Nalbantoglu I, 2014, WORLD J GASTROENTERO, V20, P9026, DOI 10.3748/wjg.v20.i27.9026; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Ndumele CE, 2011, ARTERIOSCL THROM VAS, V31, P1927, DOI 10.1161/ATVBAHA.111.228262; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Newton JL, 2009, CLIN AUTON RES, V19, P319, DOI 10.1007/s10286-009-0031-4; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Nieuwlaat R, 2008, EUR HEART J, V29, P1181, DOI 10.1093/eurheartj/ehn139; Ohsawa M, 2007, CIRC J, V71, P814, DOI 10.1253/circj.71.814; Park HW, 2012, CURR OPIN CARDIOL, V27, P24, DOI 10.1097/HCO.0b013e32834dc4e8; Perkiomaki J, 2014, J CARDIOVASC ELECTR, V25, P719, DOI 10.1111/jce.12402; Petta S, 2015, J HEPATOL, V62, P928, DOI 10.1016/j.jhep.2014.11.030; Pisto P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004973; Pisto P, 2011, METABOLISM, V60, P1515, DOI 10.1016/j.metabol.2011.03.009; Rantala AO, 1999, J INTERN MED, V245, P163, DOI 10.1046/j.1365-2796.1999.00429.x; Shen MJ, 2014, CIRC RES, V114, P1004, DOI 10.1161/CIRCRESAHA.113.302549; Sinner MF, 2013, AM J CARDIOL, V111, P219, DOI 10.1016/j.amjcard.2012.09.021; Sun W, 2015, QJM             0121; Suzuki S, 2011, J CARDIOL, V58, P116, DOI 10.1016/j.jjcc.2011.06.006; Targher G, 2008, OBESITY, V16, P1394, DOI 10.1038/oby.2008.64; Targher G, 2013, CLIN SCI, V125, P301, DOI 10.1042/CS20130036; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Tateya Sanshiro, 2013, Front Endocrinol (Lausanne), V4, P93, DOI 10.3389/fendo.2013.00093; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Yamashita T, 2013, CIRC J, V77, P864, DOI 10.1253/circj.CJ-13-0002; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4	58	88	91	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142937	10.1371/journal.pone.0142937	http://dx.doi.org/10.1371/journal.pone.0142937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571029	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700099
J	Novak, SM; Joardar, A; Gregorio, CC; Zarnescu, DC				Novak, Stefanie Mares; Joardar, Archi; Gregorio, Carol C.; Zarnescu, Daniela C.			Regulation of Heart Rate in Drosophila via Fragile X Mental Retardation Protein	PLOS ONE			English	Article							INTEGRIN ACTIVATION; GENE-EXPRESSION; MELANOGASTER; DISEASE; MUSCLE; BRAIN; MODEL	RNA binding proteins play a pivotal role in post-transcriptional gene expression regulation, however little is understood about their role in cardiac function. The Fragile X (FraX) family of RNA binding proteins is most commonly studied in the context of neurological disorders, as mutations in Fragile X Mental Retardation 1 (FMR1) are the leading cause of inherited mental retardation. More recently, alterations in the levels of Fragile X Related 1 protein, FXR1, the predominant FraX member expressed in vertebrate striated muscle, have been linked to structural and functional defects in mice and zebrafish models. FraX proteins are established regulators of translation and are known to regulate specific targets in different tissues. To decipher the direct role of FraX proteins in the heart in vivo, we turned to Drosophila, which harbors a sole, functionally conserved and ubiquitously expressed FraX protein, dFmr1. Using classical loss of function alleles as well as muscle specific RNAi knockdown, we show that Drosophila FMRP, dFmr1, is required for proper heart rate during development. Functional analyses in the context of cardiac-specific dFmr1 knockdown by RNAi demonstrate that dFmr1 is required cell autonomously in cardiac cells for regulating heart rate. Interestingly, these functional defects are not accompanied by any obvious structural abnormalities, suggesting that dFmr1 may regulate a different repertoire of targets in Drosophila than in vertebrates. Taken together, our findings support the hypothesis that dFmr1 protein is essential for proper cardiac function and establish the fly as a new model for studying the role(s) of FraX proteins in the heart.	[Novak, Stefanie Mares; Gregorio, Carol C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA; [Novak, Stefanie Mares; Gregorio, Carol C.] Univ Arizona, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Joardar, Archi; Zarnescu, Daniela C.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Zarnescu, DC (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	zarnescu@email.arizona.edu			NIH [1F31HL117520, R01 HL108625]; AHA [12PRE11900038]; Achievement Rewards for College Students: Haga scholar award [MDA256598]; Sarver Heart Center; AHA Scientist Development Grant [0930170N]; Darlene and Kalidas Madhavpeddi award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL117520, R01HL108625] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Achievement Rewards for College Students: Haga scholar award; Sarver Heart Center; AHA Scientist Development Grant(American Heart Association); Darlene and Kalidas Madhavpeddi award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by pre-doctoral fellowships NIH 1F31HL117520, AHA 12PRE11900038, and an Achievement Rewards for College Students: Haga scholar award (S.M.N.), post-doctoral fellowship MDA256598 (AJ), NIH R01 HL108625 (C.C.G.), the Sarver Heart Center, Darlene and Kalidas Madhavpeddi award, and AHA Scientist Development Grant 0930170N (D.C.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077785; Argue KJ, 2013, BEHAV NEUROSCI, V127, P725, DOI 10.1037/a0033602; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; BROADIE KS, 1993, J NEUROSCI, V13, P144; Callan MA, 2012, BRAIN RES, V1462, P151, DOI 10.1016/j.brainres.2012.03.042; Ciobanasu C, 2013, EUR J CELL BIOL, V92, P339, DOI 10.1016/j.ejcb.2013.10.009; Dulcis D, 2003, J COMP NEUROL, V465, P560, DOI 10.1002/cne.10869; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Kaufmann WE, 2004, AM J MED GENET A, V129A, P225, DOI 10.1002/ajmg.a.30229; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Medioni C, 2009, CURR OPIN GENET DEV, V19, P518, DOI 10.1016/j.gde.2009.07.004; Mientjes EJ, 2004, HUM MOL GENET, V13, P1291, DOI 10.1093/hmg/ddh150; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seyres D, 2012, BRIEF FUNCT GENOMICS, V11, P366, DOI 10.1093/bfgp/els028; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; te Riele ASJM, 2015, TRENDS CARDIOVAS MED, V25, P191, DOI 10.1016/j.tcm.2014.11.003; Valencik ML, 2006, CIRC RES, V99, P1403, DOI 10.1161/01.RES.0000252291.88540.ac; van't Padje S, 2009, J EXP BIOL, V212, P2564, DOI 10.1242/jeb.032532; VIGOREAUX JO, 1991, J MUSCLE RES CELL M, V12, P340, DOI 10.1007/BF01738589; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Whitman SA, 2011, CIRC RES, V109, P262, DOI 10.1161/CIRCRESAHA.111.244244; Wolf MJ, 2011, CIRC RES, V109, P794, DOI 10.1161/CIRCRESAHA.111.244897; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981	33	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142836	10.1371/journal.pone.0142836	http://dx.doi.org/10.1371/journal.pone.0142836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571124	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700082
J	Warren, JG; Lincoln, JE; Kirkpatrick, BC				Warren, Jeremy G.; Lincoln, James E.; Kirkpatrick, Bruce C.			Insights into the Activity and Substrate Binding of Xylella fastidiosa Polygalacturonase by Modification of a Unique QMK Amino Acid Motif Using Protein Chimeras	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; PIERCES-DISEASE; ERWINIA-CAROTOVORA; CRYSTAL-STRUCTURE; ENDOPOLYGALACTURONASE II; ASPERGILLUS-NIGER; CELL WALLS; AGROBACTERIUM; GRAPEVINE; PLANTS	Polygalacturonases (EC 3.2.1.15) catalyze the random hydrolysis of 1, 4-alpha-D-galactosiduronic linkages in pectate and other galacturonans. Xylella fastidiosa possesses a single polygalacturonase gene, pglA (PD1485), and X. fastidiosa mutants deficient in the production of polygalacturonase are non-pathogenic and show a compromised ability to systemically infect grapevines. These results suggested that grapevines expressing sufficient amounts of an inhibitor of X. fastidiosa polygalacturonase might be protected from disease. Previous work in our laboratory and others have tried without success to produce soluble active X. fastidiosa polygalacturonase for use in inhibition assays. In this study, we created two enzymatically active X. fastidiosa / A. vitis polygalacturonase chimeras, AX1A and AX2A to explore the functionality of X. fastidiosa polygalacturonase in vitro. The AX1A chimera was constructed to specifically test if recombinant chimeric protein, produced in Escherichia coli, is soluble and if the X. fastidiosa polygalacturonase catalytic amino acids are able to hydrolyze polygalacturonic acid. The AX2A chimera was constructed to evaluate the ability of a unique QMK motif of X. fastidiosa polygalacturonase, most polygalacturonases have a R(I/L)K motif, to bind to and allow the hydrolysis of polygalacturonic acid. Furthermore, the AX2A chimera was also used to explore what effect modification of the QMK motif of X. fastidiosa polygalacturonase to a conserved RIK motif has on enzymatic activity. These experiments showed that both the AX1A and AX2A polygalacturonase chimeras were soluble and able to hydrolyze the polygalacturonic acid substrate. Additionally, the modification of the QMK motif to the conserved RIK motif eliminated hydrolytic activity, suggesting that the QMK motif is important for the activity of X. fastidiosa polygalacturonase. This result suggests X. fastidiosa polygalacturonase may preferentially hydrolyze a different pectic substrate or, alternatively, it has a different mechanism of substrate binding than other polygalacturonases characterized to date.	[Warren, Jeremy G.; Lincoln, James E.; Kirkpatrick, Bruce C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Warren, JG (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	jgwarren@ucdavis.edu			California Department of Agriculture Pierce's Disease Control Program [12-0129]	California Department of Agriculture Pierce's Disease Control Program	This work was supported by the California Department of Agriculture Pierce's Disease Control Program (12-0129). BCK received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero CB, 2005, MOL PLANT PATHOL, V6, P43, DOI 10.1111/j.1364-3703.2004.00262.x; Armand S, 2000, J BIOL CHEM, V275, P691, DOI 10.1074/jbc.275.1.691; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Choi JK, 2004, PROTEINS, V55, P22, DOI 10.1002/prot.10434; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; DAVIS MJ, 1978, SCIENCE, V199, P75, DOI 10.1126/science.199.4324.75; FRY SM, 1990, PHYTOPATHOLOGY, V80, P66, DOI 10.1094/Phyto-80-66; FRY SM, 1990, PHYTOPATHOLOGY, V80, P61, DOI 10.1094/Phyto-80-61; Goodey N. M., 2009, V22, P1; GROSS KC, 1982, HORTSCIENCE, V17, P491; Herlache TC, 1997, APPL ENVIRON MICROB, V63, P338, DOI 10.1128/AEM.63.1.338-346.1997; HILL BL, 1995, PHYTOPATHOLOGY, V85, P1368, DOI 10.1094/Phyto-85-1368; KADO CI, 1970, PHYTOPATHOLOGY, V60, P969, DOI 10.1094/Phyto-60-969; KEEGSTRA K, 1973, PLANT PHYSIOL, V51, P188, DOI 10.1104/pp.51.1.188; LEI SP, 1985, J BACTERIOL, V164, P831, DOI 10.1128/JB.164.2.831-835.1985; Markovic O, 2001, PROTEIN ENG, V14, P615, DOI 10.1093/protein/14.9.615; Petersen TN, 1997, STRUCTURE, V5, P533, DOI 10.1016/S0969-2126(97)00209-8; Pickersgill R, 1998, J BIOL CHEM, V273, P24660, DOI 10.1074/jbc.273.38.24660; Prade RA, 1999, BIOTECHNOL GENET ENG, V16, P361, DOI 10.1080/02648725.1999.10647984; Punt PJ, 2011, ANNU REV MICROBIOL, V65, P57, DOI 10.1146/annurev.micro.112408.134009; RODRIGUEZPALENZUELA P, 1991, J BACTERIOL, V173, P6547, DOI 10.1128/jb.173.20.6547-6552.1991; Roper MC, 2007, MOL PLANT MICROBE IN, V20, P411, DOI 10.1094/MPMI-20-4-0411; SCHELL MA, 1988, J BACTERIOL, V170, P4501, DOI 10.1128/jb.170.10.4501-4508.1988; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Warren JG, 2016, MOL PLANT PATHOL, V17, P480, DOI 10.1111/mpp.12293	26	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142694	10.1371/journal.pone.0142694	http://dx.doi.org/10.1371/journal.pone.0142694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571265	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700063
J	Pulskens, WP; Verkaik, M; Sheedfar, F; van Loon, EP; van de Sluis, B; Vervloet, MG; Hoenderop, JG; Bindels, RJ				Pulskens, Wilco P.; Verkaik, Melissa; Sheedfar, Fareeba; van Loon, Ellen P.; van de Sluis, Bart; Vervloet, Mark G.; Hoenderop, Joost G.; Bindels, Rene J.		NIGRAM Consortium	Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure	PLOS ONE			English	Article							GROWTH-FACTOR 23; MINERAL METABOLISM; GENE-EXPRESSION; CA2+ TRANSPORT; KLOTHO; DISEASE; CHANNEL; TRPV5; MOUSE; FGF23	Impaired mineral homeostasis and inflammation are hallmarks of chronic kidney disease (CKD), yet the underlying mechanisms of electrolyte regulation during CKD are still unclear. Here, we applied two different murine models, partial nephrectomy and adenine-enriched dietary intervention, to induce kidney failure and to investigate the subsequent impact on systemic and local renal factors involved in Ca2+ and P-i regulation. Our results demonstrated that both experimental models induce features of CKD, as reflected by uremia, and elevated renal neutrophil gelatinase-associated lipocalin (NGAL) expression. In our model kidney failure was associated with polyuria, hypercalcemia and elevated urinary Ca2+ excretion. In accordance, CKD augmented systemic PTH and affected the FGF23-alpha klotho-vitamin-D axis by elevating circulatory FGF23 levels and reducing renal alpha klotho expression. Interestingly, renal FGF23 expression was also induced by inflammatory stimuli directly. Renal expression of Cyp27b1, but not Cyp24a1, and blood levels of 1,25-dihydroxy vitamin D-3 were significantly elevated in both models. Furthermore, kidney failure was characterized by enhanced renal expression of the transient receptor potential cation channel subfamily V member 5 (TRPV5), calbindin-D-28k, and sodium-dependent P-i transporter type 2b (NaP(i)2b), whereas the renal expression of sodium-dependent P-i transporter type 2a (NaP(i)2a) and type 3 (PIT2) were reduced. Together, our data indicates two different models of experimental kidney failure comparably associate with disturbed FGF23-alpha klotho-vitaminD signalling and a deregulated electrolyte homeostasis. Moreover, this study identifies local tubular, possibly inflammation-or PTH- and/or FGF23-associated, adaptive mechanisms, impacting on Ca2+/P-i homeostasis, hence enabling new opportunities to target electrolyte disturbances that emerge as a consequence of CKD development.	[Pulskens, Wilco P.; Sheedfar, Fareeba; van Loon, Ellen P.; Hoenderop, Joost G.; Bindels, Rene J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6525 ED Nijmegen, Netherlands; [Pulskens, Wilco P.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [Verkaik, Melissa; Vervloet, Mark G.] Vrije Univ Amsterdam, Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Mol Genet Sect, NL-9713 AV Groningen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; University of Groningen	Bindels, RJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6525 ED Nijmegen, Netherlands.	rene.bindels@radboudumc.nl	Pulskens, Wilco/P-6023-2015; Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Pulskens, Wilco/0000-0001-9697-3189; Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365; Vervloet, Marc/0000-0003-4607-9415; , Fareeba/0000-0002-1315-1903	Dutch Kidney Foundation [CP10.11]	Dutch Kidney Foundation	This project is part of the NIGRAM consortium, financially supported by the Dutch Kidney Foundation (CP10.11). WPP, MV, EPL, FS, MGV, JGH and RJB are authors who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Banchaabouchi M, 1998, METABOLISM, V47, P355; Alexander RT, 2009, J AM SOC NEPHROL, V20, P2371, DOI 10.1681/ASN.2008121273; Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Blaine J, 2011, ADV CHRONIC KIDNEY D, V18, P77, DOI 10.1053/j.ackd.2011.01.005; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 2013, CLIN J AM SOC NEPHRO, V8, P2132, DOI 10.2215/CJN.04260413; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Brymora A, 2007, J NEPHROL, V20, P423; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen NX, 2012, CURR HYPERTENS REP, V14, P228, DOI 10.1007/s11906-012-0265-8; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dai JC, 2006, BONE, V38, P509, DOI 10.1016/j.bone.2005.10.007; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; Drueke TB, 2013, KIDNEY INT, V83, P13, DOI 10.1038/ki.2012.370; Drueke TB, 2010, KIDNEY INT, V78, P1057, DOI 10.1038/ki.2010.339; Fuernau G, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0713-8; GAGNON RF, 1983, UROL RES, V11, P11, DOI 10.1007/BF00272702; GAGNON RF, 1990, NEPHRON, V54, P70, DOI 10.1159/000185812; Gava Agata L, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P167; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gok DE, 2011, J ENDOCRINOL INVEST, V34, P3, DOI [10.1007/BF03346687, 10.3275/6902]; Helvig CF, 2010, KIDNEY INT, V78, P463, DOI 10.1038/ki.2010.168; Hill KM, 2013, KIDNEY INT, V83, P959, DOI 10.1038/ki.2012.403; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Hoenderop JGJ, 2003, PFLUG ARCH EUR J PHY, V446, P304, DOI 10.1007/s00424-003-1045-8; Hoenderop JGJ, 2001, J AM SOC NEPHROL, V12, P1342, DOI 10.1681/ASN.V1271342; Hofmeister MV, 2009, AM J PHYSIOL-RENAL, V296, pF194, DOI 10.1152/ajprenal.90495.2008; Hruska KA, 2007, SEMIN DIALYSIS, V20, P309, DOI 10.1111/j.1525-139X.2007.00300.x; Hu MC, 2012, NEPHROL DIAL TRANSPL, V27, P2650, DOI 10.1093/ndt/gfs160; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Huang CL, 2012, ADV EXP MED BIOL, V728, P100, DOI 10.1007/978-1-4614-0887-1_7; Jia T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-116; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Komaba H, 2012, NAT REV NEPHROL, V8, P484, DOI 10.1038/nrneph.2012.116; Kondo M, 2014, N-S ARCH PHARMACOL, V387, P909, DOI 10.1007/s00210-014-1023-z; Kuro-O M, 2012, CURR OPIN NEPHROL HY, V21, P362, DOI 10.1097/MNH.0b013e32835422ad; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Lafage-Proust MH, 2010, KIDNEY INT, V77, P390, DOI 10.1038/ki.2009.512; Lambers TT, 2006, EMBO J, V25, P2978, DOI 10.1038/sj.emboj.7601186; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; Molony DA, 2011, ADV CHRONIC KIDNEY D, V18, P120, DOI 10.1053/j.ackd.2011.02.004; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Murer H, 2010, J NEPHROL, V23, pS145; Nakai K, 2010, J NEPHROL, V23, P619; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Nitta K, 2014, NEPHRON CLIN PRACT, V128, P1, DOI 10.1159/000365787; Ortiz A, EUROPEAN J PHARM; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Poss J, 2013, EUR HEART J-ACUTE CA, V2, P211, DOI 10.1177/2048872613494025; Portale AA, 2014, CLIN J AM SOC NEPHRO, V9, P344, DOI 10.2215/CJN.05840513; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Russo D, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/364890; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Sakan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086301; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Santana AC, THALIDOMIDE SUPPRESS, P1140; Santana AC, 2013, NEPHROL DIAL TRANSPL, V28, P1140, DOI 10.1093/ndt/gfs569; Schiavi SC, 2012, J AM SOC NEPHROL, V23, P1691, DOI 10.1681/ASN.2011121213; Shimamura Y, 2012, CLIN EXP NEPHROL, V16, P722, DOI 10.1007/s10157-012-0621-7; Silver J, 2010, PEDIATR NEPHROL, V25, P2241, DOI 10.1007/s00467-010-1565-3; Stitt-Cavanagh EM, 2010, J AM SOC NEPHROL, V21, P1678, DOI 10.1681/ASN.2009121234; Suyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029483; Takemoto F, 2003, KIDNEY INT, V64, P414, DOI 10.1046/j.1523-1755.2003.00114.x; Tamura M, 2009, HISTOCHEM CELL BIOL, V131, P483, DOI 10.1007/s00418-009-0557-5; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Tucker PS, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/806358; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; van Abel M, 2005, KIDNEY INT, V68, P1708, DOI 10.1111/j.1523-1755.2005.00587.x; van der Hagen EAE, 2014, PFLUG ARCH EUR J PHY, V466, P2077, DOI 10.1007/s00424-014-1470-x; Weir Matthew R, 2011, Am J Manag Care, V17 Suppl 15, pS396; Wolf M, 2012, KIDNEY INT, V82, P737, DOI 10.1038/ki.2012.176; Yan L, 2014, ARTERIOSCL THROM VAS, V34, P1399, DOI 10.1161/ATVBAHA.114.303508; Yang Hai-Chun, 2010, Drug Discov Today Dis Models, V7, P13, DOI 10.1016/j.ddmod.2010.08.002	79	25	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142510	10.1371/journal.pone.0142510	http://dx.doi.org/10.1371/journal.pone.0142510			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566277	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500028
J	Saddouk, FZ; Sun, LY; Liu, YF; Jiang, M; Singer, DV; Backs, J; Van Riper, D; Ginnan, R; Schwarz, JJ; Singer, HA				Saddouk, Fatima Z.; Sun, Li-Yan; Liu, Yong Feng; Jiang, Miao; Singer, Diane V.; Backs, Johannes; Van Riper, Dee; Ginnan, Roman; Schwarz, John J.; Singer, Harold A.			Ca2+/calmodulin-dependent protein kinase II-gamma (CaMKII gamma) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling	FASEB JOURNAL			English	Article						Camk2g; Camk2d; restenosis	DELTA ISOFORM REGULATION; NEOINTIMA FORMATION; TUMOR-SUPPRESSOR; CAROTID-ARTERY; ACTIVATION; EXPRESSION; P53; CYCLE; GENE; INHIBITION	Vascular smooth muscle (VSM) expresses calcium/calmodulin-dependent protein kinase II (CaMKII)-delta and -gamma isoforms. CaMKII delta promotes VSM proliferation and vascular remodeling. We tested CaMKII gamma function in vascular remodeling after injury. CaMKII gamma protein decreased 90% 14 d after balloon injury in rat carotid artery. Intraluminal transduction of adenovirus encoding CaMKII gamma(c) rescued expression to 35% of uninjured controls, inhibited neointima formation (>70%), inhibited VSM proliferation (>60%), and increased expression of the cell-cycle inhibitor p21 (>2-fold). Comparable doses of CaMKII delta(2) adenovirus had no effect. Similar dynamics in CaMKII gamma mRNA and protein expression were observed in ligated mouse carotid arteries, correlating closely with expression of VSM differentiation markers. Targeted deletion of CaMKII gamma in smooth muscle resulted in a 20-fold increase in neointimal area, with a 3-fold increase in the cell proliferation index, no change in apoptosis, and a 60% decrease in p21 expression. In cultured VSM, CaMKII gamma overexpression induced p53 mRNA (1.7 fold) and protein (1.8-fold) expression; induced the p53 target gene p21 (3-fold); decreased VSM cell proliferation (>50%); and had no effect on expression of apoptosis markers. We conclude that regulated CaMKII gamma isoform composition is an important determinant of the injury-induced vasculoproliferative response and that CaMKII gamma and -delta isoforms have nonequivalent, opposing functions.	[Saddouk, Fatima Z.; Sun, Li-Yan; Liu, Yong Feng; Jiang, Miao; Singer, Diane V.; Van Riper, Dee; Ginnan, Roman; Schwarz, John J.; Singer, Harold A.] Albany Med Coll, Ctr Cardiovasc Sci, MC-8,47 New Scotland Ave, Albany, NY 12208 USA; [Backs, Johannes] Heidelberg Univ, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany	Albany Medical College; Ruprecht Karls University Heidelberg	Singer, HA (corresponding author), Albany Med Coll, Ctr Cardiovasc Sci, MC-8,47 New Scotland Ave, Albany, NY 12208 USA.	singerh@mail.amc.edu		Schwarz, John/0000-0002-8713-4778	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01HL049426, R01HL092510]; Albany Medical College Weir Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049426, R01HL092510] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Albany Medical College Weir Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by Grants R01HL049426 and R01HL092510 from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (to H.A.S.) and by the Albany Medical College Weir Fund.	Abraham ST, 1996, J BIOL CHEM, V271, P2506, DOI 10.1074/jbc.271.5.2506; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Althoff TF, 2012, J EXP MED, V209, P2277, DOI 10.1084/jem.20120350; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Backs J, 2010, P NATL ACAD SCI USA, V107, P81, DOI 10.1073/pnas.0912658106; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Ginnan R, 2013, J BIOL CHEM, V288, P29703, DOI 10.1074/jbc.M113.477257; Gray CBB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00015; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hayashi S, 2000, HYPERTENSION, V35, P237, DOI 10.1161/01.HYP.35.1.237; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kitchen CM, 2013, GENE, V513, P82, DOI 10.1016/j.gene.2012.10.073; Krause K, 2001, BIOCHEM BIOPH RES CO, V284, P743, DOI 10.1006/bbrc.2001.5040; Kreusser MM, 2014, CIRCULATION, V130, P1262, DOI 10.1161/CIRCULATIONAHA.114.006185; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; Lipskaia L, 2005, CIRC RES, V97, P488, DOI 10.1161/01.RES.0000180663.42594.aa; Liu YF, 2013, J BIOL CHEM, V288, P33519, DOI 10.1074/jbc.M113.490870; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Lu X, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000984; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; Mancarella S, 2013, FASEB J, V27, P893, DOI 10.1096/fj.12-215293; Marganski WA, 2005, CIRC RES, V97, P541, DOI 10.1161/01.RES.0000182630.29093.0d; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; O'Carroll SJ, 2000, BIOTECHNIQUES, V28, P408, DOI 10.2144/00283bm03; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Rokolya A, 2000, AM J PHYSIOL-CELL PH, V278, pC537, DOI 10.1152/ajpcell.2000.278.3.C537; Roque M, 2000, ARTERIOSCL THROM VAS, V20, P335, DOI 10.1161/01.ATV.20.2.335; Saha K, 2014, J BIOL CHEM, V289, P11443, DOI 10.1074/jbc.M113.543165; Saura M, 2014, FASEB J, V28, P4719, DOI 10.1096/fj.14-252460; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Scott JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071550; Scott JA, 2012, AM J PHYSIOL-HEART C, V302, pH1953, DOI 10.1152/ajpheart.00978.2011; Singer HA, 1997, J BIOL CHEM, V272, P9393; Singer HA, 2012, J PHYSIOL-LONDON, V590, P1349, DOI 10.1113/jphysiol.2011.222232; Skelding KA, 2011, CELL CYCLE, V10, P631, DOI 10.4161/cc.10.4.14798; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Streb JW, 2005, J BIOL CHEM, V280, P4125, DOI 10.1074/jbc.M412466200; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Weinreuter M, 2014, EMBO MOL MED, V6, P1231, DOI 10.15252/emmm.201403848; Wu XJ, 2011, ARTERIOSCL THROM VAS, V31, P2000, DOI 10.1161/ATVBAHA.111.225144; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Zhang M, 2015, HYPERTENSION, V65, P335, DOI 10.1161/HYPERTENSIONAHA.114.04467; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhang W, 2011, CIRC RES, V109, P534, DOI 10.1161/CIRCRESAHA.111.246777; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhu LJ, 2014, VASC PHARMACOL, V60, P75, DOI 10.1016/j.vph.2014.01.001; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	68	22	23	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1051	1064		10.1096/fj.15-279158	http://dx.doi.org/10.1096/fj.15-279158			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26567004	Green Published			2022-12-26	WOS:000370387800005
J	Toth, MA; Majoros, AK; Vig, AT; Migh, E; Nyitrai, M; Mihaly, J; Bugyi, B				Toth, Monika Agnes; Majoros, Andrea Kinga; Vig, Andrea Terez; Migh, Ede; Nyitrai, Miklos; Mihaly, Jozsef; Bugyi, Beata			Biochemical Activities of the Wiskott-Aldrich Syndrome Homology Region 2 Domains of Sarcomere Length Short (SALS) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-FILAMENT NUCLEATION; BACTERIAL EFFECTOR VOPL; X-RAY-SCATTERING; WH2 DOMAINS; CORDON-BLEU; F-ACTIN; PROFILIN; TROPOMYOSIN; MUSCLE; SPIRE	Drosophila melanogaster sarcomere length short (SALS) is a recently identified Wiskott-Aldrich syndrome protein homology 2 (WH2) domain protein involved in skeletal muscle thin filament regulation. SALS was shown to be important for the establishment of the proper length and organization of sarcomeric actin filaments. Here, we present the first detailed characterization of the biochemical activities of the tandem WH2 domains of SALS (SALS-WH2). Our results revealed that SALS-WH2 binds both monomeric and filamentous actin and shifts the monomer-filament equilibrium toward the monomeric actin. In addition, SALS-WH2 can bind to but fails to depolymerize phalloidin-or jasplakinolide-bound actin filaments. These interactions endow SALS-WH2 with the following two major activities in the regulation of actin dynamics: SALS-WH2 sequesters actin monomers into non-polymerizable complexes and enhances actin filament disassembly by severing, which is modulated by tropomyosin. We also show that profilin does not influence the activities of the WH2 domains of SALS in actin dynamics. In conclusion, the tandem WH2 domains of SALS are multifunctional regulators of actin dynamics. Our findings suggest that the activities of the WH2 domains do not reconstitute the presumed biological function of the full-length protein. Consequently, the interactions of the WH2 domains of SALS with actin must be tuned in the cellular context by other modules of the protein and/or sarcomeric components for its proper functioning.	[Toth, Monika Agnes; Majoros, Andrea Kinga; Vig, Andrea Terez; Nyitrai, Miklos; Bugyi, Beata] Univ Pecs, Sch Med, Dept Biophys, H-7624 Pecs, Hungary; [Migh, Ede; Mihaly, Jozsef] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6726 Szeged, Hungary; [Nyitrai, Miklos; Bugyi, Beata] Szentagothai Res Ctr, H-7624 Pecs, Hungary; [Nyitrai, Miklos] Nucl Mitochondrial Interact Res Grp, H-1051 Budapest, Hungary; [Nyitrai, Miklos] Off Subsidized Res Units, H-1051 Budapest, Hungary; [Mihaly, Jozsef] Univ Pecs, Hungarian Acad Sci, H-1051 Budapest, Hungary	University of Pecs; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; University of Pecs	Bugyi, B (corresponding author), Univ Pecs, Sch Med, Dept Biophys, Szigeti Str 12, H-7624 Pecs, Hungary.	beata.bugyi@aok.pte.hu		Mihaly, Jozsef/0000-0003-3399-2424; Bugyi, Beata/0000-0003-4181-3633; Migh, Ede/0000-0002-8312-6463; Nyitrai, Miklos/0000-0002-6229-4337	Hungarian Science Foundation (OTKA) [K109689, K109330, NN 107776]; National Innovation Office "Baross Gabor" Program [REG-DD-09-1-2009-0009 Tirfm 09]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]	Hungarian Science Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Innovation Office "Baross Gabor" Program; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This work was supported by Hungarian Science Foundation (OTKA) Grants K109689 (to B. B.), K109330 (to J. M.), and NN 107776 (to M. N.), National Innovation Office "Baross Gabor" Program Grant REG-DD-09-1-2009-0009 Tirfm 09 (to B. B.), and by the European Union and the State of Hungary and co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 "National Excellence Program." The authors declare that they have no conflicts of interest with the contents of this article.	Avvaru BS, 2015, J STRUCT BIOL, V190, P192, DOI 10.1016/j.jsb.2015.03.008; Bai J, 2007, DEV CELL, V13, P828, DOI 10.1016/j.devcel.2007.10.003; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Boquet I, 2000, CELL, V102, P797, DOI 10.1016/S0092-8674(00)00068-4; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; BROSCHAT KO, 1990, J BIOL CHEM, V265, P21323; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Bugyi B, 2010, EMBO J, V29, P14, DOI 10.1038/emboj.2009.316; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; Didry D, 2012, EMBO J, V31, P1000, DOI 10.1038/emboj.2011.461; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Ducka AM, 2010, P NATL ACAD SCI USA, V107, P11757, DOI 10.1073/pnas.1005347107; Ghoshdastider U, 2013, CYTOSKELETON, V70, P775, DOI 10.1002/cm.21149; Gutsche-Perelroizen I, 1999, J BIOL CHEM, V274, P6234, DOI 10.1074/jbc.274.10.6234; Hanson J., 1963, Journal of Molecular Biology, V6, P46; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Hertzog M, 2002, J BIOL CHEM, V277, P14786, DOI 10.1074/jbc.M112064200; Hertzog M., 2005, CURR PROTOC CELL BIO; Husson C, 2011, MOL CELL, V43, P464, DOI 10.1016/j.molcel.2011.07.010; Husson C, 2010, ANN NY ACAD SCI, V1194, P44, DOI 10.1111/j.1749-6632.2010.05473.x; Kis-Bicskei N, 2013, CYTOSKELETON, V70, P755, DOI 10.1002/cm.21143; Kudryashov DS, 2004, BIOPHYS J, V87, P1136, DOI 10.1529/biophysj.104.042242; MIKI M, 1987, EUR J BIOCHEM, V168, P339, DOI 10.1111/j.1432-1033.1987.tb13425.x; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Nworu CU, 2015, J CELL SCI, V128, P239, DOI 10.1242/jcs.152702; Nyitrai M, 2003, BIOCHEM J, V370, P839, DOI 10.1042/BJ20021519; Oda T, 2005, BIOPHYS J, V88, P2727, DOI 10.1529/biophysj.104.047753; Olson B. J., 2001, CURR PROTOC PROTEIN; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Pernier J, 2013, NAT STRUCT MOL BIOL, V20, P1069, DOI 10.1038/nsmb.2639; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2013, MOL BIOL CELL, V24, P1103, DOI 10.1091/mbc.E13-01-0030; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Rebowski G, 2008, P NATL ACAD SCI USA, V105, P10785, DOI 10.1073/pnas.0801650105; Renault L, 2008, TRENDS CELL BIOL, V18, P494, DOI 10.1016/j.tcb.2008.07.008; Renault L, 2013, CYTOSKELETON, V70, P686, DOI 10.1002/cm.21140; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110; Yuen M, 2014, J CLIN INVEST, V124, P4693, DOI 10.1172/JCI75199; Zahm JA, 2013, CELL, V155, P423, DOI 10.1016/j.cell.2013.09.019; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	53	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					667	680		10.1074/jbc.M115.683904	http://dx.doi.org/10.1074/jbc.M115.683904			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26578512	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000367830500016
J	Snodgrass, RG; Boss, M; Zezina, E; Weigert, A; Dehne, N; Fleming, I; Bruene, B; Namgaladze, D				Snodgrass, Ryan G.; Boss, Marcel; Zezina, Ekaterina; Weigert, Andreas; Dehne, Nathalie; Fleming, Ingrid; Bruene, Bernhard; Namgaladze, Dmitry			Hypoxia Potentiates Palmitate-induced Pro-inflammatory Activation of Primary Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; fatty acid; hypoxia; inflammation; macrophage	ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL COMPLEX-III; SATURATED FATTY-ACIDS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; OXIDATIVE STRESS; LOCAL PROLIFERATION; JNK ACTIVATION; OBESITY; PHOSPHATASES	Pro-inflammatory cytokines secreted by adipose tissue macrophages (ATMs) contribute to chronic low-grade inflammation and obesity-induced insulin resistance. Recent studies have shown that adipose tissue hypoxia promotes an inflammatory phenotype in ATMs. However, our understanding of how hypoxia modulates the response of ATMs to free fatty acids within obese adipose tissue is limited. We examined the effects of hypoxia (1% O-2) on the pro-inflammatory responses of human monocyte-derived macrophages to the saturated fatty acid palmitate. Compared with normoxia, hypoxia significantly increased palmitate-induced mRNA expression and protein secretion of IL-6 and IL-1. Although palmitate-induced endoplasmic reticulum stress and nuclear factor B pathway activation were not enhanced by hypoxia, hypoxia increased the activation of JNK and p38 mitogen-activated protein kinase signaling in palmitate-treated cells. Inhibition of JNK blocked the hypoxic induction of pro-inflammatory cytokine expression, whereas knockdown of hypoxia-induced transcription factors HIF-1 and HIF-2 alone or in combination failed to reduce IL-6 and only modestly reduced IL-1 gene expression in palmitate-treated hypoxic macrophages. Enhanced pro-inflammatory cytokine production and JNK activity under hypoxia were prevented by inhibiting reactive oxygen species generation. In addition, silencing of dual-specificity phosphatase 16 increased normoxic levels of IL-6 and IL-1 and reduced the hypoxic potentiation in palmitate-treated macrophages. The secretome of hypoxic palmitate-treated macrophages promoted IL-6 and macrophage chemoattractant protein 1 expression in primary human adipocytes, which was sensitive to macrophage JNK inhibition. Our results reveal that the coexistence of hypoxia along with free fatty acids exacerbates macrophage-mediated inflammation.	[Snodgrass, Ryan G.; Boss, Marcel; Zezina, Ekaterina; Weigert, Andreas; Dehne, Nathalie; Bruene, Bernhard; Namgaladze, Dmitry] Goethe Univ Frankfurt, Ctr Mol Med, Inst Biochem 1, D-60590 Frankfurt, Germany; [Fleming, Ingrid] Goethe Univ Frankfurt, Fac Med, Inst Vasc Signaling, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Namgaladze, D (corresponding author), Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Theodor Stern Kai 7,Bldg 74, D-60590 Frankfurt, Germany.	namgaladze@biochem.uni-frankfurt.de	Fleming, Ingrid/AAB-6123-2022; Snodgrass, Ryan G./AAH-5110-2021; Weigert, Andreas/E-6540-2010; Fleming, Ingrid/L-1225-2014; Snodgrass, Ryan G/U-1031-2018	Fleming, Ingrid/0000-0003-1881-3635; Snodgrass, Ryan G./0000-0001-9896-5297; Weigert, Andreas/0000-0002-7529-1952; Fleming, Ingrid/0000-0003-1881-3635; Snodgrass, Ryan G/0000-0001-9896-5297; Zezina, Ekaterina/0000-0003-0800-2513	Deutsche Forschungsgemeinschaft [NA429/2-1, Z01, A05, B04]; Else Kroner Fresenius Foundation;  [SFB1039]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Fresenius Foundation; 	This study was supported by Deutsche Forschungsgemeinschaft Grants NA429/2-1, SFB1039 Teilprojekt, A05, B04, and Z01, and SFB815, Teilprojekt A08) and by the Else Kroner Fresenius Foundation (Translational Research Innovation-Pharma, TRIP). The authors declare that they have no conflicts of interest with the contents of this article.	Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Berdichevsky A, 2010, J BIOL CHEM, V285, P21581, DOI 10.1074/jbc.M109.093633; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Choe SS, 2014, DIABETES, V63, P3359, DOI 10.2337/db13-1965; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Dehne N, 2014, J LEUKOCYTE BIOL, V95, P129, DOI 10.1189/jlb.0113045; Dehne N, 2009, EXP CELL RES, V315, P1791, DOI 10.1016/j.yexcr.2009.03.019; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y; Han JM, 2013, J IMMUNOL, V191, P527, DOI 10.4049/jimmunol.1301035; Harwood HJ, 2012, NEUROPHARMACOLOGY, V63, P57, DOI 10.1016/j.neuropharm.2011.12.010; Hauner H, 2000, METH MOL B, V155, P239; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Huang GH, 2011, IMMUNITY, V35, P45, DOI 10.1016/j.immuni.2011.05.014; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Ishiyama J, 2011, J LIPID RES, V52, P299, DOI 10.1194/jlr.m007104; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; O'Rourke RW, 2011, DIABETOLOGIA, V54, P1480, DOI 10.1007/s00125-011-2103-y; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Portella AOV, 2004, TRANSPL P, V36, P846, DOI 10.1016/j.transproceed.2004.03.047; Rios P, 2014, ANTIOXID REDOX SIGN, V20, P2251, DOI 10.1089/ars.2013.5709; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Snodgrass RG, 2013, J IMMUNOL, V191, P4337, DOI 10.4049/jimmunol.1300298; Srinivasan S, 2007, ANN NY ACAD SCI, V1117, P51, DOI 10.1196/annals.1402.067; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Wang CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108855; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wu J, 2009, AM J PHYSIOL-RENAL, V297, pF1622, DOI 10.1152/ajprenal.00078.2009; Ye JP, 2011, CURR DIABETES REP, V11, P203, DOI 10.1007/s11892-011-0183-1	48	54	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					413	424		10.1074/jbc.M115.686709	http://dx.doi.org/10.1074/jbc.M115.686709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578520	hybrid, Green Published			2022-12-26	WOS:000367589500034
J	Chen, SC; Telinius, N; Lin, HT; Huang, MC; Lin, CC; Chou, CH; Hjortdal, J				Chen, Shih-Cheng; Telinius, Niklas; Lin, Han-Tse; Huang, Min-Chang; Lin, Chien-Chen; Chou, Cheng-Hung; Hjortdal, Jesper			Use of Fish Scale-Derived BioCornea to Seal Full-Thickness Corneal Perforations in Pig Models	PLOS ONE			English	Article							TISSUE QUALITY PARAMETERS; AMNIOTIC MEMBRANE; DONOR CORNEAS; FIBRIN GLUE; MANAGEMENT; MATRIX; MULTILAYER; VALIDATION	The aim of this study was to test the use of BioCornea, a fish scale-derived collagen matrix for sealing full-thickness corneal perforations in mini-pigs. Two series of experiments were carried out in 8 Lan-Yu and 3 Gottingen mini-pigs, respectively. A 2mm central full thickness corneal perforation was made with surgical scissors and 2mm trephines. The perforations were sealed immediately by suturing BioCornea to the wounded cornea. The conditions of each patched cornea were followed-up daily for 3 or 4 days. Status of operated eyes was assessed with slit lamp examination or optical coherence tomography (OCT). Animals were sacrificed after the study period and the corneas operated were fixated for histological examination. Both OCT imaging and handheld slit lamp observations indicated that a stable ocular integrity of the perforated corneas was maintained, showing no leakage of aqueous humor, normal depth of anterior chamber and only mild swelling of the wounded cornea. Hematoxylin and eosin staining of the patched cornea showed no epithelial ingrowths to the perforated wounds and no severe leucocyte infiltration of the stroma. The fish scale-derived BioCornea is capable to seal full-thickness corneal perforation and stabilize the integrity of ocular anterior chamber in pre-clinic mini-pig models. BioCornea seems to be a safe and effective alternative for emergency treatment of corneal perforations.	[Chen, Shih-Cheng] Aeon Astron Europe BV, Leiden, Netherlands; [Telinius, Niklas; Hjortdal, Jesper] Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus, Denmark; [Lin, Han-Tse; Huang, Min-Chang; Lin, Chien-Chen; Chou, Cheng-Hung] Body Organ Biomed Corp, Taipei, Taiwan	Aarhus University	Hjortdal, J (corresponding author), Aarhus Univ Hosp, Dept Ophthalmol, DK-8000 Aarhus, Denmark.	jesper.hjortdal@dadlnet.dk		Chen, Shih-Cheng/0000-0002-4764-0510	Aeon Astron Europe; Aeon Astron Europe B.V.; Body Organ Biomedical Corp.	Aeon Astron Europe; Aeon Astron Europe B.V.; Body Organ Biomedical Corp.	Aeon Astron Europe sponsored all experiments. The expenditures associated with the experiments were covered by Aeon Astron Europe B.V. and Body Organ Biomedical Corp. Aeon Astron Europe B.V. and Body Organ Biomedical Corp. provided support in the form of salaries for authors SCC, HTL, MCH, CCL and CHC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aslam SA, 2007, INJURY, V38, P594, DOI 10.1016/j.injury.2006.04.122; Chirila T V, 1999, Gesnerus, V56, P96; Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x; Grau AE, 2012, CORNEA, V31, P98, DOI 10.1097/ICO.0b013e31821f28a2; Griffith M, 2014, CURR OPIN OPHTHALMOL, V25, P240, DOI 10.1097/ICU.0000000000000049; Hamill M Bowes, 2002, Ophthalmol Clin North Am, V15, P185, DOI 10.1016/S0896-1549(02)00018-4; Hart A, 1997, INJURY, V28, P527, DOI 10.1016/S0020-1383(97)83472-9; Ikoma T, 2003, J STRUCT BIOL, V142, P327, DOI 10.1016/S1047-8477(03)00053-4; Jhanji V, 2011, SURV OPHTHALMOL, V56, P522, DOI 10.1016/j.survophthal.2011.06.003; Kara S, 2014, CASE REP OPHTHALMOL, V2014, DOI 10.1155/2014/351534; Kim EC, 2010, CAN J OPHTHALMOL, V45, P9; Lee W, 2014, INT J OPHTHALMOL-CHI, V7, P587, DOI 10.3980/j.issn.2222-3959.2014.04.01; Lekskul M, 2000, CORNEA, V19, P313, DOI 10.1097/00003226-200005000-00011; Lin CC, 2010, EUR CELLS MATER, V19, P50, DOI 10.22203/eCM.v019a06; Lynch AP, 2013, EXP EYE RES, V108, P42, DOI 10.1016/j.exer.2012.12.012; Michael JG, 2002, ANN EMERG MED, V40, P69, DOI 10.1067/mem.2002.124757; Nubile M, 2007, J CATARACT REFR SURG, V33, P1636, DOI 10.1016/j.jcrs.2007.04.040; Omobolanle Adio Adedayo, 2012, BMC Res Notes, V5, P683, DOI 10.1186/1756-0500-5-683; PORTNOY SL, 1989, SURV OPHTHALMOL, V34, P47, DOI 10.1016/0039-6257(89)90129-X; Rana M, 2013, CONTACT LENS ANTERIO, V36, P156, DOI 10.1016/j.clae.2013.03.006; Rijneveld WJ, 2011, ACTA OPHTHALMOL, V89, P734, DOI 10.1111/j.1755-3768.2009.01805.x; Rijneveld WJ, 2010, CORNEA, V29, P128, DOI 10.1097/ICO.0b013e3181ac07bc; Savino G, 2010, ACTA OPHTHALMOL, V88, pe15, DOI 10.1111/j.1755-3768.2009.01522.x; Sharma A, 2003, OPHTHALMOLOGY, V110, P291, DOI 10.1016/S0161-6420(02)01558-0; Sii F, 2005, CLIN EXP OPHTHALMOL, V33, P532, DOI 10.1111/j.1442-9071.2005.01076.x; Solomon A, 2002, OPHTHALMOLOGY, V109, P694, DOI 10.1016/S0161-6420(01)01032-6; Taravella MJ, 2001, CORNEA, V20, P220, DOI 10.1097/00003226-200103000-00024; van Essen TH, 2013, INVEST OPHTH VIS SCI, V54, P3224, DOI 10.1167/iovs.13-11799; Vora Gargi K, 2013, Int Ophthalmol Clin, V53, P1, DOI 10.1097/IIO.0b013e3182a12c08; Yuan F, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/914542; Zhou Y, 2011, CORNEA, V30, P73, DOI 10.1097/ICO.0b013e3181dc8184	31	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143511	10.1371/journal.pone.0143511	http://dx.doi.org/10.1371/journal.pone.0143511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599018	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600076
J	Go, YM; Liang, YL; Uppal, K; Soltow, QA; Promislow, DEL; Wachtman, LM; Jones, DP				Go, Young-Mi; Liang, Yongliang; Uppal, Karan; Soltow, Quinlyn A.; Promislow, Daniel E. L.; Wachtman, Lynn M.; Jones, Dean P.			Metabolic Characterization of the Common Marmoset (Callithrix jacchus)	PLOS ONE			English	Article							NEW-WORLD PRIMATES; METHIONINE ADENOSYLTRANSFERASE; S-ADENOSYLMETHIONINE; HEART-MITOCHONDRIA; L-TRYPTOPHAN; PLASMA; MICE; DIET; CONVERSION; CARNITINE	High-resolution metabolomics has created opportunity to integrate nutrition and metabolism into genetic studies to improve understanding of the diverse radiation of primate species. At present, however, there is very little information to help guide experimental design for study of wild populations. In a previous non-targeted metabolomics study of common marmosets (Callithrix jacchus), Rhesus macaques, humans, and four non-primate mammalian species, we found that essential amino acids (AA) and other central metabolites had interspecies variation similar to intraspecies variation while non-essential AA, environmental chemicals and catabolic waste products had greater interspecies variation. The present study was designed to test whether 55 plasma metabolites, including both nutritionally essential and non-essential metabolites and catabolic products, differ in concentration in common marmosets and humans. Significant differences were present for more than half of the metabolites analyzed and included AA, vitamins and central lipid metabolites, as well as for catabolic products of AA, nucleotides, energy metabolism and heme. Three environmental chemicals were present at low nanomolar concentrations but did not differ between species. Sex and age differences in marmosets were present for AA and nucleotide metabolism and warrant additional study. Overall, the results suggest that quantitative, targeted metabolomics can provide a useful complement to non-targeted metabolomics for studies of diet and environment interactions in primate evolution.	[Go, Young-Mi; Liang, Yongliang; Uppal, Karan; Soltow, Quinlyn A.; Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Clin Biomarkers Lab, Atlanta, GA 30322 USA; [Promislow, Daniel E. L.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Promislow, Daniel E. L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Wachtman, Lynn M.] Harvard Univ, New England Primate Res Ctr, Southborough, MA 01772 USA	Emory University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University	Jones, DP (corresponding author), Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Clin Biomarkers Lab, Atlanta, GA 30322 USA.	dpjones@emory.edu		Promislow, Daniel/0000-0001-7088-4495; Uppal, Karan/0000-0001-5985-1668	NIH [AG038746, ES023485, ES 025632, HL113451, ES019776, OD018006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES019776, R01ES023485, R21ES025632, T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038746, P30AG013280] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH grants, AG038746 (DJ, DP, LW), ES023485 (DJ, YG), ES 025632 (DJ, YG), HL113451 (DJ), ES019776 (DJ), and OD018006 (DJ).	Banton SA, 2015, J AM ASS LA IN PRESS; Barton RA, 2006, AM J PRIMATOL, V68, P545, DOI 10.1002/ajp.20251; Baxter VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082747; Berstad A, 2014, SCAND J GASTROENTERO, V49, P1493, DOI 10.3109/00365521.2014.936034; Bouchardet da Fonseca G.A., 1984, Primates, V25, P441, DOI 10.1007/BF02381667; Bravo R, 2013, AGE, V35, P1277, DOI 10.1007/s11357-012-9419-5; Capuron L, 2014, CURR PHARM DESIGN, V20, P6048, DOI 10.2174/1381612820666140317110217; CHALMERS DT, 1983, LAB ANIM, V17, P270, DOI 10.1258/002367783781062217; Coimbra-Fiho AF, 1978, TREE GOUGING EXUDATE, P105; Committee NRCU, 2011, GUIDE CARE USE LAB A; Cribbs SK, 2014, AIDS RES HUM RETROV, V30, P579, DOI [10.1089/aid.2013.0198, 10.1089/AID.2013.0198]; Frediani JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108854; GARBER PA, 1992, AM J PHYS ANTHROPOL, V88, P411, DOI 10.1002/ajpa.1330880402; Go YM, 2015, TOXICOL SCI, V148, P531, DOI 10.1093/toxsci/kfv198; Go YM, 2015, TOXICOL SCI, V147, P524, DOI 10.1093/toxsci/kfv149; Go YM, 2015, AMINO ACIDS, V47, P589, DOI 10.1007/s00726-014-1893-x; Go YM, 2015, AM J PHYSIOL-REG I, V308, pR62, DOI 10.1152/ajpregu.00278.2014; GUTTLER F, 1984, EUR J PEDIATR, V142, P126, DOI 10.1007/BF00445592; He C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004860; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Ingenbleek Y, 2013, NUTR REV, V71, P413, DOI 10.1111/nure.12050; Johnson JM, 2010, ANALYST, V135, P2864, DOI 10.1039/c0an00333f; Jones DP, 2012, ANNU REV NUTR, V32, P183, DOI 10.1146/annurev-nutr-072610-145159; Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054; KLOSTERMAN LL, 1986, ENDOCRINOLOGY, V118, P424, DOI 10.1210/endo-118-1-424; Liu WJ, 2013, ASIAN PAC J CANCER P, V14, P6433, DOI 10.7314/APJCP.2013.14.11.6433; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Lu SC, 2005, ALCOHOL, V35, P227, DOI 10.1016/j.alcohol.2005.03.011; Ludlage E, 2003, COMPARATIVE MED, V53, P369; McWhorter TJ, 2007, AM J PRIMATOL, V69, P1399, DOI 10.1002/ajp.20443; Muller N, 2014, AM J PRIMATOL, V76, P230, DOI 10.1002/ajp.22225; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; PARADIES G, 1994, ANN NY ACAD SCI, V717, P233, DOI 10.1111/j.1749-6632.1994.tb12093.x; Park YH, 2012, TOXICOLOGY, V295, P47, DOI 10.1016/j.tox.2012.02.007; PETERS JH, 1971, COMP BIOCHEM PHYSIOL, V39, P639, DOI 10.1016/0305-0491(71)90208-2; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Ross Corinna N, 2012, J Aging Res, V2012, P567143, DOI 10.1155/2012/567143; Salinas JL, 2014, MEM I OSWALDO CRUZ, V109, P589, DOI 10.1590/0074-0276140043; Sethumadhavan S, 2006, BIOGERONTOLOGY, V7, P101, DOI 10.1007/s10522-006-6497-8; Shibata K, 2003, ADV EXP MED BIOL, V527, P435; Soltow QA, 2013, METABOLOMICS, V9, pS132, DOI 10.1007/s11306-011-0332-1; Tardif S, 1998, LAB ANIM SCI, V48, P264; Tardif SD, 2011, ILAR J, V52, P54, DOI 10.1093/ilar.52.1.54; Tardif SD, 2009, OBESITY, V17, P1499, DOI 10.1038/oby.2009.77; Tardito S, 2012, AMINO ACIDS, V42, P2507, DOI 10.1007/s00726-011-0981-4; Terakata M, 2013, J NUTR, V143, P1046, DOI 10.3945/jn.113.176875; Uppal K, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-15; Villasenor A, 2014, BRIT J PHARMACOL, V171, P2230, DOI 10.1111/bph.12494; Wachtman LM, 2011, COMPARATIVE MED, V61, P278; Wachtman LM, 2011, OBESITY, V19, P1145, DOI 10.1038/oby.2010.303; Yamada H, 2012, FREE RADICAL BIO MED, V52, P1716, DOI 10.1016/j.freeradbiomed.2012.02.033; Yu TW, 2009, BIOINFORMATICS, V25, P1930, DOI 10.1093/bioinformatics/btp291; Zagajewski J, 2012, J PHYSIOL PHARMACOL, V63, P613; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100; Zhao JY, 2015, DIABETES CARE, V38, P220, DOI 10.2337/dc14-2033; Zhou XM, 2014, NAT GENET, V46, P1303, DOI 10.1038/ng.3137; Ziegler TE, 2013, J AM ASSOC LAB ANIM, V52, P756	59	21	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142916	10.1371/journal.pone.0142916	http://dx.doi.org/10.1371/journal.pone.0142916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581102	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600067
J	Nouatin, O; Gbedande, K; Ibitokou, S; Vianou, B; Houngbegnon, P; Ezinmegnon, S; Borgella, S; Akplogan, C; Cottrell, G; Varani, S; Massougbodji, A; Moutairou, K; Troye-Blomberg, M; Deloron, P; Luty, AJF; Fievet, N				Nouatin, Odilon; Gbedande, Komi; Ibitokou, Samad; Vianou, Bertin; Houngbegnon, Parfait; Ezinmegnon, Sem; Borgella, Sophie; Akplogan, Carine; Cottrell, Gilles; Varani, Stefania; Massougbodji, Achille; Moutairou, Kabirou; Troye-Blomberg, Marita; Deloron, Philippe; Luty, Adrian J. F.; Fievet, Nadine			Infants' Peripheral Blood Lymphocyte Composition Reflects Both Maternal and Post-Natal Infection with Plasmodium falciparum	PLOS ONE			English	Article							REGULATORY T-CELLS; ALPHA-INDUCED APOPTOSIS; HUMAN NK-CELLS; CORD BLOOD; PLACENTAL MALARIA; IMMUNE-RESPONSES; IN-UTERO; CYTOKINE RESPONSES; TGF-BETA; CD4(+)	Maternal parasitoses modulate fetal immune development, manifesting as altered cellular immunological activity in cord blood that may be linked to enhanced susceptibility to infections in early life. Plasmodium falciparum typifies such infections, with distinct placental infection-related changes in cord blood exemplified by expanded populations of parasite antigen-specific regulatory T cells. Here we addressed whether such early-onset cellular immunological alterations persist through infancy. Specifically, in order to assess the potential impacts of P. falciparum infections either during pregnancy or during infancy, we quantified lymphocyte subsets in cord blood and in infants' peripheral blood during the first year of life. The principal age-related changes observed, independent of infection status, concerned decreases in the frequencies of CD4(+), NKdim and NKT cells, whilst CD8(+), Treg and Teff cells' frequencies increased from birth to 12 months of age. P. falciparum infections present at delivery, but not those earlier in gestation, were associated with increased frequencies of Treg and CD8(+) T cells but fewer CD4(+) and NKT cells during infancy, thus accentuating the observed age-related patterns. Overall, P. falciparum infections arising during infancy were associated with a reversal of the trends associated with maternal infection i.e. with more CD4(+) cells, with fewer Treg and CD8(+) cells. We conclude that maternal P. falciparum infection at delivery has significant and, in some cases, year-long effects on the composition of infants' peripheral blood lymphocyte populations. Those effects are superimposed on separate and independent age-as well as infant infection-related alterations that, respectively, either match or run counter to them.	[Nouatin, Odilon; Gbedande, Komi; Ibitokou, Samad; Vianou, Bertin; Houngbegnon, Parfait; Ezinmegnon, Sem; Borgella, Sophie; Akplogan, Carine; Cottrell, Gilles; Massougbodji, Achille; Fievet, Nadine] Univ Abomey Calavi, Fac Sci Sante, CERPAGE, Cotonou, Benin; [Nouatin, Odilon; Gbedande, Komi; Ibitokou, Samad; Vianou, Bertin; Houngbegnon, Parfait; Ezinmegnon, Sem; Akplogan, Carine; Moutairou, Kabirou] Univ Abomey Calavi, Fac Sci & Tech, Dept Biochim & Biol Cellulaire, Cotonou, Benin; [Borgella, Sophie; Cottrell, Gilles; Deloron, Philippe; Fievet, Nadine] Inst Rech Dev, MERIT UMR Mere & Enfant Face Infect Trop D216, Paris, France; [Cottrell, Gilles; Deloron, Philippe; Fievet, Nadine] Univ Paris 05, Fac Pharm, PRES Sorbonne Paris Cite, Paris, France; [Varani, Stefania] Univ Bologna, Microbiol Unit, Dept Diagnost Expt & Specialty Med, Bologna, Italy; [Troye-Blomberg, Marita] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Luty, Adrian J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	University of Abomey Calavi; University of Abomey Calavi; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Bologna; Stockholm University; Radboud University Nijmegen	Fievet, N (corresponding author), Univ Abomey Calavi, Fac Sci Sante, CERPAGE, Cotonou, Benin.	fievet.nadine@ird.fr	Varani, Stefania/AAZ-1856-2021; Troye-Blomberg, Marita/B-9210-2016; Luty, Adrian/CAH-2547-2022; Deloron, Philippe/G-6305-2010	Troye-Blomberg, Marita/0000-0002-2804-0325; Deloron, Philippe/0000-0003-4705-2484; Luty, Adrian John Frederick/0000-0001-8830-3425; Cottrell, Gilles/0000-0002-7964-8963; VARANI, STEFANIA/0000-0003-0862-4937; GBEDANDE, Komi/0000-0002-3229-5566; Fievet, Nadine/0000-0003-2272-9794	European 7th Framework Programme [200889]; Ministere des Affaires Etrangeres of France (project REFS) [2006-22]; Institut de Recherche pour le Developpement; AIRD-DPF; French Ambassy	European 7th Framework Programme(European Commission); Ministere des Affaires Etrangeres of France (project REFS); Institut de Recherche pour le Developpement; AIRD-DPF; French Ambassy	This paper describes work undertaken in the context of the STOPPAM project, 'Strategies To Prevent Pregnancy Associated Malaria' (www.stoppam.org), a Small & Medium Scale Collaborative Project supported by the European 7th Framework Programme under contract number 200889. This work was also supported by the Ministere des Affaires Etrangeres of France (project REFS No. 2006-22), the Institut de Recherche pour le Developpement, which contributed to the study financially and with research material. Financial support was also provided by the AIRD-DPF to SI and KG (PhD research scholarship) and the French Ambassy to KG (PhD research scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2008, J INFECT DIS, V198, P928, DOI 10.1086/591057; Aggarwal S, 2000, GENES IMMUN, V1, P271, DOI 10.1038/sj.gene.6363674; Ateba-Ngoa U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114630; Azuma T, 2003, CANCER RES, V63, P4516; Huynh BT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-72; Bisseye C, 2011, CLIN EXP IMMUNOL, V166, P366, DOI 10.1111/j.1365-2249.2011.04467.x; Bisseye C, 2009, CLIN EXP IMMUNOL, V158, P287, DOI 10.1111/j.1365-2249.2009.04014.x; Borgella S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080624; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brickley EB, 2015, J INFECT DIS, V211, P436, DOI 10.1093/infdis/jiu454; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; Brustoski K, 2006, J INFECT DIS, V193, P146, DOI 10.1086/498578; Brustoski K, 2005, J IMMUNOL, V174, P1738, DOI 10.4049/jimmunol.174.3.1738; Chelimo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024852; Clemente A, 2011, CELL MICROBIOL, V13, P1328, DOI 10.1111/j.1462-5822.2011.01622.x; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Cuna WR, 2009, J PARASITOL, V95, P891, DOI 10.1645/GE-1927.1; D'Andrea A, 2000, EUR J IMMUNOL, V30, P1544, DOI 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO;2-I; Dalle JH, 2005, PEDIATR RES, V57, P649, DOI 10.1203/01.PDR.0000156501.55431.20; Dauby N, 2012, LANCET INFECT DIS, V12, P330, DOI 10.1016/S1473-3099(11)70341-3; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fievet N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-251; Finney OC, 2010, EUR J IMMUNOL, V40, P47, DOI 10.1002/eji.200939708; Flanagan KL, 2010, EUR J IMMUNOL, V40, P1062, DOI 10.1002/eji.200939638; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Fuchizawa T, 2007, CLIN IMMUNOL, V125, P237, DOI 10.1016/j.clim.2007.08.004; Fujimaki W, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/305859; Gbedande K, 2013, INFECT IMMUN, V81, P2686, DOI 10.1128/IAI.00237-13; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Grindebacke H, 2009, J IMMUNOL, V183, P4360, DOI 10.4049/jimmunol.0901091; Gupta S, 2005, INT J BIOCHEM CELL B, V37, P1034, DOI 10.1016/j.biocel.2004.08.013; Harner S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015714; Hartgers FC, 2009, J INFECT DIS, V199, P1528, DOI 10.1086/598687; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Horowitz A, 2010, J IMMUNOL, V184, P6043, DOI 10.4049/jimmunol.1000106; Horowitz A, 2010, METHODS MOL BIOL, V612, P429, DOI 10.1007/978-1-60761-362-6_29; Hrdy J, 2012, CLIN EXP IMMUNOL, V170, P10, DOI 10.1111/j.1365-2249.2012.04630.x; Kabyemela E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077214; Kalanda BF, 2005, EARLY HUM DEV, V81, P841, DOI 10.1016/j.earlhumdev.2005.06.006; Kurtis JD, 2011, INFECT IMMUN, V79, P1254, DOI 10.1128/IAI.01072-10; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Mackroth MS, 2011, J IMMUNOL, V186, P2780, DOI 10.4049/jimmunol.1001188; Malhotra I, 2006, J INFECT DIS, V193, P1005, DOI 10.1086/500472; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Menzies SK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002718; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2012, ADV IMMUNOL, V115, P73, DOI 10.1016/B978-0-12-394299-9.00003-5; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; Ngoa UA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-388; Othoro C, 2008, INFECT IMMUN, V76, P1678, DOI 10.1128/IAI.01420-07; Pied S, 2000, J IMMUNOL, V164, P1463, DOI 10.4049/jimmunol.164.3.1463; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; Ralainirina N, 2007, J LEUKOCYTE BIOL, V81, P144, DOI 10.1189/jlb.0606409; REICHERT T, 1991, CLIN IMMUNOL IMMUNOP, V60, P190, DOI 10.1016/0090-1229(91)90063-G; Romagnani C, 2005, EUR J IMMUNOL, V35, P2452, DOI 10.1002/eji.200526069; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Shahabuddin S, 1998, CLIN DIAGN LAB IMMUN, V5, P632, DOI 10.1128/CDLI.5.5.632-635.1998; Smith NL, 2014, J IMMUNOL, V193, P177, DOI 10.4049/jimmunol.1400553; Soulard V, 2011, INFECT IMMUN, V79, P2801, DOI 10.1128/IAI.00203-11; Sundstrom Y, 2007, SCAND J IMMUNOL, V66, P335, DOI 10.1111/j.1365-3083.2007.01980.x; Tang Jie, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P365; Thornton CA, 2010, CURR ALLERGY ASTHM R, V10, P444, DOI 10.1007/s11882-010-0148-5; van der Vliet HJJ, 2000, BLOOD, V95, P2440, DOI 10.1182/blood.V95.7.2440.007k35_2440_2442; Vekemans J, 2000, INFECT IMMUN, V68, P5430, DOI 10.1128/IAI.68.9.5430-5434.2000; Walther B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-6; Walther B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-16; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Watanabe H, 2003, PARASITOL INT, V52, P61, DOI 10.1016/S1383-5769(02)00085-5	79	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0139606	10.1371/journal.pone.0139606	http://dx.doi.org/10.1371/journal.pone.0139606			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580401	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600001
J	Palumbo, GA; Scisciani, C; Pediconi, N; Lupacchini, L; Alfalate, D; Guerrieri, F; Calvo, L; Salerno, D; Di Cocco, S; Levrero, M; Belloni, L				Palumbo, Gianna Aurora; Scisciani, Cecilia; Pediconi, Natalia; Lupacchini, Leonardo; Alfalate, Dulce; Guerrieri, Francesca; Calvo, Ludovica; Salerno, Debora; Di Cocco, Silvia; Levrero, Massimo; Belloni, Laura			IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GENE-EXPRESSION; LIVER; INTERLEUKIN-6; STAT3; IL-6; REPLICATION; ACTIVATION; PROTEIN; DNA	The HBV covalently closed circular DNA (cccDNA) is organized as a mini-chromosome in the nuclei of infected hepatocytes by histone and non-histone proteins. Transcription from the cccDNA of the RNA replicative intermediate termed pre-genome (pgRNA), is the critical step for genome amplification and ultimately determines the rate of HBV replication. Multiple evidences suggest that cccDNA epigenetic modifications, such as histone modifications and DNA methylation, participate in regulating the transcriptional activity of the HBV cccDNA. Inflammatory cytokines (TNF alpha, LT beta) and the pleiotropic cytokine interleukin-6 (IL6) inhibit hepatitis B virus (HBV) replication and transcription. Here we show, in HepG2 cells transfected with linear HBV monomers and HBV-infected NTCP-HepG2 cells, that IL6 treatment leads to a reduction of cccDNA-bound histone acetylation paralleled by a rapid decrease in 3.5kb/pgRNA and subgenomic HBV RNAs transcription without affecting cccDNA chromatinization or cccDNA levels. IL6 repressive effect on HBV replication is mediated by a loss of HNF1 alpha and HNF4 alpha binding to the cccDNA and a redistribution of STAT3 binding from the cccDNA to IL6 cellular target genes.	[Palumbo, Gianna Aurora; Scisciani, Cecilia; Lupacchini, Leonardo; Calvo, Ludovica; Salerno, Debora; Di Cocco, Silvia; Levrero, Massimo; Belloni, Laura] Univ Roma La Sapienza, Dept Internal Med DMISM, I-00185 Rome, Italy; [Pediconi, Natalia] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Alfalate, Dulce; Levrero, Massimo] CRCL, INSERM, U1052, Lyon, France; [Guerrieri, Francesca; Salerno, Debora; Levrero, Massimo; Belloni, Laura] IIT Sapienza, Ctr Life NanoSci CLNS, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Istituto Italiano di Tecnologia - IIT	Levrero, M (corresponding author), Univ Roma La Sapienza, Dept Internal Med DMISM, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	massimo.levrero@uniroma1.it; laura.belloni@iit.it	Salerno, Debora/AAM-9940-2021; guerrieri, francesca/G-3908-2013; Lupacchini, Leonardo/C-2626-2017; Belloni, Laura/S-1432-2019; Guerrieri, Francesca/K-5504-2016; Levrero, Massimo/G-5680-2016	Guerrieri, Francesca/0000-0003-2751-6050; LUPACCHINI, LEONARDO/0000-0002-9172-7461; Guerrieri, Francesca/0000-0002-2021-4394; SALERNO, DEBORA/0000-0003-0504-1904; Levrero, Massimo/0000-0002-4978-0875	Ministero dell'Istruzione, dell'Universita e della Ricerca FIRB [RBAP10XKNC]; Ministero della Salute [43-2317822]; Fondazione Cariplo [2011-0644]; Agence Nationale de la Recherche [ANR 14 ACHN 0028 PAN]; University of Lyon-St Etienne [14IA09-ANR PALSE]; Gilead Sciences Research Scholars Program in Liver Diseases [000324-14-AR]; MIUR-FIRB; Regione Lazio; CARIPLO; IIT; Fundacao Calouste Gulbenkian; Fundacao para a Ciencia e a Tecnologia, Portugal	Ministero dell'Istruzione, dell'Universita e della Ricerca FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministero della Salute(Ministry of Health, Italy); Fondazione Cariplo(Fondazione Cariplo); Agence Nationale de la Recherche(French National Research Agency (ANR)); University of Lyon-St Etienne; Gilead Sciences Research Scholars Program in Liver Diseases; MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Regione Lazio(Regione Lazio); CARIPLO(Fondazione Cariplo); IIT(Istituto Italiano di Tecnologia - IIT); Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	Support was provided by the following grants: a) Ministero dell'Istruzione, dell'Universita e della Ricerca FIRB RBAP10XKNC to ML [www.istruzione.it/web/ricerca/home]; b) Ministero della Salute, Ric Fin Conv 43-2317822 to ML [www.salute.gov.it/porta/.../p2_5.jsp?...Ricerca%20sanitaria...finalizzata]; c) Fondazione Cariplo, 2011-0644 to ML [www.fondazionecariplo.it/it/strategia/settori-di-intervento/ricerca/]; d) Agence Nationale de la Recherche, ANR 14 ACHN 0028 PAN to ML [www.agence-nationale-recherche.fr/]; e) University of Lyon-St Etienne, 14IA09-ANR PALSE to ML [palse.universite-lyon.fr/]; f) Gilead Sciences Research Scholars Program in Liver Diseases, 000324-14-AR to LB [researchscholars.gilead.com/]. The following fellowships and support were also provided: GAP, CS, LC are supported by research contracts from MIUR-FIRB, Regione Lazio and CARIPLO, respectively. FG, DS and LB are recipients of research contracts supported by IIT. DA is supported by a fellowship from Fundacao Calouste Gulbenkian and Fundacao para a Ciencia e a Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Benhenda S, 2013, J VIROL, V87, P4360, DOI 10.1128/JVI.02574-12; Bock CT, 2001, J MOL BIOL, V307, P183, DOI 10.1006/jmbi.2000.4481; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1545, DOI 10.1016/j.ijrobp.2008.12.072; Curtil C, 2014, FASEB J, V28, P1454, DOI 10.1096/fj.13-236372; Ducroux A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004343; Galun E, 2000, VIROLOGY, V270, P299, DOI 10.1006/viro.2000.0210; GILLES PN, 1992, J VIROL, V66, P3955, DOI 10.1128/JVI.66.6.3955-3960.1992; GUNTHER S, 1995, J VIROL, V69, P5437; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Hatziapostolou M, 2013, CELL, V28, P152; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hong MH, 2012, TRANSFORMING GROWTH, V7; KAKUMU S, 1991, AM J GASTROENTEROL, V86, P1804; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Kuo TM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-41; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li J, 2002, J VIROL, V76, P5875, DOI 10.1128/JVI.76.12.5875-5881.2002; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Oh MK, 2011, J BIOL CHEM, V286, P8857, DOI 10.1074/jbc.M110.150557; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; Pollicino T, 2011, J VIROL, V85, P432, DOI 10.1128/JVI.01609-10; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Scisciani C, 2012, J HEPATOL, V56, pS18, DOI 10.1016/S0168-8278(12)60055-5; Song LH, 2003, J CLIN VIROL, V28, P93, DOI 10.1016/S1386-6532(02)00271-8; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Tropberger P, 2015, P NATL ACAD SCI US; Waris G, 2002, J VIROL, V76, P2721, DOI 10.1128/JVI.76.6.2721-2729.2002; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P287; Zhang DX, 1996, J BIOL CHEM, V271, P9503, DOI 10.1074/jbc.271.16.9503; Zheng DL, 2009, J HEPATOL, V50, P377, DOI 10.1016/j.jhep.2008.10.019; Zheng YY, 2004, J VIROL, V78, P6908, DOI 10.1128/JVI.78.13.6908-6914.2004	37	51	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142599	10.1371/journal.pone.0142599	http://dx.doi.org/10.1371/journal.pone.0142599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580974	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600049
J	Potter, AW; Gonzalez, JA; Xu, XJ				Potter, Adam W.; Gonzalez, Julio A.; Xu, Xiaojiang			Ebola Response: Modeling the Risk of Heat Stress from Personal Protective Clothing	PLOS ONE			English	Article							LIQUID COOLING SYSTEMS; VIRUS DISEASE; INTERMITTENT; EXERCISE; DESIGN; STRAIN; BODY; EFFICACY; GARMENTS	Introduction A significant number of healthcare workers have responded to aid in the relief and containment of the 2013 Ebola virus disease (EVD) outbreak in West Africa. Healthcare workers are required to wear personal protective clothing (PPC) to impede the transmission of the virus; however, the impermeable design and the hot humid environment lead to risk of heat stress. Objective Provide healthcare workers quantitative modeling and analysis to aid in the prevention of heat stress while wearing PPC in West Africa. Methods A sweating thermal manikin was used to measure the thermal (R-ct) and evaporative resistance (R-et) of the five currently used levels of PPC for healthcare workers in the West Africa EVD response. Mathematical methods of predicting the rise in core body temperature (T-c) in response to clothing, activity, and environment was used to simulate different responses to PPC levels, individual body sizes, and two hot humid conditions: morning/evening (air temperature: 25 degrees C, relative humidity: 40%, mean radiant temperature: 35 degrees C, wind velocity: 1 m/s) and mid-day (30 degrees C, 60%, 70 degrees C, 1 m/s). Results Nearly still air (0.4 m/s) measures of Rct ranged from 0.18 to 0.26 m(2) K/W and R-et ranged from 25.53 to 340.26 m(2) Pa/W. Conclusion Biophysical assessments and modeling in this study provide quantitative guidance for prevention of heat stress of healthcare workers wearing PPC responding to the EVD outbreak in West Africa.	[Potter, Adam W.; Gonzalez, Julio A.; Xu, Xiaojiang] US Army, Biophys & Biomed Modeling Div, Environm Med Res Inst, Natick, MA 01760 USA		Potter, AW (corresponding author), US Army, Biophys & Biomed Modeling Div, Environm Med Res Inst, Natick, MA 01760 USA.	adam.w.potter.civ@mail.mil	Potter, Adam/D-9893-2014	Potter, Adam/0000-0003-4980-8353				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; American Society of Testing and Materials International (ASTM), 2010, F237010 ASTM; American Society of Testing and Materials International (ASTM), 2010, F129110 ASTM; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Cadarette BC, 1991, T1491 UR ARM RES I E; Cadarette BS, 2006, ERGONOMICS, V49, P209, DOI 10.1080/00140130500436106; Cadarette BS, 2003, AIHA J, V64, P510, DOI 10.1080/15428110308984847; Cadarette BS, 2002, AVIAT SPACE ENVIR MD, V73, P665; Cadarette BS, 2001, AVIAT SPACE ENVIR MD, V72, P32; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Cheuvront SN, 2003, J APPL PHYSIOL, V94, P1841, DOI 10.1152/japplphysiol.00912.2002; Chinevere TD, 2008, EUR J APPL PHYSIOL, V103, P307, DOI 10.1007/s00421-008-0707-9; Department of the Army, 2003, TECHN MED B MED TB M; Flouris AD, 2006, ANN BIOMED ENG, V34, P359, DOI 10.1007/s10439-005-9061-9; GIVONI B, 1972, J APPL PHYSIOL, V32, P812, DOI 10.1152/jappl.1972.32.6.812; Goldman R. F., 2001, MED ASPECTS HARSH EN, V1, P3; Kuklane K, 2015, ANN OCCUP HYG, V59, P258, DOI 10.1093/annhyg/mev003; McEntire SJ, 2013, PREHOSP EMERG CARE, V17, P241, DOI 10.3109/10903127.2012.749965; Nielsen C. F., 2015, MMWR SURVEILL SUMM, V64, P1; NUNNELEY SA, 1970, SPACE LIFE SCI, V2, P335, DOI 10.1007/BF00929293; Parsons Ken., 2002, HUMAN THERMAL ENV EF, V3rd; Potter AW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132698; Potter AW, 2015, TECHNICAL REPORT, pT15; Roberts I, 2014, LANCET, V384, P2001, DOI 10.1016/S0140-6736(14)62316-3; Sawka MN, 2001, MED SCI SPORT EXER, V33, P422, DOI 10.1097/00005768-200103000-00014; SHVARTZ E, 1974, AEROSPACE MED, V45, P711; Tharion W., 2013, J SPORT HUM PERF, V1, P14; World Health Organization, 2015, EB SIT REP 8 JUL 201; Xu XJ, 2006, AVIAT SPACE ENVIR MD, V77, P644; Xu XJ, 2011, EUR J APPL PHYSIOL, V111, P3155, DOI 10.1007/s00421-011-1941-0; Xu XJ, 2004, AVIAT SPACE ENVIR MD, V75, P1065; Xu XJ, 1999, ERGONOMICS, V42, P282, DOI 10.1080/001401399185658	32	26	26	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143461	10.1371/journal.pone.0143461	http://dx.doi.org/10.1371/journal.pone.0143461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575389	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400062
J	Pan, JQ; Wang, H; Liu, X; Hu, JL; Song, WJ; Luo, J; Jiang, S; Yan, F; Zhai, BJ				Pan, Jianqing; Wang, Hao; Liu, Xinmin; Hu, Jiliang; Song, Weijian; Luo, Jie; Jiang, Shan; Yan, Fei; Zhai, Baojin			Tumor Restrictive Suicide Gene Therapy for Glioma Controlled by the FOS Promoter	PLOS ONE			English	Article							C-FOS; ONCOLYTIC ADENOVIRUSES; MALIGNANT GLIOMAS; CANCER CELLS; IN-VIVO; CARCINOMA; EXPRESSION; PROTEIN; OVARIAN; TUMORIGENESIS	Effective suicide gene delivery and expression are crucial to achieving successful effects in gene therapy. An ideal tumor-specific promoter expresses therapeutic genes in tumor cells with minimal normal tissue expression. We compared the activity of the FOS (FBJ murine osteosarcoma viral oncogene homolog) promoter with five alternative tumor-specific promoters in glioma cells and non-malignant astrocytes. The FOS promoter caused significantly higher transcriptional activity in glioma cell lines than all alternative promoters with the exception of CMV. The FOS promoter showed 13.9%, 32.4%, and 70.8% of the transcriptional activity of CMV in three glioma cell lines (U87, U251, and U373). Importantly, however, the FOS promoter showed only 1.6% of the transcriptional activity of CMV in normal astrocytes. We also tested the biologic activity of recombinant adenovirus containing the suicide gene herpes simplex virus thymidine kinase (HSV-tk) driven by the FOS promoter, including selective killing efficacy in vitro and tumor inhibition rate in vivo. Adenoviral-mediated delivery of the HSV-tk gene controlled by the FOS promoter conferred a cytotoxic effect on human glioma cells in vitro and in vivo. This study suggests that use of the FOS-tk adenovirus system is a promising strategy for glioma-specific gene therapy but still much left for improvement.	[Pan, Jianqing; Liu, Xinmin; Song, Weijian; Luo, Jie; Zhai, Baojin] Guangdong Med Coll, Affiliated Shenzhen Nanshan Hosp, Stroke Ctr, Shenzhen, Guangdong, Peoples R China; [Pan, Jianqing] Shenzhen Univ, Dept Neurol, Affiliated Shenzhen Nanshan Hosp, Shenzhen, Guangdong, Peoples R China; [Wang, Hao; Hu, Jiliang] Jinan Univ, Shenzhen Peoples Hosp, Dept Neurosurg, Shenzhen, Guangdong, Peoples R China; [Jiang, Shan] Shenzhen Univ, Inst Adv Study, Shenzhen, Guangdong, Peoples R China; [Yan, Fei] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Guangdong, Peoples R China	Guangdong Medical University; Shenzhen University; Jinan University; Shenzhen University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Pan, JQ (corresponding author), Guangdong Med Coll, Affiliated Shenzhen Nanshan Hosp, Stroke Ctr, Shenzhen, Guangdong, Peoples R China.	panjianqingsz@163.com; hujiliangsz@163.com			National Natural Science Foundation of China [81000595]; Shenzhen Governmental Basic Research Grants [JCYJ20130402113127527, JCYJ20130402151227178, JCYJ 20140416122812008, JCYJ20140828163633987, JCYJ20150402152130184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Governmental Basic Research Grants	The work was supported by the National Natural Science Foundation of China (81000595), and the Shenzhen Governmental Basic Research Grants (JCYJ20130402113127527, JCYJ20130402151227178, JCYJ 20140416122812008, JCYJ20140828163633987, JCYJ20150402152130184).	Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Bauerschmitz GJ, 2006, MOL THER, V14, P164, DOI 10.1016/j.ymthe.2006.01.010; Bi JX, 2003, BIOTECHNOL BIOENG, V81, P848, DOI 10.1002/bit.10530; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BLAND KI, 1995, ANN SURG, V221, P706, DOI 10.1097/00000658-199506000-00010; Bo YL, 2013, J NEURO-ONCOL, V112, P27, DOI 10.1007/s11060-012-1033-y; Chakraborty S, 2014, J BIOL CHEM, V289, P29074, DOI 10.1074/jbc.M114.564872; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Grundker C, 2004, EUR J ENDOCRINOL, V151, P619, DOI 10.1530/eje.0.1510619; Hashimoto Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039292; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Jin SP, 2007, PATHOL ONCOL RES, V13, P284, DOI 10.1007/BF02940306; Li W, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-547; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Pacholska A, 2012, CANCER GENE THER, V19, P870, DOI 10.1038/cgt.2012.76; Rojas JJ, 2009, GENE THER, V16, P1441, DOI 10.1038/gt.2009.103; Ryu CH, 2012, BIOCHEM BIOPH RES CO, V421, P585, DOI 10.1016/j.bbrc.2012.04.050; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Tao T, 2013, EUR J CANCER, V49, P3055, DOI 10.1016/j.ejca.2013.05.010; Wang WG, 2014, ONCOTARGET, V5, P150, DOI 10.18632/oncotarget.1430; Yamamoto S, 2003, CANCER GENE THER, V10, P179, DOI 10.1038/sj.cgt.7700551; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Zheng Y, 2014, ASIAN PAC J TROP MED, V7, P761, DOI 10.1016/S1995-7645(14)60132-2; Ziller C, 2004, CANCER LETT, V212, P43, DOI 10.1016/j.canlet.2004.03.048	25	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143112	10.1371/journal.pone.0143112	http://dx.doi.org/10.1371/journal.pone.0143112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571389	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700138
J	Durning, SP; Flanagan-Steet, H; Prasad, N; Wells, L				Durning, Sean P.; Flanagan-Steet, Heather; Prasad, Nripesh; Wells, Lance			O-Linked beta-N-acetylglucosamine (O-GlcNAc) Acts as a Glucose Sensor to Epigenetically Regulate the Insulin Gene in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCYTOPLASMIC PROTEINS; HISTONE MODIFICATIONS; CYTOPLASMIC PROTEINS; RIBOSOMAL-PROTEINS; MASS-SPECTROMETRY; BINDING-PROTEINS; STRESS-RESPONSE; MESSENGER-RNA; GLYCOSYLATION; GLCNACYLATION	The post-translational protein modification O-linked beta-N-acetylglucosamine (O-GlcNAc) is a proposed nutrient sensor that has been shown to regulate multiple biological pathways. This dynamic and inducible enzymatic modification to intracellular proteins utilizes the end product of the nutrient sensing hexosamine biosynthetic pathway, UDP-GlcNAc, as its substrate donor. Type II diabetic patients have elevated O-GlcNAc-modified proteins within pancreatic beta cells due to chronic hyperglycemia-induced glucose overload, but a molecular role for O-GlcNAc within beta cells remains unclear. Using directed pharmacological approaches in the mouse insulinoma-6 (Min6) cell line, we demonstrate that elevating nuclear O-GlcNAc increases intracellular insulin levels and preserves glucose-stimulated insulin secretion during chronic hyperglycemia. The molecular mechanism for these observed changes appears to be, at least in part, due to elevated O-GlcNAc-dependent increases in Ins1 and Ins2mRNA levels via elevations in histone H3 transcriptional activation marks. Furthermore, RNA deep sequencing reveals that this mechanism of altered gene transcription is restricted and that the majority of genes regulated by elevated O-GlcNAc levels are similarly regulated by a shift from euglycemic to hyperglycemic conditions. These findings implicate the O-GlcNAc modification as a potential mechanism for hyperglycemic-regulated gene expression in the beta cell.	[Durning, Sean P.; Flanagan-Steet, Heather; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Prasad, Nripesh] Genom Serv Lab, HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Durning, Sean P.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	University System of Georgia; University of Georgia; HudsonAlpha Institute for Biotechnology; Yale University	Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	lwells@ccrc.uga.edu		Prasad, Nripesh/0000-0003-4074-2538; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [P41GM103490, U01CA128454]; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41GM103490 and U01CA128454 (both to L. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Babaya N, 2006, DIABETOLOGIA, V49, P1222, DOI 10.1007/s00125-006-0241-4; BECKNIELSEN H, 1988, DIABETES, V37, P730, DOI 10.2337/diabetes.37.6.730; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Bucher K, 2000, DEV BIOL, V227, P533, DOI 10.1006/dbio.2000.9920; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799; COLELLA RM, 1987, METABOLISM, V36, P335, DOI 10.1016/0026-0495(87)90203-4; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Dassanayaka S, 2014, PHARMACOL THERAPEUT, V142, P62, DOI 10.1016/j.pharmthera.2013.11.005; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2006, J AM CHEM SOC, V128, P16484, DOI 10.1021/ja066743n; Ekanayake D, 2011, EUKARYOT CELL, V10, P1465, DOI 10.1128/EC.05185-11; Fred RG, 2009, MOL CELL ENDOCRINOL, V297, P28, DOI 10.1016/j.mce.2008.06.007; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; HALTIWANGER RS, 1992, BIOCHEM SOC T, V20, P264, DOI 10.1042/bst0200264; HAMMONDS P, 1987, FEBS LETT, V223, P131, DOI 10.1016/0014-5793(87)80523-9; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HART GW, 1989, CIBA F SYMP, V145, P102; Hayakawa K, 2013, J BIOL CHEM, V288, P17099, DOI 10.1074/jbc.M113.455899; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Imadome K, 2008, CANCER BIOL THER, V7, P208, DOI 10.4161/cbt.7.2.5255; Ito R, 2014, GENES CELLS, V19, P52, DOI 10.1111/gtc.12107; JAHR H, 1980, EUR J BIOCHEM, V110, P499, DOI 10.1111/j.1432-1033.1980.tb04892.x; Kochanek Kenneth D, 2015, Natl Vital Stat Rep, V63, P1; Konrad RJ, 2002, INT J MOL MED, V10, P535; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kumar A, 2014, J BIOL CHEM, V289, P13543, DOI 10.1074/jbc.M114.553321; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Marsh SA, 2013, LIFE SCI, V92, P648, DOI 10.1016/j.lfs.2012.06.011; MARSHALL S, 1980, J CLIN INVEST, V66, P763, DOI 10.1172/JCI109914; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; MARUSHIGE K, 1976, P NATL ACAD SCI USA, V73, P3937, DOI 10.1073/pnas.73.11.3937; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Muller II, 2013, DIS MODEL MECH, V6, P332, DOI 10.1242/dmm.010488; NAGAMATSU S, 1992, ENDOCRINOLOGY, V130, P748, DOI 10.1210/en.130.2.748; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Olivier-Van Stichelen S, 2014, FASEB J, V28, P3325, DOI 10.1096/fj.13-243535; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; PERMUTT MA, 1975, FED PROC, V34, P1549; Poitout V, 1996, ANNU REV MED, V47, P69; PORTE D, 1969, J CLIN INVEST, V48, P2309, DOI 10.1172/JCI106197; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Ritz-Laser B, 1999, ENDOCRINOLOGY, V140, P4005, DOI 10.1210/en.140.9.4005; Ruppert V, 2013, GENE, V512, P206, DOI 10.1016/j.gene.2012.10.055; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Skorobogatko Y, 2014, J BIOL CHEM, V289, P3602, DOI 10.1074/jbc.M113.512814; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Soesanto Y, 2011, J BIOL CHEM, V286, P26118, DOI 10.1074/jbc.M111.249508; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang P, 2012, P NATL ACAD SCI USA, V109, P17669, DOI 10.1073/pnas.1205748109; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2002, CHEM REV, V102, P431, DOI 10.1021/cr000406u; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	79	26	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2107	2118		10.1074/jbc.M115.693580	http://dx.doi.org/10.1074/jbc.M115.693580			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26598517	Green Published, hybrid			2022-12-26	WOS:000369610400006
J	Korah, J; Canaff, L; Lebrun, JJ				Korah, Juliana; Canaff, Lucie; Lebrun, Jean-Jacques			The Retinoblastoma Tumor Suppressor Protein (pRb)/E2 Promoter Binding Factor 1 (E2F1) Pathway as a Novel Mediator of TGF beta-induced Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CELL-DEATH; BECLIN 1; REGULATES AUTOPHAGY; EPITHELIAL-CELLS; SELF-DIGESTION; DAP-KINASE; C-MYC; APOPTOSIS; SMAD	TGF beta is a multifunctional cytokine that regulates cell proliferation, cell immortalization, and cell death, acting as a key homeostatic mediator in various cell types and tissues. Autophagy is a programmed mechanism that plays a pivotal role in controlling cell fate and, consequently, many physiological and pathological processes, including carcinogenesis. Although autophagy is often considered a pro-survival mechanism that renders cells viable in stressful conditions and thus might promote tumor growth, emerging evidence suggests that autophagy is also a tumor suppressor pathway. The relationship between TGF beta signaling and autophagy is context-dependent and remains unclear. TGF beta-mediated activation of autophagy has recently been suggested to contribute to the growth inhibitory effect of TGF beta in hepatocarcinoma cells. In the present study, we define a novel process of TGF beta-mediated autophagy in cancer cell lines of various origins. We found that autophagosome initiation and maturation by TGF beta is dependent on the retinoblastoma tumor suppressor protein/E2 promoter binding factor (pRb/E2F1) pathway, which we have previously established as a critical signaling axis leading to various TGF beta tumor suppressive effects. We further determined that TGF beta induces pRb/E2F1-dependent transcriptional activation of several autophagy-related genes. Together, our findings reveal that TGF beta induces autophagy through the pRb/E2F1 pathway and transcriptional activation of autophagy-related genes and further highlight the central relevance of the pRb/E2F1 pathway downstream of TGF beta signaling in tumor suppression.	[Korah, Juliana; Canaff, Lucie; Lebrun, Jean-Jacques] McGill Univ, Ctr Hlth, Dept Med, Canc Res Program, 1001 Decarie Blvd,Bloc E,Suite E02-6224, Montreal, PQ H4A 3J1, Canada	McGill University	Lebrun, JJ (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Canc Res Program, 1001 Decarie Blvd,Bloc E,Suite E02-6224, Montreal, PQ H4A 3J1, Canada.	JJ.Lebrun@mcgill.ca	Lebrun, Jean-Jacques/GNP-5222-2022		Canadian Institutes of Health Research [MOP-114904]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-114904 (to J.-J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dai M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3322; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Francis JM, 2000, J BIOL CHEM, V275, P39137, DOI 10.1074/jbc.M007212200; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gajewska M, 2005, J Physiol Pharmacol, V56 Suppl 3, P143; Godlewski MM, 2007, J PHYSIOL PHARMACOL, V58, P97; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Heidari N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.53; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Jiang H, 2010, CANCER RES, V70, P7882, DOI 10.1158/0008-5472.CAN-10-1604; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Korah J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.146; Kusama Y, 2009, APOPTOSIS, V14, P1165, DOI 10.1007/s10495-009-0390-2; Lebrun JJ, 2012, ISRN MOL BIOL, V2012, DOI [DOI 10.5402/2012/381428, 10.5402/2012/381428]; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JM, 1997, P NATL ACAD SCI USA, V94, P4948, DOI 10.1073/pnas.94.10.4948; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Marquez RT, 2012, AM J CANCER RES, V2, P214; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Shi CS, 2010, AUTOPHAGY, V6, P986, DOI 10.4161/auto.6.7.13288; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Song JR, 2011, J CELL BIOCHEM, V112, P3406, DOI 10.1002/jcb.23274; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Ueno T, 2008, AUTOPHAGY, V4, P692, DOI 10.4161/auto.6085; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Wang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010409; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; White EJ, 2011, AM J CANCER RES, V1, P362; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	68	19	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2043	2054		10.1074/jbc.M115.678557	http://dx.doi.org/10.1074/jbc.M115.678557			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26598524	Green Published, hybrid			2022-12-26	WOS:000369610400001
J	Vaiana, CA; Kurcon, T; Mahal, LK				Vaiana, Christopher A.; Kurcon, Tomasz; Mahal, Lara K.			MicroRNA-424 Predicts a Role for beta-1,4 Branched Glycosylation in Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; GALECTIN-3; ARREST; TRANSFORMATION; PROLIFERATION; EXPRESSION; ANOIKIS; TARGETS; RNA; DNA	MicroRNA regulation of protein expression plays an important role in mediating many cellular processes, from cell proliferation to cell death. The human microRNA miR-424 is up-regulated in response to anti-proliferative cytokines, such as transforming growth factor beta (TGF beta),and directly represses cell cycle progression. Our laboratory recently established that microRNA can be used as a proxy to identify biological roles of glycosylation enzymes (glycogenes). Herein we identify MGAT4A, OGT, and GALNT13 as targets of miR-424. We demonstrate that MGAT4A, an N-acetylglucosaminyltransferase that installs the beta-1,4 branch of N-glycans, is directly regulated by miR-424 in multiple mammary epithelial cell lines and observe the loss of MGAT4A in response to TGF beta, an inducer of miR-424. Knockdown of MGAT4A induces cell cycle arrest through decreasing CCND1 levels. MGAT4A does not affect levels of beta-1,6 branched N-glycans, arguing that this effect is specific to beta-1,4 branching and not due to gross changes in overall N-linked glycosylation. This work provides insight into the regulation of cell cycle progression by specific N-glycan branching patterns.	[Vaiana, Christopher A.; Kurcon, Tomasz; Mahal, Lara K.] NYU, Dept Chem, Inst Biomed Chem, New York, NY 10003 USA	New York University	Mahal, LK (corresponding author), NYU, Dept Chem, 100 Washington Sq East Rm 1001, New York, NY 10003 USA.	lkmahal@nyu.edu	Mahal, Lara/GRY-7287-2022	Mahal, Lara/0000-0003-4791-8524	Margaret Strauss Kramer Fellowship, New York University; Sokol Foundation	Margaret Strauss Kramer Fellowship, New York University; Sokol Foundation	Supported by a Margaret Strauss Kramer Fellowship, New York University.r Supported by the Sokol Foundation. To whom correspondence should be addressed: Dept. of Chemistry, New York University, 100 Washington Square East Rm. 1001, New York, NY. Tel.: 212-998-3533; Fax: 212-9954475; Email:lkmahal@nyu.edu.	Agrawal P, 2014, P NATL ACAD SCI USA, V111, P4338, DOI 10.1073/pnas.1321524111; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Barnes JW, 2015, CIRCULATION, V131, P1260, DOI 10.1161/CIRCULATIONAHA.114.013878; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; CARLBERG M, 1993, ANTICANCER RES, V13, P167; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; CRICK F, 1970, NATURE, V227, P561, DOI 10.1038/227561a0; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Freeze HH, 2014, AM J HUM GENET, V94, P161, DOI 10.1016/j.ajhg.2013.10.024; Guo YJ, 2014, INT J BIOCHEM CELL B, V53, P1, DOI 10.1016/j.biocel.2014.04.012; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Kasper BT, 2014, BIOCHEM BIOPH RES CO, V445, P774, DOI 10.1016/j.bbrc.2014.01.034; Kim HRC, 1999, CANCER RES, V59, P4148; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kurcon T, 2015, P NATL ACAD SCI USA, V112, P7327, DOI 10.1073/pnas.1502076112; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llobet-Navas D, 2014, MOL CELL BIOL, V34, P4216, DOI 10.1128/MCB.00611-14; Llobet-Navas D, 2014, GENE DEV, V28, P765, DOI 10.1101/gad.237404.114; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Oguri S, 2006, GLYCOCONJUGATE J, V23, P473, DOI 10.1007/s10719-006-6216-3; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Rahman AMA, 2015, GLYCOBIOLOGY, V25, P225, DOI 10.1093/glycob/cwu105; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738; Shimura T, 2005, CANCER RES, V65, P3535, DOI 10.1158/0008-5472.CAN-05-0104; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Takamatsu S, 2010, GLYCOBIOLOGY, V20, P485, DOI 10.1093/glycob/cwp200; Takeuchi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135644; Wahlestedt C, 2013, NAT REV DRUG DISCOV, V12, P433, DOI 10.1038/nrd4018; Walsh STR, 2010, BIOCHEMISTRY-US, V49, P8766, DOI 10.1021/bi101050h; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Zhou RW, 2014, NAT IMMUNOL, V15, P1038, DOI 10.1038/ni.3007	47	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1529	1537		10.1074/jbc.M115.672220	http://dx.doi.org/10.1074/jbc.M115.672220			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26589799	hybrid, Green Published			2022-12-26	WOS:000368068300042
J	Deak, VA; Skroblin, P; Dittmayer, C; Knobeloch, KP; Bachmann, S; Klussmann, E				Deak, Veronika Anita; Skroblin, Philipp; Dittmayer, Carsten; Knobeloch, Klaus-Peter; Bachmann, Sebastian; Klussmann, Enno			The A-kinase Anchoring Protein GSKIP Regulates GSK3 beta Activity and Controls Palatal Shelf Fusion in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CLEFT-LIP; BETA-CATENIN; HEMIFACIAL MICROSOMIA; SUBSTRATE-SPECIFICITY; CANONICAL WNT; MOUSE; GENE; PHOSPHORYLATION; PATHWAY	A-kinase anchoring proteins (AKAPs) represent a family of structurally diverse proteins, all of which bind PKA. A member of this family is glycogen synthase kinase 3 beta (GSK3 beta) interaction protein (GSKIP). GSKIP interacts with PKA and also directly interacts with GSK3 beta. The physiological function of the GSKIP protein in vivo is unknown. We developed and characterized a conditional knock-out mouse model and found that GSKIP deficiency caused lethality at birth. Embryos obtained through Caesarean section at embryonic day 18.5 were cyanotic, suffered from respiratory distress, and failed to initiate breathing properly. Additionally, all GSKIP-deficient embryos showed an incomplete closure of the palatal shelves accompanied by a delay in ossification along the fusion area of secondary palatal bones. On the molecular level, GSKIP deficiency resulted in decreased phosphorylation of GSK3 beta at Ser-9 starting early in development (embryonic day 10.5), leading to enhanced GSK3 beta activity. At embryonic day 18.5, GSK3 beta activity decreased to levels close to that of wild type. Our findings reveal a novel, crucial role for GSKIP in the coordination of GSK3 beta signaling in palatal shelf fusion.	[Deak, Veronika Anita; Skroblin, Philipp; Klussmann, Enno] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Dittmayer, Carsten; Bachmann, Sebastian] Charite, Inst Anat, D-10115 Berlin, Germany; [Knobeloch, Klaus-Peter] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Klussmann, Enno] DZHK German Ctr Cardiovasc Res, D-13347 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; German Centre for Cardiovascular Research	Klussmann, E (corresponding author), Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	enno.klussmann@mdc-berlin.de		Deak, Veronika Anita/0000-0001-8454-837X; Skroblin, Philipp/0000-0003-0321-3493; Klussmann, Enno/0000-0003-4004-5003	Else Kroner-Fresenius-Stiftung [2013_A145]; German-Israeli Foundation [G.I.F. I-1210-286.13/2012]	Else Kroner-Fresenius-Stiftung; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by grants from the Else Kroner-Fresenius-Stiftung (2013_A145) (to E. K.), and the German-Israeli Foundation (G.I.F. I-1210-286.13/2012) (to E. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Capra G, 2012, ADV OTO-RHINO-LARYNG, V73, P137, DOI 10.1159/000334471; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chou HY, 2006, BIOCHEMISTRY-US, V45, P11379, DOI 10.1021/bi061147r; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Dema A, 2015, CELL SIGNAL, V27, P2474, DOI 10.1016/j.cellsig.2015.09.008; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Funato Noriko, 2015, World J Biol Chem, V6, P121, DOI 10.4331/wjbc.v6.i3.121; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; He FL, 2010, DEV DYNAM, V239, P3235, DOI 10.1002/dvdy.22466; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hundsrucker C, 2010, J BIOL CHEM, V285, P5507, DOI 10.1074/jbc.M109.047944; Juriloff DM, 2008, BIRTH DEFECTS RES A, V82, P63, DOI 10.1002/bdra.20430; Juriloff DM, 2006, BIRTH DEFECTS RES A, V76, P574, DOI 10.1002/bdra.20302; Juriloff DM, 2005, BIRTH DEFECTS RES A, V73, P103, DOI 10.1002/bdra.20106; Juriloff DM, 1996, MAMM GENOME, V7, P789, DOI 10.1007/s003359900298; Juriloff DM, 2001, MAMM GENOME, V12, P426, DOI 10.1007/s003350010284; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kelberman D, 2001, HUM GENET, V109, P638, DOI 10.1007/s00439-001-0626-x; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kohli Sarvraj Singh, 2012, J Oral Maxillofac Pathol, V16, P64, DOI 10.4103/0973-029X.92976; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Levi B, 2011, ORGANOGENESIS, V7, P242, DOI 10.4161/org.7.4.17926; Lin CC, 2009, J CELL BIOCHEM, V108, P1325, DOI 10.1002/jcb.22362; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Liu Y, 2015, J DENT RES, V94, P961, DOI 10.1177/0022034515583532; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McCormick K, 2014, CURR OPIN GENET DEV, V27, P20, DOI 10.1016/j.gde.2014.02.001; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nelson ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025847; Peker T., 1995, GAZI MED J, V6, P55; POOLE MD, 1989, WORLD J SURG, V13, P396, DOI 10.1007/BF01660752; Sadot E, 2002, J CELL SCI, V115, P2771; Saliba J, 2015, NAT GENET, V47, P1131, DOI 10.1038/ng.3380; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shetty NB, 2014, J CLIN DIAGN RES, V8, P283, DOI 10.7860/JCDR/2014/6220.4188; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Song LY, 2009, DEVELOPMENT, V136, P3161, DOI 10.1242/dev.037440; Spittaels K, 2002, NEUROSCIENCE, V113, P797, DOI 10.1016/S0306-4522(02)00236-1; Steinberg B, 2012, J ORAL MAXIL SURG, V70, pE137, DOI 10.1016/j.joms.2012.07.034; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Yang Y, 2006, J BIOL CHEM, V281, P22352, DOI 10.1074/jbc.M603626200	50	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					681	690		10.1074/jbc.M115.701177	http://dx.doi.org/10.1074/jbc.M115.701177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582204	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000367830500017
J	Alves, CH; Ober-Blobaum, JL; Brouwers-Haspels, I; Asmawidjaja, PS; Mus, AMC; Razawy, W; Molendijk, M; Clausen, BE; Lubberts, E				Alves, C. Henrique; Ober-Blobaum, Julia L.; Brouwers-Haspels, Inge; Asmawidjaja, Patrick S.; Mus, Adriana M. C.; Razawy, Wida; Molendijk, Marlieke; Clausen, Bjorn E.; Lubberts, Erik			Dendritic Cell-Specific Deletion of beta-Catenin Results in Fewer Regulatory T-Cells without Exacerbating Autoimmune Collagen-Induced Arthritis	PLOS ONE			English	Article							BONE EROSION; RESPONSES; ACTIVATION; EXPRESSION; INDUCTION; IMMUNE; JOINT; WNT; OSTEOCLASTOGENESIS; INFLAMMATION	Dendritic cells (DCs) are professional antigen presenting cells that have the dual ability to stimulate immunity and maintain tolerance. However, the signalling pathways mediating tolerogenic DC function in vivo remain largely unknown. The beta-catenin pathway has been suggested to promote a regulatory DC phenotype. The aim of this study was to unravel the role of beta-catenin signalling to control DC function in the autoimmune collagen-induced arthritis model (CIA). Deletion of beta-catenin specifically in DCs was achieved by crossing conditional knockout mice with a CD11c-Cre transgenic mouse line. Bone marrow-derived DCs (BMDCs) were generated and used to study the maturation profile of these cells in response to a TLR2 or TLR4 ligand stimulation. CIA was induced by intra-dermal immunization with 100 mu g chicken type II collagen in complete Freund's adjuvant on days 0 and 21. CIA incidence and severity was monitored macroscopically and by histology. The T cell profile as well as their cytokine production were analysed by flow cytometry. Lack of beta-catenin specifically in DCs did not affect the spontaneous, TLR2- or TLR4-induced maturation and activation of BMDCs or their cytokine production. Moreover, no effect on the incidence and severity of CIA was observed in mice lacking beta-catenin in CD11c(+) cells. A decreased frequency of splenic CD3(+) CD8(+) T cells and of regulatory T cells (Tregs) (CD4(+)CD25(high)FoxP3(+)), but no changes in the frequency of splenic Th17 (CCR6(+)CXCR3(-)CCR4(+)), Th2 (CCR6(-)CXCR3(-)CCR4(+)) and Th1 (CCR6(-)CXCR3(+)CCR4(-)) cells were observed in these mice under CIA condition. Furthermore, the expression of IL-17A, IL-17F, IL-22, IL-4 or IFN gamma was also not affected. Our data indicate that ablation of beta-catenin expression in DCs did not alter the course and severity of CIA. We conclude that although deletion of beta-catenin resulted in a lower frequency of Tregs, this decrease was not sufficient to aggravate the onset and severity of CIA.	[Alves, C. Henrique; Brouwers-Haspels, Inge; Asmawidjaja, Patrick S.; Mus, Adriana M. C.; Razawy, Wida; Molendijk, Marlieke; Lubberts, Erik] Erasmus MC, Univ Med Ctr, Dept Rheumatol, Rotterdam, Netherlands; [Alves, C. Henrique; Brouwers-Haspels, Inge; Asmawidjaja, Patrick S.; Mus, Adriana M. C.; Razawy, Wida; Molendijk, Marlieke; Clausen, Bjorn E.; Lubberts, Erik] Erasmus MC, Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands; [Ober-Blobaum, Julia L.; Clausen, Bjorn E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Johannes Gutenberg University of Mainz	Clausen, BE (corresponding author), Erasmus MC, Univ Med Ctr, Dept Immunol, Rotterdam, Netherlands.	bclausen@uni-mainz.de; e.lubberts@erasmusmc.nl	CLAUSEN, Björn Erik/A-8229-2010; Lubberts, Erik/AAI-4657-2020; Alves, Henrique/AAH-3017-2019	CLAUSEN, Björn Erik/0000-0002-2484-7842; Alves, Henrique/0000-0001-9776-5701	Dutch Arthritis Association (Reumafonds) [11-1-306]	Dutch Arthritis Association (Reumafonds)	Funding: This work was supported by a grant from the Dutch Arthritis Association (Reumafonds, no. 11-1-306) to BEC and EL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini A, 2011, CELL IMMUNOL, V270, P114, DOI 10.1016/j.cellimm.2011.04.007; Brault V, 2001, DEVELOPMENT, V128, P1253; Campbell IK, 2000, EUR J IMMUNOL, V30, P1568, DOI 10.1002/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Corneth OBJ, 2014, ARTHRITIS RHEUMATOL, V66, P340, DOI 10.1002/art.38229; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; Fu CM, 2010, IMMUNOL RES, V46, P72, DOI 10.1007/s12026-009-8126-5; Hong Y, 2015, CANCER RES, V75, P656, DOI 10.1158/0008-5472.CAN-14-2377; Isaacs JD, 2010, NAT REV IMMUNOL, V10, P605, DOI 10.1038/nri2804; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kelchtermans H, 2005, ARTHRITIS RES THER, V7, pR402, DOI 10.1186/ar1500; Kong N, 2012, ANN RHEUM DIS, V71, P1567, DOI 10.1136/annrheumdis-2011-201052; Leung BP, 2002, J IMMUNOL, V169, P7071, DOI 10.4049/jimmunol.169.12.7071; Liang XJ, 2014, J LEUKOCYTE BIOL, V95, P179, DOI 10.1189/jlb.0613330; Lim DS, 2009, EUR J IMMUNOL, V39, P1334, DOI 10.1002/eji.200838987; Liu Y, 2014, CLIN REV ALLERG IMMU, V47, P136, DOI 10.1007/s12016-013-8402-y; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manoharan I, 2014, J IMMUNOL, V193, P4203, DOI 10.4049/jimmunol.1400614; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mellman I, 2010, SCIENCE, V329, P767, DOI 10.1126/science.1194185; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Nakamura Y, 2005, AM J PATHOL, V167, P97, DOI 10.1016/S0002-9440(10)62957-4; O'Garra A, 1998, CURR BIOL, V8, pR646, DOI 10.1016/S0960-9822(07)00413-7; Pan M, 2004, J CLIN IMMUNOL, V24, P481, DOI 10.1023/B:JOCI.0000040919.16739.44; Ren YN, 2014, INT IMMUNOPHARMACOL, V21, P247, DOI 10.1016/j.intimp.2014.05.004; Salazar L, 2008, ANN RHEUM DIS, V67, P1235, DOI 10.1136/ard.2007.072199; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Suryawanshi A, 2015, J IMMUNOL, V194, P3295, DOI 10.4049/jimmunol.1402691; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tanaka I, 2005, BIOCHEM BIOPH RES CO, V334, P973, DOI 10.1016/j.bbrc.2005.06.196; van Hamburg JP, 2009, ARTHRITIS RHEUM-US, V60, P750, DOI 10.1002/art.24329; VANDERLUGT B, 2011, PLOS ONE, V0006; Yago T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2297	38	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142972	10.1371/journal.pone.0142972	http://dx.doi.org/10.1371/journal.pone.0142972			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587585	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500027
J	Fritsch, M; Schmidt, N; Groticke, I; Frisk, AL; Keator, CS; Koch, M; Slayden, OD				Fritsch, Martin; Schmidt, Nicole; Groeticke, Ina; Frisk, Anna-Lena; Keator, Christopher S.; Koch, Markus; Slayden, Ov D.			Application of a Patient Derived Xenograft Model for Predicative Study of Uterine Fibroid Disease	PLOS ONE			English	Article							MENSTRUAL-CYCLE; REPRODUCTIVE-TRACT; LEIOMYOMAS; PROGESTERONE; EXPRESSION; GROWTH; ESTROGEN; GENE; RECEPTORS; PROLIFERATION	Human uterine fibroids, benign tumors derived from the smooth muscle layers of the uterus, impose a major health burden to up to 50% of premenopausal women in their daily life. To improve our understanding of this disease, we developed and characterized a patient-derived xenograft model by subcutaneous transplantation of pieces of human uterine fibroid tissue into three different strains of severe combined immunodeficient mice. Engrafted uterine fibroid tissue preserved the classical morphology with interwoven bundles of smooth muscle cells and an abundant deposition of collagenous matrix, similar to uterine fibroids in situ. The grafts expressed both estrogen receptor 1 and progesterone receptor. Additionally, both receptors were up-regulated by estrogen treatment. Growth of the fibroid grafts was dependent on 17 beta-estradiol and progesterone supplementation at levels similar to women with the disease and was studied for up to 60 days at maximum. Co-treatment with the antiprogestin mifepristone reduced graft growth (four independent donors, p<0.0001 two-sided t-test), as did treatment with the mTOR inhibitor rapamycin (three independent donors, p<0.0001 two-sided t-test). This in vivo animal model preserves the main histological and functional characteristics of human uterine fibroids, is amenable to intervention by pharmacological treatment, and can thus serve as an adequate model for the development of novel therapies.	[Fritsch, Martin; Schmidt, Nicole; Groeticke, Ina; Frisk, Anna-Lena; Koch, Markus] Bayer Pharma AG, Global Drug Discovery, Berlin, Germany; [Keator, Christopher S.; Slayden, Ov D.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	Bayer AG; Bayer Healthcare Pharmaceuticals; Oregon Health & Science University; Oregon National Primate Research Center	Fritsch, M (corresponding author), Bayer Pharma AG, Global Drug Discovery, Berlin, Germany.	martin.fritsch@bayer.com			Bayer Pharma AG; Oregon Science and Health University Primate Center [P51OD011092]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Bayer Pharma AG; Oregon Science and Health University Primate Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was supported by Bayer Pharma AG. The funder provided support in the form of salaries for the authors (MF, NS, IG, ALF and MK) at the time this work was conducted. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. ODS and CSK were supported by a core grant of the Oregon Science and Health University Primate Center (Grant number P51OD011092). The specific role of each author is articulated in the "authors contributions" section.	Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Baird DD, 2011, FERTIL STERIL, V95, P242, DOI 10.1016/j.fertnstert.2010.05.011; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Borkowska J, 2011, INT J DERMATOL, V50, P13, DOI 10.1111/j.1365-4632.2010.04727.x; Brosens I, 1998, FERTIL STERIL, V69, P232, DOI 10.1016/S0015-0282(97)00472-X; Cai SL, 2003, AM J PATHOL, V162, P457, DOI 10.1016/S0002-9440(10)63840-0; Cai YR, 2007, INT J ONCOL, V31, P1379; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; Chu PG, 2001, MODERN PATHOL, V14, P465, DOI 10.1038/modpathol.3880335; Crabtree JS, 2009, CANCER RES, V69, P6171, DOI 10.1158/0008-5472.CAN-08-4471; CRAMER SF, 1985, OBSTET GYNECOL, V66, P36; Downes E, 2010, EUR J OBSTET GYN R B, V152, P96, DOI 10.1016/j.ejogrb.2010.05.012; EVERITT JI, 1995, AM J PATHOL, V146, P1556; Gibbs LK, 2007, J AM ASSOC LAB ANIM, V46, P61; Gupta S, 2008, BEST PRACT RES CL OB, V22, P615, DOI 10.1016/j.bpobgyn.2008.01.008; Hassan MH, 2011, HUM REPROD, V26, P3008, DOI 10.1093/humrep/der280; Hassan MH, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.02.010; Hennig Y, 1999, MOL HUM REPROD, V5, P1150, DOI 10.1093/molehr/5.12.1150; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Jacobson GF, 2006, OBSTET GYNECOL, V107, P1278, DOI 10.1097/01.AOG.0000210640.86628.ff; Jacobson GF, 2007, AM J OBSTET GYNECOL, V196, P601, DOI 10.1016/j.ajog.2007.03.009; KAWAGUCHI K, 1991, VIRCHOWS ARCH A, V419, P309, DOI 10.1007/BF01606522; KAWAGUCHI K, 1989, AM J OBSTET GYNECOL, V160, P637, DOI 10.1016/S0002-9378(89)80046-8; Klemke M, 2010, CANCER GENET CYTOGEN, V196, P119, DOI 10.1016/j.cancergencyto.2009.09.021; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Lee BS, 1998, J CLIN ENDOCR METAB, V83, P219, DOI 10.1210/jc.83.1.219; Leppert PC, 2004, FERTIL STERIL, V82, P1182, DOI 10.1016/j.fertnstert.2004.04.030; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; MATSUSHITA K, 1984, UROL INT, V39, P303, DOI 10.1159/000280998; Mavrelos D, 2010, ULTRASOUND OBST GYN, V35, P238, DOI 10.1002/uog.7482; Mayer A, 2008, CANCER RES, V68, P4719, DOI 10.1158/0008-5472.CAN-07-6339; MURPHY AA, 1994, CURR OPIN OBSTET GYN, V6, P269; Peddada SD, 2008, P NATL ACAD SCI USA, V105, P19887, DOI 10.1073/pnas.0808188105; Rammeh-Rommani S, 2005, J Gynecol Obstet Biol Reprod (Paris), V34, P568; RYAN KD, 1980, ENDOCRINOLOGY, V106, P959, DOI 10.1210/endo-106-3-959; Severino MF, 1996, MOL HUM REPROD, V2, P823, DOI 10.1093/molehr/2.11.823; Shimomura Y, 1998, J CLIN ENDOCR METAB, V83, P2192, DOI 10.1210/jc.83.6.2192; Slayden OD, 2004, ARCH HISTOL CYTOL, V67, P393, DOI 10.1679/aohc.67.393; Stewart L, 2008, ARCH DERMATOL, V144, P1584, DOI 10.1001/archdermatol.2008.517; Stricker R, 2006, CLIN CHEM LAB MED, V44, P883, DOI 10.1515/CCLM.2006.160; Tsuiji K, 2010, TOHOKU J EXP MED, V222, P55, DOI 10.1620/tjem.222.55; Wagenfeld A, 2013, HUM REPROD, V28, P2253, DOI 10.1093/humrep/det247; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; Watanabe K, 2006, HISTOPATHOLOGY, V48, P563, DOI 10.1111/j.1365-2559.2006.02368.x; Wu XX, 2000, ACTA OBSTET GYN SCAN, V79, P397, DOI 10.1034/j.1600-0412.2000.079005397.x; Zaitseva M, 2006, MOL HUM REPROD, V12, P187, DOI 10.1093/molehr/gal018; Zhai YL, 1999, INT J GYNECOL PATHOL, V18, P20, DOI 10.1097/00004347-199901000-00004	47	12	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142429	10.1371/journal.pone.0142429	http://dx.doi.org/10.1371/journal.pone.0142429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588841	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500010
J	Dick, DG; Maxwell, EE				Dick, Daniel G.; Maxwell, Erin E.			Ontogenetic Tooth Reduction in Stenopterygius quadriscissus (Reptilia: Ichthyosauria): Negative Allometry, Changes in Growth Rate, and Early Senescence of the Dental Lamina	PLOS ONE			English	Article							TEETH; SIZE; DIFFERENTIATION	We explore the functional, developmental, and evolutionary processes which are argued to produce tooth reduction in the extinct marine reptile Stenopterygius quadriscissus (Reptilia: Ichthyosauria). We analyze the relationship between mandible growth and tooth size, shape, and count, to establish an ontogenetic trend. The pattern in S. quadriscissus is consistent with hypotheses of tooth size reduction by neutral selection, and this unusual morphology (a functionally edentulous rostrum) was produced by a series of different evolutionary developmental changes that are known for other taxa showing tooth reduction and loss. Specifically, this species evolved functional edentulism by evolutionary changes in the growth allometry of the dentition and by altering growth rates through ontogeny. This observation supports previous hypotheses that S. quadriscissus underwent ontogenetic tooth reduction. Tooth reduction in S. quadriscissus may be caused by unique selective pressures resulting from prey choice and feeding behavior, expanding our current understanding of the mechanisms producing tooth reduction.	[Dick, Daniel G.; Maxwell, Erin E.] Staatl Museum Nat Kunde Stuttgart, Dept Paleontol, Stuttgart, Germany; [Dick, Daniel G.] Univ Tubingen, Dept Geosci, Tubingen, Germany	Eberhard Karls University of Tubingen	Dick, DG (corresponding author), Staatl Museum Nat Kunde Stuttgart, Dept Paleontol, Stuttgart, Germany.	daniel.dick@smns-bw.de		Maxwell, Erin/0000-0002-6032-6251	Staatliches Museum fur Naturkunde Stuttgart	Staatliches Museum fur Naturkunde Stuttgart	The authors were funded by the Staatliches Museum fur Naturkunde Stuttgart. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armfield BA, 2013, PEERJ, V1, DOI 10.7717/peerj.24; Bottcher VR, 1989, STUTTGARTER BEITR GE, V155, P1; Brown CM, 2015, J ANAT, V226, P322, DOI 10.1111/joa.12280; Davit-Beal T, 2009, J ANAT, V214, P477, DOI 10.1111/j.1469-7580.2009.01060.x; Etter Walter, 2002, P265; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris MP, 2006, CURR BIOL, V16, P371, DOI 10.1016/j.cub.2005.12.047; Helidoniotis F, 2011, FISH RES, V112, P13, DOI 10.1016/j.fishres.2011.08.005; Heyning J. E., 1996, NATURAL HIST MUSEUM, V464, P1; Keller T., 1976, NEUE JB GEOL PALAONT, V5, P266; Kelley NP, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0709; Lainoff AJ, 2015, J EXP ZOOL PART B, V324, P255, DOI 10.1002/jez.b.22594; Louchart A, 2011, TRENDS ECOL EVOL, V26, P663, DOI 10.1016/j.tree.2011.09.004; Maisch Michael W., 2008, Palaeodiversity, P227; Mascaro J, 2014, BIOL J LINN SOC, V111, P230, DOI 10.1111/bij.12177; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; Maxwell EE, 2007, J MORPHOL, V268, P423, DOI 10.1002/jmor.10527; Maxwell EE, 2012, J PALEONTOL, V86, P105, DOI 10.1666/11-038.1; Mazin J.-M., 1983, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1983, P406; MCGOWAN C, 1979, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V166, P93; MCGOWAN C., 2003, HDB PALEOHERPETOLOGY; MEAD JG, 1975, J MAMMAL, V56, P213, DOI 10.2307/1379619; Mehrazarin S, 2011, J ENDODONT, V37, P662, DOI 10.1016/j.joen.2011.02.009; Meredith RW, 2014, SCIENCE, V346, P1336, DOI 10.1126/science.1254390; Motani R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066075; Nicholls E.L., 1997, ANCIENT MARINE REPTI; Peters H, 1999, TRENDS GENET, V15, P59, DOI 10.1016/S0168-9525(98)01662-X; Plikus MV, 2005, EVOL DEV, V7, P440, DOI 10.1111/j.1525-142X.2005.05048.x; Pollard J. E., 1968, Palaeontology, V11, P376; Rohl HJ, 2005, SOC SEDIMENT GEOL SP, V82, P165; Sander PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019480; Taper ML, 2004, NATURE OF SCIENTIFIC EVIDENCE, P488; Tokita M, 2013, EVOLUTION, V67, P260, DOI 10.1111/j.1558-5646.2012.01752.x; Urlichs Max, 1994, Stuttgarter Beitraege zur Naturkunde Serie C (Allgemeinverstaendliche Aufsaetze), V36, P1; Weidert W. K., 1990, KLASSISCHE FUNDSTELL, V2, P107; Werth A, 2000, FEEDING FORM FUNCTIO; Wurstemberger A, 1876, JAHRESHEFTE VEREINS, V32, P192	38	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141904	10.1371/journal.pone.0141904	http://dx.doi.org/10.1371/journal.pone.0141904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579712	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600025
J	Presutti, D; Santini, S; Cardinali, B; Papoff, G; Lalli, C; Samperna, S; Fustaino, V; Giannini, G; Ruberti, G				Presutti, Dario; Santini, Simonetta; Cardinali, Beatrice; Papoff, Giuliana; Lalli, Cristiana; Samperna, Simone; Fustaino, Valentina; Giannini, Giuseppe; Ruberti, Giovina			MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE-KINASE INHIBITORS; SMALL-MOLECULE INHIBITOR; LUNG-CANCER PATIENTS; ACQUIRED-RESISTANCE; GEFITINIB TREATMENT; SOMATIC MUTATIONS; DRUG-RESISTANCE; KRAS MUTATION; AXL KINASE	Epidermal growth factor receptor (EGFR), member of the human epidermal growth factor receptor (HER) family, plays a critical role in regulating multiple cellular processes including proliferation, differentiation, cell migration and cell survival. Deregulation of the EGFR signaling has been found to be associated with the development of a variety of human malignancies including lung, breast, and ovarian cancers, making inhibition of EGFR the most promising molecular targeted therapy developed in the past decade against cancer. Human non small cell lung cancers (NSCLC) with activating mutations in the EGFR gene frequently experience significant tumor regression when treated with EGFR tyrosine kinase inhibitors (TKIs), although acquired resistance invariably develops. Resistance to TKI treatments has been associated to secondary mutations in the EGFR gene or to activation of additional bypass signaling pathways including the ones mediated by receptor tyrosine kinases, Fas receptor and NF-kappa B. In more than 30-40% of cases, however, the mechanisms underpinning drug-resistance are still unknown. The establishment of cellular and mouse models can facilitate the unveiling of mechanisms leading to drug-resistance and the development or validation of novel therapeutic strategies aimed at overcoming resistance and enhancing outcomes in NSCLC patients. Here we describe the establishment and characterization of EGFR TKI-resistant NSCLC cell lines and a pilot study on the effects of a combined MET and EGFR inhibitors treatment. The characterization of the erlotinib-resistant cell lines confirmed the association of EGFR TKI resistance with loss of EGFR gene amplification and/or AXL overexpression and/or MET gene amplification and MET receptor activation. These cellular models can be instrumental to further investigate the signaling pathways associated to EGFR TKI-resistance. Finally the drugs combination pilot study shows that MET gene amplification and MET receptor activation are not sufficient to predict a positive response of NSCLC cells to a cocktail of MET and EGFR inhibitors and highlights the importance of identifying more reliable biomarkers to predict the efficacy of treatments in NSCLC patients resistant to EGFR TKI.	[Presutti, Dario; Santini, Simonetta; Cardinali, Beatrice; Papoff, Giuliana; Lalli, Cristiana; Samperna, Simone; Fustaino, Valentina; Ruberti, Giovina] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Giannini, Giuseppe] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Sapienza University Rome	Ruberti, G (corresponding author), CNR, Inst Cell Biol & Neurobiol, Campus Adriano Buzzati Traverso, Rome, Italy.	giovina.ruberti@cnr.it	PAPOFF, GIULIANA/AAX-9520-2020; Cardinali, Beatrice/M-8862-2015; Giannini, Giuseppe/B-5672-2013	PAPOFF, GIULIANA/0000-0003-2251-8794; Cardinali, Beatrice/0000-0002-3333-3384; Giannini, Giuseppe/0000-0003-0299-4056; FUSTAINO, VALENTINA/0000-0002-5708-8715; RUBERTI, Giovina/0000-0003-2367-9709; Presutti, Dario/0000-0002-0207-6338	Project FaReBio di Qualita; Italian Ministry of Economy and Finance; CNR Project "Personalised Medicine"	Project FaReBio di Qualita; Italian Ministry of Economy and Finance; CNR Project "Personalised Medicine"	GR was partially funded by Project FaReBio di Qualita, a grant from the Italian Ministry of Economy and Finance to the CNR and the CNR Project "Personalised Medicine". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Bae SY, 2015, ONCOTARGET, V6, P10146, DOI 10.18632/oncotarget.3380; Barker AJ, 2001, BIOORG MED CHEM LETT, V11, P1911, DOI 10.1016/S0960-894X(01)00344-4; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cappuzzo F, 2009, ANN ONCOL, V20, P298, DOI 10.1093/annonc/mdn635; Carlomagno F, 2002, CANCER RES, V62, P7284; Cerchia L, 2012, MOL THER, V20, P2291, DOI 10.1038/mt.2012.163; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chou TY, 2005, CLIN CANCER RES, V11, P3750, DOI 10.1158/1078-0432.CCR-04-1981; Choughule A, 2014, BRIT J CANCER, V111, P2203, DOI 10.1038/bjc.2014.401; Christensen JG, 2003, CANCER RES, V63, P7345; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Cui JJ, 2012, J MED CHEM, V55, P8091, DOI 10.1021/jm300967g; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Giles FJ, 2009, LEUKEMIA, V23, P1698, DOI 10.1038/leu.2009.111; Giles KM, 2013, MOL CANCER THER, V12, P2541, DOI 10.1158/1535-7163.MCT-13-0170; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gozdzik-Spychalska J, 2014, CURR TREAT OPTION ON, V15, P670, DOI 10.1007/s11864-014-0313-5; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hirsch FR, 2002, BRIT J CANCER, V86, P1449, DOI 10.1038/sj.bjc.6600286; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Irmer D, 2007, ONCOGENE, V26, P5693, DOI 10.1038/sj.onc.1210383; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kobayashi S, 2008, NEW ENGL J MED, V352, P786; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li S, 2014, BRIT J CANCER, V110, P2812, DOI 10.1038/bjc.2014.210; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Morabito A, 2009, ONCOLOGIST, V14, P378, DOI 10.1634/theoncologist.2008-0261; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moyer JD, 1997, CANCER RES, V57, P4838; Mueller Kelly L, 2010, J Mol Signal, V5, P8, DOI 10.1186/1750-2187-5-8; Neel DS, 2013, CLIN CANCER RES, V19, P3, DOI 10.1158/1078-0432.CCR-12-3232; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Rho JK, 2014, CANCER RES, V74, P253, DOI 10.1158/0008-5472.CAN-13-1103; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Ryan AJ, 2005, BRIT J CANCER, V92, pS6, DOI 10.1038/sj.bjc.6602603; Sattler M, 2003, CANCER RES, V63, P5462; Shibasaki S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-554; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Tang H, 2014, ASSAY DRUG DEV TECHN, V12, P80, DOI 10.1089/adt.2013.540; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Timofeevski SL, 2009, BIOCHEMISTRY-US, V48, P5339, DOI 10.1021/bi900438w; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Walter AO, 2013, CANCER DISCOV, V3, P1404, DOI 10.1158/2159-8290.CD-13-0314; Xu ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063598; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zou HY, 2012, MOL CANCER THER, V11, P1036, DOI 10.1158/1535-7163.MCT-11-0839	80	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143333	10.1371/journal.pone.0143333	http://dx.doi.org/10.1371/journal.pone.0143333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580964	gold, Green Submitted, Green Published			2022-12-26	WOS:000365154600110
J	Migita, K; Komori, A; Kozuru, H; Jiuchi, Y; Nakamura, M; Yasunami, M; Furukawa, H; Abiru, S; Yamasaki, K; Nagaoka, S; Hashimoto, S; Bekki, S; Kamitsukasa, H; Nakamura, Y; Ohta, H; Shimada, M; Takahashi, H; Mita, E; Hijioka, T; Yamashita, H; Kouno, H; Nakamuta, M; Ario, K; Muro, T; Sakai, H; Sugi, K; Nishimura, H; Yoshizawa, K; Sato, T; Naganuma, A; Komatsu, T; Oohara, Y; Makita, F; Tomizawa, M; Yatsuhashi, H				Migita, Kiyoshi; Komori, Atsumasa; Kozuru, Hideko; Jiuchi, Yuka; Nakamura, Minoru; Yasunami, Michio; Furukawa, Hiroshi; Abiru, Seigo; Yamasaki, Kazumi; Nagaoka, Shinya; Hashimoto, Satoru; Bekki, Shigemune; Kamitsukasa, Hiroshi; Nakamura, Yoko; Ohta, Hajime; Shimada, Masaaki; Takahashi, Hironao; Mita, Eiji; Hijioka, Taizo; Yamashita, Haruhiro; Kouno, Hiroshi; Nakamuta, Makoto; Ario, Keisuke; Muro, Toyokichi; Sakai, Hironori; Sugi, Kazuhiro; Nishimura, Hideo; Yoshizawa, Kaname; Sato, Takeaki; Naganuma, Atsushi; Komatsu, Tatsuji; Oohara, Yukio; Makita, Fujio; Tomizawa, Minoru; Yatsuhashi, Hiroshi			Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis	PLOS ONE			English	Article							C VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; SERUM-LEVELS; MIR-122; EXPRESSION; MIR-21; CANCER; TARGET; PROGRESSION	Recent studies have demonstrated that micro (mi) RNA molecules can be detected in the circulation and can serve as potential biomarkers of various diseases. This study used microarray analysis to identify aberrantly expressed circulating miRNAs in patients with type 1 autoimmune hepatitis (AIH) compared with healthy controls. Patients with well-documented and untreated AIH were selected from the National Hospital Organization (NHO)-AIH-liver-network database. They underwent blood sampling and liver biopsy with inflammation grading and fibrosis staging before receiving treatment. To further confirm the microarray data, circulating expression levels of miR-21 and miR-122 were quantified by real-time quantitative polymerase chain reaction in 46 AIH patients, 40 patients with chronic hepatitis C (CHC), and 13 healthy controls. Consistent with the microarray data, serum levels of miR-21 were significantly elevated in AIH patients compared with CHC patients and healthy controls. miR-21 and miR-122 serum levels correlated with alanine aminotransferase levels. Circulating levels of miR-21 and miR-122 were significantly reduced in AIH patients with liver cirrhosis, and were inversely correlated with increased stages of fibrosis. By contrast, levels of circulating miR-21 showed a significant correlation with the histological grades of inflammation in AIH. We postulate that aberrantly expressed serum miRNAs are potential biomarkers of AIH and could be implicated in AIH pathogenesis. Alternations of miR-21 and miR-122 serum levels could reflect their putative roles in the mediation of inflammatory processes in AIH.	[Migita, Kiyoshi; Komori, Atsumasa; Kozuru, Hideko; Jiuchi, Yuka; Abiru, Seigo; Yamasaki, Kazumi; Nagaoka, Shinya; Hashimoto, Satoru; Bekki, Shigemune; Kamitsukasa, Hiroshi; Nakamura, Yoko; Ohta, Hajime; Shimada, Masaaki; Takahashi, Hironao; Mita, Eiji; Hijioka, Taizo; Yamashita, Haruhiro; Kouno, Hiroshi; Nakamuta, Makoto; Ario, Keisuke; Muro, Toyokichi; Sakai, Hironori; Sugi, Kazuhiro; Nishimura, Hideo; Yoshizawa, Kaname; Sato, Takeaki; Naganuma, Atsushi; Komatsu, Tatsuji; Oohara, Yukio; Makita, Fujio; Tomizawa, Minoru; Yatsuhashi, Hiroshi] Nagasaki Med Ctr, NHO AIH study Grp, Nagasaki 8568562, Japan; [Nakamura, Minoru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hepatol, Nagasaki 852, Japan; [Yasunami, Michio] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 8528501, Japan; [Furukawa, Hiroshi] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki 3058575, Japan	Nagasaki University; Nagasaki University; University of Tsukuba	Migita, K (corresponding author), Nagasaki Med Ctr, NHO AIH study Grp, Kubara 2-1001-1 Omura, Nagasaki 8568562, Japan.	migita@nagasaki-mc.com		Naganuma, Atsushi/0000-0003-0663-0102	National Hospital Organization	National Hospital Organization	This work was supported by a grant from the National Hospital Organization.	Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Ando Y, 2013, J AUTOIMMUN, V41, P111, DOI 10.1016/j.jaut.2012.12.013; Bandiera S, 2015, J HEPATOL, V62, P448, DOI 10.1016/j.jhep.2014.10.004; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bihrer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026971; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Chen YM, 2014, LIVER INT, V34, P976, DOI 10.1111/liv.12496; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Gonzalez MV, 2000, J CELL BIOL, V150, P1199, DOI 10.1083/jcb.150.5.1199; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Heneghan MA, 2013, LANCET, V382, P1433, DOI 10.1016/S0140-6736(12)62163-1; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Li AM, 2013, INT J BIOCHEM CELL B, V45, P858, DOI 10.1016/j.biocel.2013.01.008; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng R, 2012, J CLIN INVEST, V122, P1097, DOI 10.1172/JCI46039; Obermayer-Straub P, 2000, J HEPATOL, V32, P181, DOI 10.1016/S0168-8278(00)80425-0; Qin BD, 2013, J GASTROEN HEPATOL, V28, P543, DOI 10.1111/jgh.12040; Roderburg C, 2015, LIVER INT, V35, P1172, DOI 10.1111/liv.12627; Ruan Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.47; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Sekar D, 2014, TUMOR BIOL, V35, P8387, DOI 10.1007/s13277-014-2068-9; Stagakis E, 2011, ANN RHEUM DIS, V70, P1496, DOI 10.1136/ard.2010.139857; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Xu WD, 2013, EXPERT OPIN THER TAR, V17, P659, DOI 10.1517/14728222.2013.773311; Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021; Zeng L, 2014, AUTOIMMUNITY, V47, P419, DOI 10.3109/08916934.2014.929667	39	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0136908	10.1371/journal.pone.0136908	http://dx.doi.org/10.1371/journal.pone.0136908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575387	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400002
J	Xu, Y; Shen, ZH; Li, DX; Guo, QF				Xu, Yue; Shen, Zehao; Li, Daoxin; Guo, Qinfeng			Pre-Dispersal Seed Predation in a Species-Rich Forest Community: Patterns and the Interplay with Determinants	PLOS ONE			English	Article							PREDISPERSAL; SIZE; CONSEQUENCES; PLANT; RAIN; INSECTS; REPRODUCTION; GERMINATION; POLLINATION; PHYLOGENIES	Pre-dispersal seed predation (PDSP) is commonly observed in woody plants, and recognized as a driver of seed production variability that is critical for successful regeneration. Earlier studies on PDSP and its determinants were mostly species specific, with community- level PDSP rarely estimated; and the interactions between the temporal variability of seed production and PDSP remain elusive. In this study, the community seed rain of woody plants in a mixed evergreen-deciduous broadleaf forest was monitored for seven years. We examined predation on collected seeds and analyzed the determinants of PDSP. PDSP was recorded in 17 out of 44 woody plant species, and three-quarters of PDSP was due to insect predators. Annual seed production varied substantially at community level, reversely linked with the temporal variation of PDSP rate. The PDSP rate was biased regarding fruit types, and being significantly correlated with seed mass when using phylogenetic independent contrasts (PICs) or without taking into account phylogenetic relations, especially for nuts. PDSP rate was also negatively correlated with seed density, showing a threshold-related predator satiation effect. The community-level PDSP rate was primarily determined by tree height, fruit type, and interannual variation of seed production and seed mass. Our analysis revealed a causal link between seed production and the dynamics of PDSP rate at the community level. The predator satiation effect was primarily contributed by the dominant species, whereas the rare species seemed to apply a distinct "hide-and-seek" strategy to control the risk of PDSP. The mechanistic difference of seed production between the common and rare species can shed new light on species coexistence and community assembly. Long-term monitoring of both seed rain and seed predation is required for understanding the ecological and evolutionary implications of species regeneration strategies in a species-rich forest community.	[Xu, Yue; Shen, Zehao] Peking Univ, Coll Urban & Environm Sci, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Li, Daoxin] Dalaoling Natl Forest Pk, Yichang, Hubei, Peoples R China; [Guo, Qinfeng] US Forest Serv, Eastern Forest Environm Threat Assessment Ctr, USDA, Res Triangle Pk, NC USA	Peking University; United States Department of Agriculture (USDA); United States Forest Service	Shen, ZH (corresponding author), Peking Univ, Coll Urban & Environm Sci, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China.	shenzh@urban.pku.edu.cn	Shen, Zehao/GQI-1121-2022		National Natural Science Foundation of China [31170449, 30770386, 31321061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant numbers: 31170449, 30770386 and 31321061). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, PLANT ANIMAL INTERAC; AUGSPURGER CK, 1981, ECOLOGY, V62, P775, DOI 10.2307/1937745; Blate GM, 1998, OIKOS, V82, P522, DOI 10.2307/3546373; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonal R, 2007, EVOL ECOL, V21, P367, DOI 10.1007/s10682-006-9107-y; Burgos A, 2008, FOREST ECOL MANAG, V255, P1226, DOI 10.1016/j.foreco.2007.10.032; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Carvalho P, 2005, SCIENTOMETRICS, V62, P53, DOI 10.1007/s11192-005-0003-y; Castro J, 1999, PLANT ECOL, V145, P115, DOI 10.1023/A:1009865703906; Chen L, 2010, ECOL LETT, V13, P695, DOI 10.1111/j.1461-0248.2010.01468.x; Crawley M. J., 2000, Seeds: the ecology of regeneration in plant communities, P167, DOI 10.1079/9780851994321.0167; CRAWLEY MJ, 1995, J ECOL, V83, P683, DOI 10.2307/2261636; Ehrlen J, 1996, OECOLOGIA, V108, P708, DOI 10.1007/BF00329046; Espelta JM, 2009, J ECOL, V97, P1416, DOI 10.1111/j.1365-2745.2009.01564.x; EVANS EW, 1989, OECOLOGIA, V78, P220, DOI 10.1007/BF00377159; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Figueroa JA, 2002, AUST J BOT, V50, P183, DOI 10.1071/BT01003; Froborg H, 2003, CAN J BOT, V81, P1058, DOI 10.1139/B03-099; Garcia D, 2000, J ECOL, V88, P436, DOI 10.1046/j.1365-2745.2000.00459.x; GREEN TW, 1975, ECOLOGY, V56, P1435, DOI 10.2307/1934711; GUO QF, 1995, OIKOS, V73, P251, DOI 10.2307/3545915; HAINSWORTH FR, 1984, OECOLOGIA, V63, P405, DOI 10.1007/BF00390673; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; HERRERA CM, 1984, ECOLOGY, V65, P609, DOI 10.2307/1941423; HOFFMANN LA, 1995, ECOL APPL, V5, P200, DOI 10.2307/1942063; Hubbell S.P., 2001, MG POP BIOL, V32; HUBBELL SP, 1980, OIKOS, V35, P214, DOI 10.2307/3544429; Hulme PE, 2002, GRANIVORY; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1969, EVOLUTION, V23, P1, DOI [10.2307/2406478, 10.1111/j.1558-5646.1969.tb03489.x]; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Koenig WD, 2000, AM NAT, V155, P59, DOI 10.1086/303302; Kolb A, 2007, PERSPECT PLANT ECOL, V9, P79, DOI 10.1016/j.ppees.2007.09.001; LOUDA SM, 1995, ECOLOGY, V76, P229, DOI 10.2307/1940645; Espelta JM, 2009, OECOLOGIA, V161, P559, DOI 10.1007/s00442-009-1394-x; Martins Emilia P., 1996, P22; Mendoza E, 2007, OIKOS, V116, P1841, DOI [10.1111/j.2007.0030-1299.15878.x, 10.1111/j.0030-1299.2007.15878.x]; MOLAU U, 1989, OECOLOGIA, V81, P181, DOI 10.1007/BF00379803; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; Morandini MN, 2009, REV BIOL TROP, V57, P781; Nakagawa M, 2005, BIOTROPICA, V37, P389, DOI 10.1111/j.1744-7429.2005.00051.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; O'Hara RB, 2009, ANN ZOOL FENN, V46, P124, DOI 10.5735/086.046.0205; Perez-Ramos IM, 2008, OIKOS, V117, P1386, DOI 10.1111/j.0030-1299.2008.16370.x; PETTERSSON MW, 1994, ECOGRAPHY, V17, P264, DOI 10.1111/j.1600-0587.1994.tb00102.x; Scharf FS, 1998, ECOLOGY, V79, P448, DOI 10.1890/0012-9658(1998)079[0448:IERFTE]2.0.CO;2; Schelin M, 2004, NEW FOREST, V27, P251, DOI 10.1023/B:NEFO.0000022225.75095.41; Shen ZH, 2007, J INTEGR PLANT BIOL, V49, P1294, DOI 10.1111/j.1744-7909.2007.00530.x; [沈泽昊 Shen Zehao], 2004, [生态学报, Acta Ecologica Sinica], V24, P1981; Shen ZH, 2000, ACTA BOT SIN, V42, P1089; Shibata M, 1998, ECOLOGY, V79, P54, DOI 10.1890/0012-9658(1998)079[0054:CACOMS]2.0.CO;2; TERBORGH J, 1993, VEGETATIO, V108, P375; West B. T., 2007, LINEAR MIXED MODELS; Wu Z.Y., 2002, FLORA CHINA; Xu Yue, 2012, Chinese Journal of Plant Ecology, V36, P708, DOI 10.3724/SP.J.1258.2012.00708; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang X-K, 1997, INSECTS 3 GORGE RESE; Yasaka M, 2003, FOREST ECOL MANAG, V184, P277, DOI 10.1016/S0378-1127(03)00157-9; Zywiec M, 2013, OECOLOGIA, V172, P461, DOI 10.1007/s00442-012-2502-x	62	11	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143040	10.1371/journal.pone.0143040	http://dx.doi.org/10.1371/journal.pone.0143040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575270	Green Published, gold			2022-12-26	WOS:000365153400031
J	Camats, N; Fernandez-Cancio, M; Audi, L; Mullis, PE; Moreno, F; Casado, IG; Lopez-Siguero, JP; Corripio, R; de la Vega, JAB; Blanco, JA; Fluck, CE				Camats, Nuria; Fernandez-Cancio, Monica; Audi, Laura; Mullis, Primus E.; Moreno, Francisca; Gonzalez Casado, Isabel; Pedro Lopez-Siguero, Juan; Corripio, Raquel; Bermudez de la Vega, Jose Antonio; Antonio Blanco, Jose; Flueck, Christa E.			Human MAMLD1 Gene Variations Seem Not Sufficient to Explain a 46,XY DSD Phenotype	PLOS ONE			English	Article							SEX DEVELOPMENT; MYOTUBULAR MYOPATHY; MALE HYPOGENITALISM; MUTATIONS; HYPOSPADIAS; DISORDER; XQ28; CXORF6; MTM1; POLYMORPHISMS	MAMLD1 is thought to cause disordered sex development in 46, XY patients. But its role is controversial because some MAMLD1 variants are also detected in normal individuals, several MAMLD1 mutations have wild-type activity in functional tests, and the male Mamld1-knockout mouse has normal genitalia and reproduction. Our aim was to search for MAMLD1 variations in 108 46, XY patients with disordered sex development, and to test them functionally. We detected MAMDL1 variations and compared SNP frequencies in controls and patients. We tested MAMLD1 transcriptional activity on promoters involved in sex development and assessed the effect of MAMLD1 on androgen production. MAMLD1 expression in normal steroid-producing tissues and mutant MAMLD1 protein expression were also assessed. Nine MAMLD1 mutations (7 novel) were characterized. In vitro, most MAMLD1 variants acted similarly to wild type. Only the L210X mutation showed loss of function in all tests. We detected no effect of wild-type or MAMLD1 variants on CYP17A1 enzyme activity in our cell experiments, and Western blots revealed no significant differences for MAMLD1 protein expression. MAMLD1 was expressed in human adult testes and adrenals. In conclusion, our data support the notion that MAMLD1 sequence variations may not suffice to explain the phenotype in carriers and that MAMLD1 may also have a role in adult life.	[Camats, Nuria; Mullis, Primus E.; Flueck, Christa E.] Univ Childrens Hosp Bern, Dept Clin Res, Pediat Endocrinol & Diabetol, Bern, Switzerland; [Fernandez-Cancio, Monica; Audi, Laura] Univ Autonoma Barcelona, Pediat Endocrinol Res Unit, Vall dHebron Inst Recerca,Hosp Univ Vall dHebron, CIBERER Ctr Biomed Res Rare Dis,Inst Salud Carlos, E-08193 Barcelona, Spain; [Moreno, Francisca] Hosp Infantil La Fe, Pediat Endocrinol, Valencia, Spain; [Gonzalez Casado, Isabel] Hosp Univ La Paz, Pediat Endocrinol, Madrid, Spain; [Pedro Lopez-Siguero, Juan] Hosp Materno Infantil, Pediat Endocrinol, Malaga, Spain; [Corripio, Raquel] Hosp Sabadell, Pediat Endocrinol, Sabadell, Spain; [Bermudez de la Vega, Jose Antonio] Hosp Univ Virgen Macarena, Pediat Endocrinol, Seville, Spain; [Antonio Blanco, Jose] Hosp Badalona Germans Trias & Pujol, Pediat Urol, Badalona, Spain	University of Bern; University Hospital of Bern; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitario Virgen Macarena; Hospital Germans Trias i Pujol	Fluck, CE (corresponding author), Univ Childrens Hosp Bern, Dept Clin Res, Pediat Endocrinol & Diabetol, Bern, Switzerland.	christa.flueck@dkf.unibe.ch	Camats, Nuria/K-8326-2017	Camats, Nuria/0000-0002-4863-8201; Fernandez Cancio, Monica/0000-0003-1872-3488; Flueck, Christa/0000-0002-4568-5504; Corripio, Raquel/0000-0003-3344-8269	Swiss National Science Foundation [320030-146127]; Instituto de Salud Carlos III, Madrid, Spain [CIBERER U-712]; University and Research Management and Evaluation Agency, Barcelona, Spain [2009SGR31]; private Foundation Bangerter-Rhyner, Basel, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); University and Research Management and Evaluation Agency, Barcelona, Spain; private Foundation Bangerter-Rhyner, Basel, Switzerland	This work was supported by grants of the Swiss National Science Foundation (320030-146127) to CEF, the Instituto de Salud Carlos III, Madrid, Spain CIBERER U-712 to MFC, the University and Research Management and Evaluation Agency, Barcelona, Spain (2009SGR31) to LA, and the private Foundation Bangerter-Rhyner, Basel, Switzerland to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Audi L, 2010, J CLIN ENDOCR METAB, V95, P1876, DOI 10.1210/jc.2009-2146; Bartsch O, 1999, CYTOGENET CELL GENET, V85, P310, DOI 10.1159/000015284; Baxter RM, 2013, ANNU REV GENOM HUM G, V14, P371, DOI 10.1146/annurev-genom-091212-153417; Brandao MP, 2011, ADV EXP MED BIOL, V707, P129, DOI 10.1007/978-1-4419-8002-1_28; Camats N, 2012, J CLIN ENDOCR METAB, V97, pE1294, DOI 10.1210/jc.2011-3169; Chen YG, 2010, EUR J MED GENET, V53, P122, DOI 10.1016/j.ejmg.2010.03.005; De Lorenzi L, 2010, SEX DEV, V4, P352, DOI 10.1159/000319527; Fernandez-Cancio M, 2011, INT J ANDROL, V34, pE526, DOI 10.1111/j.1365-2605.2010.01136.x; Fluck CE, 2004, MOL ENDOCRINOL, V18, P1144, DOI 10.1210/me.2003-0342; Fukami M, 2008, J BIOL CHEM, V283, P5525, DOI 10.1074/jbc.M703289200; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Gaspari L, 2011, EUR J ENDOCRINOL, V165, P579, DOI 10.1530/EJE-11-0580; Hu LJ, 1996, HUM MOL GENET, V5, P139, DOI 10.1093/hmg/5.1.139; Huang NW, 2000, J BIOL CHEM, V275, P2852, DOI 10.1074/jbc.275.4.2852; Igarashi M, 2015, SEX DEV, V9, P130, DOI 10.1159/000380842; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kalfa N, 2011, J PEDIATR UROL, V7, P585, DOI 10.1016/j.jpurol.2011.09.005; Kalfa N, 2008, EUR J ENDOCRINOL, V159, P453, DOI 10.1530/EJE-08-0085; Kalfa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032505; Kon Masafumi, 2015, Mol Cell Pediatr, V2, P7, DOI 10.1186/s40348-015-0018-2; Laporte J, 1997, GENOMICS, V41, P458, DOI 10.1006/geno.1997.4662; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Metwalley Kotb Abbass, 2012, J Med Case Rep, V6, P428, DOI 10.1186/1752-1947-6-428; Miyado M, 2012, ENDOCRINOLOGY, V153, P6033, DOI 10.1210/en.2012-1324; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019123; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Nowacka-Woszuk J, 2014, ANIM REPROD SCI, V151, P42, DOI 10.1016/j.anireprosci.2014.10.001; O'Shaughnessy PJ, 2007, J CLIN ENDOCR METAB, V92, P4792, DOI 10.1210/jc.2007-1690; Ogata T, 2012, SEMIN REPROD MED, V30, P410, DOI 10.1055/s-0032-1324725; Oliveira J, 2013, EUR J HUM GENET, V21, P540, DOI 10.1038/ejhg.2012.201; Ruiz-Arana IL, 2015, NOVEL HEMIZYGOUS MUT, DOI [10.1159/000371603, DOI 10.1159/000371603]; SWITONSKI M, 2012, HYPOSPADIAS MALE 78, V6, P128, DOI DOI 10.1159/000330921; Tsai TC, 2005, NEUROMUSCULAR DISORD, V15, P245, DOI 10.1016/j.nmd.2004.12.005; Zhang GJ, 2010, HUM MUTAT, V31, P1286, DOI 10.1002/humu.21389	35	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142831	10.1371/journal.pone.0142831	http://dx.doi.org/10.1371/journal.pone.0142831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26580071	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700079
J	Hosseini, A; Tariq, MR; Da Rosa, FT; Kesser, J; Iqbal, Z; Mora, O; Sauerwein, H; Drackley, JK; Trevisi, E; Loor, JJ				Hosseini, Afshin; Tariq, Muhammad Rizwan; Da Rosa, Fernanda Trindade; Kesser, Julia; Iqbal, Zeeshan; Mora, Ofelia; Sauerwein, Helga; Drackley, James K.; Trevisi, Erminio; Loor, Juan J.			Insulin Sensitivity in Adipose and Skeletal Muscle Tissue of Dairy Cows in Response to Dietary Energy Level and 2,4-Thiazolidinedione (TZD)	PLOS ONE			English	Article							GENE-EXPRESSION; PREPARTUM 2,4-THIAZOLIDINEDIONE; FOOD-INTAKE; METABOLIC-RESPONSES; PREGNANCY ALTERS; OBESE SUBJECTS; ADIPONECTIN; GAMMA; NUTRITION; RESISTANCE	The effects of dietary energy level and 2,4-thiazolidinedione (TZD) injection on feed intake, body fatness, blood biomarkers and TZD concentrations, genes related to insulin sensitivity in adipose tissue (AT) and skeletal muscle, and peroxisome proliferator-activated receptor gamma (PPARG) protein in subcutaneous AT (SAT) were evaluated in Holstein cows. Fourteen nonpregnant nonlactating cows were fed a control low-energy (CON, 1.30 Mcal/kg) diet to meet 100% of estimated nutrient requirements for 3 weeks, after which half of the cows were assigned to a higher-energy diet (OVE, 1.60 Mcal/kg) and half of the cows continued on CON for 6 weeks. All cows received an intravenous injection of TZD starting 2 weeks after initiation of dietary treatments and for an additional 2 weeks, which served as the washout period. Cows fed OVE had greater energy intake and body mass than CON, and TZD had no effect during the administration period. The OVE cows had greater TZD clearance rate than CON cows. The lower concentration of nonesterified fatty acids (NEFA) and greater concentration of insulin in blood of OVE cows before TZD injection indicated positive energy balance and higher insulin sensitivity. Administration of TZD increased blood concentrations of glucose, insulin, and beta-hydroxybutyrate (BHBA) at 2 to 4 weeks after diet initiation, while the concentration of NEFA and adiponectin (ADIPOQ) remained unchanged during TZD. The TZD upregulated the mRNA expression of PPARG and its targets FASN and SREBF1 in SAT, but also SUMO1 and UBC9 which encode sumoylation proteins known to down-regulate PPARG expression and curtail adipogenesis. Therefore, a post-translational response to control PPARG gene expression in SAT could be a counteregulatory mechanism to restrain adipogenesis. The OVE cows had greater expression of the insulin sensitivity-related genes IRS1, SLC2A4, INSR, SCD, INSIG1, DGAT2, and ADIPOQ in SAT. In skeletal muscle, where PPARA and its targets orchestrate carbohydrate metabolism and fatty acid oxidation, the OVE cows had greater glyceroneogenesis (higher mRNA expression of PC and PCK1), whereas CON cows had greater glucose transport (SLC2A4). Administration of TZD increased triacylglycerol concentration and altered expression of carbohydrate-and fatty acid oxidation-related genes in skeletal muscle. Results indicate that overfeeding did not affect insulin sensitivity in nonpregnant, nonlactating dairy cows. The bovine PPARG receptor appears TZD-responsive, with its activation potentially leading to greater adipogenesis and lipogenesis in SAT, while differentially regulating glucose homeostasis and fatty acid oxidation in skeletal muscle. Targeting PPARG via dietary nutraceuticals while avoiding excessive fat deposition might improve insulin sensitivity in dairy cows during times such as the peripartal period when the onset of lactation naturally decreases systemic insulin release and sensitivity in tissues such as AT.	[Hosseini, Afshin; Tariq, Muhammad Rizwan; Da Rosa, Fernanda Trindade; Iqbal, Zeeshan; Drackley, James K.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Hosseini, Afshin; Tariq, Muhammad Rizwan; Da Rosa, Fernanda Trindade; Iqbal, Zeeshan; Drackley, James K.; Loor, Juan J.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Hosseini, Afshin; Kesser, Julia; Sauerwein, Helga] Univ Bonn, D-53115 Bonn, Nrw, Germany; [Mora, Ofelia] Univ Nacl Autonoma Mexico, Queretaro 76230, Queretaro, Mexico; [Trevisi, Erminio] Univ Cattolica Sacro Cuore, Fac Sci Agr Alimentari & Ambientali, Ist Zootecn, I-29122 Piacenza, Italy	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Bonn; Universidad Nacional Autonoma de Mexico; Catholic University of the Sacred Heart	Loor, JJ (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	jloor@illinois.edu	Loor, Juan J./H-3760-2012; Sauerwein, Helga/R-8242-2019	Loor, Juan J./0000-0003-1586-4365; Rosa, Fernanda/0000-0002-8906-4056; Mora, Ofelia/0000-0002-7073-7740	German Research Foundation (DFG) [HO 4596/1-1]; University of Illinois Campus Research Board; National Institute of Food and Agriculture, Washington, DC, USA [ILLU-538-914]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Illinois Campus Research Board; National Institute of Food and Agriculture, Washington, DC, USA	Afshin Hosseini (HO 4596/1-1) received fellowship support from the German Research Foundation (DFG). Partial support for the conduct of the project was provided by the University of Illinois Campus Research Board, and Hatch funds under project ILLU-538-914, National Institute of Food and Agriculture, Washington, DC, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Allen MS, 2009, J ANIM SCI, V87, P3317, DOI 10.2527/jas.2009-1779; Allen MS, 2005, ANNU REV NUTR, V25, P523, DOI 10.1146/annurev.nutr.25.050304.092704; [Anonymous], 2007, AVANDIA ROS MAL; Arevalo-Turrubiarte M, 2012, PPAR RES, V2012, DOI 10.1155/2012/891841; Behre CJ, 2007, METABOLISM, V56, P1022, DOI 10.1016/j.metabol.2007.03.010; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; BIONAZ M, 2013, PPAR RES, DOI DOI 10.1155/2013/684159; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Cox PJ, 2000, DRUG METAB DISPOS, V28, P772; Dadson Keith, 2011, Front Endocrinol (Lausanne), V2, P62, DOI 10.3389/fendo.2011.00062; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Drackley JK, 2014, J DAIRY SCI, V97, P3420, DOI 10.3168/jds.2014-8014; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Giaginis C, 2007, J CHROMATOGR B, V857, P181, DOI 10.1016/j.jchromb.2007.07.013; Hanson RW, 2008, BIOCHIMIE, V90, P838, DOI 10.1016/j.biochi.2008.03.009; Iwamoto Y, 1996, DIABETES CARE, V19, P151, DOI 10.2337/diacare.19.2.151; Ji P, 2012, J DAIRY SCI, V95, P4333, DOI 10.3168/jds.2011-5079; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Keung W, 2013, DIABETES, V62, P711, DOI 10.2337/db12-0259; Khan MJ, 2014, GENE REGUL SYST BIO, V8, P97, DOI 10.4137/GRSB.S14116; Larsen PJ, 2003, DIABETES, V52, P2249, DOI 10.2337/diabetes.52.9.2249; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Martin GS, 1999, J ANIM SCI, V77, P630; Mielenz M, 2013, DOMEST ANIM ENDOCRIN, V44, P121, DOI 10.1016/j.domaniend.2012.10.004; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; PETTERSON JA, 1993, J NUTR, V123, P1286, DOI 10.1093/jn/123.7.1286; Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; Ravikanth C.H., 2011, INT J PHARM SCI DRUG, V3, P38; Rouviere JO, 2013, CHROMOSOMA, V122, P387, DOI 10.1007/s00412-013-0408-y; Schoenberg KM, 2012, J DAIRY SCI, V95, P670, DOI 10.3168/jds.2011-4529; Schoenberg KM, 2011, J DAIRY SCI, V94, P6021, DOI 10.3168/jds.2011-4533; Schoenberg KM, 2011, J DAIRY SCI, V94, P5523, DOI 10.3168/jds.2011-4501; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Singh SP, 2014, DOMEST ANIM ENDOCRIN, V47, P35, DOI 10.1016/j.domaniend.2013.12.001; Smith KL, 2007, J DAIRY SCI, V90, P3660, DOI 10.3168/jds.2006-650; Smith KL, 2009, J DAIRY SCI, V92, P3623, DOI 10.3168/jds.2008-1508; Sosa C, 2009, DOMEST ANIM ENDOCRIN, V36, P13, DOI 10.1016/j.domaniend.2008.08.003; Sun YG, 2009, J ANIM SCI; Tan HY, 2008, OPT COMMUN, V281, P3013, DOI 10.1016/j.optcom.2008.01.012; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Wolden-Hanson T, 2002, EXP GERONTOL, V37, P679, DOI 10.1016/S0531-5565(01)00233-9; Zierath JR, 1998, ENDOCRINOLOGY, V139, P5034, DOI 10.1210/en.139.12.5034	49	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142633	10.1371/journal.pone.0142633	http://dx.doi.org/10.1371/journal.pone.0142633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571137	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700053
J	Jang, DH; Kim, MW; Oh, SJ; Kim, JM				Jang, Dae-Hyun; Kim, Min-Wook; Oh, Se-Jeong; Kim, Jae Min			The Influence of Arm Swelling Duration on Shoulder Pathology in Breast Cancer Patients with Lymphedema	PLOS ONE			English	Article							ULTRASOUND; SURVIVORS; TRIAL; CARE	Purpose To evaluate the pathological effect of the duration of arm swelling on the shoulder pathology in patients with breast cancer-related lymphedema. Methods Forty seven breast cancer patients with unilateral arm lymphedema were assessed. The duration of the arm swelling and shoulder pain were recorded. Ultrasound examination of the shoulder joint was performed in all patients to detect any lesions. Results Abnormalities were detected by ultrasound in 41/47 (87.2%) study participants. Subacromial subdeltoid bursal thickening was found in 26/47 (55.3%) participants, distension of the biceps brachii tendon sheath was found in 14/47 (29.8%) and a supraspinatus tendon tear was found in 13/47 (27.7%). Patients with a supraspinatus tendon tear were found to have a significantly longer duration of lymphedema (1310 days vs. 398 days, p = 0.032). Conclusions The duration of arm lymphedema has a progressive pathological effect on rotator cuff. Clinicians should adopt an early management approach of shoulder pain in patients with breast cancer-related lymphedema.	[Jang, Dae-Hyun; Kim, Min-Wook; Kim, Jae Min] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Rehabil Med, Inchon, South Korea; [Oh, Se-Jeong] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Surg, Inchon, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, JM (corresponding author), Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Rehabil Med, Inchon, South Korea.	jaeminmd@gmail.com		Oh, Se Jeong/0000-0002-2583-4218; Kim, Jae Min/0000-0003-4217-3228				Ahmed RL, 2006, J CLIN ONCOL, V24, P2765, DOI 10.1200/JCO.2005.03.6749; Ebaugh D, 2011, MED HYPOTHESES, V77, P481, DOI 10.1016/j.mehy.2011.06.015; Girish G, 2011, AM J ROENTGENOL, V197, pW713, DOI 10.2214/AJR.11.6971; Harris SR, 2001, CAN MED ASSOC J, V164, P191; Hayes SC, 2008, J CLIN ONCOL, V26, P3536, DOI 10.1200/JCO.2007.14.4899; Herrera JE, 2004, ARCH PHYS MED REHAB, V85, P1939, DOI 10.1016/j.apmr.2004.06.065; Hidding JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096748; Jeong HJ, 2011, YONSEI MED J, V52, P661, DOI 10.3349/ymj.2011.52.4.661; Mellor Russell H, 2004, Breast J, V10, P496, DOI 10.1111/j.1075-122X.2004.21458.x; Moosmayer S, 2005, ACTA ORTHOP, V76, P503, DOI 10.1080/17453670510041484; Nesvold IL, 2008, ACTA ONCOL, V47, P835, DOI 10.1080/02841860801961257; Ridner SH, 2012, BREAST CANCER RES TR, V131, P147, DOI 10.1007/s10549-011-1795-5; Sheridan MA, 2006, ORTHOP CLIN N AM, V37, P531, DOI 10.1016/j.ocl.2006.09.009; Voogd AC, 2003, BRIT J SURG, V90, P76, DOI 10.1002/bjs.4010	14	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142950	10.1371/journal.pone.0142950	http://dx.doi.org/10.1371/journal.pone.0142950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571274	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700101
J	Kitchen, P; Oberg, F; Sjohamn, J; Hedfalk, K; Bill, RM; Conner, AC; Conner, MT; Tornroth-Horsefield, S				Kitchen, Philip; Oeberg, Fredrik; Sjoehamn, Jennie; Hedfalk, Kristina; Bill, Roslyn M.; Conner, Alex C.; Conner, Matthew T.; Tornroth-Horsefield, Susanna			Plasma Membrane Abundance of Human Aquaporin 5 Is Dynamically Regulated by Multiple Pathways	PLOS ONE			English	Article							X-RAY-STRUCTURE; WATER-CHANNEL; DEPENDENT PHOSPHORYLATION; TRAFFICKING; AQP5; CAMP; TRANSLOCATION; OVEREXPRESSION; ENDOCYTOSIS; ACTIVATION	Aquaporin membrane protein channels mediate cellular water flow. Human aquaporin 5 (AQP5) is highly expressed in the respiratory system and secretory glands where it facilitates the osmotically-driven generation of pulmonary secretions, saliva, sweat and tears. Dysfunctional trafficking of AQP5 has been implicated in several human disease states, including Sjogren's syndrome, bronchitis and cystic fibrosis. In order to investigate how the plasma membrane expression levels of AQP5 are regulated, we studied real-time translocation of GFP-tagged AQP5 in HEK293 cells. We show that AQP5 plasma membrane abundance in transfected HEK293 cells is rapidly and reversibly regulated by at least three independent mechanisms involving phosphorylation at Ser156, protein kinase A activity and extracellular tonicity. The crystal structure of a Ser156 phosphomimetic mutant indicates that its involvement in regulating AQP5 membrane abundance is not mediated by a conformational change of the carboxy-terminus. We suggest that together these pathways regulate cellular water flow.	[Kitchen, Philip] Univ Warwick, Mol Org, Coventry CV4 7AL, W Midlands, England; [Kitchen, Philip] Univ Warwick, Assembly Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Oeberg, Fredrik; Sjoehamn, Jennie; Hedfalk, Kristina] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Conner, Alex C.] Univ Birmingham, Sch Med, Clin & Expt Med, Birmingham, W Midlands, England; [Conner, Matthew T.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Tornroth-Horsefield, Susanna] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Lund, Sweden	University of Warwick; University of Warwick; University of Gothenburg; Aston University; University of Birmingham; Sheffield Hallam University; Lund University	Conner, AC (corresponding author), Univ Birmingham, Sch Med, Clin & Expt Med, Birmingham, W Midlands, England.	a.c.conner@bham.ac.uk; m.t.conner@shu.ac.uk; susanna.horsefield@biochemistry.lu.se	Öberg, Fredrik Kryh/B-1241-2011; Kitchen, Philip/J-6936-2019; Bill, Roslyn M/D-4554-2012	Öberg, Fredrik Kryh/0000-0002-7089-2118; Kitchen, Philip/0000-0002-1558-4673; Bill, Roslyn M/0000-0003-1331-0852; Sjohamn, Jennie/0000-0001-9360-6279; Tornroth-Horsefield, Susanna/0000-0002-9435-8243	Swedish Research Council [2009-360, 2010-5208]; European Commission [201924 EDICT]; Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick [EP/F500378/1]; Engineering and Physical Sciences Research Council [1091578] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Engineering and Physical Sciences Research Council through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Swedish Research Council (www.vr.se) grants 2009-360 and 2010-5208 (to STH), European Commission Framework Programme 7 (http://ec.europa.eu/research/fp7/index_en.cfm) Grant 201924 EDICT (to RMB) and by the Engineering and Physical Sciences Research Council (https://www.epsrc.ac.uk) through the Molecular Organisation and Assembly in Cells Doctoral Training Centre, University of Warwick, grant number EP/F500378/1 (PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Conner MT, 2012, J BIOL CHEM, V287, P11516, DOI 10.1074/jbc.M111.329219; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; Day RE, 2014, BBA-GEN SUBJECTS, V1840, P1492, DOI 10.1016/j.bbagen.2013.09.033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Frick A, 2014, P NATL ACAD SCI USA, V111, P6305, DOI 10.1073/pnas.1321406111; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200; Han ZQ, 2000, BIOCHEM BIOPH RES CO, V273, P328, DOI 10.1006/bbrc.2000.2944; Hasegawa T, 2011, AM J PHYSIOL-CELL PH, V301, pC667, DOI 10.1152/ajpcell.00058.2011; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V265, P94, DOI 10.1006/bbrc.1999.1630; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Ishikawa Y, 1998, BIOCHEM BIOPH RES CO, V245, P835, DOI 10.1006/bbrc.1998.8395; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kosugi-Tanaka C, 2006, BBA-MOL CELL RES, V1763, P337, DOI 10.1016/j.bbamcr.2006.02.005; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oberg F, 2011, MOL MEMBR BIOL, V28, P398, DOI 10.3109/09687688.2011.602219; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Reichow SL, 2013, NAT STRUCT MOL BIOL, V20, P1085, DOI 10.1038/nsmb.2630; Ribatti D, 2014, BBA-GEN SUBJECTS, V1840, P1550, DOI 10.1016/j.bbagen.2013.09.025; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Song YL, 2001, J BIOL CHEM, V276, P41288, DOI 10.1074/jbc.M107257200; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4; van Balkom BWM, 2002, J BIOL CHEM, V277, P41473, DOI 10.1074/jbc.M207525200; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Wellner RB, 2005, TISSUE ENG, V11, P1449, DOI 10.1089/ten.2005.11.1449; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woo J, 2008, CANCER LETT, V264, P54, DOI 10.1016/j.canlet.2008.01.029; Woo J, 2008, BIOCHEM BIOPH RES CO, V367, P291, DOI 10.1016/j.bbrc.2007.12.073; Woo J, 2008, BIOCHEM BIOPH RES CO, V366, P321, DOI 10.1016/j.bbrc.2007.11.078; Yang F, 2003, J BIOL CHEM, V278, P32173, DOI 10.1074/jbc.M305149200	40	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143027	10.1371/journal.pone.0143027	http://dx.doi.org/10.1371/journal.pone.0143027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569106	Green Published, Green Accepted, gold			2022-12-26	WOS:000365070700122
J	Weiterer, S; Kohlen, T; Veit, F; Sachs, L; Uhle, F; Lichtenstern, C; Weigand, MA; Henrich, M				Weiterer, Sebastian; Kohlen, Thomas; Veit, Florian; Sachs, Lydia; Uhle, Florian; Lichtenstern, Christoph; Weigand, Markus A.; Henrich, Michael			Galactomannan and Zymosan Block the Epinephrine-Induced Particle Transport in Tracheal Epithelium	PLOS ONE			English	Article							CYSTIC-FIBROSIS LUNG; BRONCHOALVEOLAR LAVAGE; AIRWAY; MILRINONE; PATHWAY; DISEASE	Background Ciliary beating by respiratory epithelial cells continuously purges pathogens from the lower airways. Here we investigated the effect of the fungal cell wall polysaccharides Galactomannan (GM) and Zymosan (Zym) on the adrenergic activated particle transport velocity (PTV) of tracheal epithelium. Methods Experiments were performed using tracheae isolated from male C57BL/6J mice. Transport velocity of the cilia bearing epithelial cells was measured by analysing recorded image sequences. Generation of reactive oxygen species (ROS) were determined using Amplex Red reagents. PCR experiments were performed on isolated tracheal epithelium to identify adrenergic receptor mRNA. Results The adrenergic receptors alpha 1D, alpha 2A, beta 1 and beta 2 have been identified in isolated tracheal epithelium. We found epinephrine responsible for an increase in PTV, which could only be reduced by selective beta-receptor-inhibition. In addition, either GM or Zym prevented the epinephrine induced PTV increase. Furthermore, we observed a strong ROS generation evoked by GM or Zym. However, epinephrine induced increase in PTV recovered in the presence of GM and Zym after application of ROS scavengers. Conclusion Both GM or Zym trigger reversible ROS generation in tracheal tissue leading to inhibition of the beta-adrenergic increase in PTV.	[Weiterer, Sebastian; Uhle, Florian; Lichtenstern, Christoph; Weigand, Markus A.] Univ Heidelberg Hosp, Dept Anaesthesiol, Heidelberg, Germany; [Kohlen, Thomas; Sachs, Lydia; Henrich, Michael] Univ Giessen, Dept Anaesthesiol & Intens Care Med, D-35390 Giessen, Germany; [Veit, Florian] Univ Giessen, UGMLC, German Lung Ctr DZL, Excellencecluster Cardiopulm Syst ECCPS, D-35390 Giessen, Germany; [Henrich, Michael] St Vincentius Clin, Dept Anaesthesiol & Intens Care Med, Karlsruhe, Germany	Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; Justus Liebig University Giessen	Weiterer, S (corresponding author), Univ Heidelberg Hosp, Dept Anaesthesiol, Heidelberg, Germany.	Sebastian.Weiterer@med.uni-Heidelberg.de	Uhle, Florian/Q-6191-2019					Abraham G, 2003, BIOCHEM PHARMACOL, V66, P1067, DOI 10.1016/S0006-2952(03)00460-X; Affolter K, 2014, AM J RESP CRIT CARE, V190, P309, DOI 10.1164/rccm.201403-0431OC; ALOUSI AA, 1986, CIRCULATION, V73, P10; BARNES PJ, 1983, EXP LUNG RES, V5, P183, DOI 10.3109/01902148309061513; Becker MJ, 2003, BRIT J HAEMATOL, V121, P448, DOI 10.1046/j.1365-2141.2003.04308.x; Birket SE, 2014, AM J RESP CRIT CARE, V190, P421, DOI 10.1164/rccm.201404-0670OC; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Dostert C, 2007, NAT IMMUNOL, V8, P17, DOI 10.1038/ni0107-17; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Keiser NW, 2015, AM J RESP CELL MOL, V52, P683, DOI 10.1165/rcmb.2014-0250OC; Klein MK, 2009, EUR RESPIR J, V33, P1113, DOI 10.1183/09031936.00015108; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Konig P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004938; Lee TWR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005599.pub3; Makni-Maalej K, 2013, BIOCHEM PHARMACOL, V85, P92, DOI 10.1016/j.bcp.2012.10.010; Mear JB, 2014, INFECT IMMUN, V82, P306, DOI 10.1128/IAI.01085-13; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Rementeria Aitor, 2005, Revista Iberoamericana de Micologia, V22, P1, DOI 10.1016/S1130-1406(05)70001-2; Roux D, 2013, CRIT CARE MED, V41, pE191, DOI 10.1097/CCM.0b013e31828a25d6; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Shimizu T, 2010, J CLIN BIOCHEM NUTR, V47, P181, DOI 10.3164/jcbn.09-112; Smith SN, 1999, AM J RESP CELL MOL, V20, P129, DOI 10.1165/ajrcmb.20.1.3278; Stoltz DA, 2015, NEW ENGL J MED, V372, P1574, DOI 10.1056/NEJMc1502191; VERDUGO P, 1980, J APPL PHYSIOL, V48, P868, DOI 10.1152/jappl.1980.48.5.868; Wang Liang, 2014, Pak J Biol Sci, V17, P254; Weiterer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091705; Whitmore LC, 2014, AM J PHYSIOL-LUNG C, V307, pL71, DOI 10.1152/ajplung.00054.2014; Wyatt TA, 1998, AM J PHYSIOL-LUNG C, V275, pL827, DOI 10.1152/ajplung.1998.275.4.L827	28	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143163	10.1371/journal.pone.0143163	http://dx.doi.org/10.1371/journal.pone.0143163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571499	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700148
J	Zhang, Y; Zou, W; Zhang, YH; Ye, WM; Chen, XD; Liu, Q; Liu, HD; Si, CF; Jia, HY				Zhang, Yuan; Zou, Wen; Zhang, Yinghui; Ye, Weimin; Chen, Xingdong; Liu, Qian; Liu, Huandi; Si, Chunfeng; Jia, Hongying			Reducing Antibiotic Use for Young Children with Intussusception following Successful Air Enema Reduction	PLOS ONE			English	Article							MANAGEMENT; DIAGNOSIS	China introduced a new policy regarding the management of antibiotic use. We evaluated the reasonableness of antibiotic use among children suffering from intussusception before and after policy. A retrospective study was conducted involving 234 young children with intussusception who were treated between January 1, 2011 and December 30, 2013. Demographics and detailed antibiotics regimens were collected. chi(2) test was used to evaluate differences between the phase I (preintervention, n = 68) and phase II (postintervention, n = 166). We determined that the overall antibiotic use rate following successful air enema reduction was 41% (97/234), which decreased from 99% (67/68) in phase I to 18% (30/166) in phase II. In phase I, prophylactic antibiotic usage reached up to 84% (56/67). The quantity of aztreonam for injection accounted for 63% (45/71), and cefamandole nafate for injection accounted for 25% (18/71). In phases II, prophylactic antibiotic usage were reduced to 13% (4/30). The quantity of aztreonam for injection was decreased to 12% (4/33) and cefamandole nafate for injection was 3% (1/33). Antibiotics' options were more diverse. In conclusion, policy intervention was effective in addressing some aspects of antibacterial drug usage among young children with intussusception. However, excessive drug use remains a public health problem. The guidelines for the antibiotic management of intussusception for children must be established in China.	[Zhang, Yuan; Jia, Hongying] Shandong Univ, Hosp 2, Ctr Evidence Based Med, Jinan 250100, Shandong, Peoples R China; [Zou, Wen] Shandong Univ, Hosp 2, Dept Pharm, Jinan 250100, Shandong, Peoples R China; [Zhang, Yinghui] Shandong Univ, Hosp 2, Dept Med Records, Jinan 250100, Shandong, Peoples R China; [Ye, Weimin; Chen, Xingdong] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Liu, Qian] Shandong Univ, Hosp 2, Dept Pediat Surg, Jinan 250100, Shandong, Peoples R China; [Liu, Huandi; Si, Chunfeng] Shandong Univ, Hosp 2, Informat Ctr, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Karolinska Institutet; Shandong University; Shandong University	Jia, HY (corresponding author), Shandong Univ, Hosp 2, Ctr Evidence Based Med, Jinan 250100, Shandong, Peoples R China.	jiahongying@sdu.edu.cn		ye, weimin/0000-0002-6859-4648	Youth Fund of the 2nd Hospital of Shandong University [Y2013010071]	Youth Fund of the 2nd Hospital of Shandong University	The study was supported by Youth Fund of the 2nd Hospital of Shandong University (Y2013010071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tokhais T, 2012, J PEDIATR SURG, V47, P928, DOI 10.1016/j.jpedsurg.2012.01.050; [Anonymous], 2011, NOTICE SPECIAL RECTI; Arnold G, 2012, PEDIAT SURG, P1069; del-Pozo G, 1999, RADIOGRAPHICS, V19, P299, DOI 10.1148/radiographics.19.2.g99mr14299; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Ito Y, 2012, PEDIATR INT, V54, P948, DOI 10.1111/j.1442-200X.2012.03622_1.x; LEBEL MH, 1988, PEDIATR INFECT DIS J, V7, P331, DOI 10.1097/00006454-198805000-00009; Lochhead A, 2013, CLIN PEDIATR, V52, P1029, DOI 10.1177/0009922813506255; Mandeville K, 2012, PEDIATR EMERG CARE, V28, P842, DOI 10.1097/PEC.0b013e318267a75e; Ministry of Health C, 2004, GUID CLIN US ANT; Pepper VK, 2012, SURG CLIN N AM, V92, P505, DOI 10.1016/j.suc.2012.03.011; Somekh E, 1996, RADIOLOGY, V200, P217, DOI 10.1148/radiology.200.1.8657914; Waseem M, 2008, PEDIATR EMERG CARE, V24, P793, DOI 10.1097/PEC.0b013e31818c2a3e; Weckx L, 2012, BRAZ J OTORHINOLAR, V78, P2, DOI 10.1590/S1808-86942012000200001	14	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142999	10.1371/journal.pone.0142999	http://dx.doi.org/10.1371/journal.pone.0142999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569111	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700113
J	Li, J; You, Y; Yue, WH; Jia, MX; Yu, H; Lu, TL; Wu, ZL; Ruan, YY; Wang, LF; Zhang, D				Li, Jun; You, Yang; Yue, Weihua; Jia, Meixiang; Yu, Hao; Lu, Tianlan; Wu, Zhiliu; Ruan, Yanyan; Wang, Lifang; Zhang, Dai			Genetic Evidence for Possible Involvement of the Calcium Channel Gene CACNA1A in Autism Pathogenesis in Chinese Han Population	PLOS ONE			English	Article							HEMIPLEGIC MIGRAINE; CEREBELLUM; HYPOPLASIA; MUTATION; BEHAVIOR; REVEAL	Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders. Recent studies suggested that calcium channel genes might be involved in the genetic etiology of ASD. CACNA1A, encoding an alpha-1 subunit of voltage-gated calcium channel, has been reported to play an important role in neural development. Previous study detected that a single nucleotide polymorphism (SNP) in CACNA1A confers risk to ASD in Central European population. However, the genetic relationship between autism and CACNA1A in Chinese Han population remains unclear. To explore the association of CACNA1A with autism, we performed a family-based association study. First, we carried out a family-based association test between twelve tagged SNPs and autism in 239 trios. To further confirm the association, the sample size was expanded to 553 trios by recruiting 314 additional trios. In a total of 553 trios, we identified association of rs7249246 and rs12609735 with autism though this would not survive after Bonferroni correction. Our findings suggest that CACNA1A might play a role in the etiology of autism.	[Li, Jun; You, Yang; Yue, Weihua; Jia, Meixiang; Yu, Hao; Lu, Tianlan; Wu, Zhiliu; Ruan, Yanyan; Wang, Lifang; Zhang, Dai] Peking Univ, Hosp 6, Inst Mental Hlth, Beijing 100191, Peoples R China; [Li, Jun; You, Yang; Yue, Weihua; Jia, Meixiang; Yu, Hao; Lu, Tianlan; Wu, Zhiliu; Ruan, Yanyan; Wang, Lifang; Zhang, Dai] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100191, Peoples R China; [Li, Jun; You, Yang; Yue, Weihua; Jia, Meixiang; Yu, Hao; Lu, Tianlan; Wu, Zhiliu; Ruan, Yanyan; Wang, Lifang; Zhang, Dai] Peking Univ, Natl Clin Res Ctr Mental Disorders, Beijing 100191, Peoples R China; [Yu, Hao; Zhang, Dai] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100191, Peoples R China; [Zhang, Dai] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Wang, LF (corresponding author), Peking Univ, Hosp 6, Inst Mental Hlth, 51 Hua Yuan Bei Rd, Beijing 100191, Peoples R China.	lifangwang@bjmu.edu.cn; daizhang@bjmu.edu.cn	You, Yang/AEF-1080-2022; Yu, Hao/GYD-8698-2022; Jia, Mei/GXZ-9967-2022	You, Yang/0000-0003-0574-7827; Yu, Hao/0000-0002-9785-8489; 	National Natural Science Foundation of China [81471383, 81471360]; Beijing Municipal Science & Technology Commission [Z131107002213100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China (81471383, 81471360) (http://www.nsfc.gov.cn/) and the Beijing Municipal Science & Technology Commission (Z131107002213100) (http://mis.bjkw.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; Berney TP, 2000, BRIT J PSYCHIAT, V176, P20, DOI 10.1192/bjp.176.1.20; Bidaud I, 2006, BBA-MOL CELL RES, V1763, P1169, DOI 10.1016/j.bbamcr.2006.08.049; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cellot G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00070; COURCHESNE E, 1994, LANCET, V343, P63, DOI 10.1016/S0140-6736(94)90923-7; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Du XF, 2013, CELL, V154, P118, DOI 10.1016/j.cell.2013.05.059; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P171, DOI 10.1023/A:1019861721160; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Fujioka S, 2012, MOVEMENT DISORD, V27, P1578, DOI 10.1002/mds.25198; Garcia-Baro-Huarte M, 2014, PEDIATR NEUROL, V51, P557, DOI 10.1016/j.pediatrneurol.2014.07.008; Gargus JJ, 2009, ANN NY ACAD SCI, V1151, P133, DOI 10.1111/j.1749-6632.2008.03572.x; HASHIMOTO T, 1995, J AUTISM DEV DISORD, V25, P1, DOI 10.1007/BF02178163; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; KRUG DA, 1980, J CHILD PSYCHOL PSYC, V21, P221, DOI 10.1111/j.1469-7610.1980.tb01797.x; Liu XX, 2014, BIOCHEM BIOPH RES CO, V452, P244, DOI 10.1016/j.bbrc.2014.08.108; Lu ATH, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-18; Macintyre G, 2010, BIOINFORMATICS, V26, pi524, DOI 10.1093/bioinformatics/btq378; Mallmann RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078598; McCauley JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-1; Myers RA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001318; Natiq A, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-40; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Pietrobon D, 2010, PFLUG ARCH EUR J PHY, V460, P375, DOI 10.1007/s00424-010-0802-8; Pletikos M, 2014, NEURON, V81, P321, DOI 10.1016/j.neuron.2013.11.018; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rajakulendran S, 2012, NAT REV NEUROL, V8, P86, DOI 10.1038/nrneurol.2011.228; Russell MB, 2011, LANCET NEUROL, V10, P457, DOI 10.1016/S1474-4422(11)70048-5; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Segarra NG, 2014, J NEUROL SCI, V342, P69, DOI 10.1016/j.jns.2014.04.027; Skafidas E, 2014, MOL PSYCHIATR, V19, P504, DOI 10.1038/mp.2012.126; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Storm Niels, 2003, Methods Mol Biol, V212, P241; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wingate M, 2014, MMWR SURVEILL SUMM, V63	40	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142887	10.1371/journal.pone.0142887	http://dx.doi.org/10.1371/journal.pone.0142887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566276	Green Published, gold, Green Submitted			2022-12-26	WOS:000367628500064
J	Riano-Umbarila, L; Ledeznna-Candanoza, LM; Serrano-Posada, H; Fernandez-Taboada, G; Olamendi-Portugal, T; Rojas-Trejo, S; Gomez-Ramirez, IV; Rudino-Pinera, E; Possani, LD; Becerril, B				Riano-Umbarila, Lidia; Ledeznna-Candanoza, Luis M.; Serrano-Posada, Hugo; Fernandez-Taboada, Guillermo; Olamendi-Portugal, Timoteo; Rojas-Trejo, Sonia; Gomez-Ramirez, Ilse V.; Rudino-Pinera, Enrique; Possani, Lourival D.; Becerril, Baltazar			Optimal Neutralization of Centruroides noxius Venom Is Understood through a Structural Complex between Two Antibody Fragments and the Cn2 Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE SENSOR; ENHANCED ACTIVATION; SODIUM-CHANNELS; SCORPION; HOFFMANN; ELECTROSTATICS; COMPONENT	The current trend of using recombinant antibody fragments in research to develop novel antidotes against scorpion stings has achieved excellent results. The polyclonal character of commercial antivenoms, obtained through the immunization of animals and which contain several neutralizing antibodies that recognize different epitopes on the toxins, guarantees the neutralization of the venoms. To avoid the use of animals, we aimed to develop an equivalent recombinant antivenom composed of a few neutralizing single chain antibody fragments (scFvs) that bind to two different epitopes on the scorpion toxins. In this study, we obtained scFv RU1 derived from scFv C1. RU1 showed a good capacity to neutralize the Cn2 toxin and whole venom of the scorpion Centruroides noxius. Previously, we had produced scFv LR, obtained from a different parental fragment (scFv 3F). LR also showed a similar neutralizing capacity. The simultaneous administration of both scFvs resulted in improved protection, which was translated as a rapid recovery of previously poisoned animals. The crystallographic structure of the ternary complex scFv LR-Cn2-scFv RU1 allowed us to identify the areas of interaction of both scFvs with the toxin, which correspond to non-overlapping sites. The epitope recognized by scFv RU1 seems to be related to a greater efficiency in the neutralization of the whole venom. In addition, the structural analysis of the complex helped us to explain the cross-reactivity of these scFvs and how they neutralize the venom.	[Riano-Umbarila, Lidia; Ledeznna-Candanoza, Luis M.; Fernandez-Taboada, Guillermo; Olamendi-Portugal, Timoteo; Rojas-Trejo, Sonia; Gomez-Ramirez, Ilse V.; Rudino-Pinera, Enrique; Possani, Lourival D.; Becerril, Baltazar] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Apartado Postal 510-3, Cuernavaca 62250, Morelos, Mexico; [Serrano-Posada, Hugo] Univ Colima, Lab Bioingn, Km 9 Carretera Coquimatlan Colima, Coquimatlan 28400, Colima, Mexico	Universidad Nacional Autonoma de Mexico; Universidad de Colima	Becerril, B (corresponding author), Av Univ 2001, Cuernavaca 62210, Morelos, Mexico.	baltazar@ibt.unam.mx		Fernandez-Taboada, Guillermo/0000-0002-3224-630X; Serrano-Posada, Hugo/0000-0002-7901-475X; Gomez, Ilse/0000-0001-7200-2310; Riano-Umbarila, Lidia/0000-0002-2531-9232; Rudino-Pinera, Enrique/0000-0001-8170-6379	NIGMS, National Institutes of Health [GM-0080]; U.S. Department of Energy [DE-AC02-98CH10886]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE))	The National Synchrotron Light Source beamline X6A was funded by NIGMS, National Institutes of Health, Grant GM-0080 and U.S. Department of Energy Contract DE-AC02-98CH10886. We thank Dr. Humberto Flores for critically reading the manuscript. We also thank the animal facility services of Biotherium from the Instituto de Biotecnologia-Universidad Nacional Autonoma de Mexico and Cipriano Balderas, Fernando Zamudio, Mario Trejo, Martin Patino, and Fredy Coronas for technical assistance in various aspects of this study. Finally, we thank the staff at National Synchrotron Light Source beamline X6A, particularly Dr. Vivian Stojanoff, for the use of data collection facilities.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALAGON AC, 1988, COMP BIOCHEM PHYS B, V89, P153, DOI 10.1016/0305-0491(88)90277-5; [Anonymous], DESM MOL DYN SYST VE; [Anonymous], MAESTR DESM INT TOOL; [Anonymous], MAESTR VERS 9 3; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Canul-Tec JC, 2011, J BIOL CHEM, V286, P20892, DOI 10.1074/jbc.M111.238410; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chippaux JP, 2012, DRUG DES DEV THER, V6, P165, DOI 10.2147/DDDT.S24754; Chippaux JP, 1998, TOXICON, V36, P823, DOI 10.1016/S0041-0101(97)00160-8; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espino-Solis GP, 2009, J PROTEOMICS, V72, P183, DOI 10.1016/j.jprot.2009.01.020; Fabrichny IP, 2012, J BIOL CHEM, V287, P14136, DOI 10.1074/jbc.M111.315382; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pintar A, 1999, J MOL BIOL, V287, P359, DOI 10.1006/jmbi.1999.2611; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; RAMIREZ AN, 1994, TOXICON, V32, P479, DOI 10.1016/0041-0101(94)90300-X; Riano-Umbarila L, 2005, FEBS J, V272, P2591, DOI 10.1111/j.1742-4658.2005.04687.x; Riano-Umbarila L, 2013, TOXICON, V76, P370, DOI 10.1016/j.toxicon.2013.09.016; Riano-Umbarila L, 2011, J BIOL CHEM, V286, P6143, DOI 10.1074/jbc.M110.189175; Schiavon E, 2006, J BIOL CHEM, V281, P20326, DOI 10.1074/jbc.M600565200; Schiavon E, 2012, TOXICON, V59, P283, DOI 10.1016/j.toxicon.2011.12.003; Selisko B, 1999, PROTEINS, V37, P130, DOI 10.1002/(SICI)1097-0134(19991001)37:1&lt;130::AID-PROT13&gt;3.0.CO;2-S; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Tang CL, 2007, J MOL BIOL, V366, P1475, DOI 10.1016/j.jmb.2006.12.001; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; ZAMUDIO F, 1992, EUR J BIOCHEM, V204, P281, DOI 10.1111/j.1432-1033.1992.tb16635.x	40	13	14	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1619	1630		10.1074/jbc.M115.685297	http://dx.doi.org/10.1074/jbc.M115.685297			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26589800	Green Published, hybrid			2022-12-26	WOS:000368620700007
J	Urresti, J; Ruiz-Meana, M; Coccia, E; Arevalo, JC; Castellano, J; Fernandez-Sanz, C; Galenkamp, KMO; Planells-Ferrer, L; Moubarak, RS; Llecha-Cano, N; Reix, S; Garcia-Dorado, D; Barneda-Zahonero, B; Comella, JX				Urresti, Jorge; Ruiz-Meana, Marisol; Coccia, Elena; Carlos Arevalo, Juan; Castellano, Jose; Fernandez-Sanz, Celia; Galenkamp, Koen M. O.; Planells-Ferrer, Laura; Moubarak, Rana S.; Llecha-Cano, Nuria; Reix, Stephanie; Garcia-Dorado, David; Barneda-Zahonero, Bruna; Comella, Joan X.			Lifeguard Inhibits Fas Ligand-mediated Endoplasmic Reticulum-Calcium Release Mandatory for Apoptosis in Type II Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY; BAX INHIBITOR-1; NERVOUS-SYSTEM; PROTEIN FAMILY; DEATH; MITOCHONDRIA; MODULATION; EXPRESSION; BRAIN	Death receptors are members of the tumor necrosis factor receptor superfamily involved in the extrinsic apoptotic pathway. Lifeguard (LFG) is a death receptor antagonist mainly expressed in the nervous system that specifically blocks Fas ligand (FasL)-induced apoptosis. To investigate its mechanism of action, we studied its subcellular localization and its interaction with members of the Bcl-2 family proteins. We performed an analysis of LFG subcellular localization in murine cortical neurons and found that LFG localizes mainly to the ER and Golgi. We confirmed these results with subcellular fractionation experiments. Moreover, we show by co-immunoprecipitation experiments that LFG interacts with Bcl-X-L and Bcl-2, but not with Bax or Bak, and this interaction likely occurs in the endoplasmic reticulum. We further investigated the relationship between LFG and Bcl-XL in the inhibition of apoptosis and found that LFG protects only type II apoptotic cells from FasL-induced death in a Bcl-X-L XL dependent manner. The observation that LFG itself is not located in mitochondria raises the question as to whether LFG in the ER participates in FasL-induced death. Indeed, we investigated the degree of calcium mobilization after FasL stimulation and found that LFG inhibits calcium release from the ER, a process that correlates with LFG blockage of cytochrome c release to the cytosol and caspase activation. On the basis of our observations, we propose that there is a required step in the induction of type II apoptotic cell death that involves calcium mobilization from the ER and that this step is modulated by LFG.	[Urresti, Jorge; Coccia, Elena; Planells-Ferrer, Laura; Moubarak, Rana S.; Llecha-Cano, Nuria; Reix, Stephanie; Barneda-Zahonero, Bruna; Comella, Joan X.] Univ Vall Hebron, Cell Signalling & Apoptosis Grp, Inst Recerca Hosp, Barcelona 08035, Spain; [Ruiz-Meana, Marisol; Castellano, Jose; Fernandez-Sanz, Celia; Garcia-Dorado, David] Univ Vall Hebron, Lab Expt Cardiol, Inst Recerca Hosp, Barcelona 08035, Spain; [Urresti, Jorge; Planells-Ferrer, Laura; Barneda-Zahonero, Bruna; Comella, Joan X.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurociencies, Bellaterra, Spain; [Carlos Arevalo, Juan] Univ Salamanca, Inst Neurociencias Castilla & Leon, Dept Cell Biol & Pathol, Salamanca 37007, Spain; [Carlos Arevalo, Juan] Inst Biomed Res Salamanca, Salamanca 37007, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; University of Salamanca	Barneda-Zahonero, B (corresponding author), Cell Signalling & Apoptosis Grp, Passeig Vall Hebron 119-129, Barcelona 08035, Spain.	bruna.barneda@vhir.org; joan.comella@vhir.org	Galenkamp, Koen/AAH-3593-2020; Comella, Joan/GQA-4279-2022; Comella, Joan X/D-7333-2012; Arévalo, Juan Carlos/J-8154-2014	Galenkamp, Koen/0000-0001-7220-6516; Comella, Joan X/0000-0002-6218-0786; Arévalo, Juan Carlos/0000-0003-1994-3095; Barneda Zahonero, Bruna/0000-0002-6557-5222; Coccia, Elena/0000-0002-9849-2423; Fernandez-Sanz, Celia/0000-0002-3437-7792; Fernandez Sanz, Celia/0000-0002-0809-0675; Moubarak, Rana/0000-0003-2096-1258	Spanish Government Ministerio de Sanidad, Servicios Sociales e Igualdad (CIBERNED) [CB06/05/1104, PIE13/00027, BFU2008-00162]; Ministerio de Economia y Competitividad Grants [SAF2010-19953, SAF2013-47989-R, BFU2011-22898]; Generalitat de Catalunya [2011FI_B 00581, 2014SGR-1609]	Spanish Government Ministerio de Sanidad, Servicios Sociales e Igualdad (CIBERNED); Ministerio de Economia y Competitividad Grants; Generalitat de Catalunya(Generalitat de Catalunya)	This work was funded by the Spanish Government Ministerio de Sanidad, Servicios Sociales e Igualdad (CIBERNED) Grants CB06/05/1104 (to J.X.C.), PIE13/00027 (to D.G.-D. and J.X.C. and BFU2008-00162 (to J.C.A.); Ministerio de Economia y Competitividad Grants SAF2010-19953 and SAF2013-47989-R (to J.X.C.) and BFU2011-22898 (to J.C.A.), and Generalitat de Catalunya Grants 2011FI_B 00581 (to J.U.) and 2014SGR-1609 (to J.X.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Beier CP, 2005, J NEUROSCI, V25, P6765, DOI 10.1523/JNEUROSCI.1700-05.2005; Bernard-Marissal N, 2012, J NEUROSCI, V32, P4901, DOI 10.1523/JNEUROSCI.5431-11.2012; Bonneau B, 2013, BBA-MOL CELL RES, V1833, P1755, DOI 10.1016/j.bbamcr.2013.01.021; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; de Mendoza TH, 2011, P NATL ACAD SCI USA, V108, P17189, DOI 10.1073/pnas.1114226108; Distelhorst CW, 2004, ONCOGENE, V23, P2875, DOI 10.1038/sj.onc.1207519; Fernandez M, 2007, J NEUROCHEM, V103, P190, DOI 10.1111/j.1471-4159.2007.04767.x; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Hunsberger JG, 2011, BRAIN RES, V1403, P19, DOI 10.1016/j.brainres.2011.05.067; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacobs SBR, 2007, CELL DEATH DIFFER, V14, P1374, DOI 10.1038/sj.cdd.4402128; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kim JH, 2012, BBA-MOL CELL RES, V1823, P876, DOI 10.1016/j.bbamcr.2012.01.016; Kobayashi T, 2003, BRAIN RES, V960, P62, DOI 10.1016/S0006-8993(02)03767-8; Krajewska M, 2002, CELL DEATH DIFFER, V9, P145, DOI 10.1038/sj/cdd/4400934; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Lisak DA, 2015, BBA-MOL CELL RES, V1853, P2104, DOI 10.1016/j.bbamcr.2015.03.002; Marques-Fernandez F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.25; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; McDonald JH, 2013, J MICROSC-OXFORD, V252, P295, DOI 10.1111/jmi.12093; Nguyen M, 2000, MOL CELL BIOL, V20, P6731, DOI 10.1128/MCB.20.18.6731-6740.2000; Park CH, 1998, BIOCHEM BIOPH RES CO, V252, P623, DOI 10.1006/bbrc.1998.9572; Pasqualetto V, 2005, J LEUKOCYTE BIOL, V78, P1106, DOI 10.1189/jlb.0105047; Reich A, 2011, J NEUROSCI, V31, P225, DOI 10.1523/JNEUROSCI.2188-10.2011; Rovere P, 1996, J IMMUNOL, V156, P4631; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schneider TJ, 1999, J EXP MED, V189, P949, DOI 10.1084/jem.189.6.949; Schweitzer B, 2002, MOL BRAIN RES, V107, P47, DOI 10.1016/S0169-328X(02)00445-X; Schweitzer B, 1998, MOL CELL NEUROSCI, V11, P260, DOI 10.1006/mcne.1998.0697; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Thomenius MJ, 2003, J CELL SCI, V116, P4493, DOI 10.1242/jcs.00829; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Vacher P, 2011, ANTI-CANCER DRUG, V22, P481, DOI 10.1097/CAD.0b013e32834433ea; Wang B, 2003, J BIOL CHEM, V278, P14461, DOI 10.1074/jbc.M209684200; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200	49	15	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1221	1234		10.1074/jbc.M115.677682	http://dx.doi.org/10.1074/jbc.M115.677682			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26582200	Green Published, hybrid			2022-12-26	WOS:000368068300018
J	Torkzaban, B; Kayvanjoo, AH; Ardalan, A; Mousavi, S; Mariotti, R; Baldoni, L; Ebrahimie, E; Ebrahimi, M; Hosseini-Mazinani, M				Torkzaban, Bahareh; Kayvanjoo, Amir Hossein; Ardalan, Arman; Mousavi, Soraya; Mariotti, Roberto; Baldoni, Luciana; Ebrahimie, Esmaeil; Ebrahimi, Mansour; Hosseini-Mazinani, Mehdi			Machine Learning Based Classification of Microsatellite Variation: An Effective Approach for Phylogeographic Characterization of Olive Populations	PLOS ONE			English	Article							OLEA-EUROPAEA L.; CULTIVATED OLIVES; GENETIC DIVERSITY; IDENTIFICATION; MARKERS; WILD	Finding efficient analytical techniques is overwhelmingly turning into a bottleneck for the effectiveness of large biological data. Machine learning offers a novel and powerful tool to advance classification and modeling solutions in molecular biology. However, these methods have been less frequently used with empirical population genetics data. In this study, we developed a new combined approach of data analysis using microsatellite marker data from our previous studies of olive populations using machine learning algorithms. Herein, 267 olive accessions of various origins including 21 reference cultivars, 132 local ecotypes, and 37 wild olive specimens from the Iranian plateau, together with 77 of the most represented Mediterranean varieties were investigated using a finely selected panel of 11 microsatellite markers. We organized data in two '4-targeted' and '16-targeted' experiments. A strategy of assaying different machine based analyses (i.e. data cleaning, feature selection, and machine learning classification) was devised to identify the most informative loci and the most diagnostic alleles to represent the population and the geography of each olive accession. These analyses revealed microsatellite markers with the highest differentiating capacity and proved efficiency for our method of clustering olive accessions to reflect upon their regions of origin. A distinguished highlight of this study was the discovery of the best combination of markers for better differentiating of populations via machine learning models, which can be exploited to distinguish among other biological populations.	[Torkzaban, Bahareh; Ardalan, Arman; Mousavi, Soraya; Hosseini-Mazinani, Mehdi] Natl Inst Genet Engn & Biotechnol, Tehran, Iran; [Kayvanjoo, Amir Hossein; Ebrahimi, Mansour] Univ Qom, Sch Basic Sci, Dept Biol, Qom, Iran; [Ardalan, Arman] Royal Inst Technol, Dept Gene Technol, Sci Life Lab, KTH, Solna, Sweden; [Mariotti, Roberto; Baldoni, Luciana] CNR, Inst Biosci & Bioresources, Perugia, Italy; [Ebrahimie, Esmaeil] Shiraz Univ, Coll Agr, Inst Biotechnol, Shiraz, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Biol Sci, Dept Genet & Evolut, Adelaide, SA, Australia; [Ebrahimie, Esmaeil] Univ S Australia, Sch Informat Technol & Math Sci, Div Informat Technol Engn & Environm, Adelaide, SA 5001, Australia; [Ebrahimie, Esmaeil] Flinders Univ S Australia, Fac Sci & Engn, Sch Biol Sci, Adelaide, SA 5001, Australia	Royal Institute of Technology; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Shiraz University; University of Adelaide; University of South Australia; Flinders University South Australia	Ebrahimi, M (corresponding author), Univ Qom, Sch Basic Sci, Dept Biol, Qom, Iran.	mansour@future.org; hosseini@nigeb.ac.ir	Mousavi, Soraya/P-4604-2018; Ebrahimie, Esmaeil/AAN-2611-2020; Baldoni, Luciana/A-4411-2016; mariotti, roberto/AAG-7294-2021; Ebrahimi, Mansour/AAO-9096-2021	Mousavi, Soraya/0000-0002-4433-2512; Ebrahimie, Esmaeil/0000-0002-4431-2861; Baldoni, Luciana/0000-0002-3221-333X; mariotti, roberto/0000-0002-9111-5123; Ebrahimi, Mansour/0000-0001-7011-2567; Kayvanjoo, Amir Hossein/0000-0003-1315-8336; BALDONI, LUCIANA/0000-0002-6636-0055	National Institute of Genetic Engineering & Biotechnology (NIGEB), Iran [437]	National Institute of Genetic Engineering & Biotechnology (NIGEB), Iran	This study was supported by the National Institute of Genetic Engineering & Biotechnology (NIGEB), Iran, in the form of funds for project number 437.	Akthar F, 2012, RAPIDMINER 5 OPERATO; Alba V, 2009, SCI HORTIC-AMSTERDAM, V123, P11, DOI 10.1016/j.scienta.2009.07.007; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Baldoni L, 2009, MOL BREEDING, V24, P213, DOI 10.1007/s11032-009-9285-8; Beiki AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044164; Belaj A, 2003, THEOR APPL GENET, V107, P736, DOI 10.1007/s00122-003-1301-5; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Besnard G, 2007, J BIOGEOGR, V34, P736, DOI 10.1111/j.1365-2699.2006.01653.x; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Caruana Rich, 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865.[38]X; Dastkar E., 2013, Crop Breeding Journal, V3, P99; Diez CM, 2012, CROP SCI, V52, P211, DOI 10.2135/cropsci2011.02.0110; Ebrahimi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096984; Gomes S, 2012, GENETIC DIVERSITY IN PLANTS, P15; Grossman D, 2004, LEARNING BAYESIAN NE, P46; Guinand B, 2002, J HERED, V93, P260, DOI 10.1093/jhered/93.4.260; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hosseini-Mazinani M, 2013, IRANIAN OLIVE CATALO; Hosseini-Mazinani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093146; Hosseini-Mazinani S, 2002, ACTA HORTIC, V634, P145; Kaniewski D, 2012, BIOL REV, V87, P885, DOI 10.1111/j.1469-185X.2012.00229.x; Kingsford C, 2008, NAT BIOTECHNOL, V26, P1011, DOI 10.1038/nbt0908-1011; Kohavi Ronny, 2002, HDB DATA MINING KNOW, P267; Kotsiantis SB, 2007, FRONT ARTIF INTEL AP, V160, P3; Langley, 1994, SELECTION RELEVANT F, P171; Lewis D. D., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P4, DOI 10.1007/BFb0026666; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Mousavi S, 2014, GENET RESOUR CROP EV, V61, P775, DOI 10.1007/s10722-013-0071-4; Nasa C, 2012, INT J COMPUTER APPL, V52; Nasiri J, 2015, J THEORETICAL BIOL; Noormohammadi Z, 2012, GENET MOL RES, V11, P707, DOI 10.4238/2012.March.19.4; Noormohammadi Z, 2007, HORTSCIENCE, V42, P1545, DOI 10.21273/HORTSCI.42.7.1545; Noormohammadi Zahra, 2009, Acta Biologica Szegediensis, V53, P27; Omrani-Sabbaghi A, 2007, SCI HORTIC-AMSTERDAM, V112, P439, DOI 10.1016/j.scienta.2006.12.051; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Poljuha D, 2008, SCI HORTIC-AMSTERDAM, V115, P223, DOI 10.1016/j.scienta.2007.08.018; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sarri V, 2006, GENOME, V49, P1606, DOI 10.1139/G06-126; Schlecht J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000093; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Weiss S. M., 1990, COMPUTER SYSTEMS LEA; Zhang H., 2004, P 17 INT FLOR ART IN; Zhao YH, 2008, ADV SPACE RES, V41, P1955, DOI 10.1016/j.asr.2007.07.020	47	9	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143465	10.1371/journal.pone.0143465	http://dx.doi.org/10.1371/journal.pone.0143465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599001	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000365862600068
J	Beatty, CD; Andres, JA; Sherratt, TN				Beatty, Christopher D.; Andres, Jose A.; Sherratt, Thomas N.			Conspicuous Coloration in Males of the Damselfly Nehalennia irene (Zygoptera: Coenagrionidae): Do Males Signal Their Unprofitability to Other Males?	PLOS ONE			English	Article							SEXUAL SELECTION; MATE RECOGNITION; CUES; EVOLUTION; POLYMORPHISM; COMPETITION; EXPRESSION; BEHAVIOR; ODONATA; TRAIT	In damselflies, sexual colour dimorphism is commonly explained as a consequence of selection on traits that increase male attractiveness to females. However, while many species in the damselfly family Coenagrionidae (Insecta: Odonata) are sexually dimorphic, the males do not engage in displays, and male competition for mates resembles a "scramble". An alternative explanation for the sexual differences in coloration within these species is that sexual dimorphism has evolved as a sex-related warning signal, with males signalling their uprofitability as mates to other males, thereby avoiding harassment from conspecifics. We evaluated an underlying assumption of the theory that male-male harassment rate is influenced by colour by comparing harassment of males of the species Nehalennia irene that had been painted to make them appear: (i) similar to an unaltered male (blue), (ii) different from a male (orange) and (iii) more similar to a female (black). When caged together we found that blue-painted males experienced significantly lower harassment than black-painted males. When unpainted males were caged with each type of painted male we found that blue-painted males and the unpainted males housed in the same cages experienced lower rates of harassment than males housed in cages where some males were painted black, suggesting that a single, reliable signal of unprofitability may benefit the individuals that carry it. While our results do not in themselves demonstrate that sexual colour dimorphism originally evolved as an intra-specific warning signal, they do show that harassment is influenced by coloration, and that such selection could conceivably maintain male coloration as a warning signal.	[Beatty, Christopher D.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Beatty, Christopher D.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Andres, Jose A.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Sherratt, Thomas N.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Santa Clara University; Cornell University; University of Saskatchewan; Carleton University	Beatty, CD (corresponding author), Santa Clara Univ, Dept Biol, 500 El Camino Real, Santa Clara, CA 95053 USA.	cbeatty@scu.edu	Beatty, Christopher/ABE-6438-2020	Beatty, Christopher/0000-0003-2641-0000	Natural Sciences Engineering and Research Council of Canada (NSERC) [315748]; Canadian Fund for Innovation (CFI) [335414]	Natural Sciences Engineering and Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation)	This project was supported by funding awarded to Thomas N. Sherratt from the Natural Sciences Engineering and Research Council of Canada (NSERC grant #315748) and the Canadian Fund for Innovation (CFI grant #335414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Andres JA, 2002, ANIM BEHAV, V63, P677, DOI 10.1006/anbe.2001.1948; BATTIN TJ, 1993, B ZOOL, V60, P353, DOI 10.1080/11250009309355839; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Brownell VR, 2000, DAMSELFLIES DRAGONFL; Bybee SM, 2012, ORG DIVERS EVOL, V12, P241, DOI 10.1007/s13127-012-0090-6; CONRAD KF, 1992, BIOL J LINN SOC, V45, P255, DOI 10.1111/j.1095-8312.1992.tb00643.x; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbett PS, 1999, DRAGONFLIES BEHAV EC; Cordero A, 1998, ANIM BEHAV, V55, P185, DOI 10.1006/anbe.1997.0603; Cordero Rivera Adolfo, 2001, Animal Behaviour Forum, V61, pF1; Cordoba-Aguilar A, 2009, BEHAV ECOL SOCIOBIOL, V63, P751, DOI 10.1007/s00265-009-0709-6; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FINCKE OM, 1994, ANIM BEHAV, V47, P1249, DOI 10.1006/anbe.1994.1174; Fisher RA, 1930, GENETICAL THEORY NAT; GIBBONS DW, 1992, J ANIM ECOL, V61, P283, DOI 10.2307/5321; Gorb SN, 1998, J INSECT BEHAV, V11, P73, DOI 10.1023/A:1020818617066; Grether GF, 1996, EVOLUTION, V50, P1949, DOI 10.1111/j.1558-5646.1996.tb03582.x; Hooper RE, 1999, PHYSIOL ENTOMOL, V24, P364, DOI 10.1046/j.1365-3032.1999.00152.x; Iserbyt A, 2011, ECOL ENTOMOL, V36, P544, DOI 10.1111/j.1365-2311.2011.01300.x; Lam E., 2004, DAMSELFLIES NE GUIDE; LAVOIE-DORNIK J, 1988, Odonatologica, V17, P337; Miller MN, 1999, J INSECT BEHAV, V12, P801, DOI 10.1023/A:1020957110842; Papaj DR, 2005, P ROY SOC B-BIOL SCI, V272, P2519, DOI 10.1098/rspb.2005.3186; Poulton EB, 1890, COLOURS ANIMALS THEI; R Core Team, 2021, R LANGUAGE ENV STAT; ROBERTSON HM, 1985, ANIM BEHAV, V33, P805, DOI 10.1016/S0003-3472(85)80013-0; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Schultz TD, 2008, ANIM BEHAV, V76, P1357, DOI 10.1016/j.anbehav.2008.04.024; Sherratt TN, 2002, P ROY SOC B-BIOL SCI, V269, P741, DOI 10.1098/rspb.2001.1944; Sherratt TN, 2003, AM NAT, V162, P377, DOI 10.1086/378047; Sherratt TN, 2001, ANIM BEHAV, V62, P653, DOI 10.1006/anbe.2001.1789; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Ubukata H., 1987, ANIMAL SOC THEORIES; Van Gossum H, 2007, ECOSCIENCE, V14, P1, DOI 10.2980/1195-6860(2007)14[1:RIBNDS]2.0.CO;2; Van Gossum H, 2007, BIOL J LINN SOC, V90, P501, DOI 10.1111/j.1095-8312.2007.00740.x; Van Gossum H, 2011, EVOL ECOL, V25, P139, DOI 10.1007/s10682-010-9388-z; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Xu MZ, 2014, ANIM BEHAV, V92, P9, DOI 10.1016/j.anbehav.2014.03.016; YANG EC, 1991, J COMP PHYSIOL A, V169, P663	40	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142684	10.1371/journal.pone.0142684	http://dx.doi.org/10.1371/journal.pone.0142684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587979	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500013
J	Calderon, LE; Liu, S; Arnold, N; Breakall, B; Rollins, J; Ndinguri, M				Calderon, Lindsay E.; Liu, Shu; Arnold, Nova; Breakall, Bethany; Rollins, Joseph; Ndinguri, Margaret			Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration	PLOS ONE			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); ACETYLCHOLINE-RECEPTOR; MESENCHYMAL TRANSITION; CIGARETTE-SMOKING; MOUSE MODEL; METASTASIS; ACTIVATION; INHIBITION; INVASION; RISK	Objectives Calcium independent group VIA phospholipase A(2) (iPLA(2)beta) and Matrix Metalloproteinase-9 (MMP-9) are upregulated in many disease states; their involvement with cancer cell migration has been a recent subject for study. Further, the molecular mechanisms mediating nicotine-induced breast cancer cell progression have not been fully investigated. This study aims to investigate whether iPLA(2)beta mediates nicotine-induced breast cancer cell proliferation and migration through both in-vitro and in-vivo techniques. Subsequently, the ability of Bromoenol Lactone (BEL) to attenuate the severity of nicotine-induced breast cancer was examined. Method and Results We found that BEL significantly attenuated both basal and nicotine-induced 4T1 breast cancer cell proliferation, via an MTT proliferation assay. Breast cancer cell migration was examined by both a scratch and transwell assay, in which, BEL was found to significantly decrease both basal and nicotine-induced migration. Additionally, nicotine-induced MMP-9 expression was found to be mediated in an iPLA(2)beta dependent manner. These results suggest that iPLA(2)beta plays a critical role in mediating both basal and nicotine-induced breast cancer cell proliferation and migration in-vitro. In an in-vivo mouse breast cancer model, BEL treatment was found to significantly reduce both basal (p<0.05) and nicotine-induced tumor growth (p<0.01). Immunohistochemical analysis showed BEL decreased nicotine-induced MMP-9, HIF-1alpha, and CD31 tumor tissue expression. Subsequently, BEL was observed to reduce nicotine-induced lung metastasis. Conclusion The present study indicates that nicotine-induced migration is mediated by MMP-9 production in an iPLA(2)beta dependent manner. Our data suggests that BEL is a possible chemotherapeutic agent as it was found to reduce both nicotine-induced breast cancer tumor growth and lung metastasis.	[Calderon, Lindsay E.; Arnold, Nova; Breakall, Bethany; Rollins, Joseph] Eastern Kentucky Univ, Dept Biol, Richmond, KY 40475 USA; [Liu, Shu] Hebei Univ, Hlth Sci Ctr, Dept Physiol, Tianjin 071000, Hebei, Peoples R China; [Ndinguri, Margaret] Eastern Kentucky Univ, Dept Chem, Richmond, KY 40475 USA	Hebei University	Calderon, LE (corresponding author), Eastern Kentucky Univ, Dept Biol, Richmond, KY 40475 USA.	Lindsay.Calderon@eku.edu		Calderon, Lindsay/0000-0003-0919-0077	National Science Foundation [1355438]; Public Health Service Grant [GM102776]; Hebei Providence Nature Science Foundation [H2015201137]; Office Of The Director [1355438] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM102776] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Hebei Providence Nature Science Foundation; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Science Foundation, 1355438, Public Health Service Grant GM102776, and Hebei Providence Nature Science Foundation, H2015201137.	ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Akiba S, 2004, BIOL PHARM BULL, V27, P1174, DOI 10.1248/bpb.27.1174; Ali T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071748; Andersson G, 1997, J ORAL PATHOL MED, V26, P117, DOI 10.1111/j.1600-0714.1997.tb00033.x; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bavarva JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067252; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Calderon LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031850; Chen CS, 2011, BREAST CANCER RES TR, V125, P73, DOI 10.1007/s10549-010-0821-3; Choi JY, 2011, J BREAST CANCER, V14, P88, DOI 10.4048/jbc.2011.14.2.88; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Davis JA, 2005, J NEUROSCI, V25, P8708, DOI 10.1523/JNEUROSCI.2853-05.2005; Desantis C., 2013, CA CANC J CLIN; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Di Cello F, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-90; Faraglia B, 2003, CARCINOGENESIS, V24, P719, DOI 10.1093/carcin/bgg013; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Guha P, 2014, BREAST CANCER RES TR, V145, P5, DOI 10.1007/s10549-014-2912-z; Hao JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057495; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; Ho JN, 2010, MOL CANCER THER, V9, P825, DOI 10.1158/1535-7163.MCT-09-0904; Jayakumar R, 2012, FOOD CHEM, V134, P1580, DOI 10.1016/j.foodchem.2012.03.101; Jo M, 2013, FREE RADICAL BIO MED, V61, P453, DOI 10.1016/j.freeradbiomed.2013.04.032; Johnson KC, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.035931; Kanaya N, 2014, NUTR CANCER, V66, P242, DOI 10.1080/01635581.2014.863366; Kispert S, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12318; Kispert SE, 2014, AM J PHYSIOL-CELL PH, V307, pC951, DOI 10.1152/ajpcell.00218.2014; Lee CH, 2011, BREAST CANCER RES TR, V129, P331, DOI 10.1007/s10549-010-1209-0; Lee SJ, 2013, PLANTA MED; Li H, 2011, AM J PATHOL, V179, P452, DOI 10.1016/j.ajpath.2011.03.027; Liu S, 2013, ARTERIOSCL THROM VAS, V33, P1568, DOI 10.1161/ATVBAHA.112.300820; Liu S, 2012, J BIOL CHEM, V287, P24739, DOI 10.1074/jbc.M112.340216; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040480; Luo JH, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1016; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Mandal CC, 2010, BIOCHEM BIOPH RES CO, V402, P602, DOI 10.1016/j.bbrc.2010.10.063; McHowat J, 2011, AM J PHYSIOL-CELL PH, V300, pC825, DOI 10.1152/ajpcell.00502.2010; Momi N, 2013, ONCOGENE, V32, P1384, DOI 10.1038/onc.2012.163; Murin S, 2004, CHEST, V125, P1467, DOI 10.1378/chest.125.4.1467; Nicotera TM, 2009, PROSTATE, V69, P1270, DOI 10.1002/pros.20968; Nikolic DM, 2007, J BIOL CHEM, V282, P33405, DOI 10.1074/jbc.M704133200; Nishioka T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3055; Nyante SJ, 2014, BRIT J CANCER, V110, P2339, DOI 10.1038/bjc.2014.132; Pierce JP, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt359; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Radenkovic S, 2013, CELL BIOCH BIOPHYSIC; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Saab-Aoude S, 2013, BIOCHIMIE, V95, P903, DOI 10.1016/j.biochi.2012.12.008; Song Y, 2007, BIOCHEM J, V406, P427, DOI 10.1042/BJ20070631; Sun B, 2010, BIOCHEM PHARMACOL, V79, P1727, DOI 10.1016/j.bcp.2010.02.005; Talhout R, 2011, INT J ENV RES PUB HE, V8, P613, DOI 10.3390/ijerph8020613; Vadali S, 2014, J LEUKOCYTE BIOL, V96, P873, DOI 10.1189/jlb.2A0414-214R; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025436; Wang SX, 2012, NAT MED, V18, P902, DOI 10.1038/nm.2711; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wilkinson DS, 2013, PSYCHOPHARMACOLOGY, V225, P201, DOI 10.1007/s00213-012-2808-8; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	62	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143277	10.1371/journal.pone.0143277	http://dx.doi.org/10.1371/journal.pone.0143277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588686	Green Published, gold, Green Submitted			2022-12-26	WOS:000365251500049
J	Semple, BD; Noble-Haeusslein, LJ; Gooyit, M; Tercovich, KG; Peng, ZH; Nguyen, TT; Schroeder, VA; Suckow, MA; Chang, M; Raber, J; Trivedi, A				Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Gooyit, Major; Tercovich, Kayleen G.; Peng, Zhihong; Nguyen, Trung T.; Schroeder, Valerie A.; Suckow, Mark A.; Chang, Mayland; Raber, Jacob; Trivedi, Alpa			Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; GENE KNOCK-OUT; MATRIX METALLOPROTEINASES; CEREBROSPINAL-FLUID; HEMORRHAGIC TRANSFORMATION; HYPOXIA-ISCHEMIA; TISSUE INHIBITOR; MESSENGER-RNA; NEURONAL LOSS	The gelatinases, matrix metalloproteinases (MMP)-2 and MMP-9, are thought to be key mediators of secondary damage in adult animal models of brain injury. Moreover, an acute increase in these proteases in plasma and brain extracellular fluid of adult patients with moderate-to-severe traumatic brain injuries (TBIs) is associated with poorer clinical outcomes and mortality. Nonetheless, their involvement after TBI in the pediatric brain remains understudied. Using a murine model of TBI at postnatal day 21 (p21), approximating a toddler-aged child, we saw upregulation of active and pro-MMP-9 and MMP-2 by gelatin zymography at 48 h post-injury. We therefore investigated the role of gelatinases on long-term structural and behavioral outcomes after injury after acute inhibition with a selective gelatinase inhibitor, p-OH SB-3CT. After systemic administration, p-OH SB-3CT crossed the blood-brain barrier at therapeutically-relevant concentrations. TBI at p21 induced hyperactivity, deficits in spatial learning and memory, and reduced sociability when mice were assessed at adulthood, alongside pronounced tissue loss in key neuroanatomical regions. Acute and short-term post-injury treatment with p-OH SB-3CT did not ameliorate these long-term behavioral, cognitive, or neuropathological deficits as compared to vehicle-treated controls, suggesting that these deficits were independent of MMP-9 and MMP-2 upregulation. These findings emphasize the vulnerability of the immature brain to the consequences of traumatic injuries. However, early upregulation of gelatinases do not appear to be key determinants of long-term recovery after an early-life injury.	[Semple, Bridgette D.; Noble-Haeusslein, Linda J.; Tercovich, Kayleen G.; Trivedi, Alpa] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94117 USA; [Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Parkville, Vic 3052, Australia; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil, San Francisco, CA 94143 USA; [Gooyit, Major; Peng, Zhihong; Nguyen, Trung T.; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Div Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Div Neurosci, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Radiat Med, Div Neurosci, Portland, OR 97201 USA	University of California System; University of California San Francisco; Royal Melbourne Hospital; University of Melbourne; University of California System; University of California San Francisco; University of Notre Dame; University of Notre Dame; University of Notre Dame; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Trivedi, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94117 USA.	alpa.mahuvakar@ucsf.edu	Tercovich, Kayleen/I-8941-2018; Peng, Zhihong/T-1359-2019	Tercovich, Kayleen/0000-0003-0450-8912; Peng, Zhihong/0000-0002-2764-4645; Suckow, Mark/0000-0001-7317-697X; Peng, Zhihong/0000-0002-3502-4657; Semple, Bridgette/0000-0002-2535-0491	National Institute of Neurological Disorders and Stroke [RO1NS077767, RO1NS050159]; Australian National Health and Medical Research Council [1052505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050159, R01NS077767] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	LJN received two grants from the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) with grant numbers RO1NS077767 and RO1NS050159. BDS received a CJ Martin Early Career Fellowship from the Australian National Health and Medical Research Council with award number 1052505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2008, SEMIN CELL DEV BIOL, V19, P42, DOI 10.1016/j.semcdb.2007.06.003; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahi M, 2001, NEUROREPORT, V12, P3003, DOI 10.1097/00001756-200109170-00050; Bednarek N, 2012, PEDIATR RES, V71, P63, DOI 10.1038/pr.2011.3; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Copin JC, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-83; Cui J, 2012, MOL NEURODEGENER, V7, P1750; Davis MJ, 2012, BEHAV BRAIN RES, V229, P21, DOI 10.1016/j.bbr.2011.12.037; Demestre M, 2005, J NEUROIMMUNOL, V159, P146, DOI 10.1016/j.jneuroim.2004.09.015; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dragun P, 2008, J PHYSIOL PHARMACOL, V59, P441; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fager N, 2000, MECH DEVELOP, V98, P105, DOI 10.1016/S0925-4773(00)00437-8; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fernandez Eva, 2011, Pharmaceutics, V3, P53, DOI 10.3390/pharmaceutics3010053; Gooyit M, 2013, J MED CHEM, V56, P8139, DOI 10.1021/jm401217d; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hsu JYC, 2006, J NEUROSCI, V26, P9841, DOI 10.1523/JNEUROSCI.1993-06.2006; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Jia F, 2014, J NEUROTRAUM, V24, P24; Jiang XF, 2001, NEUROSCI LETT, V305, P41, DOI 10.1016/S0304-3940(01)01800-6; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Kawai N, 2003, J NEUROTRAUM, V20, P649, DOI 10.1089/089771503322144563; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Konrad K, 2003, COGNITIVE BRAIN RES, V16, P425, DOI 10.1016/S0926-6410(03)00057-0; Lazarov O, 2006, J NEUROSCI, V26, P429, DOI 10.1523/JNEUROSCI.3961-05.2006; Lee M, 2005, ORG LETT, V7, P4463, DOI 10.1021/ol0517269; Lee M, 2007, CHEM BIOL DRUG DES, V70, P371, DOI 10.1111/j.1747-0285.2007.00577.x; Liu CL, 2014, TURK NEUROSURG, V24, P363, DOI 10.5137/1019-5149.JTN.8551-13.0; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lorente Leonardo, 2014, PLoS One, V9, pe94370, DOI 10.1371/journal.pone.0094370; Lu A, 2013, NEUROSCIENCE, V253, P361, DOI 10.1016/j.neuroscience.2013.08.068; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Muradashvili N, 2014, METAB BRAIN DIS, V29, P29; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Oh LYS, 1999, J NEUROSCI, V19, P8464; Omouendze PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071263; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Pardridge William M, 2005, NeuroRx, V2, P1, DOI 10.1602/neurorx.2.1.1; Pastrana E, 2006, J NEUROSCI, V26, P5347, DOI 10.1523/JNEUROSCI.1111-06.2006; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Ranasinghe HS, 2012, DEV NEUROSCI-BASEL, V34, P417, DOI 10.1159/000343257; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Semple BD, 2015, NEUROBIOL DIS, P74; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Strolin Benedetti M, 2005, Expert Opin Drug Metab Toxicol, V1, P447; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Vaillant C, 1999, J NEUROSCI, V19, P4994; Verslegers M, 2015, BRAIN STRUCT FUNCT, V220, P1601, DOI 10.1007/s00429-014-0747-3; Verslegers M, 2013, PROG NEUROBIOL, V105, P60, DOI 10.1016/j.pneurobio.2013.03.004; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yang M, 2011, CURR PROT NEUROSCI, V8; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zheng KB, 2013, NEUROL INDIA, V61, P606, DOI 10.4103/0028-3886.125258	89	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143386	10.1371/journal.pone.0143386	http://dx.doi.org/10.1371/journal.pone.0143386			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588471	Green Published, gold			2022-12-26	WOS:000365251500056
J	Sung, U; Sepehri-Rad, M; Piao, HH; Jin, L; Hughes, T; Cohen, LB; Baker, BJ				Sung, Uhna; Sepehri-Rad, Masoud; Piao, Hong Hua; Jin, Lei; Hughes, Thomas; Cohen, Lawrence B.; Baker, Bradley J.			Developing Fast Fluorescent Protein Voltage Sensors by Optimizing FRET Interactions	PLOS ONE			English	Article							ACTION-POTENTIALS; OPTICAL ELECTROPHYSIOLOGY; SENSING PHOSPHATASE; ELECTRICAL-ACTIVITY; DYNAMIC-RANGE; NEURONS; DOMAIN; GREEN; DIMERIZATION; SPIKING	FRET (Forster Resonance Energy Transfer)-based protein voltage sensors can be useful for monitoring neuronal activity in vivo because the ratio of signals between the donor and acceptor pair reduces common sources of noise such as heart beat artifacts. We improved the performance of FRET based genetically encoded Fluorescent Protein (FP) voltage sensors by optimizing the location of donor and acceptor FPs flanking the voltage sensitive domain of the Ciona intestinalis voltage sensitive phosphatase. First, we created 39 different "Nabi1" constructs by positioning the donor FP, UKG, at 8 different locations downstream of the voltage-sensing domain and the acceptor FP, mKO, at 6 positions upstream. Several of these combinations resulted in large voltage dependent signals and relatively fast kinetics. Nabi1 probes responded with signal size up to 11%Delta F/F for a 100 mV depolarization and fast response time constants both for signal activation (similar to 2ms) and signal decay (similar to 3ms). We improved expression in neuronal cells by replacing the mKO and UKG FRET pair with Clover (donor FP) and mRuby2 (acceptor FP) to create Nabi2 probes. Nabi2 probes also had large signals and relatively fast time constants in HEK293 cells. In primary neuronal culture, a Nabi2 probe was able to differentiate individual action potentials at 45 Hz.	[Sung, Uhna; Sepehri-Rad, Masoud; Piao, Hong Hua; Cohen, Lawrence B.; Baker, Bradley J.] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Jin, Lei; Cohen, Lawrence B.] Yale Univ, Sch Med, Dept Mol & Cellular Physiol, New Haven, CT USA; [Hughes, Thomas] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Korea Institute of Science & Technology (KIST); Yale University; Montana State University System; Montana State University Bozeman	Sung, U (corresponding author), Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea.	uhna.sung@gmail.com; lawrence.b.cohen@hotmail.com; bradley.baker19@gmail.com	Baker, Bradley/P-5047-2016	Baker, Bradley/0000-0003-4652-5585; Hughes, Thomas/0000-0002-8430-070X	National Institute of Health, USA [DC005259, U24NS057631]; World Class Institute program of the National Research Foundation of Korea [WCI 2009-003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS057631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC005259, R01DC005259] Funding Source: NIH RePORTER	National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class Institute program of the National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: This work was supported by: DC005259, and U24NS057631 from National Institute of Health, USA; www.nih.gov; the World Class Institute program of the National Research Foundation of Korea grant Number WCI 2009-003, www.nrf.re.kr/nrf_eng_cms/.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Akemann W, 2009, BIOPHYS J, V96, P3959, DOI 10.1016/j.bpj.2009.02.046; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Gong YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4674; Hochbaum DR, 2014, NAT METHODS, V11, P825, DOI [10.1038/NMETH.3000, 10.1038/nmeth.3000]; Jensen KK, 2001, BIOCHEMISTRY-US, V40, P938, DOI 10.1021/bi001765m; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Jung A, 2015, NEUROPHOTON IN PRESS, V2; Kotera I, 2010, ACS CHEM BIOL, V5, P215, DOI 10.1021/cb900263z; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; LOEW LM, 1985, BIOPHYS J, V47, P71, DOI 10.1016/S0006-3495(85)83878-9; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Perron A, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.005.2009; Piao HH, 2015, J NEUROSCI, V35, P372, DOI 10.1523/JNEUROSCI.3008-14.2015; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; St-Pierre F, 2014, NAT NEUROSCI, V17, P884, DOI 10.1038/nn.3709; Storace DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10212; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Tsutsui H, 2013, J PHYSIOL-LONDON, V591, P4427, DOI 10.1113/jphysiol.2013.257048; Tsutsui H, 2013, BIOPHYS J, V105, P108, DOI 10.1016/j.bpj.2013.05.051; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Villalba-Galea CA, 2013, J GEN PHYSIOL, V142, P543, DOI 10.1085/jgp.201310993; Vinkenborg JL, 2007, CHEMBIOCHEM, V8, P1119, DOI 10.1002/cbic.200700109; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zou P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5625	30	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0141585	10.1371/journal.pone.0141585	http://dx.doi.org/10.1371/journal.pone.0141585			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587834	gold, Green Published, Green Submitted			2022-12-26	WOS:000365251500004
J	Asadzadeh, M; Ahmad, S; Hagen, F; Meis, JF; Al-Sweih, N; Khan, Z				Asadzadeh, Mohammad; Ahmad, Suhail; Hagen, Ferry; Meis, Jacques F.; Al-Sweih, Noura; Khan, Ziauddin			Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis	PLOS ONE			English	Article							ANTIFUNGAL SUSCEPTIBILITY PROFILES; FLIGHT MASS-SPECTROMETRY; SENSU-LATO; GENETIC DIVERSITY; C-PARAPSILOSIS; IDENTIFICATION; METAPSILOSIS; DIFFERENTIATION; PREVALENCE; REVEALS	Candida parapsilosis has now emerged as the second or third most important cause of healthcare-associated Candida infections. Molecular studies have shown that phenotypically identified C. parapsilosis isolates represent a complex of three species, namely, C. parapsilosis, C. orthopsilosis and C. metapsilosis. Lodderomyces elongisporus is another species phenotypically closely related to the C. parapsilosis-complex. The aim of this study was to develop a simple, low cost multiplex (m) PCR assay for species-specific identification of C. parapsilosis complex isolates and to study genetic relatedness of C. orthopsilosis isolates in Kuwait. Species-specific amplicons from C. parapsilosis (171 bp), C. orthopsilosis (109 bp), C. metapsilosis (217 bp) and L. elongisporus (258 bp) were obtained in mPCR. Clinical isolates identified as C. parapsilosis (n = 380) by Vitek2 in Kuwait and an international collection of 27 C. parapsilosis complex and L. elongisporus isolates previously characterized by rDNA sequencing were analyzed to evaluate mPCR. Species-specific PCR and DNA sequencing of internal transcribed spacer (ITS) region of rDNA were performed to validate the results of mPCR. Fingerprinting of 19 clinical C. orthopsilosis isolates (including 4 isolates from a previous study) was performed by amplified fragment length polymorphism (AFLP) analysis. Phenotypically identified C. parapsilosis isolates (n = 380) were identified as C. parapsilosis sensu stricto (n = 361), C. orthopsilosis (n = 15), C. metapsilosis (n = 1) and L. elongisporus (n = 3) by mPCR. The mPCR also accurately detected all epidemiologically unrelated C. parapsilosis complex and L. elongisporus isolates. The 19 C. orthopsilosis isolates obtained from 16 patients were divided into 3 haplotypes based on ITS region sequence data. Seven distinct genotypes were identified among the 19 C. orthopsilosis isolates by AFLP including a dominant genotype (AFLP1) comprising 11 isolates recovered from 10 patients. A rapid, low-cost mPCR assay for detection and differentiation of C. parapsilosis, C. orthopsilosis, C. metapsilosis and L. elongisporus has been developed.	[Asadzadeh, Mohammad; Ahmad, Suhail; Al-Sweih, Noura; Khan, Ziauddin] Kuwait Univ, Fac Med, Dept Microbiol, Safat, Kuwait; [Hagen, Ferry; Meis, Jacques F.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Meis, Jacques F.] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands	Kuwait University; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	Khan, Z (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Safat, Kuwait.	Zkhan@hsc.edu.kw	Meis, Jacques F/A-9241-2010; Hagen, Ferry/B-9044-2009; Ahmad, Suhail/AAJ-5456-2021	Meis, Jacques F/0000-0003-3253-6080; Hagen, Ferry/0000-0002-5622-1916; asadzadeh, Mohammad/0000-0002-9151-1505	College of Graduate Studies, Kuwait University;  [SRUL 02/13]	College of Graduate Studies, Kuwait University; 	The study was supported by College of Graduate Studies, Kuwait University and Research Core Facility Grant No. SRUL 02/13.	Ahmad S, 2004, INT J MED MICROBIOL, V294, P45, DOI 10.1016/j.ijmm.2004.01.002; Asadzadeh M, 2008, MYCOSES, V51, P318, DOI 10.1111/j.1439-0507.2008.01492.x; Asadzadeh M, 2009, J MED MICROBIOL, V58, P745, DOI 10.1099/jmm.0.008235-0; Barbedo LS, 2015, J MED MICROBIOL, V64, P7, DOI 10.1099/jmm.0.080655-0; Bonfietti LX, 2012, J MED MICROBIOL, V61, P1003, DOI 10.1099/jmm.0.037812-0; Canton E, 2011, ANTIMICROB AGENTS CH, V55, P5590, DOI 10.1128/AAC.00466-11; Chao QT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109376; Chen CY, 2015, J ANTIMICROB CHEMOTH, V70, P1531, DOI 10.1093/jac/dku540; Chen YC, 2010, DIAGN MICR INFEC DIS, V68, P284, DOI 10.1016/j.diagmicrobio.2010.07.004; Clinical and Laboratory standards Institute, 2012, M27S4 CLIN LAB STAND; Cornet M, 2011, J MOL DIAGN, V13, P12, DOI 10.1016/j.jmoldx.2010.11.014; De Carolis E, 2014, MED MYCOL, V52, P123, DOI 10.1093/mmy/myt009; Vercher MD, 2011, INT J MED MICROBIOL, V301, P531, DOI 10.1016/j.ijmm.2011.02.001; Feng XB, 2014, J CLIN MICROBIOL, V52, P1758, DOI 10.1128/JCM.00105-14; Feng XB, 2012, MYCOPATHOLOGIA, V173, P229, DOI 10.1007/s11046-011-9496-5; Gago S, 2014, MED MYCOL, V52, P470, DOI 10.1093/mmy/myu009; Garcia-Effron G, 2011, J CLIN MICROBIOL, V49, P3257, DOI 10.1128/JCM.00508-11; Ghosh AK, 2015, CLIN MICROBIOL INFEC, V21, P372, DOI 10.1016/j.cmi.2014.11.009; Hays C, 2011, J MED MICROBIOL, V60, P477, DOI 10.1099/jmm.0.026633-0; Hospenthal Duane R, 2006, Ann Clin Microbiol Antimicrob, V5, P1, DOI 10.1186/1476-0711-5-1; Illnait-Zaragozi MT, 2012, MYCOSES, V55, pe138, DOI 10.1111/j.1439-0507.2012.02168.x; Jamal WY, 2014, INT J INFECT DIS, V26, P167, DOI 10.1016/j.ijid.2014.05.031; Khan ZU, 2008, ANTON LEEUW INT J G, V94, P343, DOI 10.1007/s10482-008-9251-1; Khan ZU, 2010, ANTON LEEUW INT J G, V97, P253, DOI 10.1007/s10482-009-9406-8; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P374, DOI 10.1128/JCM.01790-07; Merseguel KB, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0793-3; Mirhendi H, 2010, J MED MICROBIOL, V59, P414, DOI 10.1099/jmm.0.017293-0; ODDS FC, 1994, J CLIN MICROBIOL, V32, P1923, DOI 10.1128/JCM.32.8.1923-1929.1994; Oliveira VKP, 2014, PEDIATR NEONATOL, V55, P75, DOI 10.1016/j.pedneo.2013.07.006; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Pryszcz LP, 2014, GENOME BIOL EVOL, V6, P1069, DOI 10.1093/gbe/evu082; Riccombeni A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035750; Romeo O, 2012, DIAGN MICR INFEC DIS, V72, P234, DOI 10.1016/j.diagmicrobio.2011.12.002; Ruiz LD, 2013, MYCOPATHOLOGIA, V175, P231, DOI 10.1007/s11046-013-9616-5; Sahand IH, 2009, J MED MICROBIOL, V58, P1437, DOI 10.1099/jmm.0.011320-0; Sai SX, 2011, EUKARYOT CELL, V10, P578, DOI 10.1128/EC.00276-10; Silva AP, 2009, J CLIN MICROBIOL, V47, P2392, DOI 10.1128/JCM.02379-08; Souza ACR, 2012, J CLIN MICROBIOL, V50, P2310, DOI 10.1128/JCM.00303-12; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tavanti A, 2007, J CLIN MICROBIOL, V45, P1455, DOI 10.1128/JCM.00243-07; Tavanti A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-203; Tay ST, 2009, J MED MICROBIOL, V58, P185, DOI 10.1099/jmm.0.004242-0; Trabasso P, 2015, MYCOPATHOLOGIA, V179, P53, DOI 10.1007/s11046-014-9830-9; Zhu YX, 2015, MYCOPATHOLOGIA, V179, P111, DOI 10.1007/s11046-014-9821-x	46	38	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142880	10.1371/journal.pone.0142880	http://dx.doi.org/10.1371/journal.pone.0142880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580965	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600065
J	Ben-Simhon, Z; Judeinstein, S; Trainin, T; Harel-Beja, R; Bar-Ya'akov, I; Borochov-Neori, H; Holland, D				Ben-Simhon, Zohar; Judeinstein, Sylvie; Trainin, Taly; Harel-Beja, Rotem; Bar-Ya'akov, Irit; Borochov-Neori, Hamutal; Holland, Doron			A "White" Anthocyanin-less Pomegranate (Punica granatum L.) Caused by an Insertion in the Coding Region of the Leucoanthocyanidin Dioxygenase (LDOX; ANS) Gene	PLOS ONE			English	Article							ONIONS ALLIUM-CEPA; FRUIT CHARACTERISTICS; PINK TRAIT; BIOSYNTHESIS; ARABIDOPSIS; SYNTHASE; EXPRESSION; MUTANT; ACCUMULATION; MUTATION	Color is an important determinant of pomegranate fruit quality and commercial value. To understand the genetic factors controlling color in pomegranate, chemical, molecular and genetic characterization of a "white" pomegranate was performed. This unique accession is lacking the typical pomegranate color rendered by anthocyanins in all tissues of the plant, including flowers, fruit (skin and arils) and leaves. Steady-state gene-expression analysis indicated that none of the analyzed "white" pomegranate tissues are able to synthesize mRNA corresponding to the PgLDOX gene (leucoanthocyanidin dioxygenase, also called ANS, anthocyanidin synthase), which is one of the central structural genes in the anthocyanin-biosynthesis pathway. HPLC analysis revealed that none of the "white" pomegranate tissues accumulate anthocyanins, whereas other flavonoids, corresponding to biochemical reactions upstream of LDOX, were present. Molecular analysis of the "white" pomegranate revealed the presence of an insertion and an SNP within the coding region of PgLDOX. It was found that the SNP does not change amino acid sequence and is not fully linked with the "white" phenotype in all pomegranate accessions from the collection. On the other hand, genotyping of pomegranate accessions from the collection and segregating populations for the "white" phenotype demonstrated its complete linkage with the insertion, inherited as a recessive single-gene trait. Taken together, the results indicate that the insertion in PgLDOX is responsible for the "white" anthocyanin-less phenotype. These data provide the first direct molecular, genetic and chemical evidence for the effect of a natural modification in the LDOX gene on color accumulation in a fruit-bearing woody perennial deciduous tree. This modification can be further utilized to elucidate the physiological role of anthocyanins in protecting the tree organs from harmful environmental conditions, such as temperature and UV radiation.	[Ben-Simhon, Zohar; Trainin, Taly; Harel-Beja, Rotem; Bar-Ya'akov, Irit; Holland, Doron] Agr Res Org, Newe Yaar Res Ctr, Unit Deciduous Fruit Tree Sci, IL-30095 Ramat Yishay, Israel; [Ben-Simhon, Zohar] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Judeinstein, Sylvie; Borochov-Neori, Hamutal] Southern Arava Res & Dev, IL-88820 Hevel Eilot, Israel	Technion Israel Institute of Technology	Holland, D (corresponding author), Agr Res Org, Newe Yaar Res Ctr, Unit Deciduous Fruit Tree Sci, POB 1021, IL-30095 Ramat Yishay, Israel.	vhhollan@volcani.agri.gov.il			Israeli Ministry of Agriculture & Rural Development; Jewish National Fund (KKL); JCA Charitable Foundation	Israeli Ministry of Agriculture & Rural Development; Jewish National Fund (KKL); JCA Charitable Foundation	The authors thank the Chief Scientist of the Israeli Ministry of Agriculture & Rural Development for financing the pomegranate breeding program. The authors also thank the Jewish National Fund (KKL) and the JCA Charitable Foundation for additional financial support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Appelhagen I, 2011, GENE, V484, P62, DOI 10.1016/j.gene.2011.05.031; Bassolino L, 2013, NEW PHYTOL, V200, P650, DOI 10.1111/nph.12524; Ben-Simhon Z, 2011, PLANTA, V234, P865, DOI 10.1007/s00425-011-1438-4; Borochov-Neori H, 2011, J AGR FOOD CHEM, V59, P5325, DOI 10.1021/jf2003688; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Debes MA, 2011, AM J BOT, V98, P2077, DOI 10.3732/ajb.1000373; Dick CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018230; Dressel A, 2009, PLANT BIOLOGY, V11, P204, DOI 10.1111/j.1438-8677.2008.00099.x; Feng YuZeng, 2006, China Fruits, P57; Fischer UA, 2011, FOOD CHEM, V127, P807, DOI 10.1016/j.foodchem.2010.12.156; Ghosh D, 2007, ASIA PAC J CLIN NUTR, V16, P200; GIL MI, 1995, J SCI FOOD AGR, V68, P77, DOI 10.1002/jsfa.2740680113; Gollop R, 2001, PLANT SCI, V161, P579, DOI 10.1016/S0168-9452(01)00445-9; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Guo CJ, 2003, NUTR RES, V23, P1719, DOI 10.1016/j.nutres.2003.08.005; Hajimahmoodi M, 2008, Pak J Biol Sci, V11, P1600, DOI 10.3923/pjbs.2008.1600.1604; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Hernandez F, 1999, EUR FOOD RES TECHNOL, V210, P39, DOI 10.1007/s002170050529; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Holland D., 2008, Chronica Horticulturae, V48, P12; Holland D., 2009, Horticultural Reviews, V35, P127; Hou DX, 2004, J BIOMED BIOTECHNOL, P321, DOI 10.1155/S1110724304403040; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Kim S, 2005, THEOR APPL GENET, V110, P573, DOI 10.1007/s00122-004-1875-6; Kim S, 2004, MOL GENET GENOMICS, V272, P411, DOI 10.1007/s00438-004-1076-7; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kong JM, 2003, PHYTOCHEMISTRY, V64, P923, DOI 10.1016/S0031-9422(03)00438-2; Kotepong P, 2011, FUNCT PLANT BIOL, V38, P75, DOI 10.1071/FP10164; Kowalczyk E, 2003, POL J PHARMACOL, V55, P699; Levin G.M., 2006, POMEGRANATE ROADS SO; Li H, 2013, PLANTA, V238, P695, DOI 10.1007/s00425-013-1917-x; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Martens S, 2010, PHYTOCHEMISTRY, V71, P1040, DOI 10.1016/j.phytochem.2010.04.016; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Nakamura N., 2006, PLANT BIOTECHNOL, V23, P13, DOI DOI 10.5511/plantbiotechnology.23.13; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; Ogundiwin EA, 2008, TREE GENET GENOMES, V4, P543, DOI 10.1007/s11295-007-0130-0; Ohno S, 2013, PLANTA, V238, P331, DOI 10.1007/s00425-013-1897-x; Ohno S, 2011, PLANTA, V234, P945, DOI 10.1007/s00425-011-1456-2; Ono NN, 2011, J INTEGR PLANT BIOL, V53, P800, DOI 10.1111/j.1744-7909.2011.01073.x; Opara LU, 2009, FOOD BIOPROCESS TECH, V2, P315, DOI 10.1007/s11947-008-0095-5; Ophir R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088998; Ozguven AI, 1997, ACTA HORTIC, P345; Pelletier MK, 1997, PLANT PHYSIOL, V113, P1437, DOI 10.1104/pp.113.4.1437; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Salvatierra A, 2013, PHYTOCHEMISTRY, V90, P25, DOI 10.1016/j.phytochem.2013.02.016; Sarkhosh A, 2006, SCI HORTIC-AMSTERDAM, V111, P24, DOI 10.1016/j.scienta.2006.07.033; Saud G, 2009, GENET RESOUR CROP EV, V56, P895, DOI 10.1007/s10722-009-9487-2; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Stover E, 2007, HORTSCIENCE, V42, P1088, DOI 10.21273/HORTSCI.42.5.1088; Szankowski I, 2009, PLANTA, V229, P681, DOI 10.1007/s00425-008-0864-4; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tsuda T, 2012, MOL NUTR FOOD RES, V56, P159, DOI 10.1002/mnfr.201100526; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang LS, 2008, CANCER LETT, V269, P281, DOI 10.1016/j.canlet.2008.05.020; Wilmouth RC, 2002, STRUCTURE, V10, P93, DOI 10.1016/S0969-2126(01)00695-5; Zamani Z, 2007, J HORTIC SCI BIOTECH, V82, P11, DOI 10.1080/14620316.2007.11512192; Zenoni S, 2011, PLANT J, V68, P11, DOI 10.1111/j.1365-313X.2011.04661.x; Zhang Y, 2013, CURR BIOL, V23, P1094, DOI 10.1016/j.cub.2013.04.072; Zhao XQ, 2015, J PLANT RES, V128, P687, DOI 10.1007/s10265-015-0717-8	70	48	56	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142777	10.1371/journal.pone.0142777	http://dx.doi.org/10.1371/journal.pone.0142777			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581077	gold, Green Submitted, Green Published			2022-12-26	WOS:000365154600059
J	Hung, WC; Chen, HJ; Lin, YT; Tsai, JC; Chen, CW; Lu, HH; Tseng, SP; Jheng, YY; Leong, KH; Teng, LJ				Hung, Wei-Chun; Chen, Hsiao-Jan; Lin, Yu-Tzu; Tsai, Jui-Chang; Chen, Chiao-Wei; Lu, Hsiao-Hung; Tseng, Sung-Pin; Jheng, Yao-Yu; Leong, Kin Hong; Teng, Lee-Jene			Skin Commensal Staphylococci May Act as Reservoir for Fusidic Acid Resistance Genes	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; CASSETTE CHROMOSOME MEC; ELONGATION-FACTOR-G; AUREUS; EPIDERMIDIS; IDENTIFICATION; FUSB; SEQUENCE; ISLANDS; SPP.	We analyzed the occurrence and mechanisms of fusidic acid resistance present in staphylococci isolated from 59 healthy volunteers. The fingers of the volunteers were screened for the presence of staphylococci, and the collected isolates were tested for resistance to fusidic acid. A total of 34 fusidic acid resistant staphylococcal strains (all were coagulase-negative) were isolated from 22 individuals (22/59, 37.3%). Examination of the resistance genes revealed that acquired fusB or fusC was present in Staphylococcus epidermidis, Staphylococcus capitis subsp. urealyticus, Staphylococcus hominis subsp. hominis, Staphylococcus warneri and Staphylococcus haemolyticus. Resistance islands (RIs) carrying fusB were found in S. epidermidis and S. capitis subsp. urealyticus, while staphylococcal chromosome cassette (SCC)-related structures harboring fusC were found in S. hominis subsp. hominis. Genotypic analysis of S. epidermidis and S. hominis subsp. hominis indicated that the fus elements were disseminated in diverse genetic strain backgrounds. The fusC elements in S. hominis subsp. hominis strains were highly homologous to SCCfusC in the epidemic sequence type (ST) 239/SCCmecIII methicillin-resistant S. aureus (MRSA) or the pseudo SCCmec in ST779 MRSA. The presence of acquired fusidic acid resistance genes and their genetic environment in commensal staphylococci suggested that the skin commensal staphylococci may act as reservoir for fusidic acid resistance genes.	[Hung, Wei-Chun] Kaohsiung Med Univ, Dept Microbiol & Immunol, Kaohsiung, Taiwan; [Chen, Hsiao-Jan; Lin, Yu-Tzu; Jheng, Yao-Yu; Leong, Kin Hong; Teng, Lee-Jene] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Tsai, Jui-Chang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Med, Taipei 10764, Taiwan; [Tsai, Jui-Chang] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Chen, Chiao-Wei; Lu, Hsiao-Hung] Taipei First Girls High Sch, Taipei, Taiwan; [Tseng, Sung-Pin] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Teng, Lee-Jene] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	Kaohsiung Medical University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital	Teng, LJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	ljteng@ntu.edu.tw		Lin, Yu-Tzu/0000-0002-3815-6305; TSAI, JUI-CHANG/0000-0003-2723-6841; Tseng, sung-pin/0000-0001-8915-5268; TENG, LEE-JENE/0000-0003-0104-741X	National Science Council of Taiwan [NSC 100-2320-B-002-014-MY3]; Ministry of Science and Technology of Taiwan [MOST 103-2320-B-002-056-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (NSC 100-2320-B-002-014-MY3) and from Ministry of Science and Technology of Taiwan (MOST 103-2320-B-002-056-MY3).	Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Besier S, 2003, MOL MICROBIOL, V47, P463, DOI 10.1046/j.1365-2958.2003.03307.x; Borg A, 2015, J BIOL CHEM, V290, P3440, DOI 10.1074/jbc.M114.611608; Castanheira M, 2010, ANTIMICROB AGENTS CH, V54, P3614, DOI 10.1128/AAC.01390-09; Castanheira M, 2010, J ANTIMICROB CHEMOTH, V65, P1353, DOI 10.1093/jac/dkq094; Chen HJ, 2015, J ANTIMICROB CHEMOTH, V70, P416, DOI 10.1093/jac/dku408; Chen HJ, 2013, ANTIMICROB AGENTS CH, V57, P5737, DOI 10.1128/AAC.01433-13; Chen HJ, 2011, ANTIMICROB AGENTS CH, V55, P5842, DOI 10.1128/AAC.00592-11; Chen HJ, 2010, ANTIMICROB AGENTS CH, V54, P4985, DOI 10.1128/AAC.00523-10; Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Coutant C, 1996, DIAGN MICR INFEC DIS, V25, P9, DOI 10.1016/0732-8893(96)00070-3; Cox G, 2012, P NATL ACAD SCI USA, V109, P2102, DOI 10.1073/pnas.1117275109; den Heijer CDJ, 2014, FUTURE MICROBIOL, V9, P737, DOI [10.2217/fmb.14.36, 10.2217/FMB.14.36]; Dobie D, 2004, ARCH DIS CHILD, V89, P74, DOI 10.1136/adc.2003.019695; Du X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062742; Ender M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-62; European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Guo XH, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120016; Hauschild T, 2008, J CLIN MICROBIOL, V46, P3875, DOI 10.1128/JCM.00810-08; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Jones RN, 2011, CLIN INFECT DIS, V52, pS477, DOI 10.1093/cid/cir163; Kinnevey PM, 2013, ANTIMICROB AGENTS CH, V57, P524, DOI 10.1128/AAC.01689-12; Koripella RK, 2012, J BIOL CHEM, V287, P30257, DOI 10.1074/jbc.M112.378521; Lin YT, 2014, ANTIMICROB AGENTS CH, V58, P1224, DOI 10.1128/AAC.01772-13; Liu D, 2006, LETT APPL MICROBIOL, V43, P325, DOI 10.1111/j.1472-765X.2006.01948.x; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Mendes RE, 2012, ANTIMICROB AGENTS CH, V56, P4656, DOI 10.1128/AAC.00279-12; Norstrom T, 2007, ANTIMICROB AGENTS CH, V51, P4438, DOI 10.1128/AAC.00328-07; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; O'Brien FG, 2002, J ANTIMICROB CHEMOTH, V50, P313, DOI 10.1093/jac/dkf153; O'Neill AJ, 2007, ANTIMICROB AGENTS CH, V51, P1737, DOI 10.1128/AAC.01542-06; O'Neill AJ, 2007, J CLIN MICROBIOL, V45, P1505, DOI 10.1128/JCM.01984-06; O'Neill AJ, 2006, MOL MICROBIOL, V59, P664, DOI 10.1111/j.1365-2958.2005.04971.x; Piette A, 2009, VET MICROBIOL, V134, P45, DOI 10.1016/j.vetmic.2008.09.009; Planet PJ, 2013, MBIO, V4, DOI 10.1128/mBio.00889-13; Iorio NLP, 2012, DIAGN MICR INFEC DIS, V72, P32, DOI 10.1016/j.diagmicrobio.2011.09.017; Qin N, 2012, J BACTERIOL, V194, P4469, DOI 10.1128/JB.00827-12; Rolo J, 2012, J ANTIMICROB CHEMOTH, V67, P1333, DOI 10.1093/jac/dks068; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Wang JL, 2012, INT J ANTIMICROB AG, V40, P103, DOI 10.1016/j.ijantimicag.2012.03.010; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Yu DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087346; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058440, 10.1371/journal.pone.0066496]	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143106	10.1371/journal.pone.0143106	http://dx.doi.org/10.1371/journal.pone.0143106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581090	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600084
J	Ledo, A				Ledo, Alicia			Nature and Age of Neighbours Matter: Interspecific Associations among Tree Species Exist and Vary across Life Stages in Tropical Forests	PLOS ONE			English	Article							NEGATIVE DENSITY-DEPENDENCE; PLANT-COMMUNITIES; HABITAT ASSOCIATIONS; NEOTROPICAL FOREST; SPATIAL-PATTERNS; DIVERSITY; FACILITATION; COMPETITION; HYPOTHESES; CANOPY	Detailed information about interspecific spatial associations among tropical tree species is scarce, and hence the ecological importance of those associations may have been underestimated. However, they can play a role in community assembly and species diversity maintenance. This study investigated the spatial dependence between pairs of species. First, the spatial associations (spatial attraction and spatial repulsion) that arose between species were examined. Second, different sizes of trees were considered in order to evaluate whether the spatial relationships between species are constant or vary during the lifetime of individuals. Third, the consistency of those spatial associations with the species-habitat associations found in previous studies was assessed. Two different tropical ecosystems were investigated: a montane cloud forest and a lowland moist forest. The results showed that spatial associations among species exist, and these vary among life stages and species. The rarity of negative spatial interactions suggested that exclusive competition was not common in the studied forests. On the other hand, positive interactions were common, and the results of this study strongly suggested that habitat associations were not the only cause of spatial attraction among species. If this is true, habitat associations and density dependence are not the only mechanisms that explain species distribution and diversity; other ecological interactions, such as facilitation among species, may also play a role. These spatial associations could be important in the assembly of tropical tree communities and forest succession, and should be taken into account in future studies.	[Ledo, Alicia] Univ Aberdeen, Aberdeen, Scotland	University of Aberdeen	Ledo, A (corresponding author), Univ Aberdeen, Aberdeen, Scotland.	alicialedo@gmail.com			Universidad Politecnica de Madrid; FP7-PEOPLE-IEF Marie-Curie Action	Universidad Politecnica de Madrid; FP7-PEOPLE-IEF Marie-Curie Action	This research was funded through a PhD grant from the Universidad Politecnica de Madrid, and support of a FP7-PEOPLE-2013-IEF Marie-Curie Action.; This research was funded through a PhD grant from the Universidad Politecnica de Madrid, and finished thanks to the support of a FP7-PEOPLE-2013-IEF Marie-Curie Action. We are indebted to Wilder Caba Culquicondor for his help with the field work. I accept responsibility for all missing species identifications. Data from BCI were provided by the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the primary granting agencies that have supported the BCI plot. Thanks to Sonia Condes and Fernando Montes, supervisors of my PhD.	Bagchi R, 2011, ECOLOGY, V92, P1723, DOI 10.1890/11-0335.1; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1998, TROPICAL FOREST CENS; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hu YH, 2012, OIKOS, V121, P952, DOI 10.1111/j.1600-0706.2011.19831.x; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Illian J, 2008, STAT ANAL MODELLING; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kitajima K, 2005, ANN BOT-LONDON, V95, P535, DOI 10.1093/aob/mci051; Law R, 2000, ECOLOGY, V81, P2137, DOI 10.1890/0012-9658(2000)081[2137:ADSFNI]2.0.CO;2; Ledo A, 2013, J VEG SCI, V24, P1086, DOI 10.1111/jvs.12023; Ledo A, 2012, ACTA OECOL, V38, P49, DOI 10.1016/j.actao.2011.09.003; Ledo A, 2011, ECOL MODEL, V222, P580, DOI 10.1016/j.ecolmodel.2010.10.029; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Montgomery RA, 2002, OECOLOGIA, V131, P165, DOI 10.1007/s00442-002-0872-1; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; Pardos M, 2007, EUR J FOREST RES, V126, P37, DOI 10.1007/s10342-005-0090-6; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Scatena F.N., 2011, TROPICAL MONTANE CLO; Sheil D, 2003, TRENDS ECOL EVOL, V18, P18, DOI 10.1016/S0169-5347(02)00005-8; Uriarte M, 2012, ECOLOGY, V93, P191, DOI 10.1890/10-2422.1; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; Valiente-Banuet A, 2008, J ECOL, V96, P489, DOI 10.1111/j.1365-2745.2008.01357.x; Wiegand T, 2007, ECOLOGY, V88, P3088, DOI 10.1890/06-1350.1; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	41	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141387	10.1371/journal.pone.0141387	http://dx.doi.org/10.1371/journal.pone.0141387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581110	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600015
J	Markikou-Ouni, W; Drini, S; Bahi-Jaber, N; Chenik, M; Meddeb-Garnaoui, A				Markikou-Ouni, Wafa; Drini, Sima; Bahi-Jaber, Narges; Chenik, Mehdi; Meddeb-Garnaoui, Amel			Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation	PLOS ONE			English	Article							EXCRETED-SECRETED ANTIGENS; HOST IMMUNE-RESPONSE; NF-KAPPA-B; TYROSINE-PHOSPHATASE SHP-1; FACTOR-ALPHA PRODUCTION; VISCERAL LEISHMANIASIS; MAJOR INFECTION; T-CELLS; CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY	Leishmania parasites and some molecules they secrete are known to modulate innate immune responses through effects on dendritic cells (DCs) and macrophages. Here, we characterized four Leishmania infantum potentially excreted/secreted recombinant proteins (LipESP) identified in our laboratory: Elongation Factor 1 alpha (LiEF-1 alpha), a proteasome regulatory ATPase (LiAAA-ATPase) and two novel proteins with unknown functions, which we termed LiP15 and LiP23, by investigating their effect on in vitro differentiation and maturation of human DCs and on cytokine production by DCs and monocytes. During DCs differentiation, LipESP led to a significant decrease in CD1a. LiP23 and LiEF-1 alpha, induced a decrease of HLA-DR and an increase of CD86 surface expression, respectively. During maturation, an up-regulation of HLA-DR and CD80 was found in response to LiP15, LiP23 and LiAAA-ATPase, while an increase of CD40 expression was only observed in response to LiP15. All LipESP induced an over-expression of CD86 with significant differences between proteins. These proteins also induced significant IL-12p70 levels in immature DCs but not in monocytes. The LipESP-induced IL-12p70 production was significantly enhanced by a co-treatment with IFN-gamma in both cell populations. TNF-alpha and IL-10 were induced in DCs and monocytes with higher levels observed for LiP15 and LiAAA-ATPase. However, LPS-induced cytokine production during DC maturation or in monocyte cultures was significantly down regulated by LipESP co-treatment. Our findings suggest that LipESP strongly interfere with DCs differentiation suggesting a possible involvement in mechanisms established by the parasite for its survival. These proteins also induce DCs maturation by up-regulating several costimulatory molecules and by inducing the production of proinflammatory cytokines, which is a prerequisite for T cell activation. However, the reduced ability of LipESP-stimulated DCs and monocytes to respond to lipopolysaccharide (LPS) that can be observed during human leishmaniasis, suggests that under certain circumstances LipESP may play a role in disease progression.	[Markikou-Ouni, Wafa; Drini, Sima; Bahi-Jaber, Narges; Chenik, Mehdi; Meddeb-Garnaoui, Amel] Inst Pasteur Tunis, Lab Med Parasitol Biotechnol & Biomol, Tunis, Tunisia; [Drini, Sima] Inst Pasteur, Unite Parasitol Mol & Signalisat, Paris, France; [Bahi-Jaber, Narges] UPSP EGEAL Inst Polytech LaSalle Beauvais, Beauvais, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Meddeb-Garnaoui, A (corresponding author), Inst Pasteur Tunis, Lab Med Parasitol Biotechnol & Biomol, Tunis, Tunisia.	amel.garnaoui@pasteur.rns.tn			Tunisian Ministry for research and technology [IMM23]; Tunisian Ministry for Research and Technology	Tunisian Ministry for research and technology; Tunisian Ministry for Research and Technology	Funding was provided by IMM23, Tunisian Ministry for research and technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Blood Transfusion Service of Tunis for blood samples and especially blood donors for the generous donation of their cells. This work was supported by the Tunisian Ministry for Research and Technology.	Adams EJ, 2014, CURR OPIN IMMUNOL, V26, P1, DOI 10.1016/j.coi.2013.09.005; Agallou M, 2011, VACCINE, V29, P5053, DOI 10.1016/j.vaccine.2011.04.089; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amprey JL, 2004, INFECT IMMUN, V72, P589, DOI 10.1128/IAI.72.1.589-592.2004; Argueta-Donohue J, 2008, EXP PARASITOL, V120, P1, DOI 10.1016/j.exppara.2008.04.002; Barhoumi M, 2011, PARASITE IMMUNOL, V33, P583, DOI 10.1111/j.1365-3024.2011.01320.x; Bourreau E, 2009, INFECT IMMUN, V77, P1465, DOI 10.1128/IAI.01398-08; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Campos-Martin Y, 2006, J IMMUNOL, V176, P6172, DOI 10.4049/jimmunol.176.10.6172; Carrillo E, 2008, VACCINE, V26, P1902, DOI 10.1016/j.vaccine.2008.01.042; Chamakh-Ayari R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092708; Chaudhary R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947606; Chenik M, 2006, PARASITOLOGY, V132, P493, DOI 10.1017/S0031182005009546; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Cuervo P, 2009, J PROTEOMICS, V73, P79, DOI 10.1016/j.jprot.2009.08.006; DebRoy S, 2010, EXP PARASITOL, V126, P582, DOI 10.1016/j.exppara.2010.06.011; Donovan MJ, 2007, PARASITE IMMUNOL, V29, P515, DOI 10.1111/j.1365-3024.2007.00970.x; ELON J, 1992, ISRAEL J MED SCI, V28, P847; Favali C, 2007, J LEUKOCYTE BIOL, V82, P1401, DOI 10.1189/jlb.0307187; Favila MA, 2014, J IMMUNOL, V192, P5863, DOI 10.4049/jimmunol.1203230; Felio K, 2009, J EXP MED, V206, P2497, DOI 10.1084/jem.20090898; Fernandes ACS, 2013, FEMS MICROBIOL LETT, V340, P117, DOI 10.1111/1574-6968.12080; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Garcia MR, 1997, EUR J IMMUNOL, V27, P1005, DOI 10.1002/eji.1830270430; Ghosh M, 2006, J INFECT DIS, V194, P294, DOI 10.1086/505228; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Jayakumar A, 2008, INFECT IMMUN, V76, P2138, DOI 10.1128/IAI.01252-07; Jebbari H, 2002, INFECT IMMUN, V70, P1023, DOI 10.1128/IAI.70.2.1023-1026.2002; Kadivar M R, 2000, East Mediterr Health J, V6, P879; Kasmar AG, 2011, J EXP MED, V208, P1741, DOI 10.1084/jem.20110665; Kawashima T, 2003, J IMMUNOL, V170, P5345, DOI 10.4049/jimmunol.170.11.5345; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326; Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061; Liu D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00083; Lockridge JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021701; Mariotti S, 2002, EUR J IMMUNOL, V32, P3050, DOI 10.1002/1521-4141(200211)32:11<3050::AID-IMMU3050>3.0.CO;2-K; Markikou-Ouni W, 2012, CLIN EXP IMMUNOL, V169, P273, DOI 10.1111/j.1365-2249.2012.04611.x; Marovich MA, 2000, J IMMUNOL, V164, P5858, DOI 10.4049/jimmunol.164.11.5858; Matheoud D, 2013, CELL HOST MICROBE, V14, P15, DOI 10.1016/j.chom.2013.06.003; McDowell MA, 2002, INFECT IMMUN, V70, P3994, DOI 10.1128/IAI.70.8.3994-4001.2002; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; Nandan D, 2003, BIOCHEM BIOPH RES CO, V302, P646, DOI 10.1016/S0006-291X(03)00216-X; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Naouar I, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/636039; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Pinedo-Cancino V, 2013, AM J TROP MED HYG, V88, P559, DOI 10.4269/ajtmh.12-0587; Pletinckx K, 2011, EUR J IMMUNOL, V41, P3479, DOI 10.1002/eji.201141631; Probst P, 1997, EUR J IMMUNOL, V27, P2634, DOI 10.1002/eji.1830271024; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; Rai AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031551; Revest M, 2008, VACCINE, V26, P6119, DOI 10.1016/j.vaccine.2008.09.005; Rosa R, 2005, EXP PARASITOL, V109, P106, DOI 10.1016/j.exppara.2004.11.008; Santarem N, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/85154; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Siddiqui S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00337; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Soong L, 2008, J IMMUNOL, V180, P4355, DOI 10.4049/jimmunol.180.7.4355; Soong L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00058; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Tejle K, 2008, FEMS MICROBIOL LETT, V279, P92, DOI 10.1111/j.1574-6968.2007.01013.x; Tsigankov P, 2013, J PROTEOME RES, V12, P3405, DOI 10.1021/pr4002492; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; VANNIERSANTOS MA, 1995, EUR J CELL BIOL, V67, P112; Von Stebut E, 2007, EUR J DERMATOL, V17, P115, DOI 10.1684/ejd.2007.0122; Wiethe C, 2008, J IMMUNOL, V180, P4371, DOI 10.4049/jimmunol.180.7.4371; Zahn S, 2010, EXP DERMATOL, V19, P924, DOI 10.1111/j.1600-0625.2010.01149.x	70	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143063	10.1371/journal.pone.0143063	http://dx.doi.org/10.1371/journal.pone.0143063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581100	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600076
J	Schopmeyer, SA; Lirman, D				Schopmeyer, Stephanie A.; Lirman, Diego			Occupation Dynamics and Impacts of Damselfish Territoriality on Recovering Populations of the Threatened Staghorn Coral, Acropora cervicornis	PLOS ONE			English	Article							REEF FISHES; CORALLIOPHILA-ABBREVIATA; POMACENTRUS-LIVIDUS; HURRICANE ALLEN; STABLE STATES; DISCOVERY BAY; RESOURCE USE; RESTORATION; MORTALITY; COMMUNITY	Large-scale coral reef restoration is needed to help recover structure and function of degraded coral reef ecosystems and mitigate continued coral declines. In situ coral propagation and reef restoration efforts have scaled up significantly in past decades, particularly for the threatened Caribbean staghorn coral, Acropora cervicornis, but little is known about the role that native competitors and predators, such as farming damselfishes, have on the success of restoration. Steep declines in A. cervicornis abundance may have concentrated the negative impacts of damselfish algal farming on a much lower number of coral prey/colonies, thus creating a significant threat to the persistence and recovery of depleted coral populations. This is the first study to document the prevalence of resident damselfishes and negative effects of algal lawns on A. cervicornis along the Florida Reef Tract (FRT). Impacts of damselfish lawns on A. cervicornis colonies were more prevalent (21.6% of colonies) than those of other sources of mortality (i.e., disease (1.6%), algal/sponge overgrowth (5.6%), and corallivore predation (7.9%)), and damselfish activities caused the highest levels of tissue mortality (34.6%) among all coral stressors evaluated. The probability of damselfish occupation increased as coral colony size and complexity increased and coral growth rates were significantly lower in colonies with damselfish lawns (15.4 vs. 29.6 cm per year). Reduced growth and mortality of existing A. cervicornis populations may have a significant effect on population dynamics by potentially reducing important genetic diversity and the reproductive potential of depleted populations. On a positive note, however, the presence of resident damselfishes decreased predation by other corallivores, such as Coralliophila and Hermodice, and may offset some negative impacts caused by algal farming. While most negative impacts of damselfishes identified in this study affected large individual colonies and <50% of the A. cervicornis population along the FRT, the remaining wild staghorn population, along with the rapidly increasing restored populations, continue to fulfill important functional roles on coral reefs by providing essential habitat and refuge to other reef organisms. Although the effects of damselfish predation are, and will continue to be, pervasive, successful restoration efforts and strategic coral transplantation designs may help overcome damselfish damage by rapidly increasing A. cervicornis cover and abundance while also providing important information to educate future conservation and management decisions.	[Schopmeyer, Stephanie A.; Lirman, Diego] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, Miami, FL 33149 USA	University of Miami	Schopmeyer, SA (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	sschopmeyer@rsmas.miami.edu		Schopmeyer, Stephanie/0000-0003-4717-465X	National Oceanic and Atmospheric Administration Coral Reef Conservation Program [NA13NOS482]	National Oceanic and Atmospheric Administration Coral Reef Conservation Program	This study was supported by National Oceanic and Atmospheric Administration Coral Reef Conservation Program Award Number NA13NOS482. Funding awarded to DL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axline-Minotti BA, 2003, THESIS; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; BELK MS, 1975, COPEIA, P603; Beukers JS, 1997, OECOLOGIA, V111, P50, DOI DOI 10.1007/S004420050419); Bohnsack JA, 1982, FISH FOOD HABITS STU, P258; BRAWLEY SH, 1982, B MAR SCI, V32, P595; Casey JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1032; Catano LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118764; CLARKE RD, 1977, MAR BIOL, V40, P277, DOI 10.1007/BF00390882; D'Antonio C, 2002, RESTOR ECOL, V10, P703, DOI 10.1046/j.1526-100X.2002.01051.x; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Engeman Richard M., 2009, P171; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; FOSTER SA, 1985, OECOLOGIA, V67, P499, DOI 10.1007/BF00790020; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gordon TAC, 2015, CORAL REEFS, V34, P13, DOI 10.1007/s00338-014-1229-z; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Griffin JN, 2015, RESTOR ECOL, V23, P197, DOI 10.1111/rec.12173; Grober-Dunsmore R, 2006, MAR ECOL PROG SER, V321, P123, DOI 10.3354/meps321123; HAYES JA, 1990, J EXP MAR BIOL ECOL, V142, P25, DOI 10.1016/0022-0981(90)90135-Y; Hernandez-Delgado EA, 2001, MEM 24 S REC NAT, P77; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Hixon Mark A., 1997, P230; HOGARTH WT, 2006, FED REGISTER, P26852; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; ITZKOWITZ M, 1977, J EXP MAR BIOL ECOL, V28, P217, DOI 10.1016/0022-0981(77)90093-4; Johnson M.E., 2011, CARIBBEAN ACROPORA R; Johnston L, 2014, CORAL REEFS, V33, P1047, DOI 10.1007/s00338-014-1176-8; Jones GP, 2006, MAR ECOL PROG SER, V328, P215, DOI 10.3354/meps328215; KAUFMAN L, 1981, PALEOBIOLOGY, V7, P527, DOI 10.1017/S0094837300025562; Kaufman L, 1997, P 3 INT COR REEF S, P559; KINZIE RA, 1973, B MAR SCI, V23, P93; KLUMPP DW, 1989, J EXP MAR BIOL ECOL, V125, P145, DOI 10.1016/0022-0981(89)90040-3; KNOWLTON N, 1981, NATURE, V294, P251, DOI 10.1038/294251a0; KNOWLTON N, 1992, AM ZOOL, V32, P674; Knowlton N, 1990, SMITHSON CONTR MAR S, V31, P1, DOI DOI 10.5479/SI.01960768.31.1; Lirman D, 2014, ECOL INDIC, V44, P120, DOI 10.1016/j.ecolind.2013.10.021; Lirman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107253; Lobel PS., 1980, B MAR SCI, V30, P273; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller S.L, 2008, P 11 INT COR REEF S; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Mumby PJ, 2012, MAR ECOL PROG SER, V445, P13, DOI 10.3354/meps09450; Munday PL, 2001, OECOLOGIA, V128, P585, DOI 10.1007/s004420100690; MYRBERG AA, 1974, AM ZOOL, V14, P81; Nemeth RS, 1998, ENVIRON BIOL FISH, V53, P129, DOI 10.1023/A:1007402104047; Omori M, 2010, MAR BIOL RES, V7, P3, DOI 10.1080/17451001003642317; POTTS DC, 1977, J EXP MAR BIOL ECOL, V28, P207, DOI 10.1016/0022-0981(77)90092-2; Powles H, 2000, ICES J MAR SCI, V57, P669, DOI 10.1006/jmsc.2000.0711; Precht WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010835; RISK MJ, 1982, OECOLOGIA, V52, P376, DOI 10.1007/BF00367962; ROBERTSON DR, 1981, ECOLOGY, V62, P1162, DOI 10.2307/1937280; Roby DD, 2003, CAN J ZOOL, V81, P250, DOI 10.1139/Z02-242; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; SAMMARCO PW, 1982, MAR ECOL PROG SER, V8, P53, DOI 10.3354/meps008053; SAMMARCO PW, 1986, J EXP MAR BIOL ECOL, V98, P1, DOI 10.1016/0022-0981(86)90072-9; Schopmeyer SA, 2012, RESTOR ECOL, V20, P696, DOI 10.1111/j.1526-100X.2011.00836.x; SHINN EA, 1976, ENVIRON GEOL, V1, P241, DOI 10.1007/BF02407510; Silbiger NJ, 2014, MAR ECOL PROG SER, V515, P33, DOI 10.3354/meps10999; Silverman J, 2014, GEOCHIM COSMOCHIM AC, V144, P72, DOI 10.1016/j.gca.2014.09.011; Sponaugle S, 1996, MAR FRESHWATER RES, V47, P433, DOI 10.1071/MF9960433; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; TUNNICLIFFE V, 1983, B MAR SCI, V33, P132; Vermeij MJA, 2015, MAR ECOL PROG SER, V528, P289, DOI 10.3354/meps11243; VINE PJ, 1974, MAR BIOL, V24, P131, DOI 10.1007/BF00389347; Wellenreuther M, 2002, J EXP MAR BIOL ECOL, V273, P61, DOI 10.1016/S0022-0981(02)00145-4; Wilkes AA, 2008, SOUTHEAST NAT, V7, P483, DOI 10.1656/1528-7092-7.3.483; WILLIAMS AH, 1978, J EXP MAR BIOL ECOL, V34, P197, DOI 10.1016/S0022-0981(78)80002-1; WILLIAMS AH, 1981, ECOLOGY, V62, P1107, DOI 10.2307/1937008; WILLIAMS AH, 1984, J EXP MAR BIOL ECOL, V75, P233, DOI 10.1016/0022-0981(84)90168-0; Williams DE, 2012, CORAL REEFS, V31, P369, DOI 10.1007/s00338-011-0847-y; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143	78	31	32	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141302	10.1371/journal.pone.0141302	http://dx.doi.org/10.1371/journal.pone.0141302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580977	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600013
J	Wang, J; Yang, Y; Zhao, W; Su, HL; Zhao, YP; Chen, Y; Zhang, T; Zhang, TJ				Wang, Jun; Yang, Ying; Zhao, Wan; Su, Hualin; Zhao, Yanping; Chen, Yue; Zhang, Tao; Zhang, Tiejun			Application of Network Scale Up Method in the Estimation of Population Size for Men Who Have Sex with Men in Shanghai, China	PLOS ONE			English	Article							HIV-INFECTION; UNITED-STATES; DRUG-USERS; RISK; SEROPREVALENCE; EPIDEMIOLOGY; MSM	Background Men who have sex with men (MSM) are at high risk of HIV infection. For developing proper interventions, it is important to know the size of MSM population. However, size estimation of MSM populations is still a significant public health challenge due to high cost, hard to reach and stigma associated with the population. Objectives We aimed to estimate the social network size (c value) in general population and the size of MSM population in Shanghai, China by using the net work scale-up method. Methods A multistage random sampling was used to recruit participants aged from 18 to 60 years who had lived in Shanghai for at least 6 months. The "known population method" with adjustment of backward estimation and regression model was applied to estimate the c value. And the MSM population size was further estimated using an adjusted c value taking into account for the transmission effect through social respect level towards MSM. Results A total of 4017 participants were contacted for an interview, and 3907 participants met the inclusion criterion. The social network size (c value) of participants was 236 after adjustment. The estimated size of MSM was 36354 (95% CI: 28489-44219) for the male Shanghaies aged 18 to 60 years, and the proportion of MSM among the total male population aged 18 to 60 years in Shanghai was 0.28%. Conclusions We employed the network scale-up method and used a wide range of data sources to estimate the size of MSM population in Shanghai, which is useful for HIV prevention and intervention among the target population.	[Wang, Jun; Yang, Ying; Zhang, Tao; Zhang, Tiejun] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Wang, Jun; Yang, Ying; Zhang, Tao; Zhang, Tiejun] Fudan Univ, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Yang, Ying; Zhao, Wan; Su, Hualin; Zhao, Yanping] Minhang Dist Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Chen, Yue] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada	Fudan University; Fudan University; Shanghai Center for Disease Control & Prevention; University of Ottawa	Zhang, T (corresponding author), Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai 200433, Peoples R China.	tzhang@shmu.edu.cn; tjzhangsh@gmail.com	zhao, yan/GWC-9174-2022; zhang, Tiejun/HGD-6858-2022; Zhang, Tiejun/HDM-7091-2022		Ministry of Education of China [20120071120050]; Fundamental Research Funds for the Central Universities [10FX058, 20520133104]; Shanghai Leading Disciplinary Project [12GWZX1010]	Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Leading Disciplinary Project	This study was supported by Doctoral Fund of Ministry of Education of China (20120071120050 to TZ), Fundamental Research Funds for the Central Universities (10FX058 and 20520133104 to TZ) and the Shanghai Leading Disciplinary Project (grant no. 12GWZX1010).	Berchenko Y, 2011, SEX TRANSM INFECT, V87, P267, DOI 10.1136/sti.2011.049171; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; BERNARD HR, 1991, SOC SCI RES, V20, P109; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; Chen, 2011, CHINESE J HLTH ED, V27, P294; Dombrowski Kirk, 2012, Adv Appl Sociol, V2, P245; Drame FM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18753; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Family Health International UNAIDS WHO, 2003, WORK GROUP GLOB HIV; Guo W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071796; Handcock MS, 2015, BIOMETRICS, V71, P258, DOI 10.1111/biom.12255; Higa DH, 2013, AIDS BEHAV, V17, P1231, DOI 10.1007/s10461-013-0418-z; Hook EB, 1998, AM J EPIDEMIOL, V148, P1219; Jing LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095601; Kadushin C, 2006, J DRUG ISSUES, V36, P417, DOI 10.1177/002204260603600209; Killworth PD, 1998, EVALUATION REV, V22, P289, DOI 10.1177/0193841X9802200205; Killworth PD, 1998, SOC NETWORKS, V20, P23, DOI 10.1016/S0378-8733(96)00305-X; Landoh DE, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.341.4117; LASKA EM, 1993, BIOMETRICS, V49, P209, DOI 10.2307/2532614; Luan RS, 2005, EUR J EPIDEMIOL, V20, P581, DOI 10.1007/s10654-005-4305-4; Marcus U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-180; McCarty C, 2001, HUM ORGAN, V60, P28, DOI 10.17730/humo.60.1.efx5t9gjtgmga73y; Mumtaz GR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001663; Ning Zhen, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P848; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Okal J, 2013, SEX TRANSM INFECT, V89, P366, DOI 10.1136/sextrans-2013-051071; Paniotto V, 2009, ESTIMATING SIZE POPU; Salganik MJ, 2011, AM J EPIDEMIOL, V174, P1190, DOI 10.1093/aje/kwr246; Shokoohi Mostafa, 2010, Addict Health, V2, P81; Snidero S, 2007, SOC NETWORKS, V29, P527, DOI 10.1016/j.socnet.2007.03.003; Tsuji R, 2003, SOCIOL THEOR METHOD, V18, P15; UNAIDS/WHO, 2010, GUID EST SIZ POP MOS; World Health Organization (WHO) and The Joint United Nations Programme on HIV and AIDS (UNAIDS), GUID EST SIZ POP MOS; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Yan L W, 2006, HUANAN PREMED, V32, P9; Yan L W, 2006, HUANAN PREMED, V32, P15	38	12	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143118	10.1371/journal.pone.0143118	http://dx.doi.org/10.1371/journal.pone.0143118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26579708	gold, Green Submitted, Green Published			2022-12-26	WOS:000365154600086
J	Burke, CM; Montevecchi, WA; Regular, PM				Burke, Chantelle M.; Montevecchi, William A.; Regular, Paul M.			Seasonal Variation in Parental Care Drives Sex-Specific Foraging by a Monomorphic Seabird	PLOS ONE			English	Article							THICK-BILLED MURRES; COMMON MURRES; STABLE-ISOTOPES; URIA-LOMVIA; PROVISIONING BEHAVIOR; ACTIVITY BUDGETS; DIVING BEHAVIOR; HABITAT USE; FEMALE; STRATEGIES	Evidence of sex-specific foraging in monomorphic seabirds is increasing though the underlying mechanisms remain poorly understood. We investigate differential parental care as a mechanism for sex-specific foraging in monomorphic Common Murres (Uria aalge), where the male parent alone provisions the chick after colony departure. Using a combination of geolocation-immersion loggers and stable isotopes, we assess two hypotheses: the reproductive role specialization hypothesis and the energetic constraint hypothesis. We compare the foraging behavior of females (n = 15) and males (n = 9) during bi-parental at the colony, post-fledging male-only parental care and winter when parental care is absent. As predicted by the reproductive role specialization hypothesis, we found evidence of sex-specific foraging during post-fledging only, the stage with the greatest divergence in parental care roles. Single-parenting males spent almost twice as much time diving per day and foraged at lower quality prey patches relative to independent females. This implies a potential energetic constraint for males during the estimated 62.8 +/- 8.9 days of offspring dependence at sea. Contrary to the predictions of the energetic constraint hypothesis, we found no evidence of sex-specific foraging during biparental care, suggesting that male parents did not forage for their own benefit before colony departure in anticipation of post-fledging energy constraints. We hypothesize that unpredictable prey conditions at Newfoundland colonies in recent years may limit male parental ability to allocate additional time and energy to self-feeding during biparental care, without compromising chick survival. Our findings support differential parental care as a mechanism for sex-specific foraging in monomorphic murres, and highlight the need to consider ecological context in the interpretation of sex-specific for-aging behavior.	[Burke, Chantelle M.; Montevecchi, William A.; Regular, Paul M.] Mem Univ Newfoundland, Dept Psychol, Cognit & Behav Ecol Program, St John, NF, Canada	Memorial University Newfoundland	Burke, CM (corresponding author), Mem Univ Newfoundland, Dept Psychol, Cognit & Behav Ecol Program, St John, NF, Canada.	chantelb@mun.ca	Regular, Paul/AAY-5741-2021	Regular, Paul/0000-0003-0318-2615	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Discovery grant; Newfoundland and Labrador Murre Fund grant; Government of Canada's Program for International Polar Year	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Newfoundland and Labrador Murre Fund grant; Government of Canada's Program for International Polar Year	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC to CMB), a NSERC Discovery grant (WAM), a Newfoundland and Labrador Murre Fund grant (WAM), and the Government of Canada's Program for International Polar Year (WAM, Anthony J Gaston).	AINLEY D.G., 2021, BIRDS OF THE WORLD, DOI [10.2173/bow.commur.02, DOI 10.2173/BOW.COMMUR.02]; Bates D, LME4 LINEAR MIXED EF; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Becker BH, 2007, CONDOR, V109, P451, DOI 10.1650/0010-5422(2007)109[451:DSINAC]2.0.CO;2; BIRKHEAD TR, 1977, IBIS, V119, P80, DOI 10.1111/j.1474-919X.1977.tb02048.x; Burger A.E., 1990, Studies in Avian Biology, P71; Burke CM, 2008, WATERBIRDS, V31, P372, DOI 10.1675/1524-4695-31.3.372; Burke CM, 2011, ARCTIC, V64, P302; Cairns D.K., 1990, STUD AVIAN BIOL, V14, P84; CAIRNS DK, 1987, AUK, V104, P218, DOI 10.1093/auk/104.2.218; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cameron-MacMillan ML, 2007, BEHAV ECOL, V18, P81, DOI 10.1093/beheco/arl048; Camphuysen K, 2002, ARDEA, V90, P103; Carscadden JE, 2002, ICES J MAR SCI, V59, P1027, DOI 10.1006/jmsc.2002.1235; Cherel Y, 2005, OECOLOGIA, V145, P533, DOI 10.1007/s00442-005-0156-7; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Davoren GK, 2003, MAR ECOL PROG SER, V258, P253, DOI 10.3354/meps258253; Davoren GK, 2002, MAR ECOL PROG SER, V245, P259, DOI 10.3354/meps245259; Davoren GK, 2003, J AVIAN BIOL, V34, P44, DOI 10.1034/j.1600-048X.2003.03008.x; Davoren GK, 2003, ECOL MONOGR, V73, P463, DOI 10.1890/02-0208; Doody LM, 2008, HORM BEHAV, V53, P140, DOI 10.1016/j.yhbeh.2007.09.009; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Elliott Kyle H., 2014, Marine Ornithology, V42, P183; Elliott KH, 2013, P NATL ACAD SCI USA, V110, P9380, DOI 10.1073/pnas.1304838110; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; Falk K, 2001, ECOGRAPHY, V24, P625, DOI 10.1034/j.1600-0587.2001.240601.x; Finney SK, 1999, J AVIAN BIOL, V30, P23, DOI 10.2307/3677239; Fort J, 2009, J EXP BIOL, V212, P2483, DOI 10.1242/jeb.032300; Fraser GS, 2002, CONDOR, V104, P413, DOI 10.1650/0010-5422(2002)104[0413:MFDIPC]2.0.CO;2; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gabrielson GW, 1998, J COMP PHYSIOL B, V157, P703; Gaston A.J., 1985, P319; Gaston A.J., 1998, THE AUKS; Gonzalez-Solis J, 2000, OIKOS, V90, P390, DOI 10.1034/j.1600-0706.2000.900220.x; Halsey L, 2003, ANIM BEHAV, V65, P641, DOI 10.1006/anbe.2003.2090; Hamer KC, 2007, MAR ECOL PROG SER, V338, P295, DOI 10.3354/meps338295; Harding AMA, 2007, ECOLOGY, V88, P2024, DOI 10.1890/06-1695.1; Harris M.P., 1991, Seabird, P40; Harris MP, 2003, AUK, V120, P75, DOI 10.1642/0004-8038(2003)120[0075:POOBSB]2.0.CO;2; Hedd A, 2011, ANIM CONSERV, V14, P630, DOI 10.1111/j.1469-1795.2011.00479.x; Hedd A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085572; Hedd A, 2009, MAR BIOL, V156, P741, DOI 10.1007/s00227-008-1125-6; Hill RD, 1994, ELEPHANT SEALS POPUL; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Iqbal M, 1984, INTRO SOLAR RAD; Jones IL, 2002, AUK, V119, P1064, DOI 10.1642/0004-8038(2002)119[1064:DPOPED]2.0.CO;2; Kato A, 2000, AUK, V117, P718, DOI 10.1642/0004-8038(2000)117[0718:VIFAPB]2.0.CO;2; Linnebjerg JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072987; Luque SP, 2007, BEHAVIOUR, V144, P1315, DOI 10.1163/156853907782418213; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; McFarlane-Tranquilla L., 2014, THESIS; Monaghan P, 1998, P ROY SOC B-BIOL SCI, V265, P1731, DOI 10.1098/rspb.1998.0495; Mori Y, 2002, ANIM BEHAV, V64, P739, DOI 10.1006/anbe.2002.3093; Paredes R, 2008, CAN J ZOOL, V86, P610, DOI 10.1139/Z08-036; Paredes R, 2006, BEHAVIOUR, V143, P451, DOI 10.1163/156853906776240641; Paredes R, 2010, IBIS, V152, P48, DOI 10.1111/j.1474-919X.2009.00973.x; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2011, MAR BIOL, V158, P2199, DOI 10.1007/s00227-011-1725-4; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pinet P, 2012, ANIM BEHAV, V83, P979, DOI 10.1016/j.anbehav.2012.01.019; Pyle Peter, 2009, Marine Ornithology, V37, P219; Rector ME, 2012, GEN COMP ENDOCR, V178, P408, DOI 10.1016/j.ygcen.2012.06.008; Regular PM, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00182.1; Regular PM, 2013, ANIM BEHAV, V86, P545, DOI 10.1016/j.anbehav.2013.06.008; Regular PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026763; Robertson G.J., 2012, J OCEAN TECHNOL, V7, P42; Robertson GJ, 2004, CANADIAN WILDLIFE SE, V418; Romano MD, 2006, WATERBIRDS, V29, P407, DOI 10.1675/1524-4695(2006)29[407:TTJHOM]2.0.CO;2; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; SEALY S G, 1973, Ornis Scandinavica, V4, P113, DOI 10.2307/3676112; SPEAR LB, 1993, J ANIM ECOL, V62, P399, DOI 10.2307/5190; Stearns S.C., 1992, pi; STEWART DT, 1993, CAN J ZOOL, V71, P346, DOI 10.1139/z93-048; Thaxter CB, 2009, J AVIAN BIOL, V40, P75, DOI 10.1111/j.1600-048X.2008.04507.x; Thompson CW, 1998, AUK, V115, P653, DOI 10.2307/4089414; Tranquilla LAM, 2013, MAR ECOL PROG SER, V472, P287, DOI 10.3354/meps10053; VAROUJEAN DH, 1979, PACIFIC SEABIRD GROU, V6, P28; WANLESS S, 1986, BIRD STUDY, V33, P168, DOI 10.1080/00063658609476916; WANLESS S, 1995, CONDOR, V97, P550, DOI 10.2307/1369040; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Welcker J, 2009, IBIS, V151, P502, DOI 10.1111/j.1474-919X.2009.00931.x; Wilhelm SI, 2008, CONDOR, V110, P316, DOI 10.1525/cond.2008.8440; YDENBERG RC, 1989, ECOLOGY, V70, P1494, DOI 10.2307/1938208	83	23	23	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0141190	10.1371/journal.pone.0141190	http://dx.doi.org/10.1371/journal.pone.0141190			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575646	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400004
J	Cao, B; Mingolla, E; Yazdanbakhsh, A				Cao, Bo; Mingolla, Ennio; Yazdanbakhsh, Arash			Tuning Properties of MT and MSTd and Divisive Interactions for Eye-Movement Compensation	PLOS ONE			English	Article							CORTICAL AREAS MT; VISUAL-MOTION; NEURONS; RESPONSES; SPEED; PERFORMANCE; DIRECTION; CORTEX; MONKEY; DEPTH	The primate brain intelligently processes visual information from the world as the eyes move constantly. The brain must take into account visual motion induced by eye movements, so that visual information about the outside world can be recovered. Certain neurons in the dorsal part of monkey medial superior temporal area (MSTd) play an important role in integrating information about eye movements and visual motion. When a monkey tracks a moving target with its eyes, these neurons respond to visual motion as well as to smooth pursuit eye movements. Furthermore, the responses of some MSTd neurons to the motion of objects in the world are very similar during pursuit and during fixation, even though the visual information on the retina is altered by the pursuit eye movement. We call these neurons compensatory pursuit neurons. In this study we develop a computational model of MSTd compensatory pursuit neurons based on physiological data from single unit studies. Our model MSTd neurons can simulate the velocity tuning of monkey MSTd neurons. The model MSTd neurons also show the pursuit compensation property. We find that pursuit compensation can be achieved by divisive interaction between signals coding eye movements and signals coding visual motion. The model generates two implications that can be tested in future experiments: (1) compensatory pursuit neurons in MSTd should have the same direction preference for pursuit and retinal visual motion; (2) there should be non-compensatory pursuit neurons that show opposite preferred directions of pursuit and retinal visual motion.	[Cao, Bo] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Mingolla, Ennio] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Yazdanbakhsh, Arash] Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA; [Yazdanbakhsh, Arash] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Northeastern University; Boston University; Boston University	Yazdanbakhsh, A (corresponding author), Boston Univ, Ctr Computat Neurosci & Neural Technol, Boston, MA 02215 USA.	yazdan@bu.edu	Cao, Bo/D-1983-2017; Cao, Bo/D-1983-2017	Cao, Bo/0000-0001-9338-3271; Cao, Bo/0000-0003-3401-6900	Center of Excellence for Learning in Education, Science and Technology (CELEST, National Science Foundation (NSF)) [SBE-0354378]; Office of Naval Research (ONR) [N00014-11-1-0535]; AFOSR [FA9550-12-1-0436]; ONR [N00014-13-1-0092]	Center of Excellence for Learning in Education, Science and Technology (CELEST, National Science Foundation (NSF))(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ONR(Office of Naval Research)	This study was supported in part by the Center of Excellence for Learning in Education, Science and Technology (CELEST, National Science Foundation (NSF) SBE-0354378), Office of Naval Research (ONR, N00014-11-1-0535), AFOSR FA9550-12-1-0436, and ONR N00014-13-1-0092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cynthia Bradford and Sarah Swenson for their kind support during the completion of the manuscript. This work was supported in part by CELEST (NSF SBE-0354378), ONR N00014-11-1-0535, and AFOSR FA9550-12-1-0436. Mingolla was supported in part by ONR N00014-13-1-0092.	Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Churchland AK, 2005, J NEUROPHYSIOL, V94, P2416, DOI 10.1152/jn.00195.2005; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; GROSSBERG S, 1973, STUD APPL MATH, V52, P213; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Inaba N, 2007, J NEUROPHYSIOL, V97, P3473, DOI 10.1152/jn.01054.2006; Inaba N, 2011, J NEUROPHYSIOL, V105, P1531, DOI 10.1152/jn.00511.2010; Inaba N, 2010, CEREB CORTEX, V20, P1708, DOI 10.1093/cercor/bhp235; Kim HR, 2015, NAT NEUROSCI, V18, P129, DOI 10.1038/nn.3889; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P621, DOI 10.1152/jn.1988.60.2.621; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Nadler JW, 2009, NEURON, V63, P523, DOI 10.1016/j.neuron.2009.07.029; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; Pack C, 1998, VISION RES, V38, P3083, DOI 10.1016/S0042-6989(97)00451-3; Page WK, 1999, J NEUROPHYSIOL, V81, P596, DOI 10.1152/jn.1999.81.2.596; SAKATA H, 1983, J NEUROPHYSIOL, V49, P1364, DOI 10.1152/jn.1983.49.6.1364	19	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142964	10.1371/journal.pone.0142964	http://dx.doi.org/10.1371/journal.pone.0142964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575648	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400024
J	Krishnaveni, GV; Veena, SR; Srinivasan, K; Osmond, C; Fall, CHD				Krishnaveni, Ghattu V.; Veena, Sargoor R.; Srinivasan, Krishnamachari; Osmond, Clive; Fall, Caroline H. D.			Linear Growth and Fat and Lean Tissue Gain during Childhood: Associations with Cardiometabolic and Cognitive Outcomes in Adolescent Indian Children	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; PUNE MATERNAL NUTRITION; FOR-GESTATIONAL-AGE; 5 BIRTH COHORTS; WEIGHT-GAIN; BODY-COMPOSITION; BLOOD-PRESSURE; EARLY-LIFE; INFANCY; RISK	Background We aimed to determine how linear growth and fat and lean tissue gain during discrete age periods from birth to adolescence are related to adolescent cardiometabolic risk factors and cognitive ability. Methods Adolescents born to mothers with normal glucose tolerance during pregnancy from an Indian birth cohort (N = 486, age 13.5 years) had detailed anthropometry and measurements of body fat (fat%), fasting plasma glucose, insulin and lipid concentrations, blood pressure and cognitive function. Insulin resistance (HOMA-IR) was calculated. These outcomes were examined in relation to birth measurements and statistically independent measures (conditional SD scores) representing linear growth, and fat and lean tissue gain during birth-1, 1-2, 2-5, 5-9.5 and 9.5-13.5 years in 414 of the children with measurements at all these ages. Results Birth length and linear growth at all ages were positively associated with current height. Fat gain, particularly during 5-9.5 years was positively associated with fat% at 13.5 years (0.44 SD per SD [99.9% confidence interval: 0.29,0.58]). Greater fat gain during mid-late childhood was associated with higher systolic blood pressure (5-9.5 years: 0.23 SD per SD [0.07,0.40]) and HOMA-IR (5-9.5 years: 0.24 [0.08,0.40], 9.5-13.5 years: 0.22 [0.06,0.38]). Greater infant growth (up to age 2 years) in linear, fat or lean components was unrelated to cardiometabolic risk factors or cognitive function. Conclusion This study suggests that factors that increase linear, fat and lean growth in infancy have no adverse cardiometabolic effects in this population. Factors that increase fat gain in mid-late childhood may increase cardiometabolic risk, without any benefit to cognitive abilities.	[Krishnaveni, Ghattu V.; Veena, Sargoor R.] CSI Holdsworth Mem Hosp, Epidemiol Res Unit, Mysore, Karnataka, India; [Srinivasan, Krishnamachari] St Johns Natl Acad Hlth Sci, St Johns Res Inst, Bangalore, Karnataka, India; [Osmond, Clive; Fall, Caroline H. D.] Univ Southampton, Southampton Gen Hosp, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England	St. John's National Academy of Health Sciences; St. John's Research Institute; University of Southampton	Krishnaveni, GV (corresponding author), CSI Holdsworth Mem Hosp, Epidemiol Res Unit, Mysore, Karnataka, India.	gv.krishnaveni@gmail.com		Krishnaveni, Ghattu V/0000-0002-6532-8272; Fall, Caroline/0000-0003-4402-5552; Osmond, Clive/0000-0002-9054-4655	Parthenon Trust, Switzerland; Wellcome Trust, UK [059609/Z/99/Z, 079877/Z/06/Z, 095147/Z/10/Z]; Department for International Development, UK; Medical Research Council, UK [G0400519, 71108]; MRC [MC_UP_A620_1016, G0400519, MC_UU_12011/3] Funding Source: UKRI; Medical Research Council [G0400519, MC_UU_12011/3, MC_UP_A620_1016] Funding Source: researchfish	Parthenon Trust, Switzerland; Wellcome Trust, UK(Wellcome Trust); Department for International Development, UK; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Parthenon Trust, Switzerland; The Wellcome Trust, UK (grants: 059609/Z/99/Z, 079877/Z/06/Z, 095147/Z/10/Z) URL: www.wellcome.ac.uk; The Department for International Development, UK. URL: https://www.gov.uk/government/organisations/department-forinternational-development; The Medical Research Council, UK (grant: G0400519 [ID No. 71108]). URL: www.mrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barker DJP, 1998, MOTHERS BABIES HLTH; Beyerlein A, 2010, AM J CLIN NUTR, V92, P585, DOI 10.3945/ajcn.2009.29116; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bray GA, 2001, AM J CLIN NUTR, V73, P687; CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Demerath EW, 2014, AM J HUM BIOL, V26, P291, DOI 10.1002/ajhb.22500; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Eriksson JG, 2011, AM J CLIN NUTR, V94, p1799S, DOI 10.3945/ajcn.110.000638; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; International Institute for Population Sciences (IIPS), 2001, NAT FAM HLTH SURV NF; Joglekar CV, 2007, INT J OBESITY, V31, P1534, DOI 10.1038/sj.ijo.0803679; Jones A, 2012, HYPERTENSION, V59, P919, DOI 10.1161/HYPERTENSIONAHA.111.187716; Kehoe SH, 2011, EUR J CLIN NUTR, V65, P1263, DOI 10.1038/ejcn.2011.119; Krishnaveni GV, 2015, INT J EPIDEMIOL, V44, P28, DOI 10.1093/ije/dyu050; Krishnaveni GV, 2005, INDIAN PEDIATR, V42, P527; Kulkarni B, 2014, NUTR REV, V72, P190, DOI 10.1111/nure.12097; Kuzawa CW, 2012, AM J HUM BIOL, V24, P5, DOI 10.1002/ajhb.21227; Malda M., 2008, PSYCHOL SCI Q, V50, P451, DOI DOI 10.1177/0022022109349172; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Pietrobelli A, 2003, ACTA DIABETOL, V40, pS212, DOI 10.1007/s00592-003-0069-z; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tu YK, 2013, INT J EPIDEMIOL, V42, P1327, DOI 10.1093/ije/dyt157; Veena SR, 2010, PEDIATR RES, V67, P424, DOI 10.1203/PDR.0b013e3181d00b45; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	34	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143231	10.1371/journal.pone.0143231	http://dx.doi.org/10.1371/journal.pone.0143231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575994	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000365153400056
J	Burdett, CL; Kraus, BR; Garza, SJ; Miller, RS; Bjork, KE				Burdett, Christopher L.; Kraus, Brian R.; Garza, Sarah J.; Miller, Ryan S.; Bjork, Kathe E.			Simulating the Distribution of Individual Livestock Farms and Their Populations in the United States: An Example Using Domestic Swine (Sus scrofa domesticus) Farms	PLOS ONE			English	Article							DATABASE; HOG	Livestock distribution in the United States (U.S.) can only be mapped at a county-level or worse resolution. We developed a spatial microsimulation model called the Farm Location and Agricultural Production Simulator (FLAPS) that simulated the distribution and populations of individual livestock farms throughout the conterminous U.S. Using domestic pigs (Sus scrofa domesticus) as an example species, we customized iterative proportional-fitting algorithms for the hierarchical structure of the U.S. Census of Agriculture and imputed unpublished state-or county-level livestock population totals that were redacted to ensure confidentiality. We used a weighted sampling design to collect data on the presence and absence of farms and used them to develop a national-scale distribution model that predicted the distribution of individual farms at a 100 m resolution. We implemented microsimulation algorithms that simulated the populations and locations of individual farms using output from our imputed Census of Agriculture dataset and distribution model. Approximately 19% of county-level pig population totals were unpublished in the 2012 Census of Agriculture and needed to be imputed. Using aerial photography, we confirmed the presence or absence of livestock farms at 10,238 locations and found livestock farms were correlated with open areas, cropland, and roads, and also areas with cooler temperatures and gentler topography. The distribution of swine farms was highly variable, but cross-validation of our distribution model produced an area under the receiver-operating characteristics curve value of 0.78, which indicated good predictive performance. Verification analyses showed FLAPS accurately imputed and simulated Census of Agriculture data based on absolute percent difference values of <0.01% at the state-to-national scale, 3.26% for the county-to-state scale, and 0.03% for the individual farm-to-county scale. Our output data have many applications for risk management of agricultural systems including epidemiological studies, food safety, biosecurity issues, emergency-response planning, and conflicts between livestock and other natural resources.	[Burdett, Christopher L.; Kraus, Brian R.; Garza, Sarah J.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Miller, Ryan S.; Bjork, Kathe E.] US Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Ctr Anim Hlth, Ft Collins, CO USA; [Miller, Ryan S.; Bjork, Kathe E.] US Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Ctr Epidemiol, Ft Collins, CO USA	Colorado State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Burdett, CL (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	Chris.Burdett@colostate.edu	Miller, Ryan/H-9848-2019	Miller, Ryan/0000-0003-3892-0251	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services, Center for Epidemiology and Animal Health; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Food Safety and Applied Nutrition; USDA [11-9208-0301, 13-9208-0336]	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services, Center for Epidemiology and Animal Health; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Food Safety and Applied Nutrition; USDA(United States Department of Agriculture (USDA))	This work was funded by the U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services, Center for Epidemiology and Animal Health (http://www.aphis.usda.gov/wps/portal/?1dmy&urile=wcm:path:/APHIS_Content_Library/SA_Our_Focus/SA_Animal_Health/SA_Program_Overview/SA_CEAH). Additional funding was provided by the U.S. Department of Health and Human Services, Food and Drug Administration, Center for Food Safety and Applied Nutrition (http://www.fda.gov/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/) through an interagency grant to APHIS-VS-CEAH. Grant numbers supporting this work include USDA grant numbers 11-9208-0301 (interagency grant from FDA to USDA represented here) and 13-9208-0336. These grants were received by CB, who served as principle investigator at Colorado State University. The co-authors at APHIS-VS-CEAH had subordinate roles in study design, data analysis, publication and manuscript preparation.	[Anonymous], 2010, MAPPING SPECIES DIST; Ballas D, 2005, POPUL SPACE PLACE, V11, P13, DOI 10.1002/psp.351; Barthelemy J, 2013, TRANSPORT SCI, V47, P266, DOI 10.1287/trsc.1120.0408; Beckman RJ, 1996, TRANSPORT RES A-POL, V30, P415, DOI 10.1016/0965-8564(96)00004-3; Bishop YM., 2007, DISCRETE MULTIVARIAT; Branswell H, 2011, SCI AM, V304, P46, DOI 10.1038/scientificamerican0111-46; Bruhn M., 2012, SYNTHESIZED POPULATI; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cecchi G, 2010, AGR ECOSYST ENVIRON, V135, P98, DOI 10.1016/j.agee.2009.08.011; Chung C.A., 2004, SIMULATION MODELING; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; COSTANZA R, 1993, BIOSCIENCE, V43, P545, DOI 10.2307/1311949; DellaSala DA, 2001, NAT AREA J, V21, P124; Edwards K., 2013, SPATIAL MICROSIMULAT, P249, DOI DOI 10.1007/978-94-007-4623-7; Emelyanova IV, 2009, ENVIRON MODEL ASSESS, V14, P449, DOI 10.1007/s10666-008-9140-z; Enders C. K., 2010, APPL MISSING DATA AN; Environmental Systems Research Institute, 2012, ARCGIS 10 1; Environmental Systems Research Institute, 2015, WORLD IM; Environmental Systems Research Institute, 2015, WORLD TRANSP; Gargiulo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008828; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Herath DP, 2005, REV AGR ECON, V27, P49, DOI 10.1111/j.1467-9353.2004.00207.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Lanzas C, 2010, NAT REV MICROBIOL, V8, P139, DOI 10.1038/nrmicro2268; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manly B.F.J., 2002, RESOURCE SELECTION A; Martin MK, 2015, PREV VET MED, V120, P131, DOI 10.1016/j.prevetmed.2015.04.010; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; Prosser DJ, 2011, AGR ECOSYST ENVIRON, V141, P381, DOI 10.1016/j.agee.2011.04.002; R Core Team, 2013, R LANG ENV STAT COMP; Roe B, 2002, AM J AGR ECON, V84, P259, DOI 10.1111/1467-8276.00296; Ryan J, 2009, GEOGR ANAL, V41, P181, DOI 10.1111/j.1538-4632.2009.00750.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; StataCorp, 2011, STAT STAT SOFTW REL; Tildesley MJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002723; Tildesley MJ, 2010, P NATL ACAD SCI USA, V107, P1041, DOI 10.1073/pnas.0909047107; USDA-NASS (National Agricultural Statistics Service), 2012, CENS AGR; Vose D., 2008, RISK ANAL QUANTITATI; Wint W., 2007, GRIDDED LIVESTOCK WO; WONG DWS, 1992, PROF GEOGR, V44, P340, DOI 10.1111/j.0033-0124.1992.00340.x	44	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0140338	10.1371/journal.pone.0140338	http://dx.doi.org/10.1371/journal.pone.0140338			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571497	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700002
J	Fouquet, B; Ghosn, J; Quertainmont, Y; Salmon, D; Rioux, C; Duvivier, C; Delfraissy, JF; Misrahi, M				Fouquet, Baptiste; Ghosn, Jade; Quertainmont, Yann; Salmon, Dominique; Rioux, Christophe; Duvivier, Claudine; Delfraissy, Jean-Francois; Misrahi, Micheline			Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study	PLOS ONE			English	Article							INTRAVENOUS-DRUG-USERS; HIV-1 INFECTION; DISEASE PROGRESSION; CCR5 VARIANTS; HOST FACTORS; SUSCEPTIBILITY; RESISTANCE; GENE; AIDS; POLYMORPHISMS	Hepatitis C virus (HCV) causes persistent infection in 75% of cases and is a major public health problem worldwide. More than 92% of intravenous drug users (IDU) infected by human immunodeficiency virus type 1 (HIV-1) are seropositive for HCV, and it is conceivable that some HIV-1-infected IDU who remain uninfected by HCV may be genetically resistant. Here we conducted a case-control study to identify mutations in HCV entry coreceptors in HIV-infected IDU who remained uninfected by HCV. We recruited 138 patients, comprising 22 HIV+ HCV-case IDU and 116 HIV+ HCV+ control IDU. We focused on coreceptors in which point mutations are known to abolish HCV infectivity in vitro. Our previous study of the Claudin-1 gene revealed no specific variants in the same case population. Here we performed direct genomic sequencing of the Claudin-6, Claudin-9, Occludin and Scavenger receptor-B1 (SCARB1) gene coding regions. Most HIV+ HCV-IDU had no mutations in HCV coreceptors. However, two HIV+ HCV-patients harbored a total of four specific mutations/variants of HCV entry factors that were not found in the HIV+ HCV+ controls. One case patient harbored heterozygous variants of both Claudin-6 and Occludin, and the other case patient harbored two heterozygous variants of SCARB1. This suggests that HCV resistance might involve complex genetic events and factors other than coreceptors, a situation similar to that reported for HIV-1 resistance.	[Fouquet, Baptiste; Misrahi, Micheline] Univ Paris 11, Hop Univ Paris Sud, Fac Med, Hop Bicetre, F-94275 Le Kremlin Bicetre, France; [Ghosn, Jade] Hop Hotel Dieu, Hop Univ Paris Ctr, AP HP, Unite Fonct Therapeut Immunoinfectiol, F-75181 Paris, France; [Ghosn, Jade] Univ Paris 05, Sorbonne Paris Cite, EA 7327, Fac Med Necker, Paris, France; [Quertainmont, Yann; Delfraissy, Jean-Francois] Hop Bicetre, Hop Univ Paris Sud, AP HP, Serv Med Interne, F-94275 Le Kremlin Bicetre, France; [Salmon, Dominique] Hop Cochin, Hop Univ Paris Ctr, AP HP, Serv Med Interne, F-75674 Paris, France; [Rioux, Christophe] Hop Bichat Claude Bernard, Hop Univ Paris Nord Val de Seine, AP HP, Serv Malad Infect & Trop, F-75877 Paris 18, France; [Duvivier, Claudine] Inst Pasteur, Ctr Med, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ghosn, J (corresponding author), Hop Hotel Dieu, Hop Univ Paris Ctr, AP HP, Unite Fonct Therapeut Immunoinfectiol, F-75181 Paris, France.	jade.ghosn@htd.aphp.fr	Fouquet, Baptiste/GXH-8827-2022		French National Agency for Research on AIDS and Viral Hepatitis (ANRS) [ANRS AO-1-2008, ANRS AO-2-2013]; Roche laboratories; Janssen laboratories	French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR)); Roche laboratories; Janssen laboratories	This work was supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) (grants ANRS AO-1-2008 and ANRS AO-2-2013) and by grants from Roche laboratories (Dr. Alexandrina Pinta) and Janssen laboratories (Dr. Rima Lahoulou). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adojaan M, 2007, AIDS RES HUM RETROV, V23, P193, DOI 10.1089/aid.2006.0113; Alvarez V, 1998, HUM GENET, V102, P483, DOI 10.1007/s004390050726; Andreoni M, 2012, EUR REV MED PHARMACO, V16, P1473; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2010, VIRUSES-BASEL, V2, P692, DOI 10.3390/v2030692; Bekker V, 2010, J VIRAL HEPATITIS, V17, P192, DOI 10.1111/j.1365-2893.2009.01166.x; Belouzard S, 2011, CENT EUR J BIOL, V6, P933, DOI 10.2478/s11535-011-0076-y; Capoulade-Metay C, 2004, AIDS, V18, P2243, DOI 10.1097/00002030-200411190-00004; Chatterjee A, 2012, DIS MARKERS, V32, P143, DOI [10.1155/2012/147148, 10.3233/DMA-2011-0874]; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Ding Q, 2014, CELL HOST MICROBE, V16, P562, DOI 10.1016/j.chom.2014.10.009; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Ghosn J, 2015, J MED VIROL, V87, P619, DOI 10.1002/jmv.24088; Haid S, 2010, J VIROL, V84, P964, DOI 10.1128/JVI.01504-09; Huik K, 2010, J INFECT DIS, V201, P730, DOI 10.1086/650491; Larsen C, 2004, EUROSURVEILLANCE, V2008, p[13, 18888]; Li H, 2014, INFECT GENET EVOL, V24, P99, DOI 10.1016/j.meegid.2014.03.009; Loko MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-303; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Teixeira SLM, 2009, INFECT GENET EVOL, V9, P638, DOI 10.1016/j.meegid.2009.03.007; Marmor M, 2001, J ACQ IMMUN DEF SYND, V27, P472, DOI 10.1097/00126334-200108150-00009; Martinson JJ, 2000, AIDS, V14, P483, DOI 10.1097/00002030-200003310-00003; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Nkenfou Celine Nguefeu, 2013, BMC Res Notes, V6, P288, DOI 10.1186/1756-0500-6-288; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Restrepo C, 2011, AIDS REV, V13, P30; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Salem AH, 2009, AIDS RES HUM RETROV, V25, P973, DOI 10.1089/aid.2009.0066; Samreen B, 2012, INFECT GENET EVOL, V12, P1699, DOI 10.1016/j.meegid.2012.07.010; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sarkar K, 2010, J HEALTH POPUL NUTR, V28, P130; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; Su B, 1999, AM J HUM GENET, V65, P1047, DOI 10.1086/302568; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Wang FS, 2003, JAIDS-J ACQ IMM DEF, V32, P124, DOI 10.1097/00126334-200302010-00002; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zheng BJ, 2002, AIDS, V16, P2480, DOI 10.1097/00002030-200212060-00016; Zona L, 2014, VIRUSES-BASEL, V6, P875, DOI 10.3390/v6020875; Zwolinska K, 2013, AIDS RES HUM RETROV, V29, P54, DOI [10.1089/aid.2011.0362, 10.1089/AID.2011.0362]	45	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142698	10.1371/journal.pone.0142698	http://dx.doi.org/10.1371/journal.pone.0142698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571379	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700064
J	Surace, SC; Pfister, JP				Surace, Simone Carlo; Pfister, Jean-Pascal			A Statistical Model for In Vivo Neuronal Dynamics	PLOS ONE			English	Article							MOTOR CORTEX; FIRE MODEL; ADAPTATION; FRAMEWORK; CELLS	Single neuron models have a long tradition in computational neuroscience. Detailed biophysical models such as the Hodgkin-Huxley model as well as simplified neuron models such as the class of integrate-and-fire models relate the input current to the membrane potential of the neuron. Those types of models have been extensively fitted to in vitro data where the input current is controlled. Those models are however of little use when it comes to characterize intracellular in vivo recordings since the input to the neuron is not known. Here we propose a novel single neuron model that characterizes the statistical properties of in vivo recordings. More specifically, we propose a stochastic process where the subthreshold membrane potential follows a Gaussian process and the spike emission intensity depends nonlinearly on the membrane potential as well as the spiking history. We first show that the model has a rich dynamical repertoire since it can capture arbitrary subthreshold autocovariance functions, firing-rate adaptations as well as arbitrary shapes of the action potential. We then show that this model can be efficiently fitted to data without overfitting. We finally show that this model can be used to characterize and therefore precisely compare various intracellular in vivo recordings from different animals and experimental conditions.	[Surace, Simone Carlo] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland; [Surace, Simone Carlo; Pfister, Jean-Pascal] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Surace, Simone Carlo; Pfister, Jean-Pascal] ETH, Zurich, Switzerland	University of Bern; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Surace, SC (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	surace@ini.uzh.ch	Surace, Simone Carlo/U-3760-2019	Pfister, Jean-Pascal/0000-0002-1847-3389; Surace, Simone Carlo/0000-0001-9321-6481	Swiss National Science Foundation [PZ00P3_137200, PP00P3_150637]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation: S.C.S. and J.P.P grant PZ00P3_137200 and PP00P3_150637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ADV NEURAL INFORM PR; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Bach FR, 2004, IEEE T SIGNAL PROCES, V52, P2189, DOI 10.1109/TSP.2004.831032; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1865, DOI 10.1152/jn.1993.69.6.1865; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Cunningham John P, 2007, ADV NEURAL INFORM PR, P329; Druckmann S, 2007, FRONT NEUROSCI-SWITZ, V1, P7, DOI 10.3389/neuro.01.1.1.001.2007; EFRON B, 1978, BIOMETRIKA, V65, P457, DOI 10.2307/2335893; El Boustani S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000519; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Gerstner W, 2002, SPIKING NEURON MODEL; Gerstner W, 2009, SCIENCE, V326, P379, DOI 10.1126/science.1181936; Gray RM, 2006, FOUND TRENDS COMMUN, V2, DOI 10.1561/0100000006; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hamaguchi K, 2014, ELIFE, V3, DOI 10.7554/eLife.01833; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; KATSAGGELOS AK, 1991, IEEE T SIGNAL PROCES, V39, P729, DOI 10.1109/78.80894; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lindner B, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031916; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Macke Jakob H, 2012, ADV NEURAL INFORM PR, V24, P1350; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MATSUMURA M, 1988, EXP BRAIN RES, V70, P463; Mensi S, 2012, J NEUROPHYSIOL, V107, P1756, DOI 10.1152/jn.00408.2011; Moller J, 1998, SCAND J STAT, V25, P451, DOI 10.1111/1467-9469.00115; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2010, J COMPUT NEUROSCI, V29, P107, DOI 10.1007/s10827-009-0179-x; Pfister JP, 2010, NAT NEUROSCI, V13, P1271, DOI 10.1038/nn.2640; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Pozzorini C, 2013, NAT NEUROSCI, V16, P942, DOI 10.1038/nn.3431; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Shinomoto S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041910; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STEIN RB, 1967, BIOPHYS J, V7, P797, DOI 10.1016/S0006-3495(67)86623-2; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Vallentin D, 2015, J NEUROSCI, V35, P299, DOI 10.1523/JNEUROSCI.3698-14.2015; Vidne M, 2012, J COMPUT NEUROSCI, V33, P97, DOI 10.1007/s10827-011-0376-2; WOODY CD, 1978, BRAIN RES, V158, P343, DOI 10.1016/0006-8993(78)90680-7	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142435	10.1371/journal.pone.0142435	http://dx.doi.org/10.1371/journal.pone.0142435			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571371	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000365070700037
J	Tamaki, S; Fukuta, M; Sekiguchi, K; Jin, Y; Nagata, S; Hayakawa, K; Hineno, S; Okamoto, T; Watanabe, M; Woltjen, K; Ikeya, M; Kato, T; Toguchida, J				Tamaki, Sakura; Fukuta, Makoto; Sekiguchi, Kazuya; Jin, Yonghui; Nagata, Sanae; Hayakawa, Kazuo; Hineno, Sho; Okamoto, Takeshi; Watanabe, Makoto; Woltjen, Knut; Ikeya, Makoto; Kato, Tomohisa, Jr.; Toguchida, Junya			SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SOFT-TISSUE SARCOMAS; GENE-EXPRESSION; SYT; SSX; TRANSLOCATION; CLASSIFICATION; TRANSCRIPT; INDUCTION; CHROMATIN	The prevalence and specificity of unique fusion oncogenes are high in a number of soft tissue sarcomas (STSs). The close relationship between fusion genes and clinicopathological features suggests that a correlation may exist between the function of fusion proteins and cellular context of the cell-of-origin of each tumor. However, most STSs are origin-unknown tumors and this issue has not yet been investigated in detail. In the present study, we examined the effects of the cellular context on the function of the synovial sarcoma (SS)-specific fusion protein, SS18-SSX, using human pluripotent stem cells (hPSCs) containing the drug-inducible SS18-SSX gene. We selected the neural crest cell (NCC) lineage for the first trial of this system, induced SS18-SSX at various differentiation stages from PSCs to NCC-derived mesenchymal stromal cells (MSCs), and compared its biological effects on each cell type. We found that the expression of FZD10, identified as an SS-specific gene, was induced by SS18-SSX at the PSC and NCC stages, but not at the MSC stage. This stage-specific induction of FZD10 correlated with stage-specific changes in histone marks associated with the FZD10 locus and also with the loss of the BAF47 protein, a member of the SWI/SNF chromatin-remodeling complex. Furthermore, the global gene expression profile of hPSC-derived NCCs was the closest to that of SS cell lines after the induction of SS18-SSX. These results clearly demonstrated that the cellular context is an important factor in the function of SS18-SSX as an epigenetic modifier.	[Tamaki, Sakura; Fukuta, Makoto; Sekiguchi, Kazuya; Jin, Yonghui; Hayakawa, Kazuo; Hineno, Sho; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan; [Fukuta, Makoto; Sekiguchi, Kazuya; Nagata, Sanae; Hayakawa, Kazuo; Watanabe, Makoto; Ikeya, Makoto; Kato, Tomohisa, Jr.; Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Kyoto, Japan; [Fukuta, Makoto; Hayakawa, Kazuo] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Sekiguchi, Kazuya; Okamoto, Takeshi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Watanabe, Makoto] Shimadzu Co Ltd, Technol Res Lab, Life Sci Res Ctr, Kyoto, Japan; [Woltjen, Knut] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Life Sci Frontiers, Kyoto, Japan	Kyoto University; Kyoto University; Nagoya City University; Kyoto University; Shimadzu Corporation; Kyoto University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan.	togjun@frontier.kyoto-u.ac.jp		Kato, Tomohisa/0000-0002-3047-9847; Woltjen, Knut/0000-0003-2293-1183; Ikeya, Makoto/0000-0002-3930-8032	Ministry of Education, Culture, Sports, Science and Technology [15H04956]; Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare [H26-084]; Grants-in-Aid for Scientific Research [15H04956] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (15H04956), and the Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare (H26-084) to JT. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2010, J BIOL CHEM, V285, P29842, DOI 10.1074/jbc.M110.116319; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Brodin B, 2001, GENE, V268, P173, DOI 10.1016/S0378-1119(01)00412-7; Cai WJ, 2011, PATHOL ONCOL RES, V17, P357, DOI 10.1007/s12253-010-9334-y; Cironi L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007904; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; Eifert C, 2012, NAT REV CANCER, V12, P572, DOI 10.1038/nrc3299; Fukuta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112291; Garcia CB, 2012, ONCOGENE, V31, P2323, DOI 10.1038/onc.2011.418; Garcia CB, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-189; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Haldar M, 2009, CANCER RES, V69, P3657, DOI 10.1158/0008-5472.CAN-08-4127; Hallor KH, 2005, GENE CHROMOSOME CANC, V44, P97, DOI 10.1002/gcc.20201; Hayakawa K, 2013, BIOCHEM BIOPH RES CO, V432, P713, DOI 10.1016/j.bbrc.2013.01.003; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ishibe T, 2008, CLIN ORTHOP RELAT R, V466, P2147, DOI 10.1007/s11999-008-0343-z; Ishida M, 2007, MOL CELL BIOL, V27, P1348, DOI 10.1128/MCB.00658-06; Jain S, 2010, INT J CLIN EXP PATHO, V3, P416; Jin YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131998; Jones KB, 2013, ONCOGENE, V32, P2365, DOI 10.1038/onc.2012.247; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kajita Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049709; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Kohashi K, 2010, MODERN PATHOL, V23, P981, DOI 10.1038/modpathol.2010.71; Kohno Y, 2006, J BIOL CHEM, V281, P38941, DOI 10.1074/jbc.M608389200; Kralik JM, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-19; Ladanyi M, 2002, CANCER RES, V62, P135; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Nagai M, 2001, P NATL ACAD SCI USA, V98, P3843, DOI 10.1073/pnas.061036798; Nagayama S, 2005, ONCOGENE, V24, P6201, DOI 10.1038/sj.onc.1208780; Nagayama S, 2002, CANCER RES, V62, P5859; Naka N, 2010, STEM CELLS, V28, P1119, DOI 10.1002/stem.452; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; SREEKANTAIAH C, 1994, AM J PATHOL, V144, P1121; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Suehara Y, 2006, PROTEOMICS, V6, P4402, DOI 10.1002/pmic.200600196; Takenaka S, 2010, INT J ONCOL, V36, P823, DOI 10.3892/ijo_00000559; Thaete C, 1999, HUM MOL GENET, V8, P585, DOI 10.1093/hmg/8.4.585; Tschoep K, 2007, CRIT REV ONCOL HEMAT, V63, P111, DOI 10.1016/j.critrevonc.2007.04.001; Tsuda M, 2005, ONCOGENE, V24, P7984, DOI 10.1038/sj.onc.1208942; Umeda K, 2015, STEM CELL REP, V4, P712, DOI 10.1016/j.stemcr.2015.02.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamada K, 2013, J CLIN INVEST, V123, P600, DOI 10.1172/JCI63572; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	50	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142991	10.1371/journal.pone.0142991	http://dx.doi.org/10.1371/journal.pone.0142991			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571495	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700112
J	Tang, X; Feng, GC; Li, XX; Cai, JX				Tang, Xin; Feng, Guo-can; Li, Xiao-xin; Cai, Jia-xin			Learning Low-Rank Class-Specific Dictionary and Sparse Intra-Class Variant Dictionary for Face Recognition	PLOS ONE			English	Article							DISCRIMINATIVE DICTIONARY; REPRESENTATION; CLASSIFICATION; CLASSIFIERS; EIGENFACES	Face recognition is challenging especially when the images from different persons are similar to each other due to variations in illumination, expression, and occlusion. If we have sufficient training images of each person which can span the facial variations of that person under testing conditions, sparse representation based classification (SRC) achieves very promising results. However, in many applications, face recognition often encounters the small sample size problem arising from the small number of available training images for each person. In this paper, we present a novel face recognition framework by utilizing low-rank and sparse error matrix decomposition, and sparse coding techniques (LRSE+SC). Firstly, the low-rank matrix recovery technique is applied to decompose the face images per class into a low-rank matrix and a sparse error matrix. The low-rank matrix of each individual is a class-specific dictionary and it captures the discriminative feature of this individual. The sparse error matrix represents the intra-class variations, such as illumination, expression changes. Secondly, we combine the low-rank part (representative basis) of each person into a supervised dictionary and integrate all the sparse error matrix of each individual into a within-individual variant dictionary which can be applied to represent the possible variations between the testing and training images. Then these two dictionaries are used to code the query image. The within-individual variant dictionary can be shared by all the subjects and only contribute to explain the lighting conditions, expressions, and occlusions of the query image rather than discrimination. At last, a reconstruction-based scheme is adopted for face recognition. Since the within-individual dictionary is introduced, LRSE+SC can handle the problem of the corrupted training data and the situation that not all subjects have enough samples for training. Experimental results show that our method achieves the state-of-the art results on AR, FERET, FRGC and LFW databases.	[Tang, Xin] Huazhong Agr Univ, Sch Sci, Wuhan, Hubei Province, Peoples R China; [Feng, Guo-can; Cai, Jia-xin] Sun Yat Sen Univ, Sch Math & Computat Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xiao-xin] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China	Huazhong Agricultural University; Sun Yat Sen University; Zhejiang University of Technology	Feng, GC (corresponding author), Sun Yat Sen Univ, Sch Math & Computat Sci, Guangzhou 510275, Guangdong, Peoples R China.	mcsfgc@mail.sysu.edu.cn			NSFC [61272338]; Fundamental Research Funds for the Central Universities of China [2662015QC033, 2662015PY046]	NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work is partially supported by the NSFC under Grant no. 61272338 and the Fundamental Research Funds for the Central Universities of China (2662015QC033 and 2662015PY046).	Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244; Baraniuk RG, 2009, FOUND COMPUT MATH, V9, P51, DOI 10.1007/s10208-007-9011-z; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chen CF, 2012, PROC CVPR IEEE, P2618, DOI 10.1109/CVPR.2012.6247981; Chen LF, 2000, PATTERN RECOGN, V33, P1713, DOI 10.1016/S0031-3203(99)00139-9; Chien JT, 2002, IEEE T PATTERN ANAL, V24, P1644, DOI 10.1109/TPAMI.2002.1114855; De la Torre F, 2003, INT J COMPUT VISION, V54, P117, DOI 10.1023/A:1023709501986; De la Torre F, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P362, DOI 10.1109/ICCV.2001.937541; Demsar J, 2006, J MACH LEARN RES, V7, P1; Deng WH, 2012, IEEE T PATTERN ANAL, V34, P1864, DOI 10.1109/TPAMI.2012.30; Fidler S, 2006, IEEE T PATTERN ANAL, V28, P337, DOI 10.1109/TPAMI.2006.46; He XF, 2005, IEEE T PATTERN ANAL, V27, P328, DOI 10.1109/TPAMI.2005.55; Huang G. B., 2007, 0749 U MASS; Jiang ZL, 2013, IEEE T PATTERN ANAL, V35, P2651, DOI 10.1109/TPAMI.2013.88; Jiang ZL, 2011, PROC CVPR IEEE, P1697, DOI 10.1109/CVPR.2011.5995354; Ke QF, 2005, PROC CVPR IEEE, P739; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Lee H., 2006, ADV NEURAL INFORM PR, P801, DOI DOI 10.1371/J0URNAL.P0NE.0006098; Lin Z., 2013, J STRUCT BIOL, V181, P116, DOI [10.1016/j.jsb.2012.10.010, DOI 10.1016/J.JSB.2012.10.010]; Liu CJ, 2002, IEEE T IMAGE PROCESS, V11, P467, DOI 10.1109/TIP.2002.999679; Lu JW, 2003, IEEE T NEURAL NETWOR, V14, P195, DOI 10.1109/TNN.2002.806647; Ma L, 2012, PROC CVPR IEEE, P2586, DOI 10.1109/CVPR.2012.6247977; Mairal J., 2008, P IEEE C COMP VIS PA, V2, P1, DOI DOI 10.1109/CVPR.2008.4587652; Malioutov D.M., 2005, P IEEE INT C AC SPEE; Martinez A., 1998, AR FACE DATABASE; Mi JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042461; Min K, 2010, P 19 ACM INT C INF K, P269; Naseem I, 2010, IEEE T PATTERN ANAL, V32, P2106, DOI 10.1109/TPAMI.2010.128; PHAM D.-S., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587408; Phillips PJ, 2005, PROC CVPR IEEE, P947; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Ramirez I, 2010, PROC CVPR IEEE, P3501, DOI 10.1109/CVPR.2010.5539964; Shen XH, 2012, PROC CVPR IEEE, P853, DOI 10.1109/CVPR.2012.6247758; Taigman Y., 2009, BMVC, P1; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wagner A, 2012, IEEE T PATTERN ANAL, V34, P372, DOI 10.1109/TPAMI.2011.112; Wang Y, 2009, IEEE T PATTERN ANAL, V31, P1968, DOI 10.1109/TPAMI.2008.244; Wei C., 2013, P 10 SOUND MUSIC COM, P1; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang M, 2012, PROC CVPR IEEE, P2224, DOI 10.1109/CVPR.2012.6247931; Yang M, 2011, IEEE I CONF COMP VIS, P543, DOI 10.1109/ICCV.2011.6126286; Yang M, 2010, IEEE IMAGE PROC, P1601, DOI 10.1109/ICIP.2010.5652363; Zhang QA, 2010, PROC CVPR IEEE, P2691, DOI 10.1109/CVPR.2010.5539989; Zhang YMZ, 2013, PROC CVPR IEEE, P676, DOI 10.1109/CVPR.2013.93; Zhang ZD, 2012, INT J COMPUT VISION, V99, P1, DOI 10.1007/s11263-012-0515-x; Zhu G., 2010, ACM MULT, P461	48	4	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142403	10.1371/journal.pone.0142403	http://dx.doi.org/10.1371/journal.pone.0142403			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571112	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700035
J	Min, B; Park, H; Lee, S; Li, Y; Choi, JM; Lee, JY; Kim, J; Choi, YD; Kwon, YG; Lee, HW; Bae, SC; Yun, CO; Chung, KC				Min, B.; Park, H.; Lee, S.; Li, Y.; Choi, J-M; Lee, J. Y.; Kim, J.; Choi, Y. D.; Kwon, Y-G; Lee, H-W; Bae, S-C; Yun, C-O; Chung, K. C.			CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer	ONCOGENE			English	Article							TISSUE TRANSGLUTAMINASE; E3 LIGASE; PROGNOSTIC-SIGNIFICANCE; PROTEIN; EXPRESSION; SUPPRESSOR; ADENOCARCINOMA; CALCIFICATION; SENSITIVITY; METASTASIS	The multifunctional enzyme transglutaminase 2 (TG2) primarily catalyzes cross-linking reactions of proteins via (gamma-glutamyl) lysine bonds. Several recent findings indicate that altered regulation of intracellular TG2 levels affects renal cancer. Elevated TG2 expression is observed in renal cancer. However, the molecular mechanism underlying TG2 degradation is not completely understood. Carboxyl-terminus of Hsp70-interacting protein (CHIP) functions as an ubiquitin E3 ligase. Previous studies reveal that CHIP deficiency mice displayed a reduced life span with accelerated aging in kidney tissues. Here we show that CHIP promotes polyubiquitination of TG2 and its subsequent proteasomal degradation. In addition, TG2 upregulation contributes to enhanced kidney tumorigenesis. Furthermore, CHIP-mediated TG2 downregulation is critical for the suppression of kidney tumor growth and angiogenesis. Notably, our findings are further supported by decreased CHIP expression in human renal cancer tissues and renal cancer cells. The present work reveals that CHIP-mediated TG2 ubiquitination and proteasomal degradation represent a novel regulatory mechanism that controls intracellular TG2 levels. Alterations in this pathway result in TG2 hyperexpression and consequently contribute to renal cancer.	[Min, B.; Chung, K. C.] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Yonsei Ro 50, Seoul 03722, South Korea; [Park, H.; Lee, S.; Choi, J-M; Kwon, Y-G; Lee, H-W] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul, South Korea; [Li, Y.; Yun, C-O] Hanyang Univ, Dept Bioengn, Coll Engn, Seoul, South Korea; [Lee, J. Y.; Choi, Y. D.] Yonsei Univ, Dept Urol, Coll Med, Seoul, South Korea; [Kim, J.] Catholic Univ Korea, Sch Med, Dept Anat, Seoul, South Korea; [Bae, S-C] Chungbuk Natl Univ, Dept Biochem, Coll Med, Cheongju, South Korea	Yonsei University; Yonsei University; Hanyang University; Yonsei University; Yonsei University Health System; Catholic University of Korea; Chungbuk National University	Chung, KC (corresponding author), Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Yonsei Ro 50, Seoul 03722, South Korea.	kchung@yonsei.ac.kr		Yun, Chae-Ok/0000-0002-9466-4531; Choi, Young Deuk/0000-0002-8545-5797	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea [2014M3C7A1064545]; Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C0093]; NRF [2015R1A2A2A01003080, 2007-0056092]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea; Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; NRF	We thank SY Kim and DH Lee for providing plasmids and JJ Hwang for providing renal cancer cell line lysates. We also thank KH Chun, IK Chung and J Song for their technical assistances, critical comments and helpful discussions. This research was supported by grants from the National Research Foundation of Korea (NRF; 2014M3C7A1064545 to KCC) funded by the Ministry of Science, ICT & Future Planning (MSIP), Republic of Korea, and from the Korea Healthcare Technology R&D Project (HI14C0093 to KCC) through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea. This work was supported in part by NRF grants (2015R1A2A2A01003080 and 2007-0056092 to KCC).	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bento CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015062; Boroughs LK, 2011, J BIOL CHEM, V286, P37094, DOI 10.1074/jbc.M111.242438; Chen NX, 2013, AM J NEPHROL, V37, P191, DOI 10.1159/000347031; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dyer LM, 2011, J NEURO-ONCOL, V101, P429, DOI 10.1007/s11060-010-0277-7; ELSASSER HP, 1993, EUR J CELL BIOL, V61, P321; Erdem S, 2015, WORLD J UROL, V33, P1553, DOI 10.1007/s00345-014-1462-7; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Fok JY, 2006, MOL CANCER THER, V5, P1493, DOI 10.1158/1535-7163.MCT-06-0083; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hidaka H, 2012, ONCOTARGET, V3, P44; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Jan CI, 2011, J PATHOL, V225, P424, DOI 10.1002/path.2921; Jang KW, 2011, J CELL BIOCHEM, V112, P3612, DOI 10.1002/jcb.23292; Johnson TS, 2007, J AM SOC NEPHROL, V18, P3078, DOI 10.1681/ASN.2006070690; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kim DS, 2011, ONCOGENE, V30, P4780, DOI 10.1038/onc.2011.183; Koleganova N, 2009, NEPHROL DIAL TRANSPL, V24, P2488, DOI 10.1093/ndt/gfp137; Ku BM, 2014, J CANCER RES CLIN, V140, P757, DOI 10.1007/s00432-014-1623-5; Ku BM, 2013, FASEB J, V27, P3487, DOI 10.1096/fj.12-224220; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Paul I, 2013, ONCOGENE, V32, P1284, DOI 10.1038/onc.2012.144; Pavlovich CP, 2004, NAT REV CANCER, V4, P381, DOI 10.1038/nrc1364; Sarkar S, 2014, ONCOGENE, V33, P26, DOI 10.1038/onc.2012.561; Su CH, 2011, CELL SIGNAL, V23, P1824, DOI 10.1016/j.cellsig.2011.06.018; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Wang SY, 2013, GUT, V62, P496, DOI 10.1136/gutjnl-2011-301522; Wang YM, 2014, CARCINOGENESIS, V35, P983, DOI 10.1093/carcin/bgt393; Wiesener MS, 2001, CANCER RES, V61, P5215; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Xu T, 2011, CANCER SCI, V102, P959, DOI 10.1111/j.1349-7006.2011.01888.x; Yakubov B, 2013, NEOPLASIA, V15, P609, DOI 10.1593/neo.121878; Yan S, 2010, EMBO J, V29, P3773, DOI 10.1038/emboj.2010.245; Yang MJ, 2011, J EXP MED, V208, P2099, DOI 10.1084/jem.20102667; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397	45	14	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 14	2016	35	28					3718	3728		10.1038/onc.2015.439	http://dx.doi.org/10.1038/onc.2015.439			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UQ	26568304				2022-12-26	WOS:000379622800010
J	Guler, G; Gartner, RM; Ziegler, C; Mantele, W				Gueler, Guennur; Gaertner, Rebecca M.; Ziegler, Christine; Maentele, Werner			Lipid-Protein Interactions in the Regulated Betaine Symporter BetP Probed by Infrared Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; CORYNEBACTERIUM-GLUTAMICUM; TRANSPORTER BETP; CARRIER BETP; GLYCINE-BETAINE; CONFORMATIONAL-CHANGES; BIOLOGICAL-MEMBRANES; PHASE-TRANSITIONS; K+; SPECIFICITY	The Na+-coupled betaine symporter BetP senses changes in the membrane state and increasing levels of cytoplasmic K+ during hyperosmotic stress latter via its C-terminal domain and regulates transport activity according to both stimuli. This intriguing sensing and regulation behavior of BetP was intensively studied in the past. It was shown by several biochemical studies that activation and regulation depends crucially on the lipid composition of the surrounding membrane. In fact, BetP is active and regulated only when negatively charged lipids are present. Recent structural studies have revealed binding of phosphatidylglycerol lipids to functional important parts of BetP, suggesting a functional role of lipid interactions. However, a regulatory role of lipid interactions could only be speculated from the snapshot provided by the crystal structure. Here, we investigate the nature of lipid-protein interactions of BetP reconstituted in closely packed two-dimensional crystals of negatively charged lipids and probed at the molecular level with Fourier transform infrared (FTIR) spectroscopy. The FTIR data indicate that K+ binding weakens the interaction of BetP especially with the anionic lipid head groups. We suggest a regulation mechanism in which lipid-protein interactions, especially with the C-terminal domain and the functional important gating helices transmembrane helice 3 (TMH3) and TMH12, confine BetP to its down-regulated transport state. As BetP is also activated by changes in the physical state of the membrane, our results point toward a more general mechanism of how active transport can be modified by dynamic lipid-protein interactions.	[Gueler, Guennur; Maentele, Werner] Goethe Univ Frankfurt, Inst Biophys, Max Von Laue Str 1, D-60438 Frankfurt, Germany; [Gaertner, Rebecca M.; Ziegler, Christine] Max Planck Inst Biophys, Dept Biol Struct, Max Von Laue Str 3, D-60438 Frankfurt, Germany; [Ziegler, Christine] Univ Regensburg, Fac Biol & Preclin Med, Univ Str 31, D-93051 Regensburg, Germany	Goethe University Frankfurt; Max Planck Society; University of Regensburg	Mantele, W (corresponding author), Goethe Univ Frankfurt, Inst Biophys, Max Von Laue Str 1, D-60438 Frankfurt, Germany.; Ziegler, C (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, Max Von Laue Str 3, D-60438 Frankfurt, Germany.	Christine.Ziegler@biophys.mpg.de; maentele@biophysik.uni-frankfurt.de	Güler, Günnur/GLQ-7527-2022	Ziegler, Christine Maria/0000-0003-3439-7213; Richter, Rebecca M./0000-0002-3831-7666	Collaborative Research Center "Transport and Communication across Biological Membranes" of Deutsche Forschungsgemeinschaft [SFB 807]	Collaborative Research Center "Transport and Communication across Biological Membranes" of Deutsche Forschungsgemeinschaft	This work was supported by Collaborative Research Center SFB 807 "Transport and Communication across Biological Membranes" of Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Arrondo JLR, 1998, CHEM PHYS LIPIDS, V96, P53, DOI 10.1016/S0009-3084(98)00080-2; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; BLUME A, 1988, BIOCHEMISTRY-US, V27, P8239, DOI 10.1021/bi00421a038; CAMERON DG, 1980, BIOCHEMISTRY-US, V19, P3665, DOI 10.1021/bi00557a005; CASAL HL, 1984, BIOCHIM BIOPHYS ACTA, V779, P381, DOI 10.1016/0304-4157(84)90017-0; Dzafic E, 2009, SPECTROCHIM ACTA A, V72, P102, DOI 10.1016/j.saa.2008.08.015; Fabian H., 2001, HDB VIB SPECTROSC, DOI [10.1002/0470027320.s8201, DOI 10.1002/0470027320.S8201, DOI 10.1002/0470027320]; FRINGELI UP, 1976, BIOCHIM BIOPHYS ACTA, V450, P101, DOI 10.1016/0005-2760(76)90302-7; Gartner RM, 2011, J MOL BIOL, V414, P327, DOI 10.1016/j.jmb.2011.10.013; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Korkmaz F, 2008, BIOCHEMISTRY-US, V47, P12126, DOI 10.1021/bi801224y; Korkmaz F, 2013, BBA-BIOMEMBRANES, V1828, P1181, DOI 10.1016/j.bbamem.2013.01.004; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Kramer R, 2009, BIOL CHEM, V390, P685, DOI 10.1515/BC.2009.068; Kramer R, 2009, AMINO ACIDS, V37, P487, DOI 10.1007/s00726-009-0271-6; LEWIS RNAH, 1994, BIOPHYS J, V67, P2367, DOI 10.1016/S0006-3495(94)80723-4; Lewis RNAH, 2013, BBA-BIOMEMBRANES, V1828, P2347, DOI 10.1016/j.bbamem.2012.10.018; LUMRY R, 1951, J AM CHEM SOC, V73, P4330, DOI 10.1021/ja01153a090; MANTSCH HH, 1991, CHEM PHYS LIPIDS, V57, P213, DOI 10.1016/0009-3084(91)90077-O; Moffat D. J., 1986, NRCC B, V18; Nicklisch SCT, 2012, BBA-BIOMEMBRANES, V1818, P359, DOI 10.1016/j.bbamem.2011.10.021; Ozcan N, 2007, J BACTERIOL, V189, P7485, DOI 10.1128/JB.00986-07; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Ozcan N, 2005, J BACTERIOL, V187, P4752, DOI 10.1128/JB.187.14.4752-4759.2005; Perez C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5231; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Perez C, 2011, EMBO REP, V12, P804, DOI 10.1038/embor.2011.102; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Peter H, 1996, J BACTERIOL, V178, P5229, DOI 10.1128/jb.178.17.5229-5234.1996; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rubenhagen R, 2000, J BIOL CHEM, V275, P735, DOI 10.1074/jbc.275.2.735; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; SIEBERT F, 1982, FEBS LETT, V141, P82, DOI 10.1016/0014-5793(82)80021-5; Sukumaran S, 2005, FEBS LETT, V579, P2546, DOI 10.1016/j.febslet.2005.03.059; Szalontai Balazs, 2009, PMC Biophys, V2, P1, DOI 10.1186/1757-5036-2-1; Tsai CJ, 2007, J STRUCT BIOL, V160, P275, DOI 10.1016/j.jsb.2007.09.008; Tsai CJ, 2011, J MOL BIOL, V407, P368, DOI 10.1016/j.jmb.2011.01.028; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	44	30	31	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4295	4307		10.1074/jbc.M114.621979	http://dx.doi.org/10.1074/jbc.M114.621979			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26592930	Green Published, hybrid			2022-12-26	WOS:000371604600003
J	Gu, XD; Huang, Y; Levison, BS; Gerstenecker, G; DiDonato, AJ; Hazen, LB; Lee, J; Gogonea, V; DiDonato, JA; Hazen, SL				Gu, Xiaodong; Huang, Ying; Levison, Bruce S.; Gerstenecker, Gary; DiDonato, Anthony J.; Hazen, Leah B.; Lee, Joonsue; Gogonea, Valentin; DiDonato, Joseph A.; Hazen, Stanley L.			Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; SERUM PARAOXONASE; LIPID-PEROXIDATION; CHOLESTEROL EFFLUX; PROTEOMIC ANALYSIS; LACTONASE ACTIVITY; PROTEIN; MYELOPEROXIDASE; HDL	Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated protein with atherosclerosis-protective and systemic anti-oxidant functions. We recently showed that PON1, myeloperoxidase, and HDL bind to one another in vivo forming a functional ternary complex (Huang, Y., Wu, Z., Riwanto, M., Gao, S., Levison, B. S., Gu, X., Fu, X., Wagner, M. A., Besler, C., Gerstenecker, G., Zhang, R., Li, X. M., Didonato, A. J., Gogonea, V., Tang, W. H., et al. (2013) J. Clin. Invest. 123, 3815-3828). However, specific residues onPON1 involved in the HDL-PON1 interaction remain unclear. Unambiguous identification of protein residues involved in docking interactions to lipid surfaces poses considerable methodological challenges. Here we describe a new strategy that uses a novel synthetic photoactivatable and click chemistry-taggable phospholipid probe, which, when incorporated into HDL, was used to identify amino acid residues on PON1 that directly interact with the lipoprotein phospholipid surface. Several specific PON1 residues (Leu-9, Tyr-185, and Tyr-293) were identified through covalent crosslinks with the lipid probes using affinity isolation coupled to liquid chromatography with on-line tandem mass spectrometry. Based upon the crystal structure for PON1, the identified residues are all localized in relatively close proximity on the surface of PON1, defining a domain that binds to the HDL lipid surface. Site-specific mutagenesis of the identified PON1 residues (Leu-9, Tyr-185, and Tyr-293), coupled with functional studies, reveals their importance in PON1 binding to HDL and both PON1 catalytic activity and stability. Specifically, the residues identified on PON1 provide important structural insights into the PON1-HDL interaction. More generally, the new photoactivatable and affinity-tagged lipid probe developed herein should prove to be a valuable tool for identifying contact sites supporting protein interactions with lipid interfaces such as found on cell membranes or lipoproteins.	[Gu, Xiaodong; Huang, Ying; Levison, Bruce S.; DiDonato, Anthony J.; Hazen, Leah B.; Lee, Joonsue; Gogonea, Valentin; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Gerstenecker, Gary; Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Hazen, SL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021	Levison, Bruce/0000-0002-1816-368X	National Institutes of Health [P01 HL076491, P01 HL103453]; Esperion; Procter Gamble; Abbott; Astra Zeneca; Liposcience Inc.; Pfizer Inc.; Roche Diagnostics; Takeda; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, U10HL109250, P01HL103453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Esperion; Procter Gamble(Procter & Gamble); Abbott(Abbott Laboratories); Astra Zeneca(AstraZeneca); Liposcience Inc.; Pfizer Inc.(Pfizer); Roche Diagnostics; Takeda(Takeda Pharmaceutical Company Ltd); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants P01 HL076491 and P01 HL103453. S. L. H. is named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. S. L. H. reports having been paid as a consultant for the following companies: Esperion and Procter & Gamble. S. L. H. reports receiving research funds from Abbott, Astra Zeneca, Liposcience Inc., Procter & Gamble, Pfizer Inc., Roche Diagnostics, and Takeda. S. L H. reports having the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from the following companies: Cleveland HeartLab, Siemens, Esperion, Frantz Biomarkers, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a Fellowship Award from the American Heart Association.	Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Alwaili K, 2012, BBA-MOL CELL BIOL L, V1821, P405, DOI 10.1016/j.bbalip.2011.07.013; Aviram M, 2000, CIRCULATION, V101, P2510, DOI 10.1161/01.CIR.101.21.2510; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Baker PW, 2000, J LIPID RES, V41, P1261; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Best MD, 2011, ACCOUNTS CHEM RES, V44, P686, DOI 10.1021/ar200060y; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Birner-Gruenberger R, 2014, PROG LIPID RES, V56, P36, DOI 10.1016/j.plipres.2014.07.003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Chang CT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/164846; Das J, 2011, CHEM REV, V111, P4405, DOI 10.1021/cr1002722; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Gaidukov L, 2005, BIOCHEMISTRY-US, V44, P11843, DOI 10.1021/bi050862i; Gaidukov Leonid, 2009, BMC Clin Pharmacol, V9, P18, DOI 10.1186/1472-6904-9-18; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gu XD, 2011, CHEM RES TOXICOL, V24, P1080, DOI 10.1021/tx200093m; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hazen SL, 2004, ARTERIOSCL THROM VAS, V24, P1143, DOI 10.1161/01.ATV.0000135267.82813.52; Heller M, 2005, PROTEOMICS, V5, P2619, DOI 10.1002/pmic.200401233; Hortin GL, 2006, BIOCHEM BIOPH RES CO, V340, P909, DOI 10.1016/j.bbrc.2005.12.098; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/NMETH.2368, 10.1038/nmeth.2368]; Josse D, 2002, J BIOL CHEM, V277, P33386, DOI 10.1074/jbc.M200108200; Kalantar-Zadeh K, 2006, AM J KIDNEY DIS, V48, P59, DOI 10.1053/j.ajkd.2006.03.047; Karlsson H, 2005, PROTEOMICS, V5, P1431, DOI 10.1002/pmic.200401010; Kennedy DJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000104; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Kontush A, 2015, HANDB EXP PHARMACOL, V224, P3, DOI 10.1007/978-3-319-09665-0_1; KUO CL, 1995, DRUG METAB DISPOS, V23, P935; Li HL, 2015, J PROTEOME RES, V14, P3082, DOI 10.1021/acs.jproteome.5b00419; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; Mackness M, 2015, GENE, V567, P12, DOI 10.1016/j.gene.2015.04.088; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MENASHE M, 1986, J BIOL CHEM, V261, P5328; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; Noto H, 2001, BIOCHEM BIOPH RES CO, V289, P395, DOI 10.1006/bbrc.2001.5985; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Rochu D, 2007, TOXICOLOGY, V233, P47, DOI 10.1016/j.tox.2006.08.037; Rosenblat M, 2006, J BIOL CHEM, V281, P7657, DOI 10.1074/jbc.M512595200; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; RYE KA, 1992, J LIPID RES, V33, P215; Rye KA, 2014, CIRC RES, V114, P143, DOI 10.1161/CIRCRESAHA.114.300632; Sag D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7354; Schmitt D, 1999, BIOCHEMISTRY-US, V38, P16904, DOI 10.1021/bi991623w; Schmitz E., 1965, ORG SYNTH, V45, P83; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 1996, J CLIN INVEST, V97, P1630, DOI 10.1172/JCI118589; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Stevens RC, 2008, P NATL ACAD SCI USA, V105, P12780, DOI 10.1073/pnas.0805865105; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P2803, DOI 10.1161/ATVBAHA.112.253930; Tang WHW, 2011, CIRC-HEART FAIL, V4, P59, DOI 10.1161/CIRCHEARTFAILURE.110.958348; Toth PP, 2013, J CLIN LIPIDOL, V7, P484, DOI 10.1016/j.jacl.2013.08.001; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Valiyaveettil M, 2012, TOXICOL LETT, V210, P87, DOI 10.1016/j.toxlet.2012.01.013; Vickers KC, 2014, J LIPID RES, V55, P4, DOI 10.1194/jlr.R035964; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810; Zhao Y, 2012, MOL GENET METAB, V105, P141, DOI 10.1016/j.ymgme.2011.09.018; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	86	21	21	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1890	1904		10.1074/jbc.M115.678334	http://dx.doi.org/10.1074/jbc.M115.678334			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26567339	Green Published, hybrid			2022-12-26	WOS:000368620700028
J	Segawa, K; Kurata, S; Nagata, S				Segawa, Katsumori; Kurata, Sachiko; Nagata, Shigekazu			Human Type IV P-type ATPases That Work as Plasma Membrane Phospholipid Flippases and Their Regulation by Caspase and Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FAMILY-MEMBERS; PHOSPHATIDYLSERINE EXPOSURE; ENDOPLASMIC-RETICULUM; SCRAMBLASE ACTIVITY; APOPTOTIC CELLS; LIPID ASYMMETRY; EXPRESSION; ACTIVATION; TRANSPORT; CLEAVAGE	In plasma membranes, flippases translocate aminophospholipids such as phosphatidylserine and phosphatidylethanolamine from the extracellular to the cytoplasmic leaflet. Mammalian ATP11C, a type IV P-type ATPase, acts as a flippase at the plasma membrane. Here, by expressing 12 human type IV P-type ATPases in ATP11C-deficient cells, we determined that ATP8A2 and ATP11A can also act as plasma membrane flippases. As with ATP11C, ATP8A2 and ATP11A localized to the plasma membrane in a CDC50A-dependent manner. ATP11A was cleaved by caspases during apoptosis, and a caspase-resistant ATP11A blocked apoptotic PtdSer exposure. In contrast, ATP8A2 was not cleaved by caspase, and cells expressing ATP8A2 did not expose PtdSer during apoptosis. Similarly, high Ca2+ concentrations inhibited the ATP11A and ATP11C PtdSer flippase activity, but ATP8A2 flippase activity was relatively resistant to Ca2+. ATP11A and ATP11C were ubiquitously expressed in human and mouse adult tissues. In contrast, ATP8A2 was expressed in specific tissues, such as the brain and testis. Thus, ATP8A2 may play a specific role in translocating PtdSer in these tissues.	[Segawa, Katsumori; Kurata, Sachiko; Nagata, Shigekazu] Osaka Univ, Immunol Frontier Res Ctr, Lab Biochem & Immunol, Suita, Osaka 5650871, Japan	Osaka University	Nagata, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Lab Biochem & Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	snagata@ifrec.osaka-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Ministry of Education, Science, Sports, and Culture in Japan; CREST, Japan Science Technology Corporation; Grants-in-Aid for Scientific Research [15K08266, 22000013] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST, Japan Science Technology Corporation(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, Sports, and Culture in Japan, and CREST, Japan Science Technology Corporation. The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2012, P NATL ACAD SCI USA, V109, P18401, DOI 10.1073/pnas.1212294109; AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; BITBOL M, 1987, BIOCHIM BIOPHYS ACTA, V904, P268, DOI 10.1016/0005-2736(87)90376-2; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; BOWMAN BJ, 1979, J BIOL CHEM, V254, P2928; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Dillon SR, 2000, J IMMUNOL, V164, P1322, DOI 10.4049/jimmunol.164.3.1322; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gong EY, 2009, REPRODUCTION, V137, P345, DOI 10.1530/REP-08-0048; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; KAMENS J, 1995, J BIOL CHEM, V270, P15250, DOI 10.1074/jbc.270.25.15250; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim YE, 2010, NAT METHODS, V7, P67, DOI [10.1038/nmeth.1405, 10.1038/NMETH.1405]; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KORENAGA R, 1993, CELL STRUCT FUNCT, V18, P95, DOI 10.1247/csf.18.95; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lhermusier T, 2011, J THROMB HAEMOST, V9, P1883, DOI 10.1111/j.1538-7836.2011.04478.x; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Schuldiner O, 2015, CELL MOL LIFE SCI, V72, P101, DOI 10.1007/s00018-014-1729-6; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Suzuki J, 2014, J BIOL CHEM, V289, P30257, DOI 10.1074/jbc.M114.583419; Suzuki J, 2014, METHOD ENZYMOL, V544, P381, DOI 10.1016/B978-0-12-417158-9.00015-7; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	59	78	80	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					762	772		10.1074/jbc.M115.690727	http://dx.doi.org/10.1074/jbc.M115.690727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26567335	Green Published, hybrid			2022-12-26	WOS:000367830500024
J	Hasemi, T; Kikukawa, T; Kamo, N; Demura, M				Hasemi, Takatoshi; Kikukawa, Takashi; Kamo, Naoki; Demura, Makoto			Characterization of a Cyanobacterial Chloride-pumping Rhodopsin and Its Conversion into a Proton Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; membrane protein; photobiology; photoreceptor; proton pump; microbial rhodopsin; retinal proteins	MARINE-BACTERIA; ION PUMP; NATRONOBACTERIUM-PHARAONIS; HALOBACTERIUM-HALOBIUM; NATRONOMONAS-PHARAONIS; HALORHODOPSIN; BACTERIORHODOPSIN; PROTEIN; CYCLE; PHOTOCYCLE	Light-driven ion-pumping rhodopsins are widely distributed in microorganisms and are now classified into the categories of outward H+ and Na+ pumps and an inward Cl- pump. These different types share a common protein architecture and utilize the photoisomerization of the same chromophore, retinal, to evoke photoreactions. Despite these similarities, successful pump-to-pump conversion had been confined to only the H+ pump bacteriorhodopsin, which was converted to a Cl- pump in 1995 by a single amino acid replacement. In this study we report the first success of the reverse conversion from a Cl- pump to a H+ pump. A novel microbial rhodopsin (MrHR) from the cyanobacterium Mastigocladopsis repens functions as a Cl- pump and belongs to a cluster that is far distant from the known Cl- pumps. With a single amino acid replacement, MrHR is converted to a H+ pump in which dissociable residues function almost completely in the H+ relay reactions. MrHR most likely evolved from a H+ pump, but it has not yet been highly optimized into a mature Cl- pump.	[Hasemi, Takatoshi; Kikukawa, Takashi; Kamo, Naoki; Demura, Makoto] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University	Kikukawa, T (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Kita Ku, N10W8, Sapporo, Hokkaido 0600810, Japan.	kikukawa@sci.hokudai.ac.jp	Demura, Makoto/F-5272-2011; Kikukawa, Takashi/F-5266-2011	Demura, Makoto/0000-0003-0912-9284; Kikukawa, Takashi/0000-0002-6185-7281	Japan Society for the Promotion of Science KAKENHI [26440042]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI (26440042; to T.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Avetisyan AV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P625; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2013, ENCY BIODIVERSITY, V6, P280; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; Chandrababunaidu MM, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00001-15; Das A, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00228-15; Das S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00226-15; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Grote M, 2011, FEMS MICROBIOL REV, V35, P1082, DOI 10.1111/j.1574-6976.2011.00281.x; Hasegawa C, 2007, PHOTOCHEM PHOTOBIOL, V83, P293, DOI 10.1562/2006-06-09-RA-916; HAVELKA WA, 1995, J MOL BIOL, V247, P726, DOI 10.1006/jmbi.1995.0176; Heberle J, 2014, BBA-BIOENERGETICS, V1837, P531, DOI 10.1016/j.bbabio.2014.02.019; HERNANDEZMARINE MC, 1992, CRYPTOGAMIE ALGOL, V13, P113; Ihara K, 2008, FEBS LETT, V582, P2931, DOI 10.1016/j.febslet.2008.07.030; Inoue K, 2015, TRENDS MICROBIOL, V23, P91, DOI 10.1016/j.tim.2014.10.009; Inoue K, 2014, J PHYS CHEM B, V118, P11190, DOI 10.1021/jp507219q; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jung K. H., 2012, 244 AM CHEM SOC NAT; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Keshari N, 2013, BIOFOULING, V29, P525, DOI 10.1080/08927014.2013.794224; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; Muroda K, 2012, BIOCHEMISTRY-US, V51, P4677, DOI 10.1021/bi300485r; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Oesterhelt D, 1995, ISR J CHEM, V35, P475; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; Sato M, 2003, J BIOCHEM, V134, P151, DOI 10.1093/jb/mvg123; SCHARF B, 1994, BIOCHEMISTRY-US, V33, P6387, DOI 10.1021/bi00187a002; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Singh D, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00064-15; Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Varo G, 1996, BIOCHEMISTRY-US, V35, P6604, DOI 10.1021/bi9601159; VARO G, 1995, BIOCHEMISTRY-US, V34, P14490, DOI 10.1021/bi00044a027; VARO G, 1995, BIOPHYS J, V68, P2062, DOI 10.1016/S0006-3495(95)80385-1; Yamashita Y, 2011, BBA-BIOMEMBRANES, V1808, P2905, DOI 10.1016/j.bbamem.2011.08.035; Yoshizawa S, 2014, P NATL ACAD SCI USA, V111, P6732, DOI 10.1073/pnas.1403051111	44	47	47	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					355	362		10.1074/jbc.M115.688614	http://dx.doi.org/10.1074/jbc.M115.688614			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578511	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000367589500028
J	Yao, JW; Bruhn, DF; Frank, MW; Lee, RE; Rock, CO				Yao, Jiangwei; Bruhn, David F.; Frank, Matthew W.; Lee, Richard E.; Rock, Charles O.			Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyl carrier protein (ACP); antibiotics; bacterial metabolism; fatty acid; fatty acid synthase (FAS); Neisseria	GRAM-POSITIVE PATHOGENS; IN-VITRO ACTIVITY; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; PHOSPHOLIPID-SYNTHESIS; CHLAMYDIA-TRACHOMATIS; ENOYL REDUCTASE; LIPOIC ACID; GONORRHOEAE; SYNTHETASE	Neisseria is a Gram-negative pathogen with phospholipids composed of straight chain saturated and monounsaturated fatty acids, the ability to incorporate exogenous fatty acids, and lipopolysaccharides that are not essential. The FabI inhibitor, AFN-1252, was deployed as a chemical biology tool to determine whether Neisseria can bypass the inhibition of fatty acid synthesis by incorporating exogenous fatty acids. Neisseria encodes a functional FabI that was potently inhibited by AFN-1252. AFN-1252 caused a dose-dependent inhibition of fatty acid synthesis in growing Neisseria, a delayed inhibition of growth phenotype, and minimal inhibition of DNA, RNA, and protein synthesis, showing that its mode of action is through inhibiting fatty acid synthesis. Isotopic fatty acid labeling experiments showed that Neisseria encodes the ability to incorporate exogenous fatty acids into its phospholipids by an acyl-acyl carrier protein-dependent pathway. However, AFN-1252 remained an effective antibacterial when Neisseria were supplemented with exogenous fatty acids. These results demonstrate that extracellular fatty acids are activated by an acyl-acyl carrier protein synthetase (AasN) and validate type II fatty acid synthesis (FabI) as a therapeutic target against Neisseria.	[Yao, Jiangwei; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Bruhn, David F.; Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Lee, Richard/J-4997-2013; Lee, Richard/AAX-3996-2021	Lee, Richard/0000-0002-2397-0443; Lee, Richard/0000-0002-2397-0443; Frank, Matthew/0000-0002-4914-1440; Yao, Jiangwei/0000-0001-7088-3468	National Institutes of Health [GM034496]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM034496 (to C. O. R) and Cancer Center Support Grant CA21765 and by the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balemans W, 2010, NATURE, V463, pE3, DOI 10.1038/nature08667; Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; BLACK PN, 1992, J BIOL CHEM, V267, P25513; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; COOPER CL, 1989, J BIOL CHEM, V264, P7384; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Hermes FAM, 2009, J BACTERIOL, V191, P6796, DOI 10.1128/JB.00798-09; HSU L, 1991, J BIOL CHEM, V266, P13783; Isabella VM, 2011, MOL MICROBIOL, V82, P489, DOI 10.1111/j.1365-2958.2011.07826.x; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; Jiang YF, 2010, BIOCHEMISTRY-US, V49, P718, DOI 10.1021/bi901890a; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Kaplan N, 2013, EUR J PHARM SCI, V50, P440, DOI 10.1016/j.ejps.2013.08.019; Kaplan N, 2013, J CHEMOTHERAPY, V25, P18, DOI 10.1179/1973947812Y.0000000063; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Karlowsky JA, 2009, ANTIMICROB AGENTS CH, V53, P3544, DOI 10.1128/AAC.00400-09; Krank J, 2007, METHOD ENZYMOL, V432, P1, DOI 10.1016/S0076-6879(07)32001-6; Low N, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001598; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Lu YJ, 2007, J BIOL CHEM, V282, P11339, DOI 10.1074/jbc.M700374200; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Miller J. H., 1972, EXPT MOL GENETICS, P25; MILLER RD, 1977, INFECT IMMUN, V17, P303, DOI 10.1128/IAI.17.2.303-312.1977; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MOSS CW, 1970, J BACTERIOL, V104, P63, DOI 10.1128/JB.104.1.63-68.1970; Muller JA, 2011, APPL ENVIRON MICROB, V77, P6889, DOI 10.1128/AEM.05213-11; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P5729, DOI 10.1128/AAC.01038-13; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P2182, DOI 10.1128/AAC.02307-12; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Parsons JB, 2011, CURR OPIN MICROBIOL, V14, P544, DOI 10.1016/j.mib.2011.07.029; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Piet JR, 2014, J INFECTION, V69, P352, DOI 10.1016/j.jinf.2014.06.005; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROCK CO, 1979, J BIOL CHEM, V254, P7116; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; SENFF LM, 1976, J BACTERIOL, V127, P874, DOI 10.1128/JB.127.2.874-880.1976; Shih GC, 1999, MOL MICROBIOL, V32, P942, DOI 10.1046/j.1365-2958.1999.01404.x; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; SUD IJ, 1975, J BACTERIOL, V124, P713, DOI 10.1128/JB.124.2.713-717.1975; SWARTLEY JS, 1995, MOL MICROBIOL, V18, P401, DOI 10.1111/j.1365-2958.1995.mmi_18030401.x; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x; Wang Y, 2013, CHEMMEDCHEM, V8, P1589, DOI 10.1002/cmdc.201300209; WISEMAN GM, 1977, INFECT IMMUN, V16, P550, DOI 10.1128/IAI.16.2.550-556.1977; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a; Yao JW, 2015, J BIOL CHEM, V290, P22163, DOI 10.1074/jbc.M115.671008; Yao JW, 2015, J BIOL CHEM, V290, P18874, DOI 10.1074/jbc.M115.657148; Yao JW, 2015, J BIOL CHEM, V290, P5940, DOI 10.1074/jbc.R114.636241; Yao JW, 2014, J BIOL CHEM, V289, P22365, DOI 10.1074/jbc.M114.584185; Yao JW, 2013, J BIOL CHEM, V288, P36261, DOI 10.1074/jbc.M113.512905; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Zhao X, 2005, BIOCHEMISTRY-US, V44, P16737, DOI 10.1021/bi051865y	63	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					171	181		10.1074/jbc.M115.699462	http://dx.doi.org/10.1074/jbc.M115.699462			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26567338	Green Published, hybrid			2022-12-26	WOS:000367589500014
J	de Gracia, P; Gallego, BI; Rojas, B; Ramirez, AI; de Hoz, R; Salazar, JJ; Trivino, A; Ramirez, JM				de Gracia, Pablo; Gallego, Beatriz I.; Rojas, Blanca; Ramirez, Ana I.; de Hoz, Rosa; Salazar, Juan J.; Trivino, Alberto; Ramirez, Jose M.			Automatic Counting of Microglial Cells in Healthy and Glaucomatous Mouse Retinas	PLOS ONE			English	Article							ELEVATED INTRAOCULAR-PRESSURE; NERVOUS-SYSTEM; IMAGE-ANALYSIS; ADULT ALBINO; RAT MODEL; QUANTIFICATION; PROLIFERATION; ACTIVATION; EXPRESSION; RESPONSES	Proliferation of microglial cells has been considered a sign of glial activation and a hallmark of ongoing neurodegenerative diseases. Microglia activation is analyzed in animal models of different eye diseases. Numerous retinal samples are required for each of these studies to obtain relevant data of statistical significance. Because manual quantification of microglial cells is time consuming, the aim of this study was develop an algorithm for automatic identification of retinal microglia. Two groups of adult male Swiss mice were used: age-matched controls (naive, n = 6) and mice subjected to unilateral laser-induced ocular hypertension (lasered; n = 9). In the latter group, both hypertensive eyes and contralateral untreated retinas were analyzed. Retinal whole mounts were immunostained with anti Iba-1 for detecting microglial cell populations. A new algorithm was developed in MATLAB for microglial quantification; it enabled the quantification of microglial cells in the inner and outer plexiform layers and evaluates the area of the retina occupied by Iba-1+ microglia in the nerve fiber-ganglion cell layer. The automatic method was applied to a set of 6,000 images. To validate the algorithm, mouse retinas were evaluated both manually and computationally; the program correctly assessed the number of cells (Pearson correlation R = 0.94 and R = 0.98 for the inner and outer plexiform layers respectively). Statistically significant differences in glial cell number were found between naive, lasered eyes and contralateral eyes (P<0.05, naive versus contralateral eyes; P<0.001, naive versus lasered eyes and contralateral versus lasered eyes). The algorithm developed is a reliable and fast tool that can evaluate the number of microglial cells in naive mouse retinas and in retinas exhibiting proliferation. The implementation of this new automatic method can enable faster quantification of microglial cells in retinal pathologies.	[de Gracia, Pablo] St Josephs Hosp, Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Gallego, Beatriz I.; Rojas, Blanca; Ramirez, Ana I.; de Hoz, Rosa; Salazar, Juan J.; Trivino, Alberto; Ramirez, Jose M.] Univ Complutense Madrid, Inst Invest Oftalmol Ramon Castroviejo, Madrid, Spain; [Gallego, Beatriz I.; Ramirez, Ana I.; de Hoz, Rosa; Salazar, Juan J.] Univ Complutense Madrid, Fac Opt & Optometria, Madrid, Spain; [Rojas, Blanca; Trivino, Alberto; Ramirez, Jose M.] Univ Complutense Madrid, Fac Med, Madrid, Spain	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid	de Gracia, P (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA.	pablodegracia@gmail.com	De Hoz, Rosa/ABF-9295-2020; ROJAS, BLANCA/V-8292-2017; Alberto, Trivino/ABG-2416-2020; Ramírez, Ana I/ABF-4789-2021; De Gracia, Pablo/B-2786-2017; Salazar, Juan J/L-6887-2014	De Hoz, Rosa/0000-0002-1581-087X; Ramírez, Ana I/0000-0002-2656-4723; Salazar, Juan J/0000-0001-5480-5902; De Gracia, Pablo/0000-0003-4319-2797	Science Foundation Arizona [BSP 0529-13]; (ISCIII) Institute of Health Carlos III (Spanish Ministry of Economy and Competitiveness); PN I-D+i; ISCIII, General Subdirection of Networks and Cooperative Research Centers; FEDER European program;  [SAF2014-53779-R]	Science Foundation Arizona; (ISCIII) Institute of Health Carlos III (Spanish Ministry of Economy and Competitiveness); PN I-D+i; ISCIII, General Subdirection of Networks and Cooperative Research Centers; FEDER European program(European Commission); 	This material is based upon works supported by Science Foundation Arizona under Grant No. BSP 0529-13. This work was also supported by the Network of Ophthalmology RETICs: "Prevention, early detection and treatment of chronic degenerative and prevalent eye disease" from the (ISCIII) Institute of Health Carlos III (Spanish Ministry of Economy and Competitiveness). This work was supported in part by the PN I-D+i 2008-2011; ISCIII, General Subdirection of Networks and Cooperative Research Centers; by the FEDER European program; by the SAF2014-53779-R: neuroinflammation in glaucoma: sequencing of glial and blood-retinal barrier damage. The role of encapsulated NSAIDs in PLGA microparticles as a neuroprotective treatment (Spanish Ministry of Economy and Competitiveness).	Aihara M, 2003, EXP EYE RES, V77, P681, DOI 10.1016/j.exer.2003.08.011; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Alyassin MA, 2009, LAB CHIP, V9, P3364, DOI 10.1039/b911882a; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Bandekar N, 2011, IEEE ENG MED BIO, P5997, DOI 10.1109/IEMBS.2011.6091482; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Bartels PH, 1996, EUR UROL, V30, P234; Biggerstaff J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-16; Bizrah M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-169; Bjornsson CS, 2008, J NEUROSCI METH, V170, P165, DOI 10.1016/j.jneumeth.2007.12.024; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; de Hoz R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083733; Drouyer E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003931; Elkabes S, 1996, J NEUROSCI, V16, P2508; Forero MG, 2012, J MICROSC-OXFORD, V246, P202, DOI 10.1111/j.1365-2818.2012.03608.x; Forero MG, 2010, CYTOM PART A, V77A, P371, DOI 10.1002/cyto.a.20877; Forero MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005441; Forero MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010557; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; GIULIAN D, 1988, J NEUROSCI, V8, P4707; Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050; Hamilton PW, 1998, ANAL QUANT CYTOL, V20, P443; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Hopkins AM, 2014, J NEUROSCI METH, V228, P100, DOI 10.1016/j.jneumeth.2014.03.006; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Inman DM, 2011, GLAUCOMA CURRENT CLI, P26; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kandel E. R., 2001, PRINCIPIOS NEUROCIEN, P19; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; Kloss CUA, 1997, J NEUROSCI RES, V49, P248; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Lam TT, 2003, INVEST OPHTH VIS SCI, V44, P638, DOI 10.1167/iovs.02-0255; LEWIS GP, 1992, J NEUROSCI, V12, P3968; Li HQ, 2004, IEEE T BIO-MED ENG, V51, P246, DOI 10.1109/TBME.2003.820400; Madeira MH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/673090; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Nedzved A, 2005, Rocz Akad Med Bialymst, V50, P284; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Plog BA, 2014, J NEUROSCI METH, V229, P44, DOI 10.1016/j.jneumeth.2014.04.001; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rojas B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-133; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Sanchez CI, 2009, MED IMAGE ANAL, V13, P650, DOI 10.1016/j.media.2009.05.005; Sharma R, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-13; Sociedad Europea de Glaucoma, 2008, TERM PAUT GIAUC; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Tezel G, 2009, INVEST OPHTH VIS SCI, V50, P1001, DOI 10.1167/iovs.08-2717; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Wang L, 2002, INVEST OPHTH VIS SCI, V43, P1088; Wang X, 2000, BRAIN RES, V878, P136, DOI 10.1016/S0006-8993(00)02727-X; Wang X, 2000, EXP BRAIN RES, V132, P476, DOI 10.1007/s002210000360; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wong ST, 2003, J NEUROSCI METH, V123, P1, DOI 10.1016/S0165-0270(02)00318-7; Xiao BG, 1998, J NEUROL SCI, V157, P1, DOI 10.1016/S0022-510X(98)00049-5; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	62	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143278	10.1371/journal.pone.0143278	http://dx.doi.org/10.1371/journal.pone.0143278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580208	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600106
J	Einfinger, K; Badrnya, S; Furtmuller, M; Handschuh, D; Lindner, H; Geiger, M				Einfinger, Katrin; Badrnya, Sigrun; Furtmueller, Margareta; Handschuh, Daniela; Lindner, Herbert; Geiger, Margarethe			Phospholipid Binding Protein C Inhibitor (PCI) Is Present on Microparticles Generated In Vitro and In Vivo	PLOS ONE			English	Article							PLATELET-DERIVED MICROPARTICLES; PROCOAGULANT ACTIVITIES; MYOCARDIAL-INFARCTION; ACTIVATED PLATELETS; TISSUE KALLIKREIN; ESCHERICHIA-COLI; HEPARIN-BINDING; HUMAN-PLASMA; ROCK-I; MEMBRANE	Protein C inhibitor is a secreted, non-specific serine protease inhibitor with broad protease reactivity. It binds glycosaminoglycans and anionic phospholipids, which can modulate its activity. Anionic phospholipids, such as phosphatidylserine are normally localized to the inner leaflet of the plasma membrane, but are exposed on activated and apoptotic cells and on plasma membrane-derived microparticles. In this report we show by flow cytometry that microparticles derived from cultured cells and activated platelets incorporated protein C inhibitor during membrane blebbing. Moreover, protein C inhibitor is present in/on microparticles circulating in normal human plasma as judged from Western blots, ELISAs, flow cytometry, and mass spectrometry. These plasma microparticles are mainly derived from megakaryocytes. They seem to be saturated with protein C inhibitor, since they do not bind added fluorescence-labeled protein C inhibitor. Heparin partially removed microparticle-bound protein C inhibitor, supporting our assumption that protein C inhibitor is bound via phospholipids. To assess the biological role of microparticle-bound protein C inhibitor we performed protease inhibition assays and co-precipitated putative binding partners on microparticles with anti-protein C inhibitor IgG. As judged from amidolytic assays microparticle-bound protein C inhibitor did not inhibit activated protein C or thrombin, nor did microparticles modulate the activity of exogenous protein C inhibitor. Among the proteins co-precipitating with protein C inhibitor, complement factors, especially complement factor 3, were most striking. Taken together, our data do not support a major role of microparticle-associated protein C inhibitor in coagulation, but rather suggest an interaction with proteins of the complement system present on these phospholipid vesicles.	[Einfinger, Katrin; Furtmueller, Margareta; Handschuh, Daniela; Geiger, Margarethe] Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Badrnya, Sigrun] Med Univ Vienna, Dept Physiol, Ctr Physiol & Pharmacol, Vienna, Austria; [Lindner, Herbert] Med Univ Innsbruck, Bioctr, Div Clin Biochem, A-6020 Innsbruck, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Innsbruck	Geiger, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Vasc Biol & Thrombosis Res, Vienna, Austria.	margarethe.geiger@meduniwien.ac.at		Furtmuller, Margareta/0000-0002-2572-6401; Geiger, Margarethe/0000-0003-2021-5319	Austrian Science Fund (FWF) [P20248-B09, P22792-B11]; Austrian Science Fund (FWF) [P 22792] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants P20248-B09 and P22792-B11 (both to MG) from the Austrian Science Fund (FWF). Web site: www.fwf.ac.at. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnitz R, 2006, PROTEOMICS, V6, P865, DOI 10.1002/pmic.200500054; Assinger A, 2014, ARTERIOSCL THROM VAS, V34, P801, DOI 10.1161/ATVBAHA.114.303287; Baumgartner P, 2007, J CELL BIOL, V179, P793, DOI 10.1083/jcb.200707165; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Biro E, 2005, J THROMB HAEMOST, V3, P2754, DOI 10.1111/j.1538-7836.2005.01646.x; Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Dasgupta SK, 2009, BLOOD, V113, P1332, DOI 10.1182/blood-2008-07-167148; Dasgupta SK, 2012, CIRCULATION, V125, P1664, DOI 10.1161/CIRCULATIONAHA.111.068833; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; ECKE S, 1992, J BIOL CHEM, V267, P7048; Ecke S, 1997, EUR J BIOCHEM, V248, P475, DOI 10.1111/j.1432-1033.1997.00475.x; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; ESPANA F, 1990, THROMB RES, V59, P593, DOI 10.1016/0049-3848(90)90418-C; Flaumenhaft R, 2006, BLOOD CELL MOL DIS, V36, P182, DOI 10.1016/j.bcmd.2005.12.019; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; GEIGER M, 1991, J BIOL CHEM, V266, P11851; Geiger M, 2007, THROMB HAEMOSTASIS, V97, P343, DOI 10.1160/TH06-09-0488; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gris JC, 1996, THROMB HAEMOSTASIS, V76, P38; Hussein MNA, 2008, THROMB RES, V121, P865, DOI 10.1016/j.thromres.2007.08.005; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Kolbel T, 2006, J VASC SURG, V43, P935, DOI 10.1016/j.jvs.2006.01.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURELL M, 1992, J CLIN INVEST, V89, P1094, DOI 10.1172/JCI115689; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; Nishioka J, 1998, J BIOL CHEM, V273, P11281, DOI 10.1074/jbc.273.18.11281; Nojima J, 2001, CLIN CHEM, V47, P1008; Perez-Casal M, 2005, BLOOD, V105, P1515, DOI 10.1182/blood-2004-05-1896; PRATT CW, 1992, J BIOL CHEM, V267, P8789; Prendes MJ, 1999, BLOOD, V94, P1300, DOI 10.1182/blood.V94.4.1300.416k26_1300_1312; PRIGLINGER U, 1994, J BIOL CHEM, V269, P14705; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Rank A, 2010, THROMB RES, V126, pE255, DOI 10.1016/j.thromres.2010.07.012; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; REZAIE AR, 1995, J BIOL CHEM, V270, P25336, DOI 10.1074/jbc.270.43.25336; Rieger D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101794; Robert S, 2009, J THROMB HAEMOST, V7, P190, DOI 10.1111/j.1538-7836.2008.03200.x; Sarg B, 2013, MOL CELL PROTEOMICS, V12, P2640, DOI 10.1074/mcp.M112.024109; SATTA N, 1994, J IMMUNOL, V153, P3245; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; SEIFFERT D, 1992, THROMB HAEMOSTASIS, V68, P657; Siljander PRM, 2011, THROMB RES, V127, pS30, DOI 10.1016/S0049-3848(10)70152-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Stavenuiter F, 2013, THROMB HAEMOSTASIS, V109, P229, DOI 10.1160/TH12-08-0622; Steppich B, 2005, THROMB HAEMOSTASIS, V93, P35, DOI 10.1160/TH04-06-0393; Suzuki K, 2008, J THROMB HAEMOST, V6, P2017, DOI 10.1111/j.1538-7836.2008.03181.x; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; SUZUKI K, 1983, J BIOL CHEM, V258, P163; TANS G, 1991, BLOOD, V77, P2641; Terrisse AD, 2010, J THROMB HAEMOST, V8, P2810, DOI 10.1111/j.1538-7836.2010.04088.x; Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414; Wahlmuller FC, 2014, THROMB HAEMOSTASIS, V111, P41, DOI 10.1160/TH13-06-0478	61	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143137	10.1371/journal.pone.0143137	http://dx.doi.org/10.1371/journal.pone.0143137			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580551	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600090
J	Heremans, E; Nackaerts, E; Vervoort, G; Vercruysse, S; Broeder, S; Strouwen, C; Swinnen, SP; Nieuwboer, A				Heremans, Elke; Nackaerts, Evelien; Vervoort, Griet; Vercruysse, Sarah; Broeder, Sanne; Strouwen, Carolien; Swinnen, Stephan P.; Nieuwboer, Alice			Amplitude Manipulation Evokes Upper Limb Freezing during Handwriting in Patients with Parkinson's Disease with Freezing of Gait	PLOS ONE			English	Article							MOTOR BLOCKS; DIAGNOSIS; VARIABILITY; PATTERNS; DISORDER; ONSET; LIFE	Background Recent studies show that besides freezing of gait (FOG), many people with Parkinson's disease (PD) also suffer from freezing in the upper limbs (FOUL). Up to now, it is unclear which task constraints provoke and explain upper limb freezing. Objective To investigate whether upper limb freezing and other kinematic abnormalities during writing are provoked by (i) gradual changes in amplitude or by (ii) sustained amplitude generation in patients with and without freezing of gait. Methods Thirty-four patients with PD, including 17 with and 17 without FOG, performed a writing task on a touch-sensitive writing tablet requiring writing at constant small and large size as well as writing at gradually increasing and decreasing size. Patients of both groups were matched for disease severity, tested while 'on' medication and compared to healthy age-matched controls. Results Fifty upper limb freezing episodes were detected in 10 patients, including 8 with and 2 without FOG. The majority of the episodes occurred when participants had to write at small or gradually decreasing size. The occurrence of FOUL and the number of FOUL episodes per patient significantly correlated with the occurrence and severity of FOG. Patients with FOUL also showed a significantly smaller amplitude in the writing parts outside the freezing episodes. Conclusions Corroborating findings of gait research, the current study supports a core problem in amplitude control underlying FOUL, both in maintaining as well as in flexibly adapting the cycle size.	[Heremans, Elke; Nackaerts, Evelien; Vervoort, Griet; Broeder, Sanne; Strouwen, Carolien; Nieuwboer, Alice] Katholieke Univ Leuven, Neuromotor Rehabil Res Grp, Dept Rehabil Sci, Leuven, Belgium; [Vercruysse, Sarah] Hasselt Univ, Ctr Stat, Hasselt, Belgium; [Swinnen, Stephan P.] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Dept Kinesiol, Leuven, Belgium	KU Leuven; Hasselt University; KU Leuven	Heremans, E (corresponding author), Katholieke Univ Leuven, Neuromotor Rehabil Res Grp, Dept Rehabil Sci, Leuven, Belgium.	elke.heremans@faber.kuleuven.be	; Nieuwboer, Alice/F-5643-2013	VERCRUYSSE, Sarah/0000-0001-7928-1981; Broeder, Sanne/0000-0002-0891-3264; Nackaerts, Evelien/0000-0002-6580-4902; Nieuwboer, Alice/0000-0003-1193-6229; Strouwen, Carolien/0000-0002-0008-0915	Research Foundation - Flanders (FWO) [G.0906.11]	Research Foundation - Flanders (FWO)(FWO)	The project was funded by the Research Foundation - Flanders (FWO) (project G.0906.11). EH is a Postdoctoral Researcher and EN a Research Assistant at the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Barbe MT, 2014, J NEUROL, V261, P330, DOI 10.1007/s00415-013-7199-1; Brichetto G, 2006, CLIN REHABIL, V20, P31, DOI 10.1191/0269215506cr913oa; Broeder S, 2014, NEUROSCIENCE, V263, P193, DOI 10.1016/j.neuroscience.2014.01.019; Brown MJN, 2015, J NEUROL, V262, P41, DOI 10.1007/s00415-014-7514-5; Chee R, 2009, BRAIN, V132, P2151, DOI 10.1093/brain/awp053; Cohen RG, 2014, J PARKINSON DIS, V4, P111, DOI 10.3233/JPD-130221; Cowie D, 2012, MOVEMENT DISORD, V27, P492, DOI 10.1002/mds.23990; Coxon JP, 2010, CEREB CORTEX, V20, P2368, DOI 10.1093/cercor/bhp306; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Heremans E, 2013, J NEURAL TRANSM, V120, P543, DOI 10.1007/s00702-012-0964-y; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Knobl P, 2012, J NEUROL NEUROSUR PS, V83, P98, DOI 10.1136/jnnp-2011-300869; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Nackaerts E, 2015, NEUROREHABI IN PRESS; Naismith SL, 2010, J CLIN NEUROSCI, V17, P984, DOI 10.1016/j.jocn.2009.12.006; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Nieuwboer A, 2009, EUR J NEUROSCI, V29, P1422, DOI 10.1111/j.1460-9568.2009.06681.x; Nonnekes J, 2014, J NEUROL, V261, P1763, DOI 10.1007/s00415-014-7422-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perez-Lloret S, 2014, JAMA NEUROL, V71, P884, DOI 10.1001/jamaneurol.2014.753; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Popovic MB, 2008, TOHOKU J EXP MED, V216, P317, DOI 10.1620/tjem.216.317; Robles-Garcia V, 2015, J APPL BIOMECH, V31, P189, DOI 10.1123/jab.2013-0319; Rosenblum S, 2013, J NEUROL, V260, P2357, DOI 10.1007/s00415-013-6996-x; Schaafsma JD, 2003, EUR J NEUROL, V10, P391, DOI 10.1046/j.1468-1331.2003.00611.x; Serbruyns L, 2015, CORTEX, V65, P128, DOI 10.1016/j.cortex.2015.01.003; Shine JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052602; Smulders K, 2015, MOVEMENT DISORD, V30, P1090, DOI 10.1002/mds.26133; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Vercruysse S, 2014, CEREB CORTEX, V24, P3154, DOI 10.1093/cercor/bht170; Vercruysse S, 2014, NEUROSCI BIOBEHAV R, V43, P213, DOI 10.1016/j.neubiorev.2014.04.010; Vercruysse S, 2012, MOVEMENT DISORD, V27, P254, DOI 10.1002/mds.24015; Walker RW, 2014, EXPERT REV MED DEVIC, V11, P243, DOI 10.1586/17434440.2014.900437; Williams AJ, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/595378; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Ziv I, 1999, ACTA NEUROL SCAND, V99, P106, DOI 10.1111/j.1600-0404.1999.tb00666.x	43	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142874	10.1371/journal.pone.0142874	http://dx.doi.org/10.1371/journal.pone.0142874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580556	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600063
J	Kapkowski, M; Siudyga, T; Sitko, R; Lelatko, J; Szade, J; Balin, K; Klimontko, J; Bartczak, P; Polanski, J				Kapkowski, Maciej; Siudyga, Tomasz; Sitko, Rafal; Lelatko, Jozef; Szade, Jacek; Balin, Katarzyna; Klimontko, Joanna; Bartczak, Piotr; Polanski, Jaroslaw			Catalytic Gas-Phase Glycerol Processing over SiO2-, Cu-, Ni- and Fe- Supported Au Nanoparticles	PLOS ONE			English	Article							DEHYDRATION; OXIDATION; ACID; ACROLEIN; OXIDES	In this study, we investigated different metal pairings of Au nanoparticles (NPs) as potential catalysts for glycerol dehydration for the first time. All of the systems preferred the formation of hydroxyacetone (HYNE). Although the bimetallics that were tested, i.e., Au NPs supported on Ni, Fe and Cu appeared to be more active than the Au/SiO2 system, only Cu supported Au NPs gave high conversion (ca. 63%) and selectivity (ca. 70%) to HYNE.	[Kapkowski, Maciej; Sitko, Rafal; Bartczak, Piotr; Polanski, Jaroslaw] Univ Silesia, Inst Chem, PL-40006 Katowice, Poland; [Siudyga, Tomasz] Silesian Tech Univ, Dept Chem, PL-44100 Gliwice, Poland; [Lelatko, Jozef] Univ Silesia, Inst Mat Sci, PL-41500 Chorzow, Poland; [Szade, Jacek; Balin, Katarzyna; Klimontko, Joanna] Univ Silesia, A Chelkowski Inst Phys, Silesian Ctr Educ & Interdisciplinary Res, PL-41500 Chorzow, Poland	University of Silesia in Katowice; Silesian University of Technology; University of Silesia in Katowice; University of Silesia in Katowice	Polanski, J (corresponding author), Univ Silesia, Inst Chem, Szkolna 9, PL-40006 Katowice, Poland.	polanski@us.edu.pl	Balin, Katarzyna/D-6225-2017; Bartczak, Piotr/V-9520-2018; Szade, Jacek/W-6169-2018	Balin, Katarzyna/0000-0002-1811-3033; Bartczak, Piotr/0000-0002-2035-8654; Lelatko, Jozef/0000-0003-1868-5426; Szade, Jacek/0000-0003-2083-4275; Sitko, Rafal/0000-0002-0469-5159; Polanski, Jaroslaw/0000-0001-7361-2671; Kapkowski, Maciej/0000-0003-1425-4522	National Research and Development Center (NCBiR) [PBS2/A5/40/2014]; DoktoRIS - Scholarship program for innovative Silesia; European Union	National Research and Development Center (NCBiR); DoktoRIS - Scholarship program for innovative Silesia; European Union(European Commission)	The research was financed by the National Research and Development Center (NCBiR) under Grant ORGANOMET No: PBS2/A5/40/2014. Author Maciej Kapkowski expresses his appreciation for the support of the DoktoRIS - Scholarship program for innovative Silesia, which is co-financed by the European Union within the framework of the ESF.; The research was co-financed by the National Research and Development Center (NCBiR) under Grant ORGANOMET No: PBS2/A5/40/2014. Author Maciej Kapkowski expresses his appreciation for the support of the DoktoRIS-Scholarship program for innovative Silesia, which is co-financed by the European Union within the framework of the ESF.	Alhanash A, 2010, APPL CATAL A-GEN, V378, P11, DOI 10.1016/j.apcata.2010.01.043; Atia H, 2008, J CATAL, V258, P71, DOI 10.1016/j.jcat.2008.05.027; Behr A, 2008, GREEN CHEM, V10, P13, DOI 10.1039/b710561d; Besson M, 2014, CHEM REV, V114, P1827, DOI 10.1021/cr4002269; Bujak P, 2012, J CATAL, V295, P15, DOI 10.1016/j.jcat.2012.06.023; Carrettin S, 2003, PHYS CHEM CHEM PHYS, V5, P1329, DOI 10.1039/b212047j; Carrettin S, 2002, CHEM COMMUN, P696, DOI 10.1039/b201112n; Chai SH, 2014, RSC ADV, V4, P4619, DOI 10.1039/c3ra46511j; Chin CW, 2006, AICHE J, V52, P3543, DOI 10.1002/aic.10951; de Oliveira AS, 2011, CHEM ENG J, V168, P765, DOI 10.1016/j.cej.2010.09.029; de Sousa FF, 2013, CHEM ENG J, V228, P442, DOI 10.1016/j.cej.2013.04.106; Deleplanque J, 2010, CATAL TODAY, V157, P351, DOI 10.1016/j.cattod.2010.04.012; Della Pina C, 2012, CHEM SOC REV, V41, P350, DOI 10.1039/c1cs15089h; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; Hughes MD, 2005, NATURE, V437, P1132, DOI 10.1038/nature04190; Kapkowski M, 2014, J CATAL, V319, P110, DOI 10.1016/j.jcat.2014.08.003; Katryniok B, 2013, ACS CATAL, V3, P1819, DOI 10.1021/cs400354p; Katryniok B, 2011, GREEN CHEM, V13, P1960, DOI 10.1039/c1gc15320j; Korzec M, 2014, J CATAL, V313, P1, DOI 10.1016/j.jcat.2014.02.008; Li CJ, 2008, P NATL ACAD SCI USA, V105, P13197, DOI 10.1073/pnas.0804348105; Massa M, 2013, J CATAL, V307, P170, DOI 10.1016/j.jcat.2013.07.022; Nguyen NH, 2011, J POLYM SCI POL CHEM, V49, P4241, DOI 10.1002/pola.24866; Okudera H, 2003, THIN SOLID FILMS, V434, P62, DOI 10.1016/S0040-6090(03)00535-2; PAGLIARO M, 2010, FUTURE GLYCEROL; Philippe S, 2013, CONCEPTS NANOCATALYS; Rao GS, 2014, J MOL CATAL A-CHEM, V395, P486, DOI 10.1016/j.molcata.2014.09.018; Rao KS, 2005, J COLLOID INTERF SCI, V289, P125, DOI 10.1016/j.jcis.2005.02.019; Sharma RV, 2014, APPL CATAL A-GEN, V477, P147, DOI 10.1016/j.apcata.2014.03.007; Skaff H, 2004, NAN SCI TEC, P29; Stosic D, 2014, CATAL TODAY, V226, P167, DOI 10.1016/j.cattod.2013.11.047; Villa A, 2015, CATAL SCI TECHNOL, V5, P55, DOI 10.1039/c4cy00976b; Zhang Y, 2012, CHEM REV, V112, P2467, DOI 10.1021/cr200260m	32	4	4	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142668	10.1371/journal.pone.0142668	http://dx.doi.org/10.1371/journal.pone.0142668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580400	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600055
J	Liberman, MC; Liberman, LD; Maison, SF				Liberman, M. Charles; Liberman, Leslie D.; Maison, Stephane F.			Chronic Conductive Hearing Loss Leads to Cochlear Degeneration	PLOS ONE			English	Article							STEM AUDITORY NUCLEI; OLIVOCOCHLEAR INNERVATION; AFFERENT INFLUENCES; SYNAPTIC RIBBONS; ACOUSTIC INJURY; RISK-FACTORS; CAT COCHLEA; OTITIS; AGE; IMPAIRMENT	Synapses between cochlear nerve terminals and hair cells are the most vulnerable elements in the inner ear in both noise-induced and age-related hearing loss, and this neuropathy is exacerbated in the absence of efferent feedback from the olivocochlear bundle. If age-related loss is dominated by a lifetime of exposure to environmental sounds, reduction of acoustic drive to the inner ear might improve cochlear preservation throughout life. To test this, we removed the tympanic membrane unilaterally in one group of young adult mice, removed the olivocochlear bundle in another group and compared their cochlear function and innervation to age-matched controls one year later. Results showed that tympanic membrane removal, and the associated threshold elevation, was counterproductive: cochlear efferent innervation was dramatically reduced, especially the lateral olivocochlear terminals to the inner hair cell area, and there was a corresponding reduction in the number of cochlear nerve synapses. This loss led to a decrease in the amplitude of the suprathreshold cochlear neural responses. Similar results were seen in two cases with conductive hearing loss due to chronic otitis media. Outer hair cell death was increased only in ears lacking medial olivocochlear innervation following olivocochlear bundle cuts. Results suggest the novel ideas that 1) the olivocochlear efferent pathway has a dramatic use-dependent plasticity even in the adult ear and 2) a component of the lingering auditory processing disorder seen in humans after persistent middle-ear infections is cochlear in origin.	[Liberman, M. Charles; Maison, Stephane F.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Liberman, M. Charles; Liberman, Leslie D.; Maison, Stephane F.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Liberman, M. Charles; Maison, Stephane F.] Harvard Program Speech & Hearing Biosci & Technol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Maison, SF (corresponding author), Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA.	stephane_maison@meei.harvard.edu			National Institute on Deafness and Other Communication Disorders (NIDCD) [R01 DC 0188, P30 DC 05209]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000188, P30DC005209] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research was supported by grants from the National Institute on Deafness and Other Communication Disorders (NIDCD): R01 DC 0188 (MCL) and P30 DC 05209 (MCL) (http://www.nidcd.nih.gov/Pages/default.aspx).	Chhan D, 2013, 36 ANN MIDW M ASS RE, V36, P66; CODY AR, 1982, HEARING RES, V6, P291, DOI 10.1016/0378-5955(82)90061-2; COLEMAN JR, 1979, EXP NEUROL, V64, P553, DOI 10.1016/0014-4886(79)90231-0; CONLEE JW, 1983, J COMP NEUROL, V217, P216, DOI 10.1002/cne.902170208; Dahmen JC, 2007, CURR OPIN NEUROBIOL, V17, P456, DOI 10.1016/j.conb.2007.07.004; Darrow KN, 2006, NAT NEUROSCI, V9, P1474, DOI 10.1038/nn1807; Darrow KN, 2006, J COMP NEUROL, V498, P403, DOI 10.1002/cne.21050; Deal JA, 2015, AM J EPIDEMIOL, V181, P680, DOI 10.1093/aje/kwu333; Deggouj N, 2012, B-ENT, V8, P105; DUBNO JR, 1984, J ACOUST SOC AM, V76, P87, DOI 10.1121/1.391011; Flores EN, 2015, CURR BIOL, V25, P606, DOI 10.1016/j.cub.2015.01.009; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Genther DJ, 2015, J GERONTOL A-BIOL, V70, P85, DOI 10.1093/gerona/glu094; GOYCOOLEA MV, 1986, LARYNGOSCOPE, V96, P1391; Gravel JS, 2006, EAR HEARING, V27, P353, DOI 10.1097/01.aud.0000224727.45342.e9; Guinan J.J., 1996, COCHLEA EDITED, P435; Guinan JJ, 2010, CURR OPIN OTOLARYNGO, V18, P447, DOI 10.1097/MOO.0b013e32833e05d6; Jesic SD, 2012, OTOL NEUROTOL, V33, P934, DOI 10.1097/MAO.0b013e318259b885; Joglekar S, 2010, ACTA OTO-LARYNGOL, V130, P472, DOI 10.3109/00016480903311252; Kandler K, 2005, TRENDS NEUROSCI, V28, P290, DOI 10.1016/j.tins.2005.04.007; Katano Hiroaki, 2005, Nihon Jibiinkoka Gakkai Kaiho, V108, P533; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kokko E, 1974, Acta Otolaryngol Suppl, V327, P1; Kolo ES, 2012, INDIAN J OTOLARYNGOL, V64, P59, DOI 10.1007/s12070-011-0251-5; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Larsen E, 2010, HEARING RES, V260, P70, DOI 10.1016/j.heares.2009.11.011; Liberman LD, 2011, J NEUROSCI, V31, P801, DOI 10.1523/JNEUROSCI.3389-10.2011; Liberman MC, 2014, J NEUROSCI, V34, P4599, DOI 10.1523/JNEUROSCI.4923-13.2014; LIBERMAN MC, 1980, HEARING RES, V3, P189, DOI 10.1016/0378-5955(80)90046-5; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; Liberman MC, 2015, HEAR RES IN PRESS; Luntz M, 2013, ACTA OTO-LARYNGOL, V133, P1173, DOI 10.3109/00016489.2013.814154; Maison SF, 2002, J NEUROSCI, V22, P10838; Maison SF, 2000, J NEUROSCI, V20, P4701, DOI 10.1523/JNEUROSCI.20-12-04701.2000; Maison SF, 2003, J COMP NEUROL, V455, P406, DOI 10.1002/cne.10490; Mehta RP, 2006, OTOL NEUROTOL, V27, P136, DOI 10.1097/01.mao.0000176177.17636.53; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Mick P, 2014, OTOLARYNG HEAD NECK, V150, P378, DOI 10.1177/0194599813518021; Pennie RA, 1998, CAN FAM PHYSICIAN, V44, P1850; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; RAJAN R, 1988, J NEUROPHYSIOL, V60, P569, DOI 10.1152/jn.1988.60.2.569; ROSEN S, 1962, ANN OTO RHINOL LARYN, V71, P727, DOI 10.1177/000348946207100313; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Ruggles D, 2012, CURR BIOL, V22, P1417, DOI 10.1016/j.cub.2012.05.025; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; SCHUKNECHT H F, 1955, J Laryngol Otol, V69, P75, DOI 10.1017/S0022215100050465; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207; Snell KB, 2000, J ACOUST SOC AM, V107, P1615, DOI 10.1121/1.428446; Sumner CJ, 2005, J NEUROPHYSIOL, V94, P4234, DOI 10.1152/jn.00401.2005; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; TUCCI DL, 1985, J COMP NEUROL, V238, P371, DOI 10.1002/cne.902380402; TUCCI DL, 1987, ANN OTO RHINOL LARYN, V96, P343, DOI 10.1177/000348948709600321; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Voss SE, 2001, J ACOUST SOC AM, V110, P1432, DOI 10.1121/1.1394195; Walton JP, 2010, HEARING RES, V264, P63, DOI 10.1016/j.heares.2010.03.002; Warr WB, 1986, ORG EFFERENT FIBERS; WEBSTER DB, 1979, ANN OTO RHINOL LARYN, V88, P684, DOI 10.1177/000348947908800515; Yehudai N, 2015, INT J PEDIATR OTORHI, V79, P26, DOI 10.1016/j.ijporl.2014.10.025; Yin YB, 2014, JARO-J ASSOC RES OTO, V15, P571, DOI 10.1007/s10162-014-0462-z	62	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142341	10.1371/journal.pone.0142341	http://dx.doi.org/10.1371/journal.pone.0142341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580411	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600046
J	Vareki, SM; Chen, D; Di Cresce, C; Ferguson, PJ; Figueredo, R; Pampillo, M; Rytelewski, M; Vincent, M; Min, WP; Zheng, XF; Koropatnick, J				Vareki, Saman Maleki; Chen, Di; Di Cresce, Christine; Ferguson, Peter J.; Figueredo, Rene; Pampillo, Macarena; Rytelewski, Mateusz; Vincent, Mark; Min, Weiping; Zheng, Xiufen; Koropatnick, James			IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells	PLOS ONE			English	Article							BASE EXCISION-REPAIR; INDOLEAMINE 2,3-DIOXYGENASE; THYMIDYLATE SYNTHASE; RESISTANCE MECHANISM; LUNG-CANCER; TUMOR-CELLS; IFN-GAMMA; EXPRESSION; INHIBITION; METABOLITE	Indoleamine 2,3-dioxygenase-1 (IDO) is an immune regulatory enzyme expressed by most human tumors. IDO levels in tumor cells correlate with increased metastasis and poor patient outcome and IDO is linked to tumor cell resistance to immunotherapy, radiation therapy, and chemotherapy. Knowledge of tumor cell-autonomous effects of IDO, independent of its well-known role in regulating and suppressing anti-tumor immune responses, is limited. Clonal populations of A549 human lung adenocarcinoma cells stably transfected with anti-IDO shRNA or scrambled control shRNA were used to study IDO effects on drug sensitivity and resistance. IFN gamma was used to induce IDO in those cells. We show, for the first time, that IDO mediates human tumor cell resistance to the candidate anticancer drugs FK866 (an NAD+ inhibitor), methoxyamine (MX, a base excision repair [BER] inhibitor) and approved anticancer drugs pemetrexed (a folate anti-metabolite) and gemcitabine (a nucleoside analogue), and combined treatment with pemetrexed and MX, in the absence of immune cells. Concurrent knockdown of IDO and thymidylate synthase (TS, a key rate-limiting enzyme in DNA synthesis and repair) sensitizes human lung cancer cells to pemetrexed and 5FUdR to a greater degree than knockdown of either target alone. We conclude that BER in IDO-expressing A549 cells plays a major role in mediating resistance to a range of approved and candidate anticancer drugs. IDO inhibitors are undergoing clinical trials primarily to improve antitumor immune responses. We show that targeting IDO alone or in combination with TS is a potentially valuable therapeutic strategy for cancer treatment, independent of immune activity and in combination with conventional chemotherapy.	[Vareki, Saman Maleki; Di Cresce, Christine; Rytelewski, Mateusz; Koropatnick, James] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Chen, Di; Min, Weiping; Zheng, Xiufen; Koropatnick, James] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Ferguson, Peter J.; Vincent, Mark; Koropatnick, James] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Koropatnick, James] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Vareki, Saman Maleki; Di Cresce, Christine; Ferguson, Peter J.; Figueredo, Rene; Pampillo, Macarena; Rytelewski, Mateusz; Vincent, Mark; Koropatnick, James] Lawson Hlth Res Inst, Canc Res Lab Program, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Koropatnick, J (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.	jkoropat@uwo.ca	Rytelewski, Mateusz/J-6184-2019	Koropatnick, James/0000-0001-6144-5941	Canadian Institutes of Health Research [MOP-827270, MOP-123454]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html)(MOP-827270 and MOP-123454). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaker HA, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-33; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Bulgar AD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.135; Creelan B, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23428; Di Cresce C, 2011, J PHARMACOL EXP THER, V338, P952, DOI 10.1124/jpet.111.183178; Dianov GL, 2011, AM J CANCER RES, V1, P845; Ferguson PJ, 2014, ONCOTARGET, V5, P2778; Ferguson PJ, 1999, BRIT J PHARMACOL, V127, P1777, DOI 10.1038/sj.bjp.0702728; Fischer JA, 2006, CANCER RES, V66, P8829, DOI 10.1158/0008-5472.CAN-06-0540; Galvani E, 2011, EXPERT OPIN INV DRUG, V20, P1343, DOI 10.1517/13543784.2011.617742; Genova C, 2013, EXPERT OPIN PHARMACO, V14, P1545, DOI 10.1517/14656566.2013.802774; Gordon MS, 2013, INVEST NEW DRUG, V31, P714, DOI 10.1007/s10637-012-9876-9; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Honeywell RJ, 2015, INT J BIOCHEM CELL B, V60, P73, DOI 10.1016/j.biocel.2014.12.010; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Inaba T, 2009, GYNECOL ONCOL, V115, P185, DOI 10.1016/j.ygyno.2009.07.015; Karanikas V, 2007, CANCER BIOL THER, V6, P1258; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Lau JP, 2004, BRIT J CANCER, V91, P1166, DOI 10.1038/sj.bjc.6602080; LORENZEN J, 1991, BRIT J CANCER, V64, P457, DOI 10.1038/bjc.1991.331; Mansfield AS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-231; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Pan K, 2008, J CANCER RES CLIN, V134, P1247, DOI 10.1007/s00432-008-0395-1; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Robinson CM, 2005, J INTERF CYTOK RES, V25, P20, DOI 10.1089/jir.2005.25.20; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sahm F, 2013, CANCER RES, V73, P3225, DOI 10.1158/0008-5472.CAN-12-3831; Sharma RA, 2007, MOL ASPECTS MED, V28, P345, DOI 10.1016/j.mam.2007.06.002; Shewach DS, 2007, J CLIN ONCOL, V25, P4043, DOI 10.1200/JCO.2007.11.5287; Sim SH, 2012, CANCER SCI, V103, P155, DOI 10.1111/j.1349-7006.2011.02158.x; Smith C, 2012, CANCER DISCOV, V2, P722, DOI 10.1158/2159-8290.CD-12-0014; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; von Heideman A, 2010, CANCER CHEMOTH PHARM, V65, P1165, DOI 10.1007/s00280-009-1125-3; Weeks LD, 2013, MOL CANCER THER, V12, P2248, DOI 10.1158/1535-7163.MCT-13-0172; Yang LY, 2000, CLIN CANCER RES, V6, P773; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; Yoshida N, 2008, CLIN CANCER RES, V14, P7251, DOI 10.1158/1078-0432.CCR-08-0991; YOSHIDA R, 1979, P NATL ACAD SCI USA, V76, P4084, DOI 10.1073/pnas.76.8.4084	45	21	22	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143435	10.1371/journal.pone.0143435	http://dx.doi.org/10.1371/journal.pone.0143435			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579709	Green Published, gold			2022-12-26	WOS:000365154600122
J	Wang, QL; Yu, SS; Dong, YW				Wang, Qing-lin; Yu, Shan-shan; Dong, Yun-wei			Parental Effect of Long Acclimatization on Thermal Tolerance of Juvenile Sea Cucumber Apostichopus japonicus	PLOS ONE			English	Article							GLOBAL CLIMATE-CHANGE; OXYGEN-CONSUMPTION; HEAT-SHOCK-PROTEIN-70 HSP70; LABEO-ROHITA; TEMPERATURE; GROWTH; RESPONSES; EVOLUTIONARY; EXPRESSION; SELENKA	To evaluate the thermal resistance of marine invertebrates to elevated temperatures under scenarios of future climate change, it is crucial to understand parental effect of long acclimatization on thermal tolerance of offspring. To test whether there is parental effect of long acclimatization, adult sea cucumbers (Apostichopus japonicus) from the same broodstock were transplanted southward and acclimatized at high temperature in field mesocosms. Four groups of juvenile sea cucumbers whose parents experienced different durations of high temperature acclimatization were established. Upper thermal limits, oxygen consumption and levels of heat shock protein mRNA of juveniles was determined to compare thermal tolerance of individuals from different groups. Juvenile sea cucumbers whose parents experienced high temperature could acquire high thermal resistance. With the increase of parental exposure duration to high temperature, offspring became less sensitive to high temperature, as indicated by higher upper thermal limits (LT50), less seasonal variations of oxygen consumption, and stable oxygen consumption rates between chronic and acute thermal stress. The relatively high levels of constitutive expression of heat-shock proteins should contribute to the high thermal tolerance. Together, these results indicated that the existence of a parental effect of long acclimatization would increase thermal tolerance of juveniles and change the thermal sensitivity of sea cucumber to future climate change.	[Wang, Qing-lin; Yu, Shan-shan; Dong, Yun-wei] Xiamen Univ, Coll Marine & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Wang, Qing-lin] Chinese Acad Fishery Sci, Beidaihe Cent Expt Stn, Qinhuangdao, Peoples R China	Xiamen University; Chinese Academy of Fishery Sciences; Beidaihe Central Experiment Station, CAFS	Dong, YW (corresponding author), Xiamen Univ, Coll Marine & Earth Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	dongyw@xmu.edu.cn	Dong, Yunwei/C-4617-2011	Dong, Yunwei/0000-0003-4550-2322	National Basic Research Program of China [2013CB956500]; Nature Science funds for Distinguished Young Scholars of Fujian Province, China [2011J06017]; National Natural Science Foundation of China [41276126, 41476115]; Fundamental Research 457 Funds for the Central Universities; Program for New Century Excellent Talents in University of Fujian Province; China Postdoctoral Science Foundation [2013M541862]; open funds of Scientific Observing and Experimental Station of South China Sea Fishery Resources and Environment, Ministry of Agriculture, P. R. China [SSCS-201207]; Fundamental Research Funds for the Central Universities	National Basic Research Program of China(National Basic Research Program of China); Nature Science funds for Distinguished Young Scholars of Fujian Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research 457 Funds for the Central Universities; Program for New Century Excellent Talents in University of Fujian Province(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); open funds of Scientific Observing and Experimental Station of South China Sea Fishery Resources and Environment, Ministry of Agriculture, P. R. China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from National Basic Research Program of China (2013CB956500), Nature Science funds for Distinguished Young Scholars of Fujian Province, China (2011J06017), National Natural Science Foundation of China (41276126, 41476115), the Fundamental Research 457 Funds for the Central Universities and Program for New Century Excellent Talents in University of Fujian Province, the China Postdoctoral Science Foundation (2013M541862), and the open funds of Scientific Observing and Experimental Station of South China Sea Fishery Resources and Environment, Ministry of Agriculture, P. R. China (SSCS-201207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors sincerely appreciate Prof. George Somero for his valuable discussions. This work was supported by grants from National Basic Research Program of China (2013CB956500), Nature Science funds for Distinguished Young Scholars of Fujian Province, China (2011J06017), National Natural Science Foundation of China (41276126, 41476115), the Fundamental Research Funds for the Central Universities, and Program for New Century Excellent Talents in University of Fujian Province, the China Postdoctoral Science Foundation (2013M541862), the open funds of Scientific Observing and Experimental Station of South China Sea Fishery Resources and Environment, Ministry of Agriculture, P. R. China (SSCS-201207).	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Baker SC, 1996, J FISH BIOL, V48, P1123, DOI 10.1006/jfbi.1996.0115; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Chatterjee N, 2004, J THERM BIOL, V29, P265, DOI 10.1016/j.jtherbio.2004.05.001; Crill WD, 1996, EVOLUTION, V50, P1205, DOI [10.2307/2410661, 10.1111/j.1558-5646.1996.tb02361.x]; Das T, 2005, J THERM BIOL, V30, P378, DOI 10.1016/j.jtherbio.2005.03.001; Dong YW, 2011, MAR BIOL, V158, P1223, DOI 10.1007/s00227-011-1642-6; Dong YW, 2008, BIOL BULL-US, V215, P173, DOI 10.2307/25470698; Dong YW, 2008, FISHERIES SCI, V74, P573, DOI 10.1111/j.1444-2906.2008.01560.x; Dong YW, 2008, AQUACULTURE, V275, P329, DOI 10.1016/j.aquaculture.2007.12.006; Dong YW, 2006, AQUACULTURE, V255, P514, DOI 10.1016/j.aquaculture.2005.12.013; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ferrer A, 2014, ENTOMOL EXP APPL, V151, P11, DOI 10.1111/eea.12163; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; HOFMANN GE, 1995, J EXP BIOL, V198, P1509; Hutchison V, 1976, THERMAL ECOLOGY, P10; Ji TT, 2008, AQUACULTURE, V283, P180, DOI 10.1016/j.aquaculture.2008.07.006; Laxminarayana A, 2005, SPC BECHE DE MER INF, V22, P48, DOI DOI 10.1038/415987A; LEROI AM, 1994, P NATL ACAD SCI USA, V91, P1917, DOI 10.1073/pnas.91.5.1917; Lesser MP, 2010, COMP BIOCHEM PHYS A, V156, P541, DOI 10.1016/j.cbpa.2010.04.012; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Meng XL, 2009, AQUACULTURE, V294, P314, DOI 10.1016/j.aquaculture.2009.06.015; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mislan KAS, 2014, GLOBAL ECOL BIOGEOGR, V23, P744, DOI 10.1111/geb.12160; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pigliucci M., 2001, SYN ECO EVO; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Runcie DE, 2012, MOL ECOL, V21, P4547, DOI 10.1111/j.1365-294X.2012.05717.x; Selvakumar S, 2005, COMP BIOCHEM PHYS A, V140, P209, DOI 10.1016/j.cbpb.2005.01.008; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Strange KT, 2002, AM MIDL NAT, V148, P120, DOI 10.1674/0003-0031(2002)148[0120:TTAGDI]2.0.CO;2; Thor P, 2014, GLOBAL CHANGE BIOL; Tomanek L, 2003, BIOL BULL-US, V205, P276, DOI 10.2307/1543291; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Tomanek L, 2008, PHYSIOL BIOCHEM ZOOL, V81, P709, DOI 10.1086/590163; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wan C, 2014, CHINA FISHERY STAT Y; Wang QL, 2013, AQUAC RES, V44, P1550, DOI 10.1111/j.1365-2109.2012.03162.x; Wang QL, 2011, AQUACULT INT, V19, P1165, DOI 10.1007/s10499-011-9436-x; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wu ZZ, 2007, MAR ENV SCI, V26, P84; Yang HS, 2005, AQUAC RES, V36, P1085, DOI 10.1111/j.1365-2109.2005.01325.x; Zhang Q, 1998, FARMING TECHNIQUES S	47	10	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143372	10.1371/journal.pone.0143372	http://dx.doi.org/10.1371/journal.pone.0143372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580550	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600117
J	Pinzan, CF; Sardinha-Silva, A; Almeida, F; Lai, LV; Lopes, CD; Lourenco, EV; Panunto-Castelo, A; Matthews, S; Roque-Barreira, MC				Pinzan, Camila Figueiredo; Sardinha-Silva, Aline; Almeida, Fausto; Lai, Livia; Lopes, Carla Duque; Lourenco, Elaine Vicente; Panunto-Castelo, Ademilson; Matthews, Stephen; Roque-Barreira, Maria Cristina			Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice	PLOS ONE			English	Article							CELL-MEDIATED-IMMUNITY; APICOMPLEXAN PARASITES; GONDII INFECTION; IFN-GAMMA; PERORAL INFECTION; TNF-ALPHA; INVASION; RESISTANCE; RECOGNITION; RESPONSES	Toxoplasmosis, a zoonotic disease caused by Toxoplasma gondii, is an important public health problem and veterinary concern. Although there is no vaccine for human toxoplasmosis, many attempts have been made to develop one. Promising vaccine candidates utilize proteins, or their genes, from microneme organelle of T. gondii that are involved in the initial stages of host cell invasion by the parasite. In the present study, we used different recombinant microneme proteins (TgMIC1, TgMIC4, or TgMIC6) or combinations of these proteins (TgMIC1-4 and TgMIC1-4-6) to evaluate the immune response and protection against experimental toxoplasmosis in C57BL/6 mice. Vaccination with recombinant TgMIC1, TgMIC4, or TgMIC6 alone conferred partial protection, as demonstrated by reduced brain cyst burden and mortality rates after challenge. Immunization with TgMIC1-4 or TgMIC1-4-6 vaccines provided the most effective protection, since 70% and 80% of mice, respectively, survived to the acute phase of infection. In addition, these vaccinated mice, in comparison to non-vaccinated ones, showed reduced parasite burden by 59% and 68%, respectively. The protective effect was related to the cellular and humoral immune responses induced by vaccination and included the release of Th1 cytokines IFN-gamma and IL12, antigen-stimulated spleen cell proliferation, and production of antigen-specific serum antibodies. Our results demonstrate that microneme proteins are potential vaccines against T. gondii, since their inoculation prevents or decreases the deleterious effects of the infection.	[Pinzan, Camila Figueiredo; Sardinha-Silva, Aline; Almeida, Fausto; Lopes, Carla Duque; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Sao Paulo, Brazil; [Lai, Livia; Matthews, Stephen] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Lourenco, Elaine Vicente] Univ Calif Los Angeles, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA; [Panunto-Castelo, Ademilson] Univ Sao Paulo, Sch Philosophy Sci & Literature Ribeirao Preto, Dept Biol, Sao Paulo, Brazil	Universidade de Sao Paulo; Imperial College London; University of California System; University of California Los Angeles; Universidade de Sao Paulo	Roque-Barreira, MC (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Sao Paulo, Brazil.	mcrbarre@fmrp.usp.br	Lopes, Carla/D-5058-2012; Almeida, Fausto/N-6540-2013; Castelo, Ademilson Panunto/C-8501-2012; Roque-Barreira, Maria-Cristina/A-4552-2008	Lopes, Carla/0000-0003-0702-5043; Almeida, Fausto/0000-0002-3782-3698; Castelo, Ademilson Panunto/0000-0003-0148-0133; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Matthews, Steve/0000-0003-0676-0927	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [05/50460-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [154963/2006-2]; BBSRC [BB/E02520X/1] Funding Source: UKRI; MRC [G0800038, G0400423, MR/J006874/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E02520X/1] Funding Source: researchfish; Medical Research Council [G0400423, G0800038] Funding Source: researchfish	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (grant number: 05/50460-1) (www.fapesp.br), by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant number: 154963/2006-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Aliberti J, 2005, NAT REV IMMUNOL, V5, P162, DOI 10.1038/nri1547; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; BUXTON D, 1993, PARASITOL TODAY, V9, P335, DOI 10.1016/0169-4758(93)90236-9; Buxton D, 1998, VET RES, V29, P289; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers Vern B., 2008, V47, P33; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1084/jem.20041672; COOK GC, 1990, Q J MED, V74, P3; de Medeiros B C, 2001, Transpl Infect Dis, V3, P24, DOI 10.1034/j.1399-3062.2001.003001024.x; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dodds EM, 2006, CURR OPIN OPHTHALMOL, V17, P557, DOI 10.1097/ICU.0b013e32801094ca; Dubey JP, 2005, J PARASITOL, V91, P1082, DOI 10.1645/GE-683.1; Dupont CD, 2012, SEMIN IMMUNOPATHOL, V34, P793, DOI 10.1007/s00281-012-0339-3; Escuissato DL, 2004, J THORAC IMAG, V19, P207, DOI 10.1097/01.rti.0000131756.13179.ae; Fang R, 2009, VET PARASITOL, V164, P134, DOI 10.1016/j.vetpar.2009.06.012; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Freyre A, 1995, J PARASITOL, V81, P1008, DOI 10.2307/3284058; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; FUHRMAN SA, 1989, J IMMUNOL, V142, P940; Garcia-Reguet N, 2000, CELL MICROBIOL, V2, P353, DOI 10.1046/j.1462-5822.2000.00064.x; Garnett JA, 2009, PROTEIN SCI, V18, P1935, DOI 10.1002/pro.204; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Huynh MH, 2006, PARASITOL RES, V98, P389, DOI 10.1007/s00436-005-0062-2; Innes EA, 2006, PARASITOLOGY, V133, pS145, DOI 10.1017/S0031182006001855; ISRAELSKI DM, 1993, CLIN INFECT DIS, V17, pS423, DOI 10.1093/clinids/17.Supplement_2.S423; Johnson LL, 2002, INFECT IMMUN, V70, P185, DOI 10.1128/IAI.70.1.185-191.2002; Kang H, 2000, J IMMUNOL, V164, P2629, DOI 10.4049/jimmunol.164.5.2629; Kessler H, 2008, J CELL SCI, V121, P947, DOI 10.1242/jcs.022350; KHAN IA, 1995, PARASITE IMMUNOL, V17, P185, DOI 10.1111/j.1365-3024.1995.tb00888.x; KONISHI E, 1992, PARASITOLOGY, V104, P427, DOI 10.1017/S003118200006368X; Liu MM, 2010, PARASITOL RES, P106; Lourenco EV, 2006, MICROBES INFECT, V8, P1244, DOI 10.1016/j.micinf.2005.11.013; Lourenco EV, 2001, GLYCOBIOLOGY, V11, P541, DOI 10.1093/glycob/11.7.541; LUFT BJ, 1988, J INFECT DIS, V157, P1, DOI 10.1093/infdis/157.1.1; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; Maser P, 2012, CURR OPIN PHARMACOL, V12, P562, DOI 10.1016/j.coph.2012.05.001; Marchant J, 2012, J BIOL CHEM, V287, P16720, DOI 10.1074/jbc.M111.325928; MCLEOD R, 1989, J IMMUNOL, V142, P3247; MOSMANN TR, 1991, IMMUNOL TODAY, V12, P49; Neyer LE, 1997, INFECT IMMUN, V65, P1675, DOI 10.1128/IAI.65.5.1675-1682.1997; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Santos JM, 2011, CELL MICROBIOL, V13, P787, DOI 10.1111/j.1462-5822.2011.01585.x; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; SCHREIBER RD, 1980, J INFECT DIS, V141, P366, DOI 10.1093/infdis/141.3.366; Sher A, 1995, CIBA F SYMP, V195, P95; Soeiro MNC, 2013, PARASITOLOGY, V140, P929, DOI 10.1017/S0031182013000292; Soldati D, 2001, INT J PARASITOL, V31, P1293, DOI 10.1016/S0020-7519(01)00257-0; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tao Q, 2013, PARASITOL RES, V112, P2871, DOI 10.1007/s00436-013-3458-4; Tomley FM, 2001, TRENDS PARASITOL, V17, P81, DOI 10.1016/S1471-4922(00)01761-X; Vercammen M, 1999, PARASITE IMMUNOL, V21, P555, DOI 10.1046/j.1365-3024.1999.00256.x; Verma R, 2013, HUM VACC IMMUNOTHER, V9, P291, DOI 10.4161/hv.22474; Wang BL, 2005, PROTEIN EXPRES PURIF, V39, P184, DOI 10.1016/j.pep.2004.09.020; Yuan ZG, 2013, VACCINE, V31, P3135, DOI 10.1016/j.vaccine.2013.05.040; Zou FC, 2009, PARASITOL INT, V58, P306, DOI 10.1016/j.parint.2009.06.002	61	39	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143087	10.1371/journal.pone.0143087	http://dx.doi.org/10.1371/journal.pone.0143087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575028	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400039
J	Short, SE; Goldberg, RE				Short, Susan E.; Goldberg, Rachel E.			Children Living with HIV-Infected Adults: Estimates for 23 Countries in sub-Saharan Africa	PLOS ONE			English	Article							PARENTAL DEATH; CAPE-TOWN; HEALTH; ORPHANS; AIDS; IMPACT; RISK; ADOLESCENTS; MOTHERS; FAMILY	Background In sub-Saharan Africa many children live in extreme poverty and experience a burden of illness and disease that is disproportionately high. The emergence of HIV and AIDS has only exacerbated long-standing challenges to improving children's health in the region, with recent cohorts experiencing pediatric AIDS and high levels of orphan status, situations which are monitored globally and receive much policy and research attention. Children's health, however, can be affected also by living with HIV-infected adults, through associated exposure to infectious diseases and the diversion of household resources away from them. While long recognized, far less research has focused on characterizing this distinct and vulnerable population of HIV-affected children. Methods Using Demographic and Health Survey data from 23 countries collected between 2003 and 2011, we estimate the percentage of children living in a household with at least one HIV-infected adult. We assess overlaps with orphan status and investigate the relationship between children and the adults who are infected in their households. Results The population of children living in a household with at least one HIV-infected adult is substantial where HIV prevalence is high; in Southern Africa, the percentage exceeded 10% in all countries and reached as high as 36%. This population is largely distinct from the orphan population. Among children living in households with tested, HIV-infected adults, most live with parents, often mothers, who are infected; nonetheless, in most countries over 20% live in households with at least one infected adult who is not a parent. Conclusion Until new infections contract significantly, improvements in HIV/AIDS treatment suggest that the population of children living with HIV-infected adults will remain substantial. It is vital to on-going efforts to reduce childhood morbidity and mortality to consider whether current care and outreach sufficiently address the distinct vulnerabilities of these children.	[Short, Susan E.] Brown Univ, Dept Sociol, Providence, RI 02912 USA; [Short, Susan E.] Brown Univ, Populat Studies & Training Ctr, Providence, RI 02912 USA; [Goldberg, Rachel E.] Univ Calif Irvine, Dept Sociol, Irvine, CA USA	Brown University; Brown University; University of California System; University of California Irvine	Short, SE (corresponding author), Brown Univ, Dept Sociol, Providence, RI 02912 USA.	susan_short@brown.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development;  [HD050469];  [1F32HD078053-01];  [5R24HD041020];  [5T32HD007338];  [R24HD047879]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD078053, R24HD041020, R24HD047879, T32HD007338] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD050469] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development [URL: http://www.nichd.nih.gov/]; HD050469 SES, 1F32HD078053-01 REG, 5R24HD041020 SES, 5T32HD007338 REG, R24HD047879 REG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwara PA, 2010, AIDS CARE, V22, P1066, DOI 10.1080/09540121.2010.498878; Anglewicz P, 2012, DEMOGRAPHY, V49, P239, DOI 10.1007/s13524-011-0072-x; [Anonymous], 2014, MIDWIFERY, V30; [Anonymous], 2013, AIDS FREE GENERATION; [Anonymous], 2016, CHILDR AIDS 2016 STA; [Anonymous], 2012, GLOB REP UNAIDS REP; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Bauman LJ, 2006, VULNERABLE CHILD YOU, V1, P56, DOI 10.1080/17450120600659077; Beegle K, 2010, DEMOGRAPHY, V47, P163; Birdthistle IJ, 2008, AIDS, V22, P759, DOI 10.1097/QAD.0b013e3282f4cac7; Bongaarts J, 2008, POPUL DEV REV, V34, P199, DOI 10.1111/j.1728-4457.2008.00217.x; Case A, 2004, DEMOGRAPHY, V41, P483, DOI 10.1353/dem.2004.0019; Case A, 2006, DEMOGRAPHY, V43, P401, DOI 10.1353/dem.2006.0022; Clark SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112563; Cluver L, 2007, AIDS CARE, V19, P318, DOI 10.1080/09540120600986578; Cluver L, 2013, AIDS CARE, V25, P748, DOI 10.1080/09540121.2013.772281; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Cluver L, 2009, AIDS CARE, V21, P732, DOI 10.1080/09540120802511885; Cluver LD, 2008, J ADOLESCENT HEALTH, V42, P410, DOI 10.1016/j.jadohealth.2007.09.022; Cluver LD, 2014, AIDS, V28, pS389, DOI 10.1097/QAD.0000000000000340; Davis B, 2012, J DEV EFFECT, V4, P1, DOI 10.1080/19439342.2012.659024; Evans DK, 2007, DEMOGRAPHY, V44, P35, DOI 10.1353/dem.2007.0002; Feranil I, 2010, ASSESSING IMPLEMENTA; Filipski MJ, 2015, AGR ECON-BLACKWELL, V46, P227, DOI 10.1111/agec.12153; Fitbomb, 2012, NO MOR SUG; Floyd S, 2007, AIDS CARE, V19, P781, DOI 10.1080/09540120601163227; Foster G, 2006, LANCET, V367, P700, DOI 10.1016/S0140-6736(06)68273-1; Goldberg RE, 2013, DEMOGRAPHY, V50, P725, DOI 10.1007/s13524-012-0150-8; Goldberg RE, 2012, POPUL RES POLICY REV, V31, P67, DOI 10.1007/s11113-011-9223-4; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Grant MJ, 2012, POP STUD-J DEMOG, V66, P279, DOI 10.1080/00324728.2012.681682; Gray GE, 2006, VULNERABLE CHILD YOU, V1, P15, DOI 10.1080/17450120600659051; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harrison A, 2014, AIDS BEHAV, V18, P595, DOI 10.1007/s10461-013-0515-z; Heymann SJ, 2008, INT J INFECT DIS, V12, P117, DOI 10.1016/j.ijid.2007.09.006; Kidman R, 2010, SOC SCI MED, V71, P966, DOI 10.1016/j.socscimed.2010.05.027; Lloyd CB, 1996, POPUL DEV REV, V22, P265, DOI 10.2307/2137435; LLOYD CB, 1992, POPUL RES POLICY REV, V11, P193, DOI 10.1007/BF00124937; Madhavan S, 2004, SOC SCI MED, V58, P1443, DOI 10.1016/S0277-9536(03)00341-1; Magadi MA, 2011, SOC SCI MED, V73, P436, DOI 10.1016/j.socscimed.2011.05.042; Miller CM, 2007, SOC SCI MED, V64, P2476, DOI 10.1016/j.socscimed.2007.03.002; Mishra V.K., 2008, DHS ANAL STUDIES, V15; Mishra V, 2007, AIDS EDUC PREV, V19, P383, DOI 10.1521/aeap.2007.19.5.383; Mishra V, 2006, B WORLD HEALTH ORGAN, V84, P537, DOI 10.2471/BLT.05.029520; Mojola SA, 2011, SOC SCI MED, V72, P149, DOI 10.1016/j.socscimed.2010.11.006; Nakiyingi JS, 2003, AIDS, V17, P1827, DOI 10.1097/00002030-200308150-00012; Parker EM, 2007, UN AFR POP STUD UAPS; Parker EM, 2009, J FAM ISSUES, V30, P813, DOI 10.1177/0192513X09331921; Pufall EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113415; Richter LM, 2009, AIDS CARE, V21, P3, DOI 10.1080/09540120902923121; Schatz E, 2015, GLOB PUBLIC HEALTH, V10, P1185, DOI 10.1080/17441692.2015.1035664; Schatz E, 2011, HEALTH PLACE, V17, P598, DOI 10.1016/j.healthplace.2010.12.017; Shangani S, 2015, CASH TRANSFERS PSYCH; Short SE, 2015, CURR OPIN PSYCHOL, V5, P78, DOI 10.1016/j.copsyc.2015.05.002; Staveteig S, 2013, Demographic patterns of HIV testing uptake in sub-Saharan Africa, V30; The United States President's Emergency Plan for AIDS Relief (PEPFAR), 2012, PEPFAR BLUEPR CREAT; UNAIDS, 2013, 2013 GLOB FACT SHEET; UNICEF, 2014, STAT WORLDS CHILDR 2; Yeatman S, 2009, STUD FAMILY PLANN, V40, P261, DOI 10.1111/j.1728-4465.2009.00210.x; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43	60	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142580	10.1371/journal.pone.0142580	http://dx.doi.org/10.1371/journal.pone.0142580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7BR	26575484	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400013
J	Geary, M; Fielding, AH; McGowan, PJK; Marsden, SJ				Geary, Matthew; Fielding, Alan H.; McGowan, Philip J. K.; Marsden, Stuart J.			Scenario-Led Habitat Modelling of Land Use Change Impacts on Key Species	PLOS ONE			English	Article							GROUSE TETRAO-TETRIX; AGRI-ENVIRONMENT SCHEMES; BLACK GROUSE; CONSERVATION; BIODIVERSITY; POPULATION; MANAGEMENT; BRITAIN; LANDSCAPES; FRAGMENTATION	Accurate predictions of the impacts of future land use change on species of conservation concern can help to inform policy-makers and improve conservation measures. If predictions are spatially explicit, predicted consequences of likely land use changes could be accessible to land managers at a scale relevant to their working landscape. We introduce a method, based on open source software, which integrates habitat suitability modelling with scenario-building, and illustrate its use by investigating the effects of alternative land use change scenarios on landscape suitability for black grouse Tetrao tetrix. Expert opinion was used to construct five near-future (twenty years) scenarios for the 800 km(2) study site in upland Scotland. For each scenario, the cover of different land use types was altered by 5-30% from 20 random starting locations and changes in habitat suitability assessed by projecting a MaxEnt suitability model onto each simulated landscape. A scenario converting grazed land to moorland and open forestry was the most beneficial for black grouse, and 'increased grazing' (the opposite conversion) the most detrimental. Positioning of new landscape blocks was shown to be important in some situations. Increasing the area of open-canopy forestry caused a proportional decrease in suitability, but suitability gains for the 'reduced grazing' scenario were nonlinear. 'Scenario-led' landscape simulation models can be applied in assessments of the impacts of land use change both on individual species and also on diversity and community measures, or ecosystem services. A next step would be to include landscape configuration more explicitly in the simulation models, both to make them more realistic, and to examine the effects of habitat placement more thoroughly. In this example, the recommended policy would be incentives on grazing reduction to benefit black grouse.	[Geary, Matthew; Fielding, Alan H.; Marsden, Stuart J.] Manchester Metropolitan Univ, Sch Sci & Environm, Div Biol & Conservat Ecol, Manchester M15 6BH, Lancs, England; [McGowan, Philip J. K.] Newcastle Univ, Biol Field Stn, World Pheasant Assoc, Heddon On The Wall, England	Manchester Metropolitan University; Newcastle University - UK	Geary, M (corresponding author), Univ Chester, Dept Biol Sci, Chester, Cheshire, England.	M.geary@Chester.ac.uk		Marsden, Stuart/0000-0002-0205-960X; Geary, Matthew/0000-0003-0951-6110	World Pheasant Association from the Henry Angest Foundation; World Pheasant Association from the Howman Charitable Foundation; World Pheasant Association from the Mactaggart Third Charitable Trust; World Pheasant Association from the PF Charitable Trust; World Pheasant Association from the AF Wallace Charity Trust; Dalton Research Institute	World Pheasant Association from the Henry Angest Foundation; World Pheasant Association from the Howman Charitable Foundation; World Pheasant Association from the Mactaggart Third Charitable Trust; World Pheasant Association from the PF Charitable Trust; World Pheasant Association from the AF Wallace Charity Trust; Dalton Research Institute	This study was part of a PhD studentship funded through the World Pheasant Association (from the Henry Angest Foundation, Howman Charitable Foundation, Mactaggart Third Charitable Trust, PF Charitable Trust and AF Wallace Charity Trust) and the Dalton Research Institute. These fundign sources do not provide grant numbers.	Aldridge CL, 2008, DIVERS DISTRIB, V14, P983, DOI 10.1111/j.1472-4642.2008.00502.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; BAINES D, 1994, IBIS, V136, P39, DOI 10.1111/j.1474-919X.1994.tb08129.x; Baines D, 1996, IBIS, V138, P177, DOI 10.1111/j.1474-919X.1996.tb04326.x; BAINES D, 1995, BIRD STUDY, V42, P122, DOI 10.1080/00063659509477158; Baines D, 2000, CAH ETHOLOGIE FONDAM; Baines D, 2007, WILDLIFE BIOL, V13, P109, DOI 10.2981/0909-6396(2007)13[109:VITVRO]2.0.CO;2; Biehl L, 2002, COMPUT GEOSCI-UK, V28, P1153, DOI 10.1016/S0098-3004(02)00033-X; Calladine J, 2002, J APPL ECOL, V39, P772, DOI 10.1046/j.1365-2664.2002.00753.x; Caryl FM, 2012, J MAMMAL, V93, P464, DOI 10.1644/11-MAMM-A-149.1; CHERRILL AJ, 1995, BIOL CONSERV, V71, P313, DOI 10.1016/0006-3207(94)00053-S; Cramp S., 1980, HDB BIRDS EUROPE MID; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellis S, 2011, J INSECT CONSERV, V15, P69, DOI 10.1007/s10841-010-9324-0; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Ficetola GF, 2014, CURR ZOOL, V60, P170, DOI 10.1093/czoolo/60.2.170; Fielding AH, 2007, CLUSTER AND CLASSIFICATION TECHNIQUES FOR THE BIOSCIENCES, P1, DOI 10.2277/ 0521618002; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2010, DIVERS DISTRIB, V16, P321, DOI 10.1111/j.1472-4642.2010.00641.x; Fraser of Allander Institute, 2010, EC STUD GROUS MOORS; Fuller RJ, 1999, BIOL CONSERV, V91, P73, DOI 10.1016/S0006-3207(99)00039-7; Garcia J, 2007, BIOL CONSERV, V137, P45, DOI 10.1016/j.biocon.2007.01.013; Geary M, POPUL ECOL IN PRESS; Geary M, 2012, THESIS; Geary M, 2013, IBIS, V155, P792, DOI 10.1111/ibi.12090; Gilbert G, 2011, BIRD MONITORING METH; Gillings S, 2005, P ROY SOC B-BIOL SCI, V272, P733, DOI 10.1098/rspb.2004.3010; GOWDA KC, 1984, PATTERN RECOGN, V17, P667, DOI 10.1016/0031-3203(84)90020-7; Hancock M, 1999, BIRD STUDY, V46, P1, DOI 10.1080/00063659909461110; Hayward GD, 1999, CONSERV BIOL, V13, P168, DOI 10.1046/j.1523-1739.1999.97449.x; Hepinstall JA, 2008, LANDSCAPE ECOL, V23, P1257, DOI 10.1007/s10980-008-9296-6; Hijmans R. J., 2012, DISMO SPECIES DISTRI; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Knick ST, 2013, ECOL EVOL, V3, P1539, DOI 10.1002/ece3.557; Kupfer JA, 2012, PROG PHYS GEOG, V36, P400, DOI 10.1177/0309133312439594; Lahoz-Monfort JJ, 2010, J APPL ECOL, V47, P1094, DOI 10.1111/j.1365-2664.2010.01854.x; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lindstrom J, 1998, J BIRDS W PALEARCT, V2, P173; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Macchi L, 2013, AGR ECOSYST ENVIRON, V174, P11, DOI 10.1016/j.agee.2013.04.011; Mcrae BH, 2008, ECOL MODEL, V219, P77, DOI 10.1016/j.ecolmodel.2008.08.001; Morris J, 2000, LAND USE POLICY, V17, P241, DOI 10.1016/S0264-8377(00)00021-1; Olsson EGA, 2000, LANDSCAPE ECOL, V15, P155, DOI 10.1023/A:1008173628016; PACK B, 2010, ROAD AHEAD SCOTLAND; Pearce-Higgins JW, 2007, IBIS, V149, P143, DOI 10.1111/j.1474-919X.2006.00623.x; Perkins AJ, 2011, J APPL ECOL, V48, P514, DOI 10.1111/j.1365-2664.2011.01958.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Polce C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076308; R Development Core Team, 2012, R LANG ENV STAT COMP; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Scottish Government, 2014, ABSTR SCOTT AGR STAT; Scottish Government, 2003, LIST RUR PRIOR OPT; Sim IMW, 2005, BIRD STUDY, V52, P261, DOI 10.1080/00063650509461399; Sim IMW, 2008, BIRD STUDY, V55, P304, DOI 10.1080/00063650809461536; Smith GM, 1999, COUNTRYSIDE SURVEY 2; Starling-Westerberg A, 2001, BIRD STUDY, V48, P76, DOI 10.1080/00063650109461205; THOMPSON DBA, 1995, BIOL CONSERV, V71, P163, DOI 10.1016/0006-3207(94)00043-P; VanDerWal J, 2012, SPECIES DISTRIBUTION; Virgos E, 2010, ANIM BIOL, V60, P423, DOI 10.1163/157075610X523297; Warren C., 2002, MANAGING SCOTLANDS E; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Watson A, 2008, GROUSE; Wilting A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009612	72	3	4	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142477	10.1371/journal.pone.0142477	http://dx.doi.org/10.1371/journal.pone.0142477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569604	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000365070700042
J	Ozeki, Y; Igarashi, M; Doe, M; Tamaru, A; Kinoshita, N; Ogura, Y; Iwamoto, T; Sawa, R; Umekita, M; Enany, S; Nishiuchi, Y; Osada-Oka, M; Hayashi, T; Niki, M; Tateishi, Y; Hatano, M; Matsumoto, S				Ozeki, Yuriko; Igarashi, Masayuki; Doe, Matsumi; Tamaru, Aki; Kinoshita, Naoko; Ogura, Yoshitoshi; Iwamoto, Tomotada; Sawa, Ryuichi; Umekita, Maya; Enany, Shymaa; Nishiuchi, Yukiko; Osada-Oka, Mayuko; Hayashi, Tetsuya; Niki, Mamiko; Tateishi, Yoshitaka; Hatano, Masaki; Matsumoto, Sohkichi			A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Gueren	PLOS ONE			English	Article							XDR TUBERCULOSIS; CYCLIC-PEPTIDES; BCG; PROTEIN; IDENTIFICATION; CYCLOMARINS; INFECTION; VACCINES; IMMUNITY; HEALTH	Tuberculosis (TB) is a serious infectious disease caused by a bacterial pathogen. Mortality from tuberculosis was estimated at 1.5 million deaths worldwide in 2013. Development of new TB drugs is needed to not only to shorten the medication period but also to treat multidrug resistant and extensively drug-resistant TB. Mycobacterium tuberculosis (Mtb)grows slowly and only multiplies once or twice per day. Therefore, conventional drug screening takes more than 3 weeks. Additionally, a biosafety level-3 (BSL-3) facility is required. Thus, we developed a new screening method to identify TB drug candidates by utilizing luciferase- expressing recombinant Mycobacterium bovis bacillus Calmette-Gueren (rBCG). Using this method, we identified several candidates in 4 days in a non-BSL-3 facility. We screened 10,080 individual crude extracts derived from Actinomyces and Streptomyces and identified 137 extracts which possessed suppressive activity to the luciferase of rBCG. Among them, 41 compounds inhibited the growth of both Mtb H37Rv and the extensively drug-resistant Mtb (XDR-Mtb) strains. We purified the active substance of the 1904-1 extract, which possessed strong activity toward rBCG, Mtb H37Rv, and XDR-Mtb but was harmless to the host eukaryotic cells. The MIC of this substance was 0.13 mu g/ml, 0.5 mu g/ml, and 2.0-7.5 mu g/ml against rBCG, H37Rv, and 2 XDR-strains, respectively. Its efficacy was specific to acid-fast bacterium except for the Mycobacterium avium intracellular complex. Mass spectrometry and nuclear magnetic resonance analyses revealed that the active substance of 1904-1 was cyclomarin A. To confirm the mode of action of the 1904-1-derived compound, resistant BCG clones were used. Whole genome DNA sequence analysis showed that these clones contained a mutation in the clpc gene which encodes caseinolytic protein, an essential component of an ATP-dependent proteinase, and the likely target of the active substance of 1904-1. Our method provides a rapid and convenient screen to identify an anti-mycobacterial drug.	[Ozeki, Yuriko; Enany, Shymaa; Tateishi, Yoshitaka; Matsumoto, Sohkichi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Bacteriol, Niigata, Japan; [Igarashi, Masayuki; Kinoshita, Naoko; Sawa, Ryuichi; Umekita, Maya; Hatano, Masaki] Microbial Chem Res Fdn, Dept Microbiol, Inst Microbial Chem, Tokyo, Japan; [Doe, Matsumi] Osaka City Univ, Grad Sch Sci, Osaka 558, Japan; [Tamaru, Aki] Osaka Prefectural Inst Publ Hlth, Bacteriol Div, Osaka 537, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Div Bioenvironm Sci, Frontier Sci Res Ctr, Miyazaki, Japan; [Iwamoto, Tomotada] Kobe Inst Hlth, Dept Microbiol, Kobe, Hyogo, Japan; [Enany, Shymaa] Suez Canal Univ, Dept Microbiol & Immunol, Fac Pharm, Ismailia, Egypt; [Nishiuchi, Yukiko] Osaka City Univ, Sch Med, Toneyama Inst TB Res, Osaka 545, Japan; [Osada-Oka, Mayuko] Kyoto Prefectural Univ, Food Hyg & Environm Hlth Div Appl Life Sci, Grad Sch Life & Environm Sci, Kyoto 606, Japan; [Niki, Mamiko] Osaka City Univ, Grad Sch Med, Dept Bacteriol, Osaka 558, Japan	Niigata University; Osaka Metropolitan University; Osaka Prefectural Institute of Public Health; University of Miyazaki; Egyptian Knowledge Bank (EKB); Suez Canal University; Osaka Metropolitan University; Kyoto Prefectural University; Osaka Metropolitan University	Ozeki, Y (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Bacteriol, Niigata, Japan.	yuriozeki@med.niigata-u.ac.jp	Igarashi, Masayuki/AAG-1628-2020; Enany, Shymaa/F-2053-2010; Iwamoto, Tomotada/I-8944-2019; Hayashi, Tetsuya/ABA-1074-2020	Enany, Shymaa/0000-0002-7827-6504; Iwamoto, Tomotada/0000-0002-2650-0308; Nishiuchi, Yukiko/0000-0002-2973-9285; Matsumoto, Sohkichi/0000-0002-6106-7538	Ministry of Health, Labour and Welfare of Japan [H25-Shiko-ippan-005]; Japan Society for the Promotion of Science [24390106, 24501015]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Research on Emerging and Reemerging Infectious Diseases from the Ministry of Health, Labour and Welfare of Japan http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/index.html, H25-Shiko-ippan-005 (S Matsumoto); and Scientific Research (B) and (C) from the Japan Society for the Promotion of Science http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm, 24390106 (S Matsumoto), 24501015 (Y Ozeki).	Alcaide F, 2003, J CLIN MICROBIOL, V41, P2867, DOI 10.1128/JCM.41.7.2867-2871.2003; ALDOVINI A, 1991, NATURE, V351, P479, DOI 10.1038/351479a0; Burki T, 2014, LANCET INFECT DIS, V14, P102, DOI 10.1016/S1473-3099(14)70006-4; Cox E, 2014, NEW ENGL J MED, V371, P689, DOI 10.1056/NEJMp1314385; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; Gandotra S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001040; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; JACOBS WR, 1993, SCIENCE, V260, P819, DOI 10.1126/science.8484123; JACOBS WR, 1987, NATURE, V327, P532, DOI 10.1038/327532a0; Katsube T, 2007, J BACTERIOL, V189, P8241, DOI 10.1128/JB.00550-07; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; LANGERMANN S, 1994, J EXP MED, V180, P2277, DOI 10.1084/jem.180.6.2277; LANGERMANN S, 1994, NATURE, V372, P552, DOI 10.1038/372552a0; Lewin A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-91; Matsumoto S, 1998, J EXP MED, V188, P845, DOI 10.1084/jem.188.5.845; Matsumoto S, 1999, MICROBIOL IMMUNOL, V43, P1027, DOI 10.1111/j.1348-0421.1999.tb01232.x; Matsumoto S, 1996, FEMS MICROBIOL LETT, V135, P237; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Ollinger J, 2012, J BACTERIOL, V194, P663, DOI 10.1128/JB.06142-11; Rao A, 2007, APPL ENVIRON MICROB, V73, P1320, DOI 10.1128/AEM.02461-06; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Renner MK, 1999, J AM CHEM SOC, V121, P11273, DOI 10.1021/ja992482o; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schultz AW, 2008, J AM CHEM SOC, V130, P4507, DOI 10.1021/ja711188x; Singh V, 2014, ANTIMICROB AGENTS CH, V58, P1389, DOI 10.1128/AAC.01301-13; STANECK JL, 1974, APPL MICROBIOL, V28, P226, DOI 10.1128/AEM.28.2.226-231.1974; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Van Rie A, 2006, LANCET, V368, P1554, DOI 10.1016/S0140-6736(06)69575-5; Yamada H, 2000, J UROLOGY, V164, P526, DOI 10.1016/S0022-5347(05)67417-4	32	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0141658	10.1371/journal.pone.0141658	http://dx.doi.org/10.1371/journal.pone.0141658			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571296	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700009
J	Abadio, AKR; Kioshima, ES; Leroux, V; Martins, NF; Maigret, B; Felipe, MSS				Rodrigues Abadio, Ana Karina; Kioshima, Erika Seki; Leroux, Vincent; Martins, Natalia Florencio; Maigret, Bernard; Soares Felipe, Maria Sueli			Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus	PLOS ONE			English	Article							MOLECULAR-DYNAMICS TRAJECTORIES; PLASMODIUM-FALCIPARUM; FUNGAL-INFECTIONS; ESCHERICHIA-COLI; OXIDATIVE STRESS; AMPHOTERICIN-B; INVASIVE ASPERGILLOSIS; MAMMALIAN THIOREDOXIN; LATIN-AMERICA; ACTIVE-SITE	The prevalence of invasive fungal infections worldwide has increased in the last decades. The development of specific drugs targeting pathogenic fungi without producing collateral damage to mammalian cells is a daunting pharmacological challenge. Indeed, many of the toxicities and drug interactions observed with contemporary antifungal therapies can be attributed to "nonselective" interactions with enzymes or cell membrane systems found in mammalian host cells. A computer-aided screening strategy against the TRR1 protein of Paracoccidioides lutzii is presented here. Initially, a bank of commercially available compounds from Life Chemicals provider was docked to model by virtual screening simulations. The small molecules that interact with the model were ranked and, among the best hits, twelve compounds out of 3,000 commercially-available candidates were selected. These molecules were synthesized for validation and in vitro antifungal activity assays for Paracoccidioides lutzii and P. brasiliensis were performed. From 12 molecules tested, 3 harbor inhibitory activity in antifungal assays against the two pathogenic fungi. Corroborating these findings, the molecules have inhibitory activity against the purified recombinant enzyme TRR1 in biochemical assays. Therefore, a rational combination of molecular modeling simulations and virtual screening of new drugs has provided a cost-effective solution to an early-stage medicinal challenge. These results provide a promising technique to the development of new and innovative drugs.	[Rodrigues Abadio, Ana Karina] Univ Mato Grosso State UNEMAT, Dept Biol, Nova Xavantina, Mato Grosso, Brazil; [Kioshima, Erika Seki] Univ Estadual Maringa, Dept Clin Anal & Biomed, Maringa, Parana, Brazil; [Leroux, Vincent; Maigret, Bernard] Lorraine Univ, LORIA, Nancy, France; [Martins, Natalia Florencio] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil; [Soares Felipe, Maria Sueli] Univ Brasilia UnB, Dept Cellular Biol, Brasilia, DF, Brazil	Universidade do Estado de Mato Grosso; Universidade Estadual de Maringa; Universite de Lorraine; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia	Abadio, AKR (corresponding author), Univ Mato Grosso State UNEMAT, Dept Biol, Nova Xavantina, Mato Grosso, Brazil.	anakarina.abadio@gmail.com	KIOSHIMA, ERIKA S/L-9305-2018; martins, natalia florencio/AAE-7875-2019; Felipe, Maria Sueli/L-6260-2016	KIOSHIMA, ERIKA S/0000-0003-3290-8577; Felipe, Maria Sueli/0000-0003-4347-6853; Leroux, Vincent/0000-0002-4142-0883; martins, natalia florencio/0000-0002-8816-4258	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAP-DF (Fundacao de Apoio a Pesquisa do Distrito Federal)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAP-DF (Fundacao de Apoio a Pesquisa do Distrito Federal)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The funding was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (http://www.cnpq.br/) and FAP-DF (Fundacao de Apoio a Pesquisa do Distrito Federal) (http://www.fap.df.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadio AKR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-75; Andricopulo AD, 2006, BIOORG MED CHEM LETT, V16, P2283, DOI 10.1016/j.bmcl.2006.01.027; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Beautrait A, 2008, J MOL MODEL, V14, P135, DOI 10.1007/s00894-007-0257-9; Buitrago MJ, 2012, ENFERM INFEC MICR CL, V30, P407, DOI 10.1016/j.eimc.2011.09.014; Cappelletty D, 2007, PHARMACOTHERAPY, V27, P369, DOI 10.1592/phco.27.3.369; Chapman Stanley W, 2008, Trans Am Clin Climatol Assoc, V119, P197; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Colombo AL, 2011, MED MYCOL, V49, P785, DOI 10.3109/13693786.2011.577821; Coutinho Ziadir Francisco, 2002, Cad. Saúde Pública, V18, P1441, DOI 10.1590/S0102-311X2002000500037; Cruz RC, 2013, J CLIN MICROBIOL, V51, P436, DOI 10.1128/JCM.02231-12; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Derengowski LS, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-13; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Dietze R, 1999, AM J TROP MED HYG, V60, P837, DOI 10.4269/ajtmh.1999.60.837; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Fanos V, 2000, J CHEMOTHERAPY, V12, P463, DOI 10.1179/joc.2000.12.6.463; Fernandez J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087300, 10.1371/journal.pone.0100872]; Fiskus W, 2014, CANCER RES, V74, P2520, DOI 10.1158/0008-5472.CAN-13-2033; Fundacao Universidade de Brasilia-FUB e Harmonic Pharma, 2013, Composicao farmaceutica baseada no composto [2-benzenosulfonil-4-(tolueno-4-sulfonil)-tiazol-5-il]-furan-2-ilmetil-amina e seu uso na pre-paracao de um medicamento para o tratamento de infeccoes causadas por micro-organismos do genero paracoccidioides spp, Patent No. [Br 10 2013 032984 3, 2013100329843]; Fundacao Universidade de Brasilia-FUB e Harmonic Pharma, 2013, FUNDACAO UNIVERSIDAD; Fundacao Universidade de Brasilia-FUB e Harmonic Pharma, 2013, BR, V10; Gasteiger J., 1990, TETRAHEDRON COMPUT M, V3, P537, DOI DOI 10.1016/0898-5529(90)90156-3; Ghosh S, 2006, CURR OPIN CHEM BIOL, V10, P194, DOI 10.1016/j.cbpa.2006.04.002; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUMPHREYS DD, 1994, J PHYS CHEM-US, V98, P6885, DOI 10.1021/j100078a035; Ianiri G, 2015, MBIO, V6, DOI 10.1128/mBio.02334-14; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Johann S, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-30; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kett DH, 2011, CRIT CARE MED, V39, P665, DOI 10.1097/CCM.0b013e318206c1ca; Kim A, 2011, MYCOSES, V54, pE301, DOI 10.1111/j.1439-0507.2010.01903.x; Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X; Korb O, 2012, J CHEM INF MODEL, V52, P1262, DOI 10.1021/ci2005934; Kortagere S, 2010, J CHEM INF MODEL, V50, P840, DOI 10.1021/ci100039k; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lipinski CA, 2011, ADV DRUG DEL RER, V46, P3; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McGinnis MR, 1997, ANTIMICROB AGENTS CH, V41, P1832, DOI 10.1128/AAC.41.8.1832; Missall TA, 2005, EUKARYOT CELL, V4, P487, DOI 10.1128/EC.4.2.487-489.2005; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakai T, 2003, ANTIMICROB AGENTS CH, V47, P1376, DOI 10.1128/AAC.47.4.1376-1381.2003; National Committee for Clinical Laboratory Standards, 2002, APPROVED STANDARD M2; Netto C F, 1969, Rev Inst Med Trop Sao Paulo, V11, P177; Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683; Osguthorpe DJ, 2012, J PHYS CHEM B, V116, P6952, DOI 10.1021/jp3003992; Peman J, 2012, ENFERM INFEC MICR CL, V30, P90, DOI 10.1016/j.eimc.2011.09.004; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; Queiroz-Telles F, 2007, CLIN INFECT DIS, V45, P1462, DOI 10.1086/522973; Restrepo A, 2008, SEMIN RESP CRIT CARE, V29, P182, DOI 10.1055/s-2008-1063857; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; SANBLAS G, 1993, J MED VET MYCOL, V31, P99; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Svegelj MB, 2011, J CHEM INF MODEL, V51, P1716, DOI 10.1021/ci2001499; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; Tavares LD, 2011, EUR J MED CHEM, V46, P4448, DOI 10.1016/j.ejmech.2011.07.019; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Theobald AJ, 2012, BIOCHEMISTRY-US, V51, P4764, DOI 10.1021/bi3005076; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; Tonini J, 2015, THER DRUG MONIT, V37, P685, DOI 10.1097/FTD.0000000000000199; Tragiannidis A, 2012, CLIN INFECT DIS, V54, P258, DOI 10.1093/cid/cir786; Uziel O, 2004, J BACTERIOL, V186, P326, DOI 10.1128/JB.186.2.326-334.2004; Veine DM, 1998, PROTEIN SCI, V7, P369; Villoutreix BO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021117; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang KR, 2014, PEPTIDES, V56, P22, DOI 10.1016/j.peptides.2014.03.005; Wang PF, 1999, BIOCHEMISTRY-US, V38, P3187, DOI 10.1021/bi982674g; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x; WILLIAMS CH, 1995, FASEB J, V9, P1267, DOI 10.1096/fasebj.9.13.7557016; Wills EA, 2000, EMERG THERAP TARGETS, V4, P1; Yoshida T, 2003, ANTIOXID REDOX SIGN, V5, P563, DOI 10.1089/152308603770310211; Zaki NZ, 2012, AFR J MICROBIOL RES, V6, P1796, DOI 10.5897/AJMR11.1295; Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331; Zhang ZY, 2009, BBA-PROTEINS PROTEOM, V1794, P124, DOI 10.1016/j.bbapap.2008.09.011; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	90	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142926	10.1371/journal.pone.0142926	http://dx.doi.org/10.1371/journal.pone.0142926			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569405	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700096
J	Sampson, VB; Vetter, NS; Kamara, DF; Collier, AB; Gresh, RC; Kolb, EA				Sampson, Valerie B.; Vetter, Nancy S.; Kamara, Davida F.; Collier, Anderson B.; Gresh, Renee C.; Kolb, E. Anders			Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; PHASE-II TRIAL; EWS-FLI1; COMBINATION; IRINOTECAN; INHIBITOR; APOPTOSIS; RECEPTOR; TUMORS; P53	Histone deacetylase inhibitors (HDACi) have been evaluated in patients with Ewing sarcoma (EWS) but demonstrated limited activity. To better understand the potential for HDACi in EWS, we evaluated the combination of the HDACi vorinostat, with DNA damaging agents SN-38 (the active metabolite of irinotecan and topoisomerase 1 inhibitor) plus the alkylating agent temozolomide (ST). Drugs were evaluated in sequential and simultaneous combinations in two EWS cell lines. Results demonstrate that cell viability, DNA damage and reactive oxygen species (ROS) production are dependent on the sequence of drug administration. Enhanced cytotoxicity is exhibited in vitro in EWS cell lines treated with ST administered before vorinostat, which was modestly higher than concomitant treatment and superior to vorinostat administered before ST. Drug combinations downregulate cyclin D1 to induce G0/G1 arrest and promote apoptosis by cleavage of caspase-3 and PARP. When ST is administered before or concomitantly with vorinostat there is activation of STAT3, MAPK and the p53 pathway. In contrast, when vorinostat is administered before ST, there is DNA repair, increased AKT phosphorylation and reduced H2B acetylation. Inhibition of AKT using the small molecule inhibitor MK-2206 did not restore H2B acetylation. Combining ST with the dual ALK and IGF-1R inhibitor, AZD3463 simultaneously inhibited STAT3 and AKT to enhance the cytotoxic effects of ST and further reduce cell growth suggesting that STAT3 and AKT activation were in part mediated by ALK and IGF-1R signaling. In summary, potent antiproliferative and proapoptotic activity were demonstrated for ST induced DNA damage before or simultaneous with HDAC inhibition and cell death was mediated through the p53 pathway. These observations may aid in designing new protocols for treating pediatric patients with high-risk EWS.	[Sampson, Valerie B.; Vetter, Nancy S.; Kamara, Davida F.; Gresh, Renee C.; Kolb, E. Anders] Nemours AI duPont Hosp Children, Nemours Ctr Canc & Blood Disorders, Wilmington, DE 19803 USA; [Collier, Anderson B.] Univ Mississippi, Med Ctr, Childrens Healthcare Mississippi, Dept Pediat,Div Hematol & Oncol, Jackson, MS 39216 USA	Nemours Alfred I. duPont Hospital for Children; University of Mississippi; University of Mississippi Medical Center	Kolb, EA (corresponding author), Nemours AI duPont Hosp Children, Nemours Ctr Canc & Blood Disorders, Wilmington, DE 19803 USA.	eakolb@nemours.org	Sampson, Valerie/AAP-8773-2021	Kolb, E. Anders/0000-0003-2854-9014	Institutional Development Awards (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103464, P30GM114736]; Andrew Mc Donough B+ Foundation; 4evrSTRONG Foundation; Nemours Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464, P30GM114736] Funding Source: NIH RePORTER	Institutional Development Awards (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Andrew Mc Donough B+ Foundation; 4evrSTRONG Foundation; Nemours Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the support of the Cell Science Core of the Center for Pediatric Research which is supported by Institutional Development Awards (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant numbers P20GM103464 and P30GM114736, the Andrew Mc Donough B+ Foundation, the 4evrSTRONG Foundation and Nemours Biomedical Research.	Abrey LE, 2001, J NEURO-ONCOL, V53, P259, DOI 10.1023/A:1012226718323; Arndt CAS, 2012, MAYO CLIN PROC, V87, P475, DOI 10.1016/j.mayocp.2012.01.015; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Bevins RL, 2005, CANCER RES, V65, P6957, DOI 10.1158/0008-5472.CAN-05-0836; Caporali S, 2004, MOL PHARMACOL, V66, P478; Casey DA, 2009, PEDIATR BLOOD CANCER, V53, P1029, DOI 10.1002/pbc.22206; Chibbaro S, 2004, J NEURO-ONCOL, V67, P77, DOI 10.1023/B:NEON.0000021728.36747.93; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Daud AI, 2009, CLIN CANCER RES, V15, P2479, DOI 10.1158/1078-0432.CCR-08-1931; Duchman KR, 2015, CANCER EPIDEMIOL, V39, P189, DOI 10.1016/j.canep.2014.12.012; Erkizan HV, 2011, CELL CYCLE, V10, P3397, DOI 10.4161/cc.10.19.17734; Ferrari S, 2010, TUMORI, V96, P213, DOI 10.1177/030089161009600205; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Gray J, 2012, CANCER BIOL THER, V13, P614, DOI 10.4161/cbt.19848; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; Guerzoni C, 2015, CLIN CANCER RES, V21, P146, DOI 10.1158/1078-0432.CCR-14-0492; Hawkins DS, 2011, PEDIATR BLOOD CANCER, V57, P535, DOI 10.1002/pbc.23126; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Hummel TR, 2013, PEDIATR BLOOD CANCER, V60, P1452, DOI 10.1002/pbc.24541; Juengel E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053100; Keshelava N, 2009, PEDIATR BLOOD CANCER, V53, P505, DOI 10.1002/pbc.21988; Kim JS, 2015, ONCOTARGET, V6, P16746, DOI 10.18632/oncotarget.3796; Kitange GJ, 2012, CLIN CANCER RES, V18, P4070, DOI 10.1158/1078-0432.CCR-12-0560; Kolb EA, 2012, PEDIATR BLOOD CANCER, V58, P729, DOI 10.1002/pbc.23157; Kolb EA, 2010, PEDIATR BLOOD CANCER, V55, P67, DOI 10.1002/pbc.22479; Kurmasheva RT, 2009, CANCER RES, V69, P7662, DOI 10.1158/0008-5472.CAN-09-1693; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Lerman DM, 2015, PEDIATR BLOOD CANCER, V62, P759, DOI 10.1002/pbc.25340; Lu CY, 2011, J BIOL CHEM, V286, P27494, DOI 10.1074/jbc.M111.224089; May WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080060; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Mullins CD, 2012, CANCER-AM CANCER SOC, V118, P3173, DOI 10.1002/cncr.26613; Naumann SC, 2009, BRIT J CANCER, V100, P322, DOI 10.1038/sj.bjc.6604856; Niemeyer BF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116895; Osuna D, 2009, REV RECENT CLIN TRIA, V4, P12, DOI 10.2174/157488709787047585; Pishas KI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11465; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Sampson VB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00132; Sarcar B, 2010, J NEURO-ONCOL, V99, P201, DOI 10.1007/s11060-010-0127-7; Sharifi S, 2015, ADV PHARM BULL, V5, P351, DOI 10.15171/apb.2015.049; Singh RP, 1999, J BIOL CHEM, V274, P19593, DOI 10.1074/jbc.274.28.19593; Spiller SE, 2006, J NEURO-ONCOL, V79, P259, DOI 10.1007/s11060-006-9142-0; Subbiah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018424; Thurow HS, 2013, MOL BIOL REP, V40, P4929, DOI 10.1007/s11033-013-2593-4; Tosso PN, 2014, J MED CHEM, V57, P10290, DOI 10.1021/jm501372p; Wagner LM, 2007, PEDIATR BLOOD CANCER, V48, P132, DOI 10.1002/pbc.20697; Yung WKA, 1999, J CLIN ONCOL, V17, P2762, DOI 10.1200/JCO.1999.17.9.2762	49	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142704	10.1371/journal.pone.0142704	http://dx.doi.org/10.1371/journal.pone.0142704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571493	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700065
J	Xu, CF; Qiao, ZG; Lu, YD; Zhang, DQ; Jia, ZY; Zhuang, XH; Shi, YQ; Xu, T; Xing, LH; Shen, JQ				Xu, Chunfang; Qiao, Zhenguo; Lu, Yongda; Zhang, Deqing; Jia, Zhenyu; Zhuang, Xiaohui; Shi, Yuqi; Xu, Ting; Xing, Lihua; Shen, Jiaqing			Influence of Fatty Liver on the Severity and Clinical Outcome in Acute Pancreatitis	PLOS ONE			English	Article							DISEASE; OBESITY; MORTALITY; PREDICTION; MECHANISMS; MARKERS; SCORE	Acute pancreatitis (AP) is a common disease in the department of gastroenterology with variable severity, from being mild and self-limited to severe and fatal. The early diagnosis and accurate prediction of AP severity are of great importance. Our primary observation showed that fatty liver (FL) was frequently detected in patients with AP. In this retrospective study, we aimed to evaluate the relation between FL and the severity and outcomes of AP. The medical records of 2671 patients with AP were reviewed retrospectively, and characteristics of AP patients were recorded. FL was assessed by abdominal CT scan, and AP patients were categorized by the occurrence of FL for the analysis. The variation of mortality, clinical severity and the appearance of CT were analyzed between the non-FL group and FL groups. Compared with patients without FL, an obviously higher rate of death and higher frequency of severe AP (SAP) and necrotizing AP (ANP) were observed in patients with FL, as well as the incidence of local complications and systemic complications. Taking obesity into consideration, a higher rate of death and more severe AP were found in patients with FL, no matter whether they were obese or not. Alcoholic fatty liver (AFL) and nonalcoholic fatty liver (NAFL) were also separated for comparison in this study; the incidence of ANP and the clinical severity had no significant difference between the AFL and NAFL groups. In conclusion, FL could influence the severity and clinical outcome and may play a prognostic role in AP. This study is of clinical significance, because few reports have been previously issued on FL and AP.	[Xu, Chunfang; Lu, Yongda; Zhang, Deqing; Jia, Zhenyu; Zhuang, Xiaohui; Shi, Yuqi; Xu, Ting; Xing, Lihua; Shen, Jiaqing] Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China; [Qiao, Zhenguo] Nantong Univ, Affiliated Wujiang Hosp, Dept Gastroenterol, Nantong, Jiangsu, Peoples R China	Soochow University - China; Nantong University	Shen, JQ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China.	sjqsz@126.com		qiao, zhen guo/0000-0002-9079-956X	National Natural Science Foundation of China [81300375]; Suzhou Municipal Science and Technology Development [SYS201333, SYS201461]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Municipal Science and Technology Development	This work was supported in part by a grant from the National Natural Science Foundation of China (no. 81300375) and Suzhou Municipal Science and Technology Development (SYS201333 and SYS201461). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya C, 2014, PANCREATOLOGY, V14, P403, DOI 10.1016/j.pan.2014.06.004; Al Mofleh IA, 2008, WORLD J GASTROENTERO, V14, P675, DOI 10.3748/wjg.14.675; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bedogni G, 2014, WORLD J GASTROENTERO, V20, P9050, DOI 10.3748/wjg.v20.i27.9050; Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831; Bonfrate L, 2014, BEST PRACT RES CL GA, V28, P623, DOI 10.1016/j.bpg.2014.07.013; Clemens Dahn L, 2014, World J Gastrointest Pathophysiol, V5, P147, DOI 10.4291/wjgp.v5.i3.147; Criddle DN, 2015, PANCREATOLOGY, V15, pS6, DOI 10.1016/j.pan.2015.02.009; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Dyson J, 2014, DIGEST DIS, V32, P597, DOI 10.1159/000360511; Fan JG, 2011, J DIGEST DIS, V12, P38, DOI 10.1111/j.1751-2980.2010.00476.x; Garip G, 2013, WORLD J GASTROENTERO, V19, P8065, DOI 10.3748/wjg.v19.i44.8065; Gomatos IP, 2014, EXPERT REV MOL DIAGN, V14, P333, DOI 10.1586/14737159.2014.897608; Jia RR, 2015, PANCREAS, V44, P321, DOI 10.1097/MPA.0000000000000284; Johnson CD, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4859; Johnson CD, 2004, PANCREATOLOGY, V4, P1, DOI 10.1159/000077021; Klop B, 2013, CURR OPIN LIPIDOL, V24, P321, DOI 10.1097/MOL.0b013e3283606845; Lankisch PG, 2015, LANCET IN PRESS; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Limanond P, 2004, RADIOLOGY, V230, P276, DOI 10.1148/radiol.2301021176; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Lowenfels Albert B, 2009, Curr Gastroenterol Rep, V11, P97; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Papagianni M, 2015, WORLD J HEPATOL, V7, P638, DOI 10.4254/wjh.v7.i4.638; Pereda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044383; Pezzilli R, 2010, PANCREATOLOGY, V10, P523, DOI 10.1159/000314602; Phillip Veit, 2014, World J Gastrointest Pathophysiol, V5, P158, DOI 10.4291/wjgp.v5.i3.158; Pitchumoni CS, 2005, J CLIN GASTROENTEROL, V39, P798, DOI 10.1097/01.mcg.0000177257.87939.00; Popa C C, 2014, J Med Life, V7, P525; Qian Yan, 2005, Hepatobiliary Pancreat Dis Int, V4, P173; Reddy SK, 2013, WORLD J GASTROENTERO, V19, P8301, DOI 10.3748/wjg.v19.i45.8301; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Shin KY, 2011, GUT LIVER, V5, P335, DOI 10.5009/gnl.2011.5.3.335; Singh VK, 2009, AM J GASTROENTEROL, V104, P966, DOI 10.1038/ajg.2009.28; Song M, 2015, AM J PHYSIOL-GASTR L; [中华医学会肝病学分会脂肪肝和酒精性肝病学组 The Chinese National Workshop on Fatty L], 2010, [中华肝脏病杂志, Chinese Journal of Hepatology], V18, P167; Upchurch E, 2014, BRIT J HOSP MED, V75, P698, DOI 10.12968/hmed.2014.75.12.698; Valdivielso P, 2014, EUR J INTERN MED, V25, P689, DOI 10.1016/j.ejim.2014.08.008; Wu BU, 2008, GUT, V57, P1698, DOI 10.1136/gut.2008.152702; Yang CJ, 2014, DIGEST LIVER DIS, V46, P446, DOI 10.1016/j.dld.2014.01.158; Yeh MM, 2014, GASTROENTEROLOGY, V147, P754, DOI 10.1053/j.gastro.2014.07.056	42	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142278	10.1371/journal.pone.0142278	http://dx.doi.org/10.1371/journal.pone.0142278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571385	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700028
J	Belanger, F; Angers, JP; Fortier, E; Hammond-Martel, I; Costantino, S; Drobetsky, E; Wurtele, H				Belanger, Francois; Angers, Jean-Philippe; Fortier, Emile; Hammond-Martel, Ian; Costantino, Santiago; Drobetsky, Elliot; Wurtele, Hugo			Mutations in Replicative Stress Response Pathways Are Associated with S Phase-specific Defects in Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; HUMAN-CELLS; DEGRON SYSTEM; CHECKPOINT; PROTEIN; ATR; KINASE; ACTIVATION	Nucleotide excision repair (NER) is a highly conserved pathway that removes helix-distorting DNA lesions induced by a plethora of mutagens, including UV light. Our laboratory previously demonstrated that human cells deficient in either ATM and Rad3-related (ATR) kinase or translesion DNA polymerase eta (i.e. key proteins that promote the completion of DNA replication in response to UV-induced replicative stress) are characterized by profound inhibition of NER exclusively during S phase. Toward elucidating the mechanistic basis of this phenomenon, we developed a novel assay to quantify NER kinetics as a function of cell cycle in the model organism Saccharomyces cerevisiae. Using this assay, we demonstrate that in yeast, deficiency of the ATR homologue Mec1 or of any among several other proteins involved in the cellular response to replicative stress significantly abrogates NER uniquely during S phase. Moreover, initiation of DNA replication is required for manifestation of this defect, and S phase NER proficiency is correlated with the capacity of individual mutants to respond to replicative stress. Importantly, we demonstrate that partial depletion of Rfa1 recapitulates defective S phase-specific NER in wild type yeast; moreover, ectopic RPA1-3 overexpression rescues such deficiency in either ATR or polymerase eta-deficient human cells. Our results strongly suggest that reduction of NER capacity during periods of enhanced replicative stress, ostensibly caused by inordinate sequestration of RPA at stalled DNA replication forks, represents a conserved feature of the multifaceted eukaryotic DNA damage response.	[Belanger, Francois; Angers, Jean-Philippe; Fortier, Emile; Hammond-Martel, Ian; Costantino, Santiago; Drobetsky, Elliot; Wurtele, Hugo] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Angers, Jean-Philippe] Univ Montreal, Programme Biol Mol, Montreal, PQ H3T 1J4, Canada; [Costantino, Santiago] Univ Montreal, Dept Ophtalmol, Montreal, PQ H3T 1J4, Canada; [Drobetsky, Elliot; Wurtele, Hugo] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Drobetsky, E (corresponding author), Hop Maison Neuve Rosemont, Ctr Rech, 5415 Blvd Assompt, Montreal, PQ H1T 2M4, Canada.	elliot.drobetsky@umontreal.ca; hugo.wurtele@umontreal.ca	Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635	Canadian Institutes for Health Research [MOP-123438, MOP-133470]; Natural Sciences and Engineering Research Council of Canada [RGPIN 435636-2013, RGPIN 355603-2011, RGPIN-2014-05285]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by Canadian Institutes for Health Research Grants MOP-123438 (to H. W.) and MOP-133470 (to E. D.) and by Natural Sciences and Engineering Research Council of Canada Discovery Grants RGPIN 435636-2013 (to H. W.), RGPIN 355603-2011 (to S. C.), and RGPIN-2014-05285 (to E. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Auclair Y, 2010, DNA REPAIR, V9, P754, DOI 10.1016/j.dnarep.2010.03.013; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Belanger F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085294; Berens TJ, 2012, MOL BIOL CELL, V23, P1058, DOI 10.1091/mbc.E11-10-0852; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Cortez D, 2005, GENE DEV, V19, P1007, DOI 10.1101/gad.1316905; Despras E, 2010, HUM MOL GENET, V19, P1690, DOI 10.1093/hmg/ddq046; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Gerald JNF, 2002, J CELL SCI, V115, P1749; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Javaheri A, 2006, P NATL ACAD SCI USA, V103, P13771, DOI 10.1073/pnas.0511192103; Johnson R, 2007, PLOS GENET, V3, P2338, DOI 10.1371/journal.pgen.0030223; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Loignon M, 2002, CARCINOGENESIS, V23, P35, DOI 10.1093/carcin/23.1.35; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; REYNOLDS RJ, 1981, J BACTERIOL, V146, P692, DOI 10.1128/JB.146.2.692-704.1981; Sabatinos SA, 2012, MOL CELL BIOL, V32, P4986, DOI 10.1128/MCB.01060-12; Schreier WJ, 2015, ANNU REV PHYS CHEM, V66, P497, DOI 10.1146/annurev-physchem-040214-121821; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Taschner M, 2010, MOL CELL BIOL, V30, P436, DOI 10.1128/MCB.00822-09; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Tsaalbi-Shtylik A, 2014, NUCLEIC ACIDS RES, V42, P4406, DOI 10.1093/nar/gkt1412; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Wurtele H, 2012, MOL CELL BIOL, V32, P154, DOI 10.1128/MCB.05415-11; YARBRO JW, 1992, SEMIN ONCOL, V19, P1; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	52	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					522	537		10.1074/jbc.M115.685883	http://dx.doi.org/10.1074/jbc.M115.685883			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26578521	Green Published, hybrid			2022-12-26	WOS:000367830500002
J	Leong, WY; Guo, H; Ma, O; Huang, H; Cantor, AB; Friedman, AD				Leong, Wan Yee; Guo, Hong; Ma, Ou; Huang, Hui; Cantor, Alan B.; Friedman, Alan D.			Runx1 Phosphorylation by Src Increases Trans-activation via Augmented Stability, Reduced Histone Deacetylase (HDAC) Binding, and Increased DNA Affinity, and Activated Runx1 Favors Granulopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; CBF-BETA-SMMHC; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; ADULT HEMATOPOIESIS; DIFFERENTIATION; AML1; INHIBITION; PROTEINS	Src phosphorylates Runx1 on one central and four C-terminal tyrosines. We find that activated Src synergizes with Runx1 to activate a Runx1 luciferase reporter. Mutation of the four Runx1 C-terminal tyrosines to aspartate or glutamate to mimic phosphorylation increases trans-activation of the reporter in 293T cells and allows induction of Cebpa or Pu.1 mRNAs in 32Dcl3 myeloid cells, whereas mutation of these residues to phenylalanine to prevent phosphorylation obviates these effects. Three mechanisms contribute to increased Runx1 activity upon tyrosine modification as follows: increased stability, reduced histone deacetylase (HDAC) interaction, and increased DNA binding. Mutation of the five modified Runx1 tyrosines to aspartate markedly reduced co-immunoprecipitation with HDAC1 and HDAC3, markedly increased stability in cycloheximide or in the presence of co-expressed Cdh1, an E3 ubiquitin ligase coactivator, with reduced ubiquitination, and allowed DNA-binding in gel shift assay similar to wild-type Runx1. In contrast, mutation of these residues to phenylalanine modestly increased HDAC interaction, modestly reduced stability, and markedly reduced DNA binding in gel shift assays and as assessed by chromatin immunoprecipitation with the -14-kb Pu.1 or +37-kb Cebpa enhancers after stable expression in 32Dcl3 cells. Affinity for CBF beta, the Runx1 DNA-binding partner, was not affected by these tyrosine modifications, and in vitro translated CBF beta markedly increased DNA affinity of both the translated phenylalanine and aspartate Runx1 variants. Finally, further supporting a positive role for Runx1 tyrosine phosphorylation during granulopoiesis, mutation of the five Src-modified residues to aspartate but not phenylalanine allows Runx1 to increase Cebpa and granulocyte colony formation by Runx1-deleted murine marrow.	[Leong, Wan Yee; Guo, Hong; Ma, Ou; Friedman, Alan D.] Johns Hopkins Univ, Div Pediat Oncol, Baltimore, MD 21231 USA; [Huang, Hui; Cantor, Alan B.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; [Huang, Hui; Cantor, Alan B.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Friedman, AD (corresponding author), Johns Hopkins Univ, CRB 1, Rm 253,1650 Orleans St, Baltimore, MD 21231 USA.	afriedm2@jhmi.edu		Cantor, Alan/0000-0002-5136-028X	National Institutes of Health [U01 HL099775, R01 HL082952]; National Institutes of Health Cancer Center [P30 CA006973]; Gabrielle's Angel Foundation; Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA006973, T32CA060441] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082952, U01HL099775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation; Giant Food Children's Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants U01 HL099775 (to A. D. F.) and R01 HL082952 (to A. B. C.), National Institutes of Health Cancer Center Core Grant P30 CA006973, a grant from the Gabrielle's Angel Foundation (to A. B. C.), and by the Giant Food Children's Cancer Research Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Britos-Bray M, 1998, BLOOD, V92, P4344, DOI 10.1182/blood.V92.11.4344.423a01_4344_4352; Cai XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028430; Cao WS, 1997, ONCOGENE, V15, P1315, DOI 10.1038/sj.onc.1201305; Chan G, 2011, BLOOD, V117, P4253, DOI 10.1182/blood-2010-11-319517; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Cooper S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126385; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; Friedman AD, 1999, LEUKEMIA, V13, P1932, DOI 10.1038/sj.leu.2401590; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Goyama S, 2015, ONCOGENE, V34, P3483, DOI 10.1038/onc.2014.305; Goyama S, 2013, J CLIN INVEST, V123, P3876, DOI 10.1172/JCI68557; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; Guo H, 2014, J LEUKOCYTE BIOL, V96, P419, DOI 10.1189/jlb.2AB0314-145R; Guo H, 2012, BLOOD, V119, P4408, DOI 10.1182/blood-2011-12-397091; Guo H, 2011, J BIOL CHEM, V286, P208, DOI 10.1074/jbc.M110.149013; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Huang H, 2012, GENE DEV, V26, P1587, DOI 10.1101/gad.192054.112; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kim J, 2004, BLOOD CELL MOL DIS, V32, P302, DOI 10.1016/j.bcmd.2003.12.004; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Kuvardina ON, 2015, BLOOD, V125, P3570, DOI 10.1182/blood-2014-11-610519; Mermel CH, 2006, BLOOD, V108, P2562, DOI 10.1182/blood-2006-05-024307; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Swiers G, 2010, INT J DEV BIOL, V54, P1151, DOI 10.1387/ijdb.103106gs; Tang JL, 2009, BLOOD, V114, P5352, DOI 10.1182/blood-2009-05-223784; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; VALTIERI M, 1987, J IMMUNOL, V138, P3829; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	40	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					826	836		10.1074/jbc.M115.674234	http://dx.doi.org/10.1074/jbc.M115.674234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26598521	Green Published, hybrid			2022-12-26	WOS:000367830500029
J	Yin, L; Zheng, LJ; Jiang, X; Liu, WB; Han, F; Cao, J; Liu, JY				Yin, Li; Zheng, Li-juan; Jiang, Xiao; Liu, Wen-bin; Han, Fei; Cao, Jia; Liu, Jin-yi			Effects of Low-Dose Diethylstilbestrol Exposure on DNA Methylation in Mouse Spermatocytes	PLOS ONE			English	Article							ENDOCRINE DISRUPTING CHEMICALS; POTENTIAL TUMOR-SUPPRESSOR; RETINOID-X-RECEPTOR; GERM-CELLS; INCREASED EXPRESSION; BREAST-CANCER; LUNG-CANCER; IN-UTERO; APOPTOSIS; GROWTH	Evidence from previous studies suggests that the male reproductive system can be disrupted by fetal or neonatal exposure to diethylstilbestrol (DES). However, the molecular basis for this effect remains unclear. To evaluate the effects of DES on mouse spermatocytes and to explore its potential mechanism of action, the levels of DNA methyltransferases (DNMTs) and DNA methylation induced by DES were detected. The results showed that low doses of DES inhibited cell proliferation and cell cycle progression and induced apoptosis in GC-2 cells, an immortalized mouse pachytene spermatocyte-derived cell line, which reproduces primary cells responses to E2. Furthermore, global DNA methylation levels were increased and the expression levels of DNMTs were altered in DES-treated GC-2 cells. A total of 141 differentially methylated DNA sites were detected by microarray analysis. Rxra, an important component of the retinoic acid signaling pathway, and mybph, a RhoA pathway-related protein, were found to be hypermethylated, and Prkcd, an apoptosis-related protein, was hypomethylated. These results showed that low-dose DES was toxic to spermatocytes and that DNMT expression and DNA methylation were altered in DES-exposed cells. Taken together, these data demonstrate that DNA methylation likely plays an important role in mediating DES-induced spermatocyte toxicity in vitro.	[Yin, Li; Zheng, Li-juan; Jiang, Xiao; Liu, Wen-bin; Han, Fei; Cao, Jia; Liu, Jin-yi] Third Mil Med Univ, Coll Prevent Med, Inst Toxicol, Chongqing, Peoples R China; [Zheng, Li-juan] Gansu Peoples Hosp, Lanzhou, Peoples R China	Army Medical University	Liu, JY (corresponding author), Third Mil Med Univ, Coll Prevent Med, Inst Toxicol, Chongqing, Peoples R China.	jinyiliutmmu@163.com	liu, wen/HGE-3071-2022; Han, Fei/AAH-2028-2020; Han, Fei/AAG-9260-2020	Han, Fei/0000-0002-0265-5487	Key Program of National Natural Science Foundation of China [81030052]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: Funded by Key Program of National Natural Science Foundation of China, No. 81030052.	Ahuja HS, 2003, J BIOL REG HOMEOS AG, V17, P29; Bromberg KD, 2007, CANCER RES, V67, P8172, DOI 10.1158/0008-5472.CAN-07-0045; Chappell J, 2013, GENE DEV, V27, P725, DOI 10.1101/gad.211300.112; Choi KJ, 2014, J BIOSCIENCES, V39, P97, DOI 10.1007/s12038-013-9406-8; Choudhry S, 2012, J UROLOGY, V188, P1450, DOI 10.1016/j.juro.2012.03.047; De Souza AP, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-15; Dyachenko OV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P77, DOI 10.1134/S0006297914020011; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Haddad R, 2013, TOXICOL APPL PHARM, V266, P27, DOI 10.1016/j.taap.2012.10.018; Harris RM, 2012, MATURITAS, V72, P108, DOI 10.1016/j.maturitas.2012.03.002; Heng K, 2012, INT J ANDROL, V35, P353, DOI 10.1111/j.1365-2605.2011.01231.x; Hoover RN, 2011, NEW ENGL J MED, V365, P1304, DOI 10.1056/NEJMoa1013961; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Pharmaceuticals, 2012, IARC MONOGR EVAL CAR, V100, P1; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Jin Q, 2007, IN VIVO, V21, P593; Kalfa N, 2011, FERTIL STERIL, V95, P2574, DOI 10.1016/j.fertnstert.2011.02.047; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kanome T, 2007, ONCOGENE, V26, P5991, DOI 10.1038/sj.onc.1210423; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kim E, 2010, J NEUROPHYSIOL, V104, P3439, DOI 10.1152/jn.00525.2010; Klip H, 2002, LANCET, V359, P1102, DOI 10.1016/S0140-6736(02)08152-7; Krick S, 2008, P NATL ACAD SCI USA, V105, P14106, DOI 10.1073/pnas.0801146105; Kuang E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003007; Kubalak SW, 2002, DEVELOPMENT, V129, P733; Kuzbari O, 2013, REPROD TOXICOL, V37, P24, DOI 10.1016/j.reprotox.2013.01.005; LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003; LEE MS, 1993, SCIENCE, V260, P1117, DOI 10.1126/science.8388124; Li Y, 2014, ENVIRON HEALTH PERSP, V122, P262, DOI 10.1289/ehp.1307351; Li YL, 2011, REPROD TOXICOL, V31, P26, DOI 10.1016/j.reprotox.2010.09.007; Liu WB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.366; Liu WB, 2014, INT J CANCER, V134, P1311, DOI 10.1002/ijc.28472; Liu XZ, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201300053; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; Nair R, 2003, J BIOL CHEM, V278, P6470, DOI 10.1074/jbc.M209319200; Newbold Retha R, 2008, Fertil Steril, V89, pe55, DOI 10.1016/j.fertnstert.2008.01.062; Reed CE, 2013, BIRTH DEFECTS RES C, V99, P134, DOI 10.1002/bdrc.21035; Roig MB, 2009, CELL DEATH DIFFER, V16, P230, DOI 10.1038/cdd.2008.145; Rosenauer A, 1998, CANCER RES, V58, P5110; Ruden DM, 2005, HUM MOL GENET, V14, pR149, DOI 10.1093/hmg/ddi103; Sakurai Y, 2001, BIOL PHARM BULL, V24, P973, DOI 10.1248/bpb.24.973; Sales LB, 2013, TOXICOL IN VITRO, V27, P1634, DOI 10.1016/j.tiv.2013.04.005; Sato K, 2009, ENDOCR J, V56, P131, DOI 10.1507/endocrj.K08E-239; Schenkel AR, 2007, CELL COMMUN ADHES, V14, P227, DOI 10.1080/15419060701755966; Shi JF, 2012, BIOCHEM BIOPH RES CO, V427, P47, DOI 10.1016/j.bbrc.2012.08.144; Smith JM, 2004, DEV DYNAM, V230, P366, DOI 10.1002/dvdy.20053; Song N, 2011, ACTA HISTOCHEM CYTOC, V44, P183, DOI 10.1267/ahc.11027; Subauste AR, 2010, DIFFERENTIATION, V80, P140, DOI 10.1016/j.diff.2010.05.006; Subramaniam D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00080; Sun DJY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089696; Takashima S, 2009, BIOL REPROD, V81, P155, DOI 10.1095/biolreprod.108.074708; Uanschou C, 2013, PLANT CELL, V25, P4924, DOI 10.1105/tpc.113.118521; Virtanen HE, 2012, MOL CELL ENDOCRINOL, V355, P208, DOI 10.1016/j.mce.2011.11.015; Volle DH, 2009, J CLIN INVEST, V119, P3752, DOI 10.1172/JCI38521; Woo S, 2012, J CELL BIOL, V198, P941, DOI 10.1083/jcb.201203012; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Wu X, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096230; Xia L, 2013, J PROTEOME RES, V12, P4280, DOI 10.1021/pr400089v; Xu Chen, 2014, Zhonghua Nan Ke Xue, V20, P387; Yamashita S, 2006, CURR PHARM DESIGN, V12, P1505, DOI 10.2174/138161206776389840; Zamudio NM, 2008, REPRODUCTION, V136, P131, DOI 10.1530/REP-07-0576; Zhang HY, 2014, AM J PHYSIOL-CELL PH, V306, pC648, DOI 10.1152/ajpcell.00351.2013	62	7	7	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143143	10.1371/journal.pone.0143143	http://dx.doi.org/10.1371/journal.pone.0143143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588706	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500033
J	Chang, YJ; Shen, EL; Wen, LY; Yu, JJ; Zhu, DY; Zhao, Q				Chang, Yujie; Shen, Erli; Wen, Liuying; Yu, Jingjuan; Zhu, Dengyun; Zhao, Qian			Seed-Specific Expression of the Arabidopsis AtMAP18 Gene Increases both Lysine and Total Protein Content in Maize	PLOS ONE			English	Article							AMINO-ACIDS; ENDOSPERM; ZEIN; QUALITY; MUTANT; CYTOSKELETON; OPAQUE-2; ENCODES; GROWTH; PLANTS	Lysine is the most limiting essential amino acid for animal nutrition in maize grains. Expression of naturally lysine-rich protein genes can increase the lysine and protein contents in maize seeds. AtMAP18 from Arabidopsis thaliana encoding a microtubule-associated protein with high-lysine content was introduced into the maize genome with the seed-specific promoter F128. The protein and lysine contents of different transgenic offspring were increased prominently in the six continuous generations investigated. Expression of AtMAP18 increased both zein and non-zein protein in the transgenic endosperm. Compared with the wild type, more protein bodies were observed in the endosperm of transgenic maize. These results implied that, as a cytoskeleton binding protein, AtMAP18 facilitated the formation of protein bodies, which led to accumulation of both zein and non-zein proteins in the transgenic maize grains. Furthermore, F1 hybrid lines with high lysine, high protein and excellent agronomic traits were obtained by hybridizing T-6 transgenic offspring with other wild type inbred lines. This article provides evidence supporting the use of cytoskeleton-associated proteins to improve the nutritional value of maize.	[Chang, Yujie; Shen, Erli; Wen, Liuying; Yu, Jingjuan; Zhu, Dengyun; Zhao, Qian] China Agr Univ, Coll Biol Sci, State Key Lab Agr Biotechnol, Beijing 100094, Peoples R China	China Agricultural University	Zhao, Q (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agr Biotechnol, Beijing 100094, Peoples R China.	zhaoqian@cau.edu.cn			National Natural Science Foundation [31171258]; Ministry of Agriculture of China for Transgenic Research [2014ZX08009-003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China for Transgenic Research	This work was supported by National Natural Science Foundation (Grant No. 31171258) and the projects (No. 2014ZX08009-003) from the Ministry of Agriculture of China for Transgenic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Sai-Ming Samuel Sun (The Chinese University of Hong Kong) for providing the vector pSB130. This work was supported by National Natural Science Foundation (Grant No. 31171258) and the projects (No. 2014ZX08009-003) from the Ministry of Agriculture of China for Transgenic Research.	Abe S, 2003, PLANT PHYSIOL BIOCH, V41, P125, DOI 10.1016/S0981-9428(02)00016-5; Azama K, 2003, PLANTA, V217, P628, DOI 10.1007/s00425-003-1016-5; Azevedo RA, 2010, AMINO ACIDS, V39, P979, DOI 10.1007/s00726-010-0576-5; Clore AM, 1996, PLANT CELL, V8, P2003, DOI 10.2307/3870408; Coleman CE, 1997, P NATL ACAD SCI USA, V94, P7094, DOI 10.1073/pnas.94.13.7094; Frame BR, 2002, PLANT PHYSIOL, V129, P13, DOI 10.1104/pp.000653; Galili G, 2013, PLANT BIOTECHNOL J, V11, P211, DOI 10.1111/pbi.12025; Gibbon BC, 2005, TRENDS GENET, V21, P227, DOI 10.1016/j.tig.2005.02.009; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Hournard NM, 2007, PLANT BIOTECHNOL J, V5, P605, DOI 10.1111/j.1467-7652.2007.00265.x; Huang SL, 2007, PLANT J, V51, P406, DOI 10.1111/j.1365-313X.2007.03153.x; Jia M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-60; Kirma M, 2012, J EXP BOT, V63, P4995, DOI 10.1093/jxb/ers119; Lang ZH, 2004, PLANT SCI, V166, P1227, DOI 10.1016/j.plantsci.2003.12.036; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060543; Lopez-Valenzuela JA, 2004, PLANT PHYSIOL, V135, P1784, DOI 10.1104/pp.104.042259; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matheka Jonathan M, 2013, BMC Res Notes, V6, P448, DOI 10.1186/1756-0500-6-448; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Pan YL, 2015, PLANTA, V241, P57, DOI 10.1007/s00425-014-2164-5; Prasanna BM, 2001, CURRENT SCI, V81, P25; Prasanna BM, 2001, CURRENT SCI, V81, P10; Reyes AR, 2009, PLANT MOL BIOL, V69, P81, DOI 10.1007/s11103-008-9409-2; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; TSAI CY, 1974, CEREAL CHEM, V51, P825; Tuteja N, 2012, J BIOSCIENCES, V37, P167, DOI 10.1007/s12038-012-9187-5; Wang G, 2011, GENETICS, V189, P1281, DOI 10.1534/genetics.111.133967; Wang MZ, 2013, INT J MOL SCI, V14, P9459, DOI 10.3390/ijms14059459; Wang X, 2007, PLANT CELL, V19, P877, DOI 10.1105/tpc.106.048579; Wenefrida I, 2013, J AGR FOOD CHEM, V61, P11702, DOI 10.1021/jf4016812; Wenefrida Ida, 2009, Recent Pat DNA Gene Seq, V3, P219; Wu YR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00240; Wu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032850; Wu YR, 2011, GENETICS, V188, P1019, DOI 10.1534/genetics.111.131078; Yu Jingjuan, 2005, Food and Nutrition Bulletin, V26, P427; Yuan LL, 2014, PLANT PHYSIOL, V164, P119, DOI 10.1104/pp.113.230961; Yue J, 2014, INT J MOL SCI, V15, P5350, DOI 10.3390/ijms15045350; Zhu L, 2013, PLANT CELL, V25, P851, DOI 10.1105/tpc.113.110528	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142952	10.1371/journal.pone.0142952	http://dx.doi.org/10.1371/journal.pone.0142952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580206	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600070
J	Akula, S; Thorpe, M; Boinapally, V; Hellman, L				Akula, Srinivas; Thorpe, Michael; Boinapally, Vamsi; Hellman, Lars			Granule Associated Serine Proteases of Hematopoietic Cells - An Analysis of Their Appearance and Diversification during Vertebrate Evolution	PLOS ONE			English	Article							EXTENDED SUBSTRATE-SPECIFICITY; BOVINE DUODENAL MUCOSA; RODENT ALPHA-CHYMASES; HUMAN CATHEPSIN-G; HUMAN GRANZYME-A; MAST-CELL; CLEAVAGE SPECIFICITY; NEUTROPHIL ELASTASE; MAMMALIAN EVOLUTION; MULTIPLE GRANZYMES	Serine proteases are among the most abundant granule constituents of several hematopoietic cell lineages including mast cells, neutrophils, cytotoxic T cells and NK cells. These proteases are stored in their active form in the cytoplasmic granules and in mammals are encoded from four different chromosomal loci: the chymase locus, the met-ase locus, the T cell tryptase and the mast cell tryptase locus. In order to study their appearance during vertebrate evolution we have performed a bioinformatic analysis of related genes and gene loci from a large panel of metazoan animals from sea urchins to placental mammals for three of these loci: the chymase, met-ase and granzyme A/K loci. Genes related to mammalian granzymes A and K were the most well conserved and could be traced as far back to cartilaginous fish. Here, the granzyme A and K genes were found in essentially the same chromosomal location from sharks to humans. However in sharks, no genes clearly identifiable as members of the chymase or met-ase loci were found. A selection of these genes seemed to appear with bony fish, but sometimes in other loci. Genes related to mammalian met-ase locus genes were found in bony fish. Here, the most well conserved member was complement factor D. However, genes distantly related to the neutrophil proteases were also identified in this locus in several bony fish species, indicating that this locus is also old and appeared at the base of bony fish. In fish, a few of the chymase locus-related genes were found in a locus with bordering genes other than the mammalian chymase locus and some were found in the fish met-ase locus. This indicates that a convergent evolution rather than divergent evolution has resulted in chymase locus-related genes in bony fish.	[Akula, Srinivas; Thorpe, Michael; Boinapally, Vamsi; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, SE-75124 Uppsala, Sweden	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Box 596, SE-75124 Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Thorpe, Michael/P-6838-2015; Akula, Srinivas/GYJ-1463-2022	Thorpe, Michael/0000-0002-4771-0080; 	Vetenskapsradet in SWEDEN [621-2011-5007]	Vetenskapsradet in SWEDEN	Funded by Vetenskapsradet in SWEDEN grant number 621-2011-5007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad J, 2014, BIOL CHEM, V395, P1253, DOI 10.1515/hsz-2014-0174; Akula S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096903; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Aveskogh M, 1997, IMMUNOGENETICS, V46, P181, DOI 10.1007/s002510050260; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Bovenschen N, 2010, IMMUNOL REV, V235, P117, DOI 10.1111/j.0105-2896.2010.00889.x; CAPUTO A, 1994, NAT STRUCT BIOL, V1, P364, DOI 10.1038/nsb0694-364; Caughey GH, 2006, CURR RESPIR MED REV, V2, P263, DOI 10.2174/157339806778019024; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Flajnik MF, 2014, CURR BIOL, V24, pR1060, DOI 10.1016/j.cub.2014.09.070; Fu ZR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131720; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Hink-Schauer C, 2003, NAT STRUCT BIOL, V10, P535, DOI 10.1038/nsb945; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kervinen J, 2008, J BIOL CHEM, V283, P427, DOI 10.1074/jbc.M707157200; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2011, FEBS J, V278, P2635, DOI 10.1111/j.1742-4658.2011.08189.x; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Lunderius C, 2000, EUR J IMMUNOL, V30, P3396, DOI 10.1002/1521-4141(2000012)30:12<3396::AID-IMMU3396>3.0.CO;2-O; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Pemberton AD, 1997, BIOCHEM J, V323, P719, DOI 10.1042/bj3230719; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; PEREIRA HA, 1990, LIFE SCI, V46, P189, DOI 10.1016/0024-3205(90)90104-Y; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; PERONA JJ, 1995, PROTEIN SCI, V4, P337; POE M, 1991, J BIOL CHEM, V266, P98; Praveen K, 2006, MOL IMMUNOL, V43, P1152, DOI 10.1016/j.molimm.2005.07.027; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Reimer JM, 2010, IMMUNOGENETICS, V62, P369, DOI 10.1007/s00251-010-0443-2; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; TANAKA T, 1985, BIOCHEMISTRY-US, V24, P2040, DOI 10.1021/bi00329a036; Thorpe M, 2012, INT IMMUNOL, V24, P771, DOI 10.1093/intimm/dxs081; Volanakis JE, 1996, PROTEIN SCI, V5, P553; Wernersson S, 2006, DEV COMP IMMUNOL, V30, P901, DOI 10.1016/j.dci.2005.10.014; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; ZAMOLODCHIKOVA TS, 1995, EUR J BIOCHEM, V227, P866, DOI 10.1111/j.1432-1033.1995.tb20212.x; ZAMOLODCHIKOVA TS, 1995, EUR J BIOCHEM, V227, P873, DOI 10.1111/j.1432-1033.1995.tb20213.x; Zhou F, 2010, INT REV IMMUNOL, V29, P38, DOI 10.3109/08830180903247889	50	32	34	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143091	10.1371/journal.pone.0143091	http://dx.doi.org/10.1371/journal.pone.0143091			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569620	Green Published, gold			2022-12-26	WOS:000365070700134
J	Anderson, R; Maga, AM				Anderson, Ryan; Maga, A. Murat			A Novel Procedure for Rapid Imaging of Adult Mouse Brains with MicroCT Using Iodine-Based Contrast	PLOS ONE			English	Article							MAGNETIC-RESONANCE; CT; TOMOGRAPHY; EMBRYOS; ATLAS; REGISTRATION; TOOL	High-resolution Magnetic Resonance Imaging (MRI) has been the primary modality for obtaining 3D cross-sectional anatomical information in animals for soft tissue, particularly brain. However, costs associated with MRI can be considerably high for large phenotypic screens for gross differences in the structure of the brain due to pathology and/or experimental manipulations. MicroCT (mCT), especially benchtop mCT, is becoming a common laboratory equipment with throughput rates equal or faster than any form of high-resolution MRI at lower costs. Here we explore adapting previously developed contrast based mCT to image adult mouse brains in-situ. We show that 2% weight per volume (w/v) iodine-potassium iodide solution can be successfully used to image adult mouse brains within 48 hours post-mortem when a structural support matrix is used. We demonstrate that hydrogel can be effectively used as a perfusant which limits the tissue shrinkage due to iodine.	[Anderson, Ryan; Maga, A. Murat] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Maga, A. Murat] Univ Washington, Dept Pediat, Div Craniofacial Med, Seattle, WA 98195 USA; [Maga, A. Murat] Univ Washington, Dept Oral Biol, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maga, AM (corresponding author), Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA.	maga@uw.edu		Maga, A. Murat/0000-0002-7921-9018	National Institute of Dental and Craniofacial Research Pathways [DE021417]; Seattle Children's Research Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE021417, R00DE021417] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research Pathways; Seattle Children's Research Institute; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	A National Institute of Dental and Craniofacial Research Pathways to Independence Award (DE021417) and a Seattle Children's Research Institute internal grant to AMM funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2009, NEUROSCIENCE, V162, P1339, DOI 10.1016/j.neuroscience.2009.05.070; Budin F, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00015; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Descamps E, 2014, BELG J ZOOL, V144, P20; Dhenain M, 2001, DEV BIOL, V232, P458, DOI 10.1006/dbio.2001.0189; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; Larina IV, 2011, CURR OPIN GENET DEV, V21, P579, DOI 10.1016/j.gde.2011.09.004; Li XJ, 2007, J ANAT, V211, P798, DOI 10.1111/j.1469-7580.2007.00825.x; Metscher BD, 2011, COLD SPRING HARB PRO, V2011, DOI [10.1101/pdb.prot067033, DOI 10.1101/PDB.PROT067033]; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Ou YM, 2014, IEEE T MED IMAGING, V33, P2039, DOI 10.1109/TMI.2014.2330355; Ou YM, 2011, MED IMAGE ANAL, V15, P622, DOI 10.1016/j.media.2010.07.002; Quintana L, 2011, COLD SPRING HARBOR P, V2011, DOI [10.1101/pdb.top116, DOI 10.1101/PDB.TOP116]; Saito S, 2012, BRIT J RADIOL, V85, pE973, DOI 10.1259/bjr/13040401; Scouten C.W., 2006, MICROSC TODAY, V14, P26, DOI [10.1017/s1551929500057631, DOI 10.1017/S1551929500057631]; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Syed SH, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3560300; Wehrl HF, 2015, HISTOL HISTOPATHOL, V30, P601, DOI 10.14670/HH-30.601; Wong MD, 2014, DEVELOPMENT, V141, P2533, DOI 10.1242/dev.107722; Wong MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084321; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; Zhang JY, 2005, NEUROIMAGE, V26, P1042, DOI 10.1016/j.neuroimage.2005.03.009	24	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142974	10.1371/journal.pone.0142974	http://dx.doi.org/10.1371/journal.pone.0142974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571123	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700109
J	Hill, MG; Wurms, KV; Davy, MW; Gould, E; Allan, A; Mauchline, NA; Luo, ZW; Chee, AA; Stannard, K; Storey, RD; Rikkerink, EH				Hill, M. Garry; Wurms, Kirstin V.; Davy, Marcus W.; Gould, Elaine; Allan, Andrew; Mauchline, Nicola A.; Luo, Zhiwei; Chee, Annette Ah; Stannard, Kate; Storey, Roy D.; Rikkerink, Erik H.			Transcriptome Analysis of Kiwifruit (Actinidia chinensis) Bark in Response to Armoured Scale Insect (Hemiberlesia lataniae) Feeding	PLOS ONE			English	Article							HYPERSENSITIVE RESPONSE; PLANT DEFENSE; CELL-DEATH; PRIMARY METABOLISM; SALICYLIC-ACID; ARABIDOPSIS; RESISTANCE; IMMUNITY; PATHOGEN; GENE	The kiwifruit cultivar Actinidia chinensis 'Hort16A' is resistant to the polyphagous armoured scale insect pest Hemiberlesia lataniae (Hemiptera: Diaspididae). A cDNA microarray consisting of 17,512 unigenes selected from over 132,000 expressed sequence tags (ESTs) was used to measure the transcriptomic profile of the A. chinensis 'Hort16A' canes in response to a controlled infestation of H. lataniae. After 2 days, 272 transcripts were differentially expressed. After 7 days, 5,284 (30%) transcripts were differentially expressed. The transcripts were grouped into 22 major functional categories using MapMan software. After 7 days, transcripts associated with photosynthesis (photosystem II) were significantly down-regulated, while those associated with secondary metabolism were significantly upregulated. A total of 643 transcripts associated with response to stress were differentially expressed. This included biotic stress-related transcripts orthologous with pathogenesis related proteins, the phenylpropanoid pathway, NBS-LRR (R) genes, and receptor-like kinase-leucine rich repeat signalling proteins. While transcriptional studies are not conclusive in their own right, results were suggestive of a defence response involving both ETI and PTI, with predominance of the SA signalling pathway. Exogenous application of an SA-mimic decreased H. lataniae growth on A. chinensis 'Hort16A' plants in two laboratory experiments.	[Hill, M. Garry; Davy, Marcus W.; Mauchline, Nicola A.; Stannard, Kate; Storey, Roy D.] New Zealand Inst Plant & Food Res Ltd PFR, Te Puke, New Zealand; [Wurms, Kirstin V.; Gould, Elaine; Chee, Annette Ah] Plant & Food Res Ltd PFR, Waikato Mail Ctr, Hamilton, New Zealand; [Allan, Andrew; Luo, Zhiwei; Rikkerink, Erik H.] Plant & Food Res Ltd PFR, Auckland, New Zealand	New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd	Hill, MG (corresponding author), New Zealand Inst Plant & Food Res Ltd PFR, 412 1 Rd RD2, Te Puke, New Zealand.	garry.hill@plantandfood.co.nz	Chee, Annette Ah/K-7934-2017; Mauchline, Nicola A/L-6184-2018; Wurms, Kirstin/K-7899-2017	Chee, Annette Ah/0000-0003-3770-4987; Mauchline, Nicola A/0000-0003-2077-5455; Wurms, Kirstin/0000-0002-7592-1643; Storey, Roy/0000-0003-1375-7136; Luo, Zhiwei/0000-0002-7605-9768	Ministry for Business, Innovation and Employment [CO6X0301]; New Zealand Institute for Plant Food Research; Foundation for Research Science and Technology (Ministry for Business, Innovation and Employment) [CO6X0301]	Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); New Zealand Institute for Plant Food Research; Foundation for Research Science and Technology (Ministry for Business, Innovation and Employment)	The work was funded by the New Zealand Foundation for Research Science and Technology (latterly Ministry for Business, Innovation and Employment) grant CO6X0301 and New Zealand Institute for Plant & Food Research core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jo Stirling for technical assistance and Helen Boldingh for advice on laboratory procedures. Sue Gardiner and three anonymous referees made invaluable suggestions on earlier drafts. We are grateful to Ross Crowhurst for assistance with gene mining. The work was funded by Foundation for Research Science and Technology (Ministry for Business, Innovation and Employment) grant CO6X0301.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Coaker G, 2012, MOL PLANT IMMUNITY, P41; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; Dempsey D'Maris Amick, 2011, Arabidopsis Book, V9, pe0156, DOI 10.1199/tab.0156; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dubey NK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-241; Edwards R, 2008, J ECON ENTOMOL, V101, P1944, DOI 10.1603/0022-0493-101.6.1944; Elsayed G., 2011, Archives of Phytopathology and Plant Protection, V44, P1534, DOI 10.1080/03235408.2010.507957; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Ferguson A. R., 2007, Horticultural Reviews, V33, P1, DOI 10.1002/9780470168011.ch1; Fiil BK, 2011, PLANT SIGNAL BEHAV, V6, P1425, DOI 10.4161/psb.6.10.16759; Foldi I., 1990, P257; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gechev TS, 2005, IUBMB LIFE, V57, P181, DOI 10.1080/15216540500090793; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gohre V, 2012, MOL PLANT MICROBE IN, V25, P1083, DOI 10.1094/MPMI-11-11-0301; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Hill MG, 2007, ACTA HORTIC, P685, DOI 10.17660/ActaHortic.2007.753.90; Hill MG, 2011, ARTHROPOD-PLANT INTE, V5, P149, DOI 10.1007/s11829-011-9124-9; Hill MG, 2010, NEW ZEAL J CROP HORT, V38, P69, DOI 10.1080/01140671003767974; Hill M. G., 2009, New Zealand Plant Protection, V62, P56; Hill M. G., 2005, New Zealand Plant Protection, V58, P288; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Janda T, 2014, ACTA PHYSIOL PLANT, V36, P2537, DOI 10.1007/s11738-014-1620-y; Janssen BJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-16; Jiang YQ, 2009, PLANT MOL BIOL, V69, P91, DOI 10.1007/s11103-008-9408-3; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Koteja J., 1990, P243; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Major IT, 2010, PHOTOSYNTH RES, V104, P41, DOI 10.1007/s11120-009-9507-2; MORALES CF, 1988, NEW ZEAL J EXP AGR, V16, P77, DOI 10.1080/03015521.1988.10425618; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Morant AV, 2008, PHYTOCHEMISTRY, V69, P1795, DOI 10.1016/j.phytochem.2008.03.006; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Narusaka Y, 2003, PLANT CELL PHYSIOL, V44, P1246, DOI 10.1093/pcp/pcg138; Normark BB, 2011, GENETICA, V139, P551, DOI 10.1007/s10709-010-9513-5; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Petersen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014364; Pieterse CMJ, 2014, INDUCED RESISTANCE FOR PLANT DEFENSE: A SUSTAINABLE APPROACH TO CROP PROTECTION, 2ND EDITION, P58; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Reglinski T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00024; Richael C, 1999, PHYSIOL MOL PLANT P, V55, P5, DOI 10.1006/pmpp.1999.0209; Rose M., 1990, P357; Rotter A, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-10; Rozen S, 2000, Methods Mol Biol, V132, P365; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Villada ES, 2009, J EXP BOT, V60, P3269, DOI 10.1093/jxb/erp163; Smith CM, 2012, ANNU REV ENTOMOL, V57, P309, DOI 10.1146/annurev-ento-120710-100642; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Sun TJ, 2014, PLANT J, V77, P748, DOI 10.1111/tpj.12425; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Vandersompele J, 2002, GENOME BIOL, V3; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Walters DR, 2005, PHYSIOL MOL PLANT P, V66, P40, DOI 10.1016/j.pmpp.2005.04.002; Wu LT, 2011, AFR J MICROBIOL RES, V5, P5481, DOI 10.5897/AJMR11.781; Wurms KV, 2011, ACTA HORTIC, P525, DOI 10.17660/ActaHortic.2011.913.70; Wurms K, 2011, J PHYTOPATHOL, V159, P435, DOI 10.1111/j.1439-0434.2011.01786.x; Wurms KV, 2013, ACTA PHYTOPATHOLOG S, V43, P256; [No title captured]	78	13	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0141664	10.1371/journal.pone.0141664	http://dx.doi.org/10.1371/journal.pone.0141664			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571404	Green Submitted, gold, Green Published			2022-12-26	WOS:000365070700010
J	Jacomin, AC; Bescond, A; Soleilhac, E; Gallet, B; Schoehn, G; Fauvarque, MO; Taillebourg, E				Jacomin, Anne-Claire; Bescond, Amandine; Soleilhac, Emmanuelle; Gallet, Benoit; Schoehn, Guy; Fauvarque, Marie-Odile; Taillebourg, Emmanuel			The Deubiquitinating Enzyme UBPY Is Required for Lysosomal Biogenesis and Productive Autophagy in Drosophila	PLOS ONE			English	Article							IN-VIVO; FAT-BODY; UBIQUITINATION; MELANOGASTER; TRAFFICKING; INDUCTION; GROWTH; DEUBIQUITYLATION; DEGRADATION; STARVATION	Autophagy is a catabolic process that delivers cytoplasmic components to the lysosomes. Protein modification by ubiquitination is involved in this pathway: it regulates the stability of autophagy regulators such as BECLIN-1 and it also functions as a tag targeting specific substrates to autophagosomes. In order to identify deubiquitinating enzymes (DUBs) involved in autophagy, we have performed a genetic screen in the Drosophila larval fat body. This screen identified Uch-L3, Usp45, Usp12 and Ubpy. In this paper, we show that Ubpy loss of function results in the accumulation of autophagosomes due to a blockade of the autophagy flux. Furthermore, analysis by electron and confocal microscopy of Ubpy-depleted fat body cells revealed altered lysosomal morphology, indicating that Ubpy inactivation affects lysosomal maintenance and/or biogenesis. Lastly, we have shown that shRNA mediated inactivation of UBPY in HeLa cells affects autophagy in a different way: in UBPY-depleted HeLa cells autophagy is deregulated.	[Jacomin, Anne-Claire; Bescond, Amandine; Soleilhac, Emmanuelle; Fauvarque, Marie-Odile; Taillebourg, Emmanuel] Univ Grenoble Alpes, F-38041 Grenoble, France; [Jacomin, Anne-Claire; Bescond, Amandine; Soleilhac, Emmanuelle; Fauvarque, Marie-Odile; Taillebourg, Emmanuel] CEA DSV iRTSV BGE Gen & Chem, F-38054 Grenoble, France; [Jacomin, Anne-Claire; Bescond, Amandine; Soleilhac, Emmanuelle; Fauvarque, Marie-Odile; Taillebourg, Emmanuel] INSERM, U1038, F-38054 Grenoble, France; [Gallet, Benoit; Schoehn, Guy] Univ Grenoble Alpes, IBS, F-38044 Grenoble, France; [Gallet, Benoit; Schoehn, Guy] CNRS, IBS, F-38044 Grenoble, France; [Gallet, Benoit; Schoehn, Guy] CEA, IBS, F-38044 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Fauvarque, MO (corresponding author), Univ Grenoble Alpes, F-38041 Grenoble, France.	marie-odile.fauvarque@cea.fr; emmanuel.taillebourg@cea.fr	Jacomin, Anne-Claire/K-1009-2019	Jacomin, Anne-Claire/0000-0001-8761-1514; Soleilhac, Emmanuelle/0000-0002-4335-6029; Schoehn, Guy/0000-0002-1459-3201; GALLET, Benoit/0000-0001-8758-7681; Fauvarque, Marie-Odile/0000-0001-5020-3701; taillebourg, emmanuel/0000-0002-9328-6997	Grenoble Instruct centre (ISBG) [UMS 3518 CNRS-CEA-UJF-EMBL]; FRISBI [ANR-10-INSB-05-02]; GRAL within Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]; FINOVI foundation	Grenoble Instruct centre (ISBG); FRISBI; GRAL within Grenoble Partnership for Structural Biology (PSB); FINOVI foundation	This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). This work was supported by the FINOVI foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asha H, 2003, GENETICS, V163, P203; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Beau I, 2008, TRENDS CELL BIOL, V18, P311, DOI 10.1016/j.tcb.2008.05.001; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Broemer M, 2010, MOL CELL, V40, P810, DOI 10.1016/j.molcel.2010.11.011; Carre-Mouka A, 2007, GENETICS, V176, P409, DOI 10.1534/genetics.106.063826; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Cornelissen T, 2014, HUMAN MOL GENETICS; Durcan TM, 2014, EMBO J, V33, P2473, DOI 10.15252/embj.201489729; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Engel E, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0041-2; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hans F, 2014, J BIOL CHEM, V289, P19164, DOI 10.1074/jbc.M114.561704; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hutchins AP, 2013, MOL BIOL EVOL, V30, P1172, DOI 10.1093/molbev/mst022; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Klionsky DJ, 2013, J INNATE IMMUN, V5, P427, DOI 10.1159/000351979; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Lee CY, 2001, DEVELOPMENT, V128, P1443; Li S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001239; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Luo WF, 2012, GENE DEV, V26, P2536, DOI 10.1101/gad.200584.112; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Mulakkal NC, 2014, BIOMED RES INT, V2014, P24; Neufeld TP, 2008, METHOD ENZYMOL, V451, P653, DOI 10.1016/S0076-6879(08)03236-9; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nezis IP, 2010, J CELL BIOL, V190, P523, DOI 10.1083/jcb.201002035; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pignoni F, 1997, DEVELOPMENT, V124, P271; Pircs K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044214; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shi CS, 2010, AUTOPHAGY, V6, P986, DOI 10.4161/auto.6.7.13288; Taillebourg E, 2012, AUTOPHAGY, V8, P767, DOI 10.4161/auto.19381; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; Xia RH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001238; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang JZ, 2014, DEVELOPMENT, V141, P1473, DOI 10.1242/dev.099564; Zhang JZ, 2012, G3-GENES GENOM GENET, V2, P1563, DOI 10.1534/g3.112.003780; Zhou RF, 2013, J BIOL CHEM, V288, P5389, DOI 10.1074/jbc.M112.425272	55	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143078	10.1371/journal.pone.0143078	http://dx.doi.org/10.1371/journal.pone.0143078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571504	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700130
J	Micera, A; Stampachiacchiere, B; Di Zazzo, A; Sgrulletta, R; Cortes, M; Normando, EM; Lambiase, A; Bonini, S				Micera, Alessandra; Stampachiacchiere, Barbara; Di Zazzo, Antonio; Sgrulletta, Roberto; Cortes, Magdalena; Normando, Eduardo Maria; Lambiase, Alessandro; Bonini, Stefano			NGF Modulates trkA(NGFR)/p75(NTR) in alpha SMA-Expressing Conjunctival Fibroblasts from Human Ocular Cicatricial Pemphigoid (OCP)	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; TISSUE-REPAIR; FIBROTIC DISEASE; FIBROSIS; MYOFIBROBLAST; P75(NTR); PROLIFERATION; PATHOGENESIS; MECHANISMS	Objective In a previous study, we reported the upregulation of Nerve Growth Factor (NGF) and trkA(NGFR) expression in Ocular Cicatricial Pemphigoid (OCP), an inflammatory and remodeling eye disease. Herein, we hypothesize a potential NGF-driven mechanism on fibroblasts (FBs) during OCP remodeling events. To verify, human derived OCP-FBs were isolated and characterized either at baseline or after NGF exposure. Materials and Methods Conjunctival biopsies were obtained from 7 patients having OCP and 6 control subjects (cataract surgery). Both conjunctivas and primary FB cultures were characterised for alpha SMA, NGF and trkA(NGFR)/p75(NTR) expression. Subcultures were exposed to NGF and evaluated for aSMA, NGF, trkA(NGFR)/p75(NTR) expression as well as TGF beta 1/IL4 release. For analysis, early and advanced subgroups were defined according to clinical parameters. Results OCP-conjunctivas showed alpha SMA-expressing FBs and high NGF levels. Advanced OCP-FBs showed higher alpha SMA expression associated with higher p75(NTR) and lower trkA(NGFR) expression, as compared to early counterparts. alpha SMA expression was in keeping with disease severity and correlated to p75(NTR). NGF exposure did not affect trkA(NGFR) levels in early OCP-FBs while decreased both alpha SMA/p75(NTR) expression and TGF beta 1/IL4 release. These effects were not observed in advanced OCP-FBs. Conclusions Taken together, these data are suggestive for a NGF/p75(NTR) task in the potential modulation of OCP fibrosis and encourages further studies to fully understand the underlying mechanism occurring in fibrosis. NGF/p75(NTR) might be viewed as a potential therapeutic target.	[Micera, Alessandra; Stampachiacchiere, Barbara; Cortes, Magdalena] IRCCS GB Bietti Fdn, Rome, Italy; [Di Zazzo, Antonio; Sgrulletta, Roberto; Bonini, Stefano] Univ Campus Biomed, Dept Ophthalmol, Rome, Italy; [Normando, Eduardo Maria] UCL Inst Ophthalmol, Visual Neurosci, Glaucoma & Retinal Degenerat Res Grp, London EC1V 9EL, England; [Normando, Eduardo Maria] Imperial Coll Healthcare Trust, Western Eye Hosp, London NW1 5QH, England; [Lambiase, Alessandro] Univ Roma La Sapienza, Dept Organi Senso, Ophthalmol, I-00185 Rome, Italy	IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University Campus Bio-Medico - Rome Italy; University of London; University College London; Sapienza University Rome	Micera, A (corresponding author), IRCCS GB Bietti Fdn, Rome, Italy.	amicera@gmail.com; s.bonini@unicampus.it	Bonini, Stefano/A-2250-2012; Bonini, Sergio/T-6594-2019; Lambiase, Alessandro/K-3902-2016; Micera, Alessandra/J-3373-2013	Bonini, Stefano/0000-0002-7787-2144; Bonini, Sergio/0000-0003-0079-3031; Lambiase, Alessandro/0000-0002-8974-991X; Normando, Eduardo Maria/0000-0002-5774-8082	Italian Ministry of Health (MoH); Fondazione Roma; Ministry of Health (Italy)	Italian Ministry of Health (MoH)(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission); Ministry of Health (Italy)(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health (MoH) and by the intramural financial support (Fondazione Roma). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The data of this study were partially presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology, 2007, Fort-Lauderdale, Florida (Stampachiacchiere et al., Invest. Ophthalmol. Vis. Sci. 2007 48: E-Abstract 5306). This study was partially supported by Ministry of Health (Italy). The authors wish to express gratitude to Fondazione Roma for continuous support. Special thanks to Dr. Eleonora Perrella for her valuable contribution (Pathology, UCBM).	Ahmed M, 2004, PROG RETIN EYE RES, V23, P579, DOI 10.1016/j.preteyeres.2004.05.005; Aloe L, 1999, BIOMED REV, V10, P3; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bonini S, 1999, INT ARCH ALLERGY IMM, V118, P159, DOI 10.1159/000024055; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen K, 2005, J LEUKOCYTE BIOL, V77, P166, DOI 10.1189/jlb.0904538; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Durrani K, 2011, SURV OPHTHALMOL, V56, P474, DOI 10.1016/j.survophthal.2011.05.003; Elder MJ, 1996, BRIT J OPHTHALMOL, V80, P292, DOI 10.1136/bjo.80.4.292; Hempstead Barbara L., 2006, Current Alzheimer Research, V3, P19, DOI 10.2174/156720506775697061; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Jelaska A, 1999, SPRINGER SEMIN IMMUN, V21, P385, DOI 10.1007/BF00870301; Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701; Kirzhner M, 2011, SEMIN OPHTHALMOL, V26, P270, DOI 10.3109/08820538.2011.588660; Kraft AD, 2009, NEUROTOXICOLOGY, V30, P785, DOI 10.1016/j.neuro.2009.07.001; Lambiase A, 1998, INVEST OPHTH VIS SCI, V39, P1272; Lambiase A, 2011, ARCH ITAL BIOL, V149, P283, DOI 10.4449/aib.v149i2.1363; Lambiase A, 2011, ARCH OPHTHALMOL-CHIC, V129, P981, DOI 10.1001/archophthalmol.2011.200; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Levi-Montalcini R, 1998, NEUROREPORT, V9, pR71; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Matrone C, 2009, P NATL ACAD SCI USA, V106, P11358, DOI 10.1073/pnas.0904998106; Micera A, 2004, CYTOKINE GROWTH F R, V15, P411, DOI 10.1016/j.cytogfr.2004.09.003; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Micera A, 2007, MOL VIS, V13, P981; Micera A, 2007, CYTOKINE GROWTH F R, V18, P245, DOI 10.1016/j.cytogfr.2007.04.004; Miserocchi E, 2002, OPHTHALMOLOGY, V109, P111, DOI 10.1016/S0161-6420(01)00863-6; MONDINO BJ, 1981, OPHTHALMOLOGY, V88, P95; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Razzaque MS, 2003, INVEST OPHTH VIS SCI, V44, P3417, DOI 10.1167/iovs.02-1084; Razzaque MS, 2003, INVEST OPHTH VIS SCI, V44, P1998, DOI 10.1167/iovs.02-0967; Razzaque MS, 2001, HISTOL HISTOPATHOL, V16, P1203, DOI 10.14670/HH-16.1203; Sacher C, 2005, AM J CLIN DERMATOL, V6, P93, DOI 10.2165/00128071-200506020-00004; Saw VPJ, 2011, AM J PATHOL, V178, P187, DOI 10.1016/j.ajpath.2010.11.013; Schor NF, 2005, PROG NEUROBIOL, V77, P201, DOI 10.1016/j.pneurobio.2005.10.006; Sgrulletta R, 2007, EUR J OPHTHALMOL, V17, P121, DOI 10.1177/112067210701700117; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Foster CS, 2004, CURR OPIN ALLERGY CL, V4, P435, DOI 10.1097/00130832-200410000-00017; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Williams GP, 2011, EYE, V25, P1207, DOI 10.1038/eye.2011.175; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zampieri N, 2006, BIOCHEM SOC T, V34, P607, DOI 10.1042/BST0340607; Zhou Y, 2009, CELL RES, V19, P525, DOI 10.1038/cr.2009.47	49	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142737	10.1371/journal.pone.0142737	http://dx.doi.org/10.1371/journal.pone.0142737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569118	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700066
J	Stejskal, K; Streinzer, M; Dyer, A; Paulus, HF; Spaethe, J				Stejskal, Kerstin; Streinzer, Martin; Dyer, Adrian; Paulus, Hannes F.; Spaethe, Johannes			Functional Significance of Labellum Pattern Variation in a Sexually Deceptive Orchid (Ophrys heldreichii): Evidence of Individual Signature Learning Effects	PLOS ONE			English	Article							HONEYBEE APIS-MELLIFERA; COLOR DISCRIMINATION; RECOGNIZE IMAGES; NECTAR GUIDES; POLLINATION; EVOLUTION; VISION; MIMICRY; PERCEPTION; PREFERENCE	Mimicking female insects to attract male pollinators is an important strategy in sexually deceptive orchids of the genus Ophrys, and some species possess flowers with conspicuous labellum patterns. The function of the variation of the patterns remains unresolved, with suggestions that these enhance pollinator communication. We investigated the possible function of the labellum pattern in Ophrys heldreichii, an orchid species in which the conspicuous and complex labellum pattern contrasts with a dark background. The orchid is pollinated exclusively by males of the solitary bee, Eucera berlandi. Comparisons of labellum patterns revealed that patterns within inflorescences are more similar than those of other conspecific plants. Field observations showed that the males approach at a great speed and directly land on flowers, but after an unsuccessful copulation attempt, bees hover close and visually scan the labellum pattern for up to a minute. Learning experiments conducted with honeybees as an accessible model of bee vision demonstrated that labellum patterns of different plants can be reliably learnt; in contrast, patterns of flowers from the same inflorescence could not be discriminated. These results support the hypothesis that variable labellum patterns in O. heldreichii are involved in flower-pollinator communication which would likely help these plants to avoid geitonogamy.	[Stejskal, Kerstin; Paulus, Hannes F.] Univ Vienna, Fac Life Sci, Dept Integrat Zool, Vienna, Austria; [Streinzer, Martin; Spaethe, Johannes] Univ Wurzburg, Biozentrum, Dept Behav Physiol & Sociobiol, D-97070 Wurzburg, Germany; [Dyer, Adrian] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Dyer, Adrian] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia	University of Vienna; University of Wurzburg; Monash University; Royal Melbourne Institute of Technology (RMIT)	Stejskal, K (corresponding author), Univ Vienna, Fac Life Sci, Dept Integrat Zool, Vienna, Austria.	kerstin.stejskal@univie.ac.at	Streinzer, Martin/AAE-2359-2019; Spaethe, Johannes/B-8826-2014	Spaethe, Johannes/0000-0002-0734-2869; Streinzer, Martin/0000-0002-6656-7224	Austrian Science Fund (FWF) [P21521-B17]; Australian Research Council [DP0878968/DP0987989/DP130100015]; Austrian Science Fund (FWF) [P 21521] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Australian Research Council(Australian Research Council); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank the Austrian Science Fund (FWF): P21521-B17 for financial support. AGD acknowledges the Australian Research Council DP0878968/DP0987989/DP130100015 for financial support.	ANDERSON AM, 1979, J COMP PHYSIOL, V130, P173, DOI 10.1007/BF00611051; Avargues-Weber A, 2010, J EXP BIOL, V213, P593, DOI 10.1242/jeb.039263; Avargues-Weber A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2384; Avargues-Weber A, 2012, P NATL ACAD SCI USA, V109, P7481, DOI 10.1073/pnas.1202576109; Avargues-Weber A, 2011, ANNU REV ENTOMOL, V56, P423, DOI 10.1146/annurev-ento-120709-144855; Avargues-Weber A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015370; Ayasse M, 2000, EVOLUTION, V54, P1995, DOI 10.1111/j.0014-3820.2000.tb01243.x; Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Collishaw SM, 2000, PERCEPTION, V29, P893, DOI 10.1068/p2949; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Dafni A, 1996, BOT J LINN SOC, V120, P371, DOI 10.1111/j.1095-8339.1996.tb00487.x; Delforge P., 2006, ORCHIDS EUROPE N AFR; Dyer AG, 2008, J EXP BIOL, V211, P1180, DOI 10.1242/jeb.016683; Dyer AG, 2012, J EXP BIOL, V215, P397, DOI 10.1242/jeb.060954; Dyer AG, 2012, J EXP BIOL, V215, P387, DOI 10.1242/jeb.038190; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Dyer AG, 2005, J COMP PHYSIOL A, V191, P547, DOI 10.1007/s00359-005-0622-z; Efler D, 2000, VISION RES, V40, P3391, DOI 10.1016/S0042-6989(00)00189-9; Ellis AG, 2010, AM NAT, V176, pE143, DOI 10.1086/656487; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Giurfa M, 1999, ANIM BEHAV, V57, P315, DOI 10.1006/anbe.1998.0957; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Hopkins R, 2012, SCIENCE, V335, P1090, DOI 10.1126/science.1215198; Hopkins R, 2011, NATURE, V469, P411, DOI 10.1038/nature09641; Horridge A, 2000, VISION RES, V40, P2589, DOI 10.1016/S0042-6989(00)00096-1; Horridge A, 2009, J EXP BIOL, V212, P2721, DOI 10.1242/jeb.030916; Horridge A, 2009, J INSECT PHYSIOL, V55, P499, DOI 10.1016/j.jinsphys.2009.03.006; Johnson SD, 1998, FUNCT ECOL, V12, P289; KULLENBERG B, 1976, ZOOL SCR, V5, P13, DOI 10.1111/j.1463-6409.1976.tb00678.x; KULLENBERG B, 1950, OIKOS, V2, P2; Kullenberg B, 1961, STUDIES OPHRYS POLLI, P1; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Land MF, 2013, VISION INSECTS STRUC, P708; Lehrer M, 1999, J COMP PHYSIOL A, V184, P195, DOI 10.1007/s003590050318; Lehrer M, 1999, INT J PLANT SCI, V160, pS51, DOI 10.1086/314216; LEHRER M, 1985, J COMP PHYSIOL A, V157, P405, DOI 10.1007/BF00615140; Leonard AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055914; Leonard AS, 2011, FUNCT ECOL, V25, P1293, DOI 10.1111/j.1365-2435.2011.01885.x; Lunau K, 2000, PLANT SYST EVOL, V222, P89, DOI 10.1007/BF00984097; Lunau K, 1997, BIOL UNSERER Z, V27, P169; Lynn SK, 2005, EVOLUTION, V59, P1300, DOI 10.1111/j.0014-3820.2005.tb01780.x; MANNING AUBREY, 1956, BEHAVIOUR, V9, P114, DOI 10.1163/156853956X00273; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; NILSSON LA, 1992, TRENDS ECOL EVOL, V7, P255, DOI 10.1016/0169-5347(92)90170-G; Osche, 1979, BIOL UNSERER ZEIT, V9, P161, DOI DOI 10.1002/BIUZ; Paulus H.F., 1988, Verhandlungen der Deutschen Zoologischen Gesellschaft, V81, P25; Paulus H. F., 2007, Denisia, P255; Paulus H.F., 1983, ORCHIDEE, P65; Paulus H.F., 1983, ORCHIDEE SONDERHEFT, P73; Paulus H.F., 2005, ORCHIDEEN DEUTSCHLAN, P98; Paulus Hannes F., 1997, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Oesterreich, V134, P133; PAULUS HF, 1990, ISRAEL J BOT, V39, P43; Pouyanne A., 1917, B SOC HIST NATURELLE, V8, P6; Rakosy D, 2012, ARTHROPOD-PLANT INTE, V6, P671, DOI 10.1007/s11829-012-9217-0; Rodriguez-Girones MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071551; Schiestl FP, 2010, CURR BIOL, V20, pR1020, DOI 10.1016/j.cub.2010.10.019; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; Schiestl FP, 2002, PLANT SYST EVOL, V234, P111, DOI 10.1007/s00606-002-0187-z; Sedeek KEM, 2014, MOL ECOL, V23, P6192, DOI 10.1111/mec.12992; Sheehan MJ, 2011, SCIENCE, V334, P1272, DOI 10.1126/science.1211334; Spaethe J, 2007, PLANT SYST EVOL, V264, P31, DOI 10.1007/s00606-006-0503-0; Spaethe Johannes, 2010, Communicative & Integrative Biology, V3, P139; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; Stach S, 2005, BEHAV BRAIN RES, V161, P8, DOI 10.1016/j.bbr.2005.02.008; Streinzer M, 2010, ARTHROPOD-PLANT INTE, V4, P141, DOI 10.1007/s11829-010-9093-4; Streinzer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057702; Streinzer M, 2009, J EXP BIOL, V212, P1365, DOI 10.1242/jeb.027482; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2013, SCI AM, V309, P62; Vereecken NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4786, DOI 10.1098/rspb.2012.1804; WASER NM, 1985, OECOLOGIA, V67, P121, DOI 10.1007/BF00378462; Wehner R, 1981, COMP PHYS EVOLUTION, VVII/ 6C, P287, DOI DOI 10.1007/978-3642-67868-4; Whitehead MR, 2015, J EVOLUTION BIOL, V28, P1526, DOI 10.1111/jeb.12673; Wu W, 2013, J COMP PHYSIOL A, V199, P45, DOI 10.1007/s00359-012-0767-5; Zhang SW, 2004, J EXP BIOL, V207, P3289, DOI 10.1242/jeb.01155	81	15	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142971	10.1371/journal.pone.0142971	http://dx.doi.org/10.1371/journal.pone.0142971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571020	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700108
J	Guo, SH; Skala, WG; Magdolen, V; Briza, P; Biniossek, ML; Schilling, O; Kellermann, J; Brandstetter, H; Goettig, P				Guo, Shihui; Skala, Wolfgang; Magdolen, Viktor; Briza, Peter; Biniossek, Martin L.; Schilling, Oliver; Kellermann, Josef; Brandstetter, Hans; Goettig, Peter			A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN GLANDULAR KALLIKREIN; HUMAN SEMINAL PLASMA; PROTEASE INHIBITORS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; PANCREATIC KALLIKREIN; SUBSTRATE-SPECIFICITY; SERINE PROTEINASE; CLEAVAGE SITES	Human kallikrein-related peptidase 2 (KLK2) is a key serine protease in semen liquefaction and prostate cancer together with KLK3/prostate-specific antigen. In order to decipher the function of its potential N-glycosylation site, we produced pro-KLK2 in Leishmania tarentolae cells and compared it with its non-glycosylated counterpart from Escherichia coli expression. Mass spectrometry revealed that Asn-95 carries a core glycan, consisting of two GlcNAc and three hexoses. Autocatalytic activation was retarded in glyco-pro-KLK2, whereas the activated glyco-form exhibited an increased proteolytic resistance. The specificity patterns obtained by the PICS (proteomic identification of protease cleavage sites) method are similar for both KLK2 variants, with a major preference for P1-Arg. However, glycosylation changes the enzymatic activity of KLK2 in a drastically substrate-dependent manner. Although glyco-KLK2 has a considerably lower catalytic efficiency than glycan-free KLK2 toward peptidic substrates with P2-Phe, the situation was reverted toward protein substrates, such as glyco-pro-KLK2 itself. These findings can be rationalized by the glycan-carrying 99-loop that prefers to cover the active site like a lid. By contrast, the non-glycosylated 99-loop seems to favor a wide open conformation, which mostly increases the apparent affinity for the substrates (i.e. by a reduction of Km). Also, the cleavage pattern and kinetics in autolytic inactivation of both KLK2 variants can be explained by a shift of the target sites due to the presence of the glycan. These striking effects of glycosylation pave the way to a deeper understanding of kallikrein-related peptidase biology and pathology.	[Guo, Shihui; Skala, Wolfgang; Briza, Peter; Brandstetter, Hans; Goettig, Peter] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Magdolen, Viktor] Tech Univ Munich, Klinikum Rechts Isar, Klin Forschergrp Frauenklin, D-81675 Munich, Germany; [Biniossek, Martin L.; Schilling, Oliver] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Schilling, Oliver] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Schilling, Oliver] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Schilling, Oliver] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Kellermann, Josef] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Salzburg University; Technical University of Munich; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Goettig, P (corresponding author), Salzburg Univ, Dept Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.	peter.goettig@sbg.ac.at	Schilling, O/AAC-8302-2019; Guo, shihui/AAT-2810-2021; guo, shihui/GPX-4901-2022; Goettig, Peter/K-4508-2019; Briza, Peter/D-7309-2012; Esser-Skala, Wolfgang/L-9370-2017; Brandstetter, Hans/E-6754-2011; Goettig, Peter/R-7996-2017	Guo, shihui/0000-0002-0542-1221; guo, shihui/0000-0002-0542-1221; Goettig, Peter/0000-0002-2430-1970; Briza, Peter/0000-0002-4941-6782; Esser-Skala, Wolfgang/0000-0002-7350-4045; Brandstetter, Hans/0000-0002-6089-3045; Goettig, Peter/0000-0002-2430-1970; Schilling, Oliver/0000-0001-7678-7653	Austrian Science Fund FWF D-A-CH Project [I631-B11]; Deutsche Forschungsgemeinschaft D-A-CH Project [MA1236/8-1]; Deutsche Forschungsgemeinschaft [SCHI 871/2, SCHI 871/5, SCHI 871/6, GR 1748/6, INST 39/900-1, SFB850]; European Research Council [ERC-2011-StG 282111-ProteaSys]; Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]; Austrian Science Fund (FWF) [I 631] Funding Source: researchfish	Austrian Science Fund FWF D-A-CH Project(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft D-A-CH Project; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund FWF D-A-CH Project I631-B11 (to S. G., W. S., H. B., and P. G.) and Deutsche Forschungsgemeinschaft D-A-CH Project MA1236/8-1 (to V. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Deutsche Forschungsgemeinschaft Grants SCHI 871/2, SCHI 871/5, SCHI 871/6, GR 1748/6, and INST 39/900-1 and Grant SFB850 (Project B8), a starting grant of the European Research Council (Programme "Ideas"; Call identifier: ERC-2011-StG 282111-ProteaSys), and the Excellence Initiative of the German Federal and State Governments (EXC 294, BIOSS).	Aminetzach YT, 2009, CURR BIOL, V19, P1925, DOI 10.1016/j.cub.2009.09.022; Avgeris M, 2012, BIOL CHEM, V393, P301, DOI 10.1515/hsz-2011-0260; Baird TT, 2006, PROTEIN SCI, V15, P1229, DOI 10.1110/ps.062179006; BAKER AR, 1985, DNA-J MOLEC CELL BIO, V4, P445, DOI 10.1089/dna.1985.4.445; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Behnken HN, 2014, J PROTEOME RES, V13, P997, DOI 10.1021/pr400999y; Biniossek ML, 2012, PROTEOMICS, V12, P1303, DOI 10.1002/pmic.201100569; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BODE W, 1983, J MOL BIOL, V164, P237, DOI 10.1016/0022-2836(83)90077-3; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bosques CJ, 2004, J AM CHEM SOC, V126, P8421, DOI 10.1021/ja0496266; Bowman KK, 2000, PROTEIN EXPRES PURIF, V20, P405, DOI 10.1006/prep.2000.1342; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Carvalho AL, 2002, J MOL BIOL, V322, P325, DOI 10.1016/S0022-2836(02)00705-2; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; Cloutier SM, 2002, EUR J BIOCHEM, V269, P2747, DOI 10.1046/j.1432-1033.2002.02960.x; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Debela M, 2006, J MOL BIOL, V362, P1094, DOI 10.1016/j.jmb.2006.08.003; Denmeade SR, 2001, PROSTATE, V48, P122, DOI 10.1002/pros.1088; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Deperthes D, 1996, J ANDROL, V17, P659; Deperthes D, 1995, BBA-GEN SUBJECTS, V1245, P311, DOI 10.1016/0304-4165(95)00118-2; Fenner G, 1931, NATURWISSENSCHAFTEN, V19, P310; Frenette G, 1997, BBA-GEN SUBJECTS, V1334, P109, DOI 10.1016/S0304-4165(96)00080-3; FUKUSHIMA D, 1985, BIOCHEMISTRY-US, V24, P8037, DOI 10.1021/bi00348a030; Gilgunn S, 2013, NAT REV UROL, V10, P99, DOI 10.1038/nrurol.2012.258; Grauer LS, 1998, J ANDROL, V19, P407; Guo SH, 2014, BIOL CHEM, V395, P959, DOI 10.1515/hsz-2014-0140; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Herrala A, 1997, CLIN CHEM, V43, P279; HOWARD S C, 1991, Glycobiology, V1, P411, DOI 10.1093/glycob/1.4.411; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuzmanov U, 2012, PROTEOMICS, V12, P799, DOI 10.1002/pmic.201100371; Kuzmanov U, 2009, MOL CELL PROTEOMICS, V8, P791, DOI 10.1074/mcp.M800516-MCP200; Lebrilla CB, 2009, MOL BIOSYST, V5, P17, DOI 10.1039/b811781k; Lovgren J, 1999, EUR J BIOCHEM, V262, P781, DOI 10.1046/j.1432-1327.1999.00433.x; Lovgren J, 1999, J ANDROL, V20, P348; Lovgren J, 1999, EUR J BIOCHEM, V266, P1050, DOI 10.1046/j.1432-1327.1999.00946.x; Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martens L, 2005, BIOINFORMATICS, V21, P3584, DOI 10.1093/bioinformatics/bti588; Matsuda Y, 2002, ARCH ANDROLOGY, V48, P295, DOI 10.1080/01485010290031600; Meola J, 2006, GENET MOL BIOL, V29, P193, DOI 10.1590/S1415-47572006000200001; Mikolajczyk SD, 2000, UROLOGY, V55, P41, DOI 10.1016/S0090-4295(99)00372-6; Mikolajczyk SD, 1998, PROSTATE, V34, P44; Mikolajczyk SD, 1997, EUR J BIOCHEM, V246, P440, DOI 10.1111/j.1432-1033.1997.00440.x; O'Connor SE, 1998, CHEM BIOL, V5, P427, DOI 10.1016/S1074-5521(98)90159-4; OESTERLING JE, 1991, J UROLOGY, V145, P907, DOI 10.1016/S0022-5347(17)38491-4; Rajakoski K, 1997, PROSTATE CANCER P D, V1, P16, DOI 10.1038/sj.pcan.4500206; Raspi G, 1996, J CHROMATOGR B, V684, P265, DOI 10.1016/0378-4347(96)00144-2; Recker F, 1998, CANCER, V83, P2540, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2540::AID-CNCR20>3.0.CO;2-V; REIGMAN PHJ, 1989, BIOCHEM BIOPH RES CO, V159, P95, DOI 10.1016/0006-291X(89)92409-1; RIEGMAN PHJ, 1989, FEBS LETT, V247, P123, DOI 10.1016/0014-5793(89)81253-0; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; Ryslava H, 2013, J PROTEOMICS, V92, P80, DOI 10.1016/j.jprot.2013.03.025; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHEDLICH LJ, 1987, DNA-J MOLEC CELL BIO, V6, P429, DOI 10.1089/dna.1987.6.429; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2011, BIOL CHEM, V392, P1031, DOI 10.1515/BC.2011.158; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; Shang ZQ, 2014, TUMOR BIOL, V35, P1881, DOI 10.1007/s13277-013-1253-6; Skala W, 2014, J BIOL CHEM, V289, P34267, DOI 10.1074/jbc.M114.598201; Song HW, 2002, ARCH BIOCHEM BIOPHYS, V400, P1, DOI 10.1006/abbi.2001.2737; Stura EA, 2011, J MOL BIOL, V414, P530, DOI 10.1016/j.jmb.2011.10.007; Takayama TK, 1997, J BIOL CHEM, V272, P21582, DOI 10.1074/jbc.272.34.21582; Tang J, 2005, J BIOL CHEM, V280, P41077, DOI 10.1074/jbc.M506766200; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Tsiftsoglou SA, 2006, BBA-PROTEINS PROTEOM, V1764, P1757, DOI 10.1016/j.bbapap.2006.09.007; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166; White KY, 2009, J PROTEOME RES, V8, P620, DOI 10.1021/pr8007545; Williams SA, 2010, PROSTATE, V70, P788, DOI 10.1002/pros.21111; WITTWER AJ, 1989, BIOCHEMISTRY-US, V28, P7662, DOI 10.1021/bi00445a022; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; Yoon H, 2009, BIOL CHEM, V390, P373, DOI 10.1515/BC.2009.026; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	76	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					593	604		10.1074/jbc.M115.691097	http://dx.doi.org/10.1074/jbc.M115.691097			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582203	hybrid, Green Published			2022-12-26	WOS:000367830500008
J	Macdonald, PJ; Francy, CA; Stepanyants, N; Lehman, L; Baglio, A; Mears, JA; Qi, X; Ramachandran, R				Macdonald, Patrick J.; Francy, Christopher A.; Stepanyants, Natalia; Lehman, Lance; Baglio, Anthony; Mears, Jason A.; Qi, Xin; Ramachandran, Rajesh			Distinct Splice Variants of Dynamin-related Protein 1 Differentially Utilize Mitochondrial Fission Factor as an Effector of Cooperative GTPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; cardiolipin; fluorescence resonance energy transfer (FRET); GTPase; mitochondria; dynamin-related protein 1; isoforms; mitochondrial dynamics; mitochondrial fission factor	PLECKSTRIN HOMOLOGY DOMAIN; CONFORMATIONAL-CHANGES; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; DRP1 RECRUITMENT; MEMBRANE; MID51; MFF; CURVATURE; MID49	Multiple isoforms of the mitochondrial fission GTPase dynamin-related protein 1 (Drp1) arise from the alternative splicing of its single gene-encoded pre-mRNA transcript. Among these, the longer Drp1 isoforms, expressed selectively in neurons, bear unique polypeptide sequences within their GTPase and variable domains, known as the A-insert and the B-insert, respectively. Their functions remain unresolved. A comparison of the various biochemical and biophysical properties of the neuronally expressed isoforms with that of the ubiquitously expressed, and shortest, Drp1 isoform (Drp1-short) has revealed the effect of these inserts on Drp1 function. Utilizing various biochemical, biophysical, and cellular approaches, we find that the A- and B-inserts distinctly alter the oligomerization propensity of Drp1 in solution as well as the preferred curvature of helical Drp1 self-assembly on membranes. Consequently, these sequences also suppress Drp1 cooperative GTPase activity. Mitochondrial fission factor (Mff), a tail-anchored membrane protein of the mitochondrial outer membrane that recruits Drp1 to sites of ensuing fission, differentially stimulates the disparate Drp1 isoforms and alleviates the autoinhibitory effect imposed by these sequences on Drp1 function. Moreover, the differential stimulatory effects of Mff on Drp1 isoforms are dependent on the mitochondrial lipid, cardiolipin (CL). Although Mff stimulation of the intrinsically cooperative Drp1-short isoform is relatively modest, CL-independent, and even counter-productive at high CL concentrations, Mff stimulation of the much less cooperative longest Drp1 isoform (Drp1-long) is robust and occurs synergistically with increasing CL content. Thus, membrane-anchored Mff differentially regulates various Drp1 isoforms by functioning as an allosteric effector of cooperative GTPase activity.	[Macdonald, Patrick J.; Stepanyants, Natalia; Lehman, Lance; Baglio, Anthony; Qi, Xin; Ramachandran, Rajesh] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Francy, Christopher A.; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Francy, Christopher A.; Mears, Jason A.; Qi, Xin] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Francy, Christopher A.; Mears, Jason A.; Ramachandran, Rajesh] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Ramachandran, R (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	rxr275@case.edu	Qi, Xin/L-9279-2019; Ramachandran, Rajesh/A-1337-2011; Qi, Xin/D-1512-2013	Qi, Xin/0000-0002-9578-3890; Ramachandran, Rajesh/0000-0002-4645-2841; Qi, Xin/0000-0002-9578-3890; Mears, Jason/0000-0002-5199-4872; Macdonald, Patrick/0000-0002-4641-954X	American Heart Association (AHA) [13BGIA14810010]; AHA Scientist Development Grant [12SDG9130039]; National Institutes of Health R01 Grant [NS088192]; National Institutes of Health Training Grant [2T32GM008803-11A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088192] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); AHA Scientist Development Grant(American Heart Association); National Institutes of Health R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by American Heart Association (AHA) Beginning Grant-in-Aid (13BGIA14810010) (to R. R.). This work is also supported by the AHA Scientist Development Grant (12SDG9130039) (to J. A. M.), National Institutes of Health R01 Grant NS088192 (to X. Q.), and National Institutes of Health Training Grant 2T32GM008803-11A1 (to C. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Ceppi P, 2005, P NATL ACAD SCI USA, V102, P16269, DOI 10.1073/pnas.0508157102; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Clinton RW, 2016, J BIOL CHEM, V291, P478, DOI 10.1074/jbc.M115.680025; Francy CA, 2015, J BIOL CHEM, V290, P11692, DOI 10.1074/jbc.M114.610881; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Loson OC, 2014, STRUCTURE, V22, P367, DOI 10.1016/j.str.2014.01.001; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Mattila JP, 2015, NATURE, V524, P109, DOI 10.1038/nature14509; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mehrotra N, 2014, MOL BIOL CELL, V25, P879, DOI 10.1091/mbc.E13-09-0548; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873; Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; Reubold TF, 2015, NATURE, V525, P404, DOI 10.1038/nature14880; Richter V, 2015, CELL MOL LIFE SCI, V72, P3695, DOI 10.1007/s00018-015-1950-y; Richter V, 2014, J CELL BIOL, V204, P477, DOI 10.1083/jcb.201311014; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9136; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Uo T, 2009, EXP NEUROL, V218, P274, DOI 10.1016/j.expneurol.2009.05.010; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wenger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071835; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	54	59	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					493	507		10.1074/jbc.M115.680181	http://dx.doi.org/10.1074/jbc.M115.680181			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578513	hybrid, Green Published			2022-12-26	WOS:000367589500043
J	Benedeti, PD; da Silva, LG; de Paula, EM; Shenkoru, T; Marcondes, MI; Monteiro, HF; Amorati, B; Yeh, Y; Poulson, SR; Faciola, AP				Benedeti, Pedro Del Bianco; da Silva, Lorrayny Galoro; de Paula, Eduardo Marostegan; Shenkoru, Teshome; Marcondes, Marcos Inacio; Monteiro, Hugo Fernando; Amorati, Brad; Yeh, Yenling; Poulson, Simon Roger; Faciola, Antonio Pinheiro			Effects of Partial Replacement of Corn with Glycerin on Ruminal Fermentation in a Dual-Flow Continuous Culture System	PLOS ONE			English	Article							IN-VITRO FERMENTATION; VOLATILE FATTY-ACIDS; RUMEN FERMENTATION; CRUDE GLYCERIN; NUTRIENT DIGESTIBILITY; PURINE DERIVATIVES; BLOOD METABOLITES; FEEDING GLYCEROL; SOYBEAN-MEAL; DIETS	The objective of this study was to evaluate the effects of partially replacing dry ground corn with glycerin on ruminal fermentation using a dual-flow continuous culture system. Six fermenters (1,223 +/- 21 ml) were used in a replicated 3x3 Latin square arrangement with three periods of 10 d each, with 7 d for diet adaptation and 3 d for sample collections. All diets contained 75% concentrate and three dietary glycerin levels (0, 15, and 30% on dry matter basis), totaling six replicates per treatment. Fermenters were fed 72 g of dry matter/d equally divided in two meals/d, at 0800 and 2000 h. Solid and liquid dilution rates were adjusted daily to 5.5 and 11%/h, respectively. On d 8, 9, and 10, samples of 500 ml of solid and liquid digesta effluent were mixed, homogenized, and stored at -20 degrees C. Subsamples of 10 ml were collected and preserved with 0.2 mL of a 50% H2SO4 solution for later determination of NH3-N and volatile fatty acids. Microbial biomass was isolated from fermenters for chemical analysis at the end of each experimental period. Data were analyzed using the MIXED procedure in SAS with alpha = 0.05. Glycerin levels did not affect apparent digestibility of DM (P-Lin. = 0.13; P-Quad. = 0.40), OM (P-Lin. = 0.72; P-Quad. = 0.15), NDF (P-Lin. = 0.38; P-Quad. = 0.50) and ADF (P-Lin. = 0.91; P-Quad. = 0.18). Also, glycerin inclusion did not affect true digestibility of DM (P-Lin. = 0.35; P-Quad. = 0.48), and OM (P-Lin. = 0.08; P-Quad. = 0.19). Concentrations of propionate (P < 0.01) and total volatile fatty acids (P < 0.01) increased linearly and concentrations of acetate (P < 0.01), butyrate (P = 0.01), iso-valerate (P < 0.01), and total branched-chain volatile fatty acids, as well as the acetate: propionate ratio (P < 0.01) decreased with glycerin inclusion. Linear increases on NH3-N concentration in digesta effluent (P < 0.01) and on NH3-N flow (P < 0.01) were observed due to glycerin inclusion in the diets. Crude protein digestibility (P = 0.04) and microbial N flow (P = 0.04) were greater in the control treatment compared with the other treatments and responded quadratically with glycerin inclusion. Furthermore, the inclusion of glycerin linearly decreased (P = 0.02) non-ammonia N flow. Glycerin levels did not affect the flows of total N (P-Lin. = 0.79; P-Quad. = 0.35), and dietary N (P-Lin. = 0.99; P-Quad. = 0.07), as well as microbial efficiency (P-Lin. = 0.09; P-Quad. = 0.07). These results suggest that partially replacing dry ground corn with glycerin may change ruminal fermentation, by increasing total volatile fatty acids, and propionate concentration without affecting microbial efficiency, which may improve glucogenic potential of beef cattle diets.	[Benedeti, Pedro Del Bianco; da Silva, Lorrayny Galoro; de Paula, Eduardo Marostegan; Shenkoru, Teshome; Monteiro, Hugo Fernando; Amorati, Brad; Yeh, Yenling; Faciola, Antonio Pinheiro] Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA; [Benedeti, Pedro Del Bianco; Marcondes, Marcos Inacio] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Monteiro, Hugo Fernando] Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil; [Poulson, Simon Roger] Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Universidade Federal de Vicosa; Universidade Estadual de Maringa; Nevada System of Higher Education (NSHE); University of Nevada Reno	Faciola, AP (corresponding author), Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA.	afaciola@cabnr.unr.edu	Monteiro, Hugo/ADT-8240-2022; de Paula, Eduardo Marostegan/S-8509-2019; Faciola, Antonio/AAF-3865-2019; da Silva, Lorrayny Galoro/H-2312-2019; Faciola, Antonio/U-4800-2018; Del Bianco Benedeti, Pedro/C-3120-2016; Marcondes, Marcos/AAH-7553-2020	de Paula, Eduardo Marostegan/0000-0002-1891-6303; Faciola, Antonio/0000-0003-0935-6233; da Silva, Lorrayny Galoro/0000-0002-7843-1623; Faciola, Antonio/0000-0003-0935-6233; Del Bianco Benedeti, Pedro/0000-0003-2515-8974; Marcondes, Marcos/0000-0003-4843-2809	National Institute of Food and Agriculture (NIFA) [1003089]; Brazilian National Council for Scientific and Technological Development (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES)	National Institute of Food and Agriculture (NIFA); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the National Institute of Food and Agriculture (NIFA), Project number: 1003089, the Brazilian National Council for Scientific and Technological Development (CNPq), and Coordination for the Improvement of Higher Education Personnel (CAPES). The funding agencies had no role in the study design, data collection, and analyses, decision to publish, or preparation of the manuscript.	AOAC, 2007, OFFICIAL METHODS ANA, V18th; Avila JS, 2011, ANIM FEED SCI TECH, V166-67, P265, DOI 10.1016/j.anifeedsci.2011.04.016; Avila-Stagno J, 2014, BRIT J NUTR, V111, P829, DOI 10.1017/S0007114513003206; Bach A, 2008, J ANIM SCI, V86, P1364, DOI 10.2527/jas.2007-0736; Bargo F, 2003, J DAIRY SCI, V86, P1330, DOI 10.3168/jds.S0022-0302(03)73718-7; Barton L, 2013, LIVEST SCI, V155, P53, DOI 10.1016/j.livsci.2013.04.010; Benedeti PDB, 2014, LIVEST SCI, V165, P51, DOI 10.1016/j.livsci.2014.04.027; BERGMAN EN, 1968, AM J PHYSIOL, V215, P874; BERGNER H, 1995, ARCH ANIM NUTR, V48, P245, DOI 10.1080/17450399509381845; Calsamiglia S, 1996, J ANIM SCI, V74, P1375; CHANEY AL, 1962, CLIN CHEM, V8, P130; Chanjula P, 2014, ASIAN AUSTRAL J ANIM, V27, P365, DOI 10.5713/ajas.2013.13494; DAVIS CS, 1989, APPL STAT-J ROY ST C, V38, P535, DOI 10.2307/2347751; DeFrain JM, 2004, J DAIRY SCI, V87, P4195, DOI 10.3168/jds.S0022-0302(04)73564-X; DIJKSTRA J, 1994, LIVEST PROD SCI, V39, P61, DOI 10.1016/0301-6226(94)90154-6; DONKIN S., 2008, REV BRAS ZOOTECN, V37, P280, DOI DOI 10.1590/S1516-35982008001300032; El-Nor SA, 2010, ANIM FEED SCI TECH, V162, P99, DOI 10.1016/j.anifeedsci.2010.09.012; Fuentes MC, 2009, J DAIRY SCI, V92, P4456, DOI 10.3168/jds.2008-1722; GOETSCH AL, 1987, ANIM FEED SCI TECH, V18, P151, DOI 10.1016/0377-8401(87)90044-7; Griswold KE, 2003, J ANIM SCI, V81, P329; Hales KE, 2013, J ANIM SCI, V91, P4277, DOI 10.2527/jas.2013-6341; HOOVER WH, 1976, J ANIM SCI, V43, P528, DOI 10.2527/jas1976.432528x; Kijora C, 1998, ARCH ANIM NUTR, V51, P341, DOI 10.1080/17450399809381931; Krueger NA, 2010, BIORESOURCE TECHNOL, V101, P8469, DOI 10.1016/j.biortech.2010.06.010; Mach N, 2009, J ANIM SCI, V87, P632, DOI 10.2527/jas.2008-0987; NRC (National Research Council), 2000, NUTR REQ BEEF CATTL, DOI DOI 10.17226/19014; Owens F.N., 1988, RUMINANT ANIMAL DIGE, P145; Ramos MH, 2012, J ANIM SCI, V90, P892, DOI 10.2527/jas.2011-4099; REMOND B, 1993, ANIM FEED SCI TECH, V41, P121, DOI 10.1016/0377-8401(93)90118-4; Rico DE, 2012, J DAIRY SCI, V95, P3310, DOI 10.3168/jds.2011-5059; Schoonmaker JP, 2004, J ANIM SCI, V82, P137; Schroder A., 1999, INT RAP C GOSF REG I, P241; Shin JH, 2012, J DAIRY SCI, V95, P4006, DOI 10.3168/jds.2011-5121; SMITH SB, 1984, J NUTR, V114, P792, DOI 10.1093/jn/114.4.792; Soder KJ, 2013, J DAIRY SCI, V96, P3228, DOI 10.3168/jds.2012-6307; Stewart CS., 1997, RUMEN MICROBIAL ECOS, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2]; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Versemann B.A., 2008, J ANIM SCI, V86, P478; Wanapat M, 1999, ASIAN AUSTRAL J ANIM, V12, P904, DOI 10.5713/ajas.1999.904; Wang C, 2009, LIVEST SCI, V121, P15, DOI 10.1016/j.livsci.2008.05.010; WELLER RA, 1974, BRIT J NUTR, V32, P341, DOI 10.1079/BJN19740087; Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C; WINDSCHITL PM, 1988, J ANIM SCI, V66, P2948	44	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143201	10.1371/journal.pone.0143201	http://dx.doi.org/10.1371/journal.pone.0143201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599015	gold, Green Published, Green Submitted			2022-12-26	WOS:000365853900076
J	Burbelo, PD; Klimavicz, JS; Deeks, SG; Kovacs, JA; Ragheb, JA				Burbelo, Peter D.; Klimavicz, James S.; Deeks, Steve G.; Kovacs, Joseph A.; Ragheb, Jack A.			Lack of Evidence for Molecular Mimicry in HIV-Infected Subjects	PLOS ONE			English	Article							LUCIFERASE IMMUNOPRECIPITATION SYSTEMS; COMMON IMMUNOLOGICAL EPITOPE; ANTIERYTHROPOIETIN ANTIBODIES; POSITIVE INDIVIDUALS; AUTOIMMUNE-DISEASE; AUTOANTIBODIES; IMMUNODEFICIENCY; ANEMIA; QUANTIFICATION; ERYTHROPOIETIN	Previous studies in HIV patients have reported autoantibodies to several human proteins, including erythropoietin (EPO), interferon-alpha (IFN-alpha), interleukin-2 (IL-2), and HLA-DR, as potential mediators of anemia or immunosuppression. The etiology of these autoantibodies has been attributed to molecular mimicry between HIV epitopes and self-proteins. Here, the Luciferase Immunoprecipitation System (LIPS) was used to investigate the presence of such autoantibodies in HIV-infected adults. High levels of antibodies to HIV proteins such as capsid (p24), matrix (p17), envelope (gp41), and reverse transcriptase (RT) were detected using LIPS in both untreated and anti-retroviral-treated HIV-infected individuals but not in uninfected controls. LIPS readily detected anti-EPO autoantibodies in serum samples from subjects with presumptive pure red cell aplasia but not in any of the samples from HIV-infected or uninfected individuals. Similarly, subjects with HIV lacked autoantibodies to IFN-alpha, IL-2, HLA-DR and the immunoglobulin lambda light chain; all purported targets of molecular mimicry. While molecular mimicry between pathogen proteins and self-proteins is a commonly proposed mechanism for autoantibody production, the findings presented here indicate such a process is not common in HIV disease.	[Burbelo, Peter D.; Klimavicz, James S.] Natl Inst Dent & Craniofacial Res, Dent Clin Res Core, NIH, Bethesda, MD 20892 USA; [Deeks, Steve G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kovacs, Joseph A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Ragheb, Jack A.] US FDA, Off Biol Prod, OPQ, CDER, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); US Food & Drug Administration (FDA)	Burbelo, PD (corresponding author), Natl Inst Dent & Craniofacial Res, Dent Clin Res Core, NIH, Bethesda, MD 20892 USA.	burbelop@nidcr.nih.gov	Kovacs, Joseph/AAU-6105-2021	Kovacs, Joseph/0000-0002-5191-9880; Deeks, Steven/0000-0001-6371-747X; Klimavicz, James/0000-0002-3439-1906	Divisions of Intramural Research, National Institute of Dental and Craniofacial Research; NIH Clinical Center; CDER, Food and Drug Administration, Foundation for AIDS Research (amFAR); Delaney AIDS Research Enterprise (DARE) [U19AI096109]; UCSF/Gladstone Institute of Virology & Immunology CFAR [P30 AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U19AI096109] Funding Source: NIH RePORTER	Divisions of Intramural Research, National Institute of Dental and Craniofacial Research; NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); CDER, Food and Drug Administration, Foundation for AIDS Research (amFAR); Delaney AIDS Research Enterprise (DARE); UCSF/Gladstone Institute of Virology & Immunology CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Divisions of Intramural Research, National Institute of Dental and Craniofacial Research, the NIH Clinical Center, and the CDER, Food and Drug Administration, Foundation for AIDS Research (amFAR), the Delaney AIDS Research Enterprise (DARE, U19AI096109), the UCSF/Gladstone Institute of Virology & Immunology CFAR (P30 AI027763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atassi MZ, 2008, AUTOIMMUNITY, V41, P123, DOI 10.1080/08916930801929021; BOST KL, 1988, IMMUNOLOGY, V65, P611; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Burbelo PD, 2007, BIOCHEM BIOPH RES CO, V352, P889, DOI 10.1016/j.bbrc.2006.11.140; Burbelo PD, 2015, TRANSL RES, V165, P325, DOI 10.1016/j.trsl.2014.08.006; Burbelo PD, 2014, J INFECT DIS, V209, P1613, DOI 10.1093/infdis/jit667; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Chen YH, 1997, IMMUNOL LETT, V55, P15, DOI 10.1016/S0165-2478(96)02644-2; Chen YH, 1997, MOL IMMUNOL, V34, P1259, DOI 10.1016/S0161-5890(98)00011-X; Ching KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032001; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; GOLDING H, 1989, J CLIN INVEST, V83, P1430, DOI 10.1172/JCI114034; Hoesel W, 2004, J IMMUNOL METHODS, V294, P101, DOI 10.1016/j.jim.2004.08.017; Liu E, 2007, CLIN IMMUNOL, V125, P120, DOI 10.1016/j.clim.2007.08.005; Maksyutov A. Z., 2002, Molekulyarnaya Biologiya (Moscow), V36, P447; Mendoza D, 2012, BLOOD, V119, P4645, DOI 10.1182/blood-2011-10-381996; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Rose NR, 2000, CELL MOL LIFE SCI, V57, P542, DOI 10.1007/PL00000716; Sheikh V, 2014, AIDS, V28, P31, DOI 10.1097/QAD.0000000000000006; SILVESTRIS F, 1995, CLIN IMMUNOL IMMUNOP, V75, P197, DOI 10.1006/clin.1995.1072; Sipsas NV, 1999, J INFECT DIS, V180, P2044, DOI 10.1086/315156; SLOAND EM, 1991, JAMA-J AM MED ASSOC, V266, P2861, DOI 10.1001/jama.266.20.2861; Tacey R, 2003, J IMMUNOL METHODS, V283, P317, DOI 10.1016/j.jim.2003.09.003; Tsiakalos A, 2011, J INFECT DIS, V204, P902, DOI 10.1093/infdis/jir433; Tsiakalos A, 2010, J INFECTION, V60, P238, DOI 10.1016/j.jinf.2009.12.013; Tzioufas AG, 1997, ARTHRITIS RHEUM-US, V40, P2212, DOI 10.1002/art.1780401216; Wu G, 2004, AM J KIDNEY DIS, V44, P264, DOI 10.1053/j.ajkd.2004.04.031; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zandman-Goddard Gisele, 2002, Autoimmunity Reviews, V1, P329, DOI 10.1016/S1568-9972(02)00086-1	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0127662	10.1371/journal.pone.0127662	http://dx.doi.org/10.1371/journal.pone.0127662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599070	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900001
J	Davin, A; Monti, MC; Polito, L; Vaccaro, R; Abbondanza, S; Gnesi, M; Villani, S; Guaita, A				Davin, Annalisa; Monti, Maria Cristina; Polito, Letizia; Vaccaro, Roberta; Abbondanza, Simona; Gnesi, Marco; Villani, Simona; Guaita, Antonio			Influence of Serotonin Transporter Gene Polymorphisms and Adverse Life Events on Depressive Symptoms in the Elderly: A Population-Based Study	PLOS ONE			English	Article							5-HTTLPR POLYMORPHISM; AFFECTIVE-DISORDERS; MAJOR DEPRESSION; AGE-DIFFERENCES; OLDER-ADULTS; ASSOCIATION; SUSCEPTIBILITY; DEMENTIA; ONSET; METAANALYSIS	Background Depression is common in the elderly. The role of genetic and environmental factors in modulating depressive symptoms is not clear. Methods We evaluated the influence of serotonin transporter gene polymorphisms and recent adverse life events on depressive symptoms in an elderly Italian population. We used data from "InveCe.Ab", a population-based study of 1321 subjects aged 70-74 years. We used the 15-item Geriatric Depression Scale (GDS) to assess depressive symptoms-a GDS score >= 5 points (GDS >= 5) indicated the presence of clinically relevant symptoms-and performed 5-HTTLPR and rs25531 genotyping to obtain the triallelic polymorphism of the serotonin transporter. We used the Geriatric Adverse Life Events Scale to measure adverse life events, and logistic regression models to evaluate the role of genotype and recent adverse life events in depressive symptoms, controlling for potential confounders and independent predictors. Results Two hundred subjects (15.76%) had a GDS >= 5. The 5-HTTLPR triallelic polymorphism was significantly associated with GDS >= 5. Only S'S' carriers showed an increased risk of depressive symptoms (ORadj = 1.81, p = .022); one extra adverse life event increased this risk by 14%(p = .061) independently of genotype. Other factors significantly related to GDS >= 5 were: female gender (ORadj = 2.49, p < .001), age (ORadj = 1.19, p = .007), a history of depression (ORadj = 4.73, p < .001), and comorbidity (ORadj = 1.23, p = .001). One extra adverse life event increased the risk of depressive symptoms by 57%(p = .005) only in the L'L' carriers, while antidepressant intake was directly related to GDS >= 5 in the L'S' carriers (ORadj = 2.46, p = .036) and borderline significant in the S'S' carriers (ORadj = 2.41, p = .081). Discussion The S'S' genotype and recent exposure to adverse life events were independently associated with depressive symptoms. The S'S' genotype, compared with the environment, exerted a predominant effect on depressive symptoms, suggesting that it reduces the efficacy of antidepressant therapy. We conclude that genetics may be an important risk factor for depressive symptoms in late adulthood.	[Davin, Annalisa; Polito, Letizia; Vaccaro, Roberta; Abbondanza, Simona; Guaita, Antonio] Golgi Cenci Fdn, Abbiategrasso, Italy; [Monti, Maria Cristina; Gnesi, Marco; Villani, Simona] Univ Pavia, Dept Publ Hlth Expt & Forens Med, Sect Biostat & Clin Epidemiol, I-27100 Pavia, Italy; [Vaccaro, Roberta] C Golgi Geriatr Inst, Abbiategrasso, Italy	University of Pavia	Davin, A (corresponding author), Golgi Cenci Fdn, Abbiategrasso, Italy.	a.davin@golgicenci.it	Davin, Annalisa/AAB-8602-2022; Guaita, Antonio/Q-1787-2019; Vaccaro, Roberta/AAK-8117-2020	Davin, Annalisa/0000-0002-5597-7586; Guaita, Antonio/0000-0003-3954-5932; Gnesi, Marco/0000-0001-6022-6325; /0000-0003-2517-6515; Abbondanza, Simona/0000-0002-6042-7298; Monti, Maria Cristina/0000-0003-1586-527X				Aldwin CM, 1996, J GERONTOL B-PSYCHOL, V51, pP179, DOI 10.1093/geronb/51B.4.P179; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; [Anonymous], 2007, DSM 4 T MANUALE DIAG; Bjorklof GH, 2013, DEMENT GERIATR COGN, V35, P121, DOI 10.1159/000346633; Blazer DG, 2005, PSYCHOL MED, V35, P1241, DOI 10.1017/S0033291705004411; Bogdan R, 2014, J CHILD PSYCHOL PSYC, V55, P448, DOI 10.1111/jcpp.12142; Brown SM, 2006, COGN AFFECT BEHAV NE, V6, P44, DOI 10.3758/CABN.6.1.44; Buber I, 2011, COMP POPUL STUD, V36, P103, DOI 10.4232/10.CPoS-2011-02en; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Cho HJ, 2005, MOL PSYCHIATR, V10, P771, DOI 10.1038/sj.mp.4001663; Choi S, 2014, PSYCHIAT Q; Chou KL, 2008, J AFFECT DISORDERS, V106, P191, DOI 10.1016/j.jad.2007.05.028; Cicirelli VG, 2009, J GERONTOL B-PSYCHOL, V64, P24, DOI 10.1093/geronb/gbn024; Cohen-Woods S, 2013, PSYCHOL MED, V43, P673, DOI 10.1017/S0033291712001286; Cole MG, 2008, AM J GERIAT PSYCHIAT, V16, P435, DOI 10.1097/JGP.0b013e318162f174; CONWELL Y, 1993, J AM GERIATR SOC, V41, P38, DOI 10.1111/j.1532-5415.1993.tb05945.x; Costafreda SG, 2013, J AFFECT DISORDERS, V150, P96, DOI 10.1016/j.jad.2013.02.028; de Craen AJM, 2003, INT J GERIATR PSYCH, V18, P63, DOI 10.1002/gps.773; Devanand DP, 2002, AM J GERIAT PSYCHIAT, V10, P265; Diniz BS, 2014, DEPRESS ANXIETY, V31, P787, DOI 10.1002/da.22226; Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Fabbri C, 2014, CAN J PSYCHIAT, V59, P62, DOI 10.1177/070674371405900202; Favaro A, 2014, PSYCHIAT RES-NEUROIM, V223, P157, DOI 10.1016/j.pscychresns.2014.05.006; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Furlong RA, 1998, AM J MED GENET, V81, P58, DOI 10.1002/(SICI)1096-8628(19980207)81:1<58::AID-AJMG11>3.0.CO;2-V; Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555; Guaita A, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-98; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Heils A, 1996, J NEUROCHEM, V66, P2621; Hoehe MR, 1998, AM J MED GENET, V81, P1, DOI 10.1002/(SICI)1096-8628(19980207)81:1<1::AID-AJMG1>3.0.CO;2-2; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Janzing JGE, 2002, INT J GERIATR PSYCH, V17, P1, DOI 10.1002/gps.526; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Knight BG, 2007, AGING MENT HEALTH, V11, P538, DOI 10.1080/13607860601086561; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Luijendijk HJ, 2008, ARCH GEN PSYCHIAT, V65, P1394, DOI 10.1001/archpsyc.65.12.1394; Luppa M, 2012, J AFFECT DISORDERS, V136, P212, DOI 10.1016/j.jad.2010.11.033; Luppa M, 2013, INT PSYCHOGERIATR, V25, P292, DOI 10.1017/S1041610212001688; Mast BT, 2008, BIOL PSYCHIAT, V64, P320, DOI 10.1016/j.biopsych.2008.01.025; Mazure CM, 2002, AM J GERIAT PSYCHIAT, V10, P297, DOI 10.1176/appi.ajgp.10.3.297; McHugh RK, 2010, DRUG ALCOHOL DEPEN, V108, P1, DOI 10.1016/j.drugalcdep.2009.11.017; Mendlewicz J, 2004, EUR J HUM GENET, V12, P377, DOI 10.1038/sj.ejhg.5201149; Mezuk B, 2012, INT J GERIATR PSYCH, V27, P879, DOI 10.1002/gps.2807; Narasimhan S, 2012, PHARMACOGENOMICS, V13, P441, DOI [10.2217/PGS.12.1, 10.2217/pgs.12.1]; Nolen-Hoeksema S, 2002, PSYCHOL AGING, V17, P116, DOI 10.1037//0882-7974.17.1.116; Ornstein K, 2014, INT J AGING HUM DEV, V78, P133, DOI 10.2190/AG.78.2.c; Parker GB, 2015, J AFFECT DISORDERS, V182, P91, DOI 10.1016/j.jad.2015.04.041; Peerenboom L, 2015, J AFFECT DISORDERS, V182, P26, DOI 10.1016/j.jad.2015.04.033; Polito L, 2015, J SLEEP RES, V24, P215, DOI 10.1111/jsr.12248; Power T, 2010, NEUROBIOL AGING, V31, P886, DOI 10.1016/j.neurobiolaging.2008.06.006; Regan CO, 2013, INT J GERIATR PSYCH, V28, P1280, DOI 10.1002/gps.3955; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Schwarzbach M, 2014, INT J GERIATR PSYCH, V29, P1, DOI 10.1002/gps.3971; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Starkstein SE, 2008, INT REV PSYCHIATR, V20, P382, DOI 10.1080/09540260802094480; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014; Wancata J, 2006, ACTA PSYCHIAT SCAND, V114, P398, DOI 10.1111/j.1600-0447.2006.00888.x; Way BM, 2010, PSYCHOSOM MED, V72, P107, DOI 10.1097/PSY.0b013e3181ce6a7d; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Whitbourne S., 2011, HDB PSYCHOL AGING, P311, DOI [DOI 10.1016/B978-0-12-380882-0.00020-6, 10.1016/B978-0-12-380882-0.00020-6]; Yan XY, 2011, J INT MED RES, V39, P1142, DOI 10.1177/147323001103900402; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588	70	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143395	10.1371/journal.pone.0143395	http://dx.doi.org/10.1371/journal.pone.0143395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26598970	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900107
J	Wibaux, A; Thota, P; Mastej, J; Prince, DL; Carty, N; Johnson, P				Wibaux, Anne; Thota, Priyaleela; Mastej, Jozef; Prince, Daniel L.; Carty, Neal; Johnson, Peter			Antimicrobial Activity of a Novel Vascular Access Film Dressing Containing Chlorhexidine Gluconate	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CATHETER-RELATED INFECTIONS; BLOOD-STREAM INFECTIONS; PREVENTION; SKIN; COLONIZATION; HOSPITALS; ADHESIVE; DEVICES; ADULTS	Background Covering insertion sites with chlorhexidine impregnated dressings has been proven to be clinically effective in reducing catheter related blood stream infections (CR-BSI). Two chlorhexidine gluconate (CHG)-impregnated dressings are commercially available, a polyurethane foam disk and a film dressing containing a chlorhexidine gluconate-impregnated gel pad. While both have demonstrated efficacy in clinical settings, the major drawback of high cost and impaired IV insertion site visibility limits their usage. A new, simple film dressing containing CHG within its adhesive layer is now available. The objective of this study was to test the in vitro antimicrobial efficacy of the new dressing in comparison to the CHG-impregnated gel dressing. Methods Quantitative aliquots of suspensions (concentration of 1.0x10(6) to 5.0x10(6) cfu/sample) of clinically relevant challenge organisms (Staphylococcus species, gram-negative bacilli, Candida albicans) were incubated in contact with the new CHG-containing film dressing, a placebo version of the same (negative control) and the commercially available CHG-impregnated gel dressing (positive control). Serial dilutions of the surviving organisms were quantified using the pour plate after 1, 3, 5, and 7 days of incubation in order to calculate an antimicrobial log(10) reduction for each organism/dressing combination at each point in time. Results The new CHG-containing film dressing delivered greater than 5.0 log(10) reduction throughout the 7 days on all aerobic gram-negative bacilli and Staphylococcus species tested. As of day 1 the CHG-containing film dressing provided greater than 5.0 log(10) reduction on Candida albicans. There were no statistically significant differences in the log10 reduction between the two dressings tested. Conclusion The new CHG-containing film dressing was found to be as effective as the chlorhexidine gluconate-impregnated gel dressing on clinically relevant microbes.	[Wibaux, Anne; Thota, Priyaleela; Carty, Neal; Johnson, Peter] Vanc Med Technol, Chicago, IL 60606 USA; [Mastej, Jozef; Prince, Daniel L.] Gibraltar Labs Inc, Fairfield, NJ 07004 USA		Wibaux, A (corresponding author), Vanc Med Technol, 20 N Wacker Dr,Suite 2240, Chicago, IL 60606 USA.	anne.wibaux@averydennison.com		Carty, Neal/0000-0003-1329-4506	Vancive Medical TechnologiesTM, an Avery Dennison business	Vancive Medical TechnologiesTM, an Avery Dennison business	This work was supported by Vancive Medical TechnologiesTM, an Avery Dennison business. The funders had a role in study design, data analysis, decision to publish, and preparation of the manuscript. The funders had no role in the data collection.	Bashir MH, 2012, AM J INFECT CONTROL, V40, P344, DOI 10.1016/j.ajic.2011.03.030; Carty N, 2014, J ANTIMICROB CHEMOTH, V69, P2224, DOI 10.1093/jac/dku096; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Davies Julian, 2006, Can J Infect Dis Med Microbiol, V17, P287; Denton GW, 2001, DISINFECTION STERILI, P321; Exline MC, 2013, CRIT CARE, V17, DOI 10.1186/cc12551; Garland JS, 2001, PEDIATRICS, V107, P1431, DOI 10.1542/peds.107.6.1431; Karpanen TJ, 2011, J ANTIMICROB CHEMOTH, V66, P1777, DOI 10.1093/jac/dkr191; Kaye KS, 2008, CLIN INFECT DIS, V46, P1568, DOI 10.1086/587673; Levy I, 2005, PEDIATR INFECT DIS J, V24, P676, DOI 10.1097/01.inf.0000172934.98865.14; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mann TJ, 2001, ANAESTH INTENS CARE, V29, P600, DOI 10.1177/0310057X0102900606; Marchaim D, 2010, CLIN MICROBIOL INFEC, V16, P747, DOI 10.1111/j.1469-0691.2009.02934.x; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Palmore TN, 2013, CLIN INFECT DIS, V57, P1593, DOI 10.1093/cid/cit531; Poole M D, 1993, Ear Nose Throat J, V72, P433; Popovich KJ, 2012, INFECT CONT HOSP EP, V33, P889, DOI 10.1086/667371; Pujol M, 2007, J HOSP INFECT, V67, P22, DOI 10.1016/j.jhin.2007.06.017; Safdar N, 2014, CRIT CARE MED, V42, P1703, DOI 10.1097/CCM.0000000000000319; Shah H, 2013, NEUROHOSPITALIST, V3, P144, DOI 10.1177/1941874413476043; Tattevin P, 2012, CLIN INFECT DIS, V55, P781, DOI 10.1093/cid/cis527; Timsit JF, 2012, AM J RESP CRIT CARE, V186, P1272, DOI 10.1164/rccm.201206-1038OC; Timsit JF, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-34; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Ye X, 2011, AM J INFECT CONTROL, V39, P647, DOI 10.1016/j.ajic.2010.11.008; Zingg Walter, 2009, Int J Antimicrob Agents, V34 Suppl 4, pS38, DOI 10.1016/S0924-8579(09)70565-5	27	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143035	10.1371/journal.pone.0143035	http://dx.doi.org/10.1371/journal.pone.0143035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599087	Green Submitted, Green Published, gold			2022-12-26	WOS:000365853900059
J	Duque-Afonso, J; Smith, KS; Cleary, ML				Duque-Afonso, Jesus; Smith, Kevin S.; Cleary, Michael L.			Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice	PLOS ONE			English	Article							ACUTE-LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR; LEUCINE-ZIPPER; TRANSACTIVATION DOMAINS; ANTIAPOPTOTIC ACTIVITY; GENE; E2A; TRANSFORMATION; APOPTOSIS; FUSION	Chromosomal translocations are driver mutations of human cancers, particularly leukemias. They define disease subtypes and are used as prognostic markers, for minimal residual disease monitoring and therapeutic targets. Due to their low incidence, several translocations and their biological consequences remain poorly characterized. To address this, we engineered mouse strains that conditionally express E2A-HLF, a fusion oncogene from the translocation t(17; 19) associated with 1% of pediatric B-cell precursor ALL. Conditional oncogene activation and expression were directed to the B-cell compartment by the Cre driver promoters CD19 or Mb1 (Iga, CD79a), or to the hematopoietic stem cell compartment by the Mx1 promoter. E2A-HLF expression in B-cell progenitors induced hyposplenia and lymphopenia, whereas expression in hematopoietic stem/progenitor cells was embryonic lethal. Increased cell death was detected in E2A-HLF expressing cells, suggesting the need for cooperating genetic events that suppress cell death for B-cell oncogenic transformation. E2A-HLF/Mb1. Cre aged mice developed a fatal myeloproliferative-like disorder with low frequency characterized by leukocytosis, anemia, hepatosplenomegaly and organ-infiltration by mature myelocytes. In conclusion, we have developed conditional E2A-HLF knock-in mice, which provide an experimental platform to study cooperating genetic events and further elucidate translational biology in cross-species comparative studies.	[Duque-Afonso, Jesus; Smith, Kevin S.; Cleary, Michael L.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Cleary, ML (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	mcleary@stanford.edu			German Research Foundation (Deutsche Forschungsgemeinschaft) [DU 1287/2-1]; Lucile Packard Foundation for Children's Health; Child Health Research Institute; Stanford NIH-NCATS-CTSA [UL1 TR001085]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Lucile Packard Foundation for Children's Health; Child Health Research Institute; Stanford NIH-NCATS-CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding: JDA was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, ref. DU 1287/2-1). MLC was supported by the Lucile Packard Foundation for Children's Health, the Child Health Research Institute and the Stanford NIH-NCATS-CTSA grant #UL1 TR001085. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altura RA, 1998, BLOOD, V92, P1397, DOI 10.1182/blood.V92.4.1397.416k19_1397_1405; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; DEDERA DA, 1993, CELL, V74, P833, DOI 10.1016/0092-8674(93)90463-Z; Duque-Afonso J, 2015, J CLIN INVEST, V125, P3667, DOI 10.1172/JCI81158; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; Hirose K, 2010, BLOOD, V116, P962, DOI 10.1182/blood-2009-09-244673; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Honda H, 1999, BLOOD, V93, P2780; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; HUNGER SP, 1994, BLOOD, V83, P2970, DOI 10.1182/blood.V83.10.2970.2970; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Inaba T, 1996, NATURE, V382, P541, DOI 10.1038/382541a0; INABA T, 1994, MOL CELL BIOL, V14, P3403, DOI 10.1128/MCB.14.5.3403; Inukai T, 2007, LEUKEMIA, V21, P288, DOI 10.1038/sj.leu.2404496; Inukai T, 1998, MOL CELL BIOL, V18, P6035, DOI 10.1128/MCB.18.10.6035; Inukai T, 2005, BLOOD, V105, P4437, DOI 10.1182/blood-2004-08-2976; Inukai T, 1999, MOL CELL, V4, P343, DOI 10.1016/S1097-2765(00)80336-6; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; Okuya M, 2010, J BIOL CHEM, V285, P1850, DOI 10.1074/jbc.M109.023762; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; RAIMONDI SC, 1991, BLOOD, V77, P2016; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Roberts KG, 2015, NAT REV CLIN ONCOL, V12, P344, DOI 10.1038/nrclinonc.2015.38; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seidel MG, 2001, ONCOGENE, V20, P5718, DOI 10.1038/sj.onc.1204591; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith KS, 2002, MOL CELL BIOL, V22, P7678, DOI 10.1128/MCB.22.21.7678-7688.2002; Smith KS, 1999, MOL CELL BIOL, V19, P4443; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Yamasaki N, 2010, ONCOGENE, V29, P1963, DOI 10.1038/onc.2009.475; YOSHIHARA T, 1995, MOL CELL BIOL, V15, P3247; Zhang X, 2012, LEUKEMIA, V26, P2483, DOI 10.1038/leu.2012.139; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	44	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143216	10.1371/journal.pone.0143216	http://dx.doi.org/10.1371/journal.pone.0143216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588248	Green Submitted, gold, Green Published			2022-12-26	WOS:000365251500039
J	Zheng, J; Hu, ZH; Guan, XL; Dou, DQ; Bai, G; Wang, Y; Guo, YT; Li, W; Leng, PS				Zheng, Jian; Hu, Zenghui; Guan, Xuelian; Dou, Dequan; Bai, Guo; Wang, Yu; Guo, Yingtian; Li, Wei; Leng, Pingsheng			Transcriptome Analysis of Syringa oblata Lindl. Inflorescence Identifies Genes Associated with Pigment Biosynthesis and Scent Metabolism	PLOS ONE			English	Article							EXPRESSION ANALYSIS; CHALCONE SYNTHASE; FLORAL SCENT; ANTHOCYANIN BIOSYNTHESIS; DIFFERENTIAL EXPRESSION; TEMPORAL EXPRESSION; GENOME ANNOTATION; RNA-SEQ; ARABIDOPSIS; R2R3-MYB	Syringa oblata Lindl. is a woody ornamental plant with high economic value and characteristics that include early flowering, multiple flower colors, and strong fragrance. Despite a long history of cultivation, the genetics and molecular biology of S. oblata are poorly understood. Transcriptome and expression profiling data are needed to identify genes and to better understand the biological mechanisms of floral pigments and scents in this species. Nine cDNA libraries were obtained from three replicates of three developmental stages: inflorescence with enlarged flower buds not protruded, inflorescence with corolla lobes not displayed, and inflorescence with flowers fully opened and emitting strong fragrance. Using the Illumina RNA-Seq technique, 319,425,972 clean reads were obtained and were assembled into 104,691 final unigenes (average length of 853 bp), 41.75% of which were annotated in the NCBI non-redundant protein database. Among the annotated unigenes, 36,967 were assigned to gene ontology categories and 19,956 were assigned to eukaryoticorthologous groups. Using the Kyoto Encyclopedia of Genes and Genomes pathway database, 12,388 unigenes were sorted into 286 pathways. Based on these transcriptomic data, we obtained a large number of candidate genes that were differentially expressed at different flower stages and that were related to floral pigment biosynthesis and fragrance metabolism. This comprehensive transcriptomic analysis provides fundamental information on the genes and pathways involved in flower secondary metabolism and development in S. oblata, providing a useful database for further research on S. oblata and other plants of genus Syringa.	[Zheng, Jian; Hu, Zenghui; Guan, Xuelian; Dou, Dequan; Bai, Guo; Wang, Yu; Guo, Yingtian; Leng, Pingsheng] Beijing Agr Univ, Coll Landscape Architecture, Beijing 102206, Peoples R China; [Zheng, Jian] Beijing Engn Res Ctr Rural Landscape Planning & D, Beijing 102206, Peoples R China; [Li, Wei] Qingdao Agr Univ, Coll Landscape Architecture & Forestry, Qingdao 266100, Peoples R China	Beijing University of Agriculture; Qingdao Agricultural University	Leng, PS (corresponding author), Beijing Agr Univ, Coll Landscape Architecture, Beijing 102206, Peoples R China.	zhengjian770116@163.com	Guo, Yingtian/GLT-2017-2022		Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD20154043]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality [CITIDHT20150503]; Building Project of Beijing Laboratory of Urban and Rural Ecological Environment [PXM2015-014207-000014]	Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality; Building Project of Beijing Laboratory of Urban and Rural Ecological Environment	Funding: Funding was provided by The Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT& The Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (CIT& The Building Project of Beijing Laboratory of Urban and Rural Ecological Environment (PXM2015-014207-000014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Ben Zvi MM, 2008, PLANT BIOTECHNOL J, V6, P403, DOI 10.1111/j.1467-7652.2008.00329.x; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Cardoso S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046021; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; [崔洪霞 Cui Hongxia], 2004, [植物研究, Bulletin of Botanical Research], V24, P141; Deng MingHua, 2012, African Journal of Biotechnology, V11, P2389; Dudareva N, 1996, PLANT CELL, V8, P1137, DOI 10.1105/tpc.8.7.1137; Dudareva N, 2003, PLANT CELL, V15, P1227, DOI 10.1105/tpc.011015; Elomaa P, 2003, PLANT PHYSIOL, V133, P1831, DOI 10.1104/pp.103.026039; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Feng LG, 2014, PLANT PHYSIOL BIOCH, V75, P80, DOI 10.1016/j.plaphy.2013.12.006; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ge XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087693; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Guitton Y, 2010, PHYSIOL PLANTARUM, V138, P150, DOI 10.1111/j.1399-3054.2009.01315.x; Hao RJ, 2014, BIOCHEM SYST ECOL, V54, P23, DOI 10.1016/j.bse.2013.12.007; Hatayama M, 2006, PLANT BIOTECHNOL, V23, P273; Hendel-Rahmanim K, 2007, PLANTA, V226, P1491, DOI 10.1007/s00425-007-0582-3; Hu K, 2010, THESIS, P63; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; [回瑞华 Hui Ruihua], 2002, [质谱学报, Journal of Chinese Mass Spectrometry Society], V23, P210; Iwashina Tsukasa, 2001, Journal of Japanese Botany, V76, P166; [黄金霞 Jinxia Huang], 2006, [植物学通报, Chinese Bulletin of Botany], V23, P321; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kunu W., 2012, African Journal of Biotechnology, V11, P12702; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085480; Li ZuGuang, 2006, Journal of Zhejiang Forestry College, V23, P159; Liu DF, 2013, PLOS ONE, V9; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muhlemann JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040381; Nagegowda DA, 2010, FEBS LETT, V584, P2965, DOI 10.1016/j.febslet.2010.05.045; Nakatsuka A, 2003, PLANT SCI, V165, P759, DOI 10.1016/S0168-9452(03)00254-1; Nakatsuka T, 2005, PLANT SCI, V168, P1309, DOI 10.1016/j.plantsci.2005.01.009; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ogata J., 2004, PLANT BIOTECHNOL, V21, P367, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.21.367; Pelletier MK, 1996, PLANT PHYSIOL, V111, P339, DOI 10.1104/pp.111.1.339; Pelletier MK, 1997, PLANT PHYSIOL, V113, P1437, DOI 10.1104/pp.113.4.1437; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Spitzer-Rimon B, 2012, PLANT CELL, V24, P5089, DOI 10.1105/tpc.112.105247; Spitzer-Rimon B, 2010, PLANT CELL, V22, P1961, DOI 10.1105/tpc.109.067280; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Svenson SE, 2014, AM NURSERYMAN, V214, P38; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Togami J, 2011, PLANT BIOTECHNOL-NAR, V28, P231, DOI 10.5511/plantbiotechnology.11.0106b; Verdonk JC, 2005, PLANT CELL, V17, P1612, DOI 10.1105/tpc.104.028837; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yamagishi M, 2010, PLANT CELL PHYSIOL, V51, P463, DOI 10.1093/pcp/pcq011; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yuan YW, 2013, CURR OPIN PLANT BIOL, V16, P422, DOI 10.1016/j.pbi.2013.05.004; [张辉秀 Zhang Huixiu], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P790; Zhang JX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-279; Zhao J, 2012, KOREAN J HORTIC SCI, V30, P617, DOI 10.7235/hort.2012.12055; Zhou L, 2011, AFR J BIOTECHNOL, V10, P1275	65	31	35	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142542	10.1371/journal.pone.0142542	http://dx.doi.org/10.1371/journal.pone.0142542			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587670	Green Published, gold			2022-12-26	WOS:000365251500011
J	Kamarajan, C; Pandey, AK; Chorlian, DB; Manz, N; Stimus, AT; Anokhin, AP; Bauer, LO; Kuperman, S; Kramer, J; Bucholz, KK; Schuckit, MA; Hesselbrock, VM; Porjesz, B				Kamarajan, Chella; Pandey, Ashwini K.; Chorlian, David B.; Manz, Niklas; Stimus, Arthur T.; Anokhin, Andrey P.; Bauer, Lance O.; Kuperman, Samuel; Kramer, John; Bucholz, Kathleen K.; Schuckit, Marc A.; Hesselbrock, Victor M.; Porjesz, Bernice			Deficient Event-Related Theta Oscillations in Individuals at Risk for Alcoholism: A Study of Reward Processing and Impulsivity Features	PLOS ONE			English	Article							FEEDBACK-RELATED NEGATIVITY; CURRENT SOURCE DENSITY; MEDIAL FRONTAL-CORTEX; AUDITORY ODDBALL TASK; GAMMA BAND RESPONSE; SCHOOL-AGE CHILDREN; FAMILY-HISTORY; BRAIN OSCILLATIONS; SEX-DIFFERENCES; DEVELOPMENTAL-CHANGES	Background Individuals at high risk to develop alcoholism often manifest neurocognitive deficits as well as increased impulsivity. Event-related oscillations (EROs) have been used to effectively measure brain (dys) function during cognitive tasks in individuals with alcoholism and related disorders and in those at risk to develop these disorders. The current study examines ERO theta power during reward processing as well as impulsivity in adolescent and young adult subjects at high risk for alcoholism. Methods EROs were recorded during a monetary gambling task (MGT) in 12-25 years old participants (N = 1821; males = 48%) from high risk alcoholic families (HR, N = 1534) and comparison low risk community families (LR, N = 287) from the Collaborative Study on the Genetics of Alcoholism (COGA). Impulsivity scores and prevalence of externalizing diagnoses were also compared between LR and HR groups. Results HR offspring showed lower theta power and decreased current source density (CSD) activity than LR offspring during loss and gain conditions. Younger males had higher theta power than younger females in both groups, while the older HR females showed more theta power than older HR males. Younger subjects showed higher theta power than older subjects in each comparison. Differences in topography (i.e., frontalization) between groups were also observed. Further, HR subjects across gender had higher impulsivity scores and increased prevalence of externalizing disorders compared to LR subjects. Conclusions As theta power during reward processing is found to be lower not only in alcoholics, but also in HR subjects, it is proposed that reduced reward-related theta power, in addition to impulsivity and externalizing features, may be related in a predisposition to develop alcoholism and related disorders.	[Kamarajan, Chella; Pandey, Ashwini K.; Chorlian, David B.; Manz, Niklas; Stimus, Arthur T.; Porjesz, Bernice] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Anokhin, Andrey P.; Bucholz, Kathleen K.] Washington Univ, Sch Med, St Louis, MO USA; [Bauer, Lance O.; Hesselbrock, Victor M.] Univ Connecticut, Ctr Hlth, Farmington, CT USA; [Kuperman, Samuel; Kramer, John] Univ Iowa, Iowa City, IA USA; [Schuckit, Marc A.] Univ Calif San Diego, San Diego, CA 92103 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Washington University (WUSTL); University of Connecticut; University of Iowa; University of California System; University of California San Diego	Kamarajan, C (corresponding author), Suny Downstate Med Ctr, Brooklyn, NY 11203 USA.	kam@hbnl.downstate.edu	Kamarajan, Chella/C-5671-2019; Pandey, Ashwini Kumar/D-6788-2013; Manz, Niklas/A-3234-2009	Kamarajan, Chella/0000-0003-2291-6880; Pandey, Ashwini Kumar/0000-0002-2688-7901; Manz, Niklas/0000-0003-1483-915X; Anokhin, Andrey/0000-0001-8158-6346; Kuperman, Samuel/0000-0002-5995-1981	NIH grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U10AA008401]; National Institute on Drug Abuse (NIDA); NIAAA [AA05524]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA003510, R37AA005524, R01AA005524, U10AA008401, F31AA005524] Funding Source: NIH RePORTER	NIH grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	NIH grant U10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (http://www.niaaa.nih.gov/) and the National Institute on Drug Abuse (NIDA)(http://www.drugabuse.gov/) (BP, VMH), and grant AA05524 (BP) from NIAAA (http://www.niaaa.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We continue to be inspired by our memories of Henri Begleiter and Theodore Reich, founding PI and Co-PI of COGA, and also owe a debt of gratitude to other past organizers of COGA, including Ting-Kai Li, currently a consultant with COGA, P. Michael Conneally, Raymond Crowe, and Wendy Reich, for their critical contributions. This study is supported by NIH grant U10AA008401 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and grant AA05524 (PI: Bernice Porjesz) from NIAAA.	ALEXANDER JE, 1994, INT J PSYCHOPHYSIOL, V17, P35, DOI 10.1016/0167-8760(94)90053-1; Barratt ES., 1985, MOTIVATION EMOTION P, P137, DOI DOI 10.1371/JOURNAL.PONE.0129139; Bas ~ar E, 1999, BRAIN FUNCTION OSCIL; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; Basar E, 2015, INT J PSYCHOPHYSIOL; Basar E., 1999, BRAIN FUNCTION OSCIL, VI; Basar E, 2008, BRAIN RES, V1235, P172, DOI 10.1016/j.brainres.2008.06.103; Basar Erol, 2013, Dialogues Clin Neurosci, V15, P291; Basar Erol, 2013, Suppl Clin Neurophysiol, V62, P303; Basar-Eroglu C, 2001, INT J PSYCHOPHYSIOL, V39, P167, DOI 10.1016/S0167-8760(00)00140-9; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; BEGLEITER H, 1987, ALCOHOL, V4, P315, DOI 10.1016/0741-8329(87)90029-2; Begleiter H, 1995, ALCOHOL HEALTH RES W, V19, P228; BEGLEITER H, 1984, SCIENCE, V225, P1493, DOI 10.1126/science.6474187; Bell MA, 2012, J COGN DEV, V13, P281, DOI 10.1080/15248372.2012.691143; Benegal V, 1995, PSYCHIATR GENET, V5, P149, DOI 10.1097/00041444-199524000-00001; BERMAN SM, 1993, ALCOHOL, V10, P69, DOI 10.1016/0741-8329(93)90055-S; Bernat EM, 2011, J ABNORM PSYCHOL, V120, P352, DOI 10.1037/a0022124; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Boord Peter R., 2007, Journal of Integrative Neuroscience, V6, P205, DOI 10.1142/S0219635207001416; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; CHATRIAN GE, 1988, J CLIN NEUROPHYSIOL, V5, P183, DOI 10.1097/00004691-198804000-00005; Chorlian DB, 2015, BEHAV BRAIN RES, V292, P342, DOI 10.1016/j.bbr.2015.06.020; Chuang CC, 2014, BIOMED OPT EXPRESS, V5, P2503, DOI 10.1364/BOE.5.002503; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; COHEN HL, 1994, ALCOHOL, V11, P583, DOI 10.1016/0741-8329(94)90087-6; Cohen HL, 1997, BIOL PSYCHIAT, V42, P57, DOI 10.1016/S0006-3223(96)00221-1; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Cottencin O, 2009, EUR PSYCHIAT, V24, P195, DOI 10.1016/j.eurpsy.2008.12.003; Courehesne E, 1990, ISSUES EVENT RELATED; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Cservenka A, 2014, PSYCHIAT RES-NEUROIM, V221, P210, DOI 10.1016/j.pscychresns.2013.12.004; Cservenka A, 2012, ALCOHOL CLIN EXP RES, V36, P604, DOI 10.1111/j.1530-0277.2011.01650.x; Cuijpers P, 1999, ADDICTION, V94, P1489, DOI 10.1046/j.1360-0443.1999.941014895.x; Davies PL, 2004, DEV NEUROPSYCHOL, V25, P355, DOI 10.1207/s15326942dn2503_6; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; de Greck M, 2009, HUM BRAIN MAPP, V30, P1691, DOI 10.1002/hbm.20634; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Dick DM, 2013, TWIN RES HUM GENET, V16, P661, DOI 10.1017/thg.2013.20; Dick DM, 2010, ADDICT BIOL, V15, P217, DOI 10.1111/j.1369-1600.2009.00190.x; DREJER K, 1985, ALCOHOL CLIN EXP RES, V9, P498, DOI 10.1111/j.1530-0277.1985.tb05590.x; Dustman RE, 1999, CLIN NEUROPHYSIOL, V110, P1399, DOI 10.1016/S1388-2457(99)00102-9; Ecuyer-Dab I, 2004, COGNITION, V91, P221, DOI 10.1016/j.cognition.2003.09.007; Edenberg HJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S2; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fein G, 2008, DRUG ALCOHOL DEPEN, V92, P141, DOI 10.1016/j.drugalcdep.2007.07.017; Field AP, 1988, NEWSLETTER MATH STAT, V6, P13; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; Freunberger R, 2007, BRAIN RES BULL, V71, P593, DOI 10.1016/j.brainresbull.2006.11.014; Freunberger R, 2011, BRAIN RES, V1375, P93, DOI 10.1016/j.brainres.2010.12.048; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Garcia-Garcia M, 2008, BIOL PSYCHOL, V79, P307, DOI 10.1016/j.biopsycho.2008.07.006; Gasbarri A, 2006, BEHAV BRAIN RES, V168, P177, DOI 10.1016/j.bbr.2005.07.034; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P100, DOI 10.1016/0013-4694(88)90205-2; Gehring W.J., 2004, ERRORS CONFLICTS BRA; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Geier C, 2009, PHARMACOL BIOCHEM BE, V93, P212, DOI 10.1016/j.pbb.2009.01.021; Giancola PR, 1996, ALCOHOL CLIN EXP RES, V20, P740, DOI 10.1111/j.1530-0277.1996.tb01680.x; Gilmore CS, 2012, BRAIN BEHAV, V2, P796, DOI 10.1002/brb3.95; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Guntekin B, 2007, NEUROSCI LETT, V424, P94, DOI 10.1016/j.neulet.2007.07.052; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V65, P294, DOI 10.1016/j.ijpsycho.2007.03.009; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V64, P91, DOI 10.1016/j.ijpsycho.2006.07.003; Haas L F, 2003, J Neurol Neurosurg Psychiatry, V74, P9, DOI 10.1136/jnnp.74.1.9; Hammerer D, 2012, DEV PSYCHOL, V48, P862, DOI 10.1037/a0027342; Hammerer D, 2011, J COGNITIVE NEUROSCI, V23, P579, DOI 10.1162/jocn.2010.21475; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Hall JR, 2007, PSYCHOL SCI, V18, P326, DOI 10.1111/j.1467-9280.2007.01899.x; Hardie TL, 2008, AM J ADDICTION, V17, P319, DOI 10.1080/10550490802139010; Harper J, 2014, CLIN NEUROPHYSIOL, V125, P124, DOI 10.1016/j.clinph.2013.06.025; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Hauser TU, 2015, NEUROIMAGE, V104, P347, DOI 10.1016/j.neuroimage.2014.09.018; Herting MM, 2011, NEUROIMAGE, V54, P2582, DOI 10.1016/j.neuroimage.2010.10.030; Hill SY, 1999, BIOL PSYCHIAT, V46, P970, DOI 10.1016/S0006-3223(99)00032-3; HJORTH B, 1991, J CLIN NEUROPHYSIOL, V8, P391, DOI 10.1097/00004691-199110000-00004; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Holguin SR, 1999, BIOL PSYCHIAT, V46, P281, DOI 10.1016/S0006-3223(98)00247-9; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Jausovec N, 2008, INTELLIGENCE, V36, P383, DOI 10.1016/j.intell.2007.09.002; Jausovec N, 2009, NEUROIMAGE, V45, P198, DOI 10.1016/j.neuroimage.2008.11.013; Javadi AH, 2014, J COGNITIVE NEUROSCI, V26, P2670, DOI 10.1162/jocn_a_00677; Javadi AH, 2014, NEUROPSYCHOLOGIA, V56, P280, DOI 10.1016/j.neuropsychologia.2014.01.021; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P651, DOI 10.1111/j.1469-8986.1989.tb03167.x; Jones KA, 2004, INT J PSYCHOPHYSIOL, V53, P75, DOI 10.1016/j.ijpsycho.2004.02.004; Jones KA, 2006, CLIN NEUROPHYSIOL, V117, P2128, DOI 10.1016/j.clinph.2006.02.028; Kahana MJ, 2001, CURR OPIN NEUROBIOL, V11, P739, DOI 10.1016/S0959-4388(01)00278-1; Kamarajan C, 2006, BIOL PSYCHIAT, V59, P625, DOI 10.1016/j.biopsych.2005.08.017; Kamarajan C, 2005, BIOL PSYCHOL, V69, P353, DOI 10.1016/j.biopsycho.2004.08.004; Kamarajan C, 2004, INT J PSYCHOPHYSIOL, V51, P155, DOI 10.1016/j.ijpsycho.2003.09.004; Kamarajan C, 2008, BRAIN RES, V1235, P45, DOI 10.1016/j.brainres.2008.06.051; Kamarajan C, 2015, INT J PSYCHOPHYSIOL, V98, P182, DOI 10.1016/j.ijpsycho.2015.09.005; Kamarajan C, 2015, INT J PSYCHOPHYSIOL, V97, P310, DOI 10.1016/j.ijpsycho.2014.10.013; Kamarajan C, 2012, HUM BRAIN MAPP, V33, P1019, DOI 10.1002/hbm.21267; Kamarajan C, 2010, J PSYCHIATR RES, V44, P576, DOI 10.1016/j.jpsychires.2009.11.019; Kamarajan C, 2009, BEHAV BRAIN RES, V197, P62, DOI 10.1016/j.bbr.2008.08.011; Karakas S, 2000, NEUROSCI LETT, V285, P45, DOI 10.1016/S0304-3940(00)01022-3; Kayser J, 2014, INT J PSYCHOPHYSIOL, V91, P104, DOI 10.1016/j.ijpsycho.2013.12.003; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klimesch W, 2006, CEREB CORTEX, V16, P280, DOI 10.1093/cercor/bhi107; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; Klimesch W, 1997, NEUROSCI LETT, V238, P9, DOI 10.1016/S0304-3940(97)00771-4; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2001, CLIN NEUROPHYSIOL, V112, P1174, DOI 10.1016/S1388-2457(01)00545-4; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Knyazev GG, 2008, CLIN NEUROPHYSIOL, V119, P556, DOI 10.1016/j.clinph.2007.11.041; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Knyazev GG, 2010, EMOTION, V10, P678, DOI 10.1037/a0019175; Kolev V, 2002, CLIN NEUROPHYSIOL, V113, P901, DOI 10.1016/S1388-2457(02)00106-2; Koob GF, 2013, CURR TOP BEHAV NEURO, V13, P3, DOI 10.1007/7854_2011_129; Kovacevic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043957; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; KUPERMAN S, 1995, ELECTROEN CLIN NEURO, V94, P462, DOI 10.1016/0013-4694(94)00312-9; Ladouceur CD, 2007, DEVELOPMENTAL SCI, V10, P874, DOI 10.1111/j.1467-7687.2007.00639.x; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Liu Y, 2014, PSYCHOPHYSIOLOGY; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Makris N, 2008, BIOL PSYCHIAT, V64, P192, DOI 10.1016/j.biopsych.2008.01.018; Marco-Pallares J, 2008, NEUROPSYCHOLOGIA, V46, P241, DOI 10.1016/j.neuropsychologia.2007.07.016; Marinkovic K, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00121; MATOUSEK M, 1973, ELECTROEN CLIN NEURO, V35, P603, DOI 10.1016/0013-4694(73)90213-7; Matousek M., 1973, AUTOMATION CLIN ELEC, P75; Mennes M, 2008, PSYCHOPHYSIOLOGY; Mizuhara H, 2007, NEUROIMAGE, V36, P232, DOI 10.1016/j.neuroimage.2007.02.026; Mohr PNC, 2010, NEUROSCI BIOBEHAV R, V34, P678, DOI 10.1016/j.neubiorev.2009.05.010; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; NUNEZ P L, 1989, Brain Topography, V2, P141, DOI 10.1007/BF01128851; Nunez P.L, 1981, ELECT FIELDS BRAIN N; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; Nurnberger JI, 2004, ARCH GEN PSYCHIAT, V61, P1246, DOI 10.1001/archpsyc.61.12.1246; OBOYLE M, 1993, PERS INDIV DIFFER, V14, P609, DOI 10.1016/0191-8869(93)90156-W; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; OCONNOR S, 1986, PROG NEURO-PSYCHOPH, V10, P211, DOI 10.1016/0278-5846(86)90075-8; OCONNOR S, 1987, ALCOHOL, V4, P323; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Padmanabhapillai A, 2006, INT J PSYCHOPHYSIOL, V60, P15, DOI 10.1016/j.ijpsycho.2005.03.026; Padmanabhapillai A, 2006, INT J PSYCHOPHYSIOL, V62, P262, DOI 10.1016/j.ijpsycho.2006.05.012; Pandey AK., 2012, J ADDICT RES THER, V7, P3844, DOI [DOI 10.4172/2155-6105.S7-001, 10.4172/2155-6105.S7-001]; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; POLICH J, 1994, PSYCHOL BULL, V115, P55, DOI 10.1037/0033-2909.115.1.55; PORJESZ B, 1987, ALCOHOL, V4, P283, DOI 10.1016/0741-8329(87)90024-3; Porjesz B, 2005, CLIN NEUROPHYSIOL, V116, P993, DOI 10.1016/j.clinph.2004.12.016; Porjesz B, 1996, INT CONGR SER, V1099, P539; Porjesz Bernice, 2007, ScientificWorldJournal, V7, P131; Prescott CA, 2002, ALCOHOL RES HEALTH, V26, P264; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Ramachandran G, 1996, ALCOHOL CLIN EXP RES, V20, P9, DOI 10.1111/j.1530-0277.1996.tb01035.x; Ramsey SE, 1997, J STUD ALCOHOL, V58, P606, DOI 10.15288/jsa.1997.58.606; Rangaswamy M, 2007, INT J PSYCHOPHYSIOL, V63, P3, DOI 10.1016/j.ijpsycho.2006.10.003; Rangaswamy Madhavi, 2014, Handb Clin Neurol, V125, P383, DOI 10.1016/B978-0-444-62619-6.00023-9; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; RICE JP, 1995, ALCOHOL CLIN EXP RES, V19, P1018, DOI 10.1111/j.1530-0277.1995.tb00983.x; Rohrbaugh JW, 1997, INT J PSYCHOPHYSIOL, V25, P111, DOI 10.1016/S0167-8760(96)00714-3; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Romer D, 2009, NEUROPSYCHOLOGIA, V47, P2916, DOI 10.1016/j.neuropsychologia.2009.06.019; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; SAUNDERS JT, 1973, AM J ORTHOPSYCHIAT, V43, P789, DOI 10.1111/j.1939-0025.1973.tb00851.x; SCHACTER DL, 1977, BIOL PSYCHOL, V5, P47, DOI 10.1016/0301-0511(77)90028-X; Schmiedt C, 2005, COGNITIVE BRAIN RES, V25, P936, DOI 10.1016/j.cogbrainres.2005.09.015; Schmiedt-Fehr C, 2011, CLIN NEUROPHYSIOL, V122, P1156, DOI 10.1016/j.clinph.2010.10.045; Segalowitz SJ, 2010, BRAIN COGNITION, V72, P86, DOI 10.1016/j.bandc.2009.10.003; Segalowitz SJ, 2008, DEVELOPMENTAL PSYCHOPHYSIOLOGY: THEORY, SYSTEMS, AND METHODS, P1; Shen X, 2005, INT J NEUROSCI, V115, P1631, DOI 10.1080/00207450590958484; SHER KJ, 1991, J ABNORM PSYCHOL, V100, P427, DOI 10.1037/0021-843X.100.4.427; SHER KJ, 1994, J ABNORM PSYCHOL, V103, P92, DOI 10.1037/0021-843X.103.1.92; Silverman I, 2007, ARCH SEX BEHAV, V36, P261, DOI 10.1007/s10508-006-9168-6; Spadoni AD, 2013, AM J DRUG ALCOHOL AB, V39, P356, DOI 10.3109/00952990.2013.818680; Squeglia LM, 2014, PSYCHOL MED, V44, P2775, DOI 10.1017/S0033291714000609; Srinivasan R, 1999, INT J BIOELECTROMAGN, V1, P102, DOI DOI 10.1109/IEMBS.1988.95290; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Stice E, 2014, PSYCHOL ADDICT BEHAV, V28, P805, DOI 10.1037/a0034460; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Stoltenberg SF, 2008, ADDICT BEHAV, V33, P252, DOI 10.1016/j.addbeh.2007.09.004; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tenke CE, 2012, CLIN NEUROPHYSIOL, V123, P2328, DOI 10.1016/j.clinph.2012.06.005; Toyomaki A, 2005, NEUROREPORT, V16, P1865, DOI 10.1097/01.wnr.0000185962.96217.36; Trujillo LT, 2007, CLIN NEUROPHYSIOL, V118, P645, DOI 10.1016/j.clinph.2006.11.009; Van der Stelt O, 1998, ALCOHOL, V15, P119, DOI 10.1016/S0741-8329(97)00106-7; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Wackermann J, 1998, ELECTROEN CLIN NEURO, V107, P415, DOI 10.1016/S0013-4694(98)00090-X; Wang KM, 1999, BRAIN TOPOGR, V12, P19, DOI 10.1023/A:1022225522447; Wetherill RR, 2012, BRAIN RES, V1432, P66, DOI 10.1016/j.brainres.2011.11.013; WHIPPLE SC, 1991, ALCOHOL, V8, P321, DOI 10.1016/0741-8329(91)90497-K; Yener GG, 2007, INT J PSYCHOPHYSIOL, V64, P46, DOI 10.1016/j.ijpsycho.2006.07.006; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yordanova J, 1998, J PSYCHOPHYSIOL, V12, P113; Yordanova J, 1997, EVOKED POTENTIAL, V104, P418, DOI 10.1016/S0168-5597(97)00054-3; Yordanova J, 2006, NEUROIMAGE, V32, P940, DOI 10.1016/j.neuroimage.2006.03.056; Yordanova J, 2009, J PSYCHOPHYSIOL, V23, P174, DOI 10.1027/0269-8803.23.4.174; Yordanova J, 2008, DEVELOPMENTAL PSYCHOPHYSIOLOGY: THEORY, SYSTEMS, AND METHODS, P15; Yordanova JY, 1996, ELECTROEN CLIN NEURO, V99, P527; Yu RJ, 2006, NEUROREPORT, V17, P1649, DOI 10.1097/01.wnr.0000236866.39328.1d; Yun L., 2013, INT J SIGNAL P, V65, P245; Yurgelun-Todd DA, 2006, NEUROSCI LETT, V406, P194, DOI 10.1016/j.neulet.2006.07.046	212	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142659	10.1371/journal.pone.0142659	http://dx.doi.org/10.1371/journal.pone.0142659			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580209	Green Published, gold			2022-12-26	WOS:000365154600054
J	Moreno, P; Lara-Chica, M; Soler-Torronteras, R; Caro, T; Medina, M; Alvarez, A; Salvatierra, A; Munoz, E; Calzado, MA				Moreno, Paula; Lara-Chica, Maribel; Soler-Torronteras, Rafael; Caro, Teresa; Medina, Manuel; Alvarez, Antonio; Salvatierra, Angel; Munoz, Eduardo; Calzado, Marco A.			The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer	PLOS ONE			English	Article							MURINE HOMOLOGS; PROLIFERATION; TUMORIGENESIS; PROGRESSION; INHIBITION; PHENOTYPE; SURVIVAL; HIF	Objectives Lung cancer is the leading cause of cancer-related deaths worldwide. Overall 5-year survival has shown little improvement over the last decades. Seven in absentia homolog (SIAH) proteins are E3 ubiquitin ligases that mediate proteasomal protein degradation by poly-ubiquitination. Even though SIAH proteins play a key role in several biological processes, their role in human cancer remains controversial. The aim of the study was to document SIAH2 expression pattern at different levels (mRNA, protein level and immunohistochemistry) in human non-small cell lung cancer (NSCLC) samples compared to surrounding healthy tissue from the same patient, and to analyse the association with clinicopathological features. Materials and Methods One hundred and fifty-two samples from a patient cohort treated surgically for primary lung cancer were obtained for the study. Genic and protein expression levels of SIAH2 were analysed and compared with clinic-pathologic variables. Results The present study is the first to analyze the SIAH2 expression pattern at different levels (RNA, protein expression and immunohistochemistry) in non-small cell lung cancer (NSCLC). We found that SIAH2 protein expression is significantly enhanced in human lung adenocarcinoma (ADC) and squamous cell lung cancer (SCC). Paradoxically, non-significant changes at RNA level were found, suggesting a post-traductional regulatory mechanism. More importantly, an increased correlation between SIAH2 expression and tumor grade was detected, suggesting that this protein could be used as a prognostic biomarker to predict lung cancer progression. Likewise, SIAH2 protein expression showed a strong positive correlation with fluorodeoxyglucose (2-deoxy-2(F-18) fluoro-D-glucose) uptake in primary NSCLC, which may assist clinicians in stratifying patients at increased overall risk of poor survival. Additionally, we described an inverse correlation between the expression of SIAH2 and the levels of one of its substrates, the serine/threonine kinase DYRK2. Conclusions Our results provide insight into the potential use of SIAH2 as a novel target for lung cancer treatment.	[Moreno, Paula; Lara-Chica, Maribel; Soler-Torronteras, Rafael; Munoz, Eduardo; Calzado, Marco A.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, E-14004 Cordoba, Spain; [Caro, Teresa; Medina, Manuel] Univ Cordoba, Dept Pathol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, E-14004 Cordoba, Spain; [Alvarez, Antonio; Salvatierra, Angel] Hosp Univ Reina Sofia, Thorac Surg & Lung Transplantat Unit, Cordoba 14004, Spain	Universidad de Cordoba; Universidad de Cordoba	Calzado, MA (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, E-14004 Cordoba, Spain.	mcalzado@uco.es	Salvatierra, Angel/E-4530-2015; Munoz, Eduardo/I-5225-2012; Calzado, Marco A./S-2295-2019; Alvarez, Antonio/AAM-6126-2021; Lara Chica, Maribel/GRF-0887-2022; Calzado, Marco/E-9046-2016	Munoz, Eduardo/0000-0001-8478-5842; Calzado, Marco A./0000-0002-5338-535X; Alvarez, Antonio/0000-0003-1531-9543; Calzado, Marco/0000-0002-5338-535X; MORENO, PAULA/0000-0003-4403-7035; Caro Cuenca, Teresa/0000-0003-4838-8684; Lara-Chica, Maribel/0000-0003-2908-9929	Ministerio de Economia y Competitividad MICINN [SAF2010-17122]; Consejeria de Salud (Junta de Andalucia) [PI-0650-2010, PI-0246-2013]; Instituto de Salud Carlos III [PIE14/00005]	Ministerio de Economia y Competitividad MICINN(Spanish Government); Consejeria de Salud (Junta de Andalucia)(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Ministerio de Economia y Competitividad MICINN (SAF2010-17122) to MAC, Consejeria de Salud (Junta de Andalucia) (PI-0650-2010) to MAC, Consejeria de Salud (Junta de Andalucia) (PI-0246-2013) to MAC, and Instituto de Salud Carlos III, Award Number: PIE14/00005 (FLEXI-MET) to MAC.	Ahmed AU, 2008, JNCI-J NATL CANCER I, V100, P1606, DOI 10.1093/jnci/djn365; Behling KC, 2011, BREAST CANCER RES TR, V129, P717, DOI 10.1007/s10549-010-1254-8; Brauckhoff A, 2011, J HEPATOL, V55, P1049, DOI 10.1016/j.jhep.2011.02.019; Bruzzoni-Giovanelli H, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-10; Butler CA, 2006, RESP MED, V100, P1642, DOI 10.1016/j.rmed.2005.12.006; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Chan P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2828; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Erridge SC, 2007, NAT CLIN PRACT ONCOL, V4, P570, DOI 10.1038/ncponc0932; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Holloway AJ, 1997, GENOMICS, V41, P160, DOI 10.1006/geno.1997.4642; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2009, CANCER RES, V69, P8835, DOI 10.1158/0008-5472.CAN-09-1676; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kim H, 2004, J AM SOC NEPHROL, V15, P2042, DOI 10.1097/01.ASN.0000133490.00348.59; Kramer OH, 2013, LEUKEMIA, V27, P792, DOI 10.1038/leu.2012.284; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Malz M, 2012, INT J CANCER, V131, P2016, DOI 10.1002/ijc.27473; Manser R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004699.pub2; Moller A, 2009, ONCOGENE, V28, P289, DOI 10.1038/onc.2008.382; Muller S, 2014, ONCOTARGET, V5, P3184; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Perez M, 2012, J MOL CELL BIOL, V4, P316, DOI 10.1093/jmcb/mjs047; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qi JF, 2013, CELL BIOCHEM BIOPHYS, V67, P15, DOI 10.1007/s12013-013-9636-2; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Wong CSF, 2013, CANCER RES, V73, P2400, DOI 10.1158/0008-5472.CAN-12-4348; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Yoshibayashi H, 2007, ONCOL REP, V17, P549	38	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143376	10.1371/journal.pone.0143376	http://dx.doi.org/10.1371/journal.pone.0143376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580787	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600118
J	Huo, Z; Wu, HW; Li, J; Li, SQ; Wu, SF; Liu, YY; Luo, YF; Cao, JL; Zeng, X; Liang, ZY				Huo, Zhen; Wu, Huanwen; Li, Ji; Li, Shanqing; Wu, Shafei; Liu, Yuanyuan; Luo, Yufeng; Cao, Jinling; Zeng, Xuan; Liang, Zhiyong			Primary Pulmonary Mucoepidermoid Carcinoma: Histopathological and Moleculargenetic Studies of 26 Cases	PLOS ONE			English	Article							CRTC3-MAML2 FUSION TRANSCRIPT; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; LUNG-CANCER; PROGNOSTIC-FACTORS; CLINICOPATHOLOGICAL SIGNIFICANCE; EGFR; EXPRESSION; GENE; CLASSIFICATION	Introduction Pulmonary mucoepidermoid carcinoma (PMEC) is an uncommon neoplasm of the lung and the main salivary gland-type lung carcinoma. The aims of this study were to review the clinicopathological and immunohistochemical features of PMEC and characterize the genetic events in PMEC. Methods We reviewed the pathology cases in our hospital and found 34 initially diagnosed PMEC cases, 26 of which were confirmed as PMEC after excluding 8 cases of MEC-like pulmonary carcinoma. The clinicopathological characteristics of the 26 PMEC cases and the 8 cases of MEC-like pulmonary carcinoma were retrospectively reviewed. MAML2 rearrangement was detected by fluorescence In Situ Hybridization (FISH). Immunostains of ALK, calponin, collagen IV, CK7, EGFR, HER2, Ki-67, Muc5Ac, p63, p40, and TTF-1 were performed. DNA was extracted from 23 cases of PMEC. Mutation profiling of the EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 genes were carried out using next-generation sequencing (NGS), Sanger sequencing, and quantitative polymerase chain reaction (QPCR) in 9 successfully amplified cases. Results Twenty-six cases of PMEC (18 low-grade, 8 high-grade) included 13 men and 13 women aged 12-79 years. Twenty-two cases had a central/endobronchial growth pattern, and 4 cases had a peribronchial growth pattern. Immunohistochemically, CK7, Muc5Ac, p40, and p63 were positive in all cases (26/26); EGFR was positive in 11 cases (11/26); TTF-1, Calponin, HER2 and ALK were negative in all cases (0/26). MAML2 rearrangement was identified in 12 of 18 PMEC cases. No mutations were detected in any of the 7 genes in the 9 cases that qualified for mutation analysis. Twenty-three PMEC patients had follow-up information with a median interval of 32.6 months. Both the 5- and 10-year overall survival rates (OS) were 72.1%, and a high-grade tumor was an adverse prognostic factor in PMEC. There were 8 cases of MEC-like pulmonary carcinoma aged 36-78 years: 2 cases were located in the bronchus, and 6 cases were located in the lung. p63 and TTF-1 were positive in all cases (8/8), p40 was positive in 5 cases (5/8), and ALK was positive in 5 cases (5/8). No cases of MAML2 rearrangement were detected, but there were 5 cases of ALK rearrangement. Conclusions PMEC is a primary malignant pulmonary tumor with a relatively good prognosis that is historically characterized by the presence of mucous cells and a lack of keratinization. There are distinct differences between PMEC and MEC-like pulmonary carcinoma in tumor location preference, immunophenotype, and molecular genetics, and the differential diagnosis is critical due to the therapeutic and prognostic considerations.	[Huo, Zhen; Wu, Huanwen; Li, Ji; Wu, Shafei; Liu, Yuanyuan; Luo, Yufeng; Cao, Jinling; Zeng, Xuan; Liang, Zhiyong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Huo, Zhen; Wu, Huanwen; Li, Ji; Li, Shanqing; Wu, Shafei; Liu, Yuanyuan; Luo, Yufeng; Cao, Jinling; Zeng, Xuan; Liang, Zhiyong] Peking Union Med Coll, Beijing 100730, Peoples R China; [Li, Shanqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Thorac Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zeng, X (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China.	zengxuan88@yahoo.com; liangzhiyong1220@yahoo.com	liu, yuanyuan/GWZ-5838-2022	Wu, Huanwen/0000-0002-3996-3176				Achcar RDD, 2009, HUM PATHOL, V40, P854, DOI 10.1016/j.humpath.2008.11.007; Anzick SL, 2010, GENE CHROMOSOME CANC, V49, P59, DOI 10.1002/gcc.20719; Behboudi A, 2006, GENE CHROMOSOME CANC, V45, P470, DOI 10.1002/gcc.20306; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Brandwein MS, 2001, AM J SURG PATHOL, V25, P835, DOI 10.1097/00000478-200107000-00001; Chan ES, 2013, PATHOLOGY, V45, P698, DOI 10.1097/PAT.0000000000000014; Cheng L, 2012, MODERN PATHOL, V25, P347, DOI 10.1038/modpathol.2011.215; Chin CH, 2008, RESPIROLOGY, V13, P275, DOI 10.1111/j.1440-1843.2007.01207.x; Clauditz TS, 2011, PATHOLOGY, V43, P459, DOI 10.1097/PAT.0b013e3283484a60; Cros J, 2013, ANN ONCOL, V24, P2624, DOI 10.1093/annonc/mdt338; Ellis G, 2008, AFIP ATLAS TUMOR PAT, P225; ElNayal A, 2013, AM J ROENTGENOL, V201, pW57, DOI 10.2214/AJR.12.9579; Han SW, 2008, LUNG CANCER, V61, P30, DOI 10.1016/j.lungcan.2007.11.014; Handra-Luca A, 2005, AM J SURG PATHOL, V29, P881, DOI 10.1097/01.pas.0000159103.95360.e8; Ishikawa Y, 2015, WHO CLASSIFICATION T, P99; Jee KJ, 2013, MODERN PATHOL, V26, P213, DOI 10.1038/modpathol.2012.154; Jiang L, 2014, INT J CLIN EXP PATHO, V7, P6792; Kim HS, 2013, LUNG CANCER, V80, P249, DOI 10.1016/j.lungcan.2013.02.015; Kitazaki T, 2005, LUNG CANCER, V50, P19, DOI 10.1016/j.lungcan.2005.05.005; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Macarenco RS, 2008, MODERN PATHOL, V21, P1168, DOI 10.1038/modpathol.2008.113; Miyabe S, 2009, J ORAL MAXIL SURG, V67, P1432, DOI 10.1016/j.joms.2009.03.021; Molina JR, 2007, CANCER-AM CANCER SOC, V110, P2253, DOI 10.1002/cncr.23048; Nakano T, 2013, HISTOPATHOLOGY, V63, P378, DOI 10.1111/his.12183; Nakayama T, 2009, MODERN PATHOL, V22, P1575, DOI 10.1038/modpathol.2009.126; Nguyen LHP, 2003, J OTOLARYNGOL, V32, P328, DOI 10.2310/7070.2003.11438; Noda H, 2013, CANCER SCI, V104, P85, DOI 10.1111/cas.12039; O'Neill ID, 2012, LUNG CANCER, V78, P125, DOI 10.1016/j.lungcan.2012.07.006; Okumura Y, 2011, HISTOPATHOLOGY, V59, P90, DOI 10.1111/j.1365-2559.2011.03890.x; Roden AC, 2014, MODERN PATHOL, V27, P1479, DOI 10.1038/modpathol.2014.72; Rossi G, 2009, LUNG CANCER, V63, P159, DOI 10.1016/j.lungcan.2008.09.007; Serra A, 2007, J PEDIATR SURG, V42, DOI 10.1016/j.jpedsurg.2007.04.031; Shang JB, 2008, ONCOL REP, V19, P435; SMETANA H F, 1952, Mil Surg, V111, P335; Stenman G, 2014, ORAL ONCOL, V50, P683, DOI 10.1016/j.oraloncology.2014.04.008; Tonon G, 2003, NAT GENET, V33; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Xi JJ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-232; Yamatani C, 2014, LUNG CANCER, V84, P45, DOI 10.1016/j.lungcan.2014.01.010; Yamazaki K, 2014, J LARYNGOL OTOL, V128, P91, DOI 10.1017/S0022215113003459; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Yu YF, 2012, J CANCER RES CLIN, V138, P1421, DOI 10.1007/s00432-012-1211-5; Zhu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094399; Zhu F, 2013, J THORAC ONCOL, V8, P1578, DOI 10.1097/JTO.0b013e3182a7d272	44	36	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143169	10.1371/journal.pone.0143169	http://dx.doi.org/10.1371/journal.pone.0143169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575266	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400051
J	Garcia-Knight, MA; Nduati, E; Hassan, AS; Gambo, F; Odera, D; Etyang, TJ; Hajj, NJ; Berkley, JA; Urban, BC; Rowland-Jones, SL				Garcia-Knight, Miguel A.; Nduati, Eunice; Hassan, Amin S.; Gambo, Faith; Odera, Dennis; Etyang, Timothy J.; Hajj, Nassim J.; Berkley, James Alexander; Urban, Britta C.; Rowland-Jones, Sarah L.			Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants	PLOS ONE			English	Article							CYTOMEGALOVIRUS-INFECTION; IMMUNE-RESPONSES; INCREASED RISK; CHILDREN BORN; LYMPHOCYTES; BCG; NEWBORNS; IMMUNIZATION; ACTIVATION; POPULATION	Implementation of successful prevention of mother-to-child transmission of HIV strategies has resulted in an increased population of HIV-exposed uninfected (HEU) infants. HEU infants have higher rates of morbidity and mortality than HIV-unexposed (HU) infants. Numerous factors may contribute to poor health in HEU infants including immunological alterations. The present study assessed T-cell phenotype and function in HEU infants with a focus on memory Th1 responses to vaccination. We compared cross-sectionally selected parameters at 3 and 12 months of age in HIV-exposed (n = 42) and HU (n = 28) Kenyan infants. We measured ex vivo activated and bulk memory CD4 and CD8 T-cells and regulatory T-cells by flow cytometry. In addition, we measured the magnitude, quality and memory phenotype of antigen-specific T-cell responses to Bacillus Calmette-Guerin and Tetanus Toxoid vaccine antigens, and the magnitude and quality of the T cell response following polyclonal stimulation with staphylococcal enterotoxin B. Finally, the influence of maternal disease markers on the immunological parameters measured was assessed in HEU infants. Few perturbations were detected in ex vivo T-cell subsets, though amongst HEU infants maternal HIV viral load positively correlated with CD8 T cell immune activation at 12 months. Conversely, we observed age-dependent differences in the magnitude and poly-functionality of IL-2 and TNF-alpha responses to vaccine antigens particularly in Th1 cells. These changes mirrored those seen following polyclonal stimulation, where at 3 months, cytokine responses were higher in HEU infants compared to HU infants, and at 12 months, HEU infant cytokine responses were consistently lower than those seen in HU infants. Finally, reduced effector memory Th1 responses to vaccine antigens were observed in HEU infants at 3 and 12 months and higher central memory Th1 responses to M. tuberculosis antigens were observed at 3 months only. Long-term monitoring of vaccine efficacy and T-cell immunity in this vulnerable population is warranted.	[Garcia-Knight, Miguel A.; Berkley, James Alexander; Rowland-Jones, Sarah L.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Garcia-Knight, Miguel A.; Nduati, Eunice; Hassan, Amin S.; Gambo, Faith; Odera, Dennis; Etyang, Timothy J.; Berkley, James Alexander; Urban, Britta C.] KEMRI Wellcome Trust Res Program, Ctr Geog Med Res, Kilifi, Kenya; [Hajj, Nassim J.] Kilifi Cty Hosp, Comprehens Care & Res Clin, Kilifi, Kenya; [Urban, Britta C.] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England	University of Oxford; Liverpool School of Tropical Medicine; University of Liverpool	Garcia-Knight, MA (corresponding author), Univ Oxford, Nuffield Dept Clin Med, NDM Res Bldg, Oxford, England.	miguel.garciaknight@ndm.ox.ac.uk	Urban, Britta/W-6087-2018	Urban, Britta/0000-0002-4197-8393; Hassan, Amin S./0000-0001-5296-4264; Berkley, James/0000-0002-1236-849X; Garcia Knight, Miguel Antonio/0000-0001-9556-3719	Wellcome Trust [089567/Z/09/Z, 095068/Z/10/Z, WT079082]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (http://www.wellcome.ac.uk/) grant 089567/Z/09/Z to MGK, grant 095068/Z/10/Z to EN and grant WT079082 to BCU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramczuk BM, 2011, CLIN VACCINE IMMUNOL, V18, P1406, DOI 10.1128/CVI.05065-11; Afran L, 2014, CLIN EXP IMMUNOL, V176, P11, DOI 10.1111/cei.12251; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Bunders M, 2005, AIDS, V19, P1071, DOI 10.1097/01.aids.0000174454.63250.22; Cellerai C, 2007, EUR J IMMUNOL, V37, P1129, DOI 10.1002/eji.200636885; CHEYNIER R, 1992, EUR J IMMUNOL, V22, P2211, DOI 10.1002/eji.1830220905; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; D'Arena G, 1998, HAEMATOLOGICA, V83, P197; de Deus N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0766-6; Elliott AM, 2010, VACCINE, V29, P247, DOI 10.1016/j.vaccine.2010.10.047; Giaquinto C, 2004, AIDS, V18, P2009, DOI 10.1097/00002030-200410210-00005; GILL TJ, 1983, J CLIN INVEST, V72, P987, DOI 10.1172/JCI111071; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hanna-Wakim R, 2009, J INFECT DIS, V200, P1921, DOI 10.1086/648375; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Jones CE, 2015, AIDS, V29, P155, DOI 10.1097/QAD.0000000000000536; Jones CE, 2011, JAMA-J AM MED ASSOC, V305, P576, DOI 10.1001/jama.2011.100; Kagina BMN, 2009, VACCINE, V27, P5488, DOI 10.1016/j.vaccine.2009.06.103; Kidzeru EB, 2014, AIDS, V28, P1421, DOI 10.1097/QAD.0000000000000292; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; Kolte L, 2011, PEDIATR INFECT DIS J, V30, P325, DOI 10.1097/INF.0b013e3182019bc3; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Le Chenadec J, 2003, AIDS, V17, P2053, DOI 10.1097/00002030-200309260-00006; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Longwe H, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0115-y; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Mansoor N, 2009, J INFECT DIS, V199, P982, DOI 10.1086/597304; Mazzola TN, 2011, AIDS, V25, P2079, DOI 10.1097/QAD.0b013e32834bba0a; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; Miles DJC, 2010, IMMUNOLOGY, V129, P446, DOI 10.1111/j.1365-2567.2009.03186.x; Miles DJC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002905; Mofenson LM, 2015, CLIN INFECT DIS, V60, P1357, DOI 10.1093/cid/civ064; National AIDS and STI Control Programme, 2014, KENY HIV EST REP 201; National AIDS and STI Control Programme, 2011, GUID ANT THER KENY; Nduati E, BMC PUBLIC IN PRESS; Ono E, 2008, BRAZ J MED BIOL RES, V41, P700, DOI 10.1590/S0100-879X2008000800011; Ota MOC, 1999, AIDS, V13, P996, DOI 10.1097/00002030-199905280-00020; Pacheco SE, 2006, J INFECT DIS, V194, P1089, DOI 10.1086/507645; Rich KC, 1997, CLIN DIAGN LAB IMMUN, V4, P358, DOI 10.1128/CDLI.4.3.358-361.1997; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sanz M., 2013, VIENTO SUR, P31; Shapiro RL, 2010, CLIN INFECT DIS, V50, P445, DOI 10.1086/649887; Slogrove A, 2012, J TROP PEDIATRICS, V58, P505, DOI 10.1093/tropej/fms019; Slyker JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020375; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Soares AP, 2013, J INFECT DIS, V207, P1084, DOI 10.1093/infdis/jis941; Tena-Coki NG, 2010, AM J RESP CRIT CARE, P182; Van Rie A, 2006, CLIN VACCINE IMMUNOL, V13, P246, DOI 10.1128/CVI.13.2.246-252.2006; Venugopalan V, 2009, PHARMACOTHERAPY, V29, P373, DOI 10.1592/phco.29.4.373; von Mollendorf C, 2015, CLIN INFECT DIS, V60, P1346, DOI 10.1093/cid/civ059; World Health Organization, 2021, ANT DRUGS TREAT PREG	55	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143043	10.1371/journal.pone.0143043	http://dx.doi.org/10.1371/journal.pone.0143043			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569505	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000365070700124
J	Holle, D; Schulte-Steinberg, B; Wurthmann, S; Naegel, S; Ayzenberg, I; Diener, HC; Katsarava, Z; Obermann, M				Holle, Dagny; Schulte-Steinberg, Benedict; Wurthmann, Sebastian; Naegel, Steffen; Ayzenberg, Ilya; Diener, Hans-Christoph; Katsarava, Zaza; Obermann, Mark			Persistent Postural-Perceptual Dizziness: A Matter of Higher, Central Dysfunction?	PLOS ONE			English	Article							NOCICEPTIVE BLINK REFLEX; MOTION SICKNESS; MIGRAINE SUFFERERS; BODY SWAY; VERTIGO; HABITUATION; STIMULATION; DISORDERS; HEADACHE; ANXIETY	Objective Persistent postural-perceptual dizziness (PPPD) is the most common vestibular disorder in the age group between 30 and 50 years. It is considered to be based on a multisensory maladjustment involving alterations of sensory response pattern including vestibular, visual and motion stimuli. Previous data supported a link between vestibular and pain mechanism. The aim of the study was to investigate whether other sensory inputs such as pain stimuli might be altered in terms of a more widespread central perception dysfunction in this disorder. Methods Nociceptive blink reflex was measured in 27 patients with PPPD and compared with 27 healthy, age and gender matched controls. The habituation of the R2 component of the blink reflex was evaluated as the percentage area-under-the curve (AUC) decrease in ten consecutive blocks of five averaged rectified responses. Additionally, clinical characteristics were evaluated. Results In patients with PPPD a lack of habituation was observed compared to healthy controls. Relative AUC decreased between the first and the tenth block by 19.48% in PPPD patients and by 31.63% (p = 0.035) in healthy controls. There was no correlation between clinical data (course of disease, comorbid depression, medication, trigger factors) or electrophysiological data (perception threshold, pain threshold, stimulus intensity) and habituation pattern. No trigeminal sensitization in terms of facilitation of absolute values could be detected. Conclusion Our study results supports the hypothesis of the multisensory dimension of impaired sensory processing in patients with PPPD extends beyond vestibular/visual motion stimuli and reflexive postural/oculomotor control mechanisms to other sensory inputs such as pain perception in terms of a more generalized disturbed habituation pattern.	[Holle, Dagny; Schulte-Steinberg, Benedict; Wurthmann, Sebastian; Naegel, Steffen; Diener, Hans-Christoph; Obermann, Mark] Univ Duisburg Essen, Dept Neurol, Essen, Germany; [Ayzenberg, Ilya] Ruhr Univ Bochum, Dept Neurol, Bochum, Germany; [Katsarava, Zaza] Evangel Hosp Unna, Dept Neurol, Unna, Germany	University of Duisburg Essen; Ruhr University Bochum	Holle, D (corresponding author), Univ Duisburg Essen, Dept Neurol, Essen, Germany.	dagny.holle@uk-essen.de	Katsarava, Zaza/M-3967-2016; katsarava, zaza/AAH-6404-2019; Naegel, Steffen/ABI-4859-2020; Ayzenberg, Ilya/AAK-5545-2020; Diener, Hans-Christoph/AAF-7275-2019; Holle-Lee, Dagny/H-1609-2019	Katsarava, Zaza/0000-0001-8401-2583; katsarava, zaza/0000-0002-9932-1159; Naegel, Steffen/0000-0003-1727-9362; , Ilya/0000-0002-6009-792X	Grunenthal; Allergan; German Ministry of Education and Research (BMBF); Almirall; AstraZeneca; Bayer; Galaxo-Smith-Kline; Janssen-Cilag; Pfizer; German Research Council (DFG); European Union; Biogen; Merck; German Federal Ministry of Education and Research BMBF [01EM 0513]	Grunenthal(HAL Allergy Group); Allergan(AbbVieAllergan); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Almirall(Almirall); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Galaxo-Smith-Kline; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); German Research Council (DFG)(German Research Foundation (DFG)); European Union(European Commission); Biogen(Biogen); Merck(Merck & Company); German Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	Dagny Holle has received a research grant from Grunenthal, Allergan and the German Ministry of Education and Research (BMBF). Benedict Schulte-Steinberg reports nothing to disclose. Sebastian Wurthmann reports nothing to disclose. Steffen Naegel reports nothing to disclose. Ilya Ayzenberg reports nothing to disclose. Hans-Christoph Diener has received honoraria for participation in clinical trials, contribution to advisory boards or lectures from Addex Pharma, Allergan, Almirall, AstraZeneca, Bayer Vital, Berlin Chemie, Coherex Medical, CoLucid, Bohringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Grunenthal, Janssen-Cilag, Lilly, La Roche, 3M Medica, Minster, MSD, Novartis, Johnson & Johnson, Pierre Fabre, Pfizer, Schaper and Brummer, SanofiAventis, and Weber & Weber; received research support from Allergan, Almirall, AstraZeneca, Bayer, Galaxo-Smith-Kline, Janssen-Cilag, and Pfizer. Headache research at the Department of Neurology in Essen is supported by the German Research Council (DFG), the German Ministry of Education and Research (BMBF), and the European Union. Zaza Katsarava: has received research grants and honoraria from Allergan, Bayer, Biogen and Merck, and is an advisory board member for Allergan. Headache research at the Department of Neurology in Essen is supported by the German Research Council (DFG), the German Ministry of Education and Research (BMBF), and the European Union. Mark Obermann: has received scientific grants by the German Federal Ministry of Education and Research BMBF 01EM 0513. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Allena M, 2007, CEPHALALGIA, V27, P1150, DOI 10.1111/j.1468-2982.2007.01414.x; Balaban CD, 2011, J VESTIBUL RES-EQUIL, V21, P315, DOI 10.3233/VES-2011-0428; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Best C, 2006, J NEUROL NEUROSUR PS, V77, P658, DOI 10.1136/jnnp.2005.072934; Brandt T, 1996, NEUROLOGY, V46, P1515, DOI 10.1212/WNL.46.6.1515; BRANDT T, 1986, MUNCHEN MED WOCHEN, V128, P247; Di Clemente L, 2007, BRAIN, V130, P765, DOI 10.1093/brain/awl351; Di Clemente L, 2005, HEADACHE, V45, P1388, DOI 10.1111/j.1526-4610.2005.00271.x; Drummond PD, 2004, BRAIN, V127, P526, DOI 10.1093/brain/awh061; Drummond PD, 2002, CEPHALALGIA, V22, P117, DOI 10.1046/j.1468-2982.2002.00332.x; Furman JM, 2001, J ANXIETY DISORD, V15, P9, DOI 10.1016/S0887-6185(00)00040-2; Furman JM, 2005, J NEUROL NEUROSUR PS, V76, P1, DOI 10.1136/jnnp.2004.048926; Furman JM, 2003, CURR OPIN NEUROL, V16, P5, DOI 10.1097/00019052-200302000-00002; Furman JM, 2011, J HEADACHE PAIN, V12, P81, DOI 10.1007/s10194-010-0250-z; Granston A, 2005, CEPHALALGIA, V25, P219, DOI 10.1111/j.1468-2982.2004.00844.x; Halberstadt AL, 2009, NEUROBIOL LEARN MEM, V92, P243, DOI 10.1016/j.nlm.2008.05.015; Holmberg J, 2009, J NEUROL, V256, P1258, DOI 10.1007/s00415-009-5110-x; Jackson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130733; Kapfhammer HP, 1997, ACTA NEUROL SCAND, V95, P23, DOI 10.1111/j.1600-0404.1997.tb00063.x; Katsarava Z, 2003, CEPHALALGIA, V23, P814, DOI 10.1046/j.1468-2982.2003.00591.x; Katsarava Z, 2002, CLIN NEUROPHYSIOL, V113, P1932, DOI 10.1016/S1388-2457(02)00307-3; Kaube H, 2000, CLIN NEUROPHYSIOL, V111, P413, DOI 10.1016/S1388-2457(99)00295-3; Krafczyk S, 1999, NEUROSCI LETT, V259, P149, DOI 10.1016/S0304-3940(98)00917-3; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Linde K, 2015, ANN FAM MED, V13, P69, DOI 10.1370/afm.1687; Marano E, 2005, HEADACHE, V45, P325, DOI 10.1111/j.1526-4610.2005.05069.x; Marcus DA, 2005, EXPERT OPIN PHARMACO, V6, P2691, DOI 10.1517/14656566.6.15.2691; Marmura MJ, 2015, HEADACHE, V55, P3, DOI 10.1111/head.12499; May A, 2007, CURR OPIN NEUROL, V20, P306, DOI 10.1097/WCO.0b013e328136c20b; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432; Obermann M, 2014, CEPHALALGIA, V34, P1053, DOI 10.1177/0333102414527650; PENDERS CA, 1971, J NEUROL NEUROSUR PS, V34, P674, DOI 10.1136/jnnp.34.6.674; Restuccia D, 2014, CEPHALALGIA, V34, P201, DOI 10.1177/0333102413508241; Ruckenstein MJ, 2009, OTOLARYNG CLIN N AM, V42, P71, DOI 10.1016/j.otc.2008.09.011; Sand T, 2008, CLIN NEUROPHYSIOL, V119, P1190, DOI 10.1016/j.clinph.2008.01.007; Schniepp R, 2014, J NEUROL, V261, P738, DOI 10.1007/s00415-014-7259-1; Schniepp R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00115; Schoenen J, 1996, BIOMED PHARMACOTHER, V50, P71, DOI 10.1016/0753-3322(96)84716-0; Staab JP, 2007, ARCH OTOLARYNGOL, V133, P170, DOI 10.1001/archotol.133.2.170; Staab Jeffrey P, 2012, Continuum (Minneap Minn), V18, P1118, DOI 10.1212/01.CON.0000421622.56525.58; Staab JP, 2011, J VESTIBUL RES-EQUIL, V21, P331, DOI 10.3233/VES-2011-0426; Staab JP, 2006, CURR OPIN NEUROL, V19, P41, DOI 10.1097/01.wco.0000198102.95294.1f; Strupp M, 2003, NERVENARZT, V74, P911, DOI 10.1007/s00115-003-1567-5; Wuehr M, 2013, J NEUROL, V260, P1314, DOI 10.1007/s00415-012-6797-7; Zhou FM, 2005, NEURON, V46, P65, DOI 10.1016/j.neuron.2005.02.010	46	26	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142468	10.1371/journal.pone.0142468	http://dx.doi.org/10.1371/journal.pone.0142468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569392	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700040
J	Nelson, MD; Janssen, T; York, N; Lee, KH; Schoofs, L; Raizen, DM				Nelson, Matthew D.; Janssen, Tom; York, Neil; Lee, Kun He; Schoofs, Liliane; Raizen, David M.			FRPR-4 Is a G-Protein Coupled Neuropeptide Receptor That Regulates Behavioral Quiescence and Posture in Caenorhabditis elegans	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; GENE FAMILIES; STRESS; SLEEP	Neuropeptides signal through G-protein coupled receptors (GPCRs) to regulate a broad array of animal behaviors and physiological processes. The Caenorhabditis elegans genome encodes approximately 100 predicted neuropeptide receptor GPCRs, but in vivo roles for only a few have been identified. We describe here a role for the GPCR FRPR-4 in the regulation of behavioral quiescence and locomotive posture. FRPR-4 is activated in cell culture by several neuropeptides with an amidated isoleucine-arginine-phenylalanine (IRF) motif or an amidated valine-arginine-phenylalanine (VRF) motif at their carboxy termini, including those encoded by the gene flp-13. Loss of frpr-4 function results in a minor feeding quiescence defect after heat-induced cellular stress. Overexpression of frpr-4 induces quiescence of locomotion and feeding as well as an exaggerated body bend posture. The exaggerated body bend posture requires the gene flp-13. While frpr-4 is expressed broadly, selective overexpression of frpr-4 in the proprioceptive DVA neurons results in exaggerated body bends that require flp-13 in the ALA neuron. Our results suggest that FLP-13 and other neuropeptides signal through FRPR-4 and other receptors to regulate locomotion posture and behavioral quiescence.	[Nelson, Matthew D.; Lee, Kun He; Raizen, David M.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nelson, Matthew D.; York, Neil] St Josephs Univ, Dept Biol, Philadelphia, PA 19131 USA; [Janssen, Tom; Schoofs, Liliane] Univ Leuven, Funct Genom & Prote Lab, Leuven, Belgium	University of Pennsylvania; Pennsylvania Medicine; Saint Joseph's University; KU Leuven	Nelson, MD (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.	mnelson@sju.edu	Janssen, Tom/AAC-1849-2020; schoofs, liliane/ABD-2943-2020; Raizen, David/ABB-1478-2020; PhD/K-3106-2019; Nelson, Matthew/HHD-2152-2022; Schoofs, Liliane/F-2815-2010; Nelson, Matthew/N-1462-2013	Schoofs, Liliane/0000-0002-1673-432X; Nelson, Matthew/0000-0002-2085-8974	National Institute of Health [R01NS064030, R01NS0884322, T32HL07713]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088432, R21NS091500, R01NS064030] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Health grants R01NS064030 (DMR), R01NS0884322 (DMR), and T32HL07713 (MDN) (http://nih.gov/).	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Beets I, 2012, SCIENCE, V338, P543, DOI 10.1126/science.1226860; Beets I, 2011, METHODS MOL BIOL, V789, P377, DOI 10.1007/978-1-61779-310-3_25; Belfer SJ, 2013, SLEEP, V36, P689, DOI 10.5665/sleep.2628; Cai T, 2004, J NEUROSCI, V24, P3115, DOI 10.1523/JNEUROSCI.0101-04.2004; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Davis MW, 1995, J NEUROSCI, V15, P8408; Garrison JL, 2012, SCIENCE, V338, P540, DOI 10.1126/science.1226201; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hill AJ, 2014, CURR BIOL, V24, P2399, DOI 10.1016/j.cub.2014.08.040; Hobert Oliver, 2013, WormBook, P1, DOI 10.1895/wormbook.1.161.1; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Janssen T, 2010, ANN NY ACAD SCI, V1200, P1, DOI 10.1111/j.1749-6632.2010.05506.x; Keating CD, 2003, CURR BIOL, V13, P1715, DOI 10.1016/j.cub.2003.09.003; Lenz O, 2015, BRAIN BEHAV IMMUN, V47, P141, DOI 10.1016/j.bbi.2014.12.028; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 2010, ADV EXP MED BIOL, V692, P98; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nelson MD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3846; Nelson MD, 2014, CURR BIOL, V24, P2406, DOI 10.1016/j.cub.2014.08.037; Nelson MD, 2011, METHODS MOL BIOL, V772, P459, DOI 10.1007/978-1-61779-228-1_27; Peymen K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00090; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Robinson CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054971; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Salkoff L, 2001, NEUROSCIENCE, V103, P853, DOI 10.1016/S0306-4522(01)00079-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scimemi A, 2009, MOL NEUROBIOL, V40, P289, DOI 10.1007/s12035-009-8087-7; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Trojanowski NF, 2014, J NEUROPHYSIOL, V112, P951, DOI 10.1152/jn.00150.2014; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu CC, 2014, J NEUROSCI METH, V223, P35, DOI 10.1016/j.jneumeth.2013.11.026; Zimmerman JE, 2008, SLEEP, V31, P1587, DOI 10.1093/sleep/31.11.1587	44	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142938	10.1371/journal.pone.0142938	http://dx.doi.org/10.1371/journal.pone.0142938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571132	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700100
J	Song, K; Hu, W; Yue, F; Zou, J; Li, WJ; Chen, Q; Yao, QZ; Sun, WJ; Liu, LY				Song, Kun; Hu, Wei; Yue, Fei; Zou, Jing; Li, Wenjiao; Chen, Qi; Yao, Qizhi; Sun, Weijia; Liu, Leyuan			Transforming Growth Factor TGF beta Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal Adenocarcinomas	PLOS ONE			English	Article							CANCER; LRPPRC; INHIBITION; SUPPRESSES; IDENTIFICATION; EXPRESSION; PARTNERS; SUBUNIT; PATHWAY	Background and Aim Autophagy is a cellular process to regulate the turnover of misfolded/aggregated proteins or dysfunctional organelles such as damaged mitochondria. Microtubule-associated protein MAP1S (originally named C19ORF5) is a widely-distributed homologue of neuronal-specific MAP1A and MAP1B with which autophagy marker light chain 3 (LC3) was originally co-purified. MAP1S bridges autophagic components with microtubules and mitochondria through LC3 and positively regulates autophagy flux from autophagosomal biogenesis to degradation. The MAP1S-mediated autophagy suppresses tumorigenesis as suggested in a mouse liver cancer model and in prostate cancer patients. The TGF beta signaling pathway plays a central role in pancreatic tumorigenesis, and high levels of TGF beta suggest a tumor suppressive function and predict a better survival for some patients with resectable pancreatic ductal adenocarcinoma. In this study, we try to understand the relationship between TGF beta and MAP1S-mediated autophagy in pancreatic ductal adenocarcinoma. Methods We collected the tumor and its adjacent normal tissues from 33 randomly selected patients of pancreatic ductal adenocarcinomas to test the association between TGF beta and autophagy markers MAP1S and LC3. Then we tested the cause and effect relation between TGF beta and autophagy markers in cultured pancreatic cancer cell lines. Results Here we show that levels of TGF beta and autophagy markers MAP1S and LC3 are dramatically elevated in tumor tissues from patients with pancreatic ductal adenocarcinomas. TGF beta increases levels of MAP1S protein and enhances autophagy flux. Conclusion TGF beta may suppress the development of pancreatic ductal adenocarcinomas by enhancing MAP1S-mediated autophagy.	[Song, Kun; Sun, Weijia] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha 410008, Hunan, Peoples R China; [Song, Kun; Yue, Fei; Zou, Jing; Li, Wenjiao; Chen, Qi; Liu, Leyuan] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX USA; [Hu, Wei] First Peoples Hosp, Lian Yungang City, Jiangsu, Peoples R China; [Yao, Qizhi] Baylor Coll Med, Dept Surg, Mol Surgeon Res Ctr, Houston, TX 77030 USA; [Liu, Leyuan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA	Central South University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Sun, WJ (corresponding author), Cent S Univ, Xiangya Hosp, Dept Gen Surg, Xiangya Rd 87, Changsha 410008, Hunan, Peoples R China.	sunweijia2009@126.com; lliu@ibt.tamhsc.edu	Li, Wenjiao/J-2198-2019; Yue, Fei/N-1891-2018	Li, Wenjiao/0000-0003-1308-8489; Song, Kun/0000-0003-3822-2891	NIH NCI [CA142862]; NATIONAL CANCER INSTITUTE [R01CA142862] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH NCI CA142862 to Leyuan Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Birnbaum DJ, 2012, CELL CYCLE, V11, P683, DOI 10.4161/cc.11.4.19130; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chen R, 2015, LAB INVEST, V95, P43, DOI 10.1038/labinvest.2014.128; Duan XH, 2013, MOL MED REP, V7, P991, DOI 10.3892/mmr.2013.1272; Duan XH, 2011, MED ONCOL, V28, P466, DOI 10.1007/s12032-010-9480-9; Duesberg P, 2000, CELL MOTIL CYTOSKEL, V47, P81; Farrow JM, 2014, NAT REV UROL, V11, P508, DOI 10.1038/nrurol.2014.196; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P1199, DOI 10.1053/j.gastro.2013.02.007; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Hezel AF, 2012, CANCER RES, V72, P4840, DOI 10.1158/0008-5472.CAN-12-0634; Jiang XH, 2015, MOL CARCINOGEN, V54, P1194, DOI 10.1002/mc.22193; Jiang XH, 2014, CANCER-AM CANCER SOC, V120, P1228, DOI 10.1002/cncr.28551; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Kohlberger PD, 1999, ANTICANCER RES, V19, P2189; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li XS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0818-y; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Liu LY, 2009, CELL CYCLE, V8, P1616, DOI 10.4161/cc.8.10.8577; Liu LY, 2005, CANCER RES, V65, P4191, DOI 10.1158/0008-5472.CAN-04-3865; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Mann SS, 1996, J NEUROSCI RES, V43, P535, DOI 10.1002/(SICI)1097-4547(19960301)43:5<535::AID-JNR3>3.0.CO;2-J; MANN SS, 1994, J BIOL CHEM, V269, P11492; McClintock B, 1942, P NATL ACAD SCI USA, V28, P458, DOI 10.1073/pnas.28.11.458; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Neuzillet C, 2014, ONCOTARGET, V5, P78, DOI 10.18632/oncotarget.1569; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; ROBERTS AB, 1985, CANCER SURV, V4, P683; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Sousa CM, 2014, CARCINOGENESIS, V35, P1441, DOI 10.1093/carcin/bgu097; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Wang AH, 2005, J BIOL CHEM, V280, P29117, DOI 10.1074/jbc.M500295200; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wolpin BM, 2014, ONCOLOGIST, V19, P637, DOI 10.1634/theoncologist.2014-0086; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yue F, 2015, AGING-US, V7, P839, DOI 10.18632/aging.100818; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306	47	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143150	10.1371/journal.pone.0143150	http://dx.doi.org/10.1371/journal.pone.0143150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571030	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700144
J	Manhas, R; Gowri, VS; Madhubala, R				Manhas, Reetika; Gowri, Venkatraman Subramanian; Madhubala, Rentala			Leishmania donovani Encodes a Functional Selenocysteinyl-tRNA Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOPROTEIN-T; HIGH-THROUGHPUT; IDENTIFICATION; TRYPANOSOMA; COMPLEXES; MECHANISM; EUPATHDB; PATHWAY	The synthesis of selenocysteine, the 21st amino acid, occurs on its transfer RNA (tRNA), tRNA(Sec). tRNASec is initially aminoacylated with serine by seryl-tRNA synthetase and the resulting seryl moiety is converted to phosphoserine by O-phosphoseryl- tRNA kinase (PSTK) in eukaryotes. The selenium donor, selenophosphate is synthesized from selenide and ATP by selenophosphate synthetase. Selenocysteinyl-tRNA synthase (SepSecS) then uses the O-phosphoseryl-tRNA(Sec) and selenophosphate to form Sec-tRNA(Sec) in eukaryotes. Here, we report the characterization of selenocysteinyl-tRNA synthase from Leishmania donovani. Kinetoplastid SepSecS enzymes are phylogenetically closer to worm SepSecS. LdSepSecS was found to exist as a tetramer. Leishmania SepSecS enzyme was found to be active and able to complement the Delta selA deletion in Escherichia coli JS1 strain only in the presence of archaeal PSTK, indicating the conserved nature of the PSTK-SepSecS pathway. LdSepSecS was found to localize in the cytoplasm of the parasite. Gene deletion studies indicate that Leishmania SepSecS is dispensable for the parasite survival. The parasite was found to encode three selenoproteins, which were only expressed in the presence of SepSecS. Selenoproteins of L. donovani are not required for the growth of the promastigotes. Auranofin, a known inhibitor of selenoprotein synthesis showed the same sensitivity toward the wild-type and null mutants suggesting its effect is not through binding to selenoproteins. The three-dimensional structural comparison indicates that human and Leishmania homologs are structurally highly similar but their association modes leading to tetramerization seem different.	[Manhas, Reetika; Gowri, Venkatraman Subramanian; Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Madhubala, R (corresponding author), Jawaharlal Nehru Univ, New Delhi 110067, India.	rentala@outlook.com		Manhas, Reetika/0000-0002-0220-2330; V Subramanian, Gowri/0000-0002-4404-6401; madhubala, rentala/0000-0002-0034-399X	Department of Biotechnology, Goverment of India; Department of Science and Technology-Promotion of University Research and Scientific Excellence grant; University Grants Commission, India	Department of Biotechnology, Goverment of India; Department of Science and Technology-Promotion of University Research and Scientific Excellence grant; University Grants Commission, India(University Grants Commission, India)	The work was supported by grants from the Department of Biotechnology, Goverment of India, and a Department of Science and Technology-Promotion of University Research and Scientific Excellence grant (to R. Madhubala). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of funding from the University Grants Commission, India.r Kothari post-doctoral fellow supported by the University Grants Commission, India.	Aeby E, 2009, MOL BIOCHEM PARASIT, V168, P191, DOI 10.1016/j.molbiopara.2009.08.007; Aeby E, 2009, P NATL ACAD SCI USA, V106, P5088, DOI 10.1073/pnas.0901575106; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Aurrecoechea C, 2013, NUCLEIC ACIDS RES, V41, pD684, DOI 10.1093/nar/gks1113; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; BATES PA, 1994, PARASITOLOGY, V108, P1, DOI 10.1017/S0031182000078458; Cassago A, 2006, MOL BIOCHEM PARASIT, V149, P128, DOI 10.1016/j.molbiopara.2006.05.002; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Darveau A., 1995, METH NEUROSCI, V26, P77, DOI DOI 10.1016/S1043-9471(06)80084-4; Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Di Sarra F, 2013, EUR J INORG CHEM, P2718, DOI 10.1002/ejic.201300058; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; Gowri VS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-621; Grumolato L, 2008, FASEB J, V22, P1756, DOI 10.1096/fj.06-075820; Harbut MB, 2015, P NATL ACAD SCI USA, V112, P4453, DOI 10.1073/pnas.1504022112; Herkel J, 2002, HEPATOLOGY, V35, P403, DOI 10.1053/jhep.2002.30699; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ilari A, 2012, AMINO ACIDS, V42, P803, DOI 10.1007/s00726-011-0997-9; Jackson-Rosario S, 2009, J BIOL INORG CHEM, V14, P507, DOI 10.1007/s00775-009-0466-z; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P4012, DOI 10.1093/nar/gkl541; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Sambrook J, 1989, MOL CLONING; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sculaccio SA, 2008, MOL BIOCHEM PARASIT, V162, P165, DOI 10.1016/j.molbiopara.2008.08.009; Sengupta A, 2009, BIOCHEM CELL BIOL, V87, P953, DOI [10.1139/O09-064, 10.1139/o09-064]; Shchedrina VA, 2011, J BIOL CHEM, V286, P42937, DOI 10.1074/jbc.M111.310920; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; Talbot S, 2008, BRIT J PHARMACOL, V154, P940, DOI 10.1038/bjp.2008.161; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104	46	12	13	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1203	1220		10.1074/jbc.M115.695007	http://dx.doi.org/10.1074/jbc.M115.695007			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26586914	Green Published, hybrid			2022-12-26	WOS:000368068300017
J	Cheng, CY; Tu, WL; Wang, SH; Tang, PC; Chen, CF; Chen, HH; Lee, YP; Chen, SE; Huang, SY				Cheng, Chuen-Yu; Tu, Wei-Lin; Wang, Shih-Han; Tang, Pin-Chi; Chen, Chih-Feng; Chen, Hsin-Hsin; Lee, Yen-Pai; Chen, Shuen-Ei; Huang, San-Yuan			Annotation of Differential Gene Expression in Small Yellow Follicles of a Broiler-Type Strain of Taiwan Country Chickens in Response to Acute Heat Stress	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; EGG-PRODUCTION; GRANULOSA-CELLS; GROWTH-FACTOR; ACTIVATION; PROTEIN; HSP25; IDENTIFICATION; NEUTROPHIL; CAVEOLAE	This study investigated global gene expression in the small yellow follicles (6-8 mm diameter) of broiler-type B strain Taiwan country chickens (TCCs) in response to acute heat stress. Twelve 30-wk-old TCC hens were divided into four groups: control hens maintained at 25 degrees C and hens subjected to 38 degrees C acute heat stress for 2 h without recovery (H2R0), with 2-h recovery (H2R2), and with 6-h recovery (H2R6). Small yellow follicles were collected for RNA isolation and microarray analysis at the end of each time point. Results showed that 69, 51, and 76 genes were upregulated and 58, 15, 56 genes were downregulated after heat treatment of H2R0, H2R2, and H2R6, respectively, using a cutoff value of two-fold or higher. Gene ontology analysis revealed that these differentially expressed genes are associated with the biological processes of cell communication, developmental process, protein metabolic process, immune system process, and response to stimuli. Upregulation of heat shock protein 25, interleukin 6, metallopeptidase 1, and metalloproteinase 13, and downregulation of type II alpha 1 collagen, discoidin domain receptor tyrosine kinase 2, and Kruppel-like factor 2 suggested that acute heat stress induces proteolytic disintegration of the structural matrix and inflamed damage and adaptive responses of gene expression in the follicle cells. These suggestions were validated through gene expression, using quantitative real-time polymerase chain reaction. Functional annotation clarified that interleukin 6-related pathways play a critical role in regulating acute heat stress responses in the small yellow follicles of TCC hens.	[Cheng, Chuen-Yu; Tu, Wei-Lin; Wang, Shih-Han; Tang, Pin-Chi; Chen, Chih-Feng; Lee, Yen-Pai; Chen, Shuen-Ei; Huang, San-Yuan] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Tang, Pin-Chi; Chen, Chih-Feng; Chen, Shuen-Ei; Huang, San-Yuan] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Tang, Pin-Chi; Chen, Chih-Feng; Chen, Shuen-Ei; Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Integrat & Evolutionary Galliformes Genom, iEGG Ctr, Taichung 40227, Taiwan; [Chen, Hsin-Hsin] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Nanosci & Nanotechnol, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Chen, SE (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.	shueneic@dragon.nchu.edu.tw; syhuang@dragon.nchu.edu.tw	Wang, Shih-Han/HGA-7092-2022; Chen, Shuen-Ei/AAE-3574-2019; Chen, Shuen-Ei/B-2341-2019	Chen, Shuen-Ei/0000-0003-1737-2591	Ministry of Science and Technology (NSC) [102-2321-B-005-013, 101-2311-B-005-008-MY3]; Ministry of Science and Technology (MOST) [103-2321-B-005-010]; Ministry of Education (under the ATU plan), Executive Yuan, Taiwan	Ministry of Science and Technology (NSC); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Ministry of Education (under the ATU plan), Executive Yuan, Taiwan	This study was supported in part by grants from Ministry of Science and Technology (NSC# 102-2321-B-005-013, MOST# 103-2321-B-005-010, and NSC# 101-2311-B-005-008-MY3), and the Ministry of Education (under the ATU plan), Executive Yuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye JJ, 2011, VET ARHIV, V81, P119; Beaupre CE, 1997, BIOL REPROD, V56, P1570, DOI 10.1095/biolreprod56.6.1570; Beckham JT, 2010, LASER SURG MED, V42, P752, DOI 10.1002/lsm.20983; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; Chao CH, 2001, POULTRY SCI, V80, P535, DOI 10.1093/ps/80.5.535; Chen CF, 2007, THERIOGENOLOGY, V68, P1305, DOI 10.1016/j.theriogenology.2007.08.032; Cray C, 2009, COMPARATIVE MED, V59, P517; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; EMERY DA, 1984, POULTRY SCI, V63, P2027, DOI 10.3382/ps.0632027; EVANS MI, 1988, GENE DEV, V2, P116, DOI 10.1101/gad.2.1.116; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Hernandez AG, 2003, REPRODUCTION, V125, P683, DOI 10.1530/rep.0.1250683; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Johnson AL, 2009, GEN COMP ENDOCR, V163, P12, DOI 10.1016/j.ygcen.2008.11.012; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Kang L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-352; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Katoh Y, 2004, FEBS LETT, V565, P28, DOI 10.1016/j.febslet.2003.12.085; Kim HJ, 2010, PLOS ONE, V6; Knight J, 2012, AMBIO, V41, P206, DOI 10.1007/s13280-011-0178-9; Kuo YM, 2005, THERIOGENOLOGY, V64, P1490, DOI 10.1016/j.theriogenology.2005.03.020; KUSHNER I, 1993, PERSPECT BIOL MED, V36, P611; Lee YP, 2007, BRIT POULTRY SCI, V48, P113, DOI 10.1080/00071660701261302; Li C, 2011, POULTRY SCI, V90, P1028, DOI 10.3382/ps.2010-01144; Liang GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086894; Lindner RA, 2000, EUR J BIOCHEM, V267, P1923, DOI 10.1046/j.1432-1327.2000.01188.x; Liu Y, 2006, CELL STRESS CHAPERON, V11, P379, DOI 10.1379/CSC-210.1; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; Mason SW, 1997, EMBO J, V16, P163, DOI 10.1093/emboj/16.1.163; Matsumoto H, 2010, COMP BIOCHEM PHYS A, V157, P68, DOI 10.1016/j.cbpa.2010.04.019; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; New M, 2011, PHILOS T R SOC A, V369, P6, DOI 10.1098/rsta.2010.0303; Onagbesan O, 2009, ANIM REPROD SCI, V111, P121, DOI 10.1016/j.anireprosci.2008.09.017; Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x; Rogers RS, 1985, J APPL PHYSIOL, V118, P98, DOI DOI 10.1152/JAPPLPHYSI0L.00286.2014; Ross EA, 2006, BLOOD, V107, P1178, DOI 10.1182/blood-2005-07-2692; Rozenboim I, 2007, POULTRY SCI, V86, P1760, DOI 10.1093/ps/86.8.1760; Saha SK, 2007, CELL PHYSIOL BIOCHEM, V19, P67, DOI 10.1159/000099193; Sakatani M, 2012, J DAIRY SCI, V95, P3080, DOI 10.3168/jds.2011-4986; SAS, 2010, SAS STAT US GUID VER; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Star L, 2008, POULTRY SCI, V87, P1022, DOI 10.3382/ps.2007-00142; Tan TQ, 2010, CELL BIOL INT, V34, P769, DOI 10.1042/CBI20090244; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Yen TTH, 2014, PROTEIN PEPTIDE LETT, V21, P306, DOI 10.2174/09298665113206660115; VANMIERT ASJPAM, 1995, VET QUART, V17, P41, DOI 10.1080/01652176.1995.9694530; Wang SH, 2013, THERIOGENOLOGY, V79, P374, DOI 10.1016/j.theriogenology.2012.10.010; Woessner JF, 1998, CONNECT TISSUE RES, V39, P69, DOI 10.3109/03008209809023913; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Xu L, 2005, J BIOL CHEM, V280, P548, DOI 10.1074/jbc.M411036200; Zhu GY, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114249	55	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143418	10.1371/journal.pone.0143418	http://dx.doi.org/10.1371/journal.pone.0143418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587838	Green Submitted, gold, Green Published			2022-12-26	WOS:000365251500060
J	Ayme, L; Jolivet, P; Nicaud, JM; Chardot, T				Ayme, Laure; Jolivet, Pascale; Nicaud, Jean-Marc; Chardot, Thierry			Molecular Characterization of the Elaeis guineensis Medium-Chain Fatty Acid Diacylglycerol Acyltransferase DGAT1-1 by Heterologous Expression in Yarrowia lipolytica	PLOS ONE			English	Article							N-TERMINAL FRAGMENT; ARABIDOPSIS-THALIANA; TRIACYLGLYCEROL BIOSYNTHESIS; LIPID-ACCUMULATION; BINDING-SITES; OIL CONTENT; KEY ENZYME; YEAST; CLONING; IDENTIFICATION	Diacylglycerol acyltransferases (DGAT) are involved in the acylation of sn-1,2-diacylglycerol. Palm kernel oil, extracted from Elaeis guineensis (oil palm) seeds, has a high content of medium-chain fatty acids mainly lauric acid (C12:0). A putative E. guineensis diacylglycerol acyltransferase gene (EgDGAT1-1) is expressed at the onset of lauric acid accumulation in the seed endosperm suggesting that it is a determinant of medium-chain triacylglycerol storage. To test this hypothesis, we thoroughly characterized EgDGAT1-1 activity through functional complementation of a Yarrowia lipolytica mutant strain devoid of neutral lipids. EgDGAT1-1 expression is sufficient to restore triacylglycerol accumulation in neosynthesized lipid droplets. A comparative functional study with Arabidopsis thaliana DGAT1 highlighted contrasting substrate specificities when the recombinant yeast was cultured in lauric acid supplemented medium. The EgDGAT1-1 expressing strain preferentially accumulated medium-chain triacylglycerols whereas AtDGAT1 expression induced long-chain triacylglycerol storage in Y. lipolytica. EgDGAT1-1 localized to the endoplasmic reticulum where TAG biosynthesis takes place. Reestablishing neutral lipid accumulation in the Y. lipolytica mutant strain did not induce major reorganization of the yeast microsomal proteome. Overall, our findings demonstrate that EgDGAT1-1 is an endoplasmic reticulum DGAT with preference for medium-chain fatty acid substrates, in line with its physiological role in palm kernel. The characterized EgDGAT1-1 could be used to promote medium-chain triacylglycerol accumulation in microbial-produced oil for industrial chemicals and cosmetics.	[Ayme, Laure; Jolivet, Pascale; Chardot, Thierry] INRA, UMR1318, Inst Jean Pierre Bourgin Saclay Plant Sci, F-78026 Versailles, France; [Ayme, Laure; Jolivet, Pascale; Chardot, Thierry] AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France; [Ayme, Laure; Jolivet, Pascale; Chardot, Thierry] AgroParisTech, Micalis, INRA UMR1319, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chardot, T (corresponding author), INRA, UMR1318, Inst Jean Pierre Bourgin Saclay Plant Sci, F-78026 Versailles, France.	thierry.chardot@versailles.inra.fr	NICAUD, Jean-marc/ABA-9076-2021	Chardot, Thierry/0000-0001-6689-6151	French Government [ANR-11-BTBR-0003]	French Government	This work is carried out within ProBio3 project ANR-11-BTBR-0003, selected in Investissements d'Avenir Program, with financial support from French Government, managed by Research National Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah C, 2014, J PROTEOMICS, V108, P354, DOI 10.1016/j.jprot.2014.05.028; Ayme L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092237; Barth G, 2003, TOP CURR GENET, V2, P227; Beopoulos A, 2012, APPL MICROBIOL BIOT, V93, P1523, DOI 10.1007/s00253-011-3506-x; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Blein-Nicolas M, 2013, MOL BIOL EVOL, V30, P1368, DOI 10.1093/molbev/mst050; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; DEVSHONY S, 1992, J AM OIL CHEM SOC, V69, P595, DOI 10.1007/BF02636115; Dong SB, 2014, GENE, V542, P16, DOI 10.1016/j.gene.2014.03.028; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; FOLCH J, 1957, J BIOL CHEM, V226, P497; Froissard M, 2009, FEMS YEAST RES, V9, P428, DOI 10.1111/j.1567-1364.2009.00483.x; Gallart-Ayala H, 2013, ANAL CHIM ACTA, V796, P75, DOI 10.1016/j.aca.2013.08.006; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Guo ZM, 2001, J LIPID RES, V42, P1282; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hobbs DH, 1999, FEBS LETT, V452, P145, DOI 10.1016/S0014-5793(99)00646-8; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; KATAVIC V, 1995, PLANT PHYSIOL, V108, P399, DOI 10.1104/pp.108.1.399; Klug L, 2014, BBA-MOL CELL BIOL L, V1841, P215, DOI 10.1016/j.bbalip.2013.11.005; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Liang MH, 2013, PROG LIPID RES, V52, P395, DOI 10.1016/j.plipres.2013.05.002; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Lopes JLS, 2014, BBA-BIOMEMBRANES, V1838, P3145, DOI 10.1016/j.bbamem.2014.08.017; Hernandez ML, 2012, PLANT PHYSIOL, V160, P215, DOI 10.1104/pp.112.201541; Manas-Fernandez A, 2009, LIPIDS, V44, P555, DOI 10.1007/s11745-009-3303-9; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Metzger JO, 2009, EUR J LIPID SCI TECH, V111, P865, DOI 10.1002/ejlt.200900130; Mlickova K, 2004, APPL ENVIRON MICROB, V70, P3918, DOI 10.1128/AEM.70.7.3918-3924.2004; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pan X, 2013, J BIOL CHEM, V288, P24173, DOI 10.1074/jbc.M113.475699; Papanikolaou S, 2002, APPL MICROBIOL BIOT, V58, P308, DOI 10.1007/s00253-001-0897-0; Routaboul JM, 1999, PLANT PHYSIOL BIOCH, V37, P831, DOI 10.1016/S0981-9428(99)00115-1; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siloto RMP, 2008, BIOCHEM BIOPH RES CO, V373, P350, DOI 10.1016/j.bbrc.2008.06.031; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Spanova M, 2010, J BIOL CHEM, V285, P6127, DOI 10.1074/jbc.M109.074229; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Turchetto-Zolet AC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-263; Weselake RJ, 2008, J EXP BOT, V59, P3543, DOI 10.1093/jxb/ern206; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	62	24	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143113	10.1371/journal.pone.0143113	http://dx.doi.org/10.1371/journal.pone.0143113			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581109	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600085
J	Szabat, M; Pedzinski, T; Czapik, T; Kierzek, E; Kierzek, R				Szabat, Marta; Pedzinski, Tomasz; Czapik, Tomasz; Kierzek, Elzbieta; Kierzek, Ryszard			Structural Aspects of the Antiparallel and Parallel Duplexes Formed by DNA, 2 '-O-Methyl RNA and RNA Oligonucleotides	PLOS ONE			English	Article							NEAREST-NEIGHBOR MODEL; STRANDED DNA; TRIPLE-HELIX; WATSON-CRICK; BASE-PAIRS; SPECTROSCOPY; STABILITY; NMR; LNA	This study investigated the influence of the nature of oligonucleotides on the abilities to form antiparallel and parallel duplexes. Base pairing of homopurine DNA, 2'-O-MeRNA and RNA oligonucleotides with respective homopyrimidine DNA, 2'-O-MeRNA and RNA as well as chimeric oligonucleotides containing LNA resulted in the formation of 18 various duplexes. UV melting, circular dichroism and fluorescence studies revealed the influence of nucleotide composition on duplex structure and thermal stability depending on the buffer pH value. Most duplexes simultaneously adopted both orientations. However, at pH 5.0, parallel duplexes were more favorable. Moreover, the presence of LNA nucleotides within a homopyrimidine strand favored the formation of parallel duplexes.	[Szabat, Marta; Czapik, Tomasz; Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland; [Pedzinski, Tomasz] Adam Mickiewicz Univ, Dept Chem, PL-61614 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Adam Mickiewicz University	Kierzek, R (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	rkierzek@ibch.poznan.pl	Czapik, Tomasz/AAM-7961-2020; Szabat, Marta/AAD-1372-2021; Czapik, Tomasz/GVU-2363-2022	Czapik, Tomasz/0000-0002-8124-1003; Szabat, Marta/0000-0001-5772-0808; Czapik, Tomasz/0000-0002-8124-1003; Pedzinski, Tomasz/0000-0002-4765-6264; Kierzek, Elzbieta/0000-0002-5563-003X; Kierzek, Ryszard/0000-0002-7644-0016	National Science Center grants [UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098, UMO-2013/08/A/ST5/00295, UMO-2013/08/M/NZ1/01062]; Polish Ministry of Science and Higher Education, under the KNOW program	National Science Center grants; Polish Ministry of Science and Higher Education, under the KNOW program	This work was supported by National Science Center grants: UMO-2011/03/B/NZ1/00576, UMO-2011/03/B/ST5/01098, UMO-2013/08/A/ST5/00295 to RK, and UMO-2013/08/M/NZ1/01062 to EK. This publication was also supported by the Polish Ministry of Science and Higher Education, under the KNOW program.	ABOULELA F, 1994, J MOL BIOL, V243, P458, DOI 10.1006/jmbi.1994.1672; Avino A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/763658; Bhattacharyya J, 2011, BIOCHEMISTRY-US, V50, P7414, DOI 10.1021/bi200477g; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Clark CL, 1997, NUCLEIC ACIDS RES, V25, P4098, DOI 10.1093/nar/25.20.4098; Cubero E, 2002, J AM CHEM SOC, V124, P3133, DOI 10.1021/ja011928+; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; Duca M, 2008, NUCLEIC ACIDS RES, V36, P5123, DOI 10.1093/nar/gkn493; EVERTSZ EM, 1994, NUCLEIC ACIDS RES, V22, P3293, DOI 10.1093/nar/22.16.3293; FELSENFELD G, 1957, BIOCHIM BIOPHYS ACTA, V26, P457, DOI 10.1016/0006-3002(57)90091-4; Garcia RG, 1999, NUCLEIC ACIDS RES, V27, P1991, DOI 10.1093/nar/27.9.1991; Gracie K, 2014, ANALYST, V139, P3735, DOI 10.1039/c4an00680a; Kierzek E, 2005, NUCLEIC ACIDS RES, V33, P5082, DOI 10.1093/nar/gki789; Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4461, DOI 10.1093/nar/gkg632; Kierzek E, 2009, BIOCHEMISTRY-US, V48, P4377, DOI 10.1021/bi9002056; KIERZEK R, 1986, BIOCHEMISTRY-US, V25, P7840, DOI 10.1021/bi00372a009; Kumar TS, 2009, BIOORG MED CHEM LETT, V19, P2396, DOI 10.1016/j.bmcl.2009.03.079; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P1; Maciaszek A, 2015, ORG BIOMOL CHEM, V13, P2375, DOI 10.1039/c4ob02364a; Mairal T, 2008, ANAL BIOANAL CHEM, V390, P989, DOI 10.1007/s00216-007-1346-4; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; Miyoshi D, 2014, CHEMMEDCHEM, V9, P2156, DOI 10.1002/cmdc.201402157; Neidle S, 2001, BIOPOLYMERS, V56, P195, DOI 10.1002/1097-0282(2000)56:3<195::AID-BIP10009>3.0.CO;2-5; OTTO C, 1991, BIOCHEMISTRY-US, V30, P3062, DOI 10.1021/bi00226a012; Parvathy VR, 2002, NUCLEIC ACIDS RES, V30, P1500, DOI 10.1093/nar/30.7.1500; PATTABIRAMAN N, 1986, BIOPOLYMERS, V25, P1603, DOI 10.1002/bip.360250903; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; RAGHUNATHAN G, 1994, BIOPOLYMERS, V34, P1573, DOI 10.1002/bip.360341202; RAMSING NB, 1988, NUCLEIC ACIDS RES, V16, P6659, DOI 10.1093/nar/16.14.6659; RAMSING NB, 1989, BIOCHEMISTRY-US, V28, P9528, DOI 10.1021/bi00450a042; Reither S, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-27; RIPPE K, 1992, EMBO J, V11, P3777, DOI 10.1002/j.1460-2075.1992.tb05463.x; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; TCHURIKOV NA, 1989, FEBS LETT, V257, P415, DOI 10.1016/0014-5793(89)81585-6; Tchurikov NA, 2000, J BIOL CHEM, V275, P26523, DOI 10.1074/jbc.M002833200; Turner D. H, 2000, NUCL ACIDS STRUCTURE, P259; VANDESANDE JH, 1988, SCIENCE, V241, P551, DOI 10.1126/science.3399890; Veitia R, 2000, J THEOR BIOL, V206, P317, DOI 10.1006/jtbi.2000.2119; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yang XL, 1998, BIOPHYS J, V75, P1163, DOI 10.1016/S0006-3495(98)74035-4; Yildirim I, 2014, J PHYS CHEM B, V118, P14177, DOI 10.1021/jp506703g	42	8	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143354	10.1371/journal.pone.0143354	http://dx.doi.org/10.1371/journal.pone.0143354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579720	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600113
J	Traverso, G; Ciccarelli, G; Schwartz, S; Hughes, T; Boettcher, T; Barman, R; Langer, R; Swiston, A				Traverso, G.; Ciccarelli, G.; Schwartz, S.; Hughes, T.; Boettcher, T.; Barman, R.; Langer, R.; Swiston, A.			Physiologic Status Monitoring via the Gastrointestinal Tract	PLOS ONE			English	Article							CORE TEMPERATURE; SYSTEM; PHONOCARDIOGRAM; VALIDATION; EXTRACTION	Reliable, real-time heart and respiratory rates are key vital signs used in evaluating the physiological status in many clinical and non-clinical settings. Measuring these vital signs generally requires superficial attachment of physically or logistically obtrusive sensors to subjects that may result in skin irritation or adversely influence subject performance. Given the broad acceptance of ingestible electronics, we developed an approach that enables vital sign monitoring internally from the gastrointestinal tract. Here we report initial proof-of-concept large animal (porcine) experiments and a robust processing algorithm that demonstrates the feasibility of this approach. Implementing vital sign monitoring as a stand-alone technology or in conjunction with other ingestible devices has the capacity to significantly aid telemedicine, optimize performance monitoring of athletes, military service members, and first-responders, as well as provide a facile method for rapid clinical evaluation and triage.	[Traverso, G.; Barman, R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gastroenterol, Boston, MA USA; [Traverso, G.; Barman, R.; Langer, R.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Traverso, G.; Barman, R.; Langer, R.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Ciccarelli, G.; Schwartz, S.; Hughes, T.; Boettcher, T.; Swiston, A.] MIT, Lincoln Lab, Bioengn Syst & Technol, Lexington, MA 02420 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Langer, R (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	rlanger@mit.edu; albert.swiston@ll.mit.edu	Traverso, Carlo Giovanni/ABC-9065-2020	Traverso, Carlo Giovanni/0000-0001-7851-4077; Barman, Ross/0000-0002-0370-6354	Department of the Air Force [FA8721-05-C-0002]; Office of the Assistant Secretary of Defense for Research and Engineering; NIH grant [EB000244, T32DK7191-38-S1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244, R01EB000244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES027304, F32ES027306] Funding Source: NIH RePORTER	Department of the Air Force; Office of the Assistant Secretary of Defense for Research and Engineering; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The MIT Lincoln Laboratory portion of this work was sponsored by the Department of the Air Force under Air Force Contract #FA8721-05-C-0002. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the United States Government. The MIT Campus portion of this work was sponsored by the Office of the Assistant Secretary of Defense for Research and Engineering. This work was funded in part by NIH grant EB000244 (to R.L.) and NIH grant T32DK7191-38-S1 (to G.T.).; The MIT Lincoln Laboratory portion of this work was sponsored by the Department of the Air Force under Air Force Contract #FA8721-05-C-0002. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the United States Government. The MIT Campus portion of this work was sponsored by the Office of the Assistant Secretary of Defense for Research and Engineering. This work was funded in part by NIH grant EB000244 (to R.L.) and NIH grant T32DK7191-38-S1 (to G.T.). We would like to thank Pentax for providing the endoscopic equipment used for this research, and in particular Mr. Mike Fina for facilitating access to the equipment. We also thank Kari Siegle for her excellent graphics support, and Monica Siddalls and Robert Marini for their excellent veterinary support.	Beekley MD, 2007, MIL MED, V172, P592, DOI 10.7205/MILMED.172.6.592; Chen YH, 2011, IEEE ENG MED BIO, P1957, DOI 10.1109/IEMBS.2011.6090552; Deswysen AC, 2013, CONTACT DERMATITIS, V69, P379, DOI 10.1111/cod.12137; Egdell P, 2008, EMERG MED J, V25, P745, DOI 10.1136/emj.2007.054965; Emmanuel Babatunde S., 2012, Journal of Medical Engineering & Technology, V36, P303, DOI 10.3109/03091902.2012.684831; Kahn CM, 2010, MERCK VET MANUAL; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee J, 2011, PHYSIOL MEAS, V32, P1763, DOI 10.1088/0967-3334/32/11/S04; Lopez-Herce J, 2011, INTENS CARE MED, V37, P147, DOI 10.1007/s00134-010-2006-2; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; McKenzie JE, 2004, J THERM BIOL, V29, P605, DOI 10.1016/j.jtherbio.2004.08.020; Muhammad G, 2008, SIGN PROC INF TECHN; O'Brien C, 1998, MED SCI SPORT EXER, V30, P468, DOI 10.1097/00005768-199803000-00020; Rabiner L., 2011, THEORY APPL DIGITAL; Rafiei H, 2013, INT WOUND J, V10, P116, DOI 10.1111/j.1742-481X.2011.00915.x; RANGAYYAN RM, 1988, CRIT REV BIOMED ENG, V15, P211; SAKAI A, 1971, CARDIOVASC RES, V5, P358, DOI 10.1093/cvr/5.3.358; Wang A, 2013, GASTROINTEST ENDOSC, V78, P805, DOI 10.1016/j.gie.2013.06.026; Welles AP, 2013, MIL MED, V178, P1141, DOI 10.7205/MILMED-D-12-00538	19	20	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141666	10.1371/journal.pone.0141666	http://dx.doi.org/10.1371/journal.pone.0141666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580216	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600018
J	Wang, L; Wang, ZL; Yuan, YH; Cai, R; Niu, C; Yue, TL				Wang, Ling; Wang, Zhouli; Yuan, Yahong; Cai, Rui; Niu, Chen; Yue, Tianli			Identification of Key Factors Involved in the Biosorption of Patulin by Inactivated Lactic Acid Bacteria (LAB) Cells	PLOS ONE			English	Article							APPLE JUICE; WALL COMPONENTS; YEAST; ADSORPTION; REDUCTION; MECHANISM; CONTAMINATION; METHYLATION; INDUSTRY; REMOVAL	The purpose of this study was to identify the key factors involved in patulin adsorption by heat-inactivated lactic acid bacteria (LAB) cells. For preventing bacterial contamination, a sterilization process was involved in the adsorption process. The effects of various physical, chemical, and enzymatic pre-treatments, simultaneous treatments, and post-treatments on the patulin adsorption performances of six LAB strains were evaluated. The pre-treated cells were characterized by scanning electron microscopy (SEM). Results showed that the removal of patulin by viable cells was mainly based on adsorption or degradation, depending on the specific strain. The adsorption abilities were widely increased by NaOH and esterification pre-treatments, and reduced by trypsin, lipase, iodate, and periodate pre-treatments. Additionally, the adsorption abilities were almost maintained at pH 2.2-4.0, and enhanced significantly at pH 4.0-6.0. The effects of sodium and magnesium ions on the adsorption abilities at pH 4 were slight and strain-specific. A lower proportion of patulin was released from the strain with higher adsorption ability. Analyses revealed that the physical structure of peptidoglycan was not a principal factor. Vicinal OH and carboxyl groups were not involved in patulin adsorption, while alkaline amino acids, thiol and ester compounds were important for patulin adsorption. Additionally, besides hydrophobic interaction, electrostatic interaction also participated in patulin adsorption, which was enhanced with the increase in pH (4.0-6.0).	[Wang, Ling; Wang, Zhouli; Yuan, Yahong; Cai, Rui; Niu, Chen; Yue, Tianli] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Yue, TL (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China.	yuetl305@nwsuaf.edu.cn	Cai, Rui/GRO-1869-2022; yue, tianli/AEY-3384-2022	yue, tianli/0000-0002-4768-5831	National Natural Science Foundation of China [31371814]; Science and Technology Research and Development Program of Shaanxi Province, China [2014K13-15]; Basic Research Program of Science and Technology [2013FY113400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research and Development Program of Shaanxi Province, China; Basic Research Program of Science and Technology	This work has been supported by National Natural Science Foundation of China (31371814); Science and Technology Research and Development Program of Shaanxi Province, China (2014K13-15); Basic Research Program of Science and Technology (2013FY113400).	Acar J, 1998, Z LEBENSM UNTERS F A, V207, P328, DOI 10.1007/s002170050341; Al-Degs YS, 2008, DYES PIGMENTS, V77, P16, DOI 10.1016/j.dyepig.2007.03.001; Ramirez JAA, 2014, CARBOHYD POLYM, V114, P416, DOI 10.1016/j.carbpol.2014.08.020; Banik S, 2003, BIORESOURCE TECHNOL, V87, P155, DOI 10.1016/S0960-8524(02)00169-4; Bermejo-Barrera P, 1999, J ANAL ATOM SPECTROM, V14, P1893, DOI 10.1039/a903924d; Bintsis T, 2000, J SCI FOOD AGR, V80, P637, DOI 10.1002/(SICI)1097-0010(20000501)80:6<637::AID-JSFA603>3.0.CO;2-1; Bissessur J, 2001, J FOOD PROTECT, V64, P1216, DOI 10.4315/0362-028X-64.8.1216; Burgi H, 2001, THYROID, V11, P449, DOI 10.1089/105072501300176408; Chen FL, 2004, J HETEROCYCLIC CHEM, V41, P697, DOI 10.1002/jhet.5570410507; COPE AC, 1965, J ORG CHEM, V30, P2163, DOI 10.1021/jo01018a011; Das SK, 2008, COLLOID SURFACE B, V65, P30, DOI 10.1016/j.colsurfb.2008.02.020; Fliege R, 2000, CHEM RES TOXICOL, V13, P363, DOI 10.1021/tx9901478; Fuchs S, 2008, FOOD CHEM TOXICOL, V46, P1398, DOI 10.1016/j.fct.2007.10.008; Geciova J, 2002, INT DAIRY J, V12, P541, DOI 10.1016/S0958-6946(02)00038-9; Guo C, 2012, LETT APPL MICROBIOL, V55, P453, DOI 10.1111/j.1472-765x.2012.03314.x; Guo CX, 2013, SPECTROSC SPECT ANAL, V33, P672, DOI 10.3964/j.issn.1000-0593(2013)03-0672-05; Guo CX, 2013, FOOD CONTROL, V32, P99, DOI 10.1016/j.foodcont.2012.11.009; Guo CX, 2012, J FOOD PROTECT, V75, P585, DOI 10.4315/0362-028X.JFP-11-323; Hatab S, 2012, J APPL MICROBIOL, V112, P892, DOI 10.1111/j.1365-2672.2012.05279.x; Hatab S, 2012, J FOOD SCI, V77, pM238, DOI 10.1111/j.1750-3841.2011.02615.x; Hawar S, 2013, FOOD CONTROL, V34, P502, DOI 10.1016/j.foodcont.2013.05.023; HONDA S, 1989, ANAL BIOCHEM, V177, P62, DOI 10.1016/0003-2697(89)90014-6; Joyce E, 2003, ULTRASON SONOCHEM, V10, P315, DOI 10.1016/S1350-4177(03)00101-9; Lahtinen SJ, 2004, FOOD ADDIT CONTAM A, V21, P158, DOI [10.1080/02652030310001639521, 10.1080/02646830020032300]; Leiros HKS, 2004, PROTEIN SCI, V13, P1056, DOI 10.1110/ps.03498604; Lemke SL, 1998, J AGR FOOD CHEM, V46, P3789, DOI 10.1021/jf9709461; Moake MM, 2005, COMPR REV FOOD SCI F, V4, P8, DOI 10.1111/j.1541-4337.2005.tb00068.x; Nadeem R, 2008, J HAZARD MATER, V150, P335, DOI 10.1016/j.jhazmat.2007.04.110; Park DL, 2002, ADV EXP MED BIOL, V504, P277; PAUL TR, 1994, INFECT IMMUN, V62, P1542, DOI 10.1128/IAI.62.5.1542-1550.1994; Puel O, 2010, TOXINS, V2, P613, DOI 10.3390/toxins2040613; Reddy KRN, 2010, TOXIN REV, V29, P3, DOI 10.3109/15569541003598553; Riteni A, 2003, J AGR FOOD CHEM, V51, P6086, DOI 10.1021/jf034523c; Svendsen A, 2000, BBA-PROTEIN STRUCT M, V1543, P223, DOI 10.1016/S0167-4838(00)00239-9; Topcu A, 2010, INT J FOOD MICROBIOL, V139, P202, DOI 10.1016/j.ijfoodmicro.2010.03.006; Trezl L, 2003, MOL CELL BIOCHEM, V244, P167, DOI 10.1023/A:1022499621630; van Bokhorst-van de Veen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039053; Wang L, 2015, FOOD CONTROL, V50, P104, DOI 10.1016/j.foodcont.2014.08.041; Yuan Y, 2014, LETT APPL MICROBIOL, V59, P604, DOI 10.1111/lam.12315; Yue TL, 2011, J FOOD PROTECT, V74, P149, DOI 10.4315/0362-028X.JFP-10-326; Zou ZY, 2012, FOOD SCI BIOTECHNOL, V21, P1677, DOI 10.1007/s10068-012-0223-x	41	8	10	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143431	10.1371/journal.pone.0143431	http://dx.doi.org/10.1371/journal.pone.0143431			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581099	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600121
J	Sachs, JP; Kawka, OE				Sachs, Julian P.; Kawka, Orest E.			The Influence of Growth Rate on H-2/H-1 Fractionation in Continuous Cultures of the Coccolithophorid Emiliania huxleyi and the Diatom Thalassiosira pseudonana	PLOS ONE			English	Article							HYDROGEN ISOTOPE FRACTIONATION; LONG-CHAIN ALKENONES; D/H FRACTIONATION; LIPID BIOSYNTHESIS; ISOCHRYSIS-GALBANA; SALINITY; WATER; TEMPERATURE; METABOLISM; COASTAL	The hydrogen isotope (H-2/H-1) ratio of lipids from phytoplankton is a powerful new tool for reconstructing hydroclimate variations in the geologic past from marine and lacustrine sediments. Water H-2/H-1 changes are reflected in lipid H-2/H-1 changes with R-2 > 0.99, and salinity variations have been shown to cause about a 1% change in lipid delta H-2 values per unit (ppt) change in salinity. Less understood are the effects of growth rate, nutrient limitation and light on H-2/H-1 fractionation in phytoplankton. Here we present the first published study of growth rate effects on H-2/H-1 fractionation in the lipids of coccolithophorids grown in continuous cultures. Emiliania huxleyi was cultivated in steady state at four growth rates and the delta H-2 value of individual alkenones (C-37:2, C-37:3, C-38:2, C-38:3), fatty acids (C-14:0, C-16:0, C-18:0), and 24-methyl cholest-5,22-dien-3 beta-ol (brassicasterol) were measured. 2H/1H fractionation increased in all lipids as growth rate increased by 24 parts per thousand to 79 parts per thousand(div d(-1))(-1). We attribute this response to a proportional increase in the fraction of NADPH from Photosystem I (PS1) of photosynthesis relative to NADPH from the cytosolic oxidative pentose phosphate (OPP) pathway in the synthesis of lipids as growth rate increases. A 3-endmember model is presented in which lipid hydrogen comes from NADPH produced in PS1, NADPH produced by OPP, and intracellular water. With published values or best estimates of the fractionation factors for these sources (alpha(PS1) = 0.4, alpha(OPP) = 0.75, and alpha(H2O) = 0) and half of the hydrogen in a lipid derived from water the model indicates alpha(lipid) = 0.79. This value is within the range measured for alkenones (alpha(alkenone) = 0.77 to 0.81) and fatty acids (alpha(FA) = 0.75 to 0.82) in the chemostat cultures, but is greater than the range for brassicasterol (alpha(brassicasterol) = 0.68 to 0.72). The latter is attributed to a greater proportion of hydrogen from NADPH relative to water in isoprenoid lipids. The model successfully explains the increase in H-2/H-1 fractionation in the sterol 24-methyl-cholesta-5,24(28)-dien-3 beta-ol from marine centric diatom T. pseudonana chemostat cultures as growth rate increases. Insensitivity of alpha(FA) in those same cultures may be attributable to a larger fraction of hydrogen in fatty acids sourced from intracellular water at the expense of NADPH as growth rate increases. The high sensitivity of a to growth rate in E. huxleyi lipids and a T. pseudonana sterol implies that any change in growth rate larger than similar to 0.15 div d(-1) can cause a change in delta H-2(lipid) that is larger than the analytical error of the measurement (similar to 5 parts per thousand), and needs to be considered when interpreting delta H-2(lipid) variations in sediments.	[Sachs, Julian P.; Kawka, Orest E.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sachs, JP (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	jsachs@uw.edu			National Science Foundation [OCE-1027079]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. OCE-1027079.	Bender SJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00003; Chivall D, 2014, GEOCHIM COSMOCHIM AC, V140, P381, DOI 10.1016/j.gca.2014.05.043; Chivall D, 2014, ORG GEOCHEM, V67, P31, DOI 10.1016/j.orggeochem.2013.12.002; CLEMENTSON LA, 1992, WATER RES, V26, P1171, DOI 10.1016/0043-1354(92)90177-6; COLLYER DM, 1955, J EXP BOT, V6, P256, DOI 10.1093/jxb/6.2.256; Conte MH, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001054; Conte MH, 1998, GEOCHIM COSMOCHIM AC, V62, P51, DOI 10.1016/S0016-7037(97)00327-X; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Dirghangi SS, 2013, ORG GEOCHEM, V64, P105, DOI 10.1016/j.orggeochem.2013.09.007; Dirghangi SS, 2013, GEOCHIM COSMOCHIM AC, V119, P381, DOI 10.1016/j.gca.2013.05.023; Eltgroth ML, 2005, J PHYCOL, V41, P1000, DOI 10.1111/j.1529-8817.2005.00128.x; Englebrecht AC, 2005, GEOCHIM COSMOCHIM AC, V69, P4253, DOI 10.1016/j.gca.2005.04.011; Epstein BL, 1998, PALEOCEANOGRAPHY, V13, P122, DOI 10.1029/97PA03358; ESTEP MF, 1981, PLANT PHYSIOL, V67, P474, DOI 10.1104/pp.67.3.474; ESTEP MF, 1980, GEOCHIM COSMOCHIM AC, V44, P1197, DOI 10.1016/0016-7037(80)90073-3; Garcia-Martin ML, 2001, PROG NUCL MAG RES SP, V39, P41, DOI 10.1016/S0079-6565(01)00031-0; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Halsey KH, 2011, J PHYCOL, V47, P66, DOI 10.1111/j.1529-8817.2010.00945.x; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; Herbert TD, 2001, GEOCHEM GEOPHY GEOSY, V2; Hilkert AW, 1999, RAPID COMMUN MASS SP, V13, P1226, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1226::AID-RCM575>3.0.CO;2-9; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Kleiber M., 1975, FIRE LIFE; Kreuzer HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039685; Kreuzer-Martin HW, 2006, BIOCHEMISTRY-US, V45, P13622, DOI 10.1021/bi0609164; Leduc G, 2013, EARTH PLANET SC LETT, V362, P151, DOI 10.1016/j.epsl.2012.12.003; LIVNE A, 1992, PLANT CELL PHYSIOL, V33, P1175; LUO YH, 1991, PLANT CELL PHYSIOL, V32, P897; M'boule D, 2014, GEOCHIM COSMOCHIM AC, V130, P126, DOI 10.1016/j.gca.2014.01.029; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Nelson DB, 2014, GEOCHIM COSMOCHIM AC, V133, P325, DOI 10.1016/j.gca.2014.03.007; Nelson DB, 2014, ORG GEOCHEM, V66, P38, DOI 10.1016/j.orggeochem.2013.10.013; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; Pahnke K, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001468; Popp BN, 2006, LIMNOL OCEANOGR-METH, V4, P114, DOI 10.4319/lom.2006.4.114; Prahl FG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000803; Prahl FG, 2005, DEEP-SEA RES PT I, V52, P699, DOI 10.1016/j.dsr.2004.12.001; PRAHL FG, 1988, GEOCHIM COSMOCHIM AC, V52, P2303, DOI 10.1016/0016-7037(88)90132-9; PRAHL FG, 1987, NATURE, V330, P367, DOI 10.1038/330367a0; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; Rokitta SD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1051; Rokitta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052212; Rosell-Mele A, 2013, QUATERNARY SCI REV, V72, P128, DOI 10.1016/j.quascirev.2013.04.017; Sachs J.P., 2000, GEOCHEM GEOPHY GEOSY, V1, P1035, DOI DOI 10.1029/2000GC000059; Sachs JP, 2011, GEOCHIM COSMOCHIM AC, V75, P444, DOI 10.1016/j.gca.2010.10.013; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Sachse D, 2008, GEOCHIM COSMOCHIM AC, V72, P793, DOI 10.1016/j.gca.2007.11.022; Sauer PE, 2001, GEOCHIM COSMOCHIM AC, V65, P213, DOI 10.1016/S0016-7037(00)00520-2; Schmidt Hanns-Ludwig, 2003, Phytochemistry Reviews, V2, P61, DOI 10.1023/B:PHYT.0000004185.92648.ae; Schouten S, 2006, BIOGEOSCIENCES, V3, P113, DOI 10.5194/bg-3-113-2006; Schwab VF, 2009, ORG GEOCHEM, V40, P111, DOI 10.1016/j.orggeochem.2008.09.013; Sessions AL, 1999, ORG GEOCHEM, V30, P1193, DOI 10.1016/S0146-6380(99)00094-7; Sessions AL, 2001, ANAL CHEM, V73, P200, DOI 10.1021/ac000488m; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; Simon H, 1976, ISOTOPES ORGANIC CHE, V2, P153; Smittenberg RH, 2011, QUATERNARY SCI REV, V30, P921, DOI 10.1016/j.quascirev.2011.01.012; SPOEHR HA, 1949, PLANT PHYSIOL, V24, P120, DOI 10.1104/pp.24.1.120; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Urey HC, 1932, PHYS REV, V40, P1, DOI 10.1103/PhysRev.40.1; van der Meer MTJ, 2008, EARTH PLANET SC LETT, V267, P426, DOI 10.1016/j.epsl.2007.12.001; van der Meer MTJ, 2007, EARTH PLANET SC LETT, V262, P594, DOI 10.1016/j.epsl.2007.08.014; Vasiliev I, 2013, EARTH PLANET SC LETT, V362, P272, DOI 10.1016/j.epsl.2012.11.038; WESTHEIMER FH, 1961, CHEM REV, V61, P265, DOI 10.1021/cr60211a004; Wolhowe MD, 2009, BIOGEOSCIENCES, V6, P1681, DOI 10.5194/bg-6-1681-2009; YAKIR D, 1990, PLANT PHYSIOL, V93, P325, DOI 10.1104/pp.93.1.325; Zhang XN, 2009, P NATL ACAD SCI USA, V106, P12580, DOI 10.1073/pnas.0903030106; Zhang ZH, 2007, ORG GEOCHEM, V38, P582, DOI 10.1016/j.orggeochem.2006.12.004; Zhang ZH, 2009, ORG GEOCHEM, V40, P428, DOI 10.1016/j.orggeochem.2008.11.002	74	27	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0141643	10.1371/journal.pone.0141643	http://dx.doi.org/10.1371/journal.pone.0141643			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26576007	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400006
J	Torbica, A; Maggioni, AP; Ghislandi, S				Torbica, Aleksandra; Maggioni, Aldo Pietro; Ghislandi, Simone			The Economic Crisis and Acute Myocardial Infarction: New Evidence Using Hospital-Level Data	PLOS ONE			English	Article							INVOLUNTARY JOB LOSS; FINANCIAL CRISIS; RETIREMENT SURVEY; HEALTH; MORTALITY; HEART; SUICIDES; EUROPE; RECESSION; INCREASE	Objective This research sought to assess whether and to what extent the ongoing economic crisis in Italy impacted hospitalizations, in-hospital mortality and expenditures associated with acute myocardial infarction (AMI). Methods The data were obtained from the hospital discharge database of the Italian Health Ministry and aggregated at the hospital level. Each hospital (n = 549) was observed for 4 years and was geographically located within a "Sistema Locale del Lavoro" (SLL, i.e., clusters of neighboring towns with a common economic structure). For each SLL, the intensity of the crisis was determined, defined as the 2012-2008 increase in the area-specific unemployment rate. A difference-in-differences (DiD) approach was employed to compare the increases in AMI-related outcomes across different quintiles of crisis intensity. Results Hospitals located in areas with the highest intensity of crisis (in the fifth quintile) had an increase of approximately 30 AMI cases annually (approximately 13%) compared with hospitals in area with lower crisis intensities (p<0.001). A significant increase in total hospital days was observed (13%, p<0.001) in addition to in-hospital mortality (17%, p<0.001). As a consequence, an increase of around (sci)350.000 was incurred in annual hospital expenditures for AMI (approximately 36%, p<0.001). Conclusions More attention should be given to the increase in health needs associated with the financial crisis. Policies aimed to contrast unemployment in the community by keeping and reintegrating workers in jobs could also have positive impacts on adverse health outcomes, especially in areas of high crisis intensity.	[Torbica, Aleksandra; Ghislandi, Simone] Bocconi Univ, Dept Policy Anal & Publ Management, Ctr Res Hlth & Social Care Management CERGAS, Milan, Italy; [Maggioni, Aldo Pietro] Italian Assoc Hosp Cardiologists ANMCO Res Ctr, Florence, Italy; [Ghislandi, Simone] Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy	Bocconi University; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Bocconi University	Torbica, A (corresponding author), Bocconi Univ, Dept Policy Anal & Publ Management, Ctr Res Hlth & Social Care Management CERGAS, Milan, Italy.	Aleksandra.torbica@unibocconi.it	Maggioni, Aldo Pietro/AAL-5334-2020	Maggioni, Aldo Pietro/0000-0003-2764-6779; Torbica, Aleksandra/0000-0001-8938-7608				Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Bernal JAL, 2013, EUR J PUBLIC HEALTH, V23, P732, DOI 10.1093/eurpub/ckt083; Bonamore G, 2015, SOC SCI MED, V126, P67, DOI 10.1016/j.socscimed.2014.12.017; De Vogli R, 2013, J EPIDEMIOL COMMUN H, V67, P298, DOI 10.1136/jech-2012-202112; Dupre ME, 2012, ARCH INTERN MED, V172, P1731, DOI 10.1001/2013.jamainternmed.447; Edmondson D, 2013, EUR HEART J, V34, P300, DOI 10.1093/eurheartj/ehs398; El-Sayed AM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-18; Gallo WT, 2000, J GERONTOL B-PSYCHOL, V55, pS131, DOI 10.1093/geronb/55.3.S131; Gallo WT, 2004, AM J IND MED, V45, P408, DOI 10.1002/ajim.20004; Gallus S, 2015, TOB CONTROL, V24, P82, DOI 10.1136/tobaccocontrol-2012-050856; Hernandez AV, 2012, HEART, V98, P185, DOI 10.1136/heartjnl-2011-300599; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; Martin-Moreno JM, 2010, EUR J CANCER, V46, P2525, DOI 10.1016/j.ejca.2010.07.048; Nascimento BR, 2014, HEART, V100, P1743, DOI 10.1136/heartjnl-2014-306026; Reeves A, 2014, HEALTH POLICY, V115, P1, DOI 10.1016/j.healthpol.2013.11.008; Reeves A, 2012, LANCET, V380, P1813, DOI 10.1016/S0140-6736(12)61910-2; Ruhm CJ, 2007, DEMOGRAPHY, V44, P829, DOI 10.1007/BF03208384; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Ruhm CJ, 2005, J HEALTH ECON, V24, P341, DOI 10.1016/j.jhealeco.2004.09.007; Stuckler D, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-1; Stuckler D, 2013, J EPIDEMIOL COMMUN H, V67, P467, DOI 10.1136/jech-2012-201903; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Svensson M, 2007, SOC SCI MED, V65, P833, DOI 10.1016/j.socscimed.2007.04.015; Vahtera J, 2004, BMJ-BRIT MED J, V328, P555, DOI 10.1136/bmj.37972.496262.0D	28	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142810	10.1371/journal.pone.0142810	http://dx.doi.org/10.1371/journal.pone.0142810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7BR	26574745	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400018
J	Drum, RG; Ribic, CA; Koch, K; Lonsdorf, E; Grant, E; Ahlering, M; Barnhill, L; Dailey, T; Lor, S; Mueller, C; Pavlacky, DC; Rideout, C; Sample, D				Drum, Ryan G.; Ribic, Christine A.; Koch, Katie; Lonsdorf, Eric; Grant, Evan; Ahlering, Marissa; Barnhill, Laurel; Dailey, Thomas; Lor, Socheata; Mueller, Connie; Pavlacky, David C., Jr.; Rideout, Catherine; Sample, David			Strategic Grassland Bird Conservation throughout the Annual Cycle: Linking Policy Alternatives, Landowner Decisions, and Biological Population Outcomes	PLOS ONE			English	Article							UNITED-STATES; TREATY ACT; AMERICA; MEXICO	Grassland bird habitat has declined substantially in the United States. Remaining grasslands are increasingly fragmented, mostly privately owned, and vary greatly in terms of habitat quality and protection status. A coordinated strategic response for grassland bird conservation is difficult, largely due to the scope and complexity of the problem, further compounded by biological, sociological, and economic uncertainties. We describe the results from a collaborative Structured Decision Making (SDM) workshop focused on linking social and economic drivers of landscape change to grassland bird population outcomes. We identified and evaluated alternative strategies for grassland bird conservation using a series of rapid prototype models. We modeled change in grassland and agriculture cover in hypothetical landscapes resulting from different landowner decisions in response to alternative socio-economic conservation policy decisions. Resulting changes in land cover at all three stages of the annual cycle (breeding, wintering, and migration) were used to estimate changes in grassland bird populations. Our results suggest that successful grassland bird conservation may depend upon linkages with ecosystem services on working agricultural lands and grassland-based marketing campaigns to engage the public. With further development, spatial models that link landowner decisions with biological outcomes can be essential tools for making conservation policy decisions. A coordinated non-traditional partnership will likely be necessary to clearly understand and systematically respond to the many conservation challenges facing grassland birds.	[Drum, Ryan G.] US Fish & Wildlife Serv, Bloomington, MN 47403 USA; [Ribic, Christine A.] US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA; [Koch, Katie] US Fish & Wildlife Serv, Div Migratory Birds, Marquette, MI USA; [Lonsdorf, Eric] Franklin & Marshal Coll, Lancaster, PA USA; [Grant, Evan] US Geol Survey, Patuxent Wildlife Res Ctr, SO Conte Anadromous Fish Lab, Turners Falls, MA USA; [Ahlering, Marissa] Nature Conservancy, Brookings, SD USA; [Barnhill, Laurel] US Fish & Wildlife Serv, Inventory & Monitoring, Athens, GA USA; [Dailey, Thomas] Natl Bobwhite Conservat Initiat, Columbia, MO USA; [Lor, Socheata] US Fish & Wildlife Serv, Anchorage, AK USA; [Mueller, Connie] US Fish & Wildlife Serv, Waubay, SD USA; [Pavlacky, David C., Jr.] Bird Conservancy Rockies, Brighton, CO USA; [Rideout, Catherine] Auburn Univ, East Gulf Coastal Plain Joint Venture, US Fish & Wildlife Serv, Auburn, AL 36849 USA; [Sample, David] Wisconsin Dept Nat Resources, Madison, WI USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; Franklin & Marshall College; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; Auburn University System; Auburn University; United States Department of the Interior; US Fish & Wildlife Service	Drum, RG (corresponding author), US Fish & Wildlife Serv, Bloomington, MN 47403 USA.	ryan_drum@fws.gov	, David/U-4871-2018	, David/0000-0002-8457-8023; Lonsdorf, Eric/0000-0002-2899-8576	U.S. Fish and Wildlife Service; National Conservation Training Center; U.S. Fish and Wildlife Service National Conservation Training Center (NCTC); U.S. Geological Survey	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); National Conservation Training Center; U.S. Fish and Wildlife Service National Conservation Training Center (NCTC); U.S. Geological Survey(United States Geological Survey)	Funding for this work was provided by the U.S. Fish and Wildlife Service; the Structured Decision Making workshop was hosted by the National Conservation Training Center. Funding for publication expenses was provided by the Department of Forest and Wildlife Ecology, University of Wisconsin-Madison.; The authors wish to thank the U.S. Fish and Wildlife Service National Conservation Training Center (NCTC) and the U.S. Geological Survey for their support. We also thank E. Nelson for comments on a previous draft of this manuscript and the Department of Forest and Wildlife Ecology, University of Wisconsin-Madison, for providing publication expenses.	Askins Robert A., 2007, Ornithological Monographs, V64, pi; Audubon Minnesota, 2014, GRASSHOPPER SPARROW; Azpiroz AB, 2012, J FIELD ORNITHOL, V83, P217, DOI 10.1111/j.1557-9263.2012.00372.x; Balint PJ., 2011, WICKED ENV PROBLEMS, P253, DOI [10.5822/978-1-61091-047-7, DOI 10.5822/978-1-61091-047-7]; BERLANGA H., 2010, SAVING OUR SHARED BI; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Ciuzio E, 2013, WILDLIFE SOC B, V37, P267, DOI 10.1002/wsb.266; Cooper T. R., 2012, STATUS ASSESSMENT CO; EDWARDS W, 1977, IEEE T SYST MAN CYB, V7, P326, DOI 10.1109/TSMC.1977.4309720; Evans TP, 2004, J ENVIRON MANAGE, V72, P57, DOI 10.1016/j.jenvman.2004.02.008; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Faber S., 2012, PLOWED CROP SUBSIDIE; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Fjetland CA, 2000, NAT RESOUR J, V40, P47; Grant EHC, 2013, CONSERV BIOL, V27, P1245, DOI 10.1111/cobi.12137; Macias-Duarte A, 2013, AUK, V130, P141, DOI 10.1525/auk.2012.12047; Manson SM, 2007, P NATL ACAD SCI USA, V104, P20678, DOI 10.1073/pnas.0705802104; Means B, 1998, MICH LAW REV, V97, P823, DOI 10.2307/1290321; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Murphy MT, 2003, AUK, V120, P20, DOI 10.1642/0004-8038(2003)120[0020:APTWTE]2.0.CO;2; Partners in Flight Science Committee, SPEC ASS DAT VERS 20; Peterjohn BG, 1999, STUD AVIAN BIOL, P27; Pool DB, 2014, BIOL CONSERV, V170, P274, DOI 10.1016/j.biocon.2013.12.019; Runge M, 2009, INTRO STRUCTURED DEC; Runge MC, 2011, J FISH WILDL MANAG, V2, P220, DOI 10.3996/082011-JFWM-045; Sample DW, 2003, LANDSCAPE ECOLOGY AND RESOURCE MANAGEMENT: LINKING THEORY WITH PRACTICE, P359; SAMPLE DW, 2008, VANISHING PRESENT WI, P301; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Samson F.B., 1998, STATUS TRENDS NATION, V2, P437; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; Swaty R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023002; U.S. Fish and Wildlife Service-Migratory Bird Program, 2012, MIGR BIRD PROGR FOC; USDA Farm Service Agency, CONS RES PROGR ENR C; Vickery PD, 1999, STUD AVIAN BIOL, P2; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams BK, 2011, J ENVIRON MANAGE, V92, P1346, DOI 10.1016/j.jenvman.2010.10.041; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	37	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142525	10.1371/journal.pone.0142525	http://dx.doi.org/10.1371/journal.pone.0142525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569108	Green Submitted, gold, Green Published			2022-12-26	WOS:000365070700048
J	Katorcha, E; Klimova, N; Makarava, N; Savtchenko, R; Pan, XF; Annunziata, I; Takahashi, K; Miyagi, T; Pshezhetsky, AV; d'Azzo, A; Baskakov, IV				Katorcha, Elizaveta; Klimova, Nina; Makarava, Natallia; Savtchenko, Regina; Pan, Xuefang; Annunziata, Ida; Takahashi, Kohta; Miyagi, Taeko; Pshezhetsky, Alexey V.; d'Azzo, Alessandra; Baskakov, Ilia V.			Loss of Cellular Sialidases Does Not Affect the Sialylation Status of the Prion Protein but Increases the Amounts of Its Proteolytic Fragment C1	PLOS ONE			English	Article							TRUNCATED FORMS; SCRAPIE; EXPRESSION; CLEAVAGE; IDENTIFICATION; BRAIN; MICE; DIFFERENTIATION; NEURITOGENESIS; NEURAMINIDASE	The central molecular event underlying prion diseases involves conformational change of the cellular form of the prion protein (PrPC), which is a sialoglycoprotein, into the disease-associated, transmissible form denoted PrPSc. Recent studies revealed a correlation between the sialylation status of PrPSc and incubation time to disease and introduced a new hypothesis that progression of prion diseases could be controlled or reversed by altering the sialylation level of PrPC. Of the four known mammalian sialidases, the enzymes that cleave off sialic acid residues, only NEU1, NEU3 and NEU4 are expressed in the brain. To test whether cellular sialidases control the steady-state sialylation level of PrPC and to identify the putative sialidase responsible for desialylating PrPC, we analyzed brain-derived PrPC from knockout mice deficient in Neu1, Neu3, Neu4, or from Neu3/Neu4 double knockouts. Surprisingly, no differences in the sialylation of PrPC or its proteolytic product C1 were noticed in any of the knockout mice tested as compared to the age-matched controls. However, significantly higher amounts of the C1 fragment relative to full-length PrPC were detected in the brains of Neu1 knockout mice as compared to WT mice or to the other knockout mice. Additional experiments revealed that in neuroblastoma cell line the sialylation pattern of C1 could be changed by an inhibitor of sialylatransferases. In summary, this study suggests that targeting cellular sialidases is apparently not the correct strategy for altering the sialylation levels of PrPC, whereas modulating the activity of sialylatransferases might offer a more promising approach. Our findings also suggest that catabolism of PrPC involves its a-cleavage followed by desialylation of the resulting C1 fragments by NEU1 and consequent fast degradation of the desialylated products.	[Katorcha, Elizaveta; Klimova, Nina; Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Katorcha, Elizaveta; Klimova, Nina; Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Pan, Xuefang; Pshezhetsky, Alexey V.] Univ Montreal, Div Med Genet, St Justine Univ Hosp Res Ctr, Montreal, PQ, Canada; [Annunziata, Ida; d'Azzo, Alessandra] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; [Takahashi, Kohta; Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Universite de Montreal; St Jude Children's Research Hospital; Tohoku Medical & Pharmaceutical University	Baskakov, IV (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	Baskakov@umaryland.edu			NIH [NS045585, NS074998, GM60905, DK52025]; Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan [23110002]; Canadian Diabetes Association; Canadian Institutes of Health Research [FRN 15079]; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities (ALSAC); National Tay-Sachs & Allied Disease Association (NTSAD); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052025, Z01DK052025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM060905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074998, R01NS045585, R56NS074998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Canadian Diabetes Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); National Tay-Sachs & Allied Disease Association (NTSAD); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a NIH grants NS045585 and NS074998 to IVB; by Grants-in-Aid for Scientific Research on Innovative Areas (No. 23110002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TM; and by the research grants from Canadian Diabetes Association (www.diabetes.ca) and from Canadian Institutes of Health Research (FRN 15079) to AVP. A.d'A. holds the Jewelers for Children Endowed Chair in Genetics and Gene Therapy. I.A. and A.d'A. were funded in part by NIH grants GM60905 and DK52025, the Assisi Foundation of Memphis, the American Lebanese Syrian Associated Charities (ALSAC) and the National Tay-Sachs & Allied Disease Association (NTSAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albohy A, 2013, ACS MED CHEM LETT, V4, P532, DOI 10.1021/ml400080t; Annunziata I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3734; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Barnewitz K, 2006, NEUROREPORT, V17, P527, DOI 10.1097/01.wnr.0000209003.55728.ac; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2014, CELL MOL LIFE SCI, V71, P2017, DOI 10.1007/s00018-013-1538-3; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Burkart MD, 2000, BIOORGAN MED CHEM, V8, P1937, DOI 10.1016/S0968-0896(00)00139-5; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; de Geest N, 2002, HUM MOL GENET, V11, P1455, DOI 10.1093/hmg/11.12.1455; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Endres K, 2009, NEUROBIOL DIS, V36, P233, DOI 10.1016/j.nbd.2009.07.015; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Jen A, 2010, J CELL SCI, V123, P246, DOI 10.1242/jcs.058099; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Katorcha E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004366; Kong QZ, 2012, PRION, V6, P120; Kornblatt JA, BIOCH BIOPHYS RES CO, V305, P518; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee YJ, 2014, PRION, V8, P266, DOI 10.4161/pri.32079; Lee YJ, 2013, J NEUROCHEM, V124, P310, DOI 10.1111/j.1471-4159.2012.07913.x; Liang JJ, 2012, J BIOL CHEM, V287, P16510, DOI 10.1074/jbc.M112.360891; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Macauley MS, 2014, J BIOL CHEM, V289, P35149, DOI 10.1074/jbc.M114.606517; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Minami A, 2011, NEUROIMAGE, V58, P34, DOI 10.1016/j.neuroimage.2011.06.017; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Pan T, 2002, J NEUROCHEM, V81, P1092, DOI 10.1046/j.1471-4159.2002.00909.x; Pan T, 2001, J BIOL CHEM, V276, P37284, DOI 10.1074/jbc.M107358200; Parizek P, 2001, J BIOL CHEM, V276, P44627, DOI 10.1074/jbc.M107458200; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Praus M, 2003, THROMB HAEMOSTASIS, V89, P812, DOI 10.1055/s-0037-1613466; Proshin S, 2002, NEUROCHEM RES, V27, P841, DOI 10.1023/A:1020269326825; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Sales N, 2002, EUR J NEUROSCI, V15, P1163, DOI 10.1046/j.1460-9568.2002.01953.x; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Smutova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106320; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stoppani E, 2009, CELL BIOL INT, V33, P1020, DOI 10.1016/j.cellbi.2009.06.005; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Yamaguchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041132; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; Zanoteli E, 2010, BBA-MOL BASIS DIS, V1802, P659, DOI 10.1016/j.bbadis.2010.04.002; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200	67	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143218	10.1371/journal.pone.0143218	http://dx.doi.org/10.1371/journal.pone.0143218			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569607	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700152
J	Okumura, T; Furuichi, K; Higashide, T; Sakurai, M; Hashimoto, S; Shinozaki, Y; Hara, A; Iwata, Y; Sakai, N; Sugiyama, K; Kaneko, S; Wada, T				Okumura, Toshiya; Furuichi, Kengo; Higashide, Tomomi; Sakurai, Mayumi; Hashimoto, Shin-ichi; Shinozaki, Yasuyuki; Hara, Akinori; Iwata, Yasunori; Sakai, Norihiko; Sugiyama, Kazuhisa; Kaneko, Shuichi; Wada, Takashi			Association of PAX2 and Other Gene Mutations with the Clinical Manifestations of Renal Coloboma Syndrome	PLOS ONE			English	Article							KIDNEY; PHENOTYPE; NEPHROGENESIS; EXPRESSION; HYPOPLASIA; APOPTOSIS; DISORDER; FAMILY; SIX1	Background Renal coloboma syndrome (RCS) is characterized by renal anomalies and optic nerve colobomas. PAX2 mutations contribute to RCS. However, approximately half of the patients with RCS have no mutation in PAX2 gene. Methods To investigate the incidence and effects of mutations of PAX2 and 25 candidate genes, patient genes were screened using next-generation sequence analysis, and candidate mutations were confirmed using Sanger sequencing. The correlation between mutations and clinical manifestation was evaluated. Result Thirty patients, including 26 patients (two families of five and two, 19 sporadic cases) with RCS, and 4 optic nerve coloboma only control cases were evaluated in the present study. Six PAX2 mutations in 21 probands [28%; two in family cohorts (n = 5 and n = 2) and in 4 out of 19 patients with sporadic disease] including four novel mutations were confirmed using Sanger sequencing. Moreover, four other sequence variants (CHD7, SALL4, KIF26B, and SIX4) were also confirmed, including a potentially pathogenic novel KIF26B mutation. Kidney function and proteinuria were more severe in patients with PAX2 mutations than in those without the mutation. Moreover, the coloboma score was significantly higher in patients with PAX2 gene mutations. Three out of five patients with PAX2 mutations had focal segmental glomerulosclerosis (FSGS) diagnosed from kidney biopsies. Conclusion The results of this study identify several new mutations of PAX2, and sequence variants in four additional genes, including a novel potentially pathogenic mutation in KIF26B, which may play a role in the pathogenesis of RCS.	[Okumura, Toshiya; Furuichi, Kengo; Hara, Akinori; Sakai, Norihiko; Kaneko, Shuichi] Kanazawa Univ, Fac Med, Dept Dis Control, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Furuichi, Kengo; Sakai, Norihiko] Kanazawa Univ Hosp, Div Blood Purificat, Kanazawa, Ishikawa, Japan; [Higashide, Tomomi; Sakurai, Mayumi; Sugiyama, Kazuhisa] Kanazawa Univ, Fac Med, Dept Ophthalmol, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Higashide, Tomomi; Sakurai, Mayumi; Sugiyama, Kazuhisa] Kanazawa Univ, Fac Med, Dept Visual Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Hashimoto, Shin-ichi; Shinozaki, Yasuyuki; Iwata, Yasunori; Wada, Takashi] Kanazawa Univ, Fac Med, Div Nephrol, Dept Lab Med,Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University	Furuichi, K (corresponding author), Kanazawa Univ, Fac Med, Dept Dis Control, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan.	kfuruichi@m-kanazawa.jp	Hara, Akinori/W-8522-2019		Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government [22590883, 26293126, 15K15328]; Grants-in-Aid for Scientific Research [15K09251, 15K15328] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aids from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government (#22590883, #26293126, #15K15328). There was no additional external funding received for this study.	Abraham S, 2015, J BIOL CHEM, V290, P7185, DOI 10.1074/jbc.M114.607424; Amiel J, 2000, EUR J HUM GENET, V8, P820, DOI 10.1038/sj.ejhg.5200539; Barua M, 2014, J AM SOC NEPHROL, V25, P1942, DOI 10.1681/ASN.2013070686; Bower M, 2012, HUM MUTAT, V33, P457, DOI 10.1002/humu.22020; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Cheong HI, 2007, PEDIATR NEPHROL, V22, P1283, DOI 10.1007/s00467-007-0525-z; Clark P, 2004, J AM SOC NEPHROL, V15, P299, DOI 10.1097/01.ASN.0000111248.23454.19; Cunliffe HE, 1998, J MED GENET, V35, P806, DOI 10.1136/jmg.35.10.806; Dureau P, 2001, OPHTHALMOLOGY, V108, P1912, DOI 10.1016/S0161-6420(01)00722-9; Dziarmaga A, 2006, PEDIATR NEPHROL, V21, P26, DOI 10.1007/s00467-005-2039-x; Eccles MR, 1996, HUM MOL GENET, V5, P1425, DOI 10.1093/hmg/5.Supplement_1.1425; Eccles MR, 1999, CLIN GENET, V56, P1, DOI 10.1034/j.1399-0004.1999.560101.x; Ford B, 2001, AM J MED GENET, V99, P137, DOI 10.1002/1096-8628(2000)9999:999<00::AID-AJMG1143>3.0.CO;2-F; Gong KQ, 2007, MOL CELL BIOL, V27, P7661, DOI 10.1128/MCB.00465-07; Grifone R, 2005, DEVELOPMENT, V132, P2235, DOI 10.1242/dev.01773; Higashide T, 2005, AM J OPHTHALMOL, V139, P203, DOI 10.1016/j.ajo.2004.07.021; Hill GS, 2011, KIDNEY INT, V79, P635, DOI 10.1038/ki.2010.466; Iatropoulos P, 2012, PEDIATR NEPHROL, V27, P1989, DOI 10.1007/s00467-012-2205-x; NAITO T, 1989, NEPHRON, V51, P115, DOI 10.1159/000185264; Ohtaka A, 2002, AM J KIDNEY DIS, V39, P475, DOI 10.1053/ajkd.2002.31391; Ozaki H, 2004, DEVELOPMENT, V131, P551, DOI 10.1242/dev.00943; Patel SR, 2014, PEDIATR NEPHROL, V29, P589, DOI 10.1007/s00467-013-2603-8; Porteous S, 2000, HUM MOL GENET, V9, P1, DOI 10.1093/hmg/9.1.1; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; SANYANUSIN P, 1995, HUM MOL GENET, V4, P2183, DOI 10.1093/hmg/4.11.2183; Schimmenti LA, 1997, AM J HUM GENET, V60, P869; Schimmenti Lisa A, 2003, Ophthalmic Genet, V24, P191, DOI 10.1076/opge.24.4.191.17229; Schimmenti LA, 2011, EUR J HUM GENET, V19, P1207, DOI 10.1038/ejhg.2011.102; Taranta A, 2007, CLIN NEPHROL, V67, P1; Torban E, 2000, AM J PATHOL, V157, P833, DOI 10.1016/S0002-9440(10)64597-X; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107	31	22	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142843	10.1371/journal.pone.0142843	http://dx.doi.org/10.1371/journal.pone.0142843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571382	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700084
J	Wu, XB; Yu, J; Gao, GL; Wang, X; Liu, Y; Zhu, SR; Gong, ZJ				Wu, Xiangbing; Yu, Jun; Gao, Guilin; Wang, Xin; Liu, Yang; Zhu, Shengrong; Gong, Zhongjian			Salivary Heparanase Level Is a Potential Biomarker to Diagnose and Prognose the Malignant Salivary Gland Tumor	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; CANCER; EXPRESSION; CARCINOMA; MARKERS; ANGIOGENESIS; METASTASIS; PROTEOMICS; WOMEN	Background Upregulation of heparanase has been reported in an increasing number of human cancer tissues. However, the level of salivary heparanase and its clinical significance in patients with salivary gland tumors remain unclear. Methods Salivary heparanase levels in patients with salivary gland tumors were detected using enzyme-linked immunosorbent assays (ELISAs) and the clinical significance was evaluated by analyzing the correlations among salivary heparanase levels, clinicopathological parameters, and clinical outcomes. Results The levels of salivary heparanase were significantly higher in patients with malignant salivary gland tumors than in benign tumors and normal controls (P < 0.0001). High salivary heparanase levels were positively correlated with increased lymph node metastasis (P = 0.0235) and poorer tumor node metastasis stage (TNM) (P = 0.0183). Survival analyses revealed that high salivary heparanase levels were associated with worse overall survival (P = 0.0023) and disease-free survival (DFS) (P = 0.0025). Conclusions The study shows that salivary heparanase levels, as detected by the ELISAs, can be used to diagnose and provide an accurate prognosis for malignant salivary gland tumors. Salivary heparanase level was an independent predictor in patients with malignant salivary gland tumors.	[Wu, Xiangbing; Yu, Jun; Wang, Xin; Liu, Yang; Gong, Zhongjian] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Stomatol, Wuxi, Peoples R China; [Gao, Guilin] Cent Hosp Enshi Autonomous Prefecture, Ctr Stomatol, Enshi, Peoples R China; [Zhu, Shengrong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Stomatol, Wuhan 430074, Peoples R China	Jiangnan University; Nanjing Medical University; Huazhong University of Science & Technology	Gong, ZJ (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Stomatol, Wuxi, Peoples R China.	gongzj2005@163.com			Science and Technology Development Foundation of Nanjing Medical University [JMUZD058]; National Natural Science Foundation of China [81502347]; Natural Science Foundation of jiangsu Province of China [BK20150119]	Science and Technology Development Foundation of Nanjing Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of jiangsu Province of China(Natural Science Foundation of Jiangsu Province)	This study was supported by the Science and Technology Development Foundation of Nanjing Medical University (JMUZD058), and partially supported by National Natural Science Foundation of China (81502347) and Natural Science Foundation of jiangsu Province of China (BK20150119). Especially, the publication fee will be supported by these two fundings above.	Arregger AL, 2007, CLIN ENDOCRINOL, V67, P656, DOI 10.1111/j.1365-2265.2007.02937.x; Bansal Ajay Kumar, 2012, Dent Res J (Isfahan), V9, pS9; Ben-Izhak O, 2006, NEOPLASIA, V8, P879, DOI 10.1593/neo.06382; Ferro V, 2004, MINI-REV MED CHEM, V4, P693, DOI 10.2174/1389557043403729; Gallo Alessia, 2013, Methods Mol Biol, V1024, P183, DOI 10.1007/978-1-62703-453-1_14; Gursoy UK, 2010, J CLIN PERIODONTOL, V37, P487, DOI 10.1111/j.1600-051X.2010.01563.x; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Koss Myriam A, 2009, Acta odontol. latinoam., V22, P105; Maruya S, 2004, J MOL DIAGN, V6, P180, DOI 10.1016/S1525-1578(10)60508-9; Meirovitz A, 2011, CANCER RES, V71, P2772, DOI 10.1158/0008-5472.CAN-10-3402; Nadir Y, 2014, THROMB RES, V133, pS90, DOI 10.1016/S0049-3848(14)50015-1; Nagler R, 2007, CANCER-AM CANCER SOC, V110, P2732, DOI 10.1002/cncr.23095; Nobuhisa T, 2005, J CANCER RES CLIN, V131, P229, DOI 10.1007/s00432-004-0644-x; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pascoe SJS, 2009, AIDS PATIENT CARE ST, V23, P571, DOI 10.1089/apc.2008.0225; Peeters KABM, 2011, INT ARCH ALLERGY IMM, V155, P23, DOI 10.1159/000318654; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Punyadeera C, 2011, J IMMUNOL METHODS, V373, P19, DOI 10.1016/j.jim.2011.07.013; Shafat I, 2006, BIOCHEM BIOPH RES CO, V341, P958, DOI 10.1016/j.bbrc.2006.01.048; Shibayama Y, 2009, J CHROMATOGR B, V877, P2615, DOI 10.1016/j.jchromb.2008.10.051; Stenman G, 2014, ORAL ONCOL, V50, P683, DOI 10.1016/j.oraloncology.2014.04.008; Streckfus C, 2000, CLIN CANCER RES, V6, P2363; Vibarel-Rebot N, 2015, CONTRACEPTION, V91, P245, DOI 10.1016/j.contraception.2014.11.010; Vlodavsky I, 2008, NEOPLASIA, V10, P125, DOI 10.1593/neo.07875; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Winter J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-465; Wong DT, 2006, J AM DENT ASSOC, V137, P313, DOI 10.14219/jada.archive.2006.0180; Xu YY, 2009, ASIAN PAC J CANCER P, V10, P151; Zelin J, 2008, INT J STD AIDS, V19, P665, DOI 10.1258/ijsa.2008.008132; Zeng C, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0403-9; Zhang AH, 2013, CLIN CHIM ACTA, V415, P261, DOI 10.1016/j.cca.2012.11.001; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010; Zhao D, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0619-3	33	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143009	10.1371/journal.pone.0143009	http://dx.doi.org/10.1371/journal.pone.0143009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569485	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700115
J	Zhu, XF; Wang, WX; Zhang, X; Bai, JH; Chen, G; Li, L; Li, MZ				Zhu, Xinfeng; Wang, Wenxue; Zhang, Xia; Bai, Jianhua; Chen, Gang; Li, Li; Li, Meizhang			All-Trans Retinoic Acid-Induced Deficiency of the Wnt/beta-Catenin Pathway Enhances Hepatic Carcinoma Stem Cell Differentiation	PLOS ONE			English	Article							BETA-CATENIN; ACTIVATION; WNT; PHOSPHORYLATION; PROLIFERATION; RECEPTORS; MIGRATION; ATRA; PHARMACOKINETICS; CHEMOTHERAPY	Retinoic acid (RA) is an important biological signal that directly differentiates cells during embryonic development and tumorigenesis. However, the molecular mechanism of RA-mediated differentiation in hepatic cancer stem cells (hCSCs) is not well understood. In this study, we found that mRNA expressions of RA-biosynthesis-related dehydrogenases were highly expressed in hepatocellular carcinoma. All-trans retinoic acid (ATRA) differentiated hCSCs through inhibiting the function of beta-catenin in vitro. ATRA also inhibited the function of PI3K-AKT and enhanced GSK-3 beta-dependent degradation of phosphorylated beta-catenin. Furthermore, ATRA and beta-catenin silencing both increased hCSC sensitivity to docetaxel treatment. Our results suggest that targeting beta-catenin will provide extra benefits for ATRA-mediated treatment of hepatic cancer patients.	[Zhu, Xinfeng; Zhang, Xia; Bai, Jianhua; Chen, Gang; Li, Li] Kunming Med Univ, Affiliated Calmette Hosp, Kunming 650011, Yunnan Province, Peoples R China; [Wang, Wenxue; Li, Meizhang] Yunnan Univ, Sch Life Sci, Lab Biochem & Mol Biol, Kunming 650091, Yunnan Province, Peoples R China	Kunming Medical University; Yunnan University	Li, L (corresponding author), Kunming Med Univ, Affiliated Calmette Hosp, Kunming 650011, Yunnan Province, Peoples R China.	ynkmlili62@hotmail.com.cn; mzhli@ynu.edu.cn			Yunnan Province New Academic Talent Award [YN201418]; Yunnan Province Science and Technology Agency Researching Program of Basic and Applied Sciences [2013FZ292]; National Natural Science Foundation of China [81271330, 31160237, 31260276]; Yunnan Province Science and Technology Innovation Team [2011CI123]; Talent Program of Yunnan Province [W8110305]; Foundation of School of Life Sciences of Yunnan University [2012S301]; Natural Science Foundation of Yunnan Province [2011BC003]	Yunnan Province New Academic Talent Award; Yunnan Province Science and Technology Agency Researching Program of Basic and Applied Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Science and Technology Innovation Team; Talent Program of Yunnan Province; Foundation of School of Life Sciences of Yunnan University; Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	Yunnan Province New Academic Talent Award 2014 (No. YN201418), study design, data collection and analysis, decision to publish, and preparation of the manuscript. Yunnan Province Science and Technology Agency Researching Program of Basic and Applied Sciences (No. 2013FZ292), study design, decision to publish, and preparation of the manuscript. National Natural Science Foundation of China (No. 81271330), http://www.nsfc.gov.cn/, study design, data collection and analysis, decision to publish, and preparation of the manuscript. National Natural Science Foundation of China (No. 31160237), http://www.nsfc.gov.cn/, study design, data collection and analysis, decision to publish, and preparation of the manuscript. National Natural Science Foundation of China No. 31260276), http://www.nsfc.gov.cn/, study design, data collection and analysis, decision to publish, and preparation of the manuscript. Yunnan Province Science and Technology Innovation Team (No. 2011CI123), http://www.ynstc.gov.cn/, study design, data collection and analysis, decision to publish, and preparation of the manuscript. Talent Program of Yunnan Province (No. W8110305), http://www.ynstc.gov.cn/ study design, data collection and analysis, decision to publish, and preparation of the manuscript. Foundation of School of Life Sciences of Yunnan University (No. 2012S301), http://www.ynusky.ynu.edu.cn/, study design, data collection and analysis, decision to publish, and preparation of the manuscript. Natural Science Foundation of Yunnan Province (No. 2011BC003), http://www.ynstc.gov.cn/, study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Arrieta O, 2010, J CLIN ONCOL, V28, P3463, DOI 10.1200/JCO.2009.26.6452; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Bryan M, 2011, INVEST NEW DRUG, V29, P1482, DOI 10.1007/s10637-010-9478-3; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; David KA, 2010, CANCER BIOL THER, V9, P678, DOI 10.4161/cbt.9.9.11436; DETERAWADLEIGH SD, 1994, MOL PHYLOGENET EVOL, V3, P192, DOI 10.1006/mpev.1994.1022; Dey N, 2007, MOL CELL BIOL, V27, P4179, DOI 10.1128/MCB.01352-06; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Douer D, 2001, BLOOD, V97, P73, DOI 10.1182/blood.V97.1.73; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Estey E, 1996, BLOOD, V87, P3650, DOI 10.1182/blood.V87.9.3650.bloodjournal8793650; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gupta P, 2008, P NATL ACAD SCI USA, V105, P11424, DOI 10.1073/pnas.0710561105; Gutierrez-Mazariegos J, 2014, ENDOCRINOLOGY, V155, P4275, DOI 10.1210/en.2014-1181; Gutierrez-Mazariegos J, 2014, SUBCELL BIOCHEM, V70, P55, DOI 10.1007/978-94-017-9050-5_4; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Hu X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.424; Itoh T, 2009, FEBS LETT, V583, P777, DOI 10.1016/j.febslet.2009.01.022; Kon J, 2006, J HEPATOL, V45, P90, DOI 10.1016/j.jhep.2006.01.029; Lei ZJ, 2015, ONCOGENE, V34, P3188, DOI 10.1038/onc.2015.129; Liu Y, 2014, INT J BIOCHEM CELL B, V47, P47, DOI 10.1016/j.biocel.2013.11.018; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; Martin-Padura I, 2012, LAB INVEST, V92, P952, DOI 10.1038/labinvest.2012.65; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Mongan NP, 2007, DIFFERENTIATION, V75, P853, DOI 10.1111/j.1432-0436.2007.00206.x; Muralidharan S, 2011, J IMMUNOL, V187, P5221, DOI 10.4049/jimmunol.1101585; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ozpolat B, 2003, J PHARM PHARM SCI, V6, P292; Ozpolat B, 2002, LEUKEMIA LYMPHOMA, V43, P933, DOI 10.1080/10428190290021678; Paez Juan, 2003, Cancer Treat Res, V115, P145; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Piskunov A, 2012, ONCOGENE, V31, P3333, DOI 10.1038/onc.2011.499; Rich JN, 2007, CELL STEM CELL, V1, P353, DOI 10.1016/j.stem.2007.09.011; Rinaldi F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.546; Ring A, 2014, STEM CELL REV REP, V10, P512, DOI 10.1007/s12015-014-9515-2; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; Schenk T, 2014, BRIT J CANCER, V111, P2039, DOI 10.1038/bjc.2014.412; Shah S, 2002, J BIOL CHEM, V277, P25313, DOI 10.1074/jbc.M203158200; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stavridis MP, 2010, DEVELOPMENT, V137, P881, DOI 10.1242/dev.043117; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; World Health Organization, WORLD CANC REPORT 20; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhang XJ, 2013, INT J BIOL SCI, V9, P1108, DOI 10.7150/ijbs.7232; Zulehner G, 2010, AM J PATHOL, V176, P472, DOI 10.2353/ajpath.2010.090300	66	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143255	10.1371/journal.pone.0143255	http://dx.doi.org/10.1371/journal.pone.0143255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571119	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700154
J	Nyati, P; Rivera-Perez, C; Noriega, FG				Nyati, Pratik; Rivera-Perez, Crisalejandra; Noriega, Fernando G.			Negative Feedbacks by Isoprenoids on a Mevalonate Kinase Expressed in the Corpora Allata of Mosquitoes	PLOS ONE			English	Article							JUVENILE-HORMONE BIOSYNTHESIS; SEQUENCE; PATHWAYS; IDENTIFICATION; PURIFICATION; CHOLESTEROL; INHIBITION; MECHANISM; CLONING; LIVER	Background Juvenile hormones (JH) regulate development and reproductive maturation in insects. JHs are synthesized through the mevalonate pathway (MVAP), an ancient metabolic pathway present in the three domains of life. Mevalonate kinase (MVK) is a key enzyme in the MVAP. MVK catalyzes the synthesis of phosphomevalonate (PM) by transferring the gamma-phosphoryl group from ATP to the C-5 hydroxyl oxygen of mevalonic acid (MA). Despite the importance of MVKs, these enzymes have been poorly characterized in insects. Results We functionally characterized an Aedes aegypti MVK (AaMVK) expressed in the corpora allata (CA) of the mosquito. AaMVK displayed its activity in the presence of metal cofactors. Different nucleotides were used by AaMVK as phosphoryl donors. In the presence of Mg2+, the enzyme has higher affinity for MA than ATP. The activity of AaMVK was regulated by feedback inhibition from long-chain isoprenoids, such as geranyl diphosphate (GPP) and farnesyl diphosphate (FPP). Conclusions AaMVK exhibited efficient inhibition by GPP and FPP (Ki less than 1 mu M), and none by isopentenyl pyrophosphate (IPP) and dimethyl allyl pyrophosphate (DPPM). These results suggest that GPP and FPP might act as physiological inhibitors in the synthesis of isoprenoids in the CA of mosquitoes. Changing MVK activity can alter the flux of precursors and therefore regulate juvenile hormone biosynthesis.	[Nyati, Pratik; Rivera-Perez, Crisalejandra; Noriega, Fernando G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University	Noriega, FG (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	noriegaf@fiu.edu	Rivera-Perez, Crisalejandra/AAM-1269-2021	Rivera Perez, Crisalejandra/0000-0002-9746-3225	National Institutes of Health, NIAID [AI 45545]; NIH [AI 45545]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045545] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI 45545, National Institutes of Health, NIAID (to FGN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grant AI 45545 to FGN.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMDUR BH, 1957, J AM CHEM SOC, V79, P2646, DOI 10.1021/ja01567a077; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P16461, DOI 10.1021/bi048075t; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P14594, DOI 10.1021/bi048963o; Belles X, 2005, ANNU REV ENTOMOL, V50, P181, DOI 10.1146/annurev.ento.50.071803.130356; BEYTIA E, 1970, J BIOL CHEM, V245, P5450; BORK P, 1993, PROTEIN SCI, V2, P31; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Chu XS, 2007, BBA-PROTEINS PROTEOM, V1774, P1571, DOI 10.1016/j.bbapap.2007.09.004; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DORSEY JK, 1968, J BIOL CHEM, V243, P4667; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu Z, 2008, BIOCHEMISTRY-US, V47, P3715, DOI 10.1021/bi7024386; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GOODFELLOW RD, 1971, INSECT BIOCHEM, V1, P271, DOI 10.1016/0020-1790(71)90043-6; Goodman W.G., 2012, INSECT ENDOCRINOLOGY, P310, DOI DOI 10.1016/B978-0-12-384749-2.10008-1; Hedl M, 2004, PROTEIN SCI, V13, P687, DOI 10.1110/ps.03367504; Hinson DD, 1997, J LIPID RES, V38, P2216; HOFFMAN G, 1986, NEW ENGL J MED, V314, P1610, DOI 10.1056/NEJM198606193142504; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Huang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117291; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Noriega F.G, 2014, JUVENILE HORMONE BIO, DOI [10.1155/2014/967361, DOI 10.1155/2014/967361]; Noriega FG, 2006, INSECT BIOCHEM MOLEC, V36, P366, DOI 10.1016/j.ibmb.2006.01.013; Nouzova M, 2011, INSECT BIOCHEM MOLEC, V41, P660, DOI 10.1016/j.ibmb.2011.04.008; Nyati P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071967; Potter D, 1997, J BIOL CHEM, V272, P5741, DOI 10.1074/jbc.272.9.5741; Potter D, 1997, J BIOL CHEM, V272, P25449, DOI 10.1074/jbc.272.41.25449; Primak YA, 2011, APPL ENVIRON MICROB, V77, P7772, DOI 10.1128/AEM.05761-11; RamosValdivia AC, 1997, NAT PROD REP, V14, P591, DOI 10.1039/np9971400591; Rivera-Perez C, 2014, INSECT BIOCHEM MOLEC, V51, P1, DOI 10.1016/j.ibmb.2014.05.001; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Saisho Y, 1997, ANAL BIOCHEM, V252, P89, DOI 10.1006/abio.1997.2314; Schooley DA, 1985, COMPREHENSIVE INSECT, P363; TANAKA RD, 1990, P NATL ACAD SCI USA, V87, P2872, DOI 10.1073/pnas.87.8.2872; TCHEN TT, 1958, J BIOL CHEM, V233, P1100; TOBE SS, 1985, ADV INSECT PHYSIOL, V18, P305; Voynova NE, 2004, J BACTERIOL, V186, P61, DOI 10.1128/JB.186.1.61-67.2004; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Yang D, 2002, J BIOL CHEM, V277, P9462, DOI 10.1074/jbc.M110787200	46	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0143107	10.1371/journal.pone.0143107	http://dx.doi.org/10.1371/journal.pone.0143107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566274	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500091
J	Quinn, MA; Cidlowski, JA				Quinn, Matthew A.; Cidlowski, John A.			Endogenous hepatic glucocorticoid receptor signaling coordinates sex-biased inflammatory gene expression	FASEB JOURNAL			English	Article						sexual dimorphism; liver; nanostring; inflammation; corticosteroid	PRIMARY SJOGRENS-SYNDROME; UTERINE EPITHELIAL-CELLS; NF-KAPPA-B; GROWTH-HORMONE; GENDER-DIFFERENCES; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; ANTIINFLAMMATORY ACTION; ESTRADIOL ANTAGONISM; MOUSE-LIVER; IN-VIVO	An individual's sex affects gene expression and many inflammatory diseases present in a sex-biased manner. Glucocorticoid receptors (GRs) are regulators of inflammatory genes, but their role in sex-specific responses is unclear. Our goal was to evaluate whether GR differentially regulates inflammatory gene expression in male and female mouse liver. Twenty-five percent of the 251 genes assayed by nanostring analysis were influenced by sex. Of these baseline sexually dimorphic inflammatory genes, 82% was expressed higher in female liver. Pathway analyses defined pattern-recognition receptors as the most sexually dimorphic pathway. We next exposed male and female mice to the proinflammatory stimulus LPS. Female mice had 177 genes regulated by treatment with LPS, whereas males had 149, with only 66% of LPS-regulated genes common between the sexes. To determine the contribution of GR to sexually dimorphic inflammatory genes we performed nanostring analysis on liver-specific GR knockout (LGRKO) mice in the presence or absence of LPS. Comparing LGRKO to GR(flox/flox) revealed that 36 genes required GR for sexually dimorphic expression, whereas 24 genes became sexually dimorphic in LGRKO. Fifteen percent of LPS-regulated genes in GR(flox/flox) were not regulated in male and female LGRKO mice treated with LPS. Thus, GR action is influenced by sex to regulate inflammatory gene expression.	[Quinn, Matthew A.; Cidlowski, John A.] NIEHS, Signal Transduct Lab, NIH, MD F3-07,POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Signal Transduct Lab, NIH, MD F3-07,POB 12233, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	NIH NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES090079, ZIAES090057] Funding Source: NIH RePORTER	NIH NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. D. W. Cain for technical assistance and critical reading of the manuscript and the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (NIEHS) Genomics Core for help with the nanostring analysis. This research was supported by the Intramural Research Program of the NIH NIEHS. The authors declare no conflicts of interest.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bubb KJ, 2012, BRIT J PHARMACOL, V167, P298, DOI 10.1111/j.1476-5381.2012.02036.x; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Duma D, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001077; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Elakovic I, 2011, BRAIN RES, V1384, P61, DOI 10.1016/j.brainres.2011.01.078; Garcia-Rodriguez S, 2013, J EUR ACAD DERMATOL, V27, P242, DOI 10.1111/j.1468-3083.2011.04372.x; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ghazeeri G, 2011, AM J REPROD IMMUNOL, V66, P163, DOI 10.1111/j.1600-0897.2011.01052.x; Hansen MK, 2000, AM J PHYSIOL-REG I, V278, pR331, DOI 10.1152/ajpregu.2000.278.2.R331; Hoekstra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080441; Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564; Huang QH, 1998, AM J PHYSIOL-REG I, V275, pR524, DOI 10.1152/ajpregu.1998.275.2.R524; Ishikawa I, 2000, AM J KIDNEY DIS, V35, P1072, DOI 10.1016/S0272-6386(00)70042-4; JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128; Kawakami A, 2007, J RHEUMATOL, V34, P1019; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; Kinoshita PF, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0218-z; Kovacs WJ, 2011, NAT REV RHEUMATOL, V7, P307, DOI 10.1038/nrrheum.2010.231; Kwok SK, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3780; Lahita R G, 1999, Curr Opin Rheumatol, V11, P352, DOI 10.1097/00002281-199909000-00005; Lamason R, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-2; Laz EV, 2004, MOL CELL PROTEOMICS, V3, P1170, DOI 10.1074/mcp.M400102-MCP200; LOW SC, 1993, J ENDOCRINOL, V139, P27, DOI 10.1677/joe.0.1390027; LOW SC, 1994, J ENDOCRINOL, V143, P541, DOI 10.1677/joe.0.1430541; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; McFarlane IG, 2004, HEPATOL RES, V28, P171, DOI 10.1016/j.hepres.2003.12.002; Meyer RD, 2009, MOL ENDOCRINOL, V23, P1914, DOI 10.1210/me.2009-0242; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Mittendorfer B, 2005, J NUTR, V135, P681, DOI 10.1093/jn/135.4.681; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Oakley RH, 2013, P NATL ACAD SCI USA, V110, P17035, DOI 10.1073/pnas.1302546110; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Quax RA, 2013, NAT REV ENDOCRINOL, V9, P670, DOI 10.1038/nrendo.2013.183; Quinn M, 2012, AM J PHYSIOL-GASTR L, V302, pG182, DOI 10.1152/ajpgi.00205.2011; Radwan M, 2010, J IMMUNOL, V185, P3544, DOI 10.4049/jimmunol.0904000; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Schott J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004368; Scotland RS, 2011, BLOOD, V118, P5918, DOI 10.1182/blood-2011-03-340281; Sevilla LM, 2010, MOL ENDOCRINOL, V24, P2166, DOI 10.1210/me.2010-0183; SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5; Shen W, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-17; Silverman MN, 2013, MOL PSYCHIATR, V18, P1006, DOI 10.1038/mp.2012.131; Spachidou MP, 2007, CLIN EXP IMMUNOL, V147, P497, DOI 10.1111/j.1365-2249.2006.03311.x; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TURNER BB, 1985, BRAIN RES, V343, P16, DOI 10.1016/0006-8993(85)91153-9; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Waxman D J, 2000, Novartis Found Symp, V227, P61; Waxman DJ., 2000, NOVART FDN SYMP, V227, P75; Whirledge S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111054; Whirledge S, 2013, ENDOCRINOLOGY, V154, P499, DOI 10.1210/en.2012-1748; YAMAMOTO Y, 1991, INFECT IMMUN, V59, P4089, DOI 10.1128/IAI.59.11.4089-4096.1991; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11	66	30	30	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					971	982		10.1096/fj.15-278309	http://dx.doi.org/10.1096/fj.15-278309			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26581598	Green Published			2022-12-26	WOS:000369391900043
J	Matsuda, M; Bonatti, R; Marquezini, MV; Garcia, MLB; Santos, UP; Braga, ALF; Alves, MR; Saldiva, PHN; Monteiro, MLR				Matsuda, Monique; Bonatti, Rodolfo; Marquezini, Monica V.; Garcia, Maria L. B.; Santos, Ubiratan P.; Braga, Alfesio L. F.; Alves, Milton R.; Saldiva, Paulo H. N.; Monteiro, Mario L. R.			Lacrimal Cytokines Assessment in Subjects Exposed to Different Levels of Ambient Air Pollution in a Large Metropolitan Area	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; DRY EYE PATIENTS; TEAR CYTOKINES; OCULAR SURFACE; INFLAMMATORY MARKERS; DISEASE; IMPACT; INDUCE; CONJUNCTIVITIS; INTERLEUKIN-6	Background Air pollution is one of the most environmental health concerns in the world and has serious impact on human health, particularly in the mucous membranes of the respiratory tract and eyes. However, ocular hazardous effects to air pollutants are scarcely found in the literature. Design Panel study to evaluate the effect of different levels of ambient air pollution on lacrimal film cytokine levels of outdoor workers from a large metropolitan area. Methods Thirty healthy male workers, among them nineteen professionals who work on streets (taxi drivers and traffic controllers, high pollutants exposure, Group 1) and eleven workers of a Forest Institute (Group 2, lower pollutants exposure compared to group 1) were evaluated twice, 15 days apart. Exposure to ambient PM2.5 (particulate matter equal or smaller than 2.5 mu m) was 24 hour individually collected and the collection of tears was performed to measure interleukins (IL) 2, 4, 5 and 10 and interferon gamma (IFN-gamma) levels. Data from both groups were compared using Student's t test or Mann-Whitney test for cytokines. Individual PM2.5 levels were categorized in tertiles (lower, middle and upper) and compared using one-way ANOVA. Relationship between PM2.5 and cytokine levels was evaluated using generalized estimating equations (GEE). Results PM2.5 levels in the three categories differed significantly (lower: <= 22 mu g/m(3); middle: 23-37.5 mu g/m(3); upper: >37.5 mu g/m(3); p<0.001). The subjects from the two groups were distributed unevenly in the lower category (Group 1 = 8%; Group 2 = 92%), the middle category (Group 1 = 89%; Group 2 = 11%) and the upper category (Group 1 = 100%). A significant relationship was found between IL-5 and IL-10 and PM2.5 levels of the group 1, with an average decrease of 1.65 pg/mL of IL-5 level and of 0.78 pg/mL of IL-10 level in tear samples for each increment of 50 mu g/m(3) of PM2.5 (p = 0.01 and p = 0.003, respectively). Conclusion High levels of PM2.5 exposure is associated with decrease of IL-5 and IL-10 levels suggesting a possible modulatory action of ambient air pollution on ocular surface immune response.	[Matsuda, Monique; Bonatti, Rodolfo; Alves, Milton R.; Monteiro, Mario L. R.] Univ Sao Paulo, Sch Med, Lab Invest Ophthalmol LIM 33, Sao Paulo, SP, Brazil; [Marquezini, Monica V.; Garcia, Maria L. B.; Braga, Alfesio L. F.; Saldiva, Paulo H. N.] Univ Sao Paulo, Sch Med, Lab Expt Air Pollut LPAE, Sao Paulo, SP, Brazil; [Santos, Ubiratan P.] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst InCor, Sao Paulo, SP, Brazil; [Braga, Alfesio L. F.] Univ Catolica Santos, Environm Exposure & Risk Assessment Grp, Collect Hlth Postgrad Program, Santos, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Catolica de Santos	Matsuda, M (corresponding author), Univ Sao Paulo, Sch Med, Lab Invest Ophthalmol LIM 33, Sao Paulo, SP, Brazil.	moniquematsuda@yahoo.com.br	Saldiva, Paulo HN/D-7385-2012; Santos, Ubiratan/H-7862-2012; MONTEIRO, MARIO L R/C-8891-2012; Matsuda, Monique/J-4646-2013; Braga, Alfésio L. F./G-6920-2012; Bonatti, Rodolfo/AAP-2778-2021	Saldiva, Paulo HN/0000-0003-2005-8253; Santos, Ubiratan/0000-0003-4919-884X; MONTEIRO, MARIO L R/0000-0002-7281-2791; Matsuda, Monique/0000-0003-4451-9712; Braga, Alfésio L. F./0000-0003-3254-3029; Bonatti, Rodolfo/0000-0001-9912-2582	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brasilia, Brazil [555223/2006-0, 306487/2011-0]; FAPESP/PPSUS, Sao Paulo, Brazil [2014/50110-0]; CNPq; FAPESP	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP/PPSUS, Sao Paulo, Brazil; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding: We thank the support grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (555223/2006-0 and 306487/2011-0), Brasilia, Brazil (http://www.cnpq.br/) and FAPESP/PPSUS (2014/50110-0), Sao Paulo, Brazil (http://www.fapesp.br/) to PHNS and MLRM. The CNPq and FAPESP have provided the funds for the purchase of materials for sample collection and analysis.	Acera A, 2008, OPHTHALMIC RES, V40, P315, DOI 10.1159/000150445; [Anonymous], 2006, Lancet, V368, P1302; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Boehm N, 2011, INVEST OPHTH VIS SCI, V52, P7725, DOI 10.1167/iovs.11-7266; Brucker N, 2013, SCI TOTAL ENVIRON, V463, P884, DOI 10.1016/j.scitotenv.2013.06.098; Cancado JE, 2006, ENVIRON HEALTH PERSP, V114, P725, DOI 10.1289/ehp.8485; Cançado José Eduardo Delfini, 2006, J. bras. pneumol., V32, pS5, DOI 10.1590/S1806-37132006000800003; Carreno E, 2010, ACTA OPHTHALMOL, V88, pe250, DOI 10.1111/j.1755-3768.2010.01978.x; Chang CJ, 2012, INVEST OPHTH VIS SCI, V53, P429, DOI 10.1167/iovs.11-8253; DAS M, 1991, ANN OCCUP HYG, V35, P347, DOI 10.1093/annhyg/35.3.347; de Miranda RM, 2012, AIR QUAL ATMOS HLTH, V5, P63, DOI 10.1007/s11869-010-0124-1; Toledo Giovana Iara Ferreira Moser de, 2011, Rev. bras. epidemiol., V14, P445, DOI 10.1590/S1415-790X2011000300009; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Gupta SK, 2002, OPHTHALMOLOGICA, V216, P368, DOI 10.1159/000066183; Hagan S, 2013, OCUL SURF, V11, P219, DOI 10.1016/j.jtos.2013.04.004; Handelsman Y, 2015, ENDOCR PRACT, V21, P1, DOI [10.4158/EP15672.GLSUPPL, 10.4158/EP15672.GL]; Jacquemin B, 2015, ENV HLTH PERSPECT; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee H, 2013, FREE RADICAL BIO MED, V63, P78, DOI 10.1016/j.freeradbiomed.2013.05.006; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Leonardi A, 2006, CLIN EXP ALLERGY, V36, P777, DOI 10.1111/j.1365-2222.2006.02499.x; Leonardi A, 2006, GRAEF ARCH CLIN EXP, V244, P1240, DOI 10.1007/s00417-006-0285-7; Liu JF, 2010, MOL VIS, V16, P2931; Malerbi FK, 2012, ENVIRON RES, V112, P199, DOI 10.1016/j.envres.2011.11.010; Matsuda M, 2013, J CLIN EXPT CARDIOLO, V4, P255; Na KS, 2012, INVEST OPHTH VIS SCI, V53, P5443, DOI 10.1167/iovs.11-9417; Narayanan S, 2006, INVEST OPHTH VIS SCI, V47, P2445, DOI 10.1167/iovs.05-1364; Novaes P, 2007, ENVIRON HEALTH PERSP, V115, P1753, DOI 10.1289/ehp.10363; Novaes P, 2010, ENVIRON RES, V110, P372, DOI 10.1016/j.envres.2010.03.003; Perez L, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13129; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Roszkowska AM, 2013, CURR EYE RES, V38, P335, DOI 10.3109/02713683.2012.745880; Rummenie VT, 2008, CYTOKINE, V43, P200, DOI 10.1016/j.cyto.2008.05.011; Sanchez-Carrillo CI, 2003, EPIDEMIOLOGY, V14, P536, DOI 10.1097/01.ede.0000081801.90352.bf; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Saxena R, 2003, ACTA OPHTHALMOL SCAN, V81, P491, DOI 10.1034/j.1600-0420.2003.00119.x; Tau J, 2013, INVEST OPHTH VIS SCI, V54, P4759, DOI 10.1167/iovs.12-10541; Torricelli AA, 2013, CORNEA; Tsai DH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-24; Uchino E, 2006, CYTOKINE, V33, P36, DOI 10.1016/j.cyto.2005.11.013; Uchio E, 2000, CLIN EXP ALLERGY, V30, P103; VanDerMeid KR, 2012, INVEST OPHTH VIS SCI, V53, P1512, DOI 10.1167/iovs.11-7627; Versura P, 1999, OPHTHALMOLOGICA, V213, P103, DOI 10.1159/000027401; Williams LA, 2009, ENVIRON HEALTH PERSP, V117, P373, DOI 10.1289/ehp.11580; Yin XJJ, 2004, TOXICOL SCI, V77, P263, DOI 10.1093/toxsci/kfh035; Yoon KC, 2007, CORNEA, V26, P431, DOI 10.1097/ICO.0b013e31803dcda2; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	47	21	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143131	10.1371/journal.pone.0143131	http://dx.doi.org/10.1371/journal.pone.0143131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588473	gold, Green Submitted, Green Published			2022-12-26	WOS:000365251500032
J	Baranyi, A; Amouzadeh-Ghadikolai, O; Rothenhausler, HB; Theokas, S; Robier, C; Baranyi, M; Koppitz, M; Reicht, G; Hlade, P; Meinitzer, A				Baranyi, Andreas; Amouzadeh-Ghadikolai, Omid; Rothenhaeusler, Hans-Bernd; Theokas, Simon; Robier, Christoph; Baranyi, Maria; Koppitz, Michael; Reicht, Gerhard; Hlade, Peter; Meinitzer, Andreas			Nitric Oxide-Related Biological Pathways in Patients with Major Depression	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; L-ARGININE; SYMMETRIC DIMETHYLARGININE; CARDIOVASCULAR MORTALITY; ENDOTHELIAL DYSFUNCTION; PLASMA-CONCENTRATIONS; CORONARY-ANGIOGRAPHY; LUDWIGSHAFEN RISK; AMINO-ACIDS; DISEASE	Background Major depression is a well-known risk factor for cardiovascular diseases and increased mortality following myocardial infarction. However, biomarkers of depression and increased cardiovascular risk are still missing. The aim of this prospective study was to evaluate, whether nitric-oxide (NO) related factors for endothelial dysfunction, such as global arginine bioavailability, arginase activity, L-arginine/ADMA ratio and the arginine metabolites asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) might be biomarkers for depression-induced cardiovascular risk. Methods In 71 in-patients with major depression and 48 healthy controls the Global Arginine Bioavailability Ratio (GABR), arginase activity (arginine/ornithine ratio), the L-arginine/ADMA ratio, ADMA, and SDMA were determined by high-pressure liquid chromatography. Psychiatric and laboratory assessments were obtained at baseline at the time of in-patient admittance and at the time of hospital discharge. Results The ADMA concentrations in patients with major depression were significantly elevated and the SDMA concentrations were significantly decreased in comparison with the healthy controls. Even after a first improvement of depression, ADMA and SDMA levels remained nearly unchanged. In addition, after a first improvement of depression at the time of hospital discharge, a significant decrease in arginase activity, an increased L-arginine/ADMA ratio and a trend for increased global arginine bioavailability were observed. Conclusions Our study results are evidence that in patients with major depression ADMA and SDMA might be biomarkers to indicate an increased cardiovascular threat due to depression-triggered NO reduction. GABR, the L-arginine/ADMA ratio and arginase activity might be indicators of therapy success and increased NO production after remission.	[Baranyi, Andreas; Rothenhaeusler, Hans-Bernd; Theokas, Simon; Baranyi, Maria; Koppitz, Michael] Med Univ Graz, Dept Psychiat, Graz, Austria; [Baranyi, Andreas] ARU Cambridge, Inst Int Management Practice, Cambridge, England; [Amouzadeh-Ghadikolai, Omid; Robier, Christoph; Reicht, Gerhard; Hlade, Peter] Hosp Bros St John God, Graz, Austria; [Robier, Christoph; Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Medical University of Graz; Medical University of Graz	Baranyi, A (corresponding author), Med Univ Graz, Dept Psychiat, Graz, Austria.	andreas.baranyi@klinikum-graz.at		Baranyi, Andreas/0000-0003-2389-1945; Rothenhausler, Hans-Bernd/0000-0002-8857-8557				Asif M, 2013, CURR ALZHEIMER RES, V10, P347, DOI 10.2174/1567205011310040001; Bajaj JS, 2013, J HEPATOL, V58, P38, DOI 10.1016/j.jhep.2012.08.005; Baranyi A, 2014, PSYCHOSOM MED, V76, P197, DOI 10.1097/PSY.0000000000000042; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Boger RH, 1998, ATHEROSCLEROSIS, V136, P67, DOI 10.1016/S0021-9150(97)00183-4; Chao TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071675; COOKE JP, 1991, J CLIN INVEST, V88, P1663, DOI 10.1172/JCI115481; Demas GE, 1999, J NEUROSCI, V19; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Frisch C, 2000, J NEUROSCI, V20, P6694, DOI 10.1523/JNEUROSCI.20-17-06694.2000; Gallagher D, 2012, J AFFECT DISORDERS, V142, P132, DOI 10.1016/j.jad.2012.04.012; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Kielstein H, 2015, NEPHROL DIAL TRANSPL, V30, P1699, DOI 10.1093/ndt/gfv253; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lorin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064796; Lundman P, 2001, J AM COLL CARDIOL, V38, P111, DOI 10.1016/S0735-1097(01)01318-3; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Meinitzer A, 2007, CLIN CHIM ACTA, V384, P141, DOI 10.1016/j.cca.2007.07.006; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; Mommersteeg PMC, 2015, PSYCHOSOM MED, V77, P292, DOI 10.1097/PSY.0000000000000162; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Nemeth Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135498; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; Rajapakse NW, 2009, CLIN EXP PHARMACOL P, V36, P249, DOI 10.1111/j.1440-1681.2008.05123.x; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; Schwarz EL, 2005, CLIN CHIM ACTA, V354, P83, DOI 10.1016/j.cccn.2004.11.016; Selley ML, 2004, J AFFECT DISORDERS, V80, P249, DOI 10.1016/S0165-0327(03)00135-6; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Snyder SH, 2000, AM J PSYCHIAT, V157, P1738, DOI 10.1176/appi.ajp.157.11.1738; Sourij H, 2011, ATHEROSCLEROSIS, V218, P220, DOI 10.1016/j.atherosclerosis.2011.04.041; Stewart JC, 2012, CIRCULATION, V126, P410, DOI 10.1161/CIRCULATIONAHA.112.094946; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Tsao PS, 1996, CIRCULATION, V94, P1682, DOI 10.1161/01.CIR.94.7.1682; VALLANCE P, 1992, LANCET, V339, P572; Wei JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102986; Winkelmann B. R., 2001, PHARMACOGENOMICS S1, V2, P1; Wolf A, 1997, J AM COLL CARDIOL, V29, P479, DOI 10.1016/S0735-1097(97)00523-8	43	38	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143397	10.1371/journal.pone.0143397	http://dx.doi.org/10.1371/journal.pone.0143397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581044	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600120
J	Duursma, RA				Duursma, Remko A.			Plantecophys - An R Package for Analysing and Modelling Leaf Gas Exchange Data	PLOS ONE			English	Article							INSTANTANEOUS TRANSPIRATION EFFICIENCY; VAPOR-PRESSURE DEFICIT; STOMATAL CONDUCTANCE; MESOPHYLL CONDUCTANCE; ATMOSPHERIC CO2; RESPONSE CURVES; PHOTOSYNTHESIS; TEMPERATURE; CARBON; WATER	Here I present the R package 'plantecophys', a toolkit to analyse and model leaf gas exchange data. Measurements of leaf photosynthesis and transpiration are routinely collected with portable gas exchange instruments, and analysed with a few key models. These models include the Farquhar-von Caemmerer-Berry (FvCB) model of leaf photosynthesis, the Ball-Berry models of stomatal conductance, and the coupled leaf gas exchange model which combines the supply and demand functions for CO2 in the leaf. The 'plantecophys' R package includes functions for fitting these models to measurements, as well as simulating from the fitted models to aid in interpreting experimental data. Here I describe the functionality and implementation of the new package, and give some examples of its use. I briefly describe functions for fitting the FvCB model of photosynthesis to measurements of photosynthesis-CO2 response curves ('A-C-i curves'), fitting Ball-Berry type models, modelling C3 photosynthesis with the coupled photosynthesis-stomatal conductance model, modelling C4 photosynthesis, numerical solution of optimal stomatal behaviour, and energy balance calculations using the Penman-Monteith equation. This open-source package makes technically challenging calculations easily accessible for many users and is freely available on CRAN.	[Duursma, Remko A.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia	Western Sydney University	Duursma, RA (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia.	r.duursma@westernsydney.edu.au						Ball J.T., 1987, PROGR PHOTOSYNTHESIS, P221, DOI [10.1007/978-94-017-0519-6_48, DOI 10.1007/978-94-017-0519-6_48]; Barton CVM, 2012, GLOBAL CHANGE BIOL, V18, P585, DOI 10.1111/j.1365-2486.2011.02526.x; Bonan GB, 2014, GEOSCI MODEL DEV, V7, P2193, DOI 10.5194/gmd-7-2193-2014; Buckley TN, 2014, PLANT CELL ENVIRON, V37, P2707, DOI 10.1111/pce.12343; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Cowan I R, 1977, Symp Soc Exp Biol, V31, P471; De Kauwe MG, 2015, GEOSCI MODEL DEV, V8, P431, DOI 10.5194/gmd-8-431-2015; Duursma RA, 2012, GEOSCI MODEL DEV, V5, P919, DOI 10.5194/gmd-5-919-2012; Duursma RA, CODE REPOSITORY GENE, DOI DOI 10.5281/ZENODO.32026; Duursma RA, 2014, AGR FOREST METEOROL, V189, P2, DOI 10.1016/j.agrformet.2013.12.007; Duursma RA, 2013, AGR FOREST METEOROL, V168, P168, DOI 10.1016/j.agrformet.2012.09.005; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Gu LH, 2010, PLANT CELL ENVIRON, V33, P1852, DOI 10.1111/j.1365-3040.2010.02192.x; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; LEUNING R, 1990, AUST J PLANT PHYSIOL, V17, P159, DOI 10.1071/PP9900159; LEUNING R, 1989, PLANT CELL ENVIRON, V12, P669, DOI 10.1111/j.1365-3040.1989.tb01236.x; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Lin YS, 2015, NAT CLIM CHANGE, V5, P459, DOI [10.1038/nclimate2550, 10.1038/NCLIMATE2550]; Lin YS, 2012, TREE PHYSIOL, V32, P219, DOI 10.1093/treephys/tpr141; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; MCDERMITT DK, 1989, ANN SCI FOREST, V46, pS416, DOI 10.1051/forest:19890593; Medlyn B, TUMBARUMBA GAS EXCHA, DOI [10.6084/m9.figshare.1538079, DOI 10.6084/M9.FIGSHARE.1538079]; Medlyn BE, 2002, PLANT CELL ENVIRON, V25, P1167, DOI 10.1046/j.1365-3040.2002.00891.x; Medlyn BE, 2007, TREE PHYSIOL, V27, P1687, DOI 10.1093/treephys/27.12.1687; Medlyn BE, 2013, AGR FOREST METEOROL, V182, P200, DOI 10.1016/j.agrformet.2013.04.019; Medlyn BE, 2011, GLOBAL CHANGE BIOL, V17, P2134, DOI 10.1111/j.1365-2486.2010.02375.x; Pearcey R.W., 1989, PLANT PHYSL ECOLOGY; Peltoniemi MS, 2012, TREE PHYSIOL, V32, P510, DOI 10.1093/treephys/tps023; R Core Team, 2021, R LANGUAGE ENV STAT; Ritz C, 2008, USE R, P1; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; SHARKEY TD, 1982, PLANT PHYSIOL, V69, P657, DOI 10.1104/pp.69.3.657; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Tholen D, 2012, PLANT CELL ENVIRON, V35, P2087, DOI 10.1111/j.1365-3040.2012.02538.x; von Caemmerer S, 2000, BIOCH MODELS LEAF PH; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Wang YP, 1998, AGR FOREST METEOROL, V91, P89, DOI 10.1016/S0168-1923(98)00061-6; WULLSCHLEGER SD, 1993, J EXP BOT, V44, P907, DOI 10.1093/jxb/44.5.907	41	237	240	8	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143346	10.1371/journal.pone.0143346	http://dx.doi.org/10.1371/journal.pone.0143346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581080	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600111
J	Koulgi, S; Achalere, A; Sonavane, U; Joshi, R				Koulgi, Shruti; Achalere, Archana; Sonavane, Uddhavesh; Joshi, Rajendra			Investigating DNA Binding and Conformational Variation in Temperature Sensitive p53 Cancer Mutants Using QM-MM Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; TP53 DATABASE; CORE DOMAIN; HOT-SPOT; TUMOR; MUTATIONS; RESCUE; TRANSACTIVATION; STABILITY; COMPLEX	The tp53 gene is found to be mutated in 50% of all the cancers. The p53 protein, a product of tp53 gene, is a multi-domain protein. It consists of a core DNA binding domain (DBD) which is responsible for its binding and transcription of downstream target genes. The mutations in p53 protein are responsible for creating cancerous conditions and are found to be occurring at a high frequency in the DBD region of p53. Some of these mutations are also known to be temperature sensitive (ts) in nature. They are known to exhibit partial or strong binding with DNA in the temperature range (298-306 K). Whereas, at 310 K and above they show complete loss in binding. We have analyzed the changes in binding and conformational behavior at 300 K and 310 K for three of the ts-mutants viz., V143A, R249S and R175H. QM-MM simulations have been performed on the wild type and the above mentioned ts-mutants for 30 ns each. The optimal estimate of free energy of binding for a particular number of interface hydrogen bonds was calculated using the maximum likelihood method as described by Chodera et. al (2007). This parameter has been observed to be able to mimic the binding affinity of the p53 ts-mutants at 300 K and 310 K. Thus the correlation between MM-GBSA free energy of binding and hydrogen bonds formed by the interface residues between p53 and DNA has revealed the temperature dependent nature of these mutants. The role of main chain dihedrals was obtained by performing dihedral principal component analysis (PCA). This analysis, suggests that the conformational variations in the main chain dihedrals (phi and psi) of the p53 ts-mutants may have caused reduction in the overall stability of the protein. The solvent exposure of the side chains of the interface residues were found to hamper the binding of the p53 to the DNA. Solvent Accessible Surface Area (SASA) also proved to be a crucial property in distinguishing the conformers obtained at 300 K and 310 K for the three ts-mutants from the wild type at 300 K.	[Koulgi, Shruti; Achalere, Archana; Sonavane, Uddhavesh; Joshi, Rajendra] SP Pune Univ Campus, Bioinformat Grp, Ctr Dev Adv Comp, Pune, Maharashtra, India	Centre for Development of Advanced Computing (C-DAC)	Joshi, R (corresponding author), SP Pune Univ Campus, Bioinformat Grp, Ctr Dev Adv Comp, Pune, Maharashtra, India.	rajendra@cdac.in		Sonavane, Uddhavesh/0000-0002-2482-9126; Koulgi, Shruti/0000-0002-0709-7461				[Anonymous], 2006, P53 DATABASE VERSION; Bakowies D, 1996, J PHYS CHEM-US, V100, P10580, DOI 10.1021/jp9536514; Barakat K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027651; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Butler JS, 2003, BIOCHEMISTRY-US, V42, P2396, DOI 10.1021/bi026635n; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Chitrala KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104242; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; Christgen M, 2012, LAB INVEST, V92, P1635, DOI 10.1038/labinvest.2012.126; Demir O, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002238; Di Como CJ, 1998, ONCOGENE, V16, P2527; Duan JX, 2006, BIOCHEMISTRY-US, V45, P7483, DOI 10.1021/bi0603165; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Friedlander P, 1996, J BIOL CHEM, V271, P25468, DOI 10.1074/jbc.271.41.25468; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Grochova D, 2008, ONCOGENE, V27, P1243, DOI 10.1038/sj.onc.1210748; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hubbard S.J, 1993, NACCESS, V2; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Koulgi S, 2013, J MOL MODEL, V19, P5545, DOI 10.1007/s00894-013-2042-2; Lu Q, 2007, J PHYS CHEM B, V111, P11538, DOI 10.1021/jp0742261; Martin ACR, 2002, HUM MUTAT, V19, P149, DOI 10.1002/humu.10032; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sargsyan K, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1069; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Shiraishi K, 2004, J BIOL CHEM, V279, P348, DOI 10.1074/jbc.M310815200; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Suad O, 2009, J MOL BIOL, V385, P249, DOI 10.1016/j.jmb.2008.10.063; Tan Yuhong, 2009, PMC Biophys, V2, P5, DOI 10.1186/1757-5036-2-5; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Walker RC, 2008, J COMPUT CHEM, V29, P1019, DOI 10.1002/jcc.20857; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Wright JD, 2007, J BIOSCIENCES, V32, P827, DOI 10.1007/s12038-007-0083-3; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; ZHANG W, 1994, EMBO J, V13, P2535, DOI 10.1002/j.1460-2075.1994.tb06543.x	49	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143065	10.1371/journal.pone.0143065	http://dx.doi.org/10.1371/journal.pone.0143065			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579714	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600077
J	Levenson, RM; Krupinski, EA; Navarro, VM; Wasserman, EA				Levenson, Richard M.; Krupinski, Elizabeth A.; Navarro, Victor M.; Wasserman, Edward A.			Pigeons (Columba livia) as Trainable Observers of Pathology and Radiology Breast Cancer Images	PLOS ONE			English	Article							CATEGORIZATION; PATTERNS; BEHAVIOR; SHAPE	Pathologists and radiologists spend years acquiring and refining their medically essential visual skills, so it is of considerable interest to understand how this process actually unfolds and what image features and properties are critical for accurate diagnostic performance. Key insights into human behavioral tasks can often be obtained by using appropriate animal models. We report here that pigeons (Columba livia)-which share many visual system properties with humans-can serve as promising surrogate observers of medical images, a capability not previously documented. The birds proved to have a remarkable ability to distinguish benign from malignant human breast histopathology after training with differential food reinforcement; even more importantly, the pigeons were able to generalize what they had learned when confronted with novel image sets. The birds' histological accuracy, like that of humans, was modestly affected by the presence or absence of color as well as by degrees of image compression, but these impacts could be ameliorated with further training. Turning to radiology, the birds proved to be similarly capable of detecting cancer-relevant microcalcifications on mammogram images. However, when given a different (and for humans quite difficult) task-namely, classification of suspicious mammographic densities (masses)-the pigeons proved to be capable only of image memorization and were unable to successfully generalize when shown novel examples. The birds' successes and difficulties suggest that pigeons are well-suited to help us better understand human medical image perception, and may also prove useful in performance assessment and development of medical imaging hardware, image processing, and image analysis tools.	[Levenson, Richard M.] Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Navarro, Victor M.; Wasserman, Edward A.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Krupinski, Elizabeth A.] Emory Univ, Coll Med, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA	University of California System; University of California Davis; University of Iowa; Emory University	Levenson, RM (corresponding author), Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA.	levenson@ucdavis.edu; ed-wasserman@uiowa.edu						Abbey C., 2010, HDB MED IMAGE PERCEP, P240; Badano A, 2015, J DIGIT IMAGING, V28, P41, DOI 10.1007/s10278-014-9721-0; Bailey JH, 2014, ACAD RADIOL, V21, P859, DOI 10.1016/j.acra.2013.11.022; Barrett H H, 2004, FDN IMAGE SCI; BHATT RS, 1988, J EXP PSYCHOL ANIM B, V14, P219, DOI 10.1037/0097-7403.14.3.219; BLOUGH DS, 1982, SCIENCE, V218, P397, DOI 10.1126/science.7123242; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Colucci PG, 2015, ACAD RADIOL, V22, P247, DOI 10.1016/j.acra.2014.09.014; Cook RG, 1997, J EXP PSYCHOL ANIM B, V23, P417, DOI 10.1037/0097-7403.23.4.417; Cook RG, 2005, PSYCHON B REV, V12, P350, DOI 10.3758/BF03196384; Cook RG, 2015, PSYCHOL LEARN MOTIV, V63; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Evans KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064366; Gallas BD, 2012, ACAD RADIOL, V19, P463, DOI 10.1016/j.acra.2011.12.016; Gibson BM, 2007, CURR BIOL, V17, P336, DOI 10.1016/j.cub.2006.12.025; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058; Huber L, 2000, Q J EXP PSYCHOL-B, V53, P341, DOI 10.1080/027249900750001347; Krupinski EA, 1996, ACAD RADIOL, V3, P137, DOI 10.1016/S1076-6332(05)80381-2; Krupinski EA, 2014, REP MED IMAGING, V4, P5; Krupinski EA, 2008, MED PHYS, V35, P645, DOI 10.1118/1.2830376; Krupinski EA, 2014, HEALTHCARE, V2, P94, DOI 10.3390/healthcare2010094; Krupinski Elizabeth A, 2012, J Pathol Inform, V3, P17, DOI 10.4103/2153-3539.95129; Kupinski M, 2010, HDB MED IMAGE PERCEP, P251; Lazareva OF, 2006, PERCEPT PSYCHOPHYS, V68, P711, DOI 10.3758/BF03193695; Levenson R, 2008, ARCH PATHOL LAB MED, V132, P748, DOI 10.1043/1543-2165(2008)132[748:PTMBIM]2.0.CO;2; Mahoney AM, 2011, PAN AFR MED J, V9; Naseem M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1312-z; Orel SG, 1999, RADIOLOGY, V211, P845, DOI 10.1148/radiology.211.3.r99jn31845; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Saunders R, 2010, HDB MED IMAGE PERCEP, P157; Shamshuddin S, 2014, CLIN RADIOL, V69, pE373, DOI 10.1016/j.crad.2014.04.002; Shimizu T, 1999, BEHAV BRAIN RES, V98, P183, DOI 10.1016/S0166-4328(98)00083-7; Shimizu T, 2010, BRAIN BEHAV EVOLUT, V75, P204, DOI 10.1159/000314283; Soto FA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00122; Soto FA, 2012, COGN AFFECT BEHAV NE, V12, P220, DOI 10.3758/s13415-011-0070-x; Troje NF, 1999, VISION RES, V39, P353, DOI 10.1016/S0042-6989(98)00153-9; VERHAVE T, 1966, AM PSYCHOL, V21, P109, DOI 10.1037/h0023273; Wagner RF, 2002, ACAD RADIOL, V9, P1264, DOI 10.1016/S1076-6332(03)80560-3; Wasserman Edward A., 2012, P191; WATANABE S, 1995, J EXP ANAL BEHAV, V63, P165, DOI 10.1901/jeab.1995.63-165; Wei H, 2014, COLOR RES APPL; Weinstein RS, 2012, APMIS, V120, P256, DOI 10.1111/j.1600-0463.2011.02866.x	44	47	52	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141357	10.1371/journal.pone.0141357	http://dx.doi.org/10.1371/journal.pone.0141357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581091	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600014
J	Rawi, R; Kunji, K; Haoudi, A; Bensmail, H				Rawi, Reda; Kunji, Khalid; Haoudi, Abdelali; Bensmail, Halima			Coevolution Analysis of HIV-1 Envelope Glycoprotein Complex	PLOS ONE			English	Article							STRUCTURAL BASIS; CONFORMATIONAL DYNAMICS; RESIDUE CONTACTS; ATOMIC-STRUCTURE; CLADE-C; V3 LOOP; GP120; PROTEIN; ANTIBODY; SEQUENCE	The HIV-1 Env spike is the main protein complex that facilitates HIV-1 entry into CD4(+) host cells. HIV-1 entry is a multistep process that is not yet completely understood. This process involves several protein-protein interactions between HIV-1 Env and a variety of host cell receptors along with many conformational changes within the spike. HIV-1 Env developed due to high mutation rates and plasticity escape strategies from immense immune pressure and entry inhibitors. We applied a coevolution and residue-residue contact detecting method to identify coevolution patterns within HIV-1 Env protein sequences representing all group M subtypes. We identified 424 coevolving residue pairs within HIV-1 Env. The majority of predicted pairs are residue-residue contacts and are proximal in 3D structure. Furthermore, many of the detected pairs have functional implications due to contributions in either CD4 or coreceptor binding, or variable loop, gp120-gp41, and interdomain interactions. This study provides a new dimension of information in HIV research. The identified residue couplings may not only be important in assisting gp120 and gp41 coordinate structure prediction, but also in designing new and effective entry inhibitors that incorporate mutation patterns of HIV-1 Env.	[Rawi, Reda; Kunji, Khalid; Bensmail, Halima] Hamad Bin Khalifa Univ, Qatar Comp Res Inst, Computat Sci & Engn Ctr, Doha, Qatar; [Haoudi, Abdelali] Harvard Univ, Sch Med, Div Genet & Genom, Boston Childrens Hosp, Boston, MA USA; [Haoudi, Abdelali] King Abdul Aziz Med City, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC)	Rawi, R (corresponding author), Hamad Bin Khalifa Univ, Qatar Comp Res Inst, Computat Sci & Engn Ctr, Doha, Qatar.	rrawi@qf.org.qa	Bensmail, Halima/AAT-7858-2020; Kunji, Khalid/R-4638-2019	Kunji, Khalid/0000-0003-2946-512X				Acharya P, 2013, STRUCTURE, V21, P1018, DOI 10.1016/j.str.2013.04.015; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Balakrishnan S, 2011, PROTEINS, V79, P1061, DOI 10.1002/prot.22934; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bickel PJ, 1996, AIDS RES HUM RETROV, V12, P1401, DOI 10.1089/aid.1996.12.1401; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cimbro R, 2014, P NATL ACAD SCI USA, V111, P3152, DOI 10.1073/pnas.1314718111; Davey NE, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003951; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Garimalla S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128664; Gilbert PB, 2005, AIDS RES HUM RETROV, V21, P1016, DOI 10.1089/aid.2005.21.1016; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Guttman M, 2012, J VIROL, V86, P8750, DOI 10.1128/JVI.07224-11; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Hu GQ, 2011, J VIROL, V85, P2741, DOI 10.1128/JVI.01612-10; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Korber B, 2009, CURR OPIN HIV AIDS, V4, P408, DOI 10.1097/COH.0b013e32832f129e; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Li GD, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-014-0031-8; Li Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086083, 10.1371/journal.pone.0109665, 10.1371/journal.pone.0094792]; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lu L, 2012, BBA-BIOMEMBRANES, V1818, P2950, DOI 10.1016/j.bbamem.2012.07.020; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Michel M, 2014, BIOINFORMATICS, V30, pI482, DOI 10.1093/bioinformatics/btu458; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Morellato-Castillo L, 2013, J MED CHEM, V56, P5033, DOI 10.1021/jm4002988; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Postler TS, 2012, J VIROL, V86, P1145, DOI 10.1128/JVI.06463-11; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Schnur E, 2011, J MOL BIOL, V410, P778, DOI 10.1016/j.jmb.2011.04.023; Schrodinger L., 2020, PYMOL; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Travers SAA, 2007, MOL BIOL EVOL, V24, P2787, DOI 10.1093/molbev/msm213; Wang Y., 2013, ADV CIV ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0058804; Wang Yan, 2013, Virologica Sinica, V28, P228, DOI 10.1007/s12250-013-3348-z; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Zhao YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117506; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	69	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143245	10.1371/journal.pone.0143245	http://dx.doi.org/10.1371/journal.pone.0143245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579711	Green Published, gold			2022-12-26	WOS:000365154600104
J	Szabo, DJ; Noer, A; Nagymihaly, R; Josifovska, N; Andjelic, S; Vereb, Z; Facsko, A; Moe, MC; Petrovski, G				Szabo, Dora Julia; Noer, Agate; Nagymihaly, Richard; Josifovska, Natasha; Andjelic, Sofija; Vereb, Zoltan; Facsko, Andrea; Moe, Morten C.; Petrovski, Goran			Long-Term Cultures of Human Cornea Limbal Explants Form 3D Structures Ex Vivo - Implications for Tissue Engineering and Clinical Applications	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; ADHESION MOLECULE CD44; ANATOMICAL STRUCTURE; EXPRESSION; PHENOTYPE; TRANSPLANTATION; ABCG2; NICHE	Long-term cultures of cornea limbal epithelial stem cells (LESCs) were developed and characterized for future tissue engineering and clinical applications. The limbal tissue explants were cultivated and expanded for more than 3 months in medium containing serum as the only growth supplement and without use of scaffolds. Viable 3D cell outgrowth from the explants was observed within 4 weeks of cultivation. The outgrowing cells were examined by immunofluorescent staining for putative markers of stemness (ABCG2, CK15, CK19 and Vimentin), proliferation (p63 alpha, Ki-67), limbal basal epithelial cells (CK8/18) and differentiated cornea epithelial cells (CK3 and CK12). Morphological and immunostaining analyses revealed that long-term culturing can form stratified 3D tissue layers with a clear extracellular matrix deposition and organization (collagen I, IV and V). The LESCs showed robust expression of p63a, ABCG2, and their surface marker fingerprint (CD117/c-kit, CXCR4, CD146/MCAM, CD166/ALCAM) changed over time compared to short-term LESC cultures. Overall, we provide a model for generating stem cell-rich, long-standing 3D cultures from LESCs which can be used for further research purposes and clinical transplantation.	[Szabo, Dora Julia; Nagymihaly, Richard; Josifovska, Natasha; Vereb, Zoltan; Facsko, Andrea; Petrovski, Goran] Univ Szeged, Stem Cells & Eye Res Lab, Dept Ophthalmol, Fac Med, Szeged, Hungary; [Noer, Agate; Moe, Morten C.] Oslo Univ Hosp, Ctr Eye Res, Dept Ophthalmol, Oslo, Norway; [Noer, Agate; Moe, Morten C.] Univ Oslo, Oslo, Norway; [Andjelic, Sofija] Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia	Szeged University; University of Oslo; University of Oslo; University Medical Centre Ljubljana	Petrovski, G (corresponding author), Univ Szeged, Stem Cells & Eye Res Lab, Dept Ophthalmol, Fac Med, Szeged, Hungary.	petrovski.goran@med.u-szeged.hu	Vereb, Zoltan/I-6356-2019; Vereb, Zoltan/AAR-4092-2020	Vereb, Zoltan/0000-0002-9518-2155; Petrovski, Goran/0000-0003-2905-9252; Josifovska, Natasha/0000-0002-3898-9729; Noer, Agate/0000-0003-0329-916X	EU COST Action BM1302 travel grant; South-East Norway regional health authority, Helse Sor-Ost RHF, Norway	EU COST Action BM1302 travel grant; South-East Norway regional health authority, Helse Sor-Ost RHF, Norway	DJS has been supported by an EU COST Action BM1302 travel grant to perform part of the experiments at the host site at the Norwegian Center for Stem Cell Research / Center for Eye Research, University of Oslo, Norway. AN is supported by The South-East Norway regional health authority, Helse Sor-Ost RHF, Norway.; DJS has been supported by an EU COST Action BM1302 travel grant to perform part of the experiments at the host site at the Norwegian Center for Stem Cell Research / Center for Eye Research, University of Oslo, Norway. AN is supported by The South-East Norway regional health authority, Helse Sor-Ost RHF, Norway. We like to thank Charlotte L. Ness, Kristiane Haug Berg and staff at the Center for Eye Research, Department of Ophthalmology, Oslo University Hospital for their technical support and input.	Albert R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047187; Ambrose WM, 2009, J BIOMED MATER RES B, V90B, P818, DOI 10.1002/jbm.b.31351; Andjelic S, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/232659; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Chang CY, 2008, INVEST OPHTH VIS SCI, V49, P5279, DOI 10.1167/iovs.07-1260; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; Ghoubay-Benallaoua D, 2011, MOL VIS, V17, P341; Gore A, 2014, CORNEA, V33, P65, DOI 10.1097/ICO.0000000000000002; Huang MH, 2015, CELL TISSUE RES, V359, P547, DOI 10.1007/s00441-014-2032-4; Joseph A, 2004, BRIT J OPHTHALMOL, V88, P393, DOI 10.1136/bjo.2003.018481; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Levis HJ, 2013, CURR EYE RES, V38, P41, DOI 10.3109/02713683.2012.725799; Lopez-Paniagua M, 2013, CURR EYE RES, V38, P537, DOI 10.3109/02713683.2013.767350; Lv Z, 2015, J IMMUNOL, DOI [10.4049/jimmunol.1401719, DOI 10.4049/JIMMUN0L.1401719]; McCracken MN, 2015, CLIN CANCER RES, V21, P3597, DOI 10.1158/1078-0432.CCR-14-2520; Merjava S, 2011, INVEST OPHTH VIS SCI, V52, P787, DOI 10.1167/iovs.10-5489; Merjava S, 2011, HISTOL HISTOPATHOL, V26, P323, DOI 10.14670/HH-26.323; Mi SL, 2010, TISSUE ENG PT A, V16, P2091, DOI 10.1089/ten.TEA.2009.0748; Michel M, 1996, J CELL SCI, V109, P1017; Nubile M, 2013, MOL VIS, V19, P516; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Pathak M, 2013, ACTA OPHTHALMOL, V91, P769, DOI 10.1111/j.1755-3768.2012.02521.x; Pellegrini G, 2014, STEM CELLS, V32, P26, DOI 10.1002/stem.1517; Priya CG, 2013, MICROSC RES TECHNIQ, V76, P242, DOI 10.1002/jemt.22159; Shandadfar A, 2012, EXP EYE RES, V97, P1, DOI 10.1016/j.exer.2012.01.013; Shanmuganathan VA, 2007, BRIT J OPHTHALMOL, V91, P514, DOI 10.1136/bjo.2006.102640; Utheim TP, 2009, INVEST OPHTH VIS SCI, V50, P5165, DOI 10.1167/iovs.08-2884; Yu FSX, 1998, INVEST OPHTH VIS SCI, V39, P710; Zhu SN, 1997, BRIT J OPHTHALMOL, V81, P80, DOI 10.1136/bjo.81.1.80	31	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143053	10.1371/journal.pone.0143053	http://dx.doi.org/10.1371/journal.pone.0143053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580800	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600073
J	Gomez-Hierro, A; Lambea, E; Gimenez-Zaragoza, D; Lopez-Aviles, S; Yance-Chavez, T; Montserrat, M; Pujol, MJ; Bachs, O; Aligue, R				Gomez-Hierro, Alba; Lambea, Eva; Gimenez-Zaragoza, David; Lopez-Aviles, Sandra; Yance-Chavez, Tula; Montserrat, Marta; Jesus Pujol, M.; Bachs, Oriol; Aligue, Rosa			Ssp1 CaMKK: A Sensor of Actin Polarization That Controls Mitotic Commitment through Srk1 in Schizosaccharomyces pombe	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FISSION YEAST; FORMIN FOR3P; SERINE/THREONINE KINASE; GROWTH POLARITY; STRESS-RESPONSE; CELL-DIVISION; TWINFILIN; CYCLE; LOCALIZATION	Background Calcium/calmodulin-dependent protein kinase kinase (CaMKK) is required for diverse cellular functions. Mammalian CaMKK activates CaMKs and also the evolutionarily-conserved AMP-activated protein kinase (AMPK). The fission yeast Schizosaccharomyces pombe CaMKK, Ssp1, is required for tolerance to limited glucose through the AMPK, Ssp2, and for the integration of cell growth and division through the SAD kinase Cdr2. Results Here we report that Ssp1 controls the G2/M transition by regulating the activity of the CaMK Srk1. We show that inhibition of Cdc25 by Srk1 is regulated by Ssp1; and also that restoring growth polarity and actin localization of ssp1-deleted cells by removing the actin-monomer-binding protein, twinfilin, is sufficient to suppress the ssp1 phenotype. Conclusions These findings demonstrate that entry into mitosis is mediated by a network of proteins, including the Ssp1 and Srk1 kinases. Ssp1 connects the network of components that ensures proper polarity and cell size with the network of proteins that regulates Cdk1-cyclin B activity, in which Srk1 plays an inhibitory role.	[Gomez-Hierro, Alba; Lambea, Eva; Gimenez-Zaragoza, David; Yance-Chavez, Tula; Montserrat, Marta; Jesus Pujol, M.; Bachs, Oriol; Aligue, Rosa] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, Inst Biomed Res August Pi & Sunyer IDIBAPS, Barcelona 7, Catalunya, Spain; [Lopez-Aviles, Sandra] Biotechnol Ctr Oslo, Cell Cycle Regulat, Oslo, Norway	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Aligue, R (corresponding author), Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, Inst Biomed Res August Pi & Sunyer IDIBAPS, Barcelona 7, Catalunya, Spain.	aliguerosa@ub.edu	Aligue, Rosa/AAA-2520-2019	Aligue, Rosa/0000-0002-2085-325X; Lopez-Aviles, Sandra/0000-0002-0498-1331	Spanish Ministry of Economy and Competitiveness [BFU2012-31220]; Government of Catalonia [SRG2009-1526]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Government of Catalonia(Generalitat de Catalunya)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2012-31220 to RA) and the Government of Catalonia (SRG2009-1526).	Alemany V, 2002, FEBS LETT, V524, P79, DOI 10.1016/S0014-5793(02)03006-5; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Bockhom J, 2012, NATURE COMMUNICATION, V4, P1393; Bockhorn J, 2013, BREAST CANCER RES TR, V137, P373, DOI 10.1007/s10549-012-2346-4; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Cisneros-Barroso E, 2014, NUCLEIC ACIDS RES, V42, P9573, DOI 10.1093/nar/gku684; Davie E, 2015, CURR BIOL, V25, P445, DOI 10.1016/j.cub.2014.12.034; Deng L, 2014, CURR BIOL, V24, P428, DOI 10.1016/j.cub.2014.01.009; Deng L, 2013, MOL BIOL CELL, V24, P1872, DOI 10.1091/mbc.E13-02-0104; Falck S, 2004, EMBO J, V23, P3010, DOI 10.1038/sj.emboj.7600310; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Freitag SI, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130127; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kettenbach AN, 2015, MOL CELL PROTEOMICS, V14, P1275, DOI 10.1074/mcp.M114.045245; Koyano T, 2010, BIOSCI BIOTECH BIOCH, V74, P1129, DOI 10.1271/bbb.100223; Lopez-Aviles S, 2005, MOL CELL, V17, P49, DOI 10.1016/j.molcel.2004.11.043; Lopez-Aviles S, 2008, MOL BIOL CELL, V19, P1670, DOI 10.1091/mbc.E07-07-0639; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin SG, 2005, CELL CYCLE, V4, P1046, DOI 10.4161/cc.4.8.1853; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; MATSUSAKA T, 1995, EMBO J, V14, P3325, DOI 10.1002/j.1460-2075.1995.tb07339.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; Norbury C, 1997, METHOD ENZYMOL, V283, P44; Ohmae S, 2006, J BIOL CHEM, V281, P20427, DOI 10.1074/jbc.M513212200; Palmgren S, 2002, J CELL SCI, V115, P881; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P621, DOI 10.1093/nar/20.3.621; Rasmussen CD, 2000, J BIOL CHEM, V275, P685, DOI 10.1074/jbc.275.1.685; Rupes I, 1999, MOL BIOL CELL, V10, P1495, DOI 10.1091/mbc.10.5.1495; Sanchez-Piris M, 2002, J BIOL CHEM, V277, P17722, DOI 10.1074/jbc.M200104200; Smith DA, 2002, J BIOL CHEM, V277, P33411, DOI 10.1074/jbc.M204593200; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Valbuena N, 2012, J CELL SCI, V125, P2655, DOI 10.1242/jcs.098533; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Ydenberg CA, 2015, CYTOSKELETON, V72, P349, DOI 10.1002/cm.21231	41	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143037	10.1371/journal.pone.0143037	http://dx.doi.org/10.1371/journal.pone.0143037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575035	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400029
J	Shin, A; Lee, J; Lee, J; Park, MS; Park, JW; Park, SC; Oh, JH; Kim, J				Shin, Aesun; Lee, Jeonghee; Lee, Jeeyoo; Park, Moon Sung; Park, Ji Won; Park, Sung Chan; Oh, Jae Hwan; Kim, Jeongseon			Isoflavone and Soyfood Intake and Colorectal Cancer Risk: A Case-Control Study in Korea	PLOS ONE			English	Article							PHYTOESTROGEN INTAKE; SOY CONSUMPTION; DIETARY SOY; HONG-KONG; FOOD; POLYMORPHISM; MORTALITY; PRODUCTS; BREAST; JAPAN	We aimed to assess the relationship between dietary soyfood and isoflavone intake and colorectal cancer risk in a case-control study. A total of 901 colorectal cancer cases and 2669 controls were recruited at the National Cancer Center, Korea. A semi-quantitative food frequency questionnaire was used to assess the usual dietary habits, and the isoflavone intake level was estimated from five soyfood items. A high intake of total soy products, legumes, and sprouts was associated with a reduced risk for colorectal cancer in men and women, although the middle quartiles of intake of total soy products were associated with an elevated risk. In contrast, a high intake of fermented soy paste was associated with an elevated risk for colorectal cancer in men. The groups with the highest intake quartiles of isoflavones showed a decreased risk for colorectal cancer compared to their counterparts with the lowest intake quartiles in men (odds ratio (OR): 0.67, 95% confidence interval (CI): 0.51-0.89) and women (OR: 0.65, 95% CI: 0.43-0.99). The reduced risk for the highest intake groups persisted for distal colon cancer in men and rectal cancer in women. The association between soyfood intake and colorectal cancer risk was more prominent among post-menopausal women than pre-menopausal women. In conclusion, a high intake of total soy products or dietary isoflavones was associated with a reduced risk for overall colorectal cancer, and the association may be more relevant to distal colon or rectal cancers.	[Shin, Aesun; Lee, Jeeyoo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110799, South Korea; [Lee, Jeonghee; Kim, Jeongseon] Natl Canc Ctr, Mol Epidemiol Branch, Goyang Si 410769, South Korea; [Lee, Jeeyoo] Ewha Womans Univ, Dept Nutr Sci & Food Management, Seoul 120750, South Korea; [Park, Moon Sung] Gachon Univ, Coll Nursing, Inchon 406799, South Korea; [Park, Ji Won] Seoul Natl Univ, Coll Med & Hosp, Dept Surg, Seoul 110799, South Korea; [Park, Sung Chan; Oh, Jae Hwan] Natl Canc Ctr, Ctr Colorectal Canc, Goyang Si 410769, South Korea	Seoul National University (SNU); National Cancer Center - Korea (NCC); Ewha Womans University; Gachon University; Seoul National University (SNU); National Cancer Center - Korea (NCC)	Kim, J (corresponding author), Natl Canc Ctr, Mol Epidemiol Branch, Goyang Si 410769, South Korea.	jskim@ncc.re.kr	Shin, Aesun/E-9145-2014; KIM, JEONGSEON/AAA-4643-2022	Shin, Aesun/0000-0002-6426-1969; 	National Research Foundation of Korea [2010-0010276, 2013R1A1A2A10008260]; National Cancer Center, Korea [0910220, 1210141]	National Research Foundation of Korea(National Research Foundation of Korea); National Cancer Center, Korea	The research relating to this abstract was funded by the National Research Foundation of Korea (2010-0010276, 2013R1A1A2A10008260) and the National Cancer Center, Korea (0910220, 1210141).	Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Akhter M, 2008, CANCER EPIDEM BIOMAR, V17, P2128, DOI 10.1158/1055-9965.EPI-08-0182; Budhathoki S, 2011, SCAND J GASTROENTERO, V46, P165, DOI 10.3109/00365521.2010.522720; Cho YA, 2010, EUR J CLIN NUTR, V64, P924, DOI 10.1038/ejcn.2010.95; Cotterchio M, 2006, J NUTR, V136, P3046, DOI 10.1093/jn/136.12.3046; Hjartaker A, 2013, J ONCOL, V2013, DOI 10.1155/2013/703854; Ho SY, 2006, PREV MED, V43, P20, DOI 10.1016/j.ypmed.2006.03.007; Honma N, 2013, INT J CANCER, V132, P951, DOI 10.1002/ijc.27688; HOSHIYAMA Y, 1993, TOHOKU J EXP MED, V171, P153, DOI 10.1620/tjem.171.153; Huang Xin-En, 2004, Asian Pac J Cancer Prev, V5, P419; Hwang CS, 2006, J STEROID BIOCHEM, V101, P246, DOI 10.1016/j.jsbmb.2006.06.020; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Khan M M H, 2004, Asian Pac J Cancer Prev, V5, P58; Kim J, 2009, EUR J CLIN NUTR, V63, P1057, DOI 10.1038/ejcn.2009.37; Kim JI, 2003, WORLD J GASTROENTERO, V9, P956; Ko KP, 2013, J EPIDEMIOL, V23, P337, DOI 10.2188/jea.JE20120232; KONO S, 1993, JPN J CANCER RES, V84, P13, DOI 10.1111/j.1349-7006.1993.tb02777.x; Lee Se Young, 2005, Korean J Gastroenterol, V45, P23; LeMarchand L, 1997, EPIDEMIOLOGY, V8, P658, DOI 10.1097/00001648-199710000-00008; MESSINA M, 1991, JNCI-J NATL CANCER I, V83, P541, DOI 10.1093/jnci/83.8.541; Nishi M, 1997, ONCOL REP, V4, P995; Oba S, 2007, NUTR CANCER, V57, P151, DOI 10.1080/01635580701274475; Papaxoinis K, 2010, EUR J GASTROEN HEPAT, V22, P614, DOI 10.1097/MEG.0b013e328335ef50; Park MK, 2007, ASIA PAC J CLIN NUTR, V16, P129; Ravasco P., 2005, Nutr. Hosp., V20, P165; Rossi M, 2006, CANCER EPIDEM BIOMAR, V15, P1555, DOI 10.1158/1055-9965.EPI-06-0017; Sanchez-Chino X, 2015, NUTR CANCER, V67, P401, DOI 10.1080/01635581.2015.1004729; Sarkar FH, 2002, CANCER METAST REV, V21, P265, DOI 10.1023/A:1021210910821; Sarkar FH, 2003, CANCER INVEST, V21, P744, DOI 10.1081/CNV-120023773; Shin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088079; Shin A, 2013, WORLD J GASTROENTERO, V19, P979, DOI 10.3748/wjg.v19.i7.979; Shin A, 2012, CANCER RES TREAT, V44, P219, DOI 10.4143/crt.2012.44.4.219; Shin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023196; van der Velpen V, 2014, EUR J CLIN NUTR, V68, P1141, DOI 10.1038/ejcn.2014.108; Wang L, 2009, AM J CLIN NUTR, V89, P905, DOI 10.3945/ajcn.2008.26913; Ward HA, 2010, AM J CLIN NUTR, V91, P440, DOI 10.3945/ajcn.2009.28282; Willett W., 2013, MONOGRAPHS EPIDEMIOL, V3rd; Witte JS, 1996, AM J EPIDEMIOL, V144, P1015, DOI 10.1093/oxfordjournals.aje.a008872; Yan L, 2010, CANCER EPIDEM BIOMAR, V19, P148, DOI 10.1158/1055-9965.EPI-09-0856; Yang G, 2009, AM J CLIN NUTR, V89, P577, DOI 10.3945/ajcn.2008.26742; Zhivotovskiy AS, 2012, ASIAN PAC J CANCER P, V13, P5183, DOI 10.7314/APJCP.2012.13.10.5183	41	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143228	10.1371/journal.pone.0143228	http://dx.doi.org/10.1371/journal.pone.0143228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575841	Green Submitted, Green Published, gold			2022-12-26	WOS:000365153400055
J	Aghighi, M; Golovko, D; Ansari, C; Marina, NM; Pisani, L; Kurlander, L; Klenk, C; Bhaumik, S; Wendland, M; Daldrup-Link, HE				Aghighi, Maryam; Golovko, Daniel; Ansari, Celina; Marina, Neyssa M.; Pisani, Laura; Kurlander, Lonnie; Klenk, Christopher; Bhaumik, Srabani; Wendland, Michael; Daldrup-Link, Heike E.			Imaging Tumor Necrosis with Ferumoxytol	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; RENAL-CELL CARCINOMA; PROSTATE-CANCER; CONTRAST AGENT; CLEAR-CELL; DISEASE; MODEL; MRI; THERAPY; USPIO	Objective Ultra-small superparamagnetic iron oxide nanoparticles (USPIO) are promising contrast agents for magnetic resonance imaging (MRI). USPIO mediated proton relaxation rate enhancement is strongly dependent on compartmentalization of the agent and can vary depending on their intracellular or extracellular location in the tumor microenvironment. We compared the T1- and T2-enhancement pattern of intracellular and extracellular USPIO in mouse models of cancer and pilot data from patients. A better understanding of these MR signal effects will enable non-invasive characterizations of the composition of the tumor microenvironment. Materials and Methods Six 4T1 and six MMTV-PyMT mammary tumors were grown in mice and imaged with ferumoxytol-enhanced MRI. R1 relaxation rates were calculated for different tumor types and different tumor areas and compared with histology. The transendothelial leakage rate of ferumoxytol was obtained by our measured relaxivity of ferumoxytol and compared between different tumor types, using a t-test. Additionally, 3 patients with malignant sarcomas were imaged with ferumoxytol-enhanced MRI. T1- and T2-enhancement patterns were compared with histopathology in a descriptive manner as a proof of concept for clinical translation of our observations. Results 4T1 tumors showed central areas of high signal on T1 and low signal on T2 weighted MR images, which corresponded to extracellular nanoparticles in a necrotic core on histopathology. MMTV-PyMT tumors showed little change on T1 but decreased signal on T2 weighted images, which correlated to compartmentalized nanoparticles in tumor associated macrophages. Only 4T1 tumors demonstrated significantly increased R1 relaxation rates of the tumor core compared to the tumor periphery (p<0.001). Transendothelial USPIO leakage was significantly higher for 4T1 tumors (3.4 +/- 0.9x10(-3) mL/min/100cm(3)) compared to MMTV-PyMT tumors (1.0 +/- 0.9x10(-3) mL/min/100 cm(3)). Likewise, ferumoxytol imaging in patients showed similar findings with high T1 signal in areas of tumor necrosis and low signal in areas of intracellularly compartmentalized iron. Conclusion Differential T1- and T2-enhancement patterns of USPIO in tumors enable conclusions about their intracellular and extracellular location. This information can be used to characterize the composition of the tumor microenvironment.	[Aghighi, Maryam; Ansari, Celina; Marina, Neyssa M.; Pisani, Laura; Kurlander, Lonnie; Klenk, Christopher; Daldrup-Link, Heike E.] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Golovko, Daniel] Tufts Univ, Sch Med, Medford, MA 02155 USA; [Bhaumik, Srabani] Res Circle, GE Global Res Ctr, Niskayuna, NY USA; [Wendland, Michael] Univ Calif Berkeley, Berkeley, CA 94720 USA	Stanford University; Tufts University; General Electric; University of California System; University of California Berkeley	Daldrup-Link, HE (corresponding author), Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	heiked@stanford.edu	Marina, Neyssa/B-7449-2009	Marina, Neyssa/0000-0002-7195-8887; Daldrup-Link, Heike/0000-0002-4929-819X	National Cancer Institute [R21-CA176519]; Eunice Kennedy Shriver National Institute for Child Health and Human Development [R01-HD081123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081123] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA176519] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support from the National Cancer Institute, grant number R21-CA176519 and the Eunice Kennedy Shriver National Institute for Child Health and Human Development, grant number R01-HD081123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2012, DRUG DISCOV TODAY, V17, P928, DOI 10.1016/j.drudis.2012.03.010; Ansari C, 2014, SMALL, V10, P566, DOI 10.1002/smll.201301456; Beddy P, 2014, CLIN GENITOURIN CANC, V12, P55, DOI 10.1016/j.clgc.2013.07.006; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Daldrup H, 1998, AM J ROENTGENOL, V171, P941, DOI 10.2214/ajr.171.4.9762973; Daldrup-Link H, 2012, ONCOIMMUNOLOGY, V1, P507, DOI DOI 10.4161/0NCI.19456; Daldrup-Link HE, 2003, RADIOLOGY, V229, P885, DOI 10.1148/radiol.2293021045; Daldrup-Link HE, 2006, CURR PHARM DESIGN, V12, P2661, DOI 10.2174/138161206777698774; Daldrup-Link HE, 2011, CLIN CANCER RES, V17, P5695, DOI 10.1158/1078-0432.CCR-10-3420; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Henning TD, 2009, MAGN RESON MED, V62, P325, DOI 10.1002/mrm.22011; Klenk C, 2014, LANCET ONCOL, V15, P275, DOI 10.1016/S1470-2045(14)70021-X; Li W, 2007, RADIOLOGY, V242, P873, DOI 10.1148/radiol.2423052101; Lim Hyo Soon, 2006, AJR Am J Roentgenol, V187, pW341, DOI 10.2214/AJR.04.1932; Lu M, 2010, AM J HEMATOL, V85, P315, DOI 10.1002/ajh.21656; MCLACHLAN SJ, 1994, JMRI-J MAGN RESON IM, V4, P301, DOI 10.1002/jmri.1880040313; Meier R, 2010, RADIOLOGY; Moore A, 2000, RADIOLOGY, V214, P568, DOI 10.1148/radiology.214.2.r00fe19568; Neuville A, 2014, PATHOLOGY, V46, P113, DOI 10.1097/PAT.0000000000000048; Neuwelt EA, 2007, NEUROSURGERY, V60, P601, DOI 10.1227/01.NEU.0000255350.71700.37; Pan DPJ, 2010, FUTURE MED CHEM, V2, P471, DOI 10.4155/FMC.10.5; Pichler M, 2012, AM J CLIN PATHOL, V137, P283, DOI 10.1309/AJCPLBK9L9KDYQZP; Pollheimer MJ, 2010, HUM PATHOL, V41, P1749, DOI 10.1016/j.humpath.2010.04.018; Richards CH, 2011, FUTURE ONCOL, V7, P1223, DOI [10.2217/fon.11.99, 10.2217/FON.11.99]; Roberts TPL, 1997, J MAGN RESON IMAGING, V7, P82, DOI 10.1002/jmri.1880070112; Santra S, 2009, SMALL, V5, P1862, DOI 10.1002/smll.200900389; Shi QY, 2013, CONTRAST MEDIA MOL I, V8, P281, DOI 10.1002/cmmi.1526; Shih YYI, 2011, NMR BIOMED, V24, P1353, DOI 10.1002/nbm.1698; Sigovan M, 2009, RADIOLOGY, V252, P401, DOI 10.1148/radiol.2522081484; Simon G, 2005, EUR RADIOL, V15, P895, DOI 10.1007/s00330-005-2669-1; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; Simon GH, 2006, INVEST RADIOL, V41, P45, DOI 10.1097/01.rli.0000191367.61306.83; Smith BR, 2012, NANO LETT, V12, P3369, DOI 10.1021/nl204175t; Triantafyllou M, 2013, EUR J CANCER, V49, P616, DOI 10.1016/j.ejca.2012.09.034; Turetschek K, 2001, J MAGN RESON IMAGING, V13, P882, DOI 10.1002/jmri.1126; Turetschek K, 2001, RADIOLOGY, V218, P562, DOI 10.1148/radiology.218.2.r01fe37562; Varticovski L, 2007, CLIN CANCER RES, V13, P2168, DOI 10.1158/1078-0432.CCR-06-0918; Wang ZJ, 2008, PEDIATR RADIOL, V38, P529, DOI 10.1007/s00247-008-0764-6; Yilmaz A, 2013, EUR HEART J, V34, P462, DOI 10.1093/eurheartj/ehs366; Young JK, 2012, ANN BIOMED ENG, V40, P438, DOI 10.1007/s10439-011-0472-5	42	24	25	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142665	10.1371/journal.pone.0142665	http://dx.doi.org/10.1371/journal.pone.0142665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569397	Green Published, gold			2022-12-26	WOS:000365070700058
J	Lui, JK; Parameswaran, H; Albert, MS; Lutchen, KR				Lui, Justin K.; Parameswaran, Harikrishnan; Albert, Mitchell S.; Lutchen, Kenneth R.			Linking Ventilation Heterogeneity Quantified via Hyperpolarized He-3 MRI to Dynamic Lung Mechanics and Airway Hyperresponsiveness	PLOS ONE			English	Article							MAGNETIC-RESONANCE; DEEP INSPIRATION; METHACHOLINE CHALLENGE; FLOW OBSTRUCTION; ASTHMA; BRONCHOCONSTRICTION; INFLAMMATION; SEVERITY; INHIBITION; INHALATION	Advancements in hyperpolarized helium-3 MRI (HP He-3-MRI) have introduced the ability to render and quantify ventilation patterns throughout the anatomic regions of the lung. The goal of this study was to establish how ventilation heterogeneity relates to the dynamic changes in mechanical lung function and airway hyperresponsiveness in asthmatic subjects. In four healthy and nine mild-to-moderate asthmatic subjects, we measured dynamic lung resistance and lung elastance from 0.1 to 8 Hz via a broadband ventilation waveform technique. We quantified ventilation heterogeneity using a recently developed coefficient of variation method from HP He-3-MRI imaging. Dynamic lung mechanics and imaging were performed at baseline, post-challenge, and after a series of five deep inspirations. AHR was measured via the concentration of agonist that elicits a 20% decrease in the subject's forced expiratory volume in one second compared to baseline (PC20) dose. The ventilation coefficient of variation was correlated to low-frequency lung resistance (R = 0.647, P < 0.0001), the difference between high and low frequency lung resistance (R = 0.668, P < 0.0001), and low-frequency lung elastance (R = 0.547, P = 0.0003). In asthmatic subjects with PC20 values <25 mg/mL, the coefficient of variation at baseline exhibited a strong negative trend (R = -0.798, P = 0.02) to PC20 dose. Our findings were consistent with the notion of peripheral rather than central involvement of ventilation heterogeneity. Also, the degree of AHR appears to be dependent on the degree to which baseline airway constriction creates baseline ventilation heterogeneity. HP He-3-MRI imaging may be a powerful predictor of the degree of AHR and in tracking the efficacy of therapy.	[Lui, Justin K.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Lui, Justin K.; Parameswaran, Harikrishnan; Lutchen, Kenneth R.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Albert, Mitchell S.] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Albert, Mitchell S.] Lakehead Univ, Dept Chem, Thunder Bay, ON P7B 5E1, Canada; [Albert, Mitchell S.] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Lakehead University; Northern Ontario School of Medicine	Lutchen, KR (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	justin.lui@umassmemorial.org		Parameswaran, Harikrishnan/0000-0002-5324-5517	National Heart, Lung, and Blood Institute [R01 HL62269-04, R01 HL-096797]; NIH [HL122513]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062269, K99HL122513, R01HL096797, R00HL122513] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart, Lung, and Blood Institute Grants R01 HL62269-04 and R01 HL-096797.; This work was funded by the National Heart, Lung, and Blood Institute Grants R01 HL6226904 and R01 HL-096797. HP is supported by NIH Grant HL122513.	BEHRAKIS PK, 1983, CHEST, V83, P643, DOI 10.1378/chest.83.4.643; Black LD, 2004, J APPL PHYSIOL, V96, P1808, DOI 10.1152/japplphysiol.01170.2003; Brusasco V, 1999, J APPL PHYSIOL, V87, P567, DOI 10.1152/jappl.1999.87.2.567; Campana L, 2009, J APPL PHYSIOL, V106, P1293, DOI 10.1152/japplphysiol.91428.2008; Costella S, 2012, RESPIROLOGY, V17, P1237, DOI 10.1111/j.1440-1843.2012.02250.x; de Lange EE, 2007, J ALLERGY CLIN IMMUN, V119, P1072, DOI 10.1016/j.jaci.2006.12.659; de Lange EE, 2006, CHEST, V130, P1055, DOI 10.1378/chest.130.4.1055; de Lange EE, 2009, RADIOLOGY, V250, P567, DOI 10.1148/radiol.2502080188; Downie SR, 2007, THORAX, V62, P684, DOI 10.1136/thx.2006.069682; Downie SR, 2013, J APPL PHYSIOL, V114, P770, DOI 10.1152/japplphysiol.01198.2012; Driehuys B, 2007, MAGN RESON MED, V58, P893, DOI 10.1002/mrm.21306; Farah CS, 2012, J ALLERGY CLIN IMMUN, V130, P61, DOI 10.1016/j.jaci.2012.02.015; Farrow CE, 2012, J APPL PHYSIOL, V113, P958, DOI 10.1152/japplphysiol.01618.2011; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hardaker KM, 2011, CHEST, V139, P1395, DOI 10.1378/chest.10-1839; Harris RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053216; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Kaczka DW, 1997, J APPL PHYSIOL, V82, P1531, DOI 10.1152/jappl.1997.82.5.1531; Kaminsky DA, 2008, J APPL PHYSIOL, V104, P10, DOI 10.1152/japplphysiol.00519.2007; Kapsali T, 2000, J APPL PHYSIOL, V89, P711, DOI 10.1152/jappl.2000.89.2.711; Kauczor HU, 2001, INVEST RADIOL, V36, P110, DOI 10.1097/00004424-200102000-00007; King GG, 1999, AM J RESP CRIT CARE, V160, P454, DOI 10.1164/ajrccm.160.2.9804012; King GG, 2001, AM J RESP CRIT CARE, V164, P216, DOI 10.1164/ajrccm.164.2.2006101; Leary D, 2014, J APPL PHYSIOL, V117, P353, DOI 10.1152/japplphysiol.00881.2013; Lewis TA, 2005, MAGN RESON MED, V53, P474, DOI 10.1002/mrm.20349; Lui JK, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/624683; Lundblad LKA, 2007, AM J RESP CRIT CARE, V175, P768, DOI 10.1164/rccm.200610-1410OC; Lutchen KR, 1996, J APPL PHYSIOL, V80, P1696, DOI 10.1152/jappl.1996.80.5.1696; LUTCHEN KR, 1993, J APPL PHYSIOL, V75, P478, DOI 10.1152/jappl.1993.75.1.478; Lutchen KR, 1997, J APPL PHYSIOL, V83, P1192, DOI 10.1152/jappl.1997.83.4.1192; Lutchen KR, 2001, AM J RESP CRIT CARE, V164, P207, DOI 10.1164/ajrccm.164.2.2008119; Mendonca NT, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-96; Mistry NN, 2010, MAGN RESON MED, V63, P658, DOI 10.1002/mrm.22311; Mitchell JH, 2012, RESP PHYSIOL NEUROBI, V183, P224, DOI 10.1016/j.resp.2012.06.031; Nadal JA, 1961, J APPL PHYSIOL, V16, P717; Samee S, 2003, J ALLERGY CLIN IMMUN, V111, P1205, DOI 10.1067/mai.2003.1544; Scichilone N, 2001, AM J RESP CRIT CARE, V163, P413, DOI 10.1164/ajrccm.163.2.2003119; Scichilone N, 2007, RESP MED, V101, P951, DOI 10.1016/j.rmed.2006.09.009; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Tgavalekos NT, 2007, EUR RESPIR J, V29, P1174, DOI 10.1183/09031936.00113606; Tgavalekos NT, 2005, J APPL PHYSIOL, V99, P2388, DOI 10.1152/japplphysiol.00391.2005; Thomas AC, 2012, J APPL PHYSIOL, V112, P1437, DOI 10.1152/japplphysiol.01293.2011; Tzeng YS, 2009, J APPL PHYSIOL, V106, P813, DOI 10.1152/japplphysiol.01133.2007; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Verbanck S, 2004, AM J RESP CRIT CARE, V170, P414, DOI 10.1164/rccm.200401-037OC	45	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142738	10.1371/journal.pone.0142738	http://dx.doi.org/10.1371/journal.pone.0142738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569412	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700067
J	Chauhan, AK; Moore, TL; Bi, Y; Chen, C				Chauhan, Anil K.; Moore, Terry L.; Bi, Ye; Chen, Chen			Fc gamma RIIIa-Syk Co-signal Modulates CD4(+) T-cell Response and Up-regulates Toll-like Receptor (TLR) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON-GAMMA; IMMUNE-COMPLEXES; HELPER-CELLS; COSTIMULATORY MOLECULES; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASE; GERMINAL-CENTERS; TYROSINE KINASE; DENDRITIC CELLS	CD4(+) T-cells in systemic lupus erythematosus (SLE) patients show altered T-cell receptor signaling, which utilizes Fc-receptor gamma-chain FcR gamma-Syk. A role for Fc gamma RIIIa activation from immune complex (IC) ligation and sublytic terminal complement complex (C5b-9) in CD4(+) T-cell responses is not investigated. In this study, we show that the ICs present in SLE patients by ligating to Fc gamma RIIIa on CD4(+) T-cells phosphorylate Syk and provide a co-stimulatory signal to CD4(+) T-cells in the absence of CD28 signal. This led to the development of pathogenic IL-17A(+) and IFN-gamma(high) CD4(+) T-cells in vitro. Cytokines IL-1 beta, IL-6, TGF-beta 1, and IL-23 were the only requirement for the development of both populations. SLE patients CD4(+) T-cells that expressed CD25, CD69, and CD98 bound to ICs showed pSyk and produced IFN-gamma and IL-17A. This Fc gamma RIIIa-mediated co-signal differentially up-regulated the expression of IFN pathway genes compared with CD28 co-signal. Fc gamma RIIIa-pSyk upregulated several toll-like receptor genes as well as the HMGB1 and MyD88 gene transcripts. ICs co-localized with these toll-like receptor pathway proteins. These results suggest a role for the Fc gamma RIIIa-pSyk signal in modulating adaptive immune responses.	[Chauhan, Anil K.; Moore, Terry L.; Bi, Ye; Chen, Chen] St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, 1402 South Grand Blvd, St Louis, MO 63104 USA	Saint Louis University	Chauhan, AK (corresponding author), St Louis Univ, Sch Med, Div Adult & Pediat Rheumatol, 1402 South Grand Blvd, St Louis, MO 63104 USA.	chauhana@slu.edu	Bi, Ye/A-6272-2017		National Institutes of Health RO1 Grant [A1098114]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098114] Funding Source: NIH RePORTER	National Institutes of Health RO1 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health RO1 Grant A1098114 (to A.K.C.). The authors declare that they have no conflict of interest with the content of this article.	Agarwal A, 2008, CURR OPIN ORGAN TRAN, V13, P366, DOI 10.1097/MOT.0b013e328306115b; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Amarilyo G, 2014, J IMMUNOL, V193, P540, DOI 10.4049/jimmunol.1400931; Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Cai G, 2012, J IMMUNOL, V189, P1294, DOI 10.4049/jimmunol.1102948; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chauhan AK, 2012, CLIN EXP IMMUNOL, V167, P235, DOI 10.1111/j.1365-2249.2011.04505.x; Chauhan AK, 2015, J BIOL CHEM, V290, P5127, DOI 10.1074/jbc.M114.599266; Chauhan AK, 2011, J BIOL CHEM, V286, P38627, DOI 10.1074/jbc.M111.266809; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chiu YY, 1998, J INVEST ALLERG CLIN, V8, P239; Chugh PK, 2012, EUR J INTERN MED, V23, P212, DOI 10.1016/j.ejim.2011.11.001; Conti F, 2011, CLIN REV ALLERG IMMU, V40, P192, DOI 10.1007/s12016-010-8208-0; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Crow MK, 2010, RHEUM DIS CLIN N AM, V36, P173, DOI 10.1016/j.rdc.2009.12.008; Datta SK, 1997, LUPUS, V6, P333, DOI 10.1177/096120339700600330; Davies KA, 2002, ARTHRITIS RHEUM-US, V46, P1028, DOI 10.1002/art.10189; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; ENGELHARDT W, 1995, IMMUNOBIOLOGY, V192, P297, DOI 10.1016/S0171-2985(11)80172-5; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gordon RA, 2012, ARTHRITIS RHEUM-US, V64, P3119, DOI 10.1002/art.34544; Grammatikos AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074550; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Jury EC, 2006, J IMMUNOL, V177, P7416, DOI 10.4049/jimmunol.177.10.7416; Karonitsch T, 2009, ARTHRITIS RHEUM, V60, P1463, DOI 10.1002/art.24449; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2004, J IMMUNOL, V172, P7821, DOI 10.4049/jimmunol.172.12.7821; Latour S, 1996, J BIOL CHEM, V271, P22782, DOI 10.1074/jbc.271.37.22782; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Low JM, 2009, PROTEOM CLIN APPL, V3, P829, DOI 10.1002/prca.200800073; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martin JC, 2014, CLIN IMMUNOL, V154, P1, DOI 10.1016/j.clim.2014.05.004; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Miura Y, 1989, Nihon Jinzo Gakkai Shi, V31, P201; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Noraz N, 2000, J BIOL CHEM, V275, P15832, DOI 10.1074/jbc.M908568199; Nurieva RI, 2011, IMMUNOL REV, V241, P133, DOI 10.1111/j.1600-065X.2011.01012.x; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Patole PS, 2005, J AM SOC NEPHROL, V16, P1326, DOI 10.1681/ASN.2004100820; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Pisitkun P, 2012, IMMUNITY, V37, P1104, DOI 10.1016/j.immuni.2012.08.014; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; SANDOR M, 1993, IMMUNOL TODAY, V14, P227, DOI 10.1016/0167-5699(93)90168-K; SANDOR M, 1994, P NATL ACAD SCI USA, V91, P12857, DOI 10.1073/pnas.91.26.12857; Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; van Egmond M, 2015, IMMUNOL REV, V268, P311, DOI 10.1111/imr.12333; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vermeire K, 1997, J IMMUNOL, V158, P5507; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Vogelpoel LTC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6444; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zhang YB, 2013, J IMMUNOL, V190, P4725, DOI 10.4049/jimmunol.1203024; Zhu YW, 2011, IMMUNITY, V34, P466, DOI 10.1016/j.immuni.2011.04.008	86	13	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1368	1386		10.1074/jbc.M115.684795	http://dx.doi.org/10.1074/jbc.M115.684795			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26582197	Green Published, hybrid			2022-12-26	WOS:000368068300029
J	Newport, C; Wallis, G; Siebeck, UE				Newport, Cait; Wallis, Guy; Siebeck, Ulrike E.			Same/Different Abstract Concept Learning by Archerfish (Toxotes chatareus)	PLOS ONE			English	Article							MATCHING-TO-SAMPLE; ODD-ITEM SEARCH; PIGEONS; DISCRIMINATION; COMPLEX; INFORMATION; SAMENESS; GOLDFISH; STARTS	While several phylogenetically diverse species have proved capable of learning abstract concepts, previous attempts to teach fish have been unsuccessful. In this report, the ability of archerfish (Toxotes chatareus) to learn the concepts of sameness and difference using a simultaneous two-item discrimination task was tested. Six archerfish were trained to either select a pair of same or different stimuli which were presented simultaneously. Training consisted of a 2-phase approach. Training phase 1: the symbols in the same and different pair did not change, thereby allowing the fish to solve the test through direct association. The fish were trained consecutively with four different sets of stimuli to familiarize them with the general procedure before moving on to the next training phase. Training phase 2: six different symbols were used to form the same or different pairs. After acquisition, same/different concept learning was tested by presenting fish with six novel stimuli (transfer test). Five fish successfully completed the first training phase. Only one individual passed the second training phase, however, transfer performance was consistent with chance. This individual was given further training using 60 training exemplars but the individual was unable to reach the training criterion. We hypothesize that archerfish are able to solve a limited version of the same/different test by learning the response to each possible stimulus configuration or by developing a series of relatively simple choice contingencies. We conclude that the simultaneous two-item discrimination task we describe cannot be successfully used to test the concepts of same and different in archerfish. In addition, despite considerable effort training archerfish using several tests and training methods, there is still no evidence that fish can learn an abstract concept-based test.	[Newport, Cait; Siebeck, Ulrike E.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Newport, Cait] Univ Oxford, Dept Zool, Oxford, England; [Wallis, Guy] Univ Queensland, Ctr Sensorimotor Performance, Sch Human Movement Studies, Brisbane, Qld, Australia	University of Queensland; University of Oxford; University of Queensland	Newport, C (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	caitlin.newport@zoo.ox.ac.uk	Siebeck, Ulrike E/J-6190-2014; Wallis, Guy/G-2342-2011	Siebeck, Ulrike E/0000-0003-2024-1568; Wallis, Guy/0000-0003-1601-1540	Australian Research Council [FT100100020, DP140100431]; European Union [659684]	Australian Research Council(Australian Research Council); European Union(European Commission)	This study was funded by the Australian Research Council (GW: FT100100020; UES: DP140100431) and the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement (CN: 659684). The contents of this study reflect only the authors' views and not the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avargues-Weber A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1907; Ben-Tov M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7476; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Bisazza A, 2014, ANIM COGN, V17, P1413, DOI 10.1007/s10071-014-0759-7; Blaisdell AP, 2005, LEARN BEHAV, V33, P67; BLOUGH DS, 1986, BEHAV RES METH INSTR, V18, P413, DOI 10.3758/BF03201403; BLOUGH DS, 1989, J EXP PSYCHOL ANIM B, V15, P14, DOI 10.1037/0097-7403.15.1.14; Bodily KD, 2008, J EXP PSYCHOL ANIM B, V34, P178, DOI 10.1037/0097-7403.34.1.178; CARTER DE, 1978, J EXP ANAL BEHAV, V29, P565, DOI 10.1901/jeab.1978.29-565; CHAUSSEIL M, 1991, ETHOLOGY, V87, P28; Cook RG, 2003, BEHAV PROCESS, V62, P125, DOI 10.1016/S0376-6357(03)00022-6; Gierszewski S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057363; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GOLDMAN M, 1979, J EXP ANAL BEHAV, V31, P259, DOI 10.1901/jeab.1979.31-259; HERRNSTEIN RJ, 1964, SCIENCE, V146, P549, DOI 10.1126/science.146.3643.549; KASTAK D, 1994, ANIM LEARN BEHAV, V22, P427, DOI 10.3758/BF03209162; Katz JS, 2007, COMP COGN BEHAV REV, V2, P79, DOI 10.3819/ccbr.2008.20005; Katz JS, 2006, J EXP PSYCHOL ANIM B, V32, P80, DOI 10.1037/0097-7403.32.1.80; Katz JS, 2002, J EXP PSYCHOL ANIM B, V28, P358, DOI 10.1037//0097-7403.28.4.358; Krupczynski P, 2013, J EXP BIOL, V216, P3450, DOI 10.1242/jeb.088856; LUBOW RE, 1974, J EXP ANAL BEHAV, V21, P475, DOI 10.1901/jeab.1974.21-475; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mercado E, 2000, BEHAV PROCESS, V50, P79, DOI 10.1016/S0376-6357(00)00100-5; Miller AM, 2013, ANIM BEHAV, V85, P339, DOI 10.1016/j.anbehav.2012.11.002; Newport C, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00039; Newport C, 2013, ANIM BEHAV, V86, P1265, DOI 10.1016/j.anbehav.2013.09.031; PEPPERBERG IM, 1987, ANIM LEARN BEHAV, V15, P423, DOI 10.3758/BF03205051; PREMACK D, 1983, ANNU REV PSYCHOL, V34, P351, DOI 10.1146/annurev.ps.34.020183.002031; Premack D., 1978, COGNITIVE PROCESS, P423; Reinel C, 2014, J EXP BIOL, V217, P2866, DOI 10.1242/jeb.105510; Rischawy I, 2013, J EXP BIOL, V216, P3096, DOI 10.1242/jeb.087734; Schluessel V, 2012, ANIM COGN, V15, P525, DOI 10.1007/s10071-012-0480-3; Scholtyssek C, 2013, ANIM COGN, V16, P915, DOI 10.1007/s10071-013-0624-0; Schuster S, 2012, CURR OPIN NEUROBIOL, V22, P279, DOI 10.1016/j.conb.2011.12.004; WILSON B, 1985, Q J EXP PSYCHOL-B, V37, P313, DOI 10.1080/14640748508401173; Young ME, 1997, J EXP PSYCHOL ANIM B, V23, P491, DOI 10.1037/0097-7403.23.4.491; ZENTALL T, 1974, J EXP PSYCHOL, V102, P393, DOI 10.1037/h0035970; ZERBOLIO DJ, 1983, ANIM LEARN BEHAV, V11, P341, DOI 10.3758/BF03199786	38	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143401	10.1371/journal.pone.0143401	http://dx.doi.org/10.1371/journal.pone.0143401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599071	Green Published, gold			2022-12-26	WOS:000365853900108
J	Tam, SY; Lilla, JN; Chen, CC; Kalesnikoff, J; Tsai, M				Tam, See-Ying; Lilla, Jennifer N.; Chen, Ching-Cheng; Kalesnikoff, Janet; Tsai, Mindy			RabGEF1/Rabex-5 Regulates TrkA-Mediated Neurite Outgrowth and NMDA-Induced Signaling Activation in NGF-Differentiated PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEURONAL DEVELOPMENT; NUCLEOTIDE EXCHANGE; MAST-CELLS; RABEX-5; KINASE; RECEPTORS; ENDOSOMES; UBIQUITIN; RAC	Nerve growth factor (NGF) binds to its cognate receptor TrkA and induces neuronal differentiation by activating distinct downstream signal transduction events. RabGEF1 (also known as Rabex-5) is a guanine nucleotide exchange factor for Rab5, which regulates early endosome fusion and vesicular trafficking in endocytic pathways. Here, we used the antisense (AS) expression approach to induce an NGF-dependent sustained knockdown of RabGEF1 protein expression in stable PC12 transfectants. We show that RabGEF1 is a negative regulator of NGF-induced neurite outgrowth and modulates other cellular and signaling processes that are activated by the interaction of NGF with TrkA receptors, such as cell cycle progression, cessation of proliferation, and activation of NGF-mediated downstream signaling responses. Moreover, RabGEF1 can bind to Rac1, and the activation of Rac1 upon NGF treatment is significantly enhanced in AS transfectants, suggesting that RabGEF1 is a negative regulator of NGF-induced Rac1 activation in PC12 cells. Furthermore, we show that RabGEF1 can also interact with NMDA receptors by binding to the NR2B subunit and its associated binding partner SynGAP, and negatively regulates activation of nitric oxide synthase activity induced by NMDA receptor stimulation in NGF-differentiated PC12 cells. Our data suggest that RabGEF1 is a negative regulator of TrkA-dependent neuronal differentiation and of NMDA receptor-mediated signaling activation in NGF-differentiated PC12 cells.	[Tam, See-Ying; Lilla, Jennifer N.; Chen, Ching-Cheng; Kalesnikoff, Janet; Tsai, Mindy] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Tam, SY (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	stam@stanford.edu		Tsai, Mindy/0000-0002-8421-4721	National Institutes of Health (NIH) [AI-23990]; Department of Pathology, Stanford University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023990, R01AI023990] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, Stanford University School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported in part by National Institutes of Health (NIH) grant AI-23990 (to Stephen J. Galli) and the Department of Pathology, Stanford University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Arundine M, 2003, BRAIN RES, V976, P149, DOI 10.1016/S0006-8993(03)02568-X; Bucci C, 2014, MEMBRANES, V4, P642, DOI 10.3390/membranes4040642; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen XQ, 1999, J BIOL CHEM, V274, P19901, DOI 10.1074/jbc.274.28.19901; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grimes ML, 1996, J NEUROSCI, V16, P7950; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kalesnikoff J, 2006, P NATL ACAD SCI USA, V103, P2659, DOI 10.1073/pnas.0511191103; Kalesnikoff J, 2007, BLOOD, V109, P5308, DOI 10.1182/blood-2007-01-067363; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Lamoureux P, 1997, J CELL SCI, V110, P635; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Mori Y, 2013, J BIOL CHEM, V288, P9835, DOI 10.1074/jbc.M112.427591; Nguyen LK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-52; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Obara Y, 2009, J BIOL CHEM, V284, P23564, DOI 10.1074/jbc.M109.027821; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SPAARGAREN M, 1991, J BIOL CHEM, V266, P1733; Stratmann H, 2010, CELL SIGNAL, V22, P1124, DOI 10.1016/j.cellsig.2010.03.007; Tam SY, 2004, NAT IMMUNOL, V5, P844, DOI 10.1038/ni1093; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang L, 2011, MOL BIOL CELL, V22, P3853, DOI 10.1091/mbc.E11-03-0277; XIONG LM, 1992, P NATL ACAD SCI USA, V89, P5356, DOI 10.1073/pnas.89.12.5356; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yan H, 2010, CURR BIOL, V20, P1378, DOI 10.1016/j.cub.2010.06.058; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	55	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142935	10.1371/journal.pone.0142935	http://dx.doi.org/10.1371/journal.pone.0142935			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588713	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500025
J	Ye, P; Zhang, MZ; Fan, SQ; Zhang, TW; Fu, HH; Su, XY; Gavine, PR; Liu, Q; Yin, XL				Ye, Peng; Zhang, Meizhuo; Fan, Shuqiong; Zhang, Tianwei; Fu, Haihua; Su, Xinying; Gavine, Paul R.; Liu, Qiang; Yin, Xiaolu			Intra-Tumoral Heterogeneity of HER2, FGFR2, cMET and ATM in Gastric Cancer: Optimizing Personalized Healthcare through Innovative Pathological and Statistical Analysis	PLOS ONE			English	Article							KINASE-ACTIVITY; MET; INHIBITOR; AMPLIFICATION; SENSITIVITY; EXPRESSION; THERAPY; GROWTH; CELLS	Current drug development efforts on gastric cancer are directed against several molecular targets driving the growth of this neoplasm. Intra-tumoral biomarker heterogeneity however, commonly observed in gastric cancer, could lead to biased selection of patients. MET, ATM, FGFR2, and HER2 were profiled on gastric cancer biopsy samples. An innovative pathological assessment was performed through scoring of individual biopsies against whole biopsies from a single patient to enable heterogeneity evaluation. Following this, false negative risks for each biomarker were estimated in silico. 166 gastric cancer cases with multiple biopsies from single patients were collected from Shanghai Renji Hospital. Following pre-set criteria, 56 similar to 78% cases showed low, 15 similar to 35% showed medium and 0 similar to 11% showed high heterogeneity within the biomarkers profiled. If 3 biopsies were collected from a single patient, the false negative risk for detection of the biomarkers was close to 5% (exception for FGFR2: 12.2%). When 6 biopsies were collected, the false negative risk approached 0%. Our study demonstrates the benefit of multiple biopsy sampling when considering personalized healthcare biomarker strategy, and provides an example to address the challenge of intra-tumoral biomarker heterogeneity using alternative pathological assessment and statistical methods.	[Ye, Peng; Fan, Shuqiong; Zhang, Tianwei; Fu, Haihua; Su, Xinying; Gavine, Paul R.; Yin, Xiaolu] AstraZeneca R&D, Asia & Emerging Markets iMed, Shanghai, Peoples R China; [Zhang, Meizhuo] AstraZeneca R&D, Res & Dev Informat, Shanghai, Peoples R China; [Liu, Qiang] Shanghai Jiao Tong Univ, Dept Pathol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China	AstraZeneca; AstraZeneca; Shanghai Jiao Tong University	Liu, Q (corresponding author), Shanghai Jiao Tong Univ, Dept Pathol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China.	liuq1963@sohu.com; lucy.yin@astrazeneca.com	Liu, Qiang/HHZ-3181-2022		AstraZeneca	AstraZeneca(AstraZeneca)	Funding: AstraZeneca has sponsored this study. The funder provided support in the form of salaries for authors [PY, MZ, SF, TZ, HF, XS, PG and XY] and provided facility and resources for completing this study. The specific roles of these authors are articulated in the "author contributions" section.	Bang YJ, 2010, LANCET, V376, P1302; Cunningham D, 2013, J CLIN ON S IN PRESS, V31; DEARETXABALA X, 1989, CANCER, V63, P791, DOI 10.1002/1097-0142(19890215)63:4<791::AID-CNCR2820630431>3.0.CO;2-W; Feng Y, 2011, CANCER DISCOV, V1, P550, DOI 10.1158/2159-8290.CD-11-0289; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gavine PR, 2015, MOL ONCOL, V9, P323, DOI 10.1016/j.molonc.2014.08.015; Gerlinger M, 2010, BRIT J CANCER, V103, P1139, DOI 10.1038/sj.bjc.6605912; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gilardini Montani MS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-95; Guo XN, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B42; Inskip HM, 1999, BRIT J CANCER, V79, P1304, DOI 10.1038/sj.bjc.6690209; Kim HS, 2013, PATHOBIOLOGY, V80, P127, DOI 10.1159/000346034; Kubota E, 2014, CELL CYCLE, V13, P2129, DOI 10.4161/cc.29212; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee J, 2013, DISCOV MED, V16, P7; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Min A, 2013, MOL CANCER THER, V12, P865, DOI 10.1158/1535-7163.MCT-12-0950; NALDINI L, 1991, ONCOGENE, V6, P501; Pourhoseingholi Mohamad Amin, 2015, Gastroenterol Hepatol Bed Bench, V8, P19; Power DG, 2010, CANCER TREAT REV, V36, P384, DOI 10.1016/j.ctrv.2010.01.005; Reimers MS, 2013, GASTROENTEROL REP, V1, P166, DOI 10.1093/gastro/got022; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Su X, 2014, BRIT J CANCER, V110, P967, DOI 10.1038/bjc.2013.802; Tai WY, 2010, J CONTROL RELEASE, V146, P264, DOI 10.1016/j.jconrel.2010.04.009; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Yang JY, 2012, CELL BIOCHEM BIOPHYS, V62, P221, DOI 10.1007/s12013-011-9286-1; Ye QQ, 2014, PATHOL ONCOL RES, V20, P931, DOI 10.1007/s12253-014-9776-8; YONEMURA Y, 1992, ANAL CELL PATHOL, V4, P61	29	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143207	10.1371/journal.pone.0143207	http://dx.doi.org/10.1371/journal.pone.0143207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587992	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500037
J	Louati, I; Pascault, N; Debroas, D; Bernard, C; Humbert, JF; Leloup, J				Louati, Imen; Pascault, Noemie; Debroas, Didier; Bernard, Cecile; Humbert, Jean-Francois; Leloup, Julie			Structural Diversity of Bacterial Communities Associated with Bloom-Forming Freshwater Cyanobacteria Differs According to the Cyanobacterial Genus	PLOS ONE			English	Article							HETEROTROPHIC BACTERIA; MICROCYSTIS-AERUGINOSA; BALTIC SEA; PHYLOGENETIC DIVERSITY; ENVIRONMENTAL-FACTORS; LAKE; DYNAMICS; GENERATION; SPP.; BACTERIOPLANKTON	The factors and processes driving cyanobacterial blooms in eutrophic freshwater ecosystems have been extensively studied in the past decade. A growing number of these studies concern the direct or indirect interactions between cyanobacteria and heterotrophic bacteria. The presence of bacteria that are directly attached or immediately adjacent to cyanobacterial cells suggests that intense nutrient exchanges occur between these microorganisms. In order to determine if there is a specific association between cyanobacteria and bacteria, we compared the bacterial community composition during two cyanobacteria blooms of Anabaena (filamentous and N-2-fixing) and Microcystis (colonial and non-N-2 fixing) that occurred successively within the same lake. Using high-throughput sequencing, we revealed a clear distinction between associated and free-living communities and between cyanobacterial genera. The interactions between cyanobacteria and bacteria appeared to be based on dissolved organic matter degradation and on N recycling, both for N-2-fixing and non N-2-fixing cyanobacteria. Thus, the genus and potentially the species of cyanobacteria and its metabolic capacities appeared to select for the bacterial community in the phycosphere.	[Louati, Imen; Pascault, Noemie; Humbert, Jean-Francois; Leloup, Julie] UPMC, IEES PARIS, UMR 7618, CNRS,INRA,IRD,UPEC Paris Diderot, Paris, France; [Debroas, Didier] Clermont Univ Blaise Pascal, CNRS, UMR 6023, Lab Microorganismes Genome & Environm, Aubiere, France; [Bernard, Cecile] Univ Paris 04, Museum Natl Hist Nat, CNRS, MCAM MNHN,UMR 7245, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); INRAE; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Leloup, J (corresponding author), UPMC, IEES PARIS, UMR 7618, CNRS,INRA,IRD,UPEC Paris Diderot, Paris, France.	julie.leloup@upmc.fr	Bernard, Cecile/AAE-4242-2022	Bernard, Cecile/0000-0001-7032-3989; Humbert, Jean-Francois/0000-0002-1519-5651; leloup, julie/0000-0002-2777-284X	Emergence-UPMC grant [EME 1113]	Emergence-UPMC grant	This work was supported by an Emergence-UPMC grant (EME 1113).	Bagatini IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085950; Becker JW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00111; BELL W, 1972, BIOL BULL, V143, P265, DOI 10.2307/1540052; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Carey CC, 2012, WATER RES, V46, P1394, DOI 10.1016/j.watres.2011.12.016; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Debroas D, 2009, ENVIRON MICROBIOL, V11, P2412, DOI 10.1111/j.1462-2920.2009.01969.x; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dziallas C, 2011, ENVIRON MICROBIOL, V13, P1632, DOI 10.1111/j.1462-2920.2011.02479.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eldridge SLC, 2013, LAKE RESERV MANAGE, V29, P68, DOI 10.1080/10402381.2013.775199; Ghai R, 2014, MOL ECOL, V23, P6073, DOI 10.1111/mec.12985; Giongo A, 2010, ISME J, V4, P852, DOI 10.1038/ismej.2010.16; Gumbo JR, 2011, AFR J BIOTECHNOL, V10, P8054; Haukka K, 2006, MICROB ECOL, V51, P137, DOI 10.1007/s00248-005-0049-7; Hietanen S, 2002, MAR ECOL PROG SER, V242, P73, DOI 10.3354/meps242073; Hietanen S, 2002, AQUAT MICROB ECOL, V28, P99, DOI 10.3354/ame028099; Hodkinson BP, 2009, SYMBIOSIS, V49, P163, DOI 10.1007/s13199-009-0049-3; Humbert JF, 2009, ENVIRON MICROBIOL, V11, P2339, DOI 10.1111/j.1462-2920.2009.01960.x; Jiang LJ, 2007, HYDROBIOLOGIA, V581, P161, DOI 10.1007/s10750-006-0518-0; Kolmonen E, 2004, AQUAT MICROB ECOL, V36, P201, DOI 10.3354/ame036201; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Leloup M, 2013, J ENVIRON SCI, V25, P1089, DOI 10.1016/S1001-0742(12)60208-3; Li HB, 2012, FEMS MICROBIOL ECOL, V79, P773, DOI 10.1111/j.1574-6941.2011.01262.x; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Meneghin J, 2011, AQUIFICALES DATA WAR; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Niemi RM, 2009, WATER RES, V43, P5075, DOI 10.1016/j.watres.2009.08.037; Olsen S., 1954, ESTIMATION AVAILABLE; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; PAERL HW, 1978, MICROBIAL ECOL, V4, P215, DOI 10.1007/BF02015078; Paerl HW, 1996, MICROSC RES TECHNIQ, V33, P47; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Parveen B, 2013, FEMS MICROBIOL ECOL, V83, P189, DOI 10.1111/j.1574-6941.2012.01469.x; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Ploug H, 2008, LIMNOL OCEANOGR, V53, P914, DOI 10.4319/lo.2008.53.3.0914; Ploug H, 2011, ISME J, V5, P1549, DOI 10.1038/ismej.2011.20; Ploug H, 2010, ISME J, V4, P1215, DOI 10.1038/ismej.2010.53; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2014, R LANG ENV STAT COMP; Renaud F, 2005, AQUAT MICROB ECOL, V41, P261, DOI 10.3354/ame041261; Schauer M, 2003, AQUAT MICROB ECOL, V31, P163, DOI 10.3354/ame031163; Shen H, 2011, FRESHWATER BIOL, V56, P1065, DOI 10.1111/j.1365-2427.2010.02551.x; Shi LM, 2011, ANN LIMNOL-INT J LIM, V47, P355, DOI 10.1051/limn/2011047; Shi LM, 2009, J ENVIRON SCI, V21, P1581, DOI 10.1016/S1001-0742(08)62459-6; Simonato F, 2010, SYST APPL MICROBIOL, V33, P128, DOI 10.1016/j.syapm.2009.12.006; Taib N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058950; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Tuomainen JM, 2003, FEMS MICROBIOL ECOL, V45, P83, DOI 10.1016/S0168-6496(03)00131-4; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Warnecke F, 2004, ENVIRON MICROBIOL, V6, P242, DOI 10.1111/j.1462-2920.2004.00561.x; Worm J, 1998, AQUAT MICROB ECOL, V14, P19, DOI 10.3354/ame014019; Yamamoto Y, 2009, LIMNOLOGY, V10, P185, DOI 10.1007/s10201-009-0270-z; Yamamoto Y, 2009, J LIMNOL, V68, P122, DOI 10.4081/jlimnol.2009.122; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	61	77	79	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140614	10.1371/journal.pone.0140614	http://dx.doi.org/10.1371/journal.pone.0140614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579722	Green Published, gold			2022-12-26	WOS:000365154600007
J	Turner, CB; Blount, ZD; Lenski, RE				Turner, Caroline B.; Blount, Zachary D.; Lenski, Richard E.			Replaying Evolution to Test the Cause of Extinction of One Ecotype in an Experimentally Evolved Population	PLOS ONE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; KEY INNOVATION; RISK; COMPETITION; ADAPTATION; PREDATION; GROWTH	In a long-term evolution experiment with Escherichia coli, bacteria in one of twelve populations evolved the ability to consume citrate, a previously unexploited resource in a glucose-limited medium. This innovation led to the frequency-dependent coexistence of citrate-consuming (Cit(+)) and non-consuming (Cit(-)) ecotypes, with Cit(-) bacteria persisting on the exogenously supplied glucose as well as other carbon molecules released by the Cit+ bacteria. After more than 10,000 generations of coexistence, however, the Cit(-) lineage went extinct; cells with the Cit(-) phenotype dropped to levels below detection, and the Cit(-) clade could not be detected by molecular assays based on its unique genotype. We hypothesized that this extinction was a deterministic outcome of evolutionary change within the population, specifically the appearance of a more-fit Cit(+) ecotype that competitively excluded the Cit(-) ecotype. We tested this hypothesis by re-evolving the population from a frozen population sample taken within 500 generations of the extinction and from another sample taken several thousand generations earlier, in each case for 500 generations and with 20-fold replication. To our surprise, the Cit(-) type did not go extinct in any of these replays, and Cit(-) cells also persisted in a single replicate that was propagated for 2,500 generations. Even more unexpectedly, we showed that the Cit(-) ecotype could reinvade the Cit(+) population after its extinction. Taken together, these results indicate that the extinction of the Cit(-) ecotype was not a deterministic outcome driven by competitive exclusion by the Cit(+) ecotype. The extinction also cannot be explained by demographic stochasticity alone, as the population size of the Cit(-) ecotype should have been many thousands of cells even during the daily transfer events. Instead, we infer that the extinction must have been caused by a rare chance event in which some aspect of the experimental conditions was inadvertently perturbed.	[Turner, Caroline B.; Lenski, Richard E.] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA; [Turner, Caroline B.; Lenski, Richard E.] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Turner, Caroline B.; Blount, Zachary D.; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Blount, Zachary D.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Lenski, RE (corresponding author), Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA.	lenski@msu.edu	Blount, Zachary/L-3130-2019	Lenski, Richard/0000-0002-1064-8375; Blount, Zachary/0000-0001-5153-0034; Turner, Caroline B./0000-0003-1347-518X	Environmental Protection Agency Science to Achieve Results Fellowship [FP-917112-01-0]; Michigan State University Distinguished Graduate Student Fellowship; National Science Foundation [DEB-1019989]; John Templeton Foundation; Biocomputational Evolution in Action Consortium (BEACON) Center for the Study of Evolution in Action (National Science Foundation Cooperative Agreement) [DBI-0939454]; Division Of Environmental Biology [1451740] Funding Source: National Science Foundation	Environmental Protection Agency Science to Achieve Results Fellowship; Michigan State University Distinguished Graduate Student Fellowship; National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation; Biocomputational Evolution in Action Consortium (BEACON) Center for the Study of Evolution in Action (National Science Foundation Cooperative Agreement); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by an Environmental Protection Agency Science to Achieve Results Fellowship (http://www.epa.gov/, FP-917112-01-0) and a Michigan State University Distinguished Graduate Student Fellowship (www.msu.edu) to C.B. T., a National Science Foundation grant (http://www.nsf.gov/, DEB-1019989) to R.E.L., a grant from the John Templeton Foundation (https://www.templeton.org/) to R.E.L. and Z.D.B., and the Biocomputational Evolution in Action Consortium (BEACON) Center for the Study of Evolution in Action (National Science Foundation Cooperative Agreement DBI-0939454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; BENGTSSON J, 1995, OECOLOGIA, V101, P397, DOI 10.1007/BF00329418; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; HELLING RB, 1987, GENETICS, V116, P349; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Koser SA, 1924, J BACTERIOL, V9, P59, DOI 10.1128/JB.9.1.59-77.1924; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Maddamsetti R, 2015, GENETICS, V200, P619, DOI 10.1534/genetics.115.176677; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Pos KM, 1998, J BACTERIOL, V180, P4160, DOI 10.1128/JB.180.16.4160-4165.1998; Reddy C., 2007, METHODS GEN MOL MICR; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schoener TW, 2001, NATURE, V412, P183, DOI 10.1038/35084071; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Turner CB, 2015, BIORXIV, DOI [10.1101/020958, DOI 10.1101/020958]; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Wootton JT, 2013, ECOLOGY, V94, P2117, DOI 10.1890/12-1828.1; Yedid G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037233; Yedid G, 2009, AM NAT, V173, pE139, DOI 10.1086/597228	28	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142050	10.1371/journal.pone.0142050	http://dx.doi.org/10.1371/journal.pone.0142050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581098	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600033
J	Wawruszak, A; Luszczki, JJ; Grabarska, A; Gumbarewicz, E; Dmoszynska-Graniczka, M; Polberg, K; Stepulak, A				Wawruszak, Anna; Luszczki, Jarogniew J.; Grabarska, Aneta; Gumbarewicz, Ewelina; Dmoszynska-Graniczka, Magdalena; Polberg, Krzysztof; Stepulak, Andrzej			Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; PHASE-II TRIAL; VALPROIC ACID; GENE-EXPRESSION; LUNG-CANCER; INDUCED APOPTOSIS; ANTICANCER DRUGS; ORAL VORINOSTAT; CYCLE ARREST; TUMOR-GROWTH	Histone deacetylase inhibitors (HDIs) are promising anticancer drugs, which inhibit proliferation of a wide variety of cancer cells including breast carcinoma cells. In the present study, we investigated the influence of valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA, vorinostat), alone or in combination with cisplatin (CDDP) on proliferation, induction of apoptosis and cell cycle progression in MCF7, T47D and MDA-MB-231 human breast carcinoma cell lines. The type of interaction between HDIs and CDDP was determined by an isobolographic analysis. The isobolographic analysis is a very precise and rigorous pharmacodynamic method, to determine the presence of synergism, addition or antagonism between different drugs with using variety of fixed dose ratios. Our experiments show that the combinations of CDDP with SAHA or VPA at a fixed-ratio of 1: 1 exerted additive interaction in the viability of MCF7 cells, while in T47D cells there was a tendency to synergy. In contrast, sub-additive (antagonistic) interaction was observed for the combination of CDDP with VPA in MDA-MB-231 "triple-negative" (i.e. estrogen receptor negative, progesterone receptor negative, and HER-2 negative) human breast cancer cells, whereas combination of CDDP with SAHA in the same MDA-MB-231 cell line yielded additive interaction. Additionally, combined HDIs/CDDP treatment resulted in increase in apoptosis and cell cycle arrest in all tested breast cancer cell lines in comparison with a single therapy. In conclusion, the additive interaction of CDDP with SAHA or VPA suggests that HDIs could be combined with CDDP in order to optimize treatment regimen in some human breast cancers.	[Wawruszak, Anna; Grabarska, Aneta; Gumbarewicz, Ewelina; Dmoszynska-Graniczka, Magdalena; Stepulak, Andrzej] Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland; [Luszczki, Jarogniew J.] Med Univ Lublin, Dept Pathophysiol, Lublin, Poland; [Luszczki, Jarogniew J.] Inst Rural Hlth, Isobolog Anal Lab, Lublin, Poland; [Polberg, Krzysztof; Stepulak, Andrzej] MSW Hosp, Dept Otolaryngol, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Institute of Rural Health in Lublin, Poland	Wawruszak, A (corresponding author), Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland.	anna.wawruszak@umlub.pl	Luszczki, Jarogniew J./U-7035-2018; Luszczki, Jarogniew/AAB-1113-2020	Luszczki, Jarogniew J./0000-0002-3059-0393; Luszczki, Jarogniew/0000-0002-3059-0393; Dmoszynska-Graniczka, Magdalena/0000-0002-6248-0930; Grabarska, Aneta/0000-0002-3823-1467; Stepulak, Andrzej/0000-0002-1872-394X; Wawruszak, Anna/0000-0003-2388-4577	Medical University of Lublin [DS440/2014-2015]	Medical University of Lublin	The study was supported by Medical University of Lublin DS440/2014-2015 grant.	Andreopoulou E, 2015, EXPERT OPIN PHARMACO, V16, P983, DOI 10.1517/14656566.2015.1032246; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Biswas SK, 2004, MOL CANCER THER, V3, P327; Blaheta RA, 2007, BRIT J CANCER, V96, P1699, DOI 10.1038/sj.bjc.6603777; Blaheta RA, 2002, MED RES REV, V22, P492, DOI 10.1002/med.10017; Botrugno OA, 2009, CANCER LETT, V280, P134, DOI 10.1016/j.canlet.2009.02.027; Catalano MG, 2005, J CLIN ENDOCR METAB, V90, P1383, DOI 10.1210/jc.2004-1355; Chiao MT, 2013, AUTOPHAGY, V9, P1509, DOI 10.4161/auto.25664; Chien CW, 2011, TOXICOL APPL PHARM, V257, P59, DOI 10.1016/j.taap.2011.08.018; Dawood S, 2008, J CLIN ONCOL, V26, P4891, DOI 10.1200/JCO.2007.14.1168; Denis I, 2014, ONCOTARGET, V5, P11641, DOI 10.18632/oncotarget.2604; Dodurga Y, 2014, MOL BIOL REP, V41, P4595, DOI 10.1007/s11033-014-3330-3; Eastman A, 2009, MECH ACTION CISPLATI; Erlich RB, 2009, CANCER CHEMOTH PHARM, V63, P381, DOI 10.1007/s00280-008-0747-1; Feng D, 2013, PLOS ONE, V8; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Fortunati N, 2008, CANCER LETT, V259, P156, DOI 10.1016/j.canlet.2007.10.006; Galanis E, 2009, J CLIN ONCOL, V27, P2052, DOI 10.1200/JCO.2008.19.0694; Gan CP, 2012, HEAD NECK-J SCI SPEC, V34, P344, DOI 10.1002/hed.21734; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Grabovsky Y, 2004, J PHARMACOL EXP THER, V310, P981, DOI 10.1124/jpet.104.067264; GRECO WR, 1995, PHARMACOL REV, V47, P331; Heerboth S, 2014, GENET EPIGENETICS, V6, P9, DOI 10.4137/GEG.S12270; Hiriyan J, 2015, ANTICANCER RES, V35, P229; Hirsch CL, 2004, FEBS LETT, V570, P37, DOI 10.1016/j.febslet.2004.06.018; Isakoff SJ, 2015, J CLIN ONCOL, V33, P1902, DOI 10.1200/JCO.2014.57.6660; Jiang W, 2014, INT UROL NEPHROL, V46, P941, DOI 10.1007/s11255-013-0609-6; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kim MS, 2003, CANCER RES, V63, P7291; Knutson A, 2010, ONCOL REP, V112, P3044; Kramer OH, 2014, TRENDS PHARMACOL SCI, V35, P501, DOI 10.1016/j.tips.2014.08.001; Lakshmaiah KC, 2014, J CANCER RES THER, V10, P469, DOI 10.4103/0973-1482.137937; Lee JH, 2010, P NATL ACAD SCI USA, V107, P14639, DOI 10.1073/pnas.1008522107; Lee YJ, 2012, INT J MED SCI, V9, P881, DOI 10.7150/ijms.5011; Li GF, 2012, GENET MOL RES, V11, P77, DOI 10.4238/2012.January.13.1; Lin CT, 2008, CANCER SCI, V99, P1218, DOI 10.1111/j.1349-7006.2008.00793.x; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; Luszczki JJ, 2007, N-S ARCH PHARMACOL, V375, P105, DOI 10.1007/s00210-007-0144-z; Luszczki JJ, 2006, N-S ARCH PHARMACOL, V374, P51, DOI 10.1007/s00210-006-0100-3; Luszczki JJ, 2004, N-S ARCH PHARMACOL, V369, P434, DOI 10.1007/s00210-004-0867-z; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Modesitt SC, 2008, GYNECOL ONCOL, V109, P182, DOI 10.1016/j.ygyno.2008.01.009; Nighat N, 2010, CANCER CHEMOTH PHARM, V66, P625, DOI [10.1007/s00280-010-1324-y, DOI 10.1007/S00280-010-1324-Y]; Pizarro AM, 2009, BIOCHIMIE, V91, P1198, DOI 10.1016/j.biochi.2009.03.017; Prater J, 2015, J CANC RES CLIN ONCO; Richardson P, 2008, LEUKEMIA LYMPHOMA, V49, P502, DOI 10.1080/10428190701817258; Shah RD, 2013, J CELL BIOCHEM, V114, P854, DOI 10.1002/jcb.24422; Shen J, 2007, BIOCHEM PHARMACOL, V73, P1901, DOI 10.1016/j.bcp.2007.03.009; Sidana A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/180363; Sun GC, 2015, J CANCER, V6, P996, DOI 10.7150/jca.12135; Sun PC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-76; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P1115, DOI 10.1007/s00280-009-0969-x; Tallarida RJ., 2000, DRUG SYNERGISM DOSE; Tallarida RJ, 2007, PHARMACOL THERAPEUT, V113, P197, DOI 10.1016/j.pharmthera.2006.08.002; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Travaglini L, 2009, INT J BIOCHEM CELL B, V41, P225, DOI 10.1016/j.biocel.2008.08.019; Tzao C, 2014, DIS ESOPHAGUS, V27, P693, DOI 10.1111/dote.12127; Vafaiyan Z, 2015, IRAN J BASIC MED SCI, V18, P700; Vansteenkiste J, 2008, INVEST NEW DRUG, V26, P483, DOI 10.1007/s10637-008-9131-6; Viet C, 2014, PLOS ONE, V9; Vijayaraghavalu S, 2013, MOL PHARMACEUT, V10, P337, DOI 10.1021/mp3004622; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Xu Y, 2015, INT J CLIN EXP PATHO, V8, P8291; Yang H, 2015, BRIT J CANCER, V112, P112, DOI 10.1038/bjc.2014.547; Yang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079734; Zhang L, 2012, MOL CELL BIOCHEM, V361, P39, DOI 10.1007/s11010-011-1085-x; Zhou Y, 2014, ONCOL LETT, V7, P203, DOI 10.3892/ol.2013.1666	67	46	47	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143013	10.1371/journal.pone.0143013	http://dx.doi.org/10.1371/journal.pone.0143013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580554	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600072
J	Xu, SY; Wang, DY; Zhou, DS; Lin, Y; Che, LQ; Fang, ZF; Wu, D				Xu, Shengyu; Wang, Dingyue; Zhou, Dongsheng; Lin, Yan; Che, Lianqiang; Fang, Zhengfeng; Wu, De			Reproductive Hormone and Transcriptomic Responses of Pituitary Tissue in Anestrus Gilts Induced by Nutrient Restriction	PLOS ONE			English	Article							GROWTH; GENE; OVULATION; ACTIVATION; RECEPTOR; GPR54	The onset of estrus is a critical sign of female sexual maturity. The pituitary plays a vital role in this process by the secretion of reproductive hormones. To investigate the effects of nutrient restriction on reproductive function and the underlying mechanisms involved, deep RNA sequencing of pituitary gland tissue was carried out to determine the differentially expressed genes (DEGs) between gilts in normal estrus, and gilts in which anestrus was induced by nutrient restriction. Gilts which had gone through two estrus cycles were fed a normal (CON, 2.86kg/d, n = 10) or nutrient restricted (NR, 1kg/d, n = 10) diet. The NR gilts experienced another three estrus cycles, but did not express estrus symptoms at the anticipated 6th and 7th cycles. Body weight gain in NR gilts was significantly decreased by nutrient restriction. Gilts were considered as anestrus when blood progesterone concentrations lower than 1.0 ng/mL from three consecutive blood samples were recorded. Circulating concentrations of progesterone (< 1.0 ng/mL vs. 2.1 ng/mL) and estradiol (208.6 ng/mL vs. 371.8 ng/mL) were significantly lower in the NR gilts than in the CON gilts. Between 5,360,000 and 5,370,000 sequence reads per sample from the CON and NR gilts' pituitaries were obtained and mapped to the porcine genome. Analysis of read counts revealed 185 DEGs. Expression of selected genes was validated by the use of quantitative real-time RTPCR. Bioinformatic analysis identified that the genes identified were enriched in the GO terms "neuroactive ligand-receptor interaction", "GnRH signaling pathway" and "immune response system". Our findings provide a new perspective for understanding the nutrient restriction-induced reproductive impairment at the pituitary transcriptional level, and how this is linked to hormone secretion. Moreover, the transcriptomic changes in anestrus gilts associated with nutrient restriction could be a resource for targeted studies of genes and pathways potentially involved in the regulation of reproductive function and animal health.	[Wu, De] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan 625014, Peoples R China; Sichuan Agr Univ, Inst Anim Nutr, Yaan 625014, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Wu, D (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, Minist Educ, Yaan 625014, Peoples R China.	pig2pig@sina.com.cn			National Natural Science Foundation of P.R. China [30871804]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13083]; Program form Feed Industry and Technology Research Institute of Sichuan Province [2013NZ0054]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program form Feed Industry and Technology Research Institute of Sichuan Province	This work was supported by National Natural Science Foundation (30871804) of P.R. China, Program for Changjiang Scholars and Innovative Research Team in University (IRT13083) and Program form Feed Industry and Technology Research Institute of Sichuan Province (2013NZ0054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JD, 1987, J ANIM SCI, V65, P508, DOI 10.2527/jas1987.652508x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BERGENDAHL M, 1991, BIOL REPROD, V44, P413, DOI 10.1095/biolreprod44.3.413; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; BOOTH PJ, 1994, J ANIM SCI, V72, P2415, DOI 10.2527/1994.7292415x; BOYAR RM, 1978, ANNU REV MED, V29, P509; Breen SM, 2012, ANIM REPROD SCI, V132, P193, DOI 10.1016/j.anireprosci.2012.05.013; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Castellano JM, 2009, PEPTIDES, V30, P139, DOI 10.1016/j.peptides.2008.06.007; Colledge WH, 2004, TRENDS ENDOCRIN MET, V15, P448, DOI 10.1016/j.tem.2004.09.008; Coskun M, 2013, PHARMACOL RES, V76, P1, DOI 10.1016/j.phrs.2013.06.007; de la Iglesia HO, 2006, ENDOCRINOLOGY, V147, P1148, DOI 10.1210/en.2005-1311; DYCK GW, 1979, CAN J ANIM SCI, V59, P649, DOI 10.4141/cjas79-084; Fasler-Kan E, 2013, XENOTRANSPLANTATION, V20, P469, DOI 10.1111/xen.12070; Ge XJ, 2007, J RES ADOLESCENCE, V17, P767, DOI 10.1111/j.1532-7795.2007.00546.x; Hillier SG, 2001, MOL CELL ENDOCRINOL, V179, P39, DOI 10.1016/S0303-7207(01)00469-5; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X; Hirose M, 2013, ANIM SCI J, V84, P693, DOI 10.1111/asj.12061; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loisel F, 2015, DOMEST ANIM ENDOCRIN, V53, P35, DOI 10.1016/j.domaniend.2015.04.005; Macklon NS, 2001, ARCH MED RES, V32, P595, DOI 10.1016/S0188-4409(01)00327-7; Mastorakos G, 2010, ANN NY ACAD SCI, V900, P65; Mekchay S, 2003, GENET SEL EVOL, V35, pS83, DOI 10.1051/gse:2003018; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; National Research Council, 1998, NUTR REQ SWIN, Vtenth; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; POMERANTZ SH, 1987, GAMETE RES, V17, P267, DOI 10.1002/mrd.1120170310; ROZEBOOM DW, 1993, J ANIM SCI, V71, P426, DOI 10.2527/1993.712426x; Smit LS, 1996, MOL ENDOCRINOL, V10, P519, DOI 10.1210/me.10.5.519; Stouffer RL, 2007, FRONT BIOSCI, V12, P297, DOI 10.2741/2065; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tena-Sempere M, 2006, HUM REPROD UPDATE, V12, P631, DOI 10.1093/humupd/dml023; Viswanathan G, 2014, J CLIN ENDOCR METAB, V99, pE1050, DOI 10.1210/jc.2013-3062; Zhou DS, 2014, MOL BIOL REP, V41, P4733, DOI 10.1007/s11033-014-3344-x	37	7	8	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143219	10.1371/journal.pone.0143219	http://dx.doi.org/10.1371/journal.pone.0143219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580562	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600099
J	Eissa, MM; El-Moslemany, RM; Ramadan, AA; Amer, EI; El-Azzouni, MZ; El-Khordagui, LK				Eissa, Maha M.; El-Moslemany, Riham M.; Ramadan, Alyaa A.; Amer, Eglal I.; El-Azzouni, Mervat Z.; El-Khordagui, Labiba K.			Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study	PLOS ONE			English	Article							IN-VIVO EVALUATION; VISCERAL LEISHMANIASIS; ARACHIDONIC-ACID; AMPHOTERICIN-B; HEXADECYLPHOSPHOCHOLINE; NANOPARTICLES; NANOCARRIERS; STABILITY; LIPOSOMES; MEMBRANES	Miltefosine (MFS) is an alkylphosphocholine used for the local treatment of cutaneous metastases of breast cancer and oral therapy of visceral leishmaniasis. Recently, the drug was reported in in vitro and preclinical studies to exert significant activity against different developmental stages of schistosomiasis mansoni, a widespread chronic neglected tropical disease (NTD). This justified MFS repurposing as a potential antischistosomal drug. However, five consecutive daily 20 mg/kg doses were needed for the treatment of schistosomiasis mansoni in mice. The present study aims at enhancing MFS efficacy to allow for a single 20mg/kg oral dose therapy using a nanotechnological approach based on lipid nanocapsules (LNCs) as oral nanovectors. MFS was incorporated in LNCs both as membrane-active structural alkylphospholipid component and active antischistosomal agent. MFS-LNC formulations showed high entrapment efficiency (EE%), good colloidal properties, sustained release pattern and physical stability. Further, LNCs generally decreased MFS-induced erythrocyte hemolytic activity used as surrogate indicator of membrane activity. While MFS-free LNCs exerted no antischistosomal effect, statistically significant enhancement was observed with all MFS-LNC formulations. A maximum effect was achieved with MFS-LNCs incorporating CTAB as positive charge imparting agent or oleic acid as membrane permeabilizer. Reduction of worm load, ameliorated liver pathology and extensive damage of the worm tegument provided evidence for formulation-related efficacy enhancement. Non-compartmental analysis of pharmacokinetic data obtained in rats indicated independence of antischistosomal activity on systemic drug exposure, suggesting possible gut uptake of the stable LNCs and targeting of the fluke tegument which was verified by SEM. The study findings put forward MFS-LNCs as unique oral nanovectors combining the bioactivity of MFS and biopharmaceutical advantages of LNCs, allowing targeting via the oral route. From a clinical point of view, data suggest MFS-LNCs as a potential single dose oral nanomedicine for enhanced therapy of schistosomiasis mansoni and possibly other diseases.	[Eissa, Maha M.; Amer, Eglal I.; El-Azzouni, Mervat Z.] Univ Alexandria, Fac Med, Dept Med Parasitol, Alexandria, Egypt; [El-Moslemany, Riham M.; Ramadan, Alyaa A.; El-Khordagui, Labiba K.] Univ Alexandria, Fac Pharm, Dept Pharmaceut, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	El-Khordagui, LK (corresponding author), Univ Alexandria, Fac Pharm, Dept Pharmaceut, Alexandria, Egypt.	lakhalil@gmail.com	Ramadan, Alyaa/AAL-5073-2021; Eissa, M M/S-4230-2019	Ramadan, Alyaa/0000-0003-2143-7909; Eissa, M M/0000-0003-4723-6427; Eissa, Maha/0000-0001-9572-2820; El-Moslemany, Riham/0000-0001-5594-4314				Akhtar F, 2012, BIOTECHNOL ADV, V30, P310, DOI 10.1016/j.biotechadv.2011.05.009; Azzouz S, 2006, J PARASITOL, V92, P877, DOI 10.1645/GE-632R1.1; Bertao HG, 2012, PARASITOL RES, V110, P2465, DOI 10.1007/s00436-011-2786-5; Botros S, 2003, ANTIMICROB AGENTS CH, V47, P3853, DOI 10.1128/AAC.47.12.3853-3858.2003; BREISER A, 1987, LIPIDS, V22, P925, DOI 10.1007/BF02535556; de Araujo SC, 2007, INT J PHARMACEUT, V337, P307, DOI 10.1016/j.ijpharm.2007.01.009; Cho WS, 2014, NANOTOXICOLOGY, V8, P202, DOI 10.3109/17435390.2013.773465; da Costa AV, 2008, REV SOC BRAS MED TRO, V41, P424, DOI 10.1590/S0037-86822008000400022; Date AA, 2007, ADV DRUG DELIVER REV, V59, P505, DOI 10.1016/j.addr.2007.04.009; de Sa MM, 2014, MOL INFORM, V33, P53, DOI 10.1002/minf.201300124; Dorlo TPC, 2008, J CHROMATOGR B, V865, P55, DOI 10.1016/j.jchromb.2008.02.005; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Du WW, 2013, BIOMATERIALS, V34, P794, DOI 10.1016/j.biomaterials.2012.10.003; Eissa MM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-73; Eissa MM, 2011, INT J PARASITOL, V41, P235, DOI 10.1016/j.ijpara.2010.09.010; El Ridi R, 2010, ANTIMICROB AGENTS CH, V54, P3383, DOI 10.1128/AAC.00173-10; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Groo AC, 2015, NANOMEDICINE-UK, V10, P589, DOI 10.2217/nnm.14.124; Groo AC, 2014, PHARM RES-DORDR, V31, P1753, DOI 10.1007/s11095-013-1280-4; Groo AC, 2013, INT J NANOMED, V8, P4291, DOI 10.2147/IJN.S51837; Huynh NT, 2009, INT J PHARMACEUT, V379, P201, DOI 10.1016/j.ijpharm.2009.04.026; Jumaa M, 2000, EUR J PHARM SCI, V9, P285, DOI 10.1016/S0928-0987(99)00071-8; Kepczynski M, 2011, CHEM PHYS LIPIDS, V164, P359, DOI 10.1016/j.chemphyslip.2011.04.007; Khalil NM, 2013, CURR PHARM DESIGN, V19, P7316, DOI 10.2174/138161281941131219135458; Kolenyak-Santos F., 2014, J NANOSCI NANOTECHNO, V14, P1, DOI DOI 10.1166/JNN.2014.9186; Kopetzki D, 2009, SOFT MATTER, V5, P4212, DOI 10.1039/b907339f; Lacoeuille F, 2007, INT J PHARM, V344, P143, DOI 10.1016/j.ijpharm.2007.06.014; Lamprecht A, 2002, J CONTROL RELEASE, V84, P59, DOI 10.1016/S0168-3659(02)00258-4; Lindenberg M, 2004, EUR J PHARM BIOPHARM, V58, P265, DOI 10.1016/j.ejpb.2004.03.001; LOWRY JB, 1979, J PHARM SCI, V68, P110, DOI 10.1002/jps.2600680138; Lukac ML, 2008, ACTA FACULT PHARM U, V55, P142; Mally M, 2013, J PHYS CHEM B, V117, P12086, DOI 10.1021/jp404135g; Menez C, 2006, BIOCHEM PHARMACOL, V71, P486, DOI 10.1016/j.bcp.2005.11.008; Mishra A, 2014, J NANOTECHNOL, V2014, DOI 10.1155/2014/351693; More B, 2003, J Postgrad Med, V49, P101; Moreira RA, 2014, ANTIMICROB AGENTS CH, V58, P3021, DOI 10.1128/AAC.01332-13; Morigaki K, 2007, CURR OPIN COLLOID IN, V12, P75, DOI 10.1016/j.cocis.2007.05.005; Morille M, 2010, BIOMATERIALS, V31, P321, DOI 10.1016/j.biomaterials.2009.09.044; Munoz C, 2013, TOXICOL IN VITRO, V27, P1913, DOI 10.1016/j.tiv.2013.06.010; Oliveira CNF De, 2013, PARASITIC DIS SCHIST; Olliaro P, 2014, J ANTIMICROB CHEMOTH, V69, P863, DOI 10.1093/jac/dkt491; Pabla D, 2010, EUR J PHARM SCI, V40, P466, DOI 10.1016/j.ejps.2010.05.002; Padmanabhan P, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-60; Palumbo E, 2008, BRAZ J INFECT DIS, V12, P2, DOI 10.1590/S1413-86702008000100002; Papagiannaros A, 2006, BIOMED PHARMACOTHER, V60, P36, DOI 10.1016/j.biopha.2005.09.001; Peltier S, 2006, PHARM RES-DORDR, V23, P1243, DOI 10.1007/s11095-006-0022-2; Perrier T, 2010, INT J PHARMACEUT, V396, P204, DOI 10.1016/j.ijpharm.2010.06.019; Pisarcik M, 2012, COLLOID SURFACE A, V407, P169, DOI 10.1016/j.colsurfa.2012.05.028; Pollastri MP, 2011, FUTURE MED CHEM, V3, P1307, DOI [10.4155/FMC.11.92, 10.4155/fmc.11.92]; Ramadan A, 2011, INT J NANOMED, V6, P2941, DOI 10.2147/IJN.S25791; Roger E, 2009, J CONTROL RELEASE, V140, P174, DOI 10.1016/j.jconrel.2009.08.010; Roger E, 2009, INT J PHARMACEUT, V379, P260, DOI 10.1016/j.ijpharm.2009.05.069; Selim S, 2014, AM J TROP MED HYG, V91, P973, DOI 10.4269/ajtmh.14-0328; Serrano DR, 2015, MOL PHARMACEUT, V12, P420, DOI 10.1021/mp500527x; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; SHAW MK, 1987, PARASITOLOGY, V94, P243, DOI 10.1017/S0031182000053920; Sindermann H, 2006, T ROY SOC TROP MED H, V100, pS17, DOI 10.1016/j.trstmh.2006.02.010; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; Talegaonkar Sushama, 2008, Recent Pat Drug Deliv Formul, V2, P238; Thakur A, 2013, CANCER LETT, V334, P274, DOI 10.1016/j.canlet.2012.08.022; Trinconi CT, 2014, ANTIMICROB AGENTS CH, V58, P2608, DOI 10.1128/AAC.01315-13; Zeisig R, 1996, BBA-BIOMEMBRANES, V1283, P177, DOI 10.1016/0005-2736(96)00090-9; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; Zhukova MV, 2010, PHARM CHEM J+, V44, P507, DOI 10.1007/s11094-010-0504-8	64	51	51	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0141788	10.1371/journal.pone.0141788	http://dx.doi.org/10.1371/journal.pone.0141788			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26574746	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400008
J	Iarriccio, L; Manguan-Garcia, C; Pintado-Berninches, L; Mancheno, JM; Molina, A; Perona, R; Sastre, L				Iarriccio, Laura; Manguan-Garcia, Cristina; Pintado-Berninches, Laura; Miguel Mancheno, Jose; Molina, Antonio; Perona, Rosario; Sastre, Leandro			GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant Cells	PLOS ONE			English	Article							DYSKERATOSIS-CONGENITA; RNA PSEUDOURIDYLATION; IDENTIFICATION; GENE; MUTATIONS; PROMOTER; DKC1	Dyskeratosis congenita is an inherited disease caused by mutations in genes coding for telomeric components. It was previously reported that expression of a dyskerin-derived peptide, GSE24.2, increases telomerase activity, regulates gene expression and decreases DNA damage and oxidative stress in dyskeratosis congenita patient cells. The biological activity of short peptides derived from GSE24.2 was tested and one of them, GSE4, that probed to be active, was further characterized in this article. Expression of this eleven amino acids long peptide increased telomerase activity and reduced DNA damage, oxidative stress and cell senescence in dyskerin-mutated cells. GSE4 expression also activated c-myc and TERT promoters and increase of c-myc, TERT and TERC expression. The level of biological activity of GSE4 was similar to that obtained by GSE24.2 expression. Incorporation of a dyskerin nuclear localization signal to GSE24.2 did not change its activity on promoter regulation and DNA damage protection. However, incorporation of a signal that increases the rate of nucleolar localization impaired GSE24.2 activity. Incorporation of the dyskerin nuclear localization signal to GSE4 did not alter its biological activity. Mutation of the Aspartic Acid residue that is conserved in the pseudouridine synthase domain present in GSE4 did not impair its activity, except for the repression of c-myc promoter activity and the decrease of c-myc, TERT and TERC gene expression in dyskerin-mutated cells. These results indicated that GSE4 could be of great therapeutic interest for treatment of dyskeratosis congenita patients.	[Iarriccio, Laura; Manguan-Garcia, Cristina; Pintado-Berninches, Laura; Perona, Rosario; Sastre, Leandro] UAM, CSIC, Inst Invest Biomed, Madrid, Spain; [Manguan-Garcia, Cristina; Perona, Rosario; Sastre, Leandro] CIBER Enfermedades Raras, Valencia, Spain; [Manguan-Garcia, Cristina; Perona, Rosario; Sastre, Leandro] IdiPaz, Madrid, Spain; [Miguel Mancheno, Jose] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Iarriccio, Laura; Molina, Antonio] Adv Med Projects, Madrid, Spain; [Perona, Rosario; Sastre, Leandro] Hosp Univ La Paz, IdiPaz, Biomarkers & Expt Therapeut Canc, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Hospital Universitario La Paz	Sastre, L (corresponding author), UAM, CSIC, Inst Invest Biomed, Madrid, Spain.	lsastre@iib.uam.es	; Mancheno, Jose Miguel/K-4984-2014	Sastre, Leandro/0000-0003-3613-5938; Pintado-Berninches, Laura/0000-0002-3331-7130; Mancheno, Jose Miguel/0000-0001-6943-3291	FEDER funds [PI1401495]; Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III. Spain [ER15PR07ACC114/757]; Consejo Superior de Investigaciones Cientificas [201320E075]; Ministerio de Economia y Competitividad. Spain [IPT-2012-0674-090000]; CIBER de Enfermedades Raras	FEDER funds(European Commission); Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III. Spain(Instituto de Salud Carlos III); Consejo Superior de Investigaciones Cientificas; Ministerio de Economia y Competitividad. Spain; CIBER de Enfermedades Raras	This work was supported by grants PI1401495 (supported by FEDER funds) and ER15PR07ACC114/757 (Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III. Spain), 201320E075 (Consejo Superior de Investigaciones Cientificas) and IPT-2012-0674-090000 (Ministerio de Economia y Competitividad. Spain). CM-G is supported by the CIBER de Enfermedades Raras.	Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; Angrisani A, 2014, BIOL CHEM, V395, P593, DOI 10.1515/hsz-2013-0287; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Carrillo J, 2014, CLIN TRANSL ONCOL, V16, P529, DOI 10.1007/s12094-013-1112-3; Carrillo J, 2012, BLOOD CELL MOL DIS, V49, P140, DOI 10.1016/j.bcmd.2012.05.008; Cesare AJ, 2012, CURR OPIN CELL BIOL, V24, P731, DOI 10.1016/j.ceb.2012.08.007; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Glousker G, 2015, BR J HAEMATOL; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Gu BW, 2011, AGING CELL, V10, P338, DOI 10.1111/j.1474-9726.2011.00674.x; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Heiss NS, 1999, HUM MOL GENET, V8, P2515, DOI 10.1093/hmg/8.13.2515; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Machado-Pinilla R, 2008, BLOOD, V111, P2606, DOI 10.1182/blood-2007-04-083261; Machado-Pinilla R, 2012, CLIN TRANSL ONCOL, V14, P755, DOI 10.1007/s12094-012-0865-4; Manguan-Garcia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101424; Mason PJ, 2011, CANCER GENET-NY, V204, P635, DOI 10.1016/j.cancergen.2011.11.002; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Oh S, 1999, BIOCHEM BIOPH RES CO, V263, P361, DOI 10.1006/bbrc.1999.1366; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Savage SA, 2014, PROG MOL BIOL TRANSL, V125, P41, DOI 10.1016/B978-0-12-397898-1.00002-5; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Si SY, 2011, ONCOL REP, V26, P377, DOI 10.3892/or.2011.1303; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; WRIGHT WE, 1995, NUCLEIC ACIDS RES, V23, P3794, DOI 10.1093/nar/23.18.3794; Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207	35	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142980	10.1371/journal.pone.0142980	http://dx.doi.org/10.1371/journal.pone.0142980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571381	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700111
J	Jia, GY; Di, FS; Wang, QP; Shao, JS; Gao, L; Wang, L; Li, Q; Li, NL				Jia, Guoyu; Di, Fusheng; Wang, Qipeng; Shao, Jinshuang; Gao, Lei; Wang, Lu; Li, Qiang; Li, Nali			Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; RENAL-DISEASE; US ADULTS; CONNECTION; PREVALENCE	Background Non-alcoholic fatty liver disease (NAFLD) is prevalent in individuals with type 2 diabetes mellitus (T2DM). Diabetic nephropathy (DN) is also associated with T2DM. However, little is known about the interaction between these conditions in patients with T2DM. Objective To examine the association between NAFLD and DN in patients with T2DM. Methods This retrospective study included patients seen between January 2006 and July 2014. T2DM patients were divided into two groups based on NAFLD status (with NAFLD = group A; without = group B). The cumulative incidence of DN and chronic kidney disease (CKD) staging were compared between the two groups. Liver fat content was examined in some patients. Associations among NAFLD, other factors, and DN were analyzed by the additive interaction method. Results Cumulative incidence of DN in patients from group A (58.58%) was higher than in group B (37.22%) (P = 0.005). In both groups, the number of DN patients with CKD stage 1 was greater than the number of patients with stages 2-5. Increased liver fat content was associated with increased occurrence of severe and mild albuminuria and decreased glomerular filtration rate (GFR). There were positive correlations between NAFLD and insulin resistance index (HOMA-IR), free fatty acids (FFA), tumor necrosis factor-alpha (TNF-alpha), omentin-1, visceral fat area, homocysteine (HCY), and serum uric acid (UA). Conclusion NAFLD might be a risk factor for DN. Elevated liver fat content could be associated with higher DN burden.	[Jia, Guoyu] Third Cent Hosp Tianjin, Tianjin Key Lab Artificial Cells TKL, Dept Endocrinol & Metab, Tianjin, Peoples R China; [Di, Fusheng; Shao, Jinshuang; Gao, Lei; Wang, Lu; Li, Qiang; Li, Nali] Third Cent Hosp Tianjin, Dept Endocrinol & Metab, Tianjin, Peoples R China; [Wang, Qipeng] Fourth Cent Hosp Tianjin, Dept Hemodialysis, Tianjin, Peoples R China		Di, FS (corresponding author), Third Cent Hosp Tianjin, Dept Endocrinol & Metab, Tianjin, Peoples R China.	difsh0415@sina.com						Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen J, 2003, J AM SOC NEPHROL, V14, P469, DOI 10.1097/01.ASN.0000046029.53933.09; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Furukawa M, 2013, SCI WORLD J, DOI 10.1155/2013/928197; Gaggini M, 2013, NUTRIENTS, V5, P1544, DOI 10.3390/nu5051544; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lu HY, 2009, ARCH MED RES, V40, P571, DOI 10.1016/j.arcmed.2009.07.009; Lv WS, 2013, WORLD J GASTROENTERO, V19, P3134, DOI 10.3748/wjg.v19.i20.3134; Mikolasevic I, 2013, KIDNEY BLOOD PRESS R, V37, P305, DOI 10.1159/000350158; Milic S, 2012, DIGEST DIS, V30, P158, DOI 10.1159/000336669; Mogensen CE, 1999, DIABETOLOGIA, V42, P263, DOI 10.1007/s001250051151; Nordstrand N, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-7; Orlic L, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/847539; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Takeuchi Y, 2012, INTERNAL MED, V51, P1667, DOI 10.2169/internalmedicine.51.7307; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2010, DIABETOLOGIA, V53, P1341, DOI 10.1007/s00125-010-1720-1; Targher G, 2010, CLIN J AM SOC NEPHRO, V5, P2166, DOI 10.2215/CJN.05050610; Thoemmes FJ, 2011, MULTIVAR BEHAV RES, V46, P90, DOI 10.1080/00273171.2011.540475; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Xia MF, 2012, OBESITY, V20, P444, DOI 10.1038/oby.2011.302; Zhan YT, 2012, INT J MOL SCI, V13, P14698, DOI 10.3390/ijms131114698	25	50	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142808	10.1371/journal.pone.0142808	http://dx.doi.org/10.1371/journal.pone.0142808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566287	Green Submitted, gold, Green Published			2022-12-26	WOS:000367628500055
J	Chow, CR; Ebine, K; Knab, LM; Bentrem, DJ; Kumar, K; Munshi, HG				Chow, Christina R.; Ebine, Kazumi; Knab, Lawrence M.; Bentrem, David J.; Kumar, Krishan; Munshi, Hidayatullah G.			Cancer Cell Invasion in Three-dimensional Collagen Is Regulated Differentially by G alpha(13) Protein and Discoidin Domain Receptor 1-Par3 Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PANCREATIC DUCTAL CELLS; STRESS FIBER FORMATION; PAR3 POLARITY PROTEIN; MEDIATED MIGRATION; POOR-PROGNOSIS; G12 FAMILY; EXPRESSION; DDR1; METASTASIS	Cancer cells can invade in three-dimensional collagen as single cells or as a cohesive group of cells that require coordination of cell-cell junctions and the actin cytoskeleton. To examine the role of G alpha(13), a G(12) family heterotrimeric G protein, in regulating cellular invasion in three-dimensional collagen, we established a novel method to track cell invasion by membrane type 1 matrix metalloproteinase-expressing cancer cells. We show that knockdown of G alpha(13) decreased membrane type 1 matrix metalloproteinase-driven proteolytic invasion in three-dimensional collagen and enhanced E-cadherin-mediated cell-cell adhesion. E-cadherin knockdown reversed G alpha(13) siRNA-induced cell-cell adhesion but failed to reverse the effect of G alpha(13) siRNA on proteolytic invasion. Instead, concurrent knockdown of E-cadherin and G alpha(13) led to an increased number of single cells rather than groups of cells. Significantly, knockdown of discoidin domain receptor 1 (DDR1), a collagen-binding protein that also co-localizes to cell-cell junctions, reversed the effects of G alpha(13) knockdown on cell-cell adhesion and proteolytic invasion in three-dimensional collagen. Knockdown of the polarity protein Par3, which can function downstream of DDR1, also reversed the effects of G alpha(13) knockdown on cell-cell adhesion and proteolytic invasion in three-dimensional collagen. Overall, we show that G alpha(13) and DDR1-Par3 differentially regulate cell-cell junctions and the actin cytoskeleton to mediate invasion in three-dimensional collagen.	[Chow, Christina R.; Ebine, Kazumi; Kumar, Krishan; Munshi, Hidayatullah G.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Knab, Lawrence M.; Bentrem, David J.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Ebine, Kazumi; Bentrem, David J.; Kumar, Krishan; Munshi, Hidayatullah G.] Northwestern Univ, Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Chow, Christina R.; Bentrem, David J.; Munshi, Hidayatullah G.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Munshi, HG (corresponding author), Northwestern Univ, Sch Med, Dept Med, 303 E Super Ave,Lurie 3-117, Chicago, IL 60611 USA.	h-munshi@northwestern.edu		Chow, Christina/0000-0003-3944-4234	NCI/National Institutes of Health [R01CA126888, R01CA186885]; Department of Veterans Affairs Merit Award [I01BX001363]; NCI/National Institutes of Health Training Grant [T32CA070085]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA186885, R01CA126888, T32CA070085] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001363] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); NCI/National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported NCI/National Institutes of Health Grants R01CA126888 and R01CA186885 (to H.G.M.) and Department of Veterans Affairs Merit Award I01BX001363 (to H.G.M.). This work was also supported by NCI/National Institutes of Health Training Grant T32CA070085 (to C.R.C.). The authors declare that they have no conflicts of interest with contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badea L, 2008, PACIFIC S BIOCOMPUTI, V13, P279; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Dangi-Garimella S, 2011, ONCOGENE, V30, P1002, DOI 10.1038/onc.2010.485; Dangi-Garimella S, 2011, CANCER RES, V71, P1019, DOI 10.1158/0008-5472.CAN-10-1855; Dhanasekaran Danny N, 2006, Sci STKE, V2006, ppe31, DOI 10.1126/stke.3472006pe31; Eswaramoorthy R, 2010, J CELL PHYSIOL, V224, P387, DOI 10.1002/jcp.22134; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gardner JA, 2013, PANCREAS, V42, P819, DOI 10.1097/MPA.0b013e318279c577; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Hansen C, 2006, EXP CELL RES, V312, P4011, DOI 10.1016/j.yexcr.2006.09.003; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Huo YM, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0202-1; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Ishikawa M, 2005, CANCER SCI, V96, P387, DOI 10.1111/j.1349-7006.2005.00064.x; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kozasa T, 2011, J BIOCHEM, V150, P357, DOI 10.1093/jb/mvr105; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; Munshi HG, 2004, J BIOL CHEM, V279, P39042, DOI 10.1074/jbc.M404958200; Munshi HG, 2002, J BIOL CHEM, V277, P41480, DOI 10.1074/jbc.M207695200; Ottaviano AJ, 2006, CANCER RES, V66, P7032, DOI 10.1158/0008-5472.CAN-05-4421; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shields MA, 2012, J BIOL CHEM, V287, P6218, DOI 10.1074/jbc.M111.308940; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; SINGER WD, 1994, J BIOL CHEM, V269, P19796; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang CZ, 2009, AM J PHYSIOL-CELL PH, V297, pC419, DOI 10.1152/ajpcell.00101.2009; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yang SH, 2010, ONCOL REP, V24, P311, DOI 10.3892/or_00000861; Yeh YC, 2011, MOL BIOL CELL, V22, P940, DOI 10.1091/mbc.E10-08-0678	49	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1605	1618		10.1074/jbc.M115.669606	http://dx.doi.org/10.1074/jbc.M115.669606			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26589794	Green Published, hybrid			2022-12-26	WOS:000368620700006
J	Landowski, LM; Pavez, M; Brown, LS; Gasperini, R; Taylor, BV; West, AK; Foa, L				Landowski, Lila M.; Pavez, Macarena; Brown, Lachlan S.; Gasperini, Robert; Taylor, Bruce V.; West, Adrian K.; Foa, Lisa			Low-density Lipoprotein Receptor-related Proteins in a Novel Mechanism of Axon Guidance and Peripheral Nerve Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; GROWTH CONES; NEURITE OUTGROWTH; APOLIPOPROTEIN-E; SENSORY NEURONS; DEFICIENT MICE; TRK RECEPTORS; SPINAL-CORD; METALLOTHIONEIN; MEGALIN	The low-density lipoprotein receptor-related protein receptors 1 and 2 (LRP1 and LRP2) are emerging as important cell signaling mediators in modulating neuronal growth and repair. We examined whether LRP1 and LRP2 are able to mediate a specific aspect of neuronal growth: axon guidance. We sought to identify LRP1 and LRP2 ligands that could induce axonal chemoattraction, which might have therapeutic potential. Using embryonic sensory neurons (rat dorsal root ganglia) in a growth cone turning assay, we tested a range of LRP1 and LRP2 ligands for the ability to guide growth cone navigation. Three ligands were chemorepulsive: alpha-2-macroglobulin, tissue plasminogen activator, and metallothionein III. Conversely, only one LRP ligand, metallothionein II, was found to be chemoattractive. Chemoattraction toward a gradient of metallothionein II was calcium-dependent, required the expression of both LRP1 and LRP2, and likely involves further co-receptors such as the tropomyosin- related kinase A (TrkA) receptor. The potential for LRP-mediated chemoattraction to mediate axonal regeneration was examined in vivo in a model of chemical denervation in adult rats. In these in vivo studies, metallothionein II was shown to enhance epidermal nerve fiber regeneration so that it was complete within 7 days compared with 14 days in saline-treated animals. Our data demonstrate that both LRP1 and LRP2 are necessary for metallothionein II-mediated chemotactic signal transduction and that they may form part of a signaling complex. Furthermore, the data suggest that LRP-mediated chemoattraction represents a novel, non-classical signaling system that has therapeutic potential as a disease-modifying agent for the injured peripheral nervous system.	[Landowski, Lila M.; Pavez, Macarena; Brown, Lachlan S.; Gasperini, Robert; West, Adrian K.; Foa, Lisa] Univ Tasmania, Sch Med, 17 Liverpool St, Hobart, Tas 7001, Australia; [Landowski, Lila M.; Gasperini, Robert; Taylor, Bruce V.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7001, Australia	University of Tasmania; University of Tasmania; Menzies Institute for Medical Research	Foa, L (corresponding author), Univ Tasmania, Sch Med, 17 Liverpool St, Hobart, Tas 7001, Australia.	lisa.foa@utas.edu.au	West, Adrian/AAR-8857-2021; Foa, Lisa/J-7781-2014; Landowski, Lila M/AAU-8616-2020	Foa, Lisa/0000-0003-4131-8341; Landowski, Lila M/0000-0001-6195-8536; Pavez, Macarena/0000-0003-0393-2631; Gasperini, Rob/0000-0001-6859-1247; Brown (Brown, LS), Lachlan/0000-0003-3612-8236	National Health and Medical Research Council [1068317, 1088952]; Brain Foundation grant; Australian postgraduate awards	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Brain Foundation grant; Australian postgraduate awards(Australian Government)	This work was supported by National Health and Medical Research Council Grants 1068317 (to L.F., A.W.,and R.G.) and 1088952 (to L.F., B.T., and A.W.)and a Brain Foundation grant (to A.W.). A.W.,B.T., L.F., and L.L. are named on United States Patent 8,691,765, which examines metallothionein function in neural repair, although there are no current competing financial interests.r Supported by Australian postgraduate awards.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Christ A, 2012, DEV CELL, V22, P268, DOI 10.1016/j.devcel.2011.11.023; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2003, J NEUROSCI, V23, P3336; Chung RS, 2002, EXP NEUROL, V178, P1, DOI 10.1006/exnr.2002.8017; Ortega MC, 2012, GLIA, V60, P851, DOI 10.1002/glia.22316; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fitzgerald M, 2007, EXP BRAIN RES, V183, P171, DOI 10.1007/s00221-007-1032-y; Fleming CE, 2009, J NEUROSCI, V29, P3220, DOI 10.1523/JNEUROSCI.6012-08.2009; Flores A J, 2000, Am J Orthop (Belle Mead NJ), V29, P167; Gardiner NJ, 2011, DEV NEUROBIOL, V71, P1054, DOI 10.1002/dneu.20950; GOMEZ TM, 1995, NEURON, V14, P1233, DOI 10.1016/0896-6273(95)90270-8; GORDON I, 1995, NEUROSCI LETT, V199, P1, DOI 10.1016/0304-3940(95)12006-P; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Jung EJ, 2008, EXP MOL MED, V40, P276, DOI 10.3858/emm.2008.40.3.276; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Leung JYK, 2012, CELL MOL LIFE SCI, V69, P809, DOI 10.1007/s00018-011-0790-7; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; LOHOF AM, 1992, J NEUROSCI, V12, P1253; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Mitchell CB, 2012, J NEUROCHEM, V122, P1155, DOI 10.1111/j.1471-4159.2012.07840.x; MORI T, 1990, BRAIN RES, V527, P55, DOI 10.1016/0006-8993(90)91059-P; Nusetti S, 2005, NEUROCHEM RES, V30, P1483, DOI 10.1007/s11064-005-8825-9; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Postuma RB, 1998, FEBS LETT, V428, P13, DOI 10.1016/S0014-5793(98)00475-X; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Siddiq MM, 2015, J BIOL CHEM, V290, P16343, DOI 10.1074/jbc.M114.630574; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Vaillant C, 2007, DEVELOPMENT, V134, P1745, DOI 10.1242/dev.02840; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	50	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1092	1102		10.1074/jbc.M115.668996	http://dx.doi.org/10.1074/jbc.M115.668996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26598525	Green Published, hybrid			2022-12-26	WOS:000368068300006
J	Ehrentraut, H; Ehrentraut, SF; Boehm, O; El Aissati, S; Foltz, F; Goelz, L; Goertz, D; Kebir, S; Weisheit, C; Wolf, M; Meyer, R; Baumgarten, G				Ehrentraut, Heidi; Ehrentraut, Stefan Felix; Boehm, Olaf; El Aissati, Sakina; Foltz, Fabian; Goelz, Lina; Goertz, David; Kebir, Sied; Weisheit, Christina; Wolf, Michael; Meyer, Rainer; Baumgarten, Georg			Tlr4 Deficiency Protects against Cardiac Pressure Overload Induced Hyperinflammation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RECEPTOR 4-DEFICIENT MICE; GENE-EXPRESSION; IN-VIVO; HYPERTROPHY; HEART; INFLAMMATION; ACTIVATION; MONOCYTES; IMMUNITY	Transverse aortic constriction provokes a pro-inflammatory reaction and results in cardiac hypertrophy. Endogenous ligands contribute to cardiac hypertrophy via toll-like receptor (TLR)4 binding. A lack of TLR4 signaling diminishes hypertrophy and inflammation. Wild type mice undergoing aortic constriction respond to a lipopolysaccharide second-hit stimulus with hyper-inflammation. The objective of this study was to assess whether other second-hit challenges utilizing TLR ligands provoke a comparable inflammatory reaction, and to find out whether this response is absent in TLR4 deficient mice. Assuming that cardiac stress alters the expression of pattern recognition receptors we analyzed the effects of transverse aortic constriction and second-hit virulence factor treatment on TLR expression, as well as cytokine regulation. Wild type and Tlr4(-/-) mice were subjected to three days of TAC and subsequently confronted with gram-positive TLR2 ligand lipoteichoic acid (LTA, 15mg/g bodyweight) or synthetic CpG-oligo-desoxynucleotide 1668 thioate (20 nmol/kg bodyweight, 30 min after D-galactosamin desensitization) signaling via TLR9. Hemodynamic measurements and organ preservation were performed 6 h after stimulation. Indeed, the study revealed a robust enhancement of LTA induced pattern recognition receptor and cytokine mRNA expression and a LTA-dependent reduction of hemodynamic pressure in TAC wild typemice. Second-Hit treatment with CpG-ODNs led to similar results. However, second-hit effects were abolished in Tlr4(-/-) mice. In total, these data indicate for the first time that cardiac stress increases the inflammatory response towards both, gram-negative and gram-positive, TLR ligands as well as bacterial DNA. The decrease of the inflammatory response upon TLR2 and -9 ligand challenge in TAC Tlr4(-/-) mice demonstrates that a lack of TLR4 signaling does not only prevent left ventricular hypertrophy but also protects the mice from a cardiac stress induced hyperinflammatory reaction.	[Ehrentraut, Heidi; Ehrentraut, Stefan Felix; Boehm, Olaf; El Aissati, Sakina; Foltz, Fabian; Goertz, David; Kebir, Sied; Weisheit, Christina; Baumgarten, Georg] Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, D-53105 Bonn, Germany; [El Aissati, Sakina] Marienhaus Klinikum, Bad Neuenahr Ahrweiler, Germany; [Foltz, Fabian] Asklepios Klin St Augustin, St Augustin, Germany; [Goelz, Lina; Wolf, Michael] Univ Bonn, Polyclin Orthodont, D-53111 Bonn, Germany; [Goelz, Lina; Wolf, Michael; Meyer, Rainer] Univ Hosp Bonn, Inst Physiol 2, D-53115 Bonn, Germany; [Goelz, Lina] HELIOS Med Ctr Siegburg, Klin Orthopadie & Unfallchirurg, Siegburg, Germany; [Kebir, Sied] Univ Bonn Med Ctr, Dept Neurol, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn	Ehrentraut, H (corresponding author), Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, Sigmund Freud Str 25, D-53105 Bonn, Germany.	heidi.ehrentraut@ukb.uni-bonn.com	Kebir, Sied/ABD-8792-2021; Weisheit, Christina/V-2507-2018; Meyer, Rainer/H-5871-2013	Kebir, Sied/0000-0002-0678-5852; Weisheit, Christina/0000-0002-7647-1613; Ehrentraut, Stefan/0000-0001-5747-6737	Deutsche Forschungsgemeinschaft [BA 1725/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by BA 1725/3-1, Deutsche Forschungsgemeinschaft (http://dfg.de/). GB received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, J ENDOTOXIN RES, V6, P383, DOI 10.1177/09680519000060050901; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baumgarten G, 2002, CIRCULATION, V105, P2192, DOI 10.1161/01.CIR.0000015608.37608.18; Baumgarten G, 2001, J INFECT DIS, V183, P1617, DOI 10.1086/320712; Baumgarten G, 2006, BASIC RES CARDIOL, V101, P427, DOI 10.1007/s00395-006-0597-0; Boehm O, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/217297; Boehm O, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-33; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Ehrentraut H, 2011, EUR J HEART FAIL, V13, P602, DOI 10.1093/eurjhf/hfr035; Ehrentraut SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044531; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Ifrim DC, 2014, CLIN VACCINE IMMUNOL, V21, P534, DOI 10.1128/CVI.00688-13; Jiang DS, 2014, HYPERTENSION, V63, P96, DOI 10.1161/HYPERTENSIONAHA.113.01506; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Li T, 2009, J HYPERTENS, V27, P1084, DOI 10.1097/HJH.0b013e3283293c93; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Matsuda S, 2015, J ATHEROSCLER THROMB; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; ROCKMAN HA, 1994, AM J PHYSIOL, V266, pH2468, DOI 10.1152/ajpheart.1994.266.6.H2468; Stapel H, 2006, EUR J HEART FAIL, V8, P665, DOI 10.1016/j.ejheart.2006.03.005; Valparaiso AP, 2014, J SURG RES; Weisheit C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112710; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266	26	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142921	10.1371/journal.pone.0142921	http://dx.doi.org/10.1371/journal.pone.0142921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588247	gold, Green Published, Green Submitted			2022-12-26	WOS:000365251500023
J	Negash, C; Whiting, SJ; Henry, CJ; Belachew, T; Hailemariam, TG				Negash, Canaan; Whiting, Susan J.; Henry, Carol J.; Belachew, Tefera; Hailemariam, Tewodros G.			Association between Maternal and Child Nutritional Status in Hula, Rural Southern Ethiopia: A Cross Sectional Study	PLOS ONE			English	Article							GROWTH; DETERMINANTS; EDUCATION; HEALTH; CARE	Background Maternal and child under nutrition is highly prevalent in low-income and middle-income countries, resulting in substantial increases in mortality and overall disease burden. The aim of this baseline survey was to determine the association between selected maternal characteristics, maternal nutritional status and children's nutritional status. Methods and Findings A survey with a cross sectional design was conducted between September and October 2012 in Hula, Ethiopia. The study subjects were 197 mothers of children between the ages of 6 and 23 months. Weight and height (mothers) or recumbent length (children) were measured using calibrated, standardized techniques. Seven percent of children were below -2 weight for height Z score (WHZ), 11.5% were below -2 height for age Z score (HAZ) and 9.9% were below -2 weight for age Z score (WAZ). Maternal anthropometrics were associated with child nutritional status in the bivariate analysis. Maternal BMI (r = 0.16 P = 0.02) and educational status (r = 0.25 P = 0.001) were correlated with WHZ of children while maternal height (r = 0.2 P = 0.007) was correlated with HAZ of children. After multivariate analysis, children whose mothers had salary from employment had a better WHZ score (P = 0.001) and WAZ score (P<0.001). Both maternal BMI and maternal height were associated with WHZ (P = 0.04) and HAZ (P = 0.01) score of children. Conclusion Having a mother with better nutritional status and salaried employment is a benefit for the nutritional status of the child. The interrelationship between maternal and child nutritional status stresses the value of improving maternal nutritional status as this should improve both maternal and child health outcomes. Therefore strategies to improve nutritional status of children should also include improving the nutritional status of the mother and empowering her financially.	[Negash, Canaan; Hailemariam, Tewodros G.] Wolaita Sodo Univ, Sch Publ Hlth, Wolaita, Ethiopia; [Whiting, Susan J.; Henry, Carol J.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada; [Belachew, Tefera] Jimma Univ, Dept Populat & Family Hlth, Jimma, Ethiopia	University of Saskatchewan; Jimma University	Negash, C (corresponding author), Wolaita Sodo Univ, Sch Publ Hlth, Wolaita, Ethiopia.	canaanb00@gmail.com	Hailemariam, Tewodros Getachew/AAI-2914-2020; Belachew, Tefera/AAO-5877-2020	Hailemariam, Tewodros Getachew/0000-0001-6013-2767; 	Canadian Department of Foreign Affairs, Trade and Development, International Development Research Centre (IDRC) Canadian International Food Security Research Fund (CIFSRF)	Canadian Department of Foreign Affairs, Trade and Development, International Development Research Centre (IDRC) Canadian International Food Security Research Fund (CIFSRF)	Funding: Financial support was provided by the Canadian Department of Foreign Affairs, Trade and Development, International Development Research Centre (IDRC) Canadian International Food Security Research Fund (CIFSRF), http://www.idrc.ca/EN/Pages/default.aspx). The funders had no role in decision to publish or preparation of the manuscript.	Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; Ajieroh V, 2009, QUANTITATIVE ANAL DE; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Ethiopian Society of Population Studies, 2008, MAT HLTH CAR SEEK BE; Fabunmi TM, 2013, INT J CHILD HEALTH N, V2, P39, DOI 10.6000/1929-4247.2013.02.01.7; Felisbino-Mendes MS, 2014, PLOS ONE, V9; Frost MB, 2005, SOC SCI MED, V60, P395, DOI 10.1016/j.socscimed.2004.05.010; Gewa CA, 2012, MATERN CHILD NUTR, V8, P275, DOI 10.1111/j.1740-8709.2011.00322.x; Girma W., 2002, DETERMINANTS NUTR ST; [ICFI Ethiopia Demographic and Health Survey Central AS], 2011, ICF I ETH DEM HLTH S; Kabubo-Mariara J, 2009, J AFR ECON, V18, P363, DOI 10.1093/jae/ejn024; Lamontagne JF, 1998, SOC SCI MED, V46, P403, DOI 10.1016/S0277-9536(97)00184-6; Lander RL, 2012, CAD SAUDE PUBLICA, V28, P2177, DOI 10.1590/S0102-311X2012001100017; Lourenco BH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-265; Negash C, 2014, FOOD NUTR BULL, V35, P480, DOI 10.1177/156482651403500409; Shuhaimi F., 2012, Asian Journal of Clinical Nutrition, V4, P53, DOI 10.3923/ajcn.2012.53.66; Wamani H., 2007, BMC Pediatrics, V7; World Bank, CHILD MALN	19	43	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142301	10.1371/journal.pone.0142301	http://dx.doi.org/10.1371/journal.pone.0142301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26588687	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500009
J	Shingleton, JR; Hemann, MT				Shingleton, Jennifer R.; Hemann, Michael T.			The Chromatin Regulator CHD8 Is a Context-Dependent Mediator of Cell Survival in Murine Hematopoietic Malignancies	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMOSOME-POSITIVE LEUKEMIAS; AUTISM SPECTRUM DISORDERS; HISTONE H1 RECRUITMENT; DE-NOVO MUTATIONS; TARGETED THERAPY; BURKITT-LYMPHOMA; SUPPRESSION; RESISTANCE; CANCER	Aberrant chromatin regulation is a frequent driver of leukemogenesis. Mutations in chromatin regulators often result in more stem-like cells that seed a bulk leukemic population. Inhibitors targeting these proteins represent an emerging class of therapeutics, and identifying further chromatin regulators that promote disease progression may result in additional drug targets. We identified the chromatin-modifying protein CHD8 as necessary for cell survival in a mouse model of BCR-Abl+ B-cell acute lymphoblastic leukemia. This disease has a poor prognosis despite treatment with kinase inhibitors targeting BCR-Abl. Although implicated as a risk factor in autism spectrum disorder and a tumor suppressor in prostate and lung cancer, the mechanism of CHD8's activity is still unclear and has never been studied in the context of hematopoietic malignancies. Here we demonstrate that depletion of CHD8 in B-ALL cells leads to cell death. While multiple B cell malignancies were dependent on CHD8 expression for survival, T cell malignancies displayed milder phenotypes upon CHD8 knockdown. In addition, ectopic expression of the Notch1 intracellular domain in a T cell malignancy partially alleviated the detrimental effect of CHD8 depletion. Our results demonstrate that CHD8 has a context-dependent role in cell survival, and its inhibition may be an effective treatment for B lymphoid malignancies.	[Shingleton, Jennifer R.; Hemann, Michael T.] MIT, Koch Inst Integrated Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hemann, MT (corresponding author), MIT, Koch Inst Integrated Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hemann@mit.edu			Ludwig Foundation for Cancer research; NSF graduate Fellowship	Ludwig Foundation for Cancer research; NSF graduate Fellowship(National Science Foundation (NSF))	This work was funded by the Ludwig Foundation for Cancer research (http://www.ludwigcancerresearch.org). JRS was funded by by an NSF graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim MS, 2011, HISTOPATHOLOGY, V58, P660, DOI 10.1111/j.1365-2559.2011.03819.x; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Liu-Dumlao T, 2012, CURR ONCOL REP, V14, P387, DOI 10.1007/s11912-012-0247-7; Meacham CE, 2008, GENE DEV, P483; Menon T, 2010, MOL ENDOCRINOL, V24, P1165, DOI 10.1210/me.2009-0421; Mullighan CG, 2008, GENE DEV, V22, P1411, DOI 10.1101/gad.1673908; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nie J, 2014, CANCER LETT, V354, P12, DOI 10.1016/j.canlet.2014.08.010; Nishiyama M, 2012, MOL CELL BIOL, V32, P501, DOI 10.1128/MCB.06409-11; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez-Paredes M, 2009, NUCLEIC ACIDS RES, V37, P2449, DOI 10.1093/nar/gkp101; Sakamoto I, 2000, J BIOL CHEM, V275, P32871, DOI 10.1074/jbc.M004089200; Sawada G, 2013, ONCOL REP, V30, P1137, DOI 10.3892/or.2013.2597; Subtil-Rodrfguez A, 2013, NUCLEIC ACIDS RES, P1; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tahara T, 2014, GASTROENTEROLOGY, V146, P530, DOI 10.1053/j.gastro.2013.10.060; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	38	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143275	10.1371/journal.pone.0143275	http://dx.doi.org/10.1371/journal.pone.0143275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588464	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500048
J	Manyema, M; Veerman, JL; Chola, L; Tugendhaft, A; Labadarios, D; Hofman, K				Manyema, Mercy; Veerman, J. Lennert; Chola, Lumbwe; Tugendhaft, Aviva; Labadarios, Demetre; Hofman, Karen			Decreasing the Burden of Type 2 Diabetes in South Africa: The Impact of Taxing Sugar-Sweetened Beverages	PLOS ONE			English	Article							OBESITY; OVERWEIGHT; CONSUMPTION; DISEASES; HEALTH; TAXES; RISK	Introduction Type 2 diabetes poses an increasing public health burden in South Africa (SA) with obesity as the main driver of the epidemic. Consumption of sugar sweetened beverages (SSBs) is linked to weight gain and reducing SSB consumption may significantly impact the prevalence of obesity and related diseases. We estimated the effect of a 20% SSB tax on the burden of diabetes in SA. Methods and Findings We constructed a life table-based model in Microsoft Excel (2010). Consumption data from the 2012 SA National Health and Nutrition Examination Survey, previously published own-and cross-price elasticities of SSBs and energy balance equations were used to estimate changes in daily energy intake and its projected impact on BMI arising from increased SSB prices. Diabetes relative risk and prevalent years lived with disability estimates fromthe Global Burden of Disease Study andmodelled disease epidemiology estimates from a previous study were used to estimate the effect of the BMI changes on diabetes burden. Diabetes cost estimates were obtained from the South African Council forMedical Schemes. Over 20 years, a 20% SSB tax could reduce diabetes incident cases by 106 000 in women (95% uncertainty interval (UI) 70 000-142 000) and by 54 000 in men (95% UI: 33 000-80 000); and prevalence in all adults by 4.0% (95% UI: 2.7%-5.3%). Cumulatively over twenty years, approximately 21 000 (95% UI: 14 000-29 000) adult T2DM-related deaths, 374 000 DALYs attributed to T2DM (95% UI: 299 000-463 000) and over ZAR10 billion T2DM healthcare costs (95% UI: ZAR6.8-14.0 billion) equivalent to USD860million (95% UI: USD570 million-USD1.2 billion) may be averted. Conclusion Fiscal policy on SSBs has the potential to mitigate the diabetes epidemic in South Africa and contribute to the National Department of Health goals stated in the National NCD strategic plan.	[Manyema, Mercy; Chola, Lumbwe; Tugendhaft, Aviva; Hofman, Karen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, PRICELESS SA MRC Wits Rural Publ Hlth & Hlth Tran, Johannesburg, South Africa; [Veerman, J. Lennert] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Labadarios, Demetre] Human Sci Res Council, PHHSI, Cape Town, South Africa	University of Witwatersrand; University of Queensland; Human Sciences Research Council-South Africa	Hofman, K (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, PRICELESS SA MRC Wits Rural Publ Hlth & Hlth Tran, Johannesburg, South Africa.	karen.hofman@wits.ac.za	Chola, Lumbwe/AFX-3377-2022; Veerman, Lennert/A-9973-2011	HOFMAN, KAREN/0000-0001-9512-7220; Chola, Lumbwe/0000-0001-6488-2813; Veerman, Lennert/0000-0002-3206-8232	International Development Research Center, Canada [PROP020911E]	International Development Research Center, Canada	This research was supported by grant PROP020911E from the International Development Research Center, Canada. The funding was received by KH, Director PRICELESS SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: http://www.idrc.ca/EN/Pages/default.aspx. The funding was received by KH.	Adami N, 2012, Q DIVISIONAL SEMINAR; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; [Anonymous], 415 BANQ FRANC; [Anonymous], DEP HLTH STRAT PLAN, P26; Barendregt JJ, 2010, J EPIDEMIOL COMMUN H, V64, P209, DOI 10.1136/jech.2009.090274; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974; Bertram MY, 2013, GLOBAL HEALTH ACTION, V6, P206, DOI 10.3402/gha.v6i0.19244; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P700; Briggs AD, 2013, BMJ; Briggs ADM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-860; Claro RM, 2012, AM J PUBLIC HEALTH, V102, P178, DOI 10.2105/AJPH.2011.300313; Council for Medical Schemes Research and Monitoring Unit, 2013, TRENDS CHRON DIS PRE, P3; de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922; De Wet P., 2011, DAILY MAVERICK; Dodds C, 2013, SATURDAY STAR; Dong JY, 2011, BRIT J NUTR, V106, P1649, DOI 10.1017/S000711451100540X; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Euromonitor International, 2013, SOFT DRINKS S AFR IN; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Forster M, 2011, INT J OBESITY, V35, P1071, DOI 10.1038/ijo.2010.246; Friedman Roberta R, 2012, SUGAR SWEETENED BEVE, P1; Global Burden of Disease Study, 2010, S AFR GLOB BURD DIS; Guariguata L, 2013, DIABETES RES CLIN PR; Hofman KJ, 2014, SAMJ S AFR MED J, V104, P661, DOI 10.7196/samj.8580; Hofman K, 2014, SAMJ S AFR MED J, V104, P647, DOI [10.7196/samj.8727, 10.7196/SAMJ.8727]; Holmes T, 2013, SALT SELLERS SHAKEN; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Katz I, 2009, PRIM CARE DIABETES, V3, P157, DOI 10.1016/j.pcd.2009.06.007; Kengne AP, 2013, PROG CARDIOVASC DIS, V56, P302, DOI 10.1016/j.pcad.2013.10.011; Kengne AP, 2013, HEART, V99, P1072, DOI 10.1136/heartjnl-2013-303773; Kengne AP, 2013, HEART; Leibbtandt M, 2009, 1 SALDRU; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Manyema M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105287; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Ncube-Zulu T, 2013, INT J DIABETES DEV C; Nel JH, 2002, REPORT S AFRICAN FOO; NIDS, 2013, NAT INC DYN STUD 201; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Parmalat, 2011, EV MILK NUTR INF PER; Patton GC, 2011, J ADOLESCENT HEALTH, V48, P275, DOI 10.1016/j.jadohealth.2010.06.019; Peer N, 2014, DIABETES RES CLIN PR, V103, P197, DOI 10.1016/j.diabres.2013.11.006; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Ronquest-Ross L-C, 2014, S AFR J SCI; Sachs Jeffrey D, 2001, MACR HLTH INV HLTH E; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shisana O, 2014, S AFRICAN NATL HLTH, P135; StatsSA, 2013, MID POP EST 2013; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; The CocaCola Company, 2013, PER CAP CONS CO BEV; United Nations General Assembly, 2014, A68970 UN GEN ASS; van Walbeek C., 2003, TOBACCO EXCISE TAXAT; Vorster HH, 2014, AM J CLIN NUTR; Wang LY, 2010, J ADOLESCENT HEALTH, V46, P467, DOI 10.1016/j.jadohealth.2009.11.204; Wareham Nicholas J., 2010, MEDICINE, V11, P602; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wolmarans P., 2010, CONDENSED FOOD COMPO; World Health Organization, 2005, PREV CHRON DIS VIT I, V34, P34; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	62	34	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143050	10.1371/journal.pone.0143050	http://dx.doi.org/10.1371/journal.pone.0143050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575644	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400034
J	Liu, YL; Zhang, PF; Song, ML; Hou, JL; Qing, M; Wang, WQ; Liu, CS				Liu, Yaling; Zhang, Pengfei; Song, Meiling; Hou, Junling; Qing, Mei; Wang, Wenquan; Liu, Chunsheng			Transcriptome Analysis and Development of SSR Molecular Markers in Glycyrrhiza uralensis Fisch.	PLOS ONE			English	Article							RNA-SEQ DATA; EST; DISCOVERY	Licorice is an important traditional Chinese medicine with clinical and industrial applications. Genetic resources of licorice are insufficient for analysis of molecular biology and genetic functions; as such, transcriptome sequencing must be conducted for functional characterization and development of molecular markers. In this study, transcriptome sequencing on the Illumina HiSeq 2500 sequencing platform generated a total of 5.41 Gb clean data. De novo assembly yielded a total of 46,641 unigenes. Comparison analysis using BLAST showed that the annotations of 29,614 unigenes were conserved. Further study revealed 773 genes related to biosynthesis of secondary metabolites of licorice, 40 genes involved in biosynthesis of the terpenoid backbone, and 16 genes associated with biosynthesis of glycyrrhizic acid. Analysis of unigenes larger than 1 Kb with a length of 11,702 nt presented 7,032 simple sequence repeats (SSR). Sixty-four of 69 randomly designed and synthesized SSR pairs were successfully amplified, 33 pairs of primers were polymorphism in in Glycyrrhiza uralensis Fisch., Glycyrrhiza inflata Bat., Glycyrrhiza glabra L. and Glycyrrhiza pallidiflora Maxim. This study not only presents the molecular biology data of licorice but also provides a basis for genetic diversity research and molecular marker-assisted breeding of licorice.	[Liu, Yaling; Hou, Junling; Wang, Wenquan; Liu, Chunsheng] Beijing Univ Chinese Med, Sch Chinese Pharm, Beijing 100102, Peoples R China; [Liu, Yaling; Zhang, Pengfei; Song, Meiling] Shanxi Agr Univ, Coll Life Sci, Taigu 030801, Shanxi Province, Peoples R China; [Qing, Mei] Inner Mongolia Med Univ, Hohhot 010059, Peoples R China; [Wang, Wenquan] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100193, Peoples R China; [Wang, Wenquan] Peking Union Med Coll, Beijing 100193, Peoples R China	Beijing University of Chinese Medicine; Shanxi Agricultural University; Inner Mongolia Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qing, M (corresponding author), Inner Mongolia Med Univ, Hohhot 010059, Peoples R China.	qingmei409@163.com; wwq57@126.com; max_liucs@263.com			Chinese herbal medicine standardization production technology service platform [Ministry of Consumption] [(2011) 340]; National Natural Science Foundation of China [31400285]; National Ministry of Science and Technology [2011BAI07B02]; Inner Mongolia autonomous region science and technology innovation to guide the bounty program Quality evaluation of wild and cultivated radix glycyrrhizae in Inner Mongolia region [65861161449]	Chinese herbal medicine standardization production technology service platform [Ministry of Consumption]; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Science and Technology; Inner Mongolia autonomous region science and technology innovation to guide the bounty program Quality evaluation of wild and cultivated radix glycyrrhizae in Inner Mongolia region	This study was supported by the Chinese herbal medicine standardization production technology service platform [Ministry of Consumption (2011) 340], Wang WQ; the National Natural Science Foundation of China (31400285), Liu YL; National Ministry of Science and Technology support project Optimization of licorice standardization planting base in north China and series products of comprehensive exploitation and research (2011BAI07B02), Qing M; the Inner Mongolia autonomous region science and technology innovation to guide the bounty program Quality evaluation of wild and cultivated radix glycyrrhizae in Inner Mongolia region (65861161449), Qing M.	CHAPPELL J, 1995, ANNU REV PLANT PHYS, V46, P521, DOI 10.1146/annurev.pp.46.060195.002513; Chinese Pharmacopoeia Commission, 2010, PHARM PEOPL REP CHIN, V1, p[283, 232]; Doyle J. J., 1987, PHYTOCHEM B, P11; Gao Xueyan, 2009, Zhongguo Zhong Yao Za Zhi, V34, P2695; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hao DC, 2012, SCI CHINA LIFE SCI, V55, P452, DOI 10.1007/s11427-012-4319-6; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-268; Liu JR, 2004, SHANGHAI J TRADITION, V8, P56; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083549; Long Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1111; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matsui S, 2004, INT IMMUNOPHARMACOL, V4, P1633, DOI 10.1016/j.intimp.2004.07.023; Ramilowski JA, 2013, PLANT CELL PHYSIOL, V54, P697, DOI 10.1093/pcp/pct057; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Shibata S, 2000, YAKUGAKU ZASSHI, V120, P849, DOI 10.1248/yakushi1947.120.10_849; Sun L, 2001, J CHINESE MED MAT, V24, P550; Wang B, 2013, J JILIN MED COLL, V34, P215; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; [王兴春 Wang Xingchun], 2012, [中国生物工程杂志, Journal of Chinese Biotechnology], V32, P109; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Yan YB, 2011, AM J BOT, V98, pE1, DOI 10.3732/ajb.1000387; Zhang QF, 2013, SHANDONG AGR SCI, V45, P137; 李刚, 2004, [中药材, Journal of Chinese Medicinal Materials], V27, P462	27	18	28	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143017	10.1371/journal.pone.0143017	http://dx.doi.org/10.1371/journal.pone.0143017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571372	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700120
J	Mo, YF; Yu, DX; Song, J; Zheng, K; Guo, YJ				Mo, Yuanfu; Yu, Dexin; Song, Jun; Zheng, Kun; Guo, Yajuan			A Beacon Transmission Power Control Algorithm Based on Wireless Channel Load Forecasting in VANETs	PLOS ONE			English	Article							AWARE; NETWORKS; PROTOCOL; CHALLENGES; TOPOLOGY; INTERNET	In a vehicular ad hoc network (VANET), the periodic exchange of single-hop status information broadcasts (beacon frames) produces channel loading, which causes channel congestion and induces information conflict problems. To guarantee fairness in beacon transmissions from each node and maximum network connectivity, adjustment of the beacon transmission power is an effective method for reducing and preventing channel congestion. In this study, the primary factors that influence wireless channel loading are selected to construct the KF-BCLF, which is a channel load forecasting algorithm based on a recursive Kalman filter and employs multiple regression equation. By pre-adjusting the transmission power based on the forecasted channel load, the channel load was kept within a predefined range; therefore, channel congestion was prevented. Based on this method, the CLF-BTPC, which is a transmission power control algorithm, is proposed. To verify KF-BCLF algorithm, a traffic survey method that involved the collection of floating car data along a major traffic road in Changchun City is employed. By comparing this forecast with the measured channel loads, the proposed KF-BCLF algorithm was proven to be effective. In addition, the CLF-BTPC algorithm is verified by simulating a section of eight-lane highway and a signal-controlled urban intersection. The results of the two verification process indicate that this distributed CLF-BTPC algorithm can effectively control channel load, prevent channel congestion, and enhance the stability and robustness of wireless beacon transmission in a vehicular network.	[Mo, Yuanfu; Yu, Dexin; Zheng, Kun; Guo, Yajuan] Jilin Univ, Coll Transportat, Changchun 130023, Peoples R China; [Song, Jun] Dalian Int Airport, Dalian, Peoples R China	Jilin University	Mo, YF (corresponding author), Jilin Univ, Coll Transportat, Changchun 130023, Peoples R China.	496629815@qq.com	yu, dexin/AAZ-7955-2021					Athanasios V., 2011, DELAY TOLERANT NETWO; Attar A, 2012, P IEEE, V100, P3172, DOI 10.1109/JPROC.2012.2208211; Busch C, 2012, IEEE T COMPUT, V61, P1270, DOI 10.1109/TC.2011.145; Duarte PBF, 2012, IEEE J SEL AREA COMM, V30, P119, DOI 10.1109/JSAC.2012.120111; Giuseppe C, 2009, P 43 IEEE INT C COMM, P3321; Habib S., 2013, Information Technology Journal, V12, P558, DOI 10.3923/itj.2013.558.568; Hannes H, 2010, VEHICULAR APPL INTER, P112; He Y, 2013, IEEE ACM T NETWORK, V21, P204, DOI 10.1109/TNET.2012.2202323; Javadi M. S., 2013, Information Technology Journal, V12, P243, DOI 10.3923/itj.2013.243.250; Jiau MK, 2015, IEEE INTEL TRANSP SY, V7, P62, DOI 10.1109/MITS.2015.2417974; Kashif QN, 2014, INF TECHN MULT INT C, P35; Khorakhum C, 2011, P 6 INT WORKSH INT T, P138; Li P, 2014, IEEE T PARALL DISTR, V25, P3264, DOI 10.1109/TPDS.2013.2297105; Li P, 2012, IEEE INFOCOM SER, P100, DOI 10.1109/INFCOM.2012.6195456; Liu JQ, 2016, TELECOMMUN SYST, V62, P15, DOI 10.1007/s11235-015-9979-7; Liu JQ, 2015, MOBILE NETW APPL, V20, P661, DOI 10.1007/s11036-015-0604-5; Liu L, 2015, IEEE T COMPUT, V64, P819, DOI 10.1109/TC.2013.229; Lopez-Perez D, 2014, IEEE J SEL AREA COMM, V32, P333, DOI 10.1109/JSAC.2014.141213; Lopez-Perez D, 2013, IEEE ACM T NETWORK, V21, P1145, DOI 10.1109/TNET.2012.2218124; Maxim R, 2008, P ACM WORKSH SEC AD, P161; Mean MA, 2010, P 5 ACM INT WORKSH V, P41; Meng T, 2016, IEEE T COMPUT, V65, P244, DOI 10.1109/TC.2015.2417543; Natarajan M, 2011, AD HOC NETW, V9, P1105; Oh S, 2015, TRANSPORT REV, V35, P4, DOI 10.1080/01441647.2014.992496; Peng D., 2009, SOFTWARE GUIDE, V11, P32; Reza MR, 2012, IEEE ACM UCC, P83; Sepulcre M, 2014, IEEE VEHIC NETW CONF, DOI 10.1109/VNC.2014.7013313; Shen ZJ, 2011, P IEEE, V99, P2089, DOI 10.1109/JPROC.2011.2165330; Sheng ZG, 2013, IEEE WIREL COMMUN, V20, P91, DOI 10.1109/MWC.2013.6704479; Spyropoulos T, 2010, WIREL NETW, V16, P2349, DOI 10.1007/s11276-010-0276-9; Torrent-Moreno M, 2009, IEEE T VEH TECHNOL, V58, P3684, DOI 10.1109/TVT.2009.2017545; Wan JF, 2014, IEEE COMMUN MAG, V52, P106, DOI 10.1109/MCOM.2014.6871677; Wang XF, 2012, MOBILE NETW APPL, V17, P4, DOI 10.1007/s11036-011-0316-4; Wei GY, 2011, COMPUT COMMUN, V34, P793, DOI 10.1016/j.comcom.2010.10.003; Xiao Y, 2012, IEEE T MOBILE COMPUT, V11, P1538, DOI 10.1109/TMC.2011.190; Yao YJ, 2013, IEEE INT CONF MOB, P182, DOI 10.1109/MASS.2013.44; Yen YS, 2011, MATH COMPUT MODEL, V53, P2238, DOI 10.1016/j.mcm.2010.10.008; Youssef M, 2014, IEEE COMMUN SURV TUT, V16, P92, DOI 10.1109/SURV.2013.082713.00184; Zeng YY, 2013, WIREL NETW, V19, P161, DOI 10.1007/s11276-012-0457-9; Zhang DG, 2015, SOFT COMPUT, V19, P1817, DOI 10.1007/s00500-014-1366-x; Zhang DG, 2013, MATH COMPUT MODEL, V57, P344, DOI 10.1016/j.mcm.2012.06.012; Zhang DG, 2012, COMPUT MATH APPL, V64, P1044, DOI 10.1016/j.camwa.2012.03.023; Zhang DG, 2014, IEEE T SERV COMPUT, V7, P741, DOI 10.1109/TSC.2014.2370642; Zhang DG, 2014, IEEE T IND INFORM, V10, P766, DOI 10.1109/TII.2013.2250910; Zhang XM, 2015, IEEE T MOBILE COMPUT, V14, P742, DOI 10.1109/TMC.2014.2331966; Zhou J, 2015, IEEE T INF FOREN SEC, V10, P1299, DOI 10.1109/TIFS.2015.2407326; Zhou L, 2011, IEEE J SEL AREA COMM, V29, P1358, DOI 10.1109/JSAC.2011.110803; Zhou LA, 2011, IEEE T VEH TECHNOL, V60, P692, DOI 10.1109/TVT.2010.2102782	48	9	10	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142775	10.1371/journal.pone.0142775	http://dx.doi.org/10.1371/journal.pone.0142775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571042	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700070
J	Gavin, KM; Gutman, JA; Kohrt, WM; Wei, Q; Shea, KL; Miller, HL; Sullivan, TM; Erickson, PF; Helm, KM; Acosta, AS; Childs, CR; Musselwhite, E; Varella-Garcia, M; Kelly, K; Majka, SM; Klemm, DJ				Gavin, Kathleen M.; Gutman, Jonathan A.; Kohrt, Wendy M.; Wei, Qi; Shea, Karen L.; Miller, Heidi L.; Sullivan, Timothy M.; Erickson, Paul F.; Helm, Karen M.; Acosta, Alistaire S.; Childs, Christine R.; Musselwhite, Evelyn; Varella-Garcia, Marileila; Kelly, Kimberly; Majka, Susan M.; Klemm, Dwight J.			De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue	FASEB JOURNAL			English	Article						adipogenesis; stem cell; bone marrow; polymorphic microsatellite; short tandem repeat	CRE-MEDIATED RECOMBINATION; HEMATOPOIETIC STEM-CELLS; BONE-MARROW-CELLS; BODY-WEIGHT; WHITE; FAT; BROWN; EXPRESSION; LINEAGE; MUSCLE	White adipocytes in adults are typically derived from tissue resident mesenchymal progenitors. The recent identification of de novo production of adipocytes from bone marrow progenitor-derived cells in mice challenges this paradigm and indicates an alternative lineage specification that adipocytes exist. We hypothesized that alternative lineage specification of white adipocytes is also present in human adipose tissue. Bone marrow from transgenic mice in which luciferase expression is governed by the adipocyte-restricted adiponectin gene promoter was adoptively transferred to wild-type recipient mice. Light emission was quantitated in recipients by in vivo imaging and direct enzyme assay. Adipocytes were also obtained from human recipients of hematopoietic stem cell transplantation. DNA was isolated, and microsatellite polymorphisms were exploited to quantify donor/recipient chimerism. Luciferase emission was detected from major fat depots of transplanted mice. No light emission was observed from intestines, liver, or lungs. Up to 35% of adipocytes in humans were generated from donor marrow cells in the absence of cell fusion. Nontransplanted mice and stromal-vascular fraction samples were used as negative and positive controls for the mouse and human experiments, respectively. This study provides evidence for a nontissue resident origin of an adipocyte subpopulation in both mice and humans.	[Gavin, Kathleen M.; Kohrt, Wendy M.; Shea, Karen L.] Univ Colorado, Ctr Canc, Sch Med, Dept Med,Div Geriatr Med, Aurora, CO 80045 USA; [Gutman, Jonathan A.] Univ Colorado, Ctr Canc, Sch Med, Dept Med,Div Med Oncol, Aurora, CO 80045 USA; [Miller, Heidi L.; Sullivan, Timothy M.; Erickson, Paul F.; Klemm, Dwight J.] Univ Colorado, Ctr Canc, Sch Med, Dept Med,Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Helm, Karen M.; Acosta, Alistaire S.; Childs, Christine R.] Univ Colorado, Ctr Canc, Flow Cytometry Shared Resource, Aurora, CO 80045 USA; [Musselwhite, Evelyn; Varella-Garcia, Marileila] Univ Colorado, Ctr Canc, Mol Pathol Cytogenet Shared Resource, Aurora, CO 80045 USA; [Klemm, Dwight J.] Univ Colorado, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Anschutz Med Campus, Aurora, CO 80045 USA; [Klemm, Dwight J.] Univ Colorado, Colorado Obes Res Initiat, Anschutz Med Campus, Aurora, CO 80045 USA; [Wei, Qi; Kelly, Kimberly] Childrens Hosp Colorado, Mol Diagnost Lab, Aurora, CO USA; [Majka, Susan M.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Majka, Susan M.] Vanderbilt Univ, Sch Med, Ctr Stem Cell Biol, Nashville, TN 37212 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Vanderbilt University; Vanderbilt University	Klemm, DJ (corresponding author), Univ Colorado, Anschutz Med Campus,Res 2,Campus Box B-133, Aurora, CO 80045 USA.	dwight.klemm@ucdenver.edu			U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants [R01 DK078966, R21 DK092718]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [P50 HD073063]; NIH National Institute on Aging Grants [T32 AG000279, F32 AG046957]; NIH National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards [UL1 TR001082]; NIH National Cancer Institute Centers for Common Disease Genomics Grant [P30 CA046934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD073063] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078966, R56DK078966, P30DK048520, R21DK092718, R01DK109547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG046957, T32AG000279] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; NIH National Institute on Aging Grants; NIH National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards; NIH National Cancer Institute Centers for Common Disease Genomics Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Drs. J. Lee Nelson and Vijayakrishna K. Gadi (Fred Hutchinson Cancer Research Center and University of Washington Medical Center, Seattle, WA, USA) for discussions on chimerism analysis in humans. They also thank Dr. Kristine Erlandson (University of Colorado Anschutz Medical Campus) for medical safety oversight of the project. This research was funded by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants R01 DK078966 (to D.J.K.) and R21 DK092718 (to W.M.K.); and NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant P50 HD073063 (to W.M.K.); and NIH National Institute on Aging Grants T32 AG000279 and F32 AG046957 (research fellowships to K.M.G.). This research was also supported in part by NIH National Center for Advancing Translational Sciences Colorado Clinical and Translational Science Awards Grant UL1 TR001082 and NIH National Cancer Institute Centers for Common Disease Genomics Grant P30 CA046934. The authors declare no conflicts of interest.	Araujo IM, 2010, CRIT CARE MED, V38, P1733, DOI 10.1097/CCM.0b013e3181e796d2; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Blouin K, 2005, METABOLISM, V54, P1034, DOI 10.1016/j.metabol.2005.03.006; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Burdon TJ, 2011, BONE MARROW RES, DOI 10.1155/2011/207326; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Cereijo R, 2015, ANN MED, V47, P169, DOI 10.3109/07853890.2014.952328; Cho SW, 2009, MOL THER, V17, P1979, DOI 10.1038/mt.2009.153; Coleman S R, 1998, Aesthet Surg J, V18, P388, DOI 10.1016/S1090-820X(98)70098-6; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Darzynkiewicz Z, 2010, ADV EXP MED BIOL, V676, P137; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Engfeldt P, 1988, Horm Metab Res Suppl, V19, P26; Fukata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062506; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Hoffstedt J, 2010, DIABETOLOGIA, V53, P2496, DOI 10.1007/s00125-010-1889-3; Huh JW, 2011, AM J PHYSIOL-LUNG C, V301, pL255, DOI 10.1152/ajplung.00253.2010; Jackson KA, 2002, J CELL BIOCHEM, P1, DOI 10.1002/jcb.10045; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; JOHNSON PR, 1972, J LIPID RES, V13, P2; Katz LS, 2014, AM J PHYSIOL-ENDOC M, V307, pE335, DOI 10.1152/ajpendo.00075.2014; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Koh YJ, 2007, J CLIN INVEST, V117, P3684, DOI 10.1172/JCI32504; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; LAU DCW, 1990, INT J OBESITY, V14, P193; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; Majka SM, 2014, METHOD ENZYMOL, V537, P281, DOI 10.1016/B978-0-12-411619-1.00015-X; Majka SM, 2012, ADIPOCYTE, V1, P215, DOI 10.4161/adip.21496; Majka SM, 2011, STEM CELLS, V29, P1034, DOI 10.1002/stem.653; Majka SM, 2010, P NATL ACAD SCI USA, V107, P14781, DOI 10.1073/pnas.1003512107; Mao M, 2010, SHOCK, V34, P196, DOI 10.1097/SHK.0b013e3181d49457; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; McLaughlin T, 2010, DIABETOLOGIA, V53, P369, DOI 10.1007/s00125-009-1496-3; Montoliu L, 2000, TRANSGENIC RES, V9, P237, DOI 10.1023/A:1008995730285; Pascot A, 1999, DIABETES CARE, V22, P1471, DOI 10.2337/diacare.22.9.1471; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Prota LFM, 2010, CELL TRANSPLANT, V19, P965, DOI 10.3727/096368910X506845; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Ryden M, 2015, CELL METAB, V22, P408, DOI 10.1016/j.cmet.2015.06.011; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sera Y, 2009, EXP HEMATOL, V37, P1108, DOI 10.1016/j.exphem.2009.06.008; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tao W, 2007, STEM CELLS, V25, P670, DOI 10.1634/stemcells.2006-0553; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tomiyama K, 2008, STEM CELLS, V26, P330, DOI 10.1634/stemcells.2007-0567; Turlo KA, 2010, GENETICS, V186, P959, DOI 10.1534/genetics.110.121608; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Varlamov O, 2015, ENDOCRINOLOGY, V156, P80, DOI 10.1210/en.2014-1699; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wajchenberg BL, 2002, HORM METAB RES, V34, P616, DOI 10.1055/s-2002-38256; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wise AF, 2012, NEPHROLOGY, V17, P1, DOI 10.1111/j.1440-1797.2011.01501.x; Wueest S, 2009, DIABETOLOGIA, V52, P541, DOI 10.1007/s00125-008-1223-5; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512; Yeagy BA, 2011, PEDIATR NEPHROL, V26, P1427, DOI 10.1007/s00467-011-1789-x	68	36	36	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1096	1108		10.1096/fj.15-278994	http://dx.doi.org/10.1096/fj.15-278994			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26581599	Green Published			2022-12-26	WOS:000370387800009
J	Tong, Q; Gong, AY; Zhang, XT; Lin, CC; Ma, SB; Chen, J; Hu, GK; Chen, XM				Tong, Qiang; Gong, Ai-Yu; Zhang, Xin-Tian; Lin, Chengchi; Ma, Shibin; Chen, Jing; Hu, Guoku; Chen, Xian-Ming			LincRNA-Cox2 modulates TNF-alpha-induced transcription of Il12b gene in intestinal epithelial cells through regulation of Mi-2/NuRD-mediated epigenetic histone modifications	FASEB JOURNAL			English	Article						LincRNAs; Il12b; Mi-2/NuRD complex; histone modifications; intestinal epithelium	INFLAMMATORY-BOWEL-DISEASE; LONG NONCODING RNA; NF-KAPPA-B; REMODELING COMPLEXES; MECHANISMS; ACTIVATION; EXPRESSION; MATURATION; REPRESSION; MI-2-BETA	Long intergenic noncoding RNAs (lincRNAs) can regulate the transcription of inflammatory genes and thus may represent a new group of inflammatory mediators with a potential pathogenic role in inflammatory diseases. Here, our genome-wide transcriptomic data show that TNF-alpha stimulation caused up-regulation of 171 lincRNAs and down-regulation of 196 lincRNAs in murine intestinal epithelial cells in culture. One of the up-regulated lincRNAs, lincRNA-Cox2, is an early-responsive lincRNA induced by TNF-alpha through activation of the NF-kappa B signaling pathway. Knockdown of lincRNA-Cox2 resulted in reprogramming of the gene expression profile in intestinal epithelial cells in response to TNF-alpha stimulation. Specifically, lincRNA-Cox2 silencing significantly (P < 0.05) enhanced the transcription of Il12b, a secondary late-responsive gene induced by TNF-alpha. Mechanistically, lincRNA-Cox2 promoted the recruitment of the Mi-2/nucleosome remodeling and deacetylase (Mi-2/NuRD) repressor complex to the Il12b promoter region. Recruitment of the Mi-2/NuRD complex was associated with decreased H3K27 acetylation and increased H3K27 dimethylation at the Il12b promoter region, which might contribute to Il12b trans-suppression by lincRNA-Cox2. Thus, our data demonstrate a novel mechanism of epigenetic modulation by lincRNA-Cox2 on Il12b transcription, supporting an important role for lincRNAs in the regulation of intestinal epithelial inflammatory responses.	[Tong, Qiang; Gong, Ai-Yu; Zhang, Xin-Tian; Lin, Chengchi; Ma, Shibin; Chen, Jing; Hu, Guoku; Chen, Xian-Ming] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Tong, Qiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan 430074, Peoples R China; [Hu, Guoku] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Peoples R China	Creighton University; Huazhong University of Science & Technology; University of Electronic Science & Technology of China	Chen, XM (corresponding author), Creighton Univ, Sch Med, Med Microbiol & Immunol, Criss 2,Room 529,2500 Calif Plaza, Omaha, NE 68178 USA.	xianmingchen@creighton.edu	Hu, Guoku/AAG-7233-2019	Hu, Guoku/0000-0002-4792-0416	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grants [AI095532, AI116323]; Creighton Cancer and Smoking Development Award [LB595]; NIH National Center for Research Resources Grant [G20RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095532, R01AI116323] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grants; Creighton Cancer and Smoking Development Award; NIH National Center for Research Resources Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Barbara L. Bittner for assistance in writing the manuscript. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grants AI095532 and AI116323 and by Creighton Cancer and Smoking Development Award LB595 (to X.-M.C.). This project was also supported by NIH National Center for Research Resources Grant G20RR024001. The authors declare no conflicts of interest.	Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Berthier-Vergnes O, 2005, FEBS LETT, V579, P3660, DOI 10.1016/j.febslet.2005.04.087; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; BLUTHE RM, 1994, PSYCHONEUROENDOCRINO, V19, P197, DOI 10.1016/0306-4530(94)90009-4; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cheroutre H, 2013, ADV EXP MED BIOL, V785, P43, DOI 10.1007/978-1-4614-6217-0_5; Chu C, 2012, JOVE-J VIS EXP, DOI 10.3791/3912; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Das PM, 2004, BIOTECHNIQUES, V37, P961, DOI 10.2144/04376RV01; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Dharmani Poonam, 2008, Curr Mol Pharmacol, V1, P195; Geisel J, 2014, J IMMUNOL, V192, P3530, DOI 10.4049/jimmunol.1300556; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; He F, 2012, CYTOKINE, V59, P264, DOI 10.1016/j.cyto.2012.04.008; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Kast C, 2003, J BIOL CHEM, V278, P6787, DOI 10.1074/jbc.M210935200; Lantier L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003801; Mahida YR, 2004, BEST PRACT RES CL GA, V18, P241, DOI 10.1053/ybega.2004.438; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Morey L, 2008, MOL CELL BIOL, V28, P5912, DOI 10.1128/MCB.00467-08; Murakami T, 2000, J Atheroscler Thromb, V7, P39; Musikacharoen T, 2001, J IMMUNOL, V166, P4516, DOI 10.4049/jimmunol.166.7.4516; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Pedersen J, 2014, WORLD J GASTROENTERO, V20, P64, DOI 10.3748/wjg.v20.i1.64; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Zhang H, 2008, J BIOL CHEM, V283, P22637, DOI 10.1074/jbc.M802129200; Zhang ZL, 2007, INT IMMUNOPHARMACOL, V7, P409, DOI 10.1016/j.intimp.2006.09.024	35	65	70	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1187	1197		10.1096/fj.15-279166	http://dx.doi.org/10.1096/fj.15-279166			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26578685	Green Published			2022-12-26	WOS:000370387800016
J	Garcia-Melero, A; Reverter, M; Hoque, M; Meneses-Salas, E; Koese, M; Conway, JRW; Johnsen, CH; Alvarez-Guaita, A; Morales-Paytuvi, F; Elmaghrabi, YA; Pol, A; Tebar, F; Murray, RZ; Timpson, P; Enrich, C; Grewal, T; Rentero, C				Garcia-Melero, Ana; Reverter, Meritxell; Hoque, Monira; Meneses-Salas, Elsa; Koese, Meryem; Conway, James R. W.; Johnsen, Camilla H.; Alvarez-Guaita, Anna; Morales-Paytuvi, Frederic; Elmaghrabi, Yasmin A.; Pol, Albert; Tebar, Francesc; Murray, Rachael Z.; Timpson, Paul; Enrich, Carlos; Grewal, Thomas; Rentero, Carles			Annexin A6 and Late Endosomal Cholesterol Modulate Integrin Recycling and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; BREAST-CANCER CELLS; PLASMA-MEMBRANE; MUTANT P53; SYNTAXIN 6; ENDOCYTIC TRANSPORT; C DISEASE; FETUIN-A; TRAFFICKING; COMPLEX	Annexins are a family of proteins that bind to phospholipids in a calcium-dependent manner. Earlier studies implicated annexin A6 (AnxA6) to inhibit secretion and participate in the organization of the extracellular matrix. We recently showed that elevated AnxA6 levels significantly reduced secretion of the extracellular matrix protein fibronectin (FN). Because FN is directly linked to the ability of cells to migrate, this prompted us to investigate the role of AnxA6 in cell migration. Up-regulation of AnxA6 in several cell models was associated with reduced cell migration in wound healing, individual cell tracking and three-dimensional migration/invasion assays. The reduced ability of AnxA6-expressing cells to migrate was associated with decreased cell surface expression of alpha V beta 3 and alpha 5 beta 1 integrins, both FN receptors. Mechanistically, we found that elevated AnxA6 levels interfered with syntaxin-6 (Stx6)-dependent recycling of integrins to the cell surface. AnxA6 overexpression caused mislocalization and accumulation of Stx6 and integrins in recycling endosomes, whereas siRNA-mediated AnxA6 knockdown did not modify the trafficking of integrins. Given our recent findings that inhibition of cholesterol export from late endosomes (LEs) inhibits Stx6-dependent integrin recycling and that elevated AnxA6 levels cause LE cholesterol accumulation, we propose that AnxA6 and blockage of LE cholesterol transport are critical for endosomal function required for Stx6-mediated recycling of integrins in cell migration.	[Garcia-Melero, Ana; Reverter, Meritxell; Meneses-Salas, Elsa; Johnsen, Camilla H.; Alvarez-Guaita, Anna; Morales-Paytuvi, Frederic; Tebar, Francesc; Enrich, Carlos; Rentero, Carles] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, E-08036 Barcelona, Spain; [Hoque, Monira; Koese, Meryem; Elmaghrabi, Yasmin A.; Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Conway, James R. W.; Timpson, Paul] Univ New S Wales, Fac Med, St Vincents Clin Sch, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Conway, James R. W.; Timpson, Paul] Univ New S Wales, Fac Med, Kinghorn Canc Ctr, St Vincents Clin Sch,Canc Res Program, Sydney, NSW 2010, Australia; [Pol, Albert] ICREA, Barcelona 08010, Spain; [Pol, Albert; Tebar, Francesc; Enrich, Carlos; Rentero, Carles] IDIBAPS, Ctr Recerca Biomed CELLEX, Barcelona 08036, Spain; [Murray, Rachael Z.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Tissue Repair & Regenerat Program, Brisbane, Qld 4095, Australia	University of Barcelona; University of Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; ICREA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Queensland University of Technology (QUT)	Enrich, C (corresponding author), Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, E-08036 Barcelona, Spain.	enrich@ub.edu; thomas.grewal@sydney.edu.au; carles.rentero@ub.edu	Hoque, Monira/AAN-5715-2020; Timpson, Paul/A-9429-2016; Meneses-Salas, Elsa/AGE-7998-2022; Köse, Meryem/K-7399-2013; Rentero Alfonso, Carles/L-4430-2017; Murray, Rachael/J-1370-2012; Tebar, Francesc/H-1498-2015	Köse, Meryem/0000-0002-3391-3418; Rentero Alfonso, Carles/0000-0003-4684-0278; Murray, Rachael/0000-0002-4935-7794; Tebar, Francesc/0000-0002-9522-9726; Grewal, Thomas/0000-0002-7937-8887; Timpson, Paul/0000-0002-5514-7080; Enrich, Carlos/0000-0003-0382-2993; Meneses Salas, Elsa/0000-0001-7550-253X; Morales-Paytuvi, Frederic/0000-0001-6921-5454; Conway, James/0000-0003-3787-277X; Alvarez-Guaita, Anna/0000-0002-9248-2275	Ministerio de Economia y Competitividad (MINECO) [BFU2012-36272, CSD2009-00016]; Fundacio Marato TV3 (Spain) [PI042182]; University of Sydney, Australia [U1758, U7007]; CONSOLIDER-INGENIO (MINECO) [CSD2009-00016]; Fundacio Marato TV3; ICREA Funding Source: Custom	Ministerio de Economia y Competitividad (MINECO); Fundacio Marato TV3 (Spain); University of Sydney, Australia(University of Sydney); CONSOLIDER-INGENIO (MINECO); Fundacio Marato TV3; ICREA(ICREA)	This work was supported by the Ministerio de Economia y Competitividad (MINECO) Grants BFU2012-36272 and CSD2009-00016 and Fundacio Marato TV3 Grant PI042182 (Spain) (to C.E.) and by University of Sydney, Australia Grants U1758 and U7007 (to T.G.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by CONSOLIDER-INGENIO (MINECO) Research Program Postdoctoral Fellowship Grant CSD2009-00016 and Fundacio Marato TV3. To whom correspondence may be addressed: Dept. de Biologia Cellular, Immunologia i Neurociencies, Facultat de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain. Tel.: 34-934021908; Fax: 34-4021907; E-mail:carles.rentero@ub.edu.	Alvarez-Guaita A, 2015, BRIT J PHARMACOL, V172, P1677, DOI 10.1111/bph.13022; Antalis CJ, 2011, CLIN EXP METASTAS, V28, P733, DOI 10.1007/s10585-011-9405-9; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Danilo C, 2012, CURR OPIN PHARMACOL, V12, P677, DOI 10.1016/j.coph.2012.07.009; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Day P, 2011, INT J ONCOL, V39, P863, DOI 10.3892/ijo.2011.1101; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Domon M, 2012, CELL MOL LIFE SCI, V69, P1773, DOI 10.1007/s00018-011-0894-0; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Duran JM, 2012, EMBO J, V31, P4535, DOI 10.1038/emboj.2012.317; ENRICH C, 1987, EXP CELL RES, V173, P99, DOI 10.1016/0014-4827(87)90335-1; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Green JM, 1999, J CELL BIOL, V146, P673, DOI 10.1083/jcb.146.3.673; Grewal T, 2000, J BIOL CHEM, V275, P33806, DOI 10.1074/jbc.M002662200; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Hsu VW, 2010, CURR OPIN CELL BIOL, V22, P528, DOI 10.1016/j.ceb.2010.05.008; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; JACKLE S, 1994, J BIOL CHEM, V269, P1026; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kanerva K, 2013, DEV CELL, V27, P249, DOI 10.1016/j.devcel.2013.09.016; Koese M, 2013, ONCOGENE, V32, P2858, DOI 10.1038/onc.2012.303; Koumangoye RB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-167; Kundranda MN, 2004, BBA-MOL CELL RES, V1693, P111, DOI 10.1016/j.bbamcr.2004.06.005; Lee BY, 2015, PHARMACOL THERAPEUT, V146, P132, DOI 10.1016/j.pharmthera.2014.10.001; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; PUJADES C, 1992, J CELL SCI, V102, P815; Rainero E, 2013, BIOESSAYS, V35, P523, DOI 10.1002/bies.201200160; Ramprasad OG, 2007, CELL MOTIL CYTOSKEL, V64, P199, DOI 10.1002/cm.20176; Reverter M, 2014, CELL REP, V7, P883, DOI 10.1016/j.celrep.2014.03.043; Reverter M, 2011, MOL BIOL CELL, V22, P4108, DOI 10.1091/mbc.E11-04-0332; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Sakwe AM, 2011, EXP CELL RES, V317, P823, DOI 10.1016/j.yexcr.2010.12.008; Sakwe AM, 2010, J BIOL CHEM, V285, P41827, DOI 10.1074/jbc.M110.128926; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; STAMATOGLOU SC, 1992, J CELL BIOL, V116, P1507, DOI 10.1083/jcb.116.6.1507; Sun XW, 2012, NEOPLASIA, V14, P1122, DOI 10.1593/neo.121252; Takagi H, 2002, J CELL SCI, V115, P3309; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Timpson P, 2011, JOVE-J VIS EXP, DOI 10.3791/3089; Timpson P, 2011, CANCER RES, V71, P747, DOI 10.1158/0008-5472.CAN-10-2267; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Veale KJ, 2010, TRAFFIC, V11, P1370, DOI 10.1111/j.1600-0854.2010.01094.x; de Muga SV, 2009, ONCOGENE, V28, P363, DOI 10.1038/onc.2008.386	66	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1320	1335		10.1074/jbc.M115.683557	http://dx.doi.org/10.1074/jbc.M115.683557			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26578516	Green Published, hybrid			2022-12-26	WOS:000368068300026
J	Tavoulari, S; Margheritis, E; Nagarajan, A; DeWitt, DC; Zhang, YW; Rosado, E; Ravera, S; Rhoades, E; Forrest, LR; Rudnick, G				Tavoulari, Sotiria; Margheritis, Eleonora; Nagarajan, Anu; DeWitt, David C.; Zhang, Yuan-Wei; Rosado, Edwin; Ravera, Silvia; Rhoades, Elizabeth; Forrest, Lucy R.; Rudnick, Gary			Two Na+ Sites Control Conformational Change in a Neurotransmitter Transporter Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; BINDING-SITE; SEROTONIN TRANSPORTER; ALTERNATING-ACCESS; SODIUM SYMPORTERS; MOLECULAR-DYNAMICS; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; DOPAMINE TRANSPORTER; POTENTIAL FUNCTIONS	In LeuT, a prokaryotic homolog of neurotransmitter transporters, Na+ stabilizes outward-open conformational states. We examined how each of the two LeuT Na+ binding sites contributes to Na+ -dependent closure of the cytoplasmic pathway using biochemical and biophysical assays of conformation. Mutating either of two residues that contribute to the Na2 site completely prevented cytoplasmic closure in response to Na+, suggesting that Na2 is essential for this conformational change, whereas Na1 mutants retained Na+ responsiveness. However, mutation of Na1 residues also influenced the Na+ -dependent conformational change in ways that varied depending on the position mutated. Computational analyses suggest those mutants influence the ability of Na1 binding to hydrate the substrate pathway and perturb an interaction network leading to the extracellular gate. Overall, the results demonstrate that occupation of Na2 stabilizes outward-facing conformations presumably through a direct interaction between Na+ and transmembrane helices 1 and 8, whereas Na+ binding at Na1 influences conformational change through a network of intermediary interactions. The results also provide evidence that N-terminal release and helix motions represent distinct steps in cytoplasmic pathway opening.	[Tavoulari, Sotiria; Margheritis, Eleonora; Zhang, Yuan-Wei; Rosado, Edwin; Ravera, Silvia; Rudnick, Gary] Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA; [DeWitt, David C.; Rhoades, Elizabeth] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Nagarajan, Anu; Forrest, Lucy R.] NINDS, Computat Struct Biol Sect, NIH, Rockville, MD 20852 USA	Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Rudnick, G (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	gary.rudnick@yale.edu	Ravera, Silvia/AAA-7982-2019; Margheritis, Eleonora/W-4750-2019; Rosado-Olivieri, Edwin/ABA-2653-2020; Forrest, Lucy/E-8113-2016	Ravera, Silvia/0000-0002-0803-1042; ZHANG, YUAN-WEI/0000-0002-4276-9251; Margheritis, Eleonora Germana/0000-0003-0571-3563; Forrest, Lucy/0000-0003-1855-7985	Division of Intramural Research of the National Institutes of Health, NINDS; National Institute on Drug Abuse [DA007259, DA008213]; NINDS [NS079955]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003139, R01NS079955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008213, R01DA007259] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institutes of Health, NINDS; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the Division of Intramural Research of the National Institutes of Health, NINDS (to L.R.F.), National Institute on Drug Abuse Grants DA007259 and DA008213 (to G.R.), and NINDS Grant NS079955 (to E. Rhoads). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Downloaded from http://www.jbc.org/at ISI, Thomson Scientific on January 17, 2016	Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Ben-Yona A, 2009, J BIOL CHEM, V284, P9727, DOI 10.1074/jbc.M809423200; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BIXON M, 1967, TETRAHEDRON, V23, P769, DOI 10.1016/0040-4020(67)85023-3; Borre L, 2014, J BIOL CHEM, V289, P25764, DOI 10.1074/jbc.M114.574269; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; Chen XZ, 1999, J BIOL CHEM, V274, P35089, DOI 10.1074/jbc.274.49.35089; Cheng MH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003879; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ehrnstorfer IA, 2014, NAT STRUCT MOL BIOL, V21, P990, DOI 10.1038/nsmb.2904; Ermolova N, 2006, BIOCHEMISTRY-US, V45, P4182, DOI 10.1021/bi052631h; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Fenollar-Ferrer C, 2014, BIOCHEMISTRY-US, V53, P5444, DOI 10.1021/bi500637f; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Grouleff J, 2015, BIOPHYS J, V108, P1390, DOI 10.1016/j.bpj.2015.02.010; Henry LK, 2011, J BIOL CHEM, V286, P30823, DOI 10.1074/jbc.M111.250308; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung H, 2002, J BIOL CHEM, V277, P39251, DOI 10.1074/jbc.M206319200; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Kazmier K, 2014, P NATL ACAD SCI USA, V111, P14752, DOI 10.1073/pnas.1410431111; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LAUF PK, 1987, FASEB J, V46, P2377; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Pantano DA, 2009, J PHYS CHEM B, V113, P13715, DOI 10.1021/jp901840u; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Rudnick G, 2013, MOL MEMBR BIOL, V30, P355, DOI 10.3109/09687688.2013.842658; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Staritzbichler R, 2011, J CHEM THEORY COMPUT, V7, P1167, DOI 10.1021/ct100576m; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Stolzenberg S, 2015, J BIOL CHEM, V290, P13992, DOI 10.1074/jbc.M114.625343; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu HB, 2010, P NATL ACAD SCI USA, V107, P20329, DOI 10.1073/pnas.1007150107; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao CF, 2012, BIOPHYS J, V103, P878, DOI 10.1016/j.bpj.2012.07.044; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhao YF, 2010, NAT CHEM BIOL, V6, P109, DOI [10.1038/NCHEMBIO.284, 10.1038/nchembio.284]; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133; Zomot E, 2015, J BIOL CHEM, V290, P544, DOI 10.1074/jbc.M114.617555	79	44	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1456	1471		10.1074/jbc.M115.692012	http://dx.doi.org/10.1074/jbc.M115.692012			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26582198	Green Published, hybrid			2022-12-26	WOS:000368068300036
J	Chen, HH; Sun, AH; Ojcius, DM; Hu, WL; Ge, YM; Lin, XA; Li, LJ; Pan, JP; Yan, J				Chen, Hong-Hu; Sun, Ai-Hua; Ojcius, David M.; Hu, Wei-Lin; Ge, Yu-Mei; Lin, Xu'ai; Li, Lan-Juan; Pan, Jian-Ping; Yan, Jie			Eosinophils from Murine Lamina Propria Induce Differentiation of Naive T Cells into Regulatory T Cells via TGF-beta 1 and Retinoic Acid	PLOS ONE			English	Article							DENDRITIC CELLS; REG-CELLS; GENERATION; FOXP3; QUANTIFICATION; INTESTINE; RESPONSES; T(H)17; HEALTH	Treg cells play a crucial role in immune tolerance, but mechanisms that induce Treg cells are poorly understood. We here have described eosinophils in lamina propria (LP) that displayed high aldehyde dehydrogenase (ALDH) activity, a rate-limiting step during all-trans retinoic acid (ATRA) synthesis, and expressed TGF-beta 1 mRNA and high levels of ATRA. Co-incubation assay confirmed that LP eosinophils induced the differentiation of naive T cells into Treg cells. Differentiation promoted by LP eosinophils were inhibited by blocked either TGF-beta 1 or ATRA. Peripheral blood (PB) eosinophils did not produce ATRA and could not induce Treg differentiation. These data identifies LP eosinophils as effective inducers of Treg cell differentiation through a mechanism dependent on TGF-beta 1 and ATRA.	[Chen, Hong-Hu; Hu, Wei-Lin; Lin, Xu'ai; Li, Lan-Juan; Yan, Jie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Hong-Hu; Hu, Wei-Lin; Ge, Yu-Mei; Lin, Xu'ai; Li, Lan-Juan; Yan, Jie] Zhejiang Univ, Sch Med, State Key Lab Diag & Treatment Infect Dis, Div Basic Med Microbiol,Affiliated Hosp 1, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Hong-Hu; Hu, Wei-Lin; Ge, Yu-Mei; Lin, Xu'ai; Yan, Jie] Zhejiang Univ, Dept Med Microbiol & Parasitol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Hong-Hu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China; [Sun, Ai-Hua] Zhejiang Med Coll, Fac Basic Med, Hangzhou 310053, Zhejiang, Peoples R China; [Ojcius, David M.] Univ Calif, Hlth Sci Res Inst & Mol Cell Biol, Merced, CA 95343 USA; [Pan, Jian-Ping] Zhejiang Univ City Coll, Sch Med, Dept Clin Med, Hangzhou 310015, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention; University of California System; University of California Merced; Zhejiang University City College	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; jppan@zucc.edu.cn; med_bp@zju.edu.cn	Ojcius, David/ABE-6557-2020		National Natural Science Foundation of China [30872325, 81261160321, 81171534]; National Key Lab for Diagnosis and Treatment of Infectious Diseases of China [2013-032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Lab for Diagnosis and Treatment of Infectious Diseases of China	This work was supported by grants (30872325, 81261160321 and 81171534) from the National Natural Science Foundation of China and a grant (2013-032) from the National Key Lab for Diagnosis and Treatment of Infectious Diseases of China.	Ali R, 2012, ANAL CHIM ACTA, V725, P57, DOI 10.1016/j.aca.2012.03.003; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Maloy KJ, 2005, NAT IMMUNOL, V6, P1071, DOI 10.1038/ni1105-1071; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Oluwole SF, 2004, CELL BIOCHEM BIOPHYS, P27; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rook GA, 2013, P NATL ACAD SCI USA, V110, P18360, DOI 10.1073/pnas.1313731110; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255	29	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142881	10.1371/journal.pone.0142881	http://dx.doi.org/10.1371/journal.pone.0142881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587591	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500019
J	Knauf, S; Barnett, U; Maciej, P; Klapproth, M; Ndao, I; Frischmann, S; Fischer, J; Zinner, D; Liu, H				Knauf, Sascha; Barnett, Ulrike; Maciej, Peter; Klapproth, Matthias; Ndao, Ibrahima; Frischmann, Sieghard; Fischer, Julia; Zinner, Dietmar; Liu, Hsi			High Prevalence of Antibodies against the Bacterium Treponema pallidum in Senegalese Guinea Baboons (Papio papio)	PLOS ONE			English	Article							YAWS; INFECTION; SYPHILIS; PHYLOGEOGRAPHY	The bacterium Treponema pallidum is known to cause syphilis (ssp. pallidum), yaws (ssp. pertenue), and endemic syphilis (ssp. endemicum) in humans. Nonhuman primates have also been reported to be infected with the bacterium with equally versatile clinical manifestations, from severe skin ulcerations to asymptomatic. At present all simian strains are closely related to human yaws-causing strains, an important consideration for yaws eradication. We tested clinically healthy Guinea baboons (Papio papio) at Parc National Niokolo Koba in south eastern Senegal for the presence of anti-T. pallidum antibodies. Since T. pallidum infection in this species was identified 50 years ago, and there has been no attempt to treat non-human primates for infection, it was hypothesized that a large number of West African baboons are still infected with simian strains of the yaws-bacterium. All animals were without clinical signs of treponematoses, but 18 of 20 (90%) baboons tested positive for antibodies against T. pallidum based on treponemal tests. Yet, Guinea baboons seem to develop no clinical symptoms, though it must be assumed that infection is chronic or comparable to the latent stage in human yaws infection. The non-active character is supported by the low anti-T. pallidum serum titers in Guinea baboons (median = 1: 2,560) versus serum titers that are found in genital-ulcerated olive baboons with active infection in Tanzania (range of medians among the groups of initial, moderate, and severe infected animals = 1: 15,360 to 1: 2.097e+7). Our findings provide evidence for simian infection with T. pallidum in wild Senegalese baboons. Potentially, Guinea baboons in West Africa serve as a natural reservoir for human infection, as the West African simian strain has been shown to cause sustainable yaws infection when inoculated into humans. The present study pinpoints an area where further research is needed to support the currently on-going second WHO led yaws eradication campaign with its goal to eradicate yaws by 2020.	[Knauf, Sascha] German Primate Ctr, Leibniz Inst Primate Res, Pathol Unit, Work Grp Neglected Trop Dis, Gottingen, Germany; [Barnett, Ulrike; Maciej, Peter; Klapproth, Matthias; Fischer, Julia; Zinner, Dietmar] German Primate Ctr, Leibniz Inst Primate Res, Cognit Ethol Lab, Gottingen, Germany; [Ndao, Ibrahima] Direct Parc Natl Niokolo Koba, Tambacounda, Senegal; [Frischmann, Sieghard] Mast Diagnost GmbH, Reinfeld, Germany; [Liu, Hsi] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Centers for Disease Control & Prevention - USA	Knauf, S (corresponding author), German Primate Ctr, Leibniz Inst Primate Res, Pathol Unit, Work Grp Neglected Trop Dis, Gottingen, Germany.	sknauf@dpz.eu	Knauf, Sascha/F-1661-2017; Fischer, Julia/B-6674-2008	Knauf, Sascha/0000-0001-5744-4946; Fischer, Julia/0000-0002-5807-0074	Mast Diagnostica GmbH	Mast Diagnostica GmbH	Funding: The funder (Mast Diagnostica GmbH) provided support in the form of salaries for authors [SF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P189; Baylet R, 1971, Bull Soc Pathol Exot Filiales, V64, P842; Baylet R, 1971, Bull Soc Pathol Exot Filiales, V64, P836; Carlson JA, 2011, AM J DERMATOPATH, V33, P433, DOI 10.1097/DAD.0b013e3181e8b587; Delobel J, 2010, INT J MOL SCI, V11, P4601, DOI 10.3390/ijms11114601; FRIBOURG-BLANC A, 1966, Bulletin de la Societe de Pathologie Exotique, V59, P54; Fribourg-Blanc A, 1969, Primates Med, V3, P113; GALATLUONG A, 2006, DEV PRIMATOL, P105; Harper K, 2013, DEV PRIMATOLOGY PROG, V38, P189; Harper KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050882; HAUSFATER G, 1976, BEHAVIOUR, V56, P44, DOI 10.1163/156853976X00299; Knauf S, 2012, VET PATHOL, V49, P292, DOI 10.1177/0300985811402839; Knauf S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003637; Knauf S, 2013, EMERG INFECT DIS, V19, P2058, DOI 10.3201/eid1912.130863; MAGNUSON HJ, 1956, MEDICINE, V35, P33, DOI 10.1097/00005792-195602000-00002; Marks M, 2015, LANCET INFECT DIS, V15, P1220, DOI 10.1016/S1473-3099(15)00136-X; Marks M, 2015, BRIT MED BULL, V113, P91, DOI 10.1093/bmb/ldu037; Maurice J, 2012, LANCET, V379, P1377, DOI 10.1016/S0140-6736(12)60581-9; Mitja O, 2013, LANCET, V381, P763, DOI 10.1016/S0140-6736(12)62130-8; Patzelt A, 2014, P NATL ACAD SCI USA, V111, P14740, DOI 10.1073/pnas.1405811111; Peeling RW, 2004, B WORLD HEALTH ORGAN, V82, P439; Peterman TA, 2015, EXPERT REV ANTI-INFE, V13, P161, DOI 10.1586/14787210.2015.990384; Salazar JC, 2002, MICROBES INFECT, V4, P1133, DOI 10.1016/S1286-4579(02)01638-6; SMITH JL, 1971, BRIT J VENER DIS, V47, P226; Teunis PFM, 2012, STAT MED, V31, P2240, DOI 10.1002/sim.5322; Zinner D, 2013, AM J PHYS ANTHROPOL, V150, P133, DOI 10.1002/ajpa.22185; Zinner D, 2011, DEV PRIMATOL-PROG PR, P267, DOI 10.1007/978-1-4419-7403-7_7; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83; Zobanikova M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002172	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143100	10.1371/journal.pone.0143100	http://dx.doi.org/10.1371/journal.pone.0143100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588087	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500030
J	Zhou, D; Liu, XM; Sun, Y; Ma, L; Shen, B; Zhu, CL				Zhou, Dan; Liu, Xianmiao; Sun, Yan; Ma, Lei; Shen, Bo; Zhu, Changliang			Genomic Analysis of Detoxification Supergene Families in the Mosquito Anopheles sinensis	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; CYTOCHROME-P450 GENE SUPERFAMILY; RED FLOUR BEETLE; INSECTICIDE-RESISTANCE; DROSOPHILA-MELANOGASTER; MALARIA VECTOR; CULEX-QUINQUEFASCIATUS; DIPTERA-CULICIDAE; AEDES-AEGYPTI; MOLECULAR CHARACTERIZATION	Anopheles sinensis is an important malaria vector in China and other Southeast Asian countries, and the emergence of insecticide resistance in this mosquito poses a serious threat to the efficacy of malaria control programs. The recently published An. sinensis genome and transcriptome provide an opportunity to understand the molecular mechanisms of insecticide resistance. Analysis of the An. sinensis genome revealed 174 detoxification genes, including 93 cytochrome P450s (P450s), 31 glutathione-S-transferases (GSTs), and 50 choline/carboxylesterases (CCEs). The gene number was similar to that in An. gambiae, but represented a decrease of 29% and 42% compared with Aedes aegypti and Culex quinquefasciatus, respectively. The considerable contraction in gene number in Anopheles mosquitoes mainly occurred in two detoxification supergene families, P450s and CCEs. The available An. sinensis transcriptome was also re-analyzed to further identify key resistance-associated detoxification genes. Among 174 detoxification genes, 124 (71%) were detected. Several candidate genes overexpressed in a deltamethrin-resistant strain (DR-strain) were identified as belonging to the CYP4 or CYP6 family of P450s and the Delta GST class. These generated data provide a basis for identifying the resistance-associated genes of An. sinensis at the molecular level.	[Zhou, Dan; Liu, Xianmiao; Sun, Yan; Ma, Lei; Shen, Bo; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Shen, B (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing 210029, Jiangsu, Peoples R China.	shenbo@njmu.edu.cn; clzhu@njmu.edu.cn			National Institutes of Health of US (NIH) [2R01AI075746]; National Natural Science Foundation of China [81171610, 81301458]; National S & T Major Program [2012ZX10004-219, 2012ZX10004-220]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	National Institutes of Health of US (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S & T Major Program; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health of US (NIH) (Grant No. 2R01AI075746), the National Natural Science Foundation of China (Grant No. 81171610 and 81301458), the National S & T Major Program (Grant No. 2012ZX10004-219 and 2012ZX10004-220) and Priority Academic Program Development of Jiangsu Higher Education Institutions.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Avicor SW, 2014, PROTEIN J, V33, P457, DOI 10.1007/s10930-014-9580-z; Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Blackburn AC, 1998, CYTOGENET CELL GENET, V83, P109, DOI 10.1159/000015145; Brock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060324; Cha DJ, 2015, EVOL DEV, V17, P109, DOI 10.1111/ede.12111; Chanda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024336; Chang Kyu-Sik, 2013, Osong Public Health Res Perspect, V4, P76, DOI 10.1016/j.phrp.2013.02.001; Chen WP, 2014, GENOME BIOL EVOL, V6, P1620, DOI 10.1093/gbe/evu132; Choochote W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-36; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Djegbe I, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-409; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; Edi CV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004236; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Feng LF, 2014, AQUAT TOXICOL, V149, P126, DOI 10.1016/j.aquatox.2014.02.004; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Field LM, 2002, PEST MANAG SCI, V58, P889, DOI 10.1002/ps.552; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; Hassan MM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-46; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang HZ, 2012, ANAL BIOCHEM, V431, P77, DOI 10.1016/j.ab.2012.09.011; Huchard E, 2006, P R SOC B, V273, P2595, DOI 10.1098/rspb.2006.3621; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Kang S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-151; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125362; Kiang KM, 2013, ARCH DIS CHILDHOOD-E, V98, P7, DOI 10.1136/archdischild-2011-301530; Kim JI, 2006, INSECT MOL BIOL, V15, P513, DOI 10.1111/j.1365-2583.2006.00666.x; Kozaki T, 2008, ARCH INSECT BIOCHEM, V67, P130, DOI 10.1002/arch.20229; Kwiatkowska RM, 2013, GENE, V519, P98, DOI 10.1016/j.gene.2013.01.036; Lee DW, 2006, BBA-GEN SUBJECTS, V1760, P125, DOI 10.1016/j.bbagen.2005.10.009; Li F, 2002, GENOME, V45, P1134, DOI 10.1139/G02-085; Li F, 2004, INSECT BIOCHEM MOLEC, V34, P397, DOI 10.1016/j.ibmb.2004.02.001; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Ma YJ, 2008, MOL ECOL RESOUR, V8, P1059, DOI 10.1111/j.1755-0998.2008.02154.x; MEIKLE DB, 1990, J INSECT PHYSIOL, V36, P93, DOI 10.1016/0022-1910(90)90179-J; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; MOUCHES C, 1986, SCIENCE, V233, P778, DOI 10.1126/science.3755546; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; OLSON PF, 1990, EMBO J, V9, P1219, DOI 10.1002/j.1460-2075.1990.tb08229.x; Omura T, 2010, J BIOCHEM, V147, P297, DOI 10.1093/jb/mvq001; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; PASTEUR N, 1981, BIOCHEM GENET, V19, P909, DOI 10.1007/BF00504256; Patarroyo MA, 2012, EXPERT REV VACCINES, V11, P1249, DOI [10.1586/ERV.12.91, 10.1586/erv.12.91]; PEMBLE SE, 1992, BIOCHEM J, V287, P957, DOI 10.1042/bj2870957; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Qin Q, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-92; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Raymond M, 1998, PHILOS T R SOC B, V353, P1707, DOI 10.1098/rstb.1998.0322; Reddy BPN, 2012, BIOINFORMATION, V8, P430, DOI 10.6026/97320630008430; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Rueda LM, 2011, TROP BIOMED, V28, P181; SAAD M, 1994, GENETICA, V94, P43, DOI 10.1007/BF01429219; Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Seong KM, 2012, INSECT MOL BIOL, V21, P149, DOI 10.1111/j.1365-2583.2011.01118.x; Shi HX, 2012, GENOMICS, V100, P327, DOI 10.1016/j.ygeno.2012.07.010; Shi LN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003928; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; TANG AH, 1994, J BIOL CHEM, V269, P27876; Temeyer KB, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0577-4; Tene BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061408; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Vaughan A, 1997, BIOCHEM J, V325, P359, DOI 10.1042/bj3250359; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang DQ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-164; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wongtrakul J, 2010, J MED ENTOMOL, V47, P162, DOI 10.1603/ME09132; Xing GL, 2014, J BIOL CHEM, V289, P31867, DOI 10.1074/jbc.M114.574897; Xu TL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-54; Yan LZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-609; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Zhang YX, 2014, INSECT BIOCHEM MOLEC, V46, P25, DOI 10.1016/j.ibmb.2014.01.004; Zhao PC, 2013, INSECT BIOCHEM MOLEC, V43, P260, DOI 10.1016/j.ibmb.2012.12.005; Zhou D, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-42, 10.1186/1471-2164-15-573]; Zhou SS, 2007, ZHONGGUO JI SHENG CH, V25, P439; Zhou WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056604; Zhu F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-174; Zhu G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0582-7	93	23	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143387	10.1371/journal.pone.0143387	http://dx.doi.org/10.1371/journal.pone.0143387			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588704	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500057
J	Chen, Z; Luo, J; Ma, LA; Wang, H; Cao, WT; Xu, HF; Zhu, JJ; Sun, YT; Li, J; Yao, DW; Kang, K; Gou, DM				Chen, Zhi; Luo, Jun; Ma, LiuAn; Wang, Hui; Cao, WenTing; Xu, HuiFei; Zhu, JiangJiang; Sun, YuTing; Li, Jun; Yao, DaWei; Kang, Kang; Gou, Deming			MiR130b-Regulation of PPAR gamma Coactivator-1 alpha Suppresses Fat Metabolism in Goat Mammary Epithelial Cells	PLOS ONE			English	Article							PGC-1-ALPHA GENE-EXPRESSION; REAL-TIME PCR; MICRORNA EXPRESSION; ADIPOSE-TISSUE; TRIGLYCERIDE ACCUMULATION; VIRUS-REPLICATION; LIPID-METABOLISM; GLAND; IDENTIFICATION; MILK	Fat metabolism is a complicated process regulated by a series of factors. microRNAs (miRNAs) are a class of negative regulator of proteins and play crucial roles in many biological processes; including fat metabolism. Although there have been some researches indicating that miRNAs could influence the milk fat metabolism through targeting some factors, little is known about the effect of miRNAs on goat milk fat metabolism. Here we utilized an improved miRNA detection assay, S-Poly-(T), to profile the expression of miRNAs in the goat mammary gland in different periods, and found that miR-130b was abundantly and differentially expressed in goat mammary gland. Additionally, overexpressing miR-130b impaired adipogenesis while inhibiting miR-130b enhanced adipogenesis in goat mammary epithelial cells. Utilizing 3'-UTR assay and Western Blot analusis, the protein peroxisome proliferator-activated receptor coactivator-1 alpha (PGC1 alpha), a major regulator of fat metabolism, was demonstrated to be a potential target of miR-130b. Interestingly, miR-130b potently repressed PGC1 alpha expression by targeting both the PGC1 alpha mRNA coding and 3' untranslated regions. These findings have some insight of miR-130b in mediating adipocyte differentiation by repressing PGC1 alpha expression and this contributes to further understanding about the functional significance of miRNAs in milk fat synthesis.	[Chen, Zhi; Luo, Jun; Wang, Hui; Cao, WenTing; Xu, HuiFei; Zhu, JiangJiang; Sun, YuTing; Li, Jun; Yao, DaWei] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Ma, LiuAn; Gou, Deming] Shenzhen Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Kang, Kang] Shenzhen Univ, Coll Med, Shenzhen, Guangdong, Peoples R China	Northwest A&F University - China; Shenzhen University; Shenzhen University	Luo, J (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	luojun@nwsuaf.edu.cn; dmgou@hotmail.com			National Natural Science Foundation of China [31372281]; Special Fund for Agro-scientific Research in the Public Interest [201103038]; Transgenic New Species Breeding Program of China [2014ZX08009-051B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Transgenic New Species Breeding Program of China	This research was jointly supported by the National Natural Science Foundation of China (No. 31372281), the Special Fund for Agro-scientific Research in the Public Interest (201103038), and the Transgenic New Species Breeding Program of China (2014ZX08009-051B).	Ananthanarayanan M, 2015, J BIOL CHEM, V290, P184, DOI 10.1074/jbc.M114.587030; Avery-Kiejda KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-51; Avril-Sassen S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-548; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Bionaz M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-366; Bonda DJ, 2011, LANCET NEUROL, V10, P275, DOI 10.1016/S1474-4422(11)70013-8; Bonnet M, 2013, ANIMAL, V7, P1344, DOI 10.1017/S1751731113000475; Bu DP, 2015, J DAIRY SCI, V98, P1696, DOI 10.3168/jds.2014-8217; Calvano CMC, 2014, TUMOR BIOL, V35, P7733, DOI 10.1007/s13277-014-2025-7; Chilliard Y, 2003, J DAIRY SCI, V86, P1751, DOI 10.3168/jds.S0022-0302(03)73761-8; Corona JC, 2015, NEUROCHEM RES, V40, P308, DOI 10.1007/s11064-014-1377-0; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gasparini P, 2014, ONCOTARGET, V5, P1174, DOI 10.18632/oncotarget.1682; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Hamada S, 2014, CELL SIGNAL, V26, P179, DOI 10.1016/j.cellsig.2013.11.003; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HANSEN HO, 1984, BIOCHEM J, V220, P513, DOI 10.1042/bj2200513; Hinrichs J, 2004, EUR J NUTR, V43, P12, DOI 10.1007/s00394-004-1104-8; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Hu J, 2014, EUR J CANCER, V50, P2336, DOI 10.1016/j.ejca.2014.06.005; Huang JY, 2015, RNA, V21, P385, DOI 10.1261/rna.048744.114; Humphries B, 2014, CARCINOGENESIS, V35, P2254, DOI 10.1093/carcin/bgu133; Jens M, 2015, NAT REV GENET, V16, P113, DOI 10.1038/nrg3853; Ji ZB, 2012, MOL BIOL REP, V39, P9361, DOI 10.1007/s11033-012-1779-5; Kadegowda AKG, 2009, J DAIRY SCI, V92, P4276, DOI 10.3168/jds.2008-1932; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Kong W, 2014, ONCOGENE, V33, P679, DOI 10.1038/onc.2012.636; Lee EK, 2011, MOL CELL BIOL, V31, P626, DOI 10.1128/MCB.00894-10; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lin XZ, 2013, GENE, V521, P15, DOI 10.1016/j.gene.2013.03.050; Lin XZ, 2013, GENE EXPRESSION, V16, P1, DOI 10.3727/105221613X13776146743262; Lin XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079258; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Luna P, 2008, J DAIRY SCI, V91, P20, DOI 10.3168/jds.2007-0447; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Pan SF, 2014, J CELL PHYSIOL, V229, P631, DOI 10.1002/jcp.24486; Peng J, 2015, INT J MOL SCI, V16, P1448, DOI 10.3390/ijms16011448; Peterson DG, 2004, J NUTR, V134, P2523, DOI 10.1093/jn/134.10.2523; Psilander N, 2013, EUR J APPL PHYSIOL, V113, P951, DOI 10.1007/s00421-012-2504-8; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Sharma SB, 2014, MOL CELL BIOL, V34, P4143, DOI 10.1128/MCB.00480-14; Shi HB, 2013, PPAR RES, V2013, DOI 10.1155/2013/310948; Shimoda H, 2009, J AGR FOOD CHEM, V57, P1786, DOI 10.1021/jf803441c; Shirasaki T, 2013, J VIROL, V87, P5270, DOI 10.1128/JVI.03022-12; Si L, 2014, MOL CARCINOG; Wang J, 2014, MOL ONCOL, V8, P1690, DOI 10.1016/j.molonc.2014.07.006; Wang YC, 2013, DIABETOLOGIA, V56, P2275, DOI 10.1007/s00125-013-2996-8; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhu JJ, 2015, INT J MOL SCI, V16, P1806, DOI 10.3390/ijms16011806; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	56	21	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142809	10.1371/journal.pone.0142809	http://dx.doi.org/10.1371/journal.pone.0142809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579707	Green Submitted, gold, Green Published			2022-12-26	WOS:000365154600061
J	Hadi, LA; Di Vito, C; Marfia, G; Ferraretto, A; Tringali, C; Viani, P; Riboni, L				Hadi, Loubna Abdel; Di Vito, Clara; Marfia, Giovanni; Ferraretto, Anita; Tringali, Cristina; Viani, Paola; Riboni, Laura			Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells	PLOS ONE			English	Article							CHRONIC INTESTINAL INFLAMMATION; SPHINGOLIPID METABOLISM; BREFELDIN-A; SPHINGOSINE-1-PHOSPHATE; PREVENTION; GROWTH; OVEREXPRESSION; ACCUMULATION; TRAFFICKING; ACTIVATION	The plant flavonoid luteolin exhibits different biological effects, including anticancer properties. Little is known on the molecular mechanisms underlying its actions in colorectal cancer (CRC). Here we investigated the effects of luteolin on colon cancer cells, focusing on the balance between ceramide and sphingosine-1-phosphate (S1P), two sphingoid mediators with opposite roles on cell fate. Using cultured cells, we found that physiological concentrations of luteolin induce the elevation of ceramide, followed by apoptotic death of colon cancer cells, but not of differentiated enterocytes. Pulse studies revealed that luteolin inhibits ceramide anabolism to complex sphingolipids. Further experiments led us to demonstrate that luteolin induces an alteration of the endoplasmic reticulum (ER)-Golgi flow of ceramide, pivotal to its metabolic processing to complex sphingolipids. We report that luteolin exerts its action by inhibiting both Akt activation, and sphingosine kinase (SphK) 2, with the consequent reduction of S1P, an Akt stimulator. S1P administration protected colon cancer cells from luteolin-induced apoptosis, most likely by an intracellular, receptor-independent mechanism. Overall this study reveals for the first time that the dietary flavonoid luteolin exerts toxic effects on colon cancer cells by inhibiting both S1P biosynthesis and ceramide traffic, suggesting its dietary introduction/supplementation as a potential strategy to improve existing treatments in CRC.	[Hadi, Loubna Abdel; Di Vito, Clara; Tringali, Cristina; Viani, Paola; Riboni, Laura] Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy; [Marfia, Giovanni] Univ Milan, Lab Expt Neurosurg & Cell Therapy, Fdn IRCCS Ca Granda, Osped Maggiore Policlin Milan,Neurosurg Unit, Milan, Italy; [Ferraretto, Anita] Univ Milan, LITA Segrate, Dept Biomed Sci Hlth, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan	Riboni, L (corresponding author), Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy.	laura.riboni@unimi.it	Tringali, Cristina Alessandra/Q-7259-2017; Di Vito, Clara/ABC-3385-2020; Marfia, Giovanni/AAB-8702-2020; VIANI, PAOLA/Q-5955-2017; Riboni, Laura/R-4281-2017; Marfia, Giovanni/N-4650-2014; Ferraretto, Anita/L-3543-2016	Tringali, Cristina Alessandra/0000-0002-0632-6197; Di Vito, Clara/0000-0001-7248-1710; Marfia, Giovanni/0000-0002-5849-7000; VIANI, PAOLA/0000-0002-5728-6631; Riboni, Laura/0000-0002-4149-8226; Marfia, Giovanni/0000-0002-5849-7000; Ferraretto, Anita/0000-0002-3637-5002; Abdel Hadi, loubna/0000-0002-5271-0798				Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Ferraretto A, 2007, ANTICANCER RES, V27, P3919; Galadari S, 2015, APOPTOSIS, V20, P689, DOI 10.1007/s10495-015-1109-1; Garcia-Barros M, 2014, BBA-MOL CELL BIOL L, V1841, P773, DOI 10.1016/j.bbalip.2013.09.007; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Giussani P, 2009, J BIOL CHEM, V284, P5088, DOI 10.1074/jbc.M808934200; Gjoni E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110875; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Gustin DJ, 2013, BIOORG MED CHEM LETT, V23, P4608, DOI 10.1016/j.bmcl.2013.06.030; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heringdorf DMZ, 2003, FEBS LETT, V554, P443, DOI 10.1016/S0014-5793(03)01219-5; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Le Scolan E, 2005, BLOOD, V106, P1808, DOI 10.1182/blood-2004-12-4832; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Muller R, 2010, TUMOR BIOL, V31, P341, DOI 10.1007/s13277-010-0043-7; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nagahashi Masayuki, 2014, Advances in Biological Regulation, V54, P112, DOI 10.1016/j.jbior.2013.10.001; Nemoto S, 2009, J BIOL CHEM, V284, P10422, DOI 10.1074/jbc.M900735200; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; Oskouian B, 2007, CELL CYCLE, V6, P522, DOI 10.4161/cc.6.5.3903; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; Patwardhan NN, 2015, J MED CHEM, V58, P1879, DOI 10.1021/jm501760d; Pericleous M, 2013, J GASTROINTEST ONCOL, V4, P409, DOI 10.3978/j.issn.2078-6891.2013.003; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Pyne S, 2011, TRENDS MOL MED, V17, P463, DOI 10.1016/j.molmed.2011.03.002; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; Ravishankar D, 2013, INT J BIOCHEM CELL B, V45, P2821, DOI 10.1016/j.biocel.2013.10.004; Riboni L, 2000, METHOD ENZYMOL, V311, P656; Riboni L, 2010, ADV EXP MED BIOL, V688, P24; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247; Scalbert Augustin, 2000, Journal of Nutrition, V130, p2073S; Selzner M, 2001, CANCER RES, V61, P1233; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tan SSL, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.21; Lopez PJT, 2014, CLIN MED INSIGHTS-GA, V7, P33, DOI 10.4137/CGast.S14039; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; Vogt D, 2014, BIOORGAN MED CHEM, V22, P5354, DOI 10.1016/j.bmc.2014.07.044; Xiao M, 2014, BIOMED ENVIRON SCI, V27, P197, DOI 10.3967/bes2014.040; Yester JW, 2011, CANCER METAST REV, V30, P577, DOI 10.1007/s10555-011-9305-0	58	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143384	10.1371/journal.pone.0143384	http://dx.doi.org/10.1371/journal.pone.0143384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580959	Green Published, gold			2022-12-26	WOS:000365154600119
J	Nishigori, N; Matsumoto, M; Koyama, F; Hayakawa, M; Hatakeyayama, K; Ko, S; Fujimura, Y; Nakajima, Y				Nishigori, Naoto; Matsumoto, Masanori; Koyama, Fumikazu; Hayakawa, Masaki; Hatakeyayama, Kinta; Ko, Saiho; Fujimura, Yoshihiro; Nakajima, Yoshiyuki			von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; HEPATIC VENOOCCLUSIVE DISEASE; METASTATIC COLORECTAL-CANCER; FACTOR MULTIMERS; PATHOLOGICAL RESPONSE; VONWILLEBRAND-FACTOR; PLASMA-LEVELS; BEVACIZUMAB; FLUOROURACIL; LEUCOVORIN	Oxaliplatin-based chemotherapy is widely used to treat advanced colorectal cancer (CRC). Sinusoidal obstruction syndrome (SOS) due to oxaliplatin is a serious type of chemotherapy- associated liver injury (CALI) in CRC patients. SOS is thought to be caused by the sinusoidal endothelial cell damage, which results in the release of unusually-large von Willebrand factor multimers (UL-VWFMs) from endothelial cells. To investigate the pathophysiology of CALI after oxaliplatin-based chemotherapy, we analyzed plasma concentration of von Willebrand factor (VWF) and the distribution of VWFMs in CRC patients. Twenty-three patients with advanced CRC who received oxaliplatin-based chemotherapy with (n = 6) and without (n = 17) bevacizumab were analyzed. CALI (n = 6) and splenomegaly (n = 9) were found only in patients who did not treated with bevacizumab. Plasma VWF antigen (VWF: Ag) and serum aspartate aminotransferase (AST) levels increased after chemotherapy only in patients without bevacizumab. VWFM analysis in patients who did not receive bevacizumab showed the presence of UL-VWFMs and absence of high molecular weight VWFMs during chemotherapy, especially in those with CALI. In addition, plasma VWF: Ag and AST levels increased after chemotherapy in patients with splenomegaly (n = 9), but not in patients without splenomegaly (n = 14). Histological findings in the liver tissue of patients who did not receive bevacizumab included sinusoidal dilatation and microthrombi in the sinusoids. Many microthrombi were positive for both anti-IIb/IIIa and anti-VWF antibodies. Plasma UL-VWFM levels might be increased by damage to endothelial cells as a result of oxaliplatin-based chemotherapy. Bevacizumab could prevent CALI and splenomegaly through inhibition of VWF-rich platelet thrombus formation.	[Nishigori, Naoto; Koyama, Fumikazu; Ko, Saiho; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 634, Japan; [Matsumoto, Masanori; Hayakawa, Masaki; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan; [Hatakeyayama, Kinta] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 634, Japan	Nara Medical University; Nara Medical University; Nara Medical University	Matsumoto, M (corresponding author), Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan.	mmatsumo@naramed-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan [H26-063]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22591069]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [25461456] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from the Ministry of Health, Labor, and Welfare of Japan (H26-063) to MM and YF, from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22591069) to MM, and from the Takeda Science Foundation to MM, YF, and NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AT, 2015, BLOOD, V125, P3153, DOI 10.1182/blood-2014-08-595686; BUDDE U, 1990, THROMB HAEMOSTASIS, V63, P312; Budde U, 2002, SEMIN THROMB HEMOST, V28, P173, DOI 10.1055/s-2002-27820; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Furlan M, 1996, ANN HEMATOL, V72, P341, DOI 10.1007/s002770050184; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iguchi A, 2001, BONE MARROW TRANSPL, V27, P1173, DOI 10.1038/sj.bmt.1703061; Jung EJ, 2012, ANTICANCER RES, V32, P3357; Kato S, 2006, TRANSFUSION, V46, P1444, DOI 10.1111/j.1537-2995.2006.00914.x; Kishi Y, 2010, ANN SURG ONCOL, V17, P2870, DOI 10.1245/s10434-010-1166-1; Klinger M, 2009, EJSO-EUR J SURG ONC, V35, P515, DOI 10.1016/j.ejso.2008.12.013; Lenting PJ, 2015, BLOOD, V125, P2019, DOI 10.1182/blood-2014-06-528406; MANNUCCI PM, 1977, LANCET, V1, P869; Matsumoto M, 2007, BONE MARROW TRANSPL, V40, P251, DOI 10.1038/sj.bmt.1705724; Matsumoto M, 2005, PATHOPHYSIOL HAEMO T, V34, P35, DOI 10.1159/000088546; Matsushita K, 2005, BLOOD, V105, P207, DOI 10.1182/blood-2004-04-1519; MCDONALD GB, 1984, HEPATOLOGY, V4, P116, DOI 10.1002/hep.1840040121; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Overman MJ, 2010, J CLIN ONCOL, V28, P2549, DOI 10.1200/JCO.2009.27.5701; Park YD, 2002, BONE MARROW TRANSPL, V29, P789, DOI 10.1038/sj.bmt.1703544; Perez-Rodriguez A, 2011, EUR J HAEMATOL, V87, P448, DOI 10.1111/j.1600-0609.2011.01664.x; Ribero D, 2007, CANCER-AM CANCER SOC, V110, P2761, DOI 10.1002/cncr.23099; Robinson S, 2011, SURG ONCOL, V20, P57, DOI 10.1016/j.suronc.2009.10.002; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Rubbia-Brandt L, 2004, ANN ONCOL, V15, P460, DOI 10.1093/annonc/mdh095; Rubbia-Brandt L, 2010, HISTOPATHOLOGY, V56, P430, DOI 10.1111/j.1365-2559.2010.03511.x; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; Schwarz RE, 2013, HPB, V15, P106, DOI 10.1111/j.1477-2574.2012.00558.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Uemura M, 2005, BLOOD, V106, P922, DOI 10.1182/blood-2005-01-0152; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143136	10.1371/journal.pone.0143136	http://dx.doi.org/10.1371/journal.pone.0143136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580395	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600089
J	Yang, FX; Zhu, GF				Yang, Fengxi; Zhu, Genfa			Digital Gene Expression Analysis Based on De Novo Transcriptome Assembly Reveals New Genes Associated with Floral Organ Differentiation of the Orchid Plant Cymbidium ensifolium	PLOS ONE			English	Article							MADS-BOX GENES; RNA-SEQ; FLOWER DEVELOPMENT; EVOLUTION; ARABIDOPSIS; ROLES; DIVERSITY	Cymbidium ensifolium belongs to the genus Cymbidium of the orchid family. Owing to its spectacular flower morphology, C. ensifolium has considerable ecological and cultural value. However, limited genetic data is available for this non-model plant, and the molecular mechanism underlying floral organ identity is still poorly understood. In this study, we characterize the floral transcriptome of C. ensifolium and present, for the first time, extensive sequence and transcript abundance data of individual floral organs. After sequencing, over 10 Gb clean sequence data were generated and assembled into 111,892 unigenes with an average length of 932.03 base pairs, including 1,227 clusters and 110,665 singletons. Assembled sequences were annotated with gene descriptions, gene ontology, clusters of orthologous group terms, the Kyoto Encyclopedia of Genes and Genomes, and the plant transcription factor database. From these annotations, 131 flowering-associated unigenes, 61 CONSTANS-LIKE (COL) unigenes and 90 floral homeotic genes were identified. In addition, four digital gene expression libraries were constructed for the sepal, petal, labellum and gynostemium, and 1,058 genes corresponding to individual floral organ development were identified. Among them, eight MADS-box genes were further investigated by full-length cDNA sequence analysis and expression validation, which revealed two APETALA1/AGL9-like MADS-box genes preferentially expressed in the sepal and petal, two AGAMOUS-like genes particularly restricted to the gynostemium, and four DEF-like genes distinctively expressed in different floral organs. The spatial expression of these genes varied distinctly in different floral mutant corresponding to different floral morphogenesis, which validated the specialized roles of them in floral patterning and further supported the effectiveness of our in silico analysis. This dataset generated in our study provides new insights into the molecular mechanisms underlying floral patterning of Cymbidium and supports a valuable resource for molecular breeding of the orchid plant.	[Yang, Fengxi; Zhu, Genfa] Guangdong Acad Agr Sci, Guangdong Key Lab Ornamental Plant Germplasm Inno, Environm Hort Res Inst, Guangzhou 510640, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences	Zhu, GF (corresponding author), Guangdong Acad Agr Sci, Guangdong Key Lab Ornamental Plant Germplasm Inno, Environm Hort Res Inst, Guangzhou 510640, Guangdong, Peoples R China.	genfazhu@163.com			Strategic Emerging Industries of Guangdong Province [2012A020800003]; National Natural Science Foundation of China [31471915]; Agriculture common key technology research [2011A020102007]	Strategic Emerging Industries of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture common key technology research	This research was supported by grants from the Strategic Emerging Industries of Guangdong Province (2012A020800003), the National Natural Science Foundation of China (31471915), and Agriculture common key technology research (2011A020102007).	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Cai J, 2015, NAT GENET, V47, P304, DOI 10.1038/ng0315-304a; Chang YY, 2010, PLANT PHYSIOL, V152, P837, DOI 10.1104/pp.109.147116; Chou ML, 2013, PLANTA, V237, P1425, DOI 10.1007/s00425-013-1850-z; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; da Silva JAT, 2014, SCI HORTIC-AMSTERDAM, V175, P74, DOI 10.1016/j.scienta.2014.05.008; De Paolo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102155; Du Puy D., 1988, THE GENUS CYMBIDIUM; Gravendeel B, 2004, PHILOS T ROY SOC B, V359, P1523, DOI 10.1098/rstb.2004.1529; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Hsu HF, 2002, PLANT CELL PHYSIOL, V43, P1198, DOI 10.1093/pcp/pcf143; Huang JiaPing, 1998, Journal of Beijing Forestry University, V20, P38; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim SY, 2007, PLANT SCI, V172, P319, DOI 10.1016/j.plantsci.2006.09.009; Konishi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2621; Li XY, 2013, INT J NANOMED, V8, P23, DOI 10.2147/IJN.S38507; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; LIU ZJ, 2006, CHINESE CYMBIDIUM PL; Mondragon-Palomino M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-81; Pan ZJ, 2014, NEW PHYTOL, V202, P1024, DOI 10.1111/nph.12723; Rajkumari JD, 2005, J GENET, V84, P81, DOI 10.1007/BF02715895; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Schauser L, 2005, J MOL EVOL, V60, P229, DOI 10.1007/s00239-004-0144-2; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai WC, 2010, ACTA HORTIC, V878, P115, DOI 10.17660/ActaHortic.2010.878.12; Tsai WC, 2005, PLANT CELL PHYSIOL, V46, P1125, DOI 10.1093/pcp/pci125; Tsai WC, 2004, PLANT CELL PHYSIOL, V45, P831, DOI 10.1093/pcp/pch095; Tsai WC, 2014, J SYST EVOL, V52, P397, DOI 10.1111/jse.12010; Wang HZ, 2011, PLANT SYST EVOL, V293, P101, DOI 10.1007/s00606-011-0429-z; Wang SY, 2011, PLANT CELL PHYSIOL, V52, P563, DOI 10.1093/pcp/pcr015; Wang Y, 2014, PLANT CELL TISS ORG, V116, P297, DOI 10.1007/s11240-013-0404-1; Yukawa T, 2002, BOT J LINN SOC, V138, P383, DOI 10.1046/j.1095-8339.2002.00038.x; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082	40	14	17	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142434	10.1371/journal.pone.0142434	http://dx.doi.org/10.1371/journal.pone.0142434			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580566	gold, Green Submitted, Green Published			2022-12-26	WOS:000365154600047
J	Bazakos, C; Manioudaki, ME; Sarropoulou, E; Spano, T; Kalaitzis, P				Bazakos, Christos; Manioudaki, Maria E.; Sarropoulou, Elena; Spano, Thodhoraq; Kalaitzis, Panagiotis			454 Pyrosequencing of Olive (Olea europaea L.) Transcriptome in Response to Salinity	PLOS ONE			English	Article							GENE-EXPRESSION; SALT TOLERANCE; FUNCTIONAL ANNOTATION; DROUGHT STRESS; GROWTH; IDENTIFICATION; ARABIDOPSIS; PHOTOSYNTHESIS; CULTIVARS; ABUNDANCE	Olive (Olea europaea L.) is one of the most important crops in the Mediterranean region. The expansion of cultivation in areas irrigated with low quality and saline water has negative effects on growth and productivity however the investigation of the molecular basis of salt tolerance in olive trees has been only recently initiated. To this end, we investigated the molecular response of cultivar Kalamon to salinity stress using next-generation sequencing technology to explore the transcriptome profile of olive leaves and roots and identify differentially expressed genes that are related to salt tolerance response. Out of 291,958 obtained trimmed reads, 28,270 unique transcripts were identified of which 35% are annotated, a percentage that is comparable to similar reports on non-model plants. Among the 1,624 clusters in roots that comprise more than one read, 24 were differentially expressed comprising 9 down- and 15 up-regulated genes. Respectively, inleaves, among the 2,642 clusters, 70 were identified as differentially expressed, with 14 down- and 56 up-regulated genes. Using next-generation sequencing technology we were able to identify salt-response-related transcripts. Furthermore we provide an annotated transcriptome of olive as well as expression data, which are both significant tools for further molecular studies in olive.	[Bazakos, Christos; Manioudaki, Maria E.; Spano, Thodhoraq; Kalaitzis, Panagiotis] Mediterranean Agron Inst Chania MAICh, Dept Hort Genet & Biotechnol, Iraklion, Greece; [Bazakos, Christos] Aristotle Univ Thessaloniki, Dept Hort, GR-54006 Thessaloniki, Greece; [Sarropoulou, Elena] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Crete, Greece	Aristotle University of Thessaloniki; Hellenic Centre for Marine Research	Kalaitzis, P (corresponding author), Mediterranean Agron Inst Chania MAICh, Dept Hort Genet & Biotechnol, Iraklion, Greece.	panagiot@maich.gr	Bazakos, Christos/AAI-3198-2020	Kalaitzis, Panagiotis/0000-0003-2694-4977	C.I.H.E.A.M. cooperative network Innovative Technologies in Olive Oil Authentication [GSRT-KP_14]; GSRT General Secretariat for Research and Technology; Greek Ministry of Development; European Economic Area Financial Mechanism [EL-0075]	C.I.H.E.A.M. cooperative network Innovative Technologies in Olive Oil Authentication; GSRT General Secretariat for Research and Technology; Greek Ministry of Development; European Economic Area Financial Mechanism	This work was funded by the C.I.H.E.A.M. cooperative network Innovative Technologies in Olive Oil Authentication (www.ciheam.org), the GSRT-KP_14 grant, GSRT General Secretariat for Research and Technology, Greek Ministry of Development (http://www.gsrt.gr/) and the European Economic Area Financial Mechanism grant EL-0075 (http://www.eeagrants.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2011, ARCH VIROL, V156, P397, DOI 10.1007/s00705-010-0869-8; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Atienza SG, 2004, PLANT SCI, V167, P1359, DOI 10.1016/j.plantsci.2004.07.006; Bachem CWB, 1998, PLANT MOL BIOL REP, V16, P157, DOI 10.1023/A:1007468801806; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Barakat A, 2009, BMC PLANT BIOL, V9; Bazakos C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042931; Binzel M, 2002, SALINITY ENV PLANTS; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Chartzoulakis K, 2002, SCI HORTIC-AMSTERDAM, V96, P235, DOI 10.1016/S0304-4238(02)00067-5; Chartzoulakis KS, 2005, AGR WATER MANAGE, V78, P108, DOI 10.1016/j.agwat.2005.04.025; Clauw P, 2015, PLANT PHYSIOL, V167, P800, DOI 10.1104/pp.114.254284; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cresti M., 1994, Advances in Horticultural Science, V8, P211; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Ehlting J, 2006, BIOCHEM SOC T, V34, P1192, DOI 10.1042/BST0341192; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gu RS, 2004, TREE PHYSIOL, V24, P265, DOI 10.1093/treephys/24.3.265; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jia WS, 2002, J EXP BOT, V53, P2201, DOI 10.1093/jxb/erf079; Klein I., 1994, ACTA HORTIC, V356, P176, DOI DOI 10.17660/ACTAH0RTIC.1994.356.37; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Leyva-Perez MD, 2015, DNA RES, V22, P1, DOI 10.1093/dnares/dsu033; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loreto F, 2003, PLANT CELL ENVIRON, V26, P595, DOI 10.1046/j.1365-3040.2003.00994.x; Mantri NL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-303; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; MUNNS R, 1988, AUST J PLANT PHYSIOL, V15, P717, DOI 10.1071/PP9880717; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Nonis A, 2012, J AGR FOOD CHEM, V60, P6855, DOI 10.1021/jf300419w; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ohtsu K, 2007, PLANT J, V52, P391, DOI 10.1111/j.1365-313X.2007.03244.x; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Qing DJ, 2009, PLANT CELL PHYSIOL, V50, P889, DOI 10.1093/pcp/pcp038; REIMANN C, 1992, J EXP BOT, V43, P503, DOI 10.1093/jxb/43.4.503; Riggins CW, 2010, PEST MANAG SCI, V66, P1042, DOI 10.1002/ps.2006; Rugini E., 1990, OLIVE OLEA EUROPAEA; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sarropoulou E, 2012, MAR BIOTECHNOL, V14, P634, DOI 10.1007/s10126-012-9466-z; Sarropoulou E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-157; Saud S., 2015, SUSTAIN AGR REV, V15, P371, DOI DOI 10.1007/978-3-319-09132-7_10; Sharma N, 2005, J PLANT GROWTH REGUL, V24, P28, DOI 10.1007/s00344-004-0438-z; Singh S, 2009, PLANT BIOTECHNOL REP, V3, P333, DOI 10.1007/s11816-009-0107-6; Sottosanto JB, 2004, PLANT J, V40, P752, DOI 10.1111/j.1365-313X.2004.02253.x; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Sugarbaker DJ, 2008, P NATL ACAD SCI USA, V105, P3521, DOI 10.1073/pnas.0712399105; Tabatabaei SJ, 2006, SCI HORTIC-AMSTERDAM, V108, P432, DOI 10.1016/j.scienta.2006.02.016; TATTINI M, 1992, J PLANT NUTR, V15, P1467, DOI 10.1080/01904169209364412; THERIOS IN, 1988, PLANT SOIL, V106, P105, DOI 10.1007/BF02371201; Therios IN, 2009, THER IN OL; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Wang YC, 2010, J PLANT PHYSIOL, V167, P222, DOI 10.1016/j.jplph.2009.09.008; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	70	19	21	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143000	10.1371/journal.pone.0143000	http://dx.doi.org/10.1371/journal.pone.0143000			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26576008	Green Submitted, Green Published, gold			2022-12-26	WOS:000365153400026
J	Martin-Albarracin, VL; Amico, GC; Simberloff, D; Nunez, MA				Martin-Albarracin, Valeria L.; Amico, Guillermo C.; Simberloff, Daniel; Nunez, Martin A.			Impact of Non-Native Birds on Native Ecosystems: A Global Analysis	PLOS ONE			English	Article							POTENTIAL CONSERVATION VALUE; ALIEN MAMMALS; SHARED PARASITES; RISK-ASSESSMENT; SEED DISPERSAL; PATTERNS; MANAGEMENT; INVASION; POPULATION; PREDATORS	Introduction and naturalization of non-native species is one of the most important threats to global biodiversity. Birds have been widely introduced worldwide, but their impacts on populations, communities, and ecosystems have not received as much attention as those of other groups. This work is a global synthesis of the impact of nonnative birds on native ecosystems to determine (1) what groups, impacts, and locations have been best studied; (2) which taxonomic groups and which impacts have greatest effects on ecosystems, (3) how important are bird impacts at the community and ecosystem levels, and (4) what are the known benefits of nonnative birds to natural ecosystems. We conducted an extensive literature search that yielded 148 articles covering 39 species belonging to 18 families -18% of all known naturalized species. Studies were classified according to where they were conducted: Africa, Asia, Australasia, Europe, North America, South America, Islands of the Indian, of the Pacific, and of the Atlantic Ocean. Seven types of impact on native ecosystems were evaluated: competition, disease transmission, chemical, physical, or structural impact on ecosystem, grazing/herbivory/browsing, hybridization, predation, and interaction with other non-native species. Hybridization and disease transmission were the most important impacts, affecting the population and community levels. Ecosystem-level impacts, such as structural and chemical impacts were detected. Seven species were found to have positive impacts aside from negative ones. We provide suggestions for future studies focused on mechanisms of impact, regions, and understudied taxonomic groups.	[Martin-Albarracin, Valeria L.; Amico, Guillermo C.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Simberloff, Daniel] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Nunez, Martin A.] Univ Nacl Comahue, CONICET, INIBIOMA, Grp Ecol Invasiones, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; University of Tennessee System; University of Tennessee Knoxville; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Martin-Albarracin, VL (corresponding author), Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	valemartinalba@gmail.com	Nuñez, Martin A./B-2735-2010; Amico, Guillermo C c/HGD-9402-2022	Nuñez, Martin A./0000-0003-0324-5479; Amico, Guillermo/0000-0002-3709-3111	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	VLMA was supported by a Ph.D. fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) during this project (http://www.conicet.gov.ar/new_scp/detalle.php?id=33759&datos_academicos=yes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JR, 1995, WILDLIFE BIOL, V1, P129, DOI 10.2981/wlb.1995.018; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Baker J, 2014, EMU, V114, P1, DOI 10.1071/MU12122; Banks A, 2009, REV STATUS INTRO NON; Blackburn TM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001850; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Case TJ, 1996, BIOL CONSERV, V78, P69, DOI 10.1016/0006-3207(96)00019-5; Celedon-Neghme C, 2013, PLANT ECOL, V214, P657, DOI 10.1007/s11258-013-0197-7; Chimera CG, 2010, BIOTROPICA, V42, P493, DOI 10.1111/j.1744-7429.2009.00610.x; Crooks J.A., 2011, ENCY BIOL INVASIONS, P404; Deregnaucourt S, 2005, APPL ANIM BEHAV SCI, V94, P303, DOI 10.1016/j.applanim.2005.03.002; di Castri F., 1990, BIOL INVASIONS EUROP; Dostal P, 2013, ECOL LETT, V16, P1277, DOI 10.1111/ele.12166; Duncan RP, 2003, ANNU REV ECOL EVOL S, V34, P71, DOI 10.1146/annurev.ecolsys.34.011802.132353; EBENHARD T, 1988, INTRO BIRDS MAMMALS; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Essl F, 2015, DIVERS DISTRIB, V21, P534, DOI 10.1111/ddi.12312; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Evans T, 2014, ECOL EVOL, V4, P2957, DOI 10.1002/ece3.1144; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Freed LA, 2008, EVOL ECOL RES, V10, P931; Genovesi P, 2011, ENCY BIOL INVASIONS; Keitt B., 2011, ISLAND INVASIVES ERA, P74; Kelly D, 2006, ECOL STUD-ANAL SYNTH, V186, P227; Kumschick S., 2012, NeoBiota, P69; Kumschick S, 2013, BIOL INVASIONS, V15, P785, DOI 10.1007/s10530-012-0326-6; Kumschick S, 2010, BIOL CONSERV, V143, P2757, DOI 10.1016/j.biocon.2010.07.023; Lever C., 2005, NATURALIZED BIRDS WO; Linnebjerg JF, 2010, J TROP ECOL, V26, P347, DOI 10.1017/S0266467409990617; Long J.L., 1981, INTRO BIRDS WORLD WO; Lowe S., 2000, ENCY BIOL INVASIONS; Morgan D, 2006, NEW ZEAL J ZOOL, V33, P17, DOI 10.1080/03014223.2006.9518427; Nentwig W, 2010, CONSERV BIOL, V24, P302, DOI 10.1111/j.1523-1739.2009.01289.x; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Rehfisch M., 2010, BOU P IMPACTS NONNAT; RHYMER JM, 1994, AUK, V111, P970, DOI 10.2307/4088829; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sanchez-Donoso I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039031; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Shirley SM, 2009, GLOBAL ECOL BIOGEOGR, V18, P450, DOI 10.1111/j.1466-8238.2009.00452.x; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Vitule JRS, 2012, CONSERV BIOL, V26, P1153, DOI 10.1111/j.1523-1739.2012.01950.x; Sperry LJ, 2006, ECOLOGY, V87, P603, DOI 10.1890/05-0836; Strubbe D, 2011, BIOL CONSERV, V144, P2112, DOI 10.1016/j.biocon.2011.05.001; Tompkins DM, 2000, J ANIM ECOL, V69, P829, DOI 10.1046/j.1365-2656.2000.00439.x; Tompkins DM, 2000, ECOL LETT, V3, P10, DOI 10.1046/j.1461-0248.2000.00117.x; Tompkins DM, 2001, PARASITOLOGY, V122, P187, DOI 10.1017/S0031182001007247; Watola George, 1996, P71; Wilcox RC, 2009, STUDENT RES PAPERS; Williams PA, 2006, NEW ZEAL J ECOL, V30, P285; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x; Wu JX, 2014, BIOTROPICA, V46, P175, DOI 10.1111/btp.12087	55	52	58	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143070	10.1371/journal.pone.0143070	http://dx.doi.org/10.1371/journal.pone.0143070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26576053	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400037
J	Nakajima, M; Boggs, CL				Nakajima, Mifuyu; Boggs, Carol L.			Fine-Grained Distribution of a Non-Native Resource Can Alter the Population Dynamics of a Native Consumer	PLOS ONE			English	Article							PIERID BUTTERFLIES; DISPERSAL; COEVOLUTION; LANDSCAPES; EVOLUTION; INVASION; WORLD	New interactions with non-native species can alter selection pressures on native species. Here, we examined the effect of the spatial distribution of a non-native species, a factor that determines ecological and evolutionary outcomes but that is poorly understood, particularly on a fine scale. Specifically, we explored a native butterfly population and a non-native plant on which the butterfly oviposits despite the plant's toxicity to larvae. We developed an individual-based model to describe movement and oviposition behaviors of each butterfly, which were determined by plant distribution and the butterfly's host preference genotype. We estimated the parameter values of the model from rich field data. We simulated various patterns of plant distributions and compared the rates of butterfly population growth and changes in the allele frequency of oviposition preference. Neither the number nor mean area of patches of non-native species affected the butterfly population, whereas plant abundance, patch shape, and distance to the nearest native and non-native patches altered both the population dynamics and genetics. Furthermore, we found a dramatic decrease in population growth rates when we reduced the distance to the nearest native patch from 147 m to 136 m. Thus changes in the non-native resource distribution that are critical to the fate of the native herbivore could only be detected at a fine-grained scale that matched the scale of a female butterfly's movement. In addition, we found that the native butterfly population was unlikely to be rescued by the exclusion of the allele for acceptance of the non-native plant as a host. This study thus highlights the importance of including both ecological and evolutionary dynamics in analyses of the outcome of species interactions and provides insights into habitat management for non-native species.	[Nakajima, Mifuyu; Boggs, Carol L.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Nakajima, Mifuyu; Boggs, Carol L.] Rocky Mt Biol Labs, Crested Butte, CO USA	Stanford University	Nakajima, M (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	mifuyunf@06.alumni.u-tokyo.ac.jp						Carlson SM, 2014, TRENDS ECOL EVOL, V29, P521, DOI 10.1016/j.tree.2014.06.005; CARLTON JT, 1990, MAR ECOL PROG SER, V66, P81, DOI 10.3354/meps066081; Cattarino L, 2013, LANDSCAPE ECOL, V28, P1321, DOI 10.1007/s10980-013-9881-1; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Chew FS, 2006, BIOL J LINN SOC, V88, P413, DOI 10.1111/j.1095-8312.2006.00630.x; CHEW FS, 1977, EVOLUTION, V31, P568, DOI 10.1111/j.1558-5646.1977.tb01045.x; CHEW FS, 1975, OECOLOGIA, V20, P117, DOI 10.1007/BF00369024; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; DOAK DF, 1992, THEOR POPUL BIOL, V41, P315, DOI 10.1016/0040-5809(92)90032-O; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Epperson BK, 2010, MOL ECOL, V19, P3549, DOI 10.1111/j.1365-294X.2010.04678.x; FAHRIG L, 1987, CAN J ZOOL, V65, P616, DOI 10.1139/z87-096; FAHRIG L, 1992, THEOR POPUL BIOL, V41, P300, DOI 10.1016/0040-5809(92)90031-N; Garcia D, 2011, ECOL MONOGR, V81, P103, DOI 10.1890/10-0470.1; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gustafson EJ, 1996, ECOLOGY, V77, P94, DOI 10.2307/2265659; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Keeler MS, 2008, OECOLOGIA, V156, P559, DOI 10.1007/s00442-008-1005-2; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; McGarigal K., 1994, FRAGSTATS SPATIAL PA, V2, P128; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; Morton TAL, 2015, BIOL INVASIONS, V17, P1683, DOI 10.1007/s10530-014-0826-7; Nakajima M, 2014, J LEPID SOC, V68, P175; Nakajima M, 2013, OECOLOGIA, V172, P823, DOI 10.1007/s00442-012-2537-z; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; PULLIAM HR, 1992, ECOL APPL, V2, P165, DOI 10.2307/1941773; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Romero S, 2009, LANDSCAPE ECOL, V24, P39, DOI 10.1007/s10980-008-9278-8; Ruckelshaus M, 1997, CONSERV BIOL, V11, P1298, DOI 10.1046/j.1523-1739.1997.96151.x; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Sears MW, 2011, INTEGR COMP BIOL, V51, P666, DOI 10.1093/icb/icr111; SMITH JM, 1989, PHILOS T ROY SOC B, V325, P241, DOI 10.1098/rstb.1989.0086; Turlure C, 2010, LANDSCAPE ECOL, V25, P95, DOI 10.1007/s10980-009-9403-3	35	3	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143052	10.1371/journal.pone.0143052	http://dx.doi.org/10.1371/journal.pone.0143052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575843	gold, Green Published			2022-12-26	WOS:000365153400035
J	Park, CW; Park, JS; Norwitz, ER; Moon, KC; Jun, JK; Yoon, BH				Park, Chan-Wook; Park, Joong Shin; Norwitz, Errol R.; Moon, Kyung Chul; Jun, Jong Kwan; Yoon, Bo Hyun			Timing of Histologic Progression from Chorio-Deciduitis to Chorio-Deciduo-Amnionitis in the Setting of Preterm Labor and Preterm Premature Rupture of Membranes with Sterile Amniotic Fluid	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-CELL COUNT; INTRAAMNIOTIC INFLAMMATION; INTRAUTERINE INFECTION; CLINICAL-SIGNIFICANCE; EXPECTANT MANAGEMENT; APGAR SCORE; LATENCY; OUTCOMES; CHORIOAMNIONITIS	Background Histologic chorio-deciduitis and chorio-deciduo-amnionitis (amnionitis) in extra-placental membranes are known to represent the early and advanced stages of ascending intrauterine infection. However, there are no data in humans about the time required for chorio-deciduitis to develop and for chorio-deciduitis without amnionitis to progress to chorio-deciduitis with amnionitis, and the effect of prolongation of pregnancy on the development of chorio-deciduitis and amnionitis in patients with preterm labor and intact membranes (PTL) and preterm premature rupture of membranes (preterm-PROM). We examined these issues in this study. Methods The study population consisted of 289 women who delivered preterm (133 cases with PTL, and 156 cases with preterm-PROM) and who had sterile amniotic fluid (AF) defined as a negative AF culture and the absence of inflammation as evidenced by a matrix metalloproteinase- 8 (MMP-8) level <23 ng/ml. We examined the association between amniocentesis-to-delivery interval and inflammatory status in the extra-placental membranes (i.e., inflammation-free extra-placental membranes, choroi-deciduitis only, and chorio-deciduitis with amnionitis) in patients with PTL and preterm-PROM. Results Amniocentesis-to-delivery interval was longer in cases of chorio-deciduitis with amnionitis than in cases of chorio-deciduitis only in both PTL (median [interquartile-range (IQR)]; 645.4 [319.5] vs. 113.9 [526.9] hours; P = 0.005) and preterm-PROM (131.3 [135.4] vs. 95.2 [140.5] hours; P<0.05). Amniocentesis-to-delivery interval was an independent predictor of the development of both chorio-deciduitis and amnionitis after correction for confounding variables such as gestational age at delivery in the setting of PTL, but not preterm-PROM. Conclusions These data confirm for the first time that, in cases of both PTL and preterm-PROM with sterile AF, more time is required to develop chorio-deciduitis with amnionitis than chorio-deciduitis alone in extra-placental membranes. Moreover, prolongation of pregnancy is an independent predictor of the development of both chorio-deciduitis and amnionitis in cases of PTL with sterile AF.	[Park, Chan-Wook; Park, Joong Shin; Jun, Jong Kwan; Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Norwitz, Errol R.] Tufts Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02111 USA; [Moon, Kyung Chul] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU); Tufts University; Seoul National University (SNU)	Park, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	jsparkmd@snu.ac.kr	Park, Joong Shin/D-5741-2012; PARK, Chan-Wook/G-3663-2013; Yoon, Bo Hyun/H-6344-2011	Park, Joong Shin/0000-0002-5246-0477; PARK, Chan-Wook/0000-0002-1290-6438; 	SNUH Research Fund [03-2011-0260]	SNUH Research Fund	This study was supported by the grant no. 03-2011-0260 from the SNUH Research Fund.	Aziz N, 2008, J MATERN-FETAL NEO M, V21, P821, DOI 10.1080/14767050802251255; BEAULIEU MD, 1982, CAN MED ASSOC J, V127, P214; Cahill AG, 2009, OBSTET GYNECOL, V114, P124, DOI 10.1097/AOG.0b013e3181aef106; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; COX SM, 1995, OBSTET GYNECOL, V86, P875, DOI 10.1016/0029-7844(95)00303-9; Ekin A, 2014, ARCH GYNECOL OBSTET, V290, P449, DOI 10.1007/s00404-014-3227-3; Ghidini A, 1998, J Matern Fetal Med, V7, P238; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Holst RM, 2007, J MATERN-FETAL NEO M, V20, P885, DOI 10.1080/14767050701752601; Kacerovsky M, 2015, J MATERN-FETAL NEO M, V28, P1116, DOI 10.3109/14767058.2014.944859; Kacerovsky M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126884; Kim BJ, 2005, AM J OBSTET GYNECOL, V193, pS55, DOI 10.1016/j.ajog.2005.10.172; Lee SM, 2011, PLACENTA, V32, P516, DOI 10.1016/j.placenta.2011.03.012; Lee SM, 2011, J MATERN-FETAL NEO M, V24, P37, DOI 10.3109/14767058.2010.482622; LOCKWOOD CJ, 1994, AM J OBSTET GYNECOL, V171, P1097, DOI 10.1016/0002-9378(94)90043-4; McElrath TF, 2003, AM J OBSTET GYNECOL, V189, P794, DOI 10.1067/S0002-9378(03)00814-7; MERCER BM, 1993, AM J OBSTET GYNECOL, V169, P775, DOI 10.1016/0002-9378(93)90004-3; Naef RW, 1998, AM J OBSTET GYNECOL, V178, P126, DOI 10.1016/S0002-9378(98)70638-6; Nayot D, 2012, J PERINATOL, V32, P970, DOI 10.1038/jp.2012.15; NIELSEN PV, 1987, ACTA OBSTET GYN SCAN, V66, P421, DOI 10.3109/00016348709022046; Parer JT, 2006, J MATERN-FETAL NEO M, V19, P289, DOI 10.1080/14767050500526172; Park CW, 2009, PLACENTA, V30, P613, DOI 10.1016/j.placenta.2009.04.005; Park CW, 2014, J MATERN-FETAL NEO M, V27, P98, DOI 10.3109/14767058.2013.806898; Park CW, 2009, PLACENTA, V30, P56, DOI 10.1016/j.placenta.2008.09.017; Park JS, 2001, AM J OBSTET GYNECOL, V185, P1156, DOI 10.1067/mob.2001.117679; PAUL MJ, 1991, AM J PERINAT, V8, P417, DOI 10.1055/s-2007-999428; Ramsey PS, 2005, AM J OBSTET GYNECOL, V192, P1162, DOI 10.1016/j.ajog.2004.11.035; ROMERO R, 1988, CLIN OBSTET GYNECOL, V31, P553, DOI 10.1097/00003081-198809000-00006; Seong HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.040; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; Thorngren-Jerneck K, 2001, OBSTET GYNECOL, V98, P65, DOI 10.1016/S0029-7844(01)01370-9; Ustun C, 1998, J Matern Fetal Med, V7, P243, DOI 10.1002/(SICI)1520-6661(199809/10)7:5<243::AID-MFM7>3.0.CO;2-G; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Yoon BH, 1996, OBSTET GYNECOL, V87, P231, DOI 10.1016/0029-7844(95)00380-0; Yoon BH, 1996, OBSTET GYNECOL, V88, P1034; Zervomanolakis I, 2007, ANN NY ACAD SCI, V1101, P1, DOI 10.1196/annals.1389.032	38	3	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143023	10.1371/journal.pone.0143023	http://dx.doi.org/10.1371/journal.pone.0143023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26574743	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400028
J	Wang, M; Zuo, YJ; Lin, XH; Ling, YL; Lin, XF; Li, MG; Lamoureux, E; Zheng, YF				Wang, Mei; Zuo, Yajing; Lin, Xianhua; Ling, Yunlan; Lin, Xiaofeng; Li, Mingge; Lamoureux, Ecosse; Zheng, Yingfeng			Willingness to Pay for Cataract Surgery Provided by a Senior Surgeon in Urban Southern China	PLOS ONE			English	Article								Purpose To study willingness to pay for cataract surgery and surgical service provided by a senior cataract surgeon in urban Southern China. Methods This study was a cross-sectional willingness-to-pay (WTP) interview using bidding formats. Two-hundred eleven persons with presenting visual impairment in either eye due to cataract were enrolled at a tertiary eye hospital. Participants underwent a comprehensive eye examination and a WTP interview for both surgery and service provided by a senior surgeon. Demographic information, socioeconomic status and clinical data were recorded. Results Among 211 (98% response rate) persons completing the interview, 53.6% were women and 80.6% were retired. About 72.2% had a monthly income lower than 1000 renminbi (US $161). A total of 189 (89.6%) were willing to pay for cataract and the median amount of WTP was 6000 renminbi (US$968). And 102 (50.7%) were willing to pay additional fees for surgery performed by a senior surgeon, and the median amount of WTP was 500 renminbi (US$81). In regression models adjusting for age and gender, persons with preexisting eye diseases other than cataract, were more likely to pay for cataract surgery and service provided by a senior surgeon (P = 0.04 for both). Conclusions In urban China, cataract patients, especially those with preexisting eye conditions, are willing to pay additional fees for a senior surgeon. Moving to a system where the price of cataract surgery is proportional to the consultant' skill and expertise is possible and may have a potential impact on waiting list and quality of eye care. Further studies are needed to examine the impact of such pricing system on attitudes and choices of cataract patients.	[Wang, Mei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zuo, Yajing; Ling, Yunlan; Li, Mingge; Zheng, Yingfeng] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Xianhua] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Lin, Xiaofeng] Sun Yat Sen Univ, Affiliated Shantou Hosp, Shantou Cent Hosp, Shantou, Peoples R China; [Lamoureux, Ecosse] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Lamoureux, Ecosse] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Lamoureux, Ecosse] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia	Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Sun Yat Sen University; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; University of Melbourne	Zheng, YF (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	yingfeng.zheng@qq.com	Zheng, Yingfeng/CAE-9225-2022; Zheng, Yingfeng/AAE-2983-2022; Lamoureux, Ecosse/Z-5482-2019	Zheng, Yingfeng/0000-0002-0914-7864; 	National Natural Science Foundation of China [81200685, 81100686]; Science and Technology Program of Guangzhou, China [15570001]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou, China; Fundamental Research Funds of the State Key Laboratory of Ophthalmology	This work was supported by National Natural Science Foundation of China (81200685), National Natural Science Foundation of China (81100686), Science and Technology Program of Guangzhou, China (15570001) and Fundamental Research Funds of the State Key Laboratory of Ophthalmology.	China Disabled Person's Federation (CDPF), 2005, STAT YB UND PEOPL DI, P3; China's Ministry of Health, 2005, CHIN TB CONTR PROGR, P3; China's Ministry of Health, 2015, NOT CAT SURG INF REP; Dean WH, 2012, OPHTHAL EPIDEMIOL, V19, P265, DOI 10.3109/09286586.2012.708085; Fang JH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-543; He MG, 2007, OPHTHALMOLOGY, V114, P411, DOI 10.1016/j.ophtha.2006.09.012; Huang WY, 2012, INVEST OPHTH VIS SCI, V53, P7936, DOI 10.1167/iovs.12-10903; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Ko F, 2012, ACTA OPHTHALMOL, V90, pE54, DOI 10.1111/j.1755-3768.2011.02207.x; Lewallen S, 2006, BRIT J OPHTHALMOL, V90, P11, DOI 10.1136/bjo.2005.079715; Li SZ, 1999, OPHTHALMOLOGY, V106, P1602, DOI 10.1016/S0161-6420(99)90459-1; Lin XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107615; Lin XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103860; Liu B, 2009, OPHTHALMOLOGY, V116, P1322, DOI 10.1016/j.ophtha.2009.01.030; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Shrestha MK, 2004, BRIT J OPHTHALMOL, V88, P319, DOI 10.1136/bjo.2003.026260; Venkatesh R, 2010, J CATARACT REFR SURG, V36, P1849, DOI 10.1016/j.jcrs.2010.05.025; World Health Organization, 2011, VIS IMP BLINDN; Yin QX, 2009, INVEST OPHTH VIS SCI, V50, P1069, DOI 10.1167/iovs.08-2783; Zhao J, 1999, Zhonghua Yan Ke Za Zhi, V35, P341; Zhao JL, 2010, OPHTHALMOLOGY, V117, P2120, DOI 10.1016/j.ophtha.2010.03.005; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023	22	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142858	10.1371/journal.pone.0142858	http://dx.doi.org/10.1371/journal.pone.0142858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575284	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400021
J	Zhang, WL; Liu, YW; Hu, HM; Huang, H; Bao, ZS; Yang, P; Wang, YY; You, G; Yan, W; Jiang, T; Wang, JF; Zhang, W				Zhang, Wenlong; Liu, Yanwei; Hu, Huimin; Huang, Hua; Bao, Zhaoshi; Yang, Pei; Wang, Yinyan; You, Gan; Yan, Wei; Jiang, Tao; Wang, Jiangfei; Zhang, Wei			ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1A3; E-CADHERIN EXPRESSION; CANCER STEM-CELLS; MOLECULAR CLASSIFICATION; GENE-EXPRESSION; RNA-SEQ; GLIOBLASTOMA; SNAIL; TRANSITIONS; PREDICTOR	Aldehyde dehydrogenases (ALDH) is a family of enzymes including 19 members. For now, ALDH activity had been wildly used as a marker of cancer stem cells (CSCs). But biological functions of relevant isoforms and their clinical applications are still controversial. Here, we investigate the clinical significance and potential function of ALDH1A3 in gliomas. By whole-genome transcriptome microarray and mRNA sequencing analysis, we compared the expression of ALDH1A3 in high- and low- grade gliomas as well as different molecular subtypes. Microarray analysis was performed to identify the correlated genes of ALDH1A3. We further used Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis to explore the biological function of ALDH1A3. Finally, by mRNA knockdown we revealed the relationship between ALDH1A3 and the ability of tumor invasion. ALDH1A3 overexpression was significantly associated with high grade as well as the higher mortality of gliomas in survival analysis. ALDH1A3 was characteristically highly expressed in Mesenchymal (Mes) subtype gliomas. Moreover, we found that ALDH1A3 was most relevant to extracellular matrix organization and cell adhesion biological process, and the ability of tumor invasion was suppressed after ALDH1A3 knockdown in vitro. In conclusion, ALDH1A3 can serve as a novel marker of Mes phenotype in gliomas with potential clinical prognostic value. The expression of ALDH1A3 is associated with tumor cell invasion.	[Zhang, Wenlong; Liu, Yanwei; Bao, Zhaoshi; Yang, Pei; Wang, Yinyan; You, Gan; Jiang, Tao; Wang, Jiangfei; Zhang, Wei] Beijing Tiantan Hosp, Capital Med Univ, Dept Neurosurg, Beijing, Peoples R China; [Zhang, Wenlong; Liu, Yanwei; Hu, Huimin; Huang, Hua; Bao, Zhaoshi; Yang, Pei; Wang, Yinyan; You, Gan; Jiang, Tao; Zhang, Wei] Capital Med Univ, Beijing Neurosurg Inst, Dept Mol Neuropathol, Beijing, Peoples R China; [Yan, Wei] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China	Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University; Nanjing Medical University	Wang, JF (corresponding author), Beijing Tiantan Hosp, Capital Med Univ, Dept Neurosurg, Beijing, Peoples R China.	wjf1998@sohu.com; zhangwei__vincent@163.com	Wang, Yinyan/AAJ-1160-2020		National Natural Science Foundation of China [81201993]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20121107120005]; Fok Ying Tung Education Foundation [141032]; Beijing Nova Program [xx2014B062]; National High Technology Research and Development Program [2012AA02A508]; International Science and Technology Cooperation Program [2012DFA30470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission); National High Technology Research and Development Program(National High Technology Research and Development Program of China); International Science and Technology Cooperation Program	This work was supported by grants from the National Natural Science Foundation of China (No. 81201993), Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20121107120005), Fok Ying Tung Education Foundation (No. 141032), Beijing Nova Program (No. xx2014B062), National High Technology Research and Development Program (No. 2012AA02A508), International Science and Technology Cooperation Program (No. 2012DFA30470).	Adam SA, 2012, BRAIN PATHOL, V22, P788, DOI 10.1111/j.1750-3639.2012.00592.x; Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cai JQ, 2014, ONCOTARGET, V5, P2551, DOI 10.18632/oncotarget.1838; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Raha D, 2014, CANCER RES, V74, P3579, DOI 10.1158/0008-5472.CAN-13-3456; Schafer A, 2012, NEURO-ONCOLOGY, V14, P1452, DOI 10.1093/neuonc/nos270; Shao CL, 2014, CLIN CANCER RES, V20, P4154, DOI 10.1158/1078-0432.CCR-13-3292; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yan J, 2014, BRIT J CANCER, V110, P2593, DOI 10.1038/bjc.2014.201; Yan W, 2012, NEURO-ONCOLOGY, V14, P1432, DOI 10.1093/neuonc/nos263; Yang ZL, 2013, DIS MARKERS, V2013, P163, DOI 10.1155/2013/187043; Yokoyama K, 2003, INT J ONCOL, V22, P891; Zhang W, 2013, CANCER LETT, V328, P120, DOI 10.1016/j.canlet.2012.08.033	25	18	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142856	10.1371/journal.pone.0142856	http://dx.doi.org/10.1371/journal.pone.0142856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575197	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400020
J	Cruickshank, VA; Sroczynska, P; Sankar, A; Miyagi, S; Rundsten, CF; Johansen, JV; Helin, K				Cruickshank, V. Adam; Sroczynska, Patrycja; Sankar, Aditya; Miyagi, Satoru; Rundsten, Carsten Friis; Johansen, Jens Vilstrup; Helin, Kristian			SWI/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance	PLOS ONE			English	Article							METHYLTRANSFERASE GENE EZH2; INACTIVATING MUTATIONS; DNMT3A MUTATIONS; CHROMATIN; BRG1; TET2; EXPRESSION; COMPLEX; TARGET	Alterations in chromatin structure caused by deregulated epigenetic mechanisms collaborate with underlying genetic lesions to promote cancer. SMARCA4/BRG1, a core component of the SWI/SNF ATP-dependent chromatin-remodelling complex, has been implicated by its mutational spectrum as exerting a tumour-suppressor function in many solid tumours; recently however, it has been reported to sustain leukaemogenic transformation in MLL-rearranged leukaemia in mice. Here we further explore the role of SMARCA4 and the two SWI/SNF subunits SMARCD2/BAF60B and DPF2/BAF45D in leukaemia. We observed the selective requirement for these proteins for leukaemic cell expansion and self-renewal in-vitro as well as in leukaemia. Gene expression profiling in human cells of each of these three factors suggests that they have overlapping functions in leukaemia. The gene expression changes induced by loss of the three proteins demonstrate that they are required for the expression of haematopoietic stem cell associated genes but in contrast to previous results obtained in mouse cells, the three proteins are not required for the expression of c-MYC regulated genes.	[Cruickshank, V. Adam; Sroczynska, Patrycja; Sankar, Aditya; Miyagi, Satoru; Rundsten, Carsten Friis; Johansen, Jens Vilstrup; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Cruickshank, V. Adam; Sroczynska, Patrycja; Sankar, Aditya; Miyagi, Satoru; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Miyagi, Satoru; Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr Danstem, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Helin, K (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Helin, Kristian/HDM-8306-2022; Helin, Kristian/K-2526-2019	Helin, Kristian/0000-0003-1975-6097; Vilstrup Johansen, Jens/0000-0001-7094-6801; Sankar, Aditya/0000-0002-1840-3356	Danish Medical Research Council Fellowship; EMBO Long-Term Postdoctoral Fellowship; Marie Curie Intra-European Fellowship; Danish National Research Foundation [DNRF82]; European Union grant BLUEPRINT [282510]; Lundbeck Foundation; Novo Nordisk Foundation; Danish Council for Strategic Research [12-110503]; The Danish Cancer Society [R90-A5943] Funding Source: researchfish; Novo Nordisk Foundation Section for Basic Stem Cell Biology [Helin group NNF] Funding Source: researchfish	Danish Medical Research Council Fellowship; EMBO Long-Term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European Fellowship(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); European Union grant BLUEPRINT; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); The Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation Section for Basic Stem Cell Biology	PS was funded by fellowships from: Danish Medical Research Council Fellowship: http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-sundhed-og-sygdom; EMBO Long-Term Postdoctoral Fellowship: www.embo.org; Marie Curie Intra-European Fellowship: ec.europa.eu. The research was supported by grants to KH from: The Danish National Research Foundation (DNRF82): www.dg.dk; the European Union grant BLUEPRINT (FP7/2011; 282510): ec.europa.eu/; The Lundbeck Foundation: www.lundbeckfonden.com; The Novo Nordisk Foundation: www.novonordiskfonden.dk; The Danish Council for Strategic Research (12-110503): innovationsfonden.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Bacher U, 2006, BLOOD, V107, P3847, DOI 10.1182/blood-2005-08-3522; Bennett-Lovsey R, 2002, BIOINFORMATICS, V18, P626, DOI 10.1093/bioinformatics/18.4.626; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Buscarlet M, 2014, BLOOD, V123, P1720, DOI 10.1182/blood-2013-02-483495; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Deshpande AJ, 2012, TRENDS IMMUNOL, V33, P563, DOI 10.1016/j.it.2012.06.002; Ernst T, 2012, LEUKEMIA, V26, P1701, DOI 10.1038/leu.2012.16; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Garcia-Cuellar MP, 2014, LEUKEMIA, V28, P1427, DOI 10.1038/leu.2014.40; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kingston RE, 2003, CURR PROTOC MOL BIOL, V63, DOI DOI 10.1002/0471142727.MB0901S63; Langemeijer SMC, 2011, LEUKEMIA, V25, P189, DOI 10.1038/leu.2010.243; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Matsuyama R, 2010, J BIOL CHEM, V285, P18166, DOI 10.1074/jbc.M109.077024; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Nolan GP., RETROVIRAL EXPRESSIO; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Sroczynska P, 2014, BLOOD, V123, P1870, DOI 10.1182/blood-2013-08-522094; Thol F, 2011, HAEMATOL-HEMATOL J, V96, P1238, DOI 10.3324/haematol.2011.046839; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	37	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142806	10.1371/journal.pone.0142806	http://dx.doi.org/10.1371/journal.pone.0142806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571505	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700074
J	Dudiki, T; Kadunganattil, S; Ferrara, JK; Kline, DW; Vijayaraghavan, S				Dudiki, Tejasvi; Kadunganattil, Suraj; Ferrara, John K.; Kline, Douglas W.; Vijayaraghavan, Srinivasan			Changes in Carboxy Methylation and Tyrosine Phosphorylation of Protein Phosphatase PP2A Are Associated with Epididymal Sperm Maturation and Motility	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; 2A CATALYTIC SUBUNIT; REGULATORY SUBUNIT; S-ADENOSYLHOMOCYSTEINE; TARGETED DISRUPTION; SPERMATOZOA; BINDING; FAMILY; METHYLESTERASE; REACTIVATION	Mammalian sperm contain the serine/threonine phosphatases PP1 gamma 2 and PP2A. The role of sperm PP1 gamma 2 is relatively well studied. Here we confirm the presence of PP2A in sperm and show that it undergoes marked changes in methylation (leucine 309), tyrosine phosphorylation (tyrosine 307) and catalytic activity during epididymal sperm maturation. Spermatozoa isolated from proximal caput, distal caput and caudal regions of the epididymis contain equal immuno-reactive amounts of PP2A. Using demethyl sensitive antibodies we show that PP2A is methylated at its carboxy terminus in sperm from the distal caput and caudal regions but not in sperm from the proximal caput region of the epididymis. The methylation status of PP2A was confirmed by isolation of PP2A with microcystin agarose followed by alkali treatment, which causes hydrolysis of protein carboxy methyl esters. Tyrosine phosphorylation of sperm PP2A varied inversely with methylation. That is, PP2A was tyrosine phosphorylated when it was demethylated but not when methylated. PP2A demethylation and its reciprocal tyrosine phosphorylation were also affected by treatment of sperm with L-homocysteine and adenosine, which are known to elevate intracellular S-adenosylhomocysteine, a feedback inhibitor of methyltransferases. Catalytic activity of PP2A declined during epididymal sperm maturation. Inhibition of PP2A by okadaic acid or by incubation of caudal epididymal spermatozoa with L-homocysteine and adenosine resulted in increase of sperm motility parameters including percent motility, velocity, and lateral head amplitude. Demethylation or pharmacological inhibition of PP2A also leads to an increase in phosphorylation of glycogen synthase kinase-3 (GSK3). Our results show for the first time that changes in PP2A activity due to methylation and tyrosine phosphorylation occur in sperm and that these changes may play an important role in the regulation of sperm function.	[Dudiki, Tejasvi; Kadunganattil, Suraj; Ferrara, John K.; Kline, Douglas W.; Vijayaraghavan, Srinivasan] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Dudiki, T (corresponding author), Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA.	tdudiki@kent.edu; svijayar@kent.edu	Kline, Douglas/AAH-5955-2020	Kline, Douglas/0000-0003-2555-6729; Kadunganattil, Suraj/0000-0002-4172-5011	National Institutes of Health [R15 HD068971]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD068971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health grants R15 HD068971 received by SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Bedford JM, 1990, MARSHALLS PHYSL REPR; Bhattacharjee R, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124495; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CASTANEDA E, 1983, INT J ANDROL, V6, P482, DOI 10.1111/j.1365-2605.1983.tb00562.x; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Connor JH, 1998, METH MOL B, V93, P41; FAVRE B, 1994, J BIOL CHEM, V269, P16311; FISHERFISCHBEIN J, 1985, INT J ANDROL, V8, P403, DOI 10.1111/j.1365-2605.1985.tb00853.x; GAGNON C, 1982, NEW ENGL J MED, V306, P821, DOI 10.1056/NEJM198204083061401; GAGNON C, 1984, BIOL REPROD, V30, P953, DOI 10.1095/biolreprod30.4.953; GOH P, 1985, GAMETE RES, V12, P399, DOI 10.1002/mrd.1120120407; Guo CY, 2002, J BIOL CHEM, V277, P4839, DOI 10.1074/jbc.M110092200; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Huang ZH, 2005, BIOL REPROD, V72, P384, DOI 10.1095/biolreprod.104.034140; Huang ZH, 2002, BIOL REPROD, V67, P1936, DOI 10.1095/biolreprod.102.004093; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Killilea SD, 1998, METH MOL B, V93, P23; Kloor D, 2004, TRENDS PHARMACOL SCI, V25, P294, DOI 10.1016/j.tips.2004.04.004; Kloor D, 2009, N-S ARCH PHARMACOL, V380, P215, DOI 10.1007/s00210-009-0432-x; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lee JA, 2007, J BIOL CHEM, V282, P30974, DOI 10.1074/jbc.M704861200; MacKay KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065967; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MOHRI H, 1980, EXP CELL RES, V127, P191, DOI 10.1016/0014-4827(80)90426-7; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Ortega-Gutierrez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002486; PARK IK, 1994, J BIOL CHEM, V269, P944; SANAGUSTIN JT, 1994, CELL MOTIL CYTOSKEL, V27, P206, DOI 10.1002/cm.970270303; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Somanath PR, 2004, J ANDROL, V25, P605; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Strack S, 1999, FEBS LETT, V460, P462, DOI 10.1016/S0014-5793(99)01377-0; Suzuki T, 2010, REPRODUCTION, V139, P847, DOI 10.1530/REP-08-0366; TAKAHASHI D, 1985, CELL STRUCT FUNCT, V10, P327, DOI 10.1247/csf.10.327; Thompson LJ, 1997, J BIOL CHEM, V272, P29693, DOI 10.1074/jbc.272.47.29693; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; VIJAYARAGHAVAN S, 1985, BIOL REPROD, V32, P489, DOI 10.1095/biolreprod32.3.489; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; WILLIAMSASHMAN HG, 1984, ADV ENZYME REGUL, V23, P389; YEUNG CH, 1984, GAMETE RES, V9, P99, DOI 10.1002/mrd.1120090109; Yoon SY, 2007, BIOCHEM BIOPH RES CO, V363, P811, DOI 10.1016/j.bbrc.2007.09.060; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zolnierowicz S, 1996, BIOCHEM J, V317, P187, DOI 10.1042/bj3170187	50	23	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0141961	10.1371/journal.pone.0141961	http://dx.doi.org/10.1371/journal.pone.0141961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569399	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700013
J	Johansson, EM; Garcia-Gutierrez, MS; Moscoso-Castro, M; Manzanares, J; Valverde, O				Johansson, Emily M.; Garcia-Gutierrez, Maria S.; Moscoso-Castro, Maria; Manzanares, Jorge; Valverde, Olga			Reduced Contextual Discrimination following Alcohol Consumption or MDMA Administration in Mice	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; ETHANOL DRINKING; RAT-BRAIN; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; NEURONAL DEVELOPMENT; PATTERN SEPARATION; MOUSE-BRAIN; CELL-DEATH	The recreational drugs, alcohol and 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") have both been shown to cause immune activation in vivo, and they are linked to cognitive impairment and anxiety-like behaviors in rodents. The neuronal effects of these drugs in the hippocampal area, an area that has been a focus of studies aiming to explain the mechanisms underlying anxiety related-disorders, remains poorly understood. Therefore we investigated the specific inflammatory impact of alcohol and MDMA on this area of the brain and on a hippocampal-related behavioral task. We centered our study on two inflammatory factors linked to anxiety-related disorders, namely Interleukin-1 beta (IL-1 beta) and brain-derived neurotrophic factor (BDNF). We subjected drug-consuming mice to a battery of behavioral tests to evaluate general activity, anxiety-like and depressive-live behaviors. We then introduced them to a contextual fear discrimination task and immune-related effects were examined by immunohistochemical and biochemical studies. Our results suggest that there is a relationship between the induction of immune activated pathways by voluntary alcohol consumption and a high-dose MDMA. Furthermore, the ability of mice to perform a contextual fear discrimination task was impaired by drug consumption and we report long term inflammatory alterations in the hippocampus even several weeks after drug intake. This information will be helpful for discovering new selective drug targets, and to develop treatments and preventive approaches for patients with anxiety-related disorders.	[Johansson, Emily M.; Moscoso-Castro, Maria; Valverde, Olga] Univ Pompeu Fabra, Neurobiol Behav Res Grp GReNeC, Dept Hlth & Expt Sci, IMIM,Hosp Mar,Med Res Inst, Barcelona 08003, Spain; [Garcia-Gutierrez, Maria S.; Manzanares, Jorge] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alicante, Spain; [Garcia-Gutierrez, Maria S.; Manzanares, Jorge; Valverde, Olga] Inst Salud Carlos III, RETICS, Madrid, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Instituto de Salud Carlos III	Valverde, O (corresponding author), Univ Pompeu Fabra, Neurobiol Behav Res Grp GReNeC, Dept Hlth & Expt Sci, IMIM,Hosp Mar,Med Res Inst, Barcelona Biomed Res Pk C Dr Aiguader 88, Barcelona 08003, Spain.	olga.valverde@upf.edu	Gutiérrez, Maria Salud García/AAY-6406-2021; Johansson, Emily M/J-1940-2014	Johansson, Emily M/0000-0001-8186-0747; Manzanares, Jorge/0000-0003-3830-7107; Manzanares, Jorge/0000-0002-4681-1533	Ministery of Economy [SAF2013-41761-R-FEDER]; Ministery of Health [Retic-ISCIII-FEDER-RD12/0028/0024-, 2014/020, Retic-ISCIII-FEDER-RD06/0001/1004, RD12/0028/0019]; Generalitat de Catalunya [2014SGR34]; Stiftelsen Olle Engkvist Byggmastare; Bodil Torkelssons stiftelse	Ministery of Economy; Ministery of Health; Generalitat de Catalunya(Generalitat de Catalunya); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Bodil Torkelssons stiftelse	This study was supported by Ministery of Economy (SAF2013-41761-R-FEDER), Ministery of Health (Retic-ISCIII-FEDER-RD12/0028/0024- and Plan Nacional sobre Drogas - 2014/020), and Generalitat de Catalunya (2014SGR34) to Olga Valverde; and Ministery of Health (Retic-ISCIII-FEDER-RD06/0001/1004, RD12/0028/0019) to Jorge Manzanares. Emily Johansson was a recipient of a fellowship from Stiftelsen Olle Engkvist Byggmastare and Bodil Torkelssons stiftelse.	Abad S, 2014, PSYCHOPHARMACOLOGY, V231, P863, DOI 10.1007/s00213-013-3304-5; Alfonso-Loeches S, 2011, CRIT REV CL LAB SCI, V48, P19, DOI 10.3109/10408363.2011.580567; [Anonymous], 2013, WORLD DRUG REP; [Anonymous], 2014, GLOB STAT REP ALC HL; Barrett SP, 2006, HUM PSYCHOPHARM CLIN, V21, P255, DOI 10.1002/hup.766; Buck HM, 2011, PSYCHOPHARMACOLOGY, V218, P203, DOI 10.1007/s00213-011-2388-z; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cippitelli A, 2014, ADDICT BIOL, V19, P27, DOI 10.1111/j.1369-1600.2012.00451.x; Colado MI, 1997, BRIT J PHARMACOL, V121, P827, DOI 10.1038/sj.bjp.0701201; Connor TJ, 2005, J PHARMACOL EXP THER, V312, P134, DOI 10.1124/jpet.104.073023; Danzer SC, 2002, J NEUROSCI, V22, P9754; Deak T, 2013, SPRINGER SCI, P133; Duman RS, 2002, EUR PSYCHIAT, V17, p306S; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Enquist J, 2012, NEUROPSYCHOPHARMACOL, V37, P2436, DOI 10.1038/npp.2012.102; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Gilbert PE, 2002, BEHAV NEUROSCI, V116, P63, DOI 10.1037//0735-7044.116.1.63; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hicklin TR, 2011, P NATL ACAD SCI USA, V108, P6650, DOI 10.1073/pnas.1017856108; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Johansson EM, 2011, J NEUROSCI RES, V89, P1761, DOI 10.1002/jnr.22707; Johnson JD, 2003, AM J PHYSIOL-REG I, V284, pR422, DOI 10.1152/ajpregu.00230.2002; Johnson JD, 2002, PSYCHONEUROENDOCRINO, V27, P353, DOI 10.1016/S0306-4530(01)00057-9; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; LAPCHAK PA, 1993, NEUROSCIENCE, V53, P297, DOI 10.1016/0306-4522(93)90196-M; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; Martinez-Turrillas R, 2006, NEUROSCI LETT, V402, P126, DOI 10.1016/j.neulet.2006.03.055; MCCANN UD, 1992, BIOL PSYCHIAT, V32, P950, DOI 10.1016/0006-3223(92)90185-3; McCardle K, 2004, PSYCHOPHARMACOLOGY, V173, P434, DOI 10.1007/s00213-004-1791-0; McClain JA, 2011, BRAIN BEHAV IMMUN, V25, pS120, DOI 10.1016/j.bbi.2011.01.006; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nixon K, 2006, HIPPOCAMPUS, V16, P287, DOI 10.1002/hipo.20162; Nona CN, 2013, BEHAV BRAIN RES, V242, P25, DOI 10.1016/j.bbr.2012.12.035; Orio L, 2004, J NEUROCHEM, V89, P1445, DOI 10.1111/j.1471-4159.2004.02443.x; PALKOVITS M, 1983, METHOD ENZYMOL, V103, P368; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pugh CR, 2001, NEUROSCI BIOBEHAV R, V25, P29, DOI 10.1016/S0149-7634(00)00048-8; Qin LY, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-10; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Raivio N, 2012, EUR J PHARMACOL, V687, P9, DOI 10.1016/j.ejphar.2012.04.021; Revest JM, 2014, MOL PSYCHIATR, V19, P1001, DOI 10.1038/mp.2013.134; Revest JM, 2010, MOL PSYCHIATR, V15, P1140, DOI 10.1038/mp.2010.40; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Ros-Simo C, 2013, J NEUROCHEM, V125, P736, DOI 10.1111/jnc.12247; Ros-Simo C, 2012, PSYCHOPHARMACOLOGY, V221, P511, DOI 10.1007/s00213-011-2598-4; Rubio-Araiz A, 2014, INT J NEUROPSYCHOPH, V17, P1243, DOI 10.1017/S1461145714000145; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; SCHMIDT CJ, 1987, BIOCHEM PHARMACOL, V36, P747, DOI 10.1016/0006-2952(87)90729-5; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Spivak B, 1997, BIOL PSYCHIAT, V42, P345, DOI 10.1016/S0006-3223(96)00375-7; Stevenson JR, 2009, NEUROPSYCHOPHARMACOL, V34, P1209, DOI 10.1038/npp.2008.90; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Tiwari V, 2011, J NEUROCHEM, V117, P678, DOI 10.1111/j.1471-4159.2011.07236.x; Valles SL, 2004, BRAIN PATHOL, V14, P365; Valverde O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004704; Weber GF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/141396; White AM, 2000, HIPPOCAMPUS, V10, P88, DOI 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L; Whitman BA, 2013, ALCOHOL CLIN EXP RES, V37, P2086, DOI 10.1111/acer.12189; Wilcox MV, 2014, NEUROPSYCHOPHARMACOL, V39, P579, DOI 10.1038/npp.2013.230; Winstock AR, 2001, DRUG ALCOHOL DEPEN, V64, P9, DOI 10.1016/S0376-8716(00)00215-5; Zhang L, 2014, MOL PSYCHIATR, V19, P8, DOI 10.1038/mp.2012.180; Zorumski CF, 2014, ALCOHOL, V48, P1, DOI 10.1016/j.alcohol.2013.09.045; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077	76	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142978	10.1371/journal.pone.0142978	http://dx.doi.org/10.1371/journal.pone.0142978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566284	Green Published, Green Submitted, gold			2022-12-26	WOS:000367628500082
J	Marjon, KD; Termini, CM; Karlen, KL; Saito-Reis, C; Soria, CE; Lidke, KA; Gillette, JM				Marjon, K. D.; Termini, C. M.; Karlen, K. L.; Saito-Reis, C.; Soria, C. E.; Lidke, K. A.; Gillette, J. M.			Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin	ONCOGENE			English	Article							CANCER-CELL-LINES; HEMATOPOIETIC STEM; PROGENITOR CELLS; PROTEIN; METASTASIS; MEMBRANE; ADHESION; PALMITOYLATION; EXPRESSION; INTEGRIN	Communication between acute myeloid leukemia (AML) and the bone marrow microenvironment is known to control disease progression. Therefore, regulation of AML cell trafficking and adhesion to the bone marrow is of significant interest. In this study, we demonstrate that differential expression of the membrane scaffold CD82 modulates the bone marrow homing of AML cells. By combining mutational analysis and super-resolution imaging, we identify membrane protein clustering by CD82 as a regulator of AML cell adhesion and bone marrow homing. Cluster analysis of super-resolution data indicates that N-linked glycosylation and palmitoylation of CD82 are both critical modifications that control the microdomain organization of CD82 as well as the nanoscale clustering of associated adhesion protein, N-cadherin. We demonstrate that the inhibition of CD82 glycosylation increases the molecular packing of N-cadherin and promotes the bone marrow homing of AML cells. In contrast, we find that the inhibition of CD82 palmitoylation disrupts the formation and organization of N-cadherin clusters and significantly diminishes bone marrow trafficking of AML. Taken together, these data establish a mechanism where the membrane organization of CD82, through specific posttranslational modifications, regulates N-cadherin clustering and membrane density, which impacts the in vivo trafficking of AML cells. As such, these observations provide an alternative model for targeting AML where modulation of protein organization within the membrane may be an effective treatment therapy to disrupt the bone marrow homing potential of AML cells.	[Marjon, K. D.; Termini, C. M.; Karlen, K. L.; Saito-Reis, C.; Soria, C. E.; Gillette, J. M.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, MSC 08-4640, Albuquerque, NM 87131 USA; [Lidke, K. A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico	Gillette, JM (corresponding author), Univ New Mexico, Dept Pathol, Hlth Sci Ctr, MSC 08-4640, Albuquerque, NM 87131 USA.	JGillette@salud.unm.edu	Termini, Christina/AAC-7667-2019	Termini, Christina/0000-0002-1831-1347; Saito Reis, Chelsea/0000-0002-6431-4602; Volcko, Karin Linnea/0000-0002-4234-0703	NIH [R01 HL122483-01A1]; New Mexico INBRE grant [NIH P20 GM103451]; University of New Mexico Cancer Center [NIH P30CA118100]; American Cancer Society Institutional Research Grant; NM Spatiotemporal Modeling Center [NIH T32 HL007736, NIH P50 GM085273, NIH F31 HL124977]; University of New Mexico Department of Pathology; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007736, R01HL122483, F31HL124977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273, P20GM103451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Mexico INBRE grant; University of New Mexico Cancer Center; American Cancer Society Institutional Research Grant(American Cancer Society); NM Spatiotemporal Modeling Center; University of New Mexico Department of Pathology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge all of the funding sources that made this work possible. This includes funding from an NIH R01 HL122483-01A1 to JMG, a New Mexico INBRE grant subaward to JMG (NIH P20 GM103451), pilot funding from the University of New Mexico Cancer Center (NIH P30CA118100), an American Cancer Society Institutional Research Grant, a Post-Doctoral Training Fellowship to KDM (NIH T32 HL007736), Graduate Student Training Fellowships to CMT from the NM Spatiotemporal Modeling Center (NIH P50 GM085273) and (NIH F31 HL124977), and a Graduate Student Training Fellowship to CSR (NIH T32 HL007736). We also thank the NM Spatiotemporal Modeling Center for supporting the Super-Resolution Imaging Core Facility (NIH P50 GM085273) and the University of New Mexico Cancer Center (NIH P30CA118100) for use of the Keck-UNM Small Animal Models and Imaging Shared Resource. This work was also supported through faculty start-up funds to JMG from the University of New Mexico Department of Pathology. Finally, we would like to acknowledge the technical assistance of Rebecca J. Dodd and Dr I-Ming Chen, University of New Mexico Health Sciences Center. In addition, we would like to acknowledge the assistance of Dr Ravi Majeti, Division of Hematology, Institute for Stem Cell Biology and Regenerative Medicine, and Cancer Institute, Stanford University and the Stanford University Division of Hematology Tissue Bank for samples. (http://www.nature.com/onc)	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Bassani S, 2012, INT J BIOCHEM CELL B, V44, P703, DOI 10.1016/j.biocel.2012.01.020; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Bonardi F, 2013, MOL CELL PROTEOMICS, V12, P626, DOI 10.1074/mcp.M112.021931; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; BRADSTOCK KF, 1995, LEUKEMIA LYMPHOMA, V18, P1, DOI 10.3109/10428199509064917; Bromberg O, 2012, BLOOD, V120, P303, DOI 10.1182/blood-2011-09-377853; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; DWIVEDI C, 1988, CANCER DETECT PREV, V11, P191; Ester M., 1996, P KDD 96, P1; Gibson LF, 2002, LEUKEMIA LYMPHOMA, V43, P19, DOI 10.1080/10428190210188; GIL ML, 1992, J IMMUNOL, V148, P2826; Greenbaum AM, 2012, BLOOD, V120, P295, DOI 10.1182/blood-2011-09-377457; Guzman ML, 2014, STEM CELLS, V32, P844, DOI 10.1002/stem.1597; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hong S, 2013, J CELL BIOL, V201, P131, DOI 10.1083/jcb.201211054; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; IMAI T, 1992, J IMMUNOL, V149, P2879; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Konopleva M, 2002, LEUKEMIA, V16, P1713, DOI 10.1038/sj.leu.2402608; Larochelle A, 2012, BLOOD, V119, P1848, DOI 10.1182/blood-2011-08-371583; LEBELBINAY S, 1994, CELL IMMUNOL, V154, P468, DOI 10.1006/cimm.1994.1092; Machida U, 1999, NEW ENGL J MED, V340, P810; Malik FA, 2009, HISTOL HISTOPATHOL, V24, P519, DOI 10.14670/HH-24.519; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; Mazurov D, 2007, J BIOL CHEM, V282, P3896, DOI 10.1074/jbc.M607322200; Miranti CK, 2009, CELL SIGNAL, V21, P196, DOI 10.1016/j.cellsig.2008.08.023; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nishioka C, 2013, INT J CANCER, V132, P2006, DOI 10.1002/ijc.27904; Qiu SW, 2014, LEUKEMIA RES, V38, P632, DOI 10.1016/j.leukres.2014.03.007; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Termini CM, 2014, MOL BIOL CELL, V25, P1560, DOI 10.1091/mbc.E13-11-0660; Wang H, 2012, J PROTEOMICS, V75, P1375, DOI 10.1016/j.jprot.2011.11.013; White A, 1998, ONCOGENE, V16, P3143, DOI 10.1038/sj.onc.1201852; Xu Y, 2014, INT J CLIN EXP PATHO, V7, P5569; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yoshida T, 2008, TRAFFIC, V9, P540, DOI [10.1111/j.1600-0854.2007.00700.x, 10.1111/j.1600-0854.2008.00700.x]; Zaitseva L, 2014, ONCOTARGET, V5, P9930, DOI 10.18632/oncotarget.2479; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhang J, 2006, MICRON, V37, P14, DOI 10.1016/j.micron.2005.03.014; Zhi L, 2010, CANCER LETT, V296, P65, DOI 10.1016/j.canlet.2010.03.021; Zhou B, 2004, CANCER RES, V64, P7455, DOI 10.1158/0008-5472.CAN-04-1574	48	29	30	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4132	4140		10.1038/onc.2015.449	http://dx.doi.org/10.1038/onc.2015.449			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26592446	Green Accepted, Bronze			2022-12-26	WOS:000381020900011
J	Bruser, A; Schulz, A; Rothemund, S; Ricken, A; Calebiro, D; Kleinau, G; Schoneberg, T				Brueser, Antje; Schulz, Angela; Rothemund, Sven; Ricken, Albert; Calebiro, Davide; Kleinau, Gunnar; Schoeneberg, Torsten			The Activation Mechanism of Glycoprotein Hormone Receptors with Implications in the Cause and Therapy of Endocrine Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; PROTEIN-COUPLED RECEPTORS; THYROTROPIN RECEPTOR; TSH RECEPTOR; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVITY; MOLECULAR-CLONING; THYROID-FUNCTION	Glycoprotein hormones (GPHs) are the main regulators of the pituitary-thyroid and pituitary-gonadal axes. Selective interaction between GPHs and their cognate G protein-coupled receptors ensure specificity in GPH signaling. The mechanisms of how these hormones activate glycoprotein hormone receptors (GPHRs) or how mutations and autoantibodies can alter receptor function were unclear. Based on the hypothesis that GPHRs contain an internal agonist, we systematically screened peptide libraries derived from the ectodomain for agonistic activity on the receptors. We show that a peptide (p10) derived from a conserved sequence in the C-terminal part of the extracellular N terminus can activate all GPHRs in vitro and in GPHR-expressing tissues. Inactivating mutations in this conserved region or in p10 can inhibit activation of the thyroid-stimulating hormone receptor by autoantibodies. Our data suggest an activation mechanism where, upon extracellular ligand binding, this intramolecular agonist isomerizes and induces structural changes in the 7-transmembrane helix domain, triggering G protein activation. This mechanism can explain the pathophysiology of activating autoantibodies and several mutations causing endocrine dysfunctions such as Graves disease and hypo- and hyperthyroidism. Our findings highlight an evolutionarily conserved activation mechanism of GPHRs and will further promote the development of specific ligands useful to treat Graves disease and other dysfunctions of GPHRs.	[Brueser, Antje; Schulz, Angela; Schoeneberg, Torsten] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany; [Rothemund, Sven] Univ Leipzig, Core Unit Peptide Technol, D-04103 Leipzig, Germany; [Ricken, Albert] Univ Leipzig, Fac Med, Inst Anat, D-04103 Leipzig, Germany; [Calebiro, Davide] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Calebiro, Davide] Univ Wurzburg, Rudolf Virchow Ctr, Bioimaging Ctr, D-97078 Wurzburg, Germany; [Kleinau, Gunnar] Charite, Inst Expt Pediat Endocrinol, D-13353 Berlin, Germany	Leipzig University; Leipzig University; Leipzig University; University of Wurzburg; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schoneberg, T (corresponding author), Univ Leipzig, Fac Med, Inst Biochem, Mol Biochem, Johannisallee 30, D-04103 Leipzig, Germany.	schoberg@medizin.uni-leipzig.de	Kleinau, Gunnar/GPX-6330-2022	calebiro, davide/0000-0002-3811-1553	Deutsche Forschungsgemeinschaft (SSP ThyroidTransAct) [BR 5108/1-1 AO 619225, SFB/Transregio 166]; BMBF (IFB AdipositasDiseases Leipzig) [FZ: 01EO1001]; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Wurzburg [B-281]; University of Leipzig	Deutsche Forschungsgemeinschaft (SSP ThyroidTransAct)(German Research Foundation (DFG)); BMBF (IFB AdipositasDiseases Leipzig)(Federal Ministry of Education & Research (BMBF)); Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Wurzburg; University of Leipzig	The work was supported by the Deutsche Forschungsgemeinschaft (SSP ThyroidTransAct; BR 5108/1-1 AO 619225 and SFB/Transregio 166, project C1), the BMBF (IFB AdipositasDiseases Leipzig, FZ: 01EO1001), Interdisziplinares Zentrum fur Klinische Forschung (IZKF) Wurzburg (B-281) and the University of Leipzig (Junior research grant by the Medical Faculty). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Alvarez CA, 1999, ENDOCRINOLOGY, V140, P1775, DOI 10.1210/en.140.4.1775; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Biebermann H, 2001, J CLIN ENDOCR METAB, V86, P4429, DOI 10.1210/jc.86.9.4429; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Chen CR, 2003, ENDOCRINOLOGY, V144, P1324, DOI 10.1210/en.2002-0005; Claus M, 2005, ENDOCRINOLOGY, V146, P5197, DOI 10.1210/en.2005-0713; Costagliola S, 2004, MOL ENDOCRINOL, V18, P3020, DOI 10.1210/me.2004-0231; Costanzi Stefano, 2012, Methods Mol Biol, V857, P259, DOI 10.1007/978-1-61779-588-6_11; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; deRoux N, 1996, J CLIN ENDOCR METAB, V81, P4229, DOI 10.1210/jc.81.12.4229; DUMONT JE, 1992, PHYSIOL REV, V72, P667, DOI 10.1152/physrev.1992.72.3.667; Duprez L, 1997, FEBS LETT, V409, P469, DOI 10.1016/S0014-5793(97)00532-2; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; Heitman LH, 2008, MOL PHARMACOL, V73, P518, DOI 10.1124/mol.107.039875; Ho SC, 2001, ENDOCRINOLOGY, V142, P2760, DOI 10.1210/en.142.7.2760; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Kleinau G, 2013, ENDOCR REV, V34, P691, DOI 10.1210/er.2012-1072; Kleinau G, 2011, J BIOL CHEM, V286, P25859, DOI 10.1074/jbc.M110.196980; Kleinau G, 2010, HUM MUTAT, V31, pE1519, DOI 10.1002/humu.21265; Kopp P, 1997, J CLIN INVEST, V100, P1634, DOI 10.1172/JCI119687; Krause G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052920; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majumdar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040291; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Mueller S, 2006, J BIOL CHEM, V281, P31638, DOI 10.1074/jbc.M604770200; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Neumann S, 2014, ENDOCRINOLOGY, V155, P310, DOI 10.1210/en.2013-1835; Neumann S, 2009, P NATL ACAD SCI USA, V106, P12471, DOI 10.1073/pnas.0904506106; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanders J, 2004, THYROID, V14, P560, DOI 10.1089/1050725041692918; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders P, 2011, J MOL ENDOCRINOL, V46, P81, DOI 10.1530/JME-10-0127; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schmutzler C, 1998, EXP CLIN ENDOCR DIAB, V106, pS1, DOI 10.1055/s-0029-1212036; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schulz A, 1999, MOL ENDOCRINOL, V13, P181, DOI 10.1210/me.13.2.181; Smith BR, 2007, THYROID, V17, P923, DOI 10.1089/thy.2007.0239; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Stavrou SS, 1998, J CLIN ENDOCR METAB, V83, P2091, DOI 10.1210/jc.83.6.2091; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514	58	42	43	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					508	520		10.1074/jbc.M115.701102	http://dx.doi.org/10.1074/jbc.M115.701102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582202	Green Published, hybrid			2022-12-26	WOS:000367830500001
J	Fichorova, RN; Yamamoto, HS; Fashemi, T; Foley, E; Ryan, S; Beatty, N; Dawood, H; Hayes, GR; St-Pierre, G; Sato, S; Singh, BN				Fichorova, Raina N.; Yamamoto, Hidemi S.; Fashemi, Titilayo; Foley, Evan; Ryan, Stanthia; Beatty, Noah; Dawood, Hassan; Hayes, Gary R.; St-Pierre, Guillaume; Sato, Sachiko; Singh, Bibhuti N.			Trichomonas vaginalis Lipophosphoglycan Exploits Binding to Galectin-1 and-3 to Modulate Epithelial Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCAN INTERACTIONS; INNATE IMMUNITY; EXPRESSION; CELLS; RECEPTOR; PROTEIN; MICROBICIDES; RECOGNITION; RECRUITMENT; CYTOKINES	Trichomoniasis is the most common non-viral sexually transmitted infection caused by the vaginotropic extracellular protozoan parasite Trichomonas vaginalis. The infection is recurrent, with no lasting immunity, often asymptomatic, and linked to pregnancy complications and risk of viral infection. The molecular mechanisms of immune evasion by the parasite are poorly understood. We demonstrate that galectin-1 and -3 are expressed by the human cervical and vaginal epithelial cells and act as pathogen-recognition receptors for the ceramide phosphoinositol glycan core (CPI-GC) of the dominant surface protozoan lipophosphoglycan (LPG). We used an in vitro model with siRNA galectin knockdown epithelial clones, recombinant galectins, clinical Trichomonas isolates, and mutant protozoan derivatives to dissect the function of galectin-1 and -3 in the context of Trichomonas infection. Galectin-1 suppressed chemokines that facilitate recruitment of phagocytes, which can eliminate extracellular protozoa (IL-8) or bridge innate to adaptive immunity (MIP-3 alpha and RANTES (regulated on activation normalTcell expressed and secreted)). Silencing galectin-1 increased and adding exogenous galectin-1 suppressed chemokine responses to Trichomonas or CPI-GC/LPG. In contrast, silencing galectin-3 reduced IL-8 response to LPG. Live Trichomonas depleted the extracellular levels of galectin-3. Clinical isolates and mutant Trichomonas CPI-GC that had reduced affinity to galectin-3 but maintained affinity to galectin-1 suppressed chemokine expression. Thus via CPI-GC binding, Trichomonas is capable of regulating galectin bioavailability and function to the benefit of its parasitic survival. These findings suggest novel approaches to control trichomoniasis and warrant further studies of galectin-binding diversity among clinical isolates as a possible source for symptom disparity in parasitic infections.	[Fichorova, Raina N.; Yamamoto, Hidemi S.; Fashemi, Titilayo; Foley, Evan; Ryan, Stanthia; Beatty, Noah; Dawood, Hassan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol,Lab Genital Tra, Boston, MA 02115 USA; [Hayes, Gary R.; Singh, Bibhuti N.] SUNY Upstate Med Univ, Dept Biochem, Syracuse, NY 13210 USA; [Hayes, Gary R.; Singh, Bibhuti N.] SUNY Upstate Med Univ, Dept Mol Biol, Syracuse, NY 13210 USA; [Hayes, Gary R.; Singh, Bibhuti N.] SUNY Upstate Med Univ, Dept Obstet & Gynecol, Syracuse, NY 13210 USA; [St-Pierre, Guillaume; Sato, Sachiko] Univ Laval, Fac Med, Res Ctr Infect Dis, Lab Glycobiol & Bioimaging, Quebec City, PQ G1V 4G2, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Laval University	Fichorova, RN (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, 221 Longwood Ave,RF468, Boston, MA 02115 USA.	rfichorova@rics.bwh.harvard.edu			National Institutes of Health from NIAID [5R01AI079085]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079085] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 5R01AI079085 from NIAID. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Almkvist J, 2002, J IMMUNOL, V168, P4034, DOI 10.4049/jimmunol.168.8.4034; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bastida-Corcuera FD, 2005, EUKARYOT CELL, V4, P1951, DOI 10.1128/EC.4.11.1951-1958.2005; Bhaumik P, 2013, J IMMUNOL, V190, P630, DOI 10.4049/jimmunol.1103197; Blois SM, 2014, J REPROD IMMUNOL, V101, P127, DOI 10.1016/j.jri.2013.05.005; Canny GO, 2006, J INFECT DIS, V194, P498, DOI 10.1086/505712; Chen HY, 2014, CURR OPIN MICROBIOL, V17, P75, DOI 10.1016/j.mib.2013.11.006; Cooper D, 2012, ANN NY ACAD SCI, V1253, P181, DOI 10.1111/j.1749-6632.2011.06291.x; Demmert M, 2012, CLIN EXP IMMUNOL, V167, P246, DOI 10.1111/j.1365-2249.2011.04509.x; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q; Fichorova RN, 2006, INFECT IMMUN, V74, P5773, DOI 10.1128/IAI.00631-06; Fichorova RN, 2013, SEX TRANSM INFECT, V89, P460, DOI 10.1136/sextrans-2013-051052; Fichorova RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048418; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00168-11; Fichorova RN, 2009, J REPROD IMMUNOL, V83, P185, DOI 10.1016/j.jri.2009.08.007; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; Gilbert RO, 2000, INFECT IMMUN, V68, P4200, DOI 10.1128/IAI.68.7.4200-4206.2000; Guha-Niyogi A, 2001, GLYCOBIOLOGY, V11, p45R, DOI 10.1093/glycob/11.4.45R; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Huppert JS, 2013, J INFECT DIS, V207, P1462, DOI 10.1093/infdis/jit039; Jain A, 2014, HUM REPROD, V29, P242, DOI 10.1093/humrep/det423; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Lustig G, 2013, INFECT IMMUN, V81, P1411, DOI 10.1128/IAI.01244-12; Maier O, 2012, J VIROL, V86, P10821, DOI 10.1128/JVI.01428-12; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Nieminen J, 2008, J IMMUNOL, V180, P2466, DOI 10.4049/jimmunol.180.4.2466; Nio-Kobayashi J., 2010, KAIBOUGAKU ZASSHI TO, V85, P58; Nyame AK, 2004, ARCH BIOCHEM BIOPHYS, V426, P182, DOI 10.1016/j.abb.2004.04.004; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Pelletier I, 2003, J BIOL CHEM, V278, P22223, DOI 10.1074/jbc.M302693200; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; Rabinovich GA, 2005, PARASITE IMMUNOL, V27, P103, DOI 10.1111/j.1365-3024.2005.00749.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; SATO S, 1994, J BIOL CHEM, V269, P4424; Sato S, 2014, CRIT REV IMMUNOL, V34, P147, DOI 10.1615/CritRevImmunol.2014010154; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Singh BN, 2009, GLYCOCONJUGATE J, V26, P3, DOI 10.1007/s10719-008-9157-1; SINGH BN, 1994, ARCH BIOCHEM BIOPHYS, V309, P273, DOI 10.1006/abbi.1994.1113; SINGH BN, 1993, MOL BIOCHEM PARASIT, V57, P281, DOI 10.1016/0166-6851(93)90204-B; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; St-Pierre C, 2010, METHOD ENZYMOL, V480, P267, DOI 10.1016/S0076-6879(10)80013-8; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Trifonova RT, 2009, ANTIMICROB AGENTS CH, V53, P1490, DOI 10.1128/AAC.01152-08; Trifonova RT, 2006, ANTIMICROB AGENTS CH, V50, P4005, DOI 10.1128/AAC.00588-06; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; van der Leij J, 2004, J PATHOL, V204, P511, DOI 10.1002/path.1671; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; WHO, 2012, GLOB INC PREV SEL CU	63	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					998	1013		10.1074/jbc.M115.651497	http://dx.doi.org/10.1074/jbc.M115.651497			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26589797	hybrid, Green Published			2022-12-26	WOS:000367830500045
J	Vicente, JB; Colaco, HG; Sarti, P; Leandro, P; Giuffre, A				Vicente, Joao B.; Colaco, Henrique G.; Sarti, Paolo; Leandro, Paula; Giuffre, Alessandro			S-Adenosyl-L-methionine Modulates CO and NO center dot Binding to the Human H2S-generating Enzyme Cystathionine beta-Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYLMETHIONINE SAM; CELL-PROLIFERATION; HYDROGEN-SULFIDE; STRUCTURAL-BASIS; NITRIC-OXIDE; HEME; KINETICS; DOMAIN; CBS; BIOENERGETICS	Cystathionine beta-synthase (CBS) is a key enzyme in human (patho) physiology with a central role in hydrogen sulfide metabolism. The enzyme is composed of a pyridoxal 5'-phosphate-binding catalytic domain, flanked by the following two domains: a heme-binding N-terminal domain and a regulatory C-terminal domain binding S-adenosyl-L-methionine (AdoMet). CO or NO center dot binding at the ferrous heme negatively modulates the enzyme activity. Conversely, AdoMet binding stimulates CBS activity. Here, we provide experimental evidence for a functional communication between the two domains. We report that AdoMet binding significantly enhances CBS inhibition by CO. Consistently, we observed increased affinity (similar to 5-fold) and faster association (similar to 10-fold) of CO to the ferrous heme at physiological AdoMet concentrations. NO similar to binding to reduced CBS was also enhanced by AdoMet, although to a lesser extent (similar to 2-fold higher affinity) as compared with CO. Importantly, CO and NO center dot binding was unchanged by AdoMet in a truncated form of CBS lacking the C-terminal regulatory domain. These unprecedented observations demonstrate that CBS activation by AdoMet puzzlingly sensitizes the enzyme toward inhibition by exogenous ligands, like CO and NO center dot. This further supports the notion that CBS regulation is a complex process, involving the concerted action of multiple physiologically relevant effectors.	[Vicente, Joao B.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Colaco, Henrique G.; Leandro, Paula] Univ Lisbon, Fac Pharm, Med Res Inst, Metab & Genet Grp, P-1649003 Lisbon, Portugal; [Sarti, Paolo] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Sarti, Paolo] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Sarti, Paolo] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1640003 Lisbon, Portugal; [Giuffre, Alessandro] Natl Res Council Italy, Inst Mol Biol & Pathol, I-00185 Rome, Italy	Universidade Nova de Lisboa; Universidade de Lisboa; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Universidade de Lisboa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Vicente, JB (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Av Republ, P-2780156 Oeiras, Portugal.	jvicente@itqb.unl.pt; alessandro.giuffre@uniroma1.it	Vicente, Joao B/L-8732-2016; Giuffrè, Alessandro/K-4341-2015; iMed.ULisboa, MetGen/B-5293-2014; Leandro, Paula/A-8323-2014; Colaço, Henrique/AAV-2243-2020; Colaco, Henrique/M-5790-2014	Giuffrè, Alessandro/0000-0001-5301-0681; Leandro, Paula/0000-0002-2946-9342; Colaco, Henrique/0000-0002-2026-0163; Vicente, Joao/0000-0001-5244-8059	Fundacao para a Ciencia e Tecnologia [PEst-OE/SAU/UI4013/2011, PTDC/SAU-MIC/111447/2009]; Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy PNR-CNR Aging; Fondo per gli Investimenti della Ricerca di Base [RBIN06E9Z8]; Progetti di Rilevante Interesse Nazionale [20107Z8XBW_005]; Consiglio Nazionale delle Ricerche of Italy; Fundacao para a Ciencia e Tecnologia of Portugal; Federation of European Biochemical Societies	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy PNR-CNR Aging; Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Progetti di Rilevante Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Consiglio Nazionale delle Ricerche of Italy(Consiglio Nazionale delle Ricerche (CNR)); Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology); Federation of European Biochemical Societies	This work was supported in part by Fundacao para a Ciencia e Tecnologia Grants PEst-OE/SAU/UI4013/2011 and PTDC/SAU-MIC/111447/2009 (to J. B. V.), Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy PNR-CNR Aging Program 2012-2014 (to A. G.), Fondo per gli Investimenti della Ricerca di Base RBIN06E9Z8 and Progetti di Rilevante Interesse Nazionale 20107Z8XBW_005 (to P. S.), and a bilateral grant award by Consiglio Nazionale delle Ricerche of Italy and Fundacao para a Ciencia e Tecnologia of Portugal (to A. G. and J. B. V.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a short term fellowship from the Federation of European Biochemical Societies.	Banerjee R, 2011, ANTIOXID REDOX SIGN, V15, P339, DOI 10.1089/ars.2011.3912; Bhattacharyya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079167; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carballal S, 2008, BIOCHEMISTRY-US, V47, P3194, DOI 10.1021/bi700912k; Carballal S, 2013, BIOCHEMISTRY-US, V52, P4553, DOI 10.1021/bi4004556; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; Ereno-Orbea J, 2014, P NATL ACAD SCI USA, V111, pE3845, DOI 10.1073/pnas.1414545111; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; FINKELSTEIN JD, 1982, J NUTR, V112, P1011, DOI 10.1093/jn/112.5.1011; Gherasim C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085544; Hellmich MR, 2015, ANTIOXID REDOX SIGN, V22, P424, DOI 10.1089/ars.2014.5933; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; HINTZ MJ, 1980, J BIOL CHEM, V255, P7317; Hishiki T, 2012, J MOL MED, V90, P245, DOI 10.1007/s00109-012-0875-2; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Kluijtmans LAJ, 1996, J CLIN INVEST, V98, P285, DOI 10.1172/JCI118791; Majtan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105290; McCorvie TJ, 2014, J BIOL CHEM, V289, P36018, DOI 10.1074/jbc.M114.610782; Mendes MIS, 2014, HUM MUTAT, V35, P1195, DOI 10.1002/humu.22616; Mendes MIS, 2014, J INHERIT METAB DIS, V37, P245, DOI 10.1007/s10545-013-9647-6; Modis K, 2014, NITRIC OXIDE-BIOL CH, V41, P146, DOI 10.1016/j.niox.2014.03.001; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Pey AL, 2013, BIOCHEM J, V449, P109, DOI 10.1042/BJ20120731; Prathapasinghe GA, 2008, AM J PHYSIOL-RENAL, V295, pF912, DOI 10.1152/ajprenal.00040.2008; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Puranik M, 2006, J BIOL CHEM, V281, P13433, DOI 10.1074/jbc.M600246200; Quaroni LG, 2004, BIOCHEMISTRY-US, V43, P16416, DOI 10.1021/bi049163g; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Smith AT, 2012, BIOCHEMISTRY-US, V51, P6360, DOI 10.1021/bi300421z; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Vicente JB, 2014, J BIOL CHEM, V289, P8579, DOI 10.1074/jbc.M113.507533; Yadav PK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414706	46	27	28	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					572	581		10.1074/jbc.M115.681221	http://dx.doi.org/10.1074/jbc.M115.681221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582199	hybrid, Green Published			2022-12-26	WOS:000367830500006
J	Fleck, D; Voss, M; Brankatschk, B; Giudici, C; Hampel, H; Schwenk, B; Edbauer, D; Fukumori, A; Steiner, H; Kremmer, E; Haug-Kroper, M; Rossner, MJ; Fluhrer, R; Willem, M; Haass, C				Fleck, Daniel; Voss, Matthias; Brankatschk, Ben; Giudici, Camilla; Hampel, Heike; Schwenk, Benjamin; Edbauer, Dieter; Fukumori, Akio; Steiner, Harald; Kremmer, Elisabeth; Haug-Kroeper, Martina; Rossner, Moritz J.; Fluhrer, Regina; Willem, Michael; Haass, Christian			Proteolytic Processing of Neuregulin 1 Type III by Three Intramembrane-cleaving Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; Alzheimer disease; amyloid- (AB); -secretase 1 (BACE1); -secretase; neurodegeneration	SIGNAL PEPTIDE PEPTIDASE; AMYLOID PRECURSOR PROTEIN; DEPENDENT GAMMA-SECRETASE; BETA-LIKE PEPTIDE; INTRACELLULAR DOMAIN; TRANSMEMBRANE DOMAIN; ASPARTYL PROTEASES; TNF-ALPHA; CLEAVAGE; BACE1	Numerous membrane-bound proteins undergo regulated intramembrane proteolysis. Regulated intramembrane proteolysis is initiated by shedding, and the remaining stubs are further processed by intramembrane-cleaving proteases (I-CLiPs). Neuregulin 1 type III (NRG1 type III) is a major physiological substrate of -secretase (-site amyloid precursor protein-cleaving enzyme 1 (BACE1)). BACE1-mediated cleavage is required to allow signaling of NRG1 type III. Because of the hairpin nature of NRG1 type III, two membrane-bound stubs with a type 1 and a type 2 orientation are generated by proteolytic processing. We demonstrate that these stubs are substrates for three I-CLiPs. The type 1-oriented stub is further cleaved by -secretase at an E-like site five amino acids N-terminal to the C-terminal membrane anchor and at a -like site in the middle of the transmembrane domain. The E-cleavage site is only one amino acid N-terminal to a Val/Leu substitution associated with schizophrenia. The mutation reduces generation of the NRG1 type III -peptide as well as reverses signaling. Moreover, it affects the cleavage precision of -secretase at the -site similar to certain Alzheimer disease-associated mutations within the amyloid precursor protein. The type 2-oriented membrane-retained stub of NRG1 type III is further processed by signal peptide peptidase-like proteases SPPL2a and SPPL2b. Expression of catalytically inactive aspartate mutations as well as treatment with 2,2-(2-oxo-1,3-propanediyl)bis[(phenylmethoxy)carbonyl]-l-leucyl-l-leucinamide ketone inhibits formation of N-terminal intracellular domains and the corresponding secreted C-peptide. Thus, NRG1 type III is the first protein substrate that is not only cleaved by multiple sheddases but is also processed by three different I-CLiPs.	[Fleck, Daniel; Voss, Matthias; Giudici, Camilla; Hampel, Heike; Steiner, Harald; Haug-Kroeper, Martina; Fluhrer, Regina; Willem, Michael; Haass, Christian] Univ Munich, Biomed Ctr, Biochem, D-81377 Munich, Germany; [Brankatschk, Ben; Rossner, Moritz J.] Univ Munich, Psychiat Clin, Dept Mol Neurobiol, D-80336 Munich, Germany; [Schwenk, Benjamin; Edbauer, Dieter; Fukumori, Akio; Steiner, Harald; Fluhrer, Regina; Haass, Christian] German Ctr Neurodegenerat Dis DZNE, D-81377 Munich, Germany; [Edbauer, Dieter; Kremmer, Elisabeth; Haass, Christian] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Willem, M (corresponding author), Univ Munich, Inst Metab Biochem, Feodor Lynen Str 17, D-81377 Munich, Germany.	Michael.Willem@mail03.med.uni-muenchen.de; christian.haass@mail03.med.uni-muenchen.de	Edbauer, Dieter/M-9906-2019	Edbauer, Dieter/0000-0002-7186-4653; Voss, Matthias/0000-0002-4217-3175	Deutsche Forschungsgemeinschaft [HA 1737-11, FL 635/2-1, FOR2290, HA 1737/13-1]; MetLife Award; Hans and Ilse Breuer Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MetLife Award; Hans and Ilse Breuer Foundation	This work was supported in part by Deutsche Forschungsgemeinschaft Grants HA 1737-11, FL 635/2-1, FOR2290, and HA 1737/13-1 and a MetLife Award. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Ph.D. stipends from the Hans and Ilse Breuer Foundation.	Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Brankatschk B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002351; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Chen Y, 2010, J NEUROSCI, V30, P9199, DOI 10.1523/JNEUROSCI.0605-10.2010; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fleck D, 2013, J NEUROSCI, V33, P7856, DOI 10.1523/JNEUROSCI.3372-12.2013; Fleck D, 2012, CURR ALZHEIMER RES, V9, P178, DOI 10.2174/156720512799361637; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; HAASS C, 1993, J BIOL CHEM, V268, P3021; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hogl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021337; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Orozco D, 2012, EMBO REP, V13, P759, DOI 10.1038/embor.2012.90; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Steiner H, 2001, NEUROBIOL DIS, V8, P717, DOI 10.1006/nbdi.2001.0405; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Voss M, 2012, J BIOL CHEM, V287, P43401, DOI 10.1074/jbc.M112.371369; Walss-Bass C, 2006, ACTA PSYCHIAT SCAND, V113, P314, DOI 10.1111/j.1600-0447.2005.00631.x; Walss-Bass C, 2006, BIOL PSYCHIAT, V60, P548, DOI 10.1016/j.biopsych.2006.03.017; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Zahn C, 2013, FEBS J, V280, P1653, DOI 10.1111/febs.12176; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	66	30	30	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					318	333		10.1074/jbc.M115.697995	http://dx.doi.org/10.1074/jbc.M115.697995			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26574544	hybrid, Green Published			2022-12-26	WOS:000367589500025
J	Catherine, C; Lee, SW; Ju, JW; Kim, HC; Shin, HI; Kim, YJ; Kim, DM				Catherine, Christy; Lee, Seung-Won; Ju, Jung Won; Kim, Ho-Cheol; Shin, Hyun-Il; Kim, Yu Jung; Kim, Dong-Myung			Cell-Free Expression and In Situ Immobilization of Parasite Proteins from Clonorchis sinensis for Rapid Identification of Antigenic Candidates	PLOS ONE			English	Article							VITRO EXPRESSION; HIGH-THROUGHPUT; WHEAT-GERM; CONSTRUCTION; SYSTEM; MICROARRAYS; MALARIA	Progress towards genetic sequencing of human parasites has provided the groundwork for a post-genomic approach to develop novel antigens for the diagnosis and treatment of parasite infections. To fully utilize the genomic data, however, high-throughput methodologies are required for functional analysis of the proteins encoded in the genomic sequences. In this study, we investigated cell-free expression and in situ immobilization of parasite proteins as a novel platform for the discovery of antigenic proteins. PCR-amplified parasite DNA was immobilized on microbeads that were also functionalized to capture synthesized proteins. When the microbeads were incubated in a reaction mixture for cell-free synthesis, proteins expressed from the microbead-immobilized DNA were instantly immobilized on the same microbeads, providing a physical linkage between the genetic information and encoded proteins. This approach of in situ expression and isolation enables streamlined recovery and analysis of cell-free synthesized proteins and also allows facile identification of the genes coding antigenic proteins through direct PCR of the microbead-bound DNA.	[Catherine, Christy; Lee, Seung-Won; Kim, Ho-Cheol; Kim, Dong-Myung] Chungnam Natl Univ, Dept Fine Chem Engn & Appl Chem, Daejeon 305764, South Korea; [Ju, Jung Won; Shin, Hyun-Il; Kim, Yu Jung] Natl Inst Hlth, Div Malaria & Parasit Dis, Osong 361951, South Korea	Chungnam National University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH)	Kim, DM (corresponding author), Chungnam Natl Univ, Dept Fine Chem Engn & Appl Chem, Daejeon 305764, South Korea.	dmkim@cnu.ac.kr		Ju, Jung-Won/0000-0001-5248-6995; Kim, Dong-Myung/0000-0001-7875-0694	Korea National Institute of Health [2013-E54003-00]; National Research Foundation of Korea [2014M3C1A3051473]	Korea National Institute of Health; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the grants from the Korea National Institute of Health (http://www.nih.go.kr/NIH/eng/main.jsp; grant no. 2013-E54003-00) and National Research Foundation of Korea (www.nrf.re.kr; grant no. 2014M3C1A3051473).	Angenendt P, 2006, MOL CELL PROTEOMICS, V5, P1658, DOI 10.1074/mcp.T600024-MCP200; Barik S., 2012, Molecular and Cellular Pharmacology, V4, P91; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Carlson ED, 2011, BIOTECHNOL ADV, V30, P1185, DOI DOI 10.1016/J.BI0TECHADV.2011.09.016; Catherine C, 2013, BIOTECHNOL ADV, V31, P797, DOI 10.1016/j.biotechadv.2013.04.009; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Kim TW, 2006, J BIOTECHNOL, V126, P554, DOI 10.1016/j.jbiotec.2006.05.014; Kim TW, 2006, PROTEIN EXPRES PURIF, V45, P249, DOI 10.1016/j.pep.2005.09.010; Lee KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034429; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Paul S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks940; Quertinmont LT, 2015, CHEM COMMUN, V51, P122, DOI 10.1039/c4cc08240k; Rui E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-192; Rungpragayphan S, 2003, FEBS LETT, V540, P147, DOI 10.1016/S0014-5793(03)00251-5; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Tsuboi T, 2010, ACTA TROP, V114, P171, DOI 10.1016/j.actatropica.2009.10.024; Wu W, 2012, PARASITOL RES, V111, P1879, DOI 10.1007/s00436-012-3152-y	21	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143597	10.1371/journal.pone.0143597	http://dx.doi.org/10.1371/journal.pone.0143597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599101	Green Submitted, gold, Green Published			2022-12-26	WOS:000365862600092
J	Zhao, J; Qiu, ZN; Ruan, BP; Kang, SJ; He, L; Zhang, S; Dong, GJ; Hu, J; Zeng, DL; Zhang, GH; Gao, ZY; Ren, DY; Hu, XM; Chen, G; Guo, LB; Qian, Q; Zhu, L				Zhao, Juan; Qiu, Zhennan; Ruan, Banpu; Kang, Shujing; He, Lei; Zhang, Sen; Dong, Guojun; Hu, Jiang; Zeng, Dali; Zhang, Guangheng; Gao, Zhenyu; Ren, Deyong; Hu, Xingming; Chen, Guang; Guo, Longbiao; Qian, Qian; Zhu, Li			Functional Inactivation of Putative Photosynthetic Electron Acceptor Ferredoxin C2 (FdC2) Induces Delayed Heading Date and Decreased Photosynthetic Rate in Rice	PLOS ONE			English	Article							PHOTOSYSTEM-I; PHYTOCHROMOBILIN SYNTHASE; CHLOROPHYLL SYNTHESIS; MULTICOPPER OXIDASES; ARABIDOPSIS; SYSTEM; GENE; FLOW; REDUCTASE; MUTANTS	Ferredoxin (Fd) protein as unique electron acceptor, involved in a variety of fundamental metabolic and signaling processes, which is indispensable for plant growth. The molecular mechanisms of Fd such as regulation of electron partitioning, impact of photosynthetic rate and involvement in the carbon fixing remain elusive in rice. Here we reported a heading date delay and yellowish leaf 1 (hdy1) mutant derived from Japonica rice cultivar "Nipponbare" subjected to EMS treatment. In the paddy field, the hdy1 mutant appeared at a significantly late heading date and had yellow-green leaves during the whole growth stage. Further investigation indicated that the abnormal phenotype of hdy1 was connected with depressed pigment content and photosynthetic rate. Genetic analysis results showed that the hdy1 mutant phenotype was caused by a single recessive nuclear gene mutation. Map-based cloning revealed that OsHDY1 is located on chromosome 3 and encodes an ortholog of the AtFdC2 gene. Complementation and overexpression, transgenic plants exhibited the mutant phenotype including head date, leaf color and the transcription levels of the FdC2 were completely rescued by transformation with OsHDY1. Real-time PCR revealed that the expression product of OsHDY1 was detected in almost all of the organs except root, whereas highest expression levels were observed in seeding new leaves. The lower expression levels of HDY1 and content of iron were detected in hdy1 than WT's. The FdC2:: GFP was detected in the chloroplasts of rice. Real-time PCR results showed that the expression of many photosynthetic electron transfer related genes in hdy1 were higher than WT. Our results suggest that OsFdC2 plays an important role in photosynthetic rate and development of heading date by regulating electron transfer and chlorophyll content in rice.	[Zhao, Juan; Qiu, Zhennan; Ruan, Banpu; Kang, Shujing; He, Lei; Zhang, Sen; Dong, Guojun; Hu, Jiang; Zeng, Dali; Zhang, Guangheng; Gao, Zhenyu; Ren, Deyong; Hu, Xingming; Chen, Guang; Guo, Longbiao; Qian, Qian; Zhu, Li] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Zhu, L (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.	zhuli05@caas.cn	Lei, He/N-8316-2014; qian, qian/AAH-8708-2021; Zhu, Li/AAH-9693-2021	Lei, He/0000-0001-9642-6804; Gao, Zhenyu/0000-0003-4808-2511	National Natural Science Foundation of China [31171532, 31371606]; Ministry of Agriculture of China [2014ZX08001-003, 2014ZX08001-002]; Central Level and Scientific Research Institutes for the basic research and development special fund business [2015RG001-2]; Chinese 863 Program [2012AA10A302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Central Level and Scientific Research Institutes for the basic research and development special fund business; Chinese 863 Program(National High Technology Research and Development Program of China)	The work was supported by The National Natural Science Foundation of China (Grant Nos. 31171532; 31371606), http://www.nsfc.gov.cn/. LZ; The Transgenic Plant Research and Commercialization Project of the Ministry of Agriculture of China (Grant No. 2014ZX08001-003, 2014ZX08001-002), http://www.moa.gov.cn/, LZ; The Central Level and Scientific Research Institutes for the basic research and development special fund business (Grant No. 2015RG001-2), http://www.most.gov.cn/, LZ; and The Chinese 863 Program (Grant No. 2012AA10A302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; ARNON DI, 1975, P NATL ACAD SCI USA, V72, P4961, DOI 10.1073/pnas.72.12.4961; ARNON DI, 1979, FEBS LETT, V102, P133, DOI 10.1016/0014-5793(79)80944-8; Asai K, 2002, DEVELOPMENT, V129, P265; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Chiu FY, 2010, J BIOL CHEM, V285, P5056, DOI 10.1074/jbc.M109.075747; Coschigano KT, 1998, PLANT CELL, V10, P741, DOI 10.1105/tpc.10.5.741; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Goss T, 2014, CURR PROTEIN PEPT SC, V15, P385, DOI 10.2174/1389203715666140327113733; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; Hajirezaei MR, 2002, PLANT J, V29, P281, DOI 10.1046/j.0960-7412.2001.01209.x; Hamdani S, 2015, J PLANT PHYSIOL, V177, P128, DOI 10.1016/j.jplph.2014.12.019; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Hanke GT, 2008, PLANT CELL ENVIRON, V31, P1017, DOI 10.1111/j.1365-3040.2008.01814.x; Hase Toshiharu, 2006, V24, P477; Higuchi-Takeuchi M, 2011, PLANT PHYSIOL, V157, P96, DOI 10.1104/pp.111.181248; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Izawa T, 2000, PLANT J, V22, P391, DOI 10.1046/j.1365-313X.2000.00753.x; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Jones SM, 2015, CELL MOL LIFE SCI, V72, P869, DOI 10.1007/s00018-014-1826-6; Jung KH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000164; Kang SJ, 2015, CROP SCI, V55, P284, DOI 10.2135/cropsci2014.03.0185; Kimata-Ariga Y, 2000, EMBO J, V19, P5041, DOI 10.1038/sj.emboj.7593319; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Kondou Y, 2009, PLANT J, V57, P883, DOI 10.1111/j.1365-313X.2008.03733.x; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lintala M, 2007, PLANT J, V49, P1041, DOI 10.1111/j.1365-313X.2006.03014.x; Lintala M, 2012, PLANT J, V70, P809, DOI 10.1111/j.1365-313X.2012.04930.x; Lintala M, 2009, PLANT J, V57, P1103, DOI 10.1111/j.1365-313X.2008.03753.x; [Liu Bing 刘兵], 2013, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V52, P112; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Msilini N, 2013, J PLANT PHYSIOL, V170, P1400, DOI 10.1016/j.jplph.2013.05.004; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Ogiso-Tanaka E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075959; Palatnik JF, 2003, PLANT J, V35, P332, DOI 10.1046/j.1365-313X.2003.01809.x; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; SOLOMON EI, 1993, SCIENCE, V259, P1575, DOI 10.1126/science.8384374; Tapken Wiebke, 2015, Plant Signal Behav, V10, pe1046666, DOI 10.1080/15592324.2015.1046666; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Voss I, 2011, J BIOL CHEM, V286, P50, DOI 10.1074/jbc.M110.161562; Wang PY, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-201; Wang QX, 2015, MOL PLANT, V8, P946, DOI 10.1016/j.molp.2015.02.014; Wherland S, 2014, J BIOL INORG CHEM, V19, P541, DOI 10.1007/s00775-013-1080-7; Yu CC, 2014, BIOCHEM BIOPH RES CO, V450, P1575, DOI 10.1016/j.bbrc.2014.07.043; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07663; Zhao J, 2015, NEW PHYTOL; Zhu L, 2011, PLANT MOL BIOL, V77, P475, DOI 10.1007/s11103-011-9825-6	50	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143361	10.1371/journal.pone.0143361	http://dx.doi.org/10.1371/journal.pone.0143361			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26598971	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600056
J	Mu, QJ; Li, HL; Yao, Y; Liu, SC; Yin, CG; Ma, XZ				Mu, Qing-Jie; Li, Hong-Li; Yao, Yuan; Liu, Shi-Chao; Yin, Chong-Gao; Ma, Xue-Zhen			Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; SURVIVAL; PROGRESSION; PROMOTES; CELLS; KINASE; MIGRATION	Background Chromodomain helicase/ATPase DNA-binding protein 1-like gene (CHD1L), also known as ALC1 (amplified in liver cancer 1 gene), is a new oncogene amplified in many solid tumors. Whether this gene plays a role in invasion and metastasis of breast cancer is unknown. Methods Immunohistochemistry was performed to detect the expression of CHD1L in patients with invasive ductal carcinoma and normal mammary glands. Chemotaxis, wound healing, and Transwell invasion assays were also performed to examine cell migration and invasion. Western blot analysis was conducted to detect the expression of CHD1L, MMP-2, MMP-9, pAkt/Akt, pARK5/ARK5, and pmTOR/mTOR. Moreover, ELISA was carried out to detect the expression levels of MMP-2 and MMP-9. Nude mice xenograft model was used to detect the invasion and metastasis of breast cancer cell lines. Results CHD1L overexpression was observed in 112 of 268 patients (41.8%). This overexpression was associated with lymph node metastasis (P = 0.008), tumor differentiation (P = 0.020), distant metastasis (P = 0.026), MMP-2 (P = 0.035), and MMP-9 expression (P = 0.022). In the cell experiment, reduction of CHD1L inhibited the invasion and metastasis of breast cancer cells by mediating MMP-2 and MMP-9 expression. CHD1L knockdown via siRNA suppressed EGF-induced pAkt, pARK5, and pmTOR. This knockdown inhibited the metastasis of breast cancer cells into the lungs of SCID mice. Conclusions CHD1L promoted the invasion and metastasis of breast cancer cells via the PI3K/Akt/ARK5/mTOR/MMP signaling pathway. This study identified CHD1L as a potential anti-metastasis target for therapeutic intervention in breast cancer.	[Mu, Qing-Jie] Qing Dao Univ, Qingdao, Peoples R China; [Mu, Qing-Jie] Weifang Med Univ, Clin Dept, Weifang, Peoples R China; [Li, Hong-Li] Weifang Med Univ, Med Res Ctr, Weifang 261053, Peoples R China; [Yao, Yuan] Qing Dao Univ, Affiliated Hosp, Qing Dao 260003, Peoples R China; [Liu, Shi-Chao; Ma, Xue-Zhen] Qing Dao Univ, Affiliated Hosp 2, Qing Dao Tumor Hosp, Qing Dao Cent Hosp, Qing Dao 260042, Peoples R China; [Yin, Chong-Gao] Weifang Med Univ, Coll Nursing, Weifang 261053, Peoples R China	Qingdao University; Weifang Medical University; Weifang Medical University; Qingdao University; Qingdao University; Weifang Medical University	Yin, CG (corresponding author), Weifang Med Univ, Coll Nursing, Weifang 261053, Peoples R China.	wfyinchg@163.com; maxuezhen1968@126.com			National Scientific Foundation of China [81402389]; Natural Science Foundation of Shandong Province [ZR2015HL065]; Foundation of Shandong Educational Committee [J12LK03, J13LK03]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Foundation of Shandong Educational Committee	This work was supported by the National Scientific Foundation of China (81402389), the Natural Science Foundation of Shandong Province (ZR2015HL065), and the Foundation of Shandong Educational Committee (J12LK03 and J13LK03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao BP, 2013, DISCOV MED, V16, P137; Castaneda CA, 2010, CANCER METAST REV, V29, P751, DOI 10.1007/s10555-010-9261-0; Chen LL, 2010, J CLIN INVEST, V120, P1178, DOI 10.1172/JCI40665; Chen LL, 2009, HEPATOLOGY, V50, P122, DOI 10.1002/hep.22933; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Chien CS, 2010, MOL CELL BIOCHEM, V333, P169, DOI 10.1007/s11010-009-0217-z; Grunt TW, 2013, CURR CANCER DRUG TAR, V13, P188; He WP, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-437; Ji XP, 2013, J SURG RES, V185, P84, DOI 10.1016/j.jss.2013.05.008; Jiang Hao, 2009, J Exp Ther Oncol, V8, P25; Li HL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0162-x; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031251; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Mukherjee D, 2013, AM J CANCER RES, V3, P46; Rasheed SAK, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0337-x; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Tian F, 2013, TUMOR BIOL, V34, P3687, DOI 10.1007/s13277-013-0951-4; Wang J, 2015, ONCOTARGET, V6, P1618, DOI 10.18632/oncotarget.2730; Wang XF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/894386; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Yan BA, 2010, J CELL BIOCHEM, V111, P1114, DOI 10.1002/jcb.22797; Yin CG, 2013, BREAST CANCER RES TR, V142, P297, DOI 10.1007/s10549-013-2737-1	25	19	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2015	10	11							e0143030	10.1371/journal.pone.0143030	http://dx.doi.org/10.1371/journal.pone.0143030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7AW	26599012	Green Published, Green Submitted, gold			2022-12-26	WOS:000365853900058
J	Ghosh, SS; Righi, S; Krieg, R; Kang, L; Carl, D; Wang, J; Massey, HD; Sica, DA; Gehr, TWB; Ghosh, S				Ghosh, Siddhartha S.; Righi, Samuel; Krieg, Richard; Kang, Le; Carl, Daniel; Wang, Jing; Massey, H. Davis; Sica, Domenic A.; Gehr, Todd W. B.; Ghosh, Shobha			High Fat High Cholesterol Diet (Western Diet) Aggravates Atherosclerosis, Hyperglycemia and Renal Failure in Nephrectomized LDL Receptor Knockout Mice: Role of Intestine Derived Lipopolysaccharide	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; EPITHELIAL TIGHT JUNCTION; TRANSGENIC EXPRESSION; INSULIN SENSITIVITY; MURINE MACROPHAGES; INDUCED OBESITY; RISK-FACTOR; RATS ROLE; CURCUMIN; INFLAMMATION	A high fat meal, frequently known as western diet (WD), exacerbates atherosclerosis and diabetes. Both these diseases are frequently associated with renal failure. Recent studies have shown that lipopolysaccharide (LPS) leaks into the circulation from the intestine in the setting of renal failure and after WD. However, it is not clear how renal function and associated disorders are affected by LPS. This study demonstrates that circulatory LPS exacerbates renal insufficiency, atherosclerosis and glucose intolerance. Renal insufficiency was induced by 2/3 nephrectomy in LDL receptor knockout mice. Nx animals were given normal diet (Nx) or WD (Nx+WD). The controls were sham operated animals on normal diet (control) and WD (WD). To verify if LPS plays a role in exaggerating renal insufficiency, polymyxin (PM), a known LPS antagonist, and curcumin (CU), a compound known to ameliorate chronic kidney disease (CKD), was given to Nx animals on western diet (Nx+WD+PM and Nx+WD+CU, respectively). Compared to control, all other groups displayed increased circulatory LPS. The Nx+WD cohort had the highest levels of LPS. Nx group had significant renal insufficiency and glucose intolerance but not atherosclerosis. WD had intense atherosclerosis and glucose intolerance but it did not show signs of renal insufficiency. Compared to other groups, Nx+WD had significantly higher cytokine expression, macrophage infiltration in the kidney, renal insufficiency, glucose intolerance and atherosclerosis. PM treatment blunted the expression of cytokines, deterioration of renal function and associated disorders, albeit not to the levels of Nx, and was significantly inferior to CU. PM is a non-absorbable antibiotic with LPS binding properties, hence its beneficial effect can only be due to its effect within the GI tract. We conclude that LPS may not cause renal insufficiency but can exaggerate kidney failure and associated disorders following renal insufficiency.	[Ghosh, Siddhartha S.; Righi, Samuel; Carl, Daniel; Sica, Domenic A.; Gehr, Todd W. B.] Virginia Commonwealth Univ, Div Nephrol, Richmond, VA 23284 USA; [Krieg, Richard] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Wang, Jing; Ghosh, Shobha] Virginia Commonwealth Univ, Div Pulm Med, Richmond, VA USA; [Massey, H. Davis] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA; [Kang, Le] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Ghosh, SS (corresponding author), Virginia Commonwealth Univ, Div Nephrol, Richmond, VA 23284 USA.	ssghosh@vcu.edu	Kang, Le/ABD-1116-2022	Kang, Le/0000-0003-4262-2329	Jeffress Foundation	Jeffress Foundation	This work was supported by Jeffress Foundation.	ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Al-Sadi R, 2013, J IMMUNOL, V190, P6596, DOI 10.4049/jimmunol.1201876; Amar J, 2008, AM J CLIN NUTR, V87, P1219, DOI 10.1093/ajcn/87.5.1219; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Bentata Y, 2014, AM J CARDIOVASC DIS, V4, P26; Bie JH, 2011, AM J PHYSIOL-REG I, V301, pR967, DOI 10.1152/ajpregu.00277.2011; Bie JH, 2010, J BIOL CHEM, V285, P13630, DOI 10.1074/jbc.M109.069781; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Buzello M, 2003, J AM SOC NEPHROL, V14, P311, DOI 10.1097/01.ASN.0000045048.71975.FC; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Davies B, 2011, LANCET INFECT DIS, V11, P65, DOI 10.1016/S1473-3099(10)70220-6; Davies MR, 2005, J AM SOC NEPHROL, V16, P917, DOI 10.1681/ASN.2004100835; Decleves AE, 2013, KIDNEY INT; Dempe JS, 2013, MOL NUTR FOOD RES, V57, P1543, DOI 10.1002/mnfr.201200113; Deng H, 2013, J BIOL CHEM, V288, P3897, DOI 10.1074/jbc.M112.424390; Dutta D, 2013, J DIABETES; EMMELOT CH, 1980, J HYG-CAMBRIDGE, V84, P331, DOI 10.1017/S0022172400026851; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Ghosh SS, 2012, AM J PHYSIOL-RENAL, V302, pF439, DOI 10.1152/ajprenal.00356.2010; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Ghosh SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108577; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hasan ST, 2014, ATHEROSCLEROSIS, V232, P40, DOI 10.1016/j.atherosclerosis.2013.10.016; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Hirohashi N, 1996, INFECT IMMUN, V64, P1011, DOI 10.1128/IAI.64.3.1011-1015.1996; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; Kovesdy CP, 2013, AM J CLIN NUTR, V97, P1163, DOI 10.3945/ajcn.112.036418; Kubotera N, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/954956; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Liu Z, 2013, J IMMUNOL, V191, P857, DOI 10.4049/jimmunol.1300790; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Mak RH, 2007, CURR OPIN NEPHROL HY, V16, P27, DOI 10.1097/MNH.0b013e3280117ce7; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Nguyen S, 2007, CURR OPIN NEPHROL HY, V16, P71, DOI 10.1097/MNH.0b013e32802ef4b6; Niwa T, 2013, EXPERT OPIN THER TAR, V17, P1287, DOI 10.1517/14728222.2013.829456; Odermatt A, 2011, AM J PHYSIOL-RENAL, V301, pF919, DOI 10.1152/ajprenal.00068.2011; Pavkov ME, 2012, CLIN J AM SOC NEPHRO, V7, P78, DOI 10.2215/CJN.07610711; Soetikno V, 2011, MOL NUTR FOOD RES, V55, P1655, DOI 10.1002/mnfr.201100080; Sun PP, 2009, KIDNEY INT, V76, pS20, DOI 10.1038/ki.2009.403; Terawaki H, 2010, THER APHER DIAL, V14, P477, DOI 10.1111/j.1744-9987.2010.00815.x; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Vaziri ND, 2012, NEPHROL DIAL TRANSPL, V27, P2686, DOI 10.1093/ndt/gfr624; Veniant MM, 2001, ARTERIOSCL THROM VAS, V21, P1567, DOI 10.1161/hq1001.097780; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang Y, 2009, INT J FOOD MICROBIOL, V136, P71, DOI 10.1016/j.ijfoodmicro.2009.09.001; West MA, 2008, J TRAUMA, V65, P893, DOI 10.1097/TA.0b013e3181877fde; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yamamoto S, 2011, ARTERIOSCL THROM VAS, V31, P2856, DOI 10.1161/ATVBAHA.111.237198; ZHANG XK, 1993, J EXP MED, V177, P511, DOI 10.1084/jem.177.2.511; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	60	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141109	10.1371/journal.pone.0141109	http://dx.doi.org/10.1371/journal.pone.0141109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580567	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600011
J	Miyamoto, K; Suzuki, KT; Suzuki, M; Sakane, Y; Sakuma, T; Herberg, S; Simeone, A; Simpson, D; Jullien, J; Yamamoto, T; Gurdon, JB				Miyamoto, Kei; Suzuki, Ken-ichi T.; Suzuki, Miyuki; Sakane, Yuto; Sakuma, Tetsushi; Herberg, Sarah; Simeone, Angela; Simpson, David; Jullien, Jerome; Yamamoto, Takashi; Gurdon, J. B.			The Expression of TALEN before Fertilization Provides a Rapid Knock-Out Phenotype in Xenopus laevis Founder Embryos	PLOS ONE			English	Article							TARGETED GENE DISRUPTION; EFFECTOR NUCLEASES; ZINC-FINGER; TROPICALIS; CRISPR/CAS9; TRANSCRIPTION; OOCYTES; SYSTEM; DNA; MUTAGENESIS	Recent advances in genome editing using programmable nucleases have revolutionized gene targeting in various organisms. Successful gene knock-out has been shown in Xenopus, a widely used model organism, although a system enabling less mosaic knock-out in founder embryos (F0) needs to be explored in order to judge phenotypes in the F0 generation. Here, we injected modified highly active transcription activator-like effector nuclease (TALEN) mRNA to oocytes at the germinal vesicle (GV) stage, followed by in vitro maturation and intracytoplasmic sperm injection, to achieve a full knock-out in F0 embryos. Unlike conventional injection methods to fertilized embryos, the injection of TALEN mRNA into GV oocytes allows expression of nucleases before fertilization, enabling them to work from an earlier stage. Using this procedure, most of developed embryos showed full knock-out phenotypes of the pigmentation gene tyrosinase and/or embryonic lethal gene pax6 in the founder generation. In addition, our method permitted a large 1 kb deletion. Thus, we describe nearly complete gene knock-out phenotypes in Xenopus laevis F0 embryos. The presented method will help to accelerate the production of knock-out frogs since we can bypass an extra generation of about 1 year in Xenopus laevis. Meantime, our method provides a unique opportunity to rapidly test the developmental effects of disrupting those genes that do not permit growth to an adult able to reproduce. In addition, the protocol shown here is considerably less invasive than the previously used host transfer since our protocol does not require surgery. The experimental scheme presented is potentially applicable to other organisms such as mammals and fish to resolve common issues of mosaicism in founders.	[Miyamoto, Kei; Herberg, Sarah; Simeone, Angela; Simpson, David; Jullien, Jerome; Gurdon, J. B.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; [Suzuki, Ken-ichi T.; Suzuki, Miyuki; Sakane, Yuto; Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Dept Math & Life Sci, Grad Sch Sci, Higashihiroshima 724, Japan	University of Cambridge; Hiroshima University	Miyamoto, K (corresponding author), Kinki Univ, Lab Mol Dev Biol, Fac Biol Oriented Sci & Technol, Wakayama, Japan.	kmiyamo@waka.kindai.ac.jp; suzuk107@hiroshima-u.ac.jp	Sakuma, Tetsushi/A-7615-2013; jerome, jullien/K-5565-2019; Suzuki, Ken-ichi T/G-2864-2019; jullien, jerome/AAC-1887-2022; Yamamoto, Takashi/U-4790-2017	Sakuma, Tetsushi/0000-0003-0396-1563; jerome, jullien/0000-0002-7868-0021; Suzuki, Ken-ichi T/0000-0002-4502-831X; Yamamoto, Takashi/0000-0002-6516-2903; Suzuki, Miyuki/0000-0002-7284-7505; Miyamoto, Kei/0000-0003-2912-6777; GURDON, JOHN/0000-0002-5621-3799	Wellcome Trust [RG69899]; Herchel Smith Postdoctoral Fellowship; Japan Society for the Promotion of Science (JSPS KAKENHI Grant) [25124708]; Biotechnology and Biological Sciences Research Council [BBS/B/14647] Funding Source: researchfish; Wellcome Trust [101050/Z/13/Z] Funding Source: researchfish; Grants-in-Aid for Scientific Research [26290070] Funding Source: KAKEN	Wellcome Trust(Wellcome TrustEuropean Commission); Herchel Smith Postdoctoral Fellowship; Japan Society for the Promotion of Science (JSPS KAKENHI Grant)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by grants from the Wellcome Trust to JBG (RG69899, http://www.wellcome.ac.uk/). This work is supported by Herchel Smith Postdoctoral Fellowship to KM (grant number is not available, http://www.herchelsmith.cam.ac.uk/fellowships/). This work is also supported by the Japan Society for the Promotion of Science to KTS (JSPS KAKENHI Grant Number 25124708, https://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Carroll D, 2014, METHODS, V69, P137, DOI 10.1016/j.ymeth.2014.03.026; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Hagmann M, 1996, BIOL CHEM H-S, V377, P239, DOI 10.1515/bchm3.1996.377.4.239; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hashimoto S, 2009, J REPROD DEVELOP, V55, P1, DOI 10.1262/jrd.20127; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Herberg S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14236; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Hulstrand AM, 2010, METHODS, V51, P75, DOI 10.1016/j.ymeth.2009.12.015; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Ishibashi S, 2012, BIOL OPEN, V1, P1273, DOI 10.1242/bio.20123228; James-Zorn C, 2013, NUCLEIC ACIDS RES, V41, pD865, DOI 10.1093/nar/gks1025; Jullien J, 2014, MOL CELL, V55, P524, DOI 10.1016/j.molcel.2014.06.024; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Miyamoto K, 2015, JOVE-J VIS EXP, DOI 10.3791/52496; Miyamoto K, 2013, SCIENCE, V341, P1002, DOI 10.1126/science.1240376; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakajima K, 2015, BIOL OPEN, V4, P180, DOI 10.1242/bio.201410009; Nakayama T., 2015, DEV BIOL; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Rungger-Brandle E, 2010, DEV NEUROBIOL, V70, P764, DOI 10.1002/dneu.20816; Sakane Y, 2014, DEV GROWTH DIFFER, V56, P108, DOI 10.1111/dgd.12105; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shirogane Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2252; Suzuki KT, 2013, BIOL OPEN, V2, P448, DOI 10.1242/bio.20133855; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wang FQ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0006-1; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108	36	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142946	10.1371/journal.pone.0142946	http://dx.doi.org/10.1371/journal.pone.0142946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580070	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600069
J	Taboada, S; Riesgo, A; Bas, M; Arnedo, MA; Cristobo, J; Rouse, GW; Avila, C				Taboada, Sergi; Riesgo, Ana; Bas, Maria; Arnedo, Miquel A.; Cristobo, Javier; Rouse, Greg W.; Avila, Conxita			Bone-Eating Worms Spread: Insights into Shallow-Water Osedax (Annelida, Siboglinidae) from Antarctic, Subantarctic, and Mediterranean Waters	PLOS ONE			English	Article							MESSINIAN SALINITY CRISIS; DWARF MALES; BACTERIAL ENDOSYMBIONTS; PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; TEMPORAL VARIATION; SOUTHERN-OCEAN; NORTH-ATLANTIC; MIXED MODELS; DNA	Osedax, commonly known as bone-eating worms, are unusual marine annelids belonging to Siboglinidae and represent a remarkable example of evolutionary adaptation to a specialized habitat, namely sunken vertebrate bones. Usually, females of these animals live anchored inside bone owing to a ramified root system from an ovisac, and obtain nutrition via symbiosis with Oceanospirillales gamma-proteobacteria. Since their discovery, 26 Osedax operational taxonomic units (OTUs) have been reported from a wide bathymetric range in the Pacific, the North Atlantic, and the Southern Ocean. Using experimentally deployed and naturally occurring bones we report here the presence of Osedax deceptionensis at very shallow-waters in Deception Island (type locality; Antarctica) and at moderate depths near South Georgia Island (Subantarctic). We present molecular evidence in a new phylogenetic analysis based on five concatenated genes (28S rDNA, Histone H3, 18S rDNA, 16S rDNA, and cytochrome c oxidase I-COI-), using Maximum Likelihood and Bayesian inference, supporting the placement of O. deceptionensis as a separate lineage (Clade VI) although its position still remains uncertain. This phylogenetic analysis includes a new unnamed species (O. 'mediterranea') recently discovered in the shallow-water Mediterranean Sea belonging to Osedax Clade I. A timeframe of the diversification of Osedax inferred using a Bayesian framework further suggests that Osedax diverged from other siboglinids during the Middle Cretaceous (ca. 108 Ma) and also indicates that the most recent common ancestor of Osedax extant lineages dates to the Late Cretaceous (ca. 74.8 Ma) concomitantly with large marine reptiles and teleost fishes. We also provide a phylogenetic framework that assigns newly-sequenced Osedax endosymbionts of O. deceptionensis and O. 'mediterranea' to ribospecies Rs1. Molecular analysis for O. deceptionensis also includes a COI-based haplotype network indicating that individuals from Deception Island and the South Georgia Island (ca. 1,600 km apart) are clearly the same species, confirming the well-developed dispersal capabilities reported in other congeneric taxa. In addition, we include a complete description of living features and morphological characters (including scanning and transmission electron microscopy) of O. deceptionensis, a species originally described from a single mature female, and compare it to information available for other congeneric OTUs.	[Taboada, Sergi; Riesgo, Ana; Bas, Maria; Arnedo, Miquel A.; Avila, Conxita] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Taboada, Sergi; Riesgo, Ana; Bas, Maria; Arnedo, Miquel A.; Avila, Conxita] Univ Barcelona, Fac Biol, Biodivers Res Inst IrBIO, Barcelona, Spain; [Cristobo, Javier] IEO, Ctr Oceanog Gijon, Gijon, Spain; [Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Barcelona; University of Barcelona; Spanish Institute of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	Taboada, S (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	sergiotab@gmail.com	Rouse, Greg W/F-2611-2010; Rouse, Gregory/AAW-1494-2021; Arnedo, Miquel/E-9086-2011; Cristobo, Javier/M-1949-2014; Avila, Conxita/B-9466-2008; Taboada, Sergi/AAB-9390-2021; Riesgo, Ana/E-3341-2014	Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263; Arnedo, Miquel/0000-0003-1402-4727; Cristobo, Javier/0000-0002-7725-4055; Avila, Conxita/0000-0002-5489-8376; Taboada, Sergi/0000-0003-1669-1152; Riesgo, Ana/0000-0002-7993-1523; Bas, Maria/0000-0001-8553-6557	Spanish Government through the research project ACTIQUIM-II [CTM2010-17415/ANT]; National Science Foundation Office of Polar Programs [1043749]; Spanish Government through the environmental association S'Agulla Educacio Mediambiental	Spanish Government through the research project ACTIQUIM-II; National Science Foundation Office of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Spanish Government through the environmental association S'Agulla Educacio Mediambiental	This research received support from the Spanish Government, through the research project ACTIQUIM-II (CTM2010-17415/ANT) and through the environmental association S'Agulla Educacio Mediambiental. G.W. Rouse thanks the captain and crew of RVIB Nathaniel B. Palmer Chief Scientist N.G. Wilson and the science participants during the cruise NBP13-03. This work was supported by award #1043749 from the National Science Foundation Office of Polar Programs to N.G. Wilson, G.W. Rouse and R.S. Burton.	Ahumada-Sempoal MA, 2013, PROG OCEANOGR, V118, P61, DOI 10.1016/j.pocean.2013.07.030; Amon DJ, 2014, ZOOL SCR, V43, P405, DOI 10.1111/zsc.12057; Bardet Nathalie, 1994, Historical Biology, V7, P313; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; Colgan DJ, 2000, ZOOL SCR, V29, P29, DOI 10.1046/j.1463-6409.2000.00021.x; Dahlgren TG, 2006, CAH BIOL MAR, V47, P385; Danise S, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0072; DRUMMOND AJ, 2010, GENEIOUS V5 5; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Friedman M, 2009, P NATL ACAD SCI USA, V106, P5218, DOI 10.1073/pnas.0808468106; Fujikura K, 2006, ZOOL SCI, V23, P733, DOI 10.2108/zsj.23.733; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; Glover AG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1390; Glover AG, 2005, P ROY SOC B-BIOL SCI, V272, P2587, DOI 10.1098/rspb.2005.3275; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Goffredi SK, 2014, ISME J, V8, P908, DOI 10.1038/ismej.2013.201; Goffredi SK, 2005, ENVIRON MICROBIOL, V7, P1369, DOI 10.1111/j.1462-2920.2005.00824.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Higgs ND, 2012, HIST BIOL, V24, P269, DOI 10.1080/08912963.2011.621167; Higgs ND, 2011, BIOL BULL-US, V221, P307, DOI 10.1086/BBLv221n3p307; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hipsley CA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-151; Jolivet L, 2006, SEDIMENT GEOL, V188, P9, DOI 10.1016/j.sedgeo.2006.02.004; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katz S, 2013, INVERTEBR BIOL, V132, P368, DOI 10.1111/ivb.12037; Katz S, 2011, BIOL BULL-US, V220, P128, DOI 10.1086/BBLv220n2p128; Katz S, 2010, J MORPHOL, V271, P1272, DOI 10.1002/jmor.10873; Kiel S, 2013, PALAEONTOL Z, V87, P161, DOI 10.1007/s12542-012-0158-9; Kiel S, 2011, NATURWISSENSCHAFTEN, V98, P51, DOI 10.1007/s00114-010-0740-5; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; LENAERS G, 1989, J MOL EVOL, V29, P40, DOI 10.1007/BF02106180; Lenn YD, 2003, DEEP-SEA RES PT II, V50, P1665, DOI 10.1016/S0967-0645(03)00085-7; Li YN, 2015, MOL PHYLOGENET EVOL, V85, P221, DOI 10.1016/j.ympev.2015.02.008; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Little CTS, 1999, GEOLOGY, V27, P1027, DOI 10.1130/0091-7613(1999)027<1027:LCHVCF>2.3.CO;2; Miyamoto N, 2013, NATURWISSENSCHAFTEN, V100, P285, DOI 10.1007/s00114-013-1024-7; Morris SC, 2008, ACTA PALAEONTOL POL, V53, P135; Nelson K, 2000, SYMBIOSIS, V28, P1; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2014, TRACER V1 6; Rambaut A., 2006, FIGTREE V1 3 1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouse GW, 2008, BIOL BULL-US, V214, P67, DOI 10.2307/25066661; Rouse GW, 2015, CURR BIOL, V25, P236, DOI 10.1016/j.cub.2014.11.032; Rouse GW, 2011, BIOL LETTERS, V7, P736, DOI 10.1098/rsbl.2011.0202; Rouse GW, 2009, MAR BIOL, V156, P395, DOI 10.1007/s00227-008-1091-z; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Salathe RM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-189; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Taboada S, 2015, MAR ECOL; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; Tresguerres M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0625; Verducci M, 2009, PALAEOGEOGR PALAEOCL, V280, P371, DOI 10.1016/j.palaeo.2009.06.024; Vrijenhoek RC, 2008, MOL ECOL, V17, P4535, DOI 10.1111/j.1365-294X.2008.03937.x; Vrijenhoek RC, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-74; Worsaae K, 2010, J MORPHOL, V271, P127, DOI 10.1002/jmor.10786	64	14	15	0	193	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140341	10.1371/journal.pone.0140341	http://dx.doi.org/10.1371/journal.pone.0140341			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581105	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600006
J	de Smith, AJ; Walsh, KM; Hansen, HM; Endicott, AA; Wiencke, JK; Metayer, C; Wiemels, JL				de Smith, Adam J.; Walsh, Kyle M.; Hansen, Helen M.; Endicott, Alyson A.; Wiencke, John K.; Metayer, Catherine; Wiemels, Joseph L.			Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL; MONOZYGOTIC TWINS; HISPANIC CHILDREN; COPY NUMBER; CHILDHOOD; RISK; VARIANTS; CANCER; CANDIDATE	The extent to which heritable genetic variants can affect tumor development has yet to be fully elucidated. Tumor selection of single nucleotide polymorphism (SNP) risk alleles, a phenomenon called preferential allelic imbalance (PAI), has been demonstrated in some cancer types. We developed a novel application of digital PCR termed Somatic Mutation Allelic Ratio Test using Droplet Digital PCR (SMART-ddPCR) for accurate assessment of tumor PAI, and have applied this method to test the hypothesis that heritable SNPs associated with childhood acute lymphoblastic leukemia (ALL) may demonstrate tumor PAI. These SNPs are located at CDKN2A (rs3731217) and IKZF1 (rs4132601), genes frequently lost in ALL, and at CEBPE (rs2239633), ARID5B (rs7089424), PIP4K2A (rs10764338), and GATA3 (rs3824662), genes located on chromosomes gained in high-hyperdiploid ALL. We established thresholds of AI using constitutional DNA from SNP heterozygotes, and subsequently measured allelic copy number in tumor DNA from 19-142 heterozygote samples per SNP locus. We did not find significant tumor PAI at these loci, though CDKN2A and IKZF1 SNPs showed a trend towards preferential selection of the risk allele (p = 0.17 and p = 0.23, respectively). Using a genomic copy number control ddPCR assay, we investigated somatic copy number alterations (SCNA) underlying AI at CDKN2A and IKZF1, revealing a complex range of alterations including homozygous and hemizygous deletions and copy-neutral loss of heterozygosity, with varying degrees of clonality. Copy number estimates fromddPCR showed high agreement with those from multiplex ligation-dependent probe amplification (MLPA) assays. We demonstrate that SMART-ddPCR is a highly accurate method for investigation of tumor PAI and for assessment of the somatic alterations underlying AI. Furthermore, analysis of publicly available data from The Cancer Genome Atlas identified 16 recurrent SCNA loci that contain heritable cancer risk SNPs associated with a matching tumor type, and which represent candidate PAI regions warranting further investigation.	[de Smith, Adam J.; Endicott, Alyson A.; Wiemels, Joseph L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Walsh, Kyle M.; Hansen, Helen M.; Wiencke, John K.; Wiemels, Joseph L.] Univ Calif San Francisco, Dept Neurol Surg, Div Neuroepidemiol, San Francisco, CA USA; [Metayer, Catherine] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	de Smith, AJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	adam.desmith@ucsf.edu		Walsh, Kyle/0000-0002-5879-9981; Endicott, Alyson/0000-0001-7702-4770; de Smith, Adam/0000-0003-4880-7543; Metayer, Catherine/0000-0003-3467-4145	Alex's Lemonade Stand Foundation 'A' Award; National Institutes of Health (NIH) National Cancer Institute [R01CA155461, R25CA112355]; National Institute of Environmental Health Sciences (NIEHS) [R01ES009137]; NATIONAL CANCER INSTITUTE [R25CA112355, R01CA155461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009137] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation 'A' Award; National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	AJD is supported by an Alex's Lemonade Stand Foundation 'A' Award Grant (http://www.alexslemonade.org/). This research was also supported by the National Institutes of Health (NIH) National Cancer Institute grant numbers R01CA155461 (JLW) and R25CA112355 (KMW), and by the National Institute of Environmental Health Sciences (NIEHS) grant number R01ES009137 (CM, JLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley K, 2010, INT J EPIDEMIOL, V39, P1628, DOI 10.1093/ije/dyq162; Bateman CM, 2015, LEUKEMIA, V29, P58, DOI 10.1038/leu.2014.177; Caye A, 2013, HAEMATOLOGICA, V98, P597, DOI 10.3324/haematol.2012.073965; Cazzaniga G, 2011, BLOOD, V118, P5559, DOI 10.1182/blood-2011-07-366542; Chokkalingam AP, 2013, CANCER CAUSE CONTROL, V24, P1789, DOI 10.1007/s10552-013-0256-3; Dastugue N, 2013, BLOOD, V121, P2415, DOI 10.1182/blood-2012-06-437681; Dworkin AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001136; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fleming JL, 2014, INT J CANCER, V134, P244, DOI 10.1002/ijc.28339; Gerber MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037672; Hindorff LA, CATALOG PUBLISHED GE; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; LaFramboise T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001086; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Linet MS, 1999, JNCI-J NATL CANCER I, V91, P1051, DOI 10.1093/jnci/91.12.1051; Migliorini G, 2013, BLOOD, V122, P3298, DOI 10.1182/blood-2013-03-491316; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Panzer-Grumayer ER, 2002, BLOOD, V100, P347, DOI 10.1182/blood-2002-01-0144; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Paulsson K, 2005, GENE CHROMOSOME CANC, V44, P113, DOI 10.1002/gcc.20222; Paulsson K, 2010, P NATL ACAD SCI USA, V107, P21719, DOI 10.1073/pnas.1006981107; Perez-Andreu V, 2013, NAT GENET, V45, P1494, DOI 10.1038/ng.2803; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; Raimondi SC, 1996, LEUKEMIA, V10, P213; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Schwab CJ, 2013, HAEMATOLOGICA, V98, P1081, DOI 10.3324/haematol.2013.085175; Sherborne AL, 2010, NAT GENET, V42, P492, DOI 10.1038/ng.585; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Tuupanen S, 2008, CANCER RES, V68, P14, DOI 10.1158/0008-5472.CAN-07-5766; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walsh KM, 2013, LEUKEMIA, V27, P2416, DOI 10.1038/leu.2013.130; Walsh KM, 2015, CANCER RES, V75, P4884, DOI 10.1158/0008-5472.CAN-15-1105; Walsh KM, 2014, AM J HEMATOL, V89, P721, DOI 10.1002/ajh.23727; Walsh KM, 2013, BLOOD, V121, P4808, DOI 10.1182/blood-2013-04-495390; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; Xu H, 2013, JNCI-J NATL CANCER I, V105, P733, DOI 10.1093/jnci/djt042; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143343	10.1371/journal.pone.0143343	http://dx.doi.org/10.1371/journal.pone.0143343			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575185	Green Submitted, Green Published, gold			2022-12-26	WOS:000365153400060
J	Costa, C; Pereira, S; Lima, L; Peixoto, A; Fernandes, E; Neves, D; Neves, M; Gaiteiro, C; Tavares, A; da Costa, RMG; Cruz, R; Amaro, T; Oliveira, PA; Ferreira, JA; Santos, LL				Costa, Ceu; Pereira, Sofia; Lima, Luis; Peixoto, Andreia; Fernandes, Elisabete; Neves, Diogo; Neves, Manuel; Gaiteiro, Cristiana; Tavares, Ana; Gil da Costa, Rui M.; Cruz, Ricardo; Amaro, Teresina; Oliveira, Paula A.; Ferreira, Jose Alexandre; Santos, Lucio L.			Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics	PLOS ONE			English	Article							SIALYL-TN ANTIGEN; UROTHELIAL CARCINOMA; RAPAMYCIN PATHWAY; TUMOR PROGRESSION; MAMMALIAN TARGET; HIGH-RISK; EXPRESSION; CELLS; PHENOTYPE; SURVIVAL	Muscle invasive bladder cancer (MIBC, stage >= T2) is generally associated with poor prognosis, constituting the second most common cause of death among genitourinary tumours. Due to high molecular heterogeneity significant variations in the natural history and disease outcome have been observed. This has also delayed the introduction of personalized therapeutics, making advanced stage bladder cancer almost an orphan disease in terms of treatment. Altered protein glycosylation translated by the expression of the sialyl-Tn antigen (STn) and its precursor Tn as well as the activation of the PI3K/Akt/mTOR pathway are cancer-associated events that may hold potential for patient stratification and guided therapy. Therefore, a retrospective design, 96 bladder tumours of different stages (Ta, T1-T4) was screened for STn and phosphorylated forms of Akt (pAkt), mTOR (pmTOR), S6 (pS6) and PTEN, related with the activation of the PI3K/Akt/mTOR pathway. In our series the expression of Tn was residual and was not linked to stage or outcome, while STn was statically higher in MIBC when compared to non-muscle invasive tumours (p = 0.001) and associated decreased cancer-specific survival (log rank p = 0.024). Conversely, PI3K/Akt/mTOR pathway intermediates showed an equal distribution between non-muscle invasive bladder cancer (NMIBC) and MIBC and did not associate with cancer-specif survival (CSS) in any of these groups. However, the overexpression of pAKT, pmTOR and/or pS6 allowed discriminating STn-positive advanced stage bladder tumours facing worst CSS (p = 0.027). Furthermore, multivariate Cox regression analysis revealed that overexpression of PI3K/Akt/mTOR pathway proteins in STn+ MIBC was independently associated with approximately 6-fold risk of death by cancer (p = 0.039). Mice bearing advanced stage chemically-induced bladder tumours mimicking the histological and molecular nature of human tumours were then administrated with mTOR-pathway inhibitor sirolimus (rapamycin). This decreased the number of invasive lesions and, concomitantly, the expression of STn and also pS6, the downstream effector of the PI3K/Akt/mTOR pathway. In conclusion, STn was found to be marker of poor prognosis in bladder cancer and, in combination with PI3K/Akt/mTOR pathway evaluation, holds potential to improve the stratification of stage disease. Animal experiments suggest that mTOR pathway inhibition could be a potential therapeutic approach for this specific subtype of MIBC.	[Costa, Ceu; Pereira, Sofia; Lima, Luis; Peixoto, Andreia; Fernandes, Elisabete; Neves, Diogo; Neves, Manuel; Gaiteiro, Cristiana; Tavares, Ana; Gil da Costa, Rui M.; Ferreira, Jose Alexandre; Santos, Lucio L.] Portuguese Inst Oncol, Expt Pathol & Therapeut Grp, Oporto, Portugal; [Costa, Ceu; Pereira, Sofia] Univ Porto, ICBAS, Abel Salazar Biomed Sci Inst, P-4100 Oporto, Portugal; [Costa, Ceu; Pereira, Sofia; Santos, Lucio L.] Univ Fernando Pessoa, Fac Hlth Sci, Oporto, Portugal; [Lima, Luis] Polytech Inst Oporto, Nucleo Invest & Informacao Farm, CISA, Sch Allied Hlth Sci, Oporto, Portugal; [Lima, Luis] Univ Porto IPATIMUP, Inst Pathol & Mol Immunol, Oporto, Portugal; [Tavares, Ana] Portuguese Inst Oncol, Dept Pathol, Oporto, Portugal; [Gil da Costa, Rui M.] Univ Porto, Fac Engn, Lab Proc Environm Biotechnol & Energy Engn LEPABE, P-4100 Oporto, Portugal; [Cruz, Ricardo] Portuguese Inst Oncol, Dept Urol, Oporto, Portugal; [Amaro, Teresina] Hosp Pedro Hispano, Dept Urol, Matosinhos, Portugal; [Oliveira, Paula A.] Univ Tras Os Montes & Alto Douro, Dept Vet Sci, CITAB, Vila Real, Portugal; [Ferreira, Jose Alexandre] Univ Aveiro, Mass Spectrometry Ctr, P-3800 Aveiro, Portugal; [Santos, Lucio L.] Portuguese Inst Oncol, Dept Surg Oncol, Oporto, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade Fernando Pessoa; Polytechnic Institute of Porto; Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Universidade de Coimbra; University of Tras-os-Montes & Alto Douro; Universidade de Aveiro; Universidade de Coimbra	Ferreira, JA (corresponding author), Portuguese Inst Oncol, Expt Pathol & Therapeut Grp, Rua Dr Antonio Bernardino de Almeida, Oporto, Portugal.	josealexandreferreira@ua.pt; llarasantos@gmail.com	Peixoto, Andreia/AAG-4757-2021; Pereira, sofia/AAD-6229-2021; Costa, Céu/AAD-6215-2021; Oliveira, Paula Alexandra/F-2510-2013; Ferreira, José Alexandre/ABM-1695-2022; Santos, Lúcio Lara/AAE-2822-2021; Gaiteiro, Cristiana/M-1544-2014; Gil da Costa, Rui/O-5029-2018	Peixoto, Andreia/0000-0001-9514-0775; Oliveira, Paula Alexandra/0000-0001-9519-4044; Ferreira, José Alexandre/0000-0002-0097-6148; Santos, Lúcio Lara/0000-0002-0521-5655; Gaiteiro, Cristiana/0000-0001-5438-1679; Lima, Jose/0000-0002-8906-9826; Fernandes, Elisabete/0000-0002-9907-7432; Tavares, Ana/0000-0002-3128-3328; Neves, Diogo/0000-0003-0575-3207; Gil da Costa, Rui/0000-0002-2151-2449; Lima, Luis/0000-0001-8152-9237; Costa, Ceu/0000-0003-3766-2887; Pereira, Sofia/0000-0002-3633-397X	Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/66288/2009, SFRH/BPD/101827/2014, SFRH/BPD/85462/2012, SFRH/BD/103571/2014, SFRH/BD/111242/2015]; European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF); ICBAS-UP; Portuguese Association of Urology/Pfizer	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF); ICBAS-UP; Portuguese Association of Urology/Pfizer	This work was supported by Portuguese Foundation for Science and Technology (FCT) Postdoctoral grants SFRH/BPD/66288/2009 (Jose Alexandre Ferreira), SFRH/BPD/101827/2014 (Luis Lima), SFRH/BPD/85462/2012 (Rui Gil da Costa) and PhD grants SFRH/BD/103571/2014 (Elisabete Fernandes) and SFRH/BD/111242/2015 (Andreia Peixoto). FCT is co-financed by European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF). The authors also acknowledge financial support from ICBAS-UP (Ceu Costa and Sofia Pereira) and the Portuguese Association of Urology/Pfizer prize 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo R, 2015, J CONTROL RELEASE; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Calderaro J, 2014, INT J CANCER, V134, P1776, DOI 10.1002/ijc.28518; Carrascal MA, 2014, MOL ONCOL, V8, P753, DOI 10.1016/j.molonc.2014.02.008; Chaux A, 2013, UROLOGY, V81, P116, DOI 10.1016/j.urology.2012.09.007; Ching CB, 2010, LAB INVEST, V90, P1406, DOI 10.1038/labinvest.2010.133; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Dovedi SJ, 2009, CANCER METAST REV, V28, P355, DOI 10.1007/s10555-009-9192-9; Fahmy M, 2013, HUM PATHOL, V44, P1766, DOI 10.1016/j.humpath.2012.11.026; Fernandes E, 2015, J CONTROL RELEASE, V209, P288, DOI 10.1016/j.jconrel.2015.05.003; Ferreira J, 2014, EUR UROL SUPPL, V13, pe518; Ferreira JA, 2013, MOL ONCOL, V7, P719, DOI 10.1016/j.molonc.2013.03.001; Flucke U, 2001, ANTICANCER RES, V21, P2189; Harris LD, 2008, MOL CARCINOGEN, V47, P678, DOI 10.1002/mc.20420; Julien S, 2006, GLYCOBIOLOGY, V16, P54, DOI 10.1093/glycob/cwj033; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; KJELDSEN T, 1988, CANCER RES, V48, P2214; Korkolopoulou P, 2012, BJU INT, V110, pE1237, DOI 10.1111/j.1464-410X.2012.11569.x; Lima L, 2013, BRIT J CANCER, V109, P2106, DOI 10.1038/bjc.2013.571; Lin JC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-105; Ma H, 2015, ONCOGENE, V34, P726, DOI 10.1038/onc.2014.7; Massari F, 2015, TARGET ONCOL; Miakhil I, 2013, INT J MED BIOMED RES, V2, P186, DOI DOI 10.14194/IJMBR.235; Munari E, 2013, HUM PATHOL, V44, P2668, DOI 10.1016/j.humpath.2013.07.008; Nishikawa M, 2015, UROL ONCOL, V33; Oliveira PA, 2009, ANTICANCER RES, V29, P3221; Palmeira C, 2010, ONCOL LETT, V1, P373, DOI 10.3892/ol_00000066; Pasin Erik, 2008, Rev Urol, V10, P31; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Pinto-Leite R, 2012, J TOXICOL ENV HEAL A, V75, P788, DOI 10.1080/15287394.2012.690325; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sun CH, 2011, HISTOPATHOLOGY, V58, P1054, DOI 10.1111/j.1365-2559.2011.03856.x; Tamura M, 1999, JNCI-J NATL CANCER I, V91, P1820, DOI 10.1093/jnci/91.21.1820; TSUCHIYA A, 1995, BRIT J SURG, V82, P960, DOI 10.1002/bjs.1800820734; Vasconcelos-Nobrega C, 2012, IN VIVO, V26, P727; Victorzon M, 1996, INT J CANCER, V65, P295, DOI 10.1002/(SICI)1097-0215(19960126)65:3<295::AID-IJC3>3.0.CO;2-V; Wu X, 2004, BJU INT, V93, P143, DOI 10.1111/j.1464-410X.2004.04574.x	38	50	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0141253	10.1371/journal.pone.0141253	http://dx.doi.org/10.1371/journal.pone.0141253			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569621	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700006
J	Davis, JL; Currin, CA; O'Brien, C; Raffenburg, C; Davis, A				Davis, Jenny L.; Currin, Carolyn A.; O'Brien, Colleen; Raffenburg, Craig; Davis, Amanda			Living Shorelines: Coastal Resilience with a Blue Carbon Benefit	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; SEA-LEVEL RISE; SALT MARSHES; ECOSYSTEM DEVELOPMENT; ACCUMULATION; FRESH; RATES; SEDIMENT; BRACKISH; WETLANDS	Living shorelines are a type of estuarine shoreline erosion control that incorporates native vegetation and preserves native habitats. Because they provide the ecosystem services associated with natural coastal wetlands while also increasing shoreline resilience, living shorelines are part of the natural and hybrid infrastructure approach to coastal resiliency. Marshes created as living shorelines are typically narrow (< 30 m) fringing marshes with sandy substrates that are well flushed by tides. These characteristics distinguish living shorelines from the larger meadow marshes in which most of the current knowledge about created marshes was developed. The value of living shorelines for providing both erosion control and habitat for estuarine organisms has been documented but their capacity for carbon sequestration has not. We measured carbon sequestration rates in living shorelines and sandy transplanted Spartina alterniflora marshes in the Newport River Estuary, North Carolina. The marshes sampled here range in age from 12 to 38 years and represent a continuum of soil development. Carbon sequestration rates ranged from 58 to 283 g C m(-2) yr(-1) and decreased with marsh age. The pattern of lower sequestration rates in older marshes is hypothesized to be the result of a relative enrichment of labile organic matter in younger sites and illustrates the importance of choosing mature marshes for determination of long-term carbon sequestration potential. The data presented here are within the range of published carbon sequestration rates for S. alterniflora marshes and suggest that wide-scale use of the living shoreline approach to shoreline management may come with a substantial carbon benefit.	[Davis, Jenny L.; Currin, Carolyn A.] NOAA, Natl Ocean Serv Ctr Coastal Fisheries & Habitat R, Beaufort, NC 28516 USA; [Davis, Jenny L.] Consolidated Safety Serv, Fairfax, VA USA; [O'Brien, Colleen] Eckerd Coll, St Petersburg, FL 33733 USA; [Raffenburg, Craig] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Davis, Amanda] Massachusetts Div Marine Fisheries, New Bedford, MA USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami; Massachusetts Division of Marine Fisheries	Davis, JL (corresponding author), NOAA, Natl Ocean Serv Ctr Coastal Fisheries & Habitat R, Beaufort, NC 28516 USA.	jenny.davis@noaa.gov			Defense Coastal Estuarine Research Program; Strategic Environmental Research and Development Program (SERDP); Consolidated Safety Services (CSS)	Defense Coastal Estuarine Research Program; Strategic Environmental Research and Development Program (SERDP); Consolidated Safety Services (CSS)	This work was supported by the Defense Coastal Estuarine Research Program, funded by the Strategic Environmental Research and Development Program (SERDP). The funder provided support in the form of salaries for authors [JLD] through a contract with Consolidated Safety Services (CSS). Neither the funding agency, nor CSS had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of authors are articulated in the 'author contributions' section.	[Anonymous], 2014, METH COAST WETL CREA; [Anonymous], 2011, MITIGATING CLIMATE C; Arkema KK, 2013, NAT CLIM CHANGE, V3, P913, DOI 10.1038/NCLIMATE1944; Baldock JA, 2004, MAR CHEM, V92, P39, DOI 10.1016/j.marchem.2004.06.016; Ballantine K, 2009, ECOL APPL, V19, P1467, DOI 10.1890/07-0588.1; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Bilkovic DM, 2013, ECOL ENG, V61, P469, DOI 10.1016/j.ecoleng.2013.10.011; BLUM LK, 1993, MAR ECOL PROG SER, V102, P169, DOI 10.3354/meps102169; BRICKERURSO S, 1989, ESTUARIES, V12, P300, DOI 10.2307/1351908; Bruland Gregory L., 2006, Wetlands Ecology and Management, V14, P245, DOI 10.1007/s11273-005-1116-z; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Commission for Environmental Cooperation, 2013, N AM BLUE CARB SCOP; Connor RF, 2001, GLOBAL BIOGEOCHEM CY, V15, P943, DOI 10.1029/2000GB001346; Craft C, 1999, ECOL APPL, V9, P1405, DOI 10.1890/1051-0761(1999)009[1405:TFYOED]2.0.CO;2; Craft C, 2003, ECOL APPL, V13, P1417, DOI 10.1890/02-5086; Craft C, 2002, RESTOR ECOL, V10, P248, DOI 10.1046/j.1526-100X.2002.01020.x; CRAFT CB, 1988, ESTUARIES, V11, P272, DOI 10.2307/1352014; Craft CB, 2000, WETLANDS, V20, P323, DOI 10.1672/0277-5212(2000)020[0323:SANAIF]2.0.CO;2; Currin C.A., 2010, PUGET SOUND SHORELIN, P91; Currin CA, 1996, ESTUAR COAST SHELF S, V42, P597, DOI 10.1006/ecss.1996.0039; Currin Carolyn A., 2008, Wetlands Ecology and Management, V16, P97, DOI 10.1007/s11273-007-9059-1; DAME RF, 1986, MAR ECOL PROG SER, V32, P71, DOI 10.3354/meps032071; Darby FA, 2009, THESIS; Davis JL, 2006, MANAGEMENT POLICY SC, P55; Douglass S.L., 1999, SHORE BEACH, V67, P19; ELLISON AM, 1986, AM J BOT, V73, P1548, DOI 10.2307/2443921; Fear J, 2011, N CAROLINA DIVISION; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Gittman RK, 2015, FRONT ECOL ENVIRON, V13, P301, DOI 10.1890/150065; Gittman RK, 2014, OCEAN COAST MANAGE, V102, P94, DOI 10.1016/j.ocecoaman.2014.09.016; Gittman RK, ECOL APPL IN PRESS; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; Kirwan ML, 2013, BIOGEOSCIENCES, V10, P1869, DOI 10.5194/bg-10-1869-2013; Laffoley Dd'A, 2009, MANAGEMENT NATURAL C; Manis JE, 2015, J COAST CONSERV, V19, P1, DOI 10.1007/s11852-014-0349-5; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; McVerry K, 2015, N CAROLINA SHORELINE; Morris J.T., 2012, RECARBONIZATION BIOS, P517; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Mudd SM, 2009, ESTUAR COAST SHELF S, V82, P377, DOI 10.1016/j.ecss.2009.01.028; National Oceanic and Atmospheric Administration, 2013, TID CURR SEA LEV TRE; National Oceanic and Atmospheric Administration (NOAA), 2013, NOAAS STAT COAST NAT; National Oceanographic and Atmospheric Adminstration, 2014, VERT DAT TRANSF V 3; Neubauer SC, 2002, ESTUAR COAST SHELF S, V54, P713, DOI 10.1006/ecss.2001.0854; NYMAN JA, 1991, LIMNOL OCEANOGR, V36, P1406, DOI 10.4319/lo.1991.36.7.1406; Ouyang X, 2014, BIOGEOSCIENCES, V11, P5057, DOI 10.5194/bg-11-5057-2014; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Piehler MF, 1998, RESTOR ECOL, V6, P290, DOI 10.1046/j.1526-100X.1998.00633.x; Ray-Culp M., 2007, NATL WETL NEWSL, V29, P19; REDFIELD AC, 1962, P NATL ACAD SCI USA, V48, P1728, DOI 10.1073/pnas.48.10.1728; SACCO JN, 1994, ESTUARIES, V17, P489, DOI 10.2307/1352678; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Simenstad CA, 1996, ECOL APPL, V6, P38, DOI 10.2307/2269551; Sutton-Grier AE, 2015, ENVIRON SCI POLICY, V51, P137, DOI 10.1016/j.envsci.2015.04.006; Swann L, 2008, AM FISH S S, V64, P47; Wigand C, 2015, ESTUAR COAST, V38, P1838, DOI 10.1007/s12237-014-9937-8; Wolf KL, 2011, WETLANDS, V31, P699, DOI 10.1007/s13157-011-0185-4	60	75	77	17	161	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142595	10.1371/journal.pone.0142595	http://dx.doi.org/10.1371/journal.pone.0142595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569503	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700050
J	Martin-Martin, I; Molina, R; Jimenez, M				Martin-Martin, Ines; Molina, Ricardo; Jimenez, Maribel			Kinetics of Anti-Phlebotomus perniciosus Saliva Antibodies in Experimentally Bitten Mice and Rabbits	PLOS ONE			English	Article							SAND FLY SALIVA; VISCERAL LEISHMANIASIS; LUTZOMYIA-LONGIPALPIS; IMMUNE-RESPONSE; EXPOSURE; INFANTUM; VECTOR; PROTEINS; MARKERS; BITES	Background Sand flies are hematophagous arthropods that act as vectors of Leishmania parasites. When hosts are bitten they develop cellular and humoral responses against sand fly saliva. A positive correlation has been observed between the number of bites and antibody levels indicating that anti-saliva antibody response can be used as marker of exposure to sand flies. Little is known about kinetics of antibodies against Phlebotomus perniciosus salivary gland homogenate (SGH) or recombinant salivary proteins (rSP). This work focused on the study of anti-P. perniciosus saliva antibodies in sera of mice and rabbits that were experimentally exposed to the bites of uninfected sand flies. Methodology/Principal Findings Anti-saliva antibodies were evaluated by ELISA and Western blot. In addition, antibody levels against two P. perniciosus rSP, apyrase rSP01B and D7 related protein rSP04 were determined in mice sera. Anti-saliva antibody levels increased along the immunizations and correlated with the number of sand fly bites. Anti-SGH antibody levels were detected in sera of mice five weeks after exposure, and persisted for at least three months. Anti-apyrase rSP01B antibodies followed similar kinetic responses than anti-SGH antibodies while rSP04 showed a delayed response and exhibited a greater variability among sera of immunized mice. In rabbits, anti-saliva antibodies appeared after the second week of exposure and IgG antibodies persisted at high levels, even 7 months post-exposure. Conclusions/Significance Our results contributed to increase the knowledge on the type of immune response P. perniciosus saliva and individual proteins elicited highlighting the use of rSP01B as an epidemiological marker of exposure. Anti-saliva kinetics in sera of experimentally bitten rabbits were studied for the first time. Results with rabbit model provided useful information for a better understanding of the anti-saliva antibody levels found in wild leporids in the human leishmaniasis focus in the Madrid region, Spain.	[Martin-Martin, Ines; Molina, Ricardo; Jimenez, Maribel] Inst Salud Carlos III, Unidad Entomol Med, Serv Parasitol, Ctr Nacl Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Martin-Martin, I (corresponding author), Inst Salud Carlos III, Unidad Entomol Med, Serv Parasitol, Ctr Nacl Microbiol, Madrid, Spain.	martinines@hotmail.com	Martin Martin, Ines/I-9358-2012	Martin Martin, Ines/0000-0002-0956-7324; Molina, Ricardo/0000-0001-6662-173X; Jimenez, Maribel/0000-0002-5615-3087	Spanish Ministry of Science Innovation [AGL2008-01592]; EU [FP7-2011-261504 EDENext]	Spanish Ministry of Science Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU(European Commission)	This study was partially funded by the Spanish Ministry of Science & Innovation (Project AGL2008-01592) and by the EU grant FP7-2011-261504 EDENext. The paper is catalogued by the EDENext Steering Committee as EDENext371 (http://www.edenext.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Bahia D, 2007, PARASITOL RES, V100, P449, DOI 10.1007/s00436-006-0307-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns Robert, 2005, Methods Mol Biol, V295, P1; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Clements MF, 2010, AM J TROP MED HYG, V82, P801, DOI 10.4269/ajtmh.2010.09-0336; Drahota J, 2009, PARASITE IMMUNOL, V31, P766, DOI 10.1111/j.1365-3024.2009.01155.x; Drahota J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002597; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; Giunchetti RC, 2008, VACCINE, V26, P623, DOI 10.1016/j.vaccine.2007.11.057; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Hostomska J, 2008, VECTOR-BORNE ZOONOT, V8, P443, DOI 10.1089/vbz.2007.0214; Hostomska J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-282; Jimenez M, 2014, VET PARASITOL, V202, P296, DOI 10.1016/j.vetpar.2014.03.027; Kaburi JC, 2011, J VECTOR DIS, V48, P61; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Kostalova T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003855; Martin-Martin I, 2014, VET PARASITOL, V202, P207, DOI 10.1016/j.vetpar.2014.02.045; Martin-Martin I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/526069; Martin-Martin I, 2012, ACTA TROP, V123, P22, DOI 10.1016/j.actatropica.2012.03.003; Marzouki S, 2011, AM J TROP MED HYG, V84, P653, DOI 10.4269/ajtmh.2011.10-0598; Molina R, 2012, VET PARASITOL, V190, P268, DOI 10.1016/j.vetpar.2012.05.006; Molina R., 1993, Research and Reviews in Parasitology, V51, P87; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Oliveira F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000226; Palosuo K, 1997, INT ARCH ALLERGY IMM, V114, P367, DOI 10.1159/000237696; Peng ZK, 2002, J ALLERGY CLIN IMMUN, V110, P816, DOI 10.1067/mai.2002.128736; RIBEIRO JMC, 1989, INSECT BIOCHEM, V19, P409, DOI 10.1016/0020-1790(89)90046-2; Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI 10.1017/S003118200400681X; Rohousova I, 2006, FOLIA PARASIT, V53, P161, DOI 10.14411/fp.2006.022; Rohousova I, 2011, INT J PARASITOL, V41, P481, DOI 10.1016/j.ijpara.2011.01.003; SCHWARTZ BS, 1990, AM J EPIDEMIOL, V132, P58, DOI 10.1093/oxfordjournals.aje.a115643; Schwarz A, 2010, INT J PARASITOL, V40, P1295, DOI 10.1016/j.ijpara.2010.03.013; Silva F, 2005, AM J TROP MED HYG, V72, P94, DOI 10.4269/ajtmh.2005.72.94; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; Vinhas V, 2007, EUR J IMMUNOL, V37, P3111, DOI 10.1002/eji.200737431; Vlkova M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001719; Vlkova M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001344; WHO, 2010, WHO TECH REP SER, V949, P1	40	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0140722	10.1371/journal.pone.0140722	http://dx.doi.org/10.1371/journal.pone.0140722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569103	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700003
J	Terrazas, C; Varikuti, S; Kimble, J; Moretti, E; Boyaka, PN; Satoskar, AR				Terrazas, Cesar; Varikuti, Sanjay; Kimble, Jennifer; Moretti, Ellen; Boyaka, Prosper N.; Satoskar, Abhay R.			IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani	FASEB JOURNAL			English	Article						granuloma; monocytes; neutrophils; gamma delta T cells; T(h)17	T-CELLS; MONOCYTE MIGRATION; TRYPANOSOMA-CRUZI; IMMUNE-RESPONSE; TGF-BETA; INFECTION; GRANULOMA; INTERLEUKIN-4; REQUIREMENT; MACROPHAGES	Leishmania donovani is an intracellular parasite that infects professional phagocytes and causes visceral leishmaniasis (VL). The immune response during VL has been extensively studied in the context of T-helper (T-h)1 and T(h)2 responses. Immunity against this parasite is dependent on IFN-gamma production and subsequent macrophage activation, and the T(h)2 response promotes granuloma formation. The cytokine IL-17A is associated with neutrophilic inflammation. Depletion of neutrophils during experimental VL results in enhanced parasitic loads. Furthermore, although patients resistant to VL showed enhanced levels of IL-17A in circulation, little is known about the role of IL-17A during VL infection. Here, we used IL-17A-deficient mice and IL-17A reporter mice to address the role of IL-17A during VL. IL-17A(-/-) mice were highly resistant to VL infection, showing decreased parasites in the liver and spleen. This unexpected phenotype was associated with enhanced IFN-gamma production by T cells and decreased accumulation of neutrophils and monocytes, resulting in reduced number of granulomas. We also found gamma delta T and T(h)17 cells as the main IL-17A(+) cells during VL infection. Our data reveal an unexpected role of IL-17A rendering susceptibility against L. donovani by regulating the IFN-gamma response and promoting detrimental inflammation.	[Terrazas, Cesar; Varikuti, Sanjay; Kimble, Jennifer; Moretti, Ellen; Satoskar, Abhay R.] Ohio State Univ, Dept Pathol, 1645 Neil Ave, Columbus, OH 43210 USA; [Boyaka, Prosper N.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Boyaka, Prosper N.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Terrazas, C; Satoskar, AR (corresponding author), Ohio State Univ, Dept Pathol, 1645 Neil Ave, Columbus, OH 43210 USA.	cterrazas.05@gmail.com; abhay.satoskar@osumc.edu	Satoskar, Abhay/AAB-7748-2019	Boyaka, Prosper/0000-0001-6857-9088	U.S. National Institute of Health, National Institute of Allergy and Infectious Diseases Grant [R01 AI043197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101323] Funding Source: NIH RePORTER	U.S. National Institute of Health, National Institute of Allergy and Infectious Diseases Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Yoichiro Iwakura (Department of Biophysics and Biochemistry, The University of Tokyo, Tokyo, Japan) for providing the IL-17A<SUP>-/-</SUP> mice and Dr. Tracey L. Papenfuss (Department of Veterinary Biosciences, The Ohio State University) for evaluation of granuloma. P.B. was supported by U.S. National Institute of Health, National Institute of Allergy and Infectious Diseases Grant R01 AI043197.	Alexander J, 2005, IMMUNOL LETT, V99, P17, DOI 10.1016/j.imlet.2005.01.009; Amprey JL, 2004, J EXP MED, V200, P895, DOI 10.1084/jem.20040704; Barin JG, 2012, EUR J IMMUNOL, V42, P726, DOI 10.1002/eji.201141737; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; CERVIA JS, 1993, INFECT IMMUN, V61, P1330, DOI 10.1128/IAI.61.4.1330-1333.1993; Chatelain R, 1999, PARASITE IMMUNOL, V21, P423, DOI 10.1046/j.1365-3024.1999.00240.x; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Erdmann H, 2013, IMMUNOBIOLOGY, V218, P910, DOI 10.1016/j.imbio.2012.10.005; Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Guiton R, 2010, J INFECT DIS, V202, P427, DOI 10.1086/653738; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Matthews DJ, 2000, J IMMUNOL, V164, P1458, DOI 10.4049/jimmunol.164.3.1458; McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07; McFarlane E, 2011, J INFECT DIS, V204, P36, DOI 10.1093/infdis/jir080; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; McGwire BS, 2014, QJM-INT J MED, V107, P7, DOI 10.1093/qjmed/hct116; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Murray HW, 2008, INFECT IMMUN, V76, P4088, DOI 10.1128/IAI.00490-08; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Murray HW, 2001, INT J EXP PATHOL, V82, P249, DOI 10.1046/j.1365-2613.2001.00199.x; Nascimento M. S. L., 2014, J INFECT DIS, V211; Oghumu S, 2014, EUR J IMMUNOL, V44, P450, DOI 10.1002/eji.201343477; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Rosas LE, 2006, J IMMUNOL, V177, P22, DOI 10.4049/jimmunol.177.1.22; Schwarzenberger P, 2000, J IMMUNOL, V164, P4783, DOI 10.4049/jimmunol.164.9.4783; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Silverpil E, 2011, INFLAMMATION, V34, P1, DOI 10.1007/s10753-010-9201-8; Smelt SC, 2000, J IMMUNOL, V164, P3681, DOI 10.4049/jimmunol.164.7.3681; Sousa LMA, 2014, PARASITE IMMUNOL, V36, P13, DOI 10.1111/pim.12078; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Terrazas C, 2015, J IMMUNOL METHODS, V423, P93, DOI 10.1016/j.jim.2015.04.022; Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wilson ME, 1998, J IMMUNOL, V161, P6148; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409; Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200	47	40	41	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1135	1143		10.1096/fj.15-277202	http://dx.doi.org/10.1096/fj.15-277202			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26581600	Green Published			2022-12-26	WOS:000370387800012
J	Haack, IA; Derkow, K; Riehn, M; Rentinck, MN; Kuhl, AA; Lehnardt, S; Schott, E				Haack, Ira An; Derkow, Katja; Riehn, Mathias; Rentinck, Marc-Nicolas; Kuehl, Anja A.; Lehnardt, Seija; Schott, Eckart			The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis	PLOS ONE			English	Article							SINUSOIDAL ENDOTHELIAL-CELLS; DENDRITIC CELLS; KUPFFER CELLS; LIVER; ACTIVATION; ANTIGEN; MICE; INDUCTION; HEPATOCYTES; IMMUNITY	Background The role of regulatory CD4 T cells (Treg) in immune-mediated liver disease is still under debate. It remains disputed whether Treg suppress T cell-mediated hepatitis in vivo and whether hepatic regulatory T cells are functional in patients with autoimmune hepatitis. Methods We used TF-OVA mice, which express ovalbumin in hepatocytes, to investigate the impact of Treg in a model of autoimmune hepatitis. Treg isolated from inflamed livers of TF-OVA mice were tested for their functionality in vitro. By employing double transgenic TF-OVAxDEREG (DEpletion of REGulatory T cells) mice we analyzed whether Treg-depletion aggravates autoimmune inflammation in the liver in vivo. Results CD25+ Foxp3+ CD4 T cells accumulated in the liver in the course of CD8 T cell-mediated hepatitis. Treg isolated from inflamed livers were functional to suppress CD8 T-cell proliferation in vitro. Depletion of Treg in TF-OVAxDEREG mice dramatically amplified T cell-mediated hepatitis. Repeated administration of antigen-specific CD8 T cells led to a second wave of inflammation only after depletion of Treg. Conclusion Our data add to the evidence for an important role of Treg in autoimmune hepatitis and show that Treg reduce the severity of T-cell mediated hepatitis in vivo. They constitute a key immune cell population that actively maintains a tolerogenic milieu in the liver and protects the liver against repeated inflammatory challenges.	[Haack, Ira An; Rentinck, Marc-Nicolas; Schott, Eckart] Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Derkow, Katja; Lehnardt, Seija] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Riehn, Mathias] Helmholtz Ctr Infect Res Braunschweig, Model Syst Infect & Immun, Braunschweig, Germany; [Kuehl, Anja A.] Charite, Res Ctr ImmunoSci, Dept Med Gastroenterol Infect Dis & Rheumatol 1, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schott, E (corresponding author), Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany.	eckart.schott@charite.de	Lehnardt, Seija/AAA-4113-2022	Riehn, Mathias/0000-0001-8737-5566; Kuhl, Anja/0000-0003-2293-5387	Deutsche Forschungsgemeinschaft [SFB633]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project was funded by the Deutsche Forschungsgemeinschaft, SFB633. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolino P, 2002, IMMUNOL CELL BIOL, V80, P84, DOI 10.1046/j.0818-9641.2001.01048.x; Bertolino P, 2001, J IMMUNOL, V166, P5430, DOI 10.4049/jimmunol.166.9.5430; BERTOLINO P, 1995, EUR J IMMUNOL, V25, P1932, DOI 10.1002/eji.1830250721; Bochtler P, 2008, HEPATOLOGY, V48, P1954, DOI 10.1002/hep.22559; Bottcher JP, 2013, CELL REP, V3, P779, DOI 10.1016/j.celrep.2013.02.008; Burghardt S, 2013, J IMMUNOL, V191, P5574, DOI 10.4049/jimmunol.1300826; Carambia A, 2014, J HEPATOL, V61, P594, DOI 10.1016/j.jhep.2014.04.027; de Boer YS, 2014, GASTROENTEROLOGY, V147, P443, DOI 10.1053/j.gastro.2014.04.022; Derkow K, 2007, HEPATOLOGY, V46, P1155, DOI 10.1002/HEP.21796; Derkow K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021847; Dunham RM, 2013, J IMMUNOL, V190, P2009, DOI 10.4049/jimmunol.1201937; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Foureau DM, 2014, CLIN EXPT IMMUNOLOGY; Grant CR, 2014, HEPATOLOGY, V59, P1007, DOI 10.1002/hep.26583; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ichiki Y, 2005, AUTOIMMUN REV, V4, P315, DOI 10.1016/j.autrev.2005.01.005; Kido M, 2008, GASTROENTEROLOGY, V135, P1333, DOI 10.1053/j.gastro.2008.06.042; Kondo Y, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/810939; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Kruse N, 2009, HEPATOLOGY, V50, P1904, DOI 10.1002/hep.23191; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lapierre P, 2013, HEPATOLOGY, V57, P217, DOI 10.1002/hep.26023; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Liu H, 2013, TRANSPL P, V45, P1853, DOI 10.1016/j.transproceed.2013.03.015; Longhi MS, 2006, J IMMUNOL, V176, P4484, DOI 10.4049/jimmunol.176.7.4484; Longhi MS, 2005, J AUTOIMMUN, V25, P63, DOI 10.1016/j.jaut.2005.05.001; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Luth S, 2008, J CLIN INVEST, V118, P3403, DOI 10.1172/JCI32132; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Oo YH, 2010, J IMMUNOL, V184, P2886, DOI 10.4049/jimmunol.0901216; Peiseler M, 2012, J HEPATOL, V57, P125, DOI 10.1016/j.jhep.2012.02.029; Plitas G, 2008, HEPATOLOGY, V47, P1343, DOI 10.1002/hep.22167; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Stross L, 2012, HEPATOLOGY, V56, P873, DOI 10.1002/hep.25765; Taubert R, 2014, J HEPATOL, V61, P1106, DOI 10.1016/j.jhep.2014.05.034; Tay SS, 2014, J IMMUNOL, V193, P2087, DOI 10.4049/jimmunol.1400037; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Vergani D, 2008, WORLD J GASTROENTERO, V14, P3306, DOI 10.3748/wjg.14.3306; Wei HX, 2008, J IMMUNOL, V181, P7221, DOI 10.4049/jimmunol.181.10.7221; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Wuensch SA, 2006, J IMMUNOL, V177, P1689, DOI 10.4049/jimmunol.177.3.1689; Wuensch SA, 2010, HEPATOLOGY, V52, P1068, DOI 10.1002/hep.23745; You Q, 2008, HEPATOLOGY, V48, P978, DOI 10.1002/hep.22395; Zierden M, 2010, GASTROENTEROLOGY, V139, P975, DOI 10.1053/j.gastro.2010.05.075	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143715	10.1371/journal.pone.0143715	http://dx.doi.org/10.1371/journal.pone.0143715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599014	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600109
J	Lagana, A; Veneziano, D; Spata, T; Tang, R; Zhu, H; Mohler, PJ; Kilic, A				Lagana, Alessandro; Veneziano, Dario; Spata, Tyler; Tang, Richard; Zhu, Hua; Mohler, Peter J.; Kilic, Ahmet			Identification of General and Heart-Specific miRNAs in Sheep (Ovis aries)	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; TARGETED DELETION; MIR-17-92 CLUSTER; ANIMAL-MODELS; EMERGING ROLE; MICRORNAS; EXPRESSION; BIOGENESIS; EVOLUTION; DYSREGULATION	MicroRNAs (miRNAs or miRs) are small regulatory RNAs crucial for modulation of signaling pathways in multiple organs. While the link between miRNAs and heart disease has grown more readily apparent over the past three years, these data are primarily limited to small animal models or cell-based systems. Here, we performed a high-throughput RNA sequencing (RNAseq) analysis of left ventricle and other tissue from a pre-clinical ovine model. We identified 172 novel miRNA precursors encoding a total of 264 mature miRNAs. Notably, 84 precursors were detected in both the left ventricle and other tissues. However, 10 precursors, encoding 11 mature sequences, were specific to the left ventricle. Moreover, the total 168 novel miRNA precursors included 22 non-conserved ovine-specific sequences. Our data identify and characterize novel miRNAs in the left ventricle of sheep, providing fundamental new information for our understanding of protein regulation in heart and other tissues.	[Lagana, Alessandro; Veneziano, Dario] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Veneziano, Dario] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Spata, Tyler; Tang, Richard; Zhu, Hua; Kilic, Ahmet] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Internal Med, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Catania; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lagana, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	alessandro.lagana@mssm.edu; ahmet.kilic@osumc.edu		Zhu, Hua/0000-0001-7136-7326				Abdellatif M, 2010, CIRC RES, V106, P16, DOI 10.1161/CIRCRESAHA.109.212183; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreassen R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-482; Barozai MYK, 2012, MOL BIOL REP, V39, P6259, DOI 10.1007/s11033-012-1446-x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Carmi S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002317; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chistiakov DA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/354517; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Danielson LS, 2013, FASEB J, V27, P1460, DOI 10.1096/fj.12-221994; de Wit E, 2009, GENOME RES, V19, P2064, DOI 10.1101/gr.093781.109; Dhahbi JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020509; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedlander MR, 2008, NAT BIOTECHNOL; Friedlander MR, 2012, NUCLEIC ACIDS RES, P40; Galio L, 2013, PHYSIOL GENOMICS, V45, P151, DOI 10.1152/physiolgenomics.00091.2012; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Han MY, 2012, CARDIOVASC RES, V93, P645, DOI 10.1093/cvr/cvs001; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hu HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002327; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Kim W, 2011, HEART VESSELS, V26, P342, DOI 10.1007/s00380-010-0022-3; Kim WG, 2003, INT J ARTIF ORGANS, V26, P1; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krombach GA, 2005, INVEST RADIOL, V40, P14; Lagana Alessandro, 2010, J RNAi Gene Silencing, V6, P379; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li C, 2013, BMC MED GENOMICS, P6; Li M, 2010, PLOS ONE; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li SC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S14; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Liu XJ, 2015, CELL METAB, V21, P584, DOI 10.1016/j.cmet.2015.02.014; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; Locatelli Paola, 2011, ILAR J, V52, pE16; Mahon NG, 2004, J CARD FAIL, V10, P273, DOI 10.1016/j.cardfail.2003.11.001; Marco A, 2012, SILENCE, V3, P3, DOI [10.1186/1758-907X-3-3, DOI 10.1186/1758-907X-3-3]; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; McGahon MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065809; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Moainie SL, 2002, ANN THORAC SURG, V74, P753, DOI 10.1016/S0003-4975(02)03827-4; Monnet E, 2005, ANN THORAC SURG, V79, P1445, DOI 10.1016/j.athoracsur.2004.04.002; Muroya S, 2013, J ANIMAL; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Oliveira-Carvalho V, 2013, DNA CELL BIOL, V32, P8, DOI 10.1089/dna.2012.1787; Oz MC, 2001, J CARD FAIL, V7, P18, DOI 10.1054/jcaf.2001.26654; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sheng XH, 2011, MOL BIOL REP, V38, P3161, DOI 10.1007/s11033-010-9987-3; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Spata T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/938047; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Vacchi-Suzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052442; Vacchi-Suzzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040395; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang XH, 2014, CARDIOVASC RES, V102, P385, DOI 10.1093/cvr/cvu044; WEAVER ME, 1986, CARDIOVASC RES, V20, P907, DOI 10.1093/cvr/20.12.907; Wei Z, 2011, INT J BIOL SCI; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Wong SSY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036121; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018	88	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143313	10.1371/journal.pone.0143313	http://dx.doi.org/10.1371/journal.pone.0143313			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599010	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600049
J	Enenkel, M; See, L; Karner, M; Alvarez, M; Rogenhofer, E; Baraldes-Vallverdu, C; Lanusse, C; Salse, N				Enenkel, Markus; See, Linda; Karner, Mathias; Alvarez, Monica; Rogenhofer, Edith; Baraldes-Vallverdu, Carme; Lanusse, Candela; Salse, Nuria			Food Security Monitoring via Mobile Data Collection and Remote Sensing: Results from the Central African Republic	PLOS ONE			English	Article								The Central African Republic is one of the world's most vulnerable countries, suffering from chronic poverty, violent conflicts and weak disaster resilience. In collaboration with Doctors without Borders/Medecins Sans Frontieres (MSF), this study presents a novel approach to collect information about socio-economic vulnerabilities related to malnutrition, access to resources and coping capacities. The first technical test was carried out in the North of the country (sub-prefecture Kabo) in May 2015. All activities were aimed at the investigation of technical feasibility, not at operational data collection, which requires a random sampling strategy. At the core of the study is an open-source Android application named SATIDA COLLECT that facilitates rapid and simple data collection. All assessments were carried out by local MSF staff after they had been trained for one day. Once a mobile network is available, all assessments can easily be uploaded to a database for further processing and trend analysis via MSF in-house software. On one hand, regularly updated food security assessments can complement traditional large-scale surveys, whose completion can take up to eight months. Ideally, this leads to a gain in time for disaster logistics. On the other hand, recording the location of every assessment via the smart phones' GPS receiver helps to analyze and display the coupling between drought risk and impacts over many years. Although the current situation in the Central African Republic is mostly related to violent conflict it is necessary to consider information about drought risk, because climatic shocks can further disrupt the already vulnerable system. SATIDA COLLECT can easily be adapted to local conditions or other applications, such as the evaluation of vaccination campaigns. Most importantly, it facilitates the standardized collection of information without pen and paper, as well as straightforward sharing of collected data with the MSF headquarters or other aid organizations.	[Enenkel, Markus] Vienna Univ Technol, Dept Geodesy & Geoinformat, A-1040 Vienna, Austria; [See, Linda; Karner, Mathias] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Alvarez, Monica; Baraldes-Vallverdu, Carme; Lanusse, Candela; Salse, Nuria] Doctors Borders Med Sans Frontieres MSF, Barcelona, Spain; [Rogenhofer, Edith] Doctors Borders Med Sans Frontieres MSF, Vienna, Austria	Technische Universitat Wien; International Institute for Applied Systems Analysis (IIASA)	Enenkel, M (corresponding author), Vienna Univ Technol, Dept Geodesy & Geoinformat, A-1040 Vienna, Austria.	markus.enenkel@geo.tuwien.ac.at			SATIDA (Satellite Technologies for Improved Drought-Risk Assessment); SATIDA within Austrian Space Applications Programme (ASAP10) of the Austrian Research Promotion Agency [4277353]	SATIDA (Satellite Technologies for Improved Drought-Risk Assessment); SATIDA within Austrian Space Applications Programme (ASAP10) of the Austrian Research Promotion Agency	This work was supported by (https://www.ffg.at/), grant number: 4277353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported and funded within the framework of SATIDA (Satellite Technologies for Improved Drought-Risk Assessment). SATIDA is a project within the Austrian Space Applications Programme (ASAP10) of the Austrian Research Promotion Agency (project number 4277353).	Aitamurto T, 2016, DIGIT JOURNAL, V4, P280, DOI 10.1080/21670811.2015.1034807; Anokwa Y, 2009, COMPUTER, V42, P97, DOI 10.1109/MC.2009.328; Barbier G, 2012, COMPUT MATH ORGAN TH, V18, P257, DOI 10.1007/s10588-012-9121-2; Brabham DC, 2014, AM J PREV MED, V46, P179, DOI 10.1016/j.amepre.2013.10.016; Brown M.E., 2008, FAMINE EARLY WARNING; Choi C, 2015, PREDICT FLU OUTBREAK; David Harvey TDK, 2013, ASTRON COMPUT, DOI [10.1016/j.ascom.2014.04.003, DOI 10.1016/J.ASC0M.2014.04.003]; Ericsson, 2014, SUBS AFR ER MOB REP; Famine Early Warning Systems Network (FEWSNET), 2014, IDPS FAC CRIS IPC PH; FAO/WFP, 2014, FAO WFP MARK FOOD SE; FAO/WFP, 2014, SPECIAL REPORT; Fienen MN, 2012, COMPUT GEOSCI-UK, V49, P164, DOI 10.1016/j.cageo.2012.06.015; Food and Agriculture Organization, 2009, FAO WFP JOINT GUID C; Goolsby R, 2010, ACM T INTEL SYST TEC, V1, DOI 10.1145/1858948.1858955; Hanjra MA, 2010, FOOD POLICY, V35, P365, DOI 10.1016/j.foodpol.2010.05.006; HOWE J, 2006, WIRED MAG, V14, P14; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Liu YY, 2011, HYDROL EARTH SYST SC, V15, P425, DOI 10.5194/hess-15-425-2011; Maidment RI, 2014, J GEOPHYS RES-ATMOS, V119, P10619, DOI 10.1002/2014JD021927; Meier Patrick, 2015, DIGITAL HUMANITARIAN; Mistelbauer T., 2014, GEOINFO SERIES, V40; Schepaschenko D, 2015, REMOTE SENS ENVIRON, V162, P208, DOI 10.1016/j.rse.2015.02.011; See L., 2013, International Journal of Geosciences, V4, P6; Sheffield J, 2014, B AM METEOROL SOC, V95, P861, DOI 10.1175/BAMS-D-12-00124.1; Tarnavsky E, 2014, J APPL METEOROL CLIM, V53, P2805, DOI 10.1175/JAMC-D-14-0016.1; UNICEF, 2013, IMPR CHILD NUTR THE; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1	27	19	19	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142030	10.1371/journal.pone.0142030	http://dx.doi.org/10.1371/journal.pone.0142030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581042	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000365154600032
J	Kim, M; Seo, H; Choi, Y; Yoo, I; Seo, M; Lee, CK; Kim, H; Ka, H				Kim, Mingoo; Seo, Heewon; Choi, Yohan; Yoo, Inkyu; Seo, Minseok; Lee, Chang-Kyu; Kim, Heebal; Ka, Hakhyun			Analysis of Stage-Specific Gene Expression Profiles in the Uterine Endometrium during Pregnancy in Pigs	PLOS ONE			English	Article							SECRETED PHOSPHOPROTEIN 1; MATERNAL-FETAL INTERFACE; PORCINE UTERUS; BINDING-PROTEIN; SPP1 GENE; IMPLANTATION; OSTEOPONTIN; MICROARRAY; TRANSPORT; SULFOTRANSFERASE	The uterine endometrium plays a critical role in regulating the estrous cycle and the establishment and maintenance of pregnancy in mammalian species. Many studies have investigated the expression and function of genes in the uterine endometrium, but the global expression pattern of genes and relationships among genes differentially expressed in the uterine endometrium during gestation in pigs remain unclear. Thus, this study investigated global gene expression profiles using microarray in pigs. Diverse transcriptome analyses including clustering, network, and differentially expressed gene (DEG) analyses were performed to detect endometrial gene expression changes during the different gestation stages. In total, 6,991 genes were found to be differentially expressed by comparing genes expressed on day (D) 12 of pregnancy with those on D15, D30, D60, D90 and D114 of pregnancy, and clustering analysis of detected DEGs distinguished 8 clusters. Furthermore, several pregnancy-related hub genes such as ALPPL2, RANBP17, NF1B, SPP1, and CST6 were discovered through network analysis. Finally, detected hub genes were technically validated by quantitative RT-PCR. These results suggest the complex network characteristics involved in uterine endometrial gene expression during pregnancy and indicate that diverse patterns of stage-specific gene expression and network connections may play a critical role in endometrial remodeling and in placental and fetal development to establish and maintenance of pregnancy in pigs.	[Kim, Mingoo; Seo, Heewon; Choi, Yohan; Yoo, Inkyu; Ka, Hakhyun] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Seo, Minseok; Kim, Heebal] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Lee, Chang-Kyu; Kim, Heebal] Seoul Natl Univ, Dept Anim Biotechnol, Seoul, South Korea; [Seo, Minseok; Kim, Heebal] C&K Genom, Seoul, South Korea	Yonsei University; Seoul National University (SNU); Seoul National University (SNU)	Ka, H (corresponding author), Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea.	hka@yonsei.ac.kr	Seo, Heewon/AAW-9481-2021; Kim, Heebal/A-8889-2016	Kim, Heebal/0000-0003-3064-1303	Next Generation BioGreen 21 Program [PJ01119103, PJ01110301]; National Research Foundation Grant - Korean Government, Republic of Korea [NRF-2012R1A2A2A01047079]; Rural Development Administration	Next Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); National Research Foundation Grant - Korean Government, Republic of Korea; Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the Next Generation BioGreen 21 Program (#PJ01119103; #PJ01110301), Rural Development Administration, and by the National Research Foundation Grant funded by the Korean Government (#NRF-2012R1A2A2A01047079), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Next Generation BioGreen 21 Program (#PJ01119103; #PJ01110301), Rural Development Administration, and by the National Research Foundation Grant funded by the Korean Government (#NRF-2012R1A2A2A01047079), Republic of Korea.	Badinga L, 1999, BIOL REPROD, V61, P380, DOI 10.1095/biolreprod61.2.380; Bazer FW, 2014, DIFFERENTIATION, V87, P52, DOI 10.1016/j.diff.2013.11.005; Bazer FW, 2012, MOL CELL ENDOCRINOL, V354, P22, DOI 10.1016/j.mce.2011.08.026; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burghardt RC, 2002, CELLS TISSUES ORGANS, V172, P202, DOI 10.1159/000066969; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; DAVIS DL, 1993, J REPROD FERTIL, P143; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DWYER RJ, 1980, J REPROD FERTIL, V60, P187, DOI 10.1530/jrf.0.0600187; Erikson DW, 2009, BIOL REPROD, V81, P814, DOI 10.1095/biolreprod.109.078600; FIRST NL, 1979, J ANIM SCI, V48, P1407, DOI 10.2527/jas1979.4861407x; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Garlow JE, 2002, BIOL REPROD, V66, P718, DOI 10.1095/biolreprod66.3.718; GOLDSTEIN MH, 1980, BIOL REPROD, V22, P1168, DOI 10.1093/biolreprod/22.5.1168; Green J A, 2006, Soc Reprod Fertil Suppl, V62, P163; Han SH, 2012, MOL BIOL REP, V39, P7705, DOI 10.1007/s11033-012-1606-z; Hashizume K, 2007, J REPROD DEVELOP, V53, P1, DOI 10.1262/jrd.18123; Hernandez SC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104679; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/biolreprod.103.020651; Ka H, 2000, BIOL REPROD, V62, P1772, DOI 10.1095/biolreprod62.6.1772; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kim JG, 2002, DOMEST ANIM ENDOCRIN, V23, P493, DOI 10.1016/S0739-7240(02)00172-8; King AH, 2003, BIOL REPROD, V68, P2172, DOI 10.1095/biolreprod.102.012955; KNIGHT JW, 1977, J ANIM SCI, V44, P620, DOI 10.2527/jas1977.444620x; Knoll A, 1999, ANIM GENET, V30, P466, DOI 10.1046/j.1365-2052.1999.00498-5.x; Koch P, 2000, BIOCHEM BIOPH RES CO, V278, P241, DOI 10.1006/bbrc.2000.3788; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lee JH, 2010, J CELL BIOCHEM, V111, P195, DOI 10.1002/jcb.22689; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALATHY PV, 1990, MOL ENDOCRINOL, V4, P428, DOI 10.1210/mend-4-3-428; Marrable A.W., 1971, EMBRYONIC PIG CHRONO, V1st ed.; Molina-Navarro MM, 2013, INT J CARDIOL, V168, P2837, DOI 10.1016/j.ijcard.2013.03.192; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pan HY, 2006, ENDOCRINOLOGY, V147, P4904, DOI 10.1210/en.2006-0140; Rashev P, 2005, FOLIA BIOL-PRAGUE, V51, P121; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; RICHOUX V, 1989, ANAT REC, V223, P72, DOI 10.1002/ar.1092230111; ROBERTS RM, 1988, J REPROD FERTIL, V82, P875, DOI 10.1530/jrf.0.0820875; Ross JW, 2007, ENDOCRINOLOGY, V148, P4761, DOI 10.1210/en.2007-0599; Salamonsen LA, 1999, REV REPROD, V4, P11; Seo H, 2011, BIOL REPROD, V84, P279, DOI 10.1095/biolreprod.110.086934; Seo H, 2008, ENDOCRINOLOGY, V149, P6166, DOI 10.1210/en.2008-0354; Shim J, 2013, MOL REPROD DEV, V80, P570, DOI 10.1002/mrd.22192; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Spencer T E, 2007, Soc Reprod Fertil Suppl, V64, P379; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Vallet JL, 1999, J ANIM SCI, V77, P1236; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	56	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143436	10.1371/journal.pone.0143436	http://dx.doi.org/10.1371/journal.pone.0143436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580069	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600123
J	Paknia, O; Schierwater, B				Paknia, Omid; Schierwater, Bernd			Global Habitat Suitability and Ecological Niche Separation in the Phylum Placozoa	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; TRICHOPLAX; REEF; DIVERSITY; PATTERNS; GENOME; AUC	The enigmatic placozoans, which hold a key position in the metazoan Tree of Life, have attracted substantial attention in many areas of biological and biomedical research. While placozoans have become an emerging model system, their ecology and particularly biogeography remain widely unknown. In this study, we use modelling approaches to explore habitat preferences, and distribution pattern of the placozoans phylum. We provide hypotheses for discrete ecological niche separation between genetic placozoan lineages, which may also help to understand biogeography patterns in other small marine invertebrates. We, here, used maximum entropy modelling to predict placozoan distribution using 20 environmental grids of 9.2 km(2) resolution. In addition, we used recently developed metrics of niche overlap to compare habitat suitability models of three genetic clades. The predicted distributions range from 55 degrees N to 44 degrees S and are restricted to regions of intermediate to warm sea surface temperatures. High concentrations of salinity and low nutrient concentrations appear as secondary factors. Tests of niche equivalency reveal the largest differences between placozoan clades I and III. Interestingly, the genetically well-separated clades I and V appear to be ecologically very similar. Our habitat suitability models predict a wider latitudinal distribution for placozoans, than currently described, especially in the northern hemisphere. With respect to biogeography modelling, placozoans show patterns somewhere between higher metazoan taxa and marine microorganisms, with the first group usually showing complex biogeographies and the second usually showing "no biogeography."	[Paknia, Omid; Schierwater, Bernd] TiHo Hannover, ITZ, Ecol & Evolut, Hannover, Germany; [Schierwater, Bernd] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Schierwater, Bernd] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Schierwater, Bernd] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	University of Veterinary Medicine Hannover, Foundation; Yale University; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH)	Paknia, O (corresponding author), TiHo Hannover, ITZ, Ecol & Evolut, Hannover, Germany.	omid.paknia@ecolevol.de			German Research Foundation [Schi-227/29-1]	German Research Foundation(German Research Foundation (DFG))	The study was supported by German Research Foundation grant Schi-227/29-1 to BS.; The study was supported by German Research Foundation grant Schi-227/29-1 to BS. We thank Michael Eitel for providing the placozoan geo-referenced data. OP thanks Babak Naimi for his technical assistance and comments on modelling.	Acevedo-Trejos E, 2013, GLOBAL ECOL BIOGEOGR, V22, P1060, DOI 10.1111/geb.12071; Aguilar M, 2012, ISME J, V6, P1506, DOI 10.1038/ismej.2012.12; [Anonymous], 2011, ECOLOGICAL NICHES GE; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Ball EE, 2010, MOL ECOL, V19, P2181, DOI 10.1111/j.1365-294X.2010.04618.x; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Bentlage B, 2013, GLOBAL ECOL BIOGEOGR, V22, P952, DOI 10.1111/geb.12049; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Cord A, 2011, ECOL APPL, V21, P3285, DOI 10.1890/11-0114.1; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Eitel M, 2010, MOL ECOL, V19, P2315, DOI 10.1111/j.1365-294X.2010.04617.x; Eitel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057131; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Glor RE, 2011, EVOLUTION, V65, P673, DOI 10.1111/j.1558-5646.2010.01177.x; Guidi L, 2011, J MORPHOL, V272, P371, DOI 10.1002/jmor.10922; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Keith SA, 2014, GLOBAL ECOL BIOGEOGR, V23, P517, DOI 10.1111/geb.12132; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; McClanahan TR, 2003, MAR ECOL PROG SER, V261, P135, DOI 10.3354/meps261135; Mellin C, 2010, GLOBAL ECOL BIOGEOGR, V19, P212, DOI 10.1111/j.1466-8238.2009.00513.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Naimi B, 2014, ECOGRAPHY, V37, P191, DOI 10.1111/j.1600-0587.2013.00205.x; Nakano H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05356; Navarro-Cerrillo RM, 2011, APPL VEG SCI, V14, P256, DOI 10.1111/j.1654-109X.2010.01112.x; Neustupa J, 2013, PLANT ECOL EVOL, V146, P279, DOI 10.5091/plecevo.2013.862; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Rivera-Ingraham GA, 2013, J EXP BIOL, V216, P2741, DOI 10.1242/jeb.081984; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; Schierwater B., 2013, SPEZIELLE ZOOLOGIE 1, P103; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schierwater B, 2009, INT J BIOCHEM CELL B, V41, P370, DOI 10.1016/j.biocel.2008.09.023; Schulze FE, 1883, ZOOL ANZ, V6, P92; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Voigt O, 2004, CURR BIOL, V14, pR944, DOI 10.1016/j.cub.2004.10.036; von der Chevallerie K., 2010, CAH BIOL MAR, V51, P212; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	49	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140162	10.1371/journal.pone.0140162	http://dx.doi.org/10.1371/journal.pone.0140162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580806	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600003
J	Young, AE; Choi, Y; Besen, E				Young, Amanda E.; Choi, YoonSun; Besen, Elyssa			An Exploration of the Factors Considered When Forming Expectations for Returning to Work following Sickness Absence Due to a Musculoskeletal Condition	PLOS ONE			English	Article							LOW-BACK-PAIN; RECOVERY EXPECTATIONS; TO-WORK; DISABILITY; INJURY	Introduction Workers' own expectations for returning to work following a period of sickness absence have been found to be one of the best predictors of future work status; however, there is a limited understanding of why people expect what they do. The current study was undertaken with the aim of determining what people take into consideration when forming their expectations for returning to work. Methods Thirty-four people (8 women, 26 men), who were off work due to a musculoskeletal condition, participated in one of 14 focus groups. Participants were aged 25 to 65 (M = 45, SD = 12.6), and all had been out of work for 3 months or less. Results All participants reported expecting to return to work, with the most common timeframe being approximately 30 days (Range = 1 day-12months). When explaining what they thought about when forming their expectations, participants referenced numerous considerations. Much of what was spoken about could be compartmentalized to reflect features of themselves, their condition, or their broader environmental contexts. Participant's subjective experience of these features influenced his or her expectations. Prominent themes included concerns about employability, a desire to get back to normal, no job to go back to, mixed emotions, re-injury concerns, the judgments of workplace stakeholders, being needed by their employer, waiting for input, until the money runs out, and working out what was in their best interest. Conclusions Indications are that many of the reported considerations are amenable to intervention, suggesting opportunities to assist workers in the process of returning to work.	[Young, Amanda E.; Choi, YoonSun; Besen, Elyssa] Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA	Liberty Mutual Research Institute for Safety	Young, AE (corresponding author), Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA.	amandae.young@libertymutual.com	Young, Amanda Ellen/HDN-1629-2022	Young, Amanda Ellen/0000-0002-7288-3469				Besen E, 2015, J OCCUP REHABIL, V25, P25, DOI 10.1007/s10926-014-9522-9; Brouwer S, 2010, J OCCUP REHABIL, V20, P104, DOI 10.1007/s10926-009-9214-z; Brouwer S, 2009, J OCCUP REHABIL, V19, P166, DOI 10.1007/s10926-009-9172-5; Bultmann U., 2013, HDB WORK DISABILITY, P149; CHEADLE A, 1994, AM J PUBLIC HEALTH, V84, P190, DOI 10.2105/AJPH.84.2.190; Dekkers-Sanchez PM, 2010, J REHABIL MED, V42, P544, DOI 10.2340/16501977-0544; Denzin N.K., 2013, LANDSCAPE QUALITATIV; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; Glassel A, 2011, J OCCUP REHABIL, V21, P167, DOI 10.1007/s10926-010-9277-x; Grunfeld EA, 2012, PSYCHO-ONCOLOGY, V21, P82, DOI 10.1002/pon.1874; Hammersley, 1992, WHAT IS WRONG ETHNOG; Heymans MW, 2006, J OCCUP REHABIL, V16, P685, DOI 10.1007/s10926-006-9058-8; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Iles RA, 2012, J REHABIL MED, V44, P781, DOI 10.2340/16501977-1019; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Islam SS, 2001, AM J IND MED, V39, P84, DOI 10.1002/1097-0274(200101)39:1<84::AID-AJIM8>3.3.CO;2-K; Krause N, 2001, AM J IND MED, V40, P374, DOI 10.1002/ajim.1112; Lydell M, 2011, DISABIL REHABIL, V33, P1262, DOI 10.3109/09638288.2010.527029; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; Marhold C, 2002, J OCCUP REHABIL, V12, P65, DOI 10.1023/A:1015056429505; MAYER TG, 1995, SPINE, V20, P2060, DOI 10.1097/00007632-199509150-00021; Mitchell Laura A, 2009, Curr Opin Support Palliat Care, V3, P131, DOI 10.1097/SPC.0b013e32832b7de2; Ozegovic D, 2010, SPINE, V35, pE708, DOI 10.1097/BRS.0b013e3181d12432; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Shaw W. S., 2013, HDB WORK DISABILITY, P163; Shaw WS, 2005, DISABIL REHABIL, V27, P1269, DOI 10.1080/09638280500076269; Stewart AM, 2012, J OCCUP REHABIL, V22, P1, DOI 10.1007/s10926-011-9312-6; Udry J R, 1998, Inj Prev, V4, P94; van der Giezen AM, 2000, PAIN, V87, P285, DOI 10.1016/S0304-3959(00)00292-X; Young AE, 2015, DISABIL REHABIL, V37, P1808, DOI 10.3109/09638288.2014.979299	31	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143330	10.1371/journal.pone.0143330	http://dx.doi.org/10.1371/journal.pone.0143330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7CD	26580559	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600108
J	Huang, Q; Ma, QF; Feng, J; Cheng, WY; Jia, JP; Song, HQ; Chang, H; Wu, J				Huang, Qiang; Ma, Qing-feng; Feng, Juan; Cheng, Wei-yang; Jia, Jian-ping; Song, Hai-qing; Chang, Hong; Wu, Jian			Factors Associated with In-Hospital Delay in Intravenous Thrombolysis for Acute Ischemic Stroke: Lessons from China	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; TO-NEEDLE TIMES; IMAGING TIME; CARE; IMPROVEMENT; WINDOW; TRIAL	In-hospital delay reduces the benefit of intravenous thrombolysis (IVT) in acute ischemic stroke (AIS), while factors affecting in-hospital delay are less well known in Chinese. We are aiming at determining the specific factors associated with in-hospital delay through a hospital based cohort. In-hospital delay was defined as door-to-needle time (DTN) >= 60min (standard delay criteria) or >= 75% percentile of all DTNs (severe delay criteria). Demographic data, time intervals [onset-to-door time (OTD), DTN, door-to-examination time (DTE), door-to-imaging time (DTI), door-to-laboratory time (DTL) and final-test-to-needle time (FTN, the time interval between the time obtaining the result of the last screening test and the needle time)], medical history and additional variables were calculated using Mann-Whitney U or Pearson Chi-Square tests for group comparison, and multivariate linear regression analysis was performed to identify independent variables of in-hospital delay. A total of 202 IVT cases were enrolled. The median age was 61 years and 25.2% were female. The cutoff points for the upper quartile of DTN (severe delay criteria) was 135min. When compared with the reference group without in-hospital delay, older age, shorter OTD and less referral were found in the standard delay group and male sex, presence with transient ischemic attacks or rapidly improving symptom, and with multi-model CT imaging were more frequent in the severe delay group. In the multivariate linear regression analysis, FTN (P<0.001) and DTL (P = 0.002) were significantly associated with standard delay; while DTE (P = 0.005), DTI (P = 0.033), DTL (P<0.001), and FTN (P<0.001) were positively associated with severe delay. There was not a significant change in the trend of DTNs during the study period (P = 0.054). In-hospital delay was due to multifactors in China, in which time delays of decision-making process and laboratory tests contributed the most. Efforts aiming at reducing the delay should be focused on the optimization for the items of screening tests and improvement of the pathway organization.	[Huang, Qiang; Ma, Qing-feng; Feng, Juan; Cheng, Wei-yang; Jia, Jian-ping; Song, Hai-qing; Wu, Jian] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Chang, Hong] Capital Med Univ, Xuanwu Hosp, Dept Nursing, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wu, J (corresponding author), Capital Med Univ, Shijingshan Teaching Hosp, Dept Neurol, Beijing Shijingshan Hosp, Beijing, Peoples R China.	wujianxuanwu@126.com			National Natural Science Foundation of China [81371291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81371291).	Blumenthal D, 2015, NEW ENGL J MED, V372, P1281, DOI 10.1056/NEJMp1410425; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1037, DOI 10.1001/jama.281.11.1037; Breuer L, 2013, EUR NEUROL, V69, P317, DOI 10.1159/000345702; Casaubon LK, 2015, INT J STROKE, V10, P924, DOI 10.1111/ijs.12551; Cunningham VL, 2008, CAN J EMERG MED, V10, P545; Dirks M, 2011, STROKE, V42, P1325, DOI 10.1161/STROKEAHA.110.596940; Ebinger M, 2014, JAMA-J AM MED ASSOC, V311, P1622, DOI 10.1001/jama.2014.2850; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fang K, 2014, J STROKE CEREBROVASC, V23, P427, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.029; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Fonarow GC, 2011, STROKE, V42, P2983, DOI 10.1161/STROKEAHA.111.621342; Ford AL, 2012, STROKE, V43, P3395, DOI 10.1161/STROKEAHA.112.670687; Hacke W, 2004, LANCET, V363, P768; Huang P, 2011, ACAD EMERG MED, V18, P273, DOI 10.1111/j.1553-2712.2011.01006.x; Huang Q, 2014, NEUROL SCI, V35, P1321, DOI 10.1007/s10072-014-1859-5; Huang Qiang, 2013, Zhonghua Yi Xue Za Zhi, V93, P3419; Jin HQ, 2012, STROKE, V43, P362, DOI 10.1161/STROKEAHA.111.623512; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Ming Liu, 2010, CHINESE GUIDELINES D, P146; Nolte CH, 2013, J STROKE CEREBROVASC, V22, P149, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.004; Noorian AR, 2014, J STROKE CEREBROVASC, V23, P220, DOI 10.1016/j.jstrokecerebrovasdis.2012.12.008; Pitt M, 2012, STROKE, V43, P2992, DOI 10.1161/STROKEAHA.111.638650; Rizos T, 2009, STROKE, V40, P3547, DOI 10.1161/STROKEAHA.109.562769; Sauser K, 2014, JAMA NEUROL, V71, P1155, DOI 10.1001/jamaneurol.2014.1528; Scott PA, 2013, LANCET NEUROL, V12, P139, DOI 10.1016/S1474-4422(12)70311-3; Thortveit ET, 2014, ACTA NEUROL SCAND, V130, P248, DOI 10.1111/ane.12204; Yang T, 2013, LANCET, V382, P1703, DOI 10.1016/S0140-6736(13)62401-0	28	13	18	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143145	10.1371/journal.pone.0143145	http://dx.doi.org/10.1371/journal.pone.0143145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575839	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400045
J	Lecarpentier, Y; Claes, V; Hebert, JL; Krokidis, X; Blanc, FX; Michel, F; Timbely, O				Lecarpentier, Yves; Claes, Victor; Hebert, Jean-Louis; Krokidis, Xenophon; Blanc, Francois-Xavier; Michel, Francine; Timbely, Oumar			Statistical Mechanics of the Human Placenta: A Stationary State of a Near-Equilibrium System in a Linear Regime	PLOS ONE			English	Article							MYOSIN MOLECULAR MOTORS; OXIDATIVE-PHOSPHORYLATION; STEM VILLI; SMOOTH-MUSCLE; FORCE; CELLS; HEART; THERMODYNAMICS; CONTRACTION; ACTOMYOSIN	All near-equilibrium systems under linear regime evolve to stationary states in which there is constant entropy production rate. In an open chemical system that exchanges matter and energy with the exterior, we can identify both the energy and entropy flows associated with the exchange of matter and energy. This can be achieved by applying statistical mechanics (SM), which links the microscopic properties of a system to its bulk properties. In the case of contractile tissues such as human placenta, Huxley's equations offer a phenomenological formalism for applying SM. SM was investigated in human placental stem villi (PSV) (n = 40). PSV were stimulated by means of KCl exposure (n = 20) and tetanic electrical stimulation (n = 20). This made it possible to determine statistical entropy (S), internal energy (E), affinity (A), thermodynamic force (A/T) (T: temperature), thermodynamic flow (v) and entropy production rate (A/T x v). We found that PSV operated near equilibrium, i.e., A < < 2500 J/mol and in a stationary linear regime, i.e., (A/T) varied linearly with v. As v was dramatically low, entropy production rate which quantified irreversibility of chemical processes appeared to be the lowest ever observed in any contractile system.	[Lecarpentier, Yves; Krokidis, Xenophon] Ctr Hosp Reg Meaux, Ctr Rech Clin, Meaux, France; [Claes, Victor] Univ Antwerp, Dept Pharmaceut Sci, Antwerp, Belgium; [Hebert, Jean-Louis] Hop La Pitie Salpetriere, AP HP, Inst Cardiol, Paris, France; [Blanc, Francois-Xavier] CHU Nantes, Serv Pneumol, F-44035 Nantes 01, France; [Michel, Francine; Timbely, Oumar] Ctr Hosp Reg Meaux, Serv Gynecol Obstet, Meaux, France	University of Antwerp; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes	Lecarpentier, Y (corresponding author), Ctr Hosp Reg Meaux, Ctr Rech Clin, Meaux, France.	yves.c.lecarpentier@gmail.com	Blanc, François-Xavier/D-7425-2015	Blanc, François-Xavier/0000-0001-7644-2188; Krokidis, Xenophon/0000-0003-4771-6957; Claes, Victor/0000-0002-1914-0228				Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Atkins PW., 1990, PHYS CHEM; Benirschke K., 2006, PATHOLOGY HUMAN PLAC, P1069; BRUTSAERT DL, 1973, CIRC RES, V32, P385, DOI 10.1161/01.RES.32.3.385; CAPLAN SR, 1969, P NATL ACAD SCI USA, V64, P211, DOI 10.1073/pnas.64.1.211; Demir R, 1997, MICROSC RES TECHNIQ, V38, P29; Demirel Y, 2002, BIOPHYS CHEM, V97, P87, DOI 10.1016/S0301-4622(02)00069-8; Dewey TG, 1998, J THEOR BIOL, V193, P593, DOI 10.1006/jtbi.1998.0724; Donder Th. De, 1927, AFFINITE; Dubreuil G, 1932, CR SOC BIOL, V111, P170; Farley AE, 2004, AM J PHYSIOL-REG I, V287, pR680, DOI 10.1152/ajpregu.00222.2004; FELLER AC, 1985, PLACENTA, V6, P405, DOI 10.1016/S0143-4004(85)80017-5; Graf R, 1997, CELL TISSUE RES, V290, P601, DOI 10.1007/s004410050965; GRAF R, 1995, PLACENTA, V16, P57, DOI 10.1016/0143-4004(95)90081-0; GRAF R, 1994, ANAT EMBRYOL, V190, P541; Happe H, 1907, EIER ANAT HEFTE, V32, P171; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; HUSZAR G, 1979, AM J OBSTET GYNECOL, V135, P707, DOI 10.1016/0002-9378(79)90379-X; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Iizuka S., 1916, BEITR GEBURTSH GYNAE, V19, P101; KEDEM O, 1989, BIOCHIM BIOPHYS ACTA, V1000, P411, DOI 10.1016/S0006-3002(89)80036-8; KING TM, 1965, AM J OBSTET GYNECOL, V93, P253, DOI 10.1016/0002-9378(65)90665-4; KOHNEN G, 1995, CELL TISSUE RES, V281, P231, DOI 10.1007/BF00583392; Kondepudi D., 1999, MODERN THERMODYNAMIC; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; KRANTZ KE, 1963, CLIN OBSTET GYNECOL, V6, P26, DOI 10.1097/00003081-196303000-00003; Krebs H A, 1969, Adv Enzyme Regul, V7, P397, DOI 10.1016/0065-2571(69)90030-2; Lecarpentier E, 2013, PLACENTA, V34, P1163, DOI 10.1016/j.placenta.2013.10.007; Lecarpentier Y, 2005, J THEOR BIOL, V235, P381, DOI 10.1016/j.jtbi.2005.01.018; Lecarpentier Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108814; Lecarpentier Y, 2011, CR BIOL, V334, P725, DOI 10.1016/j.crvi.2011.08.001; Leguillette Renaud, 2008, Proc Am Thorac Soc, V5, P40, DOI 10.1513/pats.200704-053VS; Levine I. N., 2003, PHYS CHEM; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MARSHALL WE, 1974, BIOCHIM BIOPHYS ACTA, V354, P1, DOI 10.1016/0304-4165(74)90046-4; MASUDA T, 1990, J BIOL CHEM, V265, P20321; Matsumura S, 2011, PLACENTA, V32, P347, DOI 10.1016/j.placenta.2011.02.008; MCGILVERY RW, 1974, J BIOL CHEM, V249, P5845; MICHAEL C, 1974, J OBSTET GYN BR COMM, V81, P307; Naujoks H, 1922, Z GEBURTSH GYNAEK Z GEBURTSH GYNAEK, V84, P304; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; PRIGOGIN.I, 1974, ANN NY ACAD SCI, V231, P99, DOI 10.1111/j.1749-6632.1974.tb20557.x; PRIGOGINE I, 1971, Quarterly Reviews of Biophysics, V4, P107; Prigogine I., 1967, INTRO THERMODYNAMICS; Rigoulet M, 1998, BBA-BIOENERGETICS, V1365, P117, DOI 10.1016/S0005-2728(98)00051-6; Spanner R., 1935, Z ANAT ENTWICKLUNGS, V105, P163, DOI [10.1007/BF02118325, DOI 10.1007/BF02118325]; SPARN HG, 1994, DIFFERENTIATION, V56, P191, DOI 10.1046/j.1432-0436.1994.5630191.x; STUCKI JW, 1980, EUR J BIOCHEM, V109, P269, DOI 10.1111/j.1432-1033.1980.tb04792.x; STUCKI JW, 1991, P ROY SOC B-BIOL SCI, V244, P197, DOI 10.1098/rspb.1991.0070; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veech RL, 2002, IUBMB LIFE, V54, P241, DOI 10.1080/15216540215678; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VIDAL C, 1994, AU DELA EQUILIBRE, P1	54	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142471	10.1371/journal.pone.0142471	http://dx.doi.org/10.1371/journal.pone.0142471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569482	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700041
J	Maurice, N; Deltheil, T; Melon, C; Degos, B; Mourre, C; Amalric, M; Kerkerian-Le Goff, L				Maurice, Nicolas; Deltheil, Thierry; Melon, Christophe; Degos, Bertrand; Mourre, Christiane; Amalric, Marianne; Kerkerian-Le Goff, Lydia			Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; NIGRA PARS RETICULATA; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; SUBTHALAMIC NUCLEUS; ANTIPSYCHOTIC-DRUGS; POTASSIUM CHANNELS; SMALL-CONDUCTANCE; RECEPTORS; SK3	Recent evidence points to a neuroprotective action of bee venom on nigral dopamine neurons in animal models of Parkinson's disease (PD). Here we examined whether bee venom also displays a symptomatic action by acting on the pathological functioning of the basal ganglia in rat PD models. Bee venom effects were assessed by combining motor behavior analyses and in vivo electrophysiological recordings in the substantia nigra pars reticulata (SNr, basal ganglia output structure) in pharmacological (neuroleptic treatment) and lesional (unilateral intranigral 6-hydroxydopamine injection) PD models. In the hemi-parkinsonian 6-hydroxydopamine lesion model, subchronic bee venom treatment significantly alleviates contralateral forelimb akinesia and apomorphine-induced rotations. Moreover, a single injection of bee venom reverses haloperidol-induced catalepsy, a pharmacological model reminiscent of parkinsonian akinetic deficit. This effect is mimicked by apamin, a blocker of small conductance Ca2+-activated K+ (SK) channels, and blocked by CyPPA, a positive modulator of these channels, suggesting the involvement of SK channels in the bee venom antiparkinsonian action. In vivo electrophysiological recordings in the substantia nigra pars reticulata (basal ganglia output structure) showed no significant effect of BV on the mean neuronal discharge frequency or pathological bursting activity. In contrast, analyses of the neuronal responses evoked by motor cortex stimulation show that bee venom reverses the 6-OHDA- and neuroleptic-induced biases in the influence exerted by the direct inhibitory and indirect excitatory striatonigral circuits. These data provide the first evidence for a beneficial action of bee venom on the pathological functioning of the cortico-basal ganglia circuits underlying motor PD symptoms with potential relevance to the symptomatic treatment of this disease.	[Maurice, Nicolas; Melon, Christophe; Kerkerian-Le Goff, Lydia] Aix Marseille Univ, CNRS, IBDM, UMR 7288, Marseille, France; [Deltheil, Thierry; Mourre, Christiane; Amalric, Marianne] Aix Marseille Univ, CNRS, LNC, UMR 7291, Marseille, France; [Degos, Bertrand] Coll France, INSERM, CNRS, CIRB,UMR 7241,U 1050, F-75231 Paris, France; [Degos, Bertrand] Hop La Pitie Salpetriere, APHP, Dept Malad Syst Nerveux, Ctr Expert Inter Reg Ile France Maladie Parkinson, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Maurice, N (corresponding author), Aix Marseille Univ, CNRS, IBDM, UMR 7288, Marseille, France.	nicolas.maurice@univ-amu.fr		Kerkerian-Le Goff, Lydia/0000-0002-7951-3479; Amalric, Marianne/0000-0002-9915-6763	Centre National de la Recherche Scientifique (CNRS); Aix Marseille Universite (AMU); Association France Parkinson; A*MIDEX project - "Investissements d'Avenir" French Government program - French National Research Agency (ANR) [ANR-11-IDEX-0001-02]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix Marseille Universite (AMU); Association France Parkinson; A*MIDEX project - "Investissements d'Avenir" French Government program - French National Research Agency (ANR)(French National Research Agency (ANR))	This work was supported by the Centre National de la Recherche Scientifique (CNRS), Aix Marseille Universite (AMU) and by a grant from Association France Parkinson (Grand Appel d'Offre 2011). This work has been carried out within the context of the DHUNE project thanks to the support of the A*MIDEX project (no ANR-11-IDEX-0001-02) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63; Alvarez-Fischer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061700; ANGULO JA, 1992, J NEUROCHEM, V58, P1104, DOI 10.1111/j.1471-4159.1992.tb09368.x; Arias-Garcia MA, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00063; Aumann TD, 2008, EXP NEUROL, V213, P419, DOI 10.1016/j.expneurol.2008.07.005; Benitez BA, 2011, NEUROPHARMACOLOGY, V60, P1176, DOI 10.1016/j.neuropharm.2010.10.024; Beyeler A, 2010, NEUROSCIENCE, V169, P158, DOI 10.1016/j.neuroscience.2010.04.061; Boraud T, 2002, PROG NEUROBIOL, V66, P265, DOI 10.1016/S0301-0082(01)00033-8; BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560; Chapman MA, 1996, J PHARMACOL EXP THER, V277, P1586; Chen L, 2014, INT J NEUROPSYCHOPH, V17, P1295, DOI 10.1017/S1461145714000236; De Groot J., 1959, THE RAT FOREBRAIN IN; Degos B, 2005, J NEUROSCI, V25, P7687, DOI 10.1523/JNEUROSCI.1056-05.2005; Deniau JM, 1996, NEUROSCIENCE, V73, P761, DOI 10.1016/0306-4522(96)00088-7; DENIAU JM, 1978, EXP BRAIN RES, V32, P409; Doo AR, 2012, BRAIN RES, V1429, P106, DOI 10.1016/j.brainres.2011.10.003; Doo AR, 2010, NEUROL RES, V32, pS88, DOI 10.1179/016164109X12537002794282; DREW KL, 1990, EUR J PHARMACOL, V187, P385, DOI 10.1016/0014-2999(90)90366-E; Faber ES, 2009, CELL BIOCHEM BIOPHYS, V55, P127, DOI 10.1007/s12013-009-9062-7; Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Herrik KF, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00011; Hickey P, 2011, DRUG DES DEV THER, V5, P241, DOI 10.2147/DDDT.S11836; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039149; Khalil WKB, 2015, NEUROCHEM INT, V80, P79, DOI 10.1016/j.neuint.2014.11.008; Kim JI, 2011, INT J NEUROSCI, V121, P209, DOI 10.3109/00207454.2010.548613; Kokot ZJ, 2009, CHROMATOGRAPHIA, V69, P1401, DOI 10.1365/s10337-009-1052-9; Kolomiets BP, 2003, NEUROSCIENCE, V117, P931, DOI 10.1016/S0306-4522(02)00824-2; Konieczny J, 2007, NEUROSCIENCE, V145, P611, DOI 10.1016/j.neuroscience.2006.12.006; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; Maltete D, 2007, J NEUROPHYSIOL, V97, P4017, DOI 10.1152/jn.01104.2006; Maurice N, 1999, J NEUROSCI, V19, P4674; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nishibayashi H, 2011, MOVEMENT DISORD, V26, P469, DOI 10.1002/mds.23502; Paxinos G., 1998, RAT BRAIN STEREOTAXI, Vfourth; Pollak P, 2002, MOVEMENT DISORD, V17, pS75, DOI 10.1002/mds.10146; Rascol O, 2011, MOVEMENT DISORD, V26, P1072, DOI 10.1002/mds.23714; Robin K, 2009, J NEUROSCI METH, V179, P142, DOI 10.1016/j.jneumeth.2009.01.020; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Salin P, 2002, J NEUROSCI, V22, P5137, DOI 10.1523/JNEUROSCI.22-12-05137.2002; Salthun-Lassalle B, 2004, J NEUROSCI, V24, P5922, DOI 10.1523/JNEUROSCI.5668-03.2004; Sano H, 2003, J NEUROSCI, V23, P9078; Sarpal D, 2004, SYNAPSE, V53, P104, DOI 10.1002/syn.20042; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schapira AHV, 2008, EUR J NEUROL, V15, P5, DOI 10.1111/j.1468-1331.2008.02055.x; STANSFELD CE, 1987, NEUROSCIENCE, V23, P893, DOI 10.1016/0306-4522(87)90166-7; STEKETEE JD, 1990, J PHARMACOL EXP THER, V254, P711; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Tachibana Y, 2008, EUR J NEUROSCI, V27, P238, DOI 10.1111/j.1460-9568.2007.05990.x; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; Wang G, 2008, FRONT BIOSCI-LANDMRK, V13, P3825, DOI 10.2741/2971; Wichmann T, 1999, EXP BRAIN RES, V125, P397, DOI 10.1007/s002210050696; Wichmann T, 2011, MOVEMENT DISORD, V26, P1032, DOI 10.1002/mds.23695; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Yang EJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-69; Yang EJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-69	58	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142838	10.1371/journal.pone.0142838	http://dx.doi.org/10.1371/journal.pone.0142838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571268	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700083
J	Bailey, JM; Hendley, AM; Lafaro, KJ; Pruski, MA; Jones, NC; Alsina, J; Younes, M; Maitra, A; McAllister, F; Iacobuzio-Donahue, CA; Leach, SD				Bailey, J. M.; Hendley, A. M.; Lafaro, K. J.; Pruski, M. A.; Jones, N. C.; Alsina, J.; Younes, M.; Maitra, A.; McAllister, F.; Iacobuzio-Donahue, C. A.; Leach, S. D.			p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells	ONCOGENE			English	Article							ADULT MICE; CANCER; METASTASIS; ACTIVATION; INDUCTION	Pancreatic cancer is one of the most lethal malignancies, with virtually all patients eventually succumbing to their disease. Mutations in p53 have been documented in >50% of pancreatic cancers. Owing to the high incidence of p53 mutations in PanIN 3 lesions and pancreatic tumors, we interrogated the comparative ability of adult pancreatic acinar and ductal cells to respond to oncogenic Kras and mutant Tp53(R172H) using Hnf1b:CreER(T2) and Mist1:CreER(T2) mice. These studies involved co-activation of a membrane-tethered GFP lineage label, allowing for direct visualization and isolation of cells undergoing Kras and mutant p53 activation. Kras activation in Mist1(+) adult acinar cells resulted in brisk PanIN formation, whereas no evidence of pancreatic neoplasia was observed for up to 6 months following Kras activation in Hnf1beta(+) adult ductal cells. In contrast to the lack of response to oncogenic Kras alone, simultaneous activation of Kras and mutant p53 in adult ductal epithelium generated invasive PDAC in 75% of mice as early as 2.5 months after tamoxifen administration. These data demonstrate that pancreatic ductal cells, whereas exhibiting relative resistance to oncogenic Kras alone, can serve as an effective cell of origin for pancreatic ductal adenocarcinoma in the setting of gain-of-function mutations in p53.	[Bailey, J. M.; Hendley, A. M.; Pruski, M. A.; Jones, N. C.] Univ Texas Hlth Sci Ctr Houston, Div Gastroenterol Hepatol & Nutr, Dept Internal Med, 6431A Fannin St MSB 1-162, Houston, TX 77030 USA; [Lafaro, K. J.; Iacobuzio-Donahue, C. A.; Leach, S. D.] Mem Sloan Kettering Canc Ctr, David Rubenstein Pancreat Canc Res Ctr, 1275 York Ave, New York, NY 10021 USA; [Alsina, J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Younes, M.] Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Maitra, A.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Maitra, A.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [McAllister, F.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [McAllister, F.] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Bailey, JM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Gastroenterol Hepatol & Nutr, Dept Internal Med, 6431A Fannin St MSB 1-162, Houston, TX 77030 USA.	Jennifer.M.Bailey@uth.tmc.edu	Alsina, Janivette/AAE-9043-2020; Iacobuzio-Donahue, Christine/ABF-1295-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Hendley, Audrey/0000-0003-0289-2092; Younes, Mamoun/0000-0001-9618-3451; Bailey-Lundberg, Jennifer/0000-0002-4750-106X	NIH [P01 CA134292, R21 CA158898, F32CA157044, T35 DK007676-22]; AACR/Pancreatic Cancer Action Network Pathway to Leadership Award; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR/Pancreatic Cancer Action Network Pathway to Leadership Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Anzer Habibulla, Danielle Blake, Mara Swaim, Jeffery Roeser and Qingfeng Zhu for their help in maintaining mouse colonies and genotyping. We thank Jorge Ferrer for providing the Hnf1b mice. This work was supported by NIH P01 CA134292 and R21 CA158898 (to SDL). JMB was supported by an NIH F32CA157044 and an AACR/Pancreatic Cancer Action Network Pathway to Leadership Award. NCJ was supported by an NIH T35 DK007676-22.	Bailey JM, 2014, GASTROENTEROLOGY, V146, P245, DOI 10.1053/j.gastro.2013.09.050; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Huang H, 2014, ONCOGENE, V33, P532, DOI 10.1038/onc.2012.619; Ji B, 2009, GASTROENTEROLOGY, V137; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; von Figura G, 2014, NAT CELL BIOL, V16, P255, DOI 10.1038/ncb2916; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066	17	78	80	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	32					4282	4288		10.1038/onc.2015.441	http://dx.doi.org/10.1038/onc.2015.441			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3YY	26592447				2022-12-26	WOS:000382149800012
J	Ko, SY; Ko, HA; Chu, KH; Shieh, TM; Chi, TC; Chen, HI; Chang, WC; Chang, SS				Ko, Shun-Yao; Ko, Hshin-An; Chu, Kuo-Hsiung; Shieh, Tzong-Ming; Chi, Tzong-Cherng; Chen, Hong-I; Chang, Weng-Cheng; Chang, Shu-Shing			The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; REDUCE OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; NEUROBLASTOMA-CELLS; IN-VITRO; BETA; SIRT1; CYTOTOXICITY; RESVERATROL; NEUROTOXICITY	Amyloid precursor protein (APP) has been modified by beta and gamma-secretase that cause amyloid deposits (plaques) in neuronal cells. Glyceraldhyde-derived AGEs has been identified as a major source of neurotoxicity in Alzheimer's disease (AD). In a previous study, we demonstrated that glyceraldehyde-derived AGEs increase APP and A beta via ROS. Furthermore, the combination of AGEs and A beta has been shown to enhance neurotoxicity. In mice, APP expression is increased by tail vein injection of AGEs. This evidence suggests a correlation between AGEs and the development of AD. However, the role played by AGEs in the pathogenesis of AD remains unclear. In this report, we demonstrate that AGEs up-regulate APP processing protein (BACE and PS1) and Sirt1 expression via ROS, but do not affect the expression of downstream antioxidant genes HO-1 and NQO-1. Moreover, we found that AGEs increase GRP78 expression and enhance the cell death-related pathway p53, bcl-2/bax ratio, caspase 3. These results indicate that AGEs impair the neuroprotective effects of Sirt1 and lead to neuronal cell death via ER stress. Our findings suggest that AGEs increase ROS production, which stimulates downstream pathways related to APP processing, A beta production, Sirt1, and GRP78, resulting in the up-regulation of cell death related pathway. This in-turn enhances neuronal cell death, which leads to the development of AD.	[Ko, Shun-Yao; Chi, Tzong-Cherng; Chen, Hong-I; Chang, Weng-Cheng] Chang Jung Christian Univ, Grad Inst Med Sci, Coll Hlth Sci, Tainan, Taiwan; [Ko, Shun-Yao; Chi, Tzong-Cherng; Chen, Hong-I; Chang, Shu-Shing] Chang Jung Christian Univ, Innovate Res Ctr Med, Tainan, Taiwan; [Ko, Hshin-An] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan; [Chu, Kuo-Hsiung] Chang Jung Christian Univ, Dept Biosci Technol, Coll Hlth Sci, Tainan, Taiwan; [Shieh, Tzong-Ming] China Med Univ, Dept Dent Hyg, Taichung, Taiwan	Chang Jung Christian University; Chang Jung Christian University; National Chung Hsing University; Chang Jung Christian University; China Medical University Taiwan	Ko, SY (corresponding author), Chang Jung Christian Univ, Grad Inst Med Sci, Coll Hlth Sci, Tainan, Taiwan.	syko@mail.cjcu.edu.tw						Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Aso E, 2013, CURR ALZHEIMER RES, V10, P290, DOI 10.2174/15672050112099990128; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Choei H, 2004, ACTA NEUROPATHOL, V108, P189, DOI 10.1007/s00401-004-0871-x; Choi CW, 2011, PLANTA MED, V77, P374, DOI 10.1055/s-0030-1250370; Costa RO, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.04.011; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Deuther-Conrad W, 2001, NEUROSCI LETT, V312, P29, DOI 10.1016/S0304-3940(01)02174-7; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Gasic-Milenkovic J, 2001, Z GERONTOL GERIATR, V34, P457, DOI 10.1007/s003910170018; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Ghemrawi R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.69; Huang KP, 2015, MOL CELL ENDOCRINOL, V399, P178, DOI 10.1016/j.mce.2014.08.014; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333; Khan RS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-3; Khan RS, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00063; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Ko SY, 2010, FREE RADICAL BIO MED, V49, P474, DOI 10.1016/j.freeradbiomed.2010.05.005; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee S, 2011, EXP EYE RES, V93, P204, DOI 10.1016/j.exer.2010.07.015; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Li JG, 2014, INT J MOL SCI, V15, P5928, DOI 10.3390/ijms15045928; Li YG, 2013, BIOCHEM BIOPH RES CO, V438, P270, DOI 10.1016/j.bbrc.2013.07.042; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039120; Liu T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03467; Loske C, 1998, J NEURAL TRANSM, V105, P1005, DOI 10.1007/s007020050108; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mruthinti S, 2006, NEUROSCIENCE, V142, P463, DOI 10.1016/j.neuroscience.2006.06.010; Mruthinti S, 2007, CURR ALZHEIMER RES, V4, P581, DOI 10.2174/156720507783018325; Munch G, 1997, BBA-MOL BASIS DIS, V1360, P17, DOI 10.1016/S0925-4439(96)00062-2; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Olivieri G, 2000, J NEUROCHEM, V74, P231, DOI 10.1046/j.1471-4159.2000.0740231.x; Olivieri G, 2001, J NEUROCHEM, V76, P224, DOI 10.1046/j.1471-4159.2001.00090.x; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Sato Takashi, 2006, Am J Alzheimers Dis Other Demen, V21, P197; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sun QR, 2014, BIOCHEM BIOPH RES CO, V447, P485, DOI 10.1016/j.bbrc.2014.04.019; Takeuchi M, 2000, J NEUROPATH EXP NEUR, V59, P1094, DOI 10.1093/jnen/59.12.1094; Takeuchi M, 2004, CURR ALZHEIMER RES, V1, P39, DOI 10.2174/1567205043480582; Uribarri J, 2014, AMINO ACIDS, V46, P301, DOI 10.1007/s00726-013-1502-4; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Wang MY, 2009, ACTA NEUROPATHOL, V118, P381, DOI 10.1007/s00401-009-0513-4; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Woltjer RL, 2003, J ALZHEIMERS DIS, V5, P467, DOI 10.3233/JAD-2003-5607; Xiong YY, 2013, DOSE-RESPONSE, V11, P270, DOI 10.2203/dose-response.12-005.Gao; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Ye QY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-82; Yuan D, 2014, INT J MOL SCI, V15, P13209, DOI 10.3390/ijms150813209; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou SS, 2014, TOXICOL LETT, V227, P113, DOI 10.1016/j.toxlet.2014.03.011	58	82	84	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143345	10.1371/journal.pone.0143345	http://dx.doi.org/10.1371/journal.pone.0143345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587989	gold, Green Published, Green Submitted			2022-12-26	WOS:000365251500053
J	Qian, D; Nan, Q; Yang, YM; Li, H; Zhou, YL; Zhu, JE; Bai, QF; Zhang, P; An, LZ; Xiang, Y				Qian, Dong; Nan, Qiong; Yang, Yueming; Li, Hui; Zhou, Yuelong; Zhu, Jingen; Bai, Qifeng; Zhang, Pan; An, Lizhe; Xiang, Yun			Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; ACTIN-BINDING PROTEIN; FILAMENT-SEVERING PROTEIN; F-ACTIN; BUNDLING PROTEIN; TERMINAL HALF; ARABIDOPSIS; CALCIUM; VILLIN; IDENTIFICATION	The villin/gelsolin/fragmin superfamily is a major group of Ca2+-dependent actin-binding proteins (ABPs) involved in various cellular processes. Members of this superfamily typically possess three or six tandem gelsolin-like (G) domains, and each domain plays a distinct role in actin filament dynamics. Although the activities of most G domains have been characterized, the biochemical function of the G3 domain remains poorly understood. In this study, we carefully compared the detailed biochemical activities of ABP29 (a new member of this family that contains the G1-G2 domains of lily ABP135) and ABP135(G1-G3) (which contains the G1-G3 domains of lily ABP135). In the presence of high Ca2+ levels in vitro (200 and 10 mu M), ABP135(G1-G3) exhibited greater actin severing and/or depolymerization and nucleating activities than ABP29, and these proteins had similar actin capping activities. However, in the presence of low levels of Ca2+ (41 nM), ABP135(G1-G3) had a weaker capping activity than ABP29. In addition, ABP29 inhibited F-actin depolymerization, as shown by dilution-mediated depolymerization assay, differing from the typical superfamily proteins. In contrast, ABP135(G1-G3) accelerated F-actin depolymerization. All of these results demonstrate that the G3 domain plays specific roles in regulating the activities of the lily villin/gelsolin/fragmin superfamily proteins.	[Qian, Dong; Nan, Qiong; Yang, Yueming; Li, Hui; Zhou, Yuelong; Zhu, Jingen; Zhang, Pan; An, Lizhe; Xiang, Yun] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China; [Bai, Qifeng] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Xiang, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Peoples R China.	xiangy@lzu.edu.cn	Bai, Qifeng/A-2950-2019; Yang, Xiaoming/GRJ-9483-2022	Bai, Qifeng/0000-0001-7296-6187; Xiang, Yun/0000-0002-5178-0700; Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program [2014CB954203]; National Natural Science Foundation of China [31270326, 30800079]; Natural Science Foundation for Distinguished Yong Scholars of Gansu Province [2013GS10064]; Program for New Century Excellent Talents in University [NCET-13-0264]; Fundamental Research Funds for the Central Universities [lzujbky-2013-243]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Distinguished Yong Scholars of Gansu Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding: This work was supported by the National Basic Research Program (2014CB954203), National Natural Science Foundation of China (31270326 and 30800079), the Natural Science Foundation for Distinguished Yong Scholars of Gansu Province (2013GS10064), the Program for New Century Excellent Talents in University (NCET-13-0264) and the Fundamental Research Funds for the Central Universities (lzujbky-2013-243).	BAZARI WL, 1988, P NATL ACAD SCI USA, V85, P4986, DOI 10.1073/pnas.85.14.4986; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; Chen CY, 2002, PLANT CELL, V14, P2175, DOI 10.1105/tpc.003038; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; Fan XX, 2004, PLANT PHYSIOL, V136, P3979, DOI 10.1104/pp.104.046326; Friederich E, 1999, J BIOL CHEM, V274, P26751, DOI 10.1074/jbc.274.38.26751; Ghoshdastider U, 2013, CYTOSKELETON, V70, P775, DOI 10.1002/cm.21149; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Gunning PW, 2015, J CELL SCI, V128, P2009, DOI 10.1242/jcs.165563; Hampton CM, 2008, STRUCTURE, V16, P1882, DOI 10.1016/j.str.2008.09.015; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; Huang SJ, 2004, J BIOL CHEM, V279, P23364, DOI 10.1074/jbc.M312973200; Huang SJ, 2003, J BIOL CHEM, V278, P44832, DOI 10.1074/jbc.M306670200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jia HL, 2013, J BIOL CHEM, V288, P32277, DOI 10.1074/jbc.M113.483594; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Klaavuniemi T, 2008, J BIOL CHEM, V283, P26071, DOI 10.1074/jbc.M803618200; Klahre U, 2000, PLANT PHYSIOL, V122, P35, DOI 10.1104/pp.122.1.35; Kolappan SL, 2003, J MOL BIOL, V329, P85, DOI 10.1016/S0022-2836(03)00383-8; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; Liu ZM, 2013, CYTOSKELETON, V70, P228, DOI 10.1002/cm.21103; Liu ZM, 2011, J BIOL CHEM, V286, P34051, DOI 10.1074/jbc.M111.237404; Ma BY, 2012, J BIOL CHEM, V287, P19008, DOI 10.1074/jbc.M111.281873; Maciver SK, 2000, FEBS LETT, V473, P71, DOI 10.1016/S0014-5793(00)01507-6; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; Messerli MA, 2000, DEV BIOL, V222, P84, DOI 10.1006/dbio.2000.9709; Mittermann I, 2005, FEBS LETT, V579, P3807, DOI 10.1016/j.febslet.2005.05.066; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; Nakayasu T, 1998, BIOCHEM BIOPH RES CO, V249, P61, DOI 10.1006/bbrc.1998.9088; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Peddada N, 2013, J BIOL CHEM, V288, P28266, DOI 10.1074/jbc.M113.463224; Pellieux C, 2003, J BIOL CHEM, V278, P29136, DOI 10.1074/jbc.M300598200; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; POPE B, 1995, BIOCHEMISTRY-US, V34, P1583, DOI 10.1021/bi00005a014; Pope BJ, 1997, BIOCHEMISTRY-US, V36, P15848, DOI 10.1021/bi972192p; Qin T, 2014, PLANT CELL, V26, P325, DOI 10.1105/tpc.113.119768; Qu XL, 2013, PLANT CELL, V25, P1803, DOI 10.1105/tpc.113.110940; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Staiger CJ, 2004, PLANT CYTOSKELETON C; Su H, 2007, J INTEGR PLANT BIOL, V49, P1183, DOI 10.1111/j.1672-9072.2007.00546.x; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; SUN HQ, 1994, J BIOL CHEM, V269, P9473; Vidali L, 2001, MOL BIOL CELL, V12, P2534, DOI 10.1091/mbc.12.8.2534; Vidali L, 1999, PROTOPLASMA, V209, P283, DOI 10.1007/BF01453456; Wang H, 2009, J BIOL CHEM, V284, P21265, DOI 10.1074/jbc.M109.019760; Wang T, 2008, MOL PLANT, V1, P1048, DOI 10.1093/mp/ssn073; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; YIN HL, 1988, J CELL BIOL, V106, P805, DOI 10.1083/jcb.106.3.805; Yokota E, 1999, PLANTA, V209, P264, DOI 10.1007/s004250050631; Yokota E, 2003, PLANT CELL PHYSIOL, V44, P1088, DOI 10.1093/pcp/pcg132; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhang Y, 2006, EMBO J, V25, P4458, DOI 10.1038/sj.emboj.7601323; Zheng YY, 2013, PLANT CELL, V25, P3405, DOI 10.1105/tpc.113.117820	60	4	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143174	10.1371/journal.pone.0143174	http://dx.doi.org/10.1371/journal.pone.0143174			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587673	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500035
J	Carter, JR; Taylor, S; Fraser, TS; Kucharski, CA; Dawson, JL; Fraser, MJ				Carter, James R.; Taylor, Samantha; Fraser, Tresa S.; Kucharski, Cheryl A.; Dawson, James L.; Fraser, Malcolm J., Jr.			Suppression of the Arboviruses Dengue and Chikungunya Using a Dual-Acting Group-I Intron Coupled with Conditional Expression of the Bax C-Terminal Domain	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; APOPTOTIC CELL-DEATH; GENE DRIVE SYSTEMS; HUMAN CANCER-CELLS; TRANSSPLICING RIBOZYMES; AEDES-ALBOPICTUS; TETRAHYMENA RIBOZYME; VIRUS-REPLICATION; MOSQUITO CELLS; CATALYTIC CORE	In portions of South Asia, vectors and patients co-infected with dengue (DENV) and chikungunya (CHIKV) are on the rise, with the potential for this occurrence in other regions of the world, for example the United States. Therefore, we engineered an antiviral approach that suppresses the replication of both arboviruses in mosquito cells using a single antiviral group I intron. We devised unique configurations of internal, external, and guide sequences that permit homologous recognition and splicing with conserved target sequences in the genomes of both viruses using a single trans-splicing Group I intron, and examined their effectiveness to suppress infections of DENV and CHIKV in mosquito cells when coupled with a proapoptotic 3' exon, Delta N Bax. RT-PCR demonstrated the utility of these introns in trans-splicing the Delta N Bax sequence downstream of either the DENV or CHIKV target site in transformed Aedes albopictus C6/36 cells, independent of the order in which the virus specific targeting sequences were inserted into the construct. This trans-splicing reaction forms DENV or CHIKV Delta N Bax RNA fusions that led to apoptotic cell death as evidenced by annexin V staining, caspase, and DNA fragmentation assays. TCID50-IFA analyses demonstrate effective suppression of DENV and CHIKV infections by our anti-arbovirus group I intron approach. This represents the first report of a dual-acting Group I intron, and demonstrates that we can target DENV and CHIKV RNAs in a sequence specific manner with a single, uniquely configured CHIKV/DENV dual targeting group I intron, leading to replication suppression of both arboviruses, and thus providing a promising single antiviral for the transgenic suppression of multiple arboviruses.	[Carter, James R.; Taylor, Samantha; Fraser, Tresa S.; Kucharski, Cheryl A.; Dawson, James L.; Fraser, Malcolm J., Jr.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	University of Notre Dame	Fraser, MJ (corresponding author), Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	fraser.1@nd.edu	Fraser, Malcolm J/C-9100-2009; Dawson, James/GZH-1195-2022	Carter, James/0000-0001-6905-1082	US National Institutes of Health (NIH) [AI097554-04]; NIH/NIAID [AI097554]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097554] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US National Institutes of Health (NIH) grant AI097554-04 to MJF.; Our thanks to Dr. Thomas Cech (University of Colorado, Boulder) for the pTT1A3-T7 plasmid. Chikungunya virus strain 181/25 used in this study was a kind gift from Dr. Scott Weaver (UTMB). This research was supported by research grant NIH/NIAID AI097554 to MJF.	Adelman ZN, 2002, J VIROL, V76, P12925, DOI 10.1128/JVI.76.24.12925-12933.2002; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; Ayre BG, 1999, P NATL ACAD SCI USA, V96, P3507, DOI 10.1073/pnas.96.7.3507; Balasubramanian K, 2007, J BIOL CHEM, V282, P18357, DOI 10.1074/jbc.M700202200; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blankenberg FG, 2008, CANCER BIOL THER, V7, P1525, DOI 10.4161/cbt.7.10.6934; Byun J, 2003, RNA, V9, P1254, DOI 10.1261/rna.5450203; Campbell TB, 1996, BIOCHEMISTRY-US, V35, P11493, DOI 10.1021/bi960510z; Carter JR, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-111; Carter JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-84; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CECH TR, 1991, CELL, V64, P667, DOI 10.1016/0092-8674(91)90494-J; Chursi S, 2014, AM J TROP MED HYG, V90, P410, DOI 10.4269/ajtmh.12-0681; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Coupe SA, 2004, J EXP BOT, V55, P59, DOI 10.1093/jxb/erh018; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Fauran P, 1996, B SOC PATHOL EXOT, V89, P163; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419; Guo F, 2002, RNA, V8, P647, DOI 10.1017/S1355838202029011; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; Higgs S, 2010, J CLIN INVEST, V120, P657, DOI 10.1172/JCI42392; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; Jeong JS, 2008, CLIN CANCER RES, V14, P281, DOI 10.1158/1078-0432.CCR-07-1524; Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915; Johnson TH, 2005, P NATL ACAD SCI USA, V102, P10176, DOI 10.1073/pnas.0501498102; Jung HS, 2005, BIOTECHNOL LETT, V27, P567, DOI 10.1007/s10529-005-2883-6; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480; Kastanos E, 2004, BIOCHEM BIOPH RES CO, V322, P930, DOI 10.1016/j.bbrc.2004.07.203; Kohler U, 1999, J MOL BIOL, V285, P1935, DOI 10.1006/jmbi.1998.2447; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kwon BS, 2005, MOL THER, V12, P824, DOI 10.1016/j.ymthe.2005.06.096; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664; Liu QZ, 2011, APOPTOSIS, V16, P105, DOI 10.1007/s10495-010-0558-9; Maddox Nancy, 2011, MLO Med Lab Obs, V43, P44; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Morens DM, 2014, N ENGL J MED; Muhlenfeld K, 1998, ARCH PHARM, V331, P259; MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307; Nava VE, 1998, J VIROL, V72, P452, DOI 10.1128/JVI.72.1.452-459.1998; Nawtaisong P, 2015, VIROLOGY, V481, P223, DOI 10.1016/j.virol.2015.02.023; Nawtaisong P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-73; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nuckols JT, 2013, VECTOR-BORNE ZOONOT, V13, P103, DOI 10.1089/vbz.2012.1013; O'Brien IEW, 1998, EXP CELL RES, V241, P46, DOI 10.1006/excr.1998.4036; O'Neill K, 2015, P NATL ACAD SCI USA, V112, pE1152, DOI 10.1073/pnas.1424469112; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Press AF, 2010, FRENCH RIVIERA SEES; Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130; Randolph SE, 2010, NAT REV MICROBIOL; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rogers CS, 2002, J CLIN INVEST, V110, P1783, DOI 10.1172/JCI200216481; RUDNICK A, 1965, SCIENCE, V149, P638, DOI 10.1126/science.149.3684.638; Ryu KJ, 2004, J MICROBIOL, V42, P361; Ryu KJ, 2003, J BIOCHEM MOL BIOL, V36, P538; Ryu KJ, 2003, MOL THER, V7, P386, DOI 10.1016/S1525-0016(02)00063-1; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Singh P, 2012, EPIDEMIOL INFECT, V140, P1337, DOI 10.1017/S0950268811001671; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; STROBEL SA, 1993, BIOCHEMISTRY-US, V32, P13593, DOI 10.1021/bi00212a027; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Thavara U, 2009, SE ASIAN J TROP MED, V40, P951; Toyota H, 2006, ANTICANCER RES, V26, P99; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Usui K, 2003, ONCOGENE, V22, P2655, DOI 10.1038/sj.onc.1206331; Van Bortel W, 2014, EURO SURVEILL, V19; VANDENHURK AF, 2009, VECTOR BORNE ZOONOTI; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Wang H, 2008, J GEN VIROL, V89, P2651, DOI 10.1099/vir.0.2008/005314-0; Watanabe T, 2000, P NATL ACAD SCI USA, V97, P8490, DOI 10.1073/pnas.150104097; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008	81	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0139899	10.1371/journal.pone.0139899	http://dx.doi.org/10.1371/journal.pone.0139899			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580561	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600002
J	Iwata, T; Ito, I; Niimi, A; Ikegami, K; Marumo, S; Tanabe, N; Nakaji, H; Kanemitsu, Y; Matsumoto, H; Kamei, J; Setou, M; Mishima, M				Iwata, Toshiyuki; Ito, Isao; Niimi, Akio; Ikegami, Koji; Marumo, Satoshi; Tanabe, Naoya; Nakaji, Hitoshi; Kanemitsu, Yoshihiro; Matsumoto, Hisako; Kamei, Junzo; Setou, Mitsutoshi; Mishima, Michiaki			Mechanical Stimulation by Postnasal Drip Evokes Cough	PLOS ONE			English	Article							RAPIDLY ADAPTING RECEPTORS; ALLERGIC RHINITIS; VARIANT ASTHMA; GUINEA-PIGS; AIRWAY RESPONSIVENESS; BRONCHIAL EPITHELIUM; MICE; CAPSAICIN; PLETHYSMOGRAPHY; INFLAMMATION	Cough affects all individuals at different times, and its economic burden is substantial. Despite these widespread adverse effects, cough research relies on animal models, which hampers our understanding of the fundamental cause of cough. Postnasal drip is speculated to be one of the most frequent causes of chronic cough; however, this is a matter of debate. Here we show that mechanical stimuli by postnasal drip cause chronic cough. We distinguished human cough from sneezes and expiration reflexes by airflow patterns. Cough and sneeze exhibited one-peak and two-peak patterns, respectively, in expiratory airflow, which were also confirmed by animal models of cough and sneeze. Transgenic mice with ciliary dyskinesia coughed substantially and showed postnasal drip in the pharynx; furthermore, their cough was completely inhibited by nasal airway blockade of postnasal drip. We successfully reproduced cough observed in these mice by injecting artificial postnasal drip in wild-type mice. These results demonstrated that mechanical stimulation by postnasal drip evoked cough. The findings of our study can therefore be used to develop new antitussive drugs that prevent the root cause of cough.	[Iwata, Toshiyuki; Ito, Isao; Niimi, Akio; Marumo, Satoshi; Tanabe, Naoya; Nakaji, Hitoshi; Kanemitsu, Yoshihiro; Matsumoto, Hisako; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Niimi, Akio] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan; [Ikegami, Koji; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Kamei, Junzo] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pathophysiol & Therapeut, Tokyo 142, Japan	Kyoto University; Nagoya City University; Hamamatsu University School of Medicine; Hoshi University	Ito, I (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	isaoito@kuhp.kyoto-u.ac.jp		Ito, Isao/0000-0003-3109-898X	Center for Women Researchers, Kyoto University; Japan Society for the Promotion of Science [20590896. II]	Center for Women Researchers, Kyoto University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Center for Women Researchers (http://www.cwr.kyoto-u.ac.jp/index.php), Kyoto University and by Japan Society for the Promotion of Science (http://www.jsps.go.jp/) Grant-in-Aid for Scientific Research number 20590896. II received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATSEL HL, 1975, AM J PHYSIOL, V229, P770, DOI 10.1152/ajplegacy.1975.229.3.770; BENNETT WD, 1990, J APPL PHYSIOL, V69, P1670, DOI 10.1152/jappl.1990.69.5.1670; Birrell MA, 2009, AM J RESP CRIT CARE, V180, P1042, DOI 10.1164/rccm.200905-0665OC; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Brozmanova M, 2006, PHYSIOL RES, V55, P577, DOI 10.33549/physiolres.930840; Canning BJ, 2004, J PHYSIOL-LONDON, V557, P543, DOI 10.1113/jphysiol.2003.057885; Chen LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059263; Dicpinigaitis PV, 2006, RESP PHYSIOL NEUROBI, V152, P356, DOI 10.1016/j.resp.2005.11.010; Fox AJ, 1996, NAT MED, V2, P814, DOI 10.1038/nm0796-814; French CT, 2005, CHEST, V127, P1991, DOI 10.1378/chest.127.6.1991; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Irwin RS, 1997, ARCH INTERN MED, V157, P1981, DOI 10.1001/archinte.157.17.1981; IRWIN RS, 1984, CHEST, V85, P346, DOI 10.1378/chest.85.3.346; Kamei J, 2007, EUR J PHARMACOL, V566, P181, DOI 10.1016/j.ejphar.2007.03.036; KAUFMAN MP, 1980, J APPL PHYSIOL, V48, P511, DOI 10.1152/jappl.1980.48.3.511; Korpaes J, 1979, COUGH OTHER RESP REF; Kunimoto K, 2012, CELL, V148, P189, DOI 10.1016/j.cell.2011.10.052; LALLOO UG, 1995, J APPL PHYSIOL, V79, P1082, DOI 10.1152/jappl.1995.79.4.1082; Leung Sum Yee, 2007, Cough, V3, P10, DOI 10.1186/1745-9974-3-10; Mazzone S. B., 2009, V187, P99, DOI 10.1007/978-3-540-79842-2_6; Miyahara S, 2005, J ALLERGY CLIN IMMUN, V116, P1020, DOI 10.1016/j.jaci.2005.08.020; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; Morice AH, 2004, PULM PHARMACOL THER, V17, P343, DOI 10.1016/j.pupt.2004.09.005; Morikawa T, 1997, PHARMACOL RES, V35, P113, DOI 10.1006/phrs.1996.0122; Nakaya M, 2006, LAB INVEST, V86, P917, DOI 10.1038/labinvest.3700452; Niimi A, 2000, LANCET, V356, P564, DOI 10.1016/S0140-6736(00)02584-8; Niimi A, 2005, J ALLERGY CLIN IMMUN, V116, P565, DOI 10.1016/j.jaci.2005.07.010; Niimi A, 1998, EUR RESPIR J, V11, P1064, DOI 10.1183/09031936.98.11051064; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; OCONNELL F, 1994, AM J RESP CRIT CARE, V150, P374, DOI 10.1164/ajrccm.150.2.8049818; PACK RJ, 1981, J ANAT, V132, P71; Pecova R, 2005, J Physiol Pharmacol, V56 Suppl 4, P171; Plevkova J, 2006, PULM PHARMACOL THER, V19, P120, DOI 10.1016/j.pupt.2005.04.004; Poliacek Ivan, 2008, Cough, V4, P1, DOI 10.1186/1745-9974-4-1; Pratter MR, 2006, CHEST, V129, p63S, DOI 10.1378/chest.129.1_suppl.63S; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Sant'Ambrogio G, 2001, RESP PHYSIOL, V125, P33, DOI 10.1016/S0034-5687(00)00203-6; Satoh I, 1998, NEUROSCI RES, V32, P131, DOI 10.1016/S0168-0102(98)00075-3; SCAPPATICCI E, 1994, ANN THORAC SURG, V57, P119, DOI 10.1016/0003-4975(94)90378-6; Schroeder K, 2002, BRIT MED J, V324, P329, DOI 10.1136/bmj.324.7333.329; Simera M, 2010, EUR J MED RES, V15, P184; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Stephens RE, 2003, AM J PHYS MED REHAB, V82, P384, DOI 10.1097/00002060-200305000-00013; Swartz MA, 2001, P NATL ACAD SCI USA, V98, P6180, DOI 10.1073/pnas.111133298; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Widdicombe J, 2006, EUR RESPIR J, V28, P10, DOI 10.1183/09031936.06.00096905; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P55, DOI 10.1113/jphysiol.1954.sp005033; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P71, DOI 10.1113/jphysiol.1954.sp005034; Widdicome J, 2003, ANAT REC PART A, V270A, P2, DOI 10.1002/ar.a.10003; Zhang QL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-61	54	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141823	10.1371/journal.pone.0141823	http://dx.doi.org/10.1371/journal.pone.0141823			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581078	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600023
J	Pistorius, PA; Hindell, MA; Tremblay, Y; Rishworth, GM				Pistorius, Pierre A.; Hindell, Mark A.; Tremblay, Yann; Rishworth, Gavin M.			Weathering a Dynamic Seascape: Influences of Wind and Rain on a Seabird's Year-Round Activity Budgets	PLOS ONE			English	Article							CAPE GANNETS; ALGOA BAY; BEHAVIOR; PATTERNS; POPULATION; FLIGHT; FOOD; INFORMATION; GUILLEMOTS; DISPERSAL	How animals respond to varying environmental conditions is fundamental to ecology and is a question that has gained impetus due to mounting evidence indicating negative effects of global change on biodiversity. Behavioural plasticity is one mechanism that enables individuals and species to deal with environmental changes, yet for many taxa information on behavioural parameters and their capacity to change are lacking or restricted to certain periods within the annual cycle. This is particularly true for seabirds where year-round behavioural information is intrinsically challenging to acquire due to their reliance on the marine environment where they are difficult to study. Using data from over 13,000 foraging trips throughout the annual cycle, acquired using new-generation automated VHF technology, we described sex-specific, year-round activity budgets in Cape gannets. Using these data we investigated the role of weather (wind and rain) on foraging activity and time allocated to nest attendance. Foraging activity was clearly influenced by wind speed, wind direction and rainfall during and outside the breeding season. Generally, strong wind conditions throughout the year resulted in relatively short foraging trips. Birds spent longer periods foraging when rainfall was moderate. Nest attendance, which was sex-specific outside of the breeding season, was also influenced by meteorological conditions. Large amounts of rainfall (> 2.5 mm per hour) and strong winds (> 13 m s(-1)) resulted in gannets spending shorter amounts of time at their nests. We discuss these findings in terms of life history strategies and implications for the use of seabirds as bio-indicators.	[Pistorius, Pierre A.; Rishworth, Gavin M.] Nelson Mandela Metropolitan Univ, Percy FitzPatrick Inst, Dept Zool, DST NRF Ctr Excellence, ZA-6031 Summerstrand, South Africa; [Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Tremblay, Yann] Ctr Rech Halieut Mediterraneenne & Tropicale, Inst Rech Dev, UMR EME Exploited Marine Ecosyst 212, F-34203 Sete, France	National Research Foundation - South Africa; Nelson Mandela University; University of Tasmania; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Pistorius, PA (corresponding author), Nelson Mandela Metropolitan Univ, Percy FitzPatrick Inst, Dept Zool, DST NRF Ctr Excellence, ZA-6031 Summerstrand, South Africa.	ppistorius@nmmu.ac.za		Hindell, Mark/0000-0002-7823-7185; Pistorius, Pierre/0000-0001-6561-7069; Tremblay, Yann/0000-0002-4653-9269	National Research Foundation (NRF) of South Africa	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This research was funded by the National Research Foundation (NRF) of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The National Research Foundation (NRF) of South Africa is thanked for funding this research. South African National Parks (SANParks) provided logistical support and accommodation on Bird Island. The field assistance of David Green and Maelle Connan is greatly appreciated. The South African Weather Service (SAWS) and Wayne Goschen are thanked for making meteorological data available to this project.	Ainley DG, 1977, ADAPTATIONS ANTARCTI, P669; Amelineau F, 2014, J EXP BIOL, V217, P876, DOI 10.1242/jeb.097915; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Barton K., 2013, MUMIN MULTIMODEL INF; Benvenuti S, 2002, POLAR BIOL, V25, P474, DOI 10.1007/s00300-002-0372-0; Burger A.E., 1990, Studies in Avian Biology, P71; Cairns D.K., 1992, Current Ornithology, V9, P37; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Crawford R.J.M., 2005, ROBERTS BIRDS SO AFR, P565; Crawford RJM, 2007, ICES J MAR SCI, V64, P169, DOI 10.1093/icesjms/fsl011; Daunt F, 2006, BEHAV ECOL SOCIOBIOL, V59, P381, DOI 10.1007/s00265-005-0061-4; Dehnhard N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079487; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Elliott KH, 2015, MAR BIOL, V162, P1739, DOI 10.1007/s00227-015-2701-1; Elliott KH, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0017-2; Finney SK, 1999, J AVIAN BIOL, V30, P23, DOI 10.2307/3677239; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Furness RW, 1996, ECOLOGY, V77, P1181, DOI 10.2307/2265587; GABRIELSEN GW, 1987, CONDOR, V89, P126, DOI 10.2307/1368766; Garthe S, 2009, MAR ECOL PROG SER, V391, P243, DOI 10.3354/meps08170; Goschen WS, 2012, AFR J MAR SCI, V34, P525, DOI 10.2989/1814232X.2012.749810; Green D, 2013, OSTRICH, V84, P123, DOI 10.2989/00306525.2013.830652; Green DB, 2015, MAR ECOL PROG SER, V537, P277, DOI 10.3354/meps11428; Green DB, 2015, ICES J MAR SCI, V72, P771, DOI 10.1093/icesjms/fsu203; Hamer KC, 1997, IBIS, V139, P31, DOI 10.1111/j.1474-919X.1997.tb04501.x; HANEY JC, 1994, AUK, V111, P427, DOI 10.2307/4088606; Harding AMA, 2007, MAR ECOL PROG SER, V352, P269, DOI 10.3354/meps07072; HATCH SA, 1987, AUK, V104, P450, DOI 10.2307/4087544; Hunt G.L. Jr, 1987, P7; Ismar SMH, 2011, WILSON J ORNITHOL, V123, P121, DOI 10.1676/10-072.1; Jaquemet S, 2008, ESTUAR COAST SHELF S, V80, P374, DOI 10.1016/j.ecss.2008.08.019; KLAGES NTW, 1994, OSTRICH, V65, P218, DOI 10.1080/00306525.1994.9639685; Kowalczyk ND, 2015, OECOLOGIA, V178, P967, DOI 10.1007/s00442-015-3294-6; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; Lund U, 2012, CIRCSTATS CIRCULAR S; Mullers RHE, 2009, ICES J MAR SCI, V66, P2244, DOI 10.1093/icesjms/fsp210; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nelson J.B, 2002, THE ATLANTIC GANNET, V2nd; Nelson JB, 1978, SULIDAE GANNETS BOOB, P231; Nelson JB, 2005, CORMORANTS THEIR REL; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; O'Donoghue SH, 2010, AFR J MAR SCI, V32, P279, DOI 10.2989/1814232X.2010.501584; Patrick SC, 2014, OIKOS, V123, P33, DOI 10.1111/j.1600-0706.2013.00406.x; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; R Core Team, 2012, R LANG ENV STAT COMP; Ramirez I, 2013, MAR ECOL PROG SER, V476, P269, DOI 10.3354/meps10083; RANDALL R, 1979, OSTRICH, V50, P168, DOI 10.1080/00306525.1979.9634106; Reed TE, 2009, J ANIM ECOL, V78, P376, DOI 10.1111/j.1365-2656.2008.01503.x; Rishworth GM, 2015, MAR ECOL PROG SER, V530, P153, DOI 10.3354/meps11317; Rishworth GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116544; Rishworth GM, 2014, METHODS ECOL EVOL, V5, P854, DOI 10.1111/2041-210X.12213; Rishworth GM, 2014, AFR ZOOL, V49, P107, DOI 10.3377/004.049.0115; Sandvik H, 2008, GLOBAL CHANGE BIOL, V14, P703, DOI 10.1111/j.1365-2486.2007.01533.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schreiber E, 2001, BIOL MARINE BIRDS, P179; SCHREIBER RW, 1984, SCIENCE, V225, P713, DOI 10.1126/science.225.4663.713; Shoji A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017760; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Spruzen FL, 2002, POLAR BIOL, V25, P296, DOI 10.1007/s00300-001-0344-9; Stearns S.C., 1992, pi; Thiebault A, 2014, BEHAV ECOL, V25, P1302, DOI 10.1093/beheco/aru132; Thiebault A, 2014, AUK, V131, P595, DOI 10.1642/AUK-13-209.1; Tremblay Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088424; UTTLEY JD, 1994, IBIS, V136, P205, DOI 10.1111/j.1474-919X.1994.tb01086.x; Weidinger K, 1996, POLAR BIOL, V16, P339; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Wolfaardt Anton C., 2012, Marine Ornithology, V40, P129	73	17	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142623	10.1371/journal.pone.0142623	http://dx.doi.org/10.1371/journal.pone.0142623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581108	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600051
J	Sarkar, S; Leo, BF; Carranza, C; Chen, S; Rivas-Santiago, C; Porter, AE; Ryan, MP; Gow, A; Chung, KF; Tetley, TD; Zhang, JF; Georgopoulos, PG; Ohman-Strickland, PA; Schwander, S				Sarkar, Srijata; Leo, Bey Fen; Carranza, Claudia; Chen, Shu; Rivas-Santiago, Cesar; Porter, Alexandra E.; Ryan, Mary P.; Gow, Andrew; Chung, Kian Fan; Tetley, Teresa D.; Zhang, Junfeng (Jim); Georgopoulos, Panos G.; Ohman-Strickland, Pamela A.; Schwander, Stephan			Modulation of Human Macrophage Responses to Mycobacterium tuberculosis by Silver Nanoparticles of Different Size and Surface Modification	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; HOST-DEFENSE; RECEPTOR; EXPRESSION; TOXICITY; CELL; ACTIVATION; EPITHELIUM	Exposure to silver nanoparticles (AgNP) used in consumer products carries potential health risks including increased susceptibility to infectious pathogens. Systematic assessments of antimicrobial macrophage immune responses in the context of AgNP exposure are important because uptake of AgNP by macrophages may lead to alterations of innate immune cell functions. In this study we examined the effects of exposure to AgNP with different particle sizes (20 and 110 nm diameters) and surface chemistry (citrate or polyvinlypyrrolidone capping) on cellular toxicity and innate immune responses against Mycobacterium tuberculosis (M.tb) by human monocyte-derived macrophages (MDM). Exposures of MDM to AgNP significantly reduced cellular viability, increased IL8 and decreased IL10 mRNA expression. Exposure of M.tb-infected MDM to AgNP suppressed M.tb-induced expression of IL1B, IL10, and TNFA mRNA. Furthermore, M.tb-induced IL-1 beta, a cytokine critical for host resistance to M.tb, was inhibited by AgNP but not by carbon black particles indicating that the observed immunosuppressive effects of AgNP are particle specific. Suppressive effects of AgNP on the M.tb-induced host immune responses were in part due to AgNP-mediated interferences with the TLR signaling pathways that culminate in the activation of the transcription factor NF-.B. AgNP exposure suppressed M.tb-induced expression of a subset of NF-.B mediated genes (CSF2, CSF3, IFNG, IL1A, IL1B, IL6, IL10, TNFA, NFKB1A). In addition, AgNP exposure increased the expression of HSPA1A mRNA and the corresponding stress-induced Hsp72 protein. Up-regulation of Hsp72 by AgNP can suppress M.tb-induced NF-kappa B activation and host immune responses. The observed ability of AgNP to modulate infectious pathogen-induced immune responses has important public health implications.	[Sarkar, Srijata; Rivas-Santiago, Cesar; Schwander, Stephan] Rutgers State Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA; [Leo, Bey Fen; Chen, Shu; Porter, Alexandra E.; Ryan, Mary P.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; [Leo, Bey Fen; Chen, Shu; Porter, Alexandra E.; Ryan, Mary P.] Univ London Imperial Coll Sci Technol & Med, London Ctr Nanotechnol, London, England; [Leo, Bey Fen] Univ Malaya, Dept Mech Engn, Kuala Lumpur, Malaysia; [Carranza, Claudia] Inst Nacl Enfermedades Resp, Dept Microbiol, Mexico City, DF, Mexico; [Gow, Andrew] Rutgers State Univ, Dept Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ USA; [Chung, Kian Fan; Tetley, Teresa D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Zhang, Junfeng (Jim)] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Zhang, Junfeng (Jim)] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Georgopoulos, Panos G.] Rutgers State Univ, Robert Wood Johnson Med Sch, Computat Chemodynam Lab, Environm & Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA; [Ohman-Strickland, Pamela A.] Rutgers State Univ, Sch Publ Hlth, Dept Biostat, Piscataway, NJ USA; [Schwander, Stephan] Rutgers State Univ, Sch Publ Hlth, Ctr Global Publ Hlth, Piscataway, NJ USA	Rutgers State University New Brunswick; Imperial College London; Imperial College London; University of London; University College London; Universiti Malaya; Rutgers State University New Brunswick; Imperial College London; Duke University; Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schwander, S (corresponding author), Rutgers State Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA.	schwansk@sph.rutgers.edu	Rivas-Santiago, Cesar/L-8627-2019; Chung, Kian Fan/B-1872-2012; Leo, Bey Fen/AAA-1455-2020; Gow, Andrew/N-8566-2013; Zhang, Junfeng/AAJ-9183-2020; Leo, Bey/HHN-7701-2022; Leo, Bey Fen/C-4133-2017; Gow, Andrew/AAR-2309-2020; Tetley, Teresa D/B-3288-2016; Carranza, Cristina/K-9578-2016	Rivas-Santiago, Cesar/0000-0002-0504-2299; Chung, Kian Fan/0000-0001-7101-1426; Gow, Andrew/0000-0003-0876-5158; Zhang, Junfeng/0000-0003-3759-6672; Leo, Bey Fen/0000-0002-8075-0295; Gow, Andrew/0000-0003-0876-5158; 	National Institute of Environmental Health Sciences [5U19 ES019536, 5R01 ES02038202, P30ES005022]; European Research Council [257182]; Else Widdowson fellowship; MRC [G0700926] Funding Source: UKRI; NERC [NE/H012893/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES019536, P30ES005022, R01ES020382] Funding Source: NIH RePORTER; Medical Research Council [G0700926] Funding Source: researchfish; Natural Environment Research Council [NE/H012893/1] Funding Source: researchfish	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Research Council(European Research Council (ERC)European Commission); Else Widdowson fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the National Institute of Environmental Health Sciences http://www.niehs.nih.gov/: 5U19 ES019536, 5R01 ES02038202, P30ES005022; European Research Council http://erc.europa.eu/: 257182; and Else Widdowson fellowship.	Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Aueviriyavit S, 2012, BIOL TRACE ELEM RES, V149, P123, DOI 10.1007/s12011-012-9403-z; Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002; Bhatt KH, 2011, CLIN VACCINE IMMUNOL, V18, P994, DOI 10.1128/CVI.00541-10; Bieber J, 2003, ANN RHEUM DIS, V62, P1118, DOI 10.1136/ard.62.11.1118; BOTELHO DJ, 2015, NANOTOXICOLOGY, P1, DOI DOI 10.3109/17435390.2015.1038330; Boucher W, 2008, J UROLOGY, V179, P1598, DOI 10.1016/j.juro.2007.11.037; Bouwmeester H, 2011, ACS NANO, V5, P4091, DOI 10.1021/nn2007145; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Carranza C, 2006, AM J RESP CRIT CARE, V173, P238, DOI 10.1164/rccm.200503-411OC; Chairuangkitti P, 2013, TOXICOL IN VITRO, V27, P330, DOI 10.1016/j.tiv.2012.08.021; Chan ED, 2010, AM J RESP CRIT CARE, V182, P990, DOI 10.1164/rccm.201006-0861ED; Chase MA, 2007, J IMMUNOL, V179, P6318, DOI 10.4049/jimmunol.179.9.6318; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Davies PDO, 2006, T ROY SOC TROP MED H, V100, P291, DOI 10.1016/j.trstmh.2005.06.034; Diaz B, 2008, SMALL, V4, P2025, DOI 10.1002/smll.200800199; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Eom HJ, 2010, ENVIRON SCI TECHNOL, V44, P8337, DOI 10.1021/es1020668; Ferat-Osorio E, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-19; Foldbjerg R, 2012, TOXICOL SCI, V130, P145, DOI 10.1093/toxsci/kfs225; Foldbjerg R, 2011, ARCH TOXICOL, V85, P743, DOI 10.1007/s00204-010-0545-5; Foldbjerg R, 2009, TOXICOL LETT, V190, P156, DOI 10.1016/j.toxlet.2009.07.009; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gopinath P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075104; Grover A, 2008, CELL MICROBIOL, V10, P1390, DOI 10.1111/j.1462-5822.2008.01135.x; Grover A, 2014, IMMUNOLOGY, V142, P111, DOI 10.1111/imm.12236; Hanley C, 2009, NANOSCALE RES LETT, V4, P1409, DOI 10.1007/s11671-009-9413-8; Hussain S, 2012, WIRES NANOMED NANOBI, V4, P169, DOI 10.1002/wnan.166; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Huynh KA, 2011, ENVIRON SCI TECHNOL, V45, P5564, DOI 10.1021/es200157h; Imperiali FG, 2001, CLIN EXP IMMUNOL, V123, P435, DOI 10.1046/j.1365-2249.2001.01481.x; Ivask A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102108; Jacobs M, 2007, EUR CYTOKINE NETW, V18, P5; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Krishnan N, 2013, TUBERCULOSIS, V93, P538, DOI 10.1016/j.tube.2013.05.002; Krutzik SR, 2001, CURR OPIN IMMUNOL, V13, P104, DOI 10.1016/S0952-7915(00)00189-8; Ku KT, 2008, J AGR FOOD CHEM, V56, P8911, DOI 10.1021/jf8019369; Landsiedel R, 2010, ADV MATER, V22, P2601, DOI 10.1002/adma.200902658; Lee JH, 2012, NANOTOXICOLOGY, V6, P667, DOI 10.3109/17435390.2011.600840; Leo BF, 2013, ENVIRON SCI TECHNOL, V47, P11232, DOI 10.1021/es403377p; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Mayer A, 2009, TOXICOLOGY, V258, P139, DOI 10.1016/j.tox.2009.01.015; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Maynard AD, 2011, TOXICOL SCI, V120, pS109, DOI 10.1093/toxsci/kfq372; Mazarati A, 2011, EXP NEUROL, V232, P143, DOI 10.1016/j.expneurol.2011.08.012; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Munusamy P, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4926547; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Pai M, 2007, EXPERT REV ANTI-INFE, V5, P385, DOI 10.1586/14787210.5.3.385; Park S, 2007, INHAL TOXICOL, V19, P59, DOI 10.1080/08958370701493282; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; PRIETO J, 1994, CELL IMMUNOL, V156, P191, DOI 10.1006/cimm.1994.1164; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Rivas-Santiago CE, 2015, INFECT IMMUN, V83, P2507, DOI 10.1128/IAI.03018-14; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Rylance J, 2015, AM J RESP CELL MOL, V52, P584, DOI 10.1165/rcmb.2014-0188OC; Sarkar S, 2012, J IMMUNOL, V188, P2778, DOI 10.4049/jimmunol.1101380; Schanen BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062816; Schanen BC, 2009, ACS NANO, V3, P2523, DOI 10.1021/nn900403h; Schwander S, 2011, AM J RESP CRIT CARE, V183, P696, DOI 10.1164/rccm.201006-0963PP; Spano A, 2007, HISTOCHEM CELL BIOL, V127, P79, DOI 10.1007/s00418-006-0227-9; Tang DL, 2007, J IMMUNOL, V179, P1236, DOI 10.4049/jimmunol.179.2.1236; Tejamaya M, 2012, ENVIRON SCI TECHNOL, V46, P7011, DOI 10.1021/es2038596; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tolaymat TM, 2010, SCI TOTAL ENVIRON, V408, P999, DOI 10.1016/j.scitotenv.2009.11.003; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Wang X, 2014, SMALL, V10, P385, DOI 10.1002/smll.201301597; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williams K, 2014, NANOTOXICOLOGY, V9, P1; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Yilma AN, 2013, INT J NANOMED, V8, P2421, DOI 10.2147/IJN.S44090; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082	88	26	27	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143077	10.1371/journal.pone.0143077	http://dx.doi.org/10.1371/journal.pone.0143077			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580078	gold, Green Submitted, Green Published			2022-12-26	WOS:000365154600078
J	Wang, XP; Liu, YL; Chen, HS; Mei, LY; He, CF; Jiang, L; Niu, ZJ; Sun, J; Luo, HJ; Li, JD; Feng, Y				Wang, Xueping; Liu, Yalan; Chen, Hongsheng; Mei, Lingyun; He, Chufeng; Jiang, Lu; Niu, Zhijie; Sun, Jie; Luo, Hunjin; Li, Jiada; Feng, Yong			LEF-1 Regulates Tyrosinase Gene Transcription In Vitro	PLOS ONE			English	Article							MELANOCYTE-SPECIFIC TRANSCRIPTION; OCULOCUTANEOUS ALBINISM; NEURAL CREST; FUNCTIONAL-ANALYSIS; MELANIN SYNTHESIS; MOLECULAR-BASIS; BETA-CATENIN; MICROPHTHALMIA; WNT; MOUSE	TYR, DCT and MITF are three important genes involved in maintaining the mature phenotype and producing melanin; they therefore participate in neural crest cell development into melanocytes. Previous studies have revealed that the Wnt signaling factor lymphoid enhancer-binding factor (LEF-1) can enhance DCT and MITF gene expression. However, whether LEF-1 also affects TYR gene expression remains unclear. In the present study, we found that LEF-1 regulated TYR transcription in vitro. LEF-1 overexpression increased TYR gene promoter activity, whereas LEF-1 knockdown by RNA interference significantly decreased TYR expression. Moreover, the core GTTTGAT sequence (-56 to -50) within the TYR promoter is essential for the effect of LEF-1 on TYR expression, and chromatin immunoprecipitation (ChIP) assay indicated that endogenous LEF-1 interacts with the TYR promoter. In addition, we observed a synergistic transactivation of the TYR promoter by LEF-1 and MITF. These data suggest that Wnt signaling plays an important role in regulating melanocyte development and differentiation.	[Wang, Xueping; Chen, Hongsheng; Mei, Lingyun; He, Chufeng; Jiang, Lu; Niu, Zhijie; Sun, Jie; Feng, Yong] Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China; [Liu, Yalan; Chen, Hongsheng; Mei, Lingyun; He, Chufeng; Jiang, Lu; Feng, Yong] Cent S Univ, Xiangya Hosp, Prov Key Lab Otolaryngol Crit Dis, Changsha, Hunan, Peoples R China; [Luo, Hunjin; Li, Jiada; Feng, Yong] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Sun, Jie] Xinjiang Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Urumqi, Peoples R China	Central South University; Central South University; Central South University; Xinjiang Medical University	Li, JD (corresponding author), Cent S Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China.	lijiada@sklmg.edu.cn; fengyong_hn@hotmail.com	Niu, Zhijie/GRS-2684-2022	Li, Jia-Da/0000-0002-4236-3518; Chen, Hongsheng/0000-0002-1373-6434	National Basic Research and Development Program of China (973 Program) [2014CB541702]; National Natural Science Foundation of China [81170923, 81470705, 81300833]; ministry of health of China [201302001]	National Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ministry of health of China	This study was supported by National Basic Research and Development Program of China (973 Program) (No. 2014CB541702, to Yong Feng), the National Natural Science Foundation of China (Nos. 81170923, 81470705 to Yong Feng; No. 81300833 to Lu Jiang), The public welfare industry research special fund projects of ministry of health of China (No. 201302001, to Yong Feng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amae S, 1998, BIOCHEM BIOPH RES CO, V247, P710, DOI 10.1006/bbrc.1998.8838; Barker N, 2000, ADV CANCER RES, V77, P1; BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; BUDD PS, 1995, GENOMICS, V29, P35, DOI 10.1006/geno.1995.1212; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cho M, 2009, BIOCHEM BIOPH RES CO, V390, P500, DOI 10.1016/j.bbrc.2009.09.124; Driskell RR, 2007, DEV BIOL, V305, P90, DOI 10.1016/j.ydbio.2007.01.038; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fukunaga-Kalabis M, 2015, J INVEST DERMATOL, V135, P1521, DOI 10.1038/jid.2015.59; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Goding CR, 2000, GENE DEV, V14, P1712; Guo HY, 2012, BIOCHEM BIOPH RES CO, V420, P799, DOI 10.1016/j.bbrc.2012.03.077; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3799, DOI 10.1093/nar/19.14.3799; KOBAYASHI T, 1995, J CELL SCI, V108, P2301; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; KWON BS, 1993, J INVEST DERMATOL, V100, P134; Land EJ, 2004, METHOD ENZYMOL, V378, P88; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Metzeler KH, 2012, BLOOD, V120, P2118, DOI 10.1182/blood-2012-02-411827; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHIBAHARA S, 1991, J BIOL CHEM, V266, P15895; Singhi AD, 2014, MODERN PATHOL, V27, P1355, DOI 10.1038/modpathol.2014.40; SLOMINSKI A, 1989, PIGM CELL RES, V2, P109, DOI 10.1111/j.1600-0749.1989.tb00170.x; SLOMINSKI A, 1985, J CANCER RES CLIN, V109, P29, DOI 10.1007/BF01884251; SPRITZ RA, 1994, HUM MOL GENET, V3, P1469, DOI 10.1093/hmg/3.suppl_1.1469; TAKEDA A, 1990, J BIOL CHEM, V265, P17792; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Wang HH, 2014, GENE, V538, P36, DOI 10.1016/j.gene.2014.01.026; Wang WJ, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/983981; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Xu SX, 2015, DNA CELL BIOL, V34, P69, DOI 10.1089/dna.2014.2590; Yamaguchi Y, 2008, FASEB J, V22, P1009, DOI 10.1096/fj.07-9475com; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; YAVUZER U, 1995, ONCOGENE, V10, P123; Zhang H, 2012, FEBS LETT, V586, P4126, DOI 10.1016/j.febslet.2012.10.006; Zhou WB, 2010, MOL CELL BIOCHEM, V343, P231, DOI 10.1007/s11010-010-0518-2	48	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143142	10.1371/journal.pone.0143142	http://dx.doi.org/10.1371/journal.pone.0143142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580798	gold, Green Submitted, Green Published			2022-12-26	WOS:000365154600091
J	Yang, YL; Yen, CT; Pai, CH; Chen, HY; Yu, SL; Lin, CY; Hu, CY; Jou, ST; Lin, DT; Lin, SR; Lin, SW				Yang, Yung-Li; Yen, Ching-Tzu; Pai, Chen-Hsueh; Chen, Hsuan-Yu; Yu, Sung-Liang; Lin, Chien-Yu; Hu, Chung-Yi; Jou, Shiann-Tarng; Lin, Dong-Tsamn; Lin, Shu-Rung; Lin, Shu-Wha			A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							SURVIVAL; TEL; MICRORNA-223; PROTEIN; GENES; CELLS	Childhood acute lymphoblastic leukemia (ALL) with t(12;21), which results in expression of the ETV6/RUNX1 fusion gene, is the most common chromosomal lesion in precursor-B (pre-B) ALL. We identified 17 microRNAs that were downregulated in ETV6/RUNX1(+) compared with ETV6/RUNX1(-) clinical samples. Among these microRNAs, miR-181a-1 was the most significantly reduced (by similar to 75%; P < 0.001). Using chromatin immunoprecipitation, we demonstrated that ETV6/RUNX1 directly binds the regulatory region of MIR181A1, and knockdown of ETV6/RUNX1 increased miR-181a-1 level. We further showed that miR-181a (functional counterpart of miR-181a-1) could target ETV6/RUNX1 and cause a reduction in the level of the oncoprotein ETV6/RUNX1, cell growth arrest, an increase in apoptosis, and induction of cell differentiation in ETV6/RUNX1(+) cell line. Moreover, ectopic expression of miR-181a also resulted in decreased CD10 hyperexpression in ETV6/RUNX1(+) primary patient samples. Taken together, our results demonstrate that MIR181A1 and ETV6/RUNX1 regulate each other, and we propose that a double negative loop involving MIR181A1 and ETV6/RUNX1 may contribute to ETV6/RUNX1-driven arrest of differentiation in pre-B ALL.	[Yang, Yung-Li; Lin, Dong-Tsamn] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 10764, Taiwan; [Yang, Yung-Li; Jou, Shiann-Tarng; Lin, Dong-Tsamn] Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yen, Ching-Tzu; Pai, Chen-Hsueh; Yu, Sung-Liang; Hu, Chung-Yi; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Clin Lab, Taipei 10764, Taiwan; [Yen, Ching-Tzu; Pai, Chen-Hsueh; Yu, Sung-Liang; Hu, Chung-Yi; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Sci, Taipei 10764, Taiwan; [Yen, Ching-Tzu; Pai, Chen-Hsueh; Yu, Sung-Liang; Hu, Chung-Yi; Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Med Biotechnol, Taipei 10764, Taiwan; [Chen, Hsuan-Yu; Lin, Chien-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Dept Biosci Technol, Coll Sci, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Nanotechnol, Coll Sci, Taoyuan, Taiwan; [Lin, Shu-Rung] Chung Yuan Christian Univ, Ctr Biomed Technol, Coll Sci, Taoyuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University	Lin, SR (corresponding author), Chung Yuan Christian Univ, Dept Biosci Technol, Coll Sci, Taoyuan, Taiwan.	shurung@cycu.edu.tw; mtshuwha@ntu.edu.tw	Chen, Hsuan-Yu/AAE-8428-2019	HU, CHUNG-YI/0000-0002-6990-3297; Pai, Chen-Hsueh/0000-0001-5425-897X; YU, SUNG-LIANG/0000-0003-4535-9036; JOU, SHIANN-TANG/0000-0003-1483-0403; LIN, SHU-WHA/0000-0001-6748-5581; YANG, YUNG-LI/0000-0002-3598-7218	National Science Council of Taiwan [NSC 102-2320-B-002-028-MY3, NSC 99-2314-B-002-016-MY3, NSC 100-2632-M-033-001-MY3, NSC 101-2632-M-033-001-MY2, NSC 102-2632-M-033-001-MY3, NSC 102-2320-B-033 -003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan, www.most.gov.tw/ (Grant No. NSC 102-2320-B-002-028-MY3, NSC 99-2314-B-002-016-MY3, NSC 100-2632-M-033-001-MY3, NSC 101-2632-M-033-001-MY2, NSC 102-2632-M-033-001-MY3, and NSC 102-2320-B-033 -003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Diakos C, 2007, BLOOD, V109, P2607, DOI 10.1182/blood-2006-04-019612; Diakos C, 2010, BLOOD, V116, P4885, DOI 10.1182/blood-2009-02-206706; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Fischer M, 2005, ONCOGENE, V24, P7579, DOI 10.1038/sj.onc.1208931; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Gefen N, 2010, LEUKEMIA, V24, P89, DOI 10.1038/leu.2009.208; Guidez F, 2000, BLOOD, V96, P2557; Gunji H, 2004, BIOCHEM BIOPH RES CO, V322, P623, DOI 10.1016/j.bbrc.2004.07.169; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Kaindl U, 2014, LEUKEMIA, V28, P600, DOI 10.1038/leu.2013.345; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Lwin T, 2013, J CLIN INVEST, V123, P4612, DOI 10.1172/JCI64210; Mesquita D, 2010, REV BRAS REUMATOL, V50, P566, DOI 10.1590/S0482-50042010000500008; Morrow M, 2007, ONCOGENE, V26, P4404, DOI 10.1038/sj.onc.1210227; Musilova K, 2015, LEUKEMIA, V29, P1004, DOI 10.1038/leu.2014.351; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Pallasch CP, 2009, BLOOD, V114, P3255, DOI 10.1182/blood-2009-06-229898; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Roehle A, 2008, BRIT J HAEMATOL, V142, P732, DOI 10.1111/j.1365-2141.2008.07237.x; Schotte D, 2011, HAEMATOL-HEMATOL J, V96, P703, DOI 10.3324/haematol.2010.026138; Starkova J, 2007, CLIN CANCER RES, V13, P1726, DOI 10.1158/1078-0432.CCR-06-2569; Torrano V, 2011, BLOOD, V118, P4910, DOI 10.1182/blood-2011-05-354266; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; Yang YL, 2010, LEUKEMIA RES, V34, P18, DOI 10.1016/j.leukres.2009.07.023; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zaliova M, 2011, LEUKEMIA, V25, P313, DOI 10.1038/leu.2010.277	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142863	10.1371/journal.pone.0142863	http://dx.doi.org/10.1371/journal.pone.0142863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580398	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600062
J	Gradinaru, I; Babaeva, E; Schwinn, DA; Oganesian, A				Gradinaru, Irina; Babaeva, Ekaterina; Schwinn, Debra A.; Oganesian, Anush			Alpha1a-Adrenoceptor Genetic Variant Triggers Vascular Smooth Muscle Cell Hyperproliferation and Agonist Induced Hypertrophy via EGFR Transactivation Pathway	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR ACTIVATION; PROTEIN-COUPLED RECEPTORS; ENHANCES MMP-2 PRODUCTION; SIGNAL-REGULATED KINASES; ARTERIAL BLOOD-PRESSURE; ANGIOTENSIN-II; CARDIAC-HYPERTROPHY; ALPHA(1)-ADRENERGIC RECEPTORS; MATRIX METALLOPROTEINASE-7	alpha(1a) Adrenergic receptors (alpha(1a)ARs) are the predominant AR subtype in human vascular smooth muscle cells (SMCs). alpha(1a)ARs in resistance vessels are crucial in the control of blood pressure, yet the impact of naturally occurring human alpha(1a)AR genetic variants in cardiovascular disorders remains poorly understood. To this end, we present novel findings demonstrating that 3D cultures of vascular SMCs expressing human alpha(1a)AR-247R (247R) genetic variant demonstrate significantly increased SMC contractility compared with cells expressing the alpha(1a)AR-WT (WT) receptor. Stable expression of 247R genetic variant also triggers MMP/EGFR-transactivation dependent serum-and agonist-independent (constitutive) hyperproliferation and agonist-dependent hypertrophy of SMCs. Agonist stimulation reduces contractility Using pathway-specific inhibitors we determined that the observed hyperproliferation of 247R-expressing cells is triggered via beta-arrestin1/Src/MMP-2/EGFR/ERK-dependent mechanism. MMP-2-specific siRNA inhibited 247R-triggered hyperproliferation indicating MMP-2 involvement in 247R-triggered hyperproliferation in SMCs. beta-arrestin1-specific shRNA also inhibited 247R-triggered hyperproliferation but did not affect hypertrophy in 247R-expressing SMCs, indicating that agonist-dependent hypertrophy is independent of beta-arrestin1. Our data reveal that in different cardiovascular cells the same human receptor genetic variant can activate alternative modulators of the same signaling pathway. Thus, our findings in SMCs demonstrate that depending on the type of cells expressing the same receptor (or receptor variant), different target-specific inhibitors could be used to modulate aberrant hyperproliferative or hypertrophic pathways in order to restore normal phenotype.	[Gradinaru, Irina; Babaeva, Ekaterina; Oganesian, Anush] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Schwinn, Debra A.] Univ Iowa, Dept Anesthesiol, Iowa City, IA USA; [Schwinn, Debra A.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Schwinn, Debra A.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Washington; University of Washington Seattle; University of Iowa; University of Iowa; University of Iowa	Oganesian, A (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	anush@u.washington.edu		Schwinn, Debra/0000-0002-9696-5231	NIH [HL49103]; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049103, R01HL049103] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH HL49103 (DAS), National Institutes of Health, www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Andersson KE, 2007, NAT CLIN PRACT UROL, V4, P368, DOI 10.1038/ncpuro0836; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Bakken AM, 2009, J VASC SURG, V49, P1296, DOI 10.1016/j.jvs.2008.12.026; Barki-Harrington L, 2004, CARDIOVASC RES, V63, P391, DOI 10.1016/j.cardiores.2004.03.011; Belsches A P, 1997, Front Biosci, V2, pd501; Block ER, 2010, J BIOL CHEM, V285, P13372, DOI 10.1074/jbc.M109.083089; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Chen LQ, 1995, J BIOL CHEM, V270, P30980, DOI 10.1074/jbc.270.52.30980; Chen ZJ, 2005, ACTA PHARMACOL SIN, V26, P1281, DOI 10.1111/j.1745-7254.2005.00224.x; Chiu CL, 2013, J BIOPHYS; Choi WS, 2004, J RECEPT SIG TRANSD, V24, P67, DOI 10.1081/RRS-120034229; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Delgado-Olguin P, 2012, NAT GENET, V44, P343, DOI 10.1038/ng.1068; Derosa G, 2006, ENDOTHELIUM-J ENDOTH, V13, P227, DOI 10.1080/10623320600780942; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Drube S, 2006, CELL SIGNAL, V18, P1633, DOI 10.1016/j.cellsig.2006.01.003; Du T, 2009, NEUROCHEM INT, V55, P593, DOI 10.1016/j.neuint.2009.05.016; Eguchi S, 1999, J BIOL CHEM, V274, P36843, DOI 10.1074/jbc.274.52.36843; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Faber JE, 2006, AM J PHYSIOL-HEART C, V291, pH2272, DOI 10.1152/ajpheart.00404.2006; Faber JE, 2001, J PHARMACOL EXP THER, V298, P441; Femminella GD, 2014, PHARMACOGEN PERS MED, V7, P267, DOI 10.2147/PGPM.S49799; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Guo JF, 2009, CIRC RES, V104, P660, DOI 10.1161/CIRCRESAHA.108.186288; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; Hayashi H, 2008, GENES CELLS, V13, P941, DOI 10.1111/j.1365-2443.2008.01218.x; Hernandez-Pacheco G, 2004, AUTON NEUROSCI-BASIC, V183, P66; Hori Y, 2012, AM J PHYSIOL-CELL PH, V303, pC947, DOI 10.1152/ajpcell.00401.2011; Hosoda C, 2005, MOL PHARMACOL, V67, P912, DOI 10.1124/mol.104.007500; Houston MC, 1992, HYPERTENSION AS A RI; JULIUS S, 1993, HYPERTENSION, V21, P886, DOI 10.1161/01.HYP.21.6.886; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Kendall RT, 2014, J BIOL CHEM, V289, P26155, DOI 10.1074/jbc.M114.595728; Kennedy E, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-6; Kim IM, 2008, P NATL ACAD SCI USA, V105, P14555, DOI 10.1073/pnas.0804745105; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kim YH, 2013, J LIPID RES, V54, P2678, DOI 10.1194/jlr.M037176; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kleine-Brueggeney M, 2014, CELL SIGNAL, V26, P1985, DOI 10.1016/j.cellsig.2014.05.007; Kreda SM, 2001, ENDOCRINOLOGY, V142, P4839, DOI 10.1210/en.142.11.4839; Lee SJ, 2008, FREE RADICAL BIO MED, V45, P1487, DOI 10.1016/j.freeradbiomed.2008.08.022; Lei B, 2005, N-S ARCH PHARMACOL, V371, P229, DOI 10.1007/s00210-005-1019-9; Lei BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072430; Lemarie CA, 2010, J MOL CELL CARDIOL, V48, P433, DOI 10.1016/j.yjmcc.2009.09.018; Li Y, 2011, AM J PHYSIOL-HEART C, V301, pH1941, DOI 10.1152/ajpheart.00338.2011; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Liu YT, 2007, J CELL PHYSIOL, V211, P205, DOI 10.1002/jcp.20924; Masuo K, 2014, CURR HYPERTENS REV; Nagareddy PR, 2010, CARDIOVASC RES, V87, P177, DOI 10.1093/cvr/cvq030; Nagareddy PR, 2009, CARDIOVASC RES, V84, P368, DOI 10.1093/cvr/cvp230; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Oganesian A, 2011, P NATL ACAD SCI USA, V108, P19796, DOI 10.1073/pnas.1116271108; Oishi K, 2002, J PHYSIOL-LONDON, V540, P139, DOI 10.1113/jphysiol.2001.013278; Patel PA, 2009, J MOL CELL CARDIOL, V46, P300, DOI 10.1016/j.yjmcc.2008.11.015; Piascik MT, 1997, J PHARMACOL EXP THER, V283, P854; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rao RS, 1997, CARDIOVASC RES, V36, P118, DOI 10.1016/S0008-6363(97)00156-9; Reder NP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037145; Risinger GM, 2006, J BIOL CHEM, V281, P25915, DOI 10.1074/jbc.M513513200; Rokosh DG, 2002, P NATL ACAD SCI USA, V99, P9474, DOI 10.1073/pnas.132552699; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rudner XL, 1999, CIRCULATION, V100, P2336, DOI 10.1161/01.CIR.100.23.2336; Sato K, 2013, INT J MOL SCI, V14, P10761, DOI 10.3390/ijms140610761; SATO KI, 1995, BIOCHEM BIOPH RES CO, V215, P1078, DOI 10.1006/bbrc.1995.2574; Savoia C, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001815; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Shah BH, 2006, J NEUROCHEM, V96, P520, DOI 10.1111/j.1471-4159.2005.03585.x; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Smiljanic K, 2014, MOL CELL BIOCHEM, V396, P147, DOI 10.1007/s11010-014-2151-y; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Tanoue A, 2003, TRENDS ENDOCRIN MET, V14, P107, DOI 10.1016/S1043-2760(03)00026-2; Tanoue A, 2002, J CLIN INVEST, V109, P765, DOI 10.1172/JCI200214001; Teeters JC, 2003, AM J PHYSIOL-HEART C, V284, pH385, DOI 10.1152/ajpheart.00658.2002; Touyz RM, 2005, CURR OPIN NEPHROL HY, V14, P125, DOI 10.1097/00041552-200503000-00007; Touyz RM, 2003, CURR OPIN NEPHROL HY, V12, P165, DOI 10.1097/00041552-200303000-00007; Ulu N, 2010, BRIT J PHARMACOL, V161, P1301, DOI 10.1111/j.1476-5381.2010.00829.x; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Watts SW, 2007, AM J PHYSIOL-HEART C, V292, pH2438, DOI 10.1152/ajpheart.00900.2006; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xin XH, 1997, MOL PHARMACOL, V51, P764, DOI 10.1124/mol.51.5.764; Zhang H, 2004, CIRC RES, V95, P989, DOI 10.1161/01.RES.0000147962.01036.bb; Zhang H, 2002, AM J PHYSIOL-HEART C, V282, pH2364, DOI 10.1152/ajpheart.00858.2001; Zhang H, 2001, CIRC RES, V89, P815, DOI 10.1161/hh2101.098379	91	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142787	10.1371/journal.pone.0142787	http://dx.doi.org/10.1371/journal.pone.0142787			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571308	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700072
J	Huh, JH; Lee, KJ; Lim, JS; Lee, MY; Park, HJ; Kim, MY; Kim, JW; Chung, CH; Shin, JY; Kim, HS; Kwon, SO; Baik, SK				Huh, Ji Hye; Lee, Kyong Joo; Lim, Jung Soo; Lee, Mi Young; Park, Hong Jun; Kim, Moon Young; Kim, Jae Woo; Chung, Choon Hee; Shin, Jang Yel; Kim, Hyun-Soo; Kwon, Sang Ok; Baik, Soon Koo			High Dietary Sodium Intake Assessed by Estimated 24-h Urinary Sodium Excretion Is Associated with NAFLD and Hepatic Fibrosis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ANGIOTENSIN-II; INSULIN-RESISTANCE; RECEPTOR BLOCKER; OBESITY; INDEX; PREVALENCE; VALIDATION; REACTIVITY; SYSTEM	Background Although high sodium intake is associated with obesity and hypertension, few studies have investigated the relationship between sodium intake and non-alcoholic fatty liver disease (NAFLD). We evaluated the association between sodium intake assessed by estimated 24-h urinary sodium excretion and NAFLD in healthy Koreans. Methods We analyzed data from 27,433 participants in the Korea National Health and Nutrition Examination Surveys (2008-2010). The total amount of sodium excretion in 24-h urine was estimated using Tanaka's equations from spot urine specimens. Subjects were defined as having NAFLD when they had high scores in previously validated NAFLD prediction models such as the hepatic steatosis index (HSI) and fatty liver index (FLI). BARD scores and FIB-4 were used to define advanced fibrosis in subjects with NAFLD. Results The participants were classified into three groups according to estimated 24-h urinary excretion tertiles. The prevalence of NAFLD as assessed by both FLI and HSI was significantly higher in the highest estimated 24-h urinary sodium excretion tertile group. Even after adjustment for confounding factors including body fat and hypertension, the association between higher estimated 24-h urinary sodium excretion and NAFLD remained significant (Odds ratios (OR) 1.39, 95% confidence interval (CI) 1.26-1.55, in HSI; OR 1.75, CI 1.39-2.20, in FLI, both P < 0.001). Further, subjects with hepatic fibrosis as assessed by BARD score and FIB-4 in NAFLD patients had higher estimated 24-h urinary sodium values. Conclusions High sodium intake was independently associated with an increased risk of NAFLD and advanced liver fibrosis.	[Huh, Ji Hye; Lim, Jung Soo; Lee, Mi Young; Chung, Choon Hee; Shin, Jang Yel] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Endocrinol & Metab, Wonju, South Korea; [Lee, Kyong Joo; Park, Hong Jun; Kim, Moon Young; Kim, Jae Woo; Kim, Hyun-Soo; Kwon, Sang Ok; Baik, Soon Koo] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol, Wonju, South Korea	Yonsei University; Yonsei University	Baik, SK (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol, Wonju, South Korea.	baiksk@yonsei.ac.kr		Chung, Choon/0000-0003-1144-7206	Gangwon Endocrine Society, Republic of Korea	Gangwon Endocrine Society, Republic of Korea	This study was supported by a grant from the Gangwon Endocrine Society, Republic of Korea. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding does not alter the authors' adherence to all the journal policies on sharing data and materials.	Baudrand R, 2014, CLIN ENDOCRINOL, V80, P677, DOI 10.1111/cen.12225; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bhatia LS, 2012, CURR OPIN CARDIOL, V27, P420, DOI 10.1097/HCO.0b013e328354829c; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Cogswell ME, 2013, AM J CLIN NUTR, V98, P1502, DOI 10.3945/ajcn.113.059436; Crestani S, 2014, VASC PHARMACOL, V60, P67, DOI 10.1016/j.vph.2013.12.001; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Huh JH, 2014, OSTEOPOROSIS INT, V25, P1053, DOI 10.1007/s00198-013-2531-2; Huh JH, 2015, METABOLISM, V64, P837, DOI 10.1016/j.metabol.2015.03.010; Ji C, 2012, REV PANAM SALUD PUBL, V32, P307, DOI 10.1590/S1020-49892012001000010; Kato J, 2012, INT J MOL MED, V30, P107, DOI 10.3892/ijmm.2012.958; Kim JH, 2011, LIVER INT, V31, P1600, DOI 10.1111/j.1478-3231.2011.02580.x; Larsen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069689; Lee JK, 2010, HEPATOLOGY, V51, P1577, DOI 10.1002/hep.23505; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051; Lee YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107584; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Libuda L, 2012, PUBLIC HEALTH NUTR, V15, P433, DOI 10.1017/S1368980011002138; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Munshi MK, 2011, EXP BIOL MED, V236, P557, DOI 10.1258/ebm.2011.010375; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Park JH, 2014, J KOREAN MED SCI, V29, pS131, DOI 10.3346/jkms.2014.29.S2.S131; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Rajagopalan S, 2002, CIRCULATION, V105, P2212, DOI 10.1161/01.CIR.0000015854.60710.10; Ruffillo G, 2011, J HEPATOL, V54, P160, DOI 10.1016/j.jhep.2010.06.028; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Vedovato M, 2004, DIABETOLOGIA, V47, P300, DOI 10.1007/s00125-003-1303-5; Yi SS, 2014, AM J PREV MED, V46, pE53, DOI 10.1016/j.amepre.2014.02.005	34	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143222	10.1371/journal.pone.0143222	http://dx.doi.org/10.1371/journal.pone.0143222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571018	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700153
J	Liu, W; Xu, C; Zhao, HY; Xia, PP; Song, RL; Gu, JH; Liu, XZ; Bian, JC; Yuan, Y; Liu, ZP				Liu, Wei; Xu, Chao; Zhao, Hongyan; Xia, Pengpeng; Song, Ruilong; Gu, Jianhong; Liu, Xuezhong; Bian, Jianchun; Yuan, Yan; Liu, Zongping			Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway	PLOS ONE			English	Article							FAS LIGAND; BONE-RESORPTION; IN-VITRO; DEATH; RECEPTOR; SYSTEM; PATHOGENESIS	Osteoprotegerin (OPG) is known to inhibit differentiation and activation of osteoclasts (OCs) by functioning as a decoy receptor blocking interactions between RANK and RANKL. However, the exact role of OPG in the survival/apoptosis of OCs remains unclear. OPG caused increased rates of apoptosis of both OCs and osteoclast precursor cells (OPCs). The expression of Fas and activated caspase-8 was increased by both 20 ng/mL and 40 ng/mL of OPG, but was markedly decreased at 80 ng/mL. Interestingly, we noted that while levels of Fas ligand (FasL) increased with increasing doses of OPG, the soluble form of FasL in the supernatant decreased. The results of a co-immunoprecipitation assay suggested that the decrease of sFasL might be caused by the binding of OPG. This would block the inhibition of the apoptosis of OCs and OPCs. Furthermore, changes in expression levels of Bax/Bcl-2, cleaved-caspase-9, cleaved-caspased-3 and the translocation of cytochrome c, illustrated that OPG induced apoptosis of OCs and OPCs via the classic Fas/FasL apoptosis pathway, and was mediated by mitochondria. Altogether, our results demonstrate that OPG induces OCs and OPCs apoptosis partly by the Fas/FasL signaling pathway.	[Liu, Wei; Xu, Chao; Zhao, Hongyan; Xia, Pengpeng; Song, Ruilong; Gu, Jianhong; Liu, Xuezhong; Bian, Jianchun; Yuan, Yan; Liu, Zongping] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Wei; Xu, Chao; Zhao, Hongyan; Xia, Pengpeng; Song, Ruilong; Gu, Jianhong; Liu, Xuezhong; Bian, Jianchun; Yuan, Yan; Liu, Zongping] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University	Liu, ZP (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China.	liuzongping@yzu.edu.cn	Xia, pengpeng/AAR-1874-2020	Xia, pengpeng/0000-0002-3693-1312; YUAN, YAN/0000-0002-1658-5328	National Natural Science Foundation of China [31172373, 31372495, 31302154]; Project of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Innovation Project of Jiangsu Province [KYZZ_0369]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Innovation Project of Jiangsu Province	This work was supported by grants from the National Natural Science Foundation of China [grant numbers 31172373, 31372495, 31302154], the Project of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Graduate Innovation Project of Jiangsu Province (KYZZ_0369).	Ando Kosei, 2008, Curr Drug Discov Technol, V5, P263, DOI 10.2174/157016308785739857; Aubin JE, 2000, OSTEOPOROSIS INT, V11, P905, DOI 10.1007/s001980070028; Baud'huin M, 2013, CYTOKINE GROWTH F R; Chamoux E, 2008, J CELL PHYSIOL, V216, P536, DOI 10.1002/jcp.21430; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Frenkel B, 2010, J CELL PHYSIOL, V224, P305, DOI 10.1002/jcp.22159; Grcevic D, 2001, CROAT MED J, V42, P384; Greenfield EM, 1999, LIFE SCI, V65, P1087, DOI 10.1016/S0024-3205(99)00156-3; Grewal IS, 2009, ADV EXP MED BIOL, V647, P1, DOI 10.1007/978-0-387-89520-8_1; Gupta S, 2003, INT J ONCOL, V22, P15; Heath DJ, 2007, CANCER RES, V67, P202, DOI 10.1158/0008-5472.CAN-06-1287; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Kameda T, 1996, BIOCHEM BIOPH RES CO, V220, P515, DOI 10.1006/bbrc.1996.0436; Kanduc D, 2002, INT J ONCOL, V21, P165; Katavic V, 2003, J IMMUNOL, V170, P1540, DOI 10.4049/jimmunol.170.3.1540; Kostenuik PJ, 2005, CURR OPIN PHARMACOL, V5, P618, DOI 10.1016/j.coph.2005.06.005; Kovacic N, 2007, J IMMUNOL, V178, P3379, DOI 10.4049/jimmunol.178.6.3379; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Marie P, 2008, M S-MED SCI, V24, P105, DOI 10.1051/medsci/2008241105; Marusic A, 2012, ARTHRITIS RES THER, V14; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Park H, 2005, J IMMUNOL, V175, P7193, DOI 10.4049/jimmunol.175.11.7193; Robertson JD, 2000, J STRUCT BIOL, V129, P346, DOI 10.1006/jsbi.2000.4254; Roux S, 2005, BIOCHEM BIOPH RES CO, V333, P42, DOI 10.1016/j.bbrc.2005.05.092; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Seeman E, 2003, OSTEOPOROSIS INT, V14, pS2, DOI 10.1007/s00198-002-1340-9; Sharma K, 2000, PHARMACOL THERAPEUT, V88, P333, DOI 10.1016/S0163-7258(00)00096-6; Shinohara Masahiro, 2007, Curr Osteoporos Rep, V5, P67; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tat Steeve Kwan, 2009, Keio Journal of Medicine, V58, P29; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang L, 2015, CELL DEATH DIFFERENT; Ware CF, 2008, CYTOKINE GROWTH F R, V19, P183, DOI 10.1016/j.cytogfr.2008.05.001; Wu XJ, 2003, ENDOCRINOLOGY, V144, P5545, DOI 10.1210/en.2003-0296; Yuan Y, 2013, PLOS ONE, V8; Zhao HY, 2015, CYTOKINE, V71, P199, DOI 10.1016/j.cyto.2014.10.007	44	28	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142519	10.1371/journal.pone.0142519	http://dx.doi.org/10.1371/journal.pone.0142519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571489	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700047
J	Lopez-Mejias, R; Genre, F; Remuzgo-Martinez, S; Robustillo-Villarino, M; Garcia-Bermudez, M; Llorca, J; Corrales, A; Gonzalez-Juanatey, C; Ubilla, B; Miranda-Filloy, JA; Mijares, V; Pina, T; Blanco, R; Alegre-Sancho, JJ; Huaranga, MAR; Sanchez, MDM; Segura, BT; Ferraz-Amaro, I; Vicente, E; Carmona, FD; Castaneda, S; Martin, J; Gonzalez-Gay, MA				Lopez-Mejias, Raquel; Genre, Fernanda; Remuzgo-Martinez, Sara; Robustillo-Villarino, Montserrat; Garcia-Bermudez, Mercedes; Llorca, Javier; Corrales, Alfonso; Gonzalez-Juanatey, Carlos; Ubilla, Begona; Miranda-Filloy, Jose A.; Mijares, Veronica; Pina, Trinitario; Blanco, Ricardo; Alegre-Sancho, Juan J.; Ramirez Huaranga, Marco A.; Minguez Sanchez, Maria D.; Tejera Segura, Beatriz; Ferraz-Amaro, Ivan; Vicente, Esther; David Carmona, F.; Castaneda, Santos; Martin, Javier; Gonzalez-Gay, Miguel A.			Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR EVENTS; DISEASE; IL-33; SUSCEPTIBILITY; ASSOCIATION; PROGRESSION; POPULATION; ULTRASOUND; ST2	Objectives To determine whether the interleukin-33 (IL-33)-interleukin-1 receptor like 1 (IL-1RL1) signaling pathway is implicated in the risk of subclinical atherosclerosis in patients with rheumatoid arthritis (RA). Methods A total of 576 Spanish RA patients from Northern Spain were genotyped for 6 well-known IL33-IL1RL1 polymorphisms (IL33 rs3939286, IL33 rs7025417, IL33 rs7044343, IL1RL1 rs2058660, IL1RL1 rs2310173 and IL1RL1 rs13015714) by TaqMan genotyping assay. The presence of subclinical atherosclerosis was determined by the assessment of carotid intima-media thickness (cIMT) by carotid ultrasound (US). Results RA patients carrying the TT genotype of the IL33 rs3939286 polymorphism had lower cIMT values than those homozygous for the CC genotype (mean +/- standard deviation (SD): 0.71 +/- 0.14 mm versus 0.76 +/- 0.16 mm, respectively) while patients carrying the CT genotype had intermediate cIMT values (mean +/- SD: 0.73 +/- 0.17 mm). Moreover, RA patients carrying the mutant allele T of the IL33 rs3939286 polymorphism exhibited significantly lower cIMT values than those carrying the wild allele C (mean +/- SD: 0.72 +/- 0.16 mm versus 0.75 +/- 0.18 mm respectively; p = 0.04). The association of both genotype and allele frequencies of IL33 rs3939286 and cIMT levels remained statistically significant after adjustment for sex, age at the time of US study, follow-up and center (p = 0.006 and p = 0.0023, respectively), evidencing that the potential effect conferred by IL33 rs3939286 may be independent of confounder factors. No association with other IL33-IL1RL1 genetic variants was observed. Conclusions In conclusion, our results may suggest a potential protective effect of the IL33 rs3939286 allele T in the risk of subclinical atherosclerosis in patients with RA.	[Lopez-Mejias, Raquel; Genre, Fernanda; Remuzgo-Martinez, Sara; Corrales, Alfonso; Ubilla, Begona; Mijares, Veronica; Pina, Trinitario; Blanco, Ricardo; Gonzalez-Gay, Miguel A.] IDIVAL, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Santander, Spain; [Robustillo-Villarino, Montserrat; Alegre-Sancho, Juan J.] Hosp Univ Doctor Peset, Dept Rheumatol, Valencia, Spain; [Garcia-Bermudez, Mercedes; David Carmona, F.; Martin, Javier] CSIC, IPBLN, Granada, Spain; [Llorca, Javier] Univ Cantabria, Sch Med, Dept Epidemiol & Computat Biol, E-39005 Santander, Spain; [Llorca, Javier] IDIVAL, CIBERESP, Santander, Spain; [Gonzalez-Juanatey, Carlos] Hosp Lucus Augusti, Dept Cardiol, Lugo, Spain; [Miranda-Filloy, Jose A.] Hosp Lucus Augusti, Dept Rheumatol, Lugo, Spain; [Ramirez Huaranga, Marco A.; Minguez Sanchez, Maria D.] Hosp Gen Univ Ciudad Real, Dept Rheumatol, Ciudad Real, Spain; [Tejera Segura, Beatriz; Ferraz-Amaro, Ivan] Hosp Univ Canarias, Dept Rheumatol, Tenerife, Spain; [Vicente, Esther; Castaneda, Santos] IIS Princesa, Hosp Univ Princesa, Dept Rheumatol, Madrid, Spain; [Gonzalez-Gay, Miguel A.] Univ Witwatersrand, Fac Hlth Sci, Cardiovasc Pathophysiol & Genom Res Unit, Sch Physiol, Johannesburg, South Africa; [Gonzalez-Gay, Miguel A.] Clin Univ Hosp Santiago de Compostela, Div Rheumatol, Hlth Res Inst Santiago de Compostela IDIS, Santiago De Compostela, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Universidad de la Laguna; University of Witwatersrand; Complexo Hospitalario Universitario de Santiago de Compostela	Gonzalez-Gay, MA (corresponding author), IDIVAL, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Santander, Spain.	miguelaggay@hotmail.com	García-Bermúdez, Mercedes/E-7708-2013; Llorca, Javier/F-7371-2011; Martin, Javier/B-8141-2008; Ferraz-Amaro, Ivan/X-1489-2019; blanco, ricardo/AAA-1248-2020; Carmona, F. David/F-9953-2016; Martín, Javier/AAV-5209-2021; Martín, María/HDL-9512-2022	García-Bermúdez, Mercedes/0000-0002-2643-5956; Llorca, Javier/0000-0001-8569-861X; Martin, Javier/0000-0002-2202-0622; Ferraz-Amaro, Ivan/0000-0003-0197-5267; blanco, ricardo/0000-0003-2344-2285; Carmona, F. David/0000-0002-1427-7639; Alegre Sancho, Juan Jose/0000-0003-1641-0875; Pina Murcia, Trinitario/0000-0001-8097-7695	European Union FEDER funds; Fondo de Investigacion Sanitaria from 'Instituto de Salud Carlos III' (ISCIII, Health Ministry, Spain) [PI06/0024, PS09/00748, PI12/00060]; RETICS Programs from 'Instituto de Salud Carlos III' (ISCIII, Health Ministry, Spain) [RD12/0009 (RIER)]; European IMI BTCure Program; "Instituto Carlos III de Salud" at the Spanish Ministry of Health (Spain) [CD12/00425]; RETICS Program (RIER) [RD12/0009/0013]	European Union FEDER funds(European Commission); Fondo de Investigacion Sanitaria from 'Instituto de Salud Carlos III' (ISCIII, Health Ministry, Spain); RETICS Programs from 'Instituto de Salud Carlos III' (ISCIII, Health Ministry, Spain); European IMI BTCure Program; "Instituto Carlos III de Salud" at the Spanish Ministry of Health (Spain); RETICS Program (RIER)	This study was supported by European Union FEDER funds and "Fondo de Investigacion Sanitaria" (grants PI06/0024, PS09/00748 and PI12/00060) from 'Instituto de Salud Carlos III' (ISCIII, Health Ministry, Spain). It was also partially supported by RETICS Programs RD12/0009 (RIER) from 'Instituto de Salud Carlos III' (ISCIII, Health Ministry, Spain), and in part by grants from the European IMI BTCure Program. RLM is a recipient of a Sara Borrell postdoctoral fellowship from the "Instituto Carlos III de Salud" at the Spanish Ministry of Health (Spain) (CD12/00425). FG and BU are supported by funds from the RETICS Program (RIER) (RD12/0009/0013).	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Corrales A, 2013, ANN RHEUM DIS, V72, P1764, DOI 10.1136/annrheumdis-2013-203688; Dessein PH, 2007, J RHEUMATOL, V34, P943; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gonzalez-Juanatey C, 2006, ARTHRIT RHEUM-ARTHR, V55, P150, DOI 10.1002/art.21707; Gonzalez-Juanatey C, 2009, SEMIN ARTHRITIS RHEU, V38, P366, DOI 10.1016/j.semarthrit.2008.01.012; Guo L, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-109; Latiano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062144; Li C, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4554; Lopez-Mejias R, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4335; Lopez-Mejias R, 2012, ATHEROSCLEROSIS, V224, P426, DOI 10.1016/j.atherosclerosis.2012.06.008; Marquez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113476; Naredo E, 2011, RHEUMATOLOGY, V50, P1860, DOI 10.1093/rheumatology/ker206; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shen JY, 2015, SEMIN ARTHRITIS RHEU, V45, P18, DOI 10.1016/j.semarthrit.2015.02.001; Tu X, 2013, AM J HUM GENET, V93, P652, DOI 10.1016/j.ajhg.2013.08.009; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105	20	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143153	10.1371/journal.pone.0143153	http://dx.doi.org/10.1371/journal.pone.0143153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571131	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700145
J	Temprado, JJ; Vieluf, S; Bricot, N; Berton, E; Sleimen-Malkoun, R				Temprado, Jean-Jacques; Vieluf, Solveig; Bricot, Nicolas; Berton, Eric; Sleimen-Malkoun, Rita			Performing Isometric Force Control in Combination with a Cognitive Task: A Multidimensional Assessment	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; POSTURAL CONTROL; OLDER-ADULTS; AGE; VARIABILITY; REGULARITY; DYNAMICS; INTERFERENCE; MOVEMENTS; ATTENTION	Introduction We used a multidimensional approach to study isometric force control in single and dual-task conditions. Methods Multiple measures of performance, efficiency, variability, and structural interference were calculated at low and higher force levels under single (force maintenance) and dual-task (force maintenance and reaction time) conditions. Results Reaction time and signal-to-noise ratio were larger in the dual-task conditions. They were also greater for the higher force condition, while sample entropy was lower. Perturbation analyses revealed smaller relative amplitude of downward perturbations for the higher force level. Discussion Attentional effort and efficiency are positively related when force level increases, and inversely related to entropy. These relations were presumably mediated by attentional investment. Behavioral perturbations show that attentional resources and structural interference models are not mutually exclusive to account for dual-task situation. Overall, the present study highlights the interest of a multidimensional assessment of force control.	[Temprado, Jean-Jacques; Vieluf, Solveig; Bricot, Nicolas; Berton, Eric; Sleimen-Malkoun, Rita] Aix Marseille Univ, CNRS, Inst Sci Mouvement UMR 7287, Marseille, France; [Bricot, Nicolas] Coll Osteopath Provence, Marseille, France; [Sleimen-Malkoun, Rita] Aix Marseille Univ, Inst Neurosci Syst UMR S 1106, INSERM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Sleimen-Malkoun, R (corresponding author), Aix Marseille Univ, CNRS, Inst Sci Mouvement UMR 7287, Marseille, France.	rita.sleimen-malkoun@univ-amu.fr	Vieluf, Solveig/AAH-9111-2020	Vieluf, Solveig/0000-0002-5532-8690; Sleimen-Malkoun, Rita/0000-0002-3508-3403	Aix-Marseille University foundation	Aix-Marseille University foundation	This study is part of the Coord-Age project (JJT, PI; RSM co-I; SV, post-doc) that was funded by Aix-Marseille University foundation A*Midex, called "Emergence & Innovation, 2013" (http://amidex.univamu.fr/).	BALDISSERA F, 1982, NEUROSCI LETT, V34, P95, DOI 10.1016/0304-3940(82)90098-2; BALDISSERA F, 1991, EXP BRAIN RES, V83, P375; Christou EA, 2002, J APPL PHYSIOL, V93, P489, DOI 10.1152/japplphysiol.00335.2001; Dettmers C, 1996, NEUROREPORT, V7, P2103, DOI 10.1097/00001756-199609020-00008; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Doumas M, 2015, J GERONTOL B-PSYCHOL, V70, P377, DOI 10.1093/geronb/gbt105; Guillery E, 2013, COGNITIVE MOTOR INTE; Hiraga CY, 2009, BEHAV BRAIN RES, V205, P10, DOI 10.1016/j.bbr.2009.07.019; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Lindberg P, 2009, EXP BRAIN RES, V193, P213, DOI 10.1007/s00221-008-1613-4; Lorist MM, 2002, J PHYSIOL-LONDON, V545, P313, DOI 10.1113/jphysiol.2002.027938; McIsaac TL, 2015, EXP BRAIN RES, V233, P2607, DOI 10.1007/s00221-015-4333-6; Patel P, 2014, NEUROSCIENCE, V260, P140, DOI 10.1016/j.neuroscience.2013.12.016; Pellecchia GL, 2005, COGNITIVE SCI, V29, P531, DOI 10.1207/s15516709cog0000_12; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Sosnov JJ, 2006, EXP BRAIN RES, V174, P86, DOI 10.1007/s00221-006-0422-x; Stins JF, 2009, GAIT POSTURE, V30, P106, DOI 10.1016/j.gaitpost.2009.04.001; Temprado JJ, 1999, J EXP PSYCHOL HUMAN, V25, P1579, DOI 10.1037/0096-1523.25.6.1579; Temprado JJ, 2001, J EXP PSYCHOL HUMAN, V27, P1303, DOI 10.1037//0096-1523.27.6.1303; Vieluf S, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0153-7; Voelcker-Rehage C, 2007, J GERONTOL B-PSYCHOL, V62, pP141, DOI 10.1093/geronb/62.3.P141; Voelcker-Rehage C, 2006, AGING NEUROPSYCHOL C, V13, P366, DOI 10.1080/138255890969339; Yogev-Seligmann G, 2010, PHYS THER, V90, P177, DOI 10.2522/ptj.20090043; Zanone PG, 2001, HUM MOVEMENT SCI, V20, P765, DOI 10.1016/S0167-9457(01)00055-0; Zijdewind I, 2006, CLIN NEUROPHYSIOL, V117, P660, DOI 10.1016/j.clinph.2005.11.016	27	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142627	10.1371/journal.pone.0142627	http://dx.doi.org/10.1371/journal.pone.0142627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW5XP	26571036	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700052
J	Wang, C; Yang, SY; Lu, HS; You, HC; Ni, M; Shan, WJ; Lin, T; Gao, X; Chen, HF; Zhou, Q; Xue, YH				Wang, Cong; Yang, Shuiyuan; Lu, Huasong; You, Hongchao; Ni, Man; Shan, Wenjun; Lin, Ting; Gao, Xiang; Chen, Haifeng; Zhou, Qiang; Xue, Yuhua			A Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNP	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNA-POLYMERASE-II; POSITIVE TRANSCRIPTION; ELONGATION; COMPLEXES; INFECTION; TRANSACTIVATION; INHIBITION; HEXIM1; BRD4	The latent reservoirs of HIV represent a major impediment to eradication of HIV/AIDS. To overcome this problem, agents that can activate latent HIV proviruses have been actively sought after, as they can potentially be used in combination with the highly active antiretroviral therapy (HAART) to eliminate the latent reservoirs. Although several chemical compounds have been shown to activate latency, they are of limited use due to high toxicity and poor clinical outcomes. In an attempt to identify natural products as effective latency activators from traditional Chinese medicinal herbs that have long been widely used in human population, we have isolated procyanidin C-13,3',3 ''-tri-O-gallate (named as REJ-C1G3) from Polygonum cuspidatum Sieb. et Zucc., that can activate HIV in latently infected Jurkat T cells. REJ-C1G3 preferentially stimulates HIV transcription in a process that depends on the viral encoded Tat protein and acts synergistically with prostratin (an activator of the NF-kappa B pathway) or JQ1 (an inhibitor of Brd4) to activate HIV latency. Our mechanistic analyses further show that REJ-C1G3 accomplishes these tasks by inducing the release of P-TEFb, a host cofactor essential for Tat-activation of HIV transcription, from the cellular P-TEFb reservoir 7SK snRNP.	[Wang, Cong; Yang, Shuiyuan; Lu, Huasong; You, Hongchao; Ni, Man; Shan, Wenjun; Lin, Ting; Gao, Xiang; Chen, Haifeng; Zhou, Qiang; Xue, Yuhua] Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China; [Lu, Huasong; Zhou, Qiang] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Xiamen University; University of California System; University of California Berkeley	Xue, YH (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, Xiamen, Fujian, Peoples R China.	xueyuhua@xmu.edu.cn	Xiang, Gao/J-2240-2014	shan, wenjun/0000-0001-5983-8455	Public Health Service from the National Institutes of Health [R01AI041757, R01AI095057]; National Natural Science Foundation of China [81201276, 81202419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041757, R01AI095057] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by Public Health Service grants R01AI041757 and R01AI095057 from the National Institutes of Health to QZ and a grant from the National Natural Science Foundation of China (81201276) to YX and (81202419) to HC.	Bedimo Roger, 2008, Curr HIV/AIDS Rep, V5, P140, DOI 10.1007/s11904-008-0022-4; Callemien D, 2008, J AM SOC BREW CHEM, V66, P109, DOI 10.1094/ASBCJ-2008-0215-01; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Dulac C, 2005, J BIOL CHEM, V280, P30619, DOI 10.1074/jbc.M502471200; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Editorial Committee of Chinese Pharmacopoeia, CHINESE PHARMACOPOEI, P194; Han JH, 2012, IMMUNOPHARM IMMUNOT, V34, P191, DOI 10.3109/08923973.2011.590499; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; KASHIWADA Y, 1986, CHEM PHARM BULL, V34, P4083; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Lu HS, 2014, P NATL ACAD SCI USA, V111, pE15, DOI 10.1073/pnas.1318503111; Lu HS, 2013, CHEM REV, V113, P8567, DOI 10.1021/cr400120z; Marsden MD, 2009, J ANTIMICROB CHEMOTH, V63, P7, DOI 10.1093/jac/dkn455; Mohammadi P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004156; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Peng W, 2013, J ETHNOPHARMACOL, V148, P729, DOI 10.1016/j.jep.2013.05.007; Ping YH, 1999, J BIOL CHEM, V274, P7399, DOI 10.1074/jbc.274.11.7399; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Samaras K, 2009, JAIDS-J ACQ IMM DEF, V50, P499, DOI 10.1097/QAI.0b013e31819c291b; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Yik JHN, 2005, J BIOL CHEM, V280, P16368, DOI 10.1074/jbc.M500912200; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	35	13	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142739	10.1371/journal.pone.0142739	http://dx.doi.org/10.1371/journal.pone.0142739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569506	Green Submitted, gold, Green Published			2022-12-26	WOS:000365070700068
J	Yang, XH; Chen, S; Chen, XH; Yang, YF				Yang, Xiaohong; Chen, Shuang; Chen, Xuhai; Yang, Yufang			How Distance Affects Semantic Integration in Discourse: Evidence from Event-Related Potentials	PLOS ONE			English	Article							WORKING-MEMORY; BRAIN POTENTIALS; EYE-MOVEMENTS; PRAGMATIC ANOMALIES; NEURAL MECHANISMS; GLOBAL COHERENCE; N400; ERP; COMPREHENSION; SENTENCE	Event-related potentials were used to investigate whether semantic integration in discourse is influenced by the number of intervening sentences between the endpoints of integration. Readers read discourses in which the last sentence contained a critical word that was either congruent or incongruent with the information introduced in the first sentence. Furthermore, for the short discourses, the first and last sentence were intervened by only one sentence while for the long discourses, they were intervened by three sentences. We found that the incongruent words elicited an N400 effect for both the short and long discourses. However, a P600 effect was only observed for the long discourses, but not for the short ones. These results suggest that although readers can successfully integrate upcoming words into the existing discourse representation, the effort required for this integration process is modulated by the number of intervening sentences. Thus, discourse distance as measured by the number of intervening sentences should be taken as an important factor for semantic integration in discourse.	[Yang, Xiaohong; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Yang, Xiaohong; Yang, Yufang] Jiangsu Normal Univ, Jiangsu Collaborat Innovat Ctr Language Abil, Xuzhou, Peoples R China; [Chen, Shuang] Zhejiang Normal Univ, Dept Psychol, Jinhua, Peoples R China; [Chen, Xuhai] Shannxi Normal Univ, Sch Psychol, Xian, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Jiangsu Normal University; Zhejiang Normal University; Shaanxi Normal University	Yang, XH (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	yangxh@psych.ac.cn; yangyf@psych.ac.cn			Natural National Science Foundation of China [31400968, 61433018]	Natural National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Natural National Science Foundation of China (website: http://www.nsfc.gov.cn/publish/portal1/; grant numbers: 31400968 and 61433018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT JE, 1993, J EXP PSYCHOL LEARN, V19, P1061, DOI 10.1037/0278-7393.19.5.1061; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Burkhardt P, 2007, NEUROREPORT, V18, P1851, DOI 10.1097/WNR.0b013e3282f1a999; Burkhardt P, 2006, BRAIN LANG, V98, P159, DOI 10.1016/j.bandl.2006.04.005; Camblin CC, 2007, J MEM LANG, V56, P103, DOI 10.1016/j.jml.2006.07.005; Chinese Linguistic Data Consortium, 2003, CLDCLAC200301 TSINGH; Colin C, 2004, CLIN NEUROPHYSIOL, V115, P1989, DOI 10.1016/j.clinph.2004.03.027; Colin C, 2002, CLIN NEUROPHYSIOL, V113, P507, DOI 10.1016/S1388-2457(02)00028-7; Cook AE, 2014, MEM COGNITION, V42, P1171, DOI 10.3758/s13421-014-0415-0; Cutler A., 1999, NEUROCOGNITION LANGU, P123, DOI DOI 10.1093/ACPROF:OSO/9780198507932.003.0005; D'Arcy RCN, 2005, COGNITIVE BRAIN RES, V22, P177, DOI 10.1016/j.cogbrainres.2004.08.007; DUFFY SA, 1990, LANG SPEECH, V33, P103, DOI 10.1177/002383099003300201; Eckstein K, 2006, J COGNITIVE NEUROSCI, V18, P1696, DOI 10.1162/jocn.2006.18.10.1696; Ferretti TR, 2013, DISCOURSE PROCESS, V50, P165, DOI 10.1080/0163853X.2013.766123; Filik R, 2008, PSYCHOPHYSIOLOGY, V45, P554, DOI 10.1111/j.1469-8986.2008.00656.x; Filik R, 2008, COGNITION, V106, P1038, DOI 10.1016/j.cognition.2007.04.006; Fodor J. A, 1983, MODULARITY MIND; Franzen PL, 2009, BIOL PSYCHOL, V80, P300, DOI 10.1016/j.biopsycho.2008.10.010; Friederici AD, 2000, J MEM LANG, V43, P476, DOI 10.1006/jmla.2000.2709; Frisch S, 2002, COGNITION, V85, pB83, DOI 10.1016/S0010-0277(02)00126-9; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Hagoort P, 2007, PHILOS T R SOC B, V362, P801, DOI 10.1098/rstb.2007.2089; Hald LA, 2007, BRAIN RES, V1146, P210, DOI 10.1016/j.brainres.2007.02.054; Hammer A, 2008, BRAIN RES, V1230, P177, DOI 10.1016/j.brainres.2008.07.004; Jiang XM, 2009, NEUROPSYCHOLOGIA, V47, P1282, DOI 10.1016/j.neuropsychologia.2009.01.013; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; KINTSCH W, 1988, PSYCHOL REV, V95, P163, DOI 10.1037/0033-295X.95.2.163; Klin CM, 1999, J MEM LANG, V40, P593, DOI 10.1006/jmla.1998.2628; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; MYERS JL, 1994, J EXP PSYCHOL LEARN, V20, P876, DOI 10.1037/0278-7393.20.4.876; Myers JL, 1998, DISCOURSE PROCESS, V26, P131, DOI 10.1080/01638539809545042; Myers JL, 2000, DISCOURSE PROCESS, V29, P179, DOI 10.1207/S15326950dp2903_1; Neumann MF, 2008, BRAIN RES, V1239, P181, DOI 10.1016/j.brainres.2008.08.039; Nieuwand MS, 2005, COGNITIVE BRAIN RES, V24, P691, DOI 10.1016/j.cogbrainres.2005.04.003; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; OBRIEN EJ, 1990, J EXP PSYCHOL LEARN, V16, P241, DOI 10.1037/0278-7393.16.2.241; Otten M, 2007, BRAIN RES, V1153, P166, DOI 10.1016/j.brainres.2007.03.058; Otten M, 2009, BRAIN RES, V1291, P92, DOI 10.1016/j.brainres.2009.07.042; Salisbury DF, 2004, BRAIN COGNITION, V55, P396, DOI 10.1016/j.bandc.2004.02.057; Sanford AJ, 2006, DISCOURSE PROCESS, V42, P99, DOI 10.1207/s15326950dp4202_1; Sanford AJ, 2011, J COGNITIVE NEUROSCI, V23, P514, DOI 10.1162/jocn.2009.21370; Stekelenburg JJ, 2012, NEUROPSYCHOLOGIA, V50, P1425, DOI 10.1016/j.neuropsychologia.2012.02.027; Strijkers K, 2011, J MEM LANG, V65, P345, DOI 10.1016/j.jml.2011.06.002; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; van de Meerendonk N, 2010, J COGNITIVE NEUROSCI, V22, P67, DOI 10.1162/jocn.2008.21170; van den Broek P, 2005, DISCOURSE PROCESS, V39, P299; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; van Schie HT, 2005, COGN NEUROPSYCHOL, V22, P364, DOI 10.1080/02643290442000338; Wang L, 2011, NEUROPSYCHOLOGIA, V49, P813, DOI 10.1016/j.neuropsychologia.2010.12.035; Wang L, 2009, BRAIN RES, V1282, P50, DOI 10.1016/j.brainres.2009.05.069; Warren T, 2008, J EXP PSYCHOL LEARN, V34, P1001, DOI 10.1037/0278-7393.34.4.1001; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; Yang XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078970; Yang XH, 2014, MEM COGNITION, V42, P325, DOI 10.3758/s13421-013-0363-0	58	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142967	10.1371/journal.pone.0142967	http://dx.doi.org/10.1371/journal.pone.0142967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW5XP	26569606	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700107
J	Yuan, QH; Furukawa, T; Tashiro, T; Okita, K; Jin, ZH; Aung, W; Sugyo, A; Nagatsu, K; Endo, H; Tsuji, AB; Zhang, MR; Masuko, T; Inoue, M; Fujibayashi, Y; Saga, T				Yuan, Qinghua; Furukawa, Takako; Tashiro, Takahiro; Okita, Kouki; Jin, Zhao-Hui; Aung, Winn; Sugyo, Aya; Nagatsu, Kotaro; Endo, Hiroko; Tsuji, Atsushi B.; Zhang, Ming-Rong; Masuko, Takashi; Inoue, Masahiro; Fujibayashi, Yasuhisa; Saga, Tsuneo			Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical Role	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; COLORECTAL-CANCER; TYROSINE KINASE; MONOCLONAL-ANTIBODIES; BREAST-CANCER; ERBB RECEPTORS; LUNG-CANCER; CELL; RESISTANCE; EXPRESSION	HER3 is overexpressed in various carcinomas including colorectal cancer (CRC), which is associated with poor prognosis, and is involved in the development of therapy resistance. Thus, an in vivo imaging technique is needed to evaluate the expression of HER3, an important therapeutic and diagnostic target. Here, we report successful HER3 PET imaging using a newly generated anti-human HER3 monoclonal antibody, Mab# 58, and a mouse model of a HER3-overexpressing xenograft tumor. Furthermore, we assessed the role of HER3 signaling in CRC cancer tissue-originated spheroid (CTOS) and applied HER3 imaging to detect endogenous HER3 in CTOS-derived xenografts. Cell binding assays of Zr-89-labeled Mab# 58 using the HER3-overexpressing cell line HER3/RH7777 demonstrated that [Zr-89] Mab# 58 specifically bound to HER3/RH7777 cells (K-d = 2.7 nM). In vivo biodistribution study in mice bearing HER3/RH7777 and its parent cell xenografts showed that tumor accumulation of [Zr-89] Mab# 58 in HER3/RH7777 xenografts was significantly higher than that in the control from day 1 to day 4, tending to increase from day 1 to day 4 and reaching 12.2 +/- 4.5% ID/g. Radioactivity in other tissues, including the control xenograft, decreased or remained unchanged from day 1 to day 6. Positron emission tomography (PET) in the same model enabled clear visualization of HER3/RH7777 xenografts but not of RH7777 xenografts. CTOS growth assay and signaling assay revealed that CRC CTOS were dependent on HER3 signaling for their growth. In PET studies of mice bearing a CRC CTOS xenograft, the tumor was clearly visualized with [Zr-89] Mab# 58 but not with the Zr-89-labeled control antibody. Thus, tumor expression of HER3 was successfully visualized by PET with Zr-89-labeled anti-HER3 antibody in CTOS xenograft-bearing mice, a model that retains the properties of the patient tumor. Non-invasive targeting of HER3 by antibodies is feasible, and it is expected to be useful for cancer diagnosis and treatment.	[Yuan, Qinghua; Furukawa, Takako; Jin, Zhao-Hui; Aung, Winn; Sugyo, Aya; Nagatsu, Kotaro; Tsuji, Atsushi B.; Zhang, Ming-Rong; Fujibayashi, Yasuhisa; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan; [Tashiro, Takahiro; Endo, Hiroko; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan; [Okita, Kouki; Masuko, Takashi] Kinki Univ, Sch Pharm, Cell Biol Lab, Dept Pharmaceut Sci, Higashi Osaka, Japan; [Okita, Kouki] Carna Biosci Inc, Kobe, Hyogo, Japan	National Institutes for Quantum Science & Technology; Osaka Medical Center for Cancer & Cardiovascular Diseases; Kindai University (Kinki University)	Furukawa, T (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	tfuru@nirs.go.jp	TSUJI, Atsushi B/I-9922-2019	TSUJI, Atsushi B/0000-0003-2726-288X	Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institute of Radiological Sciences; Carna Bioscience Inc.; Grants-in-Aid for Scientific Research [25461937] Funding Source: KAKEN	Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institute of Radiological Sciences; Carna Bioscience Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Advanced Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to YF and MI), and the National Institute of Radiological Sciences (to TS and MRZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder, Carna Bioscience Inc., provided support in the form of salaries for an author KO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Beji A, 2012, CLIN CANCER RES, V18, P956, DOI 10.1158/1078-0432.CCR-11-1186; Cai W, 2008, EUR J NUCL MED MOL I, V35, P186, DOI 10.1007/s00259-007-0560-9; Corcoran EB, 2014, MED RES REV, V34, P596, DOI 10.1002/med.21299; Cushman SM, 2015, CLIN CANCER RES, V21, P1078, DOI 10.1158/1078-0432.CCR-14-2313; Doran MG, 2014, J NUCL MED, V55, P2045, DOI 10.2967/jnumed.114.145185; Endo H, 2013, J THORAC ONCOL, V8, P131, DOI 10.1097/JTO.0b013e3182779ccf; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Furukawa T, 2014, NUCL MED BIOL, V41, P653, DOI 10.1016/j.nucmedbio.2014.05.139; Gullick WJ, 1996, CANCER SURV, V27, P339; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Kawakami H, 2014, ONCOTARGET, V5, P11847, DOI 10.18632/oncotarget.2663; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Kuo F, 2014, MOL PHARMACEUT, V11, P3996, DOI 10.1021/mp500056d; Laverman P, 2015, J NUCL MED, V56, P778, DOI 10.2967/jnumed.114.152959; Ledel F, 2014, EUR J CANCER, V50, P656, DOI 10.1016/j.ejca.2013.11.008; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; LoRusso P, 2013, CLIN CANCER RES, V19, P3078, DOI 10.1158/1078-0432.CCR-12-3051; Ma J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-105; Masuko T, 2011, CANCER SCI, V102, P25, DOI 10.1111/j.1349-7006.2010.01741.x; Normanno N, 2005, CURR DRUG TARGETS, V6, P243, DOI 10.2174/1389450053765879; Ohno Y, 2008, CANCER SCI, V99, P1000, DOI 10.1111/j.1349-7006.2008.00770.x; Okuyama H, 2013, J UROLOGY, V190, P302, DOI 10.1016/j.juro.2012.12.106; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Orlova A, 2014, EUR J NUCL MED MOL I, V41, P1450, DOI 10.1007/s00259-014-2733-7; Perk LR, 2010, EUR J NUCL MED MOL I, V37, P250, DOI 10.1007/s00259-009-1263-1; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sharp TL, 2011, 2011 WORLD MOL IM C; Sierke SL, 1997, BIOCHEM J, V322, P757, DOI 10.1042/bj3220757; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Sugyo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061230; Tanner B, 2006, J CLIN ONCOL, V24, P4317, DOI 10.1200/JCO.2005.04.8397; van der Horst EH, 2005, INT J CANCER, V115, P519, DOI 10.1002/ijc.20867; van Scheltinga AGTT, 2014, MABS-AUSTIN, V6, P1051, DOI 10.4161/mabs.29097; Wakui H, 2014, CANCER CHEMOTH PHARM, V73, P511, DOI 10.1007/s00280-014-2375-2; Wehrenberg-Klee E, 2014, J NUCL MED, V55; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143076	10.1371/journal.pone.0143076	http://dx.doi.org/10.1371/journal.pone.0143076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571416	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700129
J	Poddar, R; Rajagopal, S; Shuttleworth, CW; Paul, S				Poddar, Ranjana; Rajagopal, Sathyanarayanan; Shuttleworth, C. William; Paul, Surojit			Zn2+-dependent Activation of the Trk Signaling Pathway Induces Phosphorylation of the Brain-enriched Tyrosine Phosphatase STEP MOLECULAR BASIS FOR ZN2+-INDUCED ERK MAPK ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-SENSING RECEPTOR; PROTEIN-KINASE-C; NEUROTROPHIC FACTOR; EXTRACELLULAR ZINC; NEURONAL INJURY; PTP-SL; BDNF; RAT; FAMILY; DEATH	Excessive release of Zn2+ in the brain is implicated in the progression of acute brain injuries. Although several signaling cascades have been reported to be involved in Zn2+-induced neurotoxicity, a potential contribution of tyrosine phosphatases in this process has not been well explored. Here we show that exposure to high concentrations of Zn2+ led to a progressive increase in phosphorylation of the striatal-enriched phosphatase (STEP), a component of the excitotoxic-signaling pathway that plays a role in neuroprotection. Zn2+-mediated phosphorylation of STEP61 at multiple sites (hyperphosphorylation) was induced by the up-regulation of brain-derived neurotropic factor (BDNF), tropomyosin receptor kinase (Trk) signaling, and activation of cAMP-dependent PKA (protein kinase A). Mutational studies further show that differential phosphorylation of STEP61 at the PKA sites, Ser-160 and Ser-221 regulates the affinity of STEP61 toward its substrates. Consistent with these findings we also show that BDNF/Trk/PKA mediated signaling is required for Zn2+-induced phosphorylation of extracellular regulated kinase 2 (ERK2), a substrate of STEP that is involved in Zn2+-dependent neurotoxicity. The strong correlation between the temporal profile of STEP61 hyperphosphorylation and ERK2 phosphorylation indicates that loss of function of STEP61 through phosphorylation is necessary for maintaining sustained ERK2 phosphorylation. This interpretation is further supported by the findings that deletion of the STEP gene led to a rapid and sustained increase in ERK2 phosphorylation within minutes of exposure to Zn2+. The study provides further insight into the mechanisms of regulation of STEP61 and also offers a molecular basis for the Zn2+-induced sustained activation of ERK2.	[Poddar, Ranjana; Rajagopal, Sathyanarayanan; Paul, Surojit] Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; [Shuttleworth, C. William] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Paul, S (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurol, 1 Univ New Mexico, Albuquerque, NM 87131 USA.	spaul@salud.unm.edu			NINDS, National Institutes of Health [R01 NS059962, NS083914, NS051288]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059962, R01NS051288, R01NS083914] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant R01 NS059962 (to S. P.), NS083914 (to R. P.), and NS051288 (to C. W. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Besser L, 2009, J NEUROSCI, V29, P2890, DOI 10.1523/JNEUROSCI.5093-08.2009; Binder DK, 1999, J NEUROSCI, V19, P1424; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Bult A, 1997, EUR J CELL BIOL, V72, P337; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Colombo E, 2012, J EXP MED, V209, P521, DOI 10.1084/jem.20110698; Corona C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.73; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; Deb I, 2013, J NEUROSCI, V33, P17814, DOI 10.1523/JNEUROSCI.2346-12.2013; Franco JL, 2008, BEHAV BRAIN RES, V188, P316, DOI 10.1016/j.bbr.2007.11.012; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; FREUND WD, 1994, BRAIN RES, V654, P257, DOI 10.1016/0006-8993(94)90487-1; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Gupta VK, 2013, INT J MOL SCI, V14, P10122, DOI 10.3390/ijms140510122; He K, 2010, J NEUROCHEM, V114, P452, DOI 10.1111/j.1471-4159.2010.06762.x; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Huang EP, 1997, P NATL ACAD SCI USA, V94, P13386, DOI 10.1073/pnas.94.25.13386; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Hwang JJ, 2005, J BIOL CHEM, V280, P11995, DOI 10.1074/jbc.M403172200; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Kerchner G. A., 2000, J PHYSL; Kim HJ, 2003, NEUROBIOL DIS, V14, P110, DOI 10.1016/S0969-9961(03)00103-7; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Koyama R, 2005, NEUROSCIENTIST, V11, P282, DOI 10.1177/1073858405278266; Lenz G, 2005, J BIOL CHEM, V280, P38121, DOI 10.1074/jbc.C500363200; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; Manzerra P, 2001, P NATL ACAD SCI USA, V98, P11055, DOI 10.1073/pnas.191353598; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; Martinez-Galan JR, 2003, BRAIN RES, V963, P156, DOI 10.1016/S0006-8993(02)03964-1; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Morris DR, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/785647; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; MURAKAMI K, 1987, J BIOL CHEM, V262, P13902; Noh KM, 1999, J NEUROCHEM, V72, P1609, DOI 10.1046/j.1471-4159.1999.721609.x; Nowak G, 2003, POL J PHARMACOL, V55, P1143; Nowak G, 2004, EUR J PHARMACOL, V492, P57, DOI 10.1016/j.ejphar.2004.03.038; Park JA, 2000, J NEUROSCI, V20, P9096; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Pochwat B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/591563; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Scharfman HE, 1999, J NEUROSCI, V19, P5619; Scharfman HE, 1997, J NEUROPHYSIOL, V78, P1082, DOI 10.1152/jn.1997.78.2.1082; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; SHIRAISHI K, 1993, NEUROL RES, V15, P113; Shuttleworth CW, 2011, TRENDS PHARMACOL SCI, V32, P480, DOI 10.1016/j.tips.2011.04.001; SLOVITER RS, 1985, BRAIN RES, V330, P150, DOI 10.1016/0006-8993(85)90017-4; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; TAPLEY P, 1992, ONCOGENE, V7, P371; Tokuoka H, 2000, J CELL SCI, V113, P1059; Venkitaramani DV, 2009, SYNAPSE, V63, P69, DOI 10.1002/syn.20608; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471	58	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					813	825		10.1074/jbc.M115.663468	http://dx.doi.org/10.1074/jbc.M115.663468			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26574547	Green Published, hybrid			2022-12-26	WOS:000367830500028
J	Yu-Kemp, HC; Brieher, WM				Yu-Kemp, Hui-Chia; Brieher, William M.			Collapsin Response Mediator Protein-1 Regulates Arp2/3-dependent Actin Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE COLLAPSE; ARP2/3 COMPLEX; LISTERIA-MONOCYTOGENES; FILAMENT NUCLEATION; RHO-KINASE; MOTILITY; PHOSPHORYLATION; FAMILY; CYTOSKELETON; SURFACE	Listeria monocytogenes is a bacterial parasite that uses host proteins to assemble an Arp2/3-dependent actin comet tail to power its movement through the host cell. Initiation of comet tail assembly is more efficient in cytosol than it is under defined conditions, indicating that unknown factors contribute to the reaction. We therefore fractionated cytosol and identified CRMP-1 as a factor that facilitates Arp2/3-dependent Listeria actin cloud formation in the presence of Arp2/3 and actin alone. It also scored as an important factor for Listeria actin comet tail formation in brain cytosol. CRMP-1 does not nucleate actin assembly on its own, nor does it directly activate the Arp2/3 complex. Rather, CRMP-1 scored as an auxiliary factor that promoted the ability of Listeria ActA protein to activate the Arp2/3 complex to trigger actin assembly. CRMP-1 is one member of a family of five related proteins that modulate cell motility in response to extracellular signals. Our results demonstrate an important role for CRMP-1 in Listeria actin comet tail formation and open the possibility that CRMP-1 controls cell motility by modulating Arp2/3 activation.	[Yu-Kemp, Hui-Chia; Brieher, William M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign	Brieher, WM (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61820 USA.	wbrieher@illinois.edu		Brieher, William/0000-0002-3168-6688	National Institutes of Health [R01-GM106106-01]; American Heart Association [0930282G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM106106-01 (to W. M. B.) and by American Heart Association Scientist Development Grant 0930282G (to W. M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Alabed YZ, 2007, J NEUROSCI, V27, P1702, DOI 10.1523/JNEUROSCI.5055-06.2007; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; BRYAN J, 1985, J CELL BIOL, V101, P1236, DOI 10.1083/jcb.101.4.1236; Buel GR, 2010, J CELL BIOCHEM, V111, P20, DOI 10.1002/jcb.22659; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Hotta A, 2005, MOL BIOL CELL, V16, P32, DOI 10.1091/mbc.E04-08-0679; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Khazaei MR, 2014, J BIOL CHEM, V289, P30133, DOI 10.1074/jbc.M114.570440; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; KOCKS C, 1995, MOL MICROBIOL, V18, P413, DOI 10.1111/j.1365-2958.1995.mmi_18030413.x; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Ponnusamy R, 2013, J NEUROCHEM, V125, P855, DOI 10.1111/jnc.12188; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; SHIZUTA Y, 1976, J BIOL CHEM, V251, P6562; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Tone SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014345; Wagner AR, 2013, CURR BIOL, V23, P1990, DOI 10.1016/j.cub.2013.08.029; Wang LH, 1996, J NEUROSCI, V16, P6197; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Welch MD, 1998, METHOD ENZYMOL, V298, P52, DOI 10.1016/S0076-6879(98)98008-9; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	45	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					658	664		10.1074/jbc.C115.689265	http://dx.doi.org/10.1074/jbc.C115.689265			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26598519	hybrid, Green Published			2022-12-26	WOS:000367830500014
J	Leung-Theung-Long, S; Gouanvic, M; Coupet, CA; Ray, A; Tupin, E; Silvestre, N; Marchand, JB; Schmitt, D; Hoffmann, C; Klein, M; Seegren, P; Huaman, MC; Cristillo, AD; Inchauspe, G				Leung-Theung-Long, Stephane; Gouanvic, Marie; Coupet, Charles-Antoine; Ray, Aurelie; Tupin, Emmanuel; Silvestre, Nathalie; Marchand, Jean-Baptiste; Schmitt, Doris; Hoffmann, Chantal; Klein, Murielle; Seegren, Philip; Huaman, Maria C.; Cristillo, Anthony D.; Inchauspe, Genevieve			A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates	PLOS ONE			English	Article							CD8(+) T-CELLS; OF-THE-ART; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE EFFICACY; VIRUS ANKARA; CYNOMOLGUS MACAQUES; RHESUS MACAQUES; IN-VIVO; INFECTION; BCG	Bacille Calmette-Guerin (BCG) vaccination of new born babies can protect children against tuberculosis (TB), but fails to protect adults consistently against pulmonary TB underlying the urgent need to develop novel TB vaccines. Majority of first generation TB vaccine candidates have relied on a very limited number of antigens typically belonging to the active phase of infection. We have designed a multi-antigenic and multiphasic vaccine, based on the Modified Vaccinia Ankara virus (MVA). Up to fourteen antigens representative of the three phases of TB infection (active, latent and resuscitation) were inserted into MVA. Using three different strains of mouse (BALB/c, C57BL/6 and C3H/HeN), we show that a single vaccination results in induction of both CD4 and CD8 T cells, displaying capacity to produce multiple cytokines together with cytolytic activity targeting a large array of epitopes. As expected, dominance of responses was linked to the mouse haplotype although for a given haplotype, responses specific of at least one antigen per phase could always be detected. Vaccination of non-human primates with the 14 antigens MVA-TB candidate resulted in broad and potent cellular-based immunogenicity. The remarkable plasticity of MVA opens the road to development of a novel class of highly complex recombinant TB vaccines to be evaluated in both prophylactic and therapeutic settings.	[Leung-Theung-Long, Stephane; Gouanvic, Marie; Coupet, Charles-Antoine; Ray, Aurelie; Tupin, Emmanuel; Inchauspe, Genevieve] Transgene SA, Dept Infect Dis, Lyon, France; [Silvestre, Nathalie; Marchand, Jean-Baptiste; Schmitt, Doris; Hoffmann, Chantal; Klein, Murielle] Transgene SA, Dept Smart Virus Lab, Illkirch Graffenstaden, France; [Seegren, Philip; Huaman, Maria C.; Cristillo, Anthony D.] Adv BioSci Labs Inc, Rockville, MD USA	Transgene SA; Transgene SA	Leung-Theung-Long, S (corresponding author), Transgene SA, Dept Infect Dis, Lyon, France.	leung_theung_long@transgene.fr		LEUNG-THEUNG-LONG, Stephane/0000-0001-5590-9666; Seegren, Philip/0000-0002-7153-4670	National Institute of Allergy and Infectious Diseases [R01-AI098911]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098911] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported in part by Award Number R01-AI098911 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. SL, MG, CC, AR, ET, NS, JM, DS, CH, MK and GI are paid employees of Transgene. PS, MCH and ADC are paid employees of Advanced BioScience Laboratories, Inc. Transgene has supported all in vitro experiments and mouse studies. Advanced BioScience Laboratories, Inc. has supported primate studies. The funders provided support in the form of salaries for authors [Transgene: SL, MG, CC, AR, ET, NS, JM, DS, CH, MK, GI; Advanced BioScience Laboratories, Inc.: PS, MCH, ADC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Baldwin SL, 2014, CLIN VACCINE IMMUNOL, V21, P1309, DOI 10.1128/CVI.00372-14; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Boukhebza H, 2012, HUM VACC IMMUNOTHER, V8, P1746, DOI 10.4161/hv.21689; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; COCHRAN MA, 1985, J VIROL, V54, P30, DOI 10.1128/JVI.54.1.30-37.1985; Coler RN, 2013, J INFECT DIS, V207, P1242, DOI 10.1093/infdis/jis425; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cruz A, 2015, VACCINE, V33, P85, DOI 10.1016/j.vaccine.2014.11.013; da Costa C, 2015, INT J INFECT DIS, V32, P5, DOI 10.1016/j.ijid.2014.11.026; de Barra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115161; Derrick SC, 2013, VACCINE, V31, P4641, DOI 10.1016/j.vaccine.2013.07.032; Foulds KE, 2012, CYTOM PART A, V81A, P360, DOI 10.1002/cyto.a.22008; Fournillier A, 2007, VACCINE, V25, P7339, DOI 10.1016/j.vaccine.2007.08.020; Gilbert SC, 2013, VACCINE, V31, P4241, DOI 10.1016/j.vaccine.2013.03.020; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Gupta RK, 2010, MICROBIOL-SGM, V156, P2714, DOI 10.1099/mic.0.037622-0; Hawn TR, 2014, MICROBIOL MOL BIOL R, V78, P650, DOI 10.1128/MMBR.00021-14; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Kolibab K, 2010, CLIN VACCINE IMMUNOL, V17, P793, DOI 10.1128/CVI.00006-10; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Malkevitch NV, 2006, VIROLOGY, V353, P83, DOI 10.1016/j.virol.2006.05.012; Martin P, 2004, J MED VIROL, V74, P397, DOI 10.1002/jmv.20189; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Pitt JM, 2013, MICROB PATHOGENESIS, V58, P2, DOI 10.1016/j.micpath.2012.12.002; Remy-Ziller C, 2014, CLIN VACCINE IMMUNOL, V21, P147, DOI 10.1128/CVI.00678-13; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; Russell-Goldman E, 2008, INFECT IMMUN, V76, P4269, DOI 10.1128/IAI.01735-07; Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X; Schiroli C, 2015, INFECTION, V10, P10; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Smaill F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006843; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Verwaerde C, 2014, VACCINE, V32, P6240, DOI 10.1016/j.vaccine.2014.09.024; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WHO, 2014, GLOBAL TUBERCULOSIS; Woodworth JS, 2008, J IMMUNOL, V181, P8595, DOI 10.4049/jimmunol.181.12.8595; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09	50	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143552	10.1371/journal.pone.0143552	http://dx.doi.org/10.1371/journal.pone.0143552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599077	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600082
J	Liu, XQ; Thungrat, K; Boothe, DM				Liu, Xiaoqiang; Thungrat, Kamoltip; Boothe, Dawn M.			Multilocus Sequence Typing and Virulence Profiles in Uropathogenic Escherichia coli Isolated from Cats in the United States	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ANTIMICROBIAL RESISTANCE; STRAINS; GENES; DOGS; IDENTIFICATION; GENOTYPES; HOST; DETERMINANTS; BACTEREMIA	The population structure, virulence, and antimicrobial resistance of uropathogenic E. coli (UPEC) from cats are rarely characterized. The aim of this study was to compare and characterize the UPEC isolated from cats in four geographic regions of USA in terms of their multilocus sequence typing (MLST), virulence profiles, clinical signs, antimicrobial resistance and phylogenetic grouping. The results showed that a total of 74 E. coli isolates were typed to 40 sequence types with 10 being novel. The most frequent phylogenetic group was B2 (n = 57). The most frequent sequence types were ST73 (n = 12) and ST83 (n = 6), ST73 was represented by four multidrug resistant (MDR) and eight non-multidrug resistant (SDR) isolates, and ST83 were significantly more likely to exhibit no drug resistant (NDR) isolates carrying the highest number of virulence genes. Additionally, MDR isolates were more diverse, and followed by SDR and NDR isolates in regards to the distribution of the STs. afa/draBC was the most prevalent among the 29 virulence-associated genes. Linking virulence profile and antimicrobial resistance, the majority of virulence-associated genes tested were more prevalent in NDR isolates, and followed by SDR and MDR isolates. Twenty (50%) MLST types in this study have previously been associated with human isolates, suggesting that these STs are potentially zoonotic. Our data enhanced the understanding of E. coli population structure and virulence association from cats. The diverse and various combinations of virulence-associated genes implied that the infection control may be challenging.	[Liu, Xiaoqiang] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Thungrat, Kamoltip; Boothe, Dawn M.] Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA	Northwest A&F University - China; Auburn University System; Auburn University	Liu, XQ (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	liuxiaoqiang142@163.com			Fundamental Research Funds for the Central Universities [QN2013029]; National Science Foundation of Shaanxi province [2014JM3071]; Morris Animal Foundation [D07-MS006]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation of Shaanxi province; Morris Animal Foundation	This study was supported by the Fundamental Research Funds for the Central Universities (no. QN2013029), National Science Foundation of Shaanxi province (no. 2014JM3071), and partially supported by grant D07-MS006 from Morris Animal Foundation.	Aly SA, 2012, CAN J MICROBIOL, V58, P1288, DOI 10.1139/w2012-105; Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Boerlin P, 2005, APPL ENVIRON MICROB, V71, P6753, DOI 10.1128/AEM.71.11.6753-6761.2005; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; CLSI, 2013, VET01A4 CLSI; Cooke NM, 2010, J CLIN MICROBIOL, V48, P1099, DOI 10.1128/JCM.02017-09; Feria C, 2001, FEMS MICROBIOL LETT, V202, P205, DOI 10.1016/S0378-1097(01)00310-X; Freitag T, 2005, VET MICROBIOL, V106, P79, DOI 10.1016/j.vetmic.2004.11.014; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jaureguy F, 2007, CLIN MICROBIOL INFEC, V13, P854, DOI 10.1111/j.1469-0691.2007.01775.x; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2008, J CLIN MICROBIOL, V46, P417, DOI 10.1128/JCM.00674-07; Johnson JR, 2006, CLIN INFECT DIS, V43, pE101, DOI 10.1086/508541; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 1998, J INFECT DIS, V177, P1120, DOI 10.1086/517409; Johnson JR, 2003, J CLIN MICROBIOL, V41, P337, DOI 10.1128/JCM.41.1.337-345.2003; Johnson JR, 2001, J INFECT DIS, V183, P1546; Johnson JR, 1996, J INFECT DIS, V173, P920, DOI 10.1093/infdis/173.4.920; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Karisik E, 2008, J ANTIMICROB CHEMOTH, V61, P54, DOI 10.1093/jac/dkm401; Koczura R, 2013, MICROB ECOL, V65, P84, DOI 10.1007/s00248-012-0101-3; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; LEBOUGUENEC C, 1992, J CLIN MICROBIOL, V30, P1189, DOI 10.1128/JCM.30.5.1189-1193.1992; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mitsumori K, 1998, FEMS IMMUNOL MED MIC, V21, P261; Moreno E, 2005, DIAGN MICR INFEC DIS, V53, P93, DOI 10.1016/j.diagmicrobio.2005.05.015; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Osugui L, 2014, VET MICROBIOL, V171, P242, DOI 10.1016/j.vetmic.2014.03.027; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Piatti G, 2008, J CLIN MICROBIOL, V46, P480, DOI 10.1128/JCM.01488-07; Platell JL, 2011, ANTIMICROB AGENTS CH, V55, P3782, DOI 10.1128/AAC.00306-11; Rijavec M, 2008, J MED MICROBIOL, V57, P1329, DOI 10.1099/jmm.0.2008/002543-0; Schierack P, 2006, APPL ENVIRON MICROB, V72, P6680, DOI 10.1128/AEM.02952-05; Tarchouna M, 2013, INT J INFECT DIS, V17, pE450, DOI 10.1016/j.ijid.2013.01.025; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Thungrat K, 2015, VET MICROBIOL, V179, P287, DOI 10.1016/j.vetmic.2015.06.012; Wagner S, 2014, VET MICROBIOL, V169, P171, DOI 10.1016/j.vetmic.2014.01.003; Wang XM, 2010, FEMS MICROBIOL LETT, V306, P15, DOI 10.1111/j.1574-6968.2010.01917.x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu GH, 2012, VET MICROBIOL, V160, P197, DOI 10.1016/j.vetmic.2012.05.029; YAMAMOTO S, 1995, FEMS IMMUNOL MED MIC, V12, P85, DOI 10.1111/j.1574-695X.1995.tb00179.x; Yuri K, 1998, J VET MED SCI, V60, P287, DOI 10.1292/jvms.60.287; Zhao LX, 2009, UROLOGY, V74, P702, DOI 10.1016/j.urology.2009.01.042	44	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143335	10.1371/journal.pone.0143335	http://dx.doi.org/10.1371/journal.pone.0143335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587840	gold, Green Published, Green Submitted			2022-12-26	WOS:000365251500052
J	Ramsey, JS; Johnson, RS; Hoki, JS; Kruse, A; Mahoney, J; Hilf, ME; Hunter, WB; Hall, DG; Schroeder, FC; MacCoss, MJ; Cilia, M				Ramsey, John S.; Johnson, Richard S.; Hoki, Jason S.; Kruse, Angela; Mahoney, Jaclyn; Hilf, Mark E.; Hunter, Wayne B.; Hall, David G.; Schroeder, Frank C.; MacCoss, Michael J.; Cilia, Michelle			Metabolic Interplay between the Asian Citrus Psyllid and Its Profftella Symbiont: An Achilles' Heel of the Citrus Greening Insect Vector	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER ASIATICUS; HEMIPTERA PSYLLIDAE; STATISTICAL-MODEL; DISEASE; IDENTIFICATIONS; BIOSYNTHESIS; INFECTION; DATABASE; GENOME	'Candidatus Liberibacter asiaticus' (CLas), the bacterial pathogen associated with citrus greening disease, is transmitted by Diaphorina citri, the Asian citrus psyllid. Interactions among D. citri and its microbial endosymbionts, including 'Candidatus Profftella armatura', are likely to impact transmission of CLas. We used quantitative mass spectrometry to compare the proteomes of CLas(+) and CLas(-) populations of D. citri, and found that proteins involved in polyketide biosynthesis by the endosymbiont Profftella were up-regulated in CLas(+) insects. Mass spectrometry analysis of the Profftella polyketide diaphorin in D. citri metabolite extracts revealed the presence of a novel diaphorin-related polyketide and the ratio of these two polyketides was changed in CLas(+) insects. Insect proteins differentially expressed between CLas(+) and CLas(-) D. citri included defense and immunity proteins, proteins involved in energy storage and utilization, and proteins involved in endocytosis, cellular adhesion, and cytoskeletal remodeling which are associated with microbial invasion of host cells. Insight into the metabolic interdependence between the insect vector, its endosymbionts, and the citrus greening pathogen reveals novel opportunities for control of this disease, which is currently having a devastating impact on citrus production worldwide.	[Ramsey, John S.; Hoki, Jason S.; Kruse, Angela; Mahoney, Jaclyn; Schroeder, Frank C.; Cilia, Michelle] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Ramsey, John S.; Mahoney, Jaclyn; Cilia, Michelle] USDA ARS, Robert W Holley Ctr Agr & Hlth, Emerging Pests & Pathogens Res Unit, Ithaca, NY 14853 USA; [Johnson, Richard S.; MacCoss, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hoki, Jason S.; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Kruse, Angela; Cilia, Michelle] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY USA; [Hilf, Mark E.] USDA ARS, US Hort Res Lab, Subtrop Plant Pathol Res Unit, Ft Pierce, FL USA; [Hunter, Wayne B.; Hall, David G.] USDA ARS, US Hort Res Lab, Subtrop Insects & Hort Res Unit, Ft Pierce, FL USA	Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); University of Washington; University of Washington Seattle; Cornell University; Cornell University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cilia, M (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	mic68@cornell.edu	hunter, wayne/AAB-9096-2020	hunter, wayne/0000-0001-8603-3337; Kruse, Angela/0000-0001-8776-2769; Schroeder, Frank/0000-0002-4420-0237	Citrus Research Board [5300-155, 5300-163]; USDA ARS project [6034-22320-001-00, 8062-22000-021-00]; ARS [ARS-0423113] Funding Source: Federal RePORTER	Citrus Research Board; USDA ARS project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by Citrus Research Board: http://citrusresearch.com/; Grant numbers: 5300-155, 5300-163, USDA ARS project numbers: 6034-22320-001-00 and 8062-22000-021-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dossi FCA, 2014, MICROB ECOL, V68, P881, DOI 10.1007/s00248-014-0463-9; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Cilia M, 2009, J Biomol Tech, V20, P201; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; HALARNKAR PP, 1989, COMP BIOCHEM PHYS B, V92, P227, DOI 10.1016/0305-0491(89)90270-8; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; JIANG YP, 1987, PHYTOPATHOLOGY, V77, P949, DOI 10.1094/Phyto-77-949; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Slisz AM, 2012, J PROTEOME RES, V11, P4223, DOI 10.1021/pr300350x; Steele-Mortimer O, 2011, TRAFFIC, V12, P162, DOI 10.1111/j.1600-0854.2010.01137.x; Tetreau G, 2015, INSECT BIOCHEM MOLEC, V62, P127, DOI 10.1016/j.ibmb.2014.12.002; Tiwari S, 2011, ANN ENTOMOL SOC AM, V104, P297, DOI 10.1603/AN10128; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Zhou P, 1999, CHEM BIOL, V6, P577, DOI 10.1016/S1074-5521(99)80090-8	30	47	48	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0140826	10.1371/journal.pone.0140826	http://dx.doi.org/10.1371/journal.pone.0140826			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580079	gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600008
J	Jang, MH; Lee, S; Hwang, YS				Jang, Min-Hee; Lee, Seungho; Hwang, Yu Sik			Characterization of Silver Nanoparticles under Environmentally Relevant Conditions Using Asymmetrical Flow Field-Flow Fractionation (AF4)	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; NATURAL ORGANIC-MATTER; AGGREGATION KINETICS	The development of methods to monitor manufactured nanomaterials in the environment is one of the crucial areas for the assessment of their risk. More specifically, particle size analysis is a key element, because many properties of nanomaterial are size dependent. The sizing of nanomaterials in real environments is challenging due to their heterogeneity and reactivity with other environmental components. In this study, the fractionation and characterization of a mixture of polyvinylpyrrolidone-coated silver nanoparticles (PVP-AgNPs) of three different sizes were investigated using asymmetrical flow field-flow fractionation (AF4) coupled with UV-Vis spectrophotometry. In particular, the effects of electrolyte composition and natural organic matter (NOM) on the particle size and stability were evaluated. The fractogram peaks (i.e., stability) of three different AgNPs decreased in the presence of both 10 mM NaCl and 10mM CaCl2, while increased with increasing concentration of humic acid (HA). In addition, the hydrodynamic diameters of AgNPs in both electrolytes slightly increased with an increase of HA concentration, suggesting the adsorption (coating) of HA onto the particle surface. It is also interesting to note that an increase in the particle size depended on the types of electrolyte, which could be explained by the conformational characteristics of the adsorbed HA layers. Consistent these results, AgNPs suspended in lake water containing relatively high concentration of organic carbon (TOC) showed higher particle stability and larger particle size (i.e., by approximately 4nm) than those in river water. In conclusion, the application of AF4 coupled with highly sensitive detectors could be a powerful method to characterize nanoparticles in natural waters.	[Jang, Min-Hee; Hwang, Yu Sik] Korea Inst Toxicol, Future Environm Res Ctr, Jinju 660844, South Korea; [Lee, Seungho] Hannam Univ, Dept Chem, Daejeon 305811, South Korea; [Hwang, Yu Sik] Univ Sci & Technol, Human & Environm Toxicol Program, Daejeon 305350, South Korea	Korea Institute of Toxicology; Hannam University; University of Science & Technology (UST)	Hwang, YS (corresponding author), Korea Inst Toxicol, Future Environm Res Ctr, Jinju 660844, South Korea.	yshwang@kitox.re.kr		Lee, Seungho/0000-0002-4574-5511	Research Program for "Environmental Risk Assessment of Manufactured Nanomaterials - Korea Institute of Toxicology (KIT, Korea) [KK-1505-01]; GAIA Project - Korea Ministry of Environment [G115-00055-0403-1]	Research Program for "Environmental Risk Assessment of Manufactured Nanomaterials - Korea Institute of Toxicology (KIT, Korea); GAIA Project - Korea Ministry of Environment	This study was supported by "The GAIA Project (G115-00055-0403-1)" funded by the Korea Ministry of Environment and Research Program for "Environmental Risk Assessment of Manufactured Nanomaterials (KK-1505-01)" funded by the Korea Institute of Toxicology (KIT, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by "The GAIA Project (G115-00055-0403-1)" funded by the Korea Ministry of Environment and research program for "Environmental Risk Assessment of Manufactured Nanomaterials (KK-1505-01)" funded by the Korea Institute of Toxicology (KIT, Korea).	Au KK, 1999, GEOCHIM COSMOCHIM AC, V63, P2903, DOI 10.1016/S0016-7037(99)00268-9; Baalousha M, 2011, J CHROMATOGR A, V1218, P4078, DOI 10.1016/j.chroma.2011.04.063; Baalousha M, 2008, ENVIRON TOXICOL CHEM, V27, P1875, DOI 10.1897/07-559.1; Balnois E, 1999, ENVIRON SCI TECHNOL, V33, P3911, DOI 10.1021/es990365n; Bolea E, 2011, ANAL BIOANAL CHEM, V401, P2723, DOI 10.1007/s00216-011-5201-2; Chekli L, 2013, WATER RES, V47, P4585, DOI 10.1016/j.watres.2013.04.029; Cumberland SA, 2009, J CHROMATOGR A, V1216, P9099, DOI 10.1016/j.chroma.2009.07.021; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P7277, DOI 10.1021/es900249m; GIDDINGS JC, 1993, SCIENCE, V260, P1456, DOI 10.1126/science.8502990; Hagendorfer H, 2012, ANAL CHEM, V84, P2678, DOI 10.1021/ac202641d; HM Government, 2005, CHAR POT RISKS POS E; Huynh KA, 2011, ENVIRON SCI TECHNOL, V45, P5564, DOI 10.1021/es200157h; Johnson RL, 2009, ENVIRON SCI TECHNOL, V43, P5455, DOI 10.1021/es900474f; Karan B, 2009, ENV HLTH PERSP, V117, P1829; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kloster N, 2013, COLLOID SURFACE A, V427, P76, DOI 10.1016/j.colsurfa.2013.03.030; Lead Jr, 2000, ENVIRON SCI TECHNOL, V34, P1365, DOI 10.1021/es9907616; Messaud FA, 2009, PROG POLYM SCI, V34, P351, DOI 10.1016/j.progpolymsci.2008.11.001; Myers MN, 1997, J MICROCOLUMN SEP, V9, P151, DOI 10.1002/(SICI)1520-667X(1997)9:3<151::AID-MCS3>3.0.CO;2-0; Poda AR, 2011, J CHROMATOGR A, V1218, P4219, DOI 10.1016/j.chroma.2010.12.076; Romer I, 2011, J CHROMATOGR A, V1218, P4226, DOI 10.1016/j.chroma.2011.03.034; Schimpf M., 2000, FIELD FLOW FRACTIONA; Stankus DP, 2011, ENVIRON SCI TECHNOL, V45, P3238, DOI 10.1021/es102603p; WAHLUND KG, 1987, ANAL CHEM, V59, P1332, DOI 10.1021/ac00136a016	24	25	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143149	10.1371/journal.pone.0143149	http://dx.doi.org/10.1371/journal.pone.0143149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575993	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400046
J	Karpowicz, P; Osmulski, PA; Witkowska, J; Sikorska, E; Gizynska, M; Belczyk-Ciesielska, A; Gaczynska, ME; Jankowska, E				Karpowicz, Przemyslaw; Osmulski, Pawel A.; Witkowska, Julia; Sikorska, Emilia; Gizynska, Malgorzata; Belczyk-Ciesielska, Agnieszka; Gaczynska, Maria E.; Jankowska, Elzbieta			Interplay between Structure and Charge as a Key to Allosteric Modulation of Human 20S Proteasome by the Basic Fragment of HIV-1 Tat Protein	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; NMR CHEMICAL-SHIFTS; DRUG DISCOVERY; AMINO-ACIDS; CONFORMATIONAL-ANALYSIS; BORTEZOMIB RESISTANCE; POPULATION SHIFT; REG-ALPHA; PEPTIDE; PROLINE	The proteasome is a giant protease responsible for degradation of the majority of cytosolic proteins. Competitive inhibitors of the proteasome are used against aggressive blood cancers. However, broadening the use of proteasome-targeting drugs requires new mechanistic approaches to the enzyme's inhibition. In our previous studies we described Tat1 peptide, an allosteric inhibitor of the proteasome derived from a fragment of the basic domain of HIV-Tat1 protein. Here, we attempted to dissect the structural determinants of the proteasome inhibition by Tat1. Single- and multiple-alanine walking scans were performed. Tat1 analogs with stabilized beta-turn conformation at positions 4-5 and 8-9, pointed out by the molecular dynamics modeling and the alanine scan, were synthesized. Structure of Tat1 analogs were analyzed by circular dichroism, Fourier transform infrared and nuclear magnetic resonance spectroscopy studies, supplemented by molecular dynamics simulations. Biological activity tests and structural studies revealed that high flexibility and exposed positive charge are hallmarks of Tat1 peptide. Interestingly, stabilization of a beta-turn at the 8-9 position was necessary to significantly improve the inhibitory potency.	[Karpowicz, Przemyslaw; Witkowska, Julia; Gizynska, Malgorzata; Jankowska, Elzbieta] Univ Gdansk, Fac Chem, Dept Biomed Chem, PL-80952 Gdansk, Poland; [Karpowicz, Przemyslaw; Osmulski, Pawel A.; Gaczynska, Maria E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78229 USA; [Sikorska, Emilia] Univ Gdansk, Fac Chem, Dept Organ Chem, PL-80952 Gdansk, Poland; [Belczyk-Ciesielska, Agnieszka] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Fahrenheit Universities; University of Gdansk; University of Texas System; University of Texas Health San Antonio; Fahrenheit Universities; University of Gdansk; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Gaczynska, ME (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, San Antonio, TX 78229 USA.	gaczynska@uthscsa.edu; elzbieta.jankowska@ug.edu.pl	Jankowska, Elzbieta/ABI-6530-2020; Osmulski, Pawel/C-7751-2019; Karpowicz, Przemysław/HGU-5893-2022	Jankowska, Elzbieta/0000-0002-1099-8885; Osmulski, Pawel/0000-0002-5359-9200; Witkowska, Julia/0000-0003-0518-0162; Karpowicz, Przemyslaw/0000-0003-4912-3709; Sikorska, Emilia/0000-0001-7851-6371; Gizynska, Malgorzata/0000-0002-3206-5605	Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland; William and Ella Owens Foundation [2011/01/B/ST5/06616]; National Science Center; Ministry of Science and Higher Education [DS/530-8725-D496-15]	Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland; William and Ella Owens Foundation; National Science Center(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The equipment used for microscale thermophoresis was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland. The project was sponsored in part by The William and Ella Owens Foundation for Medical Research award (MEG and PAO), 2011/01/B/ST5/06616 (EJ), National Science Center (https://www.ncn.gov.pl) and DS/530-8725-D496-15, Ministry of Science and Higher Education (http://www.nauka.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The equipment used for microscale thermophoresis was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland. The project was sponsored in part by The William and Ella Owens Foundation for Medical Research award (MEG and PAO).	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P407, DOI 10.1107/S0108768102004895; Apcher GS, 2003, FEBS LETT, V553, P200, DOI 10.1016/S0014-5793(03)01025-1; Azevedo LM, 2013, J MED CHEM, V56, P5974, DOI 10.1021/jm400235r; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bhatnagar RS, 1996, CIRCULAR DICHROISM C, P183; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; Carlisle EA, 2007, BIOPOLYMERS, V85, P72, DOI 10.1002/bip.20614; Case D.A., 2022, AMBER 2020; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; DYSON HJ, 1988, J MOL BIOL, V201, P161, DOI 10.1016/0022-2836(88)90446-9; EBERSTADT M, 1995, ANGEW CHEM INT EDIT, V34, P1671, DOI 10.1002/anie.199516711; Eker F, 2004, BIOCHEMISTRY-US, V43, P613, DOI 10.1021/bi035740+; Formicola L, 2009, BIOORG MED CHEM LETT, V19, P83, DOI 10.1016/j.bmcl.2008.11.012; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Gaczynska M, 2003, BIOCHEMISTRY-US, V42, P8663, DOI 10.1021/bi034784f; Gaczynska M, 2014, ANTIOXID REDOX SIGN, V21, P2286, DOI 10.1089/ars.2013.5816; Goddard T. D., 2001, SPARKY 3; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; GUBA W, 1994, J AM CHEM SOC, V116, P7532, DOI 10.1021/ja00096a009; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; Huang XH, 2002, J MOL BIOL, V323, P771, DOI 10.1016/S0022-2836(02)00998-1; Jankowska E, 2004, EUR BIOPHYS J BIOPHY, V33, P454, DOI 10.1007/s00249-003-0384-x; Jankowska E, 2010, BIOPOLYMERS, V93, P481, DOI 10.1002/bip.21381; Jankowska E, 2013, CURR PHARM DESIGN, V19, P1010, DOI 10.2174/138161281906141012124358; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kloss A, 2009, EUR J PHARM BIOPHARM, V72, P219, DOI 10.1016/j.ejpb.2008.10.016; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kortuem KM, 2013, BLOOD, V121, P893, DOI 10.1182/blood-2012-10-459883; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lansdell TA, 2013, ACS CHEM BIOL, V8, P578, DOI 10.1021/cb300568r; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Lee YC, 2001, BIOPOLYMERS, V58, P548, DOI 10.1002/1097-0282(200105)58:6<548::AID-BIP1030>3.0.CO;2-B; Li XM, 2010, JNCI-J NATL CANCER I, V102, P1069, DOI 10.1093/jnci/djq198; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Ma K, 2001, BIOCHEMISTRY-US, V40, P3427, DOI 10.1021/bi0022792; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Malin EL, 2001, J PROTEIN CHEM, V20, P391, DOI 10.1023/A:1012232804665; Mao X, 2009, LEUKEMIA, V23, P585, DOI 10.1038/leu.2008.232; Melancon BJ, 2012, J MED CHEM, V55, P1445, DOI 10.1021/jm201139r; Merdanovic M, 2013, ACS CHEM BIOL, V8, P19, DOI 10.1021/cb3005935; Misicka A, 1998, LETT PEPT SCI, V5, P375, DOI 10.1023/A:1008816331360; Narang P, 2005, PHYS CHEM CHEM PHYS, V7, P2364, DOI 10.1039/b502226f; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Oberg KA, 1998, ANAL BIOCHEM, V256, P92, DOI 10.1006/abio.1997.2486; Osmulski PA, 2013, MOL PHARMACOL, V84, P104, DOI 10.1124/mol.112.083873; Pajonk F, 2004, CANC DRUG DISC DEV, P111; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Perczel A, 1996, CIRCULAR DICHROISM C, P306; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Remoli AL, 2006, BIOCHEM J, V396, P371, DOI 10.1042/BJ20051570; Ruschak AM, 2011, JNCI-J NATL CANCER I, V103, P1; Ruschak AM, 2012, P NATL ACAD SCI USA, V109, pE3454, DOI 10.1073/pnas.1213640109; Sandre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI [10.1016/j.molcel.2010.02.002, DOI 10.1016/J.MOLCEL.2010.02.002]; SAWUTZ DG, 1994, BIOCHEMISTRY-US, V33, P2373, DOI 10.1021/bi00175a004; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Seeger M, 1997, J BIOL CHEM, V272, P8145, DOI 10.1074/jbc.272.13.8145; Sikorska E, 2015, TETRAHEDRON, V71, P2013, DOI 10.1016/j.tet.2015.02.009; Sikorska E, 2012, CHEM BIOL DRUG DES, V79, P535, DOI 10.1111/j.1747-0285.2012.01318.x; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Sprangers R, 2008, BIOCHEMISTRY-US, V47, P6727, DOI 10.1021/bi8005913; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stohwasser R, 2000, EUR J BIOCHEM, V267, P6221, DOI 10.1046/j.1432-1327.2000.01706.x; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Twardowski J, 1994, RAMAN AND IR SPECTRO; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; WILLIAMSON MP, 1992, CHEM SOC REV, V21, P227, DOI 10.1039/cs9922100227; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Witkowska J, 2014, J PEPT SCI, V20, P649, DOI 10.1002/psc.2642; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; Zhang ZG, 1998, P NATL ACAD SCI USA, V95, P2807, DOI 10.1073/pnas.95.6.2807	82	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143038	10.1371/journal.pone.0143038	http://dx.doi.org/10.1371/journal.pone.0143038			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575189	gold, Green Published			2022-12-26	WOS:000365153400030
J	Huijgen, NA; Laven, JSE; Labee, CT; Louwers, YV; Willemsen, SP; Steegers-Theunissen, RPM				Huijgen, Nicole A.; Laven, Joop S. E.; Labee, Chantal T.; Louwers, Yvonne V.; Willemsen, Sten P.; Steegers-Theunissen, Regine P. M.			Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity?	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; AND/OR PHYSICAL-EXERCISE; FEMALE RHESUS-MONKEYS; BODY-MASS INDEX; OBESE WOMEN; ANTIMULLERIAN HORMONE; REPRODUCTIVE FUNCTION; SERUM CONCENTRATIONS; DOUBLE-BLIND; OVERWEIGHT	Background The composition of the diet is of increasing importance for the development and maturation of the ovarian follicles. In Polycystic Ovary Syndrome (PCOS) healthy dietary interventions improve the clinical spectrum. We hypothesized that dieting and diet inadequacy in the reproductive life course is associated with impaired programming of ovarian follicles and contributes to the severity of the PCOS phenotype. Methods and Findings To determine associations between the use of a self-initiated diet and diet inadequacy and the severity of the PCOS phenotype, we performed an explorative nested case control study embedded in a periconception cohort of 1,251 patients visiting the preconception outpatient clinic. 218 patients with PCOS and 799 subfertile controls were selected from the cohort and self-administered questionnaires, anthropometric measurements and blood samples were obtained. The Preconception Dietary Risk Score (PDR score), based on the Dutch dietary guidelines, was used to determine diet inadequacy in all women. The PDR score was negatively associated to cobalamin, serum and red blood cell folate and positively to tHcy. PCOS patients (19.9%), in particular the hyperandrogenic (HA) phenotype (22.5%) reported more often the use of a self-initiated diet than controls (13.1%; p = 0.023). The use of an inadequate diet was also significantly higher in PCOS than in controls (PDR score 3.7 vs 3.5; p = 0.017) and every point increase was associated with a more than 1.3 fold higher risk of the HA phenotype (adjusted OR 1.351, 95% CI 1.09-1.68). Diet inadequacy was independently associated with the anti-Mullerian Hormone (AMH) concentration (beta 0.084; p = 0.044; 95% CI 0.002 to 0.165) and free androgen index (beta 0.128; p = 0.013; 95% CI 0.028 to 0.229) in PCOS patients. Conclusions The use of a self-initiated diet and diet inadequacy is associated with PCOS, in particular with the severe HA phenotype. This novel finding substantiated by the association between diet inadequacy and AMH needs further investigation.	[Huijgen, Nicole A.; Labee, Chantal T.; Willemsen, Sten P.; Steegers-Theunissen, Regine P. M.] Erasmus MC, Univ Med Ctr, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Laven, Joop S. E.; Louwers, Yvonne V.] Erasmus MC, Univ Med Ctr, Div Reprod Med, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Willemsen, Sten P.] Erasmus MC, Univ Med Ctr, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Steegers-Theunissen, RPM (corresponding author), Erasmus MC, Univ Med Ctr, Dept Obstet & Gynaecol, Rotterdam, Netherlands.	r.steegers@erasmusmc.nl		Louwers, Yvonne/0000-0002-9048-7398				Abbott DH, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740001; Ackard DM, 2002, J PSYCHOSOM RES, V52, P129, DOI 10.1016/S0022-3999(01)00269-0; Altieri P, 2013, CLIN ENDOCRINOL, V78, P52, DOI 10.1111/j.1365-2265.2012.04355.x; Anderson K, 2010, AUST NZ J OBSTET GYN, V50, P8, DOI 10.1111/j.1479-828X.2009.01119.x; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Bahmani F, 2014, CLIN ENDOCRINOL, V81, P582, DOI 10.1111/cen.12451; Boxmeer JC, 2008, HUM REPROD, V23, P2570, DOI 10.1093/humrep/den292; Brown ZA, 2011, FERTIL STERIL, V96, P1259, DOI 10.1016/j.fertnstert.2011.09.002; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Ciotta L, 2011, EUR REV MED PHARMACO, V15, P509; Daan NMP, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.08.001; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Devine CM, 2000, SOC SCI MED, V50, P567, DOI 10.1016/S0277-9536(99)00314-7; Douglas CC, 2006, FERTIL STERIL, V86, P411, DOI 10.1016/j.fertnstert.2005.12.054; Dumesic DA, 2002, J CLIN ENDOCR METAB, V87, P1111, DOI 10.1210/jc.87.3.1111; Dupont C, 2012, THERIOGENOLOGY, V78, P1405, DOI 10.1016/j.theriogenology.2012.06.016; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Eisner JR, 2002, FERTIL STERIL, V77, P167, DOI 10.1016/S0015-0282(01)02947-8; Guzelmeric K, 2007, GYNECOL ENDOCRINOL, V23, P505, DOI 10.1080/09513590701554306; Hammiche F, 2011, HUM REPROD, V26, P2432, DOI 10.1093/humrep/der225; Homburg R, 2013, HUM REPROD, V28, P1077, DOI 10.1093/humrep/det015; Huijgen N, 2013, E SPEN J, V9, pe13; Jarman M, 2015, APPETITE, V95, P466, DOI 10.1016/j.appet.2015.08.008; Katz I, 2015, J PSYCHOL, V149, P461, DOI 10.1080/00223980.2014.903890; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Kosova G, 2013, MOL CELL ENDOCRINOL, V373, P29, DOI 10.1016/j.mce.2012.10.009; Kralikova M, 2011, J ASSIST REPROD GEN, V28, P863, DOI 10.1007/s10815-011-9606-9; Laven JSE, 2004, J CLIN ENDOCR METAB, V89, P318, DOI 10.1210/jc.2003-030932; Legro RS, 2012, SEMIN REPROD MED, V30, P496, DOI 10.1055/s-0032-1328878; Leveille P, 2014, J DEV ORIG HLTH DIS, V5, P88, DOI 10.1017/S2040174414000014; Moran LJ, 2013, HUM REPROD, V28, P2276, DOI 10.1093/humrep/det256; Moran L, 2010, J PSYCHOSOM OBST GYN, V31, P24, DOI 10.3109/01674820903477593; Moran LJ, 2013, J ACAD NUTR DIET, V113, P520, DOI 10.1016/j.jand.2012.11.018; Mulders AGMGJ, 2004, HUM REPROD, V19, P2036, DOI 10.1093/humrep/deh373; Netherlands Nutrition Center, 2011, RICHTL VOEDS; Nybacka A, 2013, FERTIL STERIL, V100, P1096, DOI 10.1016/j.fertnstert.2013.06.030; Nybacka A, 2011, FERTIL STERIL, V96, P1508, DOI 10.1016/j.fertnstert.2011.09.006; Riboli E, 1997, EUR J CLIN NUTR, V51, P437, DOI 10.1038/sj.ejcn.1600422; Rodrigues AMD, 2015, J HUM NUTR DIET, V28, P94, DOI 10.1111/jhn.12205; Sanchez N, 2014, INT J WOMENS HEALTH, V6, P115, DOI 10.2147/IJWH.S55748; Sinclair KD, 2014, REPROD FERT DEVELOP, V26, P99, DOI 10.1071/RD13290; Sloboda DM, 2011, HUM REPROD UPDATE, V17, P210, DOI 10.1093/humupd/dmq048; Steegers-Theunissen RPM, 2013, HUM REPROD UPDATE, V19, P640, DOI 10.1093/humupd/dmt041; Talbott EO, 2004, J CLIN ENDOCR METAB, V89, P5454, DOI 10.1210/jc.2003-032237; Thomson RL, 2008, J CLIN ENDOCR METAB, V93, P3373, DOI 10.1210/jc.2008-0751; Twigt JM, 2012, HUM REPROD, V27, P2526, DOI 10.1093/humrep/des157; Willett W., 2012, NUTR EPIDEMIOLOGY; Willett WC, 2000, EPIDEMIOL REV, V22, P82, DOI 10.1093/oxfordjournals.epirev.a018029; Wright CE, 2004, INT J OBESITY, V28, P1026, DOI 10.1038/sj.ijo.0802661	49	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142772	10.1371/journal.pone.0142772	http://dx.doi.org/10.1371/journal.pone.0142772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569630	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700069
J	Karlsen, JD; Krag, LA; Albertsen, CM; Frandsen, RP				Karlsen, Junita D.; Krag, Ludvig Ahm; Albertsen, Christoffer Moesgaard; Frandsen, Rikke Petri			From Fishing to Fish Processing: Separation of Fish from Crustaceans in the Norway Lobster-Directed Multispecies Trawl Fishery Improves Seafood Quality	PLOS ONE			English	Article							COD GADUS-MORHUA; HADDOCK MELANOGRAMMUS-AEGLEFINUS; SALMON SALMO-SALAR; ATLANTIC SALMON; NEPHROPS-NORVEGICUS; RIGOR DEVELOPMENT; CROWDING STRESS; DEMERSAL TRAWL; SHELF-LIFE; PARAMETERS	Fishing gears have negative impacts on seafood quality, especially on fish in the mixed trawl fishery targeting Norway lobster (Nephrops norvegicus). In this fishery, which is worth about (sic)80 millions in Denmark alone, the quality of fish can be significantly improved by simple gear changes. A trawl codend divided into an upper and lower codend was designed to separate fish from Norway lobster during the fishing process by encourage fish to swim into the upper codend by using a frame at the entrance of the lower codend. Separate codends for fish and Norway lobster in the same gear provide the opportunity to selectively reduce small low-value fish, which will reduce catch weight and sorting time onboard the vessel. For this horizontally divided test codend and a standard codend, in which the catch was mixed, quality assessments were performed on the same batches of fish during three steps of the value chain: i) aboard the fishing vessel; ii) at the Fishermen's Collection Central, and iii) in the production plant. Four species of fish and fillets from fish caught in the upper codend of the test codend were of significantly better quality for several of the assessed parameters compared with those caught in the standard codend: i) newly caught fish showed significantly less scale loss and discolourations and had significantly better texture; ii) landed fish had significantly better skin appearance and texture and significantly fewer discolourations; and iii) fillets showed significantly fewer blood spots and had significantly better texture. There were no differences in injuries for newly caught fish or gaping and bruises for fillets between the test and standard codends. The decrease in catch-related damages in the test codend is explained by little contact between fish and animals with hard or spiny surfaces due to successful separation of fish and Norway lobster into the upper and lower codends, respectively, and by lower catch weight in the upper codend of the test codend compared with the standard codend. The decrease in damages may also improve quality indirectly by inflicting less stress to the fish and subsequently give better texture, which offers advantages such as pre-rigor filleting and fresher products for the market. Significant improvements in fish quality can potentially increase the catch value in nationally important fisheries.	[Karlsen, Junita D.; Krag, Ludvig Ahm; Frandsen, Rikke Petri] Natl Inst Aquat Resources, DTU Aqua, DK-9850 Hirtshals, Denmark; [Albertsen, Christoffer Moesgaard] Natl Inst Aquat Resources, DTU Aqua, DK-2920 Charlottenlund, Denmark	Technical University of Denmark; Technical University of Denmark	Karlsen, JD (corresponding author), Natl Inst Aquat Resources, DTU Aqua, North Sea Sci Pk, DK-9850 Hirtshals, Denmark.	jka@aqua.dtu.dk	Karlsen, Junita/AIA-5409-2022; Albertsen, Christoffer M/P-1108-2014	Albertsen, Christoffer M/0000-0003-0088-4363; Frandsen, Rikke Petri/0000-0002-4825-8145; Karlsen, Junita Diana/0000-0002-0496-4638; Krag, Ludvig Ahm/0000-0002-1531-1499	Danish AgriFish Agency; EU through the European Fisheries Fund under the project 'VaerdiFisk' [33010-12-k-0235]	Danish AgriFish Agency; EU through the European Fisheries Fund under the project 'VaerdiFisk'	This study received financial support from the Danish AgriFish Agency and EU through the European Fisheries Fund under the project 'VaerdiFisk' (grant no. 33010-12-k-0235): Denmark and Europe invest in sustainable fisheries and aquaculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; Akse L, 2004, 102004 FISK; Andersen Urd Bente, 1994, Norwegian Journal of Agricultural Sciences, V8, P165; Asche F, 2014, ICES J MAR SCI; Ashie INA, 1996, CRIT REV FOOD SCI, V36, P87, DOI 10.1080/10408399609527720; Bjornevik M, 2010, AQUAC RES, V41, pe467, DOI 10.1111/j.1365-2109.2010.02498.x; Bonilla AC, 2007, FOOD CONTROL, V18, P352, DOI 10.1016/j.foodcont.2005.10.019; BOTTA JR, 1987, J FOOD SCI, V52, P928, DOI 10.1111/j.1365-2621.1987.tb14245.x; Digre H, 2010, FISHERIES SCI, V76, P549, DOI 10.1007/s12562-010-0254-2; Eayrs S, 2007, GUIDE BYCATCH REDUCT; Engas A, 1998, ICES J MAR SCI, V55, P835, DOI 10.1006/jmsc.1998.0352; Esaiassen M, 2004, LEBENSM-WISS TECHNOL, V37, P643, DOI 10.1016/j.lwt.2004.02.002; Esaiassen M, 2013, FOOD CONTROL, V29, P231, DOI 10.1016/j.foodcont.2012.05.065; Ferro RST, 2007, ICES J MAR SCI, V64, P1543, DOI 10.1093/icesjms/fsm099; Graham N, 2006, FISH RES, V82, P111, DOI 10.1016/j.fishres.2006.08.011; Harrell FEJr, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-1-4757-3462-1; HATTULA T, 1995, FISH RES, V23, P209, DOI 10.1016/0165-7836(94)00358-4; Herrmann B, 2013, ICES J MAR SCI, V70, P850, DOI 10.1093/icesjms/fst032; Hyldig G., 2004, Journal of Aquatic Food Product Technology, V13, P71, DOI 10.1300/J030v13n04_06; Kiessling A, 2006, AQUACULTURE, V259, P390, DOI 10.1016/j.aquaculture.2005.11.008; KORHONEN RW, 1990, J FOOD SCI, V55, P346, DOI 10.1111/j.1365-2621.1990.tb06759.x; Krag LA, 2011, FISH RES, V110, P225, DOI 10.1016/j.fishres.2011.03.009; Krag LA, 2009, FISH RES, V98, P62, DOI 10.1016/j.fishres.2009.03.012; Krag LA, 2008, FISH RES, V91, P175, DOI 10.1016/j.fishres.2007.11.022; Krag LA, 2009, ICES J MAR SCI, V66, P772, DOI 10.1093/icesjms/fsp034; Kristensen K., 2014, TMB GEN RANDOM EFFEC; Kristoffersen S, 2006, AQUAC RES, V37, P1556, DOI 10.1111/j.1365-2109.2006.01595.x; Kristoffersen S, 2006, INT J FOOD SCI TECH, V41, P861, DOI 10.1111/j.1365-2621.2005.01149.x; Love R. M., 1972, Journal of Food Technology, V7, P291, DOI 10.1089/108705702760047790; MAIN J, 1985, FISH RES, V3, P131, DOI 10.1016/0165-7836(85)90014-1; Main J, 1981, STUDY FISH CAPTURE P; Main J, 1985, BEHAV NORWAY LOBSTER, V34; Margeirsson S, 2007, J FOOD ENG, V80, P503, DOI 10.1016/j.jfoodeng.2006.05.032; Margeirsson Sveinn, 2006, P265; O'Neill FG, 2003, FISH RES, V60, P107, DOI 10.1016/S0165-7836(02)00056-5; Olsen SH, 2013, FISH RES, V147, P446, DOI 10.1016/j.fishres.2013.03.009; Ozyurt G, 2007, FISHERIES SCI, V73, P412, DOI 10.1111/j.1444-2906.2007.01349.x; Rotabakk BT, 2011, FISH RES, V112, P44, DOI 10.1016/j.fishres.2011.08.009; Roth B, 2006, AQUACULTURE, V257, P504, DOI 10.1016/j.aquaculture.2005.10.021; Roth B, 2012, FISH RES, V115, P110, DOI 10.1016/j.fishres.2011.05.003; Sangster G.l., 1990, SCOTT FISH RES REP, V46, P28; Skjervold PO, 1999, AQUACULTURE, V175, P93, DOI 10.1016/S0044-8486(99)00037-X; Skjervold PO, 2001, AQUACULTURE, V194, P315, DOI 10.1016/S0044-8486(00)00531-7; Skjervold PO, 2001, AQUACULTURE, V192, P265, DOI 10.1016/S0044-8486(00)00447-6; Suuronen Petri, 2010, P265, DOI 10.1002/9780813810966.ch11; Winger PD, 2010, BEHAV MARINE FISHES, P265	46	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0140864	10.1371/journal.pone.0140864	http://dx.doi.org/10.1371/journal.pone.0140864			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569413	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700004
J	Penedos, AR; Myers, R; Hadef, B; Aladin, F; Brown, KE				Penedos, Ana Raquel; Myers, Richard; Hadef, Besma; Aladin, Farah; Brown, Kevin E.			Assessment of the Utility of Whole Genome Sequencing of Measles Virus in the Characterisation of Outbreaks	PLOS ONE			English	Article							REAL-TIME PCR; WILD-TYPE; ANTIBODY; ELIMINATION; ENGLAND; MUMPS; WALES	Background Measles is a highly infectious disease caused by measles virus (MeV). Despite the availability of a safe and cost-effective vaccine, measles is one of the world-leading causes of death in young children. Within Europe, there is a target for eliminating endemic measles in 2015, with molecular epidemiology required on 80% of cases for inclusion/exclusion of outbreak transmission chains. Currently, MeV is genotyped on the basis of a 450 nucleotide region of the nucleoprotein gene (N-450) and the hemagglutinin gene (H). However, this is not sufficiently informative for distinguishing endemic from imported MeV. We have developed an amplicon-based method for obtaining whole genome sequences (WGS) using NGS or Sanger methodologies from cell culture isolates or oral fluid specimens, and have sequenced over 60 samples, including 42 from the 2012 outbreak in the UK. Results Overall, NGS coverage was over 90% for approximately 71% of the samples tested. Analysis of 32 WGS excluding 3' and 5' termini (WGS-t) obtained from the outbreak indicates that the single nucleotide difference found between the two major groups of N-450 sequences detected during the outbreak is most likely a result of stochastic viral mutation during endemic transmission rather than of multiple importation events: earlier strains appear to have evolved into two distinct strain clusters in 2013, one containing strains with both out-break-associated N-450 sequences. Additionally, phylogenetic analysis of each genomic region of MeV for the strains in this study suggests that the most information is acquired from the non-coding region located between the matrix and fusion protein genes (M/F NCR) and the N-450 genotyping sequence, an observation supported by entropy analysis across genotypes. Conclusions We suggest that both M/F NCR and WGS-t could be used to complement the information from classical epidemiology and N-450 sequencing to address specific questions in the context of measles elimination.	[Penedos, Ana Raquel; Myers, Richard; Hadef, Besma; Aladin, Farah; Brown, Kevin E.] Publ Hlth England, Virus Reference Dept, London NW9 5EQ, England	Public Health England	Penedos, AR (corresponding author), Guys & St Thomas Hosp, Virol Lab, Westminster Bridge Rd, London SE1 7EH, England.	Ana.Penedos@phe.gov.uk		Penedos, Ana/0000-0002-1933-0726; Brown, Kevin/0000-0002-1568-683X	Public Health England	Public Health England	This project was funded by Public Health England.	Munoz-Alia MA, 2015, VIRUS RES, V196, P122, DOI 10.1016/j.virusres.2014.11.015; Bankamp B, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-129; Baricevic M, 2007, VIRUS GENES, V35, P17, DOI 10.1007/s11262-006-0035-2; Carter CC, 2015, VIROLOGY, V474, P34, DOI 10.1016/j.virol.2014.10.019; Cohuet S, 2009, EPIDEMIOL INFECT, V137, P1759, DOI 10.1017/S0950268809002714; Dine MS, 2004, J INFECT DIS, V189, pS123, DOI 10.1086/380308; Fulton BO, 2015, CELL REP, V11, P1331, DOI 10.1016/j.celrep.2015.04.054; Gardy JL, 2015, J INFECT DIS, V212, P1574, DOI 10.1093/infdis/jiv271; Ghebrehewet S, 2013, EPIDEMIOL INFECT, V141, P1849, DOI 10.1017/S0950268812002300; Harvala H, 2016, J INFECT DIS, V213, P592, DOI 10.1093/infdis/jiv434; Heider A, 1997, ARCH VIROL, V142, P2521, DOI 10.1007/s007050050259; Hiebert J, 2014, CCDR, P40; Jones KDJ, 2014, PAEDIATR INT CHILD H, V34, pS1, DOI 10.1179/2046904714Z.000000000218; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Marston DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-444; Moore C, 2015, J CLIN VIROL, V67, P1, DOI 10.1016/j.jcv.2015.03.012; Mulders MN, 2015, RELEVE EPIDEMIOLOGIQ, V90, P373; Orton RJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1456-x; Palgen JL, 2015, PROG MOL BIOL TRANSL, V129, P1, DOI 10.1016/bs.pmbts.2014.10.001; Pegorie M, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.49.20982; PERRY KR, 1993, J MED VIROL, V40, P235, DOI 10.1002/jmv.1890400312; Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P1034; Plans-Rubio P, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18444; Ramsay ME, 2003, J INFECT DIS, V187, pS198, DOI 10.1086/368024; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Santak M, 2007, INFECT GENET EVOL, V7, P645, DOI 10.1016/j.meegid.2007.04.003; Strebel PM, 2011, J INFECT DIS, V204, pS1, DOI 10.1093/infdis/jir111; Thomas B, 2007, J MED VIROL, V79, P1587, DOI 10.1002/jmv.20997; Uzicanin A, 2011, J INFECT DIS, V204, pS133, DOI 10.1093/infdis/jir102; van den Ent MMVX, 2011, J INFECT DIS, V204, pS18, DOI 10.1093/infdis/jir081; Walsh S, 2015, EPIDEMIOL INFECT, V143, P550, DOI 10.1017/S0950268814000752; World Health Organization, 2001, RELEVE EPIDEMIOLOGIQ, V76, P242; World Health Organization, 2012, 87 WHO; World Health Organization, 2010, RELEVE EPIDEMIOLOGIQ, V85, P490	34	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143081	10.1371/journal.pone.0143081	http://dx.doi.org/10.1371/journal.pone.0143081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569100	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700131
J	Yamazaki, K; Masaki, N; Kohmura-Kobayashi, Y; Yaguchi, C; Hayasaka, T; Itoh, H; Setou, M; Kanayama, N				Yamazaki, Kaori; Masaki, Noritaka; Kohmura-Kobayashi, Yukiko; Yaguchi, Chizuko; Hayasaka, Takahiro; Itoh, Hiroaki; Setou, Mitsutoshi; Kanayama, Naohiro			Decrease in Sphingomyelin (d18:1/16:0) in Stem Villi and Phosphatidylcholine (16:0/20:4) in Terminal Villi of Human Term Placentas with Pathohistological Maternal Malperfusion	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; ASSISTED-LASER-DESORPTION/IONIZATION; PREECLAMPSIA; TROPHOBLAST; MIGRATION; DOPPLER; BRAIN	Placental villi play pivotal roles in feto-maternal transportation and phospholipids constitute a major part of the villous membrane. We have been developing and optimizing an imaging system based on a matrix-assisted laser desorption/ionization (MALDI)-based mass spectrometer, which provides clear two-dimensional molecular distribution patterns using highly sensitive mass spectrometry from mixtures of ions generated on tissue surfaces. We recently applied this technology to normal human uncomplicated term placentas and detected the specific distribution of sphingomyelin (SM) (d18:1/16:0) in stem villi and phosphatidylcholine (PC) (16:0/20:4) in terminal villi. In the present study, we applied this technology to nine placentas with maternal or fetal complications, and determined whether a relationship existed between these specific distribution patterns of phospholipid molecules and the six representative pathological findings of placentas, i.e., villitis of unknown etiology (VUE), thrombus, atherosis, chorioamnionitis (CAM), immature terminal villi, and multiple branched terminal villi. In two placentas with the first and second largest total number of positive pathological findings, i.e., five and three positive findings, the specific distribution of SM (d18: 1/16: 0) in stem villi and PC (16: 0/20: 4) in terminal villi disappeared. The common pathological findings in these two placentas were atherosis, immature terminal villi, and multiple branched terminal villi, suggesting the possible involvement of the underperfusion of maternal blood into the intervillous space. On the other hand, the number of pathological findings were two or less in the seven other placentas, in which no specific relationships were observed between the differential expression patterns of these two phospholipids in stem and terminal villi and the pathological findings of the placentas; however, the specific distribution pattern of SM (d18: 1/16: 0) in stem villi disappeared in four placentas, while that of PC (16:0/20:4) in terminal villi was preserved. These results suggested that the absence of the specific distribution of PC (16:0/20: 4) in terminal villi, possibly in combination with the absence of SM (d18:1/16:0) in stem villi, was linked to placental morphological changes in response to maternal underperfusion of the placenta.	[Yamazaki, Kaori; Kohmura-Kobayashi, Yukiko; Yaguchi, Chizuko; Itoh, Hiroaki; Kanayama, Naohiro] Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka 4313192, Japan; [Masaki, Noritaka; Hayasaka, Takahiro; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan; [Hayasaka, Takahiro] Hokkaido Univ, Fac Hlth Sci, Hlth Innovat & Technol Ctr, Sapporo, Hokkaido, Japan; [Hayasaka, Takahiro] Global Res Ctr Food & Med Innovat, Dept Food & Hlth Res NB & LSI, Sapporo, Hokkaido, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hokkaido University	Itoh, H (corresponding author), Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka 4313192, Japan.	hitou-endo@umin.ac.jp			Ministry of Education, Science, Culture and Sports, Japan [24390273, 23659534, 25670490, 15H04882]; Grants-in-Aid for Scientific Research [15H04983, 15H05897, 25670490] Funding Source: KAKEN	Ministry of Education, Science, Culture and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports, Japan (No. 24390273, No. 23659534, No. 25670490, No. 15H04882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Arizawa M., 2013, CLIN PLACENTOLOGY JA; BARNABEI O, 1963, BIOCHIM BIOPHYS ACTA, V70, P586, DOI 10.1016/0006-3002(63)90795-9; Barth WH, 1996, ULTRASOUND OBST GYN, V8, P98, DOI 10.1046/j.1469-0705.1996.08020098.x; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Chaurand P, 2012, J PROTEOMICS, V75, P4883, DOI 10.1016/j.jprot.2012.04.005; Conti N, 2015, EUR J OBSTET GYN R B, V188, P34, DOI 10.1016/j.ejogrb.2015.02.034; DESA DJ, 1973, J PATHOL, V110, P347, DOI 10.1002/path.1711100409; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Fogarty NME, 2013, AM J PATHOL, V183, P144, DOI 10.1016/j.ajpath.2013.03.016; FUJIMORI A, 1966, J BIOCHEM, V59, P332, DOI 10.1093/oxfordjournals.jbchem.a128307; Goto-Inoue N, 2009, GLYCOBIOLOGY, V19, P950, DOI 10.1093/glycob/cwp089; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; Hayasaka T, 2009, LIPIDS, V44, P837, DOI 10.1007/s11745-009-3331-5; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; Itabashi K., 2010, ACTA PEDIAT JPN, V114, P1271; Jackson SN, 2005, J AM SOC MASS SPECTR, V16, P2052, DOI 10.1016/j.jasms.2005.08.014; Ji L, 2013, MOL ASPECTS MED, V34, P981, DOI 10.1016/j.mam.2012.12.008; Kim YM, 2015, J MATERN-FETAL NEO M, V28, P1554, DOI 10.3109/14767058.2014.960835; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Kobayashi Y, 2010, PLACENTA, V31, P245, DOI 10.1016/j.placenta.2009.12.026; Korkes HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110747; Kraus F, 2004, PLACENTAL PATHOLOGY; LABOW RS, 1980, CAN J BIOCHEM CELL B, V58, P23, DOI 10.1139/o80-004; Larsen WJ, 2001, HUMAN EMBRYOLOGY, V3; Lee N, 2015, PREGNANCY HYPERTENS, V5, P131, DOI [10.1016/j.preghy.2014.10.268, DOI 10.1016/J.PREGHY.2014.10.268]; MCNAUGHT RW, 1980, J STEROID BIOCHEM, V13, P363, DOI 10.1016/0022-4731(80)90017-5; Nakamura Y, 2015, HUM PATHOL IN PRESS; Nicola C, 2005, J CLIN ENDOCR METAB, V90, P4736, DOI 10.1210/jc.2005-0413; Nicola C, 2008, BIOL REPROD, V78, P976, DOI 10.1095/biolreprod.107.065433; PERCY P, 1991, BIOCHIM BIOPHYS ACTA, V1084, P173, DOI 10.1016/0005-2760(91)90217-6; Redline RW, 2007, HUM PATHOL, V38, P1439, DOI 10.1016/j.humpath.2007.05.025; REDLINE RW, 1995, HUM PATHOL, V26, P594, DOI 10.1016/0046-8177(95)90162-0; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Roescher AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089419; Sagawa N, 2002, PLACENTA, V23, pS80, DOI 10.1053/plac.2002.0814; Seidmann L, 2014, PLACENTA, V35, P925, DOI 10.1016/j.placenta.2014.07.018; SINGH EJ, 1972, LIPIDS, V7, P26, DOI 10.1007/BF02531265; Skraskova K, 2013, J CHROMATOGR A, V1319, P1, DOI 10.1016/j.chroma.2013.10.027; Staff AC, 2010, HYPERTENSION, V56, P1026, DOI 10.1161/HYPERTENSIONAHA.110.157743; Sugimura M, 1999, PLACENTA, V20, P555, DOI 10.1053/plac.1999.0420; Sugiura Y, 2006, ANAL CHEM, V78, P8227, DOI 10.1021/ac060974v; Sugiura Y, 2009, J LIPID RES, V50, P1776, DOI 10.1194/jlr.M900047-JLR200; Todros T, 1999, OBSTET GYNECOL, V93, P499, DOI 10.1016/S0029-7844(98)00440-2; Van de Plas R, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P458; Viall CA, 2015, AUTOIMMUN REV, V14, P446, DOI 10.1016/j.autrev.2015.01.008; Yao I, 2008, PROTEOMICS, V8, P3692, DOI 10.1002/pmic.200701121; Yuki D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07130	48	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142609	10.1371/journal.pone.0142609	http://dx.doi.org/10.1371/journal.pone.0142609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569622	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700051
J	Bhogal, MS; Lanyon-Hogg, T; Johnston, KA; Warriner, SL; Baker, A				Bhogal, Moninder S.; Lanyon-Hogg, Thomas; Johnston, Katherine A.; Warriner, Stuart L.; Baker, Alison			Covalent Label Transfer between Peroxisomal Importomer Components Reveals Export-driven Import Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEIN IMPORT; TARGETING SIGNAL RECEPTOR; SACCHAROMYCES-CEREVISIAE; IN-VITRO; CYCLING RECEPTOR; PLANT PEROXISOMES; ISOCITRATE LYASE; TYPE-1 RECEPTOR; PTS2 RECEPTOR; HUMAN PEX5	Peroxisomes are vital metabolic organelles found in almost all eukaryotic organisms, and they rely exclusively on import of their matrix protein content from the cytosol. In vitro import of proteins into isolated peroxisomal fractions has provided a wealth of knowledge on the import process. However, the common method of protease protection garnered no information on the import of an N-terminally truncated PEX5 (PEX5C) receptor construct or peroxisomal malate dehydrogenase 1 (pMDH1) cargo protein into sunflower peroxisomes because of high degrees of protease susceptibility or resistance, respectively. Here we present a means for analysis of in vitro import through a covalent biotin label transfer and employ this method to the import of PEX5C. Label transfer demonstrates that the PEX5C construct is monomeric under the conditions of the import assay. This technique was capable of identifying the PEX5-PEX14 interaction as the first interaction of the import process through competition experiments. Labeling of the peroxisomal protein import machinery by PEX5C demonstrated that this interaction was independent of added cargo protein, and, strikingly, the interaction between PEX5C and the import machinery was shown to be ATP-dependent. These important mechanistic insights highlight the power of label transfer in studying interactions, rather than proteins, of interest and demonstrate that this technique should be applied to future studies of peroxisomal in vitro import.	[Bhogal, Moninder S.; Lanyon-Hogg, Thomas; Johnston, Katherine A.; Baker, Alison] Univ Leeds, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; [Bhogal, Moninder S.; Lanyon-Hogg, Thomas; Johnston, Katherine A.; Baker, Alison] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Lanyon-Hogg, Thomas; Warriner, Stuart L.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Lanyon-Hogg, Thomas; Warriner, Stuart L.] Univ Leeds, Astbury Ctr, Leeds LS2 9JT, W Yorkshire, England; [Bhogal, Moninder S.] Univ Leeds, Leeds Inst Clin Trials Res, Leeds LS2 9JT, W Yorkshire, England; [Lanyon-Hogg, Thomas] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England	University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of Leeds; Imperial College London	Baker, A (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Ctr Plant Sci, Manton 9-05, Leeds LS2 9JT, W Yorkshire, England.	a.baker@leeds.ac.uk		Lanyon-Hogg, Thomas/0000-0002-7092-8096; Warriner, Stuart/0000-0002-7589-6011	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council; University of Leeds Centre for Plant Sciences;  [BB/D D000904/1]; Biotechnology and Biological Sciences Research Council [BB/D000904/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Leeds Centre for Plant Sciences; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a BB/D D000904/1 grant to A.B. Present address: Leeds Institute of Clinical Trials Research, University of Leeds, Leeds LS2 9JT, UK.r Supported by the Engineering and Physical Sciences Research Council, Biotechnology and Biological Sciences Research Council, and the University of Leeds Centre for Plant Sciences doctoral training studentship. Present address: Department of Chemistry, Imperial College London, London SW7 2AZ, UK.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Baker A, 2014, CURR OPIN PLANT BIOL, V22, P39, DOI 10.1016/j.pbi.2014.09.003; BEHARI R, 1993, J BIOL CHEM, V268, P7315; Brickner DG, 1997, PLANT PHYSIOL, V113, P1213, DOI 10.1104/pp.113.4.1213; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Brown AI, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003426; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Ciniawsky S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8331; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Cui S, 2013, J BIOL CHEM, V288, P6014, DOI 10.1074/jbc.M112.438143; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; Francisco T, 2014, BIOCHIMIE, V98, P29, DOI 10.1016/j.biochi.2013.08.003; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Gao XP, 1996, PLANT PHYSIOL, V112, P1457, DOI 10.1104/pp.112.4.1457; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghosh D, 2010, J AM CHEM SOC, V132, P3973, DOI 10.1021/ja9109049; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Goto S, 2011, PLANT CELL, V23, P1573, DOI 10.1105/tpc.110.080770; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Hagstrom D, 2014, MOL BIOL CELL, V25, P2634, DOI 10.1091/mbc.E13-12-0716; Harano T, 2001, BIOCHEM J, V357, P157, DOI 10.1042/0264-6021:3570157; Harper CC, 2003, J BIOL CHEM, V278, P7897, DOI 10.1074/jbc.M206651200; Helm M, 2007, P NATL ACAD SCI USA, V104, P11501, DOI 10.1073/pnas.0704733104; Hensel A, 2011, J BIOL CHEM, V286, P43495, DOI 10.1074/jbc.M111.286104; HORNG JT, 1995, EUR J BIOCHEM, V230, P157, DOI 10.1111/j.1432-1033.1995.tb20546.x; Johnson TL, 2003, PLANT PHYSIOL, V133, P1991, DOI 10.1104/pp.103.028217; Khan BR, 2010, PLANT PHYSIOL, V154, P1602, DOI 10.1104/pp.110.162479; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Kunau WH, 2001, CURR BIOL, V11, pR659, DOI 10.1016/S0960-9822(01)00386-4; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Lanyon-Hogg T, 2014, FEBS LETT, V588, P2223, DOI 10.1016/j.febslet.2014.05.038; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Leon S, 2006, BBA-MOL CELL RES, V1763, P1552, DOI 10.1016/j.bbamcr.2006.08.037; Ma CL, 2013, J BIOL CHEM, V288, P27220, DOI 10.1074/jbc.M113.492694; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Matsumoto N, 2003, NAT CELL BIOL, V5, P454, DOI 10.1038/ncb982; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Miyauchi-Nanri Y, 2014, BIOCHEM J, V463, P65, DOI 10.1042/BJ20130861; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Neuhaus A, 2014, J BIOL CHEM, V289, P437, DOI 10.1074/jbc.M113.499707; Nordgren M, 2015, AUTOPHAGY, V11, P1326, DOI 10.1080/15548627.2015.1061846; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Pan DQ, 2013, NAT STRUCT MOL BIOL, V20, P987, DOI 10.1038/nsmb.2618; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Pool MR, 1998, EMBO J, V17, P6854, DOI 10.1093/emboj/17.23.6854; Pracharoenwattana I, 2007, PLANT J, V50, P381, DOI 10.1111/j.1365-313X.2007.03055.x; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Reumann S, 2009, PLANT PHYSIOL, V150, P125, DOI 10.1104/pp.109.137703; Rodrigues TA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11806; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schuhmann H, 2008, PLANT PHYSIOL, V148, P1847, DOI 10.1104/pp.108.125377; Shiozawa K, 2009, J BIOL CHEM, V284, P25334, DOI 10.1074/jbc.M109.002311; Skoulding NS, 2015, J MOL BIOL, V427, P1085, DOI 10.1016/j.jmb.2014.12.003; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422	70	7	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2460	2468		10.1074/jbc.M115.686501	http://dx.doi.org/10.1074/jbc.M115.686501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26567336	Green Published, hybrid			2022-12-26	WOS:000369610400034
J	Shi, W; Zeng, Q; Kunkel, BN; Running, MP				Shi, Wan; Zeng, Qin; Kunkel, Barbara N.; Running, Mark P.			Arabidopsis Rab Geranylgeranyltransferases Demonstrate Redundancy and Broad Substrate Specificity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE BETA-SUBUNIT; PROTEIN GAMMA-SUBUNIT; ABSCISIC-ACID; COMPONENT-A; TIP GROWTH; PRENYLATION; GTPASE; RESOURCE; GENE; FARNESYLTRANSFERASE	Posttranslational lipid modifications mediate the membrane attachment of Rab GTPases, facilitating their function in regulating intracellular vesicular trafficking. In Arabidopsis, most Rab GTPases have two C-terminal cysteines and potentially can be double-geranylgeranylated by heterodimeric Rab geranylgeranyltransferases (Rab-GGTs). Genes encoding two putative alpha subunits and two putative beta subunits of Rab-GGTs have been annotated in the Arabidopsis thaliana genome, but little is known about Rab-GGT activity in Arabidopsis. In this study, we demonstrate that four different heterodimers can be formed between putative Arabidopsis Rab-GGT alpha subunits RGTA1/ RGTA2 and beta subunits RGTB1/RGTB2, but only RGTA1.RGTB1 and RGTA1.RGTB2 exhibit bona fide Rab-GGT activity, and they are biochemically redundant in vitro. We hypothesize that RGTA2 function might be disrupted by a 12-amino acid insertion in a conserved motif. We present evidence that Arabidopsis Rab-GGTs may have preference for prenylation of C-terminal cysteines in particular positions. We also demonstrate that Arabidopsis Rab-GGTs can not only prenylate a great variety of Rab GTPases in the presence of Rab escort protein but, unlike Rab-GGT in yeast and mammals, can also prenylate certain non-Rab GTPases independently of Rab escort protein. Our findings may help to explain some of the phenotypes of Arabidopsis protein prenyltransferase mutants.	[Shi, Wan; Kunkel, Barbara N.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Zeng, Qin] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Running, Mark P.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA	Washington University (WUSTL); Donald Danforth Plant Science Center; University of Louisville	Running, MP (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	mark.running@louisville.edu	Running, Mark P./R-8950-2019		Kentucky Science and Engineering Foundation [KSEF-2841-RDE-016]; National Science Foundation [NSF-IIA-1355438, NSF-IOS-1456884]; Direct For Biological Sciences [1456884] Funding Source: National Science Foundation; Office of Integrative Activities [1355438] Funding Source: National Science Foundation	Kentucky Science and Engineering Foundation; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by Kentucky Science and Engineering Foundation Grant KSEF-2841-RDE-016 and National Science Foundation Grants NSF-IIA-1355438 and NSF-IOS-1456884 (to M.P.R.). The authors declare that they have no conflicts of interest with the contents of this article.	Anant JS, 1998, BIOCHEMISTRY-US, V37, P12559, DOI 10.1021/bi980881a; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; ARMSTRONG SA, 1995, J BIOL CHEM, V270, P7864, DOI 10.1074/jbc.270.14.7864; Baron RA, 2008, BIOCHEM J, V415, P67, DOI 10.1042/BJ20080662; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biermann B, 1996, PLANT MOL BIOL, V31, P1021, DOI 10.1007/BF00040720; Bonetta D, 2000, PLANTA, V211, P182, DOI 10.1007/s004250000283; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Charng WL, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001777; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cutler S, 1996, SCIENCE, V273, P1239, DOI 10.1126/science.273.5279.1239; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Durek T, 2004, J AM CHEM SOC, V126, P16368, DOI 10.1021/ja046164n; Dursina B, 2002, BIOCHEMISTRY-US, V41, P6805, DOI 10.1021/bi016067w; Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041; Galichet A, 2003, CURR OPIN PLANT BIOL, V6, P530, DOI 10.1016/j.pbi.2003.09.005; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guo Z, 2008, EMBO J, V27, P2444, DOI 10.1038/emboj.2008.164; Gutkowska M, 2015, J EXP BOT, V66, P213, DOI 10.1093/jxb/eru412; Hala M, 2005, J MOL BIOL, V348, P1299, DOI 10.1016/j.jmb.2005.02.002; Hala M, 2010, PLANT J, V62, P615, DOI 10.1111/j.1365-313X.2010.04172.x; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Johnson CD, 2005, PLANT PHYSIOL, V139, P722, DOI 10.1104/pp.105.065045; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Lin YK, 1996, PLANT CELL, V8, P293, DOI 10.1105/tpc.8.2.293; Loraine AE, 1996, PLANT PHYSIOL, V110, P1337, DOI 10.1104/pp.110.4.1337; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Maurer-Stroh S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-212; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mijimolle N, 2005, CANCER CELL, V7, P313, DOI 10.1016/j.ccr.2005.03.004; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Molendijk AJ, 2004, CURR OPIN PLANT BIOL, V7, P694, DOI 10.1016/j.pbi.2004.09.014; Pagni M, 2004, NUCLEIC ACIDS RES, V32, pW332, DOI 10.1093/nar/gkh479; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Pinheiro H, 2009, J CELL SCI, V122, P3749, DOI 10.1242/jcs.050625; Preuss ML, 2004, PLANT CELL, V16, P1589, DOI 10.1105/tpc.021634; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Rasteiro R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-140; Running MP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00050; Running MP, 1998, DEVELOPMENT, V125, P2545; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; SANFORD JC, 1995, ANAL BIOCHEM, V224, P547, DOI 10.1006/abio.1995.1086; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; Shi W, 2013, METHODS MOL BIOL, V1043, P147, DOI 10.1007/978-1-62703-532-3_16; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sorek N, 2011, PLANT PHYSIOL, V155, P706, DOI 10.1104/pp.110.166850; Sorek N, 2009, CURR OPIN PLANT BIOL, V12, P714, DOI 10.1016/j.pbi.2009.09.003; Tanaka D, 2008, GENES CELLS, V13, P1141, DOI 10.1111/j.1365-2443.2008.01232.x; Thole JM, 2014, PLANT J, V78, P441, DOI 10.1111/tpj.12484; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Wu YW, 2009, J BIOL CHEM, V284, P13185, DOI 10.1074/jbc.M900579200; Yalovsky S, 1996, PLANT PHYSIOL, V110, P1349, DOI 10.1104/pp.110.4.1349; Yalovsky S, 2000, PLANT CELL, V12, P1267, DOI 10.1105/tpc.12.8.1267; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583; Zhang H, 2000, STRUCTURE, V8, P241, DOI 10.1016/S0969-2126(00)00102-7; Zhang H., 2006, HDB METALLOPROTEINS, DOI [10.1002/0470028637.met002, DOI 10.1002/0470028637.MET002]	70	6	12	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1398	1410		10.1074/jbc.M115.673491	http://dx.doi.org/10.1074/jbc.M115.673491			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26589801	hybrid, Green Published			2022-12-26	WOS:000368068300031
J	Ghanem, SS; Heinrich, G; Lester, SG; Pfeiffer, V; Bhattacharya, S; Patel, PR; DeAngelis, AM; Dai, T; Ramakrishnan, SK; Smiley, ZN; Jung, DY; Lee, Y; Kitamura, T; Ergun, S; Kulkarni, RN; Kim, JK; Giovannucci, DR; Najjar, SM				Ghanem, Simona S.; Heinrich, Garrett; Lester, Sumona G.; Pfeiffer, Verena; Bhattacharya, Sumit; Patel, Payal R.; DeAngelis, Anthony M.; Dai, Tong; Ramakrishnan, Sadeesh K.; Smiley, Zachary N.; Jung, Dae Y.; Lee, Yongjin; Kitamura, Tadahiro; Ergun, Suleyman; Kulkarni, Rohit N.; Kim, Jason K.; Giovannucci, David R.; Najjar, Sonia M.			Increased Glucose-induced Secretion of Glucagon-like Peptide-1 in Mice Lacking the Carcinoembryonic Antigenrelated Cell Adhesion Molecule 2 (CEACAM2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; ENERGY-BALANCE; BETA-CELL; HOMEOSTASIS; EXPRESSION; SUBSTRATE; KINASE; BRAIN; MODEL	Carcinoembryonic antigen-related cell adhesion molecule 2 (CEACAM2) regulates food intake as demonstrated by hyperphagia in mice with the Ceacam2 null mutation (Cc2(-/-)). This study investigated whether CEACAM2 also regulates insulin secretion. Ceacam2 deletion caused an increase in beta-cell secretory function, as assessed by hyperglycemic clamp analysis, without affecting insulin response. Although CEACAM2 is expressed in pancreatic islets predominantly in non-beta-cells, basal plasma levels of insulin, glucagon and somatostatin, islet areas, and glucose-induced insulin secretion in pooled Cc2(-/-) islets were all normal. Consistent with immunofluorescence analysis showing CEACAM2 expression in distal intestinal villi, Cc2(-/-) mice exhibited a higher release of oral glucose-mediated GLP-1, an incretin that potentiates insulin secretion in response to glucose. Compared with wild type, Cc2(-/-) mice also showed a higher insulin excursion during the oral glucose tolerance test. Pretreating with exendin(9-39), a GLP-1 receptor antagonist, suppressed the effect of Ceacam2 deletion on glucose-induced insulin secretion. Moreover, GLP-1 release into the medium of GLU Tag enteroendocrine cells was increased with siRNA-mediated Ceacam2 down-regulation in parallel to an increase in Ca2+ entry through L-type voltage-dependent Ca2+ channels. Thus, CEACAM2 regulates insulinsecretion, atleastinpart, by a GLP-1-mediated mechanism, independent of confounding metabolic factors.	[Ghanem, Simona S.; Heinrich, Garrett; Lester, Sumona G.; Patel, Payal R.; DeAngelis, Anthony M.; Dai, Tong; Ramakrishnan, Sadeesh K.; Smiley, Zachary N.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Ghanem, Simona S.; Heinrich, Garrett; Lester, Sumona G.; Patel, Payal R.; DeAngelis, Anthony M.; Dai, Tong; Ramakrishnan, Sadeesh K.; Smiley, Zachary N.; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Bhattacharya, Sumit; Giovannucci, David R.] Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus, Dept Neurosci, Toledo, OH 43614 USA; [Pfeiffer, Verena] Univ Wurzburg, Inst Anat & Zellbiol, D-97070 Wurzburg, Germany; [Jung, Dae Y.; Lee, Yongjin; Kim, Jason K.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Kitamura, Tadahiro] Gunma Univ, Metab Signal Res Ctr, Inst Mol & Cellular Regulat, Gunma 3718512, Japan; [Kulkarni, Rohit N.] Brigham & Womens Hosp, Joslin Diabet Ctr, Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Kulkarni, Rohit N.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University of Wurzburg; University of Massachusetts System; University of Massachusetts Worcester; Gunma University; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital	Najjar, SM (corresponding author), Univ Toledo, Coll Med & Life Sci, Hlth Sci Campus, 3000 Arlington Ave,Mail Stop 1009, Toledo, OH 43614 USA.	sonia.najjar@utoledo.edu	Giovannucci, David R/A-5657-2018; Najjar, Sonia M/GXW-2217-2022	Kim, Jason/0000-0002-7185-042X	National Institutes of Health [R01 DK054254, R01 DK083850, R01 HL112248, R01 DK67536, R01 DK103215, R21 DE023418, U24-DK093000]; United States Department of Agriculture Grant USDA [38903-19826]; Deutsche Forschungsgemeinschaft [ER 276/9-1 TI 690/3-1, SFB 688/3 A19]; Middle-East Diabetes Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE023418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054254, U2CDK093000, R01DK083850, R01DK103215, P30DK036836, R01DK067536, U24DK093000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Grant USDA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Middle-East Diabetes Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01 DK054254, R01 DK083850, and R01 HL112248 (to S. M. N.), Grants R01 DK67536 and R01 DK103215 (to R. N. K.), Grant R21 DE023418 (to D. R. G.), and Grant U24-DK093000 (to the National Mouse Metabolic Phenotyping Center at University of Massachusetts), United States Department of Agriculture Grant USDA 38903-19826 (to S. M. N.), and Deutsche Forschungsgemeinschaft Grants ER 276/9-1 TI 690/3-1 and SFB 688/3 A19 (to S. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a predoctoral fellowship from the Middle-East Diabetes Research Center.	Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Alshahrani MM, 2014, BLOOD, V124, P2431, DOI 10.1182/blood-2014-04-569707; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chan O, 2013, TRENDS ENDOCRIN MET, V24, P616, DOI 10.1016/j.tem.2013.08.005; Cho YR, 2007, AM J PHYSIOL-ENDOC M, V293, pE327, DOI 10.1152/ajpendo.00376.2006; DALESSIO DA, 1994, J CLIN INVEST, V93, P2263, DOI 10.1172/JCI117225; DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Drucker DJ, 2015, DIABETES, V64, P317, DOI 10.2337/db14-1514; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Habib AM, 2013, DIABETOLOGIA, V56, P1413, DOI 10.1007/s00125-013-2887-z; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Heinrich G, 2010, GASTROENTEROLOGY, V139, P644, DOI 10.1053/j.gastro.2010.03.056; Iakoubov R, 2007, ENDOCRINOLOGY, V148, P1089, DOI 10.1210/en.2006-1403; Josefsen K, 1996, J ENDOCRINOL, V149, P145, DOI 10.1677/joe.0.1490145; Kedees MH, 2013, PEPTIDES, V48, P36, DOI 10.1016/j.peptides.2013.07.022; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; Osundiji MA, 2012, DIABETES, V61, P321, DOI 10.2337/db11-1050; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Patel PR, 2012, DIABETOLOGIA, V55, P763, DOI 10.1007/s00125-011-2388-x; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Reimann F, 2005, J PHYSIOL-LONDON, V563, P161, DOI 10.1113/jphysiol.2004.076414; Reimann F, 2002, DIABETES, V51, P2757, DOI 10.2337/diabetes.51.9.2757; Robitaille J, 1999, EUR J BIOCHEM, V264, P534, DOI 10.1046/j.1432-1327.1999.00660.x; Salaheldeen E, 2012, MOL REPROD DEV, V79, P843, DOI 10.1002/mrd.22123; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Shalev A, 1997, EUR J ENDOCRINOL, V137, P220, DOI 10.1530/eje.0.1370220; Sidhu SS, 2000, J PHYSIOL-LONDON, V528, P165, DOI 10.1111/j.1469-7793.2000.00165.x; Thorens B, 2010, DIABETES METAB, V36, pS45, DOI 10.1016/S1262-3636(10)70466-3; Xu E, 2009, ENDOCRINOLOGY, V150, P3503, DOI 10.1210/en.2008-1439; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	36	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					980	988		10.1074/jbc.M115.692582	http://dx.doi.org/10.1074/jbc.M115.692582			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26586918	Green Published, hybrid			2022-12-26	WOS:000367830500043
J	Lim, HJ; Kim, J; Park, CH; Lee, SA; Lee, MR; Kim, KS; Kim, J; Bae, YS				Lim, Hee Jung; Kim, Jusong; Park, Chang-Hwan; Lee, Sang A.; Lee, Man Ryul; Kim, Kye-Seong; Kim, Jaesang; Bae, Yun Soo			Regulation of c-Myc Expression by Ahnak Promotes Induced Pluripotent Stem Cell Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTORS; TRANSCRIPTION FACTOR; SOMATIC-CELLS; PROTEIN; MOUSE; INHIBITION; EFFICIENCY; INDUCTION	We have previously reported that Ahnak-mediated TGF beta signaling leads to down-regulation of c-Myc expression. Here, we show that inhibition of Ahnak can promote generation of induced pluripotent stem cells (iPSC) via up-regulation of endogenous c-Myc. Consistent with the c-Myc inhibitory role of Ahnak, mouse embryonic fibroblasts from Ahnak-deficient mouse (Ahnak(-/-) MEF) show an increased level of c-Myc expression compared with wild type MEF. Generation of iPSC with just three of the four Yamanaka factors, Oct4, Sox2, and Klf4 (hereafter 3F), was significantly enhanced in Ahnak(-/-) MEF. Similar results were obtained when Ahnak-specific shRNA was applied to wild type MEF. Of note, expression of Ahnak was significantly induced during the formation of embryoid bodies from embryonic stem cells, suggesting that Ahnak-mediated c-Myc inhibition is involved in embryoid body formation and the initial differentiation of pluripotent stem cells. The iPSC from 3F-infected Ahnak(-/-) MEF cells (Ahnak(-/-) - iPSC-3F) showed expression of all stem cell markers examined and the capability to form three primary germ layers. Moreover, injection of Ahnak(-/-) - iPSC-3F into athymic nude mice led to development of teratoma containing tissues from all three primary germ layers, indicating that iPSC from Ahnak(-/-) MEF are bona fide pluripotent stem cells. Taken together, these data provide evidence for a new role for Ahnak in cell fate determination during development and suggest that manipulation of Ahnak and the associated signaling pathway may provide a means to regulate iPSC generation.	[Lim, Hee Jung; Kim, Jusong; Kim, Jaesang; Bae, Yun Soo] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Park, Chang-Hwan; Kim, Kye-Seong] Hanyang Univ, Dept Biomed Sci, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea; [Lee, Sang A.; Lee, Man Ryul] Soon Chun Hyang Univ, Soonchunhyang Inst Med Biosci, Cheonan 31538, South Korea	Ewha Womans University; Hanyang University; Soonchunhyang University	Kim, J (corresponding author), Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea.	jkim1964@ewha.ac.kr; baeys@ewha.ac.kr			National Research Foundation of Korea [2012R1A5A1048236]; Bio & Medical Technology Development Program [2012M3A9B4028785]; Redoxomics Grant - Ministry of Science, ICT & Future Planning [2012M3A9C5048708]; Ministry of Health & Welfare, Republic of Korea [A120262]	National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program; Redoxomics Grant - Ministry of Science, ICT & Future Planning; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by National Research Foundation of Korea Grant 2012R1A5A1048236, by Bio & Medical Technology Development Program Grant 2012M3A9B4028785, Redoxomics Grant 2012M3A9C5048708 funded by the Ministry of Science, ICT & Future Planning. This work was also supported by Grant A120262 from the Ministry of Health & Welfare, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chiou SH, 2013, J EXP MED, V210, P85, DOI 10.1084/jem.20121044; Choi MK, 2014, MOL CELLS, V37, P337, DOI 10.14348/molcells.2014.0021; Dai P, 2014, SCI REP-UK, V4, DOI 10.1038/srep07323; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; Lee IH, 2004, J BIOL CHEM, V279, P26645, DOI 10.1074/jbc.M311525200; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Lim HJ, 2013, CARDIOVASC RES, V97, P302, DOI 10.1093/cvr/cvs311; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Sekiya F, 1999, J BIOL CHEM, V274, P13900, DOI 10.1074/jbc.274.20.13900; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan FZ, 2015, J BIOL CHEM, V290, P4500, DOI 10.1074/jbc.M114.609016; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Theunissen TW, 2014, CELL STEM CELL, V14, P720, DOI 10.1016/j.stem.2014.05.002; Vrbsky J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127739; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	29	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					752	761		10.1074/jbc.M115.659276	http://dx.doi.org/10.1074/jbc.M115.659276			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26598518	Green Published, hybrid			2022-12-26	WOS:000367830500023
J	Bhardwaj, A; Sankhala, RS; Olia, AS; Brooke, D; Casjens, SR; Taylor, DJ; Prevelige, PE; Cingolani, G				Bhardwaj, Anshul; Sankhala, Rajeshwer S.; Olia, Adam S.; Brooke, Dewey; Casjens, Sherwood R.; Taylor, Derek J.; Prevelige, Peter E., Jr.; Cingolani, Gino			Structural Plasticity of the Protein Plug That Traps Newly Packaged Genomes in Podoviridae Virions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; hydrogen-deuterium exchange; infection; protein folding; x-ray crystallography; DNA packaging; tail needle; trimer of hairpins; viral genome ejection	TAIL NEEDLE GP26; ATOMIC-STRUCTURE; 3-DIMENSIONAL STRUCTURE; MOLECULAR REPLACEMENT; PHAGE-P22; BACTERIOPHAGE-P22; DNA; ARCHITECTURE; EVOLUTION; REVEALS	Bacterial viruses of the P22-like family encode a specialized tail needle essential for genome stabilization after DNA packaging and implicated in Gram-negative cell envelope penetration. The atomic structure of P22 tail needle (gp26) crystallized at acidic pH reveals a slender fiber containing an N-terminal trimer of hairpins tip. Although the length and composition of tail needles vary significantly in Podoviridae, unexpectedly, the amino acid sequence of the N-terminal tip is exceptionally conserved in more than 200 genomes of P22-like phages and prophages. In this paper, we used x-ray crystallography and EM to investigate the neutral pH structure of three tail needles from bacteriophage P22, HK620, and Sf6. In all cases, we found that the N-terminal tip is poorly structured, in stark contrast to the compact trimer of hairpins seen in gp26 crystallized at acidic pH. Hydrogen-deuterium exchange mass spectrometry, limited proteolysis, circular dichroism spectroscopy, and gel filtration chromatography revealed that the N-terminal tip is highly dynamic in solution and unlikely to adopt a stable trimeric conformation at physiological pH. This is supported by the cryo-EM reconstruction of P22 mature virion tail, where the density of gp26 N-terminal tip is incompatible with a trimer of hairpins. We propose the tail needle N-terminal tip exists in two conformations: a pre-ejection extended conformation, which seals the portal vertex after genome packaging, and a postejection trimer of hairpins, which forms upon its release from the virion. The conformational plasticity of the tail needle N-terminal tip is built in the amino acid sequence, explaining its extraordinary conservation in nature.	[Bhardwaj, Anshul; Sankhala, Rajeshwer S.; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Olia, Adam S.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Brooke, Dewey; Prevelige, Peter E., Jr.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Casjens, Sherwood R.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA; [Taylor, Derek J.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Cingolani, Gino] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy	Jefferson University; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Case Western Reserve University; Consiglio Nazionale delle Ricerche (CNR)	Cingolani, G (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu	Brooke, Dewey/AAZ-8307-2021	Brooke, Dewey/0000-0003-4290-3809; Bhardwaj, Anshul/0000-0002-0897-979X	National Institutes of Health [GM100888, GM114817]; NCI Cancer Center [P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM114817, R01GM100888] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants GM100888 (to G. C.) and GM114817 (to S. R. C.). Research in this publication includes work carried out at the Sidney Kimmel Cancer Center X-ray Crystallography and Molecular Interaction Facility, which is supported in part by NCI Cancer Center Support Grant P30 CA56036. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AFONINE PV, 2013, COMPUT CRYSTALLOGR N, V0004; Andres D, 2010, J BIOL CHEM, V285, P36768, DOI 10.1074/jbc.M110.169003; Andrews D, 2005, J BIOL CHEM, V280, P5929, DOI 10.1074/jbc.C400513200; BERGET PB, 1980, J VIROL, V34, P234, DOI 10.1128/JVI.34.1.234-243.1980; Bhardwaj A, 2007, J MOL BIOL, V371, P374, DOI 10.1016/j.jmb.2007.05.051; Bhardwaj A, 2014, CURR OPIN STRUC BIOL, V25, P1, DOI 10.1016/j.sbi.2013.10.005; Bhardwaj A, 2014, ACTA CRYSTALLOGR D, V70, P342, DOI 10.1107/S1399004713027685; Bhardwaj A, 2011, J BIOL CHEM, V286, P30867, DOI 10.1074/jbc.M111.260877; Bhardwaj A, 2009, J MOL BIOL, V391, P227, DOI 10.1016/j.jmb.2009.05.069; Casjens SR, 2011, VIROLOGY, V411, P393, DOI 10.1016/j.virol.2010.12.046; Chang J, 2006, STRUCTURE, V14, P1073, DOI 10.1016/j.str.2006.05.007; Cingolani G, 2000, FEBS LETT, V484, P291, DOI 10.1016/S0014-5793(00)02154-2; Cingolani G, 2006, ACTA CRYSTALLOGR F, V62, P477, DOI 10.1107/S1744309106013856; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; ISRAEL V, 1978, J GEN VIROL, V40, P669, DOI 10.1099/0022-1317-40-3-669; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; Jin Y, 2015, VIROLOGY, V485, P128, DOI 10.1016/j.virol.2015.07.006; KASHKET ER, 1982, BIOCHEMISTRY-US, V21, P5534, DOI 10.1021/bi00265a024; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lander GC, 2009, STRUCTURE, V17, P789, DOI 10.1016/j.str.2009.04.006; Leavitt JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070936; Leavitt JC, 2013, VIROLOGY, V440, P117, DOI 10.1016/j.virol.2013.02.023; Lokareddy RK, 2013, BIOCHEMISTRY-US, V52, P938, DOI 10.1021/bi301476m; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McNulty R, 2015, J MOL BIOL, V427, P3285, DOI 10.1016/j.jmb.2015.08.013; Merckel MC, 2005, MOL CELL, V18, P161, DOI 10.1016/j.molcel.2005.03.019; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Olia AS, 2006, J MOL BIOL, V363, P558, DOI 10.1016/j.jmb.2006.08.014; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Olia AS, 2009, PROTEIN SCI, V18, P537, DOI 10.1002/pro.53; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parent KN, 2012, VIROLOGY, V427, P177, DOI 10.1016/j.virol.2012.01.040; POTEETE AR, 1977, VIROLOGY, V76, P725, DOI 10.1016/0042-6822(77)90254-9; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; Roy A, 2012, J BIOL CHEM, V287, P28196, DOI 10.1074/jbc.M112.349894; STRAUSS H, 1984, J MOL BIOL, V172, P523, DOI 10.1016/S0022-2836(84)80021-2; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang JH, 2011, STRUCTURE, V19, P496, DOI 10.1016/j.str.2011.02.010; Tang L, 2005, EMBO J, V24, P2087, DOI 10.1038/sj.emboj.7600695; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880	53	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					215	226		10.1074/jbc.M115.696260	http://dx.doi.org/10.1074/jbc.M115.696260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26574546	Green Published, hybrid			2022-12-26	WOS:000367589500017
J	Wu, YG; Zhou, J; Li, YH; Zhou, YJ; Cui, YQ; Yang, G; Hong, Y				Wu, Yougen; Zhou, Juan; Li, Yinghua; Zhou, Yunjiao; Cui, Yunqing; Yang, Gong; Hong, Yang			Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR; MAP KINASE; CELL-PROLIFERATION; EXPRESSION; RUNX2; PATHWAY; TARGET; C2C12; BMP-2	Rap1A is a member of small G proteins belonging to the Ras family. Recently, an integration of human genome-wide association studies (GWAS) and gene expression profiling study revealed that single-nucleotide polymorphisms (SNPs) within human Rap1A were strongly associated with narrow neck width in women. However, the regulatory role of Rap1A in osteoblasts remains to be elucidated. Here we report that Rap1A is a key regulator in osteoblast differentiation. Rap1A expression and activity were gradually enhanced during the induced differentiation of multipotent mesenchymal progenitor cells (C2C12) and preosteoblastic cells (MC3T3-E1). Knockdown of endogenous Rap1A significantly inhibited the osteogenic marker gene expression and matrix mineralization in cells with osteogenesis. In addition, knockdown of endogenous Rap1A suppressed the activation of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK), while overexpression of Rap1A accelerated osteoblast differentiation and enhanced the phosphorylation of ERK and p38. Taken together, our study suggests that Rap1A regulates osteoblast differentiation through modulating the ERK/p38 signaling.	[Wu, Yougen; Zhou, Juan; Li, Yinghua; Zhou, Yunjiao; Cui, Yunqing; Yang, Gong; Hong, Yang] Fudan Univ, Peoples Hosp Shanghai 5, Cent Lab, Shanghai 200240, Peoples R China; [Yang, Gong] Fudan Univ, Shanghai Canc Ctr, Inst Canc, Shanghai 200032, Peoples R China; [Yang, Gong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Hong, Yang] Fudan Univ, Peoples Hosp Shanghai 5, Dept Osteol, Shanghai 200240, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Yang, G (corresponding author), Fudan Univ, Peoples Hosp Shanghai 5, Cent Lab, Shanghai 200240, Peoples R China.	yanggong@fudan.edu.cn; hongyangcm@163.com		Wu, Yougen/0000-0002-1498-4085	Natural Science Foundation of Minhang District of Shanghai [2014MHZ055]	Natural Science Foundation of Minhang District of Shanghai	This work was supported by Natural Science Foundation of Minhang District of Shanghai, No. 2014MHZ055.	de Oliveira PT, 2003, J HISTOCHEM CYTOCHEM, V51, P633, DOI 10.1177/002215540305100509; Dorn A, 2012, CELL IMMUNOL, V276, P187, DOI 10.1016/j.cellimm.2012.05.008; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hsu YL, 2008, J BONE MINER RES, V23, P949, DOI 10.1359/JBMR.080219; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Huang YF, 2012, J BONE MINER RES, V27, P1093, DOI 10.1002/jbmr.1548; Kim JH, 2014, J CELL BIOL, V204, P1063, DOI 10.1083/jcb.201308102; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Lin KL, 2010, J BONE MINER RES, V25, P2489, DOI 10.1002/jbmr.159; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Matsushita T, 2009, MOL CELL BIOL, V29, P5843, DOI 10.1128/MCB.01549-08; Moon JS, 2014, J BONE MINER RES, V29, P1586, DOI 10.1002/jbmr.2197; Mundy C, 2014, J CELL PHYSIOL, V229, P672, DOI 10.1002/jcp.24491; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pizon V, 2000, ONCOGENE, V19, P6074, DOI 10.1038/sj.onc.1203984; Sayyah J, 2014, J BIOL CHEM, V289, P17689, DOI 10.1074/jbc.M113.536227; Sondag GR, 2014, J CELL PHYSIOL, V229, P955, DOI 10.1002/jcp.24512; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Xiang J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0125-x; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zou W, 2013, MOL CELL BIOL, V33, P830, DOI 10.1128/MCB.00790-12	26	35	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143777	10.1371/journal.pone.0143777	http://dx.doi.org/10.1371/journal.pone.0143777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599016	Green Published, gold, Green Submitted			2022-12-26	WOS:000365862600121
J	Louis, M; Hofmann, K; Broemer, M				Louis, Marcell; Hofmann, Kay; Broemer, Meike			Evolutionary Loss of Activity in De-Ubiquitylating Enzymes of the OTU Family	PLOS ONE			English	Article							OVARIAN TUMOR GENE; DROSOPHILA-MELANOGASTER; CELL-DEATH; PROTEASES; PROTEINS; SEQUENCE; DOMAIN; DEUBIQUITINASES; GENERATION; OOGENESIS	Understanding function and specificity of de-ubiquitylating enzymes (DUBs) is a major goal of current research, since DUBs are key regulators of ubiquitylation events and have been shown to be mutated in human diseases. Most DUBs are cysteine proteases, relying on a catalytic triad of cysteine, histidine and aspartate to cleave the isopeptide bond between two ubiquitin units in a poly-ubiquitin chain. We have discovered that the two Drosophila melanogaster homologues of human OTUD4, CG3251 and Otu, contain a serine instead of a cysteine in the catalytic OTU (ovarian tumor) domain. DUBs that are serine proteases instead of cysteine-or metallo-proteases have not been described. In line with this, neither CG3251 nor Otu protein were active to cleave ubiquitin chains. Re-introduction of a cysteine in the catalytic center did not render the enzymes active, indicating that further critical features for ubiquitin binding or cleavage have been lost in these proteins. Sequence analysis of OTUD4 homologues from various other species showed that within this OTU subfamily, loss of the catalytic cysteine has occurred frequently in presumably independent events, as well as gene duplications or triplications, suggesting DUB-independent functions of OTUD4 proteins. Using an in vivo RNAi approach, we show that CG3251 might function in the regulation of Inhibitor of Apoptosis (IAP)-antagonist-induced apoptosis, presumably in a DUB-independent manner.	[Louis, Marcell; Broemer, Meike] German Ctr Neurodegenerat Dis DZNE, LiMeS, D-53115 Bonn, Germany; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Cologne	Broemer, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, LiMeS, Carl Troll Str 31, D-53115 Bonn, Germany.	meike.broemer@dzne.de			Deutsche Forschungsgemeinschaft (DFG) [BR 3442/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding: This work was supported by Deutsche Forschungsgemeinschaft (DFG) (BR 3442/2-1) to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; Fernando MDA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004117; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Glenn LE, 2001, MECH DEVELOP, V102, P181, DOI 10.1016/S0925-4773(01)00314-8; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KING RC, 1988, BIOESSAYS, V8, P18, DOI 10.1002/bies.950080106; KING RC, 1986, DEV GENET, V7, P1, DOI 10.1002/dvg.1020070102; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Leulier F, 2006, CELL DEATH DIFFER, V13, P1663, DOI 10.1038/sj.cdd.4401868; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; RODESCH C, 1995, GENETICS, V141, P191; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASS GL, 1993, GENETICS, V133, P253; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Seetharam Arun, 2012, BMC Res Notes, V5, P670, DOI 10.1186/1756-0500-5-670; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; STEINHAUER WR, 1989, MOL CELL BIOL, V9, P5726, DOI 10.1128/MCB.9.12.5726; STROUD RM, 1974, SCI AM, V231, P74, DOI 10.1038/scientificamerican0774-74; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17; Zhao Y, 2015, EMBO J, V34, P1687, DOI 10.15252/embj.201490497	36	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143227	10.1371/journal.pone.0143227	http://dx.doi.org/10.1371/journal.pone.0143227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588485	Green Published, gold			2022-12-26	WOS:000365251500040
J	Mazur, A; Welker, KM; Peng, B				Mazur, Allan; Welker, Keith M.; Peng, Bin			Does the Biosocial Model Explain the Emergence of Status Differences in Conversations among Unacquainted Men?	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; AGGRESSIVE-BEHAVIOR; TESTOSTERONE; DOMINANCE; HYPOTHESIS	Fifteen triads of unacquainted men conversed for ten minutes while stress was measured in real time by pulse rate and thumb blood volume (TBV). Salivary measures of testosterone (T), cortisol (C), and the stress-related enzyme alpha-amylase (AA) were measured at the beginning and end of the session. Fully or partially transitive status hierarchies formed in 14 triads. (Highest ranked man was scored 1, lowest 3, with ties allowed.) Ten of the triads participated in Study 1, where nothing was at stake in the casual conversation. Five additional triads were run in Study 2, intended to introduce competition by offering a $20 reward to the man afterward chosen as having led the conversation. Most results from the two studies are similar, suggesting that the $20 reward had little effect. Combining studies, pulse and TBV show that conversation is more stressful than watching a video beforehand. Within the conversation, speaking turns are more stressful than listening turns, especially among the lowest ranked men, less so among those higher in rank. This supports a stress-based mechanism for status allocation among humans. Apparently, human speech is a form of status signaling, homologous with nonlinguistic status signals used by other primates, as posited by the "biosocial model." The biosocial model also posits that a physiological substrate (T, C, and AA) is related to dominance or status. Predicted effects are not replicated here, except for an inverse relationship between the stress enzyme AA and status. The mostly null results, obtained from conversations where there was little or nothing at stake, suggest that T and C (and their interaction) are not relevant to emergent status in the absence of serious competition.	[Mazur, Allan] Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA; [Welker, Keith M.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA; [Peng, Bin] Syracuse Univ, Dept Econ, Syracuse, NY 13244 USA	Syracuse University; University of Massachusetts System; University of Massachusetts Boston; Syracuse University	Mazur, A (corresponding author), Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA.	amazur@syr.edu	Peng, Bin/AAG-6796-2020					Aiken L. S., 1991, MULTIPLE REGRESSION; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Bales R, 1953, WORKING PAPERS THEOR; Batrinos ML, 2012, INT J ENDOCRINOL MET, V10, P563, DOI 10.5812/ijem.3661; BERGER J, 1972, AM SOCIOL REV, V37, P241, DOI 10.2307/2093465; BRINKERHOFF DB, 1984, J SOC BIOL STRUCT, V7, P159, DOI 10.1016/S0140-1750(84)80007-X; Burnham T, 2007, P ROYAL SOC B; Carre JM, 2008, HORM BEHAV, V54, P403, DOI 10.1016/j.yhbeh.2008.04.008; Carre JM, 2013, PSYCHONEUROENDOCRINO, V38, P2034, DOI 10.1016/j.psyneuen.2013.03.008; Chen FR, 2015, PSYCHONEUROENDOCRINO, V51, P188, DOI 10.1016/j.psyneuen.2014.09.027; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; FISEK MH, 1970, SOCIOMETRY, V33, P327, DOI 10.2307/2786161; Fiske SusanT., 2010, HDB SOCIAL PSYCHOL, V5th ed., P941, DOI DOI 10.1002/9780470561119.SOCPSY002026; Garson, 2013, HIERARCHICAL LINEAR; Giles GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113618; Goffman E., 1967, INTERACTION RITUAL E; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Granger DA, 2012, J ADOLESCENCE, V35, P1081, DOI 10.1016/j.adolescence.2012.01.005; Homans G.C., 1961, SOCIAL BEHAV ITS ELE; Jaccard J., 2003, INTERACTION EFFECTS; Kenny DA, 2002, J PERS SOC PSYCHOL, V83, P126, DOI 10.1037/0022-3514.83.1.126; Koski J, 2015, SOCIAL NEUROSCIENCE; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Maner JK, 2008, PSYCHOL SCI, V19, P764, DOI 10.1111/j.1467-9280.2008.02154.x; Manson J, 2004, PLOS ONE, V9, DOI [10.1371/journal.pone.0113135, DOI 10.1371/J0URNAL.P0NE.0113135]; Mast MS, 2002, HUM COMMUN RES, V28, P420, DOI 10.1111/j.1468-2958.2002.tb00814.x; MAZUR A, 1985, SOC FORCES, V64, P377; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; MAZUR A, 1984, AM J SOCIOL, V90, P125, DOI 10.1086/228050; Mazur A, 2015, HDB EVOLUTION SOC; Mazur A., 2005, BIOSOCIOLOGY DOMINAN; Mazur A, 2014, BIOL PSYCHOL, V96, P72, DOI 10.1016/j.biopsycho.2013.11.015; Mehta PH, 2015, CURR OPIN BEHAV SCI, V3, P163, DOI 10.1016/j.cobeha.2015.04.008; Mehta PH, 2015, PSYCHONEUROENDOCRINO, V56, P88, DOI 10.1016/j.psyneuen.2015.02.023; Mehta PH, 2010, HORM BEHAV, V58, P898, DOI 10.1016/j.yhbeh.2010.08.020; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Olmstead N, 2014, NEUROSCIENCE; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Scherbaum CA, 2009, ORGAN RES METHODS, V12, P347, DOI 10.1177/1094428107308906; Sherman GD, J PERSONALI IN PRESS; Stanton SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007543; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Zilioli S, 2014, BIOL PSYCHOL, V103, P54, DOI 10.1016/j.biopsycho.2014.07.022	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142941	10.1371/journal.pone.0142941	http://dx.doi.org/10.1371/journal.pone.0142941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26588849	Green Published, gold			2022-12-26	WOS:000365251500026
J	Preethirani, PL; Isloor, S; Sundareshan, S; Nuthanalakshmi, V; Deepthikiran, K; Sinha, AY; Rathnamma, D; Prabhu, KN; Sharada, R; Mukkur, TK; Hegde, NR				Preethirani, P. L.; Isloor, Shrikrishna; Sundareshan, S.; Nuthanalakshmi, V.; Deepthikiran, K.; Sinha, Akhauri Y.; Rathnamma, D.; Prabhu, K. Nithin; Sharada, R.; Mukkur, Trilochan K.; Hegde, Nagendra R.			Isolation, Biochemical and Molecular Identification, and In-Vitro Antimicrobial Resistance Patterns of Bacteria Isolated from Bubaline Subclinical Mastitis in South India	PLOS ONE			English	Article							SOMATIC-CELL COUNT; COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYMERASE-CHAIN-REACTION; INTRAMAMMARY INFECTION; OXACILLIN RESISTANCE; ANTIBIOTIC-RESISTANCE; CLINICAL MASTITIS; D-GLUCOSAMINIDASE; BOVINE MASTITIS; UDDER HEALTH	Buffaloes are the second largest source of milk. Mastitis is a major impediment for milk production, but not much information is available about bubaline mastitis, especially subclinical mastitis. The aim of this study was to (a) investigate the application of various tests for the diagnosis of bubaline subclinical mastitis, (b) identify the major bacteria associated with it, and (c) evaluate the antibiotic resistance pattern of the bacteria. To this end, 190 quarter milk samples were collected from 57 domesticated dairy buffaloes from organized (64 samples) and unorganized (126 samples) sectors. Of these, 48.4%, 40.0%, 45.8%, 61.1%, and 61.6% were positive for subclinical mastitis by somatic cell count, electrical conductivity, California mastitis test, bromothymol blue test, and N-acetyl glucosaminidase test, respectively. As compared to the gold standard of somatic cell count, California mastitis test performed the best. However, a combination of the two methods was found to be the best option. Microbiological evaluation, both by biochemical methods as well as by monoplex and multiplex polymerase chain reaction, revealed that coagulase-negative staphylococci were the most predominant (64.8%) bacteria, followed by streptococci (18.1%), Escherichia coli (9.8%) and Staphylococcus aureus (7.3%). Most of the pathogens were resistant to multiple antibiotics, especially to beta-lactam antibiotics. We propose that California mastitis test be combined with somatic cell count for diagnosis of subclinical mastitis in domestic dairy buffaloes. Further, our results reveal high resistance of the associated bacteria to the beta-lactam class of antibiotics, and a possible major role of coagulase-negative staphylococci in causing the disease in India.	[Preethirani, P. L.; Isloor, Shrikrishna; Sundareshan, S.; Nuthanalakshmi, V.; Deepthikiran, K.; Rathnamma, D.; Prabhu, K. Nithin; Sharada, R.] Karnataka Vet Anim & Fisheries Sci Univ, Dept Microbiol, Hebbal, Bengaluru, India; [Sinha, Akhauri Y.; Hegde, Nagendra R.] Ella Fdn, Genome Valley, Hyderabad, Andhra Pradesh, India; [Mukkur, Trilochan K.] Curtin Univ, Fac Hlth Sci, Sch Biomed Sci, Perth, WA 6845, Australia	Curtin University	Hegde, NR (corresponding author), Ella Fdn, Genome Valley, Hyderabad, Andhra Pradesh, India.	hegden@ellafoundation.org	Hegde, Nagendra R/H-3132-2019	Hegde, Nagendra R/0000-0001-5260-2159	Department of Biotechnology, Government of India [BT/Indo-US/04/06/2009]; Department of Innovation, Industry, Science and Research, Government of Australia [BF040038]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Innovation, Industry, Science and Research, Government of Australia	Funding: This work was funded in part by a grant from the Department of Biotechnology (BT/Indo-US/04/06/2009), Government of India (www.dbtindia.nic.in), to NRH and SI, and from the Department of Innovation, Industry, Science and Research (BF040038), Government of Australia (www.industry.gov.au), to TKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W. M., 2008, Global Veterinaria, V2, P41; Ali MA, 2011, J ANIM PLANT SCI-PAK, V21, P477; [Anonymous], 1995, BOVINE UDDER MASTITI; Bachaya H. A., 2005, Pakistan Veterinary Journal, V25, P134; Barrow G.I., 1993, COWAN STEELS MANUAL, V3rd; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bjork S, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-12; Bosshard PP, 2004, J CLIN MICROBIOL, V42, P2065, DOI 10.1128/JCM.42.5.2065-2073.2004; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Ceron-Munoz M, 2002, J DAIRY SCI, V85, P2885, DOI 10.3168/jds.S0022-0302(02)74376-2; Charaya G, 2014, VET WORLD, V7, P980, DOI 10.14202/vetworld.2014.980-985; Clinical and Laboratory Standards Institute, 2010, PERF STAND ANT SUSC; Collee JG, 1996, MACKIE MCCARTNEY PRA; Contreras A, 1999, SMALL RUMINANT RES, V31, P203, DOI 10.1016/S0921-4488(98)00147-3; Daly P, 2002, LETT APPL MICROBIOL, V34, P222, DOI 10.1046/j.1472-765x.2002.01074.x; de Medeiros ES, 2011, J VET DIAGN INVEST, V23, P793, DOI 10.1177/1040638711407882; De Vliegher S, 2012, J DAIRY SCI, V95, P1025, DOI 10.3168/jds.2010-4074; Dhakal IP, 2006, J VET MED B, V53, P81, DOI 10.1111/j.1439-0450.2006.00918.x; Dhakal IP, 2007, J VET MED SCI, V69, P1241, DOI 10.1292/jvms.69.1241; El-Ashker M, 2015, J DAIRY SCI, V98, P7450, DOI 10.3168/jds.2015-9432; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Food and Agriculture Organization, 2014, IMP MAST SMALL SCAL, V13, P10; Guha A, 2012, ASIAN AUSTRAL J ANIM, V25, P353, DOI 10.5713/ajas.2011.11426; Hegde R, 2011, THESIS; Hegde R, 2013, INDIAN J MICROBIOL, V53, P315, DOI 10.1007/s12088-012-0336-1; Hogan J., 1999, LAB HDB BOVINE MASTI; Jeykumar M, 2013, VET WORLD, V6, P354, DOI 10.5455/vetworld.2013.354-356; Joshi L.R., 2014, INT J APPL SCI BIOTE, V2, P29, DOI DOI 10.3126/IJASBT.V2I1.9861; Kalmus P, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-4; Khan A. Z., 2005, Pakistan Veterinary Journal, V25, P9; Khudaier B. Y., 2014, Basrah Journal of Veterinary Research, V13, P235; KITCHEN BJ, 1976, J DAIRY RES, V43, P491, DOI 10.1017/S0022029900016071; Koop G, 2012, J DAIRY SCI, V95, P7200, DOI 10.3168/jds.2012-5747; Koop G, 2012, J DAIRY SCI, V95, P5075, DOI 10.3168/jds.2012-5615; Kumar R, 2011, MICROB PATHOGENESIS, V51, P31, DOI 10.1016/j.micpath.2011.03.006; Kumar S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-186; Kurjogi M. M., 2014, INT SCH RES NOT, V2014, P1, DOI DOI 10.1155/2014/968076; Leitner G, 2004, J DAIRY RES, V71, P311, DOI 10.1017/S0022029904000305; Leitner G, 2007, J DAIRY RES, V74, P186, DOI 10.1017/S0022029906002299; Li XR, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-31; MCDONALD TJ, 1976, AM J VET RES, V37, P377; McDougall S, 2014, NEW ZEAL VET J, V62, P136, DOI 10.1080/00480169.2013.865294; Mitra M, 1995, INDIAN VET J, V72, P1310; Moroni P, 2006, J DAIRY SCI, V89, P998, DOI 10.3168/jds.S0022-0302(06)72165-8; Moroni P, 2005, PREV VET MED, V69, P163, DOI 10.1016/j.prevetmed.2004.10.013; NAGAHATA H, 1987, CAN J VET RES, V51, P126; National Academy of Agricultural Sciences, 2013, MAST MAN DAIR AN; Odierno L, 2006, J DAIRY SCI, V89, P3886, DOI 10.3168/jds.S0022-0302(06)72431-6; Pamuk S., 2010, KOCATEPE VET J, V3, P7; Persson Y, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-15; Pieterse R, 2010, BRAZ J MICROBIOL, V41, P542, DOI 10.1590/S1517-83822010000300003; Pottumarthy S, 2005, DIAGN MICR INFEC DIS, V51, P57, DOI 10.1016/j.diagmicrobio.2004.08.002; Prabhu KN, 2013, INDIAN J BIOTECHNOL, V12, P208; Pyorala S, 2003, VET RES, V34, P565, DOI 10.1051/vetres:2003026; Radostits OM, 2000, TXB DIS CATTLE SHEEP, V9th; Ramesha K. P., 2014, Indian Dairyman, V66, P94; Ranjan R, 2010, VET WORLD, V3, P17; Reneau JK, 2001, P NATL MAST COUNC RE, P18; Rovai M, 2014, J DAIRY SCI, V97, P5393, DOI 10.3168/jds.2014-7988; Ruegg PL, 2012, VET CLIN N AM-FOOD A, V28, P149, DOI 10.1016/j.cvfa.2012.03.001; Sani RN, 2015, TROP ANIM HEALTH PRO, V47, P1249, DOI 10.1007/s11250-015-0855-y; Schukken YH, 2003, VET RES, V34, P579, DOI 10.1051/vetres:2003028; Sharma A, 2007, ITAL J ANIM SCI, V6, P965; Sharma N, 2011, ASIAN AUSTRAL J ANIM, V24, P429, DOI 10.5713/ajas.2011.10233; Sheet O. H., 2010, Iraqi Journal of Veterinary Sciences, V24; Singh M., 2014, Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, V35, P67, DOI 10.5958/0974-0147.2014.00007.5; Singh M, 2001, ASIAN AUSTRAL J ANIM, V14, P189, DOI 10.5713/ajas.2001.189; SMITH KL, 1993, VET CLIN N AM-FOOD A, V9, P489, DOI 10.1016/S0749-0720(15)30616-2; Sudhan N. A., 2005, Indian Journal of Animal Research, V39, P127; Sumathi BR, 2008, VET WORLD, V1, P37; Sundareshan S, 2012, FRONT J ANIM SCI, V1, P34; Sundareshan S, 2012, CHARACTERIZATION COA; Suriyasathaporn W, 2012, ASIAN AUSTRAL J ANIM, V25, P1322, DOI 10.5713/ajas.2012.12023; Swenson JM, 2007, DIAGN MICR INFEC DIS, V58, P33, DOI 10.1016/j.diagmicrobio.2006.10.022; Taponen S, 2009, VET MICROBIOL, V134, P29, DOI 10.1016/j.vetmic.2008.09.011; Thorberg BM, 2009, J DAIRY SCI, V92, P4962, DOI 10.3168/jds.2009-2184; Tiwari J. G., 2013, Journal of Vaccines and Vaccination, V4, P1000176; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Vanderhaeghen W, 2014, J DAIRY SCI, V97, P5275, DOI 10.3168/jds.2013-7775; Vanderhaeghen W, 2015, VET J, V203, P44, DOI 10.1016/j.tvjl.2014.11.001; Velasco D, 2005, J ANTIMICROB CHEMOTH, V55, P379, DOI 10.1093/jac/dki017; Viguier C, 2009, TRENDS BIOTECHNOL, V27, P486, DOI 10.1016/j.tibtech.2009.05.004; Witte W, 2007, CLIN MICROBIOL INFEC, V13, P408, DOI 10.1111/j.1469-0691.2006.01671.x; Yokoigawa K, 2003, FEMS MICROBIOL LETT, V221, P263, DOI 10.1016/S0378-1097(03)00216-7; Zhao YQ, 2015, TROP ANIM HEALTH PRO, V47, P429, DOI 10.1007/s11250-014-0742-y	85	30	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142717	10.1371/journal.pone.0142717	http://dx.doi.org/10.1371/journal.pone.0142717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588070	Green Published, gold, Green Submitted			2022-12-26	WOS:000365251500014
J	Rameneni, JJ; Lee, Y; Dhandapani, V; Yu, X; Choi, SR; Oh, MH; Lim, YP				Rameneni, Jana Jeevan; Lee, Yeon; Dhandapani, Vignesh; Yu, Xiaona; Choi, Su Ryun; Oh, Man-Ho; Lim, Yong Pyo			Genomic and Post-Translational Modification Analysis of Leucine-Rich-Repeat Receptor-Like Kinases in Brassica rapa	PLOS ONE			English	Article							PROTEIN-KINASES; TYROSINE PHOSPHORYLATION; ARABIDOPSIS; GENES; FAMILY; GROWTH; BAK1; TRANSCRIPTOME; PEPTIDE; RNA	Among several receptor-like kinases (RLKs), leucine-rich-repeat receptor-like kinases (LRR-RLKs) are a major group of genes that play crucial roles in growth, development and stress responses in plant systems. Given that they have several functional roles, it is important to investigate their roles in Brassica rapa. In the present study, 303 LRR-RLKs were identified in the genome of B. rapa and comparative phylogenetic analysis of 1213 combined LRR-RLKs of B. rapa, Arabidopsis thaliana, Oryza sativa and Populus trichocarpa helped us to categorize the gene family into 15 subfamilies based on their sequence and structural similarities. The chromosome localizations of 293 genes allowed the prediction of duplicates, and motif conservation and intron/exon patterns showed differences among the B. rapa LRR-RLK (BrLRR-RLK) genes. Additionally, computational function annotation and expression analysis was used to predict their possible functional roles in the plant system. Biochemical results for 11 selected genes showed variations in phosphorylation activity. Interestingly, BrBAK1 showed strong auto-phosphorylation and trans-phosphorylation on its tyrosine and threonine residues compared with AtBAK1 in previous studies. The AtBAK1 receptor kinase is involved in plant growth and development, plant innate immunity, and programmed cell death, and our results suggest that BrBAK1 might also be involved in the same functions. Another interesting result was that BrBAK1, BrBRI1, BrPEPR1 and BrPEPR2 showed activity with both anti-phosphotyrosine and anti-phosphothreonine antibodies, indicating that they might have dual-specificity kinase activity. This study provides comprehensive results for the BrLRR-RLKs, revealing expansion of the gene family through gene duplications, structural similarities and variations among the genes, and potential functional roles according to gene ontology, transcriptome profiling and biochemical analysis.	[Rameneni, Jana Jeevan; Dhandapani, Vignesh; Yu, Xiaona; Choi, Su Ryun; Lim, Yong Pyo] Chungnam Natl Univ, Coll Agr & Life Sci, Dept Hort, Mol Genet & Genom Lab, Taejon 305764, South Korea; [Lee, Yeon; Oh, Man-Ho] Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon 305764, South Korea	Chungnam National University; Chungnam National University	Oh, MH (corresponding author), Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon 305764, South Korea.	manhooh@cnu.ac.kr; yplim@cnu.ac.kr	Dhandapani, Vignesh/X-6677-2019; 최, 수련/AHE-1934-2022	Dhandapani, Vignesh/0000-0002-5745-2409; Oh, Man-Ho/0000-0002-6524-3252	Ministry of Agriculture, Food and Rural Affairs (MAFRA) [213002-04-3-SB110]; Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA); Korea Forest Service (KFS); Chungnam National University; National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A401006751]	Ministry of Agriculture, Food and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of Korea); Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA)(Ministry of Oceans & Fisheries (MOF), Republic of Korea); Korea Forest Service (KFS)(Korea Forest Service); Chungnam National University; National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea)	1. JJR, VD, XY, and YPL received funds to conduct this research, from Golden Seed Project (No. 213002-04-3-SB110), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS). 2. YL and MHO received funds from Chungnam National University and Basic Science Research Program (No. 2014R1A1A401006751) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2014R1A1A401006751).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Bleecker AB, 2001, P NATL ACAD SCI USA, V107, P63; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Cheng F, 2013, PLANT CELL, V25, P1541, DOI 10.1105/tpc.113.110486; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Colcombet J, 2005, PLANT CELL, V17, P3350, DOI 10.1105/tpc.105.036731; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Dievart A, 2003, CURR OPIN PLANT BIOL, V6, P507, DOI 10.1016/S1369-5266(03)00089-X; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Godiard L, 2003, PLANT J, V36, P353, DOI 10.1046/j.1365-313X.2003.01877.x; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gou XP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-19; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hwang SG, 2011, GENETICA, V139, P1023, DOI 10.1007/s10709-011-9604-y; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Karve R, 2011, RNA, V17, P1907, DOI 10.1261/rna.2825811; Kim J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-606; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Krupa A, 2004, J MOL BIOL, V339, P1025, DOI 10.1016/j.jmb.2004.04.043; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Mosher S, 2013, PLANT J, V73, P469, DOI 10.1111/tpj.12050; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nodine MD, 2007, DEV CELL, V12, P943, DOI 10.1016/j.devcel.2007.04.003; Oh MH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00016; Oh MH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00175; Oh MH, 2011, PLANT SIGNAL BEHAV, V6, P400, DOI 10.4161/psb.6.3.14337; Oh MH, 2010, P NATL ACAD SCI USA, V107, P17827, DOI 10.1073/pnas.0915064107; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Schwessinger B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004809; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2004, MOL BIOL EVOL, V21, P828, DOI 10.1093/molbev/msh077; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Stenvik GE, 2008, PLANT CELL, V20, P1805, DOI 10.1105/tpc.108.059139; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; ten Hove CA, 2011, PLANT MOL BIOL, V76, P69, DOI 10.1007/s11103-011-9769-x; Tong CB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-689; Tsuwamoto R, 2008, PLANT J, V54, P30, DOI 10.1111/j.1365-313X.2007.03395.x; VALON C, 1993, PLANT MOL BIOL, V23, P415, DOI 10.1007/BF00029017; WALKER JC, 1990, NATURE, V345, P743, DOI 10.1038/345743a0; Wang J, 2011, J MOL EVOL, V72, P498, DOI 10.1007/s00239-011-9448-1; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2011, PLANT J, V67, P1081, DOI 10.1111/j.1365-313X.2011.04659.x; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Won SK, 2009, PLANT PHYSIOL, V150, P1459, DOI 10.1104/pp.109.140905; Wu X, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00262; Xu SL, 2008, PLANT CELL, V20, P3065, DOI 10.1105/tpc.108.063354; Yamaguchi Y, 2010, PLANT CELL, V22, P508, DOI 10.1105/tpc.109.068874; Yu DX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016818, 10.1371/journal.pone.0016079]; Zan YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-318; Zhao XY, 2013, J EXP BOT, V64, P5599, DOI 10.1093/jxb/ert323	72	29	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142255	10.1371/journal.pone.0142255	http://dx.doi.org/10.1371/journal.pone.0142255			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588465	Green Published, gold, Green Submitted			2022-12-26	WOS:000365251500008
J	Rothuizen, TC; Ocak, G; Verschuren, JJW; Dekker, FW; Rabelink, TJ; Jukema, JW; Rotmans, JI				Rothuizen, Tonia C.; Ocak, Gurbey; Verschuren, Jeffrey J. W.; Dekker, Friedo W.; Rabelink, Ton J.; Jukema, J. Wouter; Rotmans, Joris I.			Candidate Gene Analysis of Mortality in Dialysis Patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STAGE RENAL-DISEASE; CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; RECEPTOR 1 SVEGFR-1; FUNCTIONAL POLYMORPHISMS; HEMODIALYSIS-PATIENTS; CLINICAL RESTENOSIS; RISK MARKER; ASSOCIATION	Background Dialysis patients have high cardiovascular mortality risk. This study aimed to investigate the association between SNPs of genes involved in vascular processes and mortality in dialysis patients. Methods Forty two SNPs in 25 genes involved in endothelial function, vascular remodeling, cell proliferation, inflammation, coagulation and calcium/phosphate metabolism were genotyped in 1330 incident dialysis patients. The effect of SNPs on 5-years cardiovascular and non-cardiovascular mortality was investigated. Results The mortality rate was 114/1000 person-years and 49.4% of total mortality was cardiovascular. After correction for multiple testing, VEGF rs699947 was associated with all-cause mortality (HR1.48, 95% CI 1.14-1.92). The other SNPs were not associated with mortality. Conclusions This study provides further evidence that a SNP in the VEGF gene may contribute to the comorbid conditions of dialysis patients. Future studies should unravel the underlying mechanisms responsible for the increase in mortality in these patients.	[Rothuizen, Tonia C.; Rabelink, Ton J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Rothuizen, Tonia C.; Rabelink, Ton J.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Ocak, Gurbey; Dekker, Friedo W.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Verschuren, Jeffrey J. W.; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst ICIN, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rotmans, JI (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	j.i.rotmans@lumc.nl	Jukema, J. Wouter/ABD-6503-2021; Rotmans, Joris I./G-8866-2014; Rabelink, Ton J./A-5316-2008; Dekker, Friedo W/B-6452-2011	Jukema, J. Wouter/0000-0002-3246-8359; Rotmans, Joris I./0000-0001-9682-6234; Rabelink, Ton J./0000-0001-6780-5186; Dekker, Friedo W/0000-0002-2433-2494	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community Framework KP7 Programme [HEALTH-F2-2009-223004]; Center for Medical Systems Biology (CMSB), a center of excellence; Netherlands Consortium for Healthy Ageing (NCHA); BioMedical Materials institute [P3.03 DialysisXS]; Dutch Ministry of Economic Affairs, Agriculture and Innovation	Interuniversity Cardiology Institute of the Netherlands (ICIN); European Community Framework KP7 Programme; Center for Medical Systems Biology (CMSB), a center of excellence; Netherlands Consortium for Healthy Ageing (NCHA); BioMedical Materials institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation	Funding: JWJ was funded by grants from the Interuniversity Cardiology Institute of the Netherlands (ICIN), the European Community Framework KP7 Programme under grant agreement [no HEALTH-F2-2009-223004], the Center for Medical Systems Biology (CMSB), a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO) and the Netherlands Consortium for Healthy Ageing (NCHA). The funders had no role in study design, data collection and analysis, decision to publish or the preparation of the manuscript. TCR and JR were supported by the research program of the BioMedical Materials institute (P3.03 DialysisXS), co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation.	Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Allon M, 2012, AM J KIDNEY DIS, V59, P682, DOI 10.1053/j.ajkd.2011.11.036; Aucella F, 2009, ATHEROSCLEROSIS, V207, P541, DOI 10.1016/j.atherosclerosis.2009.05.011; Baas AF, 2010, EUR J HUM GENET, V18, P240, DOI 10.1038/ejhg.2009.141; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Balakrishnan VS, 2004, KIDNEY INT, V65, P1449, DOI 10.1111/j.1523-1755.2004.00531.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biselli PM, 2008, HEART VESSELS, V23, P371, DOI 10.1007/s00380-008-1057-6; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Brunet P, 2011, KIDNEY BLOOD PRESS R, V34, P284, DOI 10.1159/000327131; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Casserly LF, 2003, SEMIN DIALYSIS, V16, P245, DOI 10.1046/j.1525-139X.2003.16048.x; Chen Y, 2011, J RHEUMATOL, V38, P802, DOI 10.3899/jrheum.101095; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; COHEN M, 1986, CIRCULATION, V74, P469, DOI 10.1161/01.CIR.74.3.469; Cozzolino M, 2010, BLOOD PURIFICAT, V30, P272, DOI 10.1159/000320706; de Jager DJ, 2014, NAT REV NEPHROL, V10, P208, DOI 10.1038/nrneph.2014.8; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; den Hoedt CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061155; Doi K, 2006, J AM SOC NEPHROL, V17, P823, DOI 10.1681/ASN.2005010094; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Ewing MM, 2012, ATHEROSCLEROSIS, V221, P333, DOI 10.1016/j.atherosclerosis.2012.01.037; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Friedman DJ, 2009, J BONE MINER RES, V24, P1847, DOI [10.1359/JBMR.090516, 10.1359/jbmr.090516]; Girndt M, 2002, KIDNEY INT, V62, P949, DOI 10.1046/j.1523-1755.2002.00504.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gungor Y, 2011, RENAL FAILURE, V33, P169, DOI 10.3109/0886022X.2011.552151; He D, 2010, CAN CARD C 2010; Hernesniemi JA, 2008, ATHEROSCLEROSIS, V198, P152, DOI 10.1016/j.atherosclerosis.2007.09.024; Howell WM, 2005, J MED GENET, V42, P485, DOI 10.1136/jmg.2004.025734; Hsiao PJ, 2007, J ENDOCRINOL, V195, P265, DOI 10.1677/JOE-07-0395; Ianni M, 2013, PROSTATE CANCER P D, V16, P56, DOI 10.1038/pcan.2012.30; Jaber BL, 2004, CYTOKINE, V25, P212, DOI 10.1016/j.cyto.2003.11.004; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kim Youngsu, 2008, Korean Journal of Internal Medicine, V23, P201, DOI 10.3904/kjim.2008.23.4.201; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Lin CC, 2010, CLIN J AM SOC NEPHRO, V5, P1805, DOI 10.2215/CJN.01500210; Ma L, 2012, DNA CELL BIOL, V31, P1064, DOI 10.1089/dna.2011.1552; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Marks A, 2013, FAM PRACT, V30, P282, DOI 10.1093/fampra/cms079; Masago K, 2009, CANCER SCI, V100, P1917, DOI 10.1111/j.1349-7006.2009.01253.x; MATAS AJ, 1975, LANCET, V1, P883; Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992; Monraats PS, 2007, GENES IMMUN, V8, P44, DOI 10.1038/sj.gene.6364343; Monraats PS, 2010, EXPERT OPIN THER TAR, V14, P243, DOI 10.1517/14728220903520929; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; Monraats PS, 2005, THROMB HAEMOSTASIS, V93, P564, DOI 10.1160/TH04-11-0708; Oguri M, 2007, INT J MOL MED, V20, P533; Oishi Y, 2010, FASEB J, V24, P1780, DOI 10.1096/fj.09-146589; Pastinen T, 1998, HUM MOL GENET, V7, P1453, DOI 10.1093/hmg/7.9.1453; Pastuszczak M, 2009, POL ARCH MED WEWN, V119, P719, DOI 10.20452/pamw.821; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pons D, 2009, DIS MARKERS, V26, P75, DOI [10.1155/2009/520653, 10.3233/DMA-2009-0609]; Ram S, 2003, J INVEST MED, V51, P19, DOI 10.2310/6650.2003.33522; Regieli JJ, 2009, INT J CARDIOL, V132, P257, DOI 10.1016/j.ijcard.2007.11.100; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Shimoyama Y, 2009, AM J NEPHROL, V30, P383, DOI 10.1159/000235686; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Stenvinkel P, 2005, KIDNEY INT, V67, P2383, DOI 10.1111/j.1523-1755.2005.00345.x; Szeto CC, 2004, KIDNEY INT, V65, P1947, DOI 10.1111/j.1523-1755.2004.00605.x; Thethi I, 2012, CLIN APPL THROMB-HEM, V18, P534, DOI 10.1177/1076029611435837; van Dijk PCW, 2001, NEPHROL DIAL TRANSPL, V16, P1120, DOI 10.1093/ndt/16.6.1120; van Tiel CM, 2009, CIRCULATION, V120, P669, DOI 10.1161/CIRCULATIONAHA.108.842179; Verschuren JJW, 2013, CLIN J AM SOC NEPHRO, V8, P1358, DOI 10.2215/CJN.11091012; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; Walker SR, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-228; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Yuan JZ, 2013, NEPHROL DIAL TRANSPL, V28, P2356, DOI 10.1093/ndt/gft256; Zhou JQ, 2012, THROMB RES, V130, P602, DOI 10.1016/j.thromres.2012.05.023	74	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143079	10.1371/journal.pone.0143079	http://dx.doi.org/10.1371/journal.pone.0143079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587841	gold, Green Published, Green Submitted			2022-12-26	WOS:000365251500028
J	Zhang, JJ; Chen, G; Li, WR; Xu, TM; Gao, XM				Zhang, Jingjing; Chen, Gui; Li, Weiran; Xu, Tianmin; Gao, Xuemei			Upper Airway Changes after Orthodontic Extraction Treatment in Adults: A Preliminary Study using Cone Beam Computed Tomography	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; BIMAXILLARY PROTRUSION; CHINESE PATIENTS; MORPHOLOGY; OUTCOMES; CBCT; ADVANCEMENT; CAMOUFLAGE; POSITION; OBESITY	Objective Whether the orthodontic treatment with premolar extraction and maximum anchorage in adults will lead to a narrowed upper airway remains under debated. The study aims to investigate the airway changes after orthodontic extraction treatment in adult patients with Class II and hyperdivergent skeletal malocclusion. Materials and Methods This retrospective study enrolled 18 adults with Class II and hyperdivergent skeletal malocclusion (5 males and 13 females, 24.1 +/- 3.8 years of age, BMI 20.33 +/- 1.77 kg/m(2)). And 18 untreated controls were matched 1: 1 with the treated patients for age, sex, BMI, and skeletal pattern. CBCT images before and after treatment were obtained. DOLPHIN 11.7 software was used to reconstruct and measure the airway size, hyoid position, and craniofacial structures. Changes in the airway and craniofacial parameters from pre to post treatment were assessed by Wilcoxon signed rank test. Mann-Whitney U test was used in comparisons of the airway parameters between the treated patients and the untreated controls. Significant level was set at 0.05. Results The upper and lower incisors retracted 7.87 mm and 6.10 mm based on the measurement of U1-VRL and L1-VRL (P < 0.01), while the positions of the upper and lower molars (U6-VRL, and L6-VRL) remained stable. Volume, height, and cross-sectional area of the airway were not significantly changed after treatment, while the sagittal dimensions of SPP-SPPW, U-MPW, PAS, and V-LPW were significantly decreased (P < 0.05), and the morphology of the cross sections passing through SPP-SPPW, U-MPW, PAS, and V-LPW became anteroposteriorly compressed (P < 0.001). No significant differences in the airway volume, height, and cross-sectional area were found between the treated patients and untreated controls. Conclusions The airway changes after orthodontic treatment with premolar extraction and maximum anchorage in adults are mainly morphological changes with anteroposterior dimension compressed in airway cross sections, rather than a decrease in size.	[Zhang, Jingjing; Chen, Gui; Li, Weiran; Xu, Tianmin; Gao, Xuemei] Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University	Gao, XM (corresponding author), Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	xmgao@263.net	Li, weiran/R-6769-2019; Zhang, Jing/HII-4294-2022		National Natural Science Foundation of China [81470272]; Seeding Grant for Medicine and Engineering Sciences of Peking University [BMU20140397]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Seeding Grant for Medicine and Engineering Sciences of Peking University	The study was partly supported by National Natural Science Foundation of China (81470272, recipient XG) and the Seeding Grant for Medicine and Engineering Sciences of Peking University (BMU20140397, recipient XG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al ME, 2012, ANGLE ORTHOD, V82, P853, DOI [10.2319/10711-646.1, DOI 10.2319/101711-646.1]; Alsufyani NA, 2013, SLEEP BREATH, V17, P911, DOI 10.1007/s11325-012-0799-7; [Anonymous], 1940, STAT METHODS MED BIO; [Anonymous], 1907, TREATMENT MALOCCLUSI; Chen X, 2015, PLOS ONE, V10; Chen Y, 2012, ANGLE ORTHOD, V82, P964, DOI 10.2319/110211-675.1; Cordasco G, 2012, INT J PEDIATR OTORHI, V76, P1547, DOI 10.1016/j.ijporl.2012.07.008; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; Demir A, 2005, EUR J ORTHODONT, V27, P524, DOI 10.1093/ejo/cji046; Deng JR, 2012, SLEEP BREATH, V16, P1219, DOI 10.1007/s11325-011-0636-4; Fastuca R, 2014, PROG ORTHOD, V15, DOI 10.1186/s40510-014-0040-2; Germec-Cakan D, 2011, EUR J ORTHODONT, V33, P515, DOI 10.1093/ejo/cjq109; Guven O, 2005, J CRANIOFAC SURG, V16, P23; Hiyama S, 2001, AM J ORTHOD DENTOFAC, V120, P160, DOI 10.1067/mod.2001.113788; Katyal V, 2013, AM J ORTHOD DENTOFAC, V143, P20, DOI 10.1016/j.ajodo.2012.08.021; Kikuchi Makoto, 2005, Sleep Breath, V9, P146, DOI 10.1007/s11325-005-0028-8; Kim JS, 2013, J ORAL MAXILLOFAC SU, V71, P1601; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; Lenza MG, 2010, ORTHOD CRANIOFAC RES, V13, P96, DOI 10.1111/j.1601-6343.2010.01482.x; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094378; Liu SR, 2012, INT J ORAL MAX SURG, V41, P1112, DOI 10.1016/j.ijom.2012.03.011; Mihalik CA, 2003, AM J ORTHOD DENTOFAC, V123, P266, DOI 10.1067/mod.2003.43; PROFFIT WR, 1992, AM J ORTHOD DENTOFAC, V101, P556, DOI 10.1016/0889-5406(92)70131-S; Raffaini M, 2013, J CRANIO MAXILL SURG, V41, P552, DOI 10.1016/j.jcms.2012.11.022; Roedig JJ, 2014, J CLIN SLEEP MED, V10, P397, DOI 10.5664/jcsm.3614; Schendel SA, 2012, J ORAL MAXIL SURG, V70, P2174, DOI 10.1016/j.joms.2011.10.013; Sharma Krishna, 2014, Contemp Clin Dent, V5, P190, DOI 10.4103/0976-237X.132314; Stefanovic N, 2013, ORTHOD CRANIOFAC RES, V16, P87, DOI 10.1111/ocr.12009; Sutherland K, 2012, RESPIROLOGY, V17, P213, DOI 10.1111/j.1440-1843.2011.02082.x; Wang QZ, 2012, ANGLE ORTHOD, V82, P115, DOI 10.2319/011011-13.1; Zicari AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111675	31	15	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143233	10.1371/journal.pone.0143233	http://dx.doi.org/10.1371/journal.pone.0143233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588714	Green Published, gold, Green Submitted			2022-12-26	WOS:000365251500041
J	di Sciara, GN; Lauriano, G; Pierantonio, N; Canadas, A; Donovan, G; Panigada, S				di Sciara, Giuseppe Notarbartolo; Lauriano, Giancarlo; Pierantonio, Nino; Canadas, Ana; Donovan, Greg; Panigada, Simone			The Devil We Don't Know: Investigating Habitat and Abundance of Endangered Giant Devil Rays in the North-Western Mediterranean Sea	PLOS ONE			English	Article							DIVING BEHAVIOR; BASKING SHARKS; AERIAL SURVEY; GULF; CONSERVATION; WHALES; TOOL	The giant devil ray Mobula mobular, the only Mediterranean mobulid, is subject to mortality caused by directed and accidental captures in fisheries throughout the region. Whilst the combination of human impacts, limited range and a low reproductive potential is not inconsistent with its endangered listing, there are insufficient data to enable a quantitative assessment of trends. Without this, it is difficult to assess and prioritise threats and develop effective conservation actions. Using results from aerial surveys conducted between 2009 and 2014 over the Ligurian, Corsican, Sardinian, northern and central Tyrrhenian seas (626,228 km(2)), this study provides the first quantitative information on giant devil ray abundance and habitat choice in the western Mediterranean. Devil rays were observed in all seasons except winter, with their estimated abundance in the study area peaking in summer. The overall uncorrected mean density in the study area during summer was estimated at 0.0257 individuals km(-2) (range: 0.017-0.044), resulting in a total abundance estimate of 6,092 (12.7%CV) individuals at the surface; once corrected for availability bias, this estimate indicates a summer presence of >12,700 devil rays in the study area. Rays were mostly observed alone even if occasionally, larger aggregations up to a maximum of 18 individuals were observed. Although observed throughout the study area, spatial modelling identified their preferred habitat to be over a broad strip connecting the Tuscan Archipelago to Eastern Sardinia, over a wide range of water depths ranging from 10 to 2000m. The observed seasonal changes in giant devil ray distribution in this study, combined with similar evidence from other areas in the Mediterranean, support the hypothesis that the species undertakes latitudinal migrations across the region, taking advantage of highly productive waters in the north during summer, and warmer southern waters during winter.	[di Sciara, Giuseppe Notarbartolo; Pierantonio, Nino; Panigada, Simone] Tethys Res Inst, I-20121 Milan, Italy; [Lauriano, Giancarlo] Ist Super Protez & Ric Ambientale, I-00144 Rome, Italy; [Canadas, Ana] ALNILAM Res & Conservat Ltd, Madrid 28240, Spain; [Donovan, Greg] Int Whaling Commiss, Cambridge CB24 9NP, England	Italian Institute for Environmental Protection & Research (ISPRA)	di Sciara, GN (corresponding author), Tethys Res Inst, Viale GB Gadio 2, I-20121 Milan, Italy.	disciara@tethys.org	di Sciara, Giuseppe Notarbartolo/P-8906-2019; Canadas, Ana/AAA-5761-2019; Lauriano, Giancarlo/ABG-8461-2021; Pierantonio, Nino/AAO-7663-2020	Pierantonio, Nino/0000-0002-1210-8831; Notarbartolo di Sciara, Giuseppe/0000-0003-0353-617X	Italian Ministry of the Environment ("Ministero dell'ambiente e della tutela del territorio e del mare")	Italian Ministry of the Environment ("Ministero dell'ambiente e della tutela del territorio e del mare")	Aerial surveys for the monitoring of cetacean populations in the study area, which provided the opportunity for giant devil ray observations described in this paper, were funded by the Italian Ministry of the Environment ("Ministero dell'ambiente e della tutela del territorio e del mare"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudaya M, 2014, ASSESSMENT GAZA FISH; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akyol O, 2005, TURK J VET ANIM SCI, V29, P1225; Alexander RL, 1996, ZOOL J LINN SOC-LOND, V118, P151, DOI 10.1111/j.1096-3642.1996.tb00224.x; [Anonymous], THESIS; Banaru D, 2010, J OCEAN RES DATA, V3, P33; Bello Giambattista, 1999, Acta Adriatica, V40, P65; Bigelow HB, 1953, MEMOIR SEARS FDN M 2, VI; BINI G, 1967, ATLANTE PESCI COSTE, V1; Boero F., 1979, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V47, P27; Bradai MN, 2001, CYBIUM, V25, P389; Braun CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088170; Buckland S.T., 2001, pi; Burks CM, 2006, FISH B-NOAA, V104, P579; Canadas A., 2008, Endangered Species Research, V4, P309, DOI 10.3354/esr00073; Canadas A., 2006, Journal of Cetacean Research and Management, V8, P13; Canese Simonepietro, 2011, Endangered Species Research, V14, P171, DOI 10.3354/esr00349; CASANOVA B, 1970, Revue des Travaux de l'Institut des Peches Maritimes, V34, P205; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; Celona Antonio, 2004, Annales Series Historia Naturalis, V14, P11; Cornax MJ, 2007, THONAILLE USE DRIFTN; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Croll DA, 2012, MAR ECOL PROG SER, V465, P193, DOI 10.3354/meps09900; Dicken ML, 2013, MAR FRESHWATER RES, V64, P530, DOI 10.1071/MF12336; Druon JN, 2012, MAR ECOL PROG SER, V464, P289, DOI 10.3354/meps09810; Dulvy NK, 2014, PEERJ, V2, DOI 10.7717/peerj.400; Ebert D.A., 2013, FAO SPECIES CAT FISH, V7, P1; Fortuna CM, 2014, SCI MAR, V78, P227, DOI 10.3989/scimar.03920.30D; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; Heide-Jorgensen M. P., 2012, Journal of Cetacean Research and Management, V12, P1; Hemida Farid, 2002, Acta Adriatica, V43, P69; Hillyer E.V., 1989, COPEIA, V1989, P607; Holcer D, 2013, J APPL ICHTHYOL, V29, P139, DOI 10.1111/jai.12034; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; JACQUES G, 1989, B SOC ZOOL FR, V114, P17; Kessel ST, 2013, J MAR BIOL, V2013, P1, DOI DOI 10.1155/2013/597383; Lauriano G, 2014, MAR ENVIRON RES, V100, P86, DOI 10.1016/j.marenvres.2014.04.001; Marano G., 1983, THALASSIA SALENTINA, V13, P50; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques FFC, 2004, ADV DISTANCE SAMPLIN; Mauchline J., 1980, ADV MAR BIOL, P3; Munoz-Chapuli R, 1994, P 2 EUR SHARK RAY WO; Northridge S.P., 1991, 320 FAO; Notarbartolo di Sciara G, 1988, ATTI SOC ITAL SCI NA, V129, P396; Notarbartolo di Sciara G, 2006, IUCN RED LIST THREAT; Notarbartolo-Di-Sciara G, 2008, AQUAT CONSERV, V18, P367, DOI 10.1002/aqc.855; NOTARBARTOLODISCIARA G, 1987, ZOOL J LINN SOC-LOND, V91, P1, DOI 10.1111/j.1096-3642.1987.tb01723.x; Orsi Relini L., 1992, RAPP COMM INT MER ME, V33, P263; Orsi Relini L, 1999, BIOL MAR MEDIT, V6, P100; Panigada S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022878; RAMSEY FL, 1987, BIOMETRICS, V43, P1, DOI 10.2307/2531943; Rowat D, 2009, J EXP MAR BIOL ECOL, V368, P1, DOI 10.1016/j.jembe.2008.09.001; Scacco U., 2009, Marine Biodiversity Records, V2, pe93, DOI 10.1017/S1755267209001110; Silvi S, 1981, MONDO SOMMERSO, V251, P56; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Storai T, 2011, FISH RES, V109, P74, DOI 10.1016/j.fishres.2011.01.018; Thomas L., 2009, DISTANCE 6 0 RELEASE; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thorrold SR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5274; Walker Paddy, 2005, P71; Wilson SG, 2004, FISH OCEANOGR, V13, P283, DOI 10.1111/j.1365-2419.2004.00292.x; Wilson SK, 2005, MAR BIOL, V147, P179, DOI 10.1007/s00227-005-1556-2; Wood S., 2006, TECHNICAL REPORT; Wood S.N., 2001, R R NEWS, V1, P20; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240	65	15	16	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141189	10.1371/journal.pone.0141189	http://dx.doi.org/10.1371/journal.pone.0141189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580814	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600012
J	IJsseldijk, LL; Leopold, MF; Rebolledo, ELB; Deaville, R; Haelters, J; Ijzer, J; Jepson, PD; Grone, A				IJsseldijk, Lonneke L.; Leopold, Mardik F.; Rebolledo, Elisa L. Bravo; Deaville, Rob; Haelters, Jan; Ijzer, Jooske; Jepson, Paul D.; Grone, Andrea			Fatal Asphyxiation in Two Long-Finned Pilot Whales (Globicephala melas) Caused by Common Soles (Solea solea)	PLOS ONE			English	Article							PORPOISES PHOCOENA-PHOCOENA; STOMACH CONTENTS; ATLANTIC; NORTH	Long-finned pilot whales (Globicephala melas) are rare visitors to the southern North Sea, but recently two individual strandings occurred on the Dutch coast. Both animals shared the same, unusual cause of death: asphyxiation from a common sole (Solea solea) stuck in their nasal cavity. This is a rare cause of death in cetaceans. Whilst asphyxiation has been reported in smaller odontocetes, there are no recent records of this occurring in Globicephala species. Here we report the stranding, necropsy and diet study results as well as discuss the unusual nature of this phenomenon. Flatfish are not a primary prey species for pilot whales and are rarely eaten by other cetaceans, such as harbour porpoises (Phocoena phocoena), in which there are several reports of asphyxiation due to airway obstruction by soles. This risk may be due to the fish's flexible bodies which can enter small cavities either actively in an attempt to escape or passively due to the whale 'coughing' or 'sneezing' to rid itself of the blockage of the trachea. It is also possible that the fish enter the airways whilst the whale is re-articulating the larynx after trying to ingest large, oddly shaped prey. It is unlikely that the soles entered the airways after the death of the whales and we believe therefore that they are responsible for the death of these animals.	[IJsseldijk, Lonneke L.; Ijzer, Jooske; Grone, Andrea] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Leopold, Mardik F.; Rebolledo, Elisa L. Bravo] Wageningen IMARES, Dept Ecosyst, Den Burg, Texel, Netherlands; [Deaville, Rob; Jepson, Paul D.] Zool Soc London, Inst Zool, UK Cetacean Strandings Invest Programme, London NW1 4RY, England; [Haelters, Jan] RBINS, Operat Directorate Nat Environm, Oostende, Belgium	Utrecht University; Wageningen University & Research; Zoological Society of London	IJsseldijk, LL (corresponding author), Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands.	L.L.IJsseldijk@uu.nl	Leopold, Mardik/AAE-4679-2020					[Anonymous], VISBOECK; Benke H, 1998, ARCH FISH MAR RES, V46, P97; Bloch Dorete, 1993, Reports of the International Whaling Commission Special Issue, V14, P163; Bolin V, 2014, IRISH NAT J, V33, P155; BRABER L, 1973, Netherlands Journal of Sea Research, V6, P163, DOI 10.1016/0077-7579(73)90011-2; Buckland S.T., 1993, Reports of the International Whaling Commission Special Issue, V14, P33; Byard Roger W, 2003, J Clin Forensic Med, V10, P85, DOI 10.1016/S1353-1131(03)00009-9; Byard RW, 2010, FORENSIC SCI MED PAT, V6, P207, DOI 10.1007/s12024-010-9143-3; Camphuysen C. J., 2006, WHALES DOLPHINS N SE; De Heij A., 2005, Basteria, V69, P91; De Pierrepont JF, 2005, J MAR BIOL ASSOC UK, V85, P1539, DOI 10.1017/S0025315405012762; Desportes Genevieve, 1993, Reports of the International Whaling Commission Special Issue, V14, P305; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; Gannon DP, 1997, MAR ECOL PROG SER, V148, P1, DOI 10.3354/meps148001; Gannon DP, 1997, MAR MAMMAL SCI, V13, P405, DOI 10.1111/j.1748-7692.1997.tb00648.x; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; HULT R W, 1980, Cetology, P1; Jansen O. E, 2013, THESIS; KRUUK H, 1963, NETH J SEA RES, V2, P1; Kuiken T, 1991, P ESC WORKSH LEID; Leopold M.F., 2001, OTOLITHS N SEA FISH; Leopold MF, 2015, J SEA RES, V97, P14, DOI 10.1016/j.seares.2014.12.005; Mignucci-Giannoni Antonio A., 2009, Aquatic Mammals, V35, P48, DOI 10.1578/AM.35.1.2009.48; Monteiro S, 2015, 29 ECS C 23 25 MARCH; OIE, 2012, MAN DIAGN TESTS VACC, V1; Olson PA, 2008, ENCY MARINE MAMMALS; OVERHOLTZ WJ, 1991, FISH B-NOAA, V89, P723; Perkins M, 2015, 29 ECS C 23 25 MARCH; Reid J.B., 2003, ATLAS CETACEAN DISTR; REIDENBERG JS, 1987, ANAT RECORD, V218, P98, DOI 10.1002/ar.1092180115; Sergeant DE, 1962, B FISH RES BD CANADA, V132, P1; Shirihai H, 2006, WHALES DOLPHINS SEAL; Siebert U, 2001, J COMP PATHOL, V124, P102, DOI 10.1053/jcpa.2000.0436; Siebert U, 1993, UNTERSUCHUNGEN UNPUB; Sigurjonsson Johann, 1993, Reports of the International Whaling Commission Special Issue, V14, P407; Simon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115815; Spitz J., 2010, THESIS; Stolen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066828; Taylor B. L., 2008, IUCN RED LIST THREAT; van Egmond F, 2008, VISBOEK WERELD VOLGE; Watson Alastair, 2005, Aquatic Mammals, V31, P447, DOI 10.1578/AM.31.4.2005.447	41	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141951	10.1371/journal.pone.0141951	http://dx.doi.org/10.1371/journal.pone.0141951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580786	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600030
J	Jia, WJ; Wu, JN; Jia, HX; Yang, YP; Zhang, XL; Chen, K; Su, FX				Jia, Weijuan; Wu, Jiannan; Jia, Haixia; Yang, Yaping; Zhang, Xiaolan; Chen, Kai; Su, Fengxi			The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PROGNOSTIC VALUE; GENE-EXPRESSION; IMMUNE CELLS; CHEMOTHERAPY; RECURRENCE; MARKERS	Purpose The peripheral hematologic parameters of patients can be prognostic for many malignant tumors, including breast cancer, although their value has not been investigated among the different molecular subtypes of breast cancer. The purpose of this study was to examine the prognostic significance of the neutrophil-to-lymphocyte ratio (NLR) and the lymphocyte-to-monocyte ratio (LMR) in different molecular subtypes of breast cancer. Methods A retrospective cohort of 1570 operable breast cancer patients was recruited between January 2000 and December 2010. The counts of peripheral neutrophils, lymphocytes, monocytes and platelets were collected and applied to calculate the NLR and the LMR. Univariate and multivariate Cox proportional hazard analyses were used to assess the relationship of the NLR and the LMR with disease-free survival (DFS) and overall survival (OS) in all patients and triple negative breast cancer (TNBC) patients. Results Univariate analysis revealed that lower NLR (<= 2.0) and higher LMR (>4.8) were significantly associated with superior DFS in all patients (NLR, P = 0.005; LMR, P = 0.041) and in TNBC patients (NLR, p = 0.007; LMR, P = 0.011). However, multivariate analysis revealed that only lower NLR was a significant independent predictor of superior DFS and OS in all breast cancer patients (DFS, HR = 1.50 95% CI: 1.14-1.97, P = 0.004; OS, HR = 1.63, 95% CI: 1.07-2.49, P = 0.022) and in TNBC patients (DFS, HR = 2.58, 95% CI: 1.23-5.42, P = 0.012; OS, HR = 3.05, 95% CI: 1.08-8.61, P = 0.035). Both univariate and multivariate analysis revealed that neither the NLR nor the LMR significantly predicted DFS and OS among the patients with other molecular subtypes of breast cancer. Conclusions A higher pretreatment peripheral NLR significantly and independently indicated a poor prognosis for breast cancer and TNBC, and this measurement exhibited greater prognostic value than a lower LMR. The NLR was not a prognostic factor for other breast cancer subtypes.	[Jia, Weijuan; Su, Fengxi] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weijuan; Wu, Jiannan; Yang, Yaping; Zhang, Xiaolan; Chen, Kai; Su, Fengxi] Sun Yat Sen Univ, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Haixia] Guangzhou Med Univ, Dept Breast Surg, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Su, FX (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	fengxisu@vip.163.com	Wu, Jiannan/AAD-9358-2019		National Natural Science Foundation of China [81372817]; key laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013] 163]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes [KLB09001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes	This work was supported by National Natural Science Foundation of China (Grant number: 81372817; http://www.nsfc.gov.cn/) to FS; Grant [2013] 163 from key laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grant [2013] 163 from key laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology; Grant KLB09001 from the Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes.	Adams S, 2014, J CLIN ONCOL, V32, P2959, DOI 10.1200/JCO.2013.55.0491; Azab B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0432-4; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Buyukkaya E, 2014, CLIN APPL THROMB-HEM, V20, P159, DOI 10.1177/1076029612459675; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Deyarmin B, 2013, ANN SURG ONCOL, V20, P87, DOI 10.1245/s10434-012-2588-8; Donskov F, 2013, SEMIN CANCER BIOL, V23, P200, DOI 10.1016/j.semcancer.2013.02.001; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Engel JB, 2014, ARCH GYNECOL OBSTET, V289, P141, DOI 10.1007/s00404-013-2922-9; Fan L, 2014, LANCET ONCOL, V15, pE279, DOI 10.1016/S1470-2045(13)70567-9; Forget P, 2014, BRIT J ANAESTH, V113, P82, DOI 10.1093/bja/aet464; Forget P, 2013, ANN SURG ONCOL, V20, pS650, DOI 10.1245/s10434-013-3136-x; Forget P, 2010, ANESTH ANALG, V110, P1630, DOI 10.1213/ANE.0b013e3181d2ad07; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Guiu S, 2013, BREAST, V22, P301, DOI 10.1016/j.breast.2012.07.012; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hiller JG, 2015, CURRENT ANESTHESIOLO, V5, P291; Huang SH, 2014, CANCER; Iwamoto T, 2012, J CLIN ONCOL, V30, P729, DOI 10.1200/JCO.2011.36.2574; Khoshnoud MR, 2011, BREAST CANCER RES TR, V126, P421, DOI 10.1007/s10549-010-1202-7; Kilincalp S, 2014, EUR J CANC PREV; LI J, 2013, PLOS ONE, V8, P83069, DOI DOI 10.1371/JOURNAL.PONE.0054839; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Lorente D, 2015, ANN ONCOL, V26, P750, DOI 10.1093/annonc/mdu587; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Malyguine AM, 2012, CANCER IMMUNOL IMMUN, V61, P239, DOI 10.1007/s00262-011-1148-6; Masood S, 2005, CLIN LAB MED, V25, P809, DOI 10.1016/j.cll.2005.08.012; Matsumoto H, 2015, J CLIN PATHOL; Melichar B, 2013, CLIN CHEM LAB MED, V51, P99, DOI 10.1515/cclm-2012-0496; Molina R, 2005, TUMOR BIOL, V26, P281, DOI 10.1159/000089260; Ni XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111886; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Porrata LF, 2013, BONE MARROW RES, DOI 10.1155/2013/658371; Prabhu JS, 2014, J CANCER, V5, P156, DOI 10.7150/jca.7668; Retsky M, 2012, BREAST CANCER RES TR, V134, P881, DOI 10.1007/s10549-012-2094-5; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Yao MY, 2014, ONCOTARGETS THER, V7, P1743, DOI 10.2147/OTT.S69657; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	40	68	69	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143061	10.1371/journal.pone.0143061	http://dx.doi.org/10.1371/journal.pone.0143061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580962	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600074
J	Perez-Barberia, FJ; Small, M; Hooper, RJ; Aldezabal, A; Soriguer-Escofet, R; Bakken, GS; Gordon, IJ				Perez-Barberia, F. J.; Small, M.; Hooper, R. J.; Aldezabal, A.; Soriguer-Escofet, R.; Bakken, G. S.; Gordon, I. J.			State-Space Modelling of the Drivers of Movement Behaviour in Sympatric Species	PLOS ONE			English	Article							STANDARD OPERATIVE TEMPERATURE; RED DEER; SEXUAL SEGREGATION; LARGE HERBIVORES; GRAZING IMPACTS; SOCIAL RANK; MULE DEER; SHEEP; DENSITY; CATTLE	Understanding animal movement behaviour is key to furthering our knowledge on intra- and inter-specific competition, group cohesion, energy expenditure, habitat use, the spread of zoonotic diseases or species management. We used a radial basis function surface approximation subject to minimum description length constraint to uncover the state-space dynamical systems from time series data. This approximation allowed us to infer structure from a mathematical model of the movement behaviour of sheep and red deer, and the effect of density, thermal stress and vegetation type. Animal movement was recorded using GPS collars deployed in sheep and deer grazing a large experimental plot in winter and summer. Information on the thermal stress to which animals were exposed was estimated using the power consumption of mechanical heated models and meteorological records of a network of stations in the plot. Thermal stress was higher in deer than in sheep, with less differences between species in summer. Deer travelled more distance than sheep, and both species travelled more in summer than in winter; deer travel distance showed less seasonal differences than sheep. Animal movement was better predicted in deer than in sheep and in winter than in summer; both species showed a swarming behaviour in group cohesion, stronger in deer. At shorter separation distances swarming repulsion was stronger between species than within species. At longer separation distances inter-specific attraction was weaker than intra-specific; there was a positive density-dependent effect on swarming, and stronger in deer than in sheep. There was not clear evidence which species attracted or repelled the other; attraction between deer at long separation distances was stronger when the model accounted for thermal stress, but in general the dynamic movement behaviour was hardly affected by the thermal stress. Vegetation type affected intra-species interactions but had little effect on inter-species interactions. Our modelling approach is useful in interpreting animal interactions, in order to unravel complex cooperative or competitive behaviours, and to the best of our knowledge is the first modelling attempt to make predictions of multi-species animal movement under different habitat mosaics and abiotic environmental conditions.	[Perez-Barberia, F. J.] Univ Cordoba, Ungulate Res Unit, CRCP, Cordoba, Spain; [Perez-Barberia, F. J.] CSIC, Grp PAIDI RNM118, Estn Biol Donana, Seville 41092, Spain; [Perez-Barberia, F. J.; Hooper, R. J.] James Hutton Inst, Aberdeen AB15 8QH, Scotland; [Small, M.] Univ Western Australia, Sch Math & Stat, Crawley, WA 6009, Australia; [Aldezabal, A.] Euskal Herriko Unibertsitatea UPV EHU, Zientzia & Teknol Fak, Landare Biol & Ekol Saila, Euskal Herria 48080, Bizkaia, Spain; [Soriguer-Escofet, R.] CSIC, Estn Biol Donana, Seville 41013, Spain; [Bakken, G. S.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA; [Gordon, I. J.] James Cook Univ, Trop Environm & Soc, Townsville, Qld 4811, Australia	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); James Hutton Institute; University of Western Australia; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Indiana State University; James Cook University	Perez-Barberia, FJ (corresponding author), Univ Cordoba, Ungulate Res Unit, CRCP, Cordoba, Spain.	j.perezbarberia@gmail.com	Aldezabal, Arantza/V-7930-2017; Perez-Barberia, Javier/M-9847-2017; Gordon, Iain/S-8076-2019; Gordon, Iain J/K-8636-2012; Small, Michael/C-9807-2010; Casimiro-Soriguer, Ramon/J-1494-2014	Aldezabal, Arantza/0000-0001-7917-7690; Perez-Barberia, Javier/0000-0001-7513-5418; Gordon, Iain/0000-0001-9704-0946; Gordon, Iain J/0000-0001-9704-0946; Small, Michael/0000-0001-5378-1582; Casimiro-Soriguer, Ramon/0000-0002-9165-7766	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); 434 Leonardo da Vinci programme (European Commission); Australian Research Council [FT110100896, DP140100203]; University of Granada (Andalucia, Spain); Leonardo da Vinci programme (European Commission); NERC [BIGF010001] Funding Source: UKRI; Natural Environment Research Council [BIGF010001] Funding Source: researchfish	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); 434 Leonardo da Vinci programme (European Commission)(European Commission); Australian Research Council(Australian Research Council); University of Granada (Andalucia, Spain); Leonardo da Vinci programme (European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD), and the 434 Leonardo da Vinci programme (European Commission) provided grant-holders that assisted this study. MS is supported by an Australian Research Council Future Fellowship (FT110100896) and Discovery Project (DP140100203). FJP-B was granted a visiting researcher fellowship by University of Granada (Andalucia, Spain) when writing this paper.; This study is dedicated to the memory of our colleague Dr. Simon Thirgood, who died in his beloved Africa when working on conservation projects. We thank Glensaugh Experimental Field Station's staff for looking after the animals and providing logistic support. Alessandro Gimona who provided us with the kriging function and advice on the analysis, and Adrian Baddeley who helped us with the use of Spatstat software. The services of the Natural Environment Research Council (NERC) British Isles continuous GNSS Facility (BIGF), www.bigf.ac.uk, in providing archived GNSS data to this project, are gratefully acknowledged. The work was funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD), and the Leonardo da Vinci programme (European Commission) provided grant-holders that assisted this study. MS is supported by an Australian Research Council Future Fellowship (FT110100896) and Discovery Project (DP140100203).	AFRC, 1993, ENERGY PROTEIN REQUI; ALADOS CL, 1987, BIOL BEHAV, V12, P245; Albon SD, 2007, J APPL ECOL, V44, P1176, DOI 10.1111/j.1365-2664.2007.01318.x; [Anonymous], 1962, ENERGY METABOLISM RU; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BAKKEN GS, 1981, J THERM BIOL, V6, P23, DOI 10.1016/0306-4565(81)90038-3; BAKKEN GS, 1992, AM ZOOL, V32, P194; BAKKEN GS, 1985, AM ZOOL, V25, P933; Beaver JM, 1996, J THERM BIOL, V21, P345, DOI 10.1016/S0306-4565(96)00020-4; Bon R, 1996, BEHAV PROCESS, V38, P131, DOI 10.1016/S0376-6357(96)00029-0; Bonenfant C, 2007, ECOLOGY, V88, P3202, DOI 10.1890/07-0129.1; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Cain JW, 2008, J ARID ENVIRON, V72, P1518, DOI 10.1016/j.jaridenv.2008.02.010; Chan KS, 2005, OECOLOGIA, V145, P556, DOI 10.1007/s00442-005-0157-6; Clutton-Brock T. H., 1989, RED DEER HIGHLANDS; Clutton-Brock TH, 2004, NATURE, V429, P261, DOI 10.1038/429261a; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Conradt L, 1999, OECOLOGIA, V119, P367, DOI 10.1007/s004420050797; Conradt L, 2004, HABITAT SEGREGATION; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; CRAWFORD KM, 1983, ECOLOGY, V64, P989, DOI 10.2307/1937806; Debeffe L, 2013, ANIM BEHAV, V86, P143, DOI 10.1016/j.anbehav.2013.05.005; Deer Commission for Scotland, 2002, DEER COMM SCOTL ANN; Dennis P, 2008, J APPL ECOL, V45, P279, DOI 10.1111/j.1365-2664.2007.01378.x; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; Duncan AJ, 2001, ANIM SCI, V73, P563, DOI 10.1017/S1357729800058537; Dussault C, 2004, ECOSCIENCE, V11, P321, DOI 10.1080/11956860.2004.11682839; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; ESRI (Environmental Systems Resource Institute), 2009, ARCMAP 9 3; Evans DM, 2006, BIOL LETTERS, V2, P636, DOI 10.1098/rsbl.2006.0543; Farnsworth KD, 2002, AM NAT, V159, P24, DOI 10.1086/324114; Fernandez-Moran J, 1997, VET PARASITOL, V73, P163, DOI 10.1016/S0304-4017(97)00061-7; Ferretti F, 2011, EUR J WILDLIFE RES, V57, P775, DOI 10.1007/s10344-010-0487-5; Focardi S, 2006, ECOGRAPHY, V29, P407, DOI 10.1111/j.2006.0906-7590.04442.x; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; GRANT SA, 1976, J APPL ECOL, V13, P857, DOI 10.2307/2402261; Hester AJ, 1999, J APPL ECOL, V36, P133, DOI 10.1046/j.1365-2664.1999.00387.x; Holdo RM, 2007, J ECOL, V95, P115, DOI 10.1111/j.1365-2745.2006.01192.x; Houseal GA, 1995, CAN J ANIM SCI, V75, P501, DOI 10.4141/cjas95-076; Jennings DJ, 2004, ANIM BEHAV, V68, P213, DOI 10.1016/j.anbehav.2003.11.005; JUDD K, 1995, PHYSICA D, V82, P426, DOI 10.1016/0167-2789(95)00050-E; Kattas GD, 2013, ACTA ETHOL, V16, P21, DOI 10.1007/s10211-012-0134-0; Kattas GD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002449; Keating KA, 2007, J WILDLIFE MANAGE, V71, P1344, DOI 10.2193/2006-359; Keren EN, 2006, J THERM BIOL, V31, P371, DOI 10.1016/j.jtherbio.2005.11.029; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; KLEIN DR, 1994, OECOLOGIA, V97, P439, DOI 10.1007/BF00325880; Knoche S, 2012, J WILDLIFE MANAGE, V76, P462, DOI 10.1002/jwmg.302; Komer C, 2004, AMBIO, V13, P11; Kuznetsova A., 2013, LMERTEST TESTS RANDO; Latham J, 1999, FOREST ECOL MANAG, V120, P13, DOI 10.1016/S0378-1127(98)00539-8; MacMillan D, 2004, J ENVIRON MANAGE, V71, P261, DOI 10.1016/j.jenvman.2004.03.005; MASTELLER MA, 1988, CAN J ZOOL, V66, P2585, DOI 10.1139/z88-381; McLeod D, 2002, F99AC402A SCOTT NAT; MERRILL EH, 1991, APPL ANIM BEHAV SCI, V29, P251, DOI 10.1016/0168-1591(91)90252-S; MILNE JA, 1978, BRIT J NUTR, V40, P347, DOI 10.1079/BJN19780131; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Morris DW, 2003, EVOL ECOL, V17, P393, DOI 10.1023/A:1027304601301; Mysterud A, 2007, APPL ANIM BEHAV SCI, V108, P104, DOI 10.1016/j.applanim.2006.10.017; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nores C, 2009, CANTABRIAN CHAMOIS R, P338; Palmer SCF, 2003, ECOLOGY, V84, P2877, DOI 10.1890/02-0245; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Perez-Barberia FJ, 2007, ECOL MONOGR, V77, P631, DOI 10.1890/06-2088.1; Perez-Barberia FJ, 2013, OECOLOGIA, V173, P837, DOI 10.1007/s00442-013-2686-8; Perez-Barberia F.J., 2009, CONSERVACI N GESTI N, V1st, P106; Perez-Barberia FJ, 2002, EVOLUTION, V56, P1276; Pollock ML, 2013, RANGELAND ECOL MANAG, V66, P387, DOI 10.2111/REM-D-11-00123.1; Poudyal Neelam C., 2012, Human Dimensions of Wildlife, V17, P141, DOI 10.1080/10871209.2011.604666; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Richard E, 2010, OECOLOGIA, V163, P91, DOI 10.1007/s00442-009-1538-z; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rodriguez O, 2009, CANTABRIAN CHAMOIS R, P270; SCHAEFER JA, 1995, OECOLOGIA, V104, P39, DOI 10.1007/BF00365560; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Skarpe Christina, 2008, V195, P217, DOI 10.1007/978-3-540-72422-3_9; Small M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066701; Sokal RR, 1995, BIOMETRY; Stenseth NC, 2004, P ROY SOC B-BIOL SCI, V271, P1985, DOI 10.1098/rspb.2004.2794; Stewart KM, 2009, OECOLOGIA, V161, P303, DOI 10.1007/s00442-009-1376-z; Stewart KM, 2002, J MAMMAL, V83, P229, DOI 10.1644/1545-1542(2002)083&lt;0229:TDOEMD&gt;2.0.CO;2; Taillon J, 2007, ANIM BEHAV, V74, P265, DOI 10.1016/j.anbehav.2006.11.018; van Beest FM, 2013, J MAMMAL, V94, P691, DOI 10.1644/12-MAMM-A-080.1; van Wieren Spike E., 2008, V195, P263; Veiberg V, 2004, OECOLOGIA, V138, P135, DOI 10.1007/s00442-003-1399-9; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Yockney IJ, 2013, EPIDEMIOL INFECT, V141, P1407, DOI 10.1017/S0950268813000289; [No title captured]	93	10	10	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142707	10.1371/journal.pone.0142707	http://dx.doi.org/10.1371/journal.pone.0142707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580801	Green Published, gold, Green Accepted			2022-12-26	WOS:000365154600057
J	Ricarte, A; Marcos-Garcia, MA; Hancock, EG; Rotheray, GE				Ricarte, Antonio; Marcos-Garcia, M. Angeles; Hancock, E. Geoffrey; Rotheray, Graham E.			Neotropical Copestylum Macquart (Diptera: Syrphidae) Breeding in Fruits and Flowers, Including 7 New Species	PLOS ONE			English	Article								Ten species of Copestylum (Diptera: Syrphidae) were reared from fruits and flowers in Costa Rica, Ecuador and Trinidad. Seven were new and in this paper, we describe them, their development sites and the third stage larva and/or the puparium of all ten species. One new synonym is proposed, Copestylum pinkusi (Curran) [=Copestylum cinctiventre (Curran)]. Similarities and differences between these new and other Copestylum species, suggest they separate into two groups, referred to as the Vagum and Cinctiventre species groups. Features characterising these groups for both adult and early stages are assessed. Each species was also distinguished using adult and early stage characters. Within the Vagum group, adults were more disparate morphologically than the larval stage; this was reversed in the Cinctiventre group. Adult colour patterns are probably cryptic in function and for disguise. Vagum species have disruptive marks, while the Cinctiventre species have reflective colours. Biologically, the groups are almost distinguished by larval development sites. Vagum species use predominantly fruits and have a larval stage that is relatively generalised in form and habit. Cinctiventre species are confined to developing in flowers and the larva is more specialised. A key to both adult and early stages of all ten species is provided.	[Ricarte, Antonio; Rotheray, Graham E.] Natl Museums Collect Ctr, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Ricarte, Antonio; Marcos-Garcia, M. Angeles] Univ Alicante, Ctr Iberoamer Biodiversidad CIBIO, E-03080 Alicante, Spain; [Hancock, E. Geoffrey] Univ Glasgow, Hunterian Zool Museum, Glasgow, Lanark, Scotland	Universitat d'Alacant; University of Glasgow	Ricarte, A (corresponding author), Univ Alicante, Ctr Iberoamer Biodiversidad CIBIO, E-03080 Alicante, Spain.	ricarte24@gmail.com	Marcos García, Maria Angeles/H-7925-2015; Ricarte, Antonio/S-4483-2016	Marcos García, Maria Angeles/0000-0002-2439-2630; Ricarte, Antonio/0000-0003-2298-981X; Hancock, E Geoffrey/0000-0002-3600-4199	AECID, Agencia Espanola de Cooperacion Internacional para el Desarrollo, Ministerio de Asuntos Exteriores y de Cooperacion [A/4426/05, A/6788/06, A/3415/05, A/020305/08, A/019887/08]; S.W. Williston Diptera Research Fund of the Smithsonian Institution; Pelham-Clinton Fellowship Fund of the National Museums Scotland (E.C. Pelham-Clinton Fellowship) [NMS10/73]	AECID, Agencia Espanola de Cooperacion Internacional para el Desarrollo, Ministerio de Asuntos Exteriores y de Cooperacion; S.W. Williston Diptera Research Fund of the Smithsonian Institution; Pelham-Clinton Fellowship Fund of the National Museums Scotland (E.C. Pelham-Clinton Fellowship)	Fieldwork was funded by the AECID, Agencia Espanola de Cooperacion Internacional para el Desarrollo, Ministerio de Asuntos Exteriores y de Cooperacion (A/4426/05, A/6788/06, A/3415/05, A/020305/08 and A/019887/08; www.aecid.es). The taxonomic study was funded by the S.W. Williston Diptera Research Fund of the Smithsonian Institution (http://entomology.si.edu/) and the Pelham-Clinton Fellowship Fund of the National Museums Scotland (E.C. Pelham-Clinton Fellowship, reference NMS10/73; www.nms.ac.uk).	Curran C. H., 1926, Annals of the Entomological Society of America, V19, P50; CURRAN C. H., 1930, AMER MUS NOVITATES, V413, P1; Curran C.H., 1938, AM MUS NOVIT, V975, P1; Dusek Laska P, 1974, FOLIA FS NAT U PURKY, V15, P77; Edmunds J., 1974, DEFENCE ANIMALS SURV; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Marcos-Garcia MA, 2012, ENVIRON ENTOMOL, V41, P1544, DOI 10.1603/EN12215; Marinoni Luciane, 2004, Studia Dipterologica, V10, P565; Martinez-Falcon AP, 2012, J ARID ENVIRON, V78, P41, DOI 10.1016/j.jaridenv.2011.10.010; Rotheray EL, 2009, J INSECT CONSERV, V13, P569, DOI 10.1007/s10841-008-9204-z; Rotheray G, 1999, ZOOL J LINN SOC-LOND, V127, P1, DOI 10.1111/j.1096-3642.1999.tb01305.x; Rotheray GE, 2007, ZOOL J LINN SOC-LOND, V150, P267, DOI 10.1111/j.1096-3642.2007.00288.x; Rotheray GE, 2009, ZOOL J LINN SOC-LOND, V156, P697, DOI 10.1111/j.1096-3642.2008.00503.x; SEIFERT RP, 1979, ECOLOGY, V60, P462, DOI 10.2307/1936064; THOMPSON F C, 1972, Arquivos de Zoologia (Sao Paulo), V23, P73; Thompson F. C., 1999, Contributions on Entomology, International, V3, P321; Thompson F.C., 1981, Memoirs of the Entomological Society of Washington, P1; Wiedemann C.R.W., 1830, AUSSEREUROPAISCHE ZW	18	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142441	10.1371/journal.pone.0142441	http://dx.doi.org/10.1371/journal.pone.0142441			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580811	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000365154600048
J	Sciacca, V; Caruso, F; Beranzoli, L; Chierici, F; De Domenico, E; Embriaco, D; Favali, P; Giovanetti, G; Larosa, G; Marinaro, G; Papale, E; Pavan, G; Pellegrino, C; Pulvirenti, S; Simeone, F; Viola, S; Riccobene, G				Sciacca, Virginia; Caruso, Francesco; Beranzoli, Laura; Chierici, Francesco; De Domenico, Emilio; Embriaco, Davide; Favali, Paolo; Giovanetti, Gabriele; Larosa, Giuseppina; Marinaro, Giuditta; Papale, Elena; Pavan, Gianni; Pellegrino, Carmelo; Pulvirenti, Sara; Simeone, Francesco; Viola, Salvatore; Riccobene, Giorgio			Annual Acoustic Presence of Fin Whale (Balaenoptera physalus) Offshore Eastern Sicily, Central Mediterranean Sea	PLOS ONE			English	Article							NORTH-ATLANTIC; BLUE; CETACEANS; NOISE; CALLS; VOCALIZATIONS; BIOACOUSTICS; NEUTRINO; RANGE; ARRAY	In recent years, an increasing number of surveys have definitively confirmed the seasonal presence of fin whales (Balaenoptera physalus) in highly productive regions of the Mediterranean Sea. Despite this, very little is yet known about the routes that the species seasonally follows within the Mediterranean basin and, particularly, in the Ionian area. The present study assesses for the first time fin whale acoustic presence offshore Eastern Sicily (Ionian Sea), throughout the processing of about 10 months of continuous acoustic monitoring. The recording of fin whale vocalizations was made possible by the cabled deep-sea multidisciplinary observatory, "NEMO-SN1", deployed 25 km off the Catania harbor at a depth of about 2,100 meters. NEMO-SN1 is an operational node of the European Multidisciplinary Seafloor and water-column Observatory (EMSO) Research Infrastructure. The observatory was equipped with a low-frequency hydrophone (bandwidth: 0.05 Hz-1 kHz, sampling rate: 2 kHz) which continuously acquired data from July 2012 to May 2013. About 7,200 hours of acoustic data were analyzed by means of spectrogram display. Calls with the typical structure and patterns associated to the Mediterranean fin whale population were identified and monitored in the area for the first time. Furthermore, a background noise analysis within the fin whale communication frequency band (17.9-22.5 Hz) was conducted to investigate possible detection-masking effects. The study confirms the hypothesis that fin whales are present in the Ionian Sea throughout all seasons, with peaks in call detection rate during spring and summer months. The analysis also demonstrates that calls were more frequently detected in low background noise conditions. Further analysis will be performed to understand whether observed levels of noise limit the acoustic detection of the fin whales vocalizations, or whether the animals vocalize less in the presence of high background noise.	[Sciacca, Virginia; Caruso, Francesco; De Domenico, Emilio] Univ Messina, Dipartimento Sci Biol & Ambientali, Messina, Italy; [Sciacca, Virginia; Caruso, Francesco; Larosa, Giuseppina; Pulvirenti, Sara; Viola, Salvatore; Riccobene, Giorgio] Ist Nazl Fis Nucl, Lab Nazl Sud, I-95129 Catania, Italy; [Beranzoli, Laura; Embriaco, Davide; Favali, Paolo; Giovanetti, Gabriele; Marinaro, Giuditta] INGV, Rome, Italy; [Beranzoli, Laura; Favali, Paolo] Ist Nazl Geofis & Vulcanol, EMSO Interim Off, Rome, Italy; [Chierici, Francesco] Ist Radioastron INAF IRA, Ist Nazl Astrofis, Bologna, Italy; [Papale, Elena] CNR, IAMC Capo Granitola, Bioacoust Lab, Torretta Granitola, TP, Italy; [Pavan, Gianni] Univ Pavia, CIBRA, Dipartimento Sci Terra & Ambiente, I-27100 Pavia, Italy; [Pellegrino, Carmelo] Ist Nazl Fis Nucl, I-40126 Bologna, Italy; [Pellegrino, Carmelo] Univ Bologna, Dipartimento Fis & Astron, Bologna, Italy; [Simeone, Francesco] Ist Nazl Fis Nucl INFN Roma1, Rome, Italy	University of Messina; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale Geofisica e Vulcanologia (INGV); Istituto Nazionale Geofisica e Vulcanologia (INGV); Istituto Nazionale Astrofisica (INAF); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Pavia; Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN)	Sciacca, V (corresponding author), Univ Messina, Dipartimento Sci Biol & Ambientali, Messina, Italy.	vsciacca@unime.it	Pavan, Gianni/M-4619-2015; Pulvirenti, Sara Rita/AAE-1289-2019; Sciacca, Virginia/AAD-1528-2022; viola, Salvatore/C-1002-2014; Caruso, Francesco/AAB-4845-2019; Sciacca, Virginia/N-7205-2015; Riccobene, Giorgio/A-4502-2010; Embriaco, Davide/B-5827-2016; Favali, Paolo/AAR-5166-2021; Simeone, Francesco/L-1057-2016	Pavan, Gianni/0000-0002-4599-9028; Pulvirenti, Sara Rita/0000-0003-3017-512X; Sciacca, Virginia/0000-0002-7711-1249; viola, Salvatore/0000-0001-9511-8279; Caruso, Francesco/0000-0001-6881-3786; Sciacca, Virginia/0000-0002-7711-1249; Riccobene, Giorgio/0000-0002-0600-2774; Embriaco, Davide/0000-0001-7943-7341; Chierici, Francesco/0000-0003-1199-9705; marinaro, giuditta/0000-0002-6779-279X; Pellegrino, Carmelo/0000-0003-1530-4595; papale, elena/0000-0002-5150-9240; Giovanetti, Gabriele/0000-0002-4804-7006; BERANZOLI, LAURA/0000-0002-2273-3593	Italian Ministry of Education, Universities and Research [RBFR08NRZE]; Italian Ministry of the Environment [DPN/2008/28401]	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of the Environment	This work was conducted under the SMO (Submarine Multidisciplinary Observatory) FIRB 2008 activities, funded by the Italian Ministry of Education, Universities and Research n. RBFR08NRZE (GR FS) (https://web2.infn.it/smo/). GP has been funded by the Italian Ministry of the Environment within the project "Monitoraggio e conservazione dei cetacei in Italia" for the study and protection of marine mammals, contract n. DPN/2008/28401 (http://www.unipv.it/cibra/progettocetacei.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aissi M, 2008, J MAR BIOL ASSOC UK, V88, P1253, DOI 10.1017/S0025315408000891; Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x; Best M, 2014, OCEANOGRAPHY, V27, P167, DOI 10.5670/oceanog.2014.52; Boisseau O., 2008, Journal of Cetacean Research and Management, V10, P23; Brancato G, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P131; Canese S, 2006, J MAR BIOL ASSOC UK, V86, P903, DOI 10.1017/S0025315406013853; Caruso F., 2014, Biologia Marina Mediterranea, V21, P393; Castellote M., 2010, POPULATION IDENTITY; Castellote M, 2012, MAR MAMMAL SCI, V28, P325, DOI 10.1111/j.1748-7692.2011.00491.x; Castellote M, 2012, BIOL CONSERV, V147, P115, DOI 10.1016/j.biocon.2011.12.021; Catalano D, 2001, P 15 INT C ECS EUR C, V9, P56; Charif RA, 2002, MAR MAMMAL SCI, V18, P81, DOI 10.1111/j.1748-7692.2002.tb01020.x; Clark CW, 2009, MAR ECOL PROG SER, V395, P201, DOI 10.3354/meps08402; Clark CW, 2002, MAR MAMMAL SCI, V18, P286, DOI 10.1111/j.1748-7692.2002.tb01035.x; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; De Domenico E., 1987, DOCUMENTS TRAVAUX I, V11, P225; Defant A, 1961, PHYS OCEANOGRAPHY, V2, P395; DiSciara GN, 1997, MAR FRESHW BEHAV PHY, V30, P125; Druon JN, 2012, MAR ECOL PROG SER, V464, P289, DOI 10.3354/meps09810; Edds-Walton Peggy L., 1997, Bioacoustics, V8, P47; Embriaco D, 2010, ORION, V2010, P12; Favali P, 2013, IEEE J OCEANIC ENG, V38, P358, DOI 10.1109/JOE.2012.2224536; Favali P, 2011, NUCL INSTRUM METH A, V626, pS53, DOI 10.1016/j.nima.2010.04.139; FORCADA J, 1995, MAMMALIA, V59, P127, DOI 10.1515/mamm.1995.59.1.127; Gannier A., 1997, ESTIMATION ABONDANCE; Gannier Alexandre, 1998, Mesogee, V56, P3; Gimenez J, 2013, RAPID COMMUN MASS SP, V27, P1801, DOI 10.1002/rcm.6633; Guglielmo L, 1969, B PESCA PISC IDROBIO, V24, P71; IBM Corp, 2011, IBM SPSS STAT WIND V; KAWAMURA A, 1980, Scientific Reports of the Whales Research Institute Tokyo, P155; Klinck H, 2012, J ACOUST SOC AM, V132, pEL176, DOI 10.1121/1.4740226; KM3NeT Consortium, 2008, CONC DES DEEP SEA RE; Kusel ET, 2011, J ACOUST SOC AM, V129, P3610, DOI 10.1121/1.3583504; Marini L, 1996, EUROPEAN RES CETACEA, V9, P126; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; MCDONALD MA, 1995, J ACOUST SOC AM, V98, P712, DOI 10.1121/1.413565; McDonald MA, 1999, J ACOUST SOC AM, V105, P2643, DOI 10.1121/1.426880; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Merchant ND, 2015, METHODS ECOL EVOL, V6, P257, DOI 10.1111/2041-210X.12330; Moore SE, 1998, MAR MAMMAL SCI, V14, P617, DOI 10.1111/j.1748-7692.1998.tb00749.x; Nosengo N, 2009, NATURE, V462, P560, DOI 10.1038/462560a; Notarbartolo-di-Sciara G, 2003, MAMMAL REV, V33, P105, DOI 10.1046/j.1365-2907.2003.00005.x; Panigada, 2012, BALAENOPTERA PHYSALU; Panigada S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022878; Pavan G, 1997, MAR FRESHW BEHAV PHY, V30, P99, DOI 10.1080/10236249709379019; Pavan G., 2006, SC58E IWC, V19, P1; Pavan G, 2008, P INT EXP M IT BAS D, P7; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; PORTER MB, 1987, J ACOUST SOC AM, V82, P1349, DOI 10.1121/1.395269; Rebull OG, 2006, J ACOUST SOC AM, V120, P2077, DOI 10.1121/1.2336751; RELINI LO, 1992, B MUS I BIOL U GEN, V56, P247; Riccobene G, 2007, ASTROPART PHYS, V27, P1, DOI 10.1016/j.astropartphys.2006.08.006; Riccobene G, 2009, NUCL INSTRUM METH A, V604, pS149, DOI 10.1016/j.nima.2009.03.195; Sacca A, 2008, HYDROBIOLOGIA, V600, P89, DOI 10.1007/s10750-007-9179-x; Schlitzer R., 2012, OCEAN DATA VIEW; Simeone F., 2011, 2011 IEEE 8th International Conference on Mobile Ad-Hoc and Sensor Systems, P898, DOI 10.1109/MASS.2011.107; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Sirovic A, 2007, J ACOUST SOC AM, V122, P1208, DOI 10.1121/1.2749452; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; Stafford KM, 2005, ANIM BEHAV, V69, P951, DOI 10.1016/j.anbehav.2004.06.025; Tringali L.M., 1999, Biologia Marina Mediterranea, V6, P619; van Opzeeland Ilse, 2013, Polarforschung, V83, P47; Vella A, 2010, RAPP COMM INT MER ME, V39, P693; Viola S, 2013, NUCL INSTRUM METH A, V725, P207, DOI 10.1016/j.nima.2012.11.150; Viola S, 2015, GEOPHYS RES ABSTRACT, V17; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; Weirathmueller MJ, 2013, J ACOUST SOC AM, V133, P741, DOI 10.1121/1.4773277; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161	69	30	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141838	10.1371/journal.pone.0141838	http://dx.doi.org/10.1371/journal.pone.0141838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581104	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600024
J	Seronde, MF; Vausort, M; Gayat, E; Goretti, E; Ng, LL; Squire, IB; Vodovar, N; Sadoune, M; Samuel, JL; Thum, T; Solal, AC; Laribi, S; Plaisance, P; Wagner, DR; Mebazaa, A; Devaux, Y				Seronde, Marie-France; Vausort, Melanie; Gayat, Etienne; Goretti, Emeline; Ng, Leong L.; Squire, Iain B.; Vodovar, Nicolas; Sadoune, Malha; Samuel, Jane-Lise; Thum, Thomas; Solal, Alain Cohen; Laribi, Said; Plaisance, Patrick; Wagner, Daniel R.; Mebazaa, Alexandre; Devaux, Yvan		GREAT Network	Circulating microRNAs and Outcome in Patients with Acute Heart Failure	PLOS ONE			English	Article							BIOMARKERS; READMISSION; ASSOCIATION; MARKERS	Background The biomarker value of circulating microRNAs (miRNAs) has been extensively addressed in patients with acute coronary syndrome. However, prognostic performances of miRNAs in patients with acute heart failure (AHF) has received less attention. Methods A test cohort of 294 patients with acute dyspnea (236 AHF and 58 non-AHF) and 44 patients with stable chronic heart failure (CHF), and an independent validation cohort of 711 AHF patients, were used. Admission levels of miR-1/-21/-23/-126/-423-5p were assessed in plasma samples. Results In the test cohort, admission levels of miR-1 were lower in AHF and stable CHF patients compared to non-AHF patients (p = 0.0016). Levels of miR-126 and miR-423-5p were lower in AHF and in non-AHF patients compared to stable CHF patients (both p<0.001). Interestingly, admission levels of miR-423-5p were lower in patients who were re-admitted to the hospital in the year following the index hospitalization compared to patients who were not (p = 0.0001). Adjusted odds ratio [95% confidence interval] for one-year readmission was 0.70 [0.53-0.93] for miR-423-5p (p = 0.01). In the validation cohort, admission levels of miR-423-5p predicted 1-year mortality with an adjusted odds ratio [95% confidence interval] of 0.54 [0.36-0.82], p = 0.004. Patients within the lowest quartile of miR-423-5p were at high risk of long-term mortality (p = 0.02). Conclusions In AHF patients, low circulating levels of miR-423-5p at presentation are associated with a poor long-term outcome. This study supports the value of miR-423-5p as a prognostic biomarker of AHF.	[Seronde, Marie-France] Univ Hosp, Dept Cardiol, EA3920, Besancon, France; [Seronde, Marie-France; Gayat, Etienne; Vodovar, Nicolas; Sadoune, Malha; Samuel, Jane-Lise; Solal, Alain Cohen; Laribi, Said; Plaisance, Patrick; Mebazaa, Alexandre] Univ Paris Diderot, INSERM, UMRS 942, Paris, France; [Vausort, Melanie; Goretti, Emeline; Wagner, Daniel R.; Devaux, Yvan] Ctr Rech Publ Sante, Lab Cardiovasc Res, Luxembourg, Luxembourg; [Gayat, Etienne] St Louis Lariboisiere Hosp, Dept Anesthesiol & Crit Care, Paris, France; [Ng, Leong L.; Squire, Iain B.] Univ Leicester, Leicester, Leics, England; [Ng, Leong L.; Squire, Iain B.] Glenfield Gen Hosp, Natl Inst Hlth Res, Leicester Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England; [Thum, Thomas] IMTTS, Hannover, Germany; [Solal, Alain Cohen] Lariboisiere Hosp, Dept Cardiol, Paris, France; [Laribi, Said; Plaisance, Patrick] Lariboisiere Hosp, Dept Emergency Med, Paris, France	Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Luxembourg Institute of Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Devaux, Y (corresponding author), Ctr Rech Publ Sante, Lab Cardiovasc Res, Luxembourg, Luxembourg.	yvan.devaux@crp-sante.lu	Laribi, Said/S-3693-2016; Gayat, Etienne/ABG-5308-2021; DEVAUX, Yvan/AAK-3463-2020; Vodovar, Nicolas/S-2947-2019	Laribi, Said/0000-0003-4648-4672; Mebazaa, Alexandre/0000-0001-8715-7753; GAYAT, Etienne/0000-0002-3334-3849; Devaux, Yvan/0000-0002-5321-8543; Ng, Leong/0000-0002-6553-5749; Vodovar, Nicolas/0000-0001-8087-387X; Samuel, Jane-Lise/0000-0002-7346-2404	National Fund for Research of Luxembourg [785036]; European Commission [305507]	National Fund for Research of Luxembourg; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the National Fund for Research of Luxembourg (#785036). NV is supported by a post-doctoral fellowship from the European Commission's Seventh Framework programme under grant agreement No 305507 (HOMAGE).	Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Devaux Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070644; Devaux Y, 2013, CIRC RES, V113, pe46, DOI 10.1161/CIRCRESAHA.113.302030; Devaux Y, 2013, CIRC-CARDIOVASC GENE, V6, P290, DOI 10.1161/CIRCGENETICS.113.000077; Devaux Y, 2012, CLIN CHEM, V58, P559, DOI 10.1373/clinchem.2011.173823; Dimmeler S, 2010, EUR HEART J, V31, P2705, DOI 10.1093/eurheartj/ehq221; Ellis KL, 2013, EUR J HEART FAIL, V15, P1138, DOI 10.1093/eurjhf/hft078; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goretti E, 2014, TRENDS MOL MED; Goretti E, 2013, INT J CARDIOL, V168, P4548, DOI 10.1016/j.ijcard.2013.06.092; HOLM S, 1979, SCAND J STAT, V6, P65; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Lassus J, 2013, INT J CARDIOL, V168, P2186, DOI 10.1016/j.ijcard.2013.01.228; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Matsumoto S, 2012, BIOCHEM BIOPH RES CO, V427, P280, DOI 10.1016/j.bbrc.2012.09.039; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mebazaa Alexandre, 2008, Crit Care Med, V36, pS129, DOI 10.1097/01.CCM.0000296274.51933.4C; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ouwerkerk W, 2014, JACC-HEART FAIL, V2, P429, DOI 10.1016/j.jchf.2014.04.006; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pratt AK, 2014, CRIT CARE MED, V42, P158, DOI 10.1097/01.ccm.0000435675.91305.76; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Vogel B, 2013, EUR HEART J, V34, P2812, DOI 10.1093/eurheartj/eht256; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291	31	62	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142237	10.1371/journal.pone.0142237	http://dx.doi.org/10.1371/journal.pone.0142237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580972	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600040
J	Liu, KM; Chin, CP; Chen, CH; Chang, JH				Liu, Kwang-Ming; Chin, Chien-Pang; Chen, Chun-Hui; Chang, Jui-Han			Estimating Finite Rate of Population Increase for Sharks Based on Vital Parameters	PLOS ONE			English	Article							GULF-OF-MEXICO; SCALLOPED HAMMERHEAD SHARK; ATLANTIC SHARPNOSE SHARK; SPHYRNA-LEWINI GRIFFITH; PELAGIC THRESHER SHARK; DEMOGRAPHIC-ANALYSIS; REPRODUCTIVE-BIOLOGY; ISURUS-OXYRINCHUS; SHORTFIN MAKO; RHIZOPRIONODON-TERRAENOVAE	The vital parameter data for 62 stocks, covering 38 species, collected from the literature, including parameters of age, growth, and reproduction, were log-transformed and analyzed using multivariate analyses. Three groups were identified and empirical equations were developed for each to describe the relationships between the predicted finite rates of population increase (lambda') and the vital parameters, maximum age (T-max), age at maturity (T-m), annual fecundity (f/R-c)), size at birth (L-b), size at maturity (L-m), and asymptotic length (L-infinity). Group (1) included species with slow growth rates (0.034 yr(-1) < k < 0.103 yr(-1)) and extended longevity (26 yr < T-max < 81 yr), e.g., shortfin mako Isurus oxyrinchus, dusky shark Carcharhinus obscurus, etc.; Group (2) included species with fast growth rates (0.103 yr(-1) < k < 0.358 yr(-1)) and short longevity (9 yr < T-max < 26 yr), e.g., starspotted smoothhound Mustelus manazo, gray smoothhound M. californicus, etc.; Group (3) included late maturing species (L-m/L-infinity >= 0.75) with moderate longevity (T-max < 29 yr), e.g., pelagic thresher Alopias pelagicus, sevengill shark Notorynchus cepedianus. The empirical equation for all data pooled was also developed. The lambda' values estimated by these empirical equations showed good agreement with those calculated using conventional demographic analysis. The predictability was further validated by an independent data set of three species. The empirical equations developed in this study not only reduce the uncertainties in estimation but also account for the difference in life history among groups. This method therefore provides an efficient and effective approach to the implementation of precautionary shark management measures.	[Liu, Kwang-Ming; Chen, Chun-Hui] Natl Taiwan Ocean Univ, Inst Marine Affairs & Resource Management, Keelung 202, Taiwan; [Liu, Kwang-Ming] Natl Taiwan Ocean Univ, George Chen Shark Res Ctr, Keelung 202, Taiwan; [Liu, Kwang-Ming] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 202, Taiwan; [Chin, Chien-Pang] Nation Taiwan Univ, Inst Oceanog, Taipei 106, Taiwan; [Chin, Chien-Pang] Fisheries Res Inst, Council Agr, Keelung 202, Taiwan; [Chang, Jui-Han] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA	National Taiwan Ocean University; National Taiwan Ocean University; National Taiwan Ocean University; National Taiwan University; Taiwan Fish Research Institute; University of Maine System; University of Maine Orono	Liu, KM (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Affairs & Resource Management, Keelung 202, Taiwan.	kmliu@mail.ntou.edu.tw	Liu, Kwang-Ming/AAL-2358-2021	Chang, Jui-Han/0000-0003-0970-3442	National Science Council, Republic of China [NSC 101-2313-B-019-008-MY3, NSC 102-2313-B-019-008-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This project was funded by the National Science Council, Republic of China, through grants NSC 101-2313-B-019-008-MY3 and NSC 102-2313-B-019-008-MY3.	Anislado-Tolentino V, 2008, HIDROBIOLOGICA, V18, P31; [Anonymous], NOAATMNMFSPIFSC17; Au DW, 1997, CAN J FISH AQUAT SCI, V54, P415, DOI 10.1139/cjfas-54-2-415; Babcock EA, 2009, COLLECT VOL SCI PAP, V64, P1568; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bonfil Ramon, 1993, NOAA Technical Report NMFS, V115, P73; BRANSTETTER S, 1987, FISH B-NOAA, V85, P269; BRANSTETTER S, 1987, ENVIRON BIOL FISH, V20, P169, DOI 10.1007/BF00004952; BRANSTETTER S, 1987, ENVIRON BIOL FISH, V19, P161, DOI 10.1007/BF00005346; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Cailliet G.M., 1983, California Cooperative Oceanic Fisheries Investigations Reports, V24, P57; Cailliet G. M., 1983, NOAA TECHNICAL REPOR, P179; CAILLIET GM, 1992, AUST J MAR FRESH RES, V43, P183; Camhi MD, 2009, SHARK OPEN OCEAN BIO, P166, DOI 10.1002/9781444302516; Campana S., 2001, 2001067 CAN STOCK AS; Carlson JK, 2003, MAR FRESHWATER RES, V54, P227, DOI 10.1071/MF02153; Carlson JK, 1999, COPEIA, P684; CASEY JG, 1992, CAN J FISH AQUAT SCI, V49, P1474, DOI 10.1139/f92-162; Chang JH, 2009, FISH RES, V98, P92, DOI 10.1016/j.fishres.2009.04.005; CHEN C T, 1990, Pacific Science, V44, P156; Chen CT, 1997, ICHTHYOL RES, V44, P227, DOI 10.1007/BF02678702; Chen PM, 2006, FISH RES, V78, P374, DOI 10.1016/j.fishres.2006.01.007; CHEN S, 1989, NIPPON SUISAN GAKK, V55, P205; Chen WK, 2007, ZOOL STUD, V46, P92; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno L.J.V., 2005, FIELD GUIDE SHARKS W; Compagno LJV., 1984, FAO FISH SYNOP, P20; Cope JM, 2006, FISH B-NOAA, V104, P311; CORTES E, 1995, FISH B-NOAA, V93, P57; Cortes E, 1998, FISH RES, V39, P199, DOI 10.1016/S0165-7836(98)00183-0; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Cortes E, 1996, CAN J FISH AQUAT SCI, V53, P709, DOI 10.1139/cjfas-53-4-709; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Davidson LNK, 2015, FISH FISH, DOI 10.1111/faf.12119; Devadoss P., 1998, Indian Journal of Fisheries, V45, P29; Driggers WB, 2004, ENVIRON BIOL FISH, V71, P171, DOI 10.1007/s10641-004-0105-z; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; FABENS AJ, 1965, GROWTH, V29, P265; Francis MP, 1998, MAR FRESHWATER RES, V49, P579, DOI 10.1071/MF97076; Frisk MG, 2001, CAN J FISH AQUAT SCI, V58, P969, DOI 10.1139/cjfas-58-5-969; Froese R, 2000, J FISH BIOL, V56, P758, DOI 10.1111/j.1095-8649.2000.tb00870.x; HOENIG JM, 1983, FISH B US, V82, P898, DOI DOI 10.1890/04-0594; Hoening J.M., 1990, NOAA TECHNICAL REPOR, P1; Hoff T B, 1990, THESIS; Huang JY, 2006, THESIS; ICCAT Compliance Committee, 2011, REP INT M COMP COMM; ICCAT Shark Working Group Report, 2012, ICCAT SHARK WORK GRO; IOTC WPEB, 2010, 6 SESS IOTC WORK PAR; ISC, 2014, STOCK ASS FUT PROJ B; ISC Shark Working Group, 2013, STOCK ASS FUT PROJ B; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jensen AL, 1996, CAN J FISH AQUAT SCI, V53, P820, DOI 10.1139/cjfas-53-4-820; Jensen CF, 2002, FISH B-NOAA, V100, P727; Jiao Y, 2009, ICES J MAR SCI, V66, P367, DOI 10.1093/icesjms/fsn162; Joung SJ, 2005, ZOOL STUD, V44, P487; Joung SJ, 2005, ZOOL STUD, V44, P102; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Joung SJ, 1993, THESIS; KETCHEN KS, 1975, J FISH RES BOARD CAN, V32, P43, DOI 10.1139/f75-006; King JR, 2003, FISHERIES MANAG ECOL, V10, P249, DOI 10.1046/j.1365-2400.2003.00359.x; Kleiber P, 2009, N PAC BLUE SHARK STO; Kotas JE, 2011, BRAZ J BIOL, V71, P755, DOI 10.1590/S1519-69842011000400022; Krebs C., 1985, Q REV BIOL, DOI DOI 10.1086/407551; Liu KM, 1999, FISHERIES SCI, V65, P218, DOI 10.2331/fishsci.65.218; Liu KM, 1999, COPEIA, P68; Mollet HF, 2002, MAR FRESHWATER RES, V53, P503, DOI 10.1071/MF01083; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Neer JA, 2005, J FISH BIOL, V67, P370, DOI 10.1111/j.0022-1112.2005.00743.x; Nelson J.S., 1984, FISHES WORLD, V2nd, P523; Oshitani S, 2003, FISHERIES SCI, V69, P456, DOI 10.1046/j.1444-2906.2003.00645.x; PAULY D, 1980, J CONSEIL, V39, P175; Pauly D., 1984, ICLARM STUDIES REV, V8; Pauly D, 2002, EL BIOD CONS MAN P I; PERES MB, 1991, FISH B-NOAA, V89, P655; PETERSON I, 1984, CAN J FISH AQUAT SCI, V41, P1117, DOI 10.1139/f84-131; Pratt H.L., 1990, NOAA TECHNICAL REPOR, P17; PRATT HL, 1983, CAN J FISH AQUAT SCI, V40, P1944, DOI 10.1139/f83-224; Pratt HLJ, 1990, NOAA TECH REP NMFS, V90, P98; Santana FM, 2004, FISH B-NOAA, V102, P156; Schindler DE, 2002, ECOL APPL, V12, P735, DOI 10.2307/3060985; SCHWARTZ F J, 1984, Northeast Gulf Science, V7, P29; Simpfendorfer CA, 2000, ENVIRON BIOL FISH, V58, P335, DOI 10.1023/A:1007624828001; Simpfendorfer CA, 2002, MAR FRESHWATER RES, V53, P567, DOI 10.1071/MF01131; Skomal GB, 2003, FISH B-NOAA, V101, P627; Sminkey TR, 1995, COPEIA, P871; STEVENS JD, 1986, AUST J MAR FRESH RES, V37, P671; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; TAYLOR C. C., 1958, JOUR CONS PERM INTERNATL EXPLOR MER, V23, P366; Then AY, 2015, ICES J MAR SCI, V72, P82, DOI 10.1093/icesjms/fsu136; Thorson JT, 2015, FISH FISH, V16, P342, DOI 10.1111/faf.12061; Tsai WP, 2010, MAR FRESHWATER RES, V61, P1056, DOI 10.1071/MF09303; Walker TI, 1998, MAR FRESHWATER RES, V49, P553, DOI 10.1071/MF98017; WCPFC TCC Summary Report, 2012, TECHN COMP COMM 8 RE; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th; WOURMS JP, 1977, AM ZOOL, V17, P379; [No title captured]; [No title captured]; [No title captured]; [No title captured]	100	34	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143008	10.1371/journal.pone.0143008	http://dx.doi.org/10.1371/journal.pone.0143008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26576058	Green Published, Green Submitted, gold			2022-12-26	WOS:000365153400027
J	Fraveto, A; Cardinale, V; Bragazzi, MC; Giuliante, F; De Rose, AM; Grazi, GL; Napoletano, C; Semeraro, R; Lustri, AM; Costantini, D; Nevi, L; Di Matteo, S; Renzi, A; Carpino, G; Gaudio, E; Alvaro, D				Fraveto, Alice; Cardinale, Vincenzo; Bragazzi, Maria Consiglia; Giuliante, Felice; De Rose, Agostino Maria; Grazi, Gian Luca; Napoletano, Chiara; Semeraro, Rossella; Lustri, Anna Maria; Costantini, Daniele; Nevi, Lorenzo; Di Matteo, Sabina; Renzi, Anastasia; Carpino, Guido; Gaudio, Eugenio; Alvaro, Domenico			Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures	PLOS ONE			English	Article							BILIARY-TRACT CANCER; TYROSINE KINASE INHIBITORS; STEM-CELLS; CHOLANGIOCELLULAR CARCINOMA; LIVER-CANCER; PHASE-II; GEMCITABINE; GROWTH; OXALIPLATIN; COMBINATION	We investigated the sensitivity of intrahepatic cholangiocarcinoma (IHCCA) subtypes to chemotherapeutics and molecular targeted agents. Primary cultures of mucin-and mixed-IHCCA were prepared from surgical specimens (N. 18 IHCCA patients) and evaluated for cell proliferation (MTS assay) and apoptosis (Caspase 3) after incubation (72 hours) with increasing concentrations of different drugs. In vivo, subcutaneous human tumor xenografts were evaluated. Primary cultures of mucin-and mixed-IHCCA were characterized by a different pattern of expression of cancer stem cell markers, and by a different drug sensitivity. Gemcitabine and the Gemcitabine-Cisplatin combination were more active in inhibiting cell proliferation in mixed-IHCCA while Cisplatin or Abraxane were more effective against mucin-IHCCA, where Abraxane also enhances apoptosis. 5-Fluoracil showed a slight inhibitory effect on cell proliferation that was more significant in mixed-than mucin-IHCCA primary cultures and, induced apoptosis only in mucin-IHCCA. Among Hg inhibitors, LY2940680 and Vismodegib showed slight effects on proliferation of both IHCCA subtypes. The tyrosine kinase inhibitors, Imatinib Mesylate and Sorafenib showed significant inhibitory effects on proliferation of both mucin-and mixed-IHCCA. The MEK 1/2 inhibitor, Selumetinib, inhibited proliferation of only mucin-IHCCA while the aminopeptidase-N inhibitor, Bestatin was more active against mixed-IHCCA. The c-erbB2 blocking antibody was more active against mixed-IHCCA while, the Wnt inhibitor, LGK974, similarly inhibited proliferation of mucin-and mixed-IHCCA. Either mucin-or mixed-IHCCA showed high sensitivity to nanomolar concentrations of the dual PI3-kinase/mTOR inhibitor, NVP-BEZ235. In vivo, in subcutaneous xenografts, either NVP-BEZ235 or Abraxane, blocked tumor growth. In conclusion, mucin-and mixed-IHCCA are characterized by a different drug sensitivity. Cisplatin, Abraxane and the MEK 1/2 inhibitor, Selumetinib were more active against mucin-IHCCA while, Gemcitabine, Gemcitabine-Cisplatin combination, the c-erbB2 blocking antibody and bestatin worked better against mixed-IHCCA. Remarkably, we identified a dual PI3-kinase/mTOR inhibitor that both in vitro and in vivo, exerts dramatic antiproliferative effects against both mucin- and mixed-IHCCA.	[Fraveto, Alice; Cardinale, Vincenzo; Bragazzi, Maria Consiglia; Semeraro, Rossella; Lustri, Anna Maria; Costantini, Daniele; Nevi, Lorenzo; Di Matteo, Sabina; Alvaro, Domenico] Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, I-00185 Rome, Italy; [Carpino, Guido] Univ Rome Foro Italico, Hlth Sci, Rome, Italy; [Renzi, Anastasia; Gaudio, Eugenio] Univ Roma La Sapienza, SAIMLAL, I-00185 Rome, Italy; [Giuliante, Felice; De Rose, Agostino Maria] Univ Cattolica Sacro Cuore, Sch Med, Hepatobiliary Unit, Surg, I-00168 Rome, Italy; [Napoletano, Chiara] Univ Roma La Sapienza, Expt Med, I-00185 Rome, Italy; [Grazi, Gian Luca] Regina Elena Inst Canc Res, Hepatobiliary Surg, Rome, Italy	Sapienza University Rome; Foro Italico University of Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Alvaro, D (corresponding author), Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	domenico.alvaro@uniroma1.it	Di Matteo, Sabina/D-1876-2017; De Rose, Agostino Maria/V-4910-2019; ALVARO, Domenico/J-8600-2018; Grazi, Gian Luca/J-7215-2018; Napoletano, Chiara/AAO-1691-2021; GIULIANTE, FELICE/AAC-5066-2020; Carpino, Guido/AAB-9692-2019; Nevi, Lorenzo/B-3289-2017; Cardinale, Vincenzo/AAB-9296-2019; De Rose, Agostino/J-8414-2016; COSTANTINI, DANIELE/C-3898-2017	Di Matteo, Sabina/0000-0002-2586-7159; De Rose, Agostino Maria/0000-0003-3310-8088; ALVARO, Domenico/0000-0003-3771-9644; Grazi, Gian Luca/0000-0002-3279-0313; GIULIANTE, FELICE/0000-0003-2087-2589; Nevi, Lorenzo/0000-0003-0924-2551; Cardinale, Vincenzo/0000-0003-0234-3341; De Rose, Agostino/0000-0003-3310-8088; CARPINO, Guido/0000-0001-8570-2519; COSTANTINI, DANIELE/0000-0001-7438-4578	University "Sapienza" of Rome; Consorzio Interuniversitario Trapianti d'Organo	University "Sapienza" of Rome; Consorzio Interuniversitario Trapianti d'Organo	Funded by University "Sapienza" of Rome (DA, EG) and Consorzio Interuniversitario Trapianti d'Organo (DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2012, GASTROENTEROLOGY, V142, P1021, DOI 10.1053/j.gastro.2011.12.005; Bekaii-Saab T, 2011, J CLIN ONCOL, V29, P2357, DOI 10.1200/JCO.2010.33.9473; Bengala C, 2010, BRIT J CANCER, V102, P68, DOI 10.1038/sj.bjc.6605458; Boulter L, 2015, J CLIN INVEST, V125, P1269, DOI 10.1172/JCI76452; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Cardinale V, 2015, AM J PATHOL, V185, P1724, DOI 10.1016/j.ajpath.2015.02.010; Cardinale V, 2012, WORLD J GASTRO ONCOL, V4, P94, DOI 10.4251/wjgo.v4.i5.94; Chen MH, 2014, ONCOTARGET, V5, P2372, DOI 10.18632/oncotarget.1706; Dealis C, 2008, J CLIN ONCOL, P4590; El Khatib M, 2013, HEPATOLOGY, V57, P1035, DOI 10.1002/hep.26147; Ewald F, 2013, INT J CANCER, V133, P2065, DOI 10.1002/ijc.28214; Green MR, 2006, ANN ONCOL, V17, P1263, DOI 10.1093/annonc/mdl104; Gruenberger B, 2010, LANCET ONCOL, V11, P1142, DOI 10.1016/S1470-2045(10)70247-3; Grujic M, 2002, CANCER LETT, V182, P113, DOI 10.1016/S0304-3835(02)00086-1; Heinemann V, 2012, CANCER TREAT REV, V38, P843, DOI 10.1016/j.ctrv.2011.12.004; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Law LY, 2012, J CLIN ONCOL, V30, pE271, DOI 10.1200/JCO.2012.42.3061; Levitzki A, 2013, ANNU REV PHARMACOL, V53, P161, DOI 10.1146/annurev-pharmtox-011112-140341; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Malka D, 2014, LANCET ONCOL, V15, P819, DOI 10.1016/S1470-2045(14)70212-8; Martins MG, 2014, INVESTIGACAO, P1, DOI 10.14195/978-989-26-0696-5; Nanda Shreeya, 2010, Nat Rev Gastroenterol Hepatol, V7, P591, DOI 10.1038/nrgastro.2010.163; Oishi N, 2011, INT J BIOL SCI, V7, P517, DOI 10.7150/ijbs.7.517; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; Razumilava N, 2014, J HEPATOL, V60, P599, DOI 10.1016/j.jhep.2013.11.005; Roskoski R, 2014, PHARMACOL RES, V87, P42, DOI 10.1016/j.phrs.2014.06.001; Roth A, 2011, ONKOLOGIE, V34, P469, DOI 10.1159/000331065; Roth Joshua A, 2012, J Gastrointest Cancer, V43, P215, DOI 10.1007/s12029-010-9242-0; Strumberg D, 2005, DRUGS TODAY, V41, P773, DOI 10.1358/dot.2005.41.12.937959; Tang L, 2013, CLIN CANCER RES, V19, P2014, DOI 10.1158/1078-0432.CCR-12-0349; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yamashita T, 2013, HEPATOLOGY, V57, P1484, DOI 10.1002/hep.26168; Yothaisong S, 2013, TUMOR BIOL, V34, P3637, DOI 10.1007/s13277-013-0945-2; Zhang ZC, 2010, HEPATOLOGY, V52, P975, DOI 10.1002/hep.23773	38	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142124	10.1371/journal.pone.0142124	http://dx.doi.org/10.1371/journal.pone.0142124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571380	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700019
J	Garcia-Cano, E; Magori, S; Sun, Q; Ding, ZH; Lazarowitz, SG; Citovsky, V				Garcia-Cano, Elena; Magori, Shimpei; Sun, Qi; Ding, Zehong; Lazarowitz, Sondra G.; Citovsky, Vitaly			Interaction of Arabidopsis Trihelix-Domain Transcription Factors VFP3 and VFP5 with Agrobacterium Virulence Protein VirF	PLOS ONE			English	Article							PLANT GENETIC-TRANSFORMATION; EXPRESSION ANALYSIS; NUCLEAR IMPORT; TUMEFACIENS; BACTERIAL; SYSTEM; FAMILY; MAPMAN; IDENTIFICATION; VISUALIZATION	Agrobacterium is a natural genetic engineer of plants that exports several virulence proteins into host cells in order to take advantage of the cell machinery to facilitate transformation and support bacterial growth. One of these effectors is the F-box protein VirF, which presumably uses the host ubiquitin/proteasome system (UPS) to uncoat the packaging proteins from the invading bacterial T-DNA. By analogy to several other bacterial effectors, VirF most likely has several functions in the host cell and, therefore, several interacting partners among host proteins. Here we identify one such interactor, an Arabidopsis trihelixdomain transcription factor VFP3, and further show that its very close homolog VFP5 also interacted with VirF. Interestingly, interactions of VirF with either VFP3 or VFP5 did not activate the host UPS, suggesting that VirF might play other UPS-independent roles in bacterial infection. To better understand the potential scope of VFP3 function, we used RNAi to reduce expression of the VFP3 gene. Transcriptome profiling of these VFP3-silenced plants using high-throughput cDNA sequencing (RNA-seq) revealed that VFP3 substantially affected plant gene expression; specifically, 1,118 genes representing approximately 5% of all expressed genes were significantly either up-or down-regulated in the VFP3 RNAi line compared to wild-type Col-0 plants. Among the 507 up-regulated genes were genes implicated in the regulation of transcription, protein degradation, calcium signaling, and hormone metabolism, whereas the 611 down-regulated genes included those involved in redox regulation, light reactions of photosynthesis, and metabolism of lipids, amino acids, and cell wall. Overall, this pattern of changes in gene expression is characteristic of plants under stress. Thus, VFP3 likely plays an important role in controlling plant homeostasis.	[Garcia-Cano, Elena; Magori, Shimpei; Citovsky, Vitaly] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Sun, Qi; Ding, Zehong] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY USA; [Lazarowitz, Sondra G.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cornell University; Cornell University	Citovsky, V (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	vitaly.citovsky@stonybrook.edu		Citovsky, Vitaly/0000-0003-2024-6844	Universidad de Malaga; European Community [246550]; National Institutes of Health; National Science Foundation; United States Department of Agriculture/National Institute of Food and Agriculture; BARD; BSF; Marie Curie U-Mobility Postdoctoral Fellowship; Department of Plant Pathology; Department of Plant-Microbe Biology; Marie Curie COFUND program "U-Mobility"	Universidad de Malaga; European Community(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture/National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); BARD(US-Israel Binational Science Foundation); BSF(US-Israel Binational Science Foundation); Marie Curie U-Mobility Postdoctoral Fellowship; Department of Plant Pathology; Department of Plant-Microbe Biology; Marie Curie COFUND program "U-Mobility"	Marie Curie COFUND program "U-Mobility" cofinanced by Universidad de Malaga and the European Community's Seventh Framework Program under Grant Agreement Number 246550. Grants from National Institutes of Health, National Science Foundation, United States Department of Agriculture/National Institute of Food and Agriculture, BARD, and BSF to V. C.; We thank Jennifer Mosher for technical support and advice. RNA-seq experiments and their analyses were performed in the Cornell University Biotechnology Resource Center (BRC). E.G.C. was supported in part by the Marie Curie U-Mobility Postdoctoral Fellowship. The work in the V.C. laboratory is supported by grants from NIH, NSF, USDA/NIFA, BARD, and BSF to V.C., and the S.G.L. laboratory is supported by NIH and funds from the Departments of Plant Pathology and Plant-Microbe Biology to S.G.L.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Ballas N, 1997, P NATL ACAD SCI USA, V94, P10723, DOI 10.1073/pnas.94.20.10723; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Citovsky V, 2007, CELL MICROBIOL, V9, P9, DOI 10.1111/j.1462-5822.2006.00830.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Fang YJ, 2010, MOL GENET GENOMICS, V283, P157, DOI 10.1007/s00438-009-0507-x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Garcia-Cano Elena, 2014, J Vis Exp, DOI 10.3791/51293; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gelvin SB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00052; Giuntoli B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001950; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; JARCHOW E, 1991, P NATL ACAD SCI USA, V88, P10426, DOI 10.1073/pnas.88.23.10426; Johnston R, 2014, PLANT CELL, V26, P4718, DOI 10.1105/tpc.114.132688; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaplan-Levy RN, 2012, TRENDS PLANT SCI, V17, P163, DOI 10.1016/j.tplants.2011.12.002; Kenny B, 2002, MOL MICROBIOL, V44, P1095, DOI 10.1046/j.1365-2958.2002.02952.x; Kitakura S, 2002, PLANT CELL, V14, P451, DOI 10.1105/tpc.010360; Kitakura S, 2008, J PLANT RES, V121, P425, DOI 10.1007/s10265-008-0160-1; Kumar D, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0122690, 10.1371/jo]; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Lacroix B, 2008, P NATL ACAD SCI USA, V105, P15429, DOI 10.1073/pnas.0805641105; Lacroix B, 2013, INT J DEV BIOL, V57, P467, DOI [10.1387/ijdb.130199b1, 10.1387/ijdb.130199bl]; Li JX, 2005, P NATL ACAD SCI USA, V102, P5733, DOI 10.1073/pnas.0404118102; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Magori S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002124; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nam J, 1999, MOL GEN GENET, V261, P429, DOI 10.1007/s004380050985; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potters G, 2010, PLANT PHYSIOL BIOCH, V48, P292, DOI 10.1016/j.plaphy.2009.12.007; Qin Y, 2014, DNA RES, V21, P499, DOI 10.1093/dnares/dsu016; REGENSBURGTUINK AJG, 1993, NATURE, V363, P69, DOI 10.1038/363069a0; Rotter A, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-10; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schrammeijer B, 2001, CURR BIOL, V11, P258, DOI 10.1016/S0960-9822(01)00069-0; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Smalle J, 1998, P NATL ACAD SCI USA, V95, P3318, DOI 10.1073/pnas.95.6.3318; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sutton A, 2001, MOL CELL BIOL, V21, P3514, DOI 10.1128/MCB.21.10.3514-3522.2001; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Tzfira T, 2001, EMBO J, V20, P3596, DOI 10.1093/emboj/20.13.3596; Tzfira T, 2004, NATURE, V431, P87, DOI 10.1038/nature02857; Urbanczyk-Wochniak E, 2006, PLANT MOL BIOL, V60, P773, DOI 10.1007/s11103-005-5772-4; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; Wang XH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0339-7; Xi J, 2012, PLANT SCI, V185, P274, DOI 10.1016/j.plantsci.2011.11.013; Xie ZM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006898; Zaltsman A, 2013, P NATL ACAD SCI USA, V110, P169, DOI 10.1073/pnas.1210921110; Zaltsman A, 2010, CELL HOST MICROBE, V7, P197, DOI 10.1016/j.chom.2010.02.009; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	64	8	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142128	10.1371/journal.pone.0142128	http://dx.doi.org/10.1371/journal.pone.0142128			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571494	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700020
J	Haque, MM; Holder, LB; Skinner, MK				Haque, M. Muksitul; Holder, Lawrence B.; Skinner, Michael K.			Genome-Wide Locations of Potential Epimutations Associated with Environmentally Induced Epigenetic Transgenerational Inheritance of Disease Using a Sequential Machine Learning Prediction Approach	PLOS ONE			English	Article							PRENATAL EXPOSURE; DNA METHYLATION; TRANSCRIPTION; RESTRICTION; ALGORITHMS; MECHANISMS; RESPONSES; TARGETS; HEALTH	Environmentally induced epigenetic transgenerational inheritance of disease and phenotypic variation involves germline transmitted epimutations. The primary epimutations identified involve altered differential DNA methylation regions (DMRs). Different environmental toxicants have been shown to promote exposure (i.e., toxicant) specific signatures of germline epimutations. Analysis of genomic features associated with these epimutations identified low-density CpG regions (<3 CpG / 100bp) termed CpG deserts and a number of unique DNA sequence motifs. The rat genome was annotated for these and additional relevant features. The objective of the current study was to use a machine learning computational approach to predict all potential epimutations in the genome. A number of previously identified sperm epimutations were used as training sets. A novel machine learning approach using a sequential combination of Active Learning and Imbalance Class Learner analysis was developed. The transgenerational sperm epimutation analysis identified approximately 50K individual sites with a 1 kb mean size and 3,233 regions that had a minimum of three adjacent sites with a mean size of 3.5 kb. A select number of the most relevant genomic features were identified with the low density CpG deserts being a critical genomic feature of the features selected. A similar independent analysis with transgenerational somatic cell epimutation training sets identified a smaller number of 1,503 regions of genome-wide predicted sites and differences in genomic feature contributions. The predicted genome-wide germline (sperm) epimutations were found to be distinct from the predicted somatic cell epimutations. Validation of the genome-wide germline predicted sites used two recently identified transgenerational sperm epimutation signature sets from the pesticides dichlorodiphenyltrichloroethane (DDT) and methoxychlor (MXC) exposure lineage F3 generation. Analysis of this positive validation data set showed a 100% prediction accuracy for all the DDT-MXC sperm epimutations. Observations further elucidate the genomic features associated with transgenerational germline epimutations and identify a genome-wide set of potential epimutations that can be used to facilitate identification of epigenetic diagnostics for ancestral environmental exposures and disease susceptibility.	[Haque, M. Muksitul; Skinner, Michael K.] Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA 99164 USA; [Haque, M. Muksitul; Holder, Lawrence B.] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA	Washington State University; Washington State University	Skinner, MK (corresponding author), Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA 99164 USA.	skinner@wsu.edu			National Institutes of Health (NIH) [R01 ES012974-10]; John Templeton Foundation [50183]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by National Institutes of Health (NIH) R01 ES012974-10 to MKS and John Templeton Foundation 50183, also to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baker TR, 2014, TOXICOL SCI, V138, P403, DOI 10.1093/toxsci/kfu006; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; Bender A, 2011, METHODS MOL BIOL, V672, P175, DOI 10.1007/978-1-60761-839-3_7; Bhandari RK, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099663; Bhandari RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043380; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burdge GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028282; Chen YK, 2013, J AM MED INFORM ASSN, V20, pE253, DOI 10.1136/amiajnl-2013-001945; Crevillen P, 2014, NATURE, V515, P587, DOI 10.1038/nature13722; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Dias BG, 2015, TRENDS NEUROSCI, V38, P96, DOI 10.1016/j.tins.2014.12.003; Drummond Chris, 2003, C4 5 CLASS IMBALANCE; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Guerrero-Bosagna C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100194; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Haque MM, 2014, J COMPUT BIOL, V21, P492, DOI 10.1089/cmb.2014.0008; Haque MM, 2013, IEEE ACM T COMPUT BI, V10, P632, DOI 10.1109/TCBB.2013.38; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Holte RC, P 11 INT JOINT C ART, P813; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Kelly WG, 2014, DEV CELL, V31, P142, DOI 10.1016/j.devcel.2014.10.008; Kornfeld JW, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00057; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Lewis D.D., 1994, P 11 INT C MACH LEAR, V94, P148, DOI DOI 10.1016/B978-1-55860-335-6.50026-X; Lin WJ, 2013, BRIEF BIOINFORM, V14, P13, DOI 10.1093/bib/bbs006; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Luger G.F., 2009, ARTIF INTELL; Manikkam M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102091; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Mease D, 2007, J MACH LEARN RES, V8, P409; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Salian S, 2009, LIFE SCI, V85, P11, DOI 10.1016/j.lfs.2009.04.005; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schapire R. E., 1995, COMPUTATIONAL LEARNI, P23, DOI DOI 10.1007/3-540-59119-2_166; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Settles Burr, 2008, P C EMP METH NAT LAN, P1070, DOI DOI 10.3115/1613715.1613855; SINGER J, 1979, SCIENCE, V203, P1019, DOI 10.1126/science.424726; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-692; Skinner MK, 2014, GENOME BIOL EVOL, V6, P1972, DOI 10.1093/gbe/evu158; Skinner MK, 2014, SCI AM, V311, P44, DOI 10.1038/scientificamerican0814-44; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; Veenendaal MVE, 2013, BJOG-INT J OBSTET GY, V120, P548, DOI 10.1111/1471-0528.12136; WADDINGTON CH, 1953, SYM SOC EXP BIOL, V7, P186; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Wolstenholme JT, 2013, HORM BEHAV, V64, P833, DOI 10.1016/j.yhbeh.2013.09.007; Wrzodek C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035327; Xing YL, 2007, PLOS GENET, V3, P1598, DOI 10.1371/journal.pgen.0030151; Yaniv M, 2014, CANCER GENET-NY, V207, P352, DOI 10.1016/j.cancergen.2014.03.006	67	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142274	10.1371/journal.pone.0142274	http://dx.doi.org/10.1371/journal.pone.0142274			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571271	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700027
J	Li, L; Zhao, ZZ; Xia, JH; Xin, LL; Chen, YX; Yang, SL; Li, K				Li, Li; Zhao, Zhanzhao; Xia, Jihan; Xin, Leilei; Chen, Yaoxing; Yang, Shulin; Li, Kui			A Long-Term High-Fat/High-Sucrose Diet Promotes Kidney Lipid Deposition and Causes Apoptosis and Glomerular Hypertrophy in Bama Minipigs	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; NF-KAPPA-B; METABOLIC SYNDROME; RENAL-DISEASE; INDUCED HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; FUNCTIONAL-CHANGES; OBESITY; MICE; GLOMERULOSCLEROSIS	Metabolic syndrome can induce chronic renal injury in humans. In the present study, Bama minipigs were fed a high-fat/high-sucrose diet (HFHSD) for 23 months, which caused them to develop the pathological characteristics of metabolic syndrome, including obesity, hyper-insulinemia, and hyperlipidemia, and resulted in kidney tissue damage. In the HFHSD group, the ratio of the glomus areas to the glomerulus area and the glomerular density inside the renal cortex both decreased. Lipid deposition in the renal tubules was detected in the HFHSD group, and up-regulated expression levels of SREBP-1, FABP3 and LEPR promoted lipid deposition. The decreased levels of SOD, T-AOC and GSH-PX indicated that the antioxidant capacity of the renal tissues was diminished in the HFHSD group compared with MDA, which increased. The renal tissue in the HFHSD group exhibited clear signs of inflammation as well as significantly elevated expression of key genes associated with inflammation, including tumor necrosis factor-alpha (TNF-alpha) and macrophage migration inhibitory factor (MIF), compared with the control group. The tubular epithelial cells in the HFHSD group displayed significantly greater numbers of apoptotic cells, and the expression of proliferating cell nuclear antigen (PCNA) in the renal tubules decreased. Caspase-3 expression increased significantly, and the transcription factor nuclear factor kappa B (NF-kappa B) was activated and translocated into the nucleus. In conclusion, long-term HFHSDs cause metabolic syndrome and chronic renal tissue injury in Bama minipigs. These findings provide a foundation for further studies investigating metabolic syndrome and nephropathy.	[Li, Li; Xia, Jihan; Xin, Leilei; Yang, Shulin; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Innovat Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm, Beijing 100193, Peoples R China; [Zhao, Zhanzhao; Chen, Yaoxing] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Li, Kui] CAAS, Agr Genomes Inst Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS	Yang, SL (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Innovat Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm, Beijing 100193, Peoples R China.	yangshulin@caas.cn	Xia, Jihan/GLQ-5273-2022	Xia, Jihan/0000-0002-0035-0727	National Natural Science Foundation of China [31372276]; National Basic Research Program [2011CBA01005]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05, ASTIP-IAS-TS-4]; Shenzhen Special Fund for the Strategic Emerging Industries Development [CXZZ20140504105105077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Agricultural Science and Technology Innovation Program; Shenzhen Special Fund for the Strategic Emerging Industries Development	This study was supported by grants from the National Natural Science Foundation of China (31372276), National Basic Research Program (2011CBA01005), Agricultural Science and Technology Innovation Program (ASTIP-IAS05, ASTIP-IAS-TS-4) and Shenzhen Special Fund for the Strategic Emerging Industries Development (CXZZ20140504105105077).	Abuaisha B, 1998, DIABETES RES CLIN PR, V39, P93, DOI 10.1016/S0168-8227(97)00111-3; Al-Dahr MHS, 2010, WORLD J MED SCI, V5, P30; Aoyama M, 2012, BIOCHEM BIOPH RES CO, V419, P244, DOI 10.1016/j.bbrc.2012.02.001; Bhatti F, 2005, KIDNEY INT, V67, P1371, DOI 10.1111/j.1523-1755.2005.00214.x; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; CARO JF, 1991, J CLIN ENDOCR METAB, V73, P691, DOI 10.1210/jcem-73-4-691; Chen H, 2009, LAB ANIMAL, V38, P355, DOI 10.1038/laban1109-355; Dalla Vestra M, 2003, INT CONGR SER, V1253, P163, DOI 10.1016/S0531-5131(03)00144-4; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Dissard R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076703; EGIDO J, 1993, KIDNEY INT, V43, pS59; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Fujita A, 2005, DIABETES RES CLIN PR, V69, P113, DOI 10.1016/j.diabres.2004.11.016; Gersch MS, 2007, AM J PHYSIOL-RENAL, V293, pF1256, DOI 10.1152/ajprenal.00181.2007; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Griffin KA, 2008, AM J PHYSIOL-RENAL, V294, pF695, DOI 10.1152/ajprenal.00324.2007; GUIJARRO C, 1995, AM J KIDNEY DIS, V26, P152, DOI 10.1016/0272-6386(95)90169-8; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138; Hall JE, 2004, ADV RENAL REPLACE TH, V11, P41, DOI 10.1053/j.arrt.2003.10.007; HALL JE, 1993, HYPERTENSION, V22, P292, DOI 10.1161/01.HYP.22.3.292; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Johnson DW, 2007, NEPHROLOGY, V12, P391, DOI 10.1111/j.1440-1797.2007.00804.x; KASISKE BL, 1990, KIDNEY INT, V37, P880, DOI 10.1038/ki.1990.62; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kumar D, 2004, MOL CELL BIOCHEM, V259, P67, DOI 10.1023/B:MCBI.0000021346.03260.7e; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Liu Y, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-117; Maeda M, 2003, VET PATHOL, V40, P187, DOI 10.1354/vp.40-2-187; Makino H, 1996, CONTRIB NEPHROL, V118, P41; Meldrum KK, 2002, J UROLOGY, V168, P248, DOI 10.1016/S0022-5347(05)64902-6; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778; Samstein B, 2001, J AM SOC NEPHROL, V12, P182, DOI 10.1681/ASN.V121182; Scheuer H, 2000, AM J PHYSIOL-RENAL, V278, pF63, DOI 10.1152/ajprenal.2000.278.1.F63; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tseng ST, 2005, J FORMOS MED ASSOC, V104, P94; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; VERANI RR, 1992, AM J KIDNEY DIS, V20, P629, DOI 10.1016/S0272-6386(12)70230-5; Wei P, 2004, DIABETOLOGIA, V47, P1541, DOI 10.1007/s00125-004-1489-1; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Xi SM, 2004, INT J EXP PATHOL, V85, P223, DOI 10.1111/j.0959-9673.2004.00394.x; Xia JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132420; Xia JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113724; Yang SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13980; Yin Weidong, 2002, Int J Exp Diabetes Res, V3, P179, DOI 10.1080/15604280214274; Zhao ZZ, 2015, PANCREAS        0421	53	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142884	10.1371/journal.pone.0142884	http://dx.doi.org/10.1371/journal.pone.0142884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571016	gold, Green Submitted, Green Published			2022-12-26	WOS:000365070700090
J	Loureiro, LL; Fonseca Junior, S; Castro, NGCDE; dos Passos, RB; Porto, CPM; Pierucci, APTR				Loureiro, Luiz Lannes; Fonseca Junior, Sidnei; de Oliveira E Castro, Natalia Gomes Casanova; dos Passos, Renata Baratta; Melo Porto, Cristiana Pedrosa; Trindade Rocha Pierucci, Anna Paola			Basal Metabolic Rate of Adolescent Modern Pentathlon Athletes: Agreement between Indirect Calorimetry and Predictive Equations and the Correlation with Body Parameters	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; FAT-FREE MASS; STRESS-FRACTURES; PHYSICAL-ACTIVITY; ADULTS; WOMEN; AVAILABILITY; PERFORMANCE; VALIDATION; STATEMENT	Purpose The accurate estimative of energy needs is crucial for an optimal physical performance among athletes and the basal metabolic rate (BMR) equations often are not well adjusted for adolescent athletes requiring the use of specific methods, such as the golden standard indirect calorimetry (IC). Therefore, we had the aim to analyse the agreement between the BMR of adolescents pentathletes measured by IC and estimated by commonly used predictive equations. Methods Twenty-eight athletes (17 males and 11 females) were evaluated for BMR, using IC and the predictive equations Harris and Benedict (HB), Cunningham (CUN), Henry and Rees (HR) and FAO/WHO/UNU (FAO). Body composition was obtained using DXA and sexual maturity data were retrieved through validated questionnaires. The correlations among anthropometric variables an IC were analysed by T-student test and ICC, while the agreement between IC and the predictive equations was analysed according to Bland and Altman and by survival-agreement plotting. Results The whole sample average BMR measured by IC was significantly different from the estimated by FAO (p<0.05). Adjusting data by gender FAO and HR equations were statistically different from IC (p<0.05) among males, while female differed only for the HR equation (p<0.05). Conclusion The FAO equation underestimated athletes' BMR when compared with IC (T Test). When compared to the golden standard IC, using Bland and Altman, ICC and Survival-Agreement, the equations underestimated the energy needs of adolescent pentathlon athletes up to 300kcal/day. Therefore, they should be used with caution when estimating individual energy requirements in such populations.	[Loureiro, Luiz Lannes; Fonseca Junior, Sidnei; de Oliveira E Castro, Natalia Gomes Casanova; dos Passos, Renata Baratta; Melo Porto, Cristiana Pedrosa; Trindade Rocha Pierucci, Anna Paola] Univ Fed Rio de Janeiro, Dept Nutr, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Pierucci, APTR (corresponding author), Univ Fed Rio de Janeiro, Dept Nutr, Rio De Janeiro, Brazil.	pierucci@nutricao.ufrj.br	Pierucci, Anna Paola Trindade Rocha/AAF-3624-2019; Pierucci, Anna Paola T R/L-7979-2013; Fonseca-Junior, Sidnei Jorge SJ/O-3560-2018; Pierucci, Anna Paola/F-4835-2018	Pierucci, Anna Paola/0000-0002-9826-3081; Fonseca Junior, Sidnei Jorge/0000-0001-8708-1613	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/190.122/2010]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The study was funded by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), www.faperj.br, with grant number E-26/190.122/2010 in name of APRTP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens MPE, 2003, BRIT J NUTR, V90, P419, DOI 10.1079/BJN2003895; Alfonzo-Gonzalez G, 2004, EUR J CLIN NUTR, V58, P1125, DOI 10.1038/sj.ejcn.1601940; [Anonymous], 2009, J AM DIET ASSOC, V109, P509, DOI 10.1016/j.jada.2009.01.005; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; Campbell Christina Gayer, 2005, Nutr Clin Pract, V20, P276, DOI 10.1177/0115426505020002276; Carlsohn A, 2011, ANN NUTR METAB, V58, P239, DOI 10.1159/000330119; Cocate PG, 2009, REV BRAS MED ESPORTE, V15, P360, DOI 10.1590/S1517-86922009000600008; Compher C, 2004, J NATL MED ASSOC, V96, P209; Cruz CM, 1999, ARCH LATINOAM NUTR, V49, P232; CUNNINGHAM JJ, 1980, AM J CLIN NUTR, V33, P2372, DOI 10.1093/ajcn/33.11.2372; De Lorenzo A, 2001, EUR J CLIN NUTR, V55, P208, DOI 10.1038/sj.ejcn.1601149; Degoutte F, 2006, INT J SPORTS MED, V27, P9, DOI 10.1055/s-2005-837505; Duckham RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001920; de Oliveira FCE, 2008, NUTR HOSP, V23, P554; FAO (Food and Agriculture Organization), 2004, FAO TECHN REP SER, V1; Fonseca Paulo Henrique S., 2011, Rev. paul. pediatr., V29, P202; Frankenfield D, 2005, J AM DIET ASSOC, V105, P775, DOI 10.1016/j.jada.2005.02.005; Harris JA., 1919, BIOMETRIC STUDY BASA; HENRY CJK, 1991, EUR J CLIN NUTR, V45, P177; Hofsteenge GH, 2010, AM J CLIN NUTR, V91, P1244, DOI 10.3945/ajcn.2009.28330; Houssay BA, 1969, FISIOLOGIA HUMANA, P487; Ihle R, 2004, J BONE MINER RES, V19, P1231, DOI 10.1359/JBMR.040410; Illner K, 2000, AM J PHYSIOL-ENDOC M, V278, pE308, DOI 10.1152/ajpendo.2000.278.2.E308; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Le Meur Y, 2010, J SPORT SCI, V28, P1111, DOI 10.1080/02640414.2010.497816; Luhrmann PM, 2014, J NUTR HEALTH AGING, V8, P144; Luiz RR, 2005, J CLIN EPIDEMIOL, V58, P215, DOI 10.1016/j.jclinepi.2004.07.007; Luiz RR, 2003, J CLIN EPIDEMIOL, V56, P963, DOI 10.1016/S0895-4356(03)00164-1; Marx RG, 2001, CLIN J SPORT MED, V11, P73, DOI 10.1097/00042752-200104000-00002; Miller MD, 2005, BRIT J NUTR, V94, P976, DOI 10.1079/BJN20051593; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; Nattiv A, 2000, J Sci Med Sport, V3, P268, DOI 10.1016/S1440-2440(00)80036-5; Reed JL, 2013, J SPORT SCI, V31, P314, DOI 10.1080/02640414.2012.733019; Rodrigues AE, 2010, ARQ BRAS ENDOCRINOL, V54, P470, DOI 10.1590/S0004-27302010000500007; da Fonseca PHS, 2010, ARQ BRAS ENDOCRINOL, V54, P30, DOI 10.1590/S0004-27302010000100006; Schnackenburg KE, 2011, MED SCI SPORT EXER, V43, P2110, DOI 10.1249/MSS.0b013e31821f8634; Schneider Patrícia, 2005, Rev Bras Med Esporte, V11, P193, DOI 10.1590/S1517-86922005000300008; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; ten Haaf T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108460; Tenforde AS, 2013, MED SCI SPORT EXER, V45, P1843, DOI 10.1249/MSS.0b013e3182963d75; Thein-Nissenbaum JM, 2011, J ORTHOP SPORT PHYS, V41, P60, DOI 10.2519/jospt.2011.3312; Wahrlich V, 2001, REV SAUDE PUBL, V35, P39, DOI 10.1590/S0034-89102001000100006; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Wang ZM, 2001, OBES RES, V9, P331, DOI 10.1038/oby.2001.42; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wells JCK, 1998, NUTRITION, V14, P817, DOI 10.1016/S0899-9007(98)00092-6; Wentz L, 2012, INT J SPORT NUTR EXE, V22, P374, DOI 10.1123/ijsnem.22.5.374	50	12	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142859	10.1371/journal.pone.0142859	http://dx.doi.org/10.1371/journal.pone.0142859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569101	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700086
J	Lyu, L; Whitcomb, EA; Jiang, SH; Chang, ML; Gu, YM; Duncan, MK; Cvekl, A; Wang, WL; Limi, S; Reneker, LW; Shang, F; Du, LF; Taylor, A				Lyu, Lei; Whitcomb, Elizabeth A.; Jiang, Shuhong; Chang, Min-Lee; Gu, Yumei; Duncan, Melinda K.; Cvekl, Ales; Wang, Wei-Lin; Limi, Saima; Reneker, Lixing W.; Shang, Fu; Du, Linfang; Taylor, Allen			Unfolded-protein response-associated stabilization of p27(Cdkn1b) interferes with lens fiber cell denucleation, leading to cataract	FASEB JOURNAL			English	Article						ubiquitin; cell cycle; endoplasmic reticulum stress; nuclear disassembly	DEPENDENT KINASE INHIBITOR; MOUSE EYE LENS; A-TYPE LAMINS; ENDOPLASMIC-RETICULUM; ER STRESS; PHOSPHORYLATION SITES; UBIQUITIN LIGASE; CDK INHIBITORS; NUCLEAR LAMINA; P27(KIP1)	Failure of lens fiber cell denucleation (LFCD) is associated with congenital cataracts, but the pathobiology awaits elucidation. Recent work has suggested that mechanisms that direct the unidirectional process of LFCD are analogous to the cyclic processes associated with mitosis. We found that lens-specific mutations that elicit an unfolded-protein response (UPR) in vivo accumulate p27(Cdkn1b), show cyclin-dependent kinase (Cdk)-1 inhibition, retain their LFC nuclei, and are cataractous. Although a UPR was not detected in lenses expressing K6W-Ub, they also accumulated p27 and showed failed LFCD. Induction of a UPR in human lens epithelial cells (HLECs) also induced accumulation of p27 associated with decreased levels of S-phase kinase-associated protein (Skp)-2, a ubiquitin ligase that regulates mitosis. These cells also showed decreased lamin A/C phosphorylation and metaphase arrest. The suppression of lamin A/C phosphorylation and metaphase transition induced by the UPR was rescued by knockdown of p27. Taken together, these data indicate that accumulation of p27, whether related to the UPR or not, prevents the phosphorylation of lamin A/C and LFCD in maturing LFCs in vivo, as well as in dividing HLECs. The former leads to cataract and the latter to metaphase arrest. These results suggest that accumulation of p27 is a common mechanism underlying retention of LFC nuclei.	[Lyu, Lei; Du, Linfang] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresource & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China; [Lyu, Lei; Whitcomb, Elizabeth A.; Jiang, Shuhong; Chang, Min-Lee; Gu, Yumei; Shang, Fu; Taylor, Allen] Tufts Univ, Jean Mayer USDA, Human Nutr Res Ctr Aging, Lab Nutr & Vis Res, Boston, MA 02111 USA; [Duncan, Melinda K.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Cvekl, Ales; Wang, Wei-Lin; Limi, Saima] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA; [Reneker, Lixing W.] Univ Missouri, Sch Med, Dept Ophthalmol, Columbia, MO USA	Sichuan University; Tufts University; United States Department of Agriculture (USDA); University of Delaware; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Missouri System; University of Missouri Columbia	Du, LF (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresource & Ecoenvironm, Chengdu 610064, Sichuan, Peoples R China.; Taylor, A (corresponding author), Tufts Univ, USDA, Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	dulinfang@scu.edu.cn; allen.taylor@tufts.edu	Jiang, Shuhong/C-1596-2019; Jiang, Shuhong/AAQ-7147-2021	Duncan, Melinda/0000-0003-1570-322X; Jiang, Shuhong/0000-0003-3659-5950	U.S. Department of Agriculture, Agricultural Research Service [58-1950-4-003]; U.S. National Institutes of Health, National Eye Institute [EY13250, EY11717]; China Scholarship Council; NATIONAL EYE INSTITUTE [R29EY011717, R01EY013250, R01EY026979, R01EY015279, R01EY011717] Funding Source: NIH RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); China Scholarship Council(China Scholarship Council); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. S. Nagata for providing the DNAse II beta antibody; Dr. P. Gonczy for the gift of the pNUMA antibody; and Dr. S. Rowan, L. Bailey, and Z. Crosser for critical reading and suggestions during the preparation of the manuscript. This work was supported by U.S. Department of Agriculture, Agricultural Research Service Agreement 58-1950-4-003; U.S. National Institutes of Health, National Eye Institute Grants EY13250 and EY11717; and the China Scholarship Council.	Adhikari D, 2012, HUM MOL GENET, V21, P2476, DOI 10.1093/hmg/dds061; Alapure BV, 2012, EXP EYE RES, V102, P28, DOI 10.1016/j.exer.2012.06.004; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BLOEMENDAL H, 1977, SCIENCE, V197, P127, DOI 10.1126/science.877544; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Caceres A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013331; Chaffee BR, 2014, DEVELOPMENT, V141, P3388, DOI 10.1242/dev.106005; Chen MF, 2011, P NATL ACAD SCI USA, V108, P9119, DOI 10.1073/pnas.1100028108; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Cui XK, 2013, BBA-MOL BASIS DIS, V1832, P1167, DOI 10.1016/j.bbadis.2013.03.007; Danysh BP, 2009, EXP EYE RES, V88, P151, DOI 10.1016/j.exer.2008.08.002; Davidson PM, 2014, TRENDS CELL BIOL, V24, P247, DOI 10.1016/j.tcb.2013.11.004; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Firtina Z, 2011, GENE EXPR PATTERNS, V11, P135, DOI 10.1016/j.gep.2010.10.005; Firtina Z, 2009, J BIOL CHEM, V284, P35872, DOI 10.1074/jbc.M109.060384; Francis Peter J, 2004, Curr Opin Ophthalmol, V15, P10, DOI 10.1097/00055735-200402000-00003; FUKUSHI S, 1969, J BIOL CHEM, V244, P2041; Gao CY, 1999, EXP EYE RES, V69, P695, DOI 10.1006/exer.1999.0749; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gonzalez JM, 2011, BIOCHEM SOC T, V39, P1758, DOI 10.1042/BST20110653; Han CC, 2013, CELL SIGNAL, V25, P144, DOI 10.1016/j.cellsig.2012.09.023; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Hu R, 2008, MOL BIOL CELL, V19, P4602, DOI 10.1091/mbc.E07-11-1137; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kotak S, 2013, EMBO J, V32, P2517, DOI 10.1038/emboj.2013.172; Kotoshiba S, 2014, BBA-MOL CELL RES, V1843, P436, DOI 10.1016/j.bbamcr.2013.11.005; Liu Q, 2006, MOL VIS, V12, P931; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mall M, 2012, J CELL BIOL, V198, P981, DOI 10.1083/jcb.201205103; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Reneker LW, 2011, INVEST OPHTH VIS SCI, V52, P2100, DOI 10.1167/iovs.10-5650; Robinson ML, 1995, DEVELOPMENT, V121, P3959; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Tane S, 2014, BIOCHEM BIOPH RES CO, V443, P1105, DOI 10.1016/j.bbrc.2013.12.109; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wang WL, 2010, MOL BIOL CELL, V21, P2453, DOI 10.1091/mbc.E09-12-1031; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U	59	23	23	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1087	1095		10.1096/fj.15-278036	http://dx.doi.org/10.1096/fj.15-278036			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26590164	Green Published			2022-12-26	WOS:000370387800008
J	Brown, RSE; Wyatt, AK; Herbison, RE; Knowles, PJ; Ladyman, SR; Binart, N; Banks, WA; Grattan, DR				Brown, Rosemary S. E.; Wyatt, Amanda K.; Herbison, Ryan E.; Knowles, Penelope J.; Ladyman, Sharon R.; Binart, Nadine; Banks, William A.; Grattan, David R.			Prolactin transport into mouse brain is independent of prolactin receptor	FASEB JOURNAL			English	Article						blood-brain barrier; choroid plexus; lactation	LUTEINIZING-HORMONE SECRETION; IMMUNOREACTIVE PROLACTIN; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; MESSENGER-RNA; MATERNAL-BEHAVIOR; RAT HYPOTHALAMUS; LH-SECRETION; GENE; EXPRESSION	The anterior pituitary hormone prolactin exerts important physiologic actions in the brain. However, the mechanism by which prolactin crosses the blood-brain barrier and enters the brain is not completely understood. On the basis of high expression of the prolactin receptor in the choroid plexus, it has been hypothesized that the receptor may bind to prolactin in the blood and translocate it into the cerebrospinal fluid (CSF). This study aimed to test this hypothesis by investigating transport of I-125-labeled prolactin (I-125-prolactin) into the brain of female mice in the presence and absence of the prolactin receptor (PRLR-/-). Peripherally administered prolactin rapidly activates brain neurons, as evidenced by prolactin-induced phosphorylation of signal transducer and activator of transcription 5 (pSTAT5) in neurons within 30 min of administration. The transport of prolactin into the brain was saturable, with transport effectively blocked only by a very high dose of unlabeled ovine prolactin. Transport was regulated, as in lactating mice with chronically elevated levels of prolactin, the rate of I-125-prolactin transport into the brain was significantly increased compared to nonlactating controls. There was no change in the rate of I-125-prolactin transport into the brain in PRLR-/- mice lacking functional prolactin receptors compared to control mice, indicating transport is independent of the prolactin receptor. These data suggest that prolactin transport into the brain involves another as yet unidentified transporter molecule. Because CSF levels of I-125-prolactin were very low, even up to 90 min after administration, the data suggest that CSF is not the major route by which blood prolactin gains access to neurons in the brain.	[Brown, Rosemary S. E.; Wyatt, Amanda K.; Herbison, Ryan E.; Knowles, Penelope J.; Ladyman, Sharon R.; Grattan, David R.] Univ Otago, Ctr Neurendocrinol, Dunedin 9054, New Zealand; [Brown, Rosemary S. E.; Wyatt, Amanda K.; Herbison, Ryan E.; Knowles, Penelope J.; Ladyman, Sharon R.; Grattan, David R.] Univ Otago, Dept Anat, Otago Sch Med Sci, Dunedin 9054, New Zealand; [Binart, Nadine] Fac Med Paris Sud, INSERM, U1185, Le Kremlin Bicetre, France; [Banks, William A.] Vet Affairs Puget Sound Hlth Care Ctr, Ctr Geriatr Res Educ & Clin, Seattle, WA USA; [Banks, William A.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA	University of Otago; University of Otago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle	Grattan, DR (corresponding author), Univ Otago, Dept Anat, POB 913, Dunedin 9054, New Zealand.	dave.grattan@otago.ac.nz	Binart, Nadine/F-2949-2013; Grattan, David/M-4307-2019; Banks, William A/K-1330-2017	Binart, Nadine/0000-0002-5606-3866; Grattan, David/0000-0001-5606-2559; Banks, William A/0000-0002-0496-3619; wyatt, amanda/0000-0003-1107-3857; Ladyman, Sharon/0000-0003-3578-6763; Brown, Rosemary/0000-0001-6775-3072	Marsden Fund	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded by a grant from the Marsden Fund, administered by the Royal Society of New Zealand.	Augustine RA, 2003, J MOL ENDOCRINOL, V31, P221, DOI 10.1677/jme.0.0310221; Bakowska JC, 2003, MOL BRAIN RES, V116, P50, DOI 10.1016/S0169-328X(03)00213-4; Bakowska JC, 1997, J COMP NEUROL, V386, P161, DOI 10.1002/(SICI)1096-9861(19970922)386:2<161::AID-CNE1>3.0.CO;2-#; Balland E, 2014, CELL METAB, V19, P293, DOI 10.1016/j.cmet.2013.12.015; Banks WA, 2003, AM J PHYSIOL-ENDOC M, V285, pE10, DOI 10.1152/ajpendo.00468.2002; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Banks WA, 2012, ENDOCRINOLOGY, V153, P4111, DOI 10.1210/en.2012-1435; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Bouilly J, 2012, MOL CELL ENDOCRINOL, V356, P80, DOI 10.1016/j.mce.2011.05.004; BRIDGES RS, 1990, P NATL ACAD SCI USA, V87, P8003, DOI 10.1073/pnas.87.20.8003; BRIDGES RS, 1985, SCIENCE, V227, P782, DOI 10.1126/science.3969568; Brown RSE, 2011, BIOL REPROD, V84, P826, DOI 10.1095/biolreprod.110.089185; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Chang WP, 1996, P NATL ACAD SCI USA, V93, P5947, DOI 10.1073/pnas.93.12.5947; Clapp C., 1994, P NATL ACAD SCI USA, V91, P10384; COHENBECKER IR, 1986, NEUROENDOCRINOLOGY, V42, P328, DOI 10.1159/000124459; DEVITO WJ, 1992, ENDOCRINOLOGY, V131, P2154, DOI 10.1210/en.131.5.2154; DEVITO WJ, 1992, ENDOCRINOLOGY, V130, P2549, DOI 10.1210/en.130.5.2549; DEVITO WJ, 1995, MOL CELL ENDOCRINOL, V108, P125, DOI 10.1016/0303-7207(94)03465-6; DEVITO WJ, 1987, NEUROENDOCRINOLOGY, V46, P155, DOI 10.1159/000124813; DEVITO WJ, 1988, NEUROENDOCRINOLOGY, V47, P284, DOI 10.1159/000124926; DUTT A, 1994, NEUROENDOCRINOLOGY, V59, P413, DOI 10.1159/000126686; EMANUELE NV, 1992, MOL ENDOCRINOL, V6, P35, DOI 10.1210/me.6.1.35; FOX SR, 1987, NEUROENDOCRINOLOGY, V46, P350, DOI 10.1159/000124844; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Freemark M, 2001, ENDOCRINOLOGY, V142, P532, DOI 10.1210/en.142.2.532; FUXE K, 1977, SCIENCE, V196, P899, DOI 10.1126/science.323973; Goupille O, 1997, MOL CELL ENDOCRINOL, V127, P155, DOI 10.1016/S0303-7207(97)04005-7; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x; Grattan DR, 2015, J ENDOCRINOL, V226, pT101, DOI 10.1530/JOE-15-0213; GRATTAN DR, 1994, J ENDOCRINOL, V143, P165, DOI 10.1677/joe.0.1430165; Grattan DR, 2001, ENDOCRINOLOGY, V142, P3935, DOI 10.1210/en.142.9.3935; Halperin J, 2008, MOL ENDOCRINOL, V22, P513, DOI 10.1210/me.2007-0399; Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Langlet F, 2013, CELL METAB, V17, P607, DOI 10.1016/j.cmet.2013.03.004; Lerant A, 2001, BRAIN RES, V904, P259, DOI 10.1016/S0006-8993(01)02470-2; LESUEUR L, 1991, P NATL ACAD SCI USA, V88, P824, DOI 10.1073/pnas.88.3.824; LOGIN IS, 1977, BRAIN RES, V132, P477, DOI 10.1016/0006-8993(77)90196-2; Lucas BK, 1998, ENDOCRINOLOGY, V139, P4102, DOI 10.1210/en.139.10.4102; NICHOLSON G, 1980, BRAIN RES, V190, P447, DOI 10.1016/0006-8993(80)90287-5; NOEL MB, 1993, PHYSIOL BEHAV, V54, P151, DOI 10.1016/0031-9384(93)90057-M; ONEAL KD, 1994, J BIOL CHEM, V269, P26076; Ormandy CJ, 1997, J MAMMARY GLAND BIOL, V2, P355, DOI 10.1023/A:1026395229025; PARK SK, 1991, NEUROENDOCRINOLOGY, V53, P404, DOI 10.1159/000125748; Pi XJ, 1998, MOL BRAIN RES, V59, P1, DOI 10.1016/S0169-328X(98)00109-0; Pi XJ, 1998, J COMP NEUROL, V394, P462, DOI 10.1002/(SICI)1096-9861(19980518)394:4<462::AID-CNE5>3.0.CO;2-#; Sapsford TJ, 2012, J COMP NEUROL, V520, P1062, DOI 10.1002/cne.22775; Schaeffer M, 2013, P NATL ACAD SCI USA, V110, P1512, DOI 10.1073/pnas.1212137110; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Schuler LA, 1997, ENDOCRINOLOGY, V138, P3187, DOI 10.1210/en.138.8.3187; SHIVERS BD, 1989, NEUROENDOCRINOLOGY, V49, P23, DOI 10.1159/000125086; Tabata H, 2012, J MOL ENDOCRINOL, V48, P169, DOI 10.1530/JME-11-0122; WALSH RJ, 1990, J ANAT, V168, P137; WALSH RJ, 1978, SCIENCE, V201, P1041, DOI 10.1126/science.684427; WALSH RJ, 1987, ENDOCRINOLOGY, V120, P1846, DOI 10.1210/endo-120-5-1846; Yip SH, 2012, J NEUROENDOCRINOL, V24, P1484, DOI 10.1111/j.1365-2826.2012.02357.x	57	48	49	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					1002	1010		10.1096/fj.15-276519	http://dx.doi.org/10.1096/fj.15-276519			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26567005				2022-12-26	WOS:000369391900046
J	Bergeron, JRC; Fernandez, L; Wasney, GA; Vuckovic, M; Reffuveille, F; Hancock, REW; Strynadka, NCJ				Bergeron, Julien R. C.; Fernandez, Lucia; Wasney, Gregory A.; Vuckovic, Marija; Reffuveille, Fany; Hancock, Robert E. W.; Strynadka, Natalie C. J.			The Structure of a Type 3 Secretion System (T3SS) Ruler Protein Suggests a Molecular Mechanism for Needle Length Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAGELLAR HOOK-LENGTH; ENTEROPATHOGENIC ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY SWITCH; III SECRETION; YERSINIA-ENTEROCOLITICA; SHIGELLA-FLEXNERI; SALMONELLA-TYPHIMURIUM; YOP SECRETION; INJECTISOME NEEDLE; BASAL BODY	The type 3 secretion system (T3SS) and the bacterial flagellum are related pathogenicity-associated appendages found at the surface of many disease-causing bacteria. These appendages consist of long tubular structures that protrude away from the bacterial surface to interact with the host cell and/or promote motility. A proposed "ruler" protein tightly regulates the length of both the T3SS and the flagellum, but the molecular basis for this length control has remained poorly characterized and controversial. Using the Pseudomonas aeruginosa T3SS as a model system, we report the first structure of a T3SS ruler protein, revealing a "ball-and-chain" architecture, with a globular C-terminal domain (the ball) preceded by a long intrinsically disordered N-terminal polypeptide chain. The dimensions and stability of the globular domain do not support its potential passage through the inner lumen of the T3SS needle. We further demonstrate that a conserved motif at the N terminus of the ruler protein interacts with the T3SS autoprotease in the cytosolic side. Collectively, these data suggest a potential mechanism for needle length sensing by ruler proteins, whereby upon T3SS needle assembly, the ruler protein's N-terminal end is anchored on the cytosolic side, with the globular domain located on the extracellular end of the growing needle. Sequence analysis of T3SS and flagellar ruler proteins shows that this mechanism is probably conserved across systems.	[Bergeron, Julien R. C.; Wasney, Gregory A.; Vuckovic, Marija; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Bergeron, Julien R. C.; Hancock, Robert E. W.; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Fernandez, Lucia; Reffuveille, Fany; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca	Fernández, Lucía/ADE-1414-2022; Reffuveille, Fany/AAG-4488-2019; Fernández, Lucía/F-9858-2016; Bergeron, Julien/AGY-1707-2022; Hancock, Robert E. W./E-1145-2013	Fernández, Lucía/0000-0002-7383-7595; Hancock, Robert E. W./0000-0001-5989-8503; Reffuveille, Fany/0000-0002-0753-3761	Canadian Institute of Health Research; Howard Hughes Medical Institute International Scholar Program; Fundacion Alfonso Martin Escudero (Spain)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute International Scholar Program(Howard Hughes Medical Institute); Fundacion Alfonso Martin Escudero (Spain)	This work was supported by operating grants from the Canadian Institute of Health Research (to R. E. W. H and to N. C. J. S.) and the Howard Hughes Medical Institute International Scholar Program (to N. C. J. S.). X-ray diffraction data were collected at beamline 08B1-1 at the Canadian Light Source, which is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. Instrument support was provided by the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the University of British Columbia Blusson Fund, and the Michael Smith Foundation for Health Research. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postdoctoral fellowship from the Fundacion Alfonso Martin Escudero (Spain).	Abby SS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002983; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x; Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Aizawa S, 2012, J BACTERIOL, V194, P4797, DOI 10.1128/JB.06333-11; Aizawa S, 2012, J BACTERIOL, V194, P4798, DOI 10.1128/JB.06239-11; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Botteaux A, 2008, MOL MICROBIOL, V70, P1515, DOI 10.1111/j.1365-2958.2008.06499.x; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Burkinshaw BJ, 2015, J BIOL CHEM, V290, P10406, DOI 10.1074/jbc.M115.639013; Burkinshaw BJ, 2014, BBA-MOL CELL RES, V1843, P1649, DOI 10.1016/j.bbamcr.2014.01.035; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Deane JE, 2008, MOL MICROBIOL, V69, P267, DOI 10.1111/j.1365-2958.2008.06293.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demers JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5976; Demers JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003245; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Dohlich K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003881; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Erhardt M, 2011, EMBO J, V30, P2948, DOI 10.1038/emboj.2011.185; Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hughes KT, 2012, J BACTERIOL, V194, P4793, DOI 10.1128/JB.00343-12; Hughes KT, 2012, J BACTERIOL, V194, P4801, DOI 10.1128/JB.06454-11; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kawagishi I, 1996, J BACTERIOL, V178, P2954, DOI 10.1128/jb.178.10.2954-2959.1996; Kawamoto A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03369; Kobayashi K, 2003, J BACTERIOL, V185, P5295, DOI 10.1128/JB.185.17.5295-5300.2003; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lee VT, 2002, J BACTERIOL, V184, P3740, DOI 10.1128/JB.184.13.3740-3745.2002; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McMurry JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134884; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Mizuno S, 2011, J MOL BIOL, V409, P558, DOI 10.1016/j.jmb.2011.04.008; Feria JM, 2012, J BACTERIOL, V194, P6029, DOI 10.1128/JB.01215-12; Morris DP, 2010, BIOCHEMISTRY-US, V49, P6386, DOI 10.1021/bi100487p; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x; Ryan KA, 2005, J BACTERIOL, V187, P5742, DOI 10.1128/JB.187.16.5742-5750.2005; Sal-Man N, 2012, BIOCHEM J, V442, P119, DOI 10.1042/BJ20111620; Small J, 1983, Geriatr Nurs, V4, P166, DOI 10.1016/S0197-4572(83)80079-2; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x; Steadman D, 2014, FUTURE MICROBIOL, V9, P887, DOI [10.2217/FMB.14.46, 10.2217/fmb.14.46]; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Wagner S, 2010, P NATL ACAD SCI USA, V107, P13860, DOI 10.1073/pnas.1006985107; Wagner S, 2009, MOL MICROBIOL, V71, P692, DOI 10.1111/j.1365-2958.2008.06556.x; Wee DH, 2015, P NATL ACAD SCI USA, V112, P4098, DOI 10.1073/pnas.1423492112; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832	69	22	23	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1676	1691		10.1074/jbc.M115.684423	http://dx.doi.org/10.1074/jbc.M115.684423			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26589798	Green Published, hybrid			2022-12-26	WOS:000368620700012
J	Taga, Y; Kusubata, M; Ogawa-Goto, K; Hattori, S				Taga, Yuki; Kusubata, Masashi; Ogawa-Goto, Kiyoko; Hattori, Shunji			Developmental Stage-dependent Regulation of Prolyl 3-Hydroxylation in Tendon Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-RELATED VARIATIONS; RAT-TAIL TENDON; AMINO-ACID; ENDOPLASMIC-RETICULUM; 3-HYDROXYPROLINE; BONE; HYDROXYPROLINE; GLYCOSYLATION; HYDROXYLATION; RESIDUES	3-Hydroxyproline (3-Hyp), which is unique to collagen, is a fairly rare post-translational modification. Recent studies have suggested a function of prolyl 3-hydroxylation in fibril assembly and its relationships with certain disorders, including recessive osteogenesis imperfecta and high myopia. However, no direct evidence for the physiological and pathological roles of 3-Hyp has been presented. In this study, we first estimated the overall alterations in prolyl hydroxylation in collagens purified from skin, bone, and tail tendon of 0.5-18-month-old rats by LC-MS analysis with stable isotope-labeled collagen, which was recently developed as an internal standard for highly accurate collagen analyses. 3-Hyp was found to significantly increase in tendon collagen until 3 months after birth and then remain constant, whereas increased prolyl 3-hydroxylation was not observed in skin and bone collagen. Site-specific analysis further revealed that 3-Hyp was increased in tendon type I collagen in a specific sequence region, including a previously known modification site at Pro(707) and newly identified sites at Pro(716) and Pro(719), at the early ages. The site-specific alterations in prolyl 3-hydroxylation with aging were also observed in bovine Achilles tendon. We postulate that significant increases in 3-Hyp at the consecutive modification sites are correlated with tissue development in tendon. The present findings suggest that prolyl 3-hydroxylation incrementally regulates collagen fibril diameter in tendon.	[Taga, Yuki; Kusubata, Masashi; Ogawa-Goto, Kiyoko; Hattori, Shunji] Nippi Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan		Taga, Y (corresponding author), Nippi Res Inst Biomatrix, Kuwabara 520-11, Toride, Ibaraki 3020017, Japan.	y-taga@nippi-inc.co.jp	Taga, Yuki/I-2781-2019	Taga, Yuki/0000-0001-9100-758X				BARNES MJ, 1974, BIOCHEM J, V139, P461, DOI 10.1042/bj1390461; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; Guo H, 2014, CLIN GENET, V86, P575, DOI 10.1111/cge.12309; Hudson DM, 2015, J BIOL CHEM, V290, P8613, DOI 10.1074/jbc.M114.634915; Hudson DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093467; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Hudson DM, 2012, BIOCHEMISTRY-US, V51, P2417, DOI 10.1021/bi2019139; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Mizuno K, 2008, FEBS J, V275, P5830, DOI 10.1111/j.1742-4658.2008.06704.x; Mordechai S, 2011, AM J HUM GENET, V89, P438, DOI 10.1016/j.ajhg.2011.08.003; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; MURAI A, 1975, BIOCHIM BIOPHYS ACTA, V404, P345, DOI 10.1016/0304-4165(75)90343-8; OGLE JD, 1962, J BIOL CHEM, V237, P3667; PARRY DAD, 1977, BIOPOLYMERS, V16, P1015, DOI 10.1002/bip.1977.360160506; PARRY DAD, 1978, BIOPOLYMERS, V17, P843, DOI 10.1002/bip.1978.360170404; Perdivara I, 2013, AUST J CHEM, V66, P760, DOI 10.1071/CH13174; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573; STOLTZ M, 1973, BIOCHIM BIOPHYS ACTA, V310, P461, DOI 10.1016/0005-2795(73)90130-X; Taga Y, 2014, J AGR FOOD CHEM, V62, P12096, DOI 10.1021/jf5039597; Taga Y, 2014, J PROTEOME RES, V13, P3671, DOI 10.1021/pr500213a; Taga Y, 2013, J PROTEOME RES, V12, P2225, DOI 10.1021/pr400079d; Taga Y, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010397; Terajima M, 2014, J BIOL CHEM, V289, P22636, DOI 10.1074/jbc.M113.528513; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; Ueno T, 2010, J BIOL CHEM, V285, P29941, DOI 10.1074/jbc.M109.094607; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/BSE0520113, 10.1042/bse0520113]; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850	36	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					837	847		10.1074/jbc.M115.686105	http://dx.doi.org/10.1074/jbc.M115.686105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26567337	Green Published, hybrid			2022-12-26	WOS:000367830500030
J	Yin, DL; Yang, XH; Li, H; Fan, HM; Zhang, XL; Feng, YM; Stuart, C; Hu, D; Caudle, Y; Xie, NC; Liu, ZM; LeSage, G				Yin, Deling; Yang, Xiaohua; Li, Hui; Fan, Huimin; Zhang, Xiaoli; Feng, Yimin; Stuart, Charles; Hu, Dan; Caudle, Yi; Xie, Nanchang; Liu, Zhongmin; LeSage, Gene			beta-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BILE-DUCT LIGATION; LIVER-INJURY; PHOSPHOINOSITIDE 3-KINASE; P38 MAPK; RECEPTOR; ROLES; MOUSE; ACTIVATION; REGULATOR	Recent studies reveal that multifunctional protein beta-arrestin 2 (Arrb2) modulates cell apoptosis. Survival and various aspects of liver injury were investigated in WT and Arrb2 KO mice after bile duct ligation ( BDL). We found that deficiency of Arrb2 enhances survival and attenuates hepatic injury and fibrosis. Following BDL, Arrb2-deficient mice as compared with WT controls displayed a significant reduction of hepatocyte apoptosis as demonstrated by the TUNEL assay. Following BDL, the levels of phospho-Akt and phospho-glycogen synthase kinase 3 beta(GSK3 beta) in the livers were significantly increased in Arrb2 KO compared with WT mice, although p-p38 increased in WT but not in Arrb2-deficient mice. Inhibition of GSK3 beta following BDL decreases hepatic apoptosis and decreased p-p38 in WT mice but not in Arrb2 KO mice. Activation of Fas receptor with Jo2 reduces phospho-Akt and increases apoptosis in WT cells and WT mice but not in Arrb2-deficient cells and Arrb2-deficient mice. Consistent with direct interaction of Arrb2 with and regulating Akt phosphorylation, the expression of a full-length or N terminus but not the C terminus of Arrb2 reduces Akt phosphorylation and coimmunoprecipates with Akt. These results reveal that the protective effect of deficiency of Arrb2 is due to loss of negative regulation of Akt due to BDL and decreased downstream GSK3 beta and p38 MAPK signaling pathways.	[Yin, Deling; Yang, Xiaohua; Li, Hui; Zhang, Xiaoli; Feng, Yimin; Stuart, Charles; Hu, Dan; Caudle, Yi; Xie, Nanchang; LeSage, Gene] E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37604 USA; [Fan, Huimin; Liu, Zhongmin] Tongji Univ, Sch Med, Dept Cardiothorac Surg, Shanghai East Hosp, Shanghai 200120, Peoples R China	East Tennessee State University; Tongji University	Yin, DL (corresponding author), E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37604 USA.	yin@etsu.edu; gene_lesage@yahoo.com		Yin, Deling/0000-0003-3215-7566	National Institutes of Health from NIDDK [RO1 DK54208]; NIDA [020120]; NIGMS [094740, 114716]; National Natural Science Foundation of China [81570454, 81370433];  [C06RR0306551]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094740, R15GM114716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA020120] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health Grant RO1 DK54208 from NIDDK (to G. L.), Grant 020120 from NIDA, Grants 094740 and 114716 from NIGMS (to D. Y.), and Grant C06RR0306551 and by National Natural Science Foundation of China Grants 81570454 and 81370433. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Buchanan FG, 2006, CELL CYCLE, V5, P2060, DOI 10.4161/cc.5.18.3212; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Grambihler A, 2003, J BIOL CHEM, V278, P26831, DOI 10.1074/jbc.M303229200; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kahraman A, 2008, HEPATOLOGY, V47, P1317, DOI 10.1002/hep.22136; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LeSage GD, 2004, HEPATOLOGY, V40, P1116, DOI 10.1002/hep.20424; Li H, 2014, J BIOL CHEM, V289, P23075, DOI 10.1074/jbc.M114.591495; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Manson MM, 2003, TRENDS MOL MED, V9, P11, DOI 10.1016/S1471-4914(02)00002-3; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Menon B, 2007, J MOL CELL CARDIOL, V42, P653, DOI 10.1016/j.yjmcc.2006.12.011; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Moorman J, 2009, BBA-MOL CELL RES, V1793, P1366, DOI 10.1016/j.bbamcr.2009.05.007; Nalapareddy PD, 2009, AM J PATHOL, V175, P1077, DOI 10.2353/ajpath.2009.090304; O'Brien WT, 2011, J CLIN INVEST, V121, P3756, DOI 10.1172/JCI45194; Osawa Y, 2005, HEPATOLOGY, V42, P1320, DOI 10.1002/hep.20967; Osawa Y, 2010, HEPATOLOGY, V51, P237, DOI 10.1002/hep.23262; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Schoemaker MH, 2004, CLIN SCI, V107, P13, DOI 10.1042/CS20040090; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Wang KPC, 2011, J SURG RES, V167, P237, DOI 10.1016/j.jss.2009.07.051; Wang P, 2003, J BIOL CHEM, V278, P6363, DOI 10.1074/jbc.M210350200; Zhang Y, 2008, J NEUROIMMUNOL, V200, P71, DOI 10.1016/j.jneuroim.2008.06.014	35	13	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					605	612		10.1074/jbc.M115.655829	http://dx.doi.org/10.1074/jbc.M115.655829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26582201	Green Published, hybrid			2022-12-26	WOS:000367830500009
J	Clinton, RW; Francy, CA; Ramachandran, R; Qi, X; Mears, JA				Clinton, Ryan W.; Francy, Christopher A.; Ramachandran, Rajesh; Qi, Xin; Mears, Jason A.			Dynamin-related Protein 1 Oligomerization in Solution Impairs Functional Interactions with Membrane-anchored Mitochondrial Fission Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dynamin; electron microscopy (EM); GTPase; mitochondria; protein-protein interaction; dynamin-related protein 1; membrane remodeling; mitochondrial fission; mitochondrial fission factor; dynamin	DRP1; MFF; INHIBITION; DIVISION; DOMAIN; FRAGMENTATION; RECRUITMENT; MUTATION; FUSION	Mitochondrial fission is a crucial cellular process mediated by the mechanoenzymatic GTPase, dynamin-related protein 1 (Drp1). During mitochondrial division, Drp1 is recruited from the cytosol to the outer mitochondrial membrane by one, or several, integral membrane proteins. One such Drp1 partner protein, mitochondrial fission factor (Mff), is essential for mitochondrial division, but its mechanism of action remains unexplored. Previous studies have been limited by a weak interaction between Drp1 and Mff in vitro. Through refined in vitro reconstitution approaches and multiple independent assays, we show that removal of the regulatory variable domain (VD) in Drp1 enhances formation of a functional Drp1-Mff copolymer. This protein assembly exhibits greatly stimulated cooperative GTPase activity in solution. Moreover, when Mff was anchored to a lipid template, to mimic a more physiologic environment, significant stimulation of GTPase activity was observed with both WT and VD Drp1. Contrary to recent findings, we show that premature Drp1 self-assembly in solution impairs functional interactions with membrane-anchored Mff. Instead, dimeric Drp1 species are selectively recruited by Mff to initiate assembly of a functional fission complex. Correspondingly, we also found that the coiled-coil motif in Mff is not essential for Drp1 interactions, but rather serves to augment cooperative self-assembly of Drp1 proximal to the membrane. Taken together, our findings provide a mechanism wherein the multimeric states of both Mff and Drp1 regulate their collaborative interaction.	[Clinton, Ryan W.; Francy, Christopher A.; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Clinton, Ryan W.; Francy, Christopher A.; Qi, Xin; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Clinton, Ryan W.; Francy, Christopher A.; Ramachandran, Rajesh; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Ramachandran, Rajesh; Qi, Xin] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Mears, JA (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	jason.mears@case.edu	Qi, Xin/L-9279-2019; Qi, Xin/D-1512-2013; Ramachandran, Rajesh/A-1337-2011	Qi, Xin/0000-0002-9578-3890; Qi, Xin/0000-0002-9578-3890; Ramachandran, Rajesh/0000-0002-4645-2841; Mears, Jason/0000-0002-5199-4872; Clinton, Ryan/0000-0002-4058-6726	American Heart Association [SDG12SDG9130039, 13BGIA14810010]; National Institutes of Health [2T32GM008803-11A1, R01 NS088192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088192] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association Grants SDG12SDG9130039 (to J. A. M.) and 13BGIA14810010 (to R. R.) and National Institutes of Health Training Grant 2T32GM008803-11A1 (to C. A. F.). This work was also supported by National Institutes of Health Grant R01 NS088192 (to X. Q.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chen CH, 2000, DNA CELL BIOL, V19, P189, DOI 10.1089/104454900314573; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002; Esposito EA, 2008, J BIOMOL SCREEN, V13, P810, DOI 10.1177/1087057108322062; Francy CA, 2015, J BIOL CHEM, V290, P11692, DOI 10.1074/jbc.M114.610881; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Macdonald PJ, 2016, J BIOL CHEM, V291, P493, DOI 10.1074/jbc.M115.680181; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Otera Hidenori, 2011, Small GTPases, V2, P167; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Shrout AL, 2008, CHEM BIOL DRUG DES, V71, P278, DOI 10.1111/j.1747-0285.2008.00627.x; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Strack S, 2013, J CELL BIOL, V201, P1037, DOI 10.1083/jcb.201210045; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Su YC, 2013, HUM MOL GENET, V22, P4545, DOI 10.1093/hmg/ddt301; Tanaka A, 2006, EXP CELL RES, V312, P1671, DOI 10.1016/j.yexcr.2006.01.028; Ugarte-Uribe B, 2014, J BIOL CHEM, V289, P30645, DOI 10.1074/jbc.M114.575779; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	42	52	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					478	492		10.1074/jbc.M115.680025	http://dx.doi.org/10.1074/jbc.M115.680025			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26578514	Green Published, hybrid			2022-12-26	WOS:000367589500042
J	Dong, YB; Wang, QL; Zhang, L; Du, CG; Xiong, WW; Chen, XJ; Deng, F; Ma, ZY; Qiao, DH; Hu, CH; Ren, YL; Li, YL				Dong, Yongbin; Wang, Qilei; Zhang, Long; Du, Chunguang; Xiong, Wenwei; Chen, Xinjian; Deng, Fei; Ma, Zhiyan; Qiao, Dahe; Hu, Chunhui; Ren, Yangliu; Li, Yuling			Dynamic Proteomic Characteristics and Network Integration Revealing Key Proteins for Two Kernel Tissue Developments in Popcorn	PLOS ONE			English	Article							MAIZE ENDOSPERM DEVELOPMENT; QUALITY-RELATED TRAITS; QUANTITATIVE EXPRESSION; MASS-SPECTROMETRY; GENE-EXPRESSION; MESSENGER-RNA; DRYING RATE; PERICARP; ABUNDANCE; HEAT	The formation and development of maize kernel is a complex dynamic physiological and biochemical process that involves the temporal and spatial expression of many proteins and the regulation of metabolic pathways. In this study, the protein profiles of the endosperm and pericarp at three important developmental stages were analyzed by isobaric tags for relative and absolute quantification (iTRAQ) labeling coupled with LC-MS/MS in popcorn inbred N04. Comparative quantitative proteomic analyses among developmental stages and between tissues were performed, and the protein networks were integrated. A total of 6,876 proteins were identified, of which 1,396 were nonredundant. Specific proteins and different expression patterns were observed across developmental stages and tissues. The functional annotation of the identified proteins revealed the importance of metabolic and cellular processes, and binding and catalytic activities for the development of the tissues. The whole, endosperm-specific and pericarp-specific protein networks integrated 125, 9 and 77 proteins, respectively, which were involved in 54 KEGG pathways and reflected their complex metabolic interactions. Confirmation for the iTRAQ endosperm proteins by two-dimensional gel electrophoresis showed that 44.44% proteins were commonly found. However, the concordance between mRNA level and the protein abundance varied across different proteins, stages, tissues and inbred lines, according to the gene cloning and expression analyses of four relevant proteins with important functions and different expression levels. But the result by western blot showed their same expression tendency for the four proteins as by iTRAQ. These results could provide new insights into the developmental mechanisms of endosperm and pericarp, and grain formation in maize.	[Dong, Yongbin; Wang, Qilei; Zhang, Long; Deng, Fei; Ma, Zhiyan; Qiao, Dahe; Hu, Chunhui; Ren, Yangliu; Li, Yuling] Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Coll Agron, Zhengzhou, Peoples R China; [Du, Chunguang; Xiong, Wenwei] Montclair State Univ, Deptment Biol & Mol Biol, Montclair, NJ 07043 USA; [Chen, Xinjian] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China	Henan Agricultural University; Montclair State University; Henan Agricultural University	Li, YL (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Natl Key Lab Wheat & Maize Crop Sci, Coll Agron, 63 Nongye Rd, Zhengzhou, Peoples R China.	yuling_li@126.com	Xiong, Wenwei/G-5010-2015; Ma, Shisong/E-7225-2012	Xiong, Wenwei/0000-0002-1790-7384; Ma, Shisong/0000-0001-5563-448X; Zhang, Long/0000-0002-3856-726X	Plan for Fundamental and Forward Technology Research in Henan Province [121100910400]; Plan for Scientific Innovation Talent of Henan Province [124200510003]; Agricultural Science Creation in Henan Province; Modern Agricultural System in Industry and Technology of Henan Province [S2010-02-G01]	Plan for Fundamental and Forward Technology Research in Henan Province; Plan for Scientific Innovation Talent of Henan Province; Agricultural Science Creation in Henan Province; Modern Agricultural System in Industry and Technology of Henan Province	Funding: This work was funded by the Plan for Fundamental and Forward Technology Research in Henan Province (121100910400), the Plan for Scientific Innovation Talent of Henan Province (124200510003), the Agricultural Science Creation in Henan Province, and the Modern Agricultural System in Industry and Technology of Henan Province (S2010-02-G01).	Al-Whaibi Mohamed H., 2011, Journal of King Saud University Science, V23, P139, DOI 10.1016/j.jksus.2010.06.022; Aprile A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-821; Ayliffe MA, 2002, PLANT PHYSIOL, V129, P169, DOI 10.1104/pp.010940; Balconi C, 2007, MAYDICA, V52, P357; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Berger F, 1999, CURR OPIN PLANT BIOL, V2, P28, DOI 10.1016/S1369-5266(99)80006-5; Bondarenko PV, 2002, ANAL CHEM, V74, P4741, DOI 10.1021/ac0256991; Braun DP, 2007, FERTIL STERIL, V87, P263, DOI 10.1016/j.fertnstert.2006.06.026; Chatelain E, 2012, PLANT CELL ENVIRON, V35, P1440, DOI 10.1111/j.1365-3040.2012.02501.x; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Fukao Y, 2011, PLANT PHYSIOL, V155, P1893, DOI 10.1104/pp.110.169730; Gambin BL, 2007, MAYDICA, V52, P431; Ganeshan S, 2008, J EXP BOT, V59, P2393, DOI 10.1093/jxb/ern112; GROTEWOLD E, 1994, MOL GEN GENET, V242, P1; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HOOD EE, 1991, PLANT SCI, V79, P13, DOI 10.1016/0168-9452(91)90063-E; Monteoliva MI, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-21; ITO GM, 1991, J AM SOC HORTIC SCI, V116, P1072, DOI 10.21273/JASHS.116.6.1072; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KENNEDY EP, 1961, FED PROC, V20, P934; Kiesselbach T, 1949, NEBRASKA AGR EXP STA, V161, P3; KIESSELBACH TA, 1998, STRUCTURE REPROD COR; KINIRY JR, 1990, AGRON J, V82, P98, DOI 10.2134/agronj1990.00021962008200010023x; Lai JS, 2004, GENOME RES, V14, P1932, DOI 10.1101/gr.2780504; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; LENDING CR, 1992, PROTOPLASMA, V171, P123, DOI 10.1007/BF01403727; Li JZ, 2011, THEOR APPL GENET, V122, P771, DOI 10.1007/s00122-010-1485-4; Li L, 2007, CARBOHYD POLYM, V67, P630, DOI 10.1016/j.carbpol.2006.08.013; Liu YY, 2010, THEOR APPL GENET, V121, P433, DOI 10.1007/s00122-010-1321-x; Mechin V, 2004, PHYTOCHEMISTRY, V65, P1609, DOI 10.1016/j.phytochem.2004.04.035; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Motto M, 2011, MAYDICA, V56, P291; Motto M, 2010, GENETIKA-BELGRADE, V42, P23, DOI 10.2298/GENSR1001023M; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Olsen OA, 1999, TRENDS PLANT SCI, V4, P253, DOI 10.1016/S1360-1385(99)01431-4; Owiti J, 2011, PLANT J, V67, P145, DOI 10.1111/j.1365-313X.2011.04582.x; Pechanova O, 2013, PROTEOMICS, V13, P637, DOI 10.1002/pmic.201200275; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Prioul JL, 2008, PLANT BIOTECHNOL J, V6, P855, DOI 10.1111/j.1467-7652.2008.00368.x; PURDY JL, 1967, CROP SCI, V7, P379, DOI 10.2135/cropsci1967.0011183X000700040031x; PURDY JL, 1967, CROP SCI, V7, P294, DOI 10.2135/cropsci1967.0011183X000700040003x; Rasband W., 2009, IMAGE J; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Roy A, 2011, P S DAK ACAD SCI, V90, P186; Sabelli PA, 2005, MAYDICA, V50, P485; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Scanlon Michael J., 2009, P121, DOI 10.1007/978-0-387-79418-1_7; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; SCHWEIZER L, 1995, P NATL ACAD SCI USA, V92, P7070, DOI 10.1073/pnas.92.15.7070; Silva-Sanchez C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00211; Stymne S., 1987, Biochemistry of Plants, V9, P175; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Szymanski J, 2014, PLANT CELL, V26, P915, DOI 10.1105/tpc.113.118919; Takac T, 2011, J PROTEOMICS, V74, P577, DOI 10.1016/j.jprot.2011.02.002; Takacs EM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00115; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Verza NC, 2005, PLANT MOL BIOL, V59, P363, DOI 10.1007/s11103-005-8924-7; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walley JW, 2013, P NATL ACAD SCI USA, V110, pE4808, DOI 10.1073/pnas.1319113110; Wang XC, 2007, ELECTROPHORESIS, V28, P3976, DOI 10.1002/elps.200600805; Waters AJ, 2011, PLANT CELL, V23, P4221, DOI 10.1105/tpc.111.092668; Watson S. A., 1987, Corn: chemistry and technology., P53; [韦靖鸾 Wei Jingluan], 2011, [分子植物育种, Molecular Plant Breeding], V9, P9; Wienkoop S, 2006, J SEP SCI, V29, P2793, DOI 10.1002/jssc.200600290; WOLF MJ, 1969, AGRON J, V61, P777, DOI 10.2134/agronj1969.00021962006100050037x; Woo YM, 2001, PLANT CELL, V13, P2297, DOI 10.1105/tpc.13.10.2297; Yao RQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087142; Zhang M, 2011, P NATL ACAD SCI USA, V108, P20042, DOI 10.1073/pnas.1112186108	74	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143181	10.1371/journal.pone.0143181	http://dx.doi.org/10.1371/journal.pone.0143181			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587848	gold, Green Published, Green Submitted			2022-12-26	WOS:000365251500036
J	Li, YC; Yang, Y; Zhang, R; Yao, K; Liu, ZG				Li, Yingchun; Yang, Ying; Zhang, Rong; Yao, Kun; Liu, Zhuogang			The Mediating Role of Mental Adjustment in the Relationship between Perceived Stress and Depressive Symptoms in Hematological Cancer Patients: A Cross-Sectional Study	PLOS ONE			English	Article							PSYCHOLOGICAL ADJUSTMENT; BREAST-CANCER; PSYCHOSOMATIC SYMPTOMS; SLEEP QUALITY; COPING STYLE; MINI-MAC; ASSOCIATION; DISTRESS; ANXIETY; WOMEN	Background Depression is a particularly common psychological disorder that affects cancer patients. Diagnosed with hematological malignancies constitute a serious unpredictable and uncontrollable medical stress situation and patients are susceptible to suffer from depressive symptoms. The aims of the study were to explore the correlation between perceived stress and depressive symptoms in patients with hematological malignancies, and assess the mediating role of mental adjustment between these variables. Methods A single center, cross-sectional study was performed by convenience sampling between July 2013 and April 2014 in a hospital of China. The Center for Epidemiologic Studies Depression Scale, Perceived Stress Scale, and Mini-Mental Adjustment Scale, as well as questions about demographic and clinical factors was distributed to 300 hematological cancer patients. Completed questionnaires were received from 227 inpatients. Results The results showed that perceived stress was positively correlated with depressive symptoms. The mental adjustment significantly mediated the relationship between perceived stress and depressive symptoms. Conclusions Among hematological cancer patients perceived stress may be a risk factor for depressive symptoms, whereas positive coping style might be protective against depressive symptoms. Results showed that medical managers could support the development of mental adjustment in the patients to alleviate psychological disorders.	[Li, Yingchun; Yang, Ying; Zhang, Rong; Yao, Kun; Liu, Zhuogang] China Med Univ, Shengjing Hosp, Dept Hematol, Shenyang 110021, Peoples R China	China Medical University	Liu, ZG (corresponding author), China Med Univ, Shengjing Hosp, Dept Hematol, 39 Huaxiang Rd, Shenyang 110021, Peoples R China.	liuzhuogang432@163.com						Albrecht TA, 2012, J HOSP PALLIAT NURS, V14, P462, DOI 10.1097/NJH.0b013e318268d04e; Alcalar N, 2012, JPN J CLIN ONCOL, V42, P940, DOI 10.1093/jjco/hys119; [Anonymous], 2003, GUID CANC SERV IMPR; Batenburg A, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3517; Bergerot CD, 2015, PALLIAT SUPPORT CARE, V13, P115, DOI 10.1017/S1478951513000849; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cohen L, 2004, CANCER-AM CANCER SOC, V100, P2253, DOI 10.1002/cncr.20236; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S., 1995, MEASURING STRESS GUI, P3; Cohen S., 1988, SOCIAL PSYCHOL HLTH; Costa R, 2015, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3765, DOI 10.1002/P0N.3765]; D'Angelo B, 2003, PSYCHOL REP, V92, P416, DOI 10.2466/PR0.92.2.416-418; Daniel L, 2016, SUPPORT CARE CANCER, V24, P539, DOI 10.1007/s00520-015-2798-2; De Jonge P, 2007, PSYCHOSOM MED, V69, P735, DOI 10.1097/PSY.0b013e31815743ca; Emanuel PD, 2007, HEMATOLOGY CLIN PRIN, P389; Ferlay J, 2008, CANC INCIDENCE MORTA; Fujisawa D, 2015, PSYCHO-ONCOLOGY, DOI [10.1002/pon.3840, DOI 10.1002/P0N.3840]; Golden WL, 1992, DEPRESSION PSYCHOL T, P10; GREER S, 1987, CANCER SURV, V6, P439; Hange D, 2013, INT J GEN MED, V6, P307, DOI 10.2147/IJGM.S42201; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; He Fei, 2013, PLoS One, V8, pe82939, DOI 10.1371/journal.pone.0082939; Ho SMY, 2003, PSYCHO-ONCOLOGY, V12, P547, DOI 10.1002/pon.672; Hoffbrand AV., 2006, ESSENTIAL HAEMATOLOG, V5th ed; Hong JS, 2014, SUPPORT CARE CANCER, V22, P453, DOI 10.1007/s00520-013-1997-y; Korszun A, 2014, BRIT J HAEMATOL, V164, P790, DOI 10.1111/bjh.12698; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lazarus R.S., 1984, EMOTION ADAPTATION; Lemma S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-237; Losiak W, PROCESS COPYING STRE; Manitta V, 2011, J PAIN SYMPTOM MANAG, V42, P432, DOI 10.1016/j.jpainsymman.2010.12.008; Mashhadi MA, 2013, IRAN J CANCER PREV, V6, P12; Mehnert A, 2013, ACTA ONCOL, V52, P1102, DOI 10.3109/0284186X.2013.765063; Montgomery C, 2003, J PSYCHOSOM RES, V54, P289, DOI 10.1016/S0022-3999(02)00396-3; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pulgar A, 2015, BEHAV MED, V41, P1, DOI 10.1080/08964289.2013.833083; Pulte D, 2010, ANN ONCOL, V21, P335, DOI 10.1093/annonc/mdp309; Que JC, 2013, J PALLIAT MED, V16, P1280, DOI 10.1089/jpm.2013.0022; RANA M, 2015, J ORAL MAXILLOFAC SU, V53, P364, DOI DOI 10.1016/J.BJ0MS.2015.01.019; Rottmann N, 2010, QUAL LIFE RES, V19, P827, DOI 10.1007/s11136-010-9653-1; Sampogna F, 2009, BRIT J DERMATOL, V160, P815, DOI 10.1111/j.1365-2133.2008.08992.x; Schnoll RA, 1998, PSYCHO-ONCOLOGY, V7, P69, DOI 10.1002/(SICI)1099-1611(199803/04)7:2<69::AID-PON286>3.0.CO;2-8; Schou I, 2004, PSYCHO-ONCOLOGY, V13, P309, DOI 10.1002/pon.747; Shiloh S, 2008, PSYCHO-ONCOLOGY, V17, P746, DOI 10.1002/pon.1338; Silva SM, 2012, PSYCHOL HEALTH, V27, P1323, DOI 10.1080/08870446.2012.676644; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028610; WATSON M, 1994, J PSYCHOSOC ONCOL, V12, P33, DOI 10.1300/J077V12N03_03; Wong JYH, 2015, PSYCHOL HEALTH MED, V20, P457, DOI 10.1080/13548506.2014.951372; Wu SM, 2014, PSYCHOSOM MED, V76, P252, DOI 10.1097/PSY.0000000000000060; Yilmaz SD, 2015, CANCER NURS, V38, pE57, DOI 10.1097/NCC.0000000000000186	50	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0142913	10.1371/journal.pone.0142913	http://dx.doi.org/10.1371/journal.pone.0142913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW8LQ	26587991	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500021
J	Simonov, AN; Holien, JK; Yeung, JCI; Nguyen, AD; Corbin, CJ; Zheng, J; Kuznetsov, VL; Auchus, RJ; Conley, AJ; Bond, AM; Parker, MW; Rodgers, RJ; Martin, LL				Simonov, Alexandr N.; Holien, Jessica K.; Yeung, Joyee Chun In; Nguyen, Ann D.; Corbin, C. Jo; Zheng, Jie; Kuznetsov, Vladimir L.; Auchus, Richard J.; Conley, Alan J.; Bond, Alan M.; Parker, Michael W.; Rodgers, Raymond J.; Martin, Lisandra L.			Mechanistic Scrutiny Identifies a Kinetic Role for Cytochrome b5 Regulation of Human Cytochrome P450c17 (CYP17A1, P450 17A1)	PLOS ONE			English	Article							MOLECULAR-INTERACTIONS; ZONA-RETICULARIS; ELECTRODE; B(5); STEROIDOGENESIS; EXPRESSION; REDUCTASE; SERVER; LEVEL; 2E1	Cytochrome P450c17 (P450 17A1, CYP17A1) is a critical enzyme in the synthesis of androgens and is now a target enzyme for the treatment of prostate cancer. Cytochrome P450c17 can exhibit either one or two physiological enzymatic activities differentially regulated by cytochrome b5. How this is achieved remains unknown. Here, comprehensive in silico, in vivo and in vitro analyses were undertaken. Fluorescence Resonance Energy Transfer analysis showed close interactions within living cells between cytochrome P450c17 and cytochrome b5. In silico modeling identified the sites of interaction and confirmed that E48 and E49 residues in cytochrome b5 are essential for activity. Quartz crystal microbalance studies identified specific protein-protein interactions in a lipid membrane. Voltammetric analysis revealed that the wild type cytochrome b5, but not a mutated, E48G/E49G cyt b5, altered the kinetics of electron transfer between the electrode and the P450c17. We conclude that cytochrome b5 can influence the electronic conductivity of cytochrome P450c17 via allosteric, protein-protein interactions.	[Simonov, Alexandr N.; Yeung, Joyee Chun In; Bond, Alan M.; Martin, Lisandra L.] Monash Univ, Sch Chem, Clayton, Vic, Australia; [Holien, Jessica K.; Parker, Michael W.] St Vincents Inst Med Res, ACRF Rat Drug Discovery Ctr, Fitzroy, Vic 3065, Australia; [Nguyen, Ann D.; Corbin, C. Jo; Conley, Alan J.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Kuznetsov, Vladimir L.] Boreskov Inst Catalysis, Prospekt Lavrentieva 5, Novosibirsk, Russia; [Auchus, Richard J.] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Rodgers, Raymond J.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Discipline Obstet & Gynaecol, Adelaide, SA, Australia	Monash University; St. Vincent's Institute of Medical Research; University of California System; University of California Davis; University of California System; University of California Davis; Boreskov Institute of Catalysis, Siberian Branch, Russian Academy of Sciences; University of Michigan System; University of Michigan; University of Melbourne; Robinson Research Institute; University of Adelaide	Martin, LL (corresponding author), Monash Univ, Sch Chem, Clayton, Vic, Australia.	Lisa.Martin@monash.edu	Parker, Michael W/F-9069-2013; Martin, Lisandra L/E-4482-2010; Simonov, Alexandr N/K-1118-2013; Kuznetsov, Vladimir L/C-9648-2012; Simonov, Alexandr/B-6236-2015; Rodgers, Raymond J/C-3476-2009; Holien, Jess/V-7005-2019; Bond, Alan M/Y-7128-2018	Parker, Michael W/0000-0002-3101-1138; Martin, Lisandra L/0000-0003-0486-5813; Simonov, Alexandr N/0000-0003-3063-6539; Kuznetsov, Vladimir L/0000-0002-9087-5630; Simonov, Alexandr/0000-0003-3063-6539; Holien, Jess/0000-0002-8735-2871; Bond, Alan M/0000-0002-1113-5205; Conley, Alan/0000-0003-3798-7390	Australian Research Council; National Health and Medical Research Council; National Institutes of Health [R01GM086596]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072377] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: LLM and AMB thank the Australian Research Council, RJR the National Health and Medical Research Council and RJA the National Institutes of Health (R01GM086596) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; [Anonymous], SOLUTION STRUCTURE H, DOI DOI 10.2210/PDB2I96/PDB; Bard A. J., 2001, ELECTROCHEMICAL METH; Bond AM, 2015, ELECTROCHEM COMMUN, V57, P78, DOI 10.1016/j.elecom.2015.04.017; Bond AM, 2014, DEVELOPMENTS IN ELECTROCHEMISTRY: SCIENCE INSPIRED BY MARTIN FLEISCHMANN, P21; Bond AM, 2005, ANAL CHEM, V77, p186A, DOI 10.1021/ac053370k; Bowden JA, 2009, J CHROMATOGR B, V877, P3237, DOI 10.1016/j.jchromb.2009.08.005; Cherstiouk OV, 2010, PHYS STATUS SOLIDI B, V247, P2738, DOI 10.1002/pssb.201000352; Corbin CJ, 2003, BIOL REPROD, V69, P390, DOI 10.1095/biolreprod.103.015578; De Montellano P, 2005, CYTOCHROME P 450 STR; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Dharia S, 2004, BIOL REPROD, V71, P83, DOI 10.1095/biolreprod.103.026732; Elumeeva KV, 2013, AIP ADV, V3, DOI 10.1063/1.4829272; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Fleming BD, 2007, UBIQUITOUS ROLES CYT, V3; HOLMANS PL, 1994, ARCH BIOCHEM BIOPHYS, V312, P554, DOI 10.1006/abbi.1994.1345; Johnson DL, 2006, J MOL ENDOCRINOL, V36, P349, DOI 10.1677/jme.1.01971; Kennedy GF., MONASH ELECTROCHEMIS; Knappe D, 2010, J MED CHEM, V53, P5240, DOI 10.1021/jm100378b; Kuznetsov VL, 2010, PHYS STATUS SOLIDI B, V247, P2695, DOI 10.1002/pssb.201000211; Lee-Robichaud P, 2004, J STEROID BIOCHEM, V92, P119, DOI 10.1016/j.jsbmb.2004.07.005; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mapes S, 1999, J CLIN ENDOCR METAB, V84, P3382, DOI 10.1210/jc.84.9.3382; Mechler A, 2009, BIOMATERIALS, V30, P682, DOI 10.1016/j.biomaterials.2008.10.016; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moran FM, 2002, ENDOCRINOLOGY, V143, P3361, DOI 10.1210/en.2002-220329; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; Nguyen AD, 2009, ENDOCRINOLOGY, V150, P1748, DOI 10.1210/en.2008-1303; Nguyen AD, 2008, J ENDOCRINOL, V199, P367, DOI 10.1677/JOE-08-0337; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; Rusling JF, 2003, J COLLOID INTERF SCI, V262, P1, DOI 10.1016/S0021-9797(03)00148-6; Sagara T, 1998, J PHYS CHEM B, V102, P521, DOI 10.1021/jp9713928; Simonov AN, 2014, LANGMUIR, V30, P3264, DOI 10.1021/la404872p; Storbeck KH, 2013, MOL CELL ENDOCRINOL, V371, P87, DOI 10.1016/j.mce.2012.11.020; Szczesna-Skorupa E, 2003, J BIOL CHEM, V278, P31269, DOI 10.1074/jbc.M301489200; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Yoshimoto FK, 2015, J STEROID BIOCHEM, V151, P52, DOI 10.1016/j.jsbmb.2014.11.026	42	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0141252	10.1371/journal.pone.0141252	http://dx.doi.org/10.1371/journal.pone.0141252			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26587646	Green Published, gold, Green Submitted			2022-12-26	WOS:000365251500003
J	Tagg, KA; Ginn, AN; Partridge, SR; Iredell, JR				Tagg, Kaitlin A.; Ginn, Andrew N.; Partridge, Sally R.; Iredell, Jonathan R.			MALDI-TOF Mass Spectrometry for Multilocus Sequence Typing of Escherichia coli Reveals Diversity among Isolates Carrying bla(CMY-2)-Like Genes	PLOS ONE			English	Article							BETA-LACTAMASE GENES; RESISTANCE; PLASMIDS; EMERGENCE; VIRULENCE; TYPE-2	Effective surveillance and management of pathogenic Escherichia coli relies on robust and reproducible typing methods such as multilocus sequence typing (MLST). Typing of E. coli by MLST enables tracking of pathogenic clones that are known to carry virulence factors or spread resistance, such as the globally-prevalent ST131 lineage. Standard MLST for E. coli requires sequencing of seven alleles, or a whole genome, and can take several days. Here, we have developed and validated a nucleic-acid-based MALDI-TOF mass spectrometry (MS) method for MLST as a rapid alternative to sequencing that requires minimal operator expertise. Identification of alleles was 99.6% concordant with sequencing. We employed MLST by MALDI-TOF MS to investigate diversity among 62 E. coli isolates from Sydney, Australia, carrying a bla(CMY-2)-like gene on an IncI1 plasmid to determine whether any dominant clonal lineages are associated with the spread of this globally-disseminated resistance gene. Thirty-four known sequence types were identified, including lineages associated with human disease, animal and environmental sources. This suggests that the dissemination of bla(CMY-2)-like-genes is more complex than the simple spread of successful pathogenic clones. E. coli MLST by MALDI-TOF MS, employed here for the first time, can be utilised as an automated tool for large-scale population analyses or for targeted screening for known high-risk clones in a diagnostic setting.	[Iredell, Jonathan R.] Univ Sydney, Ctr Infect Dis & Microbiol, Westmead Inst Med Res, Westmead, NSW 2145, Australia; Westmead Hosp, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Iredell, JR (corresponding author), Univ Sydney, Ctr Infect Dis & Microbiol, Westmead Inst Med Res, Westmead, NSW 2145, Australia.	jonathan.iredell@sydney.edu.au	Partridge, Sally R/Q-9374-2019		Australian Postgraduate Award from the University of Sydney; Westmead Millennium Institute Top-Up Scholarship; National Health and Medical Research Council of Australia [G1046886, PF1002076, G1001021, G512396]; Australian Society for Antimicrobials	Australian Postgraduate Award from the University of Sydney; Westmead Millennium Institute Top-Up Scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Society for Antimicrobials	KAT was supported by an Australian Postgraduate Award from the University of Sydney and a Westmead Millennium Institute Top-Up Scholarship. ANG was supported by G1046886, JRI was supported by PF1002076 and this work was supported by G1001021 and G512396, all from the National Health and Medical Research Council of Australia. Illumina sequencing was funded by a grant from the Australian Society for Antimicrobials.	Borjesson S, 2013, CLIN MICROBIOL INFEC, V19, pE309, DOI 10.1111/1469-0691.12192; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Dunne EM, 2011, J CLIN MICROBIOL, V49, P3756, DOI 10.1128/JCM.05113-11; Ginn AN, 2013, INT J ANTIMICROB AG, V42, P19, DOI 10.1016/j.ijantimicag.2013.03.003; Goering RV, 2010, INFECT GENET EVOL, V10, P866, DOI 10.1016/j.meegid.2010.07.023; Groves MD, 2015, VET MICROBIOL, V177, P394, DOI 10.1016/j.vetmic.2015.03.006; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Honisch C, 2007, P NATL ACAD SCI USA, V104, P10649, DOI 10.1073/pnas.0704152104; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kamruzzaman M, 2013, DIAGN MICR INFEC DIS, V76, P222, DOI 10.1016/j.diagmicrobio.2013.02.016; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Manges AR, 2015, FOODBORNE PATHOG DIS, V12, P302, DOI 10.1089/fpd.2014.1860; Mataseje LF, 2010, DIAGN MICR INFEC DIS, V67, P387, DOI 10.1016/j.diagmicrobio.2010.02.027; Matsumura Y, 2013, CLIN MICROBIOL INFEC, V19, P161, DOI 10.1111/j.1469-0691.2012.03762.x; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; Naseer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041232; Oteo J, 2010, DIAGN MICR INFEC DIS, V67, P270, DOI 10.1016/j.diagmicrobio.2010.02.008; Partridge SR, 2015, INT J ANTIMICROB AG, V45, P130, DOI 10.1016/j.ijantimicag.2014.10.006; Partridge SR, 2011, ANTIMICROB AGENTS CH, V55, P4971, DOI 10.1128/AAC.00025-11; Riley LW, 2014, CLIN MICROBIOL INFEC, V20, P380, DOI 10.1111/1469-0691.12646; Rybicka M, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.10.004; Sidjabat HE, 2014, INT J ANTIMICROB AG, V44, P203, DOI 10.1016/j.ijantimicag.2014.04.016; Soderlund-Strand A, 2008, CLIN CHEM, V54, P86, DOI 10.1373/clinchem.2007.092627; Stanssens P, 2004, GENOME RES, V14, P126; Syrmis MW, 2011, CLIN MICROBIOL INFEC, V17, P1804, DOI 10.1111/j.1469-0691.2011.03521.x; Tagg KA, 2015, DIAGN MICR INFEC DIS, V83, P56, DOI 10.1016/j.diagmicrobio.2015.06.001; Tagg KA, 2014, ANTIMICROB AGENTS CH, V58, P4949, DOI 10.1128/AAC.02773-14; Voets GM, 2013, INT J FOOD MICROBIOL, V167, P359, DOI 10.1016/j.ijfoodmicro.2013.10.001; Weissman SJ, 2013, INT J ANTIMICROB AG, V41, P414, DOI 10.1016/j.ijantimicag.2013.01.006; Weissman SJ, 2012, APPL ENVIRON MICROB, V78, P1353, DOI 10.1128/AEM.06663-11; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x	35	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143446	10.1371/journal.pone.0143446	http://dx.doi.org/10.1371/journal.pone.0143446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588228	Green Published, gold			2022-12-26	WOS:000365251500063
J	Bi, XZ; Pan, WH; Yu, XP; Song, ZM; Ren, ZJ; Sun, M; Li, CH; Nan, KH				Bi, Xiu-Zeng; Pan, Wei-Hua; Yu, Xin-Ping; Song, Zong-Ming; Ren, Zeng-Jin; Sun, Min; Li, Cong-Hui; Nan, Kai-Hui			Application of 5-Fluorouracil-Polycaprolactone Sustained-Release Film in Ahmed Glaucoma Valve Implantation Inhibits Postoperative Bleb Scarring in Rabbit Eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MITOMYCIN-C; FILTRATION SURGERY; ANTERIOR SEGMENT; 5-FLUOROURACIL; POLYPROPYLENE; MICROSPHERES	This study was designed to investigate whether 5-fluorouracil (5-Fu)-polycaprolactone sustained-release film in Ahmed glaucoma valve implantation inhibits postoperative bleb scarring in rabbit eyes. Eighteen New Zealand white rabbits were randomly divided into three groups (A, B and C; n = 6 per group). Group A received combined 5-Fu-polycaprolactone sustained-release film application and Ahmed glaucoma valve implantation, group B received local infiltration of 5-Fu and Ahmed glaucoma valve implantation, and group C received Ahmed glaucoma valve implantation. Postoperative observations were made of the anterior segment, intraocular pressure, central anterior chamber depth, blebs, drainage tube, and accompanying ciliary body detachment. The pathology of the blebs and surrounding tissues were observed at month 3 postoperatively. We revealed that the 5-Fu-polycaprolactone sustained-release film maintained a release concentration range of 13.7 +/- 0.12 to 37.41 +/- 0.47 mu g/ml over three months in vitro. Postoperatively, diffuse blebs with ridges were found in all eyes in group A, two blebs were observed in group B, and no bleb formation was present in group C. The postoperative central anterior chamber depth in group A was significantly less than that of the other two groups. The postoperative intraocular pressure of group A stabilized at 6.33-8.67 mmHg, whereas that of group C gradually remained at 7.55-10.02 mmHg. The histopathology showed that the fibrous tissue thickness of the blebs in group A was significantly thinner than that of the other groups. We conclude that the 5-Fu-polycaprolactone sustained-release film had a sustained drug release effect, which promoted the inhibition of bleb scarring after Ahmed glaucoma valve implantation.	[Bi, Xiu-Zeng; Pan, Wei-Hua; Yu, Xin-Ping; Song, Zong-Ming] Wenzhou Med Coll, Hosp Optometry & Ophthalmol, Wenzhou 325027, Zhejiang, Peoples R China; [Ren, Zeng-Jin; Sun, Min; Li, Cong-Hui] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou 325027, Zhejiang, Peoples R China; [Nan, Kai-Hui] Wenzhou Engn Res Ctr Biomat, Wenzhou 325027, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Pan, WH (corresponding author), Wenzhou Med Coll, Hosp Optometry & Ophthalmol, Wenzhou 325027, Zhejiang, Peoples R China.	13738323378@163.com						Alvarado JA, 2008, AM J OPHTHALMOL, V146, P276, DOI 10.1016/j.ajo.2008.04.008; Ang LPK, 2006, INVEST OPHTH VIS SCI, V47, P105, DOI 10.1167/iovs.05-0512; Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1; Cantor L, 1998, J GLAUCOMA, V7, P240; Cui LJ, 2008, ACTA PHARMACOL SIN, V29, P1021, DOI 10.1111/j.1745-7254.2008.00833.x; Dada T, 2007, J CATARACT REFR SURG, V33, P837, DOI 10.1016/j.jcrs.2007.01.021; Fukuda S, 2009, OPHTHALMOLOGY, V116, P882, DOI 10.1016/j.ophtha.2008.12.022; Hinkle DM, 2007, EUR J OPHTHALMOL, V17, P696, DOI 10.1177/112067210701700502; Hitzman CJ, 2006, J PHARM SCI-US, V95, P1114, DOI 10.1002/jps.20591; Ishida K, 2006, OPHTHALMOLOGY, V113, P1320, DOI 10.1016/j.ophtha.2006.04.020; KRUPIN T, 1994, OPHTHALMOLOGY, V101, P651; Lee JH, 2008, ARCH PHARM RES, V31, P125, DOI 10.1007/s12272-008-1130-9; LLOYD MAE, 1994, OPHTHALMOLOGY, V101, P640; Lu F, 2011, INT J PHARMACEUT, V419, P77, DOI 10.1016/j.ijpharm.2011.07.020; Lukowski ZL, 2013, J GLAUCOMA, V22, P145, DOI 10.1097/IJG.0b013e31822e8c83; Nemeth G, 2007, J CATARACT REFR SURG, V33, P443, DOI 10.1016/j.jcrs.2006.11.013; Sahiner N, 2009, ARCH OPHTHALMOL-CHIC, V127, P448, DOI 10.1001/archophthalmol.2009.19; Sastre RL, 2007, INT J PHARMACEUT, V338, P180, DOI 10.1016/j.ijpharm.2007.02.001; Silva-Cunha A, 2009, INVEST OPHTH VIS SCI, V50, P2312, DOI 10.1167/iovs.08-2969; Wang K, 2006, GRAEF ARCH CLIN EXP, V244, P1152, DOI 10.1007/s00417-005-0251-9; YAMAMOTO T, 1990, OPHTHALMOLOGY, V97, P1204; Yin HB, 2010, J BIOMED MATER RES B, V92B, P129, DOI 10.1002/jbm.b.31498	22	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141467	10.1371/journal.pone.0141467	http://dx.doi.org/10.1371/journal.pone.0141467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26579716	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600016
J	Kumar, V; Jha, P				Kumar, Vipan; Jha, Prashant			Growth and Reproduction of Glyphosate-Resistant and Susceptible Populations of Kochia scoparia	PLOS ONE			English	Article							HORSEWEED CONYZA-CANADENSIS; EPSPS GENE AMPLIFICATION; SULFONYLUREA-RESISTANT; MANAGEMENT-PRACTICES; AMARANTHUS-PALMERI; LOLIUM-RIGIDUM; FITNESS COST; GERMINATION; SEED; HERBICIDES	Evolution of glyphosate-resistant kochia is a threat to no-till wheat-fallow and glyphosate-resistant (GR) cropping systems of the US Great Plains. The EPSPS (5-enol-pyruvylshikimate- 3-phosphate synthase) gene amplification confers glyphosate resistance in the tested Kochia scoparia (L.) Schrad populations from Montana. Experiments were conducted in spring to fall 2014 (run 1) and summer 2014 to spring 2015 (run 2) to investigate the growth and reproductive traits of the GR vs. glyphosate-susceptible (SUS) populations of K. scoparia and to determine the relationship of EPSPS gene amplification with the level of glyphosate resistance. GR K. scoparia inbred lines (CHES01 and JOP01) exhibited 2 to 14 relative copies of the EPSPS gene compared with the SUS inbred line with only one copy. In the absence of glyphosate, no differences in growth and reproductive parameters were evident between the tested GR and SUS inbred lines, across an intraspecific competition gradient (1 to 170 plants m(-2)). GR K. scoparia plants with 2 to 4 copies of the EPSPS gene survived the field-use rate (870 g ha(-1)) of glyphosate, but failed to survive the 4,350 g ha(-1) rate of glyphosate (five-times the field-use rate). In contrast, GR plants with 5 to 14 EPSPS gene copies survived the 4,350 g ha(-1) of glyphosate. The results from this research indicate that GR K. scoparia with 5 or more EPSPS gene copies will most likely persist in field populations, irrespective of glyphosate selection pressure.	[Kumar, Vipan; Jha, Prashant] Montana State Univ Bozeman, Southern Agr Res Ctr, Huntley, MT 59037 USA	Montana State University System; Montana State University Bozeman	Jha, P (corresponding author), Montana State Univ Bozeman, Southern Agr Res Ctr, Huntley, MT 59037 USA.	pjha@montana.edu	Kumar, Vipan/N-1879-2019	Kumar, Vipan/0000-0002-8301-5878	Montana Wheat and Barley Committee [4W5159]	Montana Wheat and Barley Committee	The authors acknowledge Montana Wheat and Barley Committee for funding this research, grant# 4W5159. The grant was obtained by PJ.	Al-Ahmadi MJ, 2007, J ARID ENVIRON, V68, P308, DOI 10.1016/j.jaridenv.2006.05.006; Alcorta M, 2011, WEED SCI, V59, P489, DOI 10.1614/WS-D-10-00186.1; Baker DV, 2010, INVAS PLANT SCI MANA, V3, P301, DOI 10.1614/IPSM-D-09-00016.1; Brabham CB, 2011, WEED SCI, V59, P506, DOI 10.1614/WS-D-11-00050.1; Christoffoleti PJ, 1997, WEED SCI, V45, P691; Cranston HJ, 2001, WEED SCI, V49, P164, DOI 10.1614/0043-1745(2001)049[0164:DRIK]2.0.CO;2; Davis VM, 2009, WEED SCI, V57, P417, DOI 10.1614/WS-09-006.1; Eberlein C. V., 1984, Weeds Today, V15, P5; EVERITT JH, 1983, J RANGE MANAGE, V36, P646, DOI 10.2307/3898360; Forcella F., 1985, Weeds Today, V16, P4; Friesen LF, 2009, CAN J PLANT SCI, V89, P141, DOI 10.4141/CJPS08057; Gaines TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065819; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Giacomini D, 2014, WEED SCI, V62, P29, DOI 10.1614/WS-D-13-00066.1; Glettner CE, 2015, WEED SCI, V63, P273, DOI 10.1614/WS-D-14-00040.1; Godar AS, 2015, WEED SCI, V63, P587, DOI 10.1614/WS-D-14-00145.1; Heap I, INT SURVEY HERBICIDE; Jugulam M, 2014, PLANT PHYSIOL, V166, P1200, DOI 10.1104/pp.114.242826; Kumar V, 2015, WEED TECHNOL, V29, P24, DOI 10.1614/WT-D-14-00026.1; Kumar V, 2015, WEED SCI, V63, P758, DOI 10.1614/WS-D-15-00021.1; Kumar V, 2015, CROP PROT, V71, P144, DOI 10.1016/j.cropro.2015.02.016; Kumar V, 2014, WEED TECHNOL, V28, P122, DOI 10.1614/WT-D-13-00115.1; Legere A, 2013, WEED SCI, V61, P267, DOI 10.1614/WS-D-12-00116.1; Lehnhoff EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064478; Lorentz L, 2014, J AGR FOOD CHEM, V62, P8134, DOI 10.1021/jf501040x; Menalled FD, 2007, WEED BIOL MANAG, V7, P115, DOI 10.1111/j.1445-6664.2007.00244.x; Mengistu LW, 2002, WEED SCI, V50, P498, DOI 10.1614/0043-1745(2002)050[0498:GDOK]2.0.CO;2; Nandula VK, 2014, PEST MANAG SCI, V70, P1902, DOI 10.1002/ps.3754; Pan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076872; Preston C, 2008, PEST MANAG SCI, V64, P372, DOI 10.1002/ps.1489; Preston C, 2009, WEED SCI, V57, P435, DOI 10.1614/WS-08-181.1; Salas RA, 2012, PEST MANAG SCI, V68, P1223, DOI 10.1002/ps.3342; Sbatella GM, 2010, WEED TECHNOL, V24, P392, DOI 10.1614/WT-D-09-00023.1; Schwinghamer TD, 2008, WEED SCI, V56, P37, DOI 10.1614/WS-07-098.1; STALLINGS GP, 1995, WEED SCI, V43, P95, DOI 10.1017/S0043174500080887; Steadman KJ, 2006, AUST J AGR RES, V57, P133, DOI 10.1071/AR05122; Vila-Aiub MM, 2015, WEED SCI, V63, P203, DOI 10.1614/WS-D-14-00062.1; Vila-Aiub MM, 2014, PLANTA, V239, P793, DOI 10.1007/s00425-013-2022-x; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Vila-Aiub MM, 2009, J ECOL, V97, P772, DOI 10.1111/j.1365-2745.2009.01511.x; Wiersma AT, 2015, PLANTA, V241, P463, DOI 10.1007/s00425-014-2197-9; YOUNG JA, 1981, AGRON J, V73, P957, DOI 10.2134/agronj1981.00021962007300060012x	42	16	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142675	10.1371/journal.pone.0142675	http://dx.doi.org/10.1371/journal.pone.0142675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580558	Green Published, Green Submitted, gold			2022-12-26	WOS:000365154600056
J	Lee, HB; Kim, J; Kim, SH; Kim, S; Kim, OJ; Oh, SH				Lee, Han-Bin; Kim, Jinkwon; Kim, Sang-Heum; Kim, Soonhag; Kim, Ok-Joon; Oh, Seung-Hun			Association between Serum Alkaline Phosphatase Level and Cerebral Small Vessel Disease	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; SILENT BRAIN INFARCTS; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; RISK; MORTALITY; ATHEROSCLEROSIS; PREDICTOR; DEMENTIA	Background Serum alkaline phosphatase (ALP) is a marker of vascular calcification. A high serum ALP level is associated with an increase in cardiovascular events, and predicts poor functional outcome in patients with stroke. We investigated whether serum ALP was associated with cerebral small vessel disease (cSVD) and large cerebral artery stenosis (LCAS). Methods We evaluated vascular risk factors, brain magnetic resonance images (MRIs), and MR angiograms from 1,011 neurologically healthy participants. The presence of silent lacunar infarction (SLI) and moderate-to-severe cerebral white matter hyperintensities (MS-cWMH) were evaluated as indices of cSVD on brain MRIs. Findings of extracranial arterial stenosis (ECAS) or intracranial arterial stenosis (ICAS) were considered to be indices of LCAS on MR angiograms. Results Subjects with SLI (odds ratio [OR]: 2.09; 95% confidence interval [CI]: 1.27-3.42; p = 0.004) and MS-cWMH (OR: 1.48; 95% CI; 1.03-2.13, p = 0.036) were significantly more likely to have ALP levels in the third tertile (ALP >= 195 IU/L) than the first tertile (ALP <= 155 IU/L), after adjusting for cardiovascular risk factors. The mean serum ALP level was significantly higher in patients with SLI or MS-cWMH compared to patients without those findings. After adjustment for confounding factors, the multivariate model found that the statistical significance of serum ALP remained when the presence of SLI (OR: 1.05 per 10 IU/L increase in ALP; 95% CI: 1.02-1.08; p = 0.003) or MS-cWMH (OR: 1.03 per 10 IU/L increase in ALP; 95% CI: 1.00-1.06; p = 0.025) were added to the model. There were no differences in the proportions of patients with LCAS, ICAS, and ECAS across the serum ALP tertiles. Conclusions Our study of neurologically healthy participants found a positive association between serum ALP level and indicators of cSVD, but no association between serum ALP level and the indicators of LCAS.	[Lee, Han-Bin; Kim, Jinkwon; Kim, Ok-Joon; Oh, Seung-Hun] CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea; [Kim, Sang-Heum] CHA Univ, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea; [Kim, Soonhag] Catholic Kwandong Univ, Coll Med, Inst Biomed Convergence, Gangneung Si, South Korea; [Kim, Soonhag] Catholic Kwandong Univ, Int St Marys Hosp, Inchon, South Korea	Pochon Cha University; Pochon Cha University; Catholic Kwandong University; Catholic Kwandong University	Oh, SH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea.	ohsh72@chamc.co.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and Technology [2011-0021344]; Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HC14C3297]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and Technology; Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science and Technology (2011-0021344), and a grant from the Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HC14C3297).	Alagiakrishnan Kannayiram, 2015, J Clin Med Res, V7, P297, DOI 10.14740/jocmr2119w; Bos D, 2011, ARTERIOSCL THROM VAS, V31, P2331, DOI 10.1161/ATVBAHA.111.232728; Brown WR, 2002, J NEUROL SCI, V203, P159, DOI 10.1016/S0022-510X(02)00283-6; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Chung PW, 2010, CEREBROVASC DIS, V30, P65, DOI 10.1159/000314622; Davaine JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107642; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Drueke TB, 2008, CLIN J AM SOC NEPHRO, V3, P1583, DOI 10.2215/CJN.03250708; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; Hamedani AG, 2013, NEUROLOGY, V81, P1308, DOI 10.1212/WNL.0b013e3182a8235b; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Kim J, 2013, STROKE, V44, P3547, DOI 10.1161/STROKEAHA.113.002959; Kunutsor SK, 2014, ATHEROSCLEROSIS, V236, P7, DOI 10.1016/j.atherosclerosis.2014.06.006; Leonards CO, 2012, STROKE, V43, P3046, DOI 10.1161/STROKEAHA.111.646554; Minn YK, 2014, OSTEOPOROSIS INT, V25, P2465, DOI 10.1007/s00198-014-2785-3; Monteith T, 2014, STROKE, V45, P1830, DOI 10.1161/STROKEAHA.114.005447; Park JB, 2013, EUR HEART J, V34, P920, DOI 10.1093/eurheartj/ehs419; Park SY, 2013, THROMB RES, V131, pE12, DOI 10.1016/j.thromres.2012.11.011; Ryu WS, 2010, NEUROLOGY, V75, P1995, DOI 10.1212/WNL.0b013e3181ff966a; Ryu WS, 2014, ATHEROSCLEROSIS, V232, P313, DOI 10.1016/j.atherosclerosis.2013.11.047; Sigrist MK, 2008, NEPHRON CLIN PRACT, V108, pC121, DOI 10.1159/000114202; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Vidal JS, 2010, STROKE, V41, P891, DOI 10.1161/STROKEAHA.110.579581; Wannamethee SG, 2013, ARTERIOSCL THROM VAS, V33, P1070, DOI 10.1161/ATVBAHA.112.300826; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7	31	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143355	10.1371/journal.pone.0143355	http://dx.doi.org/10.1371/journal.pone.0143355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580067	Green Submitted, gold, Green Published			2022-12-26	WOS:000365154600114
J	Yang, ZY; Dong, LM; Zhang, YS; Yang, C; Gou, SM; Li, YF; Xiong, JX; Wu, HS; Wang, CY				Yang, Zhiyong; Dong, Liming; Zhang, Yushun; Yang, Chong; Gou, Shanmiao; Li, Yongfeng; Xiong, Jiongxin; Wu, Heshui; Wang, Chunyou			Prediction of Severe Acute Pancreatitis Using a Decision Tree Model Based on the Revised Atlanta Classification of Acute Pancreatitis	PLOS ONE			English	Article							DETERMINANT-BASED CLASSIFICATION; EPIDEMIOLOGY; MANAGEMENT; SYSTEM	Objective To develop a model for the early prediction of severe acute pancreatitis based on the revised Atlanta classification of acute pancreatitis. Methods Clinical data of 1308 patients with acute pancreatitis (AP) were included in the retrospective study. A total of 603 patients who were admitted to the hospital within 36 hours of the onset of the disease were included at last according to the inclusion criteria. The clinical data were collected within 12 hours after admission. All the patients were classified as having mild acute pancreatitis (MAP), moderately severe acute pancreatitis (MSAP) and severe acute pancreatitis (SAP) based on the revised Atlanta classification of acute pancreatitis. All the 603 patients were randomly divided into training group (402 cases) and test group (201 cases). Univariate and multiple regression analyses were used to identify the independent risk factors for the development of SAP in the training group. Then the prediction model was constructed using the decision tree method, and this model was applied to the test group to evaluate its validity. Results The decision tree model was developed using creatinine, lactate dehydrogenase, and oxygenation index to predict SAP. The diagnostic sensitivity and specificity of SAP in the training group were 80.9% and 90.0%, respectively, and the sensitivity and specificity in the test group were 88.6% and 90.4%, respectively. Conclusions The decision tree model based on creatinine, lactate dehydrogenase, and oxygenation index is more likely to predict the occurrence of SAP.	[Yang, Zhiyong; Dong, Liming; Zhang, Yushun; Gou, Shanmiao; Li, Yongfeng; Xiong, Jiongxin; Wu, Heshui; Wang, Chunyou] Huazhong Univ Sci & Technol, Pancreat Dis Inst, Dept Gen Surg, Union Hosp,Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Yang, Chong] Hosp Univ Elect Sci & Technol China, Organ Transplantat Ctr, Chengdu, Sichuan, Peoples R China; [Yang, Chong] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China	Huazhong University of Science & Technology; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital	Wang, CY (corresponding author), Huazhong Univ Sci & Technol, Pancreat Dis Inst, Dept Gen Surg, Union Hosp,Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.	chunyouwang52@126.com						Acevedo-Piedra NG, 2014, CLIN GASTROENTEROL H, V12, P311, DOI 10.1016/j.cgh.2013.07.042; Augustin S, 2009, CLIN GASTROENTEROL H, V7, P1347, DOI 10.1016/j.cgh.2009.08.011; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Gao W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130412; Harrison DA, 2007, CRIT CARE MED, V35, P1703, DOI 10.1097/01.CCM.0000269031.13283.C8; Heller SJ, 1997, PANCREAS, V15, P222, DOI 10.1097/00006676-199710000-00002; Hong WD, 2011, DIGEST DIS SCI, V56, P3664, DOI 10.1007/s10620-011-1849-x; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Nawaz H, 2013, AM J GASTROENTEROL, V108, P1911, DOI 10.1038/ajg.2013.348; Rajaratnam SG, 2006, PANCREAS, V33, P27, DOI 10.1097/01.mpa.0000222315.36490.9b; Satoh K, 2011, PANCREAS, V40, P503, DOI 10.1097/MPA.0b013e318214812b; Shen HN, 2012, PANCREAS, V41, P696, DOI 10.1097/MPA.0b013e31823db941; Shen HN, 2011, PANCREAS, V40, P10, DOI 10.1097/MPA.0b013e3181f7e750; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Ueda T, 2007, SURGERY, V141, P51, DOI 10.1016/j.surg.2006.05.008; Uhl W, 2003, PANCREATOLOGY, V3, DOI 10.1159/000067684; Wu BU, 2008, GUT, V57, P1698, DOI 10.1136/gut.2008.152702; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; Zrnic Irena Krznaric, 2007, Lijec Vjesn, V129, P1	21	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143486	10.1371/journal.pone.0143486	http://dx.doi.org/10.1371/journal.pone.0143486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580397	gold, Green Published			2022-12-26	WOS:000365154600125
J	Remolina, YA; Ulloa, MM; Vargas, H; Diaz, L; Gomez, SL; Saavedra, A; Sanchez, E; Cortes, JA				Andrea Remolina, Yuly; Mercedes Ulloa, Maria; Vargas, Hernan; Diaz, Liliana; Liliana Gomez, Sandra; Saavedra, Alfredo; Sanchez, Edgar; Alberto Cortes, Jorge			Viral Infection in Adults with Severe Acute Respiratory Infection in Colombia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; TRACT INFECTIONS; INFLUENZA; VIRUSES; ILLNESS; ASSAY	Objectives To identify the viral aetiology in adult patients with severe acute respiratory infection (SARI) admitted to sentinel surveillance institutions in Bogota in 2012. Design A cross-sectional study was conducted in which microarray molecular techniques for viral identification were used on nasopharyngeal samples of adult patients submitted to the surveillance system, and further descriptions of clinical features and relevant clinical outcomes, such as mortality, need for critical care, use of mechanical ventilation and hospital stay, were obtained. Setting Respiratory infections requiring hospital admission in surveillance centres in Bogota, Colombia. Participants Ninety-one adult patients with acute respiratory infection (55% were female). Measurements Viral identification, intensive care unit admission, hospital stay, and mortality. Results Viral identification was achieved for 63 patients (69.2%). Comorbidity was frequently identified and mainly involved chronic pulmonary disease or pregnancy. Influenza, Bocavirus and Adenovirus were identified in 30.8%, 28.6% and 18.7% of the cases, respectively. Admission to the intensive care unit occurred in 42.9% of the cases, while mechanical ventilation was required for 36.3%. The average hospital stay was 9.9 days, and mortality was 15.4%. Antibiotics were empirically used in 90.1% of patients. Conclusions The prevalence of viral aetiology of SARI in this study was high, with adverse clinical outcomes, intensive care requirements and high mortality.	[Andrea Remolina, Yuly; Mercedes Ulloa, Maria; Saavedra, Alfredo; Sanchez, Edgar; Alberto Cortes, Jorge] Univ Nacl Colombia, Fac Med, Dept Internal Med, Bogota, Colombia; [Vargas, Hernan; Diaz, Liliana; Liliana Gomez, Sandra] Dist Hlth Dept, Publ Hlth Lab, Bogota, Colombia; [Alberto Cortes, Jorge] Univ Nacl Colombia, Fac Med, Infect Dis Res Grp, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia	Cortes, JA (corresponding author), Univ Nacl Colombia, Fac Med, Dept Internal Med, Bogota, Colombia.	jacortesl@unal.edu.co		Remolina Bonilla, Yuly Andrea/0000-0003-2388-5844; Cortes, Jorge/0000-0002-0882-9652	National University of Colombia [18351]	National University of Colombia	This study was supported by the National University of Colombia, grant 18351, website: http://www.dib.unal.edu.co/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tawfiq JA, 2014, LANCET INFECT DIS, V14, P992, DOI 10.1016/S1473-3099(14)70840-0; Bjarnason A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046816; Cantrell R, 2002, CLIN THER, V24, P170, DOI 10.1016/S0149-2918(02)85013-5; Clark TW, 2014, J INFECTION, V69, P507, DOI 10.1016/j.jinf.2014.07.023; CLART.PneumoVir, 2010, CAR VIR CAUS INF RES, P1; de Roux AD, 2004, CHEST, V125, P1343, DOI 10.1378/chest.125.4.1343; Falsey AR, 2013, J INFECT DIS, V208, P432, DOI 10.1093/infdis/jit190; Frobert E, 2011, J MED VIROL, V83, P150, DOI 10.1002/jmv.21932; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Kehl SC, 2009, CLIN LAB MED, V29, P661, DOI 10.1016/j.cll.2009.07.008; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Manjia R, 2014, J CLIN VIROL, V60, P90, DOI 10.1016/j.jcv.2014.03.014; Matias G, 2014, INFLUENZA OTHER RESP, V8, P507, DOI 10.1111/irv.12258; MPS INS, 2014, PROT VIG SAL PUBL IN, P1; Mulrennan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012849; Nakao A, 2014, DIAGN MICR INFEC DIS, V78, P363, DOI 10.1016/j.diagmicrobio.2013.11.005; Pavia AT, 2013, INFECT DIS CLIN N AM, V27, P157, DOI 10.1016/j.idc.2012.11.007; Radigan KA, 2011, CLIN CHEST MED, V32, P451, DOI 10.1016/j.ccm.2011.05.010; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Sultankulova K T, 2014, ScientificWorldJournal, V2014, P620580, DOI 10.1155/2014/620580; Tokman HB, 2014, CLIN LAB, V60, P1027, DOI 10.7754/Clin.Lab.2013.130731; Zaas AK, 2014, TRENDS MOL MED, V20, P579, DOI 10.1016/j.molmed.2014.08.001	28	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143152	10.1371/journal.pone.0143152	http://dx.doi.org/10.1371/journal.pone.0143152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26576054	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400047
J	Kang, SH; Jung, DJ; Lee, KY; Choi, EW; Do, JY				Kang, Seok Hui; Jung, Da Jung; Lee, Kyu Yup; Choi, Eun Woo; Do, Jun Young			Comparison of Various Anthropometric Indices as Risk Factors for Hearing Impairment in Asian Women	PLOS ONE			English	Article							BODY-MASS INDEX; DIABETES-MELLITUS; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; OLDER-ADULTS; ASSOCIATION; PREVALENCE; HEALTH; EPIDEMIOLOGY; HYPERTENSION	Background The objective of the present study was to examine the associations between various anthropometric measures and metabolic syndrome and hearing impairment in Asian women. Methods We identified 11,755 women who underwent voluntary routine health checkups at Yeungnam University Hospital between June 2008 and April 2014. Among these patients, 2,485 participants were <40 years old, and 1,072 participants lacked information regarding their laboratory findings or hearing and were therefore excluded. In total 8,198 participants were recruited into our study. Results The AUROC value for metabolic syndrome was 0.790 for the waist to hip ratio (WHR). The cutoff value was 0.939. The sensitivity and specificity for predicting metabolic syndrome were 72.7% and 71.7%, respectively. The AUROC value for hearing loss was 0.758 for WHR. The cutoff value was 0.932. The sensitivity and specificity for predicting hearing loss were 65.8% and 73.4%, respectively. The WHR had the highest AUC and was the best predictor of metabolic syndrome and hearing loss. Univariate and multivariate linear regression analyses showed that WHR levels were positively associated with four hearing thresholds including averaged hearing threshold and low, middle, and high frequency thresholds. In addition, multivariate logistic analysis revealed that those with a high WHR had a 1.347-fold increased risk of hearing loss compared with the participants with a low WHR. Conclusion Our results demonstrated that WHR may be a surrogate marker for predicting the risk of hearing loss resulting from metabolic syndrome.	[Kang, Seok Hui; Choi, Eun Woo; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Jung, Da Jung; Lee, Kyu Yup] Kyungpook Natl Univ Hosp, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital; Kyungpook National University; Kyungpook National University Hospital	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.	jydo@med.yu.ac.kr			Yeungnam University Medical Center	Yeungnam University Medical Center	This work was supported by a grant of Yeungnam University Medical Center (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, INDIAN J OTOLARYNGOL, V65, pS614, DOI 10.1007/s12070-013-0630-1; Akinpelu OV, 2014, LARYNGOSCOPE, V124, P767, DOI 10.1002/lary.24354; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; CARHART R, 1959, J SPEECH HEAR DISORD, V24, P330, DOI 10.1044/jshd.2404.330; Clark J G, 1981, ASHA, V23, P493; Cruickshanks KJ, 2015, J AM GERIATR SOC, V63, P918, DOI 10.1111/jgs.13401; Curhan SG, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.04.026; Dalton DS, 1998, DIABETES CARE, V21, P1540, DOI 10.2337/diacare.21.9.1540; de Moraes Marchiori Luciana Lozza, 2006, Braz J Otorhinolaryngol, V72, P533; El-Mansoury M, 2009, CLIN ENDOCRINOL, V71, P273, DOI 10.1111/j.1365-2265.2008.03473.x; Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1; Fukushima H, 2005, OTOLARYNG HEAD NECK, V133, P100, DOI 10.1016/j.otohns.2005.02.004; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; HARNER SG, 1981, OTOLARYNG HEAD NECK, V89, P322, DOI 10.1177/019459988108900235; Hederstierna C, 2007, ACTA OTO-LARYNGOL, V127, P149, DOI 10.1080/00016480600794446; Helzner EP, 2011, J AM GERIATR SOC, V59, P972, DOI 10.1111/j.1532-5415.2011.03444.x; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; HODGSON MJ, 1987, J OCCUP ENVIRON MED, V29, P576; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Hwang JH, 2011, CLIN ENDOCRINOL, V75, P614, DOI 10.1111/j.1365-2265.2011.04090.x; Hwang JH, 2009, OBESITY, V17, P1796, DOI 10.1038/oby.2009.66; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jennings MB, 2008, WORK, V30, P289; Kakarlapudi V, 2003, OTOL NEUROTOL, V24, P382, DOI 10.1097/00129492-200305000-00006; Kang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120372; Kishida K, 2014, BEST PRACT RES CL EN, V28, P119, DOI 10.1016/j.beem.2013.08.006; Ko KP, 2012, J EPIDEMIOL, V22, P433, DOI 10.2188/jea.JE20110164; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lee H, 2013, KOREAN J INTERN MED, V28, P456, DOI 10.3904/kjim.2013.28.4.456; Marron KH, 2014, INT J ENV RES PUB HE, V11, P7592, DOI 10.3390/ijerph110807592; Mitchell P, 2009, DIABETIC MED, V26, P483, DOI 10.1111/j.1464-5491.2009.02710.x; MORGENSTERN C, 1978, ARCH OTO-RHINO-LARYN, V220, P159, DOI 10.1007/BF00457482; NAKAE S, 1986, ARCH OTO-RHINO-LARYN, V243, P313, DOI 10.1007/BF00460208; Pacala JT, 2012, JAMA-J AM MED ASSOC, V307, P1185, DOI 10.1001/jama.2012.305; Rosenhall Ulf, 2006, Noise Health, V8, P88; Shargorodsky J, 2010, LARYNGOSCOPE, V120, P1887, DOI 10.1002/lary.21039; TACHIBANA M, 1984, ACTA OTO-LARYNGOL, V97, P257, DOI 10.3109/00016488409130987; Walling AD, 2012, AM FAM PHYSICIAN, V85, P1150; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021	42	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143119	10.1371/journal.pone.0143119	http://dx.doi.org/10.1371/journal.pone.0143119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575369	gold, Green Published, Green Submitted			2022-12-26	WOS:000365153400042
J	Kasap, M; Yegenaga, I; Akpinar, G; Tuncay, M; Aksoy, A; Karaoz, E				Kasap, Murat; Yegenaga, Itir; Akpinar, Gurler; Tuncay, Mehmet; Aksoy, Ayca; Karaoz, Erdal			Comparative Proteome Analysis of hAT-MSCs Isolated from Chronic Renal Failure Patients with Differences in Their Bone Turnover Status	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CHRONIC KIDNEY-DISEASE; METABOLIC-ACIDOSIS; ADIPOSE-TISSUE; PROTEINS; OSTEODYSTROPHY; MECHANISMS; DROSOPHILA; DIAGNOSIS; PATHWAY	The relationship between the stem cells and the bone turnover in uremic bone disease due to chronic renal failure (CRF) is not described. The aim of this study was to investigate the effect of bone turnover status on stem cell properties. To search for the presence of such link and shed some light on stem-cell relevant mechanisms of bone turnover, we carried out a study with mesenchymal stem cells. Tissue biopsies were taken from the abdominal subcutaneous adipose tissue of a CRF patient with secondary hyperparathyroidism with the high turnover bone disease. This patient underwent parathyroidectomy operation (PTX) and another sample was taken from this patient after PTX. A CRF patient with adynamic bone disease with low turnover and a healthy control were also included. Mesenchymal stem cells isolated from the subjects were analyzed using proteomic and molecular approaches. Except ALP activity, the bone turnover status did not affect common stem cell properties. However, detailed proteome analysis revealed the presence of regulated protein spots. A total of 32 protein spots were identified following 2D gel electrophoresis and MALDI-TOF/TOF analyzes. The identified proteins were classified into seven distinct groups and their potential relationship to bone turnover were discussed. Distinct protein expression patterns emerged in relation to the bone turnover status indicate a possible link between the stem cells and bone turnover in uremic bone disease due to CRF.	[Kasap, Murat; Akpinar, Gurler] Kocaeli Univ, Sch Med, DEKART Prote Lab, Dept Med Biol, Kocaeli, Turkey; [Yegenaga, Itir; Tuncay, Mehmet] Kocaeli Univ, Sch Med, Dept Internal Med, Nephrol, Kocaeli, Turkey; [Aksoy, Ayca] Kocaeli Univ, Inst Hlth Sci, Ctr Stem Cell & Gene Therapies Res & Practice, Dept Stem Cell, Kocaeli, Turkey; [Karaoz, Erdal] Liv Hosp Ctr Regenerat Med & Stem Cell Res & Mfg, Istanbul, Turkey	Kocaeli University; Kocaeli University; Kocaeli University; Ankara Liv Hospital	Yegenaga, I (corresponding author), Kocaeli Univ, Sch Med, Dept Internal Med, Nephrol, Kocaeli, Turkey.	itiryegenaga@hotmail.com	Kasap, Murat/F-7339-2018; Yegenaga, Itir/AFQ-6406-2022; Karaoz, Erdal/AAO-1470-2020; Akpınar, Gürler/F-7337-2018	Kasap, Murat/0000-0001-8527-2096; Akpınar, Gürler/0000-0002-9675-3714	Kocaeli University BAP [2011/041]	Kocaeli University BAP(Kocaeli University)	The author(s) received specific funding for this work from Kocaeli University BAP.; The authors would like to thank Dr. Gulcin Gacar for her technical assistance during flow cytometry analysis. The authors received specific funding for this work from Kocaeli University BAP Project number: 2011/041.	Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2741, DOI [10.1089/ars.2009.2683, 10.1089/ARS.2009.2683]; Akpinar G, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/457059; Amandio AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096326; Bover J, 2014, SEMIN NEPHROL, V34, P626, DOI 10.1016/j.semnephrol.2014.09.008; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; CLARKE PRR, 1975, BRIT J SURG, V62, P571, DOI 10.1002/bjs.1800620717; Cookson C, 2005, SCI AM, V293, pA6; Cozzolino M, 2005, KIDNEY INT, V68, P429, DOI 10.1111/j.1523-1755.2005.00421.x; CURTHOYS NP, 1973, J BIOL CHEM, V248, P162; DeLany JP, 2005, MOL CELL PROTEOMICS, V4, P731, DOI 10.1074/mcp.M400198-MCP200; Drueke TB, 2002, NEPHROL DIAL TRANSPL, V17, P330, DOI 10.1093/ndt/17.2.330; Ertas G, 2012, SCI WORLD J, DOI 10.1100/2012/105698; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Ferreira A, 2000, AM J MED SCI, V320, P85, DOI 10.1097/00000441-200008000-00004; Gimble JM, 2003, EXPERT OPIN BIOL TH, V3, P705, DOI 10.1517/14712598.3.5.705; Grgurevic L, 2007, INT ORTHOP, V31, P743, DOI 10.1007/s00264-007-0404-z; HONORE B, 1995, J BIOL CHEM, V270, P28780; Ibrahim H, 2008, KIDNEY INT, V73, P11, DOI 10.1038/sj.ki.5002581; Karaoz E, 2009, HISTOCHEM CELL BIOL, V132, P533, DOI 10.1007/s00418-009-0629-6; Kikuta K, 2010, PROTEOM CLIN APPL, V4, P560, DOI 10.1002/prca.200900172; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Komaba H, 2011, CLIN EXP NEPHROL, V15, P797, DOI 10.1007/s10157-011-0502-5; Lee K, 2011, J CELL MOL MED, V15, P2082, DOI 10.1111/j.1582-4934.2010.01230.x; Lopez-Flores I, 2006, AM J PHYSIOL-REG I, V291, pR1295, DOI 10.1152/ajpregu.00095.2006; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mimeault M, 2008, CLIN PHARMACOL THER, V83, P673, DOI 10.1038/sj.clpt.6100296; Mitra S, 2011, EUR J PEDIATR, V170, P1107, DOI 10.1007/s00431-011-1405-x; Moorthi RN, 2013, KIDNEY INT, V84, P886, DOI 10.1038/ki.2013.254; Ott SM, 2012, CURR OPIN NEPHROL HY, V21, P376, DOI 10.1097/MNH.0b013e32835421f6; Park HW, 2007, PROTEOMICS, V7, P2881, DOI 10.1002/pmic.200700089; Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C; Rojas-Rios P, 2014, STEM CELLS, V32, P852, DOI 10.1002/stem.1621; Shackelfold GDBL, 1975, J CAN ASSOC RADIOL, V26, P1107; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799; van Hoof D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008177; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	40	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0142934	10.1371/journal.pone.0142934	http://dx.doi.org/10.1371/journal.pone.0142934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575497	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400023
J	Kim, TB; Oh, JK; Kim, KT; Yoon, SJ; Kim, SW				Kim, Tae Beom; Oh, Jin Kyu; Kim, Kwang Taek; Yoon, Sang Jin; Kim, Soo Woong			Does the Mother or Father Determine the Offspring Sex Ratio? Investigating the Relationship between Maternal Digit Ratio and Offspring Sex Ratio	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SELECTION IN-UTERO; SON PREFERENCE; FINGER-LENGTH; NATURAL-SELECTION; TESTOSTERONE; 2ND; DOMINANCE; BIRTH; DIET	Objective In mammals, high parental testosterone levels present around the time of conception are thought to skew offspring sex ratio toward sons. The second to fourth digit ratio (digit ratio) is now widely accepted as a negative correlate of prenatal testosterone. Thus, we investigated the association between digit ratio and offspring sex ratio. Methods A total of 508 Korean patients (257 males and 251 females) less than 60 years old who had one or more offspring were prospectively enrolled. The lengths of the 2nd and 4th digits of the right hand were measured by a single investigator using a digital vernier calliper. Next, the patients' lifetime offspring birth sex ratios were investigated. Results Maternal (rather than paternal) digit ratio was significantly associated with the number of sons (r = -0.153, p = 0.015), number of daughters (r = 0.130, p = 0.039), and offspring sex ratio (r = -0.171, p = 0.007). And, the maternal digit ratio was a significant factor for predicting offspring sex ratio (B = -1.620, p = 0.008) on multiple linear regression analysis. The female patients with a lower digit ratio (< 0.95) were found to have a higher offspring sex ratio (0.609 versus 0.521, p = 0.046) compared to those with a higher digit ratio (>= 0.95). Furthermore, females in the low digit ratio group have a probability 1.138 greater of having sons than females in the high digit ratio group. Conclusions Maternal digit ratio was negatively associated with offspring sex ratio. Females with a lower digit ratio were more likely to have more male offspring compared to those with a higher digit ratio. Thus, our results suggest that the sex of offspring might be more influenced by maternal rather than paternal factors.	[Kim, Tae Beom; Oh, Jin Kyu; Kim, Kwang Taek; Yoon, Sang Jin] Gachon Univ, Gil Hosp, Dept Urol, Inchon, South Korea; [Kim, Soo Woong] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea	Gachon University; Seoul National University (SNU); Seoul National University Hospital	Kim, SW (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	swkim@snu.ac.kr	Oh, Jinkyu/AAK-8884-2020	Oh, Jin Kyu/0000-0002-5043-411X				Abbott AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042372; Alexenko AP, 2007, BIOL REPROD, V77, P599, DOI 10.1095/biolreprod.107.062174; Almond D, 2008, P NATL ACAD SCI USA, V105, P5681, DOI 10.1073/pnas.0800703105; Andersson R, 1998, HUM BIOL, V70, P1101; Belanger D, 2009, POP STUD-J DEMOG, V63, P163, DOI 10.1080/00324720902859380; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOUISSOU MF, 1978, HORM BEHAV, V11, P388, DOI 10.1016/0018-506X(78)90039-9; Cagnacci A, 2004, HUM REPROD, V19, P442, DOI 10.1093/humrep/deh071; Cameron EZ, 2008, P ROY SOC B-BIOL SCI, V275, P323, DOI 10.1098/rspb.2007.1401; Cameron EZ, 2007, BIOL LETTERS, V3, P395, DOI 10.1098/rsbl.2007.0089; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Catalano R, 2013, AM J HUM BIOL, V25, P555, DOI 10.1002/ajhb.22414; Catalano RA, 2012, AM J HUM BIOL, V24, P526, DOI 10.1002/ajhb.22265; Catalano R, 2009, PAEDIATR PERINAT EP, V23, P273, DOI 10.1111/j.1365-3016.2009.01028.x; Catalano RA, 2009, J THEOR BIOL, V257, P475, DOI 10.1016/j.jtbi.2008.12.008; Christiansen K., 1998, TESTOSTERONE, P107, DOI DOI 10.1017/CBO9780511545221.005; Chun Heeran, 2009, J Prev Med Public Health, V42, P143, DOI 10.3961/jpmph.2009.42.2.143; Chung WJ, 2007, POPUL DEV REV, V33, P757, DOI 10.1111/j.1728-4457.2007.00196.x; Chung W, 2007, J BIOSOC SCI, V39, P707, DOI 10.1017/s0021932007001988; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Coates JM, 2009, P NATL ACAD SCI USA, V106, P623, DOI 10.1073/pnas.0810907106; Dean A, 2013, J CLIN ENDOCR METAB, V98, P2230, DOI 10.1210/jc.2012-4057; Ein-Mor E, 2010, FERTIL STERIL, V93, P1961, DOI 10.1016/j.fertnstert.2008.12.036; Ellis L, 2004, SOC SCI INFORM, V43, P115, DOI 10.1177/05390184040708; Fellman J, 2010, TWIN RES HUM GENET, V13, P101, DOI 10.1375/twin.13.1.101; Fountain ED, 2008, BIOL REPROD, V78, P211, DOI 10.1095/biolreprod.107.065003; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Fukuda M, 2011, HUM REPROD, V26, P2589, DOI 10.1093/humrep/der206; Fukuda M, 2011, HUM REPROD, V26, P1551, DOI 10.1093/humrep/der107; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Garcia-Herreros M, 2010, REPROD FERT DEVELOP, V22, P533, DOI 10.1071/RD09157; GARN SM, 1975, AM J PHYS ANTHROPOL, V43, P327, DOI 10.1002/ajpa.1330430305; Gibson MA, 2003, P ROY SOC B-BIOL SCI, V270, pS108, DOI 10.1098/rsbl.2003.0031; Graffelman J, 2000, HUM BIOL, V72, P433; Grant VJ, 2008, BIOL REPROD, V78, P812, DOI 10.1095/biolreprod.107.066050; Grant VJ, 2007, J THEOR BIOL, V246, P708, DOI 10.1016/j.jtbi.2007.02.005; Grant VJ, 2010, REPRODUCTION, V140, P425, DOI 10.1530/REP-10-0137; Grant VJ, 2008, EVOL PSYCHOL-US, V6, P147; Grant VJ, 2009, J THEOR BIOL, V258, P38, DOI 10.1016/j.jtbi.2009.01.013; Grant VJ, 2005, J EXP ZOOL PART A, V303A, P1120, DOI 10.1002/jez.a.233; Grant VJ, 2001, BIOL PSYCHOL, V58, P41, DOI 10.1016/S0301-0511(01)00100-4; GRANT VJ, 1994, BRIT J MED PSYCHOL, V67, P343, DOI 10.1111/j.2044-8341.1994.tb01802.x; Grant VJ, 1996, HUM REPROD, V11, P2371; Green MP, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-21; Helle S, 2008, AM J HUM BIOL, V20, P700, DOI 10.1002/ajhb.20796; Helle S, 2008, ANIM BEHAV, V75, P1031, DOI 10.1016/j.anbehav.2007.08.015; Helle S, 2011, HUM REPROD, V26, P2588, DOI 10.1093/humrep/der204; Hesketh T, 2011, EARLY HUM DEV, V87, P759, DOI 10.1016/j.earlhumdev.2011.08.016; Hollier LP, 2015, EARLY HUM DEV, V91, P111, DOI 10.1016/j.earlhumdev.2014.12.011; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; Jung H, 2011, BJU INT, V107, P591, DOI 10.1111/j.1464-410X.2010.09490.x; Kalichman L, 2013, AM J HUM BIOL, V25, P617, DOI 10.1002/ajhb.22420; Kim DS, 2004, POPULATION, V59, P983, DOI 10.2307/3654940; Kim TB, 2012, BJU INT, V110, pE857, DOI 10.1111/j.1464-410X.2012.11343.x; Kimura K, 2005, MOL REPROD DEV, V72, P201, DOI 10.1002/mrd.20342; Kimura K, 2008, ANIM REPROD SCI, V103, P228, DOI 10.1016/j.anireprosci.2006.12.014; KRACKOW S, 1995, J THEOR BIOL, V176, P273, DOI 10.1006/jtbi.1995.0197; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; MACMAHON B, 1954, AM J HUM GENET, V6, P284; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2007, ARCH SEX BEHAV, V36, P223, DOI 10.1007/s10508-007-9171-6; Manning JT, 2011, AM J HUM BIOL, V23, P527, DOI 10.1002/ajhb.21186; Manning JT, 2002, J THEOR BIOL, V217, P93, DOI 10.1006/jtbi.2002.3014; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 2002, DIGIT RATIO A POINTE, P33; Matchock RL, 2008, AM J HUM BIOL, V20, P487, DOI 10.1002/ajhb.20763; Mathews F, 2008, P ROY SOC B-BIOL SCI, V275, P1661, DOI 10.1098/rspb.2008.0105; Matsuo K, 2009, J OBSTET GYNAECOL RE, V35, P164, DOI 10.1111/j.1447-0756.2008.00836.x; Miller BD, 2001, AM ANTHROPOL, V103, P1083, DOI 10.1525/aa.2001.103.4.1083; Mittwoch U, 1996, HUM REPROD, V11, P8; MITTWOCH U, 1989, J THEOR BIOL, V137, P445, DOI 10.1016/S0022-5193(89)80039-6; Nidadavolu V, 2006, REPROD HEALTH MATTER, V14, P160, DOI 10.1016/S0968-8080(06)27228-8; Oh JK, 2012, INT BRAZ J UROL, V38, P611, DOI 10.1590/S1677-55382012000500005; PARK CB, 1995, POPUL DEV REV, V21, P59, DOI 10.2307/2137413; PERGAMENT E, 1994, HUM REPROD, V9, P1730, DOI 10.1093/oxfordjournals.humrep.a138783; Perret M, 2005, HUM REPROD, V20, P1504, DOI 10.1093/humrep/deh802; Peters M, 2002, AM J PHYS ANTHROPOL, V117, P209, DOI 10.1002/ajpa.10029; PHELPS VR, 1952, AM J HUM GENET, V4, P72; RAY PF, 1995, J REPROD FERTIL, V104, P165; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Rueness J, 2012, HUM REPROD, V27, P283, DOI 10.1093/humrep/der347; Shargal D, 2008, THERIOGENOLOGY, V69, P673, DOI 10.1016/j.theriogenology.2007.11.017; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; Tamimi RM, 2003, BRIT MED J, V326, P1245, DOI 10.1136/bmj.326.7401.1245; Torche F, 2012, HUM REPROD, V27, P558, DOI 10.1093/humrep/der390; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Ventura T, 2013, EARLY HUM DEV, V89, P107, DOI 10.1016/j.earlhumdev.2012.08.009; Wells JCK, 2000, J THEOR BIOL, V202, P65, DOI 10.1006/jtbi.1999.1044; Westley S. B., 2007, ASIA PACIFIC ISSUES, V84, P1; Williams TJ, 2000, NATURE, V404, P455, DOI 10.1038/35006555; Zhou C, 2012, INT J PUBLIC HEALTH, V57, P459, DOI 10.1007/s00038-011-0267-3	94	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143054	10.1371/journal.pone.0143054	http://dx.doi.org/10.1371/journal.pone.0143054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575995	Green Submitted, Green Published, gold			2022-12-26	WOS:000365153400036
J	Payne, L; Heard, PJ; Scott, TB				Payne, Liam; Heard, Peter J.; Scott, Thomas B.			A Study of the Oxidation Behaviour of Pile Grade A (PGA) Nuclear Graphite Using Thermogravimetric Analysis (TGA), Scanning Electron Microscopy (SEM) and X-Ray Tomography (XRT)	PLOS ONE			English	Article							IRRADIATED GRAPHITE; THERMAL-OXIDATION; METAL-OXIDES; C-14; CARBON; GAS; AIR; TEMPERATURES; MANAGEMENT; KINETICS	Pile grade A (PGA) graphite was used as a material for moderating and reflecting neutrons in the UK's first generation Magnox nuclear power reactors. As all but one of these reactors are now shut down there is a need to understand the residual state of the material prior to decommissioning of the cores, in particular the location and concentration of key radio-contaminants such as C-14. The oxidation behaviour of unirradiated PGA graphite was studied, in the temperature range 600-1050 degrees C, in air and nitrogen using thermogravimetric analysis, scanning electron microscopy and X-ray tomography to investigate the possibility of using thermal degradation techniques to examine C-14 distribution within irradiated material. The thermal decomposition of PGA graphite was observed to follow the three oxidation regimes historically identified by previous workers with limited, uniform oxidation at temperatures below 600 degrees C and substantial, external oxidation at higher temperatures. This work demonstrates that the different oxidation regimes of PGA graphite could be developed into a methodology to characterise the distribution and concentration of C-14 in irradiated graphite by thermal treatment.	[Payne, Liam; Heard, Peter J.; Scott, Thomas B.] Univ Bristol, Interface Anal Ctr, Bristol BS8 1TL, Avon, England	University of Bristol	Payne, L (corresponding author), Univ Bristol, Interface Anal Ctr, Bristol BS8 1TL, Avon, England.	Liam.Payne@bristol.ac.uk	Heard, Peter J/C-2155-2008	Heard, Peter J/0000-0002-8926-4680	Engineering and Physical Sciences Research council; Radioactive Waste Management [EP/I036354/1]; EPSRC [EP/I036354/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I036354/1] Funding Source: researchfish	Engineering and Physical Sciences Research council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Radioactive Waste Management; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was primarily supported by joint funding from the Engineering and Physical Sciences Research council and Radioactive Waste Management under the contract GeoWaste EP/I036354/1. The funders had no role in study design, data collection and analysis associated with the paper. RWM did review the paper prior to submission.	Babout L, 2008, ACTA MATER, V56, P4242, DOI 10.1016/j.actamat.2008.04.045; Babout L, 2006, SCRIPTA MATER, V54, P829, DOI 10.1016/j.scriptamat.2005.11.028; Babout L, 2005, CARBON, V43, P765, DOI 10.1016/j.carbon.2004.11.002; Baston GMN, 2012, MINERAL MAG, V76, P3293, DOI 10.1180/minmag.2012.076.8.42; Berre C, 2006, J NUCL MATER, V352, P1, DOI 10.1016/j.jnucmat.2006.02.037; Berre C, 2008, J NUCL MATER, V381, P1, DOI 10.1016/j.jnucmat.2008.07.021; Brown TC, 1992, P COMBUST INST, V24, P1199; Burcl R., 2006, IAEATECDOC1521; CABRERA AL, 1981, CHEM PHYS LETT, V81, P402, DOI 10.1016/0009-2614(81)85638-2; CHANG HW, 1978, CARBON, V16, P17, DOI 10.1016/0008-6223(78)90109-4; Chi SH, 2008, J NUCL MATER, V381, P98, DOI 10.1016/j.jnucmat.2008.08.001; Choi WK, 2011, NUCL ENG DES, V241, P82, DOI 10.1016/j.nucengdes.2010.10.007; Contescu CI, 2008, J NUCL MATER, V381, P15, DOI 10.1016/j.jnucmat.2008.07.020; CULLIS CF, 1964, T FARADAY SOC, V60, P141, DOI 10.1039/tf9646000141; Delanny F, 1983, AM CHEM SOC NAT M SE; Dunzik-Gougar ML, 2014, J NUCL MATER, V451, P328, DOI 10.1016/j.jnucmat.2014.03.018; El-Genk MS, 2012, J NUCL MATER, V420, P141, DOI 10.1016/j.jnucmat.2011.09.027; El-Genk MS, 2011, J NUCL MATER, V411, P193, DOI 10.1016/j.jnucmat.2011.01.129; Ellis AT, 2007, ROY SOC CH, P3; Fachinger J, 2008, NUCL ENG DES, V238, P3086, DOI 10.1016/j.nucengdes.2008.02.010; Fuller L, 1997, J NUCL MATER, V240, P241, DOI 10.1016/S0022-3115(96)00462-X; GLENDENIN LE, 1948, NUCLEONICS, V2, P12; Hagos B, 2010, DIAMOND 10 C DEC IMM; HAWTIN P, 1964, CARBON, V2, P299, DOI 10.1016/0008-6223(64)90044-2; HEINTZ EA, 1966, CARBON, V4, P473, DOI 10.1016/0008-6223(66)90062-5; Hinssen HK, 2008, NUCL ENG DES, V238, P3018, DOI 10.1016/j.nucengdes.2008.02.013; Kelly B. T, 2000, IAEATECDOC1154; Kim ES, 2006, J NUCL MATER, V348, P174, DOI 10.1016/j.jnucmat.2005.09.018; Kim HR, 2011, PROGR NUCL SCI TECHN, V1, P412, DOI [10.15669/pnst.1.412, DOI 10.15669/PNST.1.412]; KOSIBA WL, 1957, ADV CATAL, V9, P398; LaBrier D, 2014, J NUCL MATER, V448, P113, DOI 10.1016/j.jnucmat.2014.01.041; Lang M, 1967, 8 BIENN CARB C BUFF; Lee JJ, 2013, J NUCL MATER, V438, P77, DOI 10.1016/j.jnucmat.2013.03.002; Lim YS, 2008, J NUCL MATER, V374, P123, DOI 10.1016/j.jnucmat.2007.07.015; Luo X, 2008, FRONTIERS ENERGY POW, V2, P471, DOI [10.1007/s11708-008-0074-6, DOI 10.1007/S11708-008-0074-6]; Luo XW, 2004, NUCL ENG DES, V227, P273, DOI 10.1016/j.nucengdes.2003.11.004; MCKEE DW, 1970, CARBON, V8, P623, DOI 10.1016/0008-6223(70)90055-2; MOORMANN R, 1994, J NUCL MATER, V212, P1178, DOI 10.1016/0022-3115(94)91017-0; Moskovic R, 2013, NUCL ENG DES, V263, P431, DOI 10.1016/j.nucengdes.2013.05.011; Nuclear Decommissioning Authority, 2013, SMSTSD1HAW6002A NUCL; Nuclear Decommissioning Authority, 2012, 16495644 NDA; Nuclear Decommissioning Authority, 2012, NDARWMD092; Nuclear Decommissioning Authority, 2014, NDASTSTY140010; O'Brien MH, 1988, EGGFSP8255 OSTI; PIIPER J, 1980, RESP PHYSIOL, V41, P233, DOI 10.1016/0034-5687(80)90073-0; Propp WA, 1998, DOE SNF REP 018; SAMPATH S, 1988, CARBON, V26, P129, DOI 10.1016/0008-6223(88)90029-2; SAMPATH S, 1985, THERMOCHIM ACTA, V86, P7, DOI 10.1016/0040-6031(85)87028-3; Shichao Z, 1996, TSINGHUA SCI TECHNOL, V1, P50; Smith TE, 2013, NUCL ENG TECHNOL, V45, P211, DOI 10.5516/NET.06.2012.025; Srinivasan M, 2011, ANL1104; Vulpius D, 2013, NUCL ENG DES, V265, P294, DOI 10.1016/j.nucengdes.2013.09.007; Wang P, 2012, J NUCL MATER, V430, P229, DOI 10.1016/j.jnucmat.2012.07.015; Wood C, 2006, EPRI1013091; Yim MS, 2006, PROG NUCL ENERG, V48, P2, DOI 10.1016/j.pnucene.2005.04.002; ZHERDEV FF, 1992, J NUCL MATER, V189, P333, DOI 10.1016/0022-3115(92)90386-Y	56	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143041	10.1371/journal.pone.0143041	http://dx.doi.org/10.1371/journal.pone.0143041			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575374	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400032
J	Avitabile, SC; Nimmo, DG; Bennett, AF; Clarke, MF				Avitabile, Sarah C.; Nimmo, Dale G.; Bennett, Andrew F.; Clarke, Michael F.			Termites Are Resistant to the Effects of Fire at Multiple Spatial Scales	PLOS ONE			English	Article							SUBTERRANEAN TERMITES; LONG-TERM; CONSERVATION; BIODIVERSITY; DIVERSITY; MANAGEMENT; BIRDS; ASSEMBLAGES; COMMUNITIES; VEGETATION	Termites play an important ecological role in many ecosystems, particularly in nutrient-poor arid and semi-arid environments. We examined the distribution and occurrence of termites in the fire-prone, semi-arid mallee region of south-eastern Australia. In addition to periodic large wildfires, land managers use fire as a tool to achieve both asset protection and ecological outcomes in this region. Twelve taxa of termites were detected by using systematic searches and grids of cellulose baits at 560 sites, clustered in 28 landscapes selected to represent different fire mosaic patterns. There was no evidence of a significant relationship between the occurrence of termite species and time-since-fire at the site scale. Rather, the occurrence of species was related to habitat features such as the density of mallee trees and large logs (>10 cm diameter). Species richness was greater in chenopod mallee vegetation on heavier soils in swales, rather than Triodia mallee vegetation of the sandy dune slopes. At the landscape scale, there was little evidence that the frequency of occurrence of termite species was related to fire, and no evidence that habitat heterogeneity generated by fire influenced termite species richness. The most influential factor at the landscape scale was the environmental gradient represented by average annual rainfall. Although termites may be associated with flammable habitat components (e.g. dead wood), they appear to be buffered from the effects of fire by behavioural traits, including nesting underground, and the continued availability of dead wood after fire. There is no evidence to support the hypothesis that a fine-scale, diverse mosaic of post-fire age-classes will enhance the diversity of termites. Rather, termites appear to be resistant to the effects of fire at multiple spatial scales.	[Avitabile, Sarah C.; Clarke, Michael F.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic 3086, Australia; [Nimmo, Dale G.; Bennett, Andrew F.] Deakin Univ, Sch Life & Environm Sci, Bundoora, Vic 3125, Australia	La Trobe University; Deakin University	Avitabile, SC (corresponding author), La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic 3086, Australia.	scavitabile@gmail.com			Parks Victoria; Department of Sustainability and Environment (Vic); Mallee Catchment Management Authority; NSW National Parks and Wildlife Service; Department of Environment and Climate Change (NSW); Lower Murray Darling Catchment Management Authority; Department for Environment and Heritage (SA); Land and Water Australia; Natural Heritage Trust; Birdlife Australia (Gluepot Reserve); Australian Wildlife Conservancy (Scotia Sanctuary); Murray Mallee Partnership	Parks Victoria; Department of Sustainability and Environment (Vic); Mallee Catchment Management Authority; NSW National Parks and Wildlife Service; Department of Environment and Climate Change (NSW); Lower Murray Darling Catchment Management Authority; Department for Environment and Heritage (SA); Land and Water Australia; Natural Heritage Trust; Birdlife Australia (Gluepot Reserve); Australian Wildlife Conservancy (Scotia Sanctuary); Murray Mallee Partnership	This study is part of a larger research project, the Mallee Fire and Biodiversity Project, which received funding and support from: Parks Victoria (http://parkweb.vic.gov.au); Department of Sustainability and Environment (Vic) (http://www.dse.vic.gov.au); Mallee Catchment Management Authority (http://www.malleecma.vic.gov.au); NSW National Parks and Wildlife Service (http://www.nationalparks.nsw.gov.au); Department of Environment and Climate Change (NSW) (http://www.environment.nsw.gov.au); Lower Murray Darling Catchment Management Authority (http://murray.lls.nsw.gov.au/home); Department for Environment and Heritage (SA) (http://www.environment.sa.gov.au/Home); Land and Water Australia (http://lwa.gov.au); Natural Heritage Trust (http://www.nationaltrust.org.au/natural-heritage); Birdlife Australia (Gluepot Reserve) (http://www.birdlife.org.au); Australian Wildlife Conservancy (Scotia Sanctuary) (http://www.australianwildlife.org); and Murray Mallee Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abensperg-Traun Max, 1996, Pacific Conservation Biology, V2, P279; ABENSPERGTRAUN M, 1995, AUST J ECOL, V20, P413, DOI 10.1111/j.1442-9993.1995.tb00557.x; Andersen AN, 2014, J APPL ECOL, V51, P1406, DOI 10.1111/1365-2664.12307; [Anonymous], 2010, R LANG ENV STAT COMP; Avitabile SC, 2013, LANDSCAPE URBAN PLAN, V117, P81, DOI 10.1016/j.landurbplan.2013.04.017; Barton K., 2014, MUMIN MULTIMODEL INF; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; BRADSTOCK RA, 1995, J APPL ECOL, V32, P76, DOI 10.2307/2404417; Bradstock RA, 2005, WILDLIFE RES, V32, P409, DOI 10.1071/WR02114; Bradstock Ross A., 2002, P238; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clarke MF, 2010, AUST J BOT, V58, P363, DOI 10.1071/BT10051; Costa GC, 2008, CAN J ZOOL, V86, P1, DOI 10.1139/Z07-107; Davies AB, 2014, ECOGRAPHY, V37, P852, DOI 10.1111/ecog.00532; Davies AB, 2012, J APPL ECOL, V49, P422, DOI 10.1111/j.1365-2664.2012.02107.x; Davies AB, 2010, AUSTRAL ECOL, V35, P482, DOI 10.1111/j.1442-9993.2010.02124.x; Davies RG, 2003, J BIOGEOGR, V30, P847, DOI 10.1046/j.1365-2699.2003.00883.x; Davies RG, 1997, J TROP ECOL, V13, P153, DOI 10.1017/S0266467400010348; Dawes-Gromadzki TZ, 2007, AUSTRAL ECOL, V32, P663, DOI 10.1111/j.1442-9993.2007.01752.x; DeSouza O, 2003, SOCIOBIOLOGY, V42, P639; Elkin CM, 2008, AM NAT, V172, P563, DOI 10.1086/590962; Farnsworth LM, 2014, DIVERS DISTRIB, V20, P663, DOI 10.1111/ddi.12181; Fischer J, 2004, J APPL ECOL, V41, P32, DOI 10.1111/j.1365-2664.2004.00869.x; Galbiati C, 2005, SOCIOBIOLOGY, V45, P925; Gill A. M., 1975, Australian Forestry, V38, P4; Goldingay RL, 2009, WILDLIFE RES, V36, P394, DOI 10.1071/WR08172; Gosper CR, 2013, AUST J BOT, V61, P11, DOI 10.1071/BT12212; Hanula JL, 2012, FORESTS, V3, P317, DOI 10.3390/f3020317; Haslem A, 2011, J APPL ECOL, V48, P247, DOI 10.1111/j.1365-2664.2010.01906.x; Haslem A, 2010, LANDSCAPE URBAN PLAN, V97, P296, DOI 10.1016/j.landurbplan.2010.07.002; JOCQUE R, 1992, J NAT HIST, V26, P1405, DOI 10.1080/00222939200770781; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones DT, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P477, DOI 10.1007/978-90-481-3977-4_17; Jones DT, 2000, J APPL ECOL, V37, P191, DOI 10.1046/j.1365-2664.2000.00464.x; Keith David A., 2002, P401; Kelly LT, 2012, J APPL ECOL, V49, P412, DOI 10.1111/j.1365-2664.2012.02124.x; Kelly LT, 2011, DIVERS DISTRIB, V17, P462, DOI 10.1111/j.1472-4642.2011.00754.x; Land Conservation Council, 1987, REP MALL AR REV; LEE KE, 1971, PEDOBIOLOGIA, V11, P376; Lindenmayer DB, 2014, DIVERS DISTRIB, V20, P467, DOI 10.1111/ddi.12172; Lindenmayer DB, 1996, WILDLIFE RES, V23, P531, DOI 10.1071/WR9960531; Luck GW, 2002, BIOL CONSERV, V105, P383, DOI 10.1016/S0006-3207(01)00222-1; Maravalhas J, 2014, J APPL ECOL; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NASH MH, 1995, BIOL FERT SOILS, V19, P15, DOI 10.1007/BF00336340; Nimmo DG, 2013, CONSERV BIOL, V27, P345, DOI 10.1111/j.1523-1739.2012.01958.x; Nimmo DG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1062, DOI 10.1111/j.1466-8238.2011.00747.x; Noble JC, 2009, J ARID ENVIRON, V73, P113, DOI 10.1016/j.jaridenv.2008.08.004; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Parr CL, 2004, J APPL ECOL, V41, P630, DOI 10.1111/j.0021-8901.2004.00920.x; Pastro LA, 2014, GLOBAL ECOL BIOGEOGR, V23, P1146, DOI 10.1111/geb.12195; Perry D.H., 1972, Western Australian Naturalist, V12, P52; Peterson CJ, 2008, ENTOMOL EXP APPL, V126, P78, DOI 10.1111/j.1570-7458.2007.00638.x; Sandell Peter, 2006, Proceedings of the Royal Society of Victoria, V118, P395; Serong M, 2008, AUST J BOT, V56, P220, DOI 10.1071/BT06148; Spiesman BJ, 2008, LANDSCAPE ECOL, V23, P313, DOI 10.1007/s10980-007-9186-3; Taylor RS, 2013, BIOL CONSERV, V159, P248, DOI 10.1016/j.biocon.2012.12.005; Taylor RS, 2012, DIVERS DISTRIB, V18, P519, DOI 10.1111/j.1472-4642.2011.00842.x; Watson SJ, 2012, ECOL APPL, V22, P685, DOI 10.1890/11-0850.1; Whitford WG, 2000, INVERTEBRATES AS WEB-MASTERS IN ECOSYSTEMS, P25, DOI 10.1079/9780851993942.0025; WHITFORD WG, 1982, OECOLOGIA, V55, P298, DOI 10.1007/BF00376915; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S., 2014, GAMM4 GEN ADDITIVE M; Zuur AF, 2009, STAT BIOL HLTH, P269	68	19	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0140114	10.1371/journal.pone.0140114	http://dx.doi.org/10.1371/journal.pone.0140114			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571383	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700001
J	Bhagwat, RM; Dholakia, BB; Kadoo, NY; Balasundaran, M; Gupta, VS				Bhagwat, Rasika M.; Dholakia, Bhushan B.; Kadoo, Narendra Y.; Balasundaran, M.; Gupta, Vidya S.			Two New Potential Barcodes to Discriminate Dalbergia Species	PLOS ONE			English	Article							PLANT DNA BARCODES; NUCLEAR RIBOSOMAL DNA; MEDICINAL-PLANTS; IDENTIFICATION; GENUS; DELIMITATION; FABACEAE; ITS1; TREE	DNA barcoding enables precise identification of species from analysis of unique DNA sequence of a target gene. The present study was undertaken to develop barcodes for different species of the genus Dalbergia, an economically important timber plant and is widely distributed in the tropics. Ten Dalbergia species selected from the Western Ghats of India were evaluated using three regions in the plastid genome (matK, rbcL, trnH-psbA), a nuclear transcribed spacer (nrITS) and their combinations, in order to discriminate them at species level. Five criteria: (i) inter and intraspecific distances, (ii) Neighbor Joining (NJ) trees, (iii) Best Match (BM) and Best Close Match (BCM), (iv) character based rank test and (v) Wilcoxon signed rank test were used for species discrimination. Among the evaluated loci, rbcL had the highest success rate for amplification and sequencing (97.6%), followed by matK (97.0%), trnH-psbA (94.7%) and nrITS (80.5%). The inter and intraspecific distances, along with Wilcoxon signed rank test, indicated a higher divergence for nrITS. The BM and BCM approaches revealed the highest rate of correct species identification (100%) with matK, matK+rbcL and matK+trnH-psb loci. These three loci, along with nrITS, were further supported by character based identification method. Considering the overall performance of these loci and their ranking with different approaches, we suggest matK and matK+rbcL as the most suitable barcodes to unambiguously differentiate Dalbergia species. These findings will potentially be helpful in delineating the various species of Dalbergia genus, as well as other related genera.	[Bhagwat, Rasika M.; Dholakia, Bhushan B.; Kadoo, Narendra Y.; Gupta, Vidya S.] CSIR Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Grp, Pune, Maharashtra, India; [Balasundaran, M.] Kerala Forest Res Inst, Forest Genet & Biotechnol Div, Trichur, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Gupta, VS (corresponding author), CSIR Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Grp, Pune, Maharashtra, India.	vs.gupta@ncl.res.in			Department of Biotechnology, New Delhi [GAP267426]; CSIR [BSC0106]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank the Department of Biotechnology, New Delhi (project code GAP267426) and the CSIR (project code BSC0106) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT VA, 1994, ANN MO BOT GARD, V81, P534, DOI 10.2307/2399902; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Arif M, 2009, PLANT MOL BIOL REP, V27, P488, DOI 10.1007/s11105-009-0097-0; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bakshi Meena, 2011, Journal of Forestry Research (Harbin), V22, P393, DOI 10.1007/s11676-011-0183-7; Baldwin BG, 1992, MOL PHYLOGENET EVOL, V1, P3, DOI 10.1016/1055-7903(92)90030-K; Bentham G, 1860, J P LINNEAN SOC BO S, VIV, P1, DOI DOI 10.1111/J.1095-8339.1860.TB02464.X; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Campbell CS, 2005, MOL PHYLOGENET EVOL, V35, P165, DOI 10.1016/j.ympev.2004.11.010; Carvalho Ad, 1989, SYSTEMATIC STUDIES G; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen R, 2013, SYST ENTOMOL, V38, P615, DOI 10.1111/syen.12018; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; DeCarvalho AM, 1997, BRITTONIA, V49, P87, DOI 10.2307/2807701; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Han JP, 2012, J SYST EVOL, V50, P227, DOI 10.1111/j.1759-6831.2012.00184.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hiremath SC, 2004, CARYOLOGIA, V57, P367, DOI 10.1080/00087114.2004.10589418; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lavin M, 2001, AM J BOT, V88, P503, DOI 10.2307/2657116; Little DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081008; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Mohana GS, 2001, AM J BOT, V88, P1181, DOI 10.2307/3558328; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nithaniyal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107669; Niyomdham C, 2002, THAILAND FOREST B BO, V30, P124; Padhye A, 2013, J THREAT TAXA; PALMER J. D., 1985, MONOGRAPHS EVOLUTION, P131, DOI DOI 10.1007/978-1-4684-4988-4_3; Pang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048833; Parveen I, 2012, MOL ECOL RESOUR, V12, P82, DOI 10.1111/j.1755-0998.2011.03071.x; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Phong DT, 2014, ASIAN J APPL SCI, V02, P116; Prain D., 1904, ANN ROYAL BOT GARDEN, V10, P1; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Ribeiro RA, 2005, ANN BOT-LONDON, V95, P1171, DOI 10.1093/aob/mci128; Ribeiro RA, 2007, SYST BOT, V32, P762, DOI 10.1600/036364407783390700; Richards E, 1994, CURR PROTOC MOL BIOL, V1; Rout GR, 2003, BIODIVERS CONSERV, V12, P197, DOI 10.1023/A:1021996020947; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shi LC, 2011, J SYST EVOL, V49, P261, DOI 10.1111/j.1759-6831.2011.00133.x; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Sun XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032057; Sunarno Bambang, 1997, Journal of Japanese Botany, V72, P198; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thothathri K, 1987, TAXONOMIC REVISION T; Tripathi AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057934; Vatanparast M, 2013, S AFR J BOT, V89, P143, DOI 10.1016/j.sajb.2013.07.001; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Weitschek E, 2013, MOL ECOL RESOUR, V13, P1043, DOI 10.1111/1755-0998.12073; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Zhang JM, 2009, SCI CHINA SER C, V52, P568, DOI 10.1007/s11427-009-0069-5	66	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142965	10.1371/journal.pone.0142965	http://dx.doi.org/10.1371/journal.pone.0142965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569490	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700106
J	Guan, X; Jin, YH; Chen, YG; Jiang, Z; Liu, Z; Zhao, ZX; Yan, P; Wang, GY; Wang, XS				Guan, Xu; Jin, Yinghu; Chen, Yinggang; Jiang, Zheng; Liu, Zheng; Zhao, Zhixun; Yan, Peng; Wang, Guiyu; Wang, Xishan			The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study	PLOS ONE			English	Article							SUBSEQUENT PRIMARY CANCERS; COLORECTAL-CANCER; RACIAL DISPARITIES; RISK; MORTALITY; CARCINOMA; RATES; YOUNG; SURVIVAL; TRENDS	Background With the expanding population of colorectal cancer (CRC) survivors in the United States, one concerning issue is the risk of developing second primary malignancies (SPMs) for these CRC survivors. The present study attempts to identify the incidence characteristics of SPMs after diagnosis of first primary colon cancer (CC) and rectal cancer (RC). Methods 189,890 CC and 83,802 RC cases were identified from Surveillance, Epidemiology and End Results Program (SEER) database. We performed rate analysis on incidence trend of SPMs in both CC and RC. Expected incidence rates were stratified by age, race and stage, calendar year of first CRC diagnosis and latency period since first CRC diagnosis. The standardized incidence ratios (SIRs), measure for estimating risk of SPMs, were calculated for CC and RC respectively. Results The trends of incidence of SPMs in both CC and RC were decreasing from 1992 to 2012. Both CC and RC survivors had higher risk of developing SPMs (SIRCC = 1.13; SIRRC = 1.05). For CC patients, the highest risks of SPM were cancers of small intestine (SIR = 4.03), colon (SIR = 1.87) and rectum (SIR = 1.80). For RC patients, the highest risks of SPMs were cancers of rectum (SIR = 2.88), small intestine (SIR = 2.16) and thyroid (SIR = 1.46). According to stratified analyses, we also identified incidence characteristics which were contributed to higher risk of developing SPMs, including the age between 20 and 40, American Indian/Alaska Native, localized stage, diagnosed at calendar year from 2002 to 2012 and the latency between 12 and 59 months. Conclusions Both CC and RC survivors remain at higher risk of developing SPMs. The identification of incidence characteristics of SPMs is extremely essential for continuous cancer surveillance among CRC survivors.	[Guan, Xu; Jin, Yinghu; Chen, Yinggang; Jiang, Zheng; Liu, Zheng; Zhao, Zhixun; Yan, Peng; Wang, Guiyu; Wang, Xishan] Harbin Med Univ, Dept Colorectal Surg, Affiliated Hosp 2, Harbin, Peoples R China; [Wang, Xishan] Chinese Acad Med Sci, Dept Colorectal Surg, Canc Inst & Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China	Harbin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Wang, GY (corresponding author), Harbin Med Univ, Dept Colorectal Surg, Affiliated Hosp 2, Harbin, Peoples R China.	guiywang@163.com; wxshan1208@126.com	jin, yinghu/AAI-5725-2020		National Natural Science Foundation of China [81272706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81272706).	Ahmed F, 2006, CANCER, V107, P1162, DOI 10.1002/cncr.22013; Bosetti C, 2011, INT J CANCER, V129, P180, DOI 10.1002/ijc.25653; Buiatti E, 1997, EUR J CANCER, V33, P1829, DOI 10.1016/S0959-8049(97)00173-1; Chatenoud L, 2014, ANN ONCOL, V25, P1843, DOI 10.1093/annonc/mdu206; Cho J, 2010, CANCER CAUSE CONTROL, V21, P2203, DOI DOI 10.1007/S10552-010-; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Deng G, 2008, EUR J CANCER, V44, P1290, DOI 10.1016/j.ejca.2008.03.014; Duval S, 2015, B CANCER, V102, P665, DOI 10.1016/j.bulcan.2015.03.017; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; ENBLAD P, 1990, CANCER, V65, P2091, DOI 10.1002/1097-0142(19900501)65:9<2091::AID-CNCR2820650934>3.0.CO;2-M; Evans HS, 2002, GUT, V50, P647, DOI 10.1136/gut.50.5.647; GIARDIELLO FM, 1995, EUR J CANCER, V31A, P1085, DOI 10.1016/0959-8049(95)00139-A; GIARDIELLO FM, 1993, GUT, V34, P1394, DOI 10.1136/gut.34.10.1394; Gill AA, 2014, DIS COLON RECTUM, V57, P1059, DOI 10.1097/DCR.0000000000000177; Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117; Hemminki K, 2001, CANCER EPIDEM BIOMAR, V10, P793; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lee YS, 2015, MEDICINE, V94, DOI [10.1097/MD.0000000000002079, 10.1097/MD.0000000000001079]; Lynch HT, 1996, CANCER, V78, P1149, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.3.CO;2-Q; McKay A, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-370; MECKLIN JP, 1991, CANCER, V68, P1109, DOI 10.1002/1097-0142(19910901)68:5<1109::AID-CNCR2820680535>3.0.CO;2-S; Minoo P, 2010, INT J ONCOL, V37, P707, DOI 10.3892/ijo_00000720; Murray LJ, 2015, PHYS MED BIOL, V60, P1237, DOI 10.1088/0031-9155/60/3/1237; O'Connell JB, 2004, AM J SURG, V187, P343, DOI 10.1016/j.amjsurg.2003.12.020; O'Connell JB, 2004, DIS COLON RECTUM, V47, P2064, DOI 10.1007/s10350-004-0738-1; O'Connell JB, 2003, AM SURGEON, V69, P866; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Phipps AI, 2013, CANCER-AM CANCER SOC, V119, P3140, DOI 10.1002/cncr.28076; Ringland CL, 2010, ANN ONCOL, V21, P92, DOI 10.1093/annonc/mdp288; Silber JH, 2014, ANN INTERN MED, V161, P845, DOI 10.7326/M14-0900; Sun LC, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-73; Tamas K, 2015, CANC TREAT REV; Vasen HFA, 1996, GASTROENTEROLOGY, V110, P1020, DOI 10.1053/gast.1996.v110.pm8612988; Veach E, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00239; Wu XF, 2009, CANCER PREV RES, V2, P617, DOI 10.1158/1940-6207.CAPR-09-0025	35	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143067	10.1371/journal.pone.0143067	http://dx.doi.org/10.1371/journal.pone.0143067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571301	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700128
J	Lamana, A; Lopez-Santalla, M; Castillo-Gonzalez, R; Ortiz, AM; Martin, J; Garcia-Vicuna, R; Gonzalez-Alvaro, I				Lamana, Amalia; Lopez-Santalla, Mercedes; Castillo-Gonzalez, Raquel; Maria Ortiz, Ana; Martin, Javier; Garcia-Vicuna, Rosario; Gonzalez-Alvaro, Isidoro			The Minor Allele of rs7574865 in the STAT4 Gene Is Associated with Increased mRNA and Protein Expression	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS	Objective The T allele of rs7574865 in STAT4 confers risk of developing autoimmune disorders. However, its functional significance remains unclear. Here we analyze how rs7574865 affects the transcription of STAT4 and its protein expression. Methods We studied 201 patients (80% female; median age, 54 years; median disease duration, 5.4 months) from PEARL study. Demographic, clinical, laboratory and therapeutic data were collected at each visit. IL-6 serum levels were measured by enzyme immune assay. The rs7574865 was genotyped using TaqMan probes. The expression levels of STAT4 mRNA were determined at 182 visits from 69 patients using quantitative real-time polymerase chain reaction. STAT4 protein was assessed by western blot in 62 samples from 34 patients. To determine the effect of different variables on the expression of STAT4 mRNA and protein, we performed multivariate longitudinal analyses using generalized linear models. Results After adjustment for age, disease activity and glucocorticoid dose as confounders, the presence of at least one copy of the T allele of rs7574865 was significantly associated with higher levels of STAT4 mRNA. Similarly, TT patients showed significantly higher levels of STAT4 protein than GG patients. IL-6 induced STAT4 and STAT5 phosphorylation in peripheral blood lymphocytes. Patients carrying at least one T allele of rs7574865 displayed lower levels of serum IL-6 compared to GG homozygous; by contrast the production of C-reactive protein was similar in both populations. Conclusion Our data suggest that the presence of the rs7574865 T allele enhances STAT4 mRNA transcription and protein expression. It may enhance the signaling of molecules depending on the STAT4 pathway.	[Lamana, Amalia; Castillo-Gonzalez, Raquel; Maria Ortiz, Ana; Garcia-Vicuna, Rosario; Gonzalez-Alvaro, Isidoro] Hosp Univ La Princesa, Inst Invest Sanitaria, Serv Reumatol, Madrid, Spain; [Lopez-Santalla, Mercedes] CSIC, Ctr Nacl Biotecnol, Dept Inmunol & Oncol, Madrid, Spain; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Gonzalez-Alvaro, I (corresponding author), Hosp Univ La Princesa, Inst Invest Sanitaria, Serv Reumatol, Madrid, Spain.	isidoro.ga@ser.es	LAMANA, AMALIA/I-6971-2017; Martin, Javier/B-8141-2008; Martín, María/HDL-9512-2022; de VicuÃa, Rosario Garcia/ABD-7892-2020; Lopez-Santalla, Mercedes/AAM-6451-2021; Lopez-Santalla, Mercedes/AAC-4161-2021; Martín, Javier/AAV-5209-2021; Lopez-Santalla, Mercedes/L-1335-2015	LAMANA, AMALIA/0000-0001-8779-5034; Martin, Javier/0000-0002-2202-0622; de VicuÃa, Rosario Garcia/0000-0001-9096-3780; Lopez-Santalla, Mercedes/0000-0002-8543-8743; Lopez-Santalla, Mercedes/0000-0002-8543-8743; Castillo-Gonzalez, Raquel/0000-0002-9877-2126	Instituto de Salud Carlos III [RD08/0075/0004, RD12/0009/0017, PI11/0551, RD08/0075/0011, RD12/0009/0004]; Roche	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Roche(Roche Holding)	This work was supported by grants awarded to IGA from the RETICS Program (RD08/0075/0004 and RD12/0009/0017 [RIER]) and FIS Program (PI11/0551) and to JM from RETICS Program (RD08/0075/0011 and RD12/0009/0004 [RIER]) from the Instituto de Salud Carlos III (www.isciii.es). Measurement of IL-6 levels described in this article was supported by different research grants from Roche to IGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson AK, 2009, ANN RHEUM DIS, V68, P1746, DOI 10.1136/ard.2008.097642; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ESTEVEVIVES J, 1993, J RHEUMATOL, V20, P2116; Hardin JW., 2007, GEN LINEAR MODELS EX, V2, DOI DOI 10.1016/j.marpol.2012.12.026; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kariuki SN, 2009, J IMMUNOL, V182, P34, DOI 10.4049/jimmunol.182.1.34; Korman BD, 2008, CURR ALLERGY ASTHM R, V8, P398, DOI 10.1007/s11882-008-0077-8; Lamana A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043661; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Z, 2010, ASS HLA DR4 PAD4 STA, V30, P1349; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Remoli ME, 2007, J LEUKOCYTE BIOL, V81, P355, DOI 10.1189/jlb.0506319; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Rueda B, 2009, HUM MOL GENET, V18, P2071, DOI 10.1093/hmg/ddp119	16	26	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142683	10.1371/journal.pone.0142683	http://dx.doi.org/10.1371/journal.pone.0142683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569609	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700060
J	Wang, L; Zhang, HM; He, K; Chang, Y; Yang, XD				Wang, Lei; Zhang, Huimao; He, Kan; Chang, Yan; Yang, Xiaodong			Active Contours Driven by Multi-Feature Gaussian Distribution Fitting Energy with Application to Vessel Segmentation	PLOS ONE			English	Article							3-DIMENSIONAL SHAPE KNOWLEDGE; JOINT IMAGE SEGMENTATION; LEVEL SET; MODEL; COLOR; FLOW	Active contour models are of great importance for image segmentation and can extract smooth and closed boundary contours of the desired objects with promising results. However, they cannot work well in the presence of intensity inhomogeneity. Hence, a novel region-based active contour model is proposed by taking image intensities and 'vesselness values' from local phase-based vesselness enhancement into account simultaneously to define a novel multi-feature Gaussian distribution fitting energy in this paper. This energy is then incorporated into a level set formulation with a regularization term for accurate segmentations. Experimental results based on publicly available STructured Analysis of the Retina (STARE) demonstrate our model is more accurate than some existing typical methods and can successfully segment most small vessels with varying width.	[Wang, Lei; Chang, Yan; Yang, Xiaodong] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Dept Med Imaging, Suzhou, Jiangsu, Peoples R China; [Zhang, Huimao; He, Kan] Jilin Univ, Hosp 1, Dept Radiol, Changchun 130023, Jilin, Peoples R China	Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS; Jilin University	Yang, XD (corresponding author), Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Dept Med Imaging, Suzhou, Jiangsu, Peoples R China.	xiaodong.yang@sibet.ac.cn	Wang, Lei/D-3672-2016		Chinese Academy of Sciences Research and Development Equipment Project [YZ201313, YZ201445]; Jiangsu Natural Science Foundation [BK20131171]	Chinese Academy of Sciences Research and Development Equipment Project; Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was funded by Chinese Academy of Sciences Research and Development Equipment Project (Grant No. YZ201313, YZ201445) (http://www.cas.cn/), and Jiangsu Natural Science Foundation (Grant No. BK20131171) (http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2007, LECT NOTES COMPUT SC, V4792, P495; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; Barchiesi M, 2010, MULTISCALE MODEL SIM, V8, P1715, DOI 10.1137/090773659; Brox T, 2005, LECT NOTES COMPUT SC, V3663, P109; Brox T, 2003, LECT NOTES COMPUT SC, V2756, P353; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; CASELLES V, 1993, NUMER MATH, V66, P1, DOI 10.1007/BF01385685; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Dong B, 2008, LECT NOTES COMPUT SC, V5241, P162, DOI 10.1007/978-3-540-85988-8_20; Estellers V, 2012, IEEE T IMAGE PROCESS, V21, P4722, DOI 10.1109/TIP.2012.2202674; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Guidry DL, 1998, P ANN INT IEEE EMBS, V20, P644, DOI 10.1109/IEMBS.1998.745498; Hong X, 2007, IEEE T NEURAL NETWOR, V18, P28, DOI 10.1109/TNN.2006.882812; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kim J, 2003, 2003 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL 2, PROCEEDINGS, P655; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; Lankton S, 2007, PROC SPIE, V6510, DOI 10.1117/12.709700; Lathen G, 2010, PATTERN RECOGN LETT, V31, P762, DOI 10.1016/j.patrec.2009.09.020; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Li CM, 2007, PROC CVPR IEEE, P339; Li CM, 2005, PROC CVPR IEEE, P162; Li CM, 2005, PROC CVPR IEEE, P430; Marin D, 2011, IEEE T MED IMAGING, V30, P146, DOI 10.1109/TMI.2010.2064333; Martinez-Perez ME, 2007, MED IMAGE ANAL, V11, P47, DOI 10.1016/j.media.2006.11.004; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; Mikic I, 1998, IEEE T MED IMAGING, V17, P274, DOI 10.1109/42.700739; Mylona EA, 2014, IEEE T CYBERNETICS, V44, P2757, DOI 10.1109/TCYB.2014.2315293; Paragios N, 2000, IEEE T PATTERN ANAL, V22, P415, DOI 10.1109/TPAMI.2000.845385; Piovano J, 2008, LECT NOTES COMPUT SC, V5303, P486, DOI 10.1007/978-3-540-88688-4_36; Piovano J, 2007, LECT NOTES COMPUT SC, V4485, P709; Rosenhahn B, 2007, INT J COMPUT VISION, V73, P243, DOI 10.1007/S11263-006-9965-3; Rousson M, 2004, LECT NOTES COMPUT SC, V3216, P209; Sethian JA, 2002, NATO SCI SER II-MATH, V75, P365; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Vese LA, 2002, INT J COMPUT VISION, V50, P271, DOI 10.1023/A:1020874308076; Wang HJ, 2013, INT J PATTERN RECOGN, V27, DOI 10.1142/S0218001413550082; Wang L, 2009, COMPUT MED IMAG GRAP, V33, P520, DOI 10.1016/j.compmedimag.2009.04.010; Wang L, 2009, SIGNAL PROCESS, V89, P2435, DOI 10.1016/j.sigpro.2009.03.014; Wu H, 2013, IEEE T PATTERN ANAL, V35, P1298, DOI 10.1109/TPAMI.2012.207; Yezzi A, 2000, IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, PROCEEDINGS, P12, DOI 10.1109/MMBIA.2000.852355; You XG, 2011, PATTERN RECOGN, V44, P2314, DOI 10.1016/j.patcog.2011.01.007; Zhao YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122332	42	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143105	10.1371/journal.pone.0143105	http://dx.doi.org/10.1371/journal.pone.0143105			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571031	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700135
J	Yagi, H; Ohkawara, B; Nakashima, H; Ito, K; Tsushima, M; Ishii, H; Noto, K; Ohta, K; Masuda, A; Imagama, S; Ishiguro, N; Ohno, K				Yagi, Hideki; Ohkawara, Bisei; Nakashima, Hiroaki; Ito, Kenyu; Tsushima, Mikito; Ishii, Hisao; Noto, Kimitoshi; Ohta, Kyotaro; Masuda, Akio; Imagama, Shiro; Ishiguro, Naoki; Ohno, Kinji			Zonisamide Enhances Neurite Elongation of Primary Motor Neurons and Facilitates Peripheral Nerve Regeneration In Vitro and in a Mouse Model	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; PROMOTE AXON REGENERATION; SPINAL-CORD-INJURY; N-TERMINAL KINASE; NEUROTROPHIC FACTORS; FUNCTIONAL RECOVERY; BLOOD-BRAIN; CALCIUM-CHANNEL; EXISTING DRUGS; GROWTH-FACTOR	No clinically applicable drug is currently available to enhance neurite elongation after nerve injury. To identify a clinically applicable drug, we screened pre-approved drugs for neurite elongation in the motor neuron-like NSC34 cells. We found that zonisamide, an anti-epileptic and anti-Parkinson's disease drug, promoted neurite elongation in cultured primary motor neurons and NSC34 cells in a concentration-dependent manner. The neurite-scratch assay revealed that zonisamide enhanced neurite regeneration. Zonisamide was also protective against oxidative stress-induced cell death of primary motor neurons. Zonisamide induced mRNA expression of nerve growth factors (BDNF, NGF, and neurotrophin-4/5), and their receptors (tropomyosin receptor kinase A and B). In a mouse model of sciatic nerve autograft, intragastric administration of zonisamide for 1 week increased the size of axons distal to the transected site 3.9-fold. Zonisamide also improved the sciatic function index, a marker for motor function of hindlimbs after sciatic nerve autograft, from 6 weeks after surgery. At 8 weeks after surgery, zonisamide was protective against denervation-induced muscle degeneration in tibialis anterior, and increased gene expression of Chrne, Colq, and Rapsn, which are specifically expressed at the neuromuscular junction. We propose that zonisamide is a potential therapeutic agent for peripheral nerve injuries as well as for neuropathies due to other etiologies.	[Yagi, Hideki; Ohkawara, Bisei; Nakashima, Hiroaki; Ito, Kenyu; Tsushima, Mikito; Ishii, Hisao; Noto, Kimitoshi; Ohta, Kyotaro; Masuda, Akio; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan; [Yagi, Hideki; Nakashima, Hiroaki; Ito, Kenyu; Tsushima, Mikito; Ohta, Kyotaro; Imagama, Shiro; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthoped Surg, Nagoya, Aichi 4648601, Japan; [Ishii, Hisao; Noto, Kimitoshi] Nagoya Univ, Grad Sch Med, Dept Hand Surg, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University	Ohno, K (corresponding author), Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan.	ohnok@med.nagoya-u.ac.jp	Masuda, Akio/H-6323-2012; Ohno, Kinji/H-4020-2012; Ohno, Kinji/ABD-5787-2020; Ishiguro, Naoki/I-1563-2012; 宏彰, 中島/AAM-6809-2021; IMAGAMA, Shiro/I-7419-2014	Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Ohkawara, Bisei/0000-0002-1987-458X	MEXT; MHLW; AMED of Japan	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MHLW(Ministry of Health, Labour and Welfare, Japan); AMED of Japan	This study was supported by Grants-in-Aid from the MEXT, MHLW, and AMED of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Asanuma M, 2010, ANN NEUROL, V67, P239, DOI 10.1002/ana.21885; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; Brandenberger R, 1996, J CELL BIOL, V135, P1583, DOI 10.1083/jcb.135.6.1583; Brockhausen J, 2008, DEV NEUROBIOL, V68, P1153, DOI 10.1002/dneu.20654; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Choudhury ME, 2012, EUR J PHARMACOL, V689, P72, DOI 10.1016/j.ejphar.2012.05.012; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Cui SS, 2003, BRAIN RES, V975, P229, DOI 10.1016/S0006-8993(03)02699-4; Dergham P, 2002, J NEUROSCI, V22, P6570; Dourson ML, 1996, REGUL TOXICOL PHARM, V24, P108, DOI 10.1006/rtph.1996.0116; English AW, 2013, P NATL ACAD SCI USA, V110, P16217, DOI 10.1073/pnas.1303646110; Foronda NM, 2007, REGUL TOXICOL PHARM, V47, P29, DOI 10.1016/j.yrtph.2006.08.005; Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/JNEUROSCI.4353-06.2007; Guise S, 2001, J NEUROSCI RES, V63, P257, DOI 10.1002/1097-4547(20010201)63:3<257::AID-JNR1019>3.0.CO;2-T; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Hirayama T, 2011, J NEUROLOGY RES, V1, P139, DOI DOI 10.4021/JNR59W; Jones G, 1996, P NATL ACAD SCI USA, V93, P5985, DOI 10.1073/pnas.93.12.5985; Jungnickel J, 2006, J NEUROBIOL, V66, P940, DOI 10.1002/neu.20265; Kawajiri S, 2010, NEUROSCI LETT, V481, P88, DOI 10.1016/j.neulet.2010.06.058; Kito M, 1996, SEIZURE, V5, P115; Komatsu M, 2000, EPILEPSIA, V41, P1091, DOI 10.1111/j.1528-1157.2000.tb00312.x; Kurimoto S, 2016, J TISSUE ENG REGEN M, V10, pE454, DOI 10.1002/term.1844; Marthiens W, 2005, MOL CELL NEUROSCI, V28, P715, DOI 10.1016/j.mcn.2004.12.001; Mimaki T, 1990, Med J Osaka Univ, V39, P13; Minato H, 1997, EPILEPSIA, V38, P975, DOI 10.1111/j.1528-1157.1997.tb01479.x; Murata M, 2004, CURR PHARM DESIGN, V10, P687, DOI 10.2174/1381612043453180; Nakamura M, 2013, CELL RES, V23, P70, DOI 10.1038/cr.2012.171; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Padhy BM, 2011, J POSTGRAD MED, V57, P153, DOI 10.4103/0022-3859.81870; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; PODUSLO JF, 1994, MOL BRAIN RES, V23, P157, DOI 10.1016/0169-328X(94)90222-4; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Satoh T, 2000, NEUROSCI LETT, V288, P163, DOI 10.1016/S0304-3940(00)01229-5; SCHAUF CL, 1987, BRAIN RES, V413, P185, DOI 10.1016/0006-8993(87)90168-5; Spejo AB, 2013, NEUROSCIENCE, V250, P715, DOI 10.1016/j.neuroscience.2013.07.043; SUZUKI S, 1992, EPILEPSY RES, V12, P21, DOI 10.1016/0920-1211(92)90087-A; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; TOMASELLI KJ, 1988, J NEUROSCI RES, V21, P275, DOI 10.1002/jnr.490210220; Trinkaus M, 2008, J NEUROCHEM, V105, P2535, DOI 10.1111/j.1471-4159.2008.05328.x; Tsuda Y, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-12; Uemura T, 2012, BIOCHEM BIOPH RES CO, V419, P130, DOI 10.1016/j.bbrc.2012.01.154; Wang ZY, 2011, INT J DEV NEUROSCI, V29, P415, DOI 10.1016/j.ijdevneu.2011.03.001; Witheford M, 2013, GLIA, V61, P1873, DOI 10.1002/glia.22564; Wright KT, 2014, SPINE J, V14, P1722, DOI 10.1016/j.spinee.2014.01.021; Yamamura S, 2009, NEUROPHARMACOLOGY, V57, P322, DOI 10.1016/j.neuropharm.2009.05.005; Yoshida S, 2005, EPILEPSY RES, V67, P153, DOI 10.1016/j.eplepsyres.2005.10.001	55	28	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142786	10.1371/journal.pone.0142786	http://dx.doi.org/10.1371/journal.pone.0142786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571146	Green Submitted, Green Published, gold			2022-12-26	WOS:000365070700071
J	Yonesaka, K; Takegawa, N; Satoh, T; Ueda, H; Yoshida, T; Takeda, M; Shimizu, T; Chiba, Y; Okamoto, I; Nishio, K; Tamura, T; Nakagawa, K				Yonesaka, Kimio; Takegawa, Naoki; Satoh, Taroh; Ueda, Hiroto; Yoshida, Takeshi; Takeda, Masayuki; Shimizu, Toshio; Chiba, Yasutaka; Okamoto, Isamu; Nishio, Kazuto; Tamura, Takao; Nakagawa, Kazuhiko			Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer	PLOS ONE			English	Article							CHEMOTHERAPY; PANITUMUMAB; SENSITIVITY; EXPRESSION; IRINOTECAN; RESISTANCE; INHIBITORS; GEFITINIB; TRIAL	Background Amphiregulin, a ligand of the epidermal growth factor receptor (EGFR), is associated with the efficacy of cetuximab, an antibody against EGFR, as treatment for colorectal cancer (CRC). In contrast, the HER3 ligand heregulin correlates with cetuximab resistance. In this study, we evaluated how the combined levels of circulating amphiregulin and heregulin affect clinical outcomes in patients who receive cetuximab as therapy against advanced CRC. Methods Plasma levels of amphiregulin and heregulin were measured by enzyme-linked immunosorbent assay in 50 patients with CRC in a training cohort, and in 10 patients in a validation cohort. The combined expression was then assessed with clinical outcome after receiver operating characteristics analysis. Results Overall response rate was 26%, and median progression-free survival was 110 days in the training cohort. Patients with high amphiregulin and low heregulin had significantly higher objective response rate at 58% and significantly longer progression-free survival of 216 days. This result was confirmed in the validation cohort. Conclusion A subgroup of CRC patients with high amphiregulin and low heregulin respond to cetuximab therapy better than other patients.	[Yonesaka, Kimio; Takegawa, Naoki; Ueda, Hiroto; Yoshida, Takeshi; Takeda, Masayuki; Shimizu, Toshio; Tamura, Takao; Nakagawa, Kazuhiko] Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan; [Satoh, Taroh] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Osaka, Japan; [Chiba, Yasutaka] Kinki Univ, Fac Med, Clin Res Ctr, Osaka, Japan; [Okamoto, Isamu] Kyushu Univ, Ctr Clin & Translat Res, Fukuoka 812, Japan; [Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan	Kindai University (Kinki University); Osaka University; Kindai University (Kinki University); Kyushu University; Kindai University (Kinki University)	Yonesaka, K (corresponding author), Kinki Univ, Fac Med, Dept Med Oncol, Osaka, Japan.	yonesaka@sakai.med.kindai.ac.jp	Satoh, Taroh/AAF-7913-2020; Satoh, Taroh/AAF-5193-2021	Satoh, Taroh/0000-0002-4615-2638				Andre T, 2013, ANN ONCOL, V24, P412, DOI 10.1093/annonc/mds465; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jacobs B, 2009, J CLIN ONCOL, V27, P5068, DOI 10.1200/JCO.2008.21.3744; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kawakami H, 2014, ONCOTARGET, V5, P11847, DOI 10.18632/oncotarget.2663; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vincenzi B, 2006, BRIT J CANCER, V94, P792, DOI 10.1038/sj.bjc.6603018; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Yonesaka K, 2015, ONCOGENE IN PRESS; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Yonesaka K, 2015, ANTICANCER RES, V35, P1683; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	21	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143132	10.1371/journal.pone.0143132	http://dx.doi.org/10.1371/journal.pone.0143132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569500	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700142
J	Frindte, K; Allgaier, M; Grossart, HP; Eckert, W				Frindte, Katharina; Allgaier, Martin; Grossart, Hans-Peter; Eckert, Werner			Microbial Response to Experimentally Controlled Redox Transitions at the Sediment Water Interface	PLOS ONE			English	Article							ANAEROBIC METHANE OXIDATION; RIBOSOMAL-RNA; COASTAL SEDIMENTS; LAKE STECHLIN; CARBON; BACTERIA; MARINE; OXYGEN; BIOGEOCHEMISTRY; METHANOGENESIS	The sediment-water interface of freshwater lakes is characterized by sharp chemical gradients, shaped by the interplay between physical, chemical and microbial processes. As dissolved oxygen is depleted in the uppermost sediment, the availability of alternative electron acceptors, e.g. nitrate and sulfate, becomes the limiting factor. We performed a time series experiment in a mesocosm to simulate the transition from aerobic to anaerobic conditions at the sediment-water interface. Our goal was to identify changes in the microbial activity due to redox transitions induced by successive depletion of available electron acceptors. Monitoring critical hydrochemical parameters in the overlying water in conjunction with a new sampling strategy for sediment bacteria enabled us to correlate redox changes in the water to shifts in the active microbial community and the expression of functional genes representing specific redox-dependent microbial processes. Our results show that during several transitions from oxic-heterotrophic condition to sulfate-reducing condition, nitrate-availability and the on-set of sulfate reduction strongly affected the corresponding functional gene expression. There was evidence of anaerobic methane oxidation with NOx. DGGE analysis revealed redox-related changes in microbial activity and expression of functional genes involved in sulfate and nitrite reduction, whereas methanogenesis and methanotrophy showed only minor changes during redox transitions. The combination of high-frequency chemical measurements and molecular methods provide new insights into the temporal dynamics of the interplay between microbial activity and specific redox transitions at the sediment-water interface.	[Frindte, Katharina] Univ Bonn, Dept Soil Sci, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany; [Allgaier, Martin] Berlin Ctr Genom Biodivers Res BeGenDiv, Berlin, Germany; [Grossart, Hans-Peter] Leibniz Inst Freshwater Ecol & Inland Fisheries, Stechlin, Germany; [Grossart, Hans-Peter] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Eckert, Werner] Israel Oceanog & Limnol Res, Yigal Allon Kinneret Limnol Lab, Migdal, Israel	University of Bonn; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam; Israel Oceanographic & Limnological Research Institute	Eckert, W (corresponding author), Israel Oceanog & Limnol Res, Yigal Allon Kinneret Limnol Lab, Migdal, Israel.	werner@ocean.org.il	Eckert, Werner/AAP-9335-2021	Eckert, Werner/0000-0002-2361-6911; Frindte, Katharina/0000-0002-6801-5853	German Research Foundation [GR1540/15-1]	German Research Foundation(German Research Foundation (DFG))	This study was funded by the the German Research Foundation (http://www.dfg.de/en/) (grant #: GR1540/15-1).	Adler M, 2011, LIMNOL OCEANOGR, V56, P1525, DOI 10.4319/lo.2011.56.4.1525; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Auman AJ, 2000, APPL ENVIRON MICROB, V66, P5259, DOI 10.1128/AEM.66.12.5259-5266.2000; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; BRANDES JA, 1995, J MAR RES, V53, P771, DOI 10.1357/0022240953213034; Bryant LD, 2010, LIMNOL OCEANOGR, V55, P950, DOI 10.4319/lo.2009.55.2.0950; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; CAPONE DG, 1988, LIMNOL OCEANOGR, V33, P725, DOI 10.4319/lo.1988.33.4_part_2.0725; Casper P, 2003, ADV LIMNOL, V58, P53; CHRISTENSEN PB, 1994, PLANT PHYSIOL, V105, P847, DOI 10.1104/pp.105.3.847; Conrad R, 2007, LIMNOL OCEANOGR, V52, P1393, DOI 10.4319/lo.2007.52.4.1393; Crosby LD, 2003, BIOTECHNIQUES, V34, P790, DOI 10.2144/03344rr01; Crump BC, 2007, APPL ENVIRON MICROB, V73, P6802, DOI 10.1128/AEM.00648-07; Deutzmann JS, 2011, APPL ENVIRON MICROB, V77, P4429, DOI 10.1128/AEM.00340-11; Dumont MG, 2011, ENVIRON MICROBIOL, V13, P1153, DOI 10.1111/j.1462-2920.2010.02415.x; Eckert W, 1997, WATER AIR SOIL POLL, V99, P401, DOI 10.1007/BF02406880; Eckert W, 2002, BIOGEOCHEMISTRY, V61, P291, DOI 10.1023/A:1020206511720; Ercolini D, 2004, J MICROBIOL METH, V56, P297, DOI 10.1016/j.mimet.2003.11.006; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; FRENZEL P, 1990, FEMS MICROBIOL ECOL, V73, P149, DOI 10.1016/0378-1097(90)90661-9; Frindte K, 2013, BIOGEOCHEMISTRY, V113, P423, DOI 10.1007/s10533-012-9769-1; Hakanson L, 1983, PRINCIPLES LAKE SEDI, P1983; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Hunter EM, 2006, APPL ENVIRON MICROB, V72, P5689, DOI 10.1128/AEM.03007-05; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Koschorreck M, 2007, HYDROBIOLOGIA, V592, P387, DOI 10.1007/s10750-007-0776-5; Lewandowski J, 2007, FRESHWATER BIOL, V52, P331, DOI 10.1111/j.1365-2427.2006.01702.x; Lorke A, 2003, LIMNOL OCEANOGR, V48, P2077, DOI 10.4319/lo.2003.48.6.2077; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nercessian O, 2005, APPL ENVIRON MICROB, V71, P6885, DOI 10.1128/AEM.71.11.6885-6899.2005; Ostrovsky I, 1996, LIMNOL OCEANOGR, V41, P323, DOI 10.4319/lo.1996.41.2.0323; Pett-Ridge J, 2005, APPL ENVIRON MICROB, V71, P6998, DOI 10.1128/AEM.71.11.6998-7007.2005; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Rahalkar M, 2009, APPL ENVIRON MICROB, V75, P119, DOI 10.1128/AEM.01350-08; Rosel S, 2012, AQUAT SCI, V74, P87, DOI 10.1007/s00027-011-0198-3; Roper HR, 2003, ADV LIMNOL, V58, P247; SANTSCHI P, 1990, MAR CHEM, V30, P269, DOI 10.1016/0304-4203(90)90076-O; Sass H, 1997, FEMS MICROBIOL ECOL, V22, P245, DOI 10.1016/S0168-6496(96)00096-7; SCHMIDT U, 1993, LIMNOL OCEANOGR, V38, P1214, DOI 10.4319/lo.1993.38.6.1214; Sivan O, 2007, GEOBIOLOGY, V5, P141, DOI 10.1111/j.1472-4669.2007.00098.x; Tsertova N, 2013, AQUAT MICROB ECOL, V70, P77, DOI 10.3354/ame01647; Tsertova N, 2011, ENV MICROBIOL REP, V3, P270, DOI 10.1111/j.1758-2229.2010.00221.x; Urakawa H, 2000, ENVIRON MICROBIOL, V2, P542, DOI 10.1046/j.1462-2920.2000.00137.x; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Ye WJ, 2009, FEMS MICROBIOL ECOL, V70, P263, DOI 10.1111/j.1574-6941.2009.00761.x	48	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0143428	10.1371/journal.pone.0143428	http://dx.doi.org/10.1371/journal.pone.0143428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599000	Green Published, Green Submitted, gold			2022-12-26	WOS:000365862600065
J	Zhan, WH; Han, TY; Zhang, CF; Xie, CF; Gan, MX; Deng, KY; Fu, MG; Wang, JB				Zhan, Weihua; Han, Tianyu; Zhang, Chenfu; Xie, Caifeng; Gan, Mingxi; Deng, Keyu; Fu, Mingui; Wang, Jian-Bin			TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins	PLOS ONE			English	Article							TRIPARTITE MOTIF; TUMOR-SUPPRESSOR; UBIQUITINATION; DEGRADATION; ASSAY; GENE; P53	TRIM protein family is an evolutionarily conserved gene family implicated in a number of critical processes including inflammation, immunity, antiviral and cancer. In an effort to profile the expression patterns of TRIM superfamily in several non-small cell lung cancer (NSCLC) cell lines, we found that the expression of 10 TRIM genes including TRIM3, TRIM7, TRIM14, TRIM16, TRIM21, TRIM22, TRIM29, TRIM59, TRIM66 and TRIM70 was significantly upregulated in NSCLC cell lines compared with the normal human bronchial epithelial (HBE) cell line, whereas the expression of 7 other TRIM genes including TRIM4, TRIM9, TRIM36, TRIM46, TRIM54, TRIM67 and TRIM76 was significantly down-regulated in NSCLC cell lines compared with that in HBE cells. As TRIM59 has been reported to act as a proto-oncogene that affects both Ras and RB signal pathways in prostate cancer models, we here focused on the role of TRIM59 in the regulation of NSCLC cell proliferation and migration. We reported that TRIM59 protein was significantly increased in various NSCLC cell lines. SiRNA-induced knocking down of TRIM59 significantly inhibited the proliferation and migration of NSCLC cell lines by arresting cell cycle in G2 phase. Moreover, TRIM59 knocking down affected the expression of a number of cell cycle proteins including CDC25C and CDK1. Finally, we knocked down TRIM59 and found that p53 protein expression levels did not upregulate, so we proposed that TRIM59 may promote NSCLC cell growth through other pathways but not the p53 signaling pathway.	[Zhan, Weihua; Han, Tianyu; Zhang, Chenfu; Xie, Caifeng; Gan, Mingxi; Deng, Keyu; Wang, Jian-Bin] Nanchang Univ, Inst Translat Med, Nanchang City 330031, Jiangxi, Peoples R China; [Fu, Mingui] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA	Nanchang University; University of Missouri System; University of Missouri Kansas City	Wang, JB (corresponding author), Nanchang Univ, Inst Translat Med, Nanchang City 330031, Jiangxi, Peoples R China.	jianbinwang1@gmail.com		Zhan, Weihua/0000-0001-7937-3384	National Natural Science Foundation of China [81372823, 31360282]; Department of Education of Jiangxi Province; National Institutes of Health [AI103618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103618] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education of Jiangxi Province; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially supported by grants to J-B Wang from the National Natural Science Foundation of China (81372823, 31360282), the Department of Education of Jiangxi Province (Science and Technology Luo Di program), and a grant to M-G Fu from the National Institutes of Health (AI103618).	Balint I, 2004, GENE, V332, P45, DOI 10.1016/j.gene.2004.02.045; Bell JL, 2013, CELL CYCLE, V12, P889, DOI 10.4161/cc.23825; Chen L, 2012, J BIOL CHEM, V287, P40106, DOI 10.1074/jbc.M112.380865; Eames HL, 2012, IMMUNOBIOLOGY, V217, P1315, DOI 10.1016/j.imbio.2012.07.026; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Johnson DH, 2014, J CLIN ONCOL, V32, P973, DOI 10.1200/JCO.2013.53.1228; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Manocha GD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-24; Marshall GM, 2010, ONCOGENE, V29, P6172, DOI 10.1038/onc.2010.340; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Raheja R, 2014, BIOCHEM J, V458, P537, DOI 10.1042/BJ20131288; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sato T, 2012, J CELL SCI, V125, P1544, DOI 10.1242/jcs.095273; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Tocchini C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004533; Valiyeva F, 2011, MOL CANCER THER, V10, P1229, DOI 10.1158/1535-7163.MCT-11-0077; Versteeg GA, 2014, CYTOKINE GROWTH F R, V25, P563, DOI 10.1016/j.cytogfr.2014.08.001; Yaguchi H, 2012, J BIOL CHEM, V287, P12050, DOI 10.1074/jbc.M111.307678; Zaman MMU, 2013, MOL CELL BIOL, V33, P4971, DOI 10.1128/MCB.00465-13; Zhou ZC, 2014, GASTROENTEROLOGY, V147, P1043, DOI 10.1053/j.gastro.2014.07.021	22	87	95	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142596	10.1371/journal.pone.0142596	http://dx.doi.org/10.1371/journal.pone.0142596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599082	gold, Green Published, Green Submitted			2022-12-26	WOS:000365862600013
J	Bac-Molenaar, JA; Fradin, EF; Rienstra, JA; Vreugdenhil, D; Keurentjes, JJB				Bac-Molenaar, Johanna A.; Fradin, Emilie F.; Rienstra, Juriaan A.; Vreugdenhil, Dick; Keurentjes, Joost J. B.			GWA Mapping of Anthocyanin Accumulation Reveals Balancing Selection of MYB90 in Arabidopsis thaliana	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FLAVONOID BIOSYNTHETIC-PATHWAY; SUCROSE-SPECIFIC INDUCTION; HIGH-LIGHT; NATURAL VARIATION; DNA POLYMORPHISM; LEAF SENESCENCE; REFERENCE GENES; TRAIT ANALYSIS; IDENTIFICATION	Induction of anthocyanin accumulation by osmotic stress was assessed in 360 accessions of Arabidopsis thaliana. A wide range of natural variation, with phenotypes ranging from green to completely red/purple rosettes, was observed. A genome wide association (GWA) mapping approach revealed that sequence diversity in a small 15 kb region on chromosome 1 explained 40% of the variation observed. Sequence and expression analyses of alleles of the candidate gene MYB90 identified a causal polymorphism at amino acid (AA) position 210 of this transcription factor of the anthocyanin biosynthesis pathway. This amino acid discriminates the two most frequent alleles of MYB90. Both alleles are present in a substantial part of the population, suggesting balancing selection between these two alleles. Analysis of the geographical origin of the studied accessions suggests that the macro climate is not the driving force behind positive or negative selection for anthocyanin accumulation. An important role for local climatic conditions is, therefore, suggested. This study emphasizes that GWA mapping is a powerful approach to identify alleles that are under balancing selection pressure in nature.	[Bac-Molenaar, Johanna A.; Fradin, Emilie F.; Rienstra, Juriaan A.; Vreugdenhil, Dick] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Bac-Molenaar, Johanna A.; Fradin, Emilie F.; Keurentjes, Joost J. B.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Keurentjes, JJB (corresponding author), Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands.	Joost.Keurentjes@wur.nl	Bac-Molenaar, Johanna/R-2265-2016	van Dijk-Fradin, Emilie/0000-0002-5186-4920; Keurentjes, Joost/0000-0001-8918-0711	Dutch Technology Foundation part of the Netherlands Organisation for Scientific Research (NWO) [10996]	Dutch Technology Foundation part of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Funding: This research is part of the 'Learning from Nature' program, supported by the Dutch Technology Foundation (http://www.stw.nl/en/, STW grant number 10996), which is part of the Netherlands Organisation for Scientific Research (NWO).	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chalker-Scott L, 2002, ADV BOT RES, V37, P103, DOI 10.1016/S0065-2296(02)37046-0; Corp IBM, 2010, IBM SPSS STAT WIND V; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Diaz C, 2008, PLANT PHYSIOL, V147, P1437, DOI 10.1104/pp.108.119040; Diaz U, 2006, PLANT CELL PHYSIOL, V47, P74, DOI 10.1093/pcp/pci225; FU YX, 1993, GENETICS, V133, P693; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gutha LR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-187; Hale KL, 2001, PLANT PHYSIOL, V126, P1391, DOI 10.1104/pp.126.4.1391; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Hasdai M, 2006, ANN APPL BIOL, V148, P113, DOI 10.1111/j.1744-7348.2006.00044.x; Hoch WA, 2001, TREE PHYSIOL, V21, P1; Ilk N, 2015, NEW PHYTOL, V206, P422, DOI 10.1111/nph.13177; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Kruijer W, 2015, GENETICS, V199, P379, DOI 10.1534/genetics.114.167916; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mitchell-Olds T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-113; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Park W, 2012, SOIL SCI PLANT NUTR, V58, P334, DOI 10.1080/00380768.2012.684643; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schulz E, 2015, PLANT CELL ENVIRON, V38, P1658, DOI 10.1111/pce.12518; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Seren U, 2012, PLANT CELL, V24, P4793, DOI 10.1105/tpc.112.108068; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sperdouli I, 2012, J PLANT PHYSIOL, V169, P577, DOI 10.1016/j.jplph.2011.12.015; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; TAJIMA F, 1989, GENETICS, V123, P585; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Winefield C, 2009, PREVALENCE FUNCTIONS, P86; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Zeng XQ, 2010, PHYSIOL PLANTARUM, V138, P215, DOI 10.1111/j.1399-3054.2009.01316.x; Zhang KM, 2010, PLANT SCI, V179, P202, DOI 10.1016/j.plantsci.2010.05.006; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	49	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143212	10.1371/journal.pone.0143212	http://dx.doi.org/10.1371/journal.pone.0143212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588092	Green Submitted, Green Published, gold			2022-12-26	WOS:000365251500038
J	Meunchan, M; Michely, S; Devillers, H; Nicaud, JM; Marty, A; Neuveglise, C				Meunchan, Muchalin; Michely, Stephanie; Devillers, Hugo; Nicaud, Jean-Marc; Marty, Alain; Neuveglise, Cecile			Comprehensive Analysis of a Yeast Lipase Family in the Yarrowia Clade	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DIFFERENTIAL EXPRESSION ANALYSIS; SP-NOV.; LIPOLYTICA LIPASE; CANDIDA-DEFORMANS; MOLECULAR-BIOLOGY; GENE-EXPRESSION; OPEN SOFTWARE; LIP2; ENANTIOSELECTIVITY	Lipases are currently the subject of intensive studies due to their large range of industrial applications. The Lip2p lipase from the yeast Yarrowia lipolytica (YlLIP2) was recently shown to be a good candidate for different biotechnological applications. Using a combination of comparative genomics approaches based on sequence similarity, synteny conservation, and phylogeny, we constructed the evolutionary scenario of the lipase family for six species of the Yarrowia clade. RNA-seq based transcriptome analysis revealed the primary role of LIP2 homologues in the assimilation of different substrates. Once identified, these YlLIP2 homologues were expressed in Y. lipolytica. The lipase Lip2a from Candida phangngensis was shown to naturally present better activity and enantioselectivity than YlLip2. Enantioselectivity was further improved by site-directed mutagenesis targeted to the substrate binding site. The mono-substituted variant V232S displayed enantioselectivity greater than 200 and a 2.5 fold increase in velocity. A double-substituted variant 97A-V232F presented reversed enantioselectivity, with a total preference for the R-enantiomer.	[Meunchan, Muchalin; Marty, Alain] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Meunchan, Muchalin; Marty, Alain] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Meunchan, Muchalin; Marty, Alain] CNRS, UMR5504, F-31400 Toulouse, France; [Meunchan, Muchalin] Khon Kaen Univ, Fac Sci, Dept Biochem, Khon Kaen 40002, Thailand; [Michely, Stephanie; Devillers, Hugo; Nicaud, Jean-Marc; Neuveglise, Cecile] INRA, UMR Micalis 1319, F-78352 Jouy En Josas, France; [Michely, Stephanie; Devillers, Hugo; Nicaud, Jean-Marc; Neuveglise, Cecile] AgroParisTech, UMR Micalis, F-78352 Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Khon Kaen University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Marty, A (corresponding author), Univ Toulouse, INSA, UPS, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France.	alain.marty@insa-toulouse.fr; ncecile@grignon.inra.fr	NICAUD, Jean-marc/ABA-9076-2021	Neuveglise, Cecile/0000-0001-5017-7830	French Government [ANR-001-01]; INRA through the AIP-Bioressources YALIP project; Thailand Research Fund (TRF); Khon Kaen University through Royal Golden Jubilee PhD program [PHD/0282/2549]; French Minister of Research via the ABIES doctoral school	French Government; INRA through the AIP-Bioressources YALIP project; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Khon Kaen University through Royal Golden Jubilee PhD program; French Minister of Research via the ABIES doctoral school	This work was performed, in partnership with the SAS PIVERT, within the frame of the French Institute for the Energy Transition (Institut pour la Transition Energetique - ITE) P.I.V.E.R.T. (www.institutpivert.com) selected as an Investment for the Future ("Investissements d'Avenir"). This work was supported as part of the Investments for the Future, by the French Government under the reference ANR-001-01 and by INRA through the AIP-Bioressources YALIP project. Muchalin Meunchan acknowledges the Thailand Research Fund (TRF) together with Khon Kaen University for financial support through Royal Golden Jubilee PhD program (grant number PHD/0282/2549) and French Embassy. Stephanie Michely has a PhD fellowship funded by the French Minister of Research via the ABIES doctoral school. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	AGGELIS G, 1993, GRASAS ACEITES, V44, P331, DOI 10.3989/gya.1993.v44.i6.1058; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barth G, 1996, NONCONVENTIONAL YEAS, P313, DOI [DOI 10.1007/978-3-642-79856-6_10, 10.1007/978-3-642-79856-6_10]; Benjamin S, 1998, YEAST, V14, P1069, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1069::AID-YEA303>3.3.CO;2-B; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigey F, 2003, YEAST, V20, P233, DOI 10.1002/yea.958; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Bordes F, 2009, CHEMBIOCHEM, V10, P1705, DOI 10.1002/cbic.200900215; Bordes F, 2007, J MICROBIOL METH, V70, P493, DOI 10.1016/j.mimet.2007.06.008; Bordes F, 2011, J BIOTECHNOL, V156, P117, DOI 10.1016/j.jbiotec.2011.06.035; Bordes F, 2010, BIOPHYS J, V99, P2225, DOI 10.1016/j.bpj.2010.07.040; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cambon E, 2010, BIOTECHNOL BIOENG, V106, P852, DOI 10.1002/bit.22770; Cardenas F, 2001, ENZYME MICROB TECH, V28, P145, DOI 10.1016/S0141-0229(00)00278-7; Casas-Godoy L, 2014, J BIOTECHNOL, V180, P30, DOI 10.1016/j.jbiotec.2014.03.018; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chang CF, 2013, ANTON LEEUW INT J G, V104, P1117, DOI 10.1007/s10482-013-0033-z; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Almeida AF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/435818; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fickers P, 2005, FUNGAL GENET BIOL, V42, P264, DOI 10.1016/j.fgb.2004.12.003; Fickers P, 2011, BIOTECHNOL ADV, V29, P632, DOI 10.1016/j.biotechadv.2011.04.005; Goncalves FAG, 2014, SCI WORLD J, DOI 10.1155/2014/476207; Gopinath SCB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/154549; Groenewald M, 2013, ANTON LEEUW INT J G, V103, P1023, DOI 10.1007/s10482-013-9882-8; Guieysse D, 2004, TETRAHEDRON-ASYMMETR, V15, P3539, DOI 10.1016/j.tetasy.2004.09.008; Guieysse D, 2003, TETRAHEDRON-ASYMMETR, V14, P317, DOI 10.1016/S0957-4166(02)00784-X; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hube B, 2000, ARCH MICROBIOL, V174, P362, DOI 10.1007/s002030000218; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knutsen AK, 2007, INT J SYST EVOL MICR, V57, P2426, DOI 10.1099/ijs.0.65200-0; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kurtzman CP, 2005, ANTON LEEUW INT J G, V88, P121, DOI 10.1007/s10482-005-2495-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Limtong S, 2008, INT J SYST EVOL MICR, V58, P515, DOI 10.1099/ijs.0.65506-0; Madzak C, 1999, MICROBIOL-UK, V145, P75, DOI 10.1099/13500872-145-1-75; Madzak C, 2000, J MOL MICROB BIOTECH, V2, P207; Masse L, 2001, BIORESOURCE TECHNOL, V77, P145, DOI 10.1016/S0960-8524(00)00146-2; Nagy E, 2014, ANTON LEEUW INT J G, V105, P697, DOI 10.1007/s10482-014-0125-4; Nagy E, 2013, INT J SYST EVOL MICR, V63, P4818, DOI 10.1099/ijs.0.057208-0; OGRYDZIAK DM, 1977, BIOCHIM BIOPHYS ACTA, V497, P525, DOI 10.1016/0304-4165(77)90209-4; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Peter G, 2004, ANTON LEEUW INT J G, V86, P105, DOI 10.1023/B:ANTO.0000036117.03847.bd; Piamtongkam R, 2011, BIOTECHNOL BIOENG, V108, P1749, DOI 10.1002/bit.23124; Pignede G, 2000, J BACTERIOL, V182, P2802, DOI 10.1128/JB.182.10.2802-2810.2000; Pleiss J, 2000, J MOL CATAL B-ENZYM, V10, P491, DOI 10.1016/S1381-1177(00)00092-8; QUINN DM, 1982, BIOCHEMISTRY-US, V21, P6872, DOI 10.1021/bi00269a038; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Tan TW, 2010, BIOTECHNOL ADV, V28, P628, DOI 10.1016/j.biotechadv.2010.05.012; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhu Q, 2015, CURR OPIN BIOTECH, V36, P65, DOI 10.1016/j.copbio.2015.08.010	57	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0143096	10.1371/journal.pone.0143096	http://dx.doi.org/10.1371/journal.pone.0143096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580812	Green Submitted, Green Published, gold			2022-12-26	WOS:000365154600082
J	Pearce, SC; Lonergan, SM; Huff-Lonergan, E; Baumgard, LH; Gabler, NK				Pearce, Sarah C.; Lonergan, Steven M.; Huff-Lonergan, Elisabeth; Baumgard, Lance H.; Gabler, Nicholas K.			Acute Heat Stress and Reduced Nutrient Intake Alter Intestinal Proteomic Profile and Gene Expression in Pigs	PLOS ONE			English	Article							TIGHT JUNCTION PERMEABILITY; POSTNATAL BODY-COMPOSITION; HYPOXIA-INDUCIBLE FACTOR; LACTATING HOLSTEIN COWS; RESIDUAL FEED-INTAKE; GROWING PIGS; BARRIER DYSFUNCTION; OXIDATIVE STRESS; METABOLISM; NUTRITION	Heat stress and reduced feed intake negatively affect intestinal integrity and barrier function. Our objective was to compare ileum protein profiles of pigs subjected to 12 hours of HS, thermal neutral ad libitum feed intake, or pair-fed to heat stress feed intake under thermal neutral conditions (pair-fed thermal neutral). 2D-Differential In Gel Electrophoresis and gene expression were performed. Relative abundance of 281 and 138 spots differed due to heat stress, compared to thermal neutral and pair-fed thermal neutral pigs, respectively. However, only 20 proteins were different due to feed intake (thermal neutral versus pair-fed thermal neutral). Heat stress increased mRNA expression of heat shock proteins and protein abundance of heat shock proteins 27, 70, 90-alpha and beta were also increased. Heat stress reduced ileum abundance of several metabolic enzymes, many of which are involved in the glycolytic or TCA pathways, indicating a change in metabolic priorities. Stress response enzymes peroxiredoxin-1 and peptidyl-prolyl cis-trans isomerase A were decreased in pair-fed thermal neutral and thermal neutral pigs compared to heat stress. Heat stress increased mRNA abundance markers of ileum hypoxia. Altogether, these data show that heat stress directly alters intestinal protein and mRNA profiles largely independent of reduced feed intake. These changes may be related to the reduced intestinal integrity associated with heat stress.	[Pearce, Sarah C.; Lonergan, Steven M.; Huff-Lonergan, Elisabeth; Baumgard, Lance H.; Gabler, Nicholas K.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Iowa State University	Gabler, NK (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	ngabler@iastate.edu	Huff-Lonergan, Elisabeth/C-7557-2009; Lonergan, Steven M/O-6233-2016; Baumgard, Lance Hall/AAZ-7090-2021	Huff-Lonergan, Elisabeth/0000-0001-5012-3277; Lonergan, Steven/0000-0002-9495-0722	USDA National Institute of Food and Agriculture Hatch Project [IOW03800]; Agriculture and Food Research Initiative [2011-67003-30007]	USDA National Institute of Food and Agriculture Hatch Project; Agriculture and Food Research Initiative	This project was supported by the USDA National Institute of Food and Agriculture Hatch Project No. IOW03800 and the Agriculture and Food Research Initiative Grant No. 2011-67003-30007.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bailey SP, 2008, MIL MED, V173, P187, DOI 10.7205/MILMED.173.2.187; Boddicker RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110859; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cruzen SM, 2015, J PROTEOMICS, V128, P141, DOI 10.1016/j.jprot.2015.07.032; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Fernandez MVS, 2014, ANIMAL, V8, P43, DOI 10.1017/S1751731113001961; Grubbs JK, 2013, J PROTEOMICS, V80, P334, DOI 10.1016/j.jprot.2013.01.017; HALES JRS, 1979, AM J PHYSIOL, V237, pH705, DOI 10.1152/ajpheart.1979.237.6.H705; He HY, 2013, PROTEOMICS, V13, P1121, DOI 10.1002/pmic.201100579; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Hildebrandt T, 2015, BIOL CHEM, V396, P523, DOI 10.1515/hsz-2014-0295; Jacobi SK, 2013, WORLD J GASTROENTERO, V19, P5094, DOI 10.3748/wjg.v19.i31.5094; Jesus P, 2014, CLIN NUTR, V33, P1046, DOI 10.1016/j.clnu.2013.11.006; Johnson JS, 2015, J ANIM SCI, V93, P82, DOI 10.2527/jas.2014-8355; Johnson JS, 2015, J ANIM SCI, V93, P71, DOI 10.2527/jas.2014-8354; Kim JK, 2006, J VIROL, V80, P689, DOI 10.1128/JVI.80.2.689-696.2006; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Lambert G. Patrick, 2008, V53, P61, DOI 10.1159/000151550; Lambert GP, 2004, EXERC SPORT SCI REV, V32, P185; Lenaerts K, 2006, J PROTEOME RES, V5, P2113, DOI 10.1021/pr060183+; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LoVecchio F, 2007, AM J EMERG MED, V25, P442, DOI 10.1016/j.ajem.2006.11.026; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Martinez-Medina M, 2009, J CLIN MICROBIOL, V47, P3968, DOI 10.1128/JCM.01484-09; MCGUIRE MA, 1989, J ANIM SCI, V67, P1050, DOI 10.2527/jas1989.6741050x; Melody JL, 2004, J ANIM SCI, V82, P1195; Nagumo Y, 2008, BIOCHEM BIOPH RES CO, V377, P921, DOI 10.1016/j.bbrc.2008.10.071; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Pearce SC, 2012, J ANIM SCI, V90, P257, DOI 10.2527/jas.52339; Pearce SC, 2015, J ANIM SCI, V93, P4702, DOI 10.2527/jas.2015-9018; Pearce SC, 2014, J ANIM SCI, V92, P5444, DOI 10.2527/jas.2014-8407; Pearce SC, 2013, J ANIM SCI, V91, P5183, DOI 10.2527/jas.2013-6759; Pearce SC, 2013, J ANIM SCI, V91, P2108, DOI 10.2527/jas.2012-5738; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Prosser C, 2004, J APPL PHYSIOL, V96, P650, DOI 10.1152/japplphysiol.00295.2003; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Quinteiro WM, 2012, AVIAN PATHOL, V41, P421, DOI 10.1080/03079457.2012.709315; Renaudeau D, 2013, J ANIM SCI, V91, P1162, DOI 10.2527/jas.2012-5689; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Rhoads RP, 2013, J ANIM SCI, V91, P2492, DOI 10.2527/jas.2012-6120; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Shkoda A, 2007, J PROTEOME RES, V6, P1114, DOI 10.1021/pr060433m; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Song F, 2011, J BIOL CHEM, V286, P8197, DOI 10.1074/jbc.C110.181347; Spreeuwenberg MAM, 2001, J NUTR, V131, P1520, DOI 10.1093/jn/131.5.1520; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Stevens C, 2013, GUT, V62, P695, DOI 10.1136/gutjnl-2011-301775; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamagata K, 2004, NEUROBIOL DIS, V17, P491, DOI 10.1016/j.nbd.2004.08.001; Yan YE, 2006, MED HYPOTHESES, V67, P609, DOI 10.1016/j.mehy.2005.12.048; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015; Zhou QQ, 2011, WORLD J GASTROENTERO, V17, P1584, DOI 10.3748/wjg.v17.i12.1584	57	31	33	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143099	10.1371/journal.pone.0143099	http://dx.doi.org/10.1371/journal.pone.0143099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7BR	26575181	Green Published, gold, Green Submitted			2022-12-26	WOS:000365153400040
J	Ma, RS; Hu, XR; Hu, GY; Yi, CF; Zhang, CJ; Li, XF; Li, YH; Jiang, H				Ma Ruisong; Hu Xiaorong; Hu Gangying; Yi Chunfeng; Zhang Changjiang; Li Xuefei; Li Yuanhong; Jiang Hong			The Protective Role of Interleukin-33 in Myocardial Ischemia and Reperfusion Is Associated with Decreased HMGB1 Expression and Up-Regulation of the P38 MAPK Signaling Pathway	PLOS ONE			English	Article							GROUP BOX 1; ISCHEMIA/REPERFUSION INJURY; CARDIOMYOCYTE APOPTOSIS; IL-33; PROTEIN; MICE; ST2; SUPPRESSION; INDUCTION; CYTOKINE	Interleukin-33 (IL-33) plays a protective role in myocardial ischemia and reperfusion (I/R) injury, but the underlying mechanism was not fully elucidated. The present study was designed to investigate whether IL-33 protects against myocardial I/R injury by regulating both P38 mitogen-activated-protein kinase (P38 MAPK), which is involved in one of the downstream signaling pathways of IL-33, and high mobility group box protein 1 (HMGB1), a late pro-inflammatory cytokine. Myocardial I/R injury increased the level of IL-33 and its induced receptor (sST) in myocardial tissue. Compared with the I/R group, the IL-33 group had significantly lower cardiac injury (lower serum creatine kinase (CK), lactate dehydrogenase (LDH), and cTnI levels and myocardial infarct size), a suppressed inflammatory response in myocardial tissue (lower expression of HMGB1, IL-6, TNF-alpha and INF-gamma) and less myocardial apoptosis (much higher Bcl-2/Bax ratio and lower cleaved caspase-3 expression). Moreover, IL-33 activated the P38 MAPK signaling pathway (up-regulating P-P38 expression) in myocardial tissue, and SB230580 partially attenuated the anti-inflammatory and anti-apoptosis effects of IL-33. These findings indicated that IL-33 protects against myocardial I/R injury by inhibiting inflammatory responses and myocardial apoptosis, which may be associated with the HMGB1 and P38 MAPK signaling pathways.	[Ma Ruisong; Hu Xiaorong; Hu Gangying; Yi Chunfeng; Li Xuefei; Jiang Hong] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Peoples R China; [Ma Ruisong; Hu Xiaorong; Hu Gangying; Yi Chunfeng; Li Xuefei; Jiang Hong] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China; [Zhang Changjiang; Li Yuanhong] Cent Hosp Enshi Tujia & Miao Autonomous Prefectur, Dept Cardiol, Enshi City, Hubei, Peoples R China	Wuhan University; Wuhan University	Li, YH (corresponding author), Cent Hosp Enshi Tujia & Miao Autonomous Prefectur, Dept Cardiol, Enshi City, Hubei, Peoples R China.	yuanhongwhu@126.com; Jianghwurm@163.com			National Natural Science foundation of China [81100146, 81370308]; Natural Science foundation of Hubei [2013CFB250]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110141120060]; Fundamental Research Funds of Wuhan City [2013070104010044]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science foundation of Hubei(Natural Science Foundation of Hubei Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds of Wuhan City	This study was partially supported by grants from the National Natural Science foundation of China (No. 81100146 and 81370308) the Natural Science foundation of Hubei (No. 2013CFB250), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20110141120060) and the Fundamental Research Funds of Wuhan City (No. 2013070104010044).	Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Bartunek J, 2008, J AM COLL CARDIOL, V52, P2166, DOI 10.1016/j.jacc.2008.09.027; Demyanets S, 2014, CYTOKINE, V67, P65, DOI 10.1016/j.cyto.2014.02.014; Dhillon OS, 2013, INT J CARDIOL, V167, P2182, DOI 10.1016/j.ijcard.2012.05.073; Ding HS, 2013, GENE, V527, P389, DOI 10.1016/j.gene.2013.05.041; Gao XF, 2015, MOL CELL BIOCHEM, V398, P135, DOI 10.1007/s11010-014-2213-1; Ha YM, 2011, BIOCHEM PHARMACOL, V82, P769, DOI 10.1016/j.bcp.2011.06.041; Hu GY, 2014, INFLAMMATION, V37, P1669, DOI 10.1007/s10753-014-9895-0; Hu XR, 2012, MOL BIOL REP, V39, P227, DOI 10.1007/s11033-011-0730-5; Hu XR, 2010, EUR J PHARMACOL, V638, P84, DOI 10.1016/j.ejphar.2010.03.059; Li S, 2013, CHINESE MED J-PEKING, V126, P1855, DOI 10.3760/cma.j.issn.0366-6999.20123530; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Rui T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056089; Rui T, 2012, CARDIOVASC RES, V94, P370, DOI 10.1093/cvr/cvs015; Sakai N, 2012, HEPATOLOGY, V56, P1468, DOI 10.1002/hep.25768; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; Sundlisaeter E, 2012, AM J PATHOL, V181, P1099, DOI 10.1016/j.ajpath.2012.06.003; Tan YH, 2015, J TRAUMA ACUTE CARE, V78, P784, DOI 10.1097/TA.0000000000000588; Thierry A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088742; Wang JC, 2013, J SURG RES, V183, P509, DOI 10.1016/j.jss.2013.02.051; Xie L, 2015, J MOL CELL CARDIOL, V80, P156, DOI 10.1016/j.yjmcc.2015.01.007; Xiong J, 2010, CHINESE MED J-PEKING, V123, P2720, DOI 10.3760/cma.j.issn.0366-6999.2010.19.019; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660; Yang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108024; Yin H, 2010, TRANSPLANTATION, V89, P1189, DOI 10.1097/TP.0b013e3181d720af; Yndestad A, 2010, INT J BIOCHEM CELL B, V42, P263, DOI 10.1016/j.biocel.2009.10.021; Zhu HF, 2013, TRANSPLANTATION, V95, P1448, DOI 10.1097/TP.0b013e318293b7e1	29	17	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143064	10.1371/journal.pone.0143064	http://dx.doi.org/10.1371/journal.pone.0143064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571038	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700126
J	Pon, CK; Lane, JR; Sloan, EK; Halls, ML				Pon, Cindy K.; Lane, J. Robert; Sloan, Erica K.; Halls, Michelle L.			The beta(2)-adrenoceptor activates a positive cAMP-calcium feedforward loop to drive breast cancer cell invasion	FASEB JOURNAL			English	Article						adrenergic receptor; GPCR; metastasis; stress	BETA-ADRENERGIC RECEPTORS; G-PROTEIN; ANTIHYPERTENSIVE MEDICATIONS; SIGNALING PATHWAY; ESTROGEN-RECEPTOR; ADENYLATE-CYCLASE; TUMOR-GROWTH; MAP KINASE; BLOCKERS; PHOSPHORYLATION	Activation of the sympathetic nervous system by stress increases breast cancer metastasis in vivo. Preclinical studies suggest that stress activates beta-adrenoceptors (beta ARs) to enhance metastasis from primary tumors and that beta-blockers may be protective in breast cancer. However, the subtype of beta AR that mediates this effect, as well as the signaling mechanisms underlying increased tumor cell dissemination, remain unclear. We show that the beta(2)AR is the only functionally relevant beta AR subtype in the highly metastatic human breast cancer cell line MDA-MB-231HM. beta(2)AR activation results in elevated cAMP (formoterol pEC(50) 9.86 +/- 0.32), increased intracellular Ca2+ (formoterol pEC(50) 8.20 +/- 0.33) and reduced phosphorylated ERK (pERK; formoterol pIC(50) 11.62 +/- 0.31). We demonstrate that a highly amplified positive feedforward loop between the cAMP and Ca2+ pathways is responsible for efficient inhibition of basal pERK. Importantly, activation of the beta(2)AR increased invasion (formoterol area under the curve [AUC] relative to vehicle: 1.82 +/- 0.36), which was dependent on the cAMP/Ca2+ loop (formoterol AUC in the presence of 2'5'-dideoxyadenosine 0.64 +/- 0.03, or BAPTA-AM 0.45 +/- 0.23) but independent of inhibition of basal pERK1/2 (vehicle AUC with U0126 0.60 +/- 0.30). Specifically targeting the positive feedforward cAMP/Ca2+ loop may be beneficial for the development of therapeutics to slow disease progression in patients with breast cancer.	[Pon, Cindy K.; Lane, J. Robert; Sloan, Erica K.; Halls, Michelle L.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, 381 Royal Parade, Parkville, Vic 3052, Australia; [Sloan, Erica K.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Cousins Ctr, Los Angeles, CA 90024 USA; [Sloan, Erica K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Sloan, Erica K.] Peter MacCallum Canc Ctr, Div Canc Surg, East Melbourne, Vic, Australia	Monash University; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Peter Maccallum Cancer Center	Halls, ML (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, 381 Royal Parade, Parkville, Vic 3052, Australia.	michelle.halls@monash.edu		Sloan, Erica/0000-0002-2355-1433; Lane, J. Robert/0000-0002-7361-7875	National Health and Medical Research Council R. D. Wright Fellowship (Canberra, ACT, Australia) [1061687]; Drug Discovery Biology Theme Strategic grant; Australian National Health and Medical Research Council [1008865]; U.S. National Institutes of Health/National Cancer Institute [CA160890]; National Breast Cancer Foundation [ECR-11-11]; NATIONAL CANCER INSTITUTE [R01CA160890] Funding Source: NIH RePORTER	National Health and Medical Research Council R. D. Wright Fellowship (Canberra, ACT, Australia); Drug Discovery Biology Theme Strategic grant; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); U.S. National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank R. J. Summers (Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University) and members of the laboratories of M.L.H. and E.K.S. for critical discussion. This work was supported by a National Health and Medical Research Council R. D. Wright Fellowship (1061687; Canberra, ACT, Australia) to M.L.H., a Drug Discovery Biology Theme Strategic grant to M.L.H., J.R.L., and E.K.S., and funding from the Australian National Health and Medical Research Council (1008865), the U.S. National Institutes of Health/National Cancer Institute (CA160890), and the National Breast Cancer Foundation (ECR-11-11).	ABRAMSON SN, 1988, BIOCHEM PHARMACOL, V37, P4289, DOI 10.1016/0006-2952(88)90609-0; Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Armaiz-Pena GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2413; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Barron TI, 2012, THER ADV MED ONCOL, V4, P113, DOI 10.1177/1758834012439738; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Beindl W, 1996, MOL PHARMACOL, V50, P415; Benitah JP, 2010, J MOL CELL CARDIOL, V48, P26, DOI 10.1016/j.yjmcc.2009.07.026; Beristain AG, 2015, ONCOGENE, V34, P1160, DOI 10.1038/onc.2014.41; Berridge M J, 1975, Adv Cyclic Nucleotide Res, V6, P1; Botteri E, 2013, BREAST CANCER RES TR, V140, P567, DOI 10.1007/s10549-013-2654-3; Bruzzone A, 2014, FASEB J, V28, P1342, DOI 10.1096/fj.13-239285; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Carie AE, 2007, ONCOGENE, V26, P3777, DOI 10.1038/sj.onc.1210172; Chang XZ, 2008, BREAST CANCER RES TR, V111, P65, DOI 10.1007/s10549-007-9761-y; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Dezong Gao, 2014, J Cancer Res Ther, V10, P998, DOI 10.4103/0973-1482.137664; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Ganz PA, 2011, BREAST CANCER RES TR, V129, P549, DOI 10.1007/s10549-011-1505-3; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Harper K, 2010, CANCER RES, V70, P4634, DOI 10.1158/0008-5472.CAN-09-3813; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Holmes S, 2013, CANCER EPIDEMIOL, V37, P881, DOI 10.1016/j.canep.2013.09.001; Ivonnet P, 2015, BRIT J PHARMACOL, V172, P173, DOI 10.1111/bph.12934; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kushnir A, 2010, ADV PHARMACOL, V59, P1, DOI 10.1016/S1054-3589(10)59001-X; Lamkin DM, 2012, BRAIN BEHAV IMMUN, V26, P635, DOI 10.1016/j.bbi.2012.01.013; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Li CI, 2013, JAMA INTERN MED, V173, P1629, DOI 10.1001/jamainternmed.2013.9071; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Liu W., 2015, ONCOTARGET, DOI 10.18632/oncotarget.5849; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONDOS C, 1977, P NATL ACAD SCI USA, V74, P5482, DOI 10.1073/pnas.74.12.5482; Madden KS, 2011, BREAST CANCER RES TR, V130, P747, DOI 10.1007/s10549-011-1348-y; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Ostapkowicz A, 2006, MOL CANCER THER, V5, P238, DOI 10.1158/1535-7163.MCT-05-0226; Pinero CP, 2012, BRIT J PHARMACOL, V166, P721, DOI 10.1111/j.1476-5381.2011.01791.x; Powe DG, 2011, BREAST CANCER RES TR, V130, P457, DOI 10.1007/s10549-011-1371-z; Powe DG, 2010, ONCOTARGET, V1, P628, DOI 10.18632/oncotarget.197; RASMUSSEN H, 1981, CALCIUM CAMP SYNARCH; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sorensen GV, 2013, J CLIN ONCOL, V31, P2265, DOI 10.1200/JCO.2012.43.9190; Spychala J, 2004, CLIN CANCER RES, V10, P708, DOI 10.1158/1078-0432.CCR-0811-03; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; VANDEWALLE B, 1990, J CANCER RES CLIN, V116, P303, DOI 10.1007/BF01612908; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Willoughby D, 2012, J CELL SCI, V125, P5850, DOI 10.1242/jcs.111427; Willoughby D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002299; Wright PT, 2014, J MOL CELL CARDIOL, V67, P38, DOI 10.1016/j.yjmcc.2013.12.003; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; XIAO RP, 1995, MOL PHARMACOL, V47, P322	65	40	43	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1144	1154		10.1096/fj.15-277798	http://dx.doi.org/10.1096/fj.15-277798			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26578688	Green Published			2022-12-26	WOS:000370387800013
J	Lin, YC; Huang, CY; Lin, IL; Shieh, JY; Chung, YT; Chen, KL				Lin, Yu-Ching; Huang, Chien-Yu; Lin, I-Ling; Shieh, Jeng-Yi; Chung, Yu-Ting; Chen, Kuan-Lin			Evaluating Functional Outcomes of Botulinum Toxin Type A Injection Combined with Occupational Therapy in the Upper Limbs of Children with Cerebral Palsy: A 9-Month Follow-Up from the Perspectives of Both Child and Caregiver	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS STATEMENT; RELIABILITY; SPASTICITY; CLASSIFICATION; INTERVENTION; PREVALENCE; VALIDITY; VERSION; MUSCLE	Objective To assess the effectiveness of combining botulinum toxin type A (BoNT-A) with functional occupational therapy (OT) at 9-month follow-up in children with cerebral palsy (CP) with bilateral upper limb impairments from the perspectives of both child and caregiver. Methods Twelve children with CP and their caregivers were assessed across 5 time points over 9 months based on the ICF after BoNT-A injection and functional OT in this open-label study. Results Significant differences were found across the 5 time points (p<.05) for both grasp and visual-motor integration with small effects (effect sizes = 0.12-0.24) and the self-care capability and performance of social function (p<.05). However, based on the effect sizes (0.02-0.14), no significant effects were found at the 4 post-test time points. Small effects were found on the psychological domain (effect sizes = 0.25-0.37) and environmental domains (effect size = 0.27) at follow-ups. Conclusion Combining a BoNT-A injection with OT not only reduced the muscle tone and increased ROM but also improved the upper limb function and self-care capability in children with CP. More importantly, these effects persisted for up to 9 months. Functional OT extends the effectiveness of a BoNT-A injection.	[Lin, Yu-Ching; Chung, Yu-Ting; Chen, Kuan-Lin] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Phys Med & Rehabil, Tainan 70101, Taiwan; [Lin, Yu-Ching] Natl Cheng Kung Univ, Coll Med, Dept Phys Med & Rehabil, Tainan 70101, Taiwan; [Lin, Yu-Ching] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 701, Taiwan; [Huang, Chien-Yu] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei 10764, Taiwan; [Lin, I-Ling] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Shieh, Jeng-Yi] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei 10764, Taiwan; [Chen, Kuan-Lin] Natl Cheng Kung Univ, Coll Med, Sch Occupat Therapy, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Taiwan University; Kaohsiung Medical University; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University	Chen, KL (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Phys Med & Rehabil, Tainan 70101, Taiwan.	klchen@mail.ncku.edu.tw	Chen, Kuan-Lin/AAC-5430-2021; Chen, Kuan-Lin/AAD-4537-2022	Chen, Kuan-Lin/0000-0001-9996-814X; SHIEH, JENG-YI/0000-0002-3906-4269	National Science Council, Taiwan [NSC 101-2314-B-006-003]; National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan [NCKUH-10407018]; Ministry of Education, Taiwan, R.O.C.; Headquarters of University Advancement at the National Cheng Kung University by the Ministry of Education, Taiwan, ROC	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan); Headquarters of University Advancement at the National Cheng Kung University by the Ministry of Education, Taiwan, ROC	This research was supported by the funding from the National Science Council, Taiwan. [NSC 101-2314-B-006-003] and the National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan [NCKUH-10407018]. This research was, in part, supported by the Ministry of Education, Taiwan, R.O.C. The Aim for the Top University Project to the National Cheng Kung University (NCKU). This research received funding from the Headquarters of University Advancement at the National Cheng Kung University, which is sponsored by the Ministry of Education, Taiwan, ROC.	Baird MW, 2010, J CHILD NEUROL, V25, P721, DOI 10.1177/0883073809346846; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Brin MF, 2014, BIOL-TARGETS THER, V8, P227, DOI 10.2147/BTT.S65603; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Chen KL, 2009, J REHABIL MED, V41, P273, DOI 10.2340/16501977-0319; Fattal-Valevski A, 2010, J CHILD NEUROL; Fehlings D, 2010, EUR J NEUROL, V17, P38, DOI 10.1111/j.1468-1331.2010.03127.x; Graham HK, 2003, J BONE JOINT SURG BR, V85B, P157, DOI 10.1302/0301620X.85B2.14066; Hoare BJ, 2010, BOTULINUM TOXIN A AD; Hoare B, 2014, J CHILD NEUROL, V29, P1066, DOI 10.1177/0883073814533196; Koman LA, 2013, J HAND SURG-AM, V38A, P435, DOI 10.1016/j.jhsa.2012.12.019; Lannin N, 2004, AUSTR OCCUPATIONAL T, V51, P208; Lin YC, 2015, ARCH PHYS MED REHAB, V96, P760, DOI 10.1016/j.apmr.2014.11.011; Love SC, 2010, EUR J NEUROL, V17, P9, DOI 10.1111/j.1468-1331.2010.03126.x; Ma J, 2004, AM J PHYS MED REHAB, V83, P774, DOI 10.1097/01.PHM.0000137315.17214.93; Molenaers G, 2010, J CHILD ORTHOP, V4, P183, DOI 10.1007/s11832-010-0246-x; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Reid SM, 2011, RES DEV DISABIL, V32, P2909, DOI 10.1016/j.ridd.2011.05.012; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Strobl W, 2015, TOXINS, V7, P1629, DOI 10.3390/toxins7051629; Wallen M, 2007, ARCH PHYS MED REHAB, V88, P1, DOI 10.1016/j.apmr.2006.10.017; Wang HH, 2006, PHYS THER, V86, P1351, DOI 10.2522/ptj.20050259; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; World Health Organization (WHO), 2001, INTERNATIONAL CLASSI; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	26	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2015	10	11							e0142769	10.1371/journal.pone.0142769	http://dx.doi.org/10.1371/journal.pone.0142769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7DU	26599003	Green Submitted, Green Published, gold			2022-12-26	WOS:000365862600017
J	Mao, JQ; Zhang, HQ; Dai, HC; Yuan, BH; Hu, TF				Mao, J. Q.; Zhang, H. Q.; Dai, H. C.; Yuan, B. H.; Hu, T. F.			Hydrodynamic and Sediment Responses of Open Channels to Exposed Pipe Encasements	PLOS ONE			English	Article							LOCAL SCOUR; DOWNSTREAM	The effects of exposed pipe encasements on the local variation of hydrodynamic and sediment conditions in a river channel are examined. Laboratory experiments are performed to assess the response of water level, flow regime and bed deformation to several representative types of concrete encasements. The experimental conditions considered are: three types of exposed pipe encasements exposed on the bed, including trapezoidal shape, circular-arc shape and polygonal shape, and three sets of discharges, including annual discharge, once-in-3-year flood, and once-in-50-year flood. Our experiments show that: (1) the amount of backwater definitely depends on the encasement geometric shape and the background discharge; (2) smaller discharges generally tend to induce local scour of river bed downstream of the encasement, and the order of sensitivity of bed deformation to the encasement geometric shape is trapezoidal > circular-arc > polygonal; (3) comparatively speaking, the polygonal encasement may be considered as a suitable protective structure for pipelines across alluvial rivers, with relatively modest effects on the local hydrodynamic conditions and bed stabilization.	[Mao, J. Q.; Zhang, H. Q.; Dai, H. C.; Hu, T. F.] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, H. Q.] Zhejiang Inst Hydraul & Estuary, Hangzhou, Zhejiang, Peoples R China; [Yuan, B. H.] Hohai Univ, Sch Earth Sci & Engn, Nanjing, Jiangsu, Peoples R China	Hohai University; Hohai University	Mao, JQ (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China.	maojq@hhu.edu.cn			National Natural Science Foundation of China [51379059, 51279047]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The study is supported by the National Natural Science Foundation of China (grant No. 51379059, 51279047), and Program for Changjiang Scholars and Innovative Research Team in University (IRT1233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZC, 2005, J HYDRAUL RES, V43, P703, DOI 10.1080/00221680509500390; Cheng L, 2003, COAST ENG J, V45, P189, DOI 10.1142/S0578563403000737; FARHOUDI J, 1985, J HYDRAUL RES, V23, P343, DOI 10.1080/00221688509499344; Kim MK, 2013, STRUCT INFRASTRUCT E, V9, P860, DOI 10.1080/15732479.2011.627349; Lan HT, 2015, J PIPELINE SYST ENG, V6, DOI 10.1061/(ASCE)PS.1949-1204.0000128; Liang DF, 2005, OCEAN ENG, V32, P1590, DOI 10.1016/j.oceaneng.2004.10.025; Moncada-M AT, 1999, J HYDRAUL ENG-ASCE, V125, P953, DOI 10.1061/(ASCE)0733-9429(1999)125:9(953); Oliveto G, 2009, J HYDRAUL ENG, V135, P846, DOI 10.1061/(ASCE)HY.1943-7900.0000078; Radice A, 2012, J HYDRAUL RES, V50, P44, DOI 10.1080/00221686.2011.641764; SEPA, 2010, ENG WAT ENV GOOD PRA; USACE, 1987, HYDR DES CRIT; USDOI, 2005, DES CRIT RED RIV VAL; Wang ZY, 1999, J HYDRAUL RES, V37, P17, DOI 10.1080/00221689909498530; Wildman LAS, 2005, GEOMORPHOLOGY, V71, P245, DOI 10.1016/j.geomorph.2004.08.018; Yen BC, 2002, J HYDRAUL ENG-ASCE, V128, P20, DOI 10.1061/(ASCE)0733-9429(2002)128:1(20); Zhang RJ, 2007, RIVER DYNAMICS, P4660; [No title captured]	18	0	0	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2015	10	11							e0143300	10.1371/journal.pone.0143300	http://dx.doi.org/10.1371/journal.pone.0143300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LQ	26588840	Green Published, Green Submitted, gold			2022-12-26	WOS:000365251500050
J	Irikura, D; Monma, C; Suzuki, Y; Nakama, A; Kai, A; Fukui-Miyazaki, A; Horiguchi, Y; Yoshinari, T; Sugita-Konishi, Y; Kamata, Y				Irikura, Daisuke; Monma, Chie; Suzuki, Yasunori; Nakama, Akiko; Kai, Akemi; Fukui-Miyazaki, Aya; Horiguchi, Yasuhiko; Yoshinari, Tomoya; Sugita-Konishi, Yoshiko; Kamata, Yoichi			Identification and Characterization of a New Enterotoxin Produced by Clostridium perfringens Isolated from Food Poisoning Outbreaks	PLOS ONE			English	Article							ARGININE ADP-RIBOSYLATION; IOTA-TOXIN; ENZYMATIC COMPONENTS; C2 TOXIN; SPIROFORME; EXPRESSION; RECEPTOR; CLONING	There is a strain of Clostridium perfringens, W5052, which does not produce a known enterotoxin. We herein report that the strain W5052 expressed a homologue of the iota-like toxin components sa and sb of C. spiroforme, named Clostridium perfringens iota-like enterotoxin, CPILE-a and CPILE-b, respectively, based on the results of a genome sequencing analysis and a systematic protein screening. In the nicotinamide glyco-hydrolase (NADase) assay the hydrolysis activity was dose-dependently increased by the concentration of rCPILE-a, as judged by the mass spectrometry analysis. In addition, the actin monomer of the lysates of Vero and L929 cells were radiolabeled in the presence of ([32P])NAD and rCPILE-a. These findings indicated that CPILE-a possesses ADP-ribosylation activity. The culture supernatant of W5052 facilitated the rounding and killing of Vero and L929 cells, but the rCPILE-a or a non-proteolyzed rCPILE-b did not. However, a trypsintreated rCPILE-b did. Moreover, a mixture of rCPILE-a and the trypsin-treated rCPILE-b enhanced the cell rounding and killing activities, compared with that induced by the trypsintreated rCPILE-b alone. The injection of the mixture of rCPILE-a and the trypsin-treated rCPILE-b into an ileum loop of rabbits evoked the swelling of the loop and accumulation of the fluid dose-dependently, suggesting that CPILE possesses enterotoxic activity. The evidence presented in this communication will facilitate the epidemiological, etiological, and toxicological studies of C. perfringens food poisoning, and also stimulate studies on the transfer of the toxins' gene(s) among the Genus Clostridium.	[Irikura, Daisuke; Yoshinari, Tomoya; Sugita-Konishi, Yoshiko; Kamata, Yoichi] Natl Inst Hlth Sci, Div Microbiol, Tokyo, Japan; [Monma, Chie; Suzuki, Yasunori; Nakama, Akiko] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Tokyo 1690073, Japan; [Kai, Akemi; Fukui-Miyazaki, Aya; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Dept Mol Biol, Osaka, Japan; [Sugita-Konishi, Yoshiko] Azabu Univ, Grad Sch Life & Environm Sci, Dept Food & Life Sci, Kanagawa, Japan; [Kamata, Yoichi] Iwate Univ, Dept Vet Med, Morioka, Iwate 020, Japan	National Institute of Health Sciences - Japan; Tokyo Metropolitan Institute of Public Health; Osaka University; Azabu University; Iwate University	Kamata, Y (corresponding author), Natl Inst Hlth Sci, Div Microbiol, Tokyo, Japan.	ykamata@iwate-u.ac.jp		Suzuki, Yasunori/0000-0001-9278-0232	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a grant from the Ministry of Health, Labour and Welfare of Japan.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bain MS, 1998, VET REC, V142, P47; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Carmen R, 2010, OPEN TOXIN J, V3, P43; Carver T, 2003, BIOINFORMATICS, V19, P1837, DOI 10.1093/bioinformatics/btg251; CZECZULIN JR, 1993, INFECT IMMUN, V61, P3429, DOI 10.1128/IAI.61.8.3429-3439.1993; Gibert M, 2000, INFECT IMMUN, V68, P3848, DOI 10.1128/IAI.68.7.3848-3853.2000; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Kobayashi K, 2008, MICROB PATHOGENESIS, V44, P265, DOI 10.1016/j.micpath.2007.10.010; McClane BA, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P423; MELVILLE SB, 1994, INFECT IMMUN, V62, P5550, DOI 10.1128/IAI.62.12.5550-5558.1994; Miyamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020376; Monma C, 2015, J CLIN MICROBIOL, V53, P859, DOI 10.1128/JCM.02859-14; Nagahama M, 2012, INFECT IMMUN, V80, P3410, DOI 10.1128/IAI.00483-12; Nagahama M, 2011, INFECT IMMUN, V79, P4353, DOI 10.1128/IAI.05677-11; NAKAMURA S, 1978, MICROBIOL IMMUNOL, V22, P591, DOI 10.1111/j.1348-0421.1978.tb00409.x; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Perelle S, 1997, FEMS MICROBIOL LETT, V146, P117, DOI [10.1016/S0378-1097(96)00463-6, 10.1111/j.1574-6968.1997.tb10180.x]; PERELLE S, 1993, INFECT IMMUN, V61, P5147, DOI 10.1128/IAI.61.12.5147-5156.1993; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; Popoff MR, 1998, BIOCHEM BIOPH RES CO, V152, P1361; Sakurai J, 1997, J TOXICOL-TOXIN REV, V16, P195, DOI 10.3109/15569549709016456; Sakurai J., 1995, Reviews in Medical Microbiology, V6, P175; Sakurai J, 2009, TOXINS, V1, P208, DOI 10.3390/toxins1020208; SIMPSON LL, 1989, INFECT IMMUN, V57, P255, DOI 10.1128/IAI.57.1.255-261.1989; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; STRONG DH, 1970, APPL MICROBIOL, V19, P980, DOI 10.1128/AEM.19.6.980-987.1970; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Uzal FA, 2008, J VET DIAGN INVEST, V20, P253, DOI 10.1177/104063870802000301; Yonogi S, 2014, INFECT IMMUN, V82, P2390, DOI 10.1128/IAI.01759-14	33	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2015	10	11							e0138183	10.1371/journal.pone.0138183	http://dx.doi.org/10.1371/journal.pone.0138183			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW8LG	26584048	Green Published, gold, Green Submitted			2022-12-26	WOS:000365250500001
J	Poyet, M; Le Roux, V; Gibert, P; Meirland, A; Prevost, G; Eslin, P; Chabrerie, O				Poyet, Mathilde; Le Roux, Vincent; Gibert, Patricia; Meirland, Antoine; Prevost, Genevieve; Eslin, Patrice; Chabrerie, Olivier			The Wide Potential Trophic Niche of the Asiatic Fruit Fly Drosophila suzukii: The Key of Its Invasion Success in Temperate Europe?	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; DIPTERA DROSOPHILIDAE; SEED DISPERSAL; FLIES DIPTERA; PARASITOIDS HYMENOPTERA; ECOSYSTEM SERVICES; OVIPOSITION; PEST; TEPHRITIDAE; ALKALOIDS	The Asiatic fruit fly Drosophila suzukii has recently invaded Europe and North and South America, causing severe damage to fruit production systems. Although agronomic host plants of that fly are now well documented, little is known about the suitability of wild and ornamental hosts in its exotic area. In order to study the potential trophic niche of D. suzukii with relation to fruit characteristics, fleshy fruits from 67 plant species were sampled in natural and anthropic ecosystems (forests, hedgerows, grasslands, coastal areas, gardens and urban areas) of the north of France and submitted to experimental infestations. A set of fruit traits (structure, colour, shape, skin texture, diameter and weight, phenology) potentially interacting with oviposition choices and development success of D. suzukii was measured. Almost half of the tested plant species belonging to 17 plant families allowed the full development of D. suzukii. This suggests that the extreme polyphagy of the fly and the very large reservoir of hosts producing fruits all year round ensure temporal continuity in resource availability and contribute to the persistence and the exceptional invasion success of D. suzukii in natural habitats and neighbouring cultivated systems. Nevertheless, this very plastic trophic niche is not systematically beneficial to the fly. Some of the tested plants attractive to D. suzukii gravid females stimulate oviposition but do not allow full larval development. Planted near sensitive crops, these "trap plants" may attract and lure D. suzukii, therefore contributing to the control of the invasive fly.	[Poyet, Mathilde; Le Roux, Vincent; Meirland, Antoine; Prevost, Genevieve; Eslin, Patrice; Chabrerie, Olivier] Univ Picardie Jules Verne, Unite Ecol & Dynam Syst Anthropises FRE CNRS 3498, Amiens, France; [Poyet, Mathilde; Gibert, Patricia] Univ Lyon 1, Lab Biometrie & Biol Evolut UMR CNRS 55, F-69622 Villeurbanne, France; [Meirland, Antoine] Maison Univ Picardie Jules Verne, Grp Etud Milieux Estuariens & Littoraux GEMEL, St Valery Sur Somme, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Chabrerie, O (corresponding author), Univ Picardie Jules Verne, Unite Ecol & Dynam Syst Anthropises FRE CNRS 3498, Amiens, France.	olivier.chabrerie@u-picardie.fr		Chabrerie, Olivier/0000-0002-8949-1859; Gibert, Patricia/0000-0002-9461-6820				ANDERSEN AN, 1988, OIKOS, V52, P337, DOI 10.2307/3565207; Aniszewski T, 2007, ALKALOIDS SECRETS LI; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Atallah J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2840; AVERILL AL, 1987, ECOLOGY, V68, P878, DOI 10.2307/1938359; Balagawi S, 2005, AUST J ENTOMOL, V44, P97, DOI 10.1111/j.1440-6055.2005.00459.x; Bargel H, 2006, FUNCT PLANT BIOL, V33, P893, DOI 10.1071/FP06139; Barthlott W., 1990, SCANNING ELECT MICRO, P69; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bellamy DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061227; BENTLEY MD, 1984, ANN ENTOMOL SOC AM, V77, P401, DOI 10.1093/aesa/77.4.401; Berg MP, 2010, EVOL ECOL, V24, P617, DOI 10.1007/s10682-009-9347-8; Berlocher S. H., 2009, Biorational tree-fruit pest management, P32, DOI 10.1079/9781845934842.0032; Bernays EA, 1999, ECOL ENTOMOL, V24, P260, DOI 10.1046/j.1365-2311.1999.00193.x; Bird TL, 2006, B ENTOMOL RES, V96, P15, DOI 10.1079/BER2005398; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bolda M.P., 2010, AGR RESOUR EC UPDATE, V13, P5, DOI DOI 10.1016/J.JFF.2015.04.027; BROWER LP, 1975, SCIENCE, V188, P19, DOI 10.1126/science.188.4183.19; Brunneton J, 2005, PLANTES TOXIQUES VEG; Burrack HJ, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM12012; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Cha DH, 2015, ENTOMOL EXP APPL, V154, P251, DOI 10.1111/eea.12276; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; Chabrerie O, 2010, BIOL INVASIONS, V12, P1891, DOI 10.1007/s10530-009-9599-9; Charles H, 2007, IMPACTS INVASIVE SPE, P217; CHEW FS, 1991, AM NAT, V138, P729, DOI 10.1086/285246; Cini A, 2014, J PEST SCI, V87, P559, DOI 10.1007/s10340-014-0617-z; Cini A, 2012, B INSECTOL, V65, P149; Clark NE, 2014, TRENDS ECOL EVOL, V29, P198, DOI 10.1016/j.tree.2014.01.009; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Daniel M., 2006, MED PLANTS CHEM PROP; Danielson PB, 1996, PESTIC BIOCHEM PHYS, V55, P172, DOI 10.1006/pest.1996.0046; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Dewick PM., 2009, MED NATURAL PRODUCTS, V3rd ed., DOI 10.1002/9780470742761.ch3; Diaz-Fleischer F, 2003, J INSECT BEHAV, V16, P537, DOI 10.1023/A:1027307424150; Dimitrov K, 2005, SEP PURIF TECHNOL, V46, P41, DOI 10.1016/j.seppur.2005.04.008; Dixon MD, 1997, OECOLOGIA, V111, P201, DOI 10.1007/s004420050226; Dreves AJ., 2009, NEW PEST ATTACKING H; DREW RAI, 1987, ANN ENTOMOL SOC AM, V80, P629, DOI 10.1093/aesa/80.5.629; Drew RAI, 2003, ENTOMOL EXP APPL, V107, P39, DOI 10.1046/j.1570-7458.2003.00039.x; DREW RAI, 1987, AUST J ZOOL, V35, P283, DOI 10.1071/ZO9870283; Dukas R, 2001, ECOL ENTOMOL, V26, P587, DOI 10.1046/j.1365-2311.2001.00359.x; Fogleman JC, 2000, CHEM-BIOL INTERACT, V125, P93, DOI 10.1016/S0009-2797(99)00161-1; Garcia D, 1999, OIKOS, V85, P536, DOI 10.2307/3546703; Garcia D, 2012, P ROY SOC B-BIOL SCI, V279, P3106, DOI 10.1098/rspb.2012.0175; Garcia D, 2010, CONSERV BIOL, V24, P1070, DOI 10.1111/j.1523-1739.2009.01440.x; Gariepy TD, 2014, J PEST SCI, V87, P17, DOI 10.1007/s10340-013-0529-3; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Gorb E, 2008, ARTHROPOD-PLANT INTE, V2, P247, DOI 10.1007/s11829-008-9049-0; Guglielmo CG, 1996, ECOLOGY, V77, P1103, DOI 10.2307/2265579; Hamby KA, 2014, ENVIRON ENTOMOL, V43, P1008, DOI 10.1603/EN13245; Harris DW, 2014, J ASIA-PAC ENTOMOL, V17, P857, DOI 10.1016/j.aspen.2014.08.006; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Held DW, 2004, OECOLOGIA, V140, P312, DOI 10.1007/s00442-004-1582-7; Heldt H.-W., 2005, PLANT BIOCH; Henneman ML, 1999, ENTOMOL EXP APPL, V93, P249, DOI 10.1023/A:1003892401712; Henry T. A, 1949, THE PLANT ALKALOIDS, V4th, P43; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; HOFFMANN AA, 1984, HEREDITY, V53, P139, DOI 10.1038/hdy.1984.69; HOFFMANN AA, 1985, AM NAT, V126, P41, DOI 10.1086/284394; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; Hortical, 2015, HORT CAL JARD; Imai K, 2004, ECOL ENTOMOL, V29, P420, DOI 10.1111/j.0307-6946.2004.00627.x; Imai K, 2006, GALLING ARTHROPODS AND THEIR ASSOCIATES: ECOLOGY AND EVOLUTION, P169, DOI 10.1007/4-431-32185-3_14; JANZEN DH, 1977, PHYTOCHEMISTRY, V16, P223, DOI 10.1016/S0031-9422(00)86790-4; Jerde CL, 2007, AM NAT, V170, P1, DOI 10.1086/518179; JOHNSON ND, 1988, J CHEM ECOL, V14, P1391, DOI 10.1007/BF01020143; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Kanzawa T., 1935, RES FRUIT FLY DROSOP; Kanzawa T., 1939, STUDIES DROSOPHILA S; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Keesey IW, 2015, J CHEM ECOL, V41, P121, DOI 10.1007/s10886-015-0544-3; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; KING PD, 1982, NEW ZEAL J EXP AGR, V10, P337, DOI 10.1080/03015521.1982.10427894; Koch K, 2008, MICRON, V39, P759, DOI 10.1016/j.micron.2007.11.010; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lambinon J., 2004, NOUVELLE FLORE BELGI, V5e; LAMPREY H F, 1974, East African Wildlife Journal, V12, P81; Lavorel S, 1998, ACTA OECOL, V19, P227, DOI 10.1016/S1146-609X(98)80027-1; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lee JC, 2015, ANN ENTOMOL SOC AM, V108, P117, DOI 10.1093/aesa/sau014; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Lee JC, 2011, PEST MANAG SCI, V67, P1358, DOI 10.1002/ps.2225; LEVINE E, 1977, J ECON ENTOMOL, V70, P603, DOI 10.1093/jee/70.5.603; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Liu ZL, 2012, PARASITOL RES, V111, P991, DOI 10.1007/s00436-012-2923-9; Louapre P, 2014, ECOL ENTOMOL, V39, P343, DOI 10.1111/een.12105; MA WW, 1990, J NAT PROD, V53, P1009, DOI 10.1021/np50070a041; MALCOLM SB, 1989, EXPERIENTIA, V45, P284, DOI 10.1007/BF01951814; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; MANZUR MI, 1984, OIKOS, V43, P265, DOI 10.2307/3544142; Matsuki M, 2011, AGR FOREST ENTOMOL, V13, P1, DOI 10.1111/j.1461-9563.2010.00492.x; Matsumura S, 1931, 6000 ILLUSTRATED INS; Mazzetto F, 2015, J ASIA-PAC ENTOMOL, V18, P321, DOI 10.1016/j.aspen.2015.04.001; MCDONALD PT, 1985, ENTOMOL EXP APPL, V37, P207, DOI 10.1007/BF00191650; MCINNIS DO, 1989, J ECON ENTOMOL, V82, P1382, DOI 10.1093/jee/82.5.1382; Milan NF, 2012, CURR BIOL, V22, P488, DOI 10.1016/j.cub.2012.01.045; Mioulane P, 2002, ENCY UNIVERSELLE 150; Mitsui H, 2006, POPUL ECOL, V48, P233, DOI 10.1007/s10144-006-0260-5; Mitsui H, 2010, ENTOMOL SCI, V13, P60, DOI 10.1111/j.1479-8298.2010.00372.x; Mortelmans J, 2012, BELG J ZOOL, V142, P143; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelson L.S., 2007, HDB POISONOUS INJURI, V2nd ed.; OAKESHOTT JG, 1989, OECOLOGIA, V78, P533, DOI 10.1007/BF00378745; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Pairon M, 2006, ACTA OECOL, V30, P238, DOI 10.1016/j.actao.2006.05.002; Pascual M, 2007, MOL ECOL, V16, P3069, DOI 10.1111/j.1365-294X.2007.03336.x; Pejchar L, 2009, TRENDS ECOL EVOL, V24, P497, DOI 10.1016/j.tree.2009.03.016; Pengelly A., 2004, CONSTITUENTS MED PLA; PHILOGENE BJR, 1984, J CHEM ECOL, V10, P115, DOI 10.1007/BF00987648; Picot S, 2008, HEREDITY, V101, P53, DOI 10.1038/hdy.2008.27; Powell K.S., 2012, ARTHROPOD MANAGEMENT, P219, DOI DOI 10.1007/978-94-007-4032-7_10; Poyet M, 2014, AGR FOREST ENTOMOL, V16, P251, DOI 10.1111/afe.12052; Poyet M, 2013, PHYSIOL ENTOMOL, V38, P45, DOI 10.1111/phen.12002; PROKOPY RJ, 1968, ENTOMOL EXP APPL, V11, P403, DOI 10.1007/BF00364572; PROKOPY RJ, 1971, ENTOMOL EXP APPL, V14, P1, DOI 10.1007/BF00341121; PROKOPY RJ, 1993, J INSECT BEHAV, V6, P167, DOI 10.1007/BF01051502; Provost M, 1998, FLORE VASCULAIRE BAS; PUECH A, 1972, J CHROMATOGR, V68, P161, DOI 10.1016/S0021-9673(00)88773-7; Rameau J.-C., 1989, FLORE FORESTIERE FRA; Rey PJ, 2014, PERSPECT PLANT ECOL, V16, P21, DOI 10.1016/j.ppees.2013.11.001; RONSCH H, 1966, PHYTOCHEMISTRY, V5, P1227, DOI 10.1016/S0031-9422(00)86118-X; Roques Alain, 2010, BioRisk, V4, P11; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; Rothe G, 2002, PLANT SCI, V163, P979, DOI 10.1016/S0168-9452(02)00247-9; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schreiber K., 1968, ALKALOIDS CHEM CHEMI, V10, P1, DOI 10.1016/S1876-0813(08)60253-5; Schwarz S, 2014, NATURWISSENSCHAFTEN, V101, P61, DOI 10.1007/s00114-013-1129-z; Senat, 2012, COMPT REND AN OFF 17; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Skuhrava M., 2010, BIORISK - Biodiversity and Ecosystem Risk Assessment, P553; Stachowicz JJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P41; Steck GJ, 2009, DROSOPHILA SUZUKII; Tela Botanica, 2015, E FLOR; VALBURG LK, 1992, OIKOS, V65, P25, DOI 10.2307/3544883; VANHAGA PR, 1954, NATURE, V174, P833, DOI 10.1038/174833b0; VARGAS RI, 1991, J ECON ENTOMOL, V84, P1503, DOI 10.1093/jee/84.5.1503; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; WEBER DC, 1994, ADVANCES IN POTATO PEST, P54; Wermelinger Beat, 2008, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V81, P1; Wilson AJ, 2012, ARTHROPOD-PLANT INTE, V6, P635, DOI 10.1007/s11829-012-9205-4; WINK M, 1990, J COMP PHYSIOL B, V160, P389, DOI 10.1007/BF01075670; Zhang K, 2014, ENTOMOL EXP APPL, V152, P148, DOI 10.1111/eea.12210	151	139	143	5	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0142785	10.1371/journal.pone.0142785	http://dx.doi.org/10.1371/journal.pone.0142785			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26581101	Green Published, gold, Green Submitted			2022-12-26	WOS:000365154600060
J	Guo, HQ; Guo, HF; Yang, YL; Sun, BZ				Guo, Haiqiang; Guo, Huifang; Yang, Yilong; Sun, Baozhi			Internal and External Factors Related to Burnout among Iron and Steel Workers: A Cross-Sectional Study in Anshan, China	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; PERCEIVED ORGANIZATIONAL SUPPORT; OCCUPATIONAL STRESS; JOB-SATISFACTION; CANCER-RISKS; NURSES; FEMALE; ASSOCIATIONS; PREVALENCE; RESOURCES	Background Burnout is a syndrome of emotional exhaustion, cynicism and reduced professional efficacy, which can result from long-term work stress. Although the burnout level is high among iron and steel workers, little is known concerning burnout among iron and steel worker. This study aimed to evaluate the burnout and to explore its associated internal and external factors in iron and steel workers. Methods A cross-sectional survey was conducted in iron and steel workers at the Anshan iron-steel complex in Anshan, northeast China. Self-administered questionnaires were distributed to 1,600 workers, and finally 1,300 questionnaires were returned. Burnout was measured using the Chinese version of the Maslach Burnout Inventory-General Survey (MBI-GS). Effort-reward imbalance (ERI), perceived organizational support (POS), and psychological capital (PsyCap) were measured anonymously. A hierarchical regression model was applied to explore the internal and external factors associated with burnout. Results Mean MBI-GS scores were 13.11 +/- 8.06 for emotional exhaustion, 6.64 +/- 6.44 for cynicism, and 28.96 +/- 10.39 for professional efficacy. Hierarchical linear regression analysis showed that ERI and POS were the most powerful predictors for emotional exhaustion and cynicism, and PsyCap was the most robust predictor for high professional efficacy. Conclusions Chinese iron and steel workers have a high level of burnout. Burnout might be associated with internal and external factors, including ERI, POS, and PsyCap. Further studies are recommended to develop an integrated model including both internal and external factors, to reduce the level of ERI, and improve POS and workers' PsyCap, thereby alleviating the level of burnout among iron and steel workers.	[Guo, Haiqiang; Sun, Baozhi] Harbin Med Univ, Sch Publ Hlth, Harbin, Peoples R China; [Guo, Huifang] Dalian Med Univ, Affiliated Hosp 1, Dept Nursing, Dalian, Peoples R China; [Yang, Yilong] China Med Univ, Sch Publ Hlth, Shenyang 110001, Peoples R China	Harbin Medical University; Dalian Medical University; China Medical University	Sun, BZ (corresponding author), Harbin Med Univ, Sch Publ Hlth, Harbin, Peoples R China.	baozhisun16@126.com						Aghilinejad M, 2012, IRAN RED CRESCENT ME, V14, P198; Ahola K, 2008, J OCCUP HEALTH, V50, P362, DOI 10.1539/joh.M8002; Aloe AM, 2014, EDUC RES REV-NETH, V12, P30, DOI 10.1016/j.edurev.2014.05.003; Avey JB, 2009, HUM RESOUR MANAGE-US, V48, P677, DOI 10.1002/hrm.20294; Backteman-Erlanson S, 2013, POLICE PRACT RES, V14, P491, DOI 10.1080/15614263.2012.736719; Brouwers A, 2000, TEACH TEACH EDUC, V16, P239, DOI 10.1016/S0742-051X(99)00057-8; Chen YE, 2013, CHINA J HLTH PSYCHOL, V21, P1509; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Dong Y.H ., 2010, STUDIES PSYCHOL BEHA, V8, P58, DOI DOI 10.3969/J.ISSN.1672-0628.2010.01.011; EISENBERGER R, 1986, J APPL PSYCHOL, V71, P500, DOI 10.1037/0021-9010.75.1.51; Feuerhahn N, 2012, INT J STRESS MANAGE, V19, P105, DOI 10.1037/a0028338; Fu J, 2013, PUBLIC HEALTH, V127, P946, DOI 10.1016/j.puhe.2012.12.017; Grimsrud TK, 1998, OCCUP ENVIRON MED, V55, P387, DOI 10.1136/oem.55.6.387; Guo HM, 2011, J SHANXI MED U, V42, P398; Hu LP, 2010, J SHANDONG NORMAL U, V25, P54; International Committee of the Fourth International, PROT CHIN STEEL WORK; Jawahar I.M., 2007, INT J STRESS MANAGE, V14, P142, DOI [10.1037/1072-5245.14.2.142, DOI 10.1037/1072-5245.14.2.142]; Kitaoka-Higashiguchi K, 2009, J OCCUP HEALTH, V51, P123, DOI 10.1539/joh.L8104; Li Jun, 2014, Journal of Environmental & Occupational Medicine, V31, P25; Lin QH, 2013, J OCCUP HEALTH, V55, P458, DOI 10.1539/joh.12-0287-OA; Liu L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-89; Luthans F, 2006, J ORGAN BEHAV, V27, P387, DOI 10.1002/job.373; Luthans F, 2004, ORGAN DYN, V33, P143, DOI 10.1016/j.orgdyn.2004.01.003; Luthans F, 2002, ACAD MANAGE EXEC, V16, P57, DOI 10.5465/AME.2002.6640181; Luthans F., 2005, MANAGE ORGAN REV, V1, P247, DOI DOI 10.1111/J.1740-8784.2005.00011.X; Luthans F, 2008, ACAD MANAG LEARN EDU, V7, P209, DOI 10.5465/AMLE.2008.32712618; Luthans F, 2007, J MANAGE, V33, P321, DOI 10.1177/0149206307300814; Manjunatha R, 2011, AUSTRALAS MED J, V4, P143, DOI 10.4066/AMJ.2011.576; Martinussen M, 2007, J CRIM JUST, V35, P239, DOI 10.1016/j.jcrimjus.2007.03.001; Maslach C, 1996, MASLACH BURNOUT INVE; Park RM, 2005, AM J IND MED, V48, P194, DOI 10.1002/ajim.20197; Peng JX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084193, 10.1371/journal.pone.0082465]; Prince SA, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-120; Rhoades L, 2002, J APPL PSYCHOL, V87, P698, DOI 10.1037//0021-9010.87.4.698; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd ed., P19; Schulz M, 2009, J PSYCHIATR MENT HLT, V16, P225, DOI 10.1111/j.1365-2850.2008.01355.x; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J, 1998, THEORIES OF ORGANIZATIONAL STRESS, P190; Tsai FJ, 2010, INT ARCH OCC ENV HEA, V83, P133, DOI 10.1007/s00420-009-0454-1; van Vegchel N, 2005, SOC SCI MED, V60, P1117, DOI 10.1016/j.socscimed.2004.06.043; Wang L, 2013, THESIS, P17; Wang LiYing, 2008, Chinese Journal of Prevention and Control of Chronic Non-Communicable Diseases, V16, P574; Wang Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-915; Wee SL, 2009, T REUTERS       0726; Weng HC, 2011, MED EDUC, V45, P835, DOI 10.1111/j.1365-2923.2011.03985.x; Wu H, 2014, J NURS MANAGE, V22, P621, DOI 10.1111/jonm.12015; Wu H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-786; Wu SY, 2007, J ADV NURS, V59, P233, DOI 10.1111/j.1365-2648.2007.04301.x; Xu ZY, 1996, AM J IND MED, V30, P1, DOI 10.1002/(SICI)1097-0274(199607)30:1<1::AID-AJIM1>3.0.CO;2-5; Xu ZY, 1996, AM J IND MED, V30, P7; Yang Wen-Jie, 2004, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V22, P422; Yu SF, 2013, IND HEALTH, V51, P180, DOI 10.2486/indhealth.MS1233; Zhu Wei, 2006, Sichuan Da Xue Xue Bao Yi Xue Ban, V37, P281	53	5	5	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2015	10	11							e0143159	10.1371/journal.pone.0143159	http://dx.doi.org/10.1371/journal.pone.0143159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CW7BR	26575031	Green Submitted, Green Published, gold			2022-12-26	WOS:000365153400049
J	Balzer, MS; Gross, MM; Lichtinghagen, R; Haller, H; Schmitt, R				Balzer, Michael S.; Gross, Mechthild M.; Lichtinghagen, Ralf; Haller, Hermann; Schmitt, Roland			Got Milk? Breastfeeding and Milk Analysis of a Mother on Chronic Hemodialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BLOOD-PRESSURE; DIALYSIS PATIENTS; UNITED-STATES; PREGNANCY OUTCOMES; SODIUM; WOMEN; METAANALYSIS; CHILDREN; PRETERM	Purpose Women on dialysis rarely become pregnant. However, the overall rate of successful pregnancies is increasing in this patient population and breastfeeding becomes an option for mothers on dialysis. In this study we performed a systematic breast milk composition analysis of a mother on chronic hemodialysis (HD). Methods Specimens of breast milk and blood were collected in regular intervals before and after HD from a 39-year old woman starting on day 10 postpartum. Samples were analyzed for electrolytes, retention solutes, nutrients and other laboratory measurements. Breast milk samples from low-risk mothers matched for postpartum age were used as controls. Results Significantly higher levels of creatinine and urea were found in pre-HD breast milk when compared to post-HD. A similar post-dialytic decrease was only found for uric acid but not for any other investigated parameter. Conversely, sodium and chloride were significantly increased in post-HD samples. Compared to controls creatinine and urea were significantly higher in pre-HD samples while the difference remained only significant for post-HD creatinine. Phosphate was significantly lower in pre-and post-HD breast milk when compared to controls, whereas calcium showed no significant differences. In terms of nutrient components glucose levels showed a strong trend for a decrease, whereas protein, triglycerides and cholesterol did not differ. Similarly, no significant differences were found in iron, potassium and magnesium content. Conclusion To the best of our knowledge this is the first report on a breastfeeding mother on chronic dialysis. Although we found differences in creatinine, urea, sodium, chloride and phosphate, our general analysis showed high similarity of our patient's breast milk to samples from low-risk control mothers. Significant variations in breast milk composition between pre- and post-HD samples suggest that breastfeeding might be preferably performed after dialysis treatment. In summary, our findings indicate that breastfeeding can be considered a viable option for newborns of mothers on dialysis.	[Balzer, Michael S.; Haller, Hermann; Schmitt, Roland] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany; [Gross, Mechthild M.] Hannover Med Sch, Midwifery Res & Educ Unit, Hannover, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Inst Clin Chem, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Balzer, MS (corresponding author), Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany.	balzer.michael@mh-hannover.de; schmitt.roland@mh-hannover.de	Balzer, Michael S./GNH-1501-2022; Gross, Mechthild M/S-4186-2018; Schmitt, Roland/AAP-4609-2021; Balzer, Michael S./GNH-1518-2022	Balzer, Michael S./0000-0003-0508-1260; Gross, Mechthild M/0000-0001-6348-0054; Balzer, Michael S./0000-0003-0508-1260; Schmitt, Roland/0000-0003-4415-8355				[Anonymous], 1980, BRIT J OBSTET GYNAEC, V87, P839; Bagon JA, 1998, AM J KIDNEY DIS, V31, P756, DOI 10.1016/S0272-6386(98)70060-5; Bartick M, 2010, PEDIATRICS, V125, pE1048, DOI 10.1542/peds.2009-1616; Barua M, 2008, CLIN J AM SOC NEPHRO, V3, P392, DOI 10.2215/CJN.04110907; Blume C, 2014, BEST PRACT RES CL OB, V28, P1123, DOI 10.1016/j.bpobgyn.2014.07.021; Chou CY, 2008, EUR J OBSTET GYN R B, V136, P165, DOI 10.1016/j.ejogrb.2007.01.017; Committee USB, 2002, EC BEN BREASTF; DAGAN R, 1982, EUR J PEDIATR, V139, P192, DOI 10.1007/BF01377355; Dee DL, 2007, PEDIATRICS, V119, pS92, DOI 10.1542/peds.2006-2089N; Ertl T, 1982, Acta Paediatr Acad Sci Hung, V23, P309; Gidrewicz DA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-216; Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461; Groothoff J, 2015, NEPHROL DIAL TRANSPL, V30, P1053, DOI 10.1093/ndt/gfv124; Haase M, 2005, NEPHROL DIAL TRANSPL, V20, P2537, DOI 10.1093/ndt/gfi044; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; Hladunewich MA, 2014, J AM SOC NEPHROL, V25, P1103, DOI 10.1681/ASN.2013080825; HOFMAN A, 1983, JAMA-J AM MED ASSOC, V250, P370, DOI 10.1001/jama.250.3.370; Holley JL, 2003, SEMIN DIALYSIS, V16, P384, DOI 10.1046/j.1525-139X.2003.16085.x; Horta BL., 2013, SHORT TERM EFFECTS B, V49; Hou S, 1999, AM J KIDNEY DIS, V33, P235, DOI 10.1016/S0272-6386(99)70296-9; HOU SH, 1994, AM J KIDNEY DIS, V23, P60, DOI 10.1016/S0272-6386(12)80813-4; KOHLER H, 1984, KIDNEY INT, V25, P124, DOI 10.1038/ki.1984.18; KOUTRAS AK, 1989, J PEDIATR GASTR NUTR, V9, P58, DOI 10.1097/00005176-198909010-00011; Kovacs CS, 2005, J MAMMARY GLAND BIOL, V10, P105, DOI 10.1007/s10911-005-5394-0; Larguia A Miguel, 2015, Adv Neurobiol, V10, P425, DOI 10.1007/978-1-4939-1372-5_20; LUCAS A, 1992, LANCET, V339, P261, DOI 10.1016/0140-6736(92)91329-7; Luders C, 2010, AM J KIDNEY DIS, V56, P77, DOI 10.1053/j.ajkd.2010.01.018; Maalouf J, 2015, AM J CLIN NUTR, V101, P1021, DOI 10.3945/ajcn.114.099770; Manisco G, 2015, CLIN KIDNEY J, V8, P293, DOI 10.1093/ckj/sfv016; Miliku K, 2015, AM J KIDNEY DIS, V66, P421, DOI 10.1053/j.ajkd.2014.12.018; Moore ER, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub2; MORTON JA, 1994, PEDIATRICS, V93, P802; Nevis IF, 2011, CLIN J AM SOC NEPHRO, V6, P2587, DOI 10.2215/CJN.10841210; Nikniaz L, 2011, HEALTH PROMOT PERSPE, V1, P140, DOI 10.5681/hpp.2011.015; Okundaye I, 1998, AM J KIDNEY DIS, V31, P766, DOI 10.1016/S0272-6386(98)70044-7; Parikh NI, 2009, AM J MED, V122, P656, DOI 10.1016/j.amjmed.2008.11.034; Piccoli GB, 2015, J AM SOC NEPHROL, V26, P2011, DOI 10.1681/ASN.2014050459; Pomeranz A, 2002, J HYPERTENS, V20, P203, DOI 10.1097/00004872-200202000-00009; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; SOUQIYYEH MZ, 1992, AM J KIDNEY DIS, V19, P235, DOI 10.1016/S0272-6386(13)80003-0; Toma H, 1999, NEPHROL DIAL TRANSPL, V14, P1511, DOI 10.1093/ndt/14.6.1511; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; WHITTEN CF, 1980, ACTA PAEDIATR SCAND, P1; Williams D, 2008, BRIT MED J, V336, P211, DOI 10.1136/bmj.39406.652986.BE	47	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0143340	10.1371/journal.pone.0143340	http://dx.doi.org/10.1371/journal.pone.0143340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571490	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700157
J	Brown, EL; Below, JE; Fischer, RSB; Essigmann, HT; Hu, H; Huff, C; Robinson, DA; Petty, LE; Aguilar, D; Bell, GI; Hanis, CL				Brown, Eric L.; Below, Jennifer E.; Fischer, Rebecca S. B.; Essigmann, Heather T.; Hu, Hao; Huff, Chad; Robinson, D. Ashley; Petty, Lauren E.; Aguilar, David; Bell, Graeme I.; Hanis, Craig L.			Genome-Wide Association Study of Staphylococcus aureus Carriage in a Community-Based Sample of Mexican-Americans in Starr County, Texas	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CYTOSKELETAL-ASSOCIATED PROTEINS; TYPE-2 DIABETES SUSCEPTIBILITY; FIBRONECTIN-BINDING PROTEINS; CBL-ASSOCIATED PROTEIN; BREAST-CANCER CELLS; NASAL CARRIAGE; RECEPTOR GENE; COMBINED IMMUNODEFICIENCY; GLUTAMATE TRANSPORTER	Staphylococcus aureus is the number one cause of hospital-acquired infections. Understanding host pathogen interactions is paramount to the development of more effective treatment and prevention strategies. Therefore, whole exome sequence and chip-based genotype data were used to conduct rare variant and genome-wide association analyses in a Mexican-American cohort from Starr County, Texas to identify genes and variants associated with S. aureus nasal carriage. Unlike most studies of S. aureus that are based on hospitalized populations, this study used a representative community sample. Two nasal swabs were collected from participants (n = 858) 11-17 days apart between October 2009 and December 2013, screened for the presence of S. aureus, and then classified as either persistent, intermittent, or non-carriers. The chip-based and exome sequence-based single variant association analyses identified 1 genome-wide significant region (KAT2B) for intermittent and 11 regions suggestively associated with persistent or intermittent S. aureus carriage. We also report top findings from gene-based burden analyses of rare functional variation. Notably, we observed marked differences between signals associated with persistent and intermittent carriage. In single variant analyses of persistent carriage, 7 of 9 genes in suggestively associated regions and all 5 top gene-based findings are associated with cell growth or tight junction integrity or are structural constituents of the cytoskeleton, suggesting that variation in genes associated with persistent carriage impact cellular integrity and morphology.	[Brown, Eric L.; Fischer, Rebecca S. B.; Essigmann, Heather T.] Univ Texas Hlth Sci Ctr Houston, Ctr Infect Dis, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Below, Jennifer E.; Petty, Lauren E.; Hanis, Craig L.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Hu, Hao; Huff, Chad] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol, Houston, TX 77030 USA; [Robinson, D. Ashley] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Aguilar, David] Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA; [Aguilar, David] Baylor Coll Med, Cardiol Sect, Houston, TX 77030 USA; [Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Bell, Graeme I.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Mississippi; University of Mississippi Medical Center; Baylor College of Medicine; Baylor College of Medicine; University of Chicago; University of Chicago	Hanis, CL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.	craig.l.hanis@uth.tmc.edu	Aguilar, David/GZM-1928-2022; Below, Jennifer E/W-2179-2018	Aguilar, David/0000-0002-0916-2722; Below, Jennifer E/0000-0002-1346-1872; Fischer, Rebecca/0000-0002-5048-2955; Below, Jennifer/0000-0002-6372-6402	NIH [R01 AI085014-01A1, R01 GM104390, HL102830, DK085501, P30DK020595]; M.D. Anderson Cancer Center Odyssey Program; Kleberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, U01DK085501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104390] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.D. Anderson Cancer Center Odyssey Program; Kleberg Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01 AI085014-01A1 (E.L. Brown and C.L. Hanis), R01 GM104390 (C.D. Huff and H. Hao), HL102830 (C.L. Hanis), DK085501 (C.L. Hanis) and P30DK020595 (G.I. Bell). H. Hao is also supported by the M.D. Anderson Cancer Center Odyssey Program. This work was also partially supported from a grant from the Kleberg Foundation to E.L. Brown. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1975, EXP CELL RES, V92, P57, DOI 10.1016/0014-4827(75)90636-9; Adams JC, 1998, EMBO J, V17, P4964, DOI 10.1093/emboj/17.17.4964; Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Bambang IF, 2013, ONCOGENE, V32, P1240, DOI 10.1038/onc.2012.149; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Bosanquet DC, 2014, INT J MOL MED, V34, P3, DOI 10.3892/ijmm.2014.1775; Bosanquet DC, 2013, J DERMATOL SCI, V71, P115, DOI 10.1016/j.jdermsci.2013.04.008; Brasacchio D, 2014, CELL DEATH DIFFER, V21, P748, DOI 10.1038/cdd.2013.203; Brauburger K, 2014, FEBS J, V281, P787, DOI 10.1111/febs.12624; Brouillette E, 2003, MICROB PATHOGENESIS, V35, P159, DOI 10.1016/S0882-4010(03)00112-8; Brouillette E, 2003, INFECT IMMUN, V71, P2292, DOI 10.1128/IAI.71.4.2292-2295.2003; Calander AM, 2006, MICROBES INFECT, V8, P1434, DOI 10.1016/j.micinf.2006.01.001; Chen SH, 2015, FEBS OPEN BIO, V5, P91, DOI 10.1016/j.fob.2015.01.004; Chen TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079359; Chetaille P, 2014, NAT GENET, V46, P1245, DOI 10.1038/ng.3113; Claassen M, 2005, FEMS IMMUNOL MED MIC, V43, P173, DOI 10.1016/j.femsim.2004.08.002; Clementi M, 1999, HUM GENET, V105, P337, DOI 10.1007/s004390051111; Cole AM, 2001, CLIN DIAGN LAB IMMUN, V8, P1064, DOI 10.1128/CDLI.8.6.1064-1069.2001; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Ding LL, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-16; Duperret EK, 2013, CELL CYCLE, V12, P3272, DOI 10.4161/cc.26385; EMBIL J, 1994, INFECT CONT HOSP EP, V15, P646; Emonts M, 2008, J INFECT DIS, V197, P1244, DOI 10.1086/533501; Emonts M, 2007, FEMS IMMUNOL MED MIC, V50, P330, DOI 10.1111/j.1574-695X.2007.00250.x; Epstein MP, 2012, AM J HUM GENET, V91, P215, DOI 10.1016/j.ajhg.2012.06.004; Fischer B, 2014, MOL GENET METAB, V112, P310, DOI 10.1016/j.ymgme.2014.05.003; Fode P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032315; Frodsham AJ, 2006, P NATL ACAD SCI USA, V103, P9148, DOI 10.1073/pnas.0602800103; Fu Z, 2009, AM J PHYSIOL-GASTR L, V297, pG632, DOI 10.1152/ajpgi.00066.2009; Gao Q, 2014, GASTROENTEROLOGY, V146, P1397, DOI 10.1053/j.gastro.2014.01.062; Garcia-Martin E, 2014, J NEUROL SCI, V338, P92, DOI 10.1016/j.jns.2013.12.022; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; Gillen AL, 2014, ADV MICROBIOLOGY, V4, P871; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Guan WH, 2014, CIRC-CARDIOVASC GENE, V7, P321, DOI 10.1161/CIRCGENETICS.113.000208; Harding James J, 2014, Hepatobiliary Surg Nutr, V3, P168, DOI 10.3978/j.issn.2304-3881.2014.07.03; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Hauck CR, 2006, CURR OPIN MICROBIOL, V9, P5, DOI 10.1016/j.mib.2005.12.002; Hayashida A, 2011, J BIOL CHEM, V286, P3288, DOI 10.1074/jbc.M110.185165; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; HERRMANN M, 1991, INFECT IMMUN, V59, P279, DOI 10.1128/IAI.59.1.279-288.1991; Hill CH, 2013, P NATL ACAD SCI USA, V110, P20479, DOI 10.1073/pnas.1311990110; Hill PC, 2001, PEDIATR INFECT DIS J, V20, P868, DOI 10.1097/00006454-200109000-00009; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hu H, 2014, NAT BIOTECHNOL, V32, P663, DOI 10.1038/nbt.2895; Hu H, 2013, GENET EPIDEMIOL, V37, P622, DOI 10.1002/gepi.21743; Hussain M, 2008, INFECT IMMUN, V76, P5615, DOI 10.1128/IAI.00480-08; ITOH F, 1993, INT J CANCER, V55, P947, DOI 10.1002/ijc.2910550612; Itoh S, 2010, INFECT IMMUN, V78, P3298, DOI 10.1128/IAI.00178-10; Jabara HH, 2013, J ALLERGY CLIN IMMUN, V132, P151, DOI 10.1016/j.jaci.2013.04.047; Jimenez-Jimenez FJ, 2014, SLEEP MED, V15, P266, DOI 10.1016/j.sleep.2013.08.800; Jiang LX, 2015, INT J CLIN EXP PATHO, V8, P319; Jin QH, 2014, MOL CELL BIOL, V34, P3746, DOI 10.1128/MCB.00622-14; Kalmeijer MD, 2002, CLIN INFECT DIS, V35, P353, DOI 10.1086/341025; Kardas F, 2013, GENE, V517, P125, DOI 10.1016/j.gene.2012.12.040; Kawai H, 2013, FEBS OPEN BIO, V3, P78, DOI 10.1016/j.fob.2013.01.002; Khajah M, 2011, J LEUKOCYTE BIOL, V89, P945, DOI 10.1189/jlb.0809546; Kildow BJ, 2012, J CLIN MICROBIOL, V50, P3744, DOI 10.1128/JCM.01488-12; Kim JY, 2013, GYNECOL ENDOCRINOL, V29, P904, DOI 10.3109/09513590.2013.813465; Kurella S, 2005, GENES IMMUN, V6, P596, DOI 10.1038/sj.gene.6364245; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lai CF, 2011, CLIN J AM SOC NEPHRO, V6, P167, DOI 10.2215/CJN.06270710; Lamminmaki S, 2012, J NEUROSCI, V32, P966, DOI 10.1523/JNEUROSCI.4007-11.2012; Lee KW, 2013, BIOCHEM BIOPH RES CO, V435, P239, DOI 10.1016/j.bbrc.2013.04.072; Leung NS, 2015, EPIDEMIOL INFECT, V143, P2430, DOI 10.1017/S0950268814003227; LEVINE MM, 1979, ANN HUM BIOL, V6, P369, DOI 10.1080/03014467900003751; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Matson SA, 2005, BBA-GENE STRUCT EXPR, V1727, P145, DOI 10.1016/j.bbaexp.2004.12.004; McKinnon ML, 2014, J ALLERGY CLIN IMMUN, V133, P1458, DOI 10.1016/j.jaci.2013.10.045; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mizuguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032449; Modak R, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-12; Moleirinho S, 2013, BIOCHEM J, V452, P183, DOI 10.1042/BJ20121642; Moore CE, 2004, CLIN DIAGN LAB IMMUN, V11, P1194, DOI 10.1128/CDLI.11.6.1194-1197.2004; Nakayama T, 2015, PROTEIN SCI, V24, P328, DOI 10.1002/pro.2619; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Nelson CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-83; Niebuhr M, 2010, EXP DERMATOL, V19, P873, DOI 10.1111/j.1600-0625.2010.01140.x; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Nurjadi D, 2013, J INFECT DIS, V207, P666, DOI 10.1093/infdis/jis735; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; Pal D, 2010, CELL CYCLE, V9, P4117, DOI 10.4161/cc.9.20.13387; PANIERAKIS C, 2009, INT J INFECT DIS; Park HY, 2012, INT J PEDIATR OTORHI, V76, P475, DOI 10.1016/j.ijporl.2011.12.028; Park Tae-Joon, 2013, Genomics & Informatics, V11, P149, DOI 10.5808/GI.2013.11.3.149; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ravnskjaer K, 2013, J CLIN INVEST, V123, P4318, DOI 10.1172/JCI69035; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Riazuddin S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-21; Robinson MV, 2014, B EXP BIOL MED+, V156, P473, DOI 10.1007/s10517-014-2377-4; Roghanian A, 2010, CELL IMMUNOL, V265, P120, DOI 10.1016/j.cellimm.2010.07.012; Roghmann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017368; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Roy D, 2014, ONCOL REP, V32, P2445, DOI 10.3892/or.2014.3502; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Safer JD, 2011, DERM-ENDOCRINOL, V3, P211, DOI [10.4161/derm.3.3.17027, 10.4161/derm.17027]; Sangvik M, 2011, J CLIN MICROBIOL, V49, P4213, DOI 10.1128/JCM.05290-11; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schumann RR, 2004, VACCINE, V22, pS21, DOI 10.1016/j.vaccine.2004.08.012; Sensi A, 2011, AM J MED GENET A, V155A, P1096, DOI 10.1002/ajmg.a.33962; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sica GL, 2001, BLOOD, V97, P2702, DOI 10.1182/blood.V97.9.2702; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Simino Jeannette, 2013, Frontiers in Genetics, V4, P277, DOI 10.3389/fgene.2013.00277; Skidmore DL, 2011, AM J MED GENET A, V155A, P1848, DOI 10.1002/ajmg.a.34057; Sollid JUE, 2014, INFECT GENET EVOL, V21, P531, DOI 10.1016/j.meegid.2013.03.020; Sozio MS, 2004, J BIOL CHEM, V279, P7760, DOI 10.1074/jbc.M309994200; Staples J, 2013, GENET EPIDEMIOL, V37, P136, DOI 10.1002/gepi.21684; Stappers MHT, 2014, J INFECT DIS, V210, P311, DOI 10.1093/infdis/jiu080; Tanaka R, 2004, MICROBIOL IMMUNOL, V48, P339, DOI 10.1111/j.1348-0421.2004.tb03515.x; Thier S, 2012, NEUROLOGY, V79, P243, DOI 10.1212/WNL.0b013e31825fdeed; Tong SYC, 2009, J INFECT DIS, V199, P1461, DOI 10.1086/598218; Tran C, 2014, GENES BRAIN BEHAV, V13, P430, DOI 10.1111/gbb.12126; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Turvey SE, 2014, J ALLERGY CLIN IMMUN, V134, P276, DOI 10.1016/j.jaci.2014.06.015; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; van Belkum A, 2007, MICROBES INFECT, V9, P1471, DOI 10.1016/j.micinf.2007.08.003; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van den Akker ELT, 2006, J INFECT DIS, V194, P814, DOI 10.1086/506367; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; VandenBergh MFQ, 1999, J LAB CLIN MED, V133, P525, DOI 10.1016/S0022-2143(99)90181-6; Verwer PEB, 2012, EUR J CLIN MICROBIOL, V31, P1067, DOI 10.1007/s10096-011-1408-6; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Vuononvirta J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026198; Wei SJ, 2013, CELL MOL LIFE SCI, V70, P4569, DOI 10.1007/s00018-013-1395-0; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Wolf EJ, 2014, DEPRESS ANXIETY, V31, P352, DOI 10.1002/da.22260; Wolthuis DFGJ, 2014, EUR J PAEDIATR NEURO, V18, P511, DOI 10.1016/j.ejpn.2014.01.003; Xiong YN, 2014, AM J PHYSIOL-REG I, V307, pR608, DOI 10.1152/ajpregu.00085.2014; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yan ML, 2013, CELL HOST MICROBE, V14, P631, DOI 10.1016/j.chom.2013.11.005; Yandell M, 2011, GENOME RES, V21, P1529, DOI 10.1101/gr.123158.111; Yang IV, 2009, GENETICS, V183, P1535, DOI 10.1534/genetics.109.107540; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; Ye Z, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00125; Yu HF, 2010, MOL CANCER RES, V8, P1501, DOI 10.1158/1541-7786.MCR-10-0186; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972; Zhang M, 2003, MOL MED, V9, P18, DOI 10.1007/BF03402103; Zhang SH, 1997, J BIOL CHEM, V272, P27281, DOI 10.1074/jbc.272.43.27281; Zia A, 2015, ACTA DIABETOL, V52, P789, DOI 10.1007/s00592-014-0700-1	159	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142130	10.1371/journal.pone.0142130	http://dx.doi.org/10.1371/journal.pone.0142130			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569114	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700021
J	Gershwin, LJ; Van Eenennaam, AL; Anderson, ML; McEligot, HA; Shao, MX; Toaff-Rosenstein, R; Taylor, JF; Neibergs, HL; Womack, J				Gershwin, Laurel J.; Van Eenennaam, Alison L.; Anderson, Mark L.; McEligot, Heather A.; Shao, Matt X.; Toaff-Rosenstein, Rachel; Taylor, Jeremy F.; Neibergs, Holly L.; Womack, James		Bovine Resp Dis Complex	Single Pathogen Challenge with Agents of the Bovine Respiratory Disease Complex	PLOS ONE			English	Article							PASTEURELLA-MULTOCIDA; MANNHEIMIA-HAEMOLYTICA; VIRAL DIARRHEA; BEEF-CALVES; PNEUMONIA; INFECTION; PATHOLOGY; BACTERIAL	Bovine respiratory disease complex (BRDC) is an important cause of mortality and morbidity in cattle; costing the dairy and beef industries millions of dollars annually, despite the use of vaccines and antibiotics. BRDC is caused by one or more of several viruses (bovine respiratory syncytial virus, bovine herpes type 1 also known as infectious bovine rhinotracheitis, and bovine viral diarrhea virus), which predispose animals to infection with one or more bacteria. These include: Pasteurella multocida, Mannheimia haemolytica, Mycoplasma bovis, and Histophilus somni. Some cattle appear to be more resistant to BRDC than others. We hypothesize that appropriate immune responses to these pathogens are subject to genetic control. To determine which genes are involved in the immune response to each of these pathogens it was first necessary to experimentally induce infection separately with each pathogen to document clinical and pathological responses in animals from which tissues were harvested for subsequent RNA sequencing. Herein these infections and animal responses are described.	[Gershwin, Laurel J.; Anderson, Mark L.; McEligot, Heather A.; Shao, Matt X.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Van Eenennaam, Alison L.; Toaff-Rosenstein, Rachel] Univ Calif Davis, Coll Agr, Dept Anim Sci, Davis, CA 95616 USA; [Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Neibergs, Holly L.] Washington State Univ, Coll Vet Med, Dept Anim Sci, Pullman, WA 99164 USA; [Womack, James] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Missouri System; University of Missouri Columbia; Washington State University; Texas A&M University System; Texas A&M University College Station	Gershwin, LJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	ljgershwin@ucdavis.edu	Van Eenennaam, Alison L/G-3481-2011	Van Eenennaam, Alison L/0000-0003-1562-162X; Hagevoort, G. Robert/0000-0002-1359-3912; Tucker, Cassandra/0000-0002-6014-444X	USDA National Institute of Food and Agriculture;  [2011-68004-30367]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); 	The study was funded by a USDA National Institute of Food and Agriculture grant for a Cordinated Research Project. PI is James Womack at Texas A & M University. Grant number is 2011-68004-30367.	Al-Ghamdi GM, 2000, J VET DIAGN INVEST, V12, P576, DOI 10.1177/104063870001200617; Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; Caswell JL, 2010, VET CLIN N AM-FOOD A, V26, P365, DOI 10.1016/j.cvfa.2010.03.003; Chase CCL, 2013, BIOLOGICALS, V41, P52, DOI 10.1016/j.biologicals.2012.09.009; COLLIE DDS, 1992, BRIT VET J, V148, P33, DOI 10.1016/0007-1935(92)90064-8; Corbeil Lynette B., 2007, Animal Health Research Reviews, V8, P151, DOI 10.1017/S1466252307001417; Dabo S. M., 2007, Animal Health Research Reviews, V8, P129, DOI 10.1017/S1466252307001399; Dagleish MP, 2010, J COMP PATHOL, V142, P157, DOI 10.1016/j.jcpa.2009.10.015; Fulton RW, 2009, J VET DIAGN INVEST, V21, P464, DOI 10.1177/104063870902100407; Gagea MI, 2006, J VET DIAGN INVEST, V18, P29, DOI 10.1177/104063870601800105; Gershwin LJ, 1998, VACCINE, V16, P1225, DOI 10.1016/S0264-410X(98)80123-0; Gershwin LJ, 2000, AM J VET RES, V61, P291, DOI 10.2460/ajvr.2000.61.291; Jones C, 2010, VET CLIN N AM-FOOD A, V26, P303, DOI 10.1016/j.cvfa.2010.04.007; Koppers-Lalic D, 2003, ARCH VIROL, V148, P2023, DOI 10.1007/s00705-003-0142-5; McGuirk SM, 2008, VET CLIN N AM-FOOD A, V24, P139, DOI 10.1016/j.cvfa.2007.10.003; Miles Delbert G., 2009, Animal Health Research Reviews, V10, P101, DOI 10.1017/S1466252309990090; PALFI V, 1989, ACTA VET HUNG, V37, P89; Prado ME, 2006, VET IMMUNOL IMMUNOP, V111, P301, DOI 10.1016/j.vetimm.2005.10.013; Ridpath J, 2010, VET CLIN N AM-FOOD A, V26, P335, DOI 10.1016/j.cvfa.2010.04.003; Singh K, 2011, VET PATHOL, V48, P338, DOI 10.1177/0300985810377182; Szeredi L, 2010, ACTA VET HUNG, V58, P341, DOI 10.1556/AVet.58.2010.3.7; Taylor JD, 2010, CAN VET J, V51, P1095; Tizioto PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131459; Wilkie IW, 2012, CURR TOP MICROBIOL, V361, P1, DOI 10.1007/82_2012_216	24	48	53	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142479	10.1371/journal.pone.0142479	http://dx.doi.org/10.1371/journal.pone.0142479			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571015	Green Published, gold			2022-12-26	WOS:000365070700043
J	Matsunaga, H; Sasaki, S; Suzuki, S; Matsushita, A; Nakamura, H; Nakamura, HM; Hirahara, N; Kuroda, G; Iwaki, H; Ohba, K; Morita, H; Oki, Y; Suda, T				Matsunaga, Hideyuki; Sasaki, Shigekazu; Suzuki, Shingo; Matsushita, Akio; Nakamura, Hirotoshi; Nakamura, Hiroko Misawa; Hirahara, Naoko; Kuroda, Go; Iwaki, Hiroyuki; Ohba, Kenji; Morita, Hiroshi; Oki, Yutaka; Suda, Takafumi			Essential Role of GATA2 in the Negative Regulation of Type 2 Deiodinase Gene by Liganded Thyroid Hormone Receptor beta 2 in Thyrotroph	PLOS ONE			English	Article							II IODOTHYRONINE DEIODINASE; RAT ANTERIOR-PITUITARY; TRANSCRIPTION FACTOR; SUBUNIT GENE; CELL-LINE; THYROXINE 5-DEIODINASE; HUMAN CHORIOCARCINOMA; TARGETED DISRUPTION; TUMOR CELLS; DNA-BINDING	The inhibition of thyrotropin (thyroid stimulating hormone; TSH) by thyroid hormone (T3) and its receptor (TR)is the central mechanism of the hypothalamus-pituitary-thyroid axis. Two transcription factors, GATA2 and Pit-1, determine thyrotroph differentiation and maintain the expression of the beta subunit of TSH (TSH beta). We previously reported that T3-dependent repression of the TSH beta gene is mediated by GATA2 but not by the reported negative T3-responsive element (nTRE). In thyrotrophs, T3 also represses mRNA of the type-2 deiodinase (D2) gene, where no nTRE has been identified. Here, the human D2 promoter fused to the CAT or modified Renilla luciferase gene was co-transfected with Pit-1 and/or GATA2 expression plasmids into cell lines including CV1 and thyrotroph-derived T alpha T1. GATA2 but not Pit-1 activated the D2 promoter. Two GATA responsive elements (GATA-REs) were identified close to cAMP responsive element. The protein kinase A activator, forskolin, synergistically enhanced GATA2-dependent activity. Gel-shift and chromatin immunoprecipitation assays with T alpha T1 cells indicated that GATA2 binds to these GATA-REs. T3 repressed the GATA2-induced activity of the D2 promoter in the presence of the pituitary-specific TR, TR beta 2. The inhibition by T3-bound TR beta 2 was dominant over the synergism between GATA2 and forskolin. The D2 promoter is also stimulated by GATA4, the major GATA in cardiomyocytes, and this activity was repressed by T3 in the presence of TR alpha 1. These data indicate that the GATA-induced activity of the D2 promoter is suppressed by T3-bound TRs via a tethering mechanism, as in the case of the TSH beta gene.	[Matsunaga, Hideyuki; Sasaki, Shigekazu; Suzuki, Shingo; Matsushita, Akio; Nakamura, Hiroko Misawa; Hirahara, Naoko; Kuroda, Go; Morita, Hiroshi; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Nakamura, Hirotoshi] Kuma Hosp, Chuo Ku, Kobe, Hyogo 6501111, Japan; [Iwaki, Hiroyuki] Seirei Hamamatsu Gen Hosp, Div Endocrinol, Naka Ku, Hamamatsu, Shizuoka 4300906, Japan; [Ohba, Kenji] Duke NUS Grad Med Sch Singapore, Singapore 169857, Singapore; [Oki, Yutaka] Hamamatsu Univ Sch Med, Dept Family & Community Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Kuma Hospital; National University of Singapore; Hamamatsu University School of Medicine	Sasaki, S (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	sasakis@hama-med.ac.jp	Ohba, Kenji/AAU-5180-2021	Ohba, Kenji/0000-0001-8538-8742	Health Sciences Research Grant Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [20591092]; Yamaguchi Endocrine Research Association; Health Sciences Research Grant	Health Sciences Research Grant Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaguchi Endocrine Research Association; Health Sciences Research Grant	This work was supported in part by a Health Sciences Research Grant Japan (http://www.nanbyou.or.jp/entry/1776) to HN; Grant-in Aid for Scientific Research Japan (https://www.jsps.go.jp/j-grantsinaid/) to S. Sasaki and HN from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 20591092); and a Yamaguchi Endocrine Research Association grant (http://www.yamaguchi-endocrine.org/) to S. Sasaki.; We are grateful to the following for providing plasmids: Drs. Kazuhiko Umesono (Kyoto University, Japan), Masayuki Yamamoto (Tsukuba University, Japan), Francisco Barros (Universidad de Oviedo, Spain) and Eric N. Olson (University of Texas Southwestern Medical Center, TX, USA). We also thank Drs. Takashi Minami, Yasuharu Kanki and Tatsuhiko Kodama (University of Tokyo) for providing anti-GATA2 antibody and Dr. Pamela Mellon (University of California, CA, USA) for TaT1 cells. This work was supported in part by a Health Sciences Research Grant to H.N., a Grant-in Aid for Scientific Research to S.S. and H.N. from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 20591092) and a Yamaguchi Endocrine Research Association grant to S.S.	Abel ED, 1999, J CLIN INVEST, V104, P291, DOI 10.1172/JCI6397; Araki O, 2003, ENDOCRINOLOGY, V144, P4459, DOI 10.1210/en.2003-0419; Baur A, 2002, EUR J ENDOCRINOL, V147, P263, DOI 10.1530/eje.0.1470263; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bianco AC, 2012, WERNER LNGBARS THYRO, P103; Brouwer JP, 2006, EUR J ENDOCRINOL, V154, P819, DOI 10.1530/eje.1.02155; Canettieri G, 2004, J MOL ENDOCRINOL, V33, P51, DOI 10.1677/jme.0.0330051; Canettieri G, 2000, ENDOCRINOLOGY, V141, P1804, DOI 10.1210/en.141.5.1804; Canettieri G, 2008, ENDOCRINOLOGY, V149, P695, DOI 10.1210/en.2007-0779; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chiamolera MI, 2012, MOL ENDOCRINOL, V26, P926, DOI 10.1210/me.2011-1290; Chiloeches A, 2008, MOL ENDOCRINOL, V22, P2466, DOI 10.1210/me.2008-0107; Christoffolete MA, 2006, ENDOCRINOLOGY, V147, P1735, DOI 10.1210/en.2005-1300; Cohen RN, 2012, CHEM BIOSYNTHESIS TH, P149; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Dentice M, 2003, MOL ENDOCRINOL, V17, P1508, DOI 10.1210/me.2002-0348; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Fonseca TL, 2013, J CLIN INVEST, V123, P1492, DOI 10.1172/JCI61231; Forsman CL, 2013, DEV BIOL, V373, P95, DOI 10.1016/j.ydbio.2012.10.007; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Gereben B, 2005, THYROID, V15, P855, DOI 10.1089/thy.2005.15.855; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Hoermann R, 2010, EUR J ENDOCRINOL, V162, P1123, DOI 10.1530/EJE-10-0106; Hong SJ, 2006, J NEUROCHEM, V98, P773, DOI 10.1111/j.1471-4159.2006.03924.x; Hosoi Y, 1999, J CLIN ENDOCR METAB, V84, P3293, DOI 10.1210/jc.84.9.3293; Huang HC, 2001, P NATL ACAD SCI USA, V98, P7348, DOI 10.1073/pnas.131198998; ITAGAKI Y, 1990, J CLIN ENDOCR METAB, V71, P340, DOI 10.1210/jcem-71-2-340; Iwaki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088610; Kadri Z, 2005, MOL CELL BIOL, V25, P7412, DOI 10.1128/MCB.25.17.7412-7422.2005; Kashiwabara Y, 2009, J MOL ENDOCRINOL, V42, P225, DOI 10.1677/JME-08-0099; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KOENIG RJ, 1984, ENDOCRINOLOGY, V115, P324, DOI 10.1210/endo-115-1-324; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; KOHRLE J, 1995, MOL CELL ENDOCRINOL, V108, P17, DOI 10.1016/0303-7207(95)92574-8; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; Luongo C, 2015, ENDOCRINOLOGY, V156, P745, DOI 10.1210/en.2014-1698; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Mendez-Pertuz M, 2003, EMBO J, V22, P3102, DOI 10.1093/emboj/cdg295; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; Minegishi N, 2005, GENES CELLS, V10, P693, DOI 10.1111/j.1365-2443.2005.00864.x; Misawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028916; Mittag J, 2009, ENDOCRINOLOGY, V150, P4443, DOI 10.1210/en.2009-0327; MURAKAMI M, 1988, ENDOCRINOLOGY, V123, P1676, DOI 10.1210/endo-123-3-1676; Nakano K, 2004, BIOCHEM J, V378, P549, DOI 10.1042/BJ20031592; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; Ohba K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018667; Santos GM, 2011, TRENDS ENDOCRIN MET, V22, P87, DOI 10.1016/j.tem.2010.11.004; SASAKI S, 1991, ENDOCRINOLOGY, V129, P511, DOI 10.1210/endo-129-1-511; Sasaki S, 2011, CONT ASPECTS ENDOCRI, P101; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; Schneider MJ, 2006, ENDOCRINOLOGY, V147, P580, DOI 10.1210/en.2005-0739; Song S, 2000, MOL CELL ENDOCRINOL, V165, P189, DOI 10.1016/S0303-7207(00)00246-X; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592, DOI 10.1128/MCB.14.8.5592; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; Tonyushkina KN, 2014, J CLIN INVEST, V124, P321, DOI 10.1172/JCI70038; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007; Wagner MS, 2003, J MOL ENDOCRINOL, V31, P541, DOI 10.1677/jme.0.0310541; Weitzel JM, 2008, THYROID RES, V1, DOI 10.1186/1756-6614-1-4; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; Wright CE, 1999, AM J PHYSIOL-CELL PH, V276, pC883, DOI 10.1152/ajpcell.1999.276.4.C883; Yusta B, 1998, ENDOCRINOLOGY, V139, P4476, DOI 10.1210/en.139.11.4476; Zeold A, 2006, ENDOCRINOLOGY, V147, P4419, DOI 10.1210/en.2005-1608; Zhang D, 2014, J CELL BIOL, V207, P753, DOI 10.1083/jcb.201406068	66	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142400	10.1371/journal.pone.0142400	http://dx.doi.org/10.1371/journal.pone.0142400			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26571013	gold, Green Published, Green Submitted			2022-12-26	WOS:000365070700034
J	Ohtani, N; Okamoto, Y; Tateishi, K; Uchiyama, H; Ohta, M				Ohtani, Nobuyo; Okamoto, Yuta; Tateishi, Kanako; Uchiyama, Hidehiko; Ohta, Mitsuaki			Increased Feeding Speed Is Associated with Higher Subsequent Sympathetic Activity in Dogs	PLOS ONE			English	Article							POWER SPECTRAL-ANALYSIS; NERVOUS-SYSTEM; HEART-RATE; VARIABILITY; SUPPRESSION; VALIDATION; RESPONSES; BEHAVIOR; OBESITY	Although the domestication process has altered the feeding behavior of dogs, some breeds still demonstrate a remarkable ability to gorge, and will eat exceptionally large quantities of food whenever it is available. Lesions in the ventromedial hypothalamus increase appetite and lead to obesity, suggesting that the autonomic nervous system plays an important role in feeding. Focusing on the autonomic activities closely involved in food intake, we investigated sympathetic activities before and after feeding in dogs. The subjects were 56 healthy dogs of 21 different breeds (29 males and 27 females). Based on feeding habits, the 56 dogs were divided into three groups: Fast (n = 19), Slow (n = 24) and Leftover (n = 13). The feeding speed and the amount of food per mouthful of the Fast dogs were significantly greater than those of the Slow and the Leftover dogs. The plasma norepinephrine level in dogs of the Fast group was significantly increased after feeding, while those in the Slow and Leftover groups were significantly decreased after feeding, compared with the pre-feeding concentrations. The low frequency/high frequency ratio of heart rate variability is a good indicator of sympathetic activity and was also significantly higher in the Fast group than in the other groups. Delayed feeding using automatic feeding equipment decreased the plasma norepinephrine concentration and low frequency/high frequency ratio observed after feeding in dogs of the Fast group. In conclusion, dogs eating rapidly with less chewing, which indicates increased sympathetic activity during feeding, may benefit from delayed feeding. The slow eating may activate the parasympathetic nervous system after feeding, which could enhance the activity of the digestive system.	[Ohtani, Nobuyo; Okamoto, Yuta; Tateishi, Kanako; Ohta, Mitsuaki] Azabu Univ, Sch Vet Med, Lab Effect Anim Human Hlth, Chuo Ku, Sagamihara, Kanagawa, Japan; [Uchiyama, Hidehiko; Ohta, Mitsuaki] Tokyo Univ Agr, Fac Agr, Lab Anim Facilitated Therapy, Atsugi, Kanagawa, Japan	Azabu University; Tokyo University of Agriculture	Ohta, M (corresponding author), Azabu Univ, Sch Vet Med, Lab Effect Anim Human Hlth, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa, Japan.	mohta@azabu-u.ac.jp			Promotion and Mutual Aid Corporation for Private Schools of Japan	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	Support was provided by a Grant-in-Aid for Matching Fund Subsidy for Private Universities from the Promotion and Mutual Aid Corporation for Private Schools of Japan.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Bertile F, 2003, BIOCHEM BIOPH RES CO, V303, P1106, DOI 10.1016/S0006-291X(03)00481-9; Bi S, 2003, AM J PHYSIOL-REG I, V285, pR1030, DOI 10.1152/ajpregu.00734.2002; Bradshaw JWS, 2006, J NUTR, V136, p1927S, DOI 10.1093/jn/136.7.1927S; Bray GA, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801269; Case L.P., 2005, DOG ITS BEHAV NUTR H, V2nd ed.; Clutton-Brock J, 2017, DOMESTIC DOG: ITS EVOLUTION, BEHAVIOR AND INTERACTIONS WITH PEOPLE, 2ND EDITION, P7; COLWILL RM, 1990, ANIM LEARN BEHAV, V18, P71, DOI 10.3758/BF03205241; EDNEY ATB, 1986, VET REC, V118, P391, DOI 10.1136/vr.118.14.391; Harthoorn LF, 2008, EUR J APPL PHYSIOL, V102, P601, DOI 10.1007/s00421-007-0622-5; INOUE K, 1991, AM J PHYSIOL, V260, pH842, DOI 10.1152/ajpheart.1991.260.3.H842; Jonckheer-Sheehy VSM, 2012, J VET BEHAV, V7, P205, DOI 10.1016/j.jveb.2011.10.006; KALRA SP, 1991, P NATL ACAD SCI USA, V88, P10931, DOI 10.1073/pnas.88.23.10931; Kano M, 2015, J VET BEHAV, V10, P194, DOI 10.1016/j.jveb.2014.12.009; Kreeger TJ, 1997, CAN J ZOOL, V75, P1549, DOI 10.1139/z97-781; Laflamme D, 1997, CANINE PRACT, V22, P10; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Messina G, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/639280; Mugford R. A., 1977, The chemical senses and nutrition, P25; NIIJIMA A, 1984, AM J PHYSIOL, V247, pR650, DOI 10.1152/ajpregu.1984.247.4.R650; Okamoto Y, 2009, J VET MED SCI, V71, P1617, DOI 10.1292/jvms.001617; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; SCHWARTZ JH, 1983, J CLIN INVEST, V72, P361, DOI 10.1172/JCI110976; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SKINNER BF, 1950, PSYCHOL REV, V57, P193, DOI 10.1037/h0054367; Valensi P, 2003, METABOLISM, V52, P815, DOI 10.1016/S0026-0495(03)00095-7; VANDERTUIG JG, 1982, LIFE SCI, V30, P913, DOI 10.1016/0024-3205(82)90619-1; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; WALGREN MC, 1987, METABOLISM, V36, P585, DOI 10.1016/0026-0495(87)90172-7; WAYNE RK, 1993, TRENDS GENET, V9, P218, DOI 10.1016/0168-9525(93)90122-X; YOUNG JB, 1980, J CLIN INVEST, V65, P1086, DOI 10.1172/JCI109761; YOUNG JB, 1977, NATURE, V269, P615, DOI 10.1038/269615a0; YOUNG JB, 1977, SCIENCE, V196, P1473, DOI 10.1126/science.867049; Zhu Y, 2014, PHYSIOL BEHAV, V123, P62, DOI 10.1016/j.physbeh.2013.10.003	34	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142899	10.1371/journal.pone.0142899	http://dx.doi.org/10.1371/journal.pone.0142899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569112	Green Published, Green Submitted, gold			2022-12-26	WOS:000365070700095
J	Smith, WW; Smith, M; Yang, DJ; Choi, PP; Moghadam, A; Li, TX; Moran, TH				Smith, Wanli W.; Smith, Megan; Yang, Dejun; Choi, Pique P.; Moghadam, Alexander; Li, Tianxia; Moran, Timothy H.			CCK Response Deficiency in Synphilin-1 Transgenic Mice	PLOS ONE			English	Article							FOOD-INTAKE; ALPHA-SYNUCLEIN; MEAL SIZE; AMYLIN; CHOLECYSTOKININ; LIRAGLUTIDE; POPULATIONS; HOMEOSTASIS; BEHAVIOR; NUCLEUS	Previously, we have identified a novel role for the cytoplasmic protein, synphilin-1(SP1), in the controls of food intake and body weight in both mice and Drosophila. Ubiquitous overexpression of human SP1 in brain neurons in transgenic mice results in hyperphagia expressed as an increase in meal size. However, the mechanisms underlying this action of SP1 remain to be determined. Here we investigate a potential role for altered gut feedback signaling in the effects of SP1 on food intake. We examined responses to peripheral administration of cholecytokinin (CCK), amylin, and the glucagon like peptide-1 (GLP-1) receptor agonist, exendin-4. Intraperitoneal administration of CCK at doses ranging from 1-10 nmol/kg significantly reduced glucose intake in wild type (WT) mice, but failed to affect intake in SP1 transgenic mice. Moreover, there was a significant attenuation of CCK-induced c-Fos expression in the dorsal vagal complex in SP1 transgenic mice. In contrast, WT and SP1 transgenic mice were similarly responsive to both amylin and exendin-4 treatment. These studies demonstrate that SP1 results in a CCK response deficiency that may contribute to the increased meal size and overall hyperphagia in synphillin-1 transgenic mice.	[Smith, Wanli W.; Yang, Dejun; Li, Tianxia] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Smith, Megan; Choi, Pique P.; Moghadam, Alexander; Moran, Timothy H.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Smith, WW (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	wsmith@rx.umaryland.edu; tmoran@jhmi.edu	Yang, Dejun/L-9865-2016	Yang, Dejun/0000-0001-5118-0652	National Institutes of Health [DK083410]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health, Grants: DK083410 to W.W.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiroa D, 2014, DIABETES, V63, P3346, DOI 10.2337/db14-0302; Bello NT, 2009, AM J PHYSIOL-REG I, V297, pR622, DOI 10.1152/ajpregu.00087.2009; Bhavsar S, 1998, PHYSIOL BEHAV, V64, P557, DOI 10.1016/S0031-9384(98)00110-3; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Gibbs J, 1997, OBES RES, V5, P284, DOI 10.1002/j.1550-8528.1997.tb00305.x; Kanoski SE, 2011, ENDOCRINOLOGY, V152, P3103, DOI 10.1210/en.2011-0174; Li TJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0082499, 10.1371/journal.pone.0092870]; Li X, 2012, INT J OBESITY, V36, P1215, DOI 10.1038/ijo.2011.235; Li X, 2014, BIORESOUR BIOPROCESS, V1, P1, DOI [10.1186/s40643-014-0013-9, DOI 10.1186/S40643-014-0013-9, DOI 10.1007/S10404-014-1340-Z]; Liu J, 2012, INT J OBESITY, V36, P1529, DOI 10.1038/ijo.2012.111; Lo CC, 2014, ENDOCRINOLOGY, V155, P1700, DOI 10.1210/en.2013-1846; LUTZ TA, 1995, PHYSIOL BEHAV, V58, P1197, DOI 10.1016/0031-9384(95)02067-5; Lutz TA, 2012, CELL MOL LIFE SCI, V69, P1947, DOI 10.1007/s00018-011-0905-1; Mietlicki-Baase EG, 2014, PHYSIOL BEHAV, V136, P39, DOI 10.1016/j.physbeh.2014.01.013; Mollet A, 2004, PHYSIOL BEHAV, V81, P149, DOI 10.1016/j.physbeh.2004.01.006; MORAN TH, 1992, AM J CLIN NUTR, V55, P286; MORAN TH, 1992, AM J PHYSIOL, V262, pR46, DOI 10.1152/ajpregu.1992.262.1.R46; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Potes CS, 2012, AM J PHYSIOL-REG I, V302, pR340, DOI 10.1152/ajpregu.00380.2011; Reda TK, 2002, OBES RES, V10, P1087, DOI 10.1038/oby.2002.147; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Ruttimann EB, 2009, ENDOCRINOLOGY, V150, P1174, DOI 10.1210/en.2008-1221; Schwartz GJ, 2004, OBES RES, V12, p102S, DOI 10.1038/oby.2004.274; Schwartz GJ, 2002, ENDOCRINOLOGY, V143, P3779, DOI 10.1210/en.2002-220352; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Smith GP, 1996, NEUROSCI BIOBEHAV R, V20, P41, DOI 10.1016/0149-7634(95)00038-G; Smith WW, 2010, HUM MOL GENET, V19, P2087, DOI 10.1093/hmg/ddq086; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Suzuki K, 2010, ENDOCR J, V57, P359, DOI 10.1507/endocrj.K10E-077; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2; Williams DL, 2009, ENDOCRINOLOGY, V150, P1680, DOI 10.1210/en.2008-1045; Zuger D, 2013, PHYSIOL BEHAV, V112, P61, DOI 10.1016/j.physbeh.2013.02.006	34	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142314	10.1371/journal.pone.0142314	http://dx.doi.org/10.1371/journal.pone.0142314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569394	Green Published, gold, Green Submitted			2022-12-26	WOS:000365070700031
J	Vrana, A; Hotz-Boendermaker, S; Stampfli, P; Hanggi, J; Seifritz, E; Humphreys, BK; Meier, ML				Vrana, Andrea; Hotz-Boendermaker, Sabina; Staempfli, Philipp; Haenggi, Juergen; Seifritz, Erich; Humphreys, B. Kim; Meier, Michael L.			Differential Neural Processing during Motor Imagery of Daily Activities in Chronic Low Back Pain Patients	PLOS ONE			English	Article							PSYCHOLOGICAL RISK-FACTORS; CORTICAL ALPHA RHYTHMS; HIGH-RESOLUTION EEG; PSYCHOPHYSIOLOGICAL INTERACTIONS; ALE METAANALYSIS; POSTURAL CONTROL; MENTAL-IMAGERY; CURRENT STATE; NECK PAIN; NETWORK	Chronic low back pain (chronic LBP) is both debilitating for patients but also a major burden on the health care system. Previous studies reported various maladaptive structural and functional changes among chronic LBP patients on spine- and supraspinal levels including behavioral alterations. However, evidence for cortical reorganization in the sensorimotor system of chronic LBP patients is scarce. Motor Imagery (MI) is suitable for investigating the cortical sensorimotor network as it serves as a proxy for motor execution. Our aim was to investigate differential MI-driven cortical processing in chronic LBP compared to healthy controls (HC) by means of functional magnetic resonance imaging (fMRI). Twenty-nine subjects (15 chronic LBP patients, 14 HC) were included in the current study. MI stimuli consisted of randomly presented video clips showing every-day activities involving different whole-body movements as well as walking on even ground and walking downstairs and upstairs. Guided by the video clips, subjects had to perform MI of these activities, subsequently rating the vividness of their MI performance. Brain activity analysis revealed that chronic LBP patients exhibited significantly reduced activity compared to HC subjects in MI-related brain regions, namely the left supplementary motor area and right superior temporal sulcus. Furthermore, psycho-physiological-interaction analysis yielded significantly enhanced functional connectivity (FC) between various MI-associated brain regions in chronic LBP patients indicating diffuse and non-specific changes in FC. Current results demonstrate initial findings about differences in MI-driven cortical processing in chronic LBP pointing towards reorganization processes in the sensorimotor network.	[Vrana, Andrea; Hotz-Boendermaker, Sabina; Humphreys, B. Kim; Meier, Michael L.] Univ Hosp Balgrist, Zurich, Switzerland; [Vrana, Andrea] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Human Movement Sci, Zurich, Switzerland; [Staempfli, Philipp; Seifritz, Erich] Univ Zurich, Dept Psychiat Psychotherapy & Psychosomat, Hosp Psychiat, Zurich, Switzerland; [Staempfli, Philipp] Univ Zurich, MR Ctr Psychiat Hosp, Zurich, Switzerland; [Staempfli, Philipp] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Haenggi, Juergen] Univ Zurich, Dept Psychol, Div Neuropsychol, Zurich, Switzerland; [Meier, Michael L.] Univ Zurich, Ctr Dent Med, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University of Zurich; University of Zurich; University of Zurich	Vrana, A (corresponding author), Univ Hosp Balgrist, Zurich, Switzerland.	avrana@isr.balgrist.ch	Hotz, S/AAL-7043-2020	Hotz, S/0000-0001-9455-6074; Hanggi, Jurgen/0000-0001-8124-6018; Meier, Michael/0000-0001-6004-8338	Foundation for the Education of Chiropractors in Switzerland; Balgrist Foundation	Foundation for the Education of Chiropractors in Switzerland; Balgrist Foundation	This work was supported by grants from (1) Foundation for the Education of Chiropractors in Switzerland and (2) Balgrist Foundation (salary payments). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson GB, 1997, J REHABILITATION RES, V34, pix; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Babiloni C, 2005, BEHAV NEUROSCI, V119, P503, DOI 10.1037/0735-7044.119.2.503; Babiloni C, 2003, EUR J NEUROSCI, V18, P1692, DOI 10.1046/j.1460-9568.2003.02851.x; Babiloni C, 2008, J PAIN, V9, P902, DOI 10.1016/j.jpain.2008.05.007; Barraclough NE, 2006, PROG BRAIN RES, V154, P135, DOI 10.1016/S00079-6123(06)54007-5; Boersma K, 2005, CLIN J PAIN, V21, P38, DOI 10.1097/00002508-200501000-00005; Bolton JE, 2002, J MANIP PHYSIOL THER, V25, P141, DOI 10.1067/mmt.2002.123333; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Brumagne S, 2008, GAIT POSTURE, V28, P657, DOI 10.1016/j.gaitpost.2008.04.015; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cholewicki J, 1996, CLIN BIOMECH, V11, P1, DOI 10.1016/0268-0033(95)00035-6; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Conson M, 2009, EXP BRAIN RES, V199, P71, DOI 10.1007/s00221-009-1974-3; Coslett HB, 2002, NEUROLOGY, V59, P357, DOI 10.1212/WNL.59.3.357; Cross ES, 2009, EUR J NEUROSCI, V30, P1383, DOI 10.1111/j.1460-9568.2009.06941.x; D'hooge R, 2013, J ELECTROMYOGR KINES, V23, P173, DOI 10.1016/j.jelekin.2012.09.003; de Lussanet MHE, 2013, HUM MOVEMENT SCI, V32, P938, DOI 10.1016/j.humov.2013.05.002; de Lussanet MHE, 2012, PAIN, V153, P1459, DOI 10.1016/j.pain.2012.04.002; Del Percio C, 2006, NEUROIMAGE, V31, P1268, DOI 10.1016/j.neuroimage.2006.01.013; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Gatti R, 2013, NEUROSCI LETT, V540, P37, DOI 10.1016/j.neulet.2012.11.039; Gerchen MF, 2014, HUM BRAIN MAPP, V35, P5071, DOI 10.1002/hbm.22532; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Guillot A, 2009, HUM BRAIN MAPP, V30, P2157, DOI 10.1002/hbm.20658; Haavik H, 2012, J ELECTROMYOGR KINES, V22, P768, DOI 10.1016/j.jelekin.2012.02.012; Han ZZ, 2013, J NEUROSCI, V33, P15442, DOI 10.1523/JNEUROSCI.5868-12.2013; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Hashmi JA, 2013, BRAIN, V136, P2751, DOI 10.1093/brain/awt211; Herrington JD, 2011, BRAIN COGNITION, V77, P372, DOI 10.1016/j.bandc.2011.09.001; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Hietanen JK, 1996, BEHAV BRAIN RES, V76, P155, DOI 10.1016/0166-4328(95)00193-X; Hodges PW, 2001, EXP BRAIN RES, V141, P261, DOI 10.1007/s002210100873; Iseki K, 2008, NEUROIMAGE, V41, P1021, DOI 10.1016/j.neuroimage.2008.03.010; Iseki Kazumi, 2010, Brain and Nerve (Tokyo), V62, P1157; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jacobs JV, 2009, NEUROSCIENCE, V164, P877, DOI 10.1016/j.neuroscience.2009.08.002; Jacobs JV, 2009, BEHAV NEUROSCI, V123, P455, DOI 10.1037/a0014479; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jeannerod M, 1999, CURR OPIN NEUROBIOL, V9, P735, DOI 10.1016/S0959-4388(99)00038-0; Kessler K, 2006, NEUROIMAGE, V33, P227, DOI 10.1016/j.neuroimage.2006.06.014; KOSSLYN SM, 1995, NEUROPSYCHOLOGIA, V33, P1335, DOI 10.1016/0028-3932(95)00067-D; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Lidbeck Jan, 2002, Pain Res Manag, V7, P81; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Lorey B, 2013, BRAIN COGNITION, V81, P139, DOI 10.1016/j.bandc.2012.09.011; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Luomajoki H, 2011, BRIT J SPORT MED, V45, P437, DOI 10.1136/bjsm.2009.060731; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Meier ML, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00424; Meier ML, 2014, J MANIP PHYSIOL THER, V37, P32, DOI 10.1016/j.jmpt.2013.09.004; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Michelon P, 2006, J NEUROPHYSIOL, V95, P811, DOI 10.1152/jn.00488.2005; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Moseley GL, 2008, PAIN, V140, P239, DOI 10.1016/j.pain.2008.08.001; Moseley GL, 2008, ARTHRIT RHEUM-ARTHR, V59, P623, DOI 10.1002/art.23580; Moseley GL, 2004, PAIN, V108, P192, DOI 10.1016/j.pain.2004.01.006; MURPHY SM, 1994, MED SCI SPORT EXER, V26, P486; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nedelko V, 2012, J NEUROL PHYS THER, V36, P182, DOI 10.1097/NPT.0b013e318272cad1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Robinson J.P.A., 2009, FUNCTIONAL PAIN SYND, P23; Roussel NA, 2013, CLIN J PAIN, V29, P625, DOI 10.1097/AJP.0b013e31826f9a71; Shenton JT, 2004, NEUROSCI LETT, V370, P19, DOI 10.1016/j.neulet.2004.07.053; Short SE, 2005, J SPORT SCI, V23, P951, DOI 10.1080/02640410400023373; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; SPIELBERGER CD, 1971, J MOTOR BEHAV, V3, P265, DOI 10.1080/00222895.1971.10734907; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Szameitat AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038506; Tahmasebi AM, 2009, NEUROIMAGE, V47, P1522, DOI 10.1016/j.neuroimage.2009.05.047; Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; Tsao H, 2011, SPINE, V36, P1721, DOI 10.1097/BRS.0b013e31821c4267; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; Verbunt JA, 2003, EUR J PAIN, V7, P9, DOI 10.1016/S1090-3801(02)00071-X; Villiger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072403; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; Wand BM, 2013, CLIN J PAIN, V29, P737, DOI 10.1097/AJP.0b013e318274b320; Wand BM, 2011, MANUAL THER, V16, P15, DOI 10.1016/j.math.2010.06.008; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; Wertli MM, 2014, SPINE J, V14, P816, DOI 10.1016/j.spinee.2013.09.036	87	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2015	10	11							e0142391	10.1371/journal.pone.0142391	http://dx.doi.org/10.1371/journal.pone.0142391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW5XP	26569602	Green Published, Green Accepted, gold			2022-12-26	WOS:000365070700033
J	Wang, C; Zhang, J; Cai, MD; Zhu, ZG; Gu, WJ; Yu, YY; Zhang, XY				Wang, Chao; Zhang, Jun; Cai, Mingdeng; Zhu, Zhenggang; Gu, Wenjie; Yu, Yingyan; Zhang, Xiaoyan			DBGC: A Database of Human Gastric Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI; CARCINOGENESIS; BIOMARKERS; RESISTANCE; CELLS; GENE	The Database of Human Gastric Cancer (DBGC) is a comprehensive database that integrates various human gastric cancer-related data resources. Human gastric cancer-related transcriptomics projects, proteomics projects, mutations, biomarkers and drug-sensitive genes from different sources were collected and unified in this database. Moreover, epidemiological statistics of gastric cancer patients in China and clinicopathological information annotated with gastric cancer cases were also integrated into the DBGC. We believe that this database will greatly facilitate research regarding human gastric cancer in many fields. DBGC is freely available at http://bminfor.tongji.edu.cn/dbgc/index.do	[Wang, Chao; Cai, Mingdeng; Gu, Wenjie; Zhang, Xiaoyan] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Zhang, Jun; Zhu, Zhenggang; Yu, Yingyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China; [Zhang, Jun; Zhu, Zhenggang; Yu, Yingyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Gastr Neoplasms, Shanghai 200030, Peoples R China; [Zhang, Jun; Zhu, Zhenggang; Yu, Yingyan] Shanghai Jiao Tong Univ, Collaborat Innovat Ctr Syst Biomed, Shanghai 200025, Peoples R China	Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, YY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China.	ruijinhospitalyyy@163.com; xyzhang@tongji.edu.cn			National Natural Science Foundation of China [81172329, 31571363, 81372644, 81372645, 8157111077]; Chinese National High Tech Program [2012AA02A504, 2012AA02A203]; International Cooperative Project from Shanghai Science and Technology Commission [12410706400]; Innovation Foundation of Translational Medicine of Shanghai Jiao Tong University School of Medicine [15ZH1002, 15ZH3001]; Fong Shu Fook Tong Foundation; Gastrointestinal Carcinoma Biobank Project of Shanghai Jiao Tong University School of Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National High Tech Program(National High Technology Research and Development Program of China); International Cooperative Project from Shanghai Science and Technology Commission; Innovation Foundation of Translational Medicine of Shanghai Jiao Tong University School of Medicine; Fong Shu Fook Tong Foundation; Gastrointestinal Carcinoma Biobank Project of Shanghai Jiao Tong University School of Medicine	This work was partially supported by grants from the National Natural Science Foundation of China (81172329, 31571363, 81372644, 81372645 and 8157111077), Chinese National High Tech Program (2012AA02A504 and 2012AA02A203), International Cooperative Project from Shanghai Science and Technology Commission (12410706400), Innovation Foundation of Translational Medicine of Shanghai Jiao Tong University School of Medicine (15ZH1002 and 15ZH3001), Fong Shu Fook Tong Foundation and Gastrointestinal Carcinoma Biobank Project of Shanghai Jiao Tong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Buetow KH, 2005, SCIENCE, V308, P821, DOI 10.1126/science.1112120; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Du PC, 2012, GENOME, V55, P697, DOI [10.1139/G2012-053, 10.1139/g2012-053]; Ferlay J, 2013, GLOBOCAN 2012 V1 0; Gadaleta E, 2011, BRIEF BIOINFORM, V12, P52, DOI 10.1093/bib/bbq010; Gao Ling, 2013, J CANC THERAPY, V4, P575; Guo Y, 2012, J BACTERIOL, V194, P4146, DOI 10.1128/JB.00804-12; Hao Y, 2008, J PROTEOME RES, V7, P3668, DOI 10.1021/pr700638k; Howlader N, 2014, SEER CANC STAT REV; Huang CH, 2014, WORLD J GASTROENTERO, V20, P1529, DOI 10.3748/wjg.v20.i6.1529; Jiang J, 2011, ONCOGENE, V30, P4498, DOI 10.1038/onc.2011.154; Ju H, 2010, J CANCER RES CLIN, V136, P195, DOI 10.1007/s00432-009-0647-8; Kwon OH, 2013, CANCER SCI, V104, P391, DOI 10.1111/cas.12076; Matsuda T, 2013, JPN J CLIN ONCOL, V43, P1157, DOI 10.1093/jjco/hyt166; Nishigaki R, 2005, PROTEOMICS, V5, P3205, DOI 10.1002/pmic.200401307; Penon D, 2014, WORLD J GASTROENTERO, V20, P8986, DOI 10.3748/wjg.v20.i27.8986; Raza Y, 2014, PATHOL ONCOL RES, V20, P839, DOI 10.1007/s12253-014-9762-1; Saltz J, 2006, BIOINFORMATICS, V22, P1910, DOI 10.1093/bioinformatics/btl272; Sulahian R, 2014, ONCOGENE, V33, P5637, DOI 10.1038/onc.2013.517; Tanaka M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-237; van Grieken NCT, 2013, BRIT J CANCER, V108, P1495, DOI 10.1038/bjc.2013.109; von Eschenbach AC, 2006, CANCER INFORM, V2, P22; Wang F, 2012, CANCER BIOMARK, V11, P259, DOI 10.3233/CBM-2012-00284; Wang X, 2008, J CANCER RES CLIN, V134, P995, DOI 10.1007/s00432-008-0367-5; Wei ZH, 2014, GENE, V537, P238, DOI 10.1016/j.gene.2013.12.061; Xian XS, 2013, ANTICANCER RES, V33, P2541; Yang YX, 2006, PROTEOMICS, V6, P2009, DOI 10.1002/pmic.200402031; Zhao X, 2012, NUCLEIC ACIDS RES, V40, pD1041, DOI 10.1093/nar/gkr1142; Zhou CF, 2013, ANTI-CANCER AGENT ME, V13, P235, DOI 10.2174/1871520611313020008	30	14	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2015	10	11							e0142591	10.1371/journal.pone.0142591	http://dx.doi.org/10.1371/journal.pone.0142591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA2MI	26566288	Green Submitted, gold, Green Published			2022-12-26	WOS:000367628500037
J	Wang, ZT; Nachtigall, PE; Akamatsu, T; Wang, KX; Wu, YP; Liu, JC; Duan, GQ; Cao, HJ; Wang, D				Wang, Zhi-Tao; Nachtigall, Paul E.; Akamatsu, Tomonari; Wang, Ke-Xiong; Wu, Yu-Ping; Liu, Jian-Chang; Duan, Guo-Qin; Cao, Han-Jiang; Wang, Ding			Passive Acoustic Monitoring the Diel, Lunar, Seasonal and Tidal Patterns in the Biosonar Activity of the Indo-Pacific Humpback Dolphins (Sousa chinensis) in the Pearl River Estuary, China	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PORPOISES PHOCOENA-PHOCOENA; TRANSMISSION BEAM PATTERN; HARBOR PORPOISES; TURSIOPS-TRUNCATUS; ECHOLOCATION BEHAVIOR; SOTALIA-GUIANENSIS; HONG-KONG; ABUNDANCE; SOUTHERN	A growing demand for sustainable energy has led to an increase in construction of offshore windfarms. Guishan windmill farm will be constructed in the Pearl River Estuary, China, which sustains the world's largest known population of Indo-Pacific humpback dolphins (Sousa chinensis). Dolphin conservation is an urgent issue in this region. By using passive acoustic monitoring, a baseline distribution of data on this species in the Pearl River Estuary during pre-construction period had been collected. Dolphin biosonar detection and its diel, lunar, seasonal and tidal patterns were examined using a Generalized Linear Model. Significant higher echolocation detections at night than during the day, in winter-spring than in summer-autumn, at high tide than at flood tide were recognized. Significant higher echolocation detections during the new moon were recognized at night time. The diel, lunar and seasonal patterns for the echolocation encounter duration also significantly varied. These patterns could be due to the spatial-temporal variability of dolphin prey and illumination conditions. The baseline information will be useful for driving further effective action on the conservation of this species and in facilitating later assessments of the effects of the offshore windfarm on the dolphins by comparing the baseline to post construction and post mitigation efforts.	[Wang, Zhi-Tao; Wang, Ke-Xiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhi-Tao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Zhi-Tao; Nachtigall, Paul E.] Univ Hawaii, Hawaii Inst Marine Biol, Marine Mammal Res Program, Honolulu, HI 96822 USA; [Akamatsu, Tomonari] Fisheries Res Agcy, Natl Res Inst Fisheries Engn, Ibaraki, Japan; [Wu, Yu-Ping] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Jian-Chang] Minist Transport, Transport Planning & Res Inst, Beijing, Peoples R China; [Duan, Guo-Qin; Cao, Han-Jiang] Hongkong Zhuhai Macao Bridge Author, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Hawaii System; Japan Fisheries Research & Education Agency (FRA); Sun Yat Sen University; Ministry of Transport of the People's Republic of China	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; Zhao, chang-lin/AAE-9022-2019	Wang, Zhi-Tao/0000-0002-5734-7385; 	National Natural Science Foundation (NNSF) of China [31070347]; Ministry of Science and Technology of China [2011BAG07B05-3]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; State Oceanic Administration of China [201105011-3]; NNSF of China [31170501]; China Scholarship Council [[2014]3026]	National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; State Oceanic Administration of China; NNSF of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	Grants for this study were provided by the National Natural Science Foundation (NNSF) of China (Grant No. 31070347), the Ministry of Science and Technology of China (Grant No. 2011BAG07B05-3), the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-EW-Z-4) and the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (Grant No. 201203086) to DW, the State Oceanic Administration of China (Grant No. 201105011-3) and NNSF of China (Grant No. 31170501) to KXW and the China Scholarship Council (Grant No. [2014]3026) to ZTW. The funders had no roles in designing the study, collecting data, analyzing data, preparing the manuscript or deciding where to publish the manuscript.	Akamatsu T, 1998, J ACOUST SOC AM, V104, P2511, DOI 10.1121/1.423757; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, P ROY SOC B-BIOL SCI, V272, P797, DOI 10.1098/rspb.2004.3024; AKAMATSU T, 1992, MARINE MAMMAL SENSORY SYSTEMS, P299; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W. W., 1993, SONAR DOLPHINS; Au W.W.L., 2008, PRINCIPLES MARINE BI; Au WWL, 1999, J ACOUST SOC AM, V106, P3699, DOI 10.1121/1.428221; Azevedo AF, 2007, J MAR BIOL ASSOC UK, V87, P201, DOI 10.1017/S0025315407054422; Barros Nelio B., 2004, Aquatic Mammals, V30, P179, DOI 10.1578/AM.30.1.2004.179; Baumann-Pickering S, 2015, BEHAV ECOL SOCIOBIOL, V69, P1553, DOI 10.1007/s00265-015-1967-0; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Berrow SD, 1996, BIOL ENVIRON, V96B, P1; Brandt MJ, 2014, MAR MAMMAL SCI, V30, P1109, DOI 10.1111/mms.12112; Brandt MJ, 2011, MAR ECOL PROG SER, V421, P205, DOI 10.3354/meps08888; Bushnell ME, 2010, J FISH BIOL, V76, P1343, DOI 10.1111/j.1095-8649.2010.02569.x; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Chen BY, 2008, MAMM BIOL, V73, P156, DOI 10.1016/j.mambio.2006.12.002; Chen T, 2011, MAMM BIOL, V76, P93, DOI 10.1016/j.mambio.2010.01.001; Chen T, 2010, MAMMALIA, V74, P117, DOI 10.1515/MAMM.2010.024; David JA, 2006, WATER ENVIRON J, V20, P48, DOI 10.1111/j.1747-6593.2005.00023.x; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; de Freitas M, 2015, J ACOUST SOC AM, V137, P3033, DOI 10.1121/1.4921277; deBruyn AMH, 2001, MAR ECOL PROG SER, V214, P307, DOI 10.3354/meps214307; Desjardins JK, 2011, J ZOOL, V285, P66, DOI 10.1111/j.1469-7998.2011.00814.x; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FISHER FH, 1977, J ACOUST SOC AM, V62, P558, DOI 10.1121/1.381574; Fury CA, 2011, ESTUAR COAST SHELF S, V93, P389, DOI 10.1016/j.ecss.2011.05.003; Goold JC, 2000, MAR MAMMAL SCI, V16, P240, DOI 10.1111/j.1748-7692.2000.tb00915.x; Gregory Paul R., 2001, Aquatic Mammals, V27, P105; Guilherme-Silveira F. R., 2009, Marine Biodiversity Records, V2, pe122, DOI 10.1017/S1755267209000906; He Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep05995; Hodge LEW, 2013, MAR MAMMAL SCI, V29, pE411, DOI 10.1111/mms.12006; Hung Samuel K., 2004, Aquatic Mammals, V30, P159, DOI 10.1578/AM.30.1.2004.159; Jefferson TA, 2000, WILDLIFE MONOGR, P1; Jefferson TA, 2002, RAFFLES B ZOOL, P43; Jefferson TA, 2014, MAR MAMMAL SCI, V30, P1494, DOI 10.1111/mms.12152; Jefferson Thomas A., 2001, Mammalian Species, V655, P1, DOI 10.1644/1545-1410(2001)655<0001:SC>2.0.CO;2; Jensen FH, 2015, J EXP BIOL, V218, P1314, DOI 10.1242/jeb.116285; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Keenan SE, 2003, AM FISH S S, V36, P167; Kerckhof F, 2010, UNDERWATER TECHNOL, V29, P137, DOI 10.3723/ut.29.137; Kimura S, 2016, J MAR BIOL ASSOC UK, V96, P845, DOI 10.1017/S0025315414000071; Langhamer O, 2012, SCI WORLD J, DOI 10.1100/2012/386713; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li Yong-zhen, 2000, Journal of Fisheries of China, V24, P312; Lin T-H, 2013, MAR BIOL, V160, P1; Lin TH, 2015, ESTUAR COAST, V38, P1376, DOI 10.1007/s12237-014-9886-2; Lin TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123943; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; Madsen PT, 2006, MAR ECOL PROG SER, V309, P279, DOI 10.3354/meps309279; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Mellink Eric, 2006, Aquatic Mammals, V32, P133, DOI 10.1578/AM.32.2.2006.133; Mendes S, 2002, MAR ECOL PROG SER, V239, P221, DOI 10.3354/meps239221; Mikkelsen L, 2013, MAR ECOL PROG SER, V481, P239, DOI 10.3354/meps10260; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Norris K.S., 1994, HAWAIIAN SPINNER DOL; Parra GJ, 2014, MAR MAMMAL SCI, V30, P1184, DOI 10.1111/mms.12088; Parsons E. C. M., 1998, Aquatic Mammals, V24, P91; Philpott E, 2007, J MAR BIOL ASSOC UK, V87, P11, DOI 10.1017/S002531540705494X; Preen A, 2004, BIOL CONSERV, V118, P205, DOI 10.1016/j.biocon.2003.08.014; Rasmussen MH, 2004, J ACOUST SOC AM, V116, P1826, DOI 10.1121/1.1775274; Reeves RR, 2008, SOUSA CHINENSIS; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Rivamonte Lorenzo A., 2009, Aquatic Mammals, V35, P269, DOI 10.1578/AM.35.2.2009.269; Scheidat M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/025102; SHANE SH, 1980, FISH B-NOAA, V78, P593; Shen PP, 2011, CONT SHELF RES, V31, P1672, DOI 10.1016/j.csr.2011.07.002; Soldevilla MS, 2010, AQUAT BIOL, V9, P49, DOI 10.3354/ab00224; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Surlykke A, 2014, SPRINGER HANDB AUDIT, V51, P1, DOI 10.1007/978-1-4614-9146-0; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Wang D., 2006, S CHIN FISH SCI, V2, P37, DOI DOI 10.3969/J.ISSN.2095-0780.2006.04.007; Wang ZT, 2015, INTEGR ZOOL, V10, P122, DOI 10.1111/1749-4877.12102; Wang ZT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110590; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Wang ZT, 2013, J ACOUST SOC AM, V133, P2479, DOI 10.1121/1.4794390; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Yamamoto Y, 2015, MARINE MAMMAL SCI; Yeung YM, 2008, PANPEARL RIVER DELTA; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhang X, 2013, CONT SHELF RES, V56, P1, DOI 10.1016/j.csr.2013.01.015; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	86	38	41	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2015	10	11							e0141807	10.1371/journal.pone.0141807	http://dx.doi.org/10.1371/journal.pone.0141807			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW7CD	26580966	Green Published, gold			2022-12-26	WOS:000365154600022
J	Wang, ZH; Liang, XW; Wu, ZQ; Lin, JL; Huang, JJ				Wang, Zhonghao; Liang, Xuanwei; Wu, Ziqiang; Lin, Jialiu; Huang, Jingjing			A Novel Method for Measuring Anterior Segment Area of the Eye on Ultrasound Biomicroscopic Images Using Photoshop	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CHAMBER ANGLE MEASUREMENT; CLOSURE GLAUCOMA; INTRAOBSERVER; THICKNESS	Purpose To describe a novel method for quantitative measurement of area parameters in ocular anterior segment ultrasound biomicroscopy (UBM) images using Photoshop software and to assess its intraobserver and interobserver reproducibility. Methods Twenty healthy volunteers with wide angles and twenty patients with narrow or closed angles were consecutively recruited. UBM images were obtained and analyzed using Photoshop software by two physicians with different-level training on two occasions. Borders of anterior segment structures including cornea, iris, lens, and zonules in the UBM image were semi-automatically defined by the Magnetic Lasso Tool in the Photoshop software according to the pixel contrast and modified by the observers. Anterior chamber area (ACA), posterior chamber area (PCA), iris cross-section area (ICA) and angle recess area (ARA) were drawn and measured. The intraobserver and interobserver reproducibilities of the anterior segment area parameters and scleral spur location were assessed by limits of agreement, coefficient of variation (CV), and intraclass correlation coefficient (ICC). Results All of the parameters were successfully measured by Photoshop. The intraobserver and interobserver reproducibilities of ACA, PCA, and ICA were good, with no more than 5% CV and more than 0.95 ICC, while the CVs of ARA were within 20%. The intraobserver and interobserver reproducibilities for defining the spur location were more than 0.97 ICCs. Although the operating times for both observers were less than 3 minutes per image, there was significant difference in the measuring time between two observers with different levels of training (p<0.001). Conclusion Measurements of ocular anterior segment areas on UBM images by Photoshop showed good intraobserver and interobserver reproducibilties. The methodology was easy to adopt and effective in measuring.	[Wang, Zhonghao; Liang, Xuanwei; Lin, Jialiu; Huang, Jingjing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Ziqiang] Ctr Adv Eye Care, Carson City, NV USA	Sun Yat Sen University	Huang, JJ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	hjjing@mail.sysu.edu.cn	Wang, Zhi-Tao/F-1176-2015; Zhao, chang-lin/AAE-9022-2019	Wang, Zhi-Tao/0000-0002-5734-7385; 	Fundamental Research Funds of State Key Laboratory of Ophthalmology (China) [2011Q02]; Guangdong Medical Research Foundation (China) [A2014240]	Fundamental Research Funds of State Key Laboratory of Ophthalmology (China); Guangdong Medical Research Foundation (China)	This study was supported by Grant 2011Q02 from the Fundamental Research Funds of State Key Laboratory of Ophthalmology (China) (URLs: http://mso.sysu.edu.cn/Item/5664.aspx), Grant A2014240 from the Guangdong Medical Research Foundation (China) (URLs: http://www.gdwst.gov.cn/lixiang/cj.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Center for Advanced Eye Care, a private medical practice, provided support in the form of salaries for author	Bolz M, 2009, OPHTHALMOLOGY, V116, P66, DOI 10.1016/j.ophtha.2008.09.042; Console JW, 2008, BRIT J OPHTHALMOL, V92, P1612, DOI 10.1136/bjo.2007.129932; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gupta P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096661; Ishikawa H, 1999, JPN J OPHTHALMOL, V43, P526, DOI 10.1016/S0021-5155(99)00139-2; Jiang YZ, 2010, INVEST OPHTH VIS SCI, V51, P2035, DOI 10.1167/iovs.09-4145; Jung JW, 2014, BRIT J OPHTHALMOL, V98, P207, DOI 10.1136/bjophthalmol-2013-303645; Leung CKS, 2006, ARCH OPHTHALMOL-CHIC, V124, P1395, DOI 10.1001/archopht.124.10.1395; Lin Z, 2014, J GLAUCOMA, V23, P61, DOI 10.1097/IJG.0b013e3182698094; Muller M, 2006, J CATARACT REFR SURG, V32, P1803, DOI 10.1016/j.jcrs.2006.07.014; PAVLIN CJ, 1992, AM J OPHTHALMOL, V113, P381, DOI 10.1016/S0002-9394(14)76159-8; Quigley HA, 2009, AM J OPHTHALMOL, V148, P657, DOI 10.1016/j.ajo.2009.08.009; Radhakrishnan S, 2005, ARCH OPHTHALMOL-CHIC, V123, P1053, DOI 10.1001/archopht.123.8.1053; Spaeth GL, 1997, J GLAUCOMA, V6, P13; TELLO C, 1994, INVEST OPHTH VIS SCI, V35, P3549; Wang BS, 2011, BRIT J OPHTHALMOL, V95, P46, DOI 10.1136/bjo.2009.178129; Wang BS, 2010, OPHTHALMOLOGY, V117, P11, DOI 10.1016/j.ophtha.2009.06.017	17	38	41	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2015	10	3							e0120843	10.1371/journal.pone.0120843	http://dx.doi.org/10.1371/journal.pone.0120843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH2XV	26580966	gold, Green Published, Green Submitted			2022-12-26	WOS:000353889600103
